PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Gauggel, S; Leinberger, R; Richardt, M				Gauggel, S; Leinberger, R; Richardt, M			Goal setting and reaction time performance in brain-damaged patients	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	21st Annual Mid-Year Conference of the International-Neuropsychological-Society	JUL   10, 1998	BUDAPEST, HUNGARY	Int Neuropsychol Soc			FEEDBACK; INVENTORY; FLUENCY; LESIONS; TASK; ERA	A god-setting approach was used to examine the way in which 62 patients with closed head injuries or cerebral vascular accidents and 47 orthopedic control patients alter their performance on a four-choice reaction time (RT) task. Both patient groups were randomly assigned to two conditions: one in which a specific and high goal was assigned and one in which a "do your best" god was given. Statistical analysis indicated that patients with a specific and high goal responded faster than patients with a "do your best" goal. No clinical or neuropsychological variables (e.g., attention, memory) had a moderating influence on the goal setting effect. These results demonstrate that goal setting as a motivational technique is a reliable and robust technique and can enhance performance (intensity of behavior) not only in healthy participants but also in brain-damaged patients.	Chemnitz Univ Technol, Dept Psychol, D-09120 Chemnitz, Germany		Gauggel, S (corresponding author), Chemnitz Univ Technol, Dept Psychol, Willelm Raabe Str 43, D-09120 Chemnitz, Germany.			Gauggel, Siegfried/0000-0002-2742-4917			Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; BANDURA A, 1983, J PERS SOC PSYCHOL, V45, P1017, DOI 10.1037/0022-3514.45.5.1017; BANDURA A, 1986, SOCIAL FDN THOUGHT A; Beck R, 1996, AGRO FOOD IND HI TEC, V7, P3; BLACKBURN HL, 1958, J ABNORM SOC PSYCH, V56, P359, DOI 10.1037/h0044132; Bortz J., 1993, STATISTIK; BROWN RA, 1974, J CLIN PSYCHOL, V30, P50, DOI 10.1002/1097-4679(197401)30:1<50::AID-JCLP2270300112>3.0.CO;2-0; Carver C. S., 1981, ATTENTION SELF REGUL; EREZ M, 1977, J APPL PSYCHOL, V62, P624, DOI 10.1037/0021-9010.62.5.624; Gauggel S, 2000, NEUROPSYCHOLOGY, V14, P125; Goldstein K, 1942, EFFECTS BRAIN INJURI; Gordon S, 1955, AM J MENT DEF, V60, P371; HOLLENBECK JR, 1987, ORGAN BEHAV HUM DEC, V40, P392, DOI 10.1016/0749-5978(87)90023-9; HOLLENBECK JR, 1989, J APPL PSYCHOL, V74, P951, DOI 10.1037/0021-9010.74.6.951; Horn W, 1983, LEISTUNGSPRUFSYSTEM; HYLAND ME, 1988, J PERS SOC PSYCHOL, V55, P642, DOI 10.1037/0022-3514.55.4.642; KERNAN MC, 1988, MOTIV EMOTION, V12, P75, DOI 10.1007/BF00992473; KLIEBHAN JM, 1967, AM J MENT DEF, V72, P220; Kluge B, 1996, ARCHAOL NACHR, V1, P254; LATHAM GP, 1983, ACAD MANAGE J, V26, P406, DOI 10.2307/256253; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Lindenberger U, 1998, PSYCHOL METHODS, V3, P218, DOI 10.1037/1082-989X.3.2.218; Locke E, 1990, THEORY GOALSETTING T; LOCKE EA, 1991, ORGAN BEHAV HUM DEC, V50, P288, DOI 10.1016/0749-5978(91)90023-M; LOCKE EA, 1981, PSYCHOL BULL, V90, P125, DOI 10.1037/0033-2909.90.1.125; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P621, DOI 10.1016/S0003-9993(97)90428-7; PRINCIPATO FR, 1983, ED TRAINING MENT APR, P141; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rousseau DM, 1997, ANNU REV PSYCHOL, V48, P515, DOI 10.1146/annurev.psych.48.1.515; SHANKWEILER DP, 1959, J COMP PHYSIOL PSYCH, V52, P546, DOI 10.1037/h0040338; STONE EF, 1984, ORGAN BEHAV HUM PERF, V34, P195, DOI 10.1016/0030-5073(84)90003-5; STURM W, 1982, NERVENARZT, V53, P395; VILKKI J, 1994, NEUROPSYCHOLOGIA, V32, P1257, DOI 10.1016/0028-3932(94)90107-4; WARNER DA, 1971, AM J MENT DEF, V75, P681; WARNER DA, 1980, ED TRAINING MENTALLY, P143; WEINBERG RS, 1994, MED SCI SPORT EXER, V26, P469; [No title captured]	38	15	17	0	4	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN	2001	23	3					351	361		10.1076/jcen.23.3.351.1178			11	Psychology, Clinical; Clinical Neurology; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	439JG	WOS:000169112900009	11404812				2022-02-06	
J	King, BH; Wright, DM; Snape, M; Dourish, CT				King, BH; Wright, DM; Snape, M; Dourish, CT			Case series: Amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities	JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						aggression; impulsivity; hyperactivity; N-methyl-D-aspartate (NMDA)	TRAUMATIC BRAIN INJURY; MK-801	Objective: A growing body of literature implicates interactions between glutamatergic and neostriatal dopaminergic neurotransmitter systems in the development and expression of impulsivity. hyperactivity, and stereotypy. Amantadine hydrochloride, a drug used in young children for influenza prophylaxis, acts both as an indirect dopamine agonist as well as an N-methyl-D-aspartate (NMDA) receptor antagonist. Thus an open clinical trial of this medication for the treatment of symptoms of impulse control disorders in children was performed. Method: A total of eight children (seven with neurodevelopmental disorders and all inpatients) with target behaviors refractory to other treatments were selected after parental informed consent. All patients were male and ranged in age from 4 to 12 years. Outcome was based on subjective consensus clinical ratings by the multidisciplinary treatment team. Results: For four of the children, amantadine was associated with marked clinical improvement. In the remainder. improvement was also observed. Amantadine was well tolerated. Conclusions: On the basis of this experience, it appears that amantadine hydrochloride or related NMDA antagonists may warrant additional study in this and related populations.	Dartmouth Med Sch, Dept Psychiat, Hanover, NH USA; Vernalis Grp PLC, Winnersh, England		King, BH (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dept Psychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.		Dourish, Colin T/B-7873-2014	Dourish, Colin T/0000-0002-3403-6330			*AM AC PED, 1991, REP COMM INF DIS, P274; FARNEBO LO, 1971, EUR J PHARMACOL, V16, P27, DOI 10.1016/0014-2999(71)90053-7; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; GLEZEN WP, 1993, PEDIATR INFECT DIS J, V12, P106; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; KING BH, 1995, DEV NEUROSCI-BASEL, V17, P47, DOI 10.1159/000111272; KORNHUBER J, 1994, J NEURAL TRANSM-SUPP, P91; Masters KJ, 1997, J AM ACAD CHILD PSY, V36, P301, DOI 10.1097/00004583-199703000-00001; Mattes J, 1980, Psychopharmacol Bull, V16, P67; *MED EC CO, 1999, PHYS DESK REF, P986; SHIELDS WD, 1985, NEUROLOGY, V35, P579, DOI 10.1212/WNL.35.4.579; STOOF JC, 1992, CLIN NEUROL NEUROSUR, V94, pS4; WENK GL, 1995, EUR J PHARM-ENVIRON, V293, P267, DOI 10.1016/S0922-4106(05)80053-7; WRIGHT PF, 1976, J INFECT DIS, V134, P144, DOI 10.1093/infdis/134.2.144	14	15	15	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-8567			J AM ACAD CHILD PSY	J. Am. Acad. Child Adolesc. Psychiatr.	JUN	2001	40	6					654	657		10.1097/00004583-200106000-00009			4	Psychology, Developmental; Pediatrics; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	433XR	WOS:000168786400009	11392342				2022-02-06	
J	Harry, GJ; Sills, R; Schlosser, MJ; Maier, WE				Harry, G. Jean; Sills, Robert; Schlosser, Michael J.; Maier, William E.			Neurodegeneration and glia response in rat hippocampus following nitro-L-arginine methyl ester (L-NAME)	NEUROTOXICITY RESEARCH			English	Article						Interleukin-1 alpha; Interleukin-6; microglia; tumor necrosis factor alpha; trimethyltin	OXIDE SYNTHASE ACTIVITY; TRAUMATIC BRAIN-INJURY; MESSENGER-RNA; ENDOTHELIAL-CELLS; INHIBITION; EXPRESSION; INDUCTION; ISCHEMIA; NEURONS; ASTROCYTES	Hippocampal neurodegeneration and glia response was examined following administration of the nitric oxide synthase inhibitor, N-w-nitro-L-arginine methyl ester (L-NAME). Male Long-Evans rats received L-NAME (50 mg/kg, ip) either once or twice a day for 4 days. Both dosing schedules decreased NOS activity by approximately 90%. At 10 and 30 days following cessation of L-NAME (2x/day), moderate neuronal death was evident in CA 1-2 pyramidal cells and dentate granule cells. Neurodegeneration was accompanied by increased astrocyte glial fibrillary acidic protein (GFAP) immunoreactivity yet, minimal astrocyte hypertrophy. Microglia response was limited to an increase in ramified microglia at 10 days, returning to normal by 30 days. As early as 4 days post-dosing (2x/day), GFAP mRNA levels were significantly elevated as were mRNA levels for tumor necrosis factor-alpha(TNF alpha), interleukin-1 alpha (IL-1 alpha), and interleukin 6 (IL-6). No alterations were seen with L-NAME dosing limited to once a day. The co-administration of a hippocampal neurotoxicant, trimethyltin (TMT), with the last dose of L-NAME (2x/day), produced an additive response pattern of neuronal degeneration including both CA1-2 and CA3-4 pyramidal neurons accompanied by TMT-induced astrocyte hypertrophy and prominent microglia reactivity. This was preceded by elevations in mRNA levels for GFAP, TNF alpha, IL-1 alpha, and IL-6 similar to those seen with each substance alone. These data suggest that high levels of L-NAME can produce a pro-inflammatory environment in the brain and that neurodegeneration and neuroglia responses in the hippocampus can be induced by an alteration in the balance and regulation of local nitric oxide levels.	[Harry, G. Jean; Sills, Robert; Maier, William E.] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC 27709 USA; [Schlosser, Michael J.] Searle Metab & Safety Evaluat, 4901 Searle Pkwy, Skokie, IL 60077 USA; [Maier, William E.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27515 USA; [Maier, William E.] Parke Davis Pharmaceut Res, 2800 Plymouth Rd, Ann Arbor, MI USA		Harry, GJ (corresponding author), Natl Inst Environm Hlth Sci, Res Triangle Pk, NC 27709 USA.	harry@niehs.nih.gov	Harry, Gaylia Jean/AAC-1171-2022	Harry, Gaylia Jean/0000-0002-0829-7318	USEPAUnited States Environmental Protection Agency [CT901915]; NIEHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [T32 ES07126]	This research was supported in part by USEPA grant CT901915 and NIEHS grant T32 ES07126.	Ayers NA, 1997, NEUROCHEM RES, V22, P81, DOI 10.1023/A:1027385522859; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Black SM, 1995, NEUROBIOL DIS, V2, P145, DOI 10.1006/nbdi.1995.0016; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CARREAU A, 1994, EUR J PHARMACOL, V256, P241, DOI 10.1016/0014-2999(94)90549-5; CHAO CC, 1992, J IMMUNOL, V149, P2736; CHAO CC, 1993, CLIN IMMUNOL IMMUNOP, V67, P178, DOI 10.1006/clin.1993.1062; Chen T Y, 1998, Acta Anaesthesiol Sin, V36, P127; CORRADIN SB, 1993, EUR J IMMUNOL, V23, P2045, DOI 10.1002/eji.1830230851; CROSS AH, 1994, J CLIN INVEST, V93, P2684, DOI 10.1172/JCI117282; DAWSON TM, 1994, J NEUROSCI, V14, P5147; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; DAWSON TM, 1994, NEUROSCIENTIST, V1, P9; Dawson VL, 1998, PROG BRAIN RES, V118, P215; DAWSON VL, 1995, CLIN EXP PHARMACOL P, V22, P305, DOI 10.1111/j.1440-1681.1995.tb02005.x; de Oliveira CF, 2000, EUR J PHARMACOL, V391, P121, DOI 10.1016/S0014-2999(99)00929-2; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; DWYER MA, 1991, BIOCHEM BIOPH RES CO, V176, P1136, DOI 10.1016/0006-291X(91)90403-T; ENDOH M, 1994, BRAIN RES, V651, P92, DOI 10.1016/0006-8993(94)90683-1; ENDOH M, 1994, NEUROSCIENCE, V63, P679, DOI 10.1016/0306-4522(94)90514-2; GALEA E, 1992, P NATL ACAD SCI USA, V89, P10945, DOI 10.1073/pnas.89.22.10945; HIBBS JB, 1990, INT CONGR SER, V897, P189; IADECOLA C, 1994, NEUROCHEM RES, V19, P501, DOI 10.1007/BF00967330; Iwase K, 1998, MOL BRAIN RES, V53, P1, DOI 10.1016/S0169-328X(97)00139-3; Kaufman PL, 1999, P NATL ACAD SCI USA, V96, P9455, DOI 10.1073/pnas.96.17.9455; Koyanagi M, 2000, HYPERTENSION, V35, P86, DOI 10.1161/01.HYP.35.1.86; LAMAS S, 1992, J CLIN INVEST, V90, P879, DOI 10.1172/JCI115963; LASZLO F, 1995, EUR J PHARMACOL, V283, P47, DOI 10.1016/0014-2999(95)00281-O; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LOWENSTEIN CJ, 1992, CELL, V70, P705, DOI 10.1016/0092-8674(92)90301-R; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; Luvara G, 1998, ARTERIOSCL THROM VAS, V18, P1408, DOI 10.1161/01.ATV.18.9.1408; MACNAUL KL, 1993, BIOCHEM BIOPH RES CO, V196, P1330, DOI 10.1006/bbrc.1993.2398; MAIER WE, 1995, J NEUROIMMUNOL, V59, P65, DOI 10.1016/0165-5728(95)00026-X; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; Mesenge C, 1996, J NEUROTRAUM, V13, P11, DOI 10.1089/neu.1996.13.11; MINCGOLOMB D, 1994, BRIT J PHARMACOL, V112, P720, DOI 10.1111/j.1476-5381.1994.tb13136.x; Mollace V, 1995, ADV NEUROIMMUNOL, V5, P421, DOI 10.1016/0960-5428(95)00026-7; MONCADA C, 1992, NEUROREPORT, V3, P530; MONCADA S, 1991, PHARMACOL REV, V43, P109; MURPHY S, 1990, J NEUROCHEM, V55, P349, DOI 10.1111/j.1471-4159.1990.tb08860.x; MURPHY S, 1993, TRENDS NEUROSCI, V16, P323, DOI 10.1016/0166-2236(93)90109-Y; Murphy S, 1995, NITRIC OXIDE NERVOUS, P164; NAKASHIMA MN, 1995, CELL MOL NEUROBIOL, V15, P341, DOI 10.1007/BF02089944; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; NOMURA Y, 1993, NEUROSCI RES, V18, P103, DOI 10.1016/0168-0102(93)90013-G; PARK SK, 1994, J NEUROSCI RES, V39, P405, DOI 10.1002/jnr.490390407; ROGERS NE, 1992, BIOCHEM BIOPH RES CO, V189, P242, DOI 10.1016/0006-291X(92)91550-A; SAKAI N, 1995, J NEUROCHEM, V65, P895; SALVEMINI D, 1992, BRIT J PHARMACOL, V106, P931, DOI 10.1111/j.1476-5381.1992.tb14437.x; SANCESARIO G, 1994, STROKE, V25, P436, DOI 10.1161/01.STR.25.2.436; SIMMONS ML, 1992, J NEUROCHEM, V59, P897, DOI 10.1111/j.1471-4159.1992.tb08328.x; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; SNYDER SH, 1992, SCIENCE, V257, P494, DOI 10.1126/science.1353273; SPARROW JR, 1994, J MOL NEUROSCI, V5, P219, DOI 10.1007/BF02736723; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Takeuchi A, 1998, EUR J NEUROSCI, V10, P1613, DOI 10.1046/j.1460-9568.1998.00168.x; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; WALLACE MN, 1994, NEUROSCIENCE, V59, P905, DOI 10.1016/0306-4522(94)90294-1; Wu J, 2000, BRIT J ANAESTH, V84, P183, DOI 10.1093/oxfordjournals.bja.a013401; XIE QW, 1994, J BIOL CHEM, V269, P4705; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; ZIELASEK J, 1992, CELL IMMUNOL, V141, P111, DOI 10.1016/0008-8749(92)90131-8; ZIELASEK J, 1995, J NEUROIMMUNOL, V58, P81, DOI 10.1016/0165-5728(94)00192-Q; Zou LB, 1998, NEUROPHARMACOLOGY, V37, P323, DOI 10.1016/S0028-3908(98)00042-2	67	15	17	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	MAY	2001	3	3					307	319		10.1007/BF03033270			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ3BB	WOS:000574918300010	15111256				2022-02-06	
J	Martin, G				Martin, G			The death of Henry II of France: A sporting death and post-mortem	AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY			English	Article						athletic injuries; brain concussion; head injury; Henry II King of France; history of medicine; orbital injury; Pare; sixteenth century; tournaments; Vesalius		In 1559 Henry II King of France was wounded in a tournament and died. A broken lance entered his right orbit, destroying his eye and leaving behind many splinters. The skull was not penetrated but infection spread intracranially. Both Ambroise Pare and Vesalius saw him and predicted death. Nine days after wounding, both attended the King's post-mortem. The story shows how difficult life was without antisepsis, anaesthesia, antibiotics or investigations. The King's stubbornness highlights the dangers of continuing to play after concussion.	Wakefield Hosp, Wellington 6039, New Zealand		Martin, G (corresponding author), Wakefield Hosp, POB 16-116, Wellington 6039, New Zealand.						Barber Richard, 1989, TOURNAMENTS JOUSTS C; Barrett N R, 1973, Ann R Coll Surg Engl, V52, P216; BAUMGARTNER FJ, 1988, HENRY 2 KING FRANCE; OMALLEY CD, 1964, A VESALIUS BRUSELS 1; Pare A, 1649, WORKS FAMOUS CHIRURG; SMITH DM, 1961, RENAISSANCE, P321	6	15	15	1	1	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	0004-8682			AUST NZ J SURG	Aust. N. Z. J. Surg.	MAY	2001	71	5					318	320		10.1046/j.1440-1622.2001.02102.x			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	445YU	WOS:000169486800013	11374484				2022-02-06	
J	Wang, JN; Lu, MQ; Yang, FZ; Zhang, XR; Baeyens, WRG; Campana, AMG				Wang, JN; Lu, MQ; Yang, FZ; Zhang, XR; Baeyens, WRG; Campana, AMG			Microdialysis with on-line chemiluminescence detection for the study of nitric oxide release in rat brain following traumatic injury	ANALYTICA CHIMICA ACTA			English	Article						microdialysis; chemiluminescence; nitric oxide; rat brain; traumatic injury	PERFORMANCE LIQUID-CHROMATOGRAPHY; REAL-TIME MEASUREMENT; LUMINOL-H2O2 CHEMILUMINESCENCE; FLUORESCENCE DETECTION; CEREBRAL-ISCHEMIA; VIVO; NITRATE; ASSAY	An on-line method was developed for the real-time detection of nitric oxide (NO) release in rat brain in vivo following traumatic injury by coupling microdialysis sampling to flow-injection chemiluminescence (CL) detection. The NO released from rat cerebellum was detected based on the CL reaction of luminol and H2O2 with a detection limit of 1 nmol l(-1). The perfusate how was set at 5 mul min(-1) in order to minimize NO loss before reaching CL detector. With this flow rate, about 5 s was equired for the solution to pass through the membrane of microdialysis probe to the detector due to the dead volume of the probe and CL cell. It was observed that the efficiency of NO penetrated from rat cerebellum into perfusate stream increased along with decrease of perfusate flow rate. The maximum efficiency of 20% could be achieved at the flow rate of 5 mul min(-1) with carefully home-made microdialysis probe. The developed method was applied to the study of the production of NO in rat cerebellum following the traumatic brain injury. The results indicated that the NO increased dramatically following traumatic brain injury and was inhibited after the injection of inhibitors such as L-arginine. (C) 2001 Elsevier Science B.V. All rights reserved.	Tsing Hua Univ, Dept Chem, Beijing 100084, Peoples R China; Xian Med Univ, Dept Orthopaed, Xian 710061, Peoples R China; State Univ Ghent, Fac Pharmaceut Sci, B-9000 Ghent, Belgium; Univ Granada, Dept Analyt Chem, E-18071 Granada, Spain		Zhang, XR (corresponding author), Tsing Hua Univ, Dept Chem, Beijing 100084, Peoples R China.		Garcia-Campana, Ana M./H-7752-2015	Garcia-Campana, Ana M./0000-0002-3191-3350; Zhang, Xinrong/0000-0002-3174-303X			Aoki T, 1997, ANAL CHIM ACTA, V349, P11, DOI 10.1016/S0003-2670(97)00273-0; Byrnes CA, 1997, PEDIATR PULM, V24, P312; deCastro MDL, 1997, ANAL CHIM ACTA, V351, P23, DOI 10.1016/S0003-2670(97)00341-3; Ishida J, 1998, ANAL CHIM ACTA, V365, P227, DOI 10.1016/S0003-2670(97)00616-8; Jones PA, 1998, NEUROSCI LETT, V249, P75, DOI 10.1016/S0304-3940(98)00372-3; KEML M, 1990, CIRC RES, V66, P1561; KIKUCHI K, 1993, ANAL CHEM, V65, P1794, DOI 10.1021/ac00061a025; KIKUCHI K, 1993, J BIOL CHEM, V268, P23106; Kojima H, 1997, NEUROSCI LETT, V233, P157, DOI 10.1016/S0304-3940(97)00648-4; Lada MW, 1996, ANAL CHEM, V68, P2790, DOI 10.1021/ac960178x; Lagerwerf FM, 1998, ANAL BIOCHEM, V257, P45, DOI 10.1006/abio.1997.2515; Mao LQ, 1998, TALANTA, V46, P1547, DOI 10.1016/S0039-9140(98)00027-7; Maskus M, 1996, ANAL CHEM, V68, P3128, DOI 10.1021/ac951063g; Obata T, 1998, COMP BIOCHEM PHYS A, V119, P309, DOI 10.1016/S1095-6433(97)00431-5; Ohta K, 1997, NEUROREPORT, V8, P2229, DOI 10.1097/00001756-199707070-00028; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; Rizzo V, 1998, J CHROMATOGR A, V798, P103, DOI 10.1016/S0021-9673(97)01186-2; Samouilov A, 1998, ANAL BIOCHEM, V258, P322, DOI 10.1006/abio.1998.2609; Yoon KW, 1996, STROKE, V27, P122, DOI 10.1161/01.STR.27.1.122	19	15	15	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670			ANAL CHIM ACTA	Anal. Chim. Acta	FEB 9	2001	428	2					173	181		10.1016/S0003-2670(00)01247-2			9	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	393GN	WOS:000166461000003					2022-02-06	
J	Visocchi, M; Tartaglione, T; Romani, R; Meglio, M				Visocchi, M; Tartaglione, T; Romani, R; Meglio, M			Spinal cord stimulation prevents the effects of combined experimental ischemic and traumatic brain injury - An MR study	STEREOTACTIC AND FUNCTIONAL NEUROSURGERY			English	Article						brain injury; cerebral ischemia; spinal cord stimulation	CEREBRAL BLOOD-FLOW; HEMODYNAMICS	Spinal cord stimulation (SCS) interferes with cerebral blood flow (CBF). In this paper we try to evaluate the possible preventing effect of SCS in an animal model of combined ischemic and traumatic injury. We studied 20 New Zealand rabbits undergoing ligature of both carotid arteries and a right hemispheric craniectomy and about 3 h mechanical injury (200 mg) over the dura. In 10 animals (control group) SCS was not delivered; in 10 (SCS group) cervical SCS was started 20 min after arterial ligation and before the craniectomy and the mechanical injury. MR examination was performed in all the animals at the end of the experiments. Compared to the control group none but one of the SCS showed lesional pattern far from the craniectomy suggesting a 'preventing' effect of SCS on the secondary damage associated with our model combined ischemic and traumatic brain injury. Copyright (C) 2002 S. Karger AG, Basel.	Catholic Univ Rome, Inst Neurosurg, I-00168 Rome, Italy; Catholic Univ Rome, Inst Radiol, I-00168 Rome, Italy				TARTAGLIONE, TOMMASO/K-5390-2017; visocchi, massimiliano/AAA-4267-2019	TARTAGLIONE, TOMMASO/0000-0003-3896-4078; visocchi, massimiliano/0000-0002-5277-4468			ALEXANDER DJ, 1980, LAB ANIM SCI, V30, P871; Garcia-March G, 1989, Acta Neurochir Suppl (Wien), V46, P102; GONZALEZ-DARDER J, 1991, Neurological Research, V13, P229; HOSOBUCHI Y, 1991, PACE, V14, P122, DOI 10.1111/j.1540-8159.1991.tb04056.x; HOSOBUCHI Y, 1986, APPL NEUROPHYSIOL, V234, P11371; Isono M, 1995, STEREOT FUNCT NEUROS, V64, P40, DOI 10.1159/000098732; KANNO T, 1989, PACE, V12, P733, DOI 10.1111/j.1540-8159.1989.tb02724.x; MATSUI T, 1989, PACE, V12, P726, DOI 10.1111/j.1540-8159.1989.tb02723.x; MEGLIO M, 1991, PACE, V14, P127, DOI 10.1111/j.1540-8159.1991.tb04057.x; MEGLIO M, 1991, ACTA NEUROCHIR, V111, P43, DOI 10.1007/BF01402512; MEGLIO M, 1986, APPL NEUROPHYSIOL, V49, P139; VISOCCHI M, 1994, STEREOT FUNCT NEUROS, V62, P186, DOI 10.1159/000098616; VISOCCHI M, 1994, STEREOT FUNCT NEUROS, V62, P103, DOI 10.1159/000098604; Visocchi M, 1999, J Neurosurg Sci, V43, P93; Visocchi M, 1996, RIV NEURORADIOL, V9, P21, DOI 10.1177/197140099600900102; Visocchi M, 2001, ACTA NEUROCHIR, V143, P177; VISOCCHI M, 1996, INS P 3 INT C, P142; VISOCCHI M, 1992, INS 1 INT C MOND ED, P59	18	15	18	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1011-6125			STEREOT FUNCT NEUROS	Stereotact. Funct. Neurosurg.		2001	76	3-4					276	281		10.1159/000066731			6	Neurosciences; Neuroimaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	605ZK	WOS:000178706800026	12378109				2022-02-06	
J	Bergsneider, M				Bergsneider, M			Management of hydrocephalus with programmable valves after traumatic brain injury and subarachnoid hemorrhage	CURRENT OPINION IN NEUROLOGY			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; CLINICAL-EXPERIENCE; HAKIM VALVE; SHUNT VALVE	Programmable shunt valves are a recent technological advance that enhance the management of most patients with hydrocephalus secondary to subarachnoid hemorrhage or traumatic brain injury. An improved understanding of the intracranial pressure dynamics occurring both before and after a cerebrospinal fluid diversionary shunt has provided a more scientific basis for the application of these valves. Curr Opin Neurol 13:661-664. (C) 2000 Lippincott Williams & Wilkins.	Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA 90095 USA		Bergsneider, M (corresponding author), Univ Calif Los Angeles, Div Neurosurg, Box 957039, Los Angeles, CA 90095 USA.						Bergsneider M, 1999, ARCH NEUROL-CHICAGO, V56, P1224, DOI 10.1001/archneur.56.10.1224; BLACK PM, 1994, NEUROSURGERY, V34, P1110, DOI 10.1227/00006123-199406000-00040; Boon AJW, 1998, J NEUROSURG, V88, P490, DOI 10.3171/jns.1998.88.3.0490; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; Guyot LL, 2000, NEUROL RES, V22, P25; KAMANO S, 1991, SURG NEUROL, V35, P381, DOI 10.1016/0090-3019(91)90050-J; LARSSON A, 1992, ACTA NEUROCHIR, V117, P15, DOI 10.1007/BF01400629; LUMENTA CB, 1990, CHILD NERV SYST, V6, P270, DOI 10.1007/BF00307663; MATSUMAE M, 1989, CHILD NERV SYST, V5, P356, DOI 10.1007/BF00271892; MCQUARRIE IG, 1984, NEUROSURGERY, V15, P484, DOI 10.1227/00006123-198410000-00002; Miyake H, 2000, J NEUROSURG, V92, P181, DOI 10.3171/jns.2000.92.1.0181; Miyake H, 1999, CHILD NERV SYST, V15, P363, DOI 10.1007/s003810050415; PANG DL, 1994, NEUROSURGERY, V35, P643, DOI 10.1227/00006123-199410000-00010; Pollack IF, 1999, NEUROSURGERY, V45, P1399, DOI 10.1097/00006123-199912000-00026; PUDENZ RH, 1991, SURG NEUROL, V35, P200, DOI 10.1016/0090-3019(91)90072-H; Reinprecht A, 1997, CHILD NERV SYST, V13, P588, DOI 10.1007/s003810050145; REINPRECHT A, 1995, ACTA NEUROCHIR, V134, P119, DOI 10.1007/BF01417677; Rohde V, 1998, ACTA NEUROCHIR, V140, P1127, DOI 10.1007/s007010050226; Sheehan JP, 1999, NEUROSURGERY, V45, P1120, DOI 10.1097/00006123-199911000-00021; WEINER HL, 1995, NEUROSURGERY, V37, P877, DOI 10.1227/00006123-199511000-00005; Yamashita N, 1999, J NEUROSURG, V91, P26, DOI 10.3171/jns.1999.91.1.0026; Yoshioka H, 2000, SURG NEUROL, V53, P119, DOI 10.1016/S0090-3019(99)00185-8; Zemack G, 2000, J NEUROSURG, V92, P941, DOI 10.3171/jns.2000.92.6.0941	23	15	20	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1350-7540			CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2000	13	6					661	664		10.1097/00019052-200012000-00008			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	425HG	WOS:000168284700008	11148666				2022-02-06	
J	Duerstock, BS; Bajaj, CL; Pascucci, V; Schikore, D; Lin, KN; Borgens, RB				Duerstock, BS; Bajaj, CL; Pascucci, V; Schikore, D; Lin, KN; Borgens, RB			Advances in three-dimensional reconstruction of the experimental spinal cord injury	COMPUTERIZED MEDICAL IMAGING AND GRAPHICS			English	Article						three-dimensional reconstruction; 3D computer visualization; 3D morphometry; spinal cord injury; neurotrauma; serial light microscopy; registration	3-DIMENSIONAL RECONSTRUCTION; ELECTRON-MICROSCOPY; RAT; SECTIONS; MICROGRAPHS; CONTUSION; ALIGNMENT; NUCLEUS; CELLS	Three-dimensional (3D) computer reconstruction is an ideal tool for evaluating the centralized pathology of mammalian spinal cord injury (SCI) where multiple anatomical features are embedded within each other. Here, we evaluate three different reconstruction algorithms to three-dimensionally visualize SCIs, We also show for the first time, that determination of the volume and surface area of pathological features is possible using the reconstructed 3D images themselves. We compare these measurements to those calculated by older morphometric approaches. Finally, we demonstrate dynamic navigation into a 3D spinal cord reconstruction (C) 2000 Elsevier Science Ltd. All rights reserved.	Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Borgens, RB (corresponding author), Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Basic Med Sci, 1244 VCPR, W Lafayette, IN 47907 USA.	cpr@vet.purdue.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR509137] Funding Source: Medline		ALLEN BA, 1990, COMPUT MED IMAG GRAP, V14, P319, DOI 10.1016/0895-6111(90)90106-L; Arndt S, 1994, Neuroimage, V1, P191, DOI 10.1006/nimg.1994.1004; BAJAJ C, 1996, P 5 INT IM ROUNDT SA, V405, P169; Bajaj CL, 1996, GRAPH MODEL IM PROC, V58, P524, DOI 10.1006/gmip.1996.0044; Bajaj CL, 1997, VISUALIZATION '97 - PROCEEDINGS, P167, DOI 10.1109/VISUAL.1997.663875; BAJAJ CL, 1998, IN PRESS COMP METH A; BALENTINE JD, 1978, LAB INVEST, V39, P236; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; BERGOGNONI M, 1999, P 13 INT C IEEE ENG, P1119; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Borgens RB, 2000, FASEB J, V14, P27, DOI 10.1096/fasebj.14.1.27; BORGENS RB, 1992, SPINAL CORD DYSFUNCT, V3, P110; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bresnahan JC, 1991, J NEUROTRAUM, V8, P91, DOI 10.1089/neu.1991.8.91; BRON C, 1990, J MICROSC-OXFORD, V157, P115, DOI 10.1111/j.1365-2818.1990.tb02952.x; Cabral B., 1994, SVV, P91, DOI DOI 10.1145/197938.197972; CHAWLA SD, 1981, CANCER BIOCHEM BIOPH, V5, P153; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; DEVERELL MH, 1993, ANAL CELL PATHOL, V5, P253; DEVIVO MJ, 1994, SPINAL CORD INJURY C, P234; Drebin R. A., 1988, Computer Graphics, V22, P65; Durikovic R, 1998, MED BIOL ENG COMPUT, V36, P276, DOI 10.1007/BF02522471; Gaunt W.A., 1978, 3 DIMENSIONAL RECONS; HALL PM, 1991, VISUALIZATION PHYSIC, P235; HALLIDAY GM, 1993, SYNAPSE, V15, P1, DOI 10.1002/syn.890150102; HARRIS KM, 1988, J NEUROSCI, V8, P4455; HASHIMOTO S, 1988, ACTA OTO-LARYNGOL, V105, P64, DOI 10.3109/00016488809119447; HIBBARD LS, 1993, J MICROSC-OXFORD, V171, P39, DOI 10.1111/j.1365-2818.1993.tb03357.x; HONGHUI G, 1996, SPIE, V2644, P2; LISS AG, 1995, J MICROSC-OXFORD, V178, P160, DOI 10.1111/j.1365-2818.1995.tb03592.x; MARTONE ME, 1993, J NEUROSCI, V13, P4636; MONTGOMERY K, 1993, SPIE, V1905, P114; Moriarty LJ, 1998, J NEUROL SCI, V155, P121, DOI 10.1016/S0022-510X(97)00203-7; NAVARRO A, 1994, ANAT RECORD, V240, P572, DOI 10.1002/ar.1092400414; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; PROTHERO JS, 1986, COMPUT BIOMED RES, V19, P361, DOI 10.1016/0010-4809(86)90048-0; Roesch S, 1996, J NEUROSCI METH, V69, P197, DOI 10.1016/S0165-0270(96)00062-3; ROSS MD, 1994, HIGH PERFORMANCE COMPUTING SYMPOSIUM 1994: GRAND CHALLENGES IN COMPUTER SIMULATION, P120; SALISBURY JR, 1994, HISTOL HISTOPATHOL, V9, P773; TOGA AW, 1990, 3 DIMENSIONAL NEUROI, P189; VUILLEMIN M, 1992, EUR J MORPHOL, V30, P181; Williams BS, 1996, COMPUT MED IMAG GRAP, V20, P433, DOI 10.1016/S0895-6111(96)00041-9; YOUNG SJ, 1987, J ELECTRON MICR TECH, V6, P207, DOI 10.1002/jemt.1060060211	43	15	18	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-6111	1879-0771		COMPUT MED IMAG GRAP	Comput. Med. Imaging Graph.	NOV-DEC	2000	24	6					389	406		10.1016/S0895-6111(00)00034-3			18	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging	362XT	WOS:000089804100005	11008186				2022-02-06	
J	Geldmacher, DS; Fritsch, T; Riedel, TM				Geldmacher, DS; Fritsch, T; Riedel, TM			Effects of stimulus properties and age on random-array letter cancellation tasks	AGING NEUROPSYCHOLOGY AND COGNITION			English	Article							TRAUMATIC BRAIN INJURY; TO-DISTRACTOR RATIO; VISUAL NEGLECT; FEATURE-INTEGRATION; ATTENTION; SEARCH; PERFORMANCE; NUMBER	Random-array letter cancellation tasks are commonly used in the clinical assessment of visuospatial function. How stimulus properties and aging affect cancellation performance is not well understood. This study evaluated the effects of stimulus factors and age on 3 measures of cancellation performance. Thirty younger and 30 older adults each completed 12 cancellation forms that varied in paper size, stimulus density, and target-to-distractor (T/D) ratio. Interactions between stimulus factors were identified for a calculated composite measure of speed and accuracy (effectiveness), a standardized measure of the time required for completion of forms, and a standardized measure of the number of omission errors. The results showed complex interactions between stimulus factors that were different for each dependent variable. These interactions were generally similar for both age groups. The findings indicate that both stimulus properties and dependent variables must be carefully considered in the design and interpretation of cancellation paradigms.	Case Western Reserve Univ, Alzheimer Ctr, Cleveland, OH 44120 USA		Geldmacher, DS (corresponding author), Case Western Reserve Univ, Alzheimer Ctr, 12200 Fairhill Rd, Cleveland, OH 44120 USA.						ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; CHATTERJEE A, 1992, NEUROPSYCHOLOGIA, V30, P1101, DOI 10.1016/0028-3932(92)90101-Q; FOLDI NS, 1992, J GERONTOL B-PSYCHOL, V47, P146; FOLK CL, 1992, PSYCHOL AGING, V7, P453, DOI 10.1037/0882-7974.7.3.453; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; GELDMACHER D, 1997, J INT NEUROPSYCH SOC, V3, P16; Geldmacher DS, 1996, BRAIN COGNITION, V32, P405, DOI 10.1006/brcg.1996.0073; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; Geldmacher DS, 1999, NEUROPSY NEUROPSY BE, V12, P28; GELDMACHER DS, 1995, J INT NEUROPSYCH SOC, V1, P129; GELDMACHER DS, 1998, ANN M AM SOC NEUR MI; Hills EC, 1998, BRAIN INJURY, V12, P69, DOI 10.1080/026990598122872; JACOBS AM, 1987, ACTA PSYCHOL, V65, P133, DOI 10.1016/0001-6918(87)90023-0; KAPLAN RF, 1991, ARCH NEUROL-CHICAGO, V48, P1263, DOI 10.1001/archneur.1991.00530240067023; Keppel G., 1991, DESIGN ANAL RES HDB; MARSHALL JC, 1989, COGNITIVE NEUROPSYCH, V6, P403, DOI 10.1080/02643298908253290; OKEN BS, 1994, J GERIATR PSYCH NEUR, V7, P163, DOI 10.1177/089198879400700307; PLUDE DJ, 1989, PSYCHOL AGING, V4, P98, DOI 10.1037/0882-7974.4.1.98; RAPCSACK SZ, 1989, ARCH NEUROL-CHICAGO, V46, P172; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Spreen O, 1991, COMPENDIUM NEUROPSYC; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VILLARDITA C, 1983, ARCH NEUROL-CHICAGO, V40, P737, DOI 10.1001/archneur.1983.04050110055008	24	15	15	0	4	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1382-5585			AGING NEUROPSYCHOL C	Aging Neuropsychol. Cogn.	SEP	2000	7	3					194	204		10.1076/1382-5585(200009)7:3;1-Q;FT194			11	Psychology, Developmental; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	369ZD	WOS:000165096900005					2022-02-06	
J	Watt, N; Penn, C				Watt, N; Penn, C			Predictors and indicators of return to work following traumatic brain injury in South Africa: Findings from a preliminary experimental database	SOUTH AFRICAN JOURNAL OF PSYCHOLOGY			English	Article							SEVERE HEAD-INJURY; REHABILITATION; EMPLOYMENT; PEOPLE	Traumatic brain injury (TBI) affects a substantial portion of the South African population every year. However. there is little empirical evidence available regarding eventual outcome after injury in South Africa. in particular, there is little information regarding the ability of head injured individuals to return to their places of employment following injury, or what factors are most closely related to a successful return to work. This study explored the return to work of a specific group of individuals with TBI, in relation to a number of domains, including: rate and nature of return to work, pre-morbid and accident variables that appeared to be related to return to work, and the relationship between return to work and other aspects of outcome, specifically communicative, cognitive, physical and emotional outcome. The study took the form of a detailed record review of a group of subjects seeking medico-legal compensation, using a specially designed data recording form and computerised database. Results indicated a poor rate of return to work in this sample (32%), with significant changes in work status post-injury. The strongest pre-morbid predictors of outcome were found to be first language and pre-injury educational level, with African language speakers and those with an educational level of matriculation or less being at a significant disadvantage Numerous communicative and cognitive difficulties were significantly related to a failure to RTW, including difficulties in: motor speech, comprehension, expression, attention, speed of processing, incidental visual memory, cognitive flexibility and insight. These results indicate the multi-factorial nature of outcome following head injury in the sample.	Univ Witwatersrand, Dept Speech Pathol & Audiol, ZA-2050 Johannesburg, South Africa		Watt, N (corresponding author), Univ Witwatersrand, Dept Speech Pathol & Audiol, Private Bag 3, ZA-2050 Johannesburg, South Africa.						AINSLEY J, 1989, COGNITIVE REHABI NOV, P28; BAYLESS JD, 1989, J CLIN EXP NEUROPSYC, V11, P913, DOI 10.1080/01688638908400944; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BLAIR JR, 1989, J REHABIL, V55, P46; Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROWN DSO, 1990, 4 UNISA HLTH PSYCH U; CHRISTENSEN AL, 1992, SCAND J REHABIL MED, P34; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DRESSER AC, 1973, ARCH NEUROL-CHICAGO, V29, P111, DOI 10.1001/archneur.1973.00490260055011; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; GILES GM, 1993, BRAIN INJURY REHABIL; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hartley L. L, 1995, COGNITIVE COMMUNICAT; HOWELL DC, 1992, STAT METHODS PSYCHOL; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JANSEN P, 1988, THESIS UNISA; Johnson R, 1987, Int Disabil Stud, V9, P49; Johnson R, 1998, NEUROPSYCHOL REHABIL, V8, P61, DOI 10.1080/713755552; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kaplan SP, 1991, CLIN NEUROPSYCHOL, V5, P360; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LYONS JL, 1988, AM J OCCUP THER, V42, P364, DOI 10.5014/ajot.42.6.364; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Najenson T, 1980, Int Rehabil Med, V2, P17; NELL V, 1990, 1 UNISA HSRC HLTH PS; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PUTNAM SH, 1992, CLIN NEUROPSYCHOL, V6, P383; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; ROLLAND J, 1993, LIVING APHASIA PSYCH, pCH13; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; SARNO MT, 1988, SCAND J REHABIL MED, P55; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Teasdale TW, 1997, NEUROPSYCHOL REHABIL, V7, P23, DOI 10.1080/713755521; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; VOGENTHALER DR, 1986, THESIS SO ILLINOIS U; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	50	15	16	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0081-2463	2078-208X		S AFR J PSYCHOL	South Afr. J. Psychol.	SEP	2000	30	3					27	37		10.1177/008124630003000305			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	381ZF	WOS:000165793400005					2022-02-06	
J	Proctor, A; Wilson, B; Sanchez, C; Wesley, E				Proctor, A; Wilson, B; Sanchez, C; Wesley, E			Executive function and verbal working memory in adolescents with closed head injury (CHI)	BRAIN INJURY			English	Article							INDIVIDUAL-DIFFERENCES; DYSEXECUTIVE SYNDROME	The relationship between executive function (EF) and working memory (WM) was studied in eight adolescents with closed head injury (CHI) and eight controls, matched for age, gender and socioeconomic status (SES). A cognitive-linguistic test (Scales of Cognitive Ability for Traumatic Brain Injury, SCATBI) was used to group CHI participants by severity. EF was tested with a measure of daily functioning (Pro-Ex) and WM was tested with a recognition memory task (RMT). When all subject test data were grouped, a positive linear correlation was found for the Pro-Ex and the RMT. A strong-to-moderate positive correlation was found for components of the EF measure and the RMT. Severity of injury influenced test performance for both the EF and WM measures, with a significance between group effects found on the RMT task. Results indicate a relationship between executive function and working memory, severity of injury and test performance and the need to assess EF of CHI adolescents with a measure of daily functioning.	Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL 61820 USA; Eastern Illinois Univ, Charleston, IL 61920 USA		Proctor, A (corresponding author), Univ Illinois, Dept Speech & Hearing Sci, 901 S 6th St, Champaign, IL 61820 USA.	aproctor@UIUC.edu					ADAMOVITCH B, 1992, SCALES COGNITIVE ABI; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Baddeley A., 1986, OXFORD PSYCHOL SERIE, V11; BADDELEY AD, 1998, HUMAN MEMORY THEORY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BRASWELL D, 1992, PROFILE EXECUTIVE CO; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DANEMAN M, 1983, J EXP PSYCHOL LEARN, V9, P561, DOI 10.1037/0278-7393.9.4.561; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; ENCKLA MB, 1996, ATTENTION MEMORY EXE, P263; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; ESTWISLE DR, 1994, CHILD DEV, V63, P1521; Gathercole S.E., 1993, WORKING MEMORY LANGU; GOLDMAN R, 1991, GOLDMAN FRISTOE WOOD; Lehto JH, 1996, Q J EXP PSYCHOL-A, V49, P29, DOI 10.1080/027249896392793; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; NORMAN DA, 1980, 99 CHIP U CAL SAN DI; Shah, 1999, MODELS WORKING MEMOR, DOI DOI 10.1017/CBO9781139174909.005; SHAH P, 1999, MODELS WORKING MEMOR, P00001; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; VANDERLINDEN M, 1992, COGNITIVE NEUROPSYCH, V9, P301, DOI 10.1080/02643299208252063; WARD JD, 1987, BRAIN INJURY, V12, P21; Wickelgren I, 1997, SCIENCE, V275, P1580, DOI 10.1126/science.275.5306.1580; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; WILSON BM, 1998, THESIS U ILLINOIS UR; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P159	31	15	20	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2000	14	7					633	647					15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	335AV	WOS:000088220600004	10914645				2022-02-06	
J	Cummings, TJ; Johnson, RR; Diaz, FG; Michael, DB				Cummings, TJ; Johnson, RR; Diaz, FG; Michael, DB			The relationship of blunt head trauma, subarachnoid hemorrhage, and rupture of pre-existing intracranial saccular aneurysms	NEUROLOGICAL RESEARCH			English	Article						head injury; subarachnoid hemorrhage; aneurysm; angiography	CAROTID-ARTERY; INJURY	Patients with a history of closed head trauma and subarachnoid hemorrhage are uncommonly diagnosed with an intracranial saccular aneurysm. This study presents a group of patients in whom a pre-existing aneurysm was discovered during work-up for traumatic subarachnoid hemorrhage. Without an accurate pre-trauma clinical history, it is difficult to define the relationship between trauma and the rupture of a preexisting intracranial saccular aneurysm. We retrospectively reviewed 130 patients who presented to Detroit Receiving Hospital between 1993 and 1997 with a diagnosis of subarachnoid hemorrhage (SAH). Of these 130 patients, 70 were spontaneous, and 60 had a history of trauma. Mechanisms of trauma include motor vehicle accident, assault, or fall from a height Of the 60 patients with subarachnoid hemorrhage and a history of trauma, 51 (86%) did not undergo conventional four-vessel angiography, and had no further neurological sequelae. Nine patients (14%) had a suspicious quantity of blood within the basal cisterns or Sylvian fissure and had a four-vessel angiogram. Five patients (8%) were diagnosed with a saccular intracranial aneurysm, and all underwent surgical clipping of the aneurysm. We conclude that the majority of patients (92%), with post-traumatic SAH do not harbor intracranial aneurysms. However, during initial evaluation, a high level of suspicion must be entertained when post-traumatic subarachnoid hemorrhage is encountered in the basal cisterns or Sylvian fissure, as 8% of our population were diagnosed with aneurysms.	Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA		Michael, DB (corresponding author), Wayne State Univ, Sch Med, Dept Neurol Surg, 4201 St Antoine 6E, Detroit, MI 48201 USA.						DOWLING G, 1988, AM J FOREN MED PATH, V9, P23, DOI 10.1097/00000433-198803000-00007; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; FREYTAG E, 1966, ARCH PATHOL, V81, P418; GROSS A, 1990, FORENSIC SCI INT, V45, P53, DOI 10.1016/0379-0738(90)90221-J; HARLAND WA, 1983, J CLIN PATHOL, V36, P1335, DOI 10.1136/jcp.36.12.1335; HILLBOM M, 1981, J NEUROL NEUROSUR PS, V44, P523, DOI 10.1136/jnnp.44.6.523; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; JENNETT B, 1975, LANCET, V1, P480; KAKARIEKA A, 1997, TRAUMATIC SUBARACHNO, P5; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; LOCKSLEY HB, 1966, J NEUROSURG, V25, P219, DOI 10.3171/jns.1966.25.2.0219; MAREK Z, 1981, AM J FOREN MED PATH, V2, P19, DOI 10.1097/00000433-198103000-00004; MCCORMICK WF, 1980, AM J FOREN MED PATH, V1, P223, DOI 10.1097/00000433-198009000-00006; NEWBARR FD, 1958, J FORENSIC SCI, V3, P174; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; Simonsen J, 1967, J Forensic Med, V14, P146; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; TAKAKURA K, 1990, NEUROLOGICAL SURG, V3, P1864; TATSUNO Y, 1974, ARCH PATHOL, V97, P211; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016; [No title captured]	22	15	17	0	7	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR	2000	22	2					165	170		10.1080/01616412.2000.11741055			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	302VD	WOS:000086385600006	10763504				2022-02-06	
J	Pettersen, JA; Skelton, RW				Pettersen, JA; Skelton, RW			Glucose enhances long-term declarative memory in mildly head-injured varsity rugby players	PSYCHOBIOLOGY			English	Article							ELDERLY HUMANS; SENILE DEMENTIA; COMPLEX MEMORY; YOUNG-ADULTS; BRAIN-DAMAGE; RECOVERY; MECHANISM; DEFICITS; TESTS; AGE	In the present investigation, we sought to determine whether glucose could enhance declarative memory in head-injured individuals, as has been shown previously with elderly and Alzheimer's patients who had preexisting memory impairments. Varsity rugby players, both with and without a history of concussions, were given glucose- or saccharin-sweetened beverages and then tested on a series of neuropsychological tests of attention and memory; their blood-glucose levels were monitored. Beverages and tests were administered in a counterbalanced, crossover design, enabling within-subjects comparisons. Previously concussed participants were found to perform slightly worse than participants with no history of concussions (controls) on the preliminary screening interview tests and tests of memory and divided attention given in the saccharin (placebo) condition. Glucose was shown to enhance performance of the previously concussed participants and impair the performance of controls on tests of long-term declarative memory. The effects of glucose on memory appeared to be related to the participants' ability to clear glucose from the blood.	Univ Victoria, Dept Psychol, Victoria, BC V8W 3P5, Canada		Skelton, RW (corresponding author), Univ Victoria, Dept Psychol, POB 3050, Victoria, BC V8W 3P5, Canada.	skelton@uvic.ca	Skelton, Ronald/E-5605-2012				ALVES WM, 1987, CLIN SPORT MED, V6, P211; ALVES WM, 1991, ATHLETIC INJURIES HE, P283; AZARI NP, 1991, PSYCHOPHARMACOLOGY, V105, P521, DOI 10.1007/BF02244373; BARTH JT, 1989, MILD HEAD INJURY, P255; Brown W. L. jr., 1958, Acta Hymenopterologica, V1, P1; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Caveness W F, 1979, Adv Neurol, V22, P1; COPE DN, 1986, J HEAD TRAUMA REHAB, V1, P34; CRAFT S, 1994, PSYCHOBIOLOGY, V22, P95; CRAFT S, 1992, J CLIN EXP NEUROPSYC, V14, P253, DOI 10.1080/01688639208402827; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GOLD PE, 1988, NEUROBIOL AGING, V9, P709, DOI 10.1016/S0197-4580(88)80136-2; GOLD PE, 1991, NEUR CONT B, V6, P391; GONDERFREDERICK L, 1987, PHYSIOL BEHAV, V41, P503, DOI 10.1016/0031-9384(87)90087-4; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL D, 1992, NZ J SPORTS MED, V20, P19; Gronwall D, 1989, MILD HEAD INJURY, P153; HALL JL, 1989, NEUROPSYCHOLOGIA, V27, P1129, DOI 10.1016/0028-3932(89)90096-1; HOCK FJ, 1987, NEUROPSYCHOBIOLOGY, V17, P145, DOI 10.1159/000118355; INGERSOLL CD, 1993, SPORTS MED, V16, P342, DOI 10.2165/00007256-199316050-00005; JENNETT B, 1975, EPILEPSY NONMISSILE; JONES MK, 1974, NEUROPSYCHOLOGIA, V12, P21, DOI 10.1016/0028-3932(74)90023-2; KANE RL, 1992, NEUROPSYCHOL REV, V3, P45; KASTE M, 1982, LANCET, V2, P1186; KOPF SR, 1994, BEHAV NEURAL BIOL, V62, P237, DOI 10.1016/S0163-1047(05)80022-6; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEVIN HS, 1989, COMPREHENSIVE NEUROL, V2, P53; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MANNING CA, 1993, NEUROBIOL AGING, V14, P523, DOI 10.1016/0197-4580(93)90034-9; MANNING CA, 1992, BEHAV NEURAL BIOL, V58, P125, DOI 10.1016/0163-1047(92)90351-4; Manning CA, 1997, PSYCHOBIOLOGY, V25, P103; MANNING CA, 1990, PSYCHOL SCI, V1, P307, DOI 10.1111/j.1467-9280.1990.tb00223.x; MARIADAS AC, 1989, NIMHANS J, V7, P37; MCLEAN A JR, 1991, Brain Injury, V5, P375, DOI 10.3109/02699059109008110; MESSIER C, 1990, BEHAV BRAIN RES, V39, P135, DOI 10.1016/0166-4328(90)90100-S; MESSIER C, 1991, NEUR CONT B, V6, P473; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; NICHOLSON CD, 1990, PSYCHOPHARMACOLOGY, V101, P147, DOI 10.1007/BF02244119; PARSONS MW, 1992, NEUROBIOL AGING, V13, P401, DOI 10.1016/0197-4580(92)90114-D; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; PETTERSEN JA, 2000, UNPUB PREVENTION CON; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; REEVES D, 1989, 891 US NAV AER MED R; REID SE, 1971, SURG GYNECOL OBSTETR, V133, P929; ROSENTHAL M, 1983, DIABETES, V32, P408, DOI 10.2337/diabetes.32.5.408; RUSSELL EW, 1975, J CONSULT CLIN PSYCH, V43, P800, DOI 10.1037/0022-006X.43.6.800; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Smith, 1973, SYMBOL DIGIT MODALIT; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Sparks J P, 1985, Br J Sports Med, V19, P71; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; WENK GL, 1989, PSYCHOPHARMACOLOGY, V99, P431, DOI 10.1007/BF00589888; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005; WRIGHTSON P, 1992, NZ J SPORTS MED, V20, P18; [No title captured]; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253; [No title captured]	63	15	15	0	2	PSYCHONOMIC SOC INC	AUSTIN	1710 FORTVIEW RD, AUSTIN, TX 78704 USA	0889-6313			PSYCHOBIOLOGY	Psychobiology	MAR	2000	28	1					81	89					9	Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	308CU	WOS:000086693600008					2022-02-06	
J	Sieg, F; Wahle, P; Pape, HC				Sieg, F; Wahle, P; Pape, HC			Cellular reactivity to mechanical axonal injury in an organotypic in vitro model of neurotrauma	JOURNAL OF NEUROTRAUMA			English	Article						axonal/dendritic injury; calretinin; dorsal thalamus; in vitro trauma model; MAP-2; NF-M; organotypic culture; visual cortex	MICROTUBULE-ASSOCIATED PROTEIN-2; TRAUMATIC BRAIN INJURY; RAT VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; CALCIUM-BINDING PROTEINS; STRETCH-INDUCED INJURY; CAJAL-RETZIUS CELLS; DIFFERENTIAL EXPRESSION; IN-VITRO; CALRETININ-IMMUNOREACTIVITY	An in vitro model of traumatic brain injury is described that is based on organotypic cocultures (OTCs) of rat neocortex and thalamus connected by reciprocal axonal projections. Localized mechanical compression of this projection was: inflicted with a mechanical device, and the effects on cell. viability, axonal morphology, and protein expression levels were analyzed. Within 24 h after insult, major cell damage occured in infragranular cortical layers containing the corticothalamic projection neurons and in thalamic regions adjacent to the mechanical impact as was assessed through the use of the vital stain Syto 21, and propidium iodide labeling, A small, but significant number of calretinin-positive interneurons in cortical and thalamic areas displayed symptoms of injury, Axonal elements, as revealed by neurofilament (NF-HIM) immunohistochemistry, in the corticothalamic transition zone displayed pathomorphological changes, such as axonal bulbs and swellings, already 4 h after insult. Densitometric analysis revealed that MAP-2a,b expression was not significantly changed within 4 h after injury. A significant reduction in MAP-2a,b amount was evident at 20 h after injury in thalamus (by 31.6%) and cortex (by 30%) maintained for 12 days in vitro (DIV), but not in OTCs aged 20 DIV, The axonally localized form MAP-2c significantly increased in cortex of 12-DIV OTCs at 4 and 20 h after insult (65.6% and 33.4%, respectively). MAP-2c levels in cortex of 20 DIV initially increased by 47.7% and declined below control values 20 h after injury. Thalamic areas revealed a delay in MAP-2c reactivity, in that expression was significantly elevated only at 20 h after injury (by 84.4% in 12-DIV and by 39.6% in 20-DIV OTCs, respectively). These data may reflect the regenerative ability of juvenile, but not of older neurons in response to mechanical axonal injury.	Otto Von Guericke Univ, Inst Physiol, Fak Med, D-39120 Magdeburg, Germany; Ruhr Univ Bochum, Fak Biol, D-4630 Bochum, Germany		Pape, HC (corresponding author), Otto Von Guericke Univ, Inst Physiol, Fak Med, Leipziger Str 44, D-39120 Magdeburg, Germany.	hanschristian.pape@medizin.uni-magdeburg.de		Sieg, Frank/0000-0001-9637-3239			ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; ARAI M, 1992, BRAIN RES, V596, P215, DOI 10.1016/0006-8993(92)91550-X; Audesirk G, 1997, DEV BRAIN RES, V102, P247, DOI 10.1016/S0165-3806(97)00100-4; BINDER LI, 1984, P NATL ACAD SCI-BIOL, V81, P5613, DOI 10.1073/pnas.81.17.5613; BISBY MA, 1992, MOL NEUROBIOL, V6, P107, DOI 10.1007/BF02780547; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; BOLZ J, 1992, J NEUROSCI, V12, P3054, DOI 10.1523/JNEUROSCI.12-08-03054.1992; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; BROERS JLV, 1985, P NATL ACAD SCI USA, V82, P4409, DOI 10.1073/pnas.82.13.4409; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Conti AC, 1998, J NEUROSCI, V18, P5663; DelRio JA, 1996, J NEUROSCI, V16, P6896; Dixon WJ, 1969, INTRO STAT ANAL, V3rd; DOLL T, 1993, J CELL SCI, V106, P633; Dusart I, 1997, J NEUROSCI, V17, P3710; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Faddis BT, 1997, J NEUROSCI, V17, P951; GARNER CC, 1988, J CELL BIOL, V106, P779, DOI 10.1083/jcb.106.3.779; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Hartel R, 1997, NEUROSCIENCE, V78, P1; HAYES RL, 1995, J NEUROTRAUM, V12, P933, DOI 10.1089/neu.1995.12.933; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HUBER G, 1984, J NEUROSCI, V4, P151; Jacobs AJ, 1997, J NEUROSCI, V17, P5206; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; JOHNSON GVW, 1991, J NEUROCHEM, V56, P1630, DOI 10.1111/j.1471-4159.1991.tb02061.x; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kanayama G, 1997, PSYCHIAT CLIN NEUROS, V51, P157, DOI 10.1111/j.1440-1819.1997.tb02379.x; KIROKAWA N, 1996, J CELL BIOL, V132, P667; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCAS JH, 1992, J NEUROTRAUM, V9, P117, DOI 10.1089/neu.1992.9.117; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; OBLINGER MM, 1988, J NEUROSCI, V8, P1747; Obst K, 1997, EUR J NEUROSCI, V9, P2571, DOI 10.1111/j.1460-9568.1997.tb01686.x; OBST K, 1995, EUR J NEUROSCI, V7, P2139, DOI 10.1111/j.1460-9568.1995.tb00636.x; PAXINOS G, 1991, ATLAS DEV BRAIN; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; RIEDERER B, 1985, P NATL ACAD SCI USA, V82, P6006, DOI 10.1073/pnas.82.17.6006; RIEDERER BM, 1995, J HISTOCHEM CYTOCHEM, V43, P1269, DOI 10.1177/43.12.8537643; Riederer BM, 1996, J COMP NEUROL, V364, P704, DOI 10.1002/(SICI)1096-9861(19960122)364:4<704::AID-CNE8>3.0.CO;2-7; RIEDERER BM, 1992, EUR J NEUROSCI, V4, P1376, DOI 10.1111/j.1460-9568.1992.tb00163.x; Ross D. T., 1992, Society for Neuroscience Abstracts, V18, P1088; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Schierle GS, 1997, CEREB CORTEX, V7, P130, DOI 10.1093/cercor/7.2.130; SHAW G, 1988, BRAIN RES, V460, P227, DOI 10.1016/0006-8993(88)90367-8; Sieg F, 1998, DEV BRAIN RES, V110, P83, DOI 10.1016/S0165-3806(98)00097-2; Smith DH, 1999, J NEUROSCI, V19, P4263; STOPPINI L, 1993, NEUROSCIENCE, V57, P985, DOI 10.1016/0306-4522(93)90043-F; Super H, 1997, DEV BRAIN RES, V98, P9, DOI 10.1016/S0165-3806(96)00154-X; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TETZLAFF W, 1991, J NEUROSCI, V11, P2528; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIERECK C, 1989, J NEUROSCI, V9, P3547; Weisenhorn DMV, 1996, EXP BRAIN RES, V108, P101; WEISSHAAR B, 1992, DEVELOPMENT, V116, P1151; Wilkemeyer MF, 1996, J NEUROSCI RES, V43, P707, DOI 10.1002/(SICI)1097-4547(19960315)43:6<707::AID-JNR7>3.0.CO;2-I; ZHANG Y, 1995, J COMP NEUROL, V361, P210, DOI 10.1002/cne.903610203	74	15	16	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	1999	16	12					1197	1213		10.1089/neu.1999.16.1197			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	266WC	WOS:000084322400007	10619198				2022-02-06	
J	Van Balen, HGG; De Mey, HRA; Van Limbeek, J				Van Balen, HGG; De Mey, HRA; Van Limbeek, J			A neurocorrective approach for MMPI-2 use with brain-damaged patients	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						brain damage; MMPI-2; personality assessment; psychosocial adjustment; rehabilitation	PROFILES; INJURY	Conventional administration of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) to aetiologically distinct brain-damaged out-patients (n = 137) revealed significant indications of psychological maladjustment. An adjustment for the endorsement of aetiology-specific items pertaining to traumatic brain injury (TBI), stroke, and whiplash was considered necessary, however, because these items may represent potentially valid symptoms or manifestations of neurological damage or dysfunction. These so-called neurologically relevant items (NRIs) were identified in a previous study. With this corrective approach, based on the complete MMPI-2 item pool, it was shown that T-score elevations could at least in part be attributed to symptoms associated with I,rain injury, regardless of the type of brain damage. Similarly, after prorated correction for the endorsement of NRIs, codetyping appeared to be substantially changed with respect to both occurrence and content of the MMPI-2 defined code:types. The validity of the NRI concept was supported by comparing NRI/non-NRI endorsement ratios of traumatically brain-injured patients with those of non-neurological patients, and with those having anxiety and somatoform disorders. To prevent unjustified interpretations when administering the MMPI-2 to brain-damaged patients, an adjustment procedure for NRI-endorsement is proposed, and difficulties in interpretation are discussed.	St Maartensklin, Nijmegen Ctr Motor Behav & Cognit, NL-6500 GM Nijmegen, Netherlands; St Maartensklin Res, Nijmegen, Netherlands; St Maartensklin, Div Rehabil Med, Nijmegen, Netherlands; Univ Nijmegen, Dept Clin & Personal Psychol, Nijmegen, Netherlands		Van Balen, HGG (corresponding author), St Maartensklin, Nijmegen Ctr Motor Behav & Cognit, POB 9011, NL-6500 GM Nijmegen, Netherlands.						ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; CRIPE LI, 1997, CLIN NEUROPSYCHOLOGY, P119; DEMEY HR, 1995, GEDRAG GEZONDHEID, V23, P179; Derksen J.J.L., 1997, MMPI 2 HANDLEIDING B; GASS CS, 1992, ARCH CLIN NEUROPSYCH, V7, P17, DOI 10.1016/0887-6177(92)90015-F; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GRAHAM JR, 1993, MMPI 2 ASSESSING PER; Greene R. L, 1991, MMPI 2 MMPI INTERPRE; Greene RL, 1997, J PERS ASSESS, V68, P20, DOI 10.1207/s15327752jpa6801_3; Kaemmer, 1989, MINNESOTA MULTIPHASI; KENDALL PC, 1978, J CONSULT CLIN PSYCH, V46, P370, DOI 10.1037/0022-006X.46.2.370; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MACK JL, 1979, MMPI CLIN RES TRENDS, P53; MILLER HB, 1995, J CLIN EXP NEUROPSYC, V17, P58, DOI 10.1080/13803399508406581; SLOORE H, 1993, MMPI 2 VRAGENBOEKJE; VanBalen HGG, 1997, INT J REHABIL RES, V20, P355, DOI 10.1097/00004356-199712000-00002; WOOTEN AJ, 1983, J CLIN PSYCHOL, V39, P392, DOI 10.1002/1097-4679(198305)39:3<392::AID-JCLP2270390313>3.0.CO;2-H	20	15	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	1999	22	4					249	259		10.1097/00004356-199912000-00001			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	270FQ	WOS:000084525100001	10669974				2022-02-06	
J	Heath, DL; Vink, R				Heath, DL; Vink, R			Concentration of brain free magnesium following severe brain injury correlates with neurologic motor outcome	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						diffuse axonal injury; trauma; rat; NMR	NUCLEAR-MAGNETIC-RESONANCE; AXONAL INJURY; RATS; MG2+; METABOLISM; PHOSPHORYLATION; DECLINE; DAMAGE; TRAUMA; MG-2+	Recent studies have shown that brain intracellular free magnesium concentration significantly declines following mild to severe, focal and diffuse traumatic brain injury. However, little is known about how this decline or its attenuation by magnesium salts relates to neurologic outcome. This study uses phosphorus magnetic resonance spectroscopy and rotarod tests to characterise the relationship between brain free magnesium concentration and neurologic motor scores following severe, diffuse traumatic brain injury in rats. An intravenous bolus of MgSO4 or MgCl2 (100 mu moles/kg) at 30 min following brain injury significantly attenuated the postinjury brain free magnesium decline. This improved magnesium homeostasis was sustained for the entire postinjury monitoring period (1 week). There was an associated significant improvement in neurologic motor function in magnesium treated rats. Moreover, the brain free magnesium concentration over the one week period was linearly correlated with the neurologic motor function (r=0.70; P < 0.001) as assessed on a daily basis. We propose that brain free magnesium concentration may be used as a prognostic indicator of neurologic motor function after traumatic brain injury. (C) 1999 Harcourt Publishers Ltd.	James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia		Vink, R (corresponding author), James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia.		Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			Bara M., 1984, MAGNESIUM, V3, P212; BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; BRAUGHLER JM, 1992, CENTRAL NERVOUS SYST, P1; COOPER PR, 1985, CENTRAL NERVOUS SYST, P217; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAGIAN MM, 1986, BIOCHIM BIOPHYS ACTA, V852, P262, DOI 10.1016/0005-2728(86)90231-8; GARFINKEL L, 1985, Magnesium, V4, P60; GRUBBS RD, 1987, MAGNESIUM, V6, P113; GUPTA RK, 1978, J BIOL CHEM, V253, P6172; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HAYES RL, 1992, CENTRAL NERVOUS SYST, P173; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Heath DL, 1996, NEUROSCI RES COMMUN, V18, P163; HELPERN JA, 1993, NEUROLOGY, V43, P1577, DOI 10.1212/WNL.43.8.1577; HOVDA DA, 1992, CENTRAL NERVOUS SYST, P47; KWACK H, 1992, CURR TOP CELL REGUL, V33, P185; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCDONALD JW, 1990, NEUROSCI LETT, V109, P234, DOI 10.1016/0304-3940(90)90569-U; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; PETROFF OAC, 1985, NEUROLOGY, V35, P1681, DOI 10.1212/WNL.35.12.1681; Povlishock JT, 1996, ACT NEUR S, V66, P81; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; RAMADAN NM, 1989, HEADACHE, V29, P416, DOI 10.1111/j.1526-4610.1989.hed2907416.x; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; TERASAKI M, 1985, P NATL ACAD SCI USA, V82, P7324, DOI 10.1073/pnas.82.21.7324; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; VINK R, 1988, J NEUROTRAUMA, V5, P365; Zhang AM, 1996, BRAIN RES, V728, P204, DOI 10.1016/S0006-8993(96)00401-5; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	41	15	15	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	1999	6	6					505	509		10.1016/S0967-5868(99)90011-5			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	265FE	WOS:000084230800012	18639191				2022-02-06	
J	Odland, RM; Sutton, RL				Odland, RM; Sutton, RL			Hyperosmosis of cerebral injury	NEUROLOGICAL RESEARCH			English	Article						osmosis; osmotic pressure; cerebral edema; stroke; traumatic brain injury; colloid osmotic pressure	BRAIN EDEMA; MICRODIALYSIS; GLUCOSE; OSMOLALITY; GLUTAMATE; ISCHEMIA; PRESSURE; LACTATE; FLUID	Changes in tissue osmolarity or cerebrospinal fluid osmolarity after cerebral injury have received little attention in the literature, but osmosis may be an important cause of early cerebral edema; This paper reviews concepts and terms relating to osmosis, and reviews the few papers in the literature which have studied osmolarity after cerebral injury. In studies of both traumatic brain injury and ischemia, tissue osmolarity is elevated. Osmolarity of cerebrospinal fluid has also been shown to increase with injury. There have been no human studies examining osmolarity of tissue or cerebrospinal fluid after cerebral injury. Theoretical implications of the osmotic gradient are discussed.	Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; Univ Minnesota, Minneapolis, MN USA		Odland, RM (corresponding author), Hennepin Cty Med Ctr, 701 Pk Ave, Minneapolis, MN 55415 USA.						ARIEFF AI, 1973, J CLIN INVEST, V52, P571, DOI 10.1172/JCI107218; AUKLAND K, 1974, ACTA PHYSIOL SCAND, V90, P485, DOI 10.1111/j.1748-1716.1974.tb05611.x; BANDARANAYAKE NM, 1978, STROKE, V9, P249, DOI 10.1161/01.STR.9.3.249; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bullock R., 1995, NEUROCHEMICAL MONITO, P64; DURING MJ, 1993, LANCET, V341, P1607; Fisher M, 1997, STROKE, V28, P866, DOI 10.1161/01.STR.28.4.866; FISHMAN RA, 1986, STROKE, P119; GAZENDAM J, 1979, J NEUROSURG, V51, P70, DOI 10.3171/jns.1979.51.1.0070; GO KG, 1981, ARCH NEUROL-CHICAGO, V38, P581, DOI 10.1001/archneur.1981.00510090075009; GO KG, 1979, J NEUROSURG, V51, P78, DOI 10.3171/jns.1979.51.1.0078; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; HAMMEL HT, 1984, PHYS CHEM LIQ, V13, P255, DOI 10.1080/00319108408080784; HAMMEL HT, 1983, PHYS CHEM LIQ, V13, P25, DOI 10.1080/00319108308080760; HAMMEL HT, 1976, OSMOSIS TENSILE SOLV, P1; HAMMEL HT, 1976, OSMOSIS TENSILE SOLV, P15; HAMMEL HT, 1976, OSMOSIS TENSILE SOLV, P70; HATASHITA S, 1986, J CEREBR BLOOD F MET, V6, P546, DOI 10.1038/jcbfm.1986.100; Hatashita S, 1990, Adv Neurol, V52, P85; HATASHITA S, 1976, P 7 INT S INTR PRESS, P969; HILLERED L, 1991, MICRODIALYSIS NEUROS, P389; HILLERED L, 1995, NEUROCHEMICAL MONITO, P59; HOFF JT, 1988, OUTFLOW CEREBROSPINA, P295; Hossman K, 1976, DYNAMICS BRAIN EDEMA, P219; KAWAMATA T, 1995, NEUROCHEMICAL MONITO, P72; KELLY MJ, 1973, PHYSICAL PRINCIPLES, P77; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1984, BRAIN EDEMA, P1; KUTCHAI HC, 1988, PHYSIOLOGY, P5; LANDOLT H, 1994, ACTA NEUROCHIR, P475; LANGEMANN H, 1995, CLIN NEUROL NEUROSUR, V97, P149, DOI 10.1016/0303-8467(94)00067-G; MATSUOKA Y, 1982, EXP NEUROL, V77, P599, DOI 10.1016/0014-4886(82)90231-X; MCDOWELL ME, 1955, AM J PHYSIOL, V180, P545, DOI 10.1152/ajplegacy.1955.180.3.545; Mori T., 1998, Journal of Neurotrauma, V15, P30; Onal C, 1997, ACTA NEUROCHIR, V139, P661, DOI 10.1007/BF01412002; PATBERG WR, 1977, EXP NEUROL, V54, P141, DOI 10.1016/0014-4886(77)90241-2; SCHIELKE GP, 1991, J CEREBR BLOOD F MET, V11, P466, DOI 10.1038/jcbfm.1991.89; Starling E H, 1896, J Physiol, V19, P312; STROCK PE, 1969, SURG GYNECOL OBSTETR, V129, P1213; SU CT, 1982, PLAST RECONSTR SURG, V70, P202, DOI 10.1097/00006534-198208000-00014; TOMITA M, 1979, EXP NEUROL, V65, P66, DOI 10.1016/0014-4886(79)90248-6; TORNHEIM PA, 1980, J NEUROSCI METH, V3, P21, DOI 10.1016/0165-0270(80)90031-X; TRANUMJENSEN J, 1981, CIRC RES, V49, P364, DOI 10.1161/01.RES.49.2.364; WILLMSKR.K, 1969, AM J PATHOL, V54, P327; Zauner A, 1996, ACT NEUR S, V67, P40	45	15	16	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL	1999	21	5					500	508		10.1080/01616412.1999.11740965			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	218JU	WOS:000081550100011	10439432				2022-02-06	
J	Halonen, T; Nissinen, J; Pitkanen, A				Halonen, T; Nissinen, J; Pitkanen, A			Neuroprotective effect of remacemide hydrochloride in a perforant pathway stimulation model of status epilepticus in the rat	EPILEPSY RESEARCH			English	Article						amygdala; antiepileptic drug; electroencephalogram; entorhinal cortex; epilepsy; hippocampus; neuronal damage; piriform cortex	TEMPORAL-LOBE EPILEPSY; HIPPOCAMPAL-LESIONS; ELECTRICAL-STIMULATION; NEURONAL DAMAGE; BRAIN; METABOLITE; MEMORY; IMPAIRMENT; INHIBITION; ISCHEMIA	Previous studies have demonstrated that remacemide and its desglycinyl metabolite, AR-R12495AA, reduce neuronal damage in animal models of ischemia, subarachnoid hemorrhage, and traumatic brain injury. The aim of the present study was to investigate whether remacemide hydrochloride also alleviates seizure-induced neuronal damage in a model of status epilepticus induced by the stimulation of the perforant pathway (PP) in the rat. Chronic oral remacemide treatment (3 x 25 mg/kg/day) was started either 2 days before or 2 h after the beginning of PP stimulation (2 mA, 20 Hz, 0.1 ms pulse duration for 60 min). The effects of remacemide treatment on the severity of seizures, electroencephalogram (EEG) parameters, seizure-induced neuronal damage in the temporal lobe regions, and memory impairment were compared to unstimulated and stimulated vehicle-treated controls, and carbamazepine-pretreated (3 x 40 mg/kg/day) rats. Both remacemide and carbamazepine pretreatments, but not remacemide posttreatment, decreased pyramidal cell damage in the CA3 and CA1 subregions of the hippocampus (P < 0.05). In addition, overall neuronal damage in the extrahippocampal temporal lobe regions (the piriform cortex, entorhinal cortex, and the amygdaloid complex) was milder in remacemide-pretreated rats compared to stimulated control rats (P < 0.01). The neuroprotective effect was most evident on the side contralateral to stimulation. Remacemide or carbamazepine pretreatment had no evident effect on the number or duration of behavioral seizures during PP stimulation. Neither drug altered the spectral parameters of the baseline EEG or prevented status epilepticus-induced EEG slowing observed 2 weeks after PP stimulation. Nor did remacemide or carbamazepine treatment alleviate spatial memory impairment determined in a Morris water-maze task 2 weeks after PP stimulation. Our data provide evidence that pretreatment with remacemide has a moderate neuroprotective effect against status epilepticus-induced neuronal damage. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Kuopio, AI Virtanen Inst Mol Sci, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Neurol, FIN-70211 Kuopio, Finland		Halonen, T (corresponding author), Univ Kuopio, AI Virtanen Inst Mol Sci, POB 1627, FIN-70211 Kuopio, Finland.						BANNAN PE, 1994, BRAIN RES, V664, P271, DOI 10.1016/0006-8993(94)91984-4; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Black MA, 1996, J NEUROCHEM, V66, P989; BORNSTEIN RA, 1988, ARCH NEUROL-CHICAGO, V45, P884, DOI 10.1001/archneur.1988.00520320074019; Cereghino J J, 1975, Adv Neurol, V11, P309; CHEUNG H, 1992, FASEB J, V6, pA1879; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; Clark Bruce, 1995, P1035; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; FISH BJ, 1991, SPEHLMANNS EEG PRIME; Halonen T, 1996, EUR J PHARMACOL, V299, P69, DOI 10.1016/0014-2999(95)00835-7; HARRIS E, 1992, MULTIPLE SIGMA PCP R, P643; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Palmer GC, 1995, ANN NY ACAD SCI, V765, P236, DOI 10.1111/j.1749-6632.1995.tb16580.x; Palmer Gene C., 1993, Drugs of the Future, V18, P1021; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Pitkanen A, 1996, EPILEPSY RES, V24, P29, DOI 10.1016/0920-1211(95)00093-3; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; SCHWARZER C, 1995, NEUROSCIENCE, V69, P831, DOI 10.1016/0306-4522(95)00268-N; SECHI GP, 1987, EPILEPSY RES, V1, P173, DOI 10.1016/0920-1211(87)90038-6; SIMON RP, 1985, J PHARMACOL EXP THER, V234, P830; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; Subramaniam S, 1996, J PHARMACOL EXP THER, V276, P161; Subramaniam S., 1993, Society for Neuroscience Abstracts, V19, P717; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; SWANSSON LW, 1992, BRAINMAPS STRUCTURE; VANLUIJTELAAR ELJM, 1995, NEUROPHARMACOLOGY, V34, P419, DOI 10.1016/0028-3908(95)00008-T; Wamil AW, 1996, EPILEPSY RES, V23, P1, DOI 10.1016/0920-1211(95)00053-4; WIESER HG, 1992, TEMPORAL LOBES LIMBI, P169; YLINEN AMA, 1991, P NATL ACAD SCI USA, V88, P7650, DOI 10.1073/pnas.88.17.7650	39	15	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211			EPILEPSY RES	Epilepsy Res.	APR	1999	34	2-3					251	269		10.1016/S0920-1211(98)00122-3			19	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194MC	WOS:000080196600019	10210040				2022-02-06	
J	Duhaime, AC; Raghupathi, R				Duhaime, AC; Raghupathi, R			Age-specific therapy for traumatic injury of the immature brain: experimental approaches	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	IIIrd International Congress of Pathophysiology	JUN 28-JUL 03, 1998	LAHTI, FINLAND			brain, traumatic injury; immature brain, trauma; traumatic injury, brain, age-specific therapy	ACUTE SUBDURAL-HEMATOMA; EXCITATORY AMINO-ACIDS; CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; PROGRAMMED CELL-DEATH; DIFFUSE AXONAL INJURY; COMA DATA-BANK; NERVOUS-SYSTEM; IN-VIVO; NEURONAL APOPTOSIS		Univ Penn, Div Neurosurg, Sch Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA		Duhaime, AC (corresponding author), Univ Penn, Div Neurosurg, Sch Med, 34th & Civ Ctr Bldg, Philadelphia, PA 19104 USA.	DUHAIME@EMAIL.CHOP.EDU					Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; BARKS JDE, 1992, BRAIN PATHOL, V2, P235, DOI 10.1111/j.1750-3639.1992.tb00697.x; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; BULLOCK R, 1990, ACT NEUR S, V51, P274; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAO Y, 1994, P NATL ACAD SCI USA, V91, P9612, DOI 10.1073/pnas.91.20.9612; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; DAVIES AM, 1995, TRENDS NEUROSCI, V18, P355, DOI 10.1016/0166-2236(95)93928-Q; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; DIGIACOMO JE, 1992, BIOL NEONATE, V61, P25, DOI 10.1159/000243527; DUHAIME A, 1992, COMPLICATIONS SEQUEL, P169; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1996, J NEUROTRAUM, V13, P79, DOI 10.1089/neu.1996.13.79; DUHAIME AC, 1996, NEUROLOGICAL SURG, P1777; DUHAIME AC, 1996, 25 ANN M CHARL S CAR; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FERNANDEZ SC, 1996, J NEUROTRAUM, V13, P612; FINIELS F, 1995, J NEUROCHEM, V65, P1027; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; INGLIS F, 1992, J NEUROTRAUM, V9, P75, DOI 10.1089/neu.1992.9.75; Kanthan R, 1996, J NEUROL NEUROSUR PS, V60, P703; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kimura H, 1996, J COMPUT ASSIST TOMO, V20, P540, DOI 10.1097/00004728-199607000-00007; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Lawrence MS, 1996, J NEUROSCI, V16, P486; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MADSEN FF, 1990, ACTA NEUROCHIR, V106, P164, DOI 10.1007/BF01809461; MADSEN FF, 1990, ACTA NEUROCHIR, V106, P24, DOI 10.1007/BF01809329; MADSEN FF, 1987, ACTA NEUROCHIR, V88, P65, DOI 10.1007/BF01400517; MADSEN FF, 1990, ACTA NEUROCHIR, V105, P150, DOI 10.1007/BF01670000; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MCINTOSH T, 1988, FRONTIERS EXCITATORY; MCINTOSH TK, 1992, J NEUROTRAUM, V9, pS201; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MERRY DE, 1994, DEVELOPMENT, V120, P301; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; OLNEY JW, 1993, APMIS, V101, P103; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; Preston GA, 1996, MOL CELL BIOL, V16, P211; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; RAGHUPATHI R, 1995, J NEUROTRAUM, V12, P966; RINK A, 1995, AM J PATHOL, V147, P1575; RORKE LB, 1992, BRAIN PATHOL, V2, P211, DOI 10.1111/j.1750-3639.1992.tb00694.x; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; SCHWARTZ LM, 1991, BIOESSAYS, V13, P389, DOI 10.1002/bies.950130805; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; STRAUSS KI, 1996, J NEUROTRAUM, V13, P620; THOMAS JM, 1971, GROWTH, V35, P259; TZIKA AA, 1993, JMRI-J MAGN RESON IM, V3, P719, DOI 10.1002/jmri.1880030506; VANNUCCI RC, 1992, BRAIN PATHOL, V2, P229, DOI 10.1111/j.1750-3639.1992.tb00696.x; WAGERLE LC, 1986, PEDIATR RES, V20, P131, DOI 10.1203/00006450-198602000-00007	80	15	15	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	FEB	1999	51	2					172	177		10.1016/S0940-2993(99)80091-8			6	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	177NZ	WOS:000079218000009	10192586				2022-02-06	
J	Slaughter, J; Johnstone, G; Petroski, G; Flax, J				Slaughter, J; Johnstone, G; Petroski, G; Flax, J			The usefulness of the Brief Symptom Inventory in the neuropsychological evaluation of traumatic brain injury	BRAIN INJURY			English	Article								Changes in the health care delivery system are forcing clinicians to use less timely and more cost efficient measures. In rehabilitation, more efficient measures of emotional-behavioural functioning are bring administered to patients with traumatic brain injury (TBI), including thr Brief Symptom Inventory (BSI), a 53 item short version of the Symptom Checklist-90 chat assesses nine different dimensions of emotional-behavioural functioning. Because the BSI was developed for use with psychiatric populations, research of the: measure with TBI populations is needed, The current study evaluated the utility of the BSI in a sample of 62 patients (34 male, 28 female, average age 35, average education 12 years) with TBI evaluated as outpatients at a midwestern rehabilitation hospital. Results indicated that: (1) subjects endorsed clinically elevated distress on seven of the nine subscales when compared to the nonnative sample; (2) the Obsessive-Compulsive (OC) subscale achieved the highest t-score (70.31); 3) the most frequent two-point profiles included the OC-Somatic (21%) and OC-Psychoticism (13%) subscales; and (3) the Global Symptom Index was significantly correlated with all nine subscales. II was concluded that caution must be used when administering the BSI to individuals with TBI due in a lack of a TBI standardization sample, the limited number of test items per subscale, and questionable labels for the different subscales (e.g. OC subscale items appear to br more reflective of TBI-related cognitive impairment than obsessive-compulsive traits).	Univ Missouri, Sch Med, Dept Psychiat Med & Rehabil, Columbia, MO USA		Slaughter, J (corresponding author), Dept Psychiat & Neurol, 1 Hosp Dr, Columbia, MO 65212 USA.						BURKE J M, 1990, Brain Injury, V4, P223, DOI 10.3109/02699059009026171; Burke J M, 1989, Brain Inj, V3, P35, DOI 10.3109/02699058909008071; BUTCHER JN, 1990, MMPI 2 MINNESOTA MUL, V2; DAHLSTROM WG, 1972, MMPI HDB GUIDE USE C, V2; DAHLSTROM WG, 1972, MMPI HDB GUIDE USE C, V1; DEROGATIS LR, 1982, BRIEF S INVENTORY BS; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; Kaplan CP, 1998, BRAIN INJURY, V12, P199, DOI 10.1080/026990598122674; TATE DG, 1994, PARAPLEGIA, V32, P473, DOI 10.1038/sc.1994.75	10	15	15	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1999	13	2					125	130		10.1080/026990599121782			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	167HQ	WOS:000078626800005	10079957				2022-02-06	
J	Jenkins, LW; Lu, YC; Johnston, WE; Lyeth, BG; Prough, DS				Jenkins, LW; Lu, YC; Johnston, WE; Lyeth, BG; Prough, DS			Combined therapy affects outcomes differentially after mild traumatic brain injury and secondary forebrain ischemia in rats	BRAIN RESEARCH			English	Article						hypothermia; traumatic brain injury; cerebral ischemia; hippocampus; spatial memory; excitotoxicity; rat	POSTISCHEMIC HYPOTHERMIA; NEUROBEHAVIORAL DEFICITS; BEHAVIORAL DEFICITS; CEREBRAL-ISCHEMIA; GLOBAL-ISCHEMIA; HIPPOCAMPUS; SCOPOLAMINE; MK-801; VULNERABILITY; MECHANISMS	Muscarinic and NMDA receptors contribute to post-traumatic hypersensitivity to secondary ischemia. However, the effect of these receptor antagonists an behavior and CA1 neuronal death after traumatic brain injury (TBI) with acute (1 h after TBI) forebrain ischemia has not been systematically assessed. We examined cognitive and motor dysfunction and the relationship of behavior deficits to neuronal death in this model using muscarinic and NMDA antagonists. Three behavioral groups (n = 10/group) of Wister rats were subjected to mild TBI and 6 min of forebrain ischemia imposed 1 h after TBI with 45 days survival. Motor and spatial memory performance were assessed using the rotarod task and Morris water maze. Seven additional groups (n = 6/group) were evaluated only for CA1 death after 7 days survival following sham, individual or combined injury with and without drug treatments. Rats were given 0.3 mg/kg MK-801 (M) and 1.0 mg/kg scopolamine (S) alone or combined (M-S) before or 45 min after TBI. Rotarod performance was tested at days 1-5 and maze performance on days 11-15 and 40-44 after M-S treatment. The 7-day studies showed M-S treatment(p < 0.01) reduced CA1 neuronal death better than either S or M alone. Behavioral groups had inadvertent post-ischemic hypothermia that decreased CA1 death and likely influenced behavioral morbidity. M-S given before TBI (p < 0.01) decreased memory deficits on day 15, while M-S treatment given after TBI was ineffective. Unexpectedly, M-S treatment before or after TBI produced transient motor deficits (p < 0.01). Memory improvement occurred independent of CA1 death. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15260 USA; Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77550 USA; Second Mil Med Univ, Chang Zheng Hosp, Dept Neurosurg, Shanghai, Peoples R China; Univ Calif Davis, Dept Neurosurg, Sacramento, CA 95817 USA		Jenkins, LW (corresponding author), Univ Pittsburgh, Dept Neurosurg, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15260 USA.		Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X; Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035365] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35365] Funding Source: Medline		ALBERS GW, 1990, CLIN NEUROPHARMACOL, V13, P177, DOI 10.1097/00002826-199006000-00001; Baena RC, 1997, NEUROLOGY, V48, P768, DOI 10.1212/WNL.48.3.768; BOTHE HW, 1986, STROKE, V17, P1160, DOI 10.1161/01.STR.17.6.1160; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DIETRICH WD, 1995, J CEREBR BLOOD F MET, V15, P960, DOI 10.1038/jcbfm.1995.122; Dietrich WD, 1996, ADV NEUROL, V71, P177; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; GREEN EJ, 1995, BRAIN RES, V702, P145, DOI 10.1016/0006-8993(95)01034-1; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hamm RJ, 1994, NEUROBIOLOGY CENTRAL, P86; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1991, J NEUROTRAUM, V8, pS173; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; JASPERS RMA, 1990, NEUROSCI LETT, V117, P149, DOI 10.1016/0304-3940(90)90135-V; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1989, CONT ISSUES NEUROLOG, V1, P47; Levin H.S., 1996, TRAUMATIC BRAIN INJU, P105; LYDEN PD, 1992, EXP NEUROL, V116, P122, DOI 10.1016/0014-4886(92)90160-R; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marion DW, 1996, CRIT CARE MED, V24, pS81; MILLER JD, 1982, CLIN NEUR, V29, P162; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MORRIS RGM, 1981, BEHAV BRAIN RES, V2, P266, DOI 10.1016/0166-4328(81)90088-7; Morris RGM., 1983, NEUROBIOLOGY HIPPOCA, P405; SHUAIB A, 1993, NEUROSCIENCE, V56, P915, DOI 10.1016/0306-4522(93)90137-5	40	15	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 30	1999	817	1-2					132	144		10.1016/S0006-8993(98)01237-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159XZ	WOS:000078201800016	9889350				2022-02-06	
J	Newcombe, R; Merry, G				Newcombe, R; Merry, G			The management of acute neurotrauma in rural and remote locations - A set of guidelines for the care of head and spinal injuries	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						head injury; spinal injury; neurotrauma; trauma management		The Neurosurgical Society of Australasia through its Trauma Committee has a long involvement in the problem of neurotrauma. The management of acute neurotrauma in rural and remote locations is of particular interest and is part of a general policy which includes education, prevention, organization of an integrated neurotrauma system and support for the Early Management of Severe Trauma (EMST) programme instituted by the Royal Australasian College of Surgeons. The management of acute neurotrauma requires a consultative approach especially in the multiple injured patient and where transfer or retrieval is necessary. As acute neurotrauma may present to general practitioners, rural surgeons or emergency departments in country hospitals, a set of guidelines has been developed to assist in the early management of acute neurotrauma. These guidelines have been previously published by the Neurosurgical Society of Australasia and the Royal Australasian College of Surgeons. They have been extensively used since 1992 by rural health and distance education groups, Royal Flying Doctor Service Emergency Management of Severe Trauma Course of the Royal Australasian College of Surgeons and by overseas education programs for neurotrauma care. This revision updates the guidelines and makes them accessible through the Journal. Reprints are available for practitioners in rural and remote settings, trauma course participants and others.	Neurosurg Soc Australasia, Trauma Comm, Deakin, ACT 2600, Australia; Royal Australasian Coll Surg, Trauma Comm, Deakin, ACT 2600, Australia		Newcombe, R (corresponding author), Neurosurg Soc Australasia, Trauma Comm, Suite A1,161 Strickland Crescent, Deakin, ACT 2600, Australia.			Fuller, John/0000-0002-9825-9103				0	15	15	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	1999	6	1					85	93		10.1016/S0967-5868(99)90619-7			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	169QZ	WOS:000078761200026	10833574				2022-02-06	
J	Newman, LM; Diekema, DS; Shubkin, CD; Klein, EJ; Quan, L				Newman, LM; Diekema, DS; Shubkin, CD; Klein, EJ; Quan, L			Pediatric wilderness recreational deaths in western Washington State	ANNALS OF EMERGENCY MEDICINE			English	Article							INJURIES; EPIDEMIOLOGY; TREKKERS; SPORTS	Study objective: To determine the causes and characteristics of pediatric recreational wilderness deaths. Methods: All deaths of children between 12 months and 20 years of age involving a wilderness recreational activity in 5 western Washington counties between 1987 and 1996 were identified by medical examiners' logs. Univariate analysis was used to examine variables such as age, gender, activity, mechanism of injury, adult presence, blood alcohol level, safety equipment, and mode of evacuation. Results: Of 40 cases meeting inclusion criteria, 90% involved male subjects and 83% of victims were 13 to 19 years old. Hiking (33%), swimming (20%), and river rafting (10%) were the most common activities. Death was most often by drowning (55%) or closed head injury (26%). No victim was alone. All children younger than 10 years of age were accompanied by an adult, in contrast to only 26% of individuals 10 years or older. Only 4 victims had drugs or alcohol in their system. Na victim wore a personal flotation device or helmet, and only 5% had foul weather gear. Although nearly one third of victims were transported by airlift, more than half of the victims were dead at the scene. Conclusion: Males and teenagers were the 2 major risk groups for recreational wilderness deaths. Traditional activities such as hiking and swimming were the most common causes of death. Children younger than 10 years died despite the presence of an adult, whereas teenagers were usually with groups of peers. The majority of victims were not prepared for adverse events with basic safety equipment.	Univ Washington, Dept Family Med, Seattle, WA 98195 USA		Diekema, DS (corresponding author), Childrens Hosp & Reg Med Ctr, Dept Emergency Serv, Mailstop CH-04,4800 Sand Point Way NE,POB 5371, Seattle, WA 98105 USA.						BIJUR PE, 1995, ARCH PEDIAT ADOL MED, V149, P1009, DOI 10.1001/archpedi.1995.02170220075010; DIETZ PE, 1974, AM J PUBLIC HEALTH, V64, P303, DOI 10.2105/AJPH.64.4.303; GENTILE DA, 1992, ANN EMERG MED, V21, P853, DOI 10.1016/S0196-0644(05)81034-0; HENNEKENS CH, 1987, EPIDEMIOLOGY MED, P32; KRAUS JF, 1984, ANNU REV PUBL HEALTH, V5, P163; *NAT SAF COUNC, 1995, ACC FACTS, P118; *NAT SPORT GOOD AS, 1988, SPORTS PART 1988; *NAT SPORT GOOD AS, 1987, SPORT PART 1987; ORLOWSKI JP, 1987, PEDIATR ANN, V17, P128; Plueckhahn V D, 1967, Med J Aust, V2, P118; RENNIE D, 1989, JAMA-J AM MED ASSOC, V261, P1045, DOI 10.1001/jama.261.7.1045; SCHUSSMAN LC, 1990, J WILDERNESS MED, V1, P235, DOI 10.1580/0953-9859-1.4.235; SHLIM DR, 1989, JAMA-J AM MED ASSOC, V261, P1017, DOI 10.1001/jama.261.7.1017; SPRING I, 1988, 100 HIKES WASHINGTON, P20; *US CENS BUR, 1990 US CENS DAT; WINTEMUTE GJ, 1987, AM J PUBLIC HEALTH, V77, P830, DOI 10.2105/AJPH.77.7.830	16	15	15	0	2	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	DEC	1998	32	6					687	692		10.1016/S0196-0644(98)70068-X			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	149DW	WOS:000077590700008	9832665				2022-02-06	
J	Shen, PJ; Gundlach, AL				Shen, PJ; Gundlach, AL			Differential spatiotemporal alterations in adrenoceptor mRNAs and binding sites in cerebral cortex following spreading depression: Selective and prolonged up-regulation of alpha(1B)-adrenoceptors	EXPERIMENTAL NEUROLOGY			English	Article						adrenergic receptors; receptor gene regulation; cerebral cortex; spreading depression; in situ hybridization histochemistry; autoradiography	ALPHA-ADRENERGIC RECEPTOR; MESSENGER-RNA EXPRESSION; LOCUS-COERULEUS NEURONS; TRAUMATIC BRAIN INJURY; IMMEDIATE-EARLY GENE; ADULT-RAT BRAIN; BETA-2-ADRENERGIC RECEPTORS; NORADRENALINE INNERVATION; MOLECULAR-CLONING; CORTICAL-NEURONS	Noradrenaline, an important transmitter in the CNS, is involved in cerebral plasticity and functional recovery after injury. Experimental brain injury, including KCl application onto the brain surface, induces a slow-moving cortical depolarization/depression wave called cortical spreading depression (CSD). Interestingly, CSD does not produce neuronal damage but can protect cortical. neurons against subsequent neurotoxic insults, although the mechanisms involved are unknown. This study examined the status of alpha- and beta-adrenoceptors (ARs) in cerebral cortex following CSD. Anesthetized rats had unilateral CSD induced by a 10-min topical application of KCl to the frontoparietal cortex and were killed at various times thereafter. Levels of alpha(1)-, alpha(2)-, beta(1)-, and beta(2)-AR mRNA and binding were examined using in situ hybridization histochemistry and radioligand autoradiography. Levels of alpha(1b)-AR mRNA in the affected neocortex were significantly increased by 20-40% at 1, 2, and 7 days (P less than or equal to 0.01) compared with contralateral levels, but were ndt sig nificantly above control values at 2 and 4 weeks after CSD induction. Cortical alpha(1B)-AR binding sites were also increased by 45-65% 1 and 2 weeks (P less than or equal to 0.01) after CSD in a similar, but delayed, profile to alpha(1b)-AR mRNA. CSD rapidly increased beta(1)-AR mRNA by 45% at 1 h (P less than or equal to 0.01) and produced a delayed decrease of 25% in alpha(2a)-AR mRNA at 2 days and 1 week (P less than or equal to 0.05), but had no effect on corresponding levels of binding sites. In contrast, CSD had no effect on the remaining AR-subtype mRNAs or binding levels in neocortex under identical conditions. These results reveal a long-term up-regulation of alpha(1B)-ARs induced by an acute cortical stimulation/depression. Subtype-selective responses of ARs to CSD reflect an important differential regulation of expression of each receptor in vivo and suggest that alpha(1B)-ARs are particularly likely to be involved in cortical adaptive responses to physical injury at both local and distant locations. (C) 1998 Academic Press.	Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med, Clin Pharmacol & Therapeut Unit, Heidelberg, Vic 3084, Australia		Gundlach, AL (corresponding author), Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med, Clin Pharmacol & Therapeut Unit, Heidelberg, Vic 3084, Australia.	agund@austin.unimelb.edu.au	Gundlach, Andrew/X-6421-2018	Gundlach, Andrew/0000-0002-6066-9692			Arabia AM, 1998, MOL BRAIN RES, V61, P195, DOI 10.1016/S0169-328X(98)00189-2; ARABIA AM, 1996, P AUST SOC CLIN EXP, V3, P84; Arakawa S, 1997, NEUROSCIENCE, V78, P1147, DOI 10.1016/S0306-4522(96)00679-3; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; AUDET MA, 1988, J COMP NEUROL, V274, P307, DOI 10.1002/cne.902740302; Bickler PE, 1996, NEUROPHARMACOLOGY, V35, P679, DOI 10.1016/S0028-3908(96)00030-5; BING GY, 1991, MOL BRAIN RES, V11, P43, DOI 10.1016/0169-328X(91)90019-T; BLENDY JA, 1991, J NEUROCHEM, V57, P1548, DOI 10.1111/j.1471-4159.1991.tb06350.x; BOYESON MG, 1992, BRAIN RES BULL, V29, P435, DOI 10.1016/0361-9230(92)90080-H; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BUCKLAND PR, 1990, NUCLEIC ACIDS RES, V18, P682, DOI 10.1093/nar/18.3.682; Caggiano AO, 1996, J COMP NEUROL, V376, P447, DOI 10.1002/(SICI)1096-9861(19961216)376:3<447::AID-CNE7>3.0.CO;2-2; CARTER DA, 1993, ENDOCRINOLOGY, V133, P2263, DOI 10.1210/en.133.5.2263; COLLINS S, 1989, P NATL ACAD SCI USA, V86, P4853, DOI 10.1073/pnas.86.13.4853; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Day HEW, 1997, J CHEM NEUROANAT, V13, P115, DOI 10.1016/S0891-0618(97)00042-2; DIETRICH WD, 1994, J CEREBR BLOOD F MET, V14, P20, DOI 10.1038/jcbfm.1994.4; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; DYVE S, 1995, SYNAPSE, V19, P88, DOI 10.1002/syn.890190204; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; Ferry B, 1997, EUR J NEUROSCI, V9, P1356, DOI 10.1111/j.1460-9568.1997.tb01490.x; FLORDELLIS CS, 1991, P NATL ACAD SCI USA, V88, P1019, DOI 10.1073/pnas.88.3.1019; FOLLESA P, 1993, MOL PHARMACOL, V43, P132; GAO B, 1995, J BIOL CHEM, V270, P5614, DOI 10.1074/jbc.270.10.5614; GROSS RA, 1982, NEUROPHARMACOLOGY, V21, P655, DOI 10.1016/0028-3908(82)90008-9; GUNDLACH AL, 1995, BRAIN RES, V672, P214, DOI 10.1016/0006-8993(94)01338-I; GUSTAFSON I, 1990, J CEREBR BLOOD F MET, V10, P885, DOI 10.1038/jcbfm.1990.145; HADCOCK JR, 1993, J NEUROCHEM, V60, P1, DOI 10.1111/j.1471-4159.1993.tb05816.x; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V109, P1, DOI 10.1111/j.1748-1716.1980.tb06557.x; HARLEY C, 1991, PROG BRAIN RES, V88, P307; Hildebrand B, 1996, N-S ARCH PHARMACOL, V354, P404, DOI 10.1007/BF00168429; HUDSON A L, 1992, Molecular Neuropharmacology, V1, P219; INOUE M, 1991, J CEREBR BLOOD F MET, V11, P242, DOI 10.1038/jcbfm.1991.56; JACOBS O, 1994, NEUROSCIENCE, V59, P827, DOI 10.1016/0306-4522(94)90287-9; KAMISAKI Y, 1992, EUR J PHARMACOL, V217, P57, DOI 10.1016/0014-2999(92)90511-2; Karkanias GB, 1996, J NEUROENDOCRINOL, V8, P449, DOI 10.1046/j.1365-2826.1996.04716.x; KASAMATSU T, 1991, PROG BRAIN RES, V88, P599; KOBAYASHI S, 1995, J CEREBR BLOOD F MET, V15, P721, DOI 10.1038/jcbfm.1995.92; KOKAIA Z, 1993, MOL BRAIN RES, V19, P277, DOI 10.1016/0169-328X(93)90126-A; KRAIG RP, 1991, J NEUROSCI, V11, P2187; KUHAR MJ, 1990, METHODS NEUROTRANSMI, P177; LANIER SM, 1991, J BIOL CHEM, V266, P10470; LAURITZEN M, 1988, BRAIN RES, V475, P317, DOI 10.1016/0006-8993(88)90620-8; LAZ TM, 1994, MOL PHARMACOL, V46, P414; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEVIN BE, 1994, RESTOR NEUROL NEUROS, V7, P5, DOI 10.3233/RNN-1994-7102; LEW R, 1985, BRIT J PHARMACOL, V85, P341, DOI 10.1111/j.1476-5381.1985.tb08867.x; LOMASNEY JW, 1991, J BIOL CHEM, V266, P6365; MACHIDA CA, 1990, J BIOL CHEM, V265, P12960; MANTYH PW, 1995, J NEUROSCI, V15, P152; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; MASON ST, 1979, J PHARM PHARMACOL, V31, P209, DOI 10.1111/j.2042-7158.1979.tb13480.x; MATSUSHIMA K, 1995, STROKE, V26, P1047, DOI 10.1161/01.STR.26.6.1047; Matsushima K, 1996, J CEREBR BLOOD F MET, V16, P221, DOI 10.1097/00004647-199603000-00006; MCCUNE SK, 1993, NEUROSCIENCE, V57, P143, DOI 10.1016/0306-4522(93)90116-W; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; NICHOLAS AP, 1993, NEUROSCIENCE, V56, P1023, DOI 10.1016/0306-4522(93)90148-9; Nicholas AP, 1996, TRENDS PHARMACOL SCI, V17, P245, DOI 10.1016/0165-6147(96)10022-5; Obrenovitch TP, 1996, BRIT J PHARMACOL, V117, P931, DOI 10.1111/j.1476-5381.1996.tb15283.x; OLENIK C, 1991, MOL BRAIN RES, V10, P259, DOI 10.1016/0169-328X(91)90069-A; OLESKEVICH S, 1989, J NEUROSCI, V9, P3803; OSHEA BD, 1993, J NEUROENDOCRINOL, V5, P697, DOI 10.1111/j.1365-2826.1993.tb00542.x; OSHEA RD, 1994, IN SITU HYBRIDIZATIO, P57; PAVLASEK J, 1993, BRAIN RES, V628, P145, DOI 10.1016/0006-8993(93)90949-N; PETITTI N, 1992, J NEUROSCI, V12, P3869; PIERIBONE VA, 1994, J NEUROSCI, V14, P4252; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; RAINBOW TC, 1984, P NATL ACAD SCI-BIOL, V81, P1585, DOI 10.1073/pnas.81.5.1585; Reutter MA, 1997, J NEUROCHEM, V68, P47; Riekkinen M, 1996, EUR J PHARMACOL, V300, P9, DOI 10.1016/0014-2999(95)00842-X; ROBINSON JP, 1989, J NEUROCHEM, V52, P690, DOI 10.1111/j.1471-4159.1989.tb02510.x; SEGUELA P, 1990, NEUROSCIENCE, V35, P249, DOI 10.1016/0306-4522(90)90079-J; Shen P.-J., 1996, Society for Neuroscience Abstracts, V22, P1768; Shen PJ, 1998, EUR J NEUROSCI, V10, P2217, DOI 10.1046/j.1460-9568.1998.00231.x; SHEN PJ, 1995, MOL BRAIN RES, V28, P222, DOI 10.1016/0169-328X(94)00208-V; SHEN PJ, 1997, P AUST NEUROSCI SOC, V8, P96; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; SIBLEY DR, 1985, NATURE, V317, P124, DOI 10.1038/317124a0; STEINDLER DA, 1981, BRAIN RES, V223, P367, DOI 10.1016/0006-8993(81)91149-5; STOROZHUK VM, 1995, NEUROSCIENCE, V68, P315, DOI 10.1016/0306-4522(95)00131-2; SUTIN J, 1992, BRAIN RES BULL, V29, P277, DOI 10.1016/0361-9230(92)90057-5; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; UNNERSTALL JR, 1985, PHARMACOL BIOCHEM BE, V22, P859, DOI 10.1016/0091-3057(85)90538-6; VOIGT MM, 1990, NUCLEIC ACIDS RES, V18, P1053, DOI 10.1093/nar/18.4.1053; Williams AM, 1997, NEUROSCIENCE, V76, P901; WinzerSerhan UH, 1997, NEUROSCIENCE, V76, P241; WinzerSerhan UH, 1997, NEUROSCIENCE, V76, P261; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9; [No title captured]	91	15	15	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	1998	154	2					612	627		10.1006/exnr.1998.6915			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	157TW	WOS:000078078600031	9878196				2022-02-06	
J	Green, ML; Foster, MA; Morris, MK; Muir, JJ; Morris, RD				Green, ML; Foster, MA; Morris, MK; Muir, JJ; Morris, RD			Parent assessment of psychological and behavioral functioning following pediatric acquired brain injury	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						assessment; validity; pediatric; psychopathology; acquired brain injury; parent-report; CBCL; PIC-R; DICA-R; VABS	ATTENTION-DEFICIT DISORDER; CLOSED-HEAD-INJURY; PSYCHIATRIC DIAGNOSES; STRUCTURED INTERVIEWS; CHILDREN; DEPRESSION; CHECKLIST; HYPERACTIVITY; ADOLESCENTS; RELIABILITY	Objective: Compare the measured prevalence rate of psychopathology and behavior disorders in 29 children with acquired brain injuries using four parent-report instruments. Method: Two questionnaires, the Child Behavior Checklist (CBCL) and the Personality Inventory for Children (PIC-R) and two interview measures, the Diagnostic Interview for Children and Adolescents (DICA-R) and the Vineland Adaptive Behavior Scales (VABS), were completed following injury or diagnosis. Results: The DICA-R identified the highest prevalence of anxiety disorders and acting-out behaviors, whereas the CBCL identified the lowest prevalence. Opposite results were found within the domain of attentional problems. Interview measures were more concordant for global psychological impairment than were questionnaires. Discussion: Discordant findings across measures are discussed in terms of type of disorder, classification model, response format, item characteristics, and scaling.	Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA		Green, ML (corresponding author), Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA.	mlgreen@mindspring.com			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R18MH047958] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH47958] Funding Source: Medline		Achenbach T, 1983, MANUAL CHILD BEHAV C; BIEDERMAN J, 1993, J CHILD PSYCHOL PSYC, V34, P1241, DOI 10.1111/j.1469-7610.1993.tb01785.x; BOYLE MH, 1993, J ABNORM CHILD PSYCH, V21, P663, DOI 10.1007/BF00916449; BRESLAU N, 1985, J AM ACAD CHILD PSY, V24, P87, DOI 10.1016/S0002-7138(09)60415-5; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Butler K, 1997, CHILD NEUROPSYCHOL, V3, P98, DOI 10.1080/09297049708401371; CARLSON GA, 1987, J AM ACAD CHILD PSY, V26, P645, DOI 10.1097/00004583-198709000-00006; Ciccetti D., 1984, VINELAND ADAPTIVE BE; CLARK E, 1987, J PSYCHOEDUCATIONAL, V5, P99; COHEN MJ, 1994, J EMOT BEHAV DISORD, V2, P31, DOI 10.1177/106342669400200104; Cole DA, 1997, J CONSULT CLIN PSYCH, V65, P110, DOI 10.1037/0022-006X.65.1.110; CRAIGHEAD WE, 1995, PSYCHOL ASSESSMENT, V7, P171, DOI 10.1037/1040-3590.7.2.171; Derogatis L.R., 1992, SCL 90 R ADM SCORING; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; DYKENS EM, 1992, J AM ACAD CHILD PSY, V31, P1131, DOI 10.1097/00004583-199211000-00023; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; HARTMANN DP, 1977, J APPL BEHAV ANAL, V10, P103, DOI 10.1901/jaba.1977.10-103; HEPPERLIN CM, 1990, J AFFECT DISORDERS, V18, P105, DOI 10.1016/0165-0327(90)90066-H; HERJANIC B, 1982, J ABNORM CHILD PSYCH, V10, P307, DOI 10.1007/BF00912324; HODGES K, 1993, J CHILD PSYCHOL PSYC, V34, P49, DOI 10.1111/j.1469-7610.1993.tb00967.x; Hodges K., 1990, PSYCHOL ASSESSMENT J, V2, P489; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; HOOPER SR, 1995, ANXIETY DISORDERS CH; JENSEN PS, 1993, AM J PSYCHIAT, V150, P1203; Jensen PS, 1996, J ABNORM CHILD PSYCH, V24, P151, DOI 10.1007/BF01441482; Kamphaus R. W., 1996, CLIN ASSESSMENT CHIL; KASHANI JH, 1985, J AM ACAD CHILD PSY, V24, P437, DOI 10.1016/S0002-7138(09)60561-6; KAZDIN AE, 1995, CONDUCT DISORDERS CH; KLINE RB, 1988, CAN J BEHAV SCI, V20, P251, DOI 10.1037/h0079929; KRONENBERG Y, 1988, ACTA PSYCHIAT SCAND, V77, P194, DOI 10.1111/j.1600-0447.1988.tb05100.x; LACHAR D, 1986, ASSESSMENT CHILD ADO; LACHAR D, 1979, ACTUARIAL ASSESSMENT; LEVIN HS, 1995, TRAUMATIC HEAD INJUR; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; MCCUBBIN HI, 1983, FAMILY ASSESSMENT IN; PEARSON DA, 1994, J SCHOOL PSYCHOL, V32, P33, DOI 10.1016/0022-4405(94)90027-2; PERRIN EC, 1991, J PEDIATR PSYCHOL, V16, P411, DOI 10.1093/jpepsy/16.4.411; PRENDERGAST M, 1988, J CHILD PSYCHOL PSYC, V29, P289, DOI 10.1111/j.1469-7610.1988.tb00717.x; RABINOWITZ J, 1993, J MIND BEHAV, V14, P297; REICH W, 1987, J ABNORM CHILD PSYCH, V15, P601, DOI 10.1007/BF00917244; Reich W., 1988, REVISED VERSION DIAG; Reynolds W. M., 1994, HDB DEPRESSION CHILD; RIS MD, 1994, J CLIN EXP NEUROPSYC, V16, P21, DOI 10.1080/01688639408402615; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; STEINGARD R, 1992, J AM ACAD CHILD PSY, V31, P449, DOI 10.1097/00004583-199205000-00010; SYLVESTER CE, 1987, J AM ACAD CHILD PSY, V26, P668, DOI 10.1097/00004583-198709000-00010; WILSON FE, 1983, BEHAV ASSESS, V5, P15; WIRT RD, 1977, MULTIDIMENSIONAL DES	49	15	15	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693			J PEDIATR PSYCHOL	J. Pediatr. Psychol.	OCT	1998	23	5					289	299		10.1093/jpepsy/23.5.289			11	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	164XX	WOS:000078489800002	9782677	Green Published, Bronze			2022-02-06	
J	Scheibel, RS; Levin, HS; Clifton, GL				Scheibel, RS; Levin, HS; Clifton, GL			Completion rates and feasibility of outcome measures: Experience in a multicenter clinical trial of systemic hypothermia for severe head injury	JOURNAL OF NEUROTRAUMA			English	Article						completion rates; outcome; head injury; clinical trial; hypothermia	PRACTICAL SCALE; COMA; DISABILITY	The National Acute Brain Injury Study: Hypothermia (NABIS:H) is an ongoing multicenter trial of systemic hypothermia for the treatment of severe head injury. Follow-up rates for the study's 3- and 6-month outcome assessments have been maintained at high levels by establishing close contact with family members, by reimbursing cost of travel, and by sending examiners to the subject's location whenever necessary. Two years into the study, global disability data (e.g., Glasgow Outcome Scale) have been obtained on 86% of patients due for 3-month assessment (n = 131) and for all subjects due at 6 months (n = 100), Over half of the patients have completed neuropsychological testing with high reliability ratings, These preliminary findings suggest that the procedures used to document data quality and increase follow-up and completion rates are being successful.	Baylor Coll Med, PM&R Res Off, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Univ Texas, Houston Med Sch, Dept Neurosurg, Houston, TX USA		Levin, HS (corresponding author), Baylor Coll Med, PM&R Res Off, Dept Phys Med & Rehabil, 333 Moursund Ave,Rm A205, Houston, TX 77030 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-32786] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS032786] Funding Source: NIH RePORTER		Benton A., 1978, MULTILINGUAL APHASIA; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; FOULKES MA, 1991, J NEUROSURG, V75, pS1, DOI 10.3171/sup.1991.75.1s.00s1; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEVIN H S, 1990, Annales de Readaptation et de Medecine Physique, V33, P35; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARHSALL LF, 1991, J NEUROSURG, V75, pS28; Matthews C, 1964, INSTRUCTIONAL MANUAL; PETRUCELLI E, 1982, INT BIBLIO ABBREVIAT; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; TEASDALE G, 1974, LANCET, V2, P81	20	15	15	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	1998	15	9					685	692		10.1089/neu.1998.15.685			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	118ZT	WOS:000075871400004	9753216				2022-02-06	
J	Talmor, D; Roytblat, L; Artru, AA; Yuri, O; Koyfman, L; Katchko, L; Shapira, Y				Talmor, D; Roytblat, L; Artru, AA; Yuri, O; Koyfman, L; Katchko, L; Shapira, Y			Phenylephrine-induced hypertension does not improve outcome after closed head trauma in rats	ANESTHESIA AND ANALGESIA			English	Article							CEREBRAL BLOOD-FLOW; BRAIN EDEMA; 5-PERCENT DEXTROSE; RAPID INFUSION; NEUROLOGICAL STATUS; 0.9-PERCENT SALINE; INFARCT VOLUME; INJURY; MAGNESIUM; ISCHEMIA	Phenylephrine-induced hypertension (increase of 30-35 mm Hg for 15 min) is reported to increase cerebral perfusion pressure and collateral flow to ischemic areas of the brain in a rat model of focal cerebral ischemia. In the present study, we examined whether phenylephrine-induced hypertension of similar magnitude and duration was beneficial in a rat model of closed head trauma (CHT). Forty-eight rats were randomized into four experimental conditions: CHT at time 0 min (yes/no), plus phenylephrine-induced hypertension (increase of 30-35 mm Hg for 15 min) at 65 min (yes/no). CHT was delivered using a weight-drop device (0.5 J). Outcome measures were neurological severity score (NSS) at 1, 4, and 24 h, and brain tissue specific gravity (microgravimetry) and injury volume (2,3,5-triphenyltetrazoium chloride) at 24h. After CHT, NSS at 24h (median +/- range) and brain tissue specific gravity (mean +/- so, injured hemisphere) were 7 +/- 2 and 1.033 +/- 0.007 without phenylephrine and 8 +/- 2 and 1.035 +/- 0.005 with phenylephrine (P = 0.43), respectively. Tissue injury volume (mean +/- so) was 335 +/- 92 mm(3) without phenylephrine and 357 +/- 154 mm(3) with phenylephrine (P > 0.62). The results of our study indicate that postinjury treatment with 15 min of phenylephrine-induced hypertension does not attenuate brain edema, reduce tissue injury volume, or improve neurological outcome after CHT in rats. Implications: Phenylephrine-induced hypertension is reported to increase cerebral perfusion pressure and blood flow in a rat model of focal cerebral ischemia. In our study, phenylephrine-induced hypertension did not decrease brain edema or tissue injury volume or improve neurological outcome in a rat model of closed head trauma.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Ben Gurion Univ Negev, Div Anesthesiol, Soroka Med Ctr, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; Kaplan Hosp, Dept Anesthesiol, IL-76100 Rehovot, Israel		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Box 356540, Seattle, WA 98195 USA.	artruaa@u.washington.edu					BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; DRUMMOND JC, 1989, STROKE, V20, P1538, DOI 10.1161/01.STR.20.11.1538; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P183; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Gurevich B, 1997, ANESTH ANALG, V84, P554, DOI 10.1097/00000539-199703000-00016; Gurevich B, 1998, J NEUROSURG, V88, P1066, DOI 10.3171/jns.1998.88.6.1066; MARMAROU A, 1978, J NEUROSURG, V49, P503; MICHENFELDER JD, 1977, STROKE, V8, P87, DOI 10.1161/01.STR.8.1.87; Narayan RK, 1996, NEUROTRAUMA; NELSON SR, 1971, J APPL PHYSIOL, V30, P268, DOI 10.1152/jappl.1971.30.2.268; Pittman JE, 1997, ANESTHESIOLOGY, V87, P1139, DOI 10.1097/00000542-199711000-00018; ROGERS AT, 1988, ANESTHESIOLOGY, V69, P547, DOI 10.1097/00000542-198810000-00015; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P51, DOI 10.1097/00008506-199701000-00012; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1995, ANESTHETIC MANAGEMEN, P285; ULRICH K, 1985, STROKE, V16, P880, DOI 10.1161/01.STR.16.5.880	25	15	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	SEP	1998	87	3					574	578		10.1097/00000539-199809000-00014			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	114QW	WOS:000075621200014	9728831				2022-02-06	
J	Yang, SY; Cui, JZ				Yang, SY; Cui, JZ			Expression of the basic fibroblast growth factor gene in mild and more severe head injury in the rat	JOURNAL OF NEUROSURGERY			English	Article						brain injury; basic fibroblast growth factor gene expression; exogenous basic fibroblast growth factor; treatment; rat	CENTRAL-NERVOUS-SYSTEM; DIFFUSE BRAIN INJURY; MESSENGER-RNA; NEURONS; IMMUNOREACTIVITY; DIFFERENTIATION; INCREASE; ISCHEMIA; MODEL	Object. The goal of this study was to investigate the relationship between basic fibroblast growth factor (bFGF) gene expression and neuropathological changes in the hippocampus after varying degrees of brain injury. Methods. Mild and severe brain injury in rats was produced by using Marmarou's method. There were 25 animals in each brain injury group and 25 additional animals served as controls. Basic fibroblast growth factor gene expression was investigated by means of RNA hybridization, in situ hybridization, immunohistochemical analysis, and histological analysis using hematoxylin and eosin staining. A 3.7-kb bFGF messenger (m)RNA was detected in the rat hippocampus in both control and injured rats. In the mild injury group its expression was increased at 12 hours after injury and peaked on the 3rd day. Neuronal degeneration in the hippocampal CA2 and CA3 sectors was maximum on that day. In the severe injury group, the expression of the bFGF gene was the same as that in the mild injury group at corresponding times, but the number of surviving neurons in the CA2 and CA3 sectors was much lower than in the mild injury group. In situ hybridization showed that the main cells that expressed bFGF mRNA were pyramidal and granulocytic neurons in all three experimental groups. The number of neurons expressing bFGF mRNA in the severe injury group was less than that in the mild injury group, but the intensity of expression was greater. Immunohistochemical staining showed that the number of neurons expressing the bFGF protein was less in the severe injury group than in the mild injury group. Conclusions. It is concluded that after mild injury then is a close relationship between the expression of the bFGF gene and the degree of histological change in the hippocampus; this indicates that as one of the growth factors, bFGF may participate in the protection and repair processes of neurons following brain injury. In severe injury there is a reduced expression of bFGF. The reason for this appears to be that more of the cells that have the potential to express bFGF have died, reducing the ability of express the bFGF gene. Conversely, it is possible that there may be an intrinsic insufficiency of expression of the gene, compatible with the known vulnerability of the hippocampus to many pathological conditions. Consideration should be given to supplying exogenous bFGF to protect the brain, particularly the hippocampus, after injury.	Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 30052, Peoples R China		Yang, SY (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 An Shan Rd, Tianjin 30052, Peoples R China.						CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CUEVAS P, 1994, NEUROL RES, V16, P365; CUEVAS P, 1986, 8TH INT S MICR AN CE, P731; DAI ZS, 1995, J NEUROSCI, V15, P5466; ERNFORS P, 1990, J NEUROSCI RES, V27, P10, DOI 10.1002/jnr.490270103; FINKLESTEIN SP, 1990, STROKE, V21, P122; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Ghosh MM, 1995, BIOREMED SER, V3, P15; GIORDANO S, 1992, DEV BIOL, V152, P293, DOI 10.1016/0012-1606(92)90136-5; HAMERMAN D, 1987, P SOC EXP BIOL MED, V186, P384; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; IWATA H, 1991, BRAIN RES, V550, P329, DOI 10.1016/0006-8993(91)91336-Y; KIYOTA Y, 1991, BRAIN RES, V545, P322, DOI 10.1016/0006-8993(91)91307-M; KUMON Y, 1993, BRAIN RES, V605, P169, DOI 10.1016/0006-8993(93)91369-4; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MENON VK, 1994, EXP NEUROL, V129, P142, DOI 10.1006/exnr.1994.1155; MORRISON RS, 1987, J NEUROSCI RES, V17, P99, DOI 10.1002/jnr.490170202; Sambrook J, 1989, MOL CLONING LAB MANU; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SCHMITZ GG, 1991, ANAL BIOCHEM, V192, P222, DOI 10.1016/0003-2697(91)90212-C; SHIMASAKI S, 1988, BIOCHEM BIOPH RES CO, V157, P256, DOI 10.1016/S0006-291X(88)80041-X; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; WALICKE PA, 1988, J NEUROSCI, V8, P2618; YUGUCHI T, 1994, MOL BRAIN RES, V25, P50, DOI 10.1016/0169-328X(94)90277-1	26	15	20	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	AUG	1998	89	2					297	302		10.3171/jns.1998.89.2.0297			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	104CM	WOS:000074994900017	9688126				2022-02-06	
J	Taher, AAY				Taher, AAY			Management of weapon injuries to the craniofacial skeleton	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						firearms; craniofacial injuries; classification; management; complications	FRACTURES	One thousand one hundred thirty-five patients suffering from different types of facial injuries caused by various weapons were treated in two university hospitals in Tehran, Iran from 1984 to 1990. The referred patients suffered from one of three types of facial injuries: soft-tissues injuries, 9.16% (N = 104); bone fractures, 18.15% (N = 206); and soft-tissue injuries and bone fractures (mixed injuries), 72.69% (N = 825). The number of male patients was greater than females (1,123 males and 12 females). Anatomically the facial injuries were classified into seven groups (lower third; middle third; upper third; lower and middle third; lower and upper third; middle and upper third; and lower, middle, and upper third). Lower-third facial injuries were the most common injuries, 72.60% (N = 824); followed by the middle-third injuries, 36.30% (N = 412); and the upper-third injuries, 20% (N = 227). The mandible was the most common site of injury in the lower-third injuries, zygomatico-orbital fractures were the most common site in the middle-third injuries, and the frontal bone was the most common site in the upper-third injuries. Of the total number of patients, 3.17% were children (N = 36) with different types of maxillofacial injuries. The majority of the injuries (52.42%; N = 595) were from bullets. The most common injuries not associated with maxillofacial injuries were head and ocular injuries. The least common were abdominal injuries. The head injuries were classified into five grades according to clinical and computed tomographic findings. Treatment of facial injuries ranged from minor repair and/or closed reduction to major soft-tissue and/or bone reconstruction. Postinjury complications were very high. The follow-up period ranged from 3 months to 3 years. The aim of this study is to add our experience in the management of facial injuries to the literature.	Baqiet Ulla Univ Hosp, Head Oral & Maxillofacial Surg Dept, Tehran, Iran		Taher, AAY (corresponding author), 147 Park Lane, Wembley HA9 7SD, Middx, England.		TAHER, ABBAS/O-5098-2017	TAHER, ABBAS/0000-0003-2417-6687			ABIOSE BO, 1986, BRIT J ORAL MAX SURG, V24, P31, DOI 10.1016/0266-4356(86)90037-9; AJAGB HA, 1980, E AFR MED J, V80, P227; ALABOSSI K, 1970, INT J ORAL SURG, V5, P8; AMOTO JJ, 1972, J CARDIOVASC SURG, V13, P147; BAKER SP, 1967, J TRAUMA, V6, P510; BANKS P, 1985, MAXILLOFACIAL INJURI, V2, P563; BARTKOWSKI SB, 1982, J MAXILLOFAC SURG, V10, P155, DOI 10.1016/S0301-0503(82)80033-7; CARTER E, 1982, AUST DENT J, V27, P227, DOI 10.1111/j.1834-7819.1982.tb04102.x; CONVERS JM, 1957, BR J PLASTIC SURG, V9, P264; CONVERSE JM, 1967, PLAST RECONSTR SURG, V39, P20, DOI 10.1097/00006534-196701000-00002; CULBERTSON WW, 1983, OTOLARYNG CLIN N AM, V16, P563; DAWSON TLG, 1953, BRIT J SURG, V41, P354; Dortzbach R K, 1987, Adv Ophthalmic Plast Reconstr Surg, V6, P287; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; GRINKLER RR, 1966, CEREBRUM CEREBRAL HE, P63; KEER NW, 1966, BR J ORAL SURG, V4, P132; MATRAS H, 1980, J CRANIOMAXILLOFAC S, V8, P25; MORGAN WC, 1971, ORAL SURG ORAL MED O, V9, P231; SHEPHERD JP, 1987, BRIT J PLAST SURG, V40, P614, DOI 10.1016/0007-1226(87)90157-3; SHUKER S, 1986, J ORAL MAXIL SURG, V44, P152, DOI 10.1016/0278-2391(86)90202-8; STYLOGIANNI L, 1991, BRIT J ORAL MAX SURG, V29, P9, DOI 10.1016/0266-4356(91)90164-Z; Taher A A, 1993, J Craniofac Surg, V4, P21; Taher A A, 1992, J Craniofac Surg, V3, P90, DOI 10.1097/00001665-199209000-00008; TAHER AAY, 1990, J CRANIO MAXILL SURG, V18, P310, DOI 10.1016/S1010-5182(05)80538-4; TAHER AAY, 1994, PLAST RECONSTR SURG, V93, P441, DOI 10.1097/00006534-199402000-00046; TAHER AAY, 1986, BRIT J ORAL MAX SURG, V24, P44, DOI 10.1016/0266-4356(86)90039-2; TAHER AAY, 1993, ORAL SURG ORAL MED O, V75, P433, DOI 10.1016/0030-4220(93)90165-Z; TAHER AAY, 1993, J CRANIO MAXILL SURG, V21, P360, DOI 10.1016/S1010-5182(05)80499-8; TAHER AAY, 1993, MED J IRAN, V7, P17; TAHER AAY, 1992, MED J ISLAMIC REPUBL, V6, P201; TAHER AAY, 1993, J CRANIOFAC SURG, V4, P53; THORESBY FP, 1967, BRIT J SURG, V54, P359, DOI 10.1002/bjs.1800540509	32	15	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	1049-2275			J CRANIOFAC SURG	J. Craniofac. Surg.	JUL	1998	9	4					371	382		10.1097/00001665-199807000-00015			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	101PA	WOS:000074876300015	9780933				2022-02-06	
J	Al-Turki, A; Armstead, WM				Al-Turki, A; Armstead, WM			Altered release of prostaglandins by opioids contributes to impaired cerebral hemodynamics following brain injury	CRITICAL CARE MEDICINE			English	Article						pigs, newborn; cerebral circulation; opioids; prostaglandins; brain injury; trauma; radioimmunoassay; cerebrospinal fluid; thromboxane; prostacyclin	PIAL ARTERY VASODILATION; NEWBORN PIG BRAIN; HEAD-INJURY; VASCULAR-RESPONSES; UNITED-STATES; RAT-BRAIN; ISCHEMIA; ABNORMALITIES; ACETYLCHOLINE; PHOSPHOLIPIDS	Objectives: After fluid percussion brain injury (FPI) in the newborn pig, pial arteries constrict and responses to dilator stimuli, including opioids, are blunted. This study was designed to determine if altered release of prostaglandins contributes to blunted opioid dilation of cerebral arteries in newborn piglets following brain injury. Design: Prospective, in vivo, cerebral hemodynamic animal study. Setting: University research laboratory. Subjects: Newborn (1- to 5-days old) piglets of either gender. Interventions: In anesthetized, newborn, 1- to 5-day-old pigs, a closed cranial window was used to measure pial artery diameter and to collect cortial periarachnoid cerebrospinal fluid (CSF) for determination of 6-keto-PGF(1 alpha), the stable metabolite of prostaglandin I-2 (PGI(2)) and thromboxane B-2 (TXB2), the stable metabolite of TXA(2), via radioimmunoassay. FPI of moderate severity (1.9 to 2.3 atmospheres) was produced by using a pendulum to strike a piston on a saline-filled cylinder that was fluid coupled to the brain via a hollow screw inserted through the cranium. Measurements and Main Results: Methionine enkephalin (Met) vasodilation was blunted after FPI but was partially restored with indomethacin pretreatment (5 mg/kg iv) (8 +/- 1 [SEM] %, 13 +/- 1%, and 20 +/- 1% vs. 1 +/- 1%, 3 +/- 1%, and 5 +/- 1% vs. 7 +/- 1%, 10 +/- 1%, and 15 +/- 1%, respectively, for 10(-10), 10(-8),and 10(-6) M Met during control conditions, after FPI, and after FPI pretreated with indomethacin, n = 6). Similarly, restoration of Met dilation after FPI was observed with SQ 29,548, a TXA(2) antagonist. Met-induced 6-keto-PGF(1 alpha) release was blunted following FPI (889 +/- 20, 1130 +/- 33, and 1886 +/- 59 vs. 2630 +/- 36, 2775 +/- 30, and 2825 +/- 36 pg/mL for control, 10(-10), and 10(-6) M Met before and after FPI, respectively, n = 6). In contrast, Met-induced TXB2 release was enhanced after FPI (340 +/- 20, 423 +/- 25, and 473 +/- 30 pg/mL vs. 518 +/- 30, 726 +/- 90, and 901 +/- 35 pg/mL for control, 10(-10), and 10(-6) M Met before and after FPI, respectively, n = 6). Leucine enkephalin-and dynorphin-induced dilation and associated prostaglandin release were similarly altered following FPI. beta endorphin-induced constriction was enhanced following FPI, and these potentiated responses were blunted after indomethacin or SQ 29,548 pretreatment. Conclusions: These data show that FPI increases CSF 6-keto-PGF(1 alpha) and TXB2 concentrations. These data suggest that altered release of prostaglandins by opioids contribute to impaired cerebral hemodynamics following FPI in piglets.	Childrens Hosp Philadelphia, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Crit Care Med, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesia, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.						ARMSTEAD WM, 1990, J PHARMACOL EXP THER, V255, P1083; Armstead WM, 1996, J NEUROTRAUM, V13, P115, DOI 10.1089/neu.1996.13.115; ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; ARMSTEAD WM, 1992, P SOC EXP BIOL MED, V199, P149; ARMSTEAD WM, 1988, AM J PHYSIOL, V255, pH401, DOI 10.1152/ajpheart.1988.255.2.H401; ARMSTEAD WM, 1989, J PHARMACOL EXP THER, V251, P1012; AVELDANO MI, 1975, J NEUROCHEM, V25, P919, DOI 10.1111/j.1471-4159.1975.tb04432.x; BAZAN NG, 1971, J NEUROCHEM, V18, P1387, DOI 10.1111/j.1471-4159.1971.tb00003.x; DEVINE JO, 1995, BRAIN RES, V675, P257, DOI 10.1016/0006-8993(95)00081-Z; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; ELLIS EF, 1989, J NEUROTRAUM, V6, P331; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Hall E D, 1985, Cent Nerv Syst Trauma, V2, P75; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; LEFFLER CW, 1989, STROKE, V20, P541, DOI 10.1161/01.STR.20.4.541; LEFFLER CW, 1989, PEDIATR RES, V25, P180; LEFFLER CW, 1990, PROSTAGLANDINS, V40, P241, DOI 10.1016/0090-6980(90)90012-K; LEFFLER CW, 1985, PROSTAGLANDINS, V30, P811, DOI 10.1016/0090-6980(85)90009-7; LEFFLER CW, 1992, AM J PHYSIOL, V263, pH746, DOI 10.1152/ajpheart.1992.263.3.H746; LESCOHIER I, 1993, PEDIATRICS, V91, P721; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; SPINEDI A, 1990, J NEUROCHEM, V54, P778, DOI 10.1111/j.1471-4159.1990.tb02318.x; Tepas J J 3rd, 1995, Semin Pediatr Surg, V4, P120; Thorogood MC, 1996, ANESTHESIOLOGY, V84, P614, DOI 10.1097/00000542-199603000-00017; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; VINK R, 1990, J NEUROSCI, V10, P3524; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; WESTCOTT JY, 1987, PROSTAGLANDINS, V34, P877, DOI 10.1016/0090-6980(87)90068-2; ZALESKA MM, 1989, J NEUROCHEM, V52, P255, DOI 10.1111/j.1471-4159.1989.tb10925.x	39	15	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	MAY	1998	26	5					917	925		10.1097/00003246-199805000-00029			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZL791	WOS:000073471900023	9590323				2022-02-06	
J	von Bierbrauer, A; Weissenborn, K				von Bierbrauer, A; Weissenborn, K			P300 after minor head injury (a follow-up examination)	ACTA NEUROLOGICA BELGICA			English	Article						minor head injury; cognitive auditory evoked potential; P300; follow-up	EVENT-RELATED POTENTIALS; EVOKED-POTENTIALS; AUDITORY-STIMULI; MENTAL STATE; LATENCY; ENCEPHALOPATHY; CONCUSSION; RECOVERY	Background and methods : The aim of the study was to examine whether - like in severe head injuries - the endogenous evoked potential P300 is influenced by minor head injury (MHI) and how the eventual abnormalities develop within a follow-up period of 8 weeks. after trauma. Therefore we examined the cognitive auditory evoked potential P300 (latency: amplitude), the neurologic state and the performance in psychometric testing (Mini-Mental-State, Number Connection test part A and B) in 15 patients within the first 24 hours as well as 1, 3 and 8 weeks after MHI. The P300 results were compared to the age-related normal ranges under consideration of the intra-individual variability. For both parameters normative values were established before in our own laboratory. Results : For the patient group as a whole the mean values for P300 latency and amplitude were always within the age-related normal range and normal intraindividual long-term variability of healthy controls, respectively. Significant posttraumatic prolongations of P300 latency were exclusively observed in the only 20% of our patients with clinically suspected posttraumatic organic brain syndrome. These prolongations of latency decreased during follow-up and on the last examination the latencies were normalised Compared to psychometric tests, P300 latency seems to be more sensitive in early detection of cerebral dysfunction. Conclusions : We conclude that, in contrast to severe head injury, in general the P300 is not affected by minor head injury. If there are clinical signs of organic brain syndrome following MHI posttraumatic prolongation of P300 latency is a marker of cerebral dysfunction and may serve as a valuable parameter for follow-up examination and documentation.	Hannover Med Sch, Dept Neurol & Clin Neurophysiol, D-3000 Hannover, Germany		von Bierbrauer, A (corresponding author), Univ Marburg Klinikum, Zentrum Innere Med, Med Abt, Poliklin, Baldinger Str, D-35033 Marburg, Germany.						BROOKS N, 1979, INT REHABIL MED, V1, P166; Brown W S, 1982, Bull Los Angeles Neurol Soc, V47, P91; COHEN SN, 1983, NEUROLOGY, V33, P1219, DOI 10.1212/WNL.33.9.1219; CONN HO, 1977, AM J DIG DIS, V22, P541, DOI 10.1007/BF01072510; Donchin E., 1979, EVOKED BRAIN POTENTI, P13, DOI DOI 10.1007/978-1-4684-3462-0_2; DRAKE ME, 1987, CLIN EVOKED POTENTIA, V5, P19; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOODIN DS, 1978, ELECTROEN CLIN NEURO, V44, P447, DOI 10.1016/0013-4694(78)90029-9; GOODIN DS, 1978, BRAIN, V101, P635, DOI 10.1093/brain/101.4.635; GRONWALL D, 1974, LANCET, V2, P605; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; KWENTUS JA, 1985, PSYCHOSOMATICS, V1, P8; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MANDELBERG IA, 1976, J NEUROL NEUROSUR PS, V36, P1001; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, V38, P275, DOI 10.1001/archneur.1981.00510050041004; NOTERMANS SLH, 1986, EUR ARCH PSY CLIN N, V235, P292, DOI 10.1007/BF00515916; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; POLICH J, 1986, ELECTROEN CLIN NEURO, V65, P236, DOI 10.1016/0168-5597(86)90059-6; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUIJS MBM, 1993, NEUROPEDIATRICS, V24, P307, DOI 10.1055/s-2008-1071562; RUSSEL WR, 1971, TRAUMATIC AMNESIAS; SKLARE DA, 1984, ELECTROEN CLIN NEURO, V59, P420, DOI 10.1016/0168-5597(84)90043-1; WEISSENBORN K, 1990, ELECTROEN CLIN NEURO, V75, P289, DOI 10.1016/0013-4694(90)90107-U; WEISSENBORN K, 1990, THESIS HANNOVER; WEISSENBORN K, 1988, Z EEG EMG, V19, P276; WERNER RA, 1991, ARCH PHYS MED REHAB, V72, P31; ZAMRINI EY, 1991, INT J NEUROSCI, V61, P113, DOI 10.3109/00207459108986279	29	15	15	0	1	ACTA MEDICA BELGICA	BRUSSELS	AVENUE CIRCULAIRE 138-A, B-1180 BRUSSELS, BELGIUM	0300-9009			ACTA NEUROL BELG	Acta Neurol. Belg.	MAR	1998	98	1					21	26					6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZT707	WOS:000074116600004	9606435				2022-02-06	
J	Martin, RC; Franzen, MD; Orey, S				Martin, RC; Franzen, MD; Orey, S			Magnitude of error as a strategy to detect feigned memory impairment	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	24th Annual Meeting of the International-Neuropsychological-Society	FEB 14-17, 1996	CHICAGO, ILLINOIS	Int Neuropsychol Soc, US PHS, Natl Inst Aging, Alzheimers Dis Cooperat Study			MILD HEAD-INJURY; SIMULATION; VALIDATION; DEFICITS	The present study introduced a magnitude of error method as a new malingering detection strategy. Thirty university students were requested to either simulate a memory impairment or to try their best. Magnitude of response error was also investigated in a group of 30 nonlitigating moderate to severe closed-head-injured patients, and 7 suspected clinical malingerers. Probability of selection values were calculated across multiple choice items from tests of recognition memory adapted for the WMS-R Logical and Visual Reproduction Memory subtests. These value scores were employed to identify analog and clinical malingerers. Analog and suspected clinical malingerers were much more likely to select low probability multiple-choice items, and often endorsed choices that neither controls nor moderate to severe CHI patients endorsed. Probability of selection value scores were able to classify 86% of the analog and 100% of the suspected clinical malingerers with 100% specificity for controls.	Univ Alabama, Dept Neurol, Epilepsy Ctr, Civitan Int Res Ctr 312, Birmingham, AL 35294 USA; Allegheny Gen Hosp, Allegheny Neuropsychiat Inst, Pittsburgh, PA 15212 USA; Univ Kentucky, Lexington, KY USA		Martin, RC (corresponding author), Univ Alabama, Dept Neurol, Epilepsy Ctr, Civitan Int Res Ctr 312, 1719 6th Ave S, Birmingham, AL 35294 USA.			Martin, Roy/0000-0001-9328-0846			Benton A., 1994, CONTRIBUTIONS NEUROP; BENTON AL, 1961, ARCH GEN PSYCHIAT, V4, P79; BERG EA, 1948, J GEN PSYCHOL, V6, P143; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; Bolter J. F., 1985, ANN M NAT AC NEUR PH; BRUHN AR, 1975, J PERS ASSESS, V39, P244, DOI 10.1207/s15327752jpa3903_5; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; CICCHETTI DV, 1994, J CLIN EXP NEUROPSYC, V16, P155, DOI 10.1080/01688639408402625; DEFILIPPIS NA, 1975, BOOKLET CATEGORY TES; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Halstead WC, 1947, BRAIN INTELLIGENCE Q; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; IVERSON GL, 1994, ARCH CLIN NEUROPSYCH, V9, P437, DOI 10.1016/0887-6177(94)90006-X; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Milanovich JR, 1996, ARCH CLIN NEUROPSYCH, V11, P53, DOI 10.1016/0887-6177(95)00016-X; MILLER H, 1972, LANCET, V1, P580; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PAUL DS, 1992, INT J CLIN NEUROPSYC, V14, P1; Rawling P, 1990, NEUROPSYCHOLOGY, V4, P223, DOI 10.1037/0894-4105.4.4.223; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rosenfeld JP, 1996, CLIN NEUROPSYCHOL, V10, P163, DOI 10.1080/13854049608406678; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Wechsler D, 1987, MEMORY SCALE REVISED	32	15	15	0	14	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	1998	12	1					84	91		10.1076/clin.12.1.84.1722			8	Psychology, Clinical; Clinical Neurology; Psychology	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ZE592	WOS:000072810000009					2022-02-06	
J	Chobor, KL; Schweiger, A				Chobor, KL; Schweiger, A			Processing of lexical ambiguity in patients with traumatic brain injury	JOURNAL OF NEUROLINGUISTICS			English	Article							SENTENCE COMPREHENSION	The goal of this study was to determine the type of cognitive functions required for the interpretation of lexical ambiguity. Brain-injured and normal subjects performed lexical decision (reaction time) and matching tasks, using three categories of ambiguous words: homonymy, polysemy and metaphor. Patients showed much slower reaction times on metaphor than normals, while accuracy rates for matching were comparable, suggesting relative intactness of the semantic interpretations of these words despite a retrieval deficit.	NYU Med Ctr, Dept Neurol, New York, NY 10016 USA; CUNY, Grad Ctr, Dept Speech & Hearing Sci, New York, NY 10021 USA		Chobor, KL (corresponding author), NYU Med Ctr, Dept Neurol, New York, NY 10016 USA.						BEARDSLEY MC, 1962, PHILOS PHENOMEN RES, V22, P293, DOI 10.2307/2104415; Brown JW, 1997, SYNTH LIBR, V258, P35; BROWNELL HH, 1990, NEUROPSYCHOLOGIA, V28, P375, DOI 10.1016/0028-3932(90)90063-T; BROWNELL HH, 1984, BRAIN LANG, V100, P717; CHIARELLO C, 1988, RIGHT HEMISPHERE CON, P59; DURKIN K, 1989, J PSYCHOLINGUIST RES, V18, P577, DOI 10.1007/BF01067161; GAGNON L, 1994, SEMANTIC PROCESSING; GARDNER H, 1983, COGNITIVE PROCESSING, P169; GARDNER H, 1994, 41 NEBR S MOT 1992 1; GAZZANIGA MS, 1983, AM PSYCHOL, V38, P525, DOI 10.1037/0003-066X.38.5.525; GILHOOLY KJ, 1980, BEHAV RES METH INSTR, V12, P428, DOI 10.3758/BF03201694; GOLDSTEIN K, 1948, LANGUAGE LANGUAGE DI; HARRIS AJ, 1958, MANUAL DIRECTIONS AD; Heaton R.K., 1981, WISCONSIN CARD SORTI; Kertesz A., 1982, W APHASIA BATTERY; KRASHEN SD, 1976, STUDIES NEUROLINGUIS, V2, P157; Lakoff G, 1993, CONT THEORY METAPHOR; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Luria A.R., 1966, HIGHER CORTICAL FUNC; MILBERG W, 1987, BRAIN LANG, V31, P138, DOI 10.1016/0093-934X(87)90065-4; ONIFER W, 1981, MEM COGNITION, V9, P225, DOI 10.3758/BF03196957; Ortony A., 1993, METAPHOR THOUGHT; Raven J. C., 1960, GUIDE STANDARD PROGR; SEARLEMAN A, 1977, PSYCHOL BULL, V84, P503, DOI 10.1037/0033-2909.84.3.503; SIMPSON GB, 1984, PSYCHOL BULL, V96, P316, DOI 10.1037/0033-2909.96.2.316; SIMPSON GB, 1987, COGNITIVE SYSTEMS, V2, P213; SWINNEY D, 1982, PERSPECTIVES MENTAL; SWINNEY DA, 1979, J VERB LEARN VERB BE, V18, P645, DOI 10.1016/S0022-5371(79)90355-4; Winner E., 1977, BRAIN, V100, P719; Zachary R., 1991, SHIPLEY I LIVING SCA; ZIFF P, 1967, FDN LANGUAGE, V3, P403	31	15	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0911-6044			J NEUROLINGUIST	J. Neurolinguist.	JAN-APR	1998	11	1-2					119	136		10.1016/S0911-6044(98)00009-8			18	Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Linguistics; Neurosciences & Neurology; Psychology	ZN372	WOS:000073639300010					2022-02-06	
J	Tate, RL				Tate, RL			"It is not only the kind of injury that matters, but the kind of head": The contribution of premorbid psychosocial factors to rehabilitation outcomes after severe traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							SEQUELAE	Two studies are reported examining the influence of premorbid psychosocial variables in determining rehabilitation outcomes after traumatic brain injury (TBI). The focus of Study 1 was indices of premorbid social maladjustment (PSM). A consecutive series of 85 subjects with TBI admitted to a rehabilitation unit was assessed 6 years post-trauma. Eleven subjects (13%) had evidence of PSM. These subjects were matched on age, gender, and severity of injury with 11 subjects in the series without evidence of PSM. There were no differences between the groups regarding overall outcome on the Glasgow Outcome Scale, level of psychosocial reintegration, or severity of neuropsychological impairments. The aim of Study 2 was to examine premorbid personality characteristics in subjects with TBI. An independent sample of 30 subjects was followed prospectively. As soon after the injury as feasible, a detailed psychosocial history was obtained from a close relative, who also rated the premorbid personality of the TBI person using the Eysenck Personality Questionnaire-Revised (EPQ-R). Nine subjects had evidence of poor premorbid histories and 17 subjects had unremarkable histories. Significant group differences were demonstrated for three of the six EPQ-R scales (Psychoticism, Addiction, and Criminality). Comparison of the two groups regarding the severity of neuropsychological impairments and level of psychosocial reintegration achieved by 6 months post-trauma, however, revealed no significant differences, replicating the results of the first study. Correlational analyses indicated that only severity of injury, and not premorbid personality variables, was related to psychosocial functioning.	Univ Sydney, Dept Psychol A16, Sydney, NSW 2006, Australia			robynt@psychvax.psych.su.oz.au					Brooks N, 1988, Acta Neurochir Suppl (Wien), V44, P59; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; DeFilippis NA, 1979, BOOKLET CATEGORY TES; Delis DC, 1987, CALIFORNIA VERBAL LE; DODWELL D, 1988, PSYCHOL MED, V18, P495, DOI 10.1017/S0033291700008035; Eysenck HJ., 1991, MANUAL EYSENCK PERSO; FAHY TJ, 1967, LANCET, V2, P475; Field, 1976, EPIDEMIOLOGY HEAD IN; Folkman S., 1984, STRESS; Heaton R.K., 1981, WISCONSIN CARD SORTI; JAMIESON KG, 1971, HEAD INJURIES, P12; JAMIESON KG, 1966, 13 NAT HLTH MED RES; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1984, CLOSED HEAD INJURY P, P37; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KOZOL HL, 1946, ARCH NEURO PSYCHIATR, V56, P245, DOI 10.1001/archneurpsyc.1946.02300200002001; KOZOL HL, 1945, ARCH NEURO PSYCHIATR, V53, P358, DOI 10.1001/archneurpsyc.1945.02300050032004; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lishman W. A., 1987, ORGANIC PSYCHIAT PSY; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LONDON PS, 1967, ANN ROY COLL SURG, V41, P4; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; ODDY M, 1984, CLOSED HEAD INJURY P, P108; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; Prigatano G. P., 1987, NEUROPSYCHOL REHABIL, P355; Selecki B R, 1967, Med J Aust, V2, P113; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Smith A., 1982, SYMBOL DIGIT MODALIT; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Symonds CP, 1943, LANCET, V1, P7; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TATE RL, 1996, P 5 C INT ASS STUD T; TSUANG MT, 1985, AM J PSYCHIAT, V142, P538; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Walsh KW., 1991, UNDERSTANDING BRAIN; WEINSTEIN GS, 1981, J CLIN PSYCHIAT, V42, P120; [No title captured]; [No title captured]	43	15	16	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN	1998	8	1					1	18		10.1080/713755554			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	YW987	WOS:000071994900001					2022-02-06	
J	Vaz, R; Sarmento, A; Borges, N; Cruz, C; Azevedo, I				Vaz, R; Sarmento, A; Borges, N; Cruz, C; Azevedo, I			Effect of mechanogated membrane ion channel blockers on experimental traumatic brain oedema	ACTA NEUROCHIRURGICA			English	Article						brain oedema; mechanogated; ion channels; trauma	SMOOTH-MUSCLE CELLS; HEAD-INJURY; VASCULAR-PERMEABILITY; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; XENOPUS OOCYTES; K+ CHANNELS; FATTY-ACIDS; EDEMA; STRETCH	Traumatic head injury leads to marked swelling of endothelial cells, both in human patients and in Marmarou's rat model. We used this model to test the hypothesis of mechanogated ion channels being involved in the formation of traumatic brain oedema. All mechanogated channel blockers tested (gadolinium, amiloride, gentamicin) significantly reduced traumatic brain oedema evaluated by Evans blue extraction ratio, either when given 15 minutes before or 30 minutes after induction of trauma (evaluation 2 hours after trauma). These results clearly support our hypothesis, opening a new way for the investigation of the treatment of a clinical situation endowed with high morbidity and mortality.	Hosp Sao Joao, Fac Med, Dept Neurosurg, P-4200 Oporto, Portugal; Hosp Sao Joao, Fac Med, Inst Pharmacol & Therapeut, P-4200 Oporto, Portugal		Vaz, R (corresponding author), Hosp Sao Joao, Fac Med, Dept Neurosurg, Alameda Prof Hernani Monteiro, P-4200 Oporto, Portugal.		Borges, Nuno/K-7051-2013; Sarmento, Antonio/M-5235-2013	Sarmento, Antonio/0000-0001-5269-7231; Vaz, Rui/0000-0001-7527-8187; Borges, Nuno/0000-0001-6357-0615			BENDER AS, 1994, ACTA NEUROCHIR, P28; BULLOCK R, 1985, J NEUROSURG, V63, P64, DOI 10.3171/jns.1985.63.1.0064; CHAN PH, 1984, NEUROLOGY, V34, P315, DOI 10.1212/WNL.34.3.315; DENK W, 1992, J NEUROPHYSIOL, V68, P927, DOI 10.1152/jn.1992.68.3.927; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; GRABOWSKI EF, 1985, J LAB CLIN MED, V105, P36; HADJUCKZOK G, 1994, J CLIN INVEST, V94, P2392; HAMILL OP, 1992, TRENDS PHARMACOL SCI, V13, P373, DOI 10.1016/0165-6147(92)90115-M; Hamill OP, 1996, PHARMACOL REV, V48, P231; Hariri R J, 1994, Neurosurg Clin N Am, V5, P687; HIGGINS CF, 1995, J PHYSIOL-LONDON, V482P, pS31; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JORGENSEN F, 1985, ACTA PHYSIOL SCAND, V124, P249; JUKKA Y, 1995, BIOPHYS J, V68, P1888; KIM DH, 1995, J PHYSIOL-LONDON, V484, P643, DOI 10.1113/jphysiol.1995.sp020693; KIMELBERG HK, 1979, BRAIN RES, V173, P111; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KIRBER MT, 1992, FEBS LETT, V297, P24, DOI 10.1016/0014-5793(92)80319-C; KITA H, 1994, ACTA NEUROCHIR, P452; LANE JW, 1993, BRIT J PHARMACOL, V108, P116, DOI 10.1111/j.1476-5381.1993.tb13449.x; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; MEVES H, 1994, PROG NEUROBIOL, V43, P175, DOI 10.1016/0301-0082(94)90012-4; MILLER VM, 1988, AM J PHYSIOL, V255, pH446, DOI 10.1152/ajpheart.1988.255.3.H446; MILLET B, 1988, BIOPHYS J, V53, pA155; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NARUSE K, 1993, AM J PHYSIOL, V264, pC1037, DOI 10.1152/ajpcell.1993.264.4.C1037; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NOMURA K, 1990, J MEMBRANE BIOL, V115, P241, DOI 10.1007/BF01868639; PENN RD, 1982, HEAD INJURY, P233; PETROU S, 1994, J GEN PHYSIOL, V103, P471, DOI 10.1085/jgp.103.3.471; STRIRINSKY VP, 1989, J CELL BIOL, V109, P331; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; VANDENBRINK WA, 1994, ACTA NEUROCHIR WIE S, V60, P455; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; VIGNE P, 1989, J BIOL CHEM, V264, P7663; Wahl M, 1993, Acta Neurochir Suppl (Wien), V57, P64; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; YOUNG W, 1994, NEUROBIOLOGY CENTRAL, P123	42	15	15	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1998	140	4					371	375		10.1007/s007010050111			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ZT038	WOS:000074041400011	9689329				2022-02-06	
J	Feldman, Z; Gurevitch, B; Artru, AA; Shapira, Y; Reichenthal, E				Feldman, Z; Gurevitch, B; Artru, AA; Shapira, Y; Reichenthal, E			Neurologic outcome with hemorrhagic hypotension after closed head trauma in rats: Effect of early versus delayed conservative fluid therapy	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						blood pressure; head trauma; hemorrhage; intravenous fluid; neurologic outcome; rats	BRAIN INJURY; INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; SMALL-VOLUME; SHOCK; RESUSCITATION; MANAGEMENT; INFUSION	Objective: This study examined (1) whether two previously reported, well-established models in rats, one a model of hemorrhagic hypotension and the other a model of closed head trauma, could be combined to evaluate neurologic outcome when hemorrhage occurs subsequent to head injury, and (2) the ability of the traditional, conservative approach to fluid therapy (3 mL of intravenous fluid for 1 mL of blood loss) to reverse the detrimental effects of hemorrhagic hypotension after closed head trauma, In addition, two strategies of fluid therapy (early and delayed) were examined. Methods: Fifty-six Sprague-Dawley male rats were divided into five groups with head injury at time 0 in groups 3 to 5, hemorrhage at 1 hour in groups 1, 2, 4, and 5, and intravenous fluid at 15 minutes (groups 2 and 5) or 60 minutes (groups 1 and 4) after hemorrhage. Head injury was delivered using a weight-drop impact of 0.5 J onto the closed cranium, Neurologic Severity Score (NSS) was determined at 1 hour (just before hemorrhage) and at 4 hours. Results: NSS at 1 hour did not differ between groups 3 to 5 (15.5 (9-24) to 16 (2-21), median (range)), The amount of bleeding did not differ between groups during the first 15 minutes of hemorrhage (2.8 +/- 0.8 to 3.7 +/- 2.0 mL, mean +/- SD), After 60 minutes, cumulative blood loss in the delayed fluid therapy groups was less (3.1 +/- 1.13 mL in group 1 and 4.25 +/- 2.39 mL in group 4) than in the early fluid therapy groups (7.73 +/- 4.41 mL in group 2 and 6.85 +/- 2.36 mL in group 5) (analysis of variance, p < 0.01), The NSS of group 3 (head injury only) improved at 4 hours after injury (12 (5-20)), whereas the NSS of groups 4 and 5 (head injury followed by hemorrhage) deteriorated (24 (17-25) and 19.5 (9-25), respectively) (Kruskal-Wallis test, p < 0.05). In all the hemorrhage groups, fluid therapy failed to restore blood pressure to prehemorrhage levels. Conclusion: It is concluded that the two individual models of hemorrhagic hypotension and closed head trauma in rats can be combined to evaluate outcome when hemorrhage occurs subsequent to head injury, Furthermore, traditional, conservative fluid therapy, whether early or delayed, failed to restore blood pressure or to improve NSS when hemorrhage occurred after head injury, Blood loss was greater with early fluid therapy whether or not head injury was present.	SOROKA MED CTR,DEPT NEUROSURG,IL-84101 BEER SHEVA,ISRAEL; SOROKA MED CTR,DEPT ANESTHESIOL,IL-84101 BEER SHEVA,ISRAEL; BEN GURION UNIV NEGEV,FAC HLTH SCI,BEER SHEVA,ISRAEL; UNIV WASHINGTON,SCH MED,DEPT ANESTHESIOL,SEATTLE,WA 98195					Feldman, Zeev/0000-0002-9719-3894			BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR SUPP, V59, P121; CHESNUT RM, 1993, HEAD INJURY, P459; GRADY MS, 1995, ANESTHETIC MANAGEMEN, P87; GUNNAR W, 1988, SURGERY, V103, P398; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KRAUSZ MM, 1992, J TRAUMA, V33, P6, DOI 10.1097/00005373-199207000-00002; LAM AM, 1995, ANESTHETIC MANAGEMEN, P181; MARSHALL LF, 1982, CLIN NEUR, V29, P312; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; RABINOVICI R, 1989, SURG GYNECOL OBSTET, V169, P137; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; TOMPKINS P, 1997, 10 INT S INTR PRESS, P5; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011	22	15	15	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	1997	43	4					667	672		10.1097/00005373-199710000-00017			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	YD167	WOS:A1997YD16700023	9356065				2022-02-06	
J	Motohashi, O; Suzuki, M; Shida, N; Umezawa, K; Sugai, K; Yoshimoto, T				Motohashi, O; Suzuki, M; Shida, N; Umezawa, K; Sugai, K; Yoshimoto, T			Hirudin suppresses the invasion of inflammatory cells and the appearance of vimentin-positive astrocytes in the rat cerebral ablation model	JOURNAL OF NEUROTRAUMA			English	Article						hirudin; reactive astrocyte reactive gliosis; thrombin; trauma	GROWTH-FACTOR; ENDOTHELIAL-CELLS; LEUKOCYTE ADHESION; NEURITE OUTGROWTH; THROMBIN-RECEPTOR; PROTEASE NEXIN-1; PROLIFERATION; MACROPHAGES; CULTURE; ASTROBLASTS	Hirudin is a specific and direct-acting thrombin inhibitor superior to heparin as an anticoagulant. Thrombin is a multifunctional molecule that acts as a serine protease locally generated from prothrombin during blood coagulation related to injury and/or inflammation. We previously reported that thrombin might be involved in the inflammatory response, glial reaction, and scar formation that occurred in central nervous system (CNS). Here we studied the suppressive effects of hirudin on the inflammation, vimentin-positive astrocytes, and glial fibrillary acidic protein (GFAP)-positive astrocytes using rat cerebral ablation models. Hirudin and vehicle solution soaked in Gelform (R) were administered to the cavity of the traumatic brain defect. Brains were examined by conventional histologic and immunohistologic technique. Antibodies for monocytes/macrophages, GFAP, and vimentin were used to assess the infiltration of inflammatory cells and reaction of astrocytes. The number of the inflammatory cells, vimentin-positive astrocytes, and GFAP-positive astrocytes were quantitatively analyzed. Hirudin suppressed the infiltration of inflammatory cells and the increase in vimentin-positive astrocytes, but had no effects on the increase in GFAP-positive astrocytes. These data suggest that thrombin may play an important role in inflammatory and glial responses to CNS injury, and that hirudin can be a candidate for the therapeutic agent that minimizes the secondary brain damage following the inflammation, and the glial reaction mediated by vimentin-positive astrocytes near the lesion site.	IWATE MED UNIV, DEPT NEUROSURG, MORIOKA, IWATE 020, JAPAN		Motohashi, O (corresponding author), TOHOKU UNIV, SCH MED, DEPT NEUROSURG, AOBA KU, 1-1 SEIRYO MACHI, SENDAI, MIYAGI 98077, JAPAN.						ALBRIGHTSON CR, 1992, J PHARMACOL EXP THER, V263, P404; BIGNAMI A, 1989, INT J DEV NEUROSCI, V7, P343, DOI 10.1016/0736-5748(89)90056-7; CAVANAUGH KP, 1990, J NEUROCHEM, V54, P1735, DOI 10.1111/j.1471-4159.1990.tb01228.x; DIJKSTRA CD, 1985, ADV EXP MED BIOL, V186, P409; FENTON JW, 1991, HAEMOSTASIS, V21, P27; FITZGERALD D, 1994, ANN NY ACAD SCI, V714, P41, DOI 10.1111/j.1749-6632.1994.tb12029.x; FURUKAWA S, 1986, BIOCHEM BIOPH RES CO, V136, P57, DOI 10.1016/0006-291X(86)90876-4; GABALDON M, 1992, ATHEROSCLEROSIS, V93, P217, DOI 10.1016/0021-9150(92)90258-I; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; GURWITZ D, 1990, J CELL PHYSIOL, V142, P155, DOI 10.1002/jcp.1041420119; HARLAN JM, 1986, J CELL BIOL, V103, P1129, DOI 10.1083/jcb.103.3.1129; HERBERT JM, 1994, BIOCHEM J, V303, P227, DOI 10.1042/bj3030227; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; JANECZKO K, 1991, FOLIA HISTOCHEM CYTO, V29, P55; JOHNSON PH, 1994, ANNU REV MED, V45, P165, DOI 10.1146/annurev.med.45.1.165; JONES A, 1990, IMMUNOLOGY, V71, P236; KAVANAUGH WM, 1988, J BIOL CHEM, V263, P8470; LORET C, 1989, J BIOL CHEM, V264, P8319; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167; OHTANI H, 1992, VIRCHOWS ARCH A, V420, P403, DOI 10.1007/BF01600511; PERRAUD F, 1987, INT J DEV NEUROSCI, V5, P181, DOI 10.1016/0736-5748(87)90028-1; PURO DG, 1990, GRAEF ARCH CLIN EXP, V228, P169, DOI 10.1007/BF00935728; REANTRAGOON S, 1994, ARCH BIOCHEM BIOPHYS, V314, P315, DOI 10.1006/abbi.1994.1448; SCHIFFER D, 1986, BRAIN RES, V374, P110, DOI 10.1016/0006-8993(86)90399-9; SHANKAR R, 1992, J BIOL CHEM, V267, P9376; SMINIA T, 1986, THYMUS, V8, P141; SMINIA T, 1986, IMMUNOBIOLOGY, V172, P72, DOI 10.1016/S0171-2985(86)80053-5; SMINIA T, 1986, CALCIFIED TISSUE INT, V39, P263, DOI 10.1007/BF02555216; TAKAMIYA Y, 1988, DEV BRAIN RES, V38, P201, DOI 10.1016/0165-3806(88)90045-4; TAS PWL, 1990, EXP CELL RES, V189, P22, DOI 10.1016/0014-4827(90)90251-5; TESFAMARIAM B, 1994, CIRC RES, V74, P930, DOI 10.1161/01.RES.74.5.930; VANDERBRUGGEGAMELKOORN GJ, 1985, IMMUNOBIOLOGY, V169, P553, DOI 10.1016/S0171-2985(85)80009-7; WORTWEIN G, 1994, BEHAV BRAIN RES, V63, P127, DOI 10.1016/0166-4328(94)90083-3	34	15	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	1997	14	10					747	754		10.1089/neu.1997.14.747			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YE057	WOS:A1997YE05700006	9383093				2022-02-06	
J	Butler, PB; Farmer, SE; Major, RE				Butler, PB; Farmer, SE; Major, RE			Improvement in gait parameters following late intervention in traumatic brain injury: a long-term follow-up report of a single case	CLINICAL REHABILITATION			English	Article								Objective: To evaluate the effect of using an optimally adjusted fixed ankle foot orthosis to control knee pain and promote improvement in gait parameters in a subject with hemiplegia following a traumatic brain injury 11 years previously. Design: This is the report of a single case, using gait laboratory facilities to monitor force alignment relative to the knee and single leg balance time with the subject barefoot. Subject: A 35-year-old woman with a right hemiplegia seen 11 years after onset. Intervention: A polypropylene fixed ankle foot orthosis was supplied to the hemiplegic limb and shoe modifications were made to optimize the position of the ground reaction force relative to the knee during stance phase of gait. This orthosis was used on a daily basis for one year. Results: Knee pain was controlled after three months use of the orthosis. Graphical results of force alignment during stance phase of gait are presented for initial assessment and at one and four years postorthotic supply. A large knee-extending effect was noted on the hemiplegic limb at initial assessment and this was reduced by 67% of its initial value at one year. A compensatory early heel lift was initially noted on the opposite limb and this was reduced by 42% of the initial height at one year. These results were maintained at four years. Right leg standing balance was not initially possible but was recorded as 5 s duration at three months and this was maintained at one and at four years. Conclusions: The use of an optimally adjusted ankle foot orthosis was effective in controlling knee pain and improving barefoot gait parameters with maintenance of the improvement alter use of the orthosis was discontinued. Further research is required to fully establish the potential of this approach in subjects with traumatic brain injury.	ROBERT JONES & AGNES HUNT ORTHOPAED HOSP NHS TRUS,ORTHOT RES & LOCOMOTOR ASSESSMENT UNIT,OSWESTRY SY10 7AG,SHROPS,ENGLAND; NEWCASTLE GEN HOSP,DEPT REG MED PHYS,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND		Butler, PB (corresponding author), ROBERT JONES & AGNES HUNT ORTHOPAED HOSP NHS TRUS,MOVEMENT CTR,OSWESTRY SY10 7AG,SHROPS,ENGLAND.						BUTLER PB, 1992, DEV MED CHILD NEUROL, V34, P567; Butler PB., 1991, PHYSIOTHERAPY, V77, P81, DOI DOI 10.1016/S0031-9406(10)63580-8; KADABA MP, 1989, ORTHOP T, V13, P329; MAJOR RE, 1992, CLIN REHABIL S, V6, P52; Meadows CB, 1995, CONS C LOW LIMB ORTH, P57; ROSENTHAL RK, 1975, J BONE JOINT SURG AM, VA 57, P545, DOI 10.2106/00004623-197557040-00019; TAIT JH, 1979, J MED ENG TECHNOL, V3, P252, DOI 10.3109/03091907909160665; TEGROEN JA, 1964, S AFR MED J, V38, P502; Wells R P, 1981, Bull Prosthet Res, V10-35, P15; Winter DA., 1987, BIOMECHANICS MOTOR C; ZIV I, 1984, DEV MED CHILD NEUROL, V26, P94; [No title captured]	12	15	15	0	2	ARNOLD, HODDER HEADLINE PLC	LONDON	338 EUSTON ROAD, LONDON, ENGLAND NW1 3BH	0269-2155			CLIN REHABIL	Clin. Rehabil.	AUG	1997	11	3					220	226		10.1177/026921559701100305			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	YA659	WOS:A1997YA65900005	9360034				2022-02-06	
J	Primus, EA; Bigler, ED; Anderson, CV; Johnson, SC; Mueller, RM; Blatter, D				Primus, EA; Bigler, ED; Anderson, CV; Johnson, SC; Mueller, RM; Blatter, D			Corpus striatum and traumatic brain injury	BRAIN INJURY			English	Article							HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; DEMENTIA; MEMORY	The possibility of a 'subcortical' syndrome differentially affecting memory in traumatic brian injury (TBI) subjects was examined. Magnetic resonance imaging scans of 46 traumatic brain injured male patients were compared with those of 34 male control subjects. Surface area measurements of the corpus striatum were calculated for both groups. Results demonstrated no significant differences in corpus striatum surface area measurements. Additionally, TBI patients were grouped according to severity of injury, as well as degree of corpus striatum atrophy, and neuropsychological outcome was examined. There were modest (r = 0.35) but significant correlations between corpus striatum degeneration and the delayed recall trial and total score of the Rey Auditory Verbal Learning Test, but no other correlations between neuropsychological and corpus striatal surface area were significant. Because subcortical pathology may have a differential effect on memory, recognition and recall memory were further analysed, but no significant differences were found. TBI subjects with the smallest corpus striatum values did not test significantly different from TBI patients with normal corpus striatum values or differences in cortical atrophy, as determined by a ventricle-to-brain ratio. These findings suggest that there is not a unique pattern of subcortical pathology involving the corpus striatum in TBI.	LDS HOSP,SALT LAKE CITY,UT		Primus, EA (corresponding author), BRIGHAM YOUNG UNIV,DEPT PSYCHOL,POB 25543,PROVO,UT 84602, USA.			Mueller, Reed/0000-0002-9881-7734			ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; AYLWARD EH, 1994, NEUROLOGY, V44, P823, DOI 10.1212/WNL.44.5.823; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BIGLER ED, 1997, NEUROIMAGING INTERAC, P163; BIGLER ED, 1996, TRAUMATIC BRAIN INJU, V2; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; COTE L, 1991, BASAL GANGLIA, P647; CUMMINGS JL, 1990, SUBCORTICAL DEMENTIA, P3; Gabrieli JDE, 1996, NEUROPSYCHOLOGY, V10, P322, DOI 10.1037/0894-4105.10.3.321; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gean AD, 1994, IMAGING HEAD TRAUMA; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Heaton RK, 1991, COMPREHENSIVE NORMS; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949, DOI 10.1001/archneur.1993.00540090052010; MAHURIN RK, 1993, COGNITION PARKINSONS, P308; MASSMAN PJ, 1990, J CLIN EXP NEUROPSYC, V12, P729, DOI 10.1080/01688639008401015; *MAYO FDN, 1986, BIOM IM RES ANALYZE; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; PARKER R, 1990, TRAUMATIC BRAIN INJU; Rey A., 1964, EXAMEN CLIN PSYCHOL; RIFAI Z, 1994, ARCH NEUROL-CHICAGO, V51, P90, DOI 10.1001/archneur.1994.00540130124021; ROSENTHAL M, 1993, TRAUMATIC BRAIN INJU; SALMON DP, 1989, ARCH NEUROL-CHICAGO, V46, P1204, DOI 10.1001/archneur.1989.00520470060028; SPREEN O, 1991, COMPENDIUM NEUROPSYC, P1800; TROSTER AI, 1993, J CLIN EXP NEUROPSYC, V15, P773, DOI 10.1080/01688639308402595; TROSTER AI, 1989, BRAIN LANG, V37, P500, DOI 10.1016/0093-934X(89)90032-1; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0	36	15	15	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	AUG	1997	11	8					577	586					10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XL930	WOS:A1997XL93000003	9251866				2022-02-06	
J	Henley, CM; Wey, K; Takashima, A; Mills, C; Granmayeh, E; Krishnappa, I; Robertson, CS				Henley, CM; Wey, K; Takashima, A; Mills, C; Granmayeh, E; Krishnappa, I; Robertson, CS			S-adenosylmethionine decarboxylase activity is decreased in the rat cortex after traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						S-adenosylmethionine decarboxylase; polyamines; brain injury; edema; trauma	CORTICAL IMPACT INJURY; MURINE LEUKEMIA-CELLS; ORNITHINE DECARBOXYLASE; CEREBRAL-ISCHEMIA; ALPHA-DIFLUOROMETHYLORNITHINE; POLYAMINE METABOLISM; CA-2+ FLUXES; STIMULATION; METHIONINE; RECOVERY	S-Adenosyl-L-methionine decarboxylase (SAMdc) and L-ornithine decarboxylase (ODC) are major enzymes regulating polyamine synthesis. Following ischemia, putrescine content increases as a result of post-traumatic activation of ODC and inhibition of SAMdc. These alterations are thought to mediate edema and cell death. The purpose of this study was to quantify SAMdc activity and edema in the brain following controlled cortical impact injury. Anesthetized adult male rats underwent a right parietal craniectomy and were subjected to cortical impact injury. Tissues were obtained from three bilateral regions: parietal cortex, motor area (CPm); parietal cortex, somatosensory area (CPs); and the pyriform cortex (CPF). SAMdc activity was determined in the postmitochondrial fraction from homogenates of fresh, unfrozen tissues by measuring the decarboxylation of S-adenosyl-L-[carboxyl-C-14] methionine. Basal SAMdc activity was determined in unoperated rats, and regional differences were noted: Activity was lower in the CPF than in the CPm and CPs. SAMdc activity decreased to the greatest extent in the ipsilateral CPm (impact site) from 1 to 72 h following traumatic brain injury. Significant edema was found in the ipsilateral CPm 1, 8, 16, 24, and 48 h after injury. Decreased SAMdc activity impairs the conversion of putrescine to polyamines and may contribute to delayed pathological changes in the brain after traumatic injury.	BAYLOR COLL MED, DEPT NEUROSURG, HOUSTON, TX 77030 USA		Henley, CM (corresponding author), BAYLOR COLL MED, BOBBY R ALFORT DEPT OTORHINOLARYNGOL & COMMUNICAT, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS027616, P01NS027616] Funding Source: NIH RePORTER		BACKOUS DD, 1994, OTOLARYNG HEAD NECK, V111, P377, DOI 10.1177/019459989411100401; Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 1996, J NEUROTRAUM, V13, P85, DOI 10.1089/neu.1996.13.85; BONDY SC, 1986, BRAIN RES, V371, P96, DOI 10.1016/0006-8993(86)90814-0; BYERS TL, 1993, BIOCHEM J, V290, P115, DOI 10.1042/bj2900115; BYERS TL, 1992, BIOCHEM J, V287, P717, DOI 10.1042/bj2870717; CESTARO B, 1994, ACTA NEUROL SCAND, V89, P32, DOI 10.1111/j.1600-0404.1994.tb05407.x; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; CROZAT A, 1992, ENDOCRINOLOGY, V130, P1131, DOI 10.1210/en.130.3.1131; DEMPSEY R J, 1988, Neurological Research, V10, P141; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; DIENEL GA, 1985, J NEUROCHEM, V44, P600, DOI 10.1111/j.1471-4159.1985.tb05454.x; GILAD GM, 1992, BIOCHEM PHARMACOL, V44, P401, DOI 10.1016/0006-2952(92)90428-L; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Henley C., 1996, Society for Neuroscience Abstracts, V22, P1184; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; HENLEY CM, 1995, HEARING RES, V84, P99, DOI 10.1016/0378-5955(95)00017-X; IQBAL Z, 1985, BIOCHEM BIOPH RES CO, V133, P563, DOI 10.1016/0006-291X(85)90943-X; KLEIHUES P, 1975, BRAIN RES, V95, P61, DOI 10.1016/0006-8993(75)90207-3; KOENIG H, 1983, P NATL ACAD SCI-BIOL, V80, P7210, DOI 10.1073/pnas.80.23.7210; KOENIG H, 1983, NATURE, V305, P530, DOI 10.1038/305530a0; KOMULAINEN H, 1987, BRAIN RES, V401, P50, DOI 10.1016/0006-8993(87)91162-0; KOZUKA M, 1988, JPN J PHARMACOL, V46, P225, DOI 10.1254/jjp.46.225; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; MATSUI Y, 1987, EUR J PHARMACOL, V144, P211, DOI 10.1016/0014-2999(87)90521-8; MORRISON LD, 1993, DEV BRAIN RES, V73, P237, DOI 10.1016/0165-3806(93)90143-X; MUSZYNSKI CA, 1993, J CEREBR BLOOD F MET, V13, P1033, DOI 10.1038/jcbfm.1993.131; PAJUNEN AEI, 1978, J NEUROCHEM, V30, P281, DOI 10.1111/j.1471-4159.1978.tb07066.x; PASCHEN W, 1988, BRAIN RES, V453, P9, DOI 10.1016/0006-8993(88)90138-2; PASCHEN W, 1994, NEUROPHARMACOLOGY PO, P223; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; PEGG AE, 1983, METHOD ENZYMOL, V94, P234; Rao AM, 1997, MOL BRAIN RES, V44, P134, DOI 10.1016/S0169-328X(96)00245-8; ROHN G, 1992, EXP NEUROL, V117, P210, DOI 10.1016/0014-4886(92)90129-E; RUSSELL DH, 1985, DRUG METAB REV, V16, P1, DOI 10.3109/03602538508991430; SATO H, 1988, BIOCHEM BIOPH RES CO, V150, P491, DOI 10.1016/0006-291X(88)90547-5; SCOTT RH, 1994, NEUROPHARMACOLOGY PO, P205; SEYOUM G, 1994, EXP TOXICOL PATHOL, V46, P177, DOI 10.1016/S0940-2993(11)80077-1; SHOHAMI E, 1992, EXP NEUROL, V117, P189, DOI 10.1016/0014-4886(92)90126-B; STURMAN JA, 1975, J NEUROCHEM, V25, P267, DOI 10.1111/j.1471-4159.1975.tb06964.x; TROUT JJ, 1986, LAB INVEST, V55, P622	42	15	15	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUL	1997	69	1					259	265					7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	XF431	WOS:A1997XF43100031	9202318				2022-02-06	
J	Ruhmann, O; Wirth, CJ; Gosse, F				Ruhmann, O; Wirth, CJ; Gosse, F			Trapezius transfer in deltoid paralysis	ORTHOPADE			German	Article						trapezius transfer; brachial plexus palsy	BRACHIAL-PLEXUS INJURIES; SHOULDER; SURGERY	In most cases the genesis of brachial plexus palsy is traumatic, often because of bike accidents. If physiotherapy and neurosurgical procedures such as nerve repair do not have the desired outcome, muscle transfer operations are possible. The results of our favored transfer of the trapezius muscle to compensate paralysis of the deltoid muscle will be presented. Preoperatively radiological, clinical and electromyographic examinations are necessary. Our results are based upon the clinical and radiological check ups and the subjective assessment of the patients. Thirty-one patients (7 female, 24 male) underwent a trapezius transfer between March 1994 and December 1996. The average age was 29 years (range 18-46 years). We performed the operations using a modification of Saha's technique. With the patient in lateral decubitus position and protection of the opposite plexus, a sagital skin incision is the first step, followed by the preparation of trapezius and deltoid muscle as well as the bony parts of the shoulder (acromion, clavicle, scapular spine). The deltoid origin is cut from the lateral third of the clavicle, the acromion and the lateral half of the scapular spine. The next step is transection of the root of the acromion and the lateral clavicle. After elevation of the remaining trapezius insertions from the clavicle and scapular spine, the proximal humerus is exposured by splitting the partly detached deltoid muscle longitudinally. Then the acromion fragment and humerus are prepared for the bone-to-bone contact. In 90 degrees of abduction the acromion fragment with its trapezius insertion is transferred and fixed to the humerus with two 4.5-mm screws. Finally the deltoid is sutured on the top of the trapezius and the skin is closed over two suction drains. Postoperatively we immobilize the operated arm in an abduction support for 6 weeks. The physiotherapy program starts on the first postoperative day with active training of elbow, hand and fingers and electrostimulation of the transferred trapezius muscle. Six weeks after the procedure we take an X-ray and start with progressive adduction of the arm. The preoperative subluxation of the humeral head was abolished in all cases. We achieved an average increase of active abduction from 7.3 degrees (range 0-45 degrees) preoperatively to 39.2 degrees (range 25 degrees-80 degrees) 1 year after the operation; the increase of forward flexion was from 20 degrees (range 0 degrees-85 degrees) to 43 degrees(range 20 degrees-90 degrees). All patients were satisfied with the improvement of stability and function of the operated shoulder. Finally we can conclude that the trapezius transfer for flail shoulder gives a satisfactory outcome regarding shoulder function and stability as well as the subjective situation of the patients.			Ruhmann, O (corresponding author), HANNOVER MED SCH,ORTHOPAD KLIN,HEIMCHENSTR 1-7,D-30625 HANNOVER,GERMANY.						AZIZ W, 1990, J BONE JOINT SURG BR, V72, P701, DOI 10.1302/0301-620X.72B4.2380231; BATEMAN J, 1954, SHOULDER ENV; BERGER A, 1991, ANN PLAS SURG, V26, P70, DOI 10.1097/00000637-199101000-00011; BERGER A, 1995, MICROSURG, V16, P43, DOI 10.1002/micr.1920160112; BERGER A, 1994, MICROSURG, V15, P760, DOI 10.1002/micr.1920151104; CHARNLEY J, 1964, J BONE JOINT SURG BR, V46, P614, DOI 10.1302/0301-620X.46B4.614; CHUANG DC, 1995, CLIN ORTHOP RELAT R, V314, P104; Chuinard R C, 1980, Orthopedics, V3, P901, DOI 10.3928/0147-7447-19800901-14; CHUNLIN H, 1991, CHINESE MED J, V104, P753; COFIELD RH, 1979, J BONE JOINT SURG AM, V61, P668, DOI 10.2106/00004623-197961050-00005; Davidson WD, 1936, J AMER MED ASSOC, V106, P2237; GOLDNER JL, 1988, HAND CLIN, V4, P223; Haas SL, 1935, J AMER MED ASSOC, V104, P99, DOI 10.1001/jama.1935.02760020015005; HARMON PH, 1950, J BONE JOINT SURG AM, V32-A, P583, DOI 10.2106/00004623-195032030-00013; HILDEBRANDT A, 1905, DEUT MED WOCHENSCHR, V39, P1578; Jager M, 1977, Aktuelle Probl Chir Orthop, V1, P80; JURGENSBECKER A, 1996, DT ARZTEBL, V93, P3262; KARVE A, 1986, J HAND SURG-BRIT, V11, P81; Knofler E W, 1978, Beitr Orthop Traumatol, V25, P137; LEFFERT RD, 1988, HAND CLIN, V4, P273; LEFFERT RD, 1980, MANAGEMENT PERIPHERA, P805; NAGANO A, 1989, CLIN ORTHOP RELAT R, V247, P97; NARAKAS AO, 1993, CLIN NEUROL NEUROSUR, V95, P89; Ober F R, 1932, JAMA-J AM MED ASSOC, V99, P2182; PFEIL J, 1985, Z ORTHOP GRENZGEB, V123, P872, DOI 10.1055/s-2008-1044770; PRONK GM, 1989, J REHABIL SCI, V2, P30; RICHARDS RR, 1988, J BONE JOINT SURG AM, V70A, P416, DOI 10.2106/00004623-198870030-00014; RICHARDS RR, 1985, CLIN ORTHOPAEDICS, V189, P250; RIEDEL G, 1928, ERG CHIR ORTHOP, V21, P489; RORABECK CH, 1980, J TRAUMA, V20, P491, DOI 10.1097/00005373-198006000-00010; ROUHOLAMIN E, 1991, INJURY, V22, P271, DOI 10.1016/0020-1383(91)90004-X; Rudigier J, 1991, BIBLIOTHEK HANDCHIRU; RUSSE O, 1978, UNFALLHEILKUNDE, V81, P299; RUSSE O, 1975, HEFTE UNFALLHEILKD, V126, P179; Saha AK., 1967, ACTA ORTHOP SCAND, VSuppl 97, P5	35	15	17	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0085-4530			ORTHOPADE	Orthopade	JUL	1997	26	7					634	642					9	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	XQ765	WOS:A1997XQ76500010					2022-02-06	
J	Fleming, JM; Strong, J; Ashton, R; Hassell, M				Fleming, JM; Strong, J; Ashton, R; Hassell, M			A 1-year longitudinal study of severe traumatic brain injury in Australia using the Sickness Impact Profile	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							SEVERE HEAD-INJURY; DISABILITY RATING-SCALE; FOLLOW-UP; SOCIAL-ADJUSTMENT; REHABILITATION; RECOVERY; RELIABILITY	Objective: To document outcome and to investigate patterns of physical and psychosocial recovery in the first year following severe traumatic brain injury (TBI) in an Australian patient sample. Design: A longitudinal prospective study of a cohort of patients, with data collection at 3, 6, 9, and 12 months post injury. Setting: A head injury rehabilitation unit in a large metropolitan public hospital. Patients: A sample of 55 patients selected from 120 consecutive admissions with severe TBI. Patients who were more than 3 months post injury on admission, who remained confused, or who had severe communication deficits or a previous neurologic disorder were excluded. Interventions: All subjects participated in a multidisciplinary inpatient rehabilitation program, followed by varied participation in outpatient rehabilitation and community-based sen ices. Main Outcome Measures: The Sickness impact Profile (SIP) provided physical, psychosocial, and total dysfunction scores at each follow-up. Outcome at 1 year was measured by the Disability Rating Scale. Results: Multivariate analysis of variance indicated that the linear trend of recovery over time was less for psychosocial dysfunction than for physical dysfunction (F(1,51) = 5.87, P < .02). One rear post injury, 22% of subjects had returned to their previous level of employability, and 42% were able to live independently. Conclusions: Recovery from TBI in this Australian sample followed a pattern similar to that observed in other countries, with psychosocial dysfunction being more persistent. Self-report measures such as the SIP in TBI research are limited by problems of diminished self-awareness.	UNIV QUEENSLAND,DEPT PSYCHOL,ST LUCIA,QLD 4067,AUSTRALIA; PRINCESS ALEXANDRA HOSP,HEAD INJURY UNIT,WOOLLOONGABBA,QLD 4102,AUSTRALIA		Fleming, JM (corresponding author), PRINCESS ALEXANDRA HOSP,OCCUPAT THERAPY DEPT,IPSWICH RD,WOOLLOONGABBA,QLD 4102,AUSTRALIA.		Fleming, Jennifer M/B-4436-2011; Strong, Jenny/F-1211-2010	Strong, Jenny/0000-0002-9367-8755			BADCOCK KA, 1988, COMMUNITY HEALTH ST, V12, P428; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brzuzy S, 1996, J HEAD TRAUMA REHAB, V11, P74, DOI 10.1097/00001199-199606000-00011; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Fleming JM, 1996, BRAIN INJURY, V10, P1; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KEPPEL G, 1982, DESIGN ANAL RES HDB; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LYLE DM, 1986, J NEUROSURG, V65, P15, DOI 10.3171/jns.1986.65.1.0015; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; NORUSSI MJ, 1990, SPSS PC PLUS STAT 4; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; POSNFORD J, 1991, NEUROPSYCHOL REHABIL, V1, P241; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wehman P., 1988, J HEAD TRAUMA REHAB, V3, P82, DOI DOI 10.1097/00001199-198812000-00012	40	15	15	0	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1997	12	3					27	40		10.1097/00001199-199706000-00004			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XC699	WOS:A1997XC69900004					2022-02-06	
J	Stoffel, M; Berger, S; Staub, F; Eriskat, J; Jacob, K; Baethmann, A				Stoffel, M; Berger, S; Staub, F; Eriskat, J; Jacob, K; Baethmann, A			The effect of dietary alpha-tocopherol on the experimental vasogenic brain edema	JOURNAL OF NEUROTRAUMA			English	Article						alpha-tocopherol; experimental head injury; free radical damage; rats; vasogenic brain edema	HUMAN-ENDOTHELIAL-CELLS; UNSATURATED FATTY-ACIDS; BASIC COMPUTER-PROGRAM; FETAL-RAT BRAIN; VITAMIN-E; LIPID-PEROXIDATION; MULTIPLE COMPARISONS; MEMBRANE INTEGRITY; ARACHIDONIC-ACID; SUPEROXIDE ANION	It has become increasingly obvious that free radicals and lipid peroxidation contribute to brain damage from trauma by mediating edema formation and ischemia. It should, therefore, be expected that the actual level of endogenous antioxidants, as for example, vitamin C and E in plasma, has an influence on the extent of free radical-induced injury. In this communication we investigate the effect of dietary changes in the free radical scavenger alpha-tocopherol on posttraumatic cerebral swelling in Sprague-Dawley rats. Low, normal, and high plasma levels of alpha-tocopherol were established by respective diets supplied over 2 weeks. Animals of all groups received the same food without alpha-tocopherol. One group was fed a vitamin E-free diet. The pellet-food for the other animals was supplemented either with 5-mg alpha-tocopherol/100 g or 250-mg alpha-tocopherol/100 g dry mass, respectively. The vitamin E-free diet lowered the alpha-tocopherol level in plasma to 30% of control, whereas supplementation with 250 mg/100 g led to a plasma concentration of 200% of control. The animals were then subjected to a focal cold injury of the left cerebral hemisphere. Twenty-four hours after trauma the brain was removed and the water content of each hemisphere was determined by the wet-dry weight method. Swelling of the traumatized hemisphere was calculated as the difference in weight between the traumatized and contralateral control hemisphere. The 2-week alpha-tocopherol supplementation or -deletion diet, respectively, did not either afford significant reduction or lead to an enhancement of traumatic brain swelling. Likewise, the increase in brain water content of the traumatized hemisphere was not affected. It is concluded that supplementation or depletion of alpha-tocopherol for 2 weeks, resulting in a marked increase or decrease of the vitamin E plasma level, does not influence formation of posttraumatic vasogenic brain edema.	UNIV MUNICH, KLINIKUM GROSSHADERN, INST SURG RES, D-81366 MUNICH, GERMANY; UNIV MUNICH, KLINIKUM GROSSHADERN, INST CLIN CHEM, D-81366 MUNICH, GERMANY								BAETHMAN A, 1978, NEUROSURG REV, V1, P85; BAETHMANN A, 1992, NEUROCHEMICAL CORREL, P295; BURTON GW, 1983, ARCH BIOCHEM BIOPHYS, V221, P281, DOI 10.1016/0003-9861(83)90145-5; BUSTO R, 1984, ANN NEUROL, V15, P441, DOI 10.1002/ana.410150507; CHAN AC, 1990, LIPIDS, V25, P17, DOI 10.1007/BF02562422; CHAN PH, 1978, SCIENCE, V201, P358, DOI 10.1126/science.663662; CHAN PH, 1984, J NEUROSCI RES, V12, P595; CHAN PH, 1984, NEUROLOGY, V34, P315, DOI 10.1212/WNL.34.3.315; CHAN PH, 1982, BRAIN RES, V248, P151, DOI 10.1016/0006-8993(82)91156-8; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; DEKEYSER J, 1992, LANCET, V339, P1562, DOI 10.1016/0140-6736(92)91830-2; DEMOPOULOS HB, 1982, CAN J PHYSIOL PHARM, V60, P1415, DOI 10.1139/y82-210; DEMOPOULOS HB, 1982, PATHOLOGY OXYGEN, P127; DRAKE JR, 1980, AM J CLIN NUTR, V33, P2386, DOI 10.1093/ajcn/33.11.2386; Elmadfa I., 1985, VITAMIN E EIGENSCHAF; FOLBERGROVA J, 1993, J CEREBR BLOOD F MET, V13, P145, DOI 10.1038/jcbfm.1993.17; FRIEDRICH W, 1987, HDB VITAMINE; FUKUZAWA K, 1981, ARCH BIOCHEM BIOPHYS, V206, P173, DOI 10.1016/0003-9861(81)90078-3; GURDJIAN ES, 1978, SURG GYNECOL OBSTET, V146, P805; HALKSMILLER M, 1986, J NEUROPATH EXP NEUR, V45, P471, DOI 10.1097/00005072-198607000-00008; HALL ED, 1986, J NEUROSURG, V64, P951, DOI 10.3171/jns.1986.64.6.0951; HALL ED, 1988, OXYGEN RADICALS TISS, P127; KAGAN VE, 1990, BIOCHEM PHARMACOL, V40, P2403, DOI 10.1016/0006-2952(90)90080-5; Klatzo I, 1980, Adv Neurol, V28, P359; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LEBEL CP, 1989, BIOCHEM BIOPH RES CO, V163, P860, DOI 10.1016/0006-291X(89)92301-2; LO WD, 1986, J NEUROCHEM, V46, P394, DOI 10.1111/j.1471-4159.1986.tb12981.x; MACHLIN LJ, 1982, ANN NY ACAD SCI, V393, P48, DOI 10.1111/j.1749-6632.1982.tb31231.x; MATSUBARA T, 1986, J CELL PHYSIOL, V127, P207, DOI 10.1002/jcp.1041270203; MAZA SR, 1987, AM HEART J, V114, P1206, DOI 10.1016/0002-8703(87)90198-0; MEYDANI M, 1988, LIPIDS, V23, P405, DOI 10.1007/BF02535510; MULLER DPR, 1989, ANN NY ACAD SCI, V570, P146; MURAKAMI K, 1997, BRAIN EDEMA, V10; NAKAJIMA M, 1991, NEUROSCI LETT, V133, P49, DOI 10.1016/0304-3940(91)90054-W; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V129, P181, DOI 10.1111/j.1748-1716.1987.tb08057.x; ORTEGA BD, 1972, STEROIDS BRAIN EDEMA, P167; PHELPS DL, 1979, PEDIATRICS, V63, P933; REDDANNA P, 1989, ANN NY ACAD SCI, V570, P136; SHUKLA A, 1995, FREE RADICAL RES, V22, P303, DOI 10.3109/10715769509145642; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Stein DG, 1991, J NEUROTRAUM, V8, P281, DOI 10.1089/neu.1991.8.281; THEODORSSONNORHEIM E, 1986, COMPUT METH PROG BIO, V23, P57, DOI 10.1016/0169-2607(86)90081-7; THEODORSSONNORHEIM E, 1987, COMPUT BIOL MED, V17, P85, DOI 10.1016/0010-4825(87)90003-5; TOIVANEN JL, 1987, PROSTAG LEUKOTR ESS, V26, P265, DOI 10.1016/0262-1746(87)90036-9; TORACK RM, 1959, AM J PATHOL, V35, P1135; TRAN K, 1992, LIPIDS, V27, P38, DOI 10.1007/BF02537056; ULLRICH V, 1989, FREE RADICAL RES COM, V7, P265, DOI 10.3109/10715768909087951; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; VATASSERY GT, 1988, J NEUROCHEM, V51, P621, DOI 10.1111/j.1471-4159.1988.tb01083.x; VONANDRIAN U, 1992, THESIS LUDWIG MAXIMI; WEI EP, 1985, AM J PHYSIOL, V248, pH157, DOI 10.1152/ajpheart.1985.248.2.H157; YOSHIDA S, 1983, NEUROLOGY, V33, P166, DOI 10.1212/WNL.33.2.166; ZAMORA R, 1991, J NUTR, V121, P50, DOI 10.1093/jn/121.1.50	55	15	15	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	1997	14	5					339	348		10.1089/neu.1997.14.339			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XE298	WOS:A1997XE29800005	9199399				2022-02-06	
J	Hoffman, SW; Stein, DG				Hoffman, SW; Stein, DG			Extract of Ginkgo biloba (EGb 761) improves behavioral performance and reduces histopathology after cortical contusion in the rat	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						traumatic brain injury; free radical scavenger; platelet activating factor antagonist; cognitive performance; spontaneous motor behavior; gliosis; neuronal sparing	FOREBRAIN CHOLINERGIC NEURONS; FACTOR PAF RECEPTOR; BASAL FOREBRAIN; FRONTAL-CORTEX; HIPPOCAMPAL-NEURONS; EXCITOTOXIC LESIONS; FREE-RADICALS; BRAIN EDEMA; ACID; GLUTAMATE	Male rats received bilateral frontal cortex contusions and were injected with 100 mg/kg of EGb 761 or an equal volume of vehicle beginning 5 min after injury and then with 1 injection/day for 7 days. The rats were tested for spontaneous motor behavior on days 1, 5, 10, and 15 postinjury and then for 10 days of spatial navigation performance in the Morris Water Maze (MWM), beginning on the day 8 after the contusion. Brain tissue was removed for examination on the 18th day after injury. Contused rats given EGb 761 performed more like intact rats on measures of spontaneous motor activity while vehicle-treated counterparts remained more active than either shams or ECb 761-treated animals by the conclusion of testing. Contusion-only rats were worse than shams on spatial performance, while those given EGb 761 were less impaired. Histological analyses indicated that EGb 761 failed to prevent loss of tissue at the primary site of impact. However, the extract reduced retrograde degeneration of neurons, gliosis in the thalamus, and ex vacuo hydrocephalus. EGb 761 treatment also decreased the loss of ChAT-positive neurons in the dorsomedial caudate-putamen and in the nucleus basalis magnocellularis (NBM). The results of this study indicate that EGb 761 could be a possible treatment for traumatic brain injury. (C) 1997 Elsevier Science Ireland Ltd.	EMORY UNIV, GRAD SCH ARTS & SCI, ATLANTA, GA 30322 USA		Hoffman, SW (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PHARMACOL & TOXICOL, BOX 980613, RICHMOND, VA 23298 USA.		Stein, Donald/AAJ-5139-2020				ASANO T, 1989, MOL CHEM NEUROPATHOL, V10, P101, DOI 10.1007/BF03159717; ATTELLA MJ, 1989, EXP NEUROL, V105, P62, DOI 10.1016/0014-4886(89)90172-6; BARTH TM, 1990, STROKE, V21, P153; BAZAN NG, 1992, EFFECTS GINKGO BILOB, P172; BITO H, 1993, J LIPID MEDIATOR, V6, P169; BITO H, 1992, NEURON, V9, P285, DOI 10.1016/0896-6273(92)90167-C; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BRAILOWSKY S, 1991, RESTOR NEUROL NEUROS, V3, P267, DOI 10.3233/RNN-1991-3505; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; CHAPMAN AG, 1989, NEUROSCI LETT, V107, P256, DOI 10.1016/0304-3940(89)90827-6; CHOPIN P, 1992, PSYCHOPHARMACOLOGY, V106, P26, DOI 10.1007/BF02253584; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DEFEUDIS FV, 1991, GINKGO BILOBA EXTRAC, P187; DELBARRE B, 1992, DRUG DEVELOP RES, V26, P419; Dimlich R V, 1990, Adv Neurol, V52, P365; DORMAN DC, 1992, AM J VET RES, V53, P138; FUKUNAGA M, 1993, AM J PHYSIOL, V264, pC1619, DOI 10.1152/ajpcell.1993.264.6.C1619; GAETANI P, 1994, NEUROCHEM RES, V19, P839, DOI 10.1007/BF00967453; GALLYAS F, 1970, ACTA NEUROPATHOL, V16, P35, DOI 10.1007/BF00686961; GAYKEMA RPA, 1991, J COMP NEUROL, V303, P563, DOI 10.1002/cne.903030405; GODUKHIN OV, 1980, NEUROSCIENCE, V5, P2151, DOI 10.1016/0306-4522(80)90131-1; Grassel E, 1992, Fortschr Med, V110, P73; HAGAN JJ, 1983, BEHAV BRAIN RES, V9, P83, DOI 10.1016/0166-4328(83)90015-3; HALLIWELL B, 1992, ANN NEUROL, V32, pS10, DOI 10.1002/ana.410320704; HITZENBERGER G, 1992, WIEN MED WOCHENSCHR, V142, P371; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; JUURLINK BHJ, 1992, NEUROREPORT, V3, P1135, DOI 10.1097/00001756-199212000-00026; KARCHER L, 1984, N-S ARCH PHARMACOL, V327, P31, DOI 10.1007/BF00504988; KIRKBY RJ, 1978, PHYSIOL BEHAV, V20, P669, DOI 10.1016/0031-9384(78)90263-9; KLEIJNEN J, 1992, BRIT J CLIN PHARMACO, V34, P352, DOI 10.1111/j.1365-2125.1992.tb05642.x; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; KORDOWER JH, 1992, EXP NEUROL, V117, P1, DOI 10.1016/0014-4886(92)90105-Y; KORNECKI E, 1991, LIPIDS, V26, P1243, DOI 10.1007/BF02536540; KRISTOFIKOVA Z, 1992, DEMENTIA, V3, P304; KUNIEVSKY B, 1992, J PHARMACOL EXP THER, V263, P562; LESCAUDRON L, 1992, EXP NEUROL, V116, P85, DOI 10.1016/0014-4886(92)90179-T; MASTERS JN, 1989, ENDOCRINOLOGY, V124, P3083, DOI 10.1210/endo-124-6-3083; MITCHELL JA, 1988, Q J EXP PSYCHOL-B, V40, P243; MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q; MUIR JL, 1993, BEHAV BRAIN RES, V57, P123, DOI 10.1016/0166-4328(93)90128-D; OBERPICHLER H, 1990, J CEREBR BLOOD F MET, V10, P133, DOI 10.1038/jcbfm.1990.17; PALMER AM, 1989, EXP BRAIN RES, V75, P659; PFISTER HW, 1992, STROKE, V23, P1798, DOI 10.1161/01.STR.23.12.1798; PORSOLT RD, 1990, PHARMACOL BIOCHEM BE, V36, P963, DOI 10.1016/0091-3057(90)90107-S; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; STOKES KA, 1990, BEHAV NEURAL BIOL, V53, P334, DOI 10.1016/0163-1047(90)90198-F; SUTTON RL, 1994, ACTA NEUROCHIR, P446; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; WEISS JH, 1994, NEUROSCIENCE, V60, P659, DOI 10.1016/0306-4522(94)90494-4; WRATHALL JR, 1992, EUR J PHARMACOL, V218, P273, DOI 10.1016/0014-2999(92)90179-8; YABE T, 1992, PHARMACOL BIOCHEM BE, V42, P595, DOI 10.1016/0091-3057(92)90004-Y	52	15	16	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.	APR	1997	11	1-2					1	12					12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XB752	WOS:A1997XB75200001	21551523				2022-02-06	
J	Yamaki, T; Murakami, N; Iwamoto, Y; Sakakibara, T; Kobori, N; Ueda, S; Kikuchi, T; Uwahodo, Y				Yamaki, T; Murakami, N; Iwamoto, Y; Sakakibara, T; Kobori, N; Ueda, S; Kikuchi, T; Uwahodo, Y			Evaluation of learning and memory dysfunction and histological findings in rats with chronic stage contusion and diffuse axonal injury	BRAIN RESEARCH			English	Article						cortical contusion; diffuse axonal injury; learning acquisition; memory retention; water maze; hippocampus; entorhinal cortex	TRAUMATIC BRAIN INJURY; CONTROLLED CORTICAL IMPACT; ENTORHINAL CORTEX; COGNITIVE DEFICITS; HIPPOCAMPAL; LESIONS; DAMAGE; CORTICOSTERONE; ACQUISITION	We previously reported a modified fluid percussion device capable of consistently producing experimental cortical contusion (CC) and diffuse axonal injury (DAI) in separate groups of rats by lateral and midline fluid percussion, respectively. The purpose of the present study was to compare the differences in learning acquisition and memory retention impairments between these two types of injured rats in the chronic stage using the Morris water maze technique. We also compared the histological differences between these two different types of traumatic brain injury. The results showed a statistically significant difference in learning acquisition impairment between the sham and CC rats and also between the sham and DAI rats. However, a significant difference in memory retention impairment was observed only between the sham and DAI rats. Histologically, the neuronal cell loss of CA3 pyramidal cells in the hippocampus was observed on the ipsilateral side in the CC and bilaterally in DAI. The neuronal cell loss was seen in bilateral entorhinal cortex layer II in DAI, but it was not seen in CC. From these results, we speculate that the marked cell loss in the hippocampus CA3 region in both CC and DAI rats was related to the impairment of spatial learning acquisition. The marked cell loss in entorhinal cortex layer LI in DAI rats may be one of the important factors in the impairment of spatial memory retention. (C) 1997 Elsevier Science B.V.	OTSUKA PHARMACEUT CO LTD,TOKUSHIMA INST NEW DRUG RES 3,TOKUSHIMA 77101,JAPAN		Yamaki, T (corresponding author), KYOTO PREFECTURAL UNIV MED,DEPT NEUROSURG,KAMIGYO KU,KAWARAMACHI HIROKOJI,KYOTO 602,JAPAN.						Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; BARTESAGHI R, 1994, NEUROSCIENCE, V61, P457, DOI 10.1016/0306-4522(94)90426-X; CATALANI A, 1993, BRAIN RES, V624, P209, DOI 10.1016/0006-8993(93)90079-3; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P414; Iwamoto Y, 1997, NEUROSURGERY, V40, P163, DOI 10.1097/00006123-199701000-00036; JARRARD LE, 1986, HIPPOCAMPUS, V4, P93; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; LEVISOHN LF, 1991, BRAIN RES, V564, P230, DOI 10.1016/0006-8993(91)91458-D; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MOSS M, 1981, J NEUROSCI, V1, P227; MURAKAMI N, 1993, ADV NEUROTRAUMA RES, V5, P42; PARKIN AJ, 1984, CORTEX, V20, P479, DOI 10.1016/S0010-9452(84)80053-2; PERTERSON DA, 1994, J NEUROSCI, V14, P6872; PLUSINELLI WA, 1982, ANN NEUROL, V11, P491; PRASAD MR, 1994, J NEUROCHEM, V63, P773; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SUTHERLAND RJ, 1989, BEHAV NEURAL BIOL, V52, P331, DOI 10.1016/S0163-1047(89)90457-3; UEKI A, 1994, J NEUROL SCI, V125, P14, DOI 10.1016/0022-510X(94)90236-4; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613; [No title captured]	40	15	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAR 28	1997	752	1-2					151	160		10.1016/S0006-8993(96)01469-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WT623	WOS:A1997WT62300017	9106451				2022-02-06	
J	Webster, JB; Bell, KR				Webster, JB; Bell, KR			Primary adrenal insufficiency following traumatic brain injury: A case report and review of the literature	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							ADDISONS-DISEASE; HEMORRHAGE; DIAGNOSIS	Primary adrenal insufficiency (PAI) is a relatively rare but serious condition that can lead to signs and symptoms ranging from mild generalized weakness and fatigue to fulminant shock and death. We present the case of a previously healthy 31-year-old man who developed PAI while undergoing rehabilitation after a severe traumatic brain injury (TBI). The patient suffered a TBI with comminuted skull fractures, bifrontal contusions, and bilateral epidural hematomas in a jet-ski accident. Acute hospitalization was prolonged by several medical complications, and the patient was admitted for subacute rehabilitation 1 month after his injury with cognitive deficits, persistent agitation, confusion, generalized weakness, and poor endurance for therapy. His weakness, fatigue, and orthostasis did not improve with attempts at gradual remobilization. The patient also had persistent anorexia, nausea, and hyponatremia despite various treatment regimens. Endocrinology workup showed normal anterior pituitary function but an abnormal response to adrenocorticotropic hormone (ACTH) stimulation, leading to the diagnosis of PAI. The patient was treated with prednisone and fludrocortisone, which resulted in improvement in clinical symptoms followed by rapid gains in all functional areas. No previous descriptions of PAI following head injury were found in the medical literature. It is important for physiatrists to be aware of this entity because symptoms of adrenal insufficiency can be similar to those commonly seen with TBI alone. PAI may also be confused with other endocrine disorders more frequently seen after TBI such as the syndrome of inappropriate antidiuretic hormone secretion. Recognition and appropriate management of adrenal insufficiency can lead to significant clinical and functional gains. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	UNIV WASHINGTON,DEPT REHABIL MED,SEATTLE,WA 98195					Bell, Kathleen/0000-0002-0928-2046			Atchison James W., 1993, Brain Injury, V7, P347, DOI 10.3109/02699059309034961; BONTKE CF, 1989, PHYS MED REHABIL STA, V3, P43; BURKE CW, 1985, CLIN ENDOCRINOL META, V14, P947, DOI 10.1016/S0300-595X(85)80084-0; BURKS DW, 1992, AM J ROENTGENOL, V158, P503, DOI 10.2214/ajr.158.3.1738984; CLAUSSEN MS, 1992, J TRAUMA, V32, P94, DOI 10.1097/00005373-199201000-00020; DEROSA G, 1987, EXP CLIN ENDOCRINOL, V90, P232, DOI 10.1055/s-0029-1210695; FEUERSTEIN B, 1991, ANN INTERN MED, V115, P785, DOI 10.7326/0003-4819-115-10-785; GOMEZ RG, 1993, J TRAUMA, V35, P870, DOI 10.1097/00005373-199312000-00012; Hansen J. R., 1993, PHYS MED REHABIL STA, V7, P569; HARDWICKE MB, 1992, ARCH INTERN MED, V152, P845, DOI 10.1001/archinte.152.4.845; HORN LJ, 1988, J HEAD TRAUMA REHABI, V3, P86; HORN LJ, 1990, REHABILITATION ADULT, P114; JOHNSTONE PAS, 1990, PSYCHOSOMATICS, V31, P103, DOI 10.1016/S0033-3182(90)72226-8; LEWIS JV, 1994, SOUTHERN MED J, V87, P1269, DOI 10.1097/00007611-199412000-00012; Murphy Joseph F., 1993, Journal of Burn Care and Rehabilitation, V14, P155, DOI 10.1097/00004630-199303000-00005; NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P127, DOI 10.1530/acta.0.0760127; ORTH DN, 1992, WILLIAMS TXB ENDOCRI, P489; STEINBOK P, 1978, NEUROSURGERY, V3, P9, DOI 10.1227/00006123-197807000-00002; SZALADOS JE, 1994, INTENS CARE MED, V20, P216, DOI 10.1007/BF01704704; VALENZUELA G, 1990, AM J GASTROENTEROL, V85, P1626; VALENZUELA GA, 1987, AM J GASTROENTEROL, V82, P1066; WERBEL SS, 1993, ENDOCRIN METAB CLIN, V22, P303, DOI 10.1016/S0889-8529(18)30168-3	22	15	16	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1997	78	3					314	318		10.1016/S0003-9993(97)90040-X			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WM783	WOS:A1997WM78300015	9084356				2022-02-06	
S	Giulian, D		Reis, DJ; Posner, JB		Giulian, D			Immune responses and dementia	FRONTIERS OF NEUROLOGY: A SYMPOSIUM IN HONOR OF FRED PLUM	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	Meeting on Frontiers of Neurology - A Symposium in Honor of Fred Plum	OCT   05, 1996	CORNELL UNIV MED COLL, NEW YORK, NEW YORK	CHARLES A DANA FDN	CORNELL UNIV MED COLL		CENTRAL-NERVOUS-SYSTEM; AMYLOID BETA-PROTEIN; MONONUCLEAR PHAGOCYTES; MAMMALIAN BRAIN; DEFICIENCY SYNDROME; ALZHEIMERS-DISEASE; AMEBOID MICROGLIA; TRAUMATIC INJURY; NEUROTOXINS; RELEASE		Baylor Coll Med, Dept Neurol, Houston, TX 77031 USA		Giulian, D (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77031 USA.						BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BOLSI DINO, 1927, RIV PAT NERV E MENT, V32, P65; Davies Peter, 1994, P327; EIKELENBOOM P, 1994, TRENDS PHARMACOL SCI, V15, P447, DOI 10.1016/0165-6147(94)90057-4; FAGAN AM, 1990, EXP NEUROL, V110, P105, DOI 10.1016/0014-4886(90)90055-W; FIULIAN D, 1994, DEV NEUROSCI, V16, P128; FLARIS NA, 1993, GLIA, V7, P34, DOI 10.1002/glia.440070108; GAMES D, 1992, NEUROBIOL AGING, V13, P569, DOI 10.1016/0197-4580(92)90057-5; GIULIAN D, 1993, J NEUROSCI, V13, P29; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1995, J NEUROSCI, V15, P7712; Giulian D, 1996, J NEUROSCI, V16, P3139; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Giulian D, 1996, J NEUROSCI, V16, P6021; GIULIAN D, 1993, J NEUROSCI RES, V36, P681, DOI 10.1002/jnr.490360609; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GIULIAN D, 1993, P NATL ACAD SCI USA, V90, P2769, DOI 10.1073/pnas.90.7.2769; GIULIAN D, 1988, J NEUROSCI, V8, P2485; GIULIAN D, 1990, SCIENCE, V250, P1593, DOI 10.1126/science.2148832; GIULIAN D, 1995, NEUROCHEM INT, V27, P119, DOI 10.1016/0197-0186(95)00067-I; Giulian D., 1992, CURR TOP NEUROL, V12, P23; HEYES MP, 1989, ANN NEUROL, V26, P275; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; KOO EH, 1993, P NATL ACAD SCI USA, V90, P4748, DOI 10.1073/pnas.90.10.4748; MASLIAH E, 1992, J NEUROPATH EXP NEUR, V51, P585; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; PETITO CK, 1992, ANN NEUROL, V32, P658, DOI 10.1002/ana.410320509; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; RIOHORTEGA P, 1932, CYTOLOGY CELLULAR PA, P481; ROBERTS PJ, 1987, BIOCHEM SOC T, V15, P218, DOI 10.1042/bst0150218; SAITO K, 1993, BIOCHEM J, V291, P11, DOI 10.1042/bj2910011; SNIDER WD, 1983, ANN NEUROL, V14, P403, DOI 10.1002/ana.410140404; Terry R. D., 1994, ALZHEIMERS DIS; Wujek JR, 1996, NEUROBIOL AGING, V17, P107, DOI 10.1016/0197-4580(95)02020-9; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	40	15	15	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-096-4	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1997	835						91	110		10.1111/j.1749-6632.1997.tb48621.x			20	Multidisciplinary Sciences; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology	BK36C	WOS:000071899600009	9616765				2022-02-06	
J	Sataloff, RT; Mandel, S; Muscal, E; Park, CH; Rosen, DC; Kim, SM; Spiegel, JR				Sataloff, RT; Mandel, S; Muscal, E; Park, CH; Rosen, DC; Kim, SM; Spiegel, JR			Single-photon-emission computed tomography (SPECT) in neurotologic assessment: A preliminary report	AMERICAN JOURNAL OF OTOLOGY			English	Article						[Tc-99m]; HMPAO SPECT; postconcussion syndrome; headache; hearing loss; vertigo; dizziness; tinnitus	TRAUMATIC BRAIN INJURY; CLOSED-HEAD-INJURY; HM-PAO-SPECT; TECHNETIUM-99M-HMPAO SPECT; CT; MRI	The single-photon-emission computed tomography (SPECT) scan enables clinicians to probe dynamic and metabolic changes in brain tissue through measurement of regional cerebral blood flow (rCBF). Diagnostic benefits of the SPECT scan in clinical neurology have been demonstrated. SPECT scanning has been shown to be more sensitive than morphologic imaging techniques [magnetic resonance imaging (MRI) and computed tomography (CT)] in many conditions. However, the use of the scan in assessing neurotologic complaints remains inadequately investigated. Few studies have explored the value of SPECT in establishing the causes of dizziness, hearing loss, and tinnitus. We studied SPECT along with MRI, CT scan, electroencephalogram (EEG), and other evaluations in patients with these neurotologic complaints. SPECT abnormalities were more frequent and prominent than those visualized by other imaging modalities. Overall, 78% of SPECT scans revealed abnormalities. Abnormalities were found in 46% of MRIs, 40% of CTs, and 29% of EEGs. The disparity between SPECT scanning and other procedures was also seen once patients were divided by their chief complaints. This study illustrates the sensitivity of SPECT scanning in evaluating neurotologic complaints and highlights the need for additional research into the importance of SPECT scanning in comprehensive neurotologic evaluation.	THOMAS JEFFERSON UNIV,DEPT OTOLARYNGOL,PHILADELPHIA,PA 19103; THOMAS JEFFERSON UNIV,DEPT NEUROL,PHILADELPHIA,PA 19103; AMER INST VOICE & EAR RES,PHILADELPHIA,PA; THOMAS JEFFERSON UNIV,DEPT RADIAT ONCOL & NUCL MED,DIV NUCL MED,PHILADELPHIA,PA 19107				Muscal, Eyal/ABD-2159-2020	Muscal, Eyal/0000-0003-1866-6129			ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; BONI F, 1990, ACTA OTORHINOLAYRNGO, V10, P539; BULLOCK R, 1990, ACT NEUR S, V51, P286; Casani A, 1990, Acta Otorhinolaryngol Ital, V10, P539; DUCOURS JL, 1990, NUCL MED COMMUN, V11, P361, DOI 10.1097/00006231-199005000-00003; GRAD A, 1989, ARCH NEUROL-CHICAGO, V46, P281, DOI 10.1001/archneur.1989.00520390047014; GRAY BG, 1992, J NUCL MED, V33, P52; HOLMAN BL, 1992, J NUCL MED, V33, P1888; ICHISE M, 1994, J NUCL MED, V35, P217; JAMIESON D, 1988, RADIOL CLIN N AM, V26, P1075; KURODA S, 1990, Neurological Surgery, V18, P167; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LAUBERT A, 1987, HNO, V35, P372; MASDEU JC, 1994, NEUROLOGY, V44, P1970, DOI 10.1212/WNL.44.10.1970; Morinaga K, 1991, No To Shinkei, V43, P891; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; PRICHARD JW, 1992, ANN NEUROL, V32, P395, DOI 10.1002/ana.410320316; ROPER SN, 1991, J NUCL MED, V32, P1684; ROPER SN, 1991, J NUCL MED, V32, P2070; SPENCER SS, 1994, EPILEPSIA, V35, pS72, DOI 10.1111/j.1528-1157.1994.tb05990.x; TUOHIMAA P, 1987, ORL J OTORHINOLARYNG, V45, P315	22	15	15	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0192-9763			AM J OTOL	Am. J. Otol.	NOV	1996	17	6					909	916					8	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	VQ203	WOS:A1996VQ20300020	8915421				2022-02-06	
J	Zafonte, RD; Mann, NR; Fichtenberg, NL				Zafonte, RD; Mann, NR; Fichtenberg, NL			Sleep disturbance in traumatic brain injury: Pharmacologic options	NEUROREHABILITATION			English	Article						traumatic brain injury; sleep; pharmacology; behavior	MINOR HEAD-INJURIES; DISORDERS; CONCUSSION; PATTERNS; SEQUELAE; ILLNESS; QUALITY	The role of sleep disturbance in the behavioral and functional sequelae following Traumatic Brain Injury is becoming increasingly well understood. Sleep disturbances occurs commonly in Traumatic Brain injury patients. Survivors of Traumatic Brain Injury may experience sleep dysfunction during all stages of recovery. An effective understanding of the pathophysiology of sleep disturbance and the role medications play in both causation and treatment is essential for facilitation of rehabilitation management and functional recovery.			Zafonte, RD (corresponding author), WAYNE STATE UNIV,REHABIL INST MICHIGAN,261 MACK BLVD,DETROIT,MI 48201, USA.		Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604			Alexandre A, 1979, Acta Neurochir Suppl (Wien), V28, P188; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; BELYAVIN A, 1987, NEUROPHARMACOLOGY, V26, P485, DOI 10.1016/0028-3908(87)90032-3; BERGAMASCO B, 1968, ELECTROEN CLIN NEURO, V24, P374, DOI 10.1016/0013-4694(68)90198-3; BOYESON M, 1994, AM J PMR, V72, P286; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CHATRIAN GE, 1963, ELECTROEN CLIN NEURO, V15, P272, DOI 10.1016/0013-4694(63)90096-8; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P3013; DONIO E, 1968, PROG BRAIN RES, V28, P113; DOUGLASS AB, 1994, SLEEP, V17, P160, DOI 10.1093/sleep/17.2.160; Edwards G B, 1993, Am J Crit Care, V2, P125; ERWIN CW, 1970, ARCH GEN PSYCHIAT, V23, P375; ESPIE CA, 1991, JAMA-J AM MED ASSOC, V262, P1479; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; FREEMON FR, 1974, ELECTROEN CLIN NEURO, V36, P657, DOI 10.1016/0013-4694(74)90232-6; GALLIARD J, 1982, ENCEPHALE, V8, P413; GATES J, 1996, GOODMAN GILMANS PHAR; GILLIN JC, 1983, PSYCHIAT ANN, V13, P367, DOI 10.3928/0048-5713-19830501-02; GRANT SM, 1991, DRUGS, V41, P889, DOI 10.2165/00003495-199141060-00007; GREENBLATT D, 1990, AM J MED S, V88, P185; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; HARRINGTON RA, 1983, DRUGS, V25, P451, DOI 10.2165/00003495-198325050-00002; HAYTHORNTHWAITE JA, 1991, J PAIN SYMPTOM MANAG, V6, P65, DOI 10.1016/0885-3924(91)90520-E; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; KUPFER D, SLEEP DISTURBANCE AC; KUPFER DJ, 1981, AM J PSYCHIAT, V138, P429; LESSARD CS, 1974, AEROSPACE MED, V45, P664; MARKAND ON, 1976, NEUROLOGY, V26, P769, DOI 10.1212/WNL.26.8.769; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MULLANEY DJ, 1980, SLEEP, V3, P83, DOI 10.1093/sleep/3.1.83; NAUTA WJH, 1946, J NEUROPHYSIOL, V9, P285, DOI 10.1152/jn.1946.9.4.285; NIRENBERG A, AM J PSYCHIAT, p151Y; PACESCHOTT EF, 1994, SLEEP, V17, P688, DOI 10.1093/sleep/17.8.688; PASSOUANT P, 1965, ELECTROEN CLIN NEURO, V18, P7266; PERTOUKA S, 1980, AM J PSYCHIAT, V137, P1518; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; RADULOVACKI M, 1985, BRAIN MECH SLEEP; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SHAPIRO CM, 1993, BRIT MED J, V306, P1532, DOI 10.1136/bmj.306.6891.1532; TRIMBLE MR, 1983, EPILEPSIA, V24, pS55, DOI 10.1111/j.1528-1157.1983.tb04644.x; VILLABLACA JR, 1976, EXP NEUROL, V53, P31, DOI 10.1016/0014-4886(76)90279-X	44	15	15	1	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	NOV	1996	7	3					189	195		10.1016/1053-8135(96)00191-6			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VQ826	WOS:A1996VQ82600004	24525888				2022-02-06	
J	Petersen, SR; Jeevanandam, M; Holaday, NJ; Lubhan, CL				Petersen, SR; Jeevanandam, M; Holaday, NJ; Lubhan, CL			Arterial-jugular vein free amino acid levels in patients with head injuries: Important role of glutamine in cerebral nitrogen metabolism	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							BLOOD-BRAIN-BARRIER; PLASMA; MUSCLE	Traumatic brain injury is the single largest contributor of trauma center deaths, Injury to the brain cannot be considered as an isolated event, affecting only this organ, Profound hypoglutaminemia, commonly seen in patients with head injuries may be caused by the diminished release of glutamine from the brain to the systemic circulation, To assess this hypothesis, we have simultaneously measured the free amino acid (AA) levels in systemic arterial(A, radial artery), cerebral venous (JV, jugular bulb), and systemic venous (PA, pulmonary artery) plasma in 11 adult patients with severe head injuries once within 48 hours of the initial injury before starting nutritional support and again after 3 to 4 days of enteral feeding, Cerebral organ (A-JV) changes of AA levels were compared with whole body systemic (A-PA) changes, Arterial total AA levels when compared with reported normal values are diminished by 46% in patients with isolated severe injuries, Cerebral outflow of glutamine is 6% of the total AA output compared with 73% in normals, The systemic outflow of glutamine in patients with brain injuries is 28% of total AA flow, Despite this high systemic output, significant hypoglutaminemia persists, Feeding for 3 days did not appreciable change the arterial plasma AA levels except that of glutamate and citrulline. A significant (p = 0.01) linear relationship between glutamine (product) and glutamate (precursor) was seen in JV samples but not in A or PA samples, The ratio of plasma glutamine to glutamate was decreased significantly only in JV during nutritional support, and this was caused mainly by an increase in glutamate levels, This may be owing to defective amidation to glutamine, inasmuch as gamma aminobutyric acid (GABA) levels were only minimally affected, Nutritional support improves the net release of glutamine from the brain, This suggests that supplementing the diet with glutamine may be beneficial to support systemic requirements in patients with severe head injuries.			Petersen, SR (corresponding author), ST JOSEPHS HOSP,MED CTR,CTR TRAUMA,350 W THOMAS RD,PHOENIX,AZ 85013, USA.						ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; COLOMBO JP, 1992, ANN NUTR METAB, V36, P23, DOI 10.1159/000177695; ERIKSSON LS, 1983, J NEUROCHEM, V41, P1324, DOI 10.1111/j.1471-4159.1983.tb00828.x; FELIG P, 1973, P SOC EXP BIOL MED, V142, P230; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; GRILL V, 1992, METABOLISM, V41, P28, DOI 10.1016/0026-0495(92)90186-E; JEEVANANDAM M, 1989, AM J CLIN NUTR, V49, P814, DOI 10.1093/ajcn/49.5.814; JEEVANANDAM M, 1995, CLIN NUTR, V14, P365, DOI 10.1016/S0261-5614(95)80054-9; MANS AM, 1982, J NEUROCHEM, V38, P705, DOI 10.1111/j.1471-4159.1982.tb08689.x; MCHENRY LC, 1966, NEW ENGL J MED, V274, P82, DOI 10.1056/NEJM196601132740206; NEWSHOLME EA, 1995, CLIN NUTR, V14, P129, DOI 10.1016/S0261-5614(95)80033-6; OLENDORF WH, 1971, AM J PHYSIOL, V221, P1629; PARDRIDGE WM, 1983, PHYSIOL REV, V63, P1481, DOI 10.1152/physrev.1983.63.4.1481; PETERSEN SR, 1993, J TRAUMA, V34, P653, DOI 10.1097/00005373-199305000-00007; RECORD CO, 1976, EUR J CLIN INVEST, V6, P387, DOI 10.1111/j.1365-2362.1976.tb00533.x; SCHURR A, 1987, BRAIN RES, V421, P125	16	15	16	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	1996	41	4					687	695		10.1097/00005373-199610000-00015			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	VL848	WOS:A1996VL84800015	8858029				2022-02-06	
J	Roos, R				Roos, R			Guidelines for managing concussion in sports - A persistent headache	PHYSICIAN AND SPORTSMEDICINE			English	Article							CONTACT-SPORTS	In their approach to managing athletes who sustain concussions, sports physicians differ at least as widely as do the many published guidelines on the subject. The scarcity of scientific evidence makes practical decisions about when an athlete can safely return to the field difficult. Efforts to forge a consensus are underway, but controversy persists around such questions as whether a brief loss of consciousness should be classified as a severe concussion.									BRUKNER P, 1993, CLIN SPORTS MED, P157; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; *CO MED SOC SPORTS, 1991, GUID MAN CONC SPORTS; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; SCHNEIDER RC, 1985, SPORTS INJURIES; STRICH SJ, 1961, LANCET, V2, P443; SWENSON EJ, 1996, ANN M AM MED SOC SPO; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1	8	15	15	0	2	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	OCT	1996	24	10					67	&		10.3810/psm.1996.10.1327			6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	VK628	WOS:A1996VK62800020	20086946				2022-02-06	
J	Nichols, JS; Beel, JA; Munro, LG				Nichols, JS; Beel, JA; Munro, LG			Detection of impaired cerebral autoregulation using spectral analysis of intracranial pressure waves	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; cerebrovascular reactivity; intracranial pressure; ischemia; spectral analysis; traumatic brain injury; FFT	HEAD-INJURED PATIENTS; FLUID PULSE-WAVE; BLOOD-FLOW; AUTO-REGULATION; PERFUSION-PRESSURE; SYSTEMS-ANALYSIS; CEREBROVASCULAR BED; HYDRAULIC MODEL; VOLUME INDEX; DYNAMICS	Successful resuscitation following severe traumatic brain injury (TBI) requires rapid evaluation of intracranial pressure (ICP), cerebrovascular reactivity (autoregulation), and cerebral metabolism. During impaired autoregulation, inadequate cerebral blood flow (CBF) can lead to ischemia while excessive CBF can result in elevated ICP. Without information regarding the state of autoregulation, treatment of either situation may ameliorate one problem but exacerbate the other. It has been hypothesized that fast Fourier transform (FFT) analysis of arterial blood pressure (BP) and ICP waves can differentiate states of intact and impaired autoregulation. BP and ICP waves were recorded in canines before and after ischemic injury during arterial normotension, hypertension, and hypotension induced with dopamine or nitroprusside infusion. Transfer functions (TFn) were calculated from FFT spectra as ratios of ICP and BP harmonic peak amplitudes to distinguish states of vasoreactivity. During normotension and hypertension, autoregulation was intact and TF1 averaged 0.05. During hypotension, TF1 averaged 0.22 (8x baseline, p < 0.010). During impaired autoregulation following ischemic injury, TF1 averaged 0.50 (18x baseline, p < 0.010; 2x nitroprusside levels, p < 0.01). This large difference in TF relative to baseline extended over a large range of BP (60 < BP < 180 mm Hg). Based on these data and previous results, it was estimated that TF can differentiate impaired autoregulation from effects solely related to elevated ICP or active vasodilation for ICP < 30-40 mm Hg. This suggests that for specific, but widely applicable physiologic conditions, spectral analysis can identify states of impaired autoregulation and, as an adjunct to traditional monitoring techniques, aid in acute resuscitation and prevention of secondary injury in TBI.	PROVENANT ST ANTHONY CENT HOSP,DIV NEUROL SURG,DENVER,CO; UNIV COLORADO,HLTH SCI CTR,DIV NEUROSURG,DENVER,CO 80204								AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AVEZAAT CJJ, 1986, ACTA NEUROCHIR, V79, P13, DOI 10.1007/BF01403461; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; CARDOSO ER, 1989, INTRACRANIAL PRESSUR, V7; CHOPP M, 1983, NEUROSURGERY, V13, P5, DOI 10.1227/00006123-198307000-00002; CHOPP M, 1980, J NEUROSURG, V53, P516, DOI 10.3171/jns.1980.53.4.0516; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; CONTANT CF, 1993, INTRACRANIAL PRESSUR, V8; CZOSNYKA M, 1988, ACTA NEUROCHIR, V93, P140, DOI 10.1007/BF01402897; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; CZOSNYKA M, 1993, ACTA NEUROCHIR, V121, P159, DOI 10.1007/BF01809269; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FOLTZ EL, 1981, SURG NEUROL, V15, P283, DOI 10.1016/S0090-3019(81)80009-2; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; GRAY WJ, 1987, J NEUROSURG, V67, P377, DOI 10.3171/jns.1987.67.3.0377; HAMER J, 1977, J NEUROSURG, V46, P36, DOI 10.3171/jns.1977.46.1.0036; HIRAI O, 1984, SURG NEUROL, V21, P67, DOI 10.1016/0090-3019(84)90404-X; KASUGA Y, 1987, J NEUROSURG, V66, P907, DOI 10.3171/jns.1987.66.6.0907; KASUGA Y, 1989, INTRACRANIAL PRESSUR, V7; KLASSEN P A, 1991, Neurological Research, V13, P194; LAKIN W D, 1992, Neurological Research, V14, P219; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LIN ES, 1991, BRIT J ANAESTH, V66, P476, DOI 10.1093/bja/66.4.476; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P547; MATSUMOTO T, 1986, ACTA NEUROCHIR, V82, P50, DOI 10.1007/BF01456319; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MICHENFELDER JD, 1977, ANESTHESIOLOGY, V46, P188, DOI 10.1097/00000542-197703000-00006; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OVERGAARD J, 1983, J NEUROSURG, V59, P439, DOI 10.3171/jns.1983.59.3.0439; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PIPER IR, 1993, NEUROSURGERY, V32, P805, DOI 10.1227/00006123-199305000-00014; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; PIPER IR, 1989, INTRACRANIAL PRESSUR, V7; PORTNOY HD, 1983, NEUROSURGERY, V13, P482, DOI 10.1227/00006123-198311000-00002; PORTNOY HD, 1982, J NEUROSURG, V56, P666, DOI 10.3171/jns.1982.56.5.0666; PORTNOY HD, 1981, NEUROSURGERY, V9, P14, DOI 10.1227/00006123-198107000-00004; PROCTOR HJ, 1988, J TRAUMA, V28, P347, DOI 10.1097/00005373-198803000-00010; REED G, 1985, AM J MED SCI, V289, P37, DOI 10.1097/00000441-198501000-00007; ROBERTSON CS, 1992, J NEUROTRAUM, V9, pS349; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SAUNDERS ML, 1979, J NEUROSURG, V51, P18, DOI 10.3171/jns.1979.51.1.0018; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; STRANDGAARD S, 1984, STROKE, V15, P413, DOI 10.1161/01.STR.15.3.413; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; TAKIZAWA H, 1987, NEUROSURGERY, V20, P355, DOI 10.1227/00006123-198703000-00001; TAKIZAWA H, 1986, J NEUROL NEUROSUR PS, V49, P1135, DOI 10.1136/jnnp.49.10.1135; TAKIZAWA H, 1986, J NEUROL NEUROSUR PS, V49, P1367, DOI 10.1136/jnnp.49.12.1367; WYLIE CR, 1975, ADV ENG MATH, P214	56	15	15	0	4	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1996	13	8					439	456		10.1089/neu.1996.13.439			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	VH009	WOS:A1996VH00900002	8880608				2022-02-06	
J	Meintjes, E; Hosgood, G; Daniloff, J				Meintjes, E; Hosgood, G; Daniloff, J			Pharmaceutic treatment of acute spinal cord trauma	COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN			English	Article							21-AMINOSTEROID U74006F; INJURY; METHYLPREDNISOLONE; NALOXONE; RECOVERY; ISCHEMIA; RATS; CATS; DEXAMETHASONE; PATHOGENESIS	Spinal cord concussion or laceration is one of the most frequent neurologic disorders seen in small animal practice. However, the complex set of events that follow spinal cord injury are not yet completely understood, and much controversy exists. Ischemic and biochemical changes that occur after mechanical trauma are believed to contribute to continued cellular destruction known as second injury. Early treatment is critical to limit the spread of secondary injury. Numerous pharmacologic agents for the treatment of acute spinal cord injury have been described, but there are many opposing views regarding the efficacy of these agents. The use and side effects of glucocorticoids, nonsteroidal antiinflammatory drugs, calcium-channel antagonists, narcotic antagonists, and numerous other potentially beneficial drugs are discussed in this article. The experimental compound tirilazad mesylate is apparently safer and more effective than drugs currently available and may be available commercially in the near future.	LOUISIANA STATE UNIV,DEPT VET ANAT,BATON ROUGE,LA 70803; LOUISIANA STATE UNIV,DEPT VET CLIN SCI,SCH VET MED,BATON ROUGE,LA 70803					Hosgood, Giselle/0000-0002-8851-8597			AKDEMIR H, 1993, RES EXP MED, V194, P297; ANDERSON DK, 1988, J NEUROSURG, V69, P562, DOI 10.3171/jns.1988.69.4.0562; BASKIN DS, 1993, J SPINAL DISORD, V6, P38; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; BELLAH JR, 1983, J AM VET MED ASSOC, V183, P1002; BERG RJ, 1985, COMP CONT EDUC PRACT, V7, P646; BLIGHT AR, 1993, ADV NEUROL, V59, P91; BRACKEN MB, 1993, J NEUROSURG, V79, P500, DOI 10.3171/jns.1993.79.4.0500; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; BRAUGHLER JM, 1982, J NEUROSURG, V56, P838, DOI 10.3171/jns.1982.56.6.0838; BRAUGHLER JM, 1987, J NEUROSURG, V67, P102, DOI 10.3171/jns.1987.67.1.0102; BRAUND KG, 1990, VET MED-US, V85, P740; BRAUND KG, 1990, VET MED-US, V85, P684; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; CAUBIT X, 1993, INT J DEV BIOL, V37, P327; COLLINS GH, 1989, BRAIN RES BULL, V22, P89, DOI 10.1016/0361-9230(89)90132-9; DELABAUME S, 1981, NEUROSCIENCE, V6, P315, DOI 10.1016/0306-4522(81)90125-1; DELAY G, 1993, J NEUROTRAUMA, V10, P25; DONG YO, 1992, CHUNG HUA WAI KO TSA, V149, P437; FLAMM ES, 1982, NEUROSURGERY, V10, P227, DOI 10.1227/00006123-198202000-00009; FRANCEL PC, 1993, J NEUROSURG, V79, P742, DOI 10.3171/jns.1993.79.5.0742; GALANDIUK S, 1993, ANN SURG, V218, P419, DOI 10.1097/00000658-199310000-00003; GOLDBERGER ME, 1990, EXP NEUROL, V107, P113, DOI 10.1016/0014-4886(90)90149-M; GORSKA T, 1993, BRAIN RES BULL, V32, P241, DOI 10.1016/0361-9230(93)90183-C; GRIFFITHS IR, 1975, J NEUROSURG, V42, P155, DOI 10.3171/jns.1975.42.2.0155; GRISSOM TE, 1994, ANESTH ANALG, V79, P66; GUHA A, 1987, J NEUROSURG, V66, P423, DOI 10.3171/jns.1987.66.3.0423; HALL ED, 1988, J NEUROSURG, V68, P462, DOI 10.3171/jns.1988.68.3.0462; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; HALL ED, 1993, ADV NEUROL, V59, P241; HALL ED, 1986, J NEUROSURG, V64, P951, DOI 10.3171/jns.1986.64.6.0951; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; HELGREN ME, 1993, EXP NEUROL, V123, P17, DOI 10.1006/exnr.1993.1137; HOERLEIN BF, 1985, J AM ANIM HOSP ASSOC, V21, P67; HOERLEIN BF, 1983, J AM ANIM HOSP ASSOC, V19, P216; HOERLEIN BF, 1982, ARCH AM COLL VET SUR, V4, P11; JANSSEN L, 1989, SPINE, V14, P23, DOI 10.1097/00007632-198901000-00005; JANSSENS LAA, 1991, J SMALL ANIM PRACT, V32, P572, DOI 10.1111/j.1748-5827.1991.tb00889.x; Kajihara K, 1973, Surg Neurol, V1, P16; KIWERSKI JE, 1993, INJURY, V24, P457, DOI 10.1016/0020-1383(93)90149-Z; Kliot M, 1990, Neurosurg Clin N Am, V1, P751; KOYANAGI I, 1993, NEUROSURGERY, V33, P285, DOI 10.1227/00006123-199308000-00016; KUHLENGEL KR, 1990, J COMP NEUROL, V293, P74, DOI 10.1002/cne.902930107; NACIMIENTO AC, 1979, SOC NEUROSCI, V5, P727; OSTERHOLM JL, 1974, J NEUROSURG, V40, P5, DOI 10.3171/jns.1974.40.1.0003; PARKER AJ, 1990, PHYSIOL BEHAV, V48, P41, DOI 10.1016/0031-9384(90)90258-6; POINTILLART V, 1993, J NEUROTRAUM, V10, P201, DOI 10.1089/neu.1993.10.201; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; QUAYUMI AK, 1994, J THORAC CARDIOVASC, V107, P1203; ROCHAT MC, 1991, COMP CONT EDUC PRACT, V13, P923; ROSS IB, 1993, SURG NEUROL, V40, P461, DOI 10.1016/0090-3019(93)90048-6; RYMER WZ, 1993, ADV NEUROL, V59, P157; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SHORES A, 1990, VET MED-US, V85, P724; Siemering G. B., 1992, Veterinary Surgery, V21, P406; SORJONEN DC, 1989, COMP CONT EDUC PRACT, V11, P248; WIETHOLTER H, 1990, J NEUROSCI METH, V32, P199, DOI 10.1016/0165-0270(90)90141-2; XU J, 1992, J NEUROTRAUM, V9, P245, DOI 10.1089/neu.1992.9.245; YOUNG W, 1993, ADV NEUROL, V59, P249; Young W, 1988, Clin Neurosurg, V34, P675; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	62	15	15	0	2	VETERINARY LEARNING SYSTEMS	TRENTON	425 PHILLIPS BLVD #100, TRENTON, NJ 08618	0193-1903			COMP CONT EDUC PRACT	Compend. Contin. Educ. Pract. Vet.	JUN	1996	18	6					625	&					10	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	UR745	WOS:A1996UR74500002					2022-02-06	
J	Janjua, KJ; Goswami, V; Sagar, G				Janjua, KJ; Goswami, V; Sagar, G			Whiplash injury associated with acute bilateral internal carotid arterial dissection	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						whiplash injury; blunt carotid trauma	TRAUMA; BELT	Internal carotid arterial occlusion, being a rare occurrence following whiplash injury, is frequently missed, We report an unusual case of a 41-year-old woman driver who was involved in a head-on collision with a truck. On admission she was noted to have sustained closed head and neck trauma with a severe whiplash injury and lower limb paraparesis, Subsequent investigations showed a right parietal lobe infarct and bilateral internal carotid arterial dissection, We conclude that acute whiplash injury can result in bilateral internal carotid arterial dissection and that clinicians treating these patients should be aware of this complication.	UNIV BIRMINGHAM,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND; CITY HOSP NHS TRUST,BIRMINGHAM,W MIDLANDS,ENGLAND								ATKINSON TJ, 1991, ORAL SURG ORAL MED O, V72, P408, DOI 10.1016/0030-4220(91)90548-Q; BENITO MC, 1990, J TRAUMA, V30, P116, DOI 10.1097/00005373-199001000-00021; DAVIS JW, 1990, J TRAUMA, V30, P1514, DOI 10.1097/00005373-199012000-00013; LI MS, 1994, J TRAUMA, V36, P265, DOI 10.1097/00005373-199402000-00025; LITTLE JM, 1969, LANCET, V2, P926; MARTIN RF, 1991, J VASC SURG, V14, P789, DOI 10.1067/mva.1991.32076; MOKRI B, 1988, J NEUROSURG, V68, P189, DOI 10.3171/jns.1988.68.2.0189; NORRIS SH, 1983, J BONE JOINT SURG BR, V65, P608, DOI 10.1302/0301-620X.65B5.6643566; RAMADAN F, 1995, J VASC SURG, V21, P46, DOI 10.1016/S0741-5214(95)70243-1; REDDY K, 1990, J TRAUMA, V30, P630, DOI 10.1097/00005373-199005000-00020; WALL SD, 1982, AM J ROENTGENOL, V138, P307, DOI 10.2214/ajr.138.2.307; WOZASEK GE, 1990, J TRAUMA, V30, P332, DOI 10.1097/00005373-199003000-00013	12	15	15	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1996	40	3					456	458		10.1097/00005373-199603000-00024			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	UA973	WOS:A1996UA97300025	8601868				2022-02-06	
J	Yamaguchi, T; Ozawa, Y; Suzuki, M; Yamamoto, M; Nakamura, T; Yamaura, A				Yamaguchi, T; Ozawa, Y; Suzuki, M; Yamamoto, M; Nakamura, T; Yamaura, A			Indeloxazine hydrochloride improves impairment of passive avoidance performance after fluid percussion brain injury in rats	NEUROPHARMACOLOGY			English	Article						fluid percussion brain injury; passive avoidance performance; cerebral activator; monoamine; acetylcholine	HEAD-INJURY; AMINO-ACIDS; MEMORY; METABOLITES; MODEL; DEGENERATION; HIPPOCAMPUS; RECEPTORS; RECOVERY	We studied behavioral and histological changes after fluid percussion brain injury and the effects of indeloxazine hydrochloride, a cerebral activator, on these post-traumatic changes in rats. An acquisition trial in passive avoidance task was conducted on the 3rd day after injury. The latency of step-through in injured rats was significantly (p<0.05) shorter than that in sham-operated rats on the 4th, 10th and 14th days after the operation. There were injury-induced neurological deficits on days 1-4 post-injury. Histological changes were observed in the peripheral area of the cortical lesion at the impact site and in the thalamus but not in the hippocampus on the 14th day. Indeloxazine (10 and 20 mg/kg, p.o.) administered once a day from the 3rd (30 min prior to the acquisition trial) to the 9th day after injury significantly (p < 0.05) improved the impairment of the passive avoidance performance without affecting locomotor activity. Indeloxazine showed no significant effects on either neurological deficits or the cortical lesion area. These results suggest that impairment of passive avoidance performance occurs without apparent histological damage in the hippocampus after fluid percussion brain injury and is attenuated by post-traumatic treatment with indeloxazine. Copyright (C) 1996 Elsevier Science Ltd.	CHIBA UNIV,SCH MED,DEPT NEUROL SURG,CHIBA 280,JAPAN		Yamaguchi, T (corresponding author), YAMANOUCHI PHARMACEUT CO LTD,CLIN PHARMACOL RES LABS,DEPT PHARMACOL,TOKYO 174,JAPAN.						ALTMAN HJ, 1984, PSYCHOPHARMACOLOGY, V84, P496, DOI 10.1007/BF00431456; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON ED, 1993, 2 GLASG INT NEUR S, P167; DOUGLAS RJ, 1967, PSYCHOL BULL, V67, P416, DOI 10.1037/h0024599; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1990, CAN J PSYCHOL, V44, P223; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; Graham D I, 1993, Acta Neurochir Suppl (Wien), V57, P41; GRONWALL D, 1974, LANCET, V2, P605; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HARADA M, 1979, BIOCHEM PHARMACOL, V28, P2645, DOI 10.1016/0006-2952(79)90041-8; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KMIECIAKKOLADA K, 1987, POL J PHARMACOL PHAR, V39, P47; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OGREN SO, 1985, ACTA PHYSL SCAND S, V544, P1; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; PIERCE JES, 1993, BRAIN RES, V624, P199, DOI 10.1016/0006-8993(93)90078-2; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SARTER M, 1991, TRENDS PHARMACOL SCI, V12, P456, DOI 10.1016/0165-6147(91)90636-7; SHIMIZUSASAMATA M, 1993, PHARMACOL BIOCHEM BE, V45, P335, DOI 10.1016/0091-3057(93)90248-R; SHIMIZUSASAMATA M, 1991, ARCH INT PHARMACOD T, V314, P74; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Sunami K, 1989, Neurol Med Chir (Tokyo), V29, P975, DOI 10.2176/nmc.29.975; YAMADA K, 1991, J CEREBR BLOOD F MET, V11, P472, DOI 10.1038/jcbfm.1991.90; YAMAGUCHI T, 1985, BIOGENIC AMINES, V3, P21; YAMAGUCHI T, 1995, BRAIN RES, V669, P107, DOI 10.1016/0006-8993(94)01268-M; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAMOTO M, 1990, Brain Dysfunction, V3, P130; YAMAMOTO M, 1993, NEUROPHARMACOLOGY, V32, P695, DOI 10.1016/0028-3908(93)90083-F	48	15	16	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0028-3908			NEUROPHARMACOLOGY	Neuropharmacology	MAR	1996	35	3					329	336		10.1016/0028-3908(95)00171-9			8	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	UQ415	WOS:A1996UQ41500012	8783208				2022-02-06	
J	Mozzoni, MP; Bailey, JS				Mozzoni, MP; Bailey, JS			Improving training methods in brain injury rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						decision matrix; feedback; outcome measurement	CHILDREN; BEHAVIOR	The effects of therapist training techniques upon treatment outcomes in traumatic brain injury (TBI) has not been widely studied. This study demonstrates that outcome scores are likely to increase when therapists work on outcome-related activities and use identified training methods. Six therapists working with five persons with TBI were subjects for this study. Therapists were targeted because their clients were not making progress on the functional independent measurement (FIM). Baseline teaching data were collected from videotapes, targeting 14 training elements within the areas of task, prompting, reinforcement, and client's behavior. Therapists were given feedback based upon the teaching diagnostic of the decision matrix. The results show that diagnostic-based intervention with therapists can result in direct, immediate, and obvious improvements in outcome measures across patients.	VANDERBILT STALLWORTH REHABIL HOSP,NASHVILLE,TN; FLORIDA STATE UNIV,TALLAHASSEE,FL 32306								BALCAZAR F, 1986, J ORGAN BEHAV MANAGE, V7, P65; BARLOW DH, 1984, SINGLE CASE EXPT DES; Bloomer J., 1979, BAY AREA FUNCTIONAL; BORNSTEIN MR, 1977, J APPL BEHAV ANAL, V10, P183, DOI 10.1901/jaba.1977.10-183; CARR EG, 1985, BEHAV MODIF, V9, P403, DOI 10.1177/01454455850094001; CARR EG, 1980, J APPL BEHAV ANAL, V13, P139; CORREA VI, 1984, J APPL BEHAV ANAL, V17, P57, DOI 10.1901/jaba.1984.17-57; CUVO AJ, 1978, VOCATIONAL EVALUATIO, V11, P13; CUVO AJ, 1983, PROGR BEHAVIOR MODIF; Daniels, 1989, PERFORMANCE MANAGEME; DUKER PC, 1980, BEHAV ANAL MODIF, V4, P71; GILES GM, 1988, AM J OCCUP THER, V42, P658, DOI 10.5014/ajot.42.10.658; GRANGER CV, 1990, GUIDE UNIFORM DATA S; Hagen C., 1972, LEVELS COGNITIVE FUN; HARCHIK AE, 1992, J APPL BEHAV ANAL, V25, P599, DOI 10.1901/jaba.1992.25-599; HOLLANDSWORTH JG, 1978, J APPL BEHAV ANAL, V11, P259, DOI 10.1901/jaba.1978.11-259; HORNER RD, 1975, J APPL BEHAV ANAL, V8, P301, DOI 10.1901/jaba.1975.8-301; HOSEK S, 1986, UCLA R3424 HLTH CAR; JACOBS HE, 1993, BEHAVIOR ANAL GUIDEL; JENNETT B, 1975, LANCET, V1, P489; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; Kazdin A., 1982, SINGLE CASE RES DESI; KOEGEL RL, 1977, J APPL BEHAV ANAL, V10, P197, DOI 10.1901/jaba.1977.10-197; KOOP S, 1980, AM J MENT DEF, V84, P616; LAWTON MP, 1982, J GERONTOL, V37, P91, DOI 10.1093/geronj/37.1.91; LEHMANN JF, 1984, ARCH PHYS MED REHAB, V65, P260; MARTIN G, 1988, BEHAVIOR MODIFICATIO; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; PIE HE, 1993, CONTINUING CARE, V5, P25; STRAIN PS, 1976, J APPL BEHAV ANAL, V9, P31, DOI 10.1901/jaba.1976.9-31; SULZERAZAROFF B, 1991, BEHAVIOR ANAL LASTIN; Wood R. L., 1987, BRAIN INJURY REHABIL; ZAHARA DJ, 1984, CLIN PSYCHOL REV, V4, P477, DOI 10.1016/0272-7358(84)90022-9; [No title captured]; [No title captured]	35	15	15	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1996	11	1					1	17		10.1097/00001199-199602000-00003			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TU021	WOS:A1996TU02100003					2022-02-06	
J	Wilson, SL; Brock, D; Powell, GE; Thwaites, H; Elliott, K				Wilson, SL; Brock, D; Powell, GE; Thwaites, H; Elliott, K			Constructing arousal profiles for vegetative state patients - A preliminary report	BRAIN INJURY			English	Article							SENSORY STIMULATION; COMA; CONSCIOUSNESS	Arousal profiles are a method that we have developed for using data derived from time sampling to examine how behaviours such as the frequency with which the eyes are observed open, and the frequency of spontaneous movements, vary in the periods immediately before and immediately after sensory stimulation treatment. We believe changes in such behaviours reflect changes in arousal. The use of this new technique is illustrated with examples from a pilot study using data from 15-day treatment blocks, gathered for 10-minute periods immediately before and after sensory stimulation treatment from three patients using single-case research methods. The patients were diagnosed as being in vegetative state following traumatic brain injury. The possible significance of the differing characteristics of the profiles is discussed.	ROYAL HOSP NEURODISABIL,OCCUPAT THERAPY DEPT,LONDON,ENGLAND; COLCHESTER INST,ESSEX SCH OCCUPAT THERAPY,COLCHESTER,ESSEX,ENGLAND		Wilson, SL (corresponding author), UNIV SURREY,DEPT PSYCHOL,GUILDFORD GU2 5XH,SURREY,ENGLAND.			Wilson, Sarah L./0000-0001-8347-5156			MALKMUR D, 1980, REHABILITATION HEADI; POWELL GE, 1994, CLIN REHABIL, V8, P54; TEASDALE G, 1974, LANCET, V2, P81; WATSON M, 1991, Brain Injury, V5, P421, DOI 10.3109/02699059109008115; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; Wilson S. L., 1992, CLIN REHABIL, V6, P181, DOI [10.1177/026921559200600301, DOI 10.1177/026921559200600301]; Wilson SL, 1993, NEUROPSYCHOL REHABIL, V3, P191, DOI 10.1080/09602019308401435; WILSON SL, 1993, 3RD ANN C INT ASS ST; [No title captured]; [No title captured]	10	15	16	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1996	10	2					105	113		10.1080/026990596124593			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UB726	WOS:A1996UB72600004	8696310				2022-02-06	
J	Himmelseher, S; Pfenninger, E; Georgieff, M				Himmelseher, S; Pfenninger, E; Georgieff, M			The effect of basic fibroblast growth factor on glutamate-injured neuroarchitecture and arachidonic acid release in adult hippocampal neurons	BRAIN RESEARCH			English	Article						excitotoxicity; basic fibroblast growth factor; arachidonic acid; mature hippocampal neuron; neuroprotection	TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; MICROTUBULE-ASSOCIATED PROTEIN-2; PYRAMIDAL NEURONS; CEREBRAL-ISCHEMIA; ASTROGLIAL CELLS; PRIMARY CULTURES; TRANSPORT SITES; RAT; DAMAGE	During development in culture, basic fibroblast growth factor (bFGF) protected immature primary hippocampal neurons against glutamate-induced neurotoxicity. We investigated the effects of bFGF on mature, differentiated rat hippocampal neurons cultured for 10-12 days after an 8-min exposure to 500 mu M glutamate. Seven days post-injury, hippocampal cells demonstrated severe reductions in cellular viability and axonal and dendritic outgrowth, which were accompanied by a marked increase in [H-3]arachidonic acid (ARA) release from prelabelled neurons. bFGF applied post-injury attenuated cell death and cytoarchitectural destruction at all concentrations used (500 pg/ml, 1, 10, 20 ng/ml). However, neurite elongation and branching processes were only significantly protected by 10 ng/ml bFGF. [H-3]ARA release decreased in a dose-related fashion within a concentration range of 1-10 ng/ml bFGF.20 ng/ml bFGF was not superior to 10 ng/ml bFGF. Therefore, bFGF's neurotropic actions appear to be concentration-dependent. Our data suggest that bFGF applied post-injury may have a neuroprotective potential for mature, differentiated, completely polarized hippocampal neurons.			Himmelseher, S (corresponding author), UNIV ULM KLINIKUM, ANASTHESIOL KLIN, SEKT EXPTL ANASTHESIOL, PK STR 11, D-89070 ULM, GERMANY.		Pfenninger, Ernst G./AAY-1535-2021				ABE K, 1987, J NEUROCHEM, V48, P503, DOI 10.1111/j.1471-4159.1987.tb04121.x; ANDERSON KJ, 1991, BRAIN RES, V562, P285, DOI 10.1016/0006-8993(91)90633-7; ANDERSON KJ, 1990, NEUROSCIENCE, V38, P311, DOI 10.1016/0306-4522(90)90030-8; ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; ASAI T, 1993, MOL BRAIN RES, V17, P174, DOI 10.1016/0169-328X(93)90088-7; BALCAR VJ, 1992, LIFE SCI, V51, P1467, DOI 10.1016/0024-3205(92)90556-5; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BARTLETT WP, 1984, J NEUROSCI, V4, P1954; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BAZAN NG, 1989, ANN NY ACAD SCI, V559, P1; BENKE TA, 1993, P NATL ACAD SCI USA, V90, P7819, DOI 10.1073/pnas.90.16.7819; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; CACERES A, 1986, J NEUROSCI, V6, P714; COOK JA, 1989, ANAL BIOCHEM, V179, P1, DOI 10.1016/0003-2697(89)90191-7; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DEMEDIUK P, 1989, ANN NY ACAD SCI, V559, P431; DESHAIES RJ, 1988, TRENDS BIOCHEM SCI, V13, P384, DOI 10.1016/0968-0004(88)90180-6; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DUMUIS A, 1990, NATURE, V347, P182, DOI 10.1038/347182a0; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FLETCHER TL, 1989, DEV BIOL, V136, P446, DOI 10.1016/0012-1606(89)90269-8; GLAUM SR, 1990, J PHARMACOL EXP THER, V253, P1293; GOUREAU O, 1993, P NATL ACAD SCI USA, V90, P4276, DOI 10.1073/pnas.90.9.4276; HARA H, 1991, EUR J PHARMACOL, V209, P195; HIRAKI Y, 1988, J BIOL CHEM, V263, P13655; JAHR CE, 1993, P NATL ACAD SCI USA, V90, P11573, DOI 10.1073/pnas.90.24.11573; KELLER M, 1985, NEUROCHEM INT, V7, P655, DOI 10.1016/0197-0186(85)90063-4; KEYSER DO, 1990, NEURON, V5, P545, DOI 10.1016/0896-6273(90)90092-T; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LAZAREWICZ JW, 1992, ADV EXP MED BIOL, V318, P73; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LOGAN A, 1992, J NEUROSCI, V12, P3828; MACMILLAN V, 1993, STROKE, V24, P1735, DOI 10.1161/01.STR.24.11.1735; MATTSON MP, 1993, EXP NEUROL, V121, P1, DOI 10.1006/exnr.1993.1066; MATTSON MP, 1989, BRAIN RES, V478, P337, DOI 10.1016/0006-8993(89)91514-X; MATTSON MP, 1989, J NEUROSCI, V9, P3728; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.ne.11.030188.000333; MCKAY R, 1990, COLD SH Q B, V55, P291; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; MURPHY T, 1989, ANN NY ACAD SCI, V559, P474; NAKATA N, 1993, BRAIN RES, V605, P354, DOI 10.1016/0006-8993(93)91766-L; PETITO CK, 1984, J CEREBR BLOOD F MET, V4, P194, DOI 10.1038/jcbfm.1984.28; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; SANFELIU C, 1990, BRAIN RES, V526, P241, DOI 10.1016/0006-8993(90)91228-9; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SIMAN R, 1989, J NEUROSCI, V9, P1579; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TAKAMI K, 1993, EXP BRAIN RES, V97, P185; VOLTERRA A, 1992, J NEUROCHEM, V59, P600, DOI 10.1111/j.1471-4159.1992.tb09411.x; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1988, DEV BRAIN RES, V40, P71, DOI 10.1016/0165-3806(88)90009-0; WATSON JD, 1987, MOL BIOL GENE, P962; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; YING Z, 1993, J CEREBR BLOOD F MET, V13, P378, DOI 10.1038/jcbfm.1993.51	59	15	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 22	1996	707	1					54	63		10.1016/0006-8993(95)01220-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TU737	WOS:A1996TU73700006	8866713				2022-02-06	
J	Persinger, MA				Persinger, MA			Clinical neurological indicators are only moderately correlated with quantitative neuropsychological test scores in patients who display mild-moderate brain impairment following closed-head injuries	PERCEPTUAL AND MOTOR SKILLS			English	Article								Quantitative comparisons were completed between mean scores for standardized neuropsychological tests (requiring 6 hr.), numbers of neurological signs (tests requiring 15 min.), anomalies within the electroencephalogram, subjective symptoms during a structured interview (requiring 20 min.), and an indicator of an organic brain syndrome for 81 patients who had sustained significant mechanical impacts to their skulls. The composite of neuropsychological scores was correlated 0.70 with a composite of neurological indicators and EEG anomalies. There were no significant correlations between neuropsychological or neurological scores and the numbers of subjective complaints, abnormal personality indicators, duration of coma or the interval of posttraumatic dysmnesia. However, the scores for the severity of the organic brain syndrome, partial complex epileptic symptoms, and subjective complaints were inversely correlated (rho=-0.35) with the duration of coma, the period of posttraumatic amnesia, and the numbers of qualitative electroencephalographic anomalies.			Persinger, MA (corresponding author), LAURENTIAN UNIV,DEPT PSYCHOL,CLIN NEUROPSYCHOL LAB,RAMSEY LAKE RD,SUDBURY,ON P3E 2C6,CANADA.						CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; LACHAR D, 1985, MMPI CLIN ASSESSMENT; Levin H. S., 1987, NEUROBEHAVIORAL RECO, P318; LEVIN HS, 1993, HEAD INJURY, P525; MAKAREC K, 1990, J RES PERS, V24, P323, DOI 10.1016/0092-6566(90)90024-Z; MILLER L, 1993, PSYCHOTHERAPY BRAIN; Niedermeyer E, 1987, ELECTROENCEPHALOGRAP; PARKER R, 1990, TRAUMATIC BRAIN INJU; PERSINGER MA, 1995, PSYCHOL REP, V77, P707, DOI 10.2466/pr0.1995.77.3.707; PERSINGER MA, 1995, PERCEPT MOTOR SKILL, V80, P1011, DOI 10.2466/pms.1995.80.3.1011; PERSINGER MA, 1994, PSYCHOL REP, V75, P1059, DOI 10.2466/pr0.1994.75.3.1059; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; Reitan R, 1985, HALSTEAD REITAN NEUR; RICHARDS P, 1992, PERCEPT MOTOR SKILL, V74, P1027, DOI 10.2466/PMS.74.4.1027-1030; Roberts RJ, 1990, NEUROPSYCHOLOGY, V4, P65; SCHOENHUBER R, 1989, MILD HEAD INJURY, P142; TILLER SG, UNPUB TEST RETEST SC; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; 1983, NEUROPSYCHOLOGICAL S	19	15	15	0	0	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	DEC	1995	81	3	2				1283	1292		10.2466/pms.1995.81.3f.1283			10	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	TQ120	WOS:A1995TQ12000040	8684927				2022-02-06	
J	YLVISAKER, M; FEENEY, T; MAHERMAXWELL, N; MESERVE, N; GEARY, PJ; DELORENZO, JP				YLVISAKER, M; FEENEY, T; MAHERMAXWELL, N; MESERVE, N; GEARY, PJ; DELORENZO, JP			SCHOOL REENTRY FOLLOWING SEVERE TRAUMATIC BRAIN INJURY - GUIDELINES FOR EDUCATIONAL-PLANNING	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						EDUCATIONAL PLANNING; SCHOOL REENTRY; TRAUMATIC BRAIN INJURY	FRONTAL-LOBE DAMAGE; HEAD-INJURY; CHILDREN; CHILDHOOD; CONSEQUENCES; DISABILITIES; BEHAVIOR; SEQUELAE; LESION	The primary purpose of this article is to present a conceptual framework designed to guide educational planning for students returning to school after severe traumatic brain injury (TBI). Eleven basic principles are offered that derive educational implications from important characteristics of many students with TBI. The article concludes with specific program considerations for students representing four different profiles of cognitive, behavioral, and academic functioning. While embracing the ideal of fully individualized educational planning, the authors argue that specific sets of services and supports are important to consider for students with identifiable profiles of ability and disability after TBI.	BOARD COOPERAT EDUC SERV,ALBANY,NY; NASSAU CTY BOARD COOPERAT EDUC SERV,MASSAPEQUA,NY; MONROE 2 ORLEANS CTY BOARD COOPERAT EDUC SERV,ROCHESTER,NY; NEW YORK STATE DEPT EDUC,OFF SPECIAL EDUC SERV,ALBANY,NY		YLVISAKER, M (corresponding author), COLL ST ROSE,DEPT COMMUN DISORDERS,432 WESTERN AVE,ALBANY,NY 12205, USA.						Begali V., 1992, HEAD INJURY CHILDREN; Benson D.F., 1986, FRONTAL LOBES; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; Benton AL, 1991, FRONTAL LOBE FUNCTIO; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P279, DOI 10.1016/0887-6177(88)90020-0; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CARR EG, 1994, COMMUNICATION BASED; *CEC, 1986, FIN REP CEC AD HOC C; COHEN SB, 1991, J HEAD TRAUMA REHAB, V6, P56; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DEPOMPEI R, 1994, TOP LANG DISORD, V15, P68, DOI 10.1097/00011363-199411000-00007; DEPOMPEI R, 1986, LANGUAGE SPEECH HEAR, V18, P292; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GLANG A, 1992, J HEAD TRAUMA REHAB, V7, P93; GOETZ L, 1987, INNOVATIVE PROGRAM D; GRATTAN LM, 1991, DEV NEUROPSYCHOL, V7, P283, DOI 10.1080/87565649109540496; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; Horner R. H, 1988, GENERALIZATION MAINT; JACOBS HE, 1993, BEHAVIOR ANAL GUIDEL; Johnson, 1987, LEARNING TOGETHER AL; Johnson D.W., 1991, JOINING TOGETHER GRO, V4; LASH M, 1992, YOUR CHILD GOES SCH; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; MATEER CA, 1992, BRAIN COGNITION, V20, P196; MIRA M, 1988, TRAUMATIC HEAD INJUR; Mira M. P., 1992, TRAUMATIC BRAIN INJU; MIRA MP, 1991, FOCUS EXCEPT CHILD, V23, P1; Orelove FP, 1991, ED CHILDREN MULTIPLE; PEARSON S, 1990, TRAUMATIC BRAIN INJU; PEARSON S, 1994, FAMILIES LIVING BRAI; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; PRESSLEY M, 1992, COGNITIVE STRATEGY R; PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383; RAINES SR, 1992, UNDERSTANDING TRAUMA; RAINFORTH B, 1993, COLLABORATIVE TEAMS; ROSEN CD, 1992, HEAD TRAUMA ED REINT; Savage R. C., 1994, ED DIMENSIONS ACQUIR; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; Savage RC, 1987, J HEAD TRAUMA REHAB, V2, P1; SAVAGE RC, 1991, HEAD INJURY FAMILY M; STELLING MW, 1986, AM J DIS CHILD, V140, P710, DOI 10.1001/archpedi.1986.02140210108037; STOKES TF, 1977, J APPL BEHAV ANAL, V10, P349, DOI 10.1901/jaba.1977.10-349; SZEKERES SF, 1994, TOP LANG DISORD, V15, P21, DOI 10.1097/00011363-199411000-00004; Szekeres Shirley F., 1992, Seminars in Speech and Language, V13, P293, DOI 10.1055/s-2008-1064204; TAYLOR HG, IN PRESS TRAUMATIC H; TELZROW C, 1990, TRAUMATIC BRAIN INJU; TELZROW CF, 1991, J HEAD TRAUMA REHAB, V6, P23; THOUSAND JS, 1990, FOCUS EXCEPT CHILD, V23, P1; Tyler J. S., 1993, TEACH EXCEPT CHILD, V25, P24; TYLER JS, 1991, LD FORUM TRANSLATING; TYLER JS, 1993, PERSPECTIVES TRAUMAT; VANDIJK J, 1986, SENSORY IMPAIRMENTS; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WILLIAMS J, 1991, HEAD INJURY FAMILY M; Wolcott G. F, 1995, ED MANUAL WHAT ED NE; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; YLVISAKER M, 1994, TOP LANG DISORD, V15, P37, DOI 10.1097/00011363-199411000-00005; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; YLVISAKER M, 1994, ED DIMENSIONS ACQUIR; YLVISAKER M, IN PRESS HEAD INJURY; YLVISAKER M, 1991, ADV CHILD NEUROPSYCH; Ylvisaker Mark, 1995, Seminars in Speech and Language, V16, P32, DOI 10.1055/s-2008-1064109	72	15	15	0	3	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1995	10	6					25	41		10.1097/00001199-199512000-00006			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ661	WOS:A1995TJ66100006					2022-02-06	
J	YLVISAKER, M; FEENEY, T; MULLINS, K				YLVISAKER, M; FEENEY, T; MULLINS, K			SCHOOL REENTRY FOLLOWING MILD TRAUMATIC BRAIN INJURY - A PROPOSED HOSPITAL-TO-SCHOOL PROTOCOL	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						HOSPITAL-TO-SCHOOL PROTOCOL; SCHOOL REENTRY; MILD TRAUMATIC BRAIN INJURY	MINOR HEAD TRAUMA; CHILDREN; CHILDHOOD; MORBIDITY; LESION	Mild traumatic brain injury (TBI) in children is generally associated with excellent long-term outcome. In rare cases sequelae persist indefinitely. More commonly, cognitive and behavioral symptoms persist for a few days to a few weeks, possibly resulting in academic and social failure that could generate consequences that outlive the neurological sequelae. This article presents a mild TBI hospital-to-school protocol that uses real academic and social tasks and contexts as the screening procedure and creates a system of temporary accommodations in the event of persisting cognitive or behavioral consequences of the injury.	THE SAGE COLL,DEPT EDUC,TROY,NY; ALBANY SCHENECTADY SCHOHARIE & SARATOGA BOARDS CO,ALBANY,NY; BROOME TIOGA CTY BOARD COOPERAT EDUC SERV,BINGHAMTON,NY		YLVISAKER, M (corresponding author), COLL ST ROSE,DEPT COMMUN DISORDERS,432 WESTERN AVE,ALBANY,NY 12205, USA.						Benson D.F., 1986, FRONTAL LOBES; BENTON A, 1991, DEV NEUROPSYCHOL, V7, P275, DOI 10.1080/87565649109540495; Benton AL, 1991, FRONTAL LOBE FUNCTIO; BIJUR PE, 1990, PEDIATRICS, V86, P269; BOLL TJ, 1983, J CLIN CHILD PSYCHOL, V12, P74, DOI 10.1080/15374418309533114; CASEY R, 1986, PEDIATRICS, V78, P497; CASEY R, 1987, PEDIATRICS, V80, P159; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1985, INJURED CHILD; GRATTAN LM, 1991, DEV NEUROPSYCHOL, V7, P283, DOI 10.1080/87565649109540496; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; JENNETT B, 1972, DEV MED CHILD NEUROL, V14, P137; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; YLVISAKER M, 1995, SEMIN SPEECH LANG, V15, P32	23	15	15	0	4	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1995	10	6					42	49		10.1097/00001199-199512000-00007			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ661	WOS:A1995TJ66100007					2022-02-06	
J	KELLER, T				KELLER, T			RAILWAY SPINE REVISITED - TRAUMATIC NEUROSIS OR NEUROTRAUMA	JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES			English	Article											KELLER, T (corresponding author), UNIV CALIF DAVIS E BAY,DIV NEUROSURG,1411 E 31ST ST,OAKLAND,CA 94602, USA.						BAILEY P, 1907, TXB LEGAL MED TAXICO, V1, P360; BAKER RH, 1920, SURG GYNECOL OBSTET, V31, P359; BAKER RP, 1983, J NEUROSURG, V58, P760, DOI 10.3171/jns.1983.58.5.0760; Beard George Miller, 1881, AM NERVOUSNESS ITS C; Beard GM, 1869, BOSTON MED SURG J, V80, P217; Bevan AD, 1895, RAILW SURG, V2, P121; BUZZARD T, 1867, LANCET, V1, P389; BUZZARD T, 1867, LANCET, V1, P390; CHARCOT J, 1995, LECONS MALADIES SYST, V3, P355; CLEVENGER SV, 1889, JAMA-J AM MED ASSOC, V12, P50; CLEVENGER SV, 1889, SPINAL CONCUSSION SU, P208; Cushing H, 1903, BOSTON MED SURG J, V148, P0250, DOI 10.1056/NEJM190303051481002; Dana C. L., 1884, MED REC, V26, P617; DANA CL, 1888, POSTGRADUATE, V3, P104; DENIS F, 1984, CLIN ORTHOP RELAT R, V189, P142; DERCUM FX, 1989, THERAPEUTIC GAZETTE, V13, P649; DUNBAR S, 1968, HIST TRAVEL AM, V3, P1052; EDES R, 1882, BOSTON MED SURG J, V107, P265; ERICHHSEN J, 1875, CONCUSSION SPINE NER, P275; Erichsen, 1866, RAILWAY OTHER INJURI; FARR W, 1975, VITAL STATISTICS MEM, P349; FRENCH R, 1969, R WHYTT SOUL MED, P90; FREUD S, 1924, COLLECT PAPERS, V1, P42; GOEPP RM, 1929, STATE BOARD QUESTION, P306; GRAY M, 1978, NEUROSES COMPREHENSI, P204; HAMMOND W, 1876, SPINAL IRRITATION; Hodges R. M., 1881, BOSTON MED SURG J, V104, P386; Hodges R. M., 1881, BOSTON MED SURG J, V104, P361, DOI [10.1056/NEJM188104211041601, DOI 10.1056/NEJM188104211041601]; HUDDLESON J, 1932, ACCIDENTS NEUROSES C, P108; Judd H., 1889, JAMA-J AM MED ASSOC, V13, P188, DOI [10.1001/jama.1889.04440040008002, DOI 10.1001/JAMA.1889.04440040008002]; KEIR M, 1927, MARCH COMMERCE, V4, P121; KNAPP P, 1888, BOSTON MED SURG J, V119, P421; MENDEL E, 1884, NEUROLOGISCHES  0515, P229; MULLEN JB, 1979, NEUROSURGERY, V5, P432, DOI 10.1227/00006123-197910000-00004; OPPENHEIM H, 1911, TXB NERVOUS DISEASES, V11, P1162; OPPENHEIM H, 1885, ARCH PSYCHIAT NERVEN, V16, P743; PAGE H, 1885, MED TIMES GAZ, P437; PAGE H, 1891, WOODS MED SEURGICAL, V10, P23; PAGE H, 1885, INJURIES SPINE SPINA, P14; PHILLIPS L, 1965, YONDER COMES TRAIN, P30; PUTNAM JJ, 1883, BOSTON MED SURG J, V104, P217; REED R, 1968, TRAIN WRECKS, P10; REYNOLDS JR, 1868, SYSTEM MED, V2, P640; RIGLER J, 1879, UEBER FOLGEN VERLETZ, P7; ROGERS L, 1944, BRIT J SURG, V32, P517; Rontgen WC, 1895, SBER PHYS MED GES WU, P132; SCHNAID E, 1985, J TRAUMA, V25, P1099; SMITH HH, 1889, JAMA-J AM MED ASSOC, V13, P181; SPITZKA E, 1883, AM J NEUROL PSYCHIAT, V2, P541; STRUMPELL A, 1887, LEHRBUCH SPECIALLEN, V11, P161; THORBURN W, 1888, MED CHRONICLE MANCHE, V9, P265; THORBURN W, 1888, MED CHRONICLE MANCHE, V9, P198; TRAFTON PG, 1984, J TRAUMA, V24, P506, DOI 10.1097/00005373-198406000-00008; TRIMBLE MR, 1981, POST TRAUMATIC NEURO, P141; VONLEYDEN E, 1878, ARK PSYCH, V8, P21; Walton G. L., 1881, BOSTON MED SURG J, V109, P337, DOI 10.1056/NEJM188310111091501; WESTPHAL C, 1878, CHARITE ANN, V5, P379; WHITE J, 1880, BOSTON MED SURG J, V102, P132; 1858, HARPERS WEEKLY  0831, P483; 1890, INDEX LIBRARY SURGEO; 1862, LANCET, V1, P79; 1980, DIAGNOSTIC STATISTIC, P238; 1856, NY TIMES        0717, P1; 1871, NY TIMES        0827, P1; 1975, COLONIAL TIMES 1970, V2, P211; 1988, NY TIMES        1011, P1	66	15	16	0	1	J HIST MED ALLIED SCI INC	CANTON	 PO BOX 487, CANTON, MA 02021	0022-5045			J HIST MED ALL SCI	J. Hist. Med. Allied Sci.	OCT	1995	50	4					507	524		10.1093/jhmas/50.4.507			18	Health Care Sciences & Services; History & Philosophy Of Science	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; History & Philosophy of Science	TB616	WOS:A1995TB61600003	7594404				2022-02-06	
J	PRIGATANO, GP				PRIGATANO, GP			1994 BERROL,SHELDON, MD, SENIOR LECTURESHIP - THE PROBLEM OF LOST NORMALITY AFTER BRAIN INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	13th Annual National Head-Injury-Foundation Conference	NOV   06, 1994	CHICAGO, IL	Head Injury Fdn		PSYCHOLOGICAL JUDGMENT; REHABILITATION; BRAIN INJURY	CLOSED HEAD-INJURY	The significant losses in higher cerebral functioning caused by moderate to severe traumatic brain injury (TBI) can leave patients frustrated and confused. A central issue in working with these individuals is to help them deal with the problem of lost normality. Impaired self-awareness, as well as denial of disability, can contribute to this problem. Helping individuals establish meaning in their life in the face of (not despite) their impairments has benefited some individuals. A brief conceptualization of the problem of lost normality is presented, and the role of neuropsychological rehabilitation in dealing with this problem is outlined.			PRIGATANO, GP (corresponding author), ST JOSEPHS HOSP,BARROW NEUROL INST,NEUROPSYCHOL SECT,PHOENIX,AZ 85013, USA.						Ben-Yishay Y, 1990, REHABILITATION ADULT; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; CAMPBELL J, 1989, HERO WITH 1000 FACES; COEN CW, 1985, FUNCTIONS BRAIN; FRANZEN EA, 1973, NEUROPSYCHOLOGIA, V11, P141, DOI 10.1016/0028-3932(73)90002-X; GINSBURG SW, 1955, COMMUNICATION PROGRA; Goldstein K., 1942, AFTEREFFECTS BRAIN I; JAHODA M, 1955, COMMUNITY PROGRAMS M; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; JUNG CG, 1957, BOLLINGER SERIES, V20, P16; Keppel G., 1989, DATA ANAL RES DESIGN; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KLONOFF P, IN PRESS J HEAD TRAU; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Peck MS., 1978, ROAD LESS TRAVELED; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1992, AUG AM PSYCH ASS CEN; PRIGATANO GP, 1991, FRONTAL LOBE FUNCTIO; PRIGATANO GP, IN PRESS BEHAVIORAL; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; PRIGATANO GP, IN PRESS NEUROPSYCHO; Watzlawick, 1983, SITUATION IS HOPELES; ZIMMERMAN RA, 1989, NEUROPSYCHOLOGY, V3, P189; [No title captured]; 1994, PARADE MAGAZINE 0911	32	15	15	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1995	10	3					87	95					9	Clinical Neurology; Rehabilitation	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RC717	WOS:A1995RC71700008					2022-02-06	
J	CAVALLO, MM; SAUCEDO, C				CAVALLO, MM; SAUCEDO, C			TRAUMATIC BRAIN INJURY IN FAMILIES FROM CULTURALLY DIVERSE POPULATIONS	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						CULTURAL DIVERSITY; SERVICE DELIVERY; TRAUMATIC BRAIN INJURY	REHABILITATION; ACCULTURATION; AMERICANS	This article presents information regarding the epidemiology of traumatic brain injury (TBI) in culturally diverse populations and factors that must be considered when providing services to these persons and their families (eg. language, level of acculturation, family values). Issues of assessment and treatment are also discussed. Recommendations for education and training of rehabilitation professionals and for providing effective clinical interventions to culturally diverse people with TBI and their families are provided.			CAVALLO, MM (corresponding author), ASSOC HELP RETARDED CHILDREN,TRAUMAT BRAIN INJURY COMMUNITY SUPPORT SERV,NEW YORK,NY, USA.						ACOSTA FX, 1982, EFFECTIVE PSYCHOTHER; Ardila A., 1994, NEUROPSYCHOLOGICAL E; AXELROD D, 1986, HEAD INJURY IN NEW Y; BARRINGER F, 1993, NY TIMES        0428, pA18; BAXTER B, 1993, NOV NAT HEAD INJ F S; BELGRAVE FZ, 1991, P NATIONAL C FUTURE; BROOKS DN, 1992, J CLIN EXP PSYCHOL, V13, P155; CHAVIRA JA, 1988, DISABILITY REHABILIT; CUELLAR I, 1988, J REHABIL, V54, P35; Del Castillo J. C., 1970, AM J PSYCHIAT, V127, P160; DIKENGIL A, 1993, J COGNITIVE REHABILI, V11, P10; Epstein LG., 1992, CULTURAL COMPETENCE; ESTRADA AL, 1990, AM J PUBLIC HEALTH, V80, P27, DOI 10.2105/AJPH.80.Suppl.27; FITZGERALD MH, 1992, J REHABIL, V58, P38; FRANKOWSKI RF, 1985, CENTRAL NERVOUS SYST; GARCIA PI, 1984, HISPANIC J BEHAV SCI, V6, P225, DOI 10.1177/07399863840063002; HAVILAND MG, 1983, J COUNS PSYCHOL, V30, P267, DOI 10.1037/0022-0167.30.2.267; HORAN K, 1990, ARIZONA COUNSEL J, V15, P6; Horan K.T., 1987, RURAL SPECIAL ED Q, V8, P19; KAY T, 1994, FAMILY SYSTEM IMPACT; LACALLE JJ, 1987, AM J FORENSIC PSYCH, V5, P29; MARSHALL CA, 1991, J COUNS DEV, V70, P225, DOI 10.1002/j.1556-6676.1991.tb01588.x; MARTINEZ C, 1988, CLIN GUIDELINES CROS; NEGY C, 1992, HISPANIC J BEHAV SCI, V14, P224, DOI 10.1177/07399863920142003; NEGY C, 1992, HISPANIC J BEHAV SCI, V14, P248, DOI 10.1177/07399863920142004; NIX L, 1993, NOV NAT HEAD INJ F S; PADILLA AM, 1992, CULTURAL COMPETENCE; Padilla AM, 1980, ACCULTURATION THEORY; PUENTE AE, 1990, HDB PSYCHOL ASSESSME; SMART JF, 1992, J REHABIL, V58, P29; SZAPOCZNIK J, 1993, AM PSYCHOL, V48, P400, DOI 10.1037/0003-066X.48.4.400; Szapocznik J, 1980, ACCULTURATION THEORY; Szapocznik J., 1980, INT J INTERCULT REL, V4, P353; *TASK FORC DEL SER, 1990, GUID PROV PSYCH SERV; VASQUEZ C, 1991, HOSP COMMUNITY PSYCH, V42, P163; WALKER S, 1993, NOV NAT HEAD INJ F S; WESTERMEYER J, 1980, HOSP COMMUNITY PSYCH, V137, P160; WILLIAMS J, 1993, STAFF DEV CLIN INTER; WILLIAMS J, 1991, HEAD INJURY FAMILY M; [No title captured]; [No title captured]; 1993, REHABIL BRIEF, V15, P1	42	15	15	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1995	10	2					66	77		10.1097/00001199-199504000-00008			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QR039	WOS:A1995QR03900008					2022-02-06	
J	DELAHUNTY, TM; JIANG, JY; BLACK, RT; LYETH, BG				DELAHUNTY, TM; JIANG, JY; BLACK, RT; LYETH, BG			DIFFERENTIAL MODULATION OF CARBACHOL AND TRANS-ACPD-STIMULATED PHOSPHOINOSITIDE TURNOVER FOLLOWING TRAUMATIC BRAIN INJURY	NEUROCHEMICAL RESEARCH			English	Article						MUSCARINIC RECEPTOR; METABOTROPIC GLUTAMATE RECEPTOR; INOSITOL PHOSPHATES; HIPPOCAMPUS; TRAUMATIC BRAIN INJURY	METABOTROPIC GLUTAMATE-RECEPTOR; INOSITOL PHOSPHOLIPID HYDROLYSIS; EXCITATORY AMINO-ACIDS; LONG-TERM POTENTIATION; RAT HIPPOCAMPUS; KINDLED RATS; RELEASE; SLICES; ENHANCEMENT; POTASSIUM	In the fluid percussion model of traumatic brain injury (TBI), we examined muscarinic and metabotropic glutamate receptor-stimulated polyphosphoinositide (PPI) turnover in rat hippocampus. Moderate injury was obtained by displacement and deformation of the brain within the closed cranial cavity using a fluid percussion device. Carbachol and(+/-)-1-Aminocyclopentane-trans-1,3-dicarboxylic acid (trans-ACPD)-stimulated PPI hydrolysis was assayed in hippocampus from injured and sham-injured controls at both 1 hour and 15 days following injury. At 1 hour after TBI, the response to carbachol was enhanced in injured rats by up to 200% but the response to trans-ACPD was diminished by as much as 28%. By contrast, at 15 days after TBI, the response to carbachol was enhanced by 25% and the response to trans-ACPD was enhanced by 73%. The ionotropic glutamate agonists N-methyl-D-aspartate (NMDA), and alpha-amino-3 hydroxy-5-methyl-4-isoxazolepropionate (AMPA), did not increase PPI hydrolysis in either sham or injured rats and injury did not alter basal hydrolysis. Thus, hippocampal muscarinic and metabotropic receptors linked to phospholipase C are differentially altered by TBI.			DELAHUNTY, TM (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,BOX 693,MCV STN RICHMOND,RICHMOND,VA 23298, USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 07288, NS 12587, NS 29995] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587, R01NS029995] Funding Source: NIH RePORTER		AKIYAMA K, 1992, BRAIN RES, V569, P71, DOI 10.1016/0006-8993(92)90370-O; ARONICA E, 1991, J NEUROCHEM, V57, P376, DOI 10.1111/j.1471-4159.1991.tb03763.x; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BIRELL GJ, 1993, NEUROPHARMACOLOGY, V32, P1351; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; CHEN CK, 1988, J NEUROCHEM, V51, P353, DOI 10.1111/j.1471-4159.1988.tb01046.x; CHOU C-L, 1991, Society for Neuroscience Abstracts, V17, P722; DELAHUNTY TM, 1988, BIOCHEM J, V255, P69, DOI 10.1042/bj2550069; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DEWITT DS, 1988, ANESTHESIOLOGY REV, V15, P31; DIAMANT S, 1990, NEUROSCI LETT, V109, P140, DOI 10.1016/0304-3940(90)90552-K; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1992, ROLE OF NEUROTRANSMITTERS IN BRAIN INJURY, P213; DIXON CE, 1993, J NEUROTRAUM, V10, pS209; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HERRERO I, 1994, EUR J NEUROSCI, V6, P115, DOI 10.1111/j.1460-9568.1994.tb00253.x; HERRERO I, 1994, NATURE, V360, P163; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KOH JY, 1991, P NATL ACAD SCI USA, V88, P9431, DOI 10.1073/pnas.88.21.9431; LIPARTITI M, 1993, LIFE SCI, V52, P85; LITTMAN L, 1993, J NEUROCHEM, V61, P586; LOMBARDI G, 1993, BRIT J PHARMACOL, V110, P1407, DOI 10.1111/j.1476-5381.1993.tb13977.x; LOVINGER DM, 1993, J NEUROPHYSIOL, V69, P1236, DOI 10.1152/jn.1993.69.4.1236; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; LYETH BG, 1992, J NEUROTRAUMA S2, V9, P463; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MOUNT HTJ, 1993, J NEUROSCI, V13, P3173; NICOLETTI F, 1988, J NEUROCHEM, V51, P725, DOI 10.1111/j.1471-4159.1988.tb01804.x; PEARCE B, 1986, EUR J PHARMACOL, V121, P231, DOI 10.1016/0014-2999(86)90494-2; PIZZI M, 1993, J NEUROCHEM, V61, P683; PRASAD RM, 1994, J NEUROCHEM, V63, P773; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; SCHOEPP DD, 1991, J NEUROCHEM, V56, P1789, DOI 10.1111/j.1471-4159.1991.tb02082.x; SCHOEPP DD, 1994, NEUROCHEM INT, V24, P439, DOI 10.1016/0197-0186(94)90092-2; SEREN MS, 1989, J NEUROCHEM, V53, P1700, DOI 10.1111/j.1471-4159.1989.tb09233.x; TIGER G, 1990, NEUROSCI LETT, V115, P243, DOI 10.1016/0304-3940(90)90462-I; ZHANG WQ, 1990, NEUROSCI LETT, V118, P57, DOI 10.1016/0304-3940(90)90248-8	47	15	15	0	0	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0364-3190			NEUROCHEM RES	Neurochem. Res.	APR	1995	20	4					405	411					7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	QY040	WOS:A1995QY04000006	7651577				2022-02-06	
J	MINTZ, MC; VANHORN, KR; LEVINE, MJ				MINTZ, MC; VANHORN, KR; LEVINE, MJ			DEVELOPMENTAL MODELS OF SOCIAL COGNITION IN ASSESSING THE ROLE OF FAMILY STRESS IN RELATIVES PREDICTIONS FOLLOWING TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							HEAD-INJURY; ANXIETY	The present study extended the utilization of developmental models of social cognition to the investigation of stress and relatives' perception of traumatic brain injury (TBI) survivors. Structured interviews were conducted with 21 TBI survivors utilizing interpersonal negotiation strategies (INS) and self understanding (self) in the framework of Selman's model of social perspective-taking and Damon and Hart's multidimensional model of self understanding. A relative group composed of 21 participants was interviewed and their predictions of the responses of the TBI survivors to the action domain of the INS stories were obtained. The relative participant group was also administered the Beck Anxiety and Depression Inventories and Leeds Scales of Depression and Anxiety. The relationships among relative groups' predictive scores, INS and self domains and stress levels were analysed. The result of the survivor groups responses on INS and self were in agreement with the previous findings that TBI survivors respond at psychosocially immature levels. Comparison of INS action scores obtained by the survivor group and predicted by relative group were within one developmental level of each other in 87.4% of the cases. Fifty-two per cent of the relative group scored in mild to moderate or greater depression and 48% scored in the mild to moderate range of anxiety on the Beck scales. Pearson correlation coefficients indicated significant negative correlations between Beck scores and predictive INS scores. ANOVA indicated significantly higher Beck depression scores in relatives of TBI survivors living in residential facilities than relatives of TBI survivors in an outpatient treatment programme. The study supports the view that developmental social cognition methods appear to advance our understanding of psychosocial adjustments and relatives' perceptions of social cognition in TBI survivors.			MINTZ, MC (corresponding author), CENT MICHIGAN UNIV,DEPT PSYCHOL,SLOAN HALL 226,MT PLEASANT,MI 48859, USA.						BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; DAMON W, 1988, UNPUB SCORING MANUAL; Derogatis L.R., 1975, BRIEF SYMPTOM INVENT; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; JENNETT B, 1975, LANCET, V3, P480; KAY T, 1988, HEAD INJURY FAMILY I; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEVINE M, 1993, 17TH POSTGR COURS RE; LEVINE MJ, 1993, BRAIN INJURY, V7, P153, DOI 10.3109/02699059309008169; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; McCubbin M.A., 1989, TREATING STRESS FAMI, P3; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; SELMAN RL, 1986, UNPUB INTERVIEW METH; SNAITH RP, 1976, BRIT J PSYCHIAT, V128, P156, DOI 10.1192/bjp.128.2.156; Van Horn K R, 1992, Brain Inj, V6, P15, DOI 10.3109/02699059209008118; WILLIAMS JM, 1987, COGNITIVE BEHAVIOR R	19	15	15	0	5	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB-MAR	1995	9	2					173	186		10.3109/02699059509008190			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QN628	WOS:A1995QN62800006	7787837				2022-02-06	
J	ACHTEREEKTE, HAM; VANDERKRUIJK, RA; HEKSTER, REM; KEUNEN, RWM				ACHTEREEKTE, HAM; VANDERKRUIJK, RA; HEKSTER, REM; KEUNEN, RWM			DIAGNOSIS OF TRAUMATIC CAROTID-ARTERY DISSECTION BY TRANSCRANIAL DOPPLER ULTRASOUND - CASE-REPORT AND REVIEW OF THE LITERATURE	SURGICAL NEUROLOGY			English	Article						ANGIOGRAPHY; DUPLEX SONOGRAPHY; TRANSCRANIAL DOPPLER RECORDINGS; TRAUMATIC CAROTID ARTERY DISSECTION	CEREBRAL BLOOD-FLOW	The clinical course, transcranial Doppler ultrasound (TCD) findings, and angiographic outcome are reported for a patient with a traumatic carotid artery dissection. Transient asymmetrical decreased middle cerebral artery blood flow velocities led to the suspicion of an internal carotid artery (ICA) stenosis. Duplex scanning and angiography subsequently demonstrated an extracranial traumatic ICA dissection in combination with a traumatic saccular aneurysm. These data imply that TCD monitoring has a potential to diagnose not only well established complications of neurotrauma, such as vasospasm and intracranial hypertension, but may also suggest the presence of traumatic extracranial carotid obstructions.			ACHTEREEKTE, HAM (corresponding author), ZIEKENHUIS LEYENBURG,DEPT NEUROL & CLIN NEUROPHYSIOL,DEPT NEURORADIOL,LEYWEG 275,2545 CH THE HAGUE,NETHERLANDS.						GAWLOWSKI J, 1989, Neurosurgical Review, V12, P386, DOI 10.1007/BF01790679; KAECH D, 1990, UNFALLCHIRURG, V93, P6; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MOKRI B, 1988, J NEUROSURG, V68, P189, DOI 10.3171/jns.1988.68.2.0189; MULLGES W, 1992, J NEUROL NEUROSUR PS, V52, P98; SAUNDERS FW, 1988, SURG NEUROL, V29, P401, DOI 10.1016/0090-3019(88)90049-3; STURZENEGGER M, 1991, ARCH NEUROL-CHICAGO, V48, P1057, DOI 10.1001/archneur.1991.00530220079023; SUNDT TM, 1986, J NEUROSURG, V64, P169, DOI 10.3171/jns.1986.64.2.0169; WATRIDGE CB, 1989, J NEUROSURG, V71, P189; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; ZELENOCK GB, 1982, ARCH SURG-CHICAGO, V117, P425	11	15	15	0	0	ELSEVIER SCIENCE PUBL CO INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.	SEP	1994	42	3					240	244		10.1016/0090-3019(94)90270-4			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QB699	WOS:A1994QB69900009	7940112				2022-02-06	
J	KONASIEWICZ, SJ; MOULTON, RJ; SHEDDEN, PM				KONASIEWICZ, SJ; MOULTON, RJ; SHEDDEN, PM			SOMATOSENSORY-EVOKED POTENTIALS AND INTRACRANIAL-PRESSURE IN SEVERE HEAD-INJURY	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							DIFFUSE AXONAL INJURY; INTRA-CRANICAL PRESSURE; NEUROFILAMENT SUBUNITS; AGGRESSIVE TREATMENT; COMATOSE CHILDREN; EARLY PREDICTION; CEREBRAL TRAUMA; SHORT-LATENCY; MANAGEMENT; DIAGNOSIS	The purpose of this study was to explore the relationship between neurologic function, using a quantitative measurement of continuous somatosensory evoked potentials (SSEPs), and intracranial pressure (ICP) following traumatic brain injury. During a 6 year period, severely head-injured patients with a Glascow Coma Scale less than or equal to 8 who were not moribund were monitored with SSEPs and ICP measurements. SSEPs from each hemisphere and ICP were recorded hourly for each patient. Neurologic outcomes were scored using the Glasgow Outcome Scale at three months post injury. Although initial SSEP amplitude did not correlate well with outcome, final SSEP summed peak to peak amplitude from both hemispheres (p = .0001), the best hemisphere (p = .0004), and the worst hemisphere (p = .0001) correlated well with the Glasgow Outcome Scale groups. Of a total of 72 patients, 40 had deteriorating SSEPs and 32 had stable or improving SSEPs. Peak ICP values were not statistically different in these groups (p = .6). Among patients with deteriorating SSEPs, 52.5% lost the greatest proportion of hemispheric electrical activity prior to ICP elevation. In the remaining patients, the percent reduction of SSEP activity after peak ICP levels was not statistically different from the percent reduction in SSEP activity prior to the peak ICP levels (p = .9). This data suggests that in a select group of patients with severe head injury, ICP does not cause SSEP deterioration, but rather is the consequence of deterioration of brain function.	UNIV TORONTO, ST MICHAELS HOSP, DIV NEUROSURG, TORONTO M5B 1A6, ON, CANADA								ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; AHMED I, 1988, CLIN ELECTROENCEPHAL, V19, P78, DOI 10.1177/155005948801900209; ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BERTRAND O, 1990, NEW TRENDS ADV TEC S, V41, P51; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; BYRNES DP, 1980, INTRACRANIAL PRESSUR, V4, P73; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; DEWEERD AW, 1985, ACTA NEUROL SCAND, V72, P489; GARCIALARREA L, 1992, J NEUROL NEUROSUR PS, V55, P792, DOI 10.1136/jnnp.55.9.792; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GOODWIN SR, 1991, CRIT CARE MED, V19, P518, DOI 10.1097/00003246-199104000-00011; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GRIMM G, 1988, LANCET, V2, P1392; GRIMM G, 1991, INTENS CARE MED, V17, P94, DOI 10.1007/BF01691430; GRIMM G, 1990, KIDNEY INT, V38, P480, DOI 10.1038/ki.1990.229; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; HUME AL, 1980, ANN NEUROL, V37, P630; Imhof H G, 1993, Aktuelle Traumatol, V23, P7; JENNETT B, 1975, LANCET, V1, P480; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5; MARMAROU A, 1991, J NEUROSURG, V75, pS21, DOI 10.3171/sup.1991.75.1s.0s21; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MOULTON R, 1991, J TRAUMA, V31, P676, DOI 10.1097/00005373-199105000-00012; MOULTON RJ, IN PRESS CAN J NEURO; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NEWLON PG, 1982, J NEUROSURG, V57, P168, DOI 10.3171/jns.1982.57.2.0168; NEWLON PG, 1985, NEUROL CLIN, V3, P675, DOI 10.1016/S0733-8619(18)31029-6; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SEYAL M, 1987, NEUROLOGY, V37, P650, DOI 10.1212/WNL.37.4.650; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; TAYLOR MJ, 1989, PEDIATR NEUROL, V5, P145, DOI 10.1016/0887-8994(89)90063-5; Turner H B, 1988, J Neurosci Nurs, V20, P236; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; YAMADA T, 1983, ARCH NEUROL-CHICAGO, V40, P215, DOI 10.1001/archneur.1983.04050040045007; YAMAKI T, 1992, ACTA NEUROCHIR, V119, P153, DOI 10.1007/BF01541800	48	15	15	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	AUG	1994	21	3					219	226		10.1017/S0317167100041196			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PC596	WOS:A1994PC59600006	8000977	Bronze			2022-02-06	
J	KOSCIULEK, JF				KOSCIULEK, JF			DIMENSIONS OF FAMILY COPING WITH HEAD-INJURY	REHABILITATION COUNSELING BULLETIN			English	Article							TRAUMATIC BRAIN INJURY; STRESS; CHILDREN	Head injury affects not only the person who sustains the injury but also the individual's entire family. Although the negative consequences of head injuries on families have been well documented, little is known about family efforts to manage the demands of a member's injury. The purpose of this study was to examine the dimensions underlying family coping with head injury. The following three dimensions were identified: (a) individual-to-family versus family-to-community coping, (b) family-respite versus head-injury-focused coping, and (c) cognitive versus behavioral coping. Implications for family stress and coping theory advancement, family assessment and intervention, and future head injury family research are discussed.			KOSCIULEK, JF (corresponding author), UNIV GEORGIA,DEPT COUNSELING & HUMAN DEV SERV,REHABIL COUNSELING PROGRAM,ATHENS,GA 30602, USA.						Bishop DS, 1988, J HEAD TRAUMA REHAB, V3, P16; Blashfield R.K., 1984, CLUSTER ANAL; Boss P., 1987, HDB MARRIAGE FAMILY, P695; BOX GEP, 1976, J AM STAT ASSOC, V71, P791, DOI 10.2307/2286841; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROWN BW, 1988, FAM RELAT, V37, P300; Copeland AP, 1991, STUDYING FAMILIES; COZBY PC, 1993, METHODS BEHAVIORAL R; Filsinger E. E., 1990, FAMILY VARIABLES CON, P90; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Graffi S, 1989, J APPLIED SOCIAL SCI, V13, P293; HAIR JF, 1987, MULTIVARIATE DATA AN; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Kay, 1991, HEAD INJURY FAMILY M, P81; KAY T, 1991, HEAD INJURY FAMILY M, P121; KAY T, 1990, TRAUMATIC BRAIN INJU, P21; KOSCIULEK JF, 1993, J REHABIL, V59, P40; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; Kruskal J. B., 1978, MULTIDIMENSIONAL SCA, V11; KRUSKAL JB, 1977, CLASSIFICATION CLUST, P17; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; Livingston MG., 1990, REHABILITATION ADULT, P225; Mathis M, 1984, J Neurosurg Nurs, V16, P36; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; MCCUBBIN HI, 1980, J MARRIAGE FAM, V42, P855, DOI 10.2307/351829; MCCUBBIN HI, 1979, J MARRIAGE FAM, V41, P237, DOI 10.2307/351693; MCCUBBIN HI, 1983, SOCIAL STRESS FAMILY, P00007, DOI DOI 10.1300/J002V06N01_02; MCCUBBIN HI, 1981, FCOPES FAMILY CRISIS; MCCUBBIN MA, 1988, FAM RELAT, V37, P203, DOI 10.2307/584321; McCubin M. A., 1991, FAMILY ASSESSMENT IN, P3; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; *NAT HEAD INJ F, 1986, TRAUM SIL EP; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PARKER RM, 1993, REHABIL COUNS BULL, V36, P130; Patterson JM, 1988, FAMILY SYSTEMS MED, V6, P202, DOI [10.1037/h0089739, DOI 10.1037/H0089739]; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Schiffman SS, 1981, INTRO MULTIDIMENSION; *SPSS INC, 1992, SPSS WIND BAS SYST U; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Willer B., 1990, CANADIAN J REHABILIT, V3, P167; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Williams J., 1990, J HEAD TRAUMA REHAB, V5, P9, DOI [https://doi.org/10.1097/00001199-199003000-00004, DOI 10.1097/00001199-199003000-00004]; Young Forrest W., 1987, MULTIDIMENSIONAL SCA; [No title captured]	53	15	15	0	1	AMER COUNSELING ASSOC	ALEXANDRIA	5999 STEVENSON AVE, ALEXANDRIA, VA 22304-3300	0034-3552			REHABIL COUNS BULL	Rehabil. Couns. Bull.	MAR	1994	37	3					244	258					15	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	NU899	WOS:A1994NU89900004					2022-02-06	
J	RIVARA, JB				RIVARA, JB			FAMILY FUNCTIONING FOLLOWING PEDIATRIC TRAUMATIC BRAIN INJURY	PEDIATRIC ANNALS			English	Article											RIVARA, JB (corresponding author), CHILDRENS HOSP & MED CTR,DEPT REHABIL MED,CH-71,4800 SAND POINT WAY NE,POB 5371,SEATTLE,WA 98105, USA.							0	15	15	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086	0090-4481			PEDIATR ANN	Pediatr. Annu.	JAN	1994	23	1					38	&		10.3928/0090-4481-19940101-09			0	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	MU563	WOS:A1994MU56300006	8152863				2022-02-06	
J	JORDAN, FM; MURDOCH, BE				JORDAN, FM; MURDOCH, BE			A PROSPECTIVE-STUDY OF THE LINGUISTIC SKILLS OF CHILDREN WITH CLOSED-HEAD INJURIES	APHASIOLOGY			English	Article								Little research in the paediatric closed-head injury (CHI) literature has attempted to follow the course of recovery of CHI children over a prolonged period, particularly in the area of linguistic recovery. The present study documented the course of recovery of the linguistic skills of a group of 11 CHI children over an 18-month period post-injury. All of the CHI children studied demonstrated measurable gains in a number of speech and language skills during the 18-month period post-injury. The results indicated that childhood CHI did not permanently disrupt the acquisition of any of the speech and language skills observed. A number of subjects did, however, continue to demonstrate measurable deficits in some language areas even at 18 months post-injury.			JORDAN, FM (corresponding author), UNIV QUEENSLAND, DEPT PSYCHOL, BRISBANE, QLD 4072, AUSTRALIA.		Murdoch, Bruce E/C-1397-2012				ALAJOUANINE T, 1965, BRAIN, V88, P653, DOI 10.1093/brain/88.4.653; BLOOM L, 1975, REV CHILD DEV RES, V4; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CARTER RL, 1982, SCIENCE, V218, P797, DOI 10.1126/science.7134973; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Enderby P, 1983, FRENCHAY DYSARTHRIA; Ewing-Cobbs L., 1985, SPEECH LANGUAGE EVAL, P97; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GADDES WH, 1973, RES MONOGRAPH, V25; HAMMILL DD, 1982, TEST LANGUAGE DEV IN; HAMMILL DD, 1987, TEST ADOLESCENT LANG, P2; HECAEN H, 1976, BRAIN LANG, V3, P114, DOI 10.1016/0093-934X(76)90009-2; JORDAN F M, 1990, Brain Injury, V4, P27; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; Kaplan E, 1983, BOSTON NAMING TEST; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Newcomer P, 1982, TEST LANGUAGE DEV; OWENS RE, 1988, LANGUAGE DEV INTRO; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SATZ P, 1981, ACQUIRED APHASIA; SEMELMINTZ E, 1982, CLIN EVALUATION LANG; Spreen O., 1969, NEUROSENSORY CTR COM; TEASDALE G, 1974, LANCET, V2, P81; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; 1983, CELF UPDATE 3	29	15	15	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	SEP-OCT	1993	7	5					503	512		10.1080/02687039308248626			10	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	LZ486	WOS:A1993LZ48600011					2022-02-06	
J	SOBUS, KML; ALEXANDER, MA; HARCKE, HT				SOBUS, KML; ALEXANDER, MA; HARCKE, HT			UNDETECTED MUSCULOSKELETAL TRAUMA IN CHILDREN WITH TRAUMATIC BRAIN INJURY OR SPINAL-CORD INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article											SOBUS, KML (corresponding author), ALFRED I DUPONT INST,1600 ROCKLAND RD,POB 269,WILMINGTON,DE 19899, USA.						CITTAPIETROLUNG.TJ, 1992, ARCH PHYS MED REHAB, V73, P289; DEUTSCH SD, 1983, SURG CLIN N AM, V63, P567; HARCKE HT, 1983, ANN RADIOL, V26, P675; MARTIN P, 1983, SEMIN NUCL MED, V13, P104; MOLNAR GE, 1985, PEDIATRIC REHABILITA, P207	5	15	15	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	1993	74	9					902	904					3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	LX551	WOS:A1993LX55100002	8379833				2022-02-06	
J	BULLOCK, R				BULLOCK, R			PATHOPHYSIOLOGICAL ALTERATIONS IN THE CENTRAL-NERVOUS-SYSTEM DUE TO TRAUMA	SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT			English	Article							SEVERE HEAD-INJURY; BRAIN; DAMAGE; TRIAL	Neurotrauma is the largest cause of death and severe disability in young adults. In this review, the pathophysiological processes which damage the brain and spinal cord, both acutely, and hours to days after injury, are discussed. Secondary, delayed damage is the major cause of bad outcome in at least 40% of patients, with severe head injury. Diffuse damage to axons, hypoxic-ischaemic damage to neurons and astrocytes, contusions, intracranial haematomas, and brain swelling are discussed. The prospect for improving outcome by pharmacological therapy, and the current status of head injury trials are presented.	UNIV GLASGOW, INST NEUROL SCI, DEPT NEUROSURG, GLASGOW G12 8QQ, SCOTLAND								Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ANDERSON DK, 1992, J NEUROTRAUM, V9, P113, DOI 10.1089/neu.1992.9.113; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; BULLOCK R, 1991, VINKEN BRUYNS HDB CL, V24, P249; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1978, INJURY, V10, P31; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169	15	15	15	0	0	E M H SWISS MEDICAL PUBLISHERS LTD	MUTTENZ	FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND	0036-7672			SCHWEIZ MED WSCHR	Schweiz. Med. Wochenschr.	MAR 20	1993	123	11					449	458					10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KT714	WOS:A1993KT71400002	8475352				2022-02-06	
J	CONFORTI, PJ; HAUG, RH; LIKAVEC, M				CONFORTI, PJ; HAUG, RH; LIKAVEC, M			MANAGEMENT OF CLOSED HEAD-INJURY IN THE PATIENT WITH MAXILLOFACIAL TRAUMA	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							INTRACRANIAL-PRESSURE; MANNITOL		ST RAPHAELS HOSP, DEPT ORAL & MAXILLOFACIAL SURG, NEW HAVEN, CT USA; METROHEALTH MED CTR CLEVELAND, CLEVELAND, OH USA; CASE WESTERN RESERVE UNIV, CLEVELAND, OH 44106 USA								Bakay L, 1980, HEAD INJURY; BATES B, 1974, GUIDE PHYSICAL EXAMI; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; CHAMBERS IR, 1990, NEUROSURGERY, V26, P421, DOI 10.1227/00006123-199003000-00007; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CRITCHLEY ER, 1988, NEUROLOGICAL EMERGEN; CUTLER RWP, 1968, BRAIN, V91, P707, DOI 10.1093/brain/91.4.707; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; GADISSEUZ P, 1989, TXB HEAD INJURY, P241; GORDON E, 1970, BRIT J ANAESTH, V42, P2, DOI 10.1093/bja/42.1.2; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; HOFFMAN WE, 1990, CLIN ANESTH, P819; JANE JA, 1982, CLIN NEUR, V29, P346; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KADIS LB, 1981, ANESTHESIA UNCOMMON, P485; KEENAN RL, 1989, TXB HEAD INJURY, P182; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LEITMAN MW, 1988, MANUAL EYE EXAMINATI; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MARSHALL SB, 1990, NEUROSCIENCE CRITICA; MCEVOY GK, 1989, AM HOSPITAL FORMULAR; MCGILLICUDDY JE, 1985, CHEST, V87, P85, DOI 10.1378/chest.87.1.85; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1984, GREENFIELDS NEUROPAT, P53; MOLLMAN HD, 1988, J NEUROSURG, V68, P737, DOI 10.3171/jns.1988.68.5.0737; MOSS E, 1979, BRIT J ANAESTH, V51, P757, DOI 10.1093/bja/51.8.757; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; POLLAY M, 1983, J NEUROSURG, V59, P945, DOI 10.3171/jns.1983.59.6.0945; ROCKOFF MA, 1988, NEUROLOGICAL NEUROSU; SAUL TG, 1988, CONNS CURRENT THERAP, P817; SIEBER FE, 1992, CRIT CARE MED, V20, P104, DOI 10.1097/00003246-199201000-00022; TEASDALE G, 1974, LANCET, V2, P81; TGRUNKEY D, 1991, NEW ENGL J MED, V324, P1259; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOSTER PS, 1990, CLIN PHARMACY, V9, P762; YOUMANS JR, 1990, NEUROLOGY SURGERY, V3	40	15	16	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	MAR	1993	51	3					298	303		10.1016/S0278-2391(10)80179-X			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	KQ334	WOS:A1993KQ33400019	8445472				2022-02-06	
J	XUE, ZY; GROSSFELD, RM				XUE, ZY; GROSSFELD, RM			STRESS PROTEIN-SYNTHESIS AND ACCUMULATION AFTER TRAUMATIC INJURY OF CRAYFISH CNS	NEUROCHEMICAL RESEARCH			English	Article						STRESS; PROTEIN; TRAUMA; CRAYFISH; CNS; WOUND	HEAT-SHOCK PROTEINS; CENTRAL NERVOUS-SYSTEM; FIBRILLARY ACIDIC PROTEIN; HYPERTHERMIA PROTECTS; GERBIL BRAIN; RAT; INDUCTION; HSP70; GENE; ISCHEMIA	By several days after a crush injury of crayfish CNS, the wound site heals. Changes in protein synthesis and accumulation occur at the lesion site and nearby. During the first few hours, synthesis of 35, 70, 90, and 150 kDa proteins is induced in the injured tissue. By one day, the relative amounts of 70-90 kDa proteins increase dramatically, particularly at the crush site and adjacent to it. The 70 kDa proteins, which are related to mammalian stress proteins (SPs), remain elevated for at least one month in the traumatized region or nearby. The crushed tissue contains an SP70 isoform not present in its uncrushed counterpart. These biochemical changes may reflect the cellular changes that accompany wound healing and/or a cellular stress response to compensate for the lesion. Since similar adaptations occur in the mammalian CNS, they may represent a phylogenetically conserved attempt to retard or repair CNS tissue deterioration.	N CAROLINA STATE UNIV,DEPT ZOOL,RALEIGH,NC 27695								AGUAYO AJ, 1981, J EXP BIOL, V95, P231; BARBE MF, 1988, SCIENCE, V241, P1817, DOI 10.1126/science.3175623; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BITTNER GD, 1981, COMP BIOCHEM PHYS A, V68, P299, DOI 10.1016/0300-9629(81)90055-4; BITTNER GD, 1988, AM ZOOL, V28, P1165; BROCK TO, 1987, J NEUROSCI, V7, P931; BROWN IR, 1990, J NEUROSCI RES, V27, P247, DOI 10.1002/jnr.490270302; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; BURDON RH, 1986, BIOCHEM J, V240, P313, DOI 10.1042/bj2400313; CHOPP M, 1989, NEUROLOGY, V39, P1396, DOI 10.1212/WNL.39.10.1396; CLEMENTE CD, 1964, INT REV NEUROBIOL, V6, P257, DOI 10.1016/S0074-7742(08)60771-0; COTMAN CW, 1985, ANN NY ACAD SCI, V457, P83, DOI 10.1111/j.1749-6632.1985.tb20800.x; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GONZALEZ MF, 1989, MOL BRAIN RES, V6, P93, DOI 10.1016/0169-328X(89)90033-8; GOWER DJ, 1989, J NEUROSURG, V70, P605, DOI 10.3171/jns.1989.70.4.0605; GROSSFELD RM, 1987, NEUROCHEM RES, V12, P977, DOI 10.1007/BF00970926; HOY RR, 1973, DEV NEUROBIOLOGY ART, P203; HUGHES J, 1981, ANAL BIOCHEM, V117, P1, DOI 10.1016/0003-2697(81)90681-3; JOHNSTON RN, 1988, SCIENCE, V242, P1551, DOI 10.1126/science.3201244; KITAMURA T, 1972, J NEUROPATHOL EXP NE, V31, P5002; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; LI GC, 1991, P NATL ACAD SCI USA, V88, P1681, DOI 10.1073/pnas.88.5.1681; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LOOMIS WF, 1982, DEV BIOL, V90, P412, DOI 10.1016/0012-1606(82)90390-6; LOWENSTEIN DH, 1990, BRAIN RES, V531, P173, DOI 10.1016/0006-8993(90)90771-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marangos P. J., 1988, NEURONAL GLIAL PROTE, P339; MENDES M, 1980, J NEUROSURG, V53, P772; MEYER MR, 1978, BRAIN RES, V143, P213, DOI 10.1016/0006-8993(78)90565-6; MIZZEN LA, 1988, J CELL BIOL, V106, P1105, DOI 10.1083/jcb.106.4.1105; Nover L., 1991, HEAT SHOCK RESPONSE; NOWAK TS, 1985, J NEUROCHEM, V45, P1635, DOI 10.1111/j.1471-4159.1985.tb07236.x; NOWAK TS, 1991, J CEREBR BLOOD F MET, V11, P432, DOI 10.1038/jcbfm.1991.84; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; PILAR G, 1972, SCIENCE, V177, P1116, DOI 10.1126/science.177.4054.1116; RAISMAN G, 1973, DYNAMICS DEGENERATIO, V22, P373; Reier P., 1983, SPINAL CORD RECONSTR, P163; RIABOWOL KT, 1988, SCIENCE, V242, P433, DOI 10.1126/science.3175665; ROCHELLE JM, 1991, NEUROCHEM RES, V16, P533, DOI 10.1007/BF00974871; RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; SUBJECK JR, 1986, AM J PHYSIOL, V250, pC1, DOI 10.1152/ajpcell.1986.250.1.C1; VASS K, 1988, ACTA NEUROPATHOL, V77, P128; WELCH WJ, 1985, J BIOL CHEM, V260, P3058; WELCH WJ, 1989, UCLA S MOL CELL BIOL, V96, P198	48	15	15	0	1	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0364-3190			NEUROCHEM RES	Neurochem. Res.	FEB	1993	18	2					209	218		10.1007/BF01474686			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	KF464	WOS:A1993KF46400015	8474563				2022-02-06	
J	NEISTADT, ME				NEISTADT, ME			THE RABIDEAU KITCHEN EVALUATION-REVISED - AN ASSESSMENT OF MEAL PREPARATION SKILL	OCCUPATIONAL THERAPY JOURNAL OF RESEARCH			English	Article						ACTIVITIES OF DAILY LIVING; INDEPENDENT LIVING SKILLS TRAUMATIC BRAIN INJURY	SCALE	This paper describes the Rabideau Kitchen Evaluation-Revised (RKE-R), an assessment of meal preparation skill for adults with traumatic brain injury (TBI) that yields information about client skill with component steps of an actual meal preparation activity-preparation of a sandwich and a hot beverage. Validity and reliability studies on this instrument are also described. An inter-rater reliability study yielded an 86% agreement among eight evaluators. A test-retest study with four adult men with TBI resulted in a Spearman rank order correlation coefficient of 0.80. Preliminary norms from a sample of 34 ambulatory men with TBI, ages 18 to 49, are reported, and suggest that the RKE-R may not be a useful evaluation tool for clients with subtle cognitive/perceptual deficits. Recommendations for modifying the RKE-R to increase the clinical information it can provide are discussed.	UNIV NEW HAMPSHIRE,SCH HLTH & HUMAN SERV,DEPT OCCUPAT THERAPY,DURHAM,NH 03824								BENSON J, 1982, AM J OCCUP THER, V36, P789, DOI 10.5014/ajot.36.12.789; DOW PW, 1989, OCCUPATIONAL THERAPY, P484; EAKIN P, 1989, BRIT J OCCUPATIONAL, V52, P11; INTAGLIATA S, 1991, OCCUP THER PRACT, V2, P26; KLEIN RM, 1982, ARCH PHYS MED REHAB, V63, P335; LAW M, 1989, AM J OCCUP THER, V43, P522, DOI 10.5014/ajot.43.8.522; LEZAK M, 1983, NEUROPSYUCHOLOGICAL; MCNENY R, 1983, REHABILITATION HEAD, P143; PANIKOFF LB, 1983, AM J OCCUP THER, V37, P735, DOI 10.5014/ajot.37.11.735; RABIDEAU GM, 1986, THESIS TUFTS U MEDFO; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENTHAL M, 1991, JUN PRAT STRAT SCI B; Trombly C., 1989, OCCUPATIONAL THERAPY; *UN DAT SYST MED R, 1990, GUID US UN DAT SET M; Wechsler, 1997, WECHSLER ADULT INTEL; [No title captured]	16	15	15	0	4	AMER OCCUP THER FOUND INC	ROCKVILLE	1383 PICCARD DR, ROCKVILLE, MD 20849-1725	0276-1599			OCCUP THER J RES	Occup. Ther. J. Res.	JUL-AUG	1992	12	4					242	253		10.1177/153944929201200404			12	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	JX734	WOS:A1992JX73400004					2022-02-06	
J	THOMAIDES, TN; KEREZOUDI, EP; CHAUDHURI, KR; CHEROPOULOS, C				THOMAIDES, TN; KEREZOUDI, EP; CHAUDHURI, KR; CHEROPOULOS, C			STUDY OF EEGS FOLLOWING 24-HOUR SLEEP-DEPRIVATION IN PATIENTS WITH POSTTRAUMATIC EPILEPSY	EUROPEAN NEUROLOGY			English	Article						POSTTRAUMATIC EPILEPSY; ACTIVATION; SLEEP DEPRIVATION; HEAD INJURY	ACTIVATION; WAKING	Routine and awake EEGs following 24-hour sleep deprivation were studied in 119 patients with closed head injury, 64 epileptics without any history of head injury and 53 healthy controls. The results were compared to CT brain scan findings. There were no epileptic discharges in routine EEGs, while EEGs after 24-hour sleep deprivation showed considerable activation, ranging from 28 to 37.5 % in those with a history of head injury or epilepsy. No correlation was found between the period elapsed between the time of injury and the activation of the EEG. Most of the patients with EEG activation after sleep deprivation had abnormal CT scans. EEGs following 24-hour sleep deprivation therefore appear to be a useful adjunct to other methods used in detecting brain damage in patients with head injury or epilepsy.	GEN HOSP, ATHENS, GREECE; ROYAL FREE HOSP, SCH MED, DEPT NEUROL SCI, LONDON, ENGLAND; UCL NATL HOSP NEUROL & NEUROSURG, DEPT EEG, AUTONOM INVEST UNIT, LONDON, ENGLAND; NIMTS HOSP, ATHENS, GREECE								ARNEBES MC, 1982, SLEEP EPILEPSY, P441; BECHINGER D, 1976, ELECTROEN CLIN NEURO, V41, P654; BENNETT DR, 1969, NEUROLOGY, V19, P375, DOI 10.1212/WNL.19.4.375; DECKLERCK AC, 1982, SLEEP EPILEPSY, P453; DEGEN R, 1980, ELECTROEN CLIN NEURO, V49, P577, DOI 10.1016/0013-4694(80)90398-3; DEGEN R, 1984, EPILEPSY SLEEP SLEEP, P273; DELRIO MB, 1940, RIV SPER FRENIATR, V64, P159; GELLER MR, 1969, DEV MED CHILD NEUROL, V11, P771; Gibbs Frederic A., 1944, AMER JOUR PSYCHIATRY, V100, P738; GUNDERSO.CH, 1973, NEUROLOGY, V23, P678, DOI 10.1212/WNL.23.7.678; Heinemann L G, 1966, Arch Psychiatr Nervenkr (1970), V208, P177, DOI 10.1007/BF00343267; JENNETT WB, 1962, EPILEPSY BLUNT HEAD; JOHNSON IC, 1971, NMNP14 NAV MED NEUR, P37; JOVANIC VJ, 1971, ARCH PSYCHIAT NERVEN, V214, P183; KLINGLER D, 1982, WIEN MED WOCHENSCHR, V132, P253; LEVI L, 1972, STRESS DISTRESS RESP, P119; LOGOTHETIS J, 1986, EUR NEUROL, V25, P134, DOI 10.1159/000116094; MATTSON RH, 1965, ARCH NEUROL-CHICAGO, V13, P310, DOI 10.1001/archneur.1965.00470030090009; RODIN EA, 1962, ELECTROEN CLIN NEURO, V14, P544, DOI 10.1016/0013-4694(62)90060-3; Roth B, 1986, Schweiz Arch Neurol Psychiatr (1985), V137, P17; SCOLLOLAVIZZARI G, 1977, EUR NEUROL, V15, P121, DOI 10.1159/000114829; WALTON J N, 1963, Med Leg J, V31, P15; WELCH LK, 1971, AEROSPACE MED, V42, P349; WILLIAMS D, 1944, J NEUROL NEUROSUR PS, V7, P131; Zouhar A, 1981, Cesk Neurol Neurochir, V44, P210	25	15	15	2	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022			EUR NEUROL	Eur. Neurol.	MAR-APR	1992	32	2					79	82		10.1159/000116796			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HH174	WOS:A1992HH17400004	1563465				2022-02-06	
J	JANI, NN; LAURENO, R; MARK, AS; BREWER, CC				JANI, NN; LAURENO, R; MARK, AS; BREWER, CC			DEAFNESS AFTER BILATERAL MIDBRAIN CONTUSION - A CORRELATION OF MAGNETIC-RESONANCE-IMAGING WITH AUDITORY BRAIN-STEM EVOKED-RESPONSES	NEUROSURGERY			English	Article						AUDITORY BRAIN STEM EVOKED RESPONSE; CONVERSION DISORDER; DEAFNESS; INFERIOR COLLICULUS; MAGNETIC RESONANCE IMAGING; MIDBRAIN TRAUMA	MIDDLE-EAR REFLEX; HEARING-LOSS; NEURONAL ORGANIZATION; POTENTIALS; LESIONS; MR	A 46-year-old woman became deaf after a closed head injury. When a computed tomographic scan failed to disclose the cause, conversion disorder was suspected. Magnetic resonance imaging, however, showed bilateral contusions of the inferior colliculi, providing objective evidence for an organic cause of hearing loss. Auditory brain stem evoked responses and stapedial reflexes also provided objective evidence of brain stem injury. This case illustrates the phenomenon of dorsal midbrain injury after head trauma. It indicates the sensitivity of magnetic resonance imaging for small focal lesions after head trauma, and it demonstrates some difficulties in the diagnosis of "hysterical" deafness.	WASHINGTON HOSP CTR,DEPT NEUROL,2A-44,110 IRVING ST NW,WASHINGTON,DC 20010; GEORGE WASHINGTON UNIV,SCH MED,WASHINGTON,DC 20052; WASHINGTON HOSP CTR,DEPT RADIOL,WASHINGTON,DC 20010; WASHINGTON HOSP CTR,DEPT HEARING & SPEECH,WASHINGTON,DC 20010								BORG E, 1973, BRAIN RES, V49, P101, DOI 10.1016/0006-8993(73)90404-6; BRANTZAWADZKI M, 1986, AM J NEURORADIOL, V7, P781; DIX MR, 1973, ACTA OTO-LARYNGOL, V75, P165, DOI 10.3109/00016487309139692; FELDMANN H, 1987, ACTA OTO-LARYNGOL, V103, P379; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; HOWDE JR, 1975, NEUROLOGY, V25, P286; MARK AS, 1989, MRI DESICIONS, V13, P26; MOLLER AR, 1983, SCAND AUDIOL, V12, P125, DOI 10.3109/01050398309076235; MOLLER AR, 1982, ELECTROEN CLIN NEURO, V53, P612, DOI 10.1016/0013-4694(82)90137-7; MOLLER AR, ACOUSTIC REFLEX SCI, P1; MOMOSE KJ, 1983, AM J NEURORADIOL, V4, P781; ROPPER AH, 1985, ANN NEUROL, V18, P80, DOI 10.1002/ana.410180114	12	15	15	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	JUL	1991	29	1					106	109		10.1227/00006123-199107000-00018			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FT164	WOS:A1991FT16400018	1870669				2022-02-06	
J	HAYES, KC; ALLATT, RD; WOLFE, DL; KASAI, T; HSIEH, J				HAYES, KC; ALLATT, RD; WOLFE, DL; KASAI, T; HSIEH, J			REINFORCEMENT OF MOTOR EVOKED-POTENTIALS IN PATIENTS WITH SPINAL-CORD INJURY	ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY			English	Article; Proceedings Paper	SYMP ON TRANSCRANIAL MAGNETIC STIMULATION AND THE MOTOR EVOKED POTENTIAL	AUG, 1989	CHICAGO, IL	E PARALYZED VET ASSOC, NATL PARALYSIS ASSOC, CHICAGO NEUROSURG CTR, FDN INVESTIGAT NEUROL DISORDERS, AMER PARALYSIS ASSOC		MOTOR EVOKED POTENTIALS; SPINAL CORD INJURY; ELECTROPHYSIOLOGY	MAGNETIC STIMULATION; HUMAN-BRAIN; TRANSCRANIAL STIMULATION; MULTIPLE-SCLEROSIS; CONDUCTION TIME; CORTEX; RESPONSES; MUSCLES; PATHWAYS; MECHANISMS	Transcranial magnetic stimulation of the motor cortex has been used to investigate the putative existence of spared motor pathways in spinal cord injured patients with clinically complete paralysis. Particular consideration was given to methods of neurological reinforcement likely to minimize the risk of false negative interpretation of absent motor evoked potentials (MEPs). The principal methods of reinforcement included target and remote muscle contractions and conditioning of MEPs with a brief (20 msec) train of cutaneous stimulation (500 Hz: duration 0.1 msec) delivered 20-150 msec prior to cortical stimulation, Twelve control subjects and 26 patients with severe traumatic spinal cord injury underwent cortical stimulation delivered from a Cadwell MES 10 (70-100% intensity) through a 9-cm focal point coil. Electromyographic responses were recorded from surface electrodes in bipolar configuration and amplified (3 dB down at 10 Hz-1 kHz) prior to storage, MEPs were recorded, following reinforcement, in muscles with clinically complete paralysis in 4/26 patients. In each case, MEPs were of low amplitude (< 0.5 mV), polyphasic, and with variable and prolonged latencies. MEPs were evoked in severely paretic (clinically incomplete paralysis) muscles in 6/8 patients only when neurological reinforcement was employed. Conditioning of MEPs in tibialis anterior with proceeding cutaneous stimulation to the plantar surface (subthreshold for evoking a flexion reflex) yielded a well-defined modulation of MEP amplitude in control subjects. An early (Conditioning-Test (C-T) intervals 20-45 msec) period of inhibition of MEPs (x = 60% of control) was followed by a period (C-T intervals 50-90 msec) of facilitation (x 345%) and a subsequent (C-T intervals 90-150 msec) period of inhibition (X 0%). In spinal cord injured patients the same conditioning paradigm failed to reveal MEPs. but did result in the appearance of suprathreshold flexion reflexes in 2 patients at 20-55 msec C-T intervals. This summation of convergent but subliminal cortical and cutaneous inputs to the target motoneuron pool provided additional evidence of preserved cortical influence on segmental structures that was not detectable by other means. These results extend previous reports of electrophysiological evidence of spared motor pathways in spinal cord injured patients with complete paralysis, and affirm the need for neurological reinforcement as a routine procedure in cortical stimulation studies of spinal cord injuries.	PARKWOOD HOSP,DEPT PHYS MED & REHABIL,LONDON,ONTARIO,CANADA; UNIV WESTERN ONTARIO,LONDON N6A 3K7,ONTARIO,CANADA								BARKER AT, 1985, LANCET, V1, P1106; BARKER AT, 1986, LANCET, V1, P1325; Barker AT, 1985, ELECTROENCEPHALOGR C, V61, P245; BARKER AT, 1988, NEUROLOGY NEUROBIOLO, V41, P231; BENECKE R, 1988, ELECTROEN CLIN NEURO, V69, P412, DOI 10.1016/0013-4694(88)90063-6; BERARDELLI A, 1988, NEUROLOGY NEUROBIOLO, V41, P219; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; CARAMIA MD, 1988, NEUROLOGY NEUROBIOLO, V41, P193; CARAMIA MD, 1990, MAGNETIC STIMULATION, P145; COWAN JMA, 1984, LANCET, V2, P304; DAY BL, 1988, J PHYSIOL-LONDON, V399, pP68; DAY BL, 1987, NEUROSCI LETT, V75, P101, DOI 10.1016/0304-3940(87)90083-8; DELETIS V, 1987, NEUROSURGERY, V20, P195; DELWAIDE PJ, 1984, J NEUROL NEUROSUR PS, V47, P190, DOI 10.1136/jnnp.47.2.190; DIMITRIJEVCIC MR, 1984, ANN NEUROL, V1644, P2169; DIMITRIJEVIC MR, 1984, ANN NEUROL, V16, P216, DOI 10.1002/ana.410160208; DIMITRIJEVIC MR, 1987, PARAPLEGIA, V25, P205, DOI 10.1038/sc.1987.35; DIMITRIJEVIC MR, 1988, NEUROLOGY NEUROBIOLO, V41, P243; EDMONDS HL, 1989, SPINE, V14, P683, DOI 10.1097/00007632-198907000-00006; GASSEL MM, 1964, NEUROLOGY, V14, P640, DOI 10.1212/WNL.14.7.640; GASSEL MM, 1964, NEUROLOGY, V14, P555, DOI 10.1212/WNL.14.6.555; GIANUTSOS J, 1987, EXP NEUROL, V98, P34, DOI 10.1016/0014-4886(87)90069-0; GOTTLIEB GL, 1970, J NEUROPHYSIOL, V33, P365, DOI 10.1152/jn.1970.33.3.365; GOTTLIEB GL, 1971, J NEUROL NEUROSUR PS, V34, P226, DOI 10.1136/jnnp.34.3.226; HESS CW, 1986, NEUROSCI LETT, V71, P235, DOI 10.1016/0304-3940(86)90565-3; HORE J, 1976, J NEUROPHYSIOL, V39, P484, DOI 10.1152/jn.1976.39.3.484; INGRAM DA, 1987, J NEUROL NEUROSUR PS, V50, P159, DOI 10.1136/jnnp.50.2.159; INGRAM DA, 1988, NEUROLOGY NEUROBIOLO, V41, P207; Jendrassik E., 1883, DTSCH ARCHIV KLIN ME, V33, P177; JONES EG, 1983, ADV NEUROL, V29, P263; Kakulas B A, 1984, Cent Nerv Syst Trauma, V1, P117; KAKULAS BA, 1987, PARAPLEGIA, V25, P212, DOI 10.1038/sc.1987.37; LANDAU WM, 1964, ARCH NEUROL-CHICAGO, V10, P117, DOI 10.1001/archneur.1964.00460140003001; LUCIER GE, 1975, J PHYSIOL-LONDON, V251, P833, DOI 10.1113/jphysiol.1975.sp011125; Meinck H. M., 1983, MOTOR CONTROL MECHAN, P787; MERTON PA, 1980, NATURE, V285, P227, DOI 10.1038/285227a0; MERTON PA, 1982, LANCET, V2, P597; MEYER DR, 1953, PSYCHOL BULL, V50, P204, DOI 10.1037/h0061173; MILLS KR, 1987, NEUROSURGERY, V20, P164; MILLS KR, 1985, ANN NEUROL, V18, P601, DOI 10.1002/ana.410180514; PORTER R, 1983, MOTOR CONTROL MECHAN; ROSSINI PM, 1988, NONINVASIVE STIMULAT, V41, P37; ROTHWELL JC, 1987, NEUROSURGERY, V20, P156; SHAHANI BT, 1971, J NEUROL NEUROSUR PS, V34, P616, DOI 10.1136/jnnp.34.5.616; THOMPSON PD, 1987, ANN NEUROL, V21, P389, DOI 10.1002/ana.410210412; TRONI W, 1988, NEUROLOGY NEUROBIOLO, V41, P73; WAXMAN SG, 1989, J NEUROL SCI, V91, P1, DOI 10.1016/0022-510X(89)90072-5; YORK DH, 1987, NEUROSURGERY, V20, P70	48	15	15	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0013-4694			ELECTROEN CLIN NEURO	Electroencephalogr. Clin. Neurophysiol.		1991				43			312	329					18	Engineering, Biomedical; Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	HB515	WOS:A1991HB51500027	1773771				2022-02-06	
J	NORDBY, HK; URDAL, P; BJORNAES, H				NORDBY, HK; URDAL, P; BJORNAES, H			THE PROGNOSIS OF PATIENTS WITH CONCUSSION AND INCREASED CREATINE KINASE-BB IN THE CEREBROSPINAL-FLUID	ACTA NEUROCHIRURGICA			English	Article									UNIV OSLO,ULLEVAL HOSP,CENT LAB,OSLO,NORWAY		NORDBY, HK (corresponding author), UNIV OSLO,ULLEVAL HOSP,DEPT NEUROSURG,OSLO,NORWAY.						BURUMA OJS, 1981, J NEUROL NEUROSUR PS, V44, P144, DOI 10.1136/jnnp.44.2.144; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; INGHAM JG, 1979, J EPIDEMIOL COMMUN H, V33, P191, DOI 10.1136/jech.33.3.191; LIDVALL HF, 1974, ACTA NEUROL SCAND, V56, P50; NORDBY HK, 1982, ACTA NEUROCHIR, V65, P93, DOI 10.1007/BF01405445; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SEKINO H, 1981, Neurologia Medico-Chirurgica, V21, P677	7	15	15	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1984	71	3-4					205	215		10.1007/BF01401315			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SV378	WOS:A1984SV37800004	6741637				2022-02-06	
J	RICHARDSON, JTE				RICHARDSON, JTE			MENTAL-IMAGERY, HUMAN-MEMORY, AND THE EFFECTS OF CLOSED HEAD-INJURY	BRITISH JOURNAL OF SOCIAL AND CLINICAL PSYCHOLOGY			English	Article											RICHARDSON, JTE (corresponding author), BRUNEL UNIV,DEPT PSYCHOL,UXBRIDGE UB8 3PH,MIDDLESEX,ENGLAND.			Richardson, John/0000-0002-6267-0603			BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; BADDELEY AD, 1973, NEUROPSYCHOLOGIA, V11, P159, DOI 10.1016/0028-3932(73)90003-1; BLACK FW, 1973, J CLIN PSYCHOL, V29, P441; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; CONKEY RC, 1938, ARCH PSYCHOLOGY, V33; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; FODOR IE, 1972, J NEUROL NEUROSUR PS, V35, P818, DOI 10.1136/jnnp.35.6.818; GLANZER M, 1966, J VERB LEARN VERB BE, V5, P351, DOI 10.1016/S0022-5371(66)80044-0; GOLDSTEIN K, 1948, LANGUAGE LANGUAGE DI; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; GRONWALL, 1974, LANCET, V2, P605; Gurdjian ES, 1943, SURGERY, V13, P333; JAMIESON KG, 1971, FIRST NOTEBOOK HEAD; JONES MK, 1974, NEUROPSYCHOLOGIA, V12, P21, DOI 10.1016/0028-3932(74)90023-2; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; MAHER B, 1974, J CONSULT CLIN PSYCH, V42, P1; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1127, DOI 10.1136/jnnp.38.11.1127; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OMMAYA AK, 1976, HEAD INJURIES; PAIVIO A, 1972, FUNCTION NATURE IMAG; PAIVIO A, 1968, J EXPT PSYCHOLOGY  2, V76; Paivio A., 1971, IMAGERY VERBAL PROCE; PARKER SA, 1976, ACTA NEUROCHIR, V34, P71, DOI 10.1007/BF01405864; RICHARDSON JT, 1974, J VERB LEARN VERB BE, V13, P709, DOI 10.1016/S0022-5371(74)80057-5; RICHARDSON JTE, 1978, BRIT J SOC CLIN PSYC, V17, P261, DOI 10.1111/j.2044-8260.1978.tb00276.x; RICHARDSON JTE, 1975, BRIT J MATH STAT PSY, V28, P235; RICHARDSON JTE, 1978, Q J EXP PSYCHOL, V30, P471, DOI 10.1080/00335557843000061; RICHARDSON JTE, 1976, BRIT J PSYCHOL, V67, P487, DOI 10.1111/j.2044-8295.1976.tb01537.x; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUTHERFORD WH, 1977, LANCET, V1, P1; THOMSEN IV, 1977, SCAND J REHABIL MED, V9, P73; Thorndike E. L., 1944, TEACHERS WORD BOOK 3; *UK OFF POP CENS S, 1970, 1970 CLASS OCC	41	15	15	1	1	BRITISH PSYCHOLOGICAL SOC	LEICESTER	ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER, LEICS, ENGLAND LE1 7DR	0007-1293			BRIT J SOC CLIN PSYC			1979	18	SEP					319	327		10.1111/j.2044-8260.1979.tb00342.x			9	Psychology, Clinical; Psychology; Psychology, Social	Social Science Citation Index (SSCI)	Psychology	HM221	WOS:A1979HM22100007	519141				2022-02-06	
J	GRUBB, RL; NAUMANN, RA; OMMAYA, AK				GRUBB, RL; NAUMANN, RA; OMMAYA, AK			RESPIRATION AND CEREBROSPINAL FLUID IN EXPERIMENTAL CEREBRAL CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article																	COOK AW, 1961, J NEUROSURG, V18, P366, DOI 10.3171/jns.1961.18.3.0366; DUCKER TB, 1968, J NEUROSURG, V28, P118, DOI 10.3171/jns.1968.28.2.0118; DUCKER TB, 1968, J NEUROSURG, V28, P112, DOI 10.3171/jns.1968.28.2.0112; DUCKER TB, 1968, J NEUROSURG, V29, P475, DOI 10.3171/jns.1968.29.5.0475; FAAS FH, 1968, J NEUROSURG, V28, P137, DOI 10.3171/jns.1968.28.2.0137; Flamm E S, 1966, Surg Forum, V17, P414; FORMAN C, 1968, BR J ANAESTH, V40, P354; HUANG CT, 1963, ARCH NEUROL-CHICAGO, V9, P545, DOI 10.1001/archneur.1963.00460110113012; INGVAR DM, 1968, SCAND J CLIN LA S102, V22; LUNDBERG N, 1959, Acta Psychiatr Scand Suppl, V34, P1; MACIVER IN, 1968, LANCET, V1, P390; MOODY RA, 1969, J NEUROSURG, V30, P482, DOI 10.3171/jns.1969.30.4.0482; NAERAA N, 1963, ACTA ANAESTH SCAND, V7, P191, DOI 10.1111/j.1399-6576.1963.tb00219.x; NAUMANN RA, IN PRESS; Ommaya A K, 1966, Ann R Coll Surg Engl, V39, P317; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1966, HEAD INJURY C P; OMMAYA AK, 1968 P INT C ACC PAT; PLUM F, 1959, ARCH NEURO PSYCHIATR, V81, P535, DOI 10.1001/archneurpsyc.1959.02340170001001; SCHNEDORF JG, 1940, SURG GYNECOL OBSTET, V70, P628; SIMMONS RL, 1968, J TRAUM, V8, P800, DOI 10.1097/00005373-196809000-00023; SIRIS JH, 1962, NEW YORK STATE J MED, V62, P1440; SWANN HE, 1960, ARCH PATHOL, V69, P557; YARNELL P, 1967, J NEUROSURG, V27, P515, DOI 10.3171/jns.1967.27.6.0515	24	15	15	1	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1970	32	3					320	&		10.3171/jns.1970.32.3.0320			0	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	F3720	WOS:A1970F372000008	4984664				2022-02-06	
J	LABAW, WL				LABAW, WL			DENIAL INSIDE OUT SUBJECTIVE EXPERIENCE WITH ANOSOGNOSIA IN CLOSED HEAD INJURY	PSYCHIATRY			English	Article																	Babinski J, 1914, REV NEUROL, V27, P845; BRAZIER ME, 1967, INT J PSYCHIATRY, V3, P40; Freud A., 1946, EGO MECHANISMS DEFEN; FULTON JF, 1929, J NERV MENT DIS, V69, P145; Goldstein K., 1939, ORGANISM; HEATH RG, 1964, J NEUROPSYCHIATRY, V5, P318; JAQUES E, 1965, INT J PSYCHOANAL, V46, P502; LaBaw W L, 1968, Med Times, V96, P821; LaBaw W L, 1966, Med Times, V94, P407; LABAW WL, IN PRESS; LABAW WL, UNPUBLISHED MANUSCRI; LABAW WL, 1967, RESIDENT PHYSICIAN, V13, P149; MACDONALD JM, 1964, AM J PSYCHIAT, V121, P366, DOI 10.1176/ajp.121.4.366; McLaurin R L, 1964, Clin Neurosurg, V12, P143; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Piaget J., 1951, PLAY DREAMS IMITATIO; SANDIFER PH, 1946, BRAIN, V69, P122, DOI 10.1093/brain/69.2.122; TABACHNICK N, 1966, ARCH GEN PSYCHIAT, V14, P60; WALSHE FMR, 1952, DISEASES NERVOUS SYS; WEINSTEIN EA, 1966, ARCH NEUROL-CHICAGO, V15, P545, DOI 10.1001/archneur.1966.00470170099012; Weinstein EA, 1955, DENIAL ILLNESS	21	15	15	0	1	GUILFORD PUBLICATIONS INC	NEW YORK	72 SPRING STREET, NEW YORK, NY 10012				PSYCHIATR			1969	32	2					174	&		10.1080/00332747.1969.11023582			0	Psychiatry	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	D3835	WOS:A1969D383500005	5792492				2022-02-06	
J	CASSEN, B; NEFF, R				CASSEN, B; NEFF, R			BLOOD-BRAIN BARRIER BEHAVIOR DURING TEMPORARY CONCUSSION	AMERICAN JOURNAL OF PHYSIOLOGY			English	Article																	BAKAY L, 1956, BLOOD BRAIN BARRIER, pCH5; Denny-Brown D, 1941, BRAIN, V64, P7; ROWBOTHAM GF, 1949, ACUTE INJURIES HEAD, P59	3	15	15	0	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0002-9513			AM J PHYSIOL	Am. J. Physiol.		1960	198	6					1296	1298		10.1152/ajplegacy.1960.198.6.1296			3	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	WE172	WOS:A1960WE17200035	13808217	Green Submitted			2022-02-06	
J	FRIEDE, RL				FRIEDE, RL			SPECIFIC CORD DAMAGE AT THE ATLAS LEVEL AS A PATHOGENIC MECHANISM IN CEREBRAL CONCUSSION	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article																	Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; GROAT R, 1950, J NEUROPATH EXP NEUR, V9, P150, DOI 10.1097/00005072-195004000-00003; HOLLISTER N, 1958, INVESTIGATIONS MECHA, V58, P130; MEESSEN H, 1949, CYTOARCHITECTONIC AT; WINDLE W. F., 1944, TRANS AMER NEUROL ASSOC, V70, P117; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210	7	15	15	0	0	AMER ASSN NEUROPATHOLOGISTS INC	LAWRENCE	1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.		1960	19	2					266	279		10.1097/00005072-196004000-00007			14	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	WB087	WOS:A1960WB08700007	13825036				2022-02-06	
J	GURDJIAN, ES; WEBSTER, JE; LISSNER, HR				GURDJIAN, ES; WEBSTER, JE; LISSNER, HR			MECHANISM OF SCALP AND SKULL INJURIES, CONCUSSION, CONTUSION AND LACERATION	JOURNAL OF NEUROSURGERY			English	Article																	BUTLER EG, 1945, J NEUROSURG, V2, P358, DOI 10.3171/jns.1945.2.4.0358; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; ZUCKERMAN S, 1940, BRIT MED J, V2, P131	3	15	15	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1958	15	2					125	128		10.3171/jns.1958.15.2.0125			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WG961	WOS:A1958WG96100001	13514509				2022-02-06	
J	GUTTMANN, E				GUTTMANN, E			LATE EFFECTS OF CLOSED HEAD INJURIES - PSYCHIATRIC OBSERVATIONS	JOURNAL OF MENTAL SCIENCE			English	Article																	ADLER A, 1945, ARCH NEURO PSYCHIATR, V53, P34, DOI 10.1001/archneurpsyc.1945.02300010044003; Botterell EH, 1944, CAN MED ASSOC J, V51, P498; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; Eysenck HJ, 1944, J MENT SCI, V90, P851, DOI 10.1192/bjp.90.381.851; FRIEDMAN AP, 1945, J NEUROSURG, V2, P36, DOI 10.3171/jns.1945.2.1.0036; Guttmann E, 1944, J MENT SCI, V90, P328; Guttmann E, 1943, Br Med J, V1, P94; Guttmann E, 1943, LANCET, V1, P10; MERRITT HH, 1943, WAR MED, V4, P61; Russell W Ritchie, 1934, Edinb Med J, V41, P129; Symonds CP, 1943, LANCET, V1, P7; [No title captured]	13	15	15	0	0	HEADLEY BROTHERS LTD	ASHFORD	INVICTA PRESS, ASHFORD TN24 8HH, KENT, ENGLAND				J MENT SCI	J. Mental Sci.		1946	92	386					1	18					18	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	YD845	WOS:A1946YD84500001	20984290				2022-02-06	
J	Rotter, R				Rotter, R			Organic brain process as late sequelae of concussions.	ZEITSCHRIFT FUR DIE GESAMTE NEUROLOGIE UND PSYCHIATRIE			German	Article																		0	15	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-4194			Z GESAMTE NEUROL PSY	Z. Gesamte Neurol. Psychiatr.		1929	119						97	108		10.1007/BF02863809			12	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	V39CB	WOS:000202641700006					2022-02-06	
J	Fahlstedt, M; Abayazid, F; Panzer, MB; Trotta, A; Zhao, W; Ghajari, M; Gilchrist, MD; Ji, SB; Kleiven, S; Li, XG; Annaidh, AN; Halldin, P				Fahlstedt, Madelen; Abayazid, Fady; Panzer, Matthew B.; Trotta, Antonia; Zhao, Wei; Ghajari, Mazdak; Gilchrist, Michael D.; Ji, Songbai; Kleiven, Svein; Li, Xiaogai; Annaidh, Aisling Ni; Halldin, Peter			Ranking and Rating Bicycle Helmet Safety Performance in Oblique Impacts Using Eight Different Brain Injury Models	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Bicycle helmet; Brain injury criteria; Concussion; Finite element models; Oblique impact tests; Test methods		Bicycle helmets are shown to offer protection against head injuries. Rating methods and test standards are used to evaluate different helmet designs and safety performance. Both strain-based injury criteria obtained from finite element brain injury models and metrics derived from global kinematic responses can be used to evaluate helmet safety performance. Little is known about how different injury models or injury metrics would rank and rate different helmets. The objective of this study was to determine how eight brain models and eight metrics based on global kinematics rank and rate a large number of bicycle helmets (n=17) subjected to oblique impacts. The results showed that the ranking and rating are influenced by the choice of model and metric. Kendall's tau varied between 0.50 and 0.95 when the ranking was based on maximum principal strain from brain models. One specific helmet was rated as 2-star when using one brain model but as 4-star by another model. This could cause confusion for consumers rather than inform them of the relative safety performance of a helmet. Therefore, we suggest that the biomechanics community should create a norm or recommendation for future ranking and rating methods.	[Fahlstedt, Madelen; Kleiven, Svein; Li, Xiaogai; Halldin, Peter] KTH Royal Inst Technol, Div Neuron Engn, Halsovagen 11C, S-14152 Huddinge, Sweden; [Abayazid, Fady; Ghajari, Mazdak] Imperial Coll London, Dyson Sch Design Engn, London, England; [Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA USA; [Panzer, Matthew B.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Trotta, Antonia; Gilchrist, Michael D.; Annaidh, Aisling Ni] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01605 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA; [Annaidh, Aisling Ni] Univ Coll Dublin, Sch Med & Med Sci, UCD Charles Inst Dermatol, Dublin 4, Ireland		Halldin, P (corresponding author), KTH Royal Inst Technol, Div Neuron Engn, Halsovagen 11C, S-14152 Huddinge, Sweden.	peter.halldin@mipsprotection.com	Ni Annaidh, Aisling/ABF-8938-2021	Ni Annaidh, Aisling/0000-0002-9929-4541	Royal Institute of Technology; FFI (Strategic Vehicle Research and Innovation); Imperial College; European UnionEuropean Commission [642662]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853]	Open access funding provided by Royal Institute of Technology. MF, SK, XL and PH have partly been financed by FFI (Strategic Vehicle Research and Innovation). FA would like to acknowledge the Imperial College President's PhD Scholarship. AT, ANA and MDG acknowledge funding from the European Union's Horizon 2020 research programme under Marie Sklodowska - Curie Grant Agreement No. 642662. WZ and SJ are supported by the NIH Grant R01 NS092853.	[Anonymous], 2012, EN1078; [Anonymous], 2008, 20632008 ASNZS; Atsumi N., 2016, INT J VEH SAF, V9, P1, DOI [10.1504/ijvs.2016.077145, DOI 10.1504/IJVS.2016.077145]; Baeck, 2013, BIOMECHANICAL MODELI; Bland ML, 2020, ANN BIOMED ENG, V48, P47, DOI 10.1007/s10439-019-02330-0; Clark JM, 2020, J SCI MED SPORT, V23, P222, DOI 10.1016/j.jsams.2019.10.006; Clark JM, 2018, ANN BIOMED ENG, V46, P986, DOI 10.1007/s10439-018-2017-7; CPSC, 1998, FED REGISTER, V63, P11711; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Curnow WJ, 2005, ACCIDENT ANAL PREV, V37, P569, DOI 10.1016/j.aap.2005.01.009; Deck C, 2019, J SAFETY RES, V71, P67, DOI 10.1016/j.jsr.2019.09.003; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Engstrom, 2017, CONSUMER TESTING BIC, DOI [10.13021/G8N889, DOI 10.13021/G8N889]; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Feist F, 2016, INT RES COUNC BIOM I; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gennarelli T.A., 1972, SAE TECHNICAL PAPER; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Ghajari M, 2013, ACCIDENT ANAL PREV, V50, P263, DOI 10.1016/j.aap.2012.04.016; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Halldin, 2018, EFFECT IMPACT VELOCI; Holbourn AHS, 1943, LANCET, V2, P438; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.1093/biomet/30.1-2.81; Kleiven, 2016, INT RES COUNCIL BIOM; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Krafft, 2013, CYCLIST INJURIES LEA; Li X., 2018, SCI REPORTS, V8, P1, DOI DOI 10.1038/s41598-017-17765-5; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Siegkas P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39953-1; Stigson, 2018, FOLKSAM TESTAR ELVA; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trotta A, 2020, INT J MECH SCI, V173, DOI 10.1016/j.ijmecsci.2020.105448; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Willinger, 2017, PROTECTION CAPABILIT; Wu SJ, 2020, BIOMECH MODEL MECHAN, V19, P927, DOI 10.1007/s10237-019-01261-y; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhao W, 2019, ANN BIOMED ENG, V47, P475, DOI 10.1007/s10439-018-02159-z; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3; Zhou Zhou, 2019, Stapp Car Crash J, V63, P1	56	14	14	2	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	MAR	2021	49	3					1097	1109		10.1007/s10439-020-02703-w		JAN 2021	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	QV2UK	WOS:000609366100003	33475893	Green Published, hybrid			2022-02-06	
J	Rui, TY; Wang, HC; Li, QQ; Cheng, Y; Gao, Y; Fang, XX; Ma, XY; Chen, G; Gao, C; Gu, ZY; Song, SC; Zhang, J; Wang, CL; Wang, ZF; Wang, T; Zhang, MY; Min, JX; Chen, XP; Tao, LY; Wang, FD; Luo, CL				Rui, Tongyu; Wang, Haochen; Li, Qianqian; Cheng, Ying; Gao, Yuan; Fang, Xuexian; Ma, Xuying; Chen, Guang; Gao, Cheng; Gu, Zhiya; Song, Shunchen; Zhang, Jian; Wang, Chunling; Wang, Zufeng; Wang, Tao; Zhang, Mingyang; Min, Junxia; Chen, Xiping; Tao, Luyang; Wang, Fudi; Luo, Chengliang			Deletion of ferritin H in neurons counteracts the protective effect of melatonin against traumatic brain injury-induced ferroptosis	JOURNAL OF PINEAL RESEARCH			English	Article						ferritin H (Fth); ferroptosis; iron homeostasis; melatonin; melatonin receptors; traumatic brain injury	GLASGOW COMA SCALE; CELL-DEATH; BARRIER DISRUPTION; IRON TRAFFICKING; OXIDATIVE STRESS; NEUROTOXICITY; INCREASES; NEURODEGENERATION; INFLAMMATION; CONTRIBUTES	Accumulating evidence demonstrates that ferroptosis may be important in the pathophysiological process of traumatic brain injury (TBI). As a major hormone of the pineal gland, melatonin exerts many beneficial effects on TBI, but there is no information regarding the effects of melatonin on ferroptosis after TBI. As expected, TBI resulted in the time-course changes of ferroptosis-related molecules expression and iron accumulation in the ipsilateral cortex. Importantly, we found that treating with melatonin potently rescued TBI induced the changes mentioned above and improved functional deficits versus vehicle. Similar results were obtained with a ferroptosis inhibitor, liproxstatin-1. Moreover, the protective effect of melatonin is likely dependent on melatonin receptor 1B (MT2). Although ferritin plays a vital role in iron metabolism by storing excess cellular iron, its precise function in the brain, and whether it involves melatonin's neuroprotection remain unexplored. Considering ferritin H (Fth) is expressed predominantly in the neurons and global loss of Fth in mice induces early embryonic lethality, we then generated neuron-specific Fth conditional knockout (Fth-KO) mice, which are viable and fertile but have altered iron metabolism. In addition, Fth-KO mice were more susceptible to ferroptosis after TBI, and the neuroprotection by melatonin was largely abolished in Fth-KO mice. In vitro siFth experiments further confirmed the results mentioned above. Taken together, these data indicate that melatonin produces cerebroprotection, at least partly by inhibiting neuronal Fth-mediated ferroptosis following TBI, supporting the notion that melatonin is an excellent ferroptosis inhibitor and its anti-ferroptosis provides a potential therapeutic target for treating TBI.	[Rui, Tongyu; Wang, Haochen; Cheng, Ying; Gao, Yuan; Ma, Xuying; Chen, Guang; Gao, Cheng; Gu, Zhiya; Song, Shunchen; Wang, Zufeng; Wang, Tao; Zhang, Mingyang; Chen, Xiping; Tao, Luyang; Luo, Chengliang] Soochow Univ, Med Coll, Dept Forens Med, Suzhou 215123, Jiangsu, Peoples R China; [Li, Qianqian] Wannan Med Coll, Sch Forens Med, Wuhu, Peoples R China; [Fang, Xuexian; Min, Junxia; Wang, Fudi] Zhejiang Univ, Sch Med, Inst Translat Med, Sch Publ Hlth,Affiliated Hosp 1, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Jian] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China; [Zhang, Jian] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Peoples R China; [Wang, Chunling] Shandong Univ, Dept Anesthesiol, Qilu Hosp, Jinan, Peoples R China		Tao, LY; Luo, CL (corresponding author), Soochow Univ, Med Coll, Dept Forens Med, Suzhou 215123, Jiangsu, Peoples R China.; Wang, FD (corresponding author), Zhejiang Univ, Sch Med, Inst Translat Med, Sch Publ Hlth,Affiliated Hosp 1, Hangzhou 310058, Zhejiang, Peoples R China.	taoluyang@suda.edu.cn; fwang@zju.edu.cn; clluo@suda.edu.cn		Wang, Fudi/0000-0001-8730-0003	National Key RD Program [2018YFA0507800]; Suzhou Municipal Science and Technology Bureau [SYS2019027]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81530062, 81971163, 81971800, 31530034, 31930057]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2020T130583]; Priority Academic Program Development of Jiangsu Higher Education Institutions	The National Key R&D Program, Grant/Award Number: 2018YFA0507800; Suzhou Municipal Science and Technology Bureau, Grant/Award Number: SYS2019027; National Natural Science Foundation of China, Grant/Award Number: 81530062, 81971163, 81971800, 31530034 and 31930057; China Postdoctoral Science Foundation, Grant/Award Number: 2020T130583; Priority Academic Program Development of Jiangsu Higher Education Institutions	Al Nimer F, 2013, ANTIOXID REDOX SIGN, V18, P784, DOI 10.1089/ars.2011.4440; Alfieri JA, 2014, J NEUROSCI, V34, P15244, DOI 10.1523/JNEUROSCI.1918-14.2014; Amadio P, 2017, THROMB HAEMOSTASIS, V117, P1486, DOI 10.1160/TH16-12-0968; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Bellelli R, 2016, CELL REP, V14, P411, DOI 10.1016/j.celrep.2015.12.065; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Chen J, 2020, CELL MOL NEUROBIOL, V40, P1165, DOI 10.1007/s10571-020-00806-5; Chen M, 2020, J PINEAL RES, V68, DOI 10.1111/jpi.12641; Chern CM, 2012, FREE RADICAL BIO MED, V52, P1634, DOI 10.1016/j.freeradbiomed.2012.01.030; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; Daglas M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00981; Darshan D, 2009, HEPATOLOGY, V50, P852, DOI 10.1002/hep.23058; De Oliveira PA, 2017, BRAIN RES, V1663, P78, DOI 10.1016/j.brainres.2017.03.002; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Ding S, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12581; Dominguez-Lopez S, 2012, J PSYCHOPHARMACOL, V26, P830, DOI 10.1177/0269881111408460; Drummen GPC, 2002, FREE RADICAL BIO MED, V33, P473, DOI 10.1016/S0891-5849(02)00848-1; DUBOCOVICH ML, 1995, TRENDS PHARMACOL SCI, V16, P50, DOI 10.1016/S0165-6147(00)88978-6; Fang XX, 2020, CIRC RES, V127, P486, DOI 10.1161/CIRCRESAHA.120.316509; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Gao C, 2020, J NEUROCHEM, V154, P190, DOI 10.1111/jnc.14983; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Gou ZX, 2020, BRAIN RES BULL, V163, P40, DOI 10.1016/j.brainresbull.2020.07.011; Guan LY, 2009, APOPTOSIS, V14, P218, DOI 10.1007/s10495-008-0295-5; Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021; He J, 2016, J ENVIRON SCI, V39, P97, DOI 10.1016/j.jes.2015.12.003; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hogarth P, 2015, J MOV DISORD, V8, P1, DOI 10.14802/jmd.14034; Ignowski E, 2018, FREE RADICAL BIO MED, V124, P328, DOI 10.1016/j.freeradbiomed.2018.06.026; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117435; Li Y, 2019, CELL DEATH DIFFER, V26, P2284, DOI 10.1038/s41418-019-0299-4; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Lu HY, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0187-x; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2019, FREE RADICAL BIO MED, V130, P215, DOI 10.1016/j.freeradbiomed.2018.10.402; Mancias JD, 2015, ELIFE, V4, DOI 10.7554/eLife.10308; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Nash B, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0237-19.2019; NaveenKumar SK, 2019, BBA-MOL BASIS DIS, V1865, P2303, DOI 10.1016/j.bbadis.2019.05.009; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Osier N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051539; Osier ND, 2017, NEUROSCI LETT, V650, P18, DOI 10.1016/j.neulet.2017.03.053; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Rui TY, 2020, NEUROCHEM INT, V132, DOI 10.1016/j.neuint.2019.104606; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Simon D, 2015, BRAIN INJURY, V29, P612, DOI 10.3109/02699052.2014.995228; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Su LJ, 2019, J BIOL CHEM, V294, P19395, DOI 10.1074/jbc.RA119.010949; Tuo QZ, 2017, MOL PSYCHIATR, V22, P1520, DOI 10.1038/mp.2017.171; Wang H, 2017, HEPATOLOGY, V66, P449, DOI 10.1002/hep.29117; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Xiao X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0501-0; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yeleswaram K, 1997, J PINEAL RES, V22, P45, DOI 10.1111/j.1600-079X.1997.tb00302.x; Zarjou A, 2013, J CLIN INVEST, V123, P4423, DOI 10.1172/JCI67867; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1	74	14	14	11	33	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3098	1600-079X		J PINEAL RES	J. Pineal Res.	MAR	2021	70	2							e12704	10.1111/jpi.12704		NOV 2020	23	Endocrinology & Metabolism; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology; Physiology	QK9JA	WOS:000594384600001	33206394				2022-02-06	
J	Li, XG; Zhou, Z; Kleiven, S				Li, Xiaogai; Zhou, Zhou; Kleiven, Svein			An anatomically detailed and personalizable head injury model: Significance of brain and white matter tract morphological variability on strain	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Traumatic brain injury; Subject-specific head model; Demons and Dramms image registration; Mesh morphing; Axonal strain; Finite element analysis	FINITE-ELEMENT MODELS; MESH GENERATION; IMAGE REGISTRATION; DEFORMATION; VALIDATION; PREDICTION; IMPACT; TISSUE; DISPLACEMENT; ALGORITHMS	Finite element head (FE) models are important numerical tools to study head injuries and develop protection systems. The generation of anatomically accurate and subject-specific head models with conforming hexahedral meshes remains a significant challenge. The focus of this study is to present two developmental works: first, an anatomically detailed FE head model with conforming hexahedral meshes that has smooth interfaces between the brain and the cerebrospinal fluid, embedded with white matter (WM) fiber tracts; second, a morphing approach for subject-specific head model generation via a new hierarchical image registration pipeline integrating Demons and Dramms deformable registration algorithms. The performance of the head model is evaluated by comparing model predictions with experimental data of brain-skull relative motion, brain strain, and intracranial pressure. To demonstrate the applicability of the head model and the pipeline, six subject-specific head models of largely varying intracranial volume and shape are generated, incorporated with subject-specific WM fiber tracts. DICE similarity coefficients for cranial, brain mask, local brain regions, and lateral ventricles are calculated to evaluate personalization accuracy, demonstrating the efficiency of the pipeline in generating detailed subject-specific head models achieving satisfactory element quality without further mesh repairing. The six head models are then subjected to the same concussive loading to study the sensitivity of brain strain to inter-subject variability of the brain and WM fiber morphology. The simulation results show significant differences in maximum principal strain and axonal strain in local brain regions (one-way ANOVA test,p < 0.001), as well as their locations also vary among the subjects, demonstrating the need to further investigate the significance of subject-specific models. The techniques developed in this study may contribute to better evaluation of individual brain injury and the development of individualized head protection systems in the future. This study also contains general aspects the research community may find useful: on the use of experimental brain strain close to or at injury level for head model validation; the hierarchical image registration pipeline can be used to morph other head models, such as smoothed-voxel models.	[Li, Xiaogai; Zhou, Zhou; Kleiven, Svein] KTH Royal Inst Technol, Dept Biomed Engn & Hlth Syst, Div Neuron Engn, S-14152 Huddinge, Sweden		Li, XG (corresponding author), KTH Royal Inst Technol, Dept Biomed Engn & Hlth Syst, Div Neuron Engn, S-14152 Huddinge, Sweden.	xiaogai@kth.se	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Kleiven, Svein/0000-0003-0125-0784; Li, Xiaogai/0000-0001-8522-4705	Royal Institute of Technology; 16 NIH Institutes and Centers - NIH Blueprint for Neuroscience Research [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; KTH-Royal Institute of Technology, Stockholm; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2016-04203, 2016-05314]; European Union's Horizon 2020 research and innovation program under the Marie Curie Grant [642662]	Open access funding provided by Royal Institute of Technology. The authors would like to acknowledge the earlier version of the Python code from Chiara Giordano, which was adapted and used in this study. Our special thanks go to Dr. Yangming Ou and Dr. Steve Pieper, who generously spent their time advising Dramms registration, and to Dr. Loic Marechal who provided great support for the usage of the software Hexotic. The authors thank the three anonymous reviewers and Prof. Peter J. Hunter for their stimulating comments and valuable suggestions that substantially improved this paper. The WUM HCP data of the six subjects used in this study were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. The computations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at Center for High Performance Computing (PDC) at KTH. Gong Jing at KTH PDC center is acknowledged for assistance for the installation of needed software on the PDC resources. The present study was supported by research funds from KTH-Royal Institute of Technology, Stockholm, the Swedish Research Council Grants (No. 2016-04203 and No. 2016-05314), and European Union's Horizon 2020 research and innovation program under the Marie Curie Grant Agreement No. 642662.	Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Atsumi N., 2016, INT J VEH SAF, V9, P1, DOI [10.1504/ijvs.2016.077145, DOI 10.1504/IJVS.2016.077145]; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Beillas P, 2017, TRAFFIC INJ PREV, V18, pS142, DOI 10.1080/15389588.2017.1307971; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Bijar A, 2016, ANN BIOMED ENG, V44, P16, DOI 10.1007/s10439-015-1497-y; Boyd SK, 2006, J BIOMECH, V39, P1287, DOI 10.1016/j.jbiomech.2005.03.006; Bradshaw DRS, 2003, THESIS U SOUTHAMPTON; Bucki M, 2010, MED IMAGE ANAL, V14, P303, DOI 10.1016/j.media.2010.02.003; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Camacho DLA, 1997, J BIOMECH, V30, P1067, DOI 10.1016/S0021-9290(97)00073-0; Castellano-Smith AD, 2001, LECT NOTES COMPUTER, P1091, DOI DOI 10.1007/3-540-45468-3_130; Couteau B, 2000, J BIOMECH, V33, P1005, DOI 10.1016/S0021-9290(00)00055-5; Davis Matthew L, 2016, Stapp Car Crash J, V60, P509; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Fernandez JW, 2004, BIOMECH MODEL MECHAN, V2, P139, DOI [10.1007/s10237-003-0036-1, 10.1007/S10237-003-0036-1]; Fonov V., 2009, NEUROIMAGE, V47, pS102; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Horstemeyer MF, 2019, ANN BIOMED ENG, V47, P1829, DOI 10.1007/s10439-019-02351-9; Hu JW, 2007, J NEUROSURG, V106, P164, DOI 10.3171/jns.2007.106.1.164; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2011, FINITE ELEM ANAL DES, V47, P1178, DOI 10.1016/j.finel.2011.05.007; Kang H.-S, 1997, P STAPP CAR CRASH J, V106, P3849; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; Li XB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30566-8; Li XG, 2019, FORENSIC SCI INT, V294, P173, DOI 10.1016/j.forsciint.2018.11.008; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Li XG, 2013, J CLIN NEUROSCI, V20, P509, DOI 10.1016/j.jocn.2012.04.019; Liu SY, 2020, SUBST USE MISUSE, V55, P2291, DOI 10.1080/10826084.2020.1801743; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Madhukar A, 2019, ANN BIOMED ENG, V47, P1832, DOI 10.1007/s10439-019-02205-4; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; Marechal L, 2009, PROCEEDINGS OF THE 18TH INTERNATIONAL MESHING ROUNDTABLE, P65, DOI 10.1007/978-3-642-04319-2_5; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Miller LE, 2019, J NEUROTRAUM, V36, P1561, DOI 10.1089/neu.2018.6037; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Morfey, 2001, P 17 INT TECHN C ENH; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nahum AM, P 21 STAPP CAR CRASH, P337; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Ommaya A.K., 1967, 11 STAPP CAR CRASH C, DOI [10.4271/670906, DOI 10.4271/670906]; Ou YM, 2014, IEEE T MED IMAGING, V33, P2039, DOI 10.1109/TMI.2014.2330355; Ou YM, 2011, MED IMAGE ANAL, V15, P622, DOI 10.1016/j.media.2010.07.002; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Park G, 2017, COMPUT METHOD BIOMEC, V20, P1151, DOI 10.1080/10255842.2017.1340459; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prange MT, 1999, P 43 STAPP CAR CRASH; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Samani A, 2001, IEEE T MED IMAGING, V20, P271, DOI 10.1109/42.921476; Sigal IA, 2008, J BIOMECH, V41, P1381, DOI 10.1016/j.jbiomech.2008.02.019; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Toga AW, 2001, IMAGE VISION COMPUT, V19, P3, DOI 10.1016/S0262-8856(00)00055-X; Trotta A, 2020, INT J MECH SCI, V173, DOI 10.1016/j.ijmecsci.2020.105448; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vandavasi VG, 2020, SELENIUM RESEARCH FOR ENVIRONMENT AND HUMAN HEALTH: PERSPECTIVES, TECHNOLOGIES AND ADVANCEMENTS, P155; VANNOORT R, 1981, BIOMATERIALS, V2, P41, DOI 10.1016/0142-9612(81)90086-7; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Viceconti M, 1998, MED ENG PHYS, V20, P1, DOI 10.1016/S1350-4533(97)00049-0; von Holst H, 2013, J APPL MATH, DOI 10.1155/2013/350359; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wu TT, 2020, J NEUROTRAUM, V37, P410, DOI 10.1089/neu.2019.6576; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhao W, 2019, ANN BIOMED ENG, V47, P475, DOI 10.1007/s10439-018-02159-z; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zhao W, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0091; Zhou Zhou, 2019, Stapp Car Crash J, V63, P1; Zhou Z, 2020, J NEUROTRAUM, V37, P1074, DOI 10.1089/neu.2019.6634; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	105	14	14	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	APR	2021	20	2					403	431		10.1007/s10237-020-01391-8		OCT 2020	29	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	QZ5PI	WOS:000576877900001	33037509	hybrid, Green Published, Green Submitted			2022-02-06	
J	Gauvin-Lepage, J; Friedman, D; Grilli, L; Sufrategui, M; De Matteo, C; Iverson, GL; Gagnon, I				Gauvin-Lepage, Jerome; Friedman, Debbie; Grilli, Lisa; Sufrategui, Maria; De Matteo, Carol; Iverson, Grant L.; Gagnon, Isabelle			Effectiveness of an Exercise-Based Active Rehabilitation Intervention for Youth Who Are Slow to Recover After Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						children and adolescent; post-concussion; trauma; active rehabilitation; exercise-based approach	TRAUMATIC BRAIN-INJURY; GENERIC CORE SCALES; MILD HEAD-INJURY; PHYSICAL-ACTIVITY; POSTCONCUSSION SYNDROME; MISERABLE MINORITY; RANDOMIZED-TRIAL; RISK-FACTORS; CHILDREN; SPORT	Objective: (1) To determine the impact of providing participants aged 8 to 17 years who are slow to recover after a concussion with a well-developed active rehabilitation intervention (ARI), compared with receiving standard care alone, on postconcussion symptoms (PCS) at 2 and 6 weeks after the initiation of ARI; and (2) to investigate functional recovery 6 weeks after initiation of ARI. Design: A multicenter prospective quasi-experimental control group design. Setting: Tertiary care pediatric trauma center and community health care providers. Participants: Forty-nine youth were enrolled (experimental n = 36; control n = 13). Procedures: Participants were assessed on 3 different occasions: (1) initial visit (baseline); (2) 2 weeks; and (3) 6 weeks after enrollment. Main Outcome Measures: Child- and parent-reported PCS were obtained by the PCS Inventory Scale (primary outcome). Secondary outcomes included: (1) mood and anxiety; (2) quality of life; (3) energy level; (4) coordination and balance; (5) neurocognition; (6) parental anxiety; and (7) satisfaction with intervention. Results: Both groups reported decrease of PCS over time (child:P= 0.01; parent:P= 0.03). Children in the experimental group presented higher quality of life (P= 0.04) and less anger (P= 0.02). A trend toward significance was observed for better tandem gait (P= 0.07) and for less general fatigue on self-reported PCS (P= 0.09) in the experimental group. Conclusions: Active rehabilitation intervention does not affect the PCS beyond the usual management, but it increases their quality of life, decreases anger, and potentially increases energy level and balance.	[Gauvin-Lepage, Jerome] Univ Montreal, Fac Nursing, Montreal, PQ, Canada; [Gauvin-Lepage, Jerome] St Justine Univ Hosp, Res Ctr, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Montreal Childrens Hosp Trauma Ctr, Hlth Ctr, Montreal, PQ, Canada; [Friedman, Debbie] Hlth Canada, Canadian Hosp Injury Reporting & Prevent Program, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Fac Med, Dept Pediat Surg, Montreal, PQ, Canada; [Friedman, Debbie] McGill Univ, Fac Med, Student Affairs, Montreal, PQ, Canada; [Grilli, Lisa; Sufrategui, Maria] McGill Univ, Montreal Childrens Hosp Trauma Ctr, Hlth Ctr, MTBI Program & Concuss Clin, Montreal, PQ, Canada; [De Matteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [De Matteo, Carol; Iverson, Grant L.] CanChild Ctr Childhood Disabil Res, Hamilton, ON, Canada; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Gagnon, Isabelle] McGill Univ, Fac Med, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Montreal Childrens Hosp Trauma Ctr, Kids & Teens Concuss Res Lab, Hlth Ctr, Montreal, PQ, Canada		Gauvin-Lepage, J (corresponding author), Univ Montreal, Montreal, PQ H1T 1C9, Canada.	jerome.gauvin-lepage@umontreal.ca		Gagnon, Isabelle/0000-0003-2043-1644	Fonds de recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Research Institute of the McGill University Health Centre	The authors thank the cooperation of the Montreal Children's Hospital Trauma Centre, McGill University Health Centre's MTBI Program and Concussion Clinic, and the CanChild Research Center at McMaster University. They also thank the "Fonds de recherche du Quebec-Sante," the Canadian Institutes for Health Research, as well as the Research Institute of the McGill University Health Centre for their financial support of this work.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blume HK, 2011, PHYS MED REH CLIN N, V22, P665, DOI 10.1016/j.pmr.2011.08.007; Bruininks BD, 2006, BRUININKS OSERETSKY; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Gadoury M, 2001, CADRE REFERENCE CLIN; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Imhoff S, 2016, J SPORTS MED, V2016, P5127374, DOI DOI 10.1155/2016/5127374; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Maroon JC, 2000, NEUROSURGERY, V47, P669; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ministere de la Sante et des Services Sociaux, 1999, CONT SERV PERS AYANT; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mrazik M, 2016, ARCH CLIN NEUROPSYCH, V31, P297, DOI 10.1093/arclin/acw013; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Pardini D., 2004, BR J SPORTS MED, V38, P661; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Salum GA, 2017, J CHILD PSYCHOL PSYC, V58, P595, DOI 10.1111/jcpp.12659; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Spielberger C, 2010, CORSINI ENCY PSYCHOL, V1; Steer, 2005, BECK YOUTH INVENTORI; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Varni JW, 2004, J DEV BEHAV PEDIATR, V25, P10, DOI 10.1097/00004703-200402000-00002; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WHO, 1992, INT STAT CLASS DIS R; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Zemek R, 2014, GUIDELINES DIAGNOSIN	56	14	14	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					423	432		10.1097/JSM.0000000000000634			10	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300018	30095507				2022-02-06	
J	Alosco, ML; Cherry, JD; Huber, BR; Tripodis, Y; Baucom, Z; Kowall, NW; Saltiel, N; Goldstein, LE; Katz, DI; Dwyer, B; Daneshvar, DH; Palmisano, JN; Martin, B; Cantu, RC; Stern, RA; Alvarez, VE; Mez, J; Stein, TD; McKee, AC				Alosco, Michael L.; Cherry, Jonathan D.; Huber, Bertrand Russell; Tripodis, Yorghos; Baucom, Zachary; Kowall, Neil W.; Saltiel, Nicole; Goldstein, Lee E.; Katz, Douglas, I; Dwyer, Brigid; Daneshvar, Daniel H.; Palmisano, Joseph N.; Martin, Brett; Cantu, Robert C.; Stern, Robert A.; Alvarez, Victor E.; Mez, Jesse; Stein, Thor D.; McKee, Ann C.			Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme	ACTA NEUROPATHOLOGICA			English	Article						Chronic traumatic encephalopathy; CTE stage; McKee CTE staging scheme; Repetitive head impacts; Neurodegenerative disease; Traumatic brain injury	ALZHEIMERS-DISEASE; NATIONAL INSTITUTE; MIXED PATHOLOGIES; CRITERIA; DIAGNOSIS; NUCLEI; SYSTEM; BRAINS; TDP-43	Chronic traumatic encephalopathy (CTE) is a tauopathy associated with repetitive head impacts (RHI) that has been neuropathologically diagnosed in American football players and other contact sport athletes. In 2013, McKee and colleagues proposed a staging scheme for characterizing the severity of the hyperphosphorylated tau (p-tau) pathology, the McKee CTE staging scheme. The staging scheme defined four pathological stages of CTE, stages I(mild)-IV(severe), based on the density and regional deposition of p-tau. The objective of this study was to test the utility of the McKee CTE staging scheme, and provide a detailed examination of the regional distribution of p-tau in CTE. We examined the relationship between the McKee CTE staging scheme and semi-quantitative and quantitative assessments of regional p-tau pathology, age at death, dementia, and years of American football play among 366 male brain donors neuropathologically diagnosed with CTE (mean age 61.86, SD 18.90). Spearman's rho correlations showed that higher CTE stage was associated with higher scores on all semi-quantitative and quantitative assessments of p-tau severity and density (p's < 0.001). The severity and distribution of CTE p-tau followed an age-dependent progression: older age was associated with increased odds for having a higher CTE stage (p < 0.001). CTE stage was independently associated with increased odds for dementia (p < 0.001). K-medoids cluster analysis of the semi-quantitative scales of p-tau across 14 regions identified 5 clusters of p-tau that conformed to increasing CTE stage (stage IV had 2 slightly different clusters), age at death, dementia, and years of American football play. There was a predilection for p-tau pathology in five regions: dorsolateral frontal cortex (DLF), superior temporal cortex, entorhinal cortex, amygdala, and locus coeruleus (LC), with CTE in the youngest brain donors and lowest CTE stage restricted to DLF and LC. These findings support the usefulness of the McKee CTE staging scheme and demonstrate the regional distribution of p-tau in CTE.	[Alosco, Michael L.; Cherry, Jonathan D.; Huber, Bertrand Russell; Tripodis, Yorghos; Kowall, Neil W.; Saltiel, Nicole; Goldstein, Lee E.; Katz, Douglas, I; Dwyer, Brigid; Daneshvar, Daniel H.; Palmisano, Joseph N.; Martin, Brett; Cantu, Robert C.; Stern, Robert A.; Alvarez, Victor E.; Mez, Jesse; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Alosco, Michael L.; Cherry, Jonathan D.; Huber, Bertrand Russell; Tripodis, Yorghos; Kowall, Neil W.; Saltiel, Nicole; Goldstein, Lee E.; Katz, Douglas, I; Dwyer, Brigid; Daneshvar, Daniel H.; Palmisano, Joseph N.; Martin, Brett; Cantu, Robert C.; Stern, Robert A.; Alvarez, Victor E.; Mez, Jesse; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA; [Cherry, Jonathan D.; Kowall, Neil W.; Goldstein, Lee E.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Dept Pathol & Lab Med, Sch Med, Boston, MA 02118 USA; [Cherry, Jonathan D.; Huber, Bertrand Russell; Kowall, Neil W.; Alvarez, Victor E.; Stein, Thor D.; McKee, Ann C.] US Dept Vet Affairs, VA Boston Healthcare Syst, Jamaica Plain, MA 02130 USA; [Alvarez, Victor E.; Stein, Thor D.; McKee, Ann C.] Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA; [Tripodis, Yorghos; Baucom, Zachary] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Huber, Bertrand Russell] VA Boston Healthcare, Natl Ctr PTSD, Boston, MA USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Dept Biomed Engn, Coll Engn, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Concuss Legacy Fdn, Boston, MA USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Katz, Douglas, I; Dwyer, Brigid] Braintree Rehabil Hosp, Braintree, MA USA; [Palmisano, Joseph N.; Martin, Brett] Boston Univ, Sch Publ Hlth, Biostat & Epidemiol Data Analyt Ctr, Boston, MA USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA		McKee, AC (corresponding author), Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis Ctr, Boston, MA 02118 USA.; McKee, AC (corresponding author), Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA.; McKee, AC (corresponding author), Boston Univ, Dept Pathol & Lab Med, Sch Med, Boston, MA 02118 USA.; McKee, AC (corresponding author), US Dept Vet Affairs, VA Boston Healthcare Syst, Jamaica Plain, MA 02130 USA.; McKee, AC (corresponding author), Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA.	amckee@bu.edu	, Bob/ABA-8507-2020		NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG057902, AG06234, RF1AG054156, K23AG046377]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS115266, U01NS086659, K23NS102399]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Department of Veterans Affairs Merit AwardUS Department of Veterans Affairs [I01-CX001038]; Nick and Lynn Buoniconti Foundation; BU-CTSI Grant [1UL1TR001430]; Alzheimer's AssociationAlzheimer's Association [AARF-17-529888]	We would like to acknowledge the many families who contributed to this work, Christopher Nowinski, Ph.D. and Lisa McHale from the Concussion Legacy Foundation, and the clinical and neuropathology research staff of the BU CTE Center, VA Boston Healthcare System and Edith Nourse Rogers VA Medical Center This work was supported by grant funding from: NIA (AG057902, AG06234, RF1AG054156, K23AG046377), NINDS (U54NS115266, U01NS086659, and K23NS102399), National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5); Department of Veterans Affairs Merit Award (I01-CX001038), the Nick and Lynn Buoniconti Foundation, and BU-CTSI Grant Number 1UL1TR001430. JC is funded by the Alzheimer's Association (AARF-17-529888). The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy, or decision, unless so designated by other official documentation. Funders did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Alosco ML, 2019, JAMA NEUROL, V76, P1298, DOI 10.1001/jamaneurol.2019.2244; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Armstrong RA, 2019, NEUROL SCI, V40, P529, DOI 10.1007/s10072-018-3686-6; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Cherry JD, 2020, BRAIN PATHOL, V30, P913, DOI 10.1111/bpa.12867; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; de Miranda AS, 2017, J NEUROL SCI, V372, P482, DOI 10.1016/j.jns.2016.10.052; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Ehrenberg AJ, 2018, J ALZHEIMERS DIS, V66, P115, DOI 10.3233/JAD-180688; Erdo F, 2017, J CEREBR BLOOD F MET, V37, P4, DOI 10.1177/0271678X16679420; Eser RA, 2018, J NEUROPATH EXP NEUR, V77, P149, DOI 10.1093/jnen/nlx113; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Forrest SL, 2019, J NEUROPATH EXP NEUR, V78, P398, DOI 10.1093/jnen/nlz017; Haneuse S, 2009, NEUROEPIDEMIOLOGY, V32, P229, DOI 10.1159/000197389; Iverson GL, 2019, J NEUROPATH EXP NEUR, V78, P615, DOI 10.1093/jnen/nlz045; James BD, 2016, BRAIN, V139, P2983, DOI 10.1093/brain/aww224; Jellinger KA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1016-8; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Serrano-Pozo A, 2016, J NEUROPATH EXP NEUR, V75, P516, DOI 10.1093/jnen/nlw026; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Udeochu Joe C, 2016, Clin Exp Neuroimmunol, V7, P114; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Wilson RS, 2013, JAMA PSYCHIAT, V70, P1320, DOI 10.1001/jamapsychiatry.2013.2224; Woerman AL, 2016, P NATL ACAD SCI USA, V113, pE8187, DOI 10.1073/pnas.1616344113; Xing CY, 2017, J CEREBR BLOOD F MET, V37, P2848, DOI 10.1177/0271678X16676826	51	14	14	37	47	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	OCT	2020	140	4					495	512		10.1007/s00401-020-02197-9		AUG 2020	18	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	NR0GL	WOS:000559628500001	32778942	Green Accepted			2022-02-06	
J	Ghirardi, L; Larsson, H; Chang, Z; Chen, Q; Quinn, PD; Hur, K; Gibbons, RD; D'Onofrio, BM				Ghirardi, Laura; Larsson, Henrik; Chang, Zheng; Chen, Qi; Quinn, Patrick D.; Hur, Kwan; Gibbons, Robert D.; D'Onofrio, Brian M.			Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents	JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						attention-deficit disorder with hyperactivity; drug therapy	DEFICIT-HYPERACTIVITY DISORDER; ADHD MEDICATION; DRUG-USE; RISK; ASSOCIATION; STIMULANT; TRENDS; IMPACT	Objective: Our objective was to determine whether attention-deficit/hyperactivity disorder (ADHD) medication is associated with a decreased risk of unintentional injuries in children and adolescents in the United States across sexes, age groups and injury types. Method: We used de-identified inpatient, outpatient, and filled prescription claims data from the Truven Health MarketScan Research Databases. Individuals were followed from January 1, 2005, date of first ADHD diagnosis, or medication prescription, or age 6 years, whichever occurred last, until December 31, 2014, first healthcare insurance disenrollment, or the first year at which their age was recorded as 19 years, whichever occurred first. A person was considered on ADHD medication during a given month if a prescription was filled in that month. The outcome was defined as emergency department visits for injuries, including traumatic brain injuries, with unintentional causes. Odds of having the outcome were compared between medicated and unmedicated months at the population-level and in within-individual analyses using logistic regression. Results: Among 1,968,146 individuals diagnosed with ADHD or receiving ADHD medication, 87,154 had at least one event. At the population level, medication use was associated with a lower risk of injuries, both in boys (odds ratio [OR] = 0.85; 95% CI = 0.84-0.86) and girls (OR = 0.87; 95% CI = 0.85-0.89). Similar results were obtained from within-individual analysis among male (OR = 0.72; 95% CI = 0.70-0.74) and female (OR = 0.72; 95% CI = 0.69-0.75) children, and among male (OR = 0.64; 95% CI = 0.60-0.67) and female (OR = 0.65; 95% CI = 0.60-0.71) adolescents. Similar results were found for traumatic brain injuries. Conclusion: ADHD medication use was associated with a reduction of different types of unintentional injuries in children and adolescents of both sexes.	[Ghirardi, Laura; Larsson, Henrik; Chang, Zheng; Chen, Qi; D'Onofrio, Brian M.] Karolinska Inst, Stockholm, Sweden; [Larsson, Henrik] Orebro Univ, Sch Med Sci, Orebro, Sweden; [D'Onofrio, Brian M.] Indiana Univ, Bloomington, IN 47405 USA; [Quinn, Patrick D.] Indiana Univ, Sch Publ Hlth, Bloomington, IN 47405 USA; [Hur, Kwan; Gibbons, Robert D.] Univ Chicago, Ctr Hlth Stat, Chicago, IL 60637 USA		Ghirardi, L (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 2A, S-17177 Stockholm, Sweden.	laura.ghirardi@ki.se		Quinn, Patrick/0000-0002-6770-8762	Swedish Research CouncilSwedish Research CouncilEuropean Commission [2018-02213, 2013-2280]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH102221]; National Institute on Drug Abuse of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R00DA040727]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH102221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R00DA040727] Funding Source: NIH RePORTER	Dr. Larsson acknowledges financial support from the Swedish Research Council (2013-2280). Dr. Larsson and Dr. D'Onofrio acknowledge support from the National Institute of Mental Health (MH102221). Dr. Chang acknowledges support from the Swedish Research Council (2018-02213). Dr. Quinn acknowledges support for this publication by the National Institute on Drug Abuse of the National Institutes of Health under award number R00DA040727. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Hur served as the statistical expert for this research.	Allison PD., 2009, FIXED EFFECTS REGRES; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Bachmann CJ, 2017, EUR NEUROPSYCHOPHARM, V27, P484, DOI 10.1016/j.euroneuro.2017.03.002; Banaschewski T, 2006, EUR CHILD ADOLES PSY, V15, P476, DOI 10.1007/s00787-006-0549-0; Borse NN, 2008, CDC CHILDHOOD INJURY; Centers for Disease Control and Prevention, NONF INJ DAT; Chang Z, 2017, JAMA PSYCHIAT, V74, P597, DOI 10.1001/jamapsychiatry.2017.0659; Chang Z, 2016, JAMA-J AM MED ASSOC, V316, P1798, DOI 10.1001/jama.2016.15380; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Coghill DR, 2014, BIOL PSYCHIAT, V76, P603, DOI 10.1016/j.biopsych.2013.10.005; Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0; Faraone SV, 2010, EUR CHILD ADOLES PSY, V19, P353, DOI 10.1007/s00787-009-0054-3; Hansen L, 2016, MARKETSCAN WHITE PAP; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lao KSJ, 2016, INT J CLIN PHARM-NET, V38, P676, DOI 10.1007/s11096-016-0285-6; Lau DT, 2012, BMJ-BRIT MED J, V26, P606, DOI DOI 10.1136/BMJ.I4515; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Lindemann C, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00220; Man KKC, 2017, CNS DRUGS, V31, P1043, DOI 10.1007/s40263-017-0485-1; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Nigg JT, 2013, CLIN PSYCHOL REV, V33, P215, DOI 10.1016/j.cpr.2012.11.005; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Quinn PD, 2017, AM J PSYCHIAT, V174, P877, DOI 10.1176/appi.ajp.2017.16060686; Raman SR, 2018, LANCET PSYCHIAT, V5, P824, DOI 10.1016/S2215-0366(18)30293-1; Raman SR, 2013, INJURY PREV, V19, P164, DOI 10.1136/injuryprev-2012-040483; Ruiz-Goikoetxea M, 2018, NEUROSCI BIOBEHAV R, V84, P63, DOI 10.1016/j.neubiorev.2017.11.007; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; van den Ban E, 2014, EUR CHILD ADOLES PSY, V23, P95, DOI 10.1007/s00787-013-0432-8; World Health Organization, 2014, INJ EUR CALL PUBL HL; Xu GF, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1471; Zetterqvist J, 2013, ACTA PSYCHIAT SCAND, V128, P70, DOI 10.1111/acps.12004	34	14	14	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0890-8567	1527-5418		J AM ACAD CHILD PSY	J. Am. Acad. Child Adolesc. Psychiatr.	AUG	2020	59	8					944	951		10.1016/j.jaac.2019.06.010			8	Psychology, Developmental; Pediatrics; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	MU6SK	WOS:000555800700010	31302218	Green Accepted			2022-02-06	
J	Cho, SJ; Park, E; Telliyan, T; Baker, A; Reid, AY				Cho, Sung-Joon; Park, Eugene; Telliyan, Tamar; Baker, Andrew; Reid, Aylin Y.			Zebrafish model of posttraumatic epilepsy	EPILEPSIA			English	Article						posttraumatic epilepsy; seizure; traumatic brain injury; zebrafish	TRAUMATIC BRAIN-INJURY; BARRIER DISRUPTION; STATUS-EPILEPTICUS; INDUCED SEIZURES; EPILEPTOGENESIS; RAT; DAMAGE; NEUROINFLAMMATION; INFLAMMATION	Objective Posttraumatic epilepsy (PTE) is defined as recurrent and unprovoked seizures occurring >1 week after traumatic brain injury (TBI). Animal studies of PTE are lengthy and expensive. In this study, we developed a cost-effective PTE animal model using zebrafish to bridge the gap between in vitro studies and low-throughput animal studies. Methods We used two different sets of parameters (G1 and G2) to induce closed-head TBI in adult zebrafish using pulsed high-intensity focused ultrasound. Injured fish and naive controls were evaluated for behavioral deficits and spontaneous behavioral seizure activity up to 21 days postinjury (DPI). We also assessed behavioral seizure susceptibility to a subconvulsive dose of pentylenetetrazole (PTZ; 2.5 mmol center dot L-1) and recorded electrophysiological signals to confirm seizure activity up to 40 DPI. In addition, we investigated injury-related changes in the blood-brain barrier and expression levels of various proteins altered in rodent and human TBI. Results The G2 parameters resulted in a more severe TBI, with a mortality rate of 25%, as well as motor dysfunction and heightened anxiety persisting at 21 DPI. One hundred percent of the G2 group showed spontaneous myocloniclike behavior, and 80% demonstrated tonic-clonic-like behavioral seizures by 21 DPI. Such activities were not detected in the naive group. After the application of 2.5 mmol center dot L(-1)PTZ, 100% of injured zebrafish had cloniclike seizures at 21 DPI, versus 30% of the naive group. We also demonstrated electrographic seizure activity at 40 DPI, which was not detected in the naive controls. Lastly, we observed acute blood-brain barrier dysfunction and increased levels of HMGB1 and ratios of phosphorylated/total Akt and tau through 21 DPI. Significance Together, the results indicate that severe TBI in the adult zebrafish leads to similar behavioral and physiological changes to those of more traditional models, including the development of PTE, and suggest this may be a useful model that can accelerate research in TBI/PTE.	[Cho, Sung-Joon; Reid, Aylin Y.] Univ Hlth Network, Div Fundamental Neurobiol, Krembil Res Inst, Toronto, ON, Canada; [Cho, Sung-Joon] Univ Toronto, Collaborat Program Neurosci, Toronto, ON, Canada; [Cho, Sung-Joon; Park, Eugene; Telliyan, Tamar; Baker, Andrew] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Baker, Andrew] Univ Toronto, Dept Anesthesia & Surg, Toronto, ON, Canada; [Reid, Aylin Y.] Univ Toronto, Dept Med, Toronto, ON, Canada		Cho, SJ (corresponding author), Toronto Western Hosp, Fundamental Neurobiol, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	sungjoon.cho@utoronto.ca		Cho, Sung-Joon/0000-0002-3277-0259	Savoy Foundation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MFE-164732]; National Research Foundation of KoreaNational Research Foundation of Korea [NRF-2019R1A6A3A03032940]; Toronto General and Western Hospital Foundation [TGTWF-1516203]	This work was supported by the Savoy Foundation (S.-J.C.), Canadian Institutes of Health Research (MFE-164732, S.-J.C.), National Research Foundation of Korea (NRF-2019R1A6A3A03032940, S.-J.C.), and Toronto General and Western Hospital Foundation (TGTWF-1516203, A.Y.R.).	Armstrong RA, 2017, NEUROPATH APPL NEURO, V43, P154, DOI 10.1111/nan.12323; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Chen YH, 2019, BRAIN RES, V1710, P163, DOI 10.1016/j.brainres.2019.01.005; Cho SJ, 2020, SENSOR ACTUAT B-CHEM, V304, DOI 10.1016/j.snb.2019.127332; Cho SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03482-6; Ding YT, 2019, J ALZHEIMERS DIS, V69, P339, DOI 10.3233/JAD-180917; Duy PQ, 2017, NEUROSCIENCE, V349, P118, DOI 10.1016/j.neuroscience.2017.02.032; Fang P, 2014, MOL NEUROBIOL, V49, P472, DOI 10.1007/s12035-013-8533-4; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gorter JA, 2015, EPILEPSY BEHAV, V49, P13, DOI 10.1016/j.yebeh.2015.04.047; Hester MS, 2016, EXP NEUROL, V280, P1, DOI 10.1016/j.expneurol.2016.03.015; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Li YJ, 2019, J PHARM PHARMACOL, V71, P390, DOI 10.1111/jphp.13040; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCutcheon V, 2017, J NEUROTRAUM, V34, P1382, DOI 10.1089/neu.2016.4497; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Michalak Z, 2013, EPILEPSY RES, V103, P167, DOI 10.1016/j.eplepsyres.2012.10.006; Mussulini BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054515; Paudel YN, 2019, J NEUROCHEM, V151, P542, DOI 10.1111/jnc.14663; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Sarnat HB, 2015, BRAIN DEV-JPN, V37, P553, DOI 10.1016/j.braindev.2014.08.010; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sen A, 2007, EPILEPSIA, V48, P1447, DOI 10.1111/j.1528-1167.2007.01107.x; Serra I, 2019, BEHAV BRAIN RES, V363, P135, DOI 10.1016/j.bbr.2019.01.040; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Siebel AM, 2015, PHARMACOL BIOCHEM BE, V139, P163, DOI 10.1016/j.pbb.2015.05.022; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Talos DM, 2018, ANN NEUROL, V83, P311, DOI 10.1002/ana.25149; Tanwar G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44264-6; Terrone G, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.107742; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tomkins Oren, 2011, Cardiovasc Psychiatry Neurol, V2011, P765923, DOI 10.1155/2011/765923; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; van Vliet EA, 2014, NEUROBIOL DIS, V63, P74, DOI 10.1016/j.nbd.2013.11.019; Wang F, 2018, EXP THER MED, V15, P4763, DOI 10.3892/etm.2018.6004; Wong M, 2011, EPILEPSY CURR, V11, P153, DOI 10.5698/1535-7511-11.5.153; Yu X, 2020, ZEBRAFISH, V17, P1	50	14	14	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	AUG	2020	61	8					1774	1785		10.1111/epi.16589		JUN 2020	12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NB2PL	WOS:000543465600001	32592416				2022-02-06	
J	Wang, H; Zhou, XM; Wu, LY; Liu, GJ; Xu, WD; Zhang, XS; Gao, YY; Tao, T; Zhou, Y; Lu, Y; Wang, J; Deng, CL; Zhuang, Z; Hang, CH; Li, W				Wang, Han; Zhou, Xiao-Ming; Wu, Ling-Yun; Liu, Guang-Jie; Xu, Wei-Dong; Zhang, Xiang-Sheng; Gao, Yong-Yue; Tao, Tao; Zhou, Yan; Lu, Yue; Wang, Juan; Deng, Chu-Lei; Zhuang, Zong; Hang, Chun-Hua; Li, Wei			Aucubin alleviates oxidative stress and inflammation via Nrf2-mediated signaling activity in experimental traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Traumatic brain injury (TBI); Aubucin; Oxidative stress; Inflammation; Nuclear factor erythroid-2 related factor 2 (Nrf2)	NRF2; PATHWAY; NEUROPROTECTION; HMGB1; MICE	Background Aucubin (Au), an iridoid glycoside from natural plants, has antioxidative and anti-inflammatory bioactivities; however, its effects on a traumatic brain injury (TBI) model remain unknown. We explored the potential role of Au in an H2O2-induced oxidant damage in primary cortical neurons and weight-drop induced-TBI in a mouse model. Methods In vitro experiments, the various concentrations of Au (50 mu g/ml, 100 mu g/ml, or 200 mu g/ml) were added in culture medium at 0 h and 6 h after neurons stimulated by H2O2(100 mu M). After exposed for 12 h, neurons were collected for western blot (WB), immunofluorescence, and M29,79-dichlorodihydrofluorescein diacetate (DCFH-DA) staining. In vivo experiments, Au (20 mg/kg or 40 mg/kg) was administrated intraperitoneally at 30 min, 12 h, 24 h, and 48 h after modeling. Brain water content, neurological deficits, and cognitive functions were measured at specific time, respectively. Cortical tissue around focal trauma was collected for WB, TdT-mediated dUTP Nick-End Labeling (TUNEL) staining, Nissl staining, quantitative real time polymerase chain reaction (q-PCR), immunofluorescence/immunohistochemistry, and enzyme linked immunosorbent assay (ELISA) at 72 h after TBI. RNA interference experiments were performed to determine the effects of nuclear factor erythroid-2 related factor 2 (Nrf2) on TBI mice with Au (40 mg/kg) treatment. Mice were intracerebroventricularly administrated with lentivirus at 72 h before TBI establishment. The cortex was obtained at 72 h after TBI and used for WB and q-PCR. Results Au enhanced the translocation of Nrf2 into the nucleus, activated antioxidant enzymes, suppressed excessive generation of reactive oxygen species (ROS), and reduced cell apoptosis both in vitro and vivo experiments. In the mice model of TBI, Au markedly attenuated brain edema, histological damages, and improved neurological and cognitive deficits. Au significantly suppressed high mobility group box 1 (HMGB1)-mediated aseptic inflammation. Nrf2 knockdown in TBI mice blunted the antioxidant and anti-inflammatory neuroprotective effects of the Au. Conclusions Taken together, our data suggest that Au provides a neuroprotective effect in TBI mice model by inhibiting oxidative stress and inflammatory responses; the mechanisms involve triggering Nrf2-induced antioxidant system.	[Wang, Han; Wu, Ling-Yun; Liu, Guang-Jie; Zhang, Xiang-Sheng; Gao, Yong-Yue; Tao, Tao; Zhou, Yan; Lu, Yue; Wang, Juan; Zhuang, Zong; Hang, Chun-Hua; Li, Wei] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Neurosurg,Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing 210008, Peoples R China; [Wang, Han; Zhou, Xiao-Ming; Xu, Wei-Dong; Deng, Chu-Lei] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Peoples R China		Hang, CH; Li, W (corresponding author), Nanjing Univ, Sch Med, Affiliated Hosp, Dept Neurosurg,Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing 210008, Peoples R China.	hang_neurosurgery@163.com; lwxzlw@126.com	Li, Wei/ABE-4301-2021	Chulei, Deng/0000-0002-8445-7408	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81870922, 81801166, 81771291, 81901203, 81971127]; China Scholarship Fund [201606190196]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [021414380361]; Medical Science and Technology Development Foundation, Nanjing Department of Health [JQX18001]	This work was funded by National Natural Science Foundation of China (NSFC) (No.81870922, No.81801166, No.81771291, No.81901203, No.81971127), the China Scholarship Fund (No. 201606190196), the Fundamental Research Funds for the Central Universities (No.021414380361), and Medical Science and Technology Development Foundation, Nanjing Department of Health (No.JQX18001).	Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Chen SY, 2019, NEUROCHEM RES, V44, P472, DOI 10.1007/s11064-018-2700-y; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Eastman CL, 2019, NEUROPHARMACOLOGY; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kragel PA, 2018, NAT NEUROSCI, V21, P283, DOI 10.1038/s41593-017-0051-7; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00153; Lu CF, 2017, TOXICOL SCI, V155, P432, DOI 10.1093/toxsci/kfw228; Lu Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1118-4; Lv HM, 2017, FREE RADICAL BIO MED, V106, P38, DOI 10.1016/j.freeradbiomed.2017.02.016; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Paudel YN, 2018, FRONT NEUROSCI, P12; Qiu YL, 2018, BIOMED PHARMACOTHER, V106, P192, DOI 10.1016/j.biopha.2018.05.070; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Shen BY, 2019, J CELL MOL MED, V23, P4063, DOI 10.1111/jcmm.14293; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singhal A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.362; Sivandzade F, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.11.017; Wang H, 2020, J SURG RES, V245, P321, DOI 10.1016/j.jss.2019.07.082; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Xue HY, 2012, MOL BIOL REP, V39, P9311, DOI 10.1007/s11033-012-1730-9; Xue HY, 2011, MOL BIOL REP, V38, P3561, DOI 10.1007/s11033-010-0466-7; Xue HY, 2012, PHYTOTHER RES, V26, P369, DOI 10.1002/ptr.3562; Xue HY, 2009, PHYTOTHER RES, V23, P980, DOI 10.1002/ptr.2734; Xue HY, 2008, SCI CHINA SER C, V51, P495, DOI 10.1007/s11427-008-0069-x; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.140; Zeng J, 2017, J NEUROINFLAMM, P14; Zeng XC, 2020, FITOTERAPIA, V140, DOI 10.1016/j.fitote.2019.104443; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhang XS, 2018, FREE RADICAL BIO MED, V124, P504, DOI 10.1016/j.freeradbiomed.2018.06.035; Zhao BL, 2005, MOL NEUROBIOL, V31, P283, DOI 10.1385/MN:31:1-3:283; Zhua YL, 2018, NEUROREPORT, V29, P1075, DOI 10.1097/WNR.0000000000001075	42	14	16	4	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUN 15	2020	17	1							188	10.1186/s12974-020-01863-9			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	MB5HJ	WOS:000542633300002	32539839	gold, Green Submitted, Green Published			2022-02-06	
J	Aslan, A; Gok, O; Beyaz, S; Arslan, E; Erman, O; Agca, CA				Aslan, Abdullah; Gok, Ozlem; Beyaz, Seda; Arslan, Emre; Erman, Orhan; Agca, Can Ali			The preventive effect of ellagic acid on brain damage in rats via regulating of Nrf-2, NF-kB and apoptotic pathway	JOURNAL OF FOOD BIOCHEMISTRY			English	Article						brain damage; carbon tetrachloride; COX-2; ellagic acid; Nrf-2; VEGF	INDUCED LIVER-DAMAGE; INDUCED LUNG DAMAGE; CARBON-TETRACHLORIDE; OXIDATIVE STRESS; MILK-THISTLE; INFLAMMATION; SUPPRESSION; INHIBITION; PROTEINS; IMPEDES	The aim of this study was to investigate the neuroprotective role of ellagic acid (EA) on CCl4-induced brain injury in rats. In this study, the rats were divided into four groups. Groups: (1) Control group; (2) EA group; (3) CCl4 group; (4) EA + CCl4 group. In brain tissue, tumor necrosis factor-alpha (TNF-alpha), nuclear factor kappa b (NF-kB), cyclooxygenase-2 (COX-2), nuclear erythroid related factor 2 (Nrf-2), cysteine-aspartic acid protease (caspase-3), VEGF (vascular endothelial growth factor) and B-cell lymphoma-2 (bcl-2) protein expression levels were analyzed by western blotting. MDA (malondialdehyde), catalase enzyme activity (CAT) and glutathione (GSH) analysis were determined by spectrophotometer. In our findings, EA ameliorated Nrf-2 and caspase-3 protein expression levels, GSH and catalase activities, NF-kB, TNF-alpha, VEGF, Bcl-2, COX-2 protein expression levels and MDA levels in CCl4 intoxicated rats. These results suggest that EA demonstrated the neuroprotective effect on CCl4-induced brain damage in rats. Practical applications Ellagic acid has different biological activities, these are; antioxidant, anti-inflammatory, antidepressant, antifibrosis, anticancer, neuroprotective and hepatoprotective. For example it was reported that EA protects the cells against DNA injury induced by free radicals and it can prevent the traumatic brain injury. These results obtained from this study reveals that EA has a protective effect against rat brain damage and it may be used as an alternative drugs for the brain injury treatment in future.	[Aslan, Abdullah] Firat Univ, Fac Sci, Dept Biol, Mol Biol & Genet Program, Elazig, Turkey; [Gok, Ozlem; Beyaz, Seda; Arslan, Emre; Erman, Orhan] Firat Univ, Fac Sci, Dept Biol, Elazig, Turkey; [Agca, Can Ali] Univ Bingol, Fac Sci, Dept Mol Biol & Genet, Bingol, Turkey		Aslan, A (corresponding author), Firat Univ, Fac Sci, Dept Biol, Mol Biol & Genet Program, Elazig, Turkey.	aaslan@firat.edu.tr	BEYAZ, SEDA/ABI-5835-2020; Aslan, Abdullah/C-9523-2016	Aslan, Abdullah/0000-0002-6243-4221; Beyaz, Seda/0000-0003-0436-8112			Aslan A., 2011, THESIS; Aslan A, 2018, BIOMED PHARMACOTHER, V105, P662, DOI 10.1016/j.biopha.2018.06.020; Aslan A, 2018, PROG NUTR, V20, P128, DOI 10.23751/pn.v20i1.6581; Aslan A, 2016, PROG NUTR, V18, P146; Aslan A, 2016, PROG NUTR, V18, P56; Aslan A, 2015, BANGL J PHARMACOL, V10, P654, DOI 10.3329/bjp.v10i3.23486; Aslan A, 2015, PROG NUTR, V17, P36; Aslan A, 2014, LIFE SCI, V117, P13, DOI 10.1016/j.lfs.2014.09.005; Avc D. E., 2008, GAZI U J GAZI ED FAC, V28, P1; Baluchnejadmojarad T, 2017, BRAIN RES, V1662, P23, DOI 10.1016/j.brainres.2017.02.021; Bari SMI, 2019, BIOSENS BIOELECTRON, V126, P82, DOI 10.1016/j.bios.2018.10.028; Basak P, 2017, TOXICOL REP, V4, P306, DOI 10.1016/j.toxrep.2017.06.002; Carloni M, 2013, BRAIN RES, V1515, P19, DOI 10.1016/j.brainres.2013.03.048; Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0; Dhingra D, 2014, J FUNCT FOODS, V10, P364, DOI 10.1016/j.jff.2014.07.011; Ding Y, 2015, EUR J PHARMACOL, V761, P405, DOI 10.1016/j.ejphar.2015.05.005; Ding Y, 2017, EXP THER MED, V14, P3375, DOI 10.3892/etm.2017.4966; Firdaus F, 2018, TOXICOL REP, V5, P411, DOI 10.1016/j.toxrep.2018.02.017; Ginsberg Y., 2018, AM J OBSTET GYNECOL, V113, P1; Goudarzi M, 2018, LIFE SCI, V198, P38, DOI 10.1016/j.lfs.2018.02.022; Grossi MR, 2014, TOXICOL LETT, V224, P240, DOI 10.1016/j.toxlet.2013.10.012; Gu L, 2014, INT IMMUNOPHARMACOL, V22, P341, DOI 10.1016/j.intimp.2014.07.005; Han W, 2017, EPILEPSY BEHAV, V68, P159, DOI 10.1016/j.yebeh.2016.12.007; Hines T., 2018, CMI; Hu SK, 2019, BIOCHEM BIOPH RES CO, V509, P585, DOI 10.1016/j.bbrc.2018.12.168; Huang Q, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12996; Ismail AFM, 2016, J PHOTOCH PHOTOBIO B, V161, P91, DOI 10.1016/j.jphotobiol.2016.04.031; Ismail AFM, 2015, J PHOTOCH PHOTOBIO B, V153, P317, DOI 10.1016/j.jphotobiol.2015.10.005; Jayakumar T, 2008, CHEM-BIOL INTERACT, V176, P108, DOI 10.1016/j.cbi.2008.08.006; Kaya I, 2012, THESIS; Keles E., 2006, J TURKISH SCINECE ED, V3, P66; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li QL, 2019, INT IMMUNOPHARMACOL, V66, P309, DOI 10.1016/j.intimp.2018.11.044; Mansouri MT, 2016, PHARM BIOL, V54, P1947, DOI 10.3109/13880209.2015.1137601; Naz K., 2014, BIOMED RES INT, V2014, P1; Nowacka MM, 2012, NEUROPEPTIDES, V46, P1, DOI 10.1016/j.npep.2011.05.005; Ogaly HA, 2015, NEUROTOXICOL TERATOL, V50, P23, DOI 10.1016/j.ntt.2015.05.005; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozsahin AD, 2009, J ANIM VET ADV, V8, P424; Pang QY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7017204; Poulose SM, 2013, J NUTR BIOCHEM, V24, P912, DOI 10.1016/j.jnutbio.2012.06.009; Rahimi VB, 2018, BIOMED PHARMACOTHER, V108, P1712, DOI 10.1016/j.biopha.2018.10.024; Rizk HA, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21977; Segev-Amzaleg N, 2013, BRAIN BEHAV IMMUN, V30, P176, DOI 10.1016/j.bbi.2012.12.016; Shendge AK, 2018, BIOMED PHARMACOTHER, V106, P454, DOI 10.1016/j.biopha.2018.06.133; Tekeli H., 2012, THESIS; Tekeli IO, 2019, INFLAMMOPHARMACOLOGY, V27, P313, DOI 10.1007/s10787-018-0485-x; Uchida K, 2017, FREE RADICAL BIO MED, V111, P169, DOI 10.1016/j.freeradbiomed.2017.02.004; Wang D. L., 2016, TRANSPORT RES, V2, P31; Wang Q, 2018, INT J DEV NEUROSCI, V71, P175, DOI 10.1016/j.ijdevneu.2018.09.008; Yigit M., 2015, THESIS; Zhao XL, 2017, NEUROSCIENCE, V346, P226, DOI 10.1016/j.neuroscience.2017.01.025	52	14	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-8884	1745-4514		J FOOD BIOCHEM	J. Food Biochem.	JUN	2020	44	6							e13217	10.1111/jfbc.13217			9	Biochemistry & Molecular Biology; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Food Science & Technology	LZ3MS	WOS:000541133100032	32250487				2022-02-06	
J	Sun, ZZ; Nyanzu, M; Yang, S; Zhu, XH; Wang, KK; Ru, JN; Yu, EX; Zhang, HL; Wang, ZZ; Shen, J; Zhuge, QC; Huang, LJ				Sun, Zhezhe; Nyanzu, Mark; Yang, Su; Zhu, Xiaohong; Wang, Kankai; Ru, Junnan; Yu, Enxing; Zhang, Hengli; Wang, Zhenzhong; Shen, Jie; Zhuge, Qichuan; Huang, Lijie			VX765 Attenuates Pyroptosis and HMGB1/TLR4/NF-kappa B Pathways to Improve Functional Outcomes in TBI Mice	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							TRAUMATIC BRAIN-INJURY; MICROGLIAL INFLAMMASOME ACTIVATION; TLR4/NF-KAPPA-B SIGNALING PATHWAY; SPINAL-CORD-INJURY; CELL-DEATH; NLRP3 INFLAMMASOME; GASDERMIN D; KAPPA-B; MOLECULAR-MECHANISMS; MURINE MODEL	Background. Traumatic brain injury (TBI) refers to temporary or permanent damage to brain function caused by penetrating objects or blunt force trauma. TBI activates inflammasome-mediated pathways and other cell death pathways to remove inactive and damaged cells, however, they are also harmful to the central nervous system. The newly discovered cell death pattern termed pyroptosis has become an area of interest. It mainly relies on caspase-1-mediated pathways, leading to cell death. Methods. Our research focus is VX765, a known caspase-1 inhibitor which may offer neuroprotection after the process of TBI. We established a controlled cortical impact (CCI) mouse model and then controlled the degree of pyroptosis in TBI with VX765. The effects of caspase-1 inhibition on inflammatory response, pyroptosis, blood-brain barrier (BBB), apoptosis, and microglia activation, in addition to neurological deficits, were investigated. Results. We found that TBI led to NOD-like receptors (NLRs) as well as absent in melanoma 2 (AIM2) inflammasome-mediated pyroptosis in the damaged cerebral cortex. VX765 curbed the expressions of indispensable inflammatory subunits (caspase-1 as well as key downstream proinflammatory cytokines such as interleukin- (IL-) 1 beta and IL-18). It also inhibited gasdermin D (GSDMD) cleavage and apoptosis-associated spot-like protein (ASC) oligomerization in the injured cortex. In addition to the above, VX765 also inhibited the inflammatory activity of the high-mobility cassette -1/Toll-like receptor 4/nuclear factor-kappa B (HMGB1/TLR4/NF-kappa B) pathway. By inhibiting pyroptosis and inflammatory mediator expression, we demonstrated that VX765 can decrease blood-brain barrier (BBB) leakage, apoptosis, and microglia polarization to exhibit its neuroprotective effects. Conclusion. In conclusion, VX765 can counteract neurological damage after TBI by reducing pyroptosis and HMGB1/TLR4/NF-kappa B pathway activities. VX765 may have a good therapeutic effect on TBI.	[Sun, Zhezhe; Nyanzu, Mark; Yang, Su; Zhu, Xiaohong; Wang, Kankai; Ru, Junnan; Yu, Enxing; Zhang, Hengli; Zhuge, Qichuan; Huang, Lijie] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou 325000, Peoples R China; [Sun, Zhezhe; Nyanzu, Mark; Yang, Su; Zhu, Xiaohong; Wang, Kankai; Ru, Junnan; Yu, Enxing; Zhang, Hengli; Zhuge, Qichuan; Huang, Lijie] Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou 325000, Peoples R China; [Wang, Zhenzhong] Yuyao Peoples Hosp, Dept Neurosurg, Ningbo 315000, Peoples R China; [Shen, Jie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Peoples R China		Zhuge, QC; Huang, LJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou 325000, Peoples R China.; Zhuge, QC; Huang, LJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou 325000, Peoples R China.	1138912640@qq.com; pojoba90@yahoo.co.uk; yangsu0575@163.com; xiaohongznick@163.com; neurowkk@163.com; 18814901108@163.com; enxingyu@gmail.com; youkuhaowan@163.com; 491074952@qq.com; 21718136@zju.edu.cn; zhugeqichuan@vip.163.com; lijiehuangwy@163.com	Huang, Lijie/AAD-3489-2022	kankai, wang/0000-0002-0800-2604	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771262, 81820108011]; Zhejiang Health Science and Technology Project [2016RCA022]; Ningbo Natural Science Foundation [2018A610310]	The work was supported by the National Natural Science Foundation of China (81771262 and 81820108011), the Zhejiang Health Science and Technology Project (2016RCA022), and the Ningbo Natural Science Foundation (2018A610310).	Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Aglietti RA, 2017, TRENDS IMMUNOL, V38, P261, DOI 10.1016/j.it.2017.01.003; Alfonso-Loeches S, 2016, NEUROCHEM RES, V41, P193, DOI 10.1007/s11064-015-1760-5; Awad F, 2018, PHARMACOL THERAPEUT, V187, P133, DOI 10.1016/j.pharmthera.2018.02.011; Bi YH, 2017, CELL PHYSIOL BIOCHEM, V43, P481, DOI 10.1159/000480474; Bilginoglu A, 2019, J CHIN MED ASSOC, V82, P452, DOI 10.1097/JCMA.0000000000000103; Chang W, 2013, MED HYPOTHESES, V81, P484, DOI 10.1016/j.mehy.2013.06.016; Cheng R, 2018, BBA-MOL BASIS DIS, V1864, P226, DOI 10.1016/j.bbadis.2017.10.025; Cheng YJ, 2017, METAB BRAIN DIS, V32, P1133, DOI 10.1007/s11011-017-0003-7; Chi W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0360-2; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; DiPeso L, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.70; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feng Y, 2017, NEUROCHEM RES, V42, P3296, DOI 10.1007/s11064-017-2372-z; Feng Y, 2016, INT J MOL MED, V37, P921, DOI 10.3892/ijmm.2016.2495; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fu SN, 2019, PSYCHOPHARMACOLOGY, V236, P2173, DOI 10.1007/s00213-019-05210-6; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Garcia JA, 2015, FASEB J, V29, P3863, DOI 10.1096/fj.15-273656; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Ishrat T, 2015, MOL NEUROBIOL, V51, P766, DOI 10.1007/s12035-014-8766-x; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Lee SW, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1423-6; Li F, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0931-8; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Liu ZJ, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12414; Lugrin J, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2292; Ma B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00378; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; McKenzie BA, 2018, P NATL ACAD SCI USA, V115, pE6065, DOI 10.1073/pnas.1722041115; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Paudel YN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00628; Qian HH, 2017, MOL MED REP, V16, P3922, DOI 10.3892/mmr.2017.7079; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Shi H, 2019, MOLECULES, V24, DOI 10.3390/molecules24020367; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Sollberger G, 2014, INNATE IMMUN-LONDON, V20, P115, DOI 10.1177/1753425913484374; Tang R, 2018, INT J BIOCHEM CELL B, V99, P64, DOI 10.1016/j.biocel.2018.03.017; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Truettner JS, 2017, J CEREBR BLOOD F MET, V37, P2952, DOI 10.1177/0271678X16680003; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Van Horn JD, 2017, TRENDS NEUROSCI, V40, P39, DOI 10.1016/j.tins.2016.10.007; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/124614; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xing Z, 2015, RNA BIOL, V12, P681, DOI 10.1080/15476286.2015.1053687; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yang J, 2013, SPINE, V38, pE1641, DOI 10.1097/BRS.0000000000000005; Yang L, 2017, METAB BRAIN DIS, V32, P1395, DOI 10.1007/s11011-017-9991-6; Yin R, 2020, J PHARM PHARMACOL, V72, P539, DOI 10.1111/jphp.13233; Zan J, 2018, NEUROREPORT, V29, P794, DOI 10.1097/WNR.0000000000001033; Zhang LM, 2019, J LEUKOCYTE BIOL, V105, P783, DOI 10.1002/JLB.4A1018-381R; Zhang Y, 2016, CLIN EXP RHEUMATOL, V34, P111; ZHANG Y, 2015, INT J NEUROPSYCHOPH, V18, DOI DOI 10.1093/IJNP/PYV025; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001	72	14	15	1	8	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.	APR 15	2020	2020								7879629	10.1155/2020/7879629			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	LJ7BB	WOS:000530315100002	32377306	Green Published, gold			2022-02-06	
J	Jiao, JH; Zhao, GJ; Wang, Y; Ren, PF; Wu, MF				Jiao, Jianhang; Zhao, Guanjie; Wang, Yang; Ren, Pengfei; Wu, Minfei			MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury	FRONTIERS IN MOLECULAR BIOSCIENCES			English	Article						spinal cord injury; MCC950; NLRP3; functional recovery; inflammatory response	TRAUMATIC BRAIN-INJURY; PROTEIN-3 INFLAMMASOME; ACTIVATION; RECOVERY; PAIN	Spinal cord injury (SCI) is a serious condition that affects bodily function; however, there is no effective therapy in clinical practice. MCC950, a selective NOD-like receptor protein-3 (NLRP3) inflammasome inhibitor, has been reported to alleviate canonical and non-canonical NLRP3 inflammasome activation of the inflammatory response in vitro and in vivo. However, the effect of MCC950 treatment on neurological post-SCI recovery remains unclear. In this study, we assessed the pharmacological effect of MCC950 on an experimental SCI model in vivo and neuronal injury in vitro. We found that MCC950 improved the grip strength, hind limb movements, spinal cord edema, and pathological injury in the SCI mice. We demonstrated that it exerted this effect by blocking NLRP3 inflammasome assembly, including NLRP3-ASC and NLRP3-Caspase-1 complexes, as well as the release of pro-inflammatory cytokines TNF-alpha, IL-1 beta, and IL-18. Moreover, we found that MCC950 reduced spinal neuron injury and NLRP3 inflammasome activation, which had been induced by oxygen-glucose deprivation (OGD) or lipopolysaccharides (LPS) in vitro. In conclusion, our findings indicate that MCC950 alleviates inflammatory response and improves functional recovery in the acute mice model of SCI by blocking NLRP3 inflammasome assembly and alleviating downstream neuroinflammation. Therefore, these findings could prove useful in the development of effective therapeutic strategies for the treatment and prognosis of SCI.	[Jiao, Jianhang; Wang, Yang; Ren, Pengfei; Wu, Minfei] Second Hosp Jilin Univ, Dept Orthoped, Changchun, Peoples R China; [Zhao, Guanjie] Jilin Univ, Dept Kidney Med, China Japan Union Hosp, Changchun, Peoples R China		Wu, MF (corresponding author), Second Hosp Jilin Univ, Dept Orthoped, Changchun, Peoples R China.	andylue2046@163.com			Science and Technology Development Plan Project of Jilin Province [20180520128JH]; Specific Talent Project for Medical and Health of Jilin Province [2019SCZT031]	This work was supported by the Science and Technology Development Plan Project of Jilin Province (No. 20180520128JH) and the Specific Talent Project for Medical and Health of Jilin Province (2019SCZT031).	Alegre F, 2017, SEMIN LIVER DIS, V37, P119, DOI 10.1055/s-0037-1601350; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Chen T, 2011, NEUROSCIENCE, V183, P203, DOI 10.1016/j.neuroscience.2011.03.038; Chen YH, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00202; Chen YH, 2019, BRAIN RES, V1710, P163, DOI 10.1016/j.brainres.2019.01.005; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Donovan J, 2018, NEUROTHERAPEUTICS, V15, P654, DOI 10.1007/s13311-018-0632-5; Gong Z, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1282-6; Grace PM, 2016, P NATL ACAD SCI USA, V113, pE3441, DOI 10.1073/pnas.1602070113; Guo M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00086; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hong P, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/9163521; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jiang W, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0980-9; Jiang W, 2016, SPINE, V41, pE330, DOI 10.1097/BRS.0000000000001287; Kudo Y, 2006, CRIT CARE MED, V34, P2820, DOI 10.1097/01.CCM.0000242522.48734.64; Kumar R, 2018, WORLD NEUROSURG, V113, pE345, DOI 10.1016/j.wneu.2018.02.033; Li YL, 2019, NEUROCHEM RES, V44, P2007, DOI 10.1007/s11064-019-02838-w; Lin WP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0521-y; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lv RX, 2019, LIFE SCI, V217, P119, DOI 10.1016/j.lfs.2018.11.053; Meng QQ, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/6386729; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Mouton-Liger F, 2018, GLIA, V66, P1736, DOI 10.1002/glia.23337; Perera AP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26775-w; Pollari E, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-74; Putatunda R, 2018, CHIN J TRAUMATOL, V21, P125, DOI 10.1016/j.cjtee.2018.02.002; Qi YJ, 2018, NEUROBIOL DIS, V114, P24, DOI 10.1016/j.nbd.2018.02.016; Qian J, 2017, BRIT J PHARMACOL, V174, P1961, DOI 10.1111/bph.13788; Quadri SA, 2020, NEUROSURG REV, V43, P425, DOI 10.1007/s10143-018-1008-3; Ren HL, 2018, STROKE, V49, P184, DOI 10.1161/STROKEAHA.117.018904; Rovira-Llopis S, 2018, ANTIOXID REDOX SIGN, V29, P749, DOI 10.1089/ars.2017.7313; Shen HH, 2018, AUTOIMMUN REV, V17, P694, DOI 10.1016/j.autrev.2018.01.020; Song LM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00063; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Wang CY, 2019, ANTIOXID REDOX SIGN, V30, P1411, DOI 10.1089/ars.2017.7440; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang L, 2018, CELL PHYSIOL BIOCHEM, V51, P1921, DOI 10.1159/000495717; Ye XC, 2017, BIOCHEM BIOPH RES CO, V485, P499, DOI 10.1016/j.bbrc.2017.02.019; Yerramothu P, 2018, EYE, V32, P491, DOI 10.1038/eye.2017.241; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5; Zhang T, 2019, SPINAL CORD, V57, P141, DOI 10.1038/s41393-018-0180-1; Zhang Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.308; Zhou KR, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9238290; Zhu YL, 2017, EXP THER MED, V14, P3304, DOI 10.3892/etm.2017.4904	48	14	14	8	16	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-889X		FRONT MOL BIOSCI	Front. Mol. Biosci.	MAR 3	2020	7								37	10.3389/fmolb.2020.00037			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LC2FG	WOS:000525142400001	32195267	Green Published, gold			2022-02-06	
J	Howell, DR; O'Brien, MJ; Fraser, J; Meehan, WP				Howell, David R.; O'Brien, Michael J.; Fraser, Joana; Meehan, William P., III			Continuing Play, Symptom Severity, and Symptom Duration After Concussion in Youth Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; symptom; mild traumatic brain injury; recovery	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; TEMPORAL WINDOW; RECOVERY; AGE; VULNERABILITY; ADOLESCENTS; MANAGEMENT; BALANCE	Objective: To determine whether continuing to play after a concussion is associated with higher symptom burden or prolonged symptom duration. Design: Patients who presented for care at a sport concussion clinic within the first 3 weeks of injury were asked whether they continued to play immediately after their injury. Setting: Sport concussion clinic within a regional tertiary care hospital. Main Outcome Measures: Clinical outcomes including symptom severity, symptom duration, age, time from injury-clinical presentation, sex, sport type, previous concussion history, and whether or not they experienced loss of consciousness or amnesia at the time of injury were recorded. Univariable comparisons between those who did and did not report continuing play were conducted. Multivariable linear regression models were constructed to identify the independent association of continuing to play postinjury with symptom burden and symptom recovery time, while controlling for the effect of potential confounding variables. Results: A total of 516 patients were included in the study, assessed a mean of 12.1 +/- 5.2 days postinjury (35% female, mean age = 14.5 +/- 2.3 years). A total of 227 (44%) continued play after sustaining a concussion. Continuing to play postconcussion was independently associated with higher symptom severity during the initial clinical evaluation [beta-coefficient = 6.144, 95% confidence interval (CI), 1.357-10.93], but not with symptom duration evaluation (beta-coefficient = 1.794, 95% CI, -15.66 to 19.25). Conclusion: Those who continued to play postconcussion presented with more severe symptoms after injury. Recognition of suspected concussion and removal from play on diagnosis confirmation may lead to better initial clinical outcomes after concussion among child and adolescent athletes.	[Howell, David R.; O'Brien, Michael J.; Fraser, Joana; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.; O'Brien, Michael J.; Fraser, Joana; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Dept Orthopaed, Boston, MA USA; [Howell, David R.; O'Brien, Michael J.; Meehan, William P., III] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Howell, David R.] Childrens Hosp Colorado, Ctr Sports Med, 13123 East 16th Ave, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [O'Brien, Michael J.; Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Ctr Sports Med, 13123 East 16th Ave, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu			Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; ElMindA Ltd.; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; Football Players Health Study at Harvard University; NFL Players Association	D. R. Howell's research is funded, in part, through a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd. W. P. Meehan receives royalties from (1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A guide for coaches and parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in Young Athlete, and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and by a grant from the Football Players Health Study at Harvard University, which is funded by the NFL Players Association. M. J. O'Brien receives royalties from Wolters Kluwer for working as an author for UpToDate and from Springer International publishing for the book, Head and Neck Injuries in Young Athletes. The remaining author reports no conflicts of interest.	Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Register-Mihalik JK, 2015, CLIN J SPORT MED, V25, P502, DOI 10.1097/JSM.0000000000000161; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74	31	14	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2020	30			1			S42	S46		10.1097/JSM.0000000000000570			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NQ6DX	WOS:000570961700005	32132476				2022-02-06	
J	Ritzel, RM; Li, Y; He, JY; Khan, N; Doran, SJ; Faden, AI; Wu, JF				Ritzel, Rodney M.; Li, Yun; He, Junyun; Khan, Niaz; Doran, Sarah J.; Faden, Alan, I; Wu, Junfang			Sustained neuronal and microglial alterations are associated with diverse neurobehavioral dysfunction long after experimental brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Chronic traumatic brain injury; Neurodegeneration; Neuroinflammation; Cognition; Depression; Microglia	UNITED-STATES; FACS; PREVALENCE; BEHAVIOR; ATROPHY; ANXIETY; STRESS; SINGLE; TASKS; YOUNG	Traumatic brain injury (TBI) can cause progressive neurodegeneration, sustained neuroinflammation and chronic neurological dysfunction. Few experimental studies have explored the long-term neurobehavioral and functional cellular changes beyond several months. The present study examined the effects of a single moderate-level TBI on functional outcome 8 months after injury. Male C57BL/6 mice were subjected to controlled cortical impact injury and followed for changes in motor performance, learning and memory, as well as depressive-like and social behavior. We also used a novel flow cytometry approach to assess cellular functions in freshly isolated neurons and microglia from the injured tissue. There were marked and diverse, sustained neurobehavioral changes in injured mice. Compared to sham controls, chronic TBI mice showed long-term deficits in gait dynamics, nest building, spatial working memory and recognition memory. The tail suspension, forced swim, and sucrose consumption tests showed a marked depressive-like phenotype that was associated with impaired sociability. At the cellular level, there were lower numbers of Thy1 (+) Tuj1 (+) neurons and higher numbers of activated CD45(lo)CD11b (+) microglia. Functionally, both neurons and microglia exhibited significantly higher levels of oxidative stress after injury. Microglia exhibited chronic deficits in phagocytosis of E. coin bacteria, and increased uptake of myelin and dying neurons. Living neurons showed decreased expression of synaptophysin and postsynaptic density (PSD)-95, along with greater numbers of microtubule-associated protein light chain 3 (LC3)-positive autophagosomes and increased mitochondrial mass that suggest dysregulation of autophagy. In summary, the late neurobehavioral changes found after murine TBI are similar to those found chronically after moderate-severe human head injury. Importantly, such changes are associated with microglial dysfunction and changes in neuronal activity.	[Ritzel, Rodney M.; Li, Yun; He, Junyun; Khan, Niaz; Doran, Sarah J.; Faden, Alan, I; Wu, Junfang] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Ritzel, Rodney M.; Li, Yun; He, Junyun; Khan, Niaz; Doran, Sarah J.; Faden, Alan, I; Wu, Junfang] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Faden, Alan, I; Wu, Junfang] Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA		Wu, JF (corresponding author), 685 W Baltimore St, Baltimore, MD 21201 USA.	junfang.wu@som.umaryland.edu		Li, Yun/0000-0003-2040-4451; Ritzel, Rodney/0000-0002-0160-2930	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ROl NS094527, ROl NS110635, ROl NS110567, F32 NS105355]; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [2R01 NR013601]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1 NS110637]	We thank Dr. Bogdan Stoica for generously providing us with the SLICK-A mice. We thank Ms. Lulu Liu for expert technical support. This study was supported by the National Institute of Neurological Disorders and Stroke for ROl NS094527 (JW), ROl NS110635 (JW/AIF), ROl NS110567 (JW), F32 NS105355 (RMR), the National Institute of Nursing Research for 2R01 NR013601 (JW/AIF), and the National Institute on Aging for RF1 NS110637 (JW).	Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Benoit A, 2018, J NEUROSCI METH, V304, P11, DOI 10.1016/j.jneumeth.2018.04.005; Berl S, 2017, J NEUROSCI METH, V283, P15, DOI 10.1016/j.jneumeth.2017.03.015; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Boone DR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214741; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Collins CE, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.005.2010; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Ferguson S, 2017, J NEUROTRAUM, V34, P1676, DOI 10.1089/neu.2016.4636; Galloway DA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00790; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Henstridge CM, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00063; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Legroux L, 2015, J NEUROSCI METH, V247, P23, DOI 10.1016/j.jneumeth.2015.03.021; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Martin D, 2017, ACS CHEM NEUROSCI, V8, P356, DOI 10.1021/acschemneuro.6b00374; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matyas JJ, 2017, J NEUROSCI, V37, P3956, DOI 10.1523/JNEUROSCI.3353-16.2017; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Pape K, 2019, NAT REV NEUROL, V15, P317, DOI 10.1038/s41582-019-0174-4; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Popescu C, 2015, J Med Life, V8, P272; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Rajendran L, 2018, J NEUROSCI, V38, P2911, DOI 10.1523/JNEUROSCI.1136-17.2017; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Ritzel RM, 2015, NEUROBIOL AGING, V36, P2153, DOI 10.1016/j.neurobiolaging.2015.02.016; Rubenstein R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00124; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Sergent-Tanguy S, 2003, J NEUROSCI METH, V129, P73, DOI 10.1016/S0165-0270(03)00210-3; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Soto I, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002279; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wojnarowicz MW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00240; Wu J., 2019, CELLS, V8; Wu JF, 2016, J NEUROTRAUM, V33, P1919, DOI 10.1089/neu.2015.4348; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamasaki T, 2018, J VIROL, V92, DOI 10.1128/JVI.01457-17; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	65	14	14	1	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	MAR	2020	136								104713	10.1016/j.nbd.2019.104713			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KQ1AI	WOS:000516662200003	31843705	Green Accepted, hybrid			2022-02-06	
J	Laksari, K; Fanton, M; Wu, LC; Nguyen, TH; Kurt, M; Giordano, C; Kelly, E; O'Keeffe, E; Wallace, E; Doherty, C; Campbell, M; Tiernan, S; Grant, G; Ruan, J; Barbat, S; Camarillo, DB				Laksari, Kaveh; Fanton, Michael; Wu, Lyndia C.; Nguyen, Taylor H.; Kurt, Mehmet; Giordano, Chiara; Kelly, Eoin; O'Keeffe, Eoin; Wallace, Eugene; Doherty, Colin; Campbell, Matthew; Tiernan, Stephen; Grant, Gerald; Ruan, Jesse; Barbat, Saeed; Camarillo, David B.			Multi-Directional Dynamic Model For Traumatic Brain Injury Detection	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; concussion; injury criterion; injury prediction	DIFFUSE AXONAL INJURY; CEREBRAL CONCUSSION; HEAD IMPACT; ENCEPHALOPATHY; DISPLACEMENT; DEFORMATION; PREDICTORS; CURVES; TISSUE	Given the worldwide adverse impact of traumatic brain injury (TBI) on the human population, its diagnosis and prediction are of utmost importance. Historically, many studies have focused on associating head kinematics to brain injury risk. Recently, there has been a push toward using computationally expensive finite element (FE) models of the brain to create tissue deformation metrics of brain injury. Here, we develop a new brain injury metric, the brain angle metric (BAM), based on the dynamics of a 3 degree-of-freedom lumped parameter brain model. The brain model is built based on the measured natural frequencies of an FE brain model simulated with live human impact data. We show that it can be used to rapidly estimate peak brain strains experienced during head rotational accelerations that cause mild TBI. In our data set, the simplified model correlates with peak principal FE strain (R-2 = 0.82). Further, coronal and axial brain model displacement correlated with fiber-oriented peak strain in the corpus callosum (R-2 = 0.77). Our proposed injury metric BAM uses the maximum angle predicted by our brain model and is compared against a number of existing rotational and translational kinematic injury metrics on a data set of head kinematics from 27 clinically diagnosed injuries and 887 non-injuries. We found that BAM performed comparably to peak angular acceleration, translational acceleration, and angular velocity in classifying injury and non-injury events. Metrics that separated time traces into their directional components had improved model deviance compare with those that combined components into a single time trace magnitude. Our brain model can be used in future work to rapidly approximate the peak strain resulting from mild to moderate head impacts and to quickly assess brain injury risk.	[Laksari, Kaveh; Camarillo, David B.] Univ Arizona, Dept Biomed Engn, 1230 N Cherry Ave,Biosci Res Labs BSRL Bldg, Tucson, AZ 85719 USA; [Laksari, Kaveh; Wu, Lyndia C.; Nguyen, Taylor H.; Kurt, Mehmet; Giordano, Chiara; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Fanton, Michael] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Wu, Lyndia C.] Univ British Columbia, Dept Mech Engn, Vancouver, BC, Canada; [Kurt, Mehmet] Stevens Inst Technol, Dept Mech Engn, Hoboken, NJ 07030 USA; [Kelly, Eoin; Wallace, Eugene; Doherty, Colin] St James Hosp, Hosp 5, Hlth Care Ctr, Dept Neurol, Dublin, Ireland; [O'Keeffe, Eoin; Campbell, Matthew] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Tiernan, Stephen] Technol Univ Dublin, Dept Mech Engn, Dublin, Ireland; [Grant, Gerald] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA; [Ruan, Jesse; Barbat, Saeed] Ford Motor Co, Dearborn, MI 48121 USA		Laksari, K (corresponding author), Univ Arizona, Dept Biomed Engn, 1230 N Cherry Ave,Biosci Res Labs BSRL Bldg, Tucson, AZ 85719 USA.	klaksari@email.arizona.edu	Wu, Lyndia/AAQ-1106-2020; Kurt, Mehmet/AAX-3303-2021	Wu, Lyndia/0000-0002-8236-032X; Nguyen, Taylor/0000-0002-1288-8882; Kurt, Mehmet/0000-0002-5618-0296; Doherty, Colin/0000-0002-8869-8567	Child Health Research Institute; Lucile Packard Foundation for Children's Health; Stanford Clinical and Translational Science Award Program (CTSA) [UL1 TR001085]; National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [3R21EB01761101S1]; David and Lucile Packard FoundationThe David & Lucile Packard Foundation [38454]; Child Health Research Institute - Transdisciplinary Initiatives Program, National Science Foundation (NSF) Graduate Research Fellowship ProgramNational Science Foundation (NSF); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 TR000093]; Ford Motor Company through the Ford-Stanford research alliance	This study was supported by the Child Health Research Institute, Lucile Packard Foundation for Children's Health, and Stanford Clinical and Translational Science Award Program (CTSA) (UL1 TR001085). The study was also partially supported by the National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) 3R21EB01761101S1; the David and Lucile Packard Foundation 38454; Child Health Research Institute - Transdisciplinary Initiatives Program, National Science Foundation (NSF) Graduate Research Fellowship Program, and NIH UL1 TR000093 for biostatistics consultation. We thank the Ford Motor Company for supporting this study through the Ford-Stanford research alliance.	Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bland M., 2018, BICYCLE HELMET STAR; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Ewing C., 1976, 760800 SAE; Ewing C., 1978, 780888 SAE, V780888, P3151; Ewing C.L., 1975, EFFECT INITIAL POSIT; Fanton M., 2018, IEEE T BIOMED ENG, V9294, P1; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; Garrick JG, 2005, CLIN J SPORT MED, V15, P385, DOI 10.1097/01.jsm.0000181438.48892.1b; Gennarelli T.A., 1987, SAE T, V96, P1355; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Gennarelli TA, 2014, PROG NEUROL SURG, V28, P243, DOI 10.1159/000358788; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C., 2014, 2014220002 SAE; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hernandez F, 2019, J NEUROTRAUM, V36, P1125, DOI 10.1089/neu.2016.4758; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hirsch A.E., 1968, TOLERANCE SUBHUMAN P; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; KING G, 2001, POLITICAL ANAL, V0009; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KORNHAUSER, 1961, AEROSPACE MED, V32, P412; KORNHAUSER M, 1954, J APPL MECH-T ASME, V21, P371; Laksari K, 2014, J MECH BEHAV BIOMED, V32, P132, DOI 10.1016/j.jmbbm.2013.12.021; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Laksari K, 2015, BIOMECH MODEL MECHAN, V14, P459, DOI 10.1007/s10237-014-0616-2; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Low T, 1987, INT RES COUNCIL BIOK, V15, P203; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NEWMAN JA, 2000, STAPP CAR CRASH J, V44, P362; NOCSAE, 2012, STAND PERF SPEC NEWL; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Ommaya A.K., 1968, JAMA-J AM MED ASSOC, V204, P75; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PELLMAN EJ, 2003, NEUROSURGERY, V53, P796; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Rowson, 2018, VARSITY FOOTBALL HEL; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; STALNAKER RL, 1971, J BIOMECH, V4, P127, DOI 10.1016/0021-9290(71)90023-6; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; TAKHOUNTS E, 2013, STAPP CAR CRASH J, V57, P1; Takhounts EG, 2008, STAPP CAR C, V52, P1; Weisstein E.W., 2004, BONFERRONI CORRECTIO; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wu L., SCI REP, V8, P1; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zou H, 2007, INT J CRASHWORTHINES, V12, P341, DOI 10.1080/13588260701433024; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	64	14	14	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2020	37	7					982	993		10.1089/neu.2018.6340		FEB 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LB3HP	WOS:000511476000001	31856650	Green Submitted, Green Published			2022-02-06	
J	Alali, AS; Temkin, N; Vavilala, MS; Lele, AV; Barber, J; Dikmen, S; Chesnut, RM				Alali, Aziz S.; Temkin, Nancy; Vavilala, Monica S.; Lele, Abhijit, V; Barber, Jason; Dikmen, Sureyya; Chesnut, Randall M.			Matching early arterial oxygenation to long-term outcome in severe traumatic brain injury: target values	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; oxygen; hyperoxia; hypoxia; resuscitation	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; METABOLISM; TRIAL; HYPOTENSION; DYSFUNCTION; CITICOLINE; HYPOXIA	OBJECTIVE The aim of this study was to examine the relationship between early arterial oxygenation thresholds and long-term outcome after severe traumatic brain injury (TBI). METHODS In a post hoc analysis of a randomized trial, adults with severe TBI were classified based on exposure to different levels of arterial oxygenation as measured using the average of arterial partial pressure of oxygen (PaO2) values obtained within 24 hours of admission. Potentially important PaO2 thresholds were defined a priori. The primary outcome was Glasgow Outcome Scale-Extended (GOSE) score at 6 months. Secondary outcomes were cognitive outcomes measured using a battery of 9 neuropsychological tests administered at 6 months, and 6-month mortality. RESULTS In adjusted analyses, oxygenation thresholds of 150 and 200 mm Hg were associated with better functional outcome at 6 months (adjusted OR for better functional outcome on GOSE 1.82 [95% CI 1.12-2.94] and 1.59 [95% CI 1.06-2.37], respectively) and improved cognitive outcome at 6 months (adjusted beta coefficients for better cognitive percentile across 9 neuropsychological tests: 6.9 [95% CI 1.3-12.5] and 6.8 [95% CI 2.4-11.3], respectively). There was no significant association between oxygenation level and 6-month mortality except at a PaO2 threshold of 200 mm Hg (OR for death 0.36, 95% CI 0.18-0.71). Higher or lower oxygenation thresholds were not associated with functional or cognitive outcome. CONCLUSIONS In this observational study, the relationship between early arterial oxygenation and long-term functional and cognitive TBI outcomes appears to be U-shaped. Mild levels of hyperoxemia within the first 24 hours after injury were associated with better long-term functional and cognitive outcomes. These findings highlight the importance of examining balanced oxygen supplementation as a potential strategy to improve TBI outcomes in future research.	[Alali, Aziz S.; Temkin, Nancy; Barber, Jason; Dikmen, Sureyya; Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Vavilala, Monica S.; Lele, Abhijit, V] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Alali, AS (corresponding author), Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA.	aalali@uw.edu		Chesnut, Randall/0000-0001-6377-3666			Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Benton A., 1994, CONTRIBUTIONS NEUROP; Benton A, 2008, J NEUROTRAUM, V25, P276; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Delis D.C., 2000, CALIFORNIA VERBAL LE; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; HANSEN JE, 1984, AM REV RESPIR DIS, V129, pS49, DOI 10.1164/arrd.1984.129.2P2.S49; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Reitan RM, 1992, TRAIL MAKING TEST MA; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rousseau A, 2010, J VASC RES, V47, P441, DOI 10.1159/000282667; Secades JJ, 2011, REV NEUROLOGIA, V52, pS1, DOI 10.33588/rn.52S02.2010787; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolfson, 1993, HALSTEAD REITAN NEUR; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	40	14	14	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2020	132	2					537	544		10.3171/2018.10.JNS18964			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KS5YL	WOS:000518384200023	30738409				2022-02-06	
J	Bashir, A; Abebe, ZA; McInnes, KA; Button, EB; Tatarnikov, I; Cheng, WH; Haber, M; Wilkinson, A; Barron, C; Diaz-Arrastia, R; Stukas, S; Cripton, PA; Wellington, CL				Bashir, Asma; Abebe, Zelalem A.; McInnes, Kurt A.; Button, Emily B.; Tatarnikov, Igor; Cheng, Wai Hang; Haber, Margalit; Wilkinson, Anna; Barron, Carlos; Diaz-Arrastia, Ramon; Stukas, Sophie; Cripton, Peter A.; Wellington, Cheryl L.			Increased severity of the CHIMERA model induces acute vascular injury, sub-acute deficits in memory recall, and chronic white matter gliosis	EXPERIMENTAL NEUROLOGY			English	Article						TBI; CHIMERA; Diffuse axonal injury; Vascular injury; Plasma biomarkers	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SEX-DIFFERENCES; PROFESSIONAL FOOTBALL; MICROVASCULAR INJURY; RISK; CONCUSSION; GENOTYPE; AGE	Traumatic brain injury (TBI) is a leading cause of death and disability in modern societies. Diffuse axonal and vascular injury are nearly universal consequences of mechanical energy impacting the head and contribute to disability throughout the injury severity spectrum. CHIMERA (Closed Head Impact Model of Engineered Rotational Acceleration) is a non-surgical, impact-acceleration model of rodent TBI that reliably produces diffuse axonal injury characterized by white matter gliosis and axonal damage. At impact energies up to 0.7 joules, which result in mild TBI in mice, CHIMERA does not produce detectable vascular or grey matter injury. This study was designed to expand CHIMERA's capacity to induce more severe injuries, including vascular damage and grey matter gliosis. This was made possible by designing a physical interface positioned between the piston and animal's head to allow higher impact energies to be transmitted to the head without causing skull fracture. Here, we assessed interface-assisted single CHIMERA TBI at 2.5 joules in wild-type mice using a study design that spanned 6 h-60 d time points. Injured animals displayed robust acute neurological deficits, elevated plasma total tau and neurofilament-light levels, transiently increased proinflammatory cytokines in brain tissue, blood-brain barrier (BBB) leakage and microstructural vascular abnormalities, and grey matter microgliosis. Memory deficits were evident at 30 d and resolved by 60 d. Intriguingly, white matter injury was not remarkable at acute time points but evolved over time, with white matter gliosis being most extensive at 60 d. Interface-assisted CHIMERA thus enables experimental modeling of distinct endophenotypes of TBI that include acute vascular and grey matter injury in addition to chronic evolution of white matter damage, similar to the natural history of human TBI.	[Bashir, Asma; Button, Emily B.; Cheng, Wai Hang; Wilkinson, Anna; Barron, Carlos; Stukas, Sophie; Wellington, Cheryl L.] Univ British Columbia, Dept Pathol & Lab Med, Djavad Mowafaghian Ctr Brain Hlth, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Bashir, Asma; Tatarnikov, Igor] Univ British Columbia, Grad Program Neurosci, 2215 Wesbrook Mak, Vancouver, BC V6T 1Z3, Canada; [Abebe, Zelalem A.; McInnes, Kurt A.; Cripton, Peter A.] Univ British Columbia, Dept Mech Engn, Int Ctr Repair Discoveries, Vancouver, BC V5Z 1M9, Canada; [Abebe, Zelalem A.; McInnes, Kurt A.; Cripton, Peter A.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC V5Z 1M9, Canada; [Tatarnikov, Igor] Univ British Columbia, Dept Med Genet, Ctr Appl Neurogenet, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Haber, Margalit; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, 51 N 39th St, Philadelphia, PA 19104 USA		Wellington, CL (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	asma.bashir@ubc.ca; ebbutton@mail.ubc.ca; anna.wilkinson@ubc.ca; cbe37@mail.ubc.ca; ramon.diaz-arrastia@uphs.upenn.edu; sophie.stukas@ubc.ca; cripton@mech.ubc.ca; wcheryl@mail.ubc.ca	Cripton, Peter Alec/AAC-8268-2020	Cripton, Peter Alec/0000-0002-5067-0833; Bashir, Asma/0000-0002-3616-9436; Tatarnikov, Igor/0000-0001-5728-7493; Cheng, Wai Hang/0000-0002-3408-9184	Weston Brain Institute [TRA140070]; University of British Columbia Doctoral Fellowship	Operating funding for this work was provided by a Transformational grant from the Weston Brain Institute to CLW (TRA140070). AB is supported by a University of British Columbia Doctoral Fellowship.	Adediran T, 2019, J SURG RES, V243, P427, DOI 10.1016/j.jss.2019.05.053; Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; Barkai G, 2004, PSYCHIAT RES-NEUROIM, V132, P279, DOI 10.1016/j.pscychresns.2004.09.004; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Haar CV, 2019, EXP NEUROL, V317, P87, DOI 10.1016/j.expneurol.2019.02.012; Holbourn AHS, 1943, LANCET, V2, P438; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Sauerbeck AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25737-6; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Stukas S, 2019, LANCET CHILD ADOLESC, V3, P558, DOI 10.1016/S2352-4642(19)30194-4; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Whyte T, 2019, J BIOMECH, V95, DOI 10.1016/j.jbiomech.2019.07.023; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	42	14	14	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2020	324								113116	10.1016/j.expneurol.2019.113116			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KF7MN	WOS:000509423400003	31734317				2022-02-06	
J	Lilja-Cyron, A; Andresen, M; Kelsen, J; Andreasen, TH; Fugleholm, K; Juhler, M				Lilja-Cyron, Alexander; Andresen, Morten; Kelsen, Jesper; Andreasen, Trine Hjorslev; Fugleholm, Kare; Juhler, Marianne			Long-Term Effect of Decompressive Craniectomy on Intracranial Pressure and Possible Implications for Intracranial Fluid Movements	NEUROSURGERY			English	Article						Cerebrospinal fluid; Cranioplasty; Decompressive craniectomy; Intracranial pressure; Telemetry; Traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; HEALTH-CARE PROFESSIONALS; TRAUMATIC BRAIN-INJURY; CRANIOPLASTY; MANAGEMENT; GUIDELINES; FEASIBILITY; INFARCTION; STATEMENT	BACKGROUND Decompressive craniectomy (DC) is used in cases of severe intracranial hypertension or impending intracranial herniation. DC effectively lowers intracranial pressure (ICP) but carries a risk of severe complications related to abnormal ICP and/or cerebrospinal fluid (CSF) circulation, eg, hygroma formation, hydrocephalus, and "syndrome of the trephined." OBJECTIVE To study the long-term effect of DC on ICP, postural ICP regulation, and intracranial pulse wave amplitude (PWA). METHODS Prospective observational study including patients undergoing DC during a 12-mo period. Telemetric ICP sensors (Neurovent-P-tel; Raumedic, Helmbrechts, Germany) were implanted in all patients. Following discharge from the neuro intensive care unit (NICU), scheduled weekly ICP monitoring sessions were performed during the rehabilitation phase. RESULTS A total of 16 patients (traumatic brain injury: 7, stroke: 9) were included (median age: 55 yr, range: 19-71 yr). Median time from NICU discharge to cranioplasty was 48 d (range: 16-98 d) and during this period, mean ICP gradually decreased from 7.8 2.0 mm Hg to -1.8 +/- 3.3 mm Hg (P = .02). The most pronounced decrease occurred during the first month. Normal postural ICP change was abolished after DC for the entire follow-up period, ie, there was no difference between ICP in supine and sitting position (P = .67). PWA was markedly reduced and decreased from initially 1.2 +/- 0.7 mm Hg to 0.4 +/- 0.3 mm Hg (P = .05). CONCLUSION Following NICU discharge, ICP decreases to negative values within 4 wk, normal postural ICP regulation is lost and intracranial PWA is diminished significantly. These abnormalities might have implications for intracranial fluid movements (eg, CSF and/or glymphatic flow) following DC and warrants further investigations.	[Lilja-Cyron, Alexander; Andresen, Morten; Andreasen, Trine Hjorslev; Fugleholm, Kare; Juhler, Marianne] Rigshosp, Dept Neurosurg, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Kelsen, Jesper] Rigshosp, Dept Orthoped Surg, Spine Sect, Copenhagen, Denmark		Lilja-Cyron, A (corresponding author), Rigshosp, Dept Neurosurg, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	alexander.lilja-cyron@regionh.dk	Andreasen, Trine/AAS-9911-2021; Fugleholm, Kare/AAW-5086-2021	Lilja-Cyron, Alexander/0000-0003-2915-249X; Hjorslev Andreasen, Trine/0000-0001-5707-8712; Andresen, Morten/0000-0002-3802-6033; Fugleholm, Kare/0000-0002-1520-7122	Council of the Danish Victims Fund [14-910-00016]	The study was funded by the Council of the Danish Victims Fund through a grant to Prof. Marianne Juhler (Grant no. 14-910-00016), including funding for salary to a clinical research fellow (Alexander Lilja-Cyron) and for purchasing of telemetric ICP monitoring equipment for the study. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; Andresen M, 2014, J NEUROSURG, V121, P797, DOI 10.3171/2014.2.JNS132209; Antes S, 2016, WORLD NEUROSURG, V91, P133, DOI 10.1016/j.wneu.2016.03.096; Antes S, 2014, ACTA NEUROCHIR, V156, P1009, DOI 10.1007/s00701-013-1991-7; Antes S, 2014, CHILD NERV SYST, V30, P331, DOI 10.1007/s00381-013-2269-3; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Barber JM, 2017, BRIT J NEUROSURG, V31, P300, DOI 10.1080/02688697.2016.1229752; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Donnelly J, 2018, THESIS, DOI [10.17863/CAM.18409, DOI 10.17863/CAM.18409]; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fletcher TL, 2016, ANN BIOMED ENG, V44, P3495, DOI 10.1007/s10439-016-1666-7; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Freimann FB, 2014, CHILD NERV SYST, V30, P689, DOI 10.1007/s00381-013-2324-0; Freimann FB, 2013, PEDIATR NEUROSURG, V49, P29, DOI 10.1159/000355561; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Honeybul S, 2017, J CRIT CARE, V39, P185, DOI 10.1016/j.jcrc.2017.03.006; Honeybul Stephen, 2014, Surg Neurol Int, V5, P83, DOI 10.4103/2152-7806.133886; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Kiefer Michael, 2012, Acta Neurochir Suppl, V114, P111, DOI 10.1007/978-3-7091-0956-4_20; Kiviniemi V, 2016, J CEREBR BLOOD F MET, V36, P1033, DOI 10.1177/0271678X15622047; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Li XG, 2013, J CLIN NEUROSCI, V20, P509, DOI 10.1016/j.jocn.2012.04.019; Lilja A, 2014, CLIN NEUROL NEUROSUR, V120, P36, DOI 10.1016/j.clineuro.2014.02.010; Lilja-Cyron A, 2018, J NEUROTRAUM, V35, P1578, DOI 10.1089/neu.2017.5589; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Parichay PJ, 2017, J CLIN NEUROSCI, V42, P97, DOI 10.1016/j.jocn.2017.04.005; Petersen LG, 2016, AM J PHYSIOL-REG I, V310, pR100, DOI 10.1152/ajpregu.00302.2015; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Sauvigny T, 2018, J NEUROSURG, V128, P819, DOI 10.3171/2016.11.JNS162263; Schmitt M, 2012, ACTA NEUROCHIR SUPPL, V113, P109, DOI 10.1007/978-3-7091-0923-6_22; Scollato A, 2015, BRIT J NEUROSURG, V29, P440, DOI 10.3109/02688697.2014.997671; Sedney CL, 2015, J NEUROSCI RURAL PRA, V6, P438, DOI 10.4103/0976-3147.158778; Smielewski P, 2005, ACT NEUR S, V95, P43; Stiver SI, 2008, ACTA NEUROCHIR SUPPL, V102, P273, DOI 10.1007/978-3-211-85578-2_51; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Torbey MT, 2015, NEUROCRIT CARE, V22, P146, DOI 10.1007/s12028-014-0085-6; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Welschehold S, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822dda12; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6	54	14	15	0	11	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	FEB	2020	86	2					231	239		10.1093/neuros/nyz049			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KN8UY	WOS:000515122000060	30768137				2022-02-06	
J	Olmsted, KRL; Bartoszek, M; Mulvaney, S; McLean, B; Turabi, A; Young, R; Kim, E; Vandermaas-Peeler, R; Morgan, JK; Constantinescu, O; Kane, S; Nguyen, C; Hirsch, S; Munoz, B; Wallace, D; Croxford, J; Lynch, JH; White, R; Walters, BB				Rae Olmsted, Kristine L.; Bartoszek, Michael; Mulvaney, Sean; McLean, Brian; Turabi, Ali; Young, Ryan; Kim, Eugene; Vandermaas-Peeler, Russ; Morgan, Jessica Kelley; Constantinescu, Octav; Kane, Shawn; Nguyen, Cuong; Hirsch, Shawn; Munoz, Breda; Wallace, Dennis; Croxford, Julie; Lynch, James H.; White, Ronald; Walters, Bradford B.			Effect of Stellate Ganglion Block Treatment on Posttraumatic Stress Disorder Symptoms A Randomized Clinical Trial	JAMA PSYCHIATRY			English	Article							AFGHANISTAN; IRAQ	This randomized clinical trial assesses differences in posttraumatic stress disorder symptom intensity in active-duty service members treated with stellate ganglion blocks or a sham procedure. Question How does stellate ganglion block compare with sham treatment in reducing the severity of posttraumatic stress disorder symptoms over 8 weeks? Findings In this sham-controlled randomized clinical trial, 2 stellate ganglion block treatments 2 weeks apart were effective in reducing Clinician-Administered PTSD Scale for DSM-5 total symptom severity scores over 8 weeks. The adjusted mean symptom change was -12.6 points for the group receiving stellate ganglion blocks, compared with -6.1 points for those receiving sham treatment, a significant difference. Meaning Stellate ganglion block treatment warrants further study as a posttraumatic stress disorder treatment adjunct. Importance This is the first multisite, randomized clinical trial of stellate ganglion block (SGB) outcomes on posttraumatic stress disorder (PTSD) symptoms. Objective To determine whether paired SGB treatments at 0 and 2 weeks would result in improvement in mean Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) total symptom severity scores from baseline to 8 weeks. Design, Setting, and Participants This multisite, blinded, sham-procedure, randomized clinical trial used a 2:1 SGB:sham ratio and was conducted from May 2016 through March 2018 in 3 US Army Interdisciplinary Pain Management Centers. Only physicians performing the procedures and the procedure nurses were aware of the intervention (but not the participants or assessors); their interactions with the participants were scripted and limited to the 2 interventions. Active-duty service members on stable psychotropic medication dosages who had a PTSD Checklist-Civilian Version (PCL-C) score of 32 or more at screening were included. Key exclusion criteria included a prior SGB treatment, selected psychiatric disorders or substance use disorders, moderate or severe traumatic brain injury, or suicidal ideation in the prior 2 months. Interventions Paired right-sided SGB or sham procedures at weeks 0 and 2. Main Outcomes and Measures Improvement of 10 or more points on mean CAPS-5 total symptom severity scores from baseline to 8 weeks, adjusted for site and baseline total symptom severity scores (planned a priori). Results Of 190 screened individuals, 113 (59.5%; 100 male and 13 female participants; mean [SD] age, 37.3 [6.7] years) were eligible and randomized (74 to SGB and 39 to sham treatment), and 108 (95.6% of 113) completed the study. Baseline characteristics were similar in the SGB and sham treatment groups, with mean (SD) CAPS-5 scores of 37.6 (11.2) and 39.8 (14.4), respectively (on a scale of 0-80); 91 (80.0%) met CAPS-5 PTSD criteria. In an intent-to-treat analysis, adjusted mean total symptom severity score change was -12.6 points (95% CI, -15.5 to -9.7 points) for the group receiving SGB treatments, compared with -6.1 points (95% CI, -9.8 to -2.3 points) for those receiving sham treatment (P = .01). Conclusions and Relevance In this trial of active-duty service members with PTSD symptoms (at a clinical threshold and subthreshold), 2 SGB treatments 2 weeks apart were effective in reducing CAPS-5 total symptom severity scores over 8 weeks. The mild-moderate baseline level of PTSD symptom severity and short follow-up time limit the generalizability of these findings, but the study suggests that SGB merits further trials as a PTSD treatment adjunct.	[Rae Olmsted, Kristine L.; Vandermaas-Peeler, Russ; Morgan, Jessica Kelley; Hirsch, Shawn; Munoz, Breda; Wallace, Dennis; Croxford, Julie; Walters, Bradford B.] RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA; [Bartoszek, Michael; Kim, Eugene] Womack Army Med Ctr, Ft Bragg, NC USA; [Mulvaney, Sean] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [McLean, Brian; Nguyen, Cuong] Tripler Army Med Ctr, Honolulu, HI 96859 USA; [Turabi, Ali; Young, Ryan; Constantinescu, Octav; White, Ronald] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Kane, Shawn] Kennedy Special Warfare Ctr & Sch, Ft Bragg, NC USA; [Lynch, James H.] Ft Bragg, US Army Special Operat Command, Ft Bragg, NC USA; [Lynch, James H.] US Army Special Operat Command, Ft Bragg, NC USA		Olmsted, KRL (corresponding author), RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.	krolmsted@rti.org	Wallace, Dennis/AAR-7005-2021; Olmsted, Kristine Rae/AAU-3979-2020	Hirsch, Shawn/0000-0001-6280-9559; Rae Olmsted, Kristine/0000-0001-7432-1569; Morgan, Jessica Kelley/0000-0003-2071-2681; kane, Shawn/0000-0002-9110-5224; Croxford, Julie/0000-0002-3720-8206	Office of the Assistant Secretary of Defense for Health Affairs through the Defense Medical Research and Development Program [W81XWH-15-2-0015]	This work was funded by the Office of the Assistant Secretary of Defense for Health Affairs through the Defense Medical Research and Development Program (grant W81XWH-15-2-0015). The US Army Medical Research Acquisition Activity is the awarding and administering acquisition office.	Alino Justin, 2013, Mil Med, V178, pe473, DOI 10.7205/MILMED-D-12-00386; Armenta RF, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1590-5; Bhatia A, 2012, CAN J ANESTH, V59, P1040, DOI 10.1007/s12630-012-9779-4; Brunetti M, 2017, PROG NEURO-PSYCHOPH, V77, P110, DOI 10.1016/j.pnpbp.2017.04.010; del Rio-Casanova L, 2016, REV NEUROSCIENCE, V27, P385, DOI 10.1515/revneuro-2015-0045; Difede J, 2014, ANNU REV MED, V65, P319, DOI 10.1146/annurev-med-051812-145438; Giourou E, 2018, WORLD J PSYCHIATR, V8, P12, DOI 10.5498/wjp.v8.i1.12; Hanling SR, 2016, REGION ANESTH PAIN M, V41, P494, DOI 10.1097/AAP.0000000000000402; Hicky A, 2012, AM J PSYCHIAT, V169, P760, DOI 10.1176/appi.ajp.2012.11111729; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holdeman TC, 2009, PSYCHIAT SERV, V60, P273, DOI 10.1176/appi.ps.60.2.273; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; LEBOVITS AH, 1990, CLIN J PAIN, V6, P153, DOI 10.1097/00002508-199006000-00015; Lee DJ, 2016, DEPRESS ANXIETY, V33, P792, DOI 10.1002/da.22511; McLean B, 2015, CUREUS, V7, DOI 10.7759/cureus.320; Michalos AC., 2014, ENCY QUALITY LIFE WE, P5954, DOI [10.1007/978-94-007-0753-5_2698, DOI 10.1007/978-94-007-0753-5_2698]; Mulvaney Sean W, 2015, J Spec Oper Med, V15, P79; Mulvaney SW, 2015, MIL MED, V180, pE601, DOI 10.7205/MILMED-D-14-00504; Mulvaney SW, 2014, MIL MED, V179, P1133, DOI 10.7205/MILMED-D-14-00151; Mulvaney SW, 2010, PAIN PRACT, V10, P359, DOI 10.1111/j.1533-2500.2010.00373.x; National Center for PTSD, US PTSD CHECKL DSM 4; National Center for PTSD, 2018, PTSD CHECKL DSM 5 PC; Pagotto LF, 2015, COMPR PSYCHIAT, V58, P68, DOI 10.1016/j.comppsych.2015.01.002; Phillips KM, 2016, J REHABIL RES DEV, V53, P413, DOI 10.1682/JRRD.2014.05.0126; Pietrzak RH, 2011, J ANXIETY DISORD, V25, P456, DOI 10.1016/j.janxdis.2010.11.010; Rauch SAM, 2019, JAMA PSYCHIAT, V76, P117, DOI 10.1001/jamapsychiatry.2018.3412; Schore AN, 2002, AUST NZ J PSYCHIAT, V36, P9, DOI 10.1046/j.1440-1614.2002.00996.x; Sloan DM, 2018, JAMA PSYCHIAT, V75, P233, DOI 10.1001/jamapsychiatry.2017.4249; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Summers MR, 2017, PAIN PRACT, V17, P546, DOI 10.1111/papr.12503; Walter KH, 2018, J TRAUMA STRESS, V31, P837, DOI 10.1002/jts.22337; Weathers F.W., 1993, 9 ANN C ISTSS; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Westerhaus MJ, 2001, BRAIN RES, V903, P117, DOI 10.1016/S0006-8993(01)02453-2; WULF H, 1992, ANAESTHESIST, V41, P146	36	14	14	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-622X	2168-6238		JAMA PSYCHIAT	JAMA Psychiatry	FEB	2020	77	2					130	138		10.1001/jamapsychiatry.2019.3474			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	KJ4SM	WOS:000512049000007	31693083	Bronze, Green Published			2022-02-06	
J	Svaldi, DO; Joshi, C; McCuen, EC; Music, JP; Hannemann, R; Leverenz, LJ; Nauman, EA; Talavage, TM				Svaldi, Diana O.; Joshi, Chetas; McCuen, Emily C.; Music, Jacob P.; Hannemann, Robert; Leverenz, Larry J.; Nauman, Eric A.; Talavage, Thomas M.			Accumulation of high magnitude acceleration events predicts cerebrovascular reactivity changes in female high school soccer athletes	BRAIN IMAGING AND BEHAVIOR			English	Article						Cerebrovascular Reactivity; Functional magnetic resonance imaging; Concussion; Mild traumatic brain injury; Subconcussive injury; Soccer	DEFAULT MODE NETWORK; CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; HEAD IMPACT EXPOSURE; 1ST EXPOSURE; FOOTBALL; CONCUSSION; SEASON; FMRI; PATHOPHYSIOLOGY	Mitigating the effects of repetitive exposure to head trauma has become a major concern for the general population, given the growing body of evidence that even asymptomatic exposure to head accelerations is linked with increased risk for negative life outcomes and that risk increases as exposure is prolonged over many years. Among women's sports, soccer currently exhibits the highest growth in participation and reports the largest number of mild traumatic brain injuries annually, making female soccer athletes a relevant population in assessing the effects of repetitive exposure to head trauma. Cerebrovascular biomarkers may be useful in assessing the effects of repetitive head trauma, as these are thought to contribute directly to neurocognitive symptoms associated with mild traumatic brain injury. Here we use fMRI paired with a hypercapnic breath hold task along with monitoring of head acceleration events, to assess the relationship between cerebrovascular brain changes and exposure to repetitive head trauma over a season of play in female high school soccer athletes. We identified longitudinal changes in cerebrovascular reactivity that were significantly associated with prolonged accumulation to high magnitude (> 75th percentile) head acceleration events. Findings argue for active monitoring of athletes during periods of exposure to head acceleration events, illustrate the importance of collecting baseline (i.e., pre-exposure) measurements, and suggest modeling as a means of guiding policy to mitigate the effects of repetitive head trauma.	[Svaldi, Diana O.; McCuen, Emily C.; Hannemann, Robert; Nauman, Eric A.; Talavage, Thomas M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 4907 USA; [Svaldi, Diana O.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Joshi, Chetas; Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Music, Jacob P.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Hannemann, Robert] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA; [Hannemann, Robert] Purdue Univ, Dept Child Psychol, W Lafayette, IN 47907 USA; [Hannemann, Robert] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Leverenz, Larry J.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA		Svaldi, DO (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 4907 USA.; Svaldi, DO (corresponding author), Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA.	dianaotero7@gmail.com		Talavage, Thomas/0000-0003-4977-6398; Svaldi, Diana/0000-0001-6265-1931	Indiana Clinical and Translational Sciences Institute Spinal Cord and Brain Injury Research Fund [SCBI 207-32]; BrainScope Company (GE-NFL Head Health Initiative)	This study was funded in part by the Indiana Clinical and Translational Sciences Institute Spinal Cord and Brain Injury Research Fund (Grant #SCBI 207-32), and the BrainScope Company (as part of a grant from the GE-NFL Head Health Initiative).	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Becelewski Janusz, 2003, Neurol Neurochir Pol, V37, P339; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Bright MG, 2013, NEUROIMAGE, V83, P559, DOI 10.1016/j.neuroimage.2013.07.007; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Chan ST, 2015, BRAIN INJURY, V29, P403, DOI 10.3109/02699052.2014.974209; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Giza CC, 2001, J ATHL TRAINING, V36, P228; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kastrup A, 2001, MAGN RESON IMAGING, V19, P13, DOI 10.1016/S0730-725X(01)00227-2; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Lewis PM, 2014, VASCULAR MECH CNS TR; Lipp I, 2015, NEUROIMAGE, V113, P387, DOI 10.1016/j.neuroimage.2015.03.004; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morris B, 2015, WHY IS US SO GOOD WO; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072	56	14	14	3	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	FEB	2020	14	1					164	174		10.1007/s11682-018-9983-0			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KJ1DP	WOS:000511797100017	30377933	Green Submitted			2022-02-06	
J	Yu, JT; Zhang, YX; Ma, HL; Zeng, R; Liu, RN; Wang, PC; Jin, XQ; Zhao, Y				Yu, Jiangtao; Zhang, Yuxian; Ma, Haoli; Zeng, Rong; Liu, Ruining; Wang, Pengcheng; Jin, Xiaoqing; Zhao, Yan			Epitranscriptomic profiling of N6-methyladenosine-related RNA methylation in rat cerebral cortex following traumatic brain injury	MOLECULAR BRAIN			English	Article						m6A methylation; Epigenetic modification; FTO; Traumatic brain injury; Rat cortex	CORTICAL IMPACT MODEL; MESSENGER-RNA; UP-REGULATION; N-6-METHYLADENOSINE; REVEALS; WRITERS; MOUSE; PATHOPHYSIOLOGY; REGENERATION; READERS	Background N6-methyladenosine (m6A) is the most prevalent post-transcriptional modification of eukaryotic mRNA. It has been reported that there is a stimulus-dependent regulation of m6A in the mammalian central nervous system in response to sensory experience, learning, and injury. The mRNA m6A methylation pattern in rat cortex after traumatic brain injury (TBI) has not been investigated. Results In this study, we conducted a genome-wide profiling of mRNA m6A methylation in rat cortex via methylated RNA immunoprecipitation sequencing (MeRIP-Seq). After TBI, the expressions of METTL14 and FTO were significantly down-regulated in rat cerebral cortex. Using MeRIP-Seq, we identified a total of 2165 significantly changed peaks, of which 1062 were significantly up-regulated and 1103 peaks were significantly down-regulated. These m6A peaks were located across 1850 genes. The analysis of both m6A peaks and mRNA expression revealed that there were 175 mRNA significantly altered methylation and expression levels after TBI. Moreover, it was found that functional FTO is necessary to repair neurological damage caused by TBI but has no effect on the spatial learning and memory abilities of TBI rats by using FTO inhibitor FB23-2. Conclusion This study explored the m6A methylation pattern of mRNA after TBI in rat cortex and identified FTO as possible intervention targets in the epigenetic modification of TBI.	[Yu, Jiangtao; Zhang, Yuxian; Zeng, Rong; Liu, Ruining; Wang, Pengcheng; Jin, Xiaoqing; Zhao, Yan] Wuhan Univ, Emergency Ctr, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Ma, Haoli] Wuhan Univ, Dept Biol Repositories, Zhongnan Hosp, Wuhan 430071, Peoples R China; [Jin, Xiaoqing; Zhao, Yan] Wuhan Univ, Hubei Clin Res Ctr Emergency & Resuscitat, Zhongnan Hosp, Wuhan 430071, Peoples R China		Zhao, Y (corresponding author), Wuhan Univ, Emergency Ctr, Zhongnan Hosp, Wuhan 430071, Peoples R China.; Zhao, Y (corresponding author), Wuhan Univ, Hubei Clin Res Ctr Emergency & Resuscitat, Zhongnan Hosp, Wuhan 430071, Peoples R China.	doctoryanzhao@whu.edu.cn			Emergency Diagnostic & Therapeutic Center of Central China; Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund [cxpy2017039, WJ2019H010/znpy2018043]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2042019kf0149]	This study was supported by the Emergency Diagnostic & Therapeutic Center of Central China, the Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund (cxpy2017039, WJ2019H010/znpy2018043), and the Fundamental Research Funds for the Central Universities (2042019kf0149). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Bailey ZS, 2015, NEUROSCI LETT, V604, P119, DOI 10.1016/j.neulet.2015.07.035; Befort K, 2003, EUR J NEUROSCI, V18, P911, DOI 10.1046/j.1460-9568.2003.02827.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Chang MQ, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170166; Cheng SX, 2018, NEUROTHERAPEUTICS, V15, P216, DOI 10.1007/s13311-017-0591-2; Cui XD, 2018, IEEE ACM T COMPUT BI, V15, P526, DOI 10.1109/TCBB.2015.2403355; Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du KZ, 2019, MOL NEUROBIOL, V56, P1596, DOI 10.1007/s12035-018-1138-1; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Huang Y, 2019, CANCER CELL, V35, P677, DOI 10.1016/j.ccell.2019.03.006; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Janova H, 2016, GLIA, V64, P635, DOI 10.1002/glia.22955; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karuppagounder SS, 2015, BRAIN RES, V1628, P273, DOI 10.1016/j.brainres.2015.07.030; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Li N, 2019, INT J GENOMICS, V2019, DOI 10.1155/2019/2146391; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Mateen BA, 2017, J NEUROTRAUM, V34, P2379, DOI 10.1089/neu.2017.5007; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Pitulescu ME, 2017, NAT CELL BIOL, V19, P915, DOI 10.1038/ncb3555; Puccio AM, 2015, ANNU REV NURS RES-SE, V33, P75, DOI 10.1891/0739-6686.33.75; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trindade A, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3171-2; Visvanathan A, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700093; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Weng YL, 2018, NEURON, V97, P313, DOI 10.1016/j.neuron.2017.12.036; White TE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2412-0; Widagdo J, 2018, J NEUROCHEM, V147, P137, DOI 10.1111/jnc.14481; Widagdo J, 2016, J NEUROSCI, V36, P6771, DOI 10.1523/JNEUROSCI.4053-15.2016; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Wu BX, 2017, CURR OPIN STRUC BIOL, V47, P67, DOI 10.1016/j.sbi.2017.05.011; Xiao X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0501-0; Xu Z, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0257-8; Yoneya T, 2001, J BIOCHEM-TOKYO, V129, P27, DOI 10.1093/oxfordjournals.jbchem.a002832; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang T, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2266-3; Zhao BS, 2018, RNA, V24, P268, DOI 10.1261/rna.064295.117; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002	57	14	14	4	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1756-6606		MOL BRAIN	Mol. Brain	JAN 28	2020	13	1							11	10.1186/s13041-020-0554-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KL8EY	WOS:000513651500001	31992337	gold, Green Published			2022-02-06	
J	Bernick, C; Shan, GG; Zetterberg, H; Banks, S; Mishra, VR; Bekris, L; Leverenz, JB; Blennow, K				Bernick, Charles; Shan, Guogen; Zetterberg, Henrik; Banks, Sarah; Mishra, Virendra R.; Bekris, Lynn; Leverenz, James B.; Blennow, Kaj			Longitudinal change in regional brain volumes with exposure to repetitive head impacts	NEUROLOGY			English	Article							PLASMA NEUROFILAMENT LIGHT; CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FIGHTERS; INJURY; CHAIN; BIOMARKERS; THALAMUS; TAU	ObjectiveThis study tests the hypothesis that certain MRI-based regional brain volumes will show reductions over time in a cohort exposed to repetitive head impacts (RHI).MethodsParticipants were drawn from the Professional Fighters Brain Health Study, a longitudinal observational study of professional fighters and controls. Participants underwent annual 3T brain MRI, computerized cognitive testing, and blood sampling for determination of neurofilament light (NfL) and tau levels. Yearly change in regional brain volume was calculated for several predetermined cortical and subcortical brain volumes and the relationship with NfL and tau levels determined.ResultsA total of 204 participants who had at least 2 assessments were included in the analyses. Compared to controls, the active boxers had an average yearly rate of decline in volumes of the left thalamus (102.3 mm(3)/y [p = 0.0004], mid anterior corpus callosum (10.2 mm(3)/y [p = 0.018]), and central corpus callosum (16.5 mm(3)/y [p = <0.0001]). Retired boxers showed the most significant volumetric declines compared to controls in left (32.1 mm(3)/y [p = 0.002]) and right (30.6 mm(3)/y [p = 0.008]) amygdala and right hippocampus (33.5 mm(3)/y [p = 0.01]). Higher baseline NfL levels were associated with greater volumetric decline in left hippocampus and mid anterior corpus callosum.ConclusionVolumetric loss in different brain regions may reflect different pathologic processes at different times among individuals exposed to RHI.	[Bernick, Charles; Mishra, Virendra R.] Cleveland Clin, Las Vegas, NV 89106 USA; [Shan, Guogen] Univ Nevada, Las Vegas, NV 89154 USA; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Banks, Sarah] Univ Calif San Diego, San Diego, CA 92103 USA; [Bekris, Lynn; Leverenz, James B.] Cleveland Clin, Cleveland, OH 44106 USA		Bernick, C (corresponding author), Cleveland Clin, Las Vegas, NV 89106 USA.	bernicc@ccf.org	Mishra, Virendra R./ABE-1942-2020	Mishra, Virendra R./0000-0002-0452-6400	Swedish Research CouncilSwedish Research CouncilEuropean Commission [2017-00915, 2018-02532]; Swedish Alzheimer Foundation [AF-742881]; Hjarnfonden, Sweden [FO2017-0243]; Swedish government [ALFGBG-715986, ALFGBG-720931]; County Councils, the ALF agreement [ALFGBG-715986, ALFGBG-720931]; European Research CouncilEuropean Research Council (ERC)European Commission [681712]; UK Dementia Research Institute at UCL; August Rapone Family Fund	K.B. holds the Torsten Soderberg Professorship in Medicine at the Royal Swedish Academy of Sciences and is supported by the Swedish Research Council (2017-00915), the Swedish Alzheimer Foundation (AF-742881), Hjarnfonden, Sweden (FO2017-0243), and a grant (ALFGBG-715986) from the Swedish state under the agreement between the Swedish government and the County Councils, the ALF agreement. H.Z. is a Wallenberg Academy Fellow supported by grants from the Swedish Research Council (2018-02532), the European Research Council (681712), the UK Dementia Research Institute at UCL, and a grant (ALFGBG-720931) from the Swedish state under the agreement between the Swedish government and the County Councils, the ALF agreement. The Article Processing Charge was funded by the August Rapone Family Fund.	Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bernick C, 2018, J NEUROTRAUM, V35, P2351, DOI 10.1089/neu.2017.5553; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; De Simoni S, 2018, BRAIN, V141, P148, DOI 10.1093/brain/awx309; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guenette JP, 2018, NEUROIMAGE-CLIN, V18, P888, DOI 10.1016/j.nicl.2018.03.026; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; Maclaren J, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.37; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Minagar A, 2013, NEUROLOGY, V80, P210, DOI 10.1212/WNL.0b013e31827b910b; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Mori E, 2002, ANN NY ACAD SCI, V977, P141, DOI 10.1111/j.1749-6632.2002.tb04809.x; Moseby-Knappe M, 2019, JAMA NEUROL, V76, P64, DOI 10.1001/jamaneurol.2018.3223; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Platero C, 2019, NEUROINFORMATICS, V17, P43, DOI 10.1007/s12021-018-9380-2; Reiter K, 2017, J ALZHEIMERS DIS, V55, P1363, DOI 10.3233/JAD-160504; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Rojas JC, 2016, ANN CLIN TRANSL NEUR, V3, P216, DOI 10.1002/acn3.290; Ross DE, 2018, PSYCHIAT RES-NEUROIM, V278, P69, DOI 10.1016/j.pscychresns.2018.05.007; Salthouse TA, 2011, J CLIN EXP NEUROPSYC, V33, P242, DOI 10.1080/13803395.2010.509922; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Wu L, 2018, NEUROREPORT, V29, P1282, DOI 10.1097/WNR.0000000000001106; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	34	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 21	2020	94	3					E232	E240		10.1212/WNL.0000000000008817			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LJ4IW	WOS:000530131000007	31871218	hybrid, Green Published			2022-02-06	
J	Stenberg, J; Haberg, AK; Follestad, T; Olsen, A; Iverson, GL; Terry, DP; Karlsen, RH; Saksvik, SB; Karaliute, M; Ek, JAN; Skandsen, T; Vik, A				Stenberg, Jonas; Haberg, Asta K.; Follestad, Turid; Olsen, Alexander; Iverson, Grant L.; Terry, Douglas P.; Karlsen, Rune H.; Saksvik, Simen B.; Karaliute, Migle; Ek, John A. N.; Skandsen, Toril; Vik, Anne			Cognitive Reserve Moderates Cognitive Outcome After Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cognitive reserve; Longitudinal studies; Neuropsychology; Post-concussion syndrome; Rehabilitation	NEUROPSYCHOLOGICAL OUTCOMES; CONCUSSION; EDUCATION; RECOVERY; VALIDITY; SCORES; AGE; PERFORMANCE; SYMPTOMS; SEQUELAE	Objective: To investigate whether cognitive reserve moderates differences in cognitive functioning between patients with mild traumatic brain injury (MTBI) and controls without MTBI and to examine whether patients with postconcussion syndrome have lower cognitive functioning than patients without postconcussion syndrome at 2 weeks and 3 months after injury. Design: Trondheim MTBI follow-up study is a longitudinal controlled cohort study with cognitive assessments 2 weeks and 3 months after injury. Setting: Recruitment at a level 1 trauma center and at a general practitioner-run, outpatient clinic. Participants: Patients with MTBI (n=160) according to the World Health Organization criteria, trauma controls (n=71), and community controls (n=79) (N=310). Main Outcome Measures: A cognitive composite score was used as outcome measure. The Vocabulary subtest was used as a proxy of cognitive reserve. Postconcussion syndrome diagnosis was assessed at 3 months with the British Columbia Postconcussion Symptom Inventory. Results: Linear mixed models demonstrated that the effect of vocabulary scores on the cognitive composite scores was larger in patients with MTBI than in community controls at 2 weeks and at 3 months after injury (P=.001). Thus, group differences in the cognitive composite score varied as a function of vocabulary scores, with the biggest differences seen among participants with lower vocabulary scores. There were no significant differences in the cognitive composite score between patients with (n=29) and without (n=131) postconcussion syndrome at 2 weeks or 3 months after injury. Conclusion: Cognitive reserve, but not postconcussion syndrome, was associated with cognitive outcome after MTBI. This supports the cognitive reserve hypothesis in the MTBI context and suggests that persons with low cognitive reserve are more vulnerable to reduced cognitive functioning if they sustain an MTBI. (C) 2019 by the American Congress of Rehabilitation Medicine. Published by Elsevier Inc.	[Stenberg, Jonas; Haberg, Asta K.; Karlsen, Rune H.; Skandsen, Toril; Vik, Anne] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Stenberg, Jonas; Vik, Anne] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Neurosurg, Trondheim, Norway; [Haberg, Asta K.] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol NTNU, Dept Publ Hlth & Nursing, Trondheim, Norway; [Olsen, Alexander; Saksvik, Simen B.; Karaliute, Migle; Ek, John A. N.] Norwegian Univ Sci & Technol NTNU, Dept Psychol, Trondheim, Norway; [Olsen, Alexander; Saksvik, Simen B.; Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Iverson, Grant L.; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Terry, Douglas P.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Red Sox Fdn, Home Base, Boston, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Massachusetts Gen Hosp Program, Boston, MA USA; [Karaliute, Migle] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Neurol & Clin Neurophysiol, Trondheim, Norway		Skandsen, T (corresponding author), NTNU, Fac Med & Heath Sci, N-7491 Trondheim, Norway.	toril.skandsen@ntnu.no	Stenberg, Jonas/AAN-4552-2021	Stenberg, Jonas/0000-0002-5769-7959	Liaison Committee [90157700, 46060918]	Supported by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (project numbers 90157700 and 46060918).	Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Bosnes O, 2009, J NORW PSYCHOL ASS, V46, P564; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Fraser EE, 2019, J NEUROTRAUM, V36, P2753, DOI 10.1089/neu.2019.6430; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hindle JV, 2014, PARKINSONISM RELAT D, V20, P1, DOI 10.1016/j.parkreldis.2013.08.010; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Knight RG, 2007, ARCH CLIN NEUROPSYCH, V22, P513, DOI 10.1016/j.acn.2007.03.005; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Magalhaes SD, 2012, CLIN NEUROPSYCHIATR, V9, P129; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Schmidt M., 1996, REY AUDITORY VERBAL; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Siqveland J., 2014, PSYCHOMETRIC EVALUAT; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Soldan A, 2018, PSYCHIAT CLIN N AM, V41, P65, DOI 10.1016/j.psc.2017.10.006; Soloveva MV, 2018, NEUROSCI BIOBEHAV R, V88, P155, DOI 10.1016/j.neubiorev.2018.03.003; Stern Y, 2017, BRAIN IMAGING BEHAV, V11, P410, DOI 10.1007/s11682-016-9566-x; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Strauss E, 2006, COMPENDIUM NEUROPSY; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Wechsler D, 2007, WECHSLER ABBREVIATED; Wechsler D., 1999, WECHLSER ABBREVIATED; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D., 2011, WECHSLER ADULT INTEL; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; World Health Organization, 1992, INT CLASS DIS ICD 10	48	14	14	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2020	101	1					72	80		10.1016/j.apmr.2019.08.477			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	KA2PR	WOS:000505640300008	31562876	hybrid, Green Published			2022-02-06	
J	Sun, Y; Zhou, YQ; Liu, YK; Zhang, HQ; Hou, GG; Meng, QG; Hou, Y				Sun, Yue; Zhou, Yan-Qiu; Liu, Yin-Kai; Zhang, Hong-Qin; Hou, Gui-Ge; Meng, Qing-Guo; Hou, Yun			Potential anti-neuroinflammatory NF-kB inhibitors based on 3,4-dihydronaphthalen-1(2H)-one derivatives	JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY			English	Article						3; 4-Dihydronaphthalen-1(2H)-one; anti-neuroinflammation; microglia polarisation; NF-kB inhibitor	NLRP3 INFLAMMASOME; KAPPA-B; MICROGLIA; ACTIVATION; AGENTS; BRAIN; 3,5-BIS(ARYLIDENE)-4-PIPERIDONES; DEMYELINATION; MINOCYCLINE; SUPPRESSES	Nuclear factor kappa B (NF-kB) inhibition represents a new therapeutic strategy for the treatment of neuroinflammatory diseases. In this study, a series of 3,4-dihydronaphthalen-1(2H)-one (DHN;6a-n, 7a-c) derivatives were synthesised and characterised by NMR and HRMS. We assessed the toxicity and anti-neuroinflammatory properties of these compounds and found that6mshowed the greatest anti-neuroinflammatory properties, with relatively low toxicity. Specifically,6msignificantly reduced reactive oxygen species production, down-regulated the expression of NOD-like receptor pyrin domain-containing protein 3 (NLRP3), apoptosis-associated speck-like protein containing a CARD (ASC), and caspase-1 and prevented lipopolysaccharide-stimulated BV2 microglia cells polarisation towards an M1 phenotype. Furthermore,6msignificantly decreased I kappa B alpha and NF-kB p65 phosphorylation, thus inhibiting the NF-kB signalling pathway. This suggests that6mmay be explored as a functional anti-neuroinflammatory agent for the treatment of inflammatory diseases in the central nervous system, such as multiple sclerosis, traumatic brain injury, stroke and spinal cord injury.	[Sun, Yue; Liu, Yin-Kai; Hou, Gui-Ge] Binzhou Med Univ, Sch Pharm, Key Lab Prescript Effect & Clin Evaluat State Adm, Yantai, Peoples R China; [Zhou, Yan-Qiu; Zhang, Hong-Qin; Hou, Yun] Binzhou Med Univ, Sch Basic Med Sci, Yantai 264003, Shandong, Peoples R China; [Meng, Qing-Guo] Yantai Univ, Sch Pharm, Yantai 264005, Peoples R China		Hou, Y (corresponding author), Binzhou Med Univ, Sch Basic Med Sci, Yantai 264003, Shandong, Peoples R China.; Meng, QG (corresponding author), Yantai Univ, Sch Pharm, Yantai 264005, Peoples R China.	qinggmeng@163.com; houyun820424@163.com		Reis, AlessanRSS/0000-0001-8486-7469	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601049, 21402010]; Shandong Provincial Natural Science FoundationNatural Science Foundation of Shandong Province [ZR2019MB032, ZR2016HP05]; College Youth Innovation Science and Technology Support Programme of Shandong province [2020KJK003]	We are grateful for financial support from the National Natural Science Foundation of China (Nos. 81601049, 21402010), Shandong Provincial Natural Science Foundation (No. ZR2019MB032, ZR2016HP05) and College Youth Innovation Science and Technology Support Programme of Shandong province (No. 2020KJK003).	Aryanpour R, 2017, INT IMMUNOPHARMACOL, V51, P131, DOI 10.1016/j.intimp.2017.08.007; Barlow JW, 2011, MED CHEM, V7, P213, DOI 1573-4064/11 $58.00+.00; Barlow JW, 2008, EUR J MED CHEM, V43, P2891, DOI 10.1016/j.ejmech.2008.02.009; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; Correale J, 2014, MULT SCLER J, V20, P1288, DOI 10.1177/1352458514533230; Cunha MI, 2020, J EXP MED, V217, DOI 10.1084/jem.20191390; Dai JZ, 2017, CELL PHYSIOL BIOCHEM, V43, P247, DOI 10.1159/000480367; Ding Y, 2012, J BIOL CHEM, V287, P8424, DOI 10.1074/jbc.M111.310136; Egan WJ, 2002, ADV DRUG DELIVER REV, V54, P273, DOI 10.1016/S0169-409X(02)00004-2; Gao CL, 2020, ANGEW CHEM INT EDIT, V59, P2429, DOI 10.1002/anie.201912489; Goldmann T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/208093; Gouverneur V., 2012, FLUORINE PHARM MED C; Hou Y, 2019, ENVIRON POLLUT, V253, P429, DOI 10.1016/j.envpol.2019.07.030; Hou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt228; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Jiang CS, 2018, J ENZYM INHIB MED CH, V33, P833, DOI 10.1080/14756366.2018.1461856; Kirby AJ, 2003, J ENZYM INHIB MED CH, V18, P27, DOI 10.1080/1475636021000049221; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Lee E, 2019, CELL DEATH DIFFER, V26, P213, DOI 10.1038/s41418-018-0124-5; Li N, 2018, EUR J MED CHEM, V147, P21, DOI 10.1016/j.ejmech.2018.01.088; Li N, 2017, ACTA CRYSTALLOGR C, V73, P1003, DOI 10.1107/S2053229617015145; Nishioku T, 2010, J PHARMACOL SCI, V112, P251, DOI 10.1254/jphs.09292SC; Ozaki E, 2015, J INFLAMM RES, V8, P15, DOI 10.2147/JIR.S51250; Pisanu A, 2014, NEUROBIOL DIS, V71, P280, DOI 10.1016/j.nbd.2014.08.011; Singh N, 2008, CATAL COMMUN, V9, P743, DOI 10.1016/j.catcom.2007.08.014; Slusarczyk J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071965; Stancu IC, 2019, ACTA NEUROPATHOL, V137, P599, DOI 10.1007/s00401-018-01957-y; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Su CM, 2019, J ENZYM INHIB MED CH, V34, P1287, DOI 10.1080/14756366.2019.1635124; Sun Y, 2019, ACTA CRYSTALLOGR C, V75, P1157, DOI 10.1107/S2053229619010118; Wang FL, 2017, RES CHEM INTERMEDIAT, V43, P5933, DOI 10.1007/s11164-017-2972-x; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Yan AJ, 2017, MOL MED REP, V16, P2491, DOI 10.3892/mmr.2017.6884; Yang HM, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00193; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4; Yao BR, 2019, EUR J MED CHEM, V167, P187, DOI 10.1016/j.ejmech.2019.02.020; Ye YZ, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00553; Zeng KW, 2014, PHYTOMEDICINE, V21, P298, DOI 10.1016/j.phymed.2013.08.016; Zhang LS, 2019, J ENZYM INHIB MED CH, V34, P264, DOI 10.1080/14756366.2018.1501042	40	14	14	6	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1475-6366	1475-6374		J ENZYM INHIB MED CH	J. Enzym. Inhib. Med. Chem.	JAN 1	2020	35	1					1631	1640		10.1080/14756366.2020.1804899			10	Biochemistry & Molecular Biology; Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	MY5GS	WOS:000558446300001	32781863	Green Published, gold			2022-02-06	
J	Wettervik, TS; Howells, T; Hillered, L; Nilsson, P; Engquist, H; Lewen, A; Enblad, P; Rostami, E				Wettervik, Teodor Svedung; Howells, Timothy; Hillered, Lars; Nilsson, Pelle; Engquist, Henrik; Lewen, Anders; Enblad, Per; Rostami, Elham			Mild Hyperventilation in Traumatic Brain Injury-Relation to Cerebral Energy Metabolism, Pressure Autoregulation, and Clinical Outcome	WORLD NEUROSURGERY			English	Article						Cerebral energy metabolism; Clinical outcome; Hyperventilation; Neurointensive care; Pressure reactivity; Traumatic brain injury	SEVERE HEAD-INJURY; BLOOD-FLOW; PROLONGED HYPERVENTILATION; MODERATE HYPERVENTILATION; NEUROINTENSIVE CARE; REACTIVITY; MANAGEMENT; THERAPY	OBJECTIVE: Hyperventilation is a controversial treatment in traumatic brain injury (TBI). Prophylactic severe hyperventilation (below 3.3 kPa/25 mm Hg) is generally avoided, due to the risk of cerebral ischemia. Mild hyperventilation (arterial pCO(2) within 4.0-4.5 kPa/30-34 mm Hg) in cases of intracranial hypertension is commonly used, but its safety and benefits are not fully elucidated. The aim of this study was to evaluate the use of mild hyperventilation and its relation to cerebral energy metabolism, pressure autoregulation, and clinical outcome in TBI. METHODS: This retrospective study was based on 120 patients with severe TBI treated at the neurointensive care unit, Uppsala University Hospital, Sweden, between 2008 and 2018. Data from cerebral microdialysis (glucose, pyruvate, and lactate), arterial pCO(2), and pressure reactivity index were analyzed for the first 3 days post-injury. RESULTS: Mild hyperventilation, 4.0-4.5 kPa (30-34 mm Hg), was more frequently used early and the patients were gradually normoventilated. Low pCO(2) was associated with slightly higher intracranial pressure and slightly lower cerebral perfusion pressure (P < 0.01). There was no univariate correlation between low pCO(2) and worse cerebral energy metabolism. Multiple linear regression analysis showed that mild hyperventilation was associated with lower pressure reactivity index on day 2 (P = 0.03), suggesting better pressure autoregulation. Younger age and lower intracranial pressure were also associated with lower pressure reactivity index. CONCLUSIONS: These findings support the notion that mild hyperventilation is safe and may improve cerebravascular reactivity.	[Wettervik, Teodor Svedung; Howells, Timothy; Hillered, Lars; Nilsson, Pelle; Lewen, Anders; Enblad, Per; Rostami, Elham] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Engquist, Henrik] Uppsala Univ, Dept Surg Sci Anesthesia & Intens Care, Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se	Wettervik, Teodor Mikael Svedung/S-5356-2017	Engquist, Henrik/0000-0002-9826-1422; enblad, per/0000-0003-4364-1919			Brandi G, 2019, CRIT CARE, V23, DOI 10.1186/s13054-018-2304-6; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carrera E, 2010, J NEUROL NEUROSUR PS, V81, P793, DOI 10.1136/jnnp.2009.174425; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Godoy DA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00250; Haubrich Christina, 1800, Acta Neurochir Suppl, V114, P153, DOI 10.1007/978-3-7091-0956-4_28; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Steiner LA, 2005, ACTA NEUROCHIR SUPPL, V95, P17; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wettervik TS, 2019, J NEUROTRAUM, V36, P1818, DOI 10.1089/neu.2018.6157; Wilson JL, 1988, J NEUROTRAUM, V15, P573; Zhang Y, 2016, ACTA NEUROCHIR SUPPL, V122, P205, DOI 10.1007/978-3-319-22533-3_41	30	14	14	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2020	133						E567	E575		10.1016/j.wneu.2019.09.099			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JX8QN	WOS:000503993700118	31561041				2022-02-06	
J	Wu, FF; Xu, K; Xu, KB; Teng, CH; Zhang, M; Xia, LL; Zhang, KR; Liu, L; Chen, ZF; Xiao, J; Wu, YQ; Zhang, HY; Chen, DQ				Wu, Fangfang; Xu, Ke; Xu, Kebin; Teng, Chenhuai; Zhang, Man; Xia, Leilei; Zhang, Kairui; Liu, Lei; Chen, Zaifeng; Xiao, Jian; Wu, Yanqing; Zhang, Hongyu; Chen, Daqing			Dl-3n-butylphthalide improves traumatic brain injury recovery via inhibiting autophagy-induced blood-brain barrier disruption and cell apoptosis	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						autophagy; blood-brain barrier; Dl-3n-butylphthalide; mitochondrial apoptosis; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; SPINAL CORD BARRIER; FUNCTIONAL RECOVERY; DL-3-N-BUTYLPHTHALIDE PREVENTS; DEATH; NEUROPROTECTION; MICE; L-3-N-BUTYLPHTHALIDE; DAMAGE; FLUX	Blood-brain barrier (BBB) disruption and neuronal apoptosis are important pathophysiological processes after traumatic brain injury (TBI). In clinical stroke, Dl-3n-butylphthalide (Dl-NBP) has a neuroprotective effect with anti-inflammatory, anti-oxidative, anti-apoptotic and mitochondrion-protective functions. However, the effect and molecular mechanism of Dl-NBP for TBI need to be further investigated. Here, we had used an animal model of TBI and SH-SY5Y/human brain microvascular endothelial cells to explore it. We found that Dl-NBP administration exerts a neuroprotective effect in TBI/OGD and BBB disorder, which up-regulates the expression of tight junction proteins and promotes neuronal survival via inhibiting mitochondrial apoptosis. The expressions of autophagy-related proteins, including ATG7, Beclin1 and LC3II, were significantly increased after TBI/OGD, and which were reversed by Dl-NBP treatment both in vivo and in vitro. Moreover, rapamycin treatment had abolished the effect of Dl-NBP for TBI recovery. Collectively, our current studies indicate that Dl-NBP treatment improved locomotor functional recovery after TBI by inhibiting the activation of autophagy and consequently blocking the junction protein loss and neuronal apoptosis. Dl-NBP, as an anti-inflammatory and anti-oxidative drug, may act as an effective strategy for TBI recovery.	[Wu, Fangfang; Teng, Chenhuai; Zhang, Man; Zhang, Kairui; Liu, Lei; Chen, Daqing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou 325027, Peoples R China; [Wu, Fangfang; Teng, Chenhuai; Zhang, Man; Zhang, Kairui; Liu, Lei; Chen, Daqing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Peoples R China; [Xu, Ke; Xiao, Jian; Zhang, Hongyu] Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou 325035, Peoples R China; [Xu, Ke; Wu, Yanqing] Wenzhou Univ, Biomed Collaborat Innovat Ctr Wenzhou, Engn Lab Zhejiang Prov Pharmaceut Dev Growth Fact, Inst Life Sci, Wenzhou, Peoples R China; [Xu, Kebin] Univ Chinese Acad Sci, HwaMei Hosp, Dept Pharm, Ningbo, Zhejiang, Peoples R China; [Xia, Leilei] Wenzhou Med Univ, Clin Inst 3, Wenzhou Peoples Hosp, Dept Emergency, Wenzhou, Peoples R China; [Chen, Zaifeng] Wenzhou Med Univ, Affiliated Cixi Hosp, Dept Neurosurg, Ningbo, Zhejiang, Peoples R China; [Zhang, Hongyu] Wenzhou Med Univ, Dongyang Peoples Hosp, Expt Res Ctr, Jinhua, Zhejiang, Peoples R China		Chen, DQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou 325027, Peoples R China.; Chen, DQ (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Peoples R China.; Zhang, HY (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou 325035, Peoples R China.; Wu, YQ (corresponding author), Wenzhou Univ, Inst Life Sci, Wenzhou 325035, Zhejiang, Peoples R China.	yqwu22094@yeah.net; hyzhang@wmu.edu.cn; cdq1965@126.com			Natural Science Foundation of Ningbo City [2018A610309]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81802251, 81772450, 81572237, 81501953]; Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences [YKFJ3-011]; Hospital Pharmacy Project of Zhejiang Pharmaceutical Association [2018ZYY35]; National Science Fund for Outstanding Young ScholarsNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars [81722028]; Zhejiang Provincial Natural Science FoundationNatural Science Foundation of Zhejiang Province [LQ18H150003, LY19H150001]; Reasearch Foundation of Hwa Mei Hospital, University of Chinese Academy of Sciences, China [2019HMKY19]	Natural Science Foundation of Ningbo City, Grant/Award Number: 2018A610309; National Natural Science Foundation of China, Grant/Award Number: 81802251, 81772450, 81572237 and 81501953; The Opening Project of Zhejiang Provincial Top Key Discipline of Pharmaceutical Sciences, Grant/Award Number: YKFJ3-011; Hospital Pharmacy Project of Zhejiang Pharmaceutical Association, Grant/Award Number: 2018ZYY35; The National Science Fund for Outstanding Young Scholars, Grant/Award Number: 81722028; Zhejiang Provincial Natural Science Foundation, Grant/Award Number: LQ18H150003 and LY19H150001; Reasearch Foundation of Hwa Mei Hospital, University of Chinese Academy of Sciences, China, Grant/Award Number: 2019HMKY19	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Andrews PJ, 2016, NEW ENGL J MED, V03, P68; Chong ZZ, 1999, ACTA PHARMACOL SIN, V20, P696; Dang B. C., 2017, NEURAL PLAST, V2017, P1; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Li JM, 2010, BRAIN RES, V1359, P216, DOI 10.1016/j.brainres.2010.08.061; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Niu F, 2019, WORLD NEUROSURG, V122, pE1090, DOI 10.1016/j.wneu.2018.10.236; Northington FJ, 2001, DEV NEUROSCI-BASEL, V23, P186, DOI 10.1159/000046141; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sun YF, 2017, BEHAV BRAIN RES, V329, P67, DOI 10.1016/j.bbr.2017.04.039; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Wang P, 2014, AUTOPHAGY, V10, P1535, DOI 10.4161/auto.29203; Wang ZT, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/240267; Wolf MS, 2019, NEUROBIOL DIS, V122, P9, DOI 10.1016/j.nbd.2018.04.018; Wu L, 2018, J NEUROTRAUM, V11; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Xie CC, 2016, AUTOPHAGY, V12, P410, DOI 10.1080/15548627.2015.1132134; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong ZL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00238; Xu J, 2017, NEUROCHEM RES, V42, P2968, DOI 10.1007/s11064-017-2328-3; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Xu XP, 2018, BBA-MOL BASIS DIS, V1864, P1663, DOI 10.1016/j.bbadis.2018.02.011; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Ye HX, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0700-6; Ye XW, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00734; Zarogoulidis P, 2016, MOL ONCOL, V10, P1516, DOI 10.1016/j.molonc.2016.08.005; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Zhang S, 2018, NEUROSCIENCE, V377, P126, DOI 10.1016/j.neuroscience.2018.02.035; Zhang T, 2014, NEUROSCIENCE, V263, P130, DOI 10.1016/j.neuroscience.2014.01.012; Zhao YY, 2017, NEUROCHEM INT, V111, P82, DOI 10.1016/j.neuint.2017.03.017; Zheng BB, 2017, INT J BIOL SCI, V13, P1520, DOI 10.7150/ijbs.21107; Zhou YL, 2016, INT J BIOL SCI, V12, P87, DOI 10.7150/ijbs.13229	47	14	15	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	JAN	2020	24	2					1220	1232		10.1111/jcmm.14691		DEC 2019	13	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	KH1OU	WOS:000502637600001	31840938	Green Published, gold			2022-02-06	
J	Wackym, PA; Balaban, CD; Zhang, PF; Siker, DA; Hundal, JS				Wackym, P. Ashley; Balaban, Carey D.; Zhang, Pengfei; Siker, David A.; Hundal, Jasdeep S.			Third Window Syndrome: Surgical Management of Cochlea-Facial Nerve Dehiscence	FRONTIERS IN NEUROLOGY			English	Article						cochlea-facial nerve dehiscence; cognitive dysfunction; dizziness; perilymph fistula; spatial disorientation; superior semicircular canal dehiscence syndrome; traumatic brain injury; vestibular migraine	TULLIO PHENOMENON; PERILYMPHATIC FISTULAS; HEARING-LOSS; BONE; ABNORMALITIES; PREVALENCE; CEREBELLUM; OUTCOMES; SURGERY; EAR	Objective: This communication is the first assessment of outcomes after surgical repair of cochlea-facial nerve dehiscence (CFD) in a series of patients. Pre- and post-operative quantitative measurement of validated survey instruments, symptoms, diagnostic findings and anonymous video descriptions of symptoms in a cohort of 16 patients with CFD and third window syndrome (TWS) symptoms were systematically studied. Study design: Observational analytic case-control study. Setting: Quaternary referral center. Patients: Group 1 had 8 patients (5 children and 3 adults) with CFD and TWS who underwent surgical management using a previously described round window reinforcement technique. Group 2 had 8 patients (2 children and 6 adults) with CFD who did not have surgical intervention. Interventions: The Dizziness Handicap Inventory (DHI) and Headache Impact Test (HIT-6) were administered pre-operatively and post-operatively. In addition, diagnostic findings of comprehensive audiometry, cervical vestibular evoked myogenic potential (cVEMP) thresholds and electrocochleography (ECoG) were studied. Symptoms before and after surgical intervention were compared. Main outcome measures: Pre- vs. post-operative DHI, HIT-6, and audiometric data were compared statistically. The thresholds and amplitudes for cVEMP in symptomatic ears, ears with cochlea-facial nerve dehiscence and ears without CFD were compared statistically. Results: There was a highly significant improvement in DHI and HIT-6 at pre- vs. post-operative (p < 0.0001 and p < 0.001, respectively). The age range was 12.8-52.9 years at the time of surgery (mean = 24.7 years). There were 6 females and 2 males. All 8 had a history of trauma before the onset of their symptoms. The mean cVEMP threshold was 75 dB nHL (SD 3.8) for the operated ear and 85.7 dB (SD 10.6) for the unoperated ear. In contrast to superior semicircular canal dehiscence, where most ears have abnormal ECoG findings suggestive of endolymphatic hydrops, only 1 of 8 operated CFD ears (1 of 16 ears) had an abnormal ECoG study. Conclusions: Overall there was a marked improvement in DHI, HIT-6 and symptoms post-operatively. Statistically significant reduction in cVEMP thresholds was observed in patients with radiographic evidence of CFD. Surgical management with round window reinforcement in patients with CFD was associated with improved symptoms and outcomes measures.	[Wackym, P. Ashley] Rutgers Robert Wood Johnson Med Sch, Dept Otolaryngol Head & Neck Surg, New Brunswick, NJ 08901 USA; [Balaban, Carey D.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Balaban, Carey D.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Balaban, Carey D.] Univ Pittsburgh, Sch Med, Dept Commun Sci & Disorders, Pittsburgh, PA USA; [Balaban, Carey D.] Univ Pittsburgh, Sch Med, Dept Bioengn, Pittsburgh, PA USA; [Zhang, Pengfei] Rutgers Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ USA; [Siker, David A.] Siker Med Imaging & Intervent, Portland, OR USA; [Hundal, Jasdeep S.] Rutgers Robert Wood Johnson Med Sch, Dept Neurosurg, New Brunswick, NJ USA		Wackym, PA (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Otolaryngol Head & Neck Surg, New Brunswick, NJ 08901 USA.	wackym@neurotology.org	Balaban, Carey/I-3467-2017	Balaban, Carey/0000-0002-3570-3844; Wackym, P. Ashley/0000-0002-2904-5072; Zhang, Pengfei/0000-0003-1132-1937	Department of Otolaryngology-Head and Neck Surgery, Rutgers Robert Wood Johnson Medical School; Ear and Skull Base Center	Funds were provided by the Department of Otolaryngology-Head and Neck Surgery, Rutgers Robert Wood Johnson Medical School, and the Ear and Skull Base Center.	Arts HA, 2009, OTOL NEUROTOL, V30, P79, DOI 10.1097/MAO.0b013e31818d1b51; Bae YJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081182; Bayliss M., 2002, HIT 6 USERS GUIDE; Bear ZW, 2015, ACTA OTO-LARYNGOL, V135, P974, DOI 10.3109/00016489.2015.1060630; BLACK FO, 1992, AM J OTOL, V13, P254; Blake DM, 2014, LARYNGOSCOPE, V124, P283, DOI 10.1002/lary.24223; COLEBATCH JG, 1994, J NEUROL NEUROSUR PS, V57, P1538, DOI 10.1136/jnnp.57.12.1538; Crane BT, 2008, LARYNGOSCOPE, V118, P1809, DOI 10.1097/MLG.0b013e31817f18fa; Dasgupta S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00306; Deveze Arnaud, 2018, Adv Otorhinolaryngol, V81, P133, DOI 10.1159/000485579; Digre KB, 2019, HEADACHE, V59, P1, DOI 10.1111/head.13456; Elmali M, 2013, EUR J RADIOL, V82, pE606, DOI 10.1016/j.ejrad.2013.06.022; Fang CH., 2017, OTOLARYNGOL CASE REP, V3, P12, DOI [10.1016/j.xocr.2017.04.003, DOI 10.1016/J.XOCR.2017.04.003]; Fang CH, 2016, OTOL NEUROTOL, V37, P967, DOI 10.1097/MAO.0000000000001057; FOX EJ, 1988, OTOLARYNG HEAD NECK, V98, P88, DOI 10.1177/019459988809800115; Friedland DR, 1999, AM J OTOL, V20, P261; Fujita T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00047; Furman JM, 2013, LANCET NEUROL, V12, P706, DOI 10.1016/S1474-4422(13)70107-8; Gianoli GJ, 2018, JAMA-J AM MED ASSOC, V320, P603, DOI 10.1001/jama.2018.8713; GOODHILL V, 1971, LARYNGOSCOPE, V81, P1462, DOI 10.1288/00005537-197109000-00010; Gopen Q, 2010, OTOL NEUROTOL, V31, P339, DOI 10.1097/MAO.0b013e3181be65a4; GORDON A G, 1976, Medical Hypotheses, V2, P125, DOI 10.1016/0306-9877(76)90067-0; Grieser BJ, 2016, JARO-J ASSOC RES OTO, V17, P103, DOI 10.1007/s10162-016-0553-0; Gurgel RK, 2012, OTOLARYNG HEAD NECK, V147, P803, DOI 10.1177/0194599812458401; Ho ML, 2017, AM J NEURORADIOL, V38, P2, DOI 10.3174/ajnr.A4922; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Hoche F, 2018, BRAIN, V141, P248, DOI 10.1093/brain/awx317; Hoffer ME, 2019, LARYNGOSCOPE INVEST, V4, P124, DOI 10.1002/lio2.231; Hornibrook J., 2012, ISRN OTOLARYNGOL, V2012; Hornibrook J., BALANCE ABNORMALITY; HUIZINGA E, 1955, J Laryngol Otol, V69, P260, DOI 10.1017/S0022215100050635; Ionescu EC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00683; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kamil RJ, 2018, OTOL NEUROTOL, V39, P765, DOI 10.1097/MAO.0000000000001838; KOHUT RI, 1992, ARCH OTOLARYNGOL, V118, P687; Koo JW, 2010, J NEUROL NEUROSUR PS, V81, P465, DOI 10.1136/jnnp.2008.155564; Manzari L, 2010, ACTA OTORHINOLARYNGO, V30, P317; Manzari L, 2013, ENT-EAR NOSE THROAT, V92, P25, DOI 10.1177/014556131309200109; MARGOLIS RH, 1995, ARCH OTOLARYNGOL, V121, P44; Meiklejohn DA, 2015, OTOL NEUROTOL, V36, P1383, DOI 10.1097/MAO.0000000000000811; Merchant SN, 2008, OTOL NEUROTOL, V29, P282, DOI 10.1097/mao.0b013e318161ab24; Mikulec AA, 2005, LARYNGOSCOPE, V115, P501, DOI 10.1097/01.mlg.0000157844.48036.e7; Minor LB, 2005, LARYNGOSCOPE, V115, P1717, DOI 10.1097/01.mlg.0000178324.55729.b7; Minor LB, 1998, ARCH OTOLARYNGOL, V124, P249, DOI 10.1001/archotol.124.3.249; Naert L, 2018, LARYNGOSCOPE, V128, P1932, DOI 10.1002/lary.27062; Noij KS, 2018, OTOL NEUROTOL, V39, P1153, DOI 10.1097/MAO.0000000000001910; Ostrowski VB, 1997, ARCH OTOLARYNGOL, V123, P646; Park JJH, 2015, AM J OTOLARYNG, V36, P347, DOI 10.1016/j.amjoto.2014.12.006; PYYKKO I, 1992, AM J OTOL, V13, P339; Ravishankar Nandini, 2007, Dis Mon, V53, P156, DOI 10.1016/j.disamonth.2007.04.006; Schart-Moren Nadine, 2018, Cochlear Implants Int, V19, P324, DOI 10.1080/14670100.2018.1481179; Schart-Moren N, 2017, AUDIOL NEURO-OTOL, V22, P41, DOI 10.1159/000475876; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schmahmann JD, 2019, NEUROSCI LETT, V688, P62, DOI 10.1016/j.neulet.2018.07.005; Sharon JD, 2016, OTOL NEUROTOL, V37, P1096, DOI 10.1097/MAO.0000000000001113; Shim YJ, 2019, OTOL NEUROTOL, V40, pE186, DOI 10.1097/MAO.0000000000002144; Song YH, 2018, OTOL NEUROTOL, V39, P1319, DOI 10.1097/MAO.0000000000002015; STROUD MH, 1970, LARYNGOSCOPE, V80, P479, DOI 10.1288/00005537-197003000-00012; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Tullio P., 1929, OHR ENTSTEHUNG SPRAC, P1; Wackym PA, 2017, LARYNGOSCOPE INVEST, V2, P225, DOI 10.1002/lio2.89; Wackym PA, 2016, OTOL NEUROTOL, V37, P70, DOI 10.1097/MAO.0000000000000928; Wackym P Ashley, 2015, Ear Nose Throat J, V94, pE8; Wackym PA, 2012, OTOL NEUROTOL, V33, P1392, DOI 10.1097/MAO.0b013e318268d234; WACKYM PA, 1993, AM J OTOL, V14, P41; Wackym PA, RIGHT COCHLEA FACIAL; Wackym PA, 2016, 7 INT S MEN DIS INN, P77; Wackym PA, ROUND WINDOW REINFOR; Wackym PA, COCHLEA FACIAL NERVE; Wackym PA, TUNING FORK TESTING; Wackym PA, SURG COCHLEA FACIAL; Ward BK, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00177; Ward BK, 2013, OTOL NEUROTOL, V34, P1421, DOI 10.1097/MAO.0b013e318287efe6; Weinreich Heather M, 2019, Adv Otorhinolaryngol, V82, P93, DOI 10.1159/000490276; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Xu D, 2019, CEPHALALGIA, V39, P1164, DOI 10.1177/0333102419829007; Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890; Yoder RM, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00032; Young L, 2010, OTOL NEUROTOL, V31, P697, DOI 10.1097/MAO.0b013e31819bd803; Zhou GW, 2007, OTOL NEUROTOL, V28, P920, DOI 10.1097/MAO.0b013e31814b25f2; Zou J, 2012, ANN OTO RHINOL LARYN, V121, P119, DOI 10.1177/000348941212100209; Zou Jing, 2010, Hear Res, V259, P36, DOI 10.1016/j.heares.2009.09.015	82	14	14	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 13	2019	10								1281	10.3389/fneur.2019.01281			24	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY9ET	WOS:000504710100001	31920911	Green Published, gold			2022-02-06	
J	Ebert, SE; Jensen, P; Ozenne, B; Armand, S; Svarer, C; Stenbaek, DS; Moeller, K; Dyssegaard, A; Thomsen, G; Steinmetz, J; Forchhammer, BH; Knudsen, GM; Pinborg, LH				Ebert, S. E.; Jensen, P.; Ozenne, B.; Armand, S.; Svarer, C.; Stenbaek, D. S.; Moeller, K.; Dyssegaard, A.; Thomsen, G.; Steinmetz, J.; Forchhammer, B. H.; Knudsen, G. M.; Pinborg, L. H.			Molecular imaging of neuroinflammation in patients after mild traumatic brain injury: a longitudinal I-123-CLINDE single photon emission computed tomography study	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						concussion; inflammation; microglia; mild traumatic brain injury; neuroinflammation; post-concussion symptoms; post-concussion syndrome; translocator protein	ACTIVATION	Background and purpose Neuroinflammation has been proposed as part of the pathogenesis of post-concussion symptoms (PCS), but the inflammatory response of the human brain to mild traumatic brain injury (mTBI) remains unknown. We hypothesized that a neuroinflammatory response is present in mTBI at 1-2 weeks post-injury and persists in patients with PCS. Methods We scanned 14 patients with mTBI without signs of structural damage at 1-2 weeks and 3-4 months post-injury and 22 healthy controls once using the single photon emission computed tomography tracer I-123-CLINDE, which visualizes translocator protein (TSPO), a protein upregulated in active immune cells. PCS was defined as three or more persisting symptoms from the Rivermead Post Concussion Symptoms Questionnaire at 3 months post-injury. Results Across brain regions, patients had significantly higher I-123-CLINDE binding to TSPO than healthy controls, both at 1-2 weeks after the injury in all patients (P = 0.011) and at 3-4 months in the seven patients with PCS (P = 0.006) and in the six patients with good recovery (P = 0.018). When the nine brain regions were tested separately and results were corrected for multiple comparisons, no individual region differed significantly, but all estimated parameters indicated increased I-123-CLINDE binding to TSPO, ranging from 2% to 19% in all patients at 1-2 weeks, 13% to 27% in patients with PCS at 3-4 months and -9% to 17% in patients with good recovery at 3-4 months. Conclusions Neuroinflammation was present in mTBI at 1-2 weeks post-injury and persisted at 3-4 months post-injury with a tendency to be most pronounced in patients with PCS.	[Ebert, S. E.; Jensen, P.; Ozenne, B.; Armand, S.; Svarer, C.; Stenbaek, D. S.; Dyssegaard, A.; Thomsen, G.; Knudsen, G. M.; Pinborg, L. H.] Rigshosp, Neurobiol Res Unit, 28 Juliane Mules Vej,3rd Floor,Bldg 6931, DK-2100 Copenhagen, Denmark; [Ebert, S. E.; Ozenne, B.; Moeller, K.; Forchhammer, B. H.; Knudsen, G. M.; Pinborg, L. H.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Moeller, K.] Rigshosp, Dept Neuroanaesthesiol, Copenhagen, Denmark; [Steinmetz, J.] Rigshosp, Trauma Ctr, Copenhagen, Denmark; [Pinborg, L. H.] Rigshosp, Dept Neurol, Copenhagen, Denmark		Pinborg, LH (corresponding author), Rigshosp, Neurobiol Res Unit, 28 Juliane Mules Vej,3rd Floor,Bldg 6931, DK-2100 Copenhagen, Denmark.	lars.pinborg@nru.dk	Knudsen, Gitte Moos/C-1368-2013; Steinmetz, Jacob/AAY-6076-2020; Moller, Kirsten/A-4751-2009	Knudsen, Gitte Moos/0000-0003-1508-6866; Steinmetz, Jacob/0000-0001-9620-8911; Pinborg, Lars Hageman/0000-0001-9024-7936; Stenbaek, Dea/0000-0002-5439-4637; Moller, Kirsten/0000-0003-3058-1072; Svarer, Claus/0000-0001-7811-1825; Elgaard Ebert, Sebastian/0000-0001-6626-0276			Albrecht DS, 2016, ACS CHEM NEUROSCI, V7, P470, DOI 10.1021/acschemneuro.6b00056; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Dmitrienko A, 2013, STAT MED, V32, P5172, DOI 10.1002/sim.5990; Feng L, 2017, J NUCL MED, V58, P989, DOI 10.2967/jnumed.116.183202; Feng L, 2014, J NUCL MED, V55, P1966, DOI 10.2967/jnumed.114.143727; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Holst KK, 2013, COMPUTATION STAT, V28, P1385, DOI 10.1007/s00180-012-0344-y; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Knudsen GM, 2016, NEUROIMAGE, V124, P1213, DOI 10.1016/j.neuroimage.2015.04.025; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Skrondal A., 2004, GEN LATENT VARIABLE; Svarer C, 2005, NEUROIMAGE, V24, P969, DOI 10.1016/j.neuroimage.2004.10.017; Vallez Garcia D, 2016, J NEUROTRAUM, V33, P1855, DOI 10.1089/neu.2015.4230	24	14	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	DEC	2019	26	12					1426	1432		10.1111/ene.13971			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ0XV	WOS:000493885800005	31002206				2022-02-06	
J	Marshall, CA; Davidson, L; Li, A; Gewurtz, R; Roy, L; Barbic, S; Kirsh, B; Lysaght, R				Marshall, Carrie Anne; Davidson, Lisa; Li, Andrea; Gewurtz, Rebecca; Roy, Laurence; Barbic, Skye; Kirsh, Bonnie; Lysaght, Rosemary			Boredom and meaningful activity in adults experiencing homelessness: A mixed-methods study	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Homeless persons; Human activities; Occupational therapy; Poverty; Well-being	TRAUMATIC BRAIN-INJURY; MENTAL-ILLNESS; SUBSTANCE USE; HOUSING 1ST; OCCUPATION; STATE; TRANSITION; ENGAGEMENT; PRONENESS; BARRIERS	Background. Boredom has been reported as a frequent problem experienced by homeless persons, with implications for mental and social well-being. Purpose. This study aimed to explore the nature and impact of boredom in the lives of homeless and formerly homeless persons. Method. A mixed-methods design was used to engage 13 participants in a structured 92-item quantitative interview using six standardized measures, followed by a semistructured qualitative interview. Correlational analyses were performed with the data compiled from the quantitative interviews, and grounded theory strategies were used to analyze our qualitative data. The two analyses were integrated at the stage of interpretation. Findings. Boredom was described as a profound and pervasive experience for homeless persons, imposing deleterious impacts on mental well-being and driving substance use. A strong positive correlation between meaningful activity and mental well-being (r(s) = .767, p <. 01) and a strong negative correlation between boredom and belonging in one's community (r(s) = -.771, p < .01) were identified.	[Marshall, Carrie Anne] Western Univ, Sch Occupat Therapy, Fac Hlth Sci, London, ON, Canada; [Marshall, Carrie Anne] Queens Univ, Occupat Therapy Program, Kingston, ON, Canada; [Davidson, Lisa] McMaster Univ, DeGroote Sch Business, Hamilton, ON, Canada; [Li, Andrea] Karp Rehabil Burnaby, Burnaby, BC, Canada; [Gewurtz, Rebecca] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Roy, Laurence] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Barbic, Skye] Univ British Columbia, Fac Med, Dept Occupat Sci & Occupat Therapy, Vancouver, BC, Canada; [Barbic, Skye] Foundry, Vancouver, BC, Canada; [Kirsh, Bonnie] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Lysaght, Rosemary] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada		Marshall, CA (corresponding author), Western Univ, Occupat Therapy Fac Hlth Sci, London, ON N6G 1H1, Canada.	carrie.marshall@uwo.ca	Barbic, Skye/AAW-4044-2020; Gewurtz, Rebecca/ABE-7350-2021; Marshall, Carrie Anne/T-2165-2019	Gewurtz, Rebecca/0000-0002-1794-7749; Marshall, Carrie Anne/0000-0002-0592-7716			[Anonymous], 2007, IMPR HLTH CAN MENT H; Babor T.F., 2001, AUDIT THE ALCOHOL US; Benbow S, 2011, J PSYCHIATR MENT HLT, V18, P687, DOI 10.1111/j.1365-2850.2011.01720.x; Brintnell E., 1994, ENGAGEMENT MEANINGFU; Canadian Observatory on Homelessness, 2012, CAN DEF HOM; Chin A, 2017, EMOTION, V17, P359, DOI 10.1037/emo0000232; Cocco KM, 1998, PSYCHOL ASSESSMENT, V10, P408, DOI 10.1037/1040-3590.10.4.408; Cohen J., 2013, STAT POWER ANAL BEHA; Corvinelli A, 2005, OCCUP THER MENT HEAL, V21, P1, DOI 10.1300/J004v21n02_01; Creswell J., 2009, RES DESIGN, V3rd; Dahlen ER, 2005, ACCIDENT ANAL PREV, V37, P341, DOI 10.1016/j.aap.2004.10.006; Dedoose, 2015, WEB APPL MAN AN PRES; Eastwood JD, 2012, PERSPECT PSYCHOL SCI, V7, P482, DOI 10.1177/1745691612456044; Fahlman SA, 2013, ASSESSMENT, V20, P68, DOI 10.1177/1073191111421303; *Farnworth L., 1998, J OCCUP SCI, V5, P140, DOI [10.1080/14427591.1998.9686442, DOI 10.1080/14427591.1998.9686442]; Frankish CJ, 2005, CAN J PUBLIC HEALTH, V96, pS23, DOI 10.1007/BF03403700; Gaetz S., 2016, STATE HOMELESSNESS C; Gerritsen CJ, 2015, INT J SOC PSYCHIATR, V61, P781, DOI 10.1177/0020764015584647; Goering, 2014, NATL HOME CHEZ SOI F; Goldberg B., 2002, OCCUP THER MENT HEAL, V18, P17, DOI [10.1300/J004v18n02_03, DOI 10.1300/J004V18N02_03, DOI 10.1300/J004V18N02_]; Goldberg Y, 2013, BEHAV SCI-BASEL, V3, P434, DOI 10.3390/bs3030434; Goldberg YK, 2011, J SOC CLIN PSYCHOL, V30, P647, DOI 10.1521/jscp.2011.30.6.647; Hopper E., 2010, OPEN HLTH SERVICES P, V3, DOI [DOI 10.2174/1874924001003020080, 10.2174/1874924001003020080, DOI 10.2174/1874924001003010080]; Hunter JA, 2016, EUR J PSYCHOL ASSESS, V32, P241, DOI 10.1027/1015-5759/a000251; Kirst M, 2015, DRUG ALCOHOL DEPEN, V146, P24, DOI 10.1016/j.drugalcdep.2014.10.019; Krausz RM, 2013, SOC PSYCH PSYCH EPID, V48, P1235, DOI 10.1007/s00127-012-0649-8; Lee CM, 2007, ADDICT BEHAV, V32, P1384, DOI 10.1016/j.addbeh.2006.09.010; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Mahar AL, 2013, DISABIL REHABIL, V35, P1026, DOI 10.3109/09638288.2012.717584; Marshall CA, 2018, CAN J OCCUP THER, V85, P33, DOI 10.1177/0008417417723351; Marshall CA, 2017, J OCCUP SCI, V24, P165, DOI 10.1080/14427591.2016.1277548; Marshall CA, 2014, CAN J OCCUP THER, V81, P330, DOI 10.1177/0008417414548573; Martin M., 2006, QUAL RES PSYCHOL, V3, P193, DOI [10.1191/1478088706qrp066oa, DOI 10.1191/1478088706QRP0660A, DOI 10.1191/1478088706QRP066OA]; Martin M, 2012, J OCCUP SCI, V19, P54, DOI 10.1080/14427591.2011.640210; McDonald AE, 2006, OCCUP THER HEALTH CA, V20, P115, DOI [10.1080/J003v20n03_08, 10.1300/J003v20n03_08]; Mercer-Lynn KB, 2014, PERS INDIV DIFFER, V56, P122, DOI 10.1016/j.paid.2013.08.034; Moll SE, 2015, CAN J OCCUP THER, V82, P9, DOI 10.1177/0008417414545981; O'Neill B, 2015, PUBLIC CULTURE, V27, P387, DOI 10.1215/08992363-2841916; O'Neill B, 2014, CULT ANTHROPOL, V29, P8, DOI 10.14506/ca29.1.03; Patterson ML, 2014, COMMUNITY MENT HLT J, V50, P604, DOI 10.1007/s10597-013-9672-9; Pickens ND, 2009, J OCCUP SCI, V16, P151, DOI 10.1080/14427591.2009.9686656; Poremski D, 2016, J URBAN HEALTH, V93, P96, DOI 10.1007/s11524-015-0012-y; Raphael-Greenfield EI, 2015, OCCUP THER MENT HEAL, V31, P35, DOI 10.1080/0164212X.2014.1001011; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Roy L, 2017, CAN J OCCUP THER, V84, P98, DOI 10.1177/0008417416688709; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Shinn M, 2010, EUROPEAN J HOMELESSN, V4, P19; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; STERGIOPOULOS V, 2015, JAMA-J AM MED ASSOC, V313, P905, DOI DOI 10.1001/JAMA.2015.1163; Strauss A., 1990, BASICS QUALITATIVE R; Taggart F., 2014, WEMWBS POPULATION NO; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Thomas Y, 2011, AUST OCCUP THER J, V58, P429, DOI 10.1111/j.1440-1630.2011.00977.x; Thomas Y, 2011, OCCUP THER HEALTH CA, V25, P38, DOI 10.3109/07380577.2010.528554; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; WEISSINGER E, 1995, LOISIR SOC-SOC LEIS, V18, P21, DOI 10.1080/07053436.1995.10715488; Weybright EH, 2015, LEISURE SCI, V37, P311, DOI 10.1080/01490400.2015.1014530	57	14	14	5	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	DEC	2019	86	5					357	370		10.1177/0008417419833402			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	JQ1NH	WOS:000498719400002	30987447				2022-02-06	
J	Plastira, I; Joshi, L; Bernhart, E; Schoene, J; Specker, E; Nazare, M; Sattler, W				Plastira, Ioanna; Joshi, Lisha; Bernhart, Eva; Schoene, Jens; Specker, Edgar; Nazare, Marc; Sattler, Wolfgang			Small-Molecule Lysophosphatidic Acid Receptor 5 (LPAR5) Antagonists: Versatile Pharmacological Tools to Regulate Inflammatory Signaling in BV-2 Microglia Cells	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						LPA5; microglia; chemokines; cytokines; neurotoxicity; transcription factors	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; MOTOR-NEURON DEATH; SPINAL-CORD; NITRIC-OXIDE; ACTIVATION; EXPRESSION; AUTOTAXIN; CONTRIBUTES; PHYSIOLOGY	Lysophosphatidic acid (LPA) species in the extracellular environment induce downstream signaling via six different G protein-coupled receptors (LPAR1-6). These signaling cascades are essential for normal brain development and function of the nervous system. However, in response to acute or chronic central nervous system (CNS) damage, LPA levels increase and aberrant signaling events can counteract brain function. Under neuro-inflammatory conditions signaling along the LPA/LPAR5 axis induces a potentially neurotoxic microglia phenotype indicating the need for new pharmacological intervention strategies. Therefore, we compared the effects of two novel small-molecule LPAR5 antagonists on LPA-induced polarization parameters of the BV-2 microglia cell line. AS2717638 is a selective piperidine-based LPAR5 antagonist (IC50 0.038 mu M) while compound 3 is a diphenylpyrazole derivative with an IC50 concentration of 0.7 mu M in BV-2 cells. Both antagonists compromised cell viability, however, at concentrations above their IC50 concentrations. Both inhibitors blunted LPA-induced phosphorylation of STAT1 and STAT3, p65, and c-Jun and consequently reduced the secretion of pro-inflammatory cyto-/chemokines (IL-6, TNF alpha, IL-1 beta, CXCL10, CXCL2, and CCL5) at non-toxic concentrations. Both compounds modulated the expression of intracellular (COX-2 and Arg1) and plasma membrane-located (CD40, CD86, and CD206) polarization markers yet only AS2717638 attenuated the neurotoxic potential of LPA-activated BV-2 cell-conditioned medium towards CATH.a neurons. Our findings from the present in vitro study suggest that the two LPAR5 antagonists represent valuable pharmacological tools to interfere with LPA-induced pro-inflammatory signaling cascades in microglia.	[Plastira, Ioanna; Joshi, Lisha; Bernhart, Eva; Sattler, Wolfgang] Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Graz, Austria; [Schoene, Jens; Specker, Edgar; Nazare, Marc] Leibniz Forschungsinst Mol Pharmakol FMP, Berlin, Germany; [Nazare, Marc] Charite, BIH, Berlin, Germany; [Nazare, Marc] MDC, Berlin, Germany; [Sattler, Wolfgang] BioTechMed Graz, Ctr Explorat Lipid, Graz, Austria		Sattler, W (corresponding author), Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Graz, Austria.; Sattler, W (corresponding author), BioTechMed Graz, Ctr Explorat Lipid, Graz, Austria.	wolfgang.sattler@medunigraz.at	Nazare, Marc/AAD-6082-2022	Nazare, Marc/0000-0002-1602-2330; Plastira, Ioanna/0000-0003-2403-9973; Joshi, Lisha/0000-0003-2714-6686	L'Oreal "For Women in Science''; Austrian Academy of Science; Austrian Science Fund (FWF)Austrian Science Fund (FWF) [DK-MOLIN W-1241]; Medical University of Graz [DK-MOLIN W-1241]; BioTechMed-Graz	This work was supported by a fellowship grant from L'Oreal "For Women in Science'' and the Austrian Academy of Science (to IP). Financial support by the Austrian Science Fund (FWF; DK-MOLIN W-1241), the Medical University of Graz (DK-MOLIN W-1241) and BioTechMed-Graz is gratefully acknowledged. The funders were not involved in the study design, collection, analysis, and interpretation of data, the writing of the article or the decision to submit for publication.	Amisten S, 2008, THROMB RES, V122, P47, DOI 10.1016/j.thromres.2007.08.014; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Awada R, 2014, J CELL BIOCHEM, V115, P2123, DOI 10.1002/jcb.24889; Awada R, 2012, FREE RADICAL BIO MED, V52, P516, DOI 10.1016/j.freeradbiomed.2011.11.014; Bernhart E, 2010, PROTEOMICS, V10, P141, DOI 10.1002/pmic.200900195; Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bottcher C, 2019, NAT NEUROSCI, V22, P78, DOI 10.1038/s41593-018-0290-2; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Chen FX, 2010, J MOL NEUROSCI, V40, P353, DOI 10.1007/s12031-009-9323-3; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Choi SH, 2005, J NEUROSCI, V25, P4082, DOI 10.1523/JNEUROSCI.4306-04.2005; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Crack PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-37; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; De-Fraja C, 1998, J NEUROSCI RES, V54, P320, DOI 10.1002/(SICI)1097-4547(19981101)54:3<320::AID-JNR3>3.0.CO;2-R; Delgado M, 2003, J BIOL CHEM, V278, P27620, DOI 10.1074/jbc.M303199200; Du LL, 2017, MOL NEUROBIOL, V54, P1992, DOI 10.1007/s12035-016-9758-9; Eisenried A, 2017, PAIN, V158, P2181, DOI 10.1097/j.pain.0000000000001019; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Garaschuk O, 2019, METHODS MOL BIOL, V2034, P27, DOI 10.1007/978-1-4939-9658-2_3; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Gu JH, 2008, J NEURO-ONCOL, V89, P9, DOI 10.1007/s11060-008-9590-9; Guneykaya D, 2018, CELL REP, V24, P2773, DOI 10.1016/j.celrep.2018.08.001; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hammond TR, 2018, ANNU REV CELL DEV BI, V34, P523, DOI 10.1146/annurev-cellbio-100616-060509; Hashioka S, 2009, NEUROBIOL AGING, V30, P1924, DOI 10.1016/j.neurobiolaging.2008.02.019; He YB, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1195-4; Herr DR, 2018, ACS CHEM NEUROSCI, V9, P398, DOI 10.1021/acschemneuro.8b00057; Herrera-Molina R, 2012, J NEUROCHEM, V123, P113, DOI 10.1111/j.1471-4159.2012.07887.x; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; Huang CF, 2008, J NEUROIMMUNOL, V204, P118, DOI 10.1016/j.jneuroim.2008.07.004; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kano K, 2008, CURR MED CHEM, V15, P2122, DOI 10.2174/092986708785747562; Kawamoto Y, 2018, BIOORGAN MED CHEM, V26, P257, DOI 10.1016/j.bmc.2017.11.038; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Kozian DH, 2016, CHEMBIOCHEM, V17, P861, DOI 10.1002/cbic.201500559; Kozian DH, 2012, BIOORG MED CHEM LETT, V22, P5239, DOI 10.1016/j.bmcl.2012.06.057; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu B, 2002, ANN NY ACAD SCI, V962, P318, DOI 10.1111/j.1749-6632.2002.tb04077.x; Lundequist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018192; Ma L, 2010, J PHARMACOL EXP THER, V333, P540, DOI 10.1124/jpet.109.164830; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Matralis AN, 2019, MED RES REV, V39, P976, DOI 10.1002/med.21551; Moller T, 2001, J BIOL CHEM, V276, P25946, DOI 10.1074/jbc.M102691200; Mukherjee S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00002; Murai N, 2017, NEUROPHARMACOLOGY, V126, P97, DOI 10.1016/j.neuropharm.2017.08.032; Nicolas Celine S, 1800, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Norris GT, 2019, J EXP MED, V216, P60, DOI 10.1084/jem.20180199; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Ohuchi H, 2008, DEV DYNAM, V237, P3280, DOI 10.1002/dvdy.21736; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Parisi C, 2016, CELL DEATH DIFFER, V23, P531, DOI 10.1038/cdd.2015.153; Plastira I, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1024-1; Plastira I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0701-9; Raivich G, 2008, J NEUROCHEM, V107, P898, DOI 10.1111/j.1471-4159.2008.05684.x; Ramesh S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071827; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rauch Isabella, 2013, JAKSTAT, V2, pe23820, DOI 10.4161/jkst.23820; Rezai-Zadeh K, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-41; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Santos-Nogueira E, 2015, J NEUROSCI, V35, P10224, DOI 10.1523/JNEUROSCI.4703-14.2015; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schilling T, 2002, NEUROSCIENCE, V109, P827, DOI 10.1016/S0306-4522(01)00534-6; Smolders SMT, 2019, PROG NEUROBIOL, V178, P60, DOI 10.1016/j.pneurobio.2019.04.001; Song WM, 2018, NAT IMMUNOL, V19, P1048, DOI 10.1038/s41590-018-0212-1; Sun L, 2012, J NEUROSCI, V32, P11330, DOI 10.1523/JNEUROSCI.0677-12.2012; Tabuchi S, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0059-5; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Tay TL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0584-3; TIGYI G, 1995, AM J PHYSIOL-HEART C, V268, pH2048, DOI 10.1152/ajpheart.1995.268.5.H2048; Tsukahara R, 2018, J PHARMACOL SCI, V136, P93, DOI 10.1016/j.jphs.2018.01.001; Ueda H, 2013, BBA-MOL CELL BIOL L, V1831, P61, DOI 10.1016/j.bbalip.2012.08.014; Umemura K, 2006, NEUROSCI LETT, V400, P97, DOI 10.1016/j.neulet.2006.02.008; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Vodicka P, 2015, J HUNTINGTONS DIS, V4, P187, DOI 10.3233/JHD-150149; Waltl S, 2013, NEUROSCI LETT, V539, P16, DOI 10.1016/j.neulet.2013.01.014; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Yang XY, 2015, NEUROL SCI, V36, P2027, DOI 10.1007/s10072-015-2295-x; Yang XS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-54; Yao LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078439; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095	98	14	15	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	NOV 29	2019	13								531	10.3389/fncel.2019.00531			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JW0MI	WOS:000502753200001	31849616	Green Published, Green Accepted, gold			2022-02-06	
J	van der Horn, HJ; Vergara, VM; Espinoza, FA; Calhoun, VD; Mayer, AR; van der Naalt, J				van der Horn, Harm J.; Vergara, Victor M.; Espinoza, Flor A.; Calhoun, Vince D.; Mayer, Andrew R.; van der Naalt, Joukje			Functional outcome is tied to dynamic brain states after mild to moderate traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						brain dynamics; fMRI; functional connectivity; mild traumatic brain injury; networks; outcome; recovery	CONNECTIVITY; COMPLAINTS; NETWORK; CLASSIFICATION; PREDICTORS; SYMPTOMATOLOGY; VALIDATION; SUBJECT; SCALE; ICA	The current study set out to investigate the dynamic functional connectome in relation to long-term recovery after mild to moderate traumatic brain injury (TBI). Longitudinal resting-state functional MRI data were collected (at 1 and 3 months postinjury) from a prospectively enrolled cohort consisting of 68 patients with TBI (92% mild TBI) and 20 healthy subjects. Patients underwent a neuropsychological assessment at 3 months postinjury. Outcome was measured using the Glasgow Outcome Scale Extended (GOS-E) at 6 months postinjury. The 57 patients who completed the GOS-E were classified as recovered completely (GOS-E = 8; n = 37) or incompletely (GOS-E < 8; n = 20). Neuropsychological test scores were similar for all groups. Patients with incomplete recovery spent less time in a segregated brain state compared to recovered patients during the second visit. Also, these patients moved less frequently from one meta-state to another as compared to healthy controls and recovered patients. Furthermore, incomplete recovery was associated with disruptions in cyclic state transition patterns, called attractors, during both visits. This study demonstrates that poor long-term functional recovery is associated with alterations in dynamics between brain networks, which becomes more marked as a function of time. These results could be related to psychological processes rather than injury-effects, which is an interesting area for further work. Another natural progression of the current study is to examine whether these dynamic measures can be used to monitor treatment effects.	[van der Horn, Harm J.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr, Dept Neurol, Groningen, Netherlands; [van der Horn, Harm J.; Vergara, Victor M.; Espinoza, Flor A.; Calhoun, Vince D.; Mayer, Andrew R.] Mind Res Network, Albuquerque, NM USA; [Vergara, Victor M.; Calhoun, Vince D.] Emory, Georgia Tech, Triinst Ctr Translat Res Neuroimaging & Data Sci, Atlanta, GA USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Neurol & Psychiat Dept, Albuquerque, NM 87131 USA		van der Horn, HJ (corresponding author), Univ Groningen, Univ Med Ctr, Dept Neurol, Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; Vergara, Victor/0000-0001-9404-0924	Dutch Brain Foundation [Ps2012-06]	Dutch Brain Foundation, Grant/Award Number: Ps2012-06	Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2017, IMPACT T1 VERSUS EPI; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Du YH, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00525; Du YH, 2016, HUM BRAIN MAPP, V37, P1005, DOI 10.1002/hbm.23086; Du YH, 2013, NEUROIMAGE, V69, P157, DOI 10.1016/j.neuroimage.2012.11.008; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Espinoza FA, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00634; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Hamster K., 1983, MULTILINGUAL APHASIA; Hentschke H, 2011, EUR J NEUROSCI, V34, P1887, DOI 10.1111/j.1460-9568.2011.07902.x; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hou WS, 2019, BRAIN CONNECT, V9, P475, DOI 10.1089/brain.2018.0629; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jammes J. G. W., 1971, STROOP KLEUR WOORD T; Kaushal M, 2019, HUM BRAIN MAPP, V40, P1211, DOI 10.1002/hbm.24440; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mayer AR, 2007, J INT NEUROPSYCH SOC, V13, P839, DOI 10.1017/S1355617707071081; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Miller RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149849; Nelson L. D., 2019, JAMA NEUROLOGY; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A., 1964, EXAMEN CLIN PSYCHOL; Salman MS, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101747; Schmand B., 1999, AMSTERDAMSE KORTE TE; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; van der Horn HJ, 2018, BRAIN IMAGING BEHAV, V12, P912, DOI 10.1007/s11682-017-9743-6; van der Horn H. J., 2019, J NEUROLOGY; van der Horn HJ, 2017, J NEUROTRAUM, V34, P3262, DOI 10.1089/neu.2017.5185; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; van der Horn HJ., 2016, J NEUROTRAUMA, V34, P1035; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vergara V.M., 2019, MILD TRAUMATIC BRAIN; Vergara VM, 2019, HUM BRAIN MAPP, V40, P2089, DOI 10.1002/hbm.24509; Vergara VM, 2018, NEUROIMAGE-CLIN, V19, P30, DOI 10.1016/j.nicl.2018.03.017; Vergara VM, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.809; Vergara VM, 2017, NEUROIMAGE, V145, P365, DOI 10.1016/j.neuroimage.2016.03.038; Verhage F, 1964, INTELLIGENCE AGE STU; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Wechsler D., 2001, WECHSLER ADULT INTEL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu XR, 2019, J AFFECT DISORDERS, V245, P1032, DOI 10.1016/j.jad.2018.11.002	60	14	14	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	FEB 15	2020	41	3					617	631		10.1002/hbm.24827		OCT 2019	15	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	KF0UA	WOS:000491156900001	31633256	Green Published, hybrid			2022-02-06	
J	Rowson, S; Campolettano, ET; Duma, SM; Stemper, B; Shah, A; Harezlak, J; Riggen, L; Mihalik, JP; Guskiewicz, KM; Giza, C; Brooks, A; Cameron, K; McAllister, T; Broglio, SP; McCrea, M				Rowson, Steven; Campolettano, Eamon T.; Duma, Stefan M.; Stemper, Brian; Shah, Alok; Harezlak, Jaroslaw; Riggen, Larry; Mihalik, Jason P.; Guskiewicz, Kevin M.; Giza, Christopher; Brooks, Alison; Cameron, Kenneth; McAllister, Thomas; Broglio, Steven P.; McCrea, Michael			Accounting for Variance in Concussion Tolerance Between Individuals: Comparing Head Accelerations Between Concussed and Physically Matched Control Subjects	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Biomechanics; Impact; Brain injury; Threshold; Football; Sensors	COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; IMPACT EXPOSURE; INJURY; BIOMECHANICS; KINEMATICS; MAGNITUDE; LOCATION; RISK	Researchers have been collecting head impact data from instrumented football players to characterize the biomechanics of concussion for the past 15 years, yet the link between biomechanical input and clinical outcome is still not well understood. We have previously shown that even though concussive biomechanics might be unremarkable in large datasets of head impacts, the impacts causing injury are of high magnitude for the concussed individuals relative to their impact history. This finding suggests a need to account for differences in tolerance at the individual level. In this study, we identified control subjects for our concussed subjects who demonstrated traits we believed were correlated to factors thought to affect injury tolerance, including height, mass, age, race, and concussion history. A total of 502 college football players were instrumented with helmet-mounted accelerometer arrays and provided complete baseline assessment data, 44 of which sustained a total of 49 concussion. Biomechanical measures quantifying impact frequency and acceleration magnitude were compared between groups. On average, we found that concussed subjects experienced 93.8 more head impacts (p = 0.0031), 10.2 more high magnitude impacts (p = 0.0157), and 1.9 x greater risk-weighted exposure (p = 0.0175) than their physically matched controls. This finding provides further evidence that head impact data need to be considered at the individual level and that cohort wide assessments may be of little value in the context of concussion.	[Rowson, Steven; Campolettano, Eamon T.; Duma, Stefan M.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Stemper, Brian; Shah, Alok; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Harezlak, Jaroslaw; Riggen, Larry] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Giza, Christopher] Univ Calif Los Angeles, David Geffen Sch Med, Steve Tisch BrainSPORT Program, Dept Neurosurg, Los Angeles, CA 90095 USA; [Giza, Christopher] Univ Calif Los Angeles, David Geffen Sch Med, Steve Tisch BrainSPORT Program, Dept Pediat, Los Angeles, CA 90095 USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped, Madison, WI USA; [Cameron, Kenneth] US Mil Acad, Keller Army Hosp, John A Feagin Jr Sports Med Fellowship, West Point, NY 10996 USA; [McAllister, Thomas] Indiana Sch Med, Dept Psychiat, Indianapolis, IN USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA		Rowson, S (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	srowson@vt.edu	Stemper, Brian/AAX-7611-2020; Rowson, Steven/B-1270-2012; Harezlak, Jaroslaw/P-8557-2014	Rowson, Steven/0000-0002-3227-0596; Cameron, Kenneth/0000-0002-6276-4482; Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - Department of Defense (DoD); U.S. Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick MD; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This investigation was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds). The authors thank the following investigators: John DiFiori (University of California Los Angeles), Darren Campbell and Gerald McGinty (United States Air Force Academy), and Steven Svoboda (United States Military Academy). The authors thank the onfield HITS operators at each site: Julia Ford and Corey Rodrigo (University of North Carolina), Gus Hendricks and Max Zeiger (University of California Los Angeles [UCLA]), Quinn Lukens (University of Wisconsin), Brett Griesemer (Virginia Tech), Dom Calhoun (Air Force), and Sean Roach (West Point).	Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Campolettano ET, 2019, ANN BIOMED ENG, V47, P2086, DOI 10.1007/s10439-019-02309-x; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003312; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Danelson KA, 2008, STAPP CAR C, V52, P59; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6	35	14	14	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2019	47	10			SI		2048	2056		10.1007/s10439-019-02329-7			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JQ0HT	WOS:000498636800002	31342336	Green Published, hybrid			2022-02-06	
J	Yan, F; Li, M; Zhang, HQ; Li, GL; Hua, Y; Shen, Y; Ji, XM; Wu, CJ; An, H; Ren, M				Yan, Feng; Li, Ming; Zhang, Hong-Qi; Li, Gui-Lin; Hua, Yang; Shen, Ying; Ji, Xun-Ming; Wu, Chuan-Jie; An, Hong; Ren, Ming			Collagen-chitosan scaffold impregnated with bone marrow mesenchymal stem cells for treatment of traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; stem cells; collagen; chitosan; scaffolds; traumatic brain injury; bone marrow mesenchymal stem cells; brain tissue engineering; neural regeneration	TISSUE; REPAIR; TRANSPLANTATION; REGENERATION; PROTECTION	Combinations of biomaterials and cells can effectively target delivery of cells or other therapeutic factors to the brain to rebuild damaged nerve pathways after brain injury. Porous collagen-chitosan scaffolds were prepared by a freeze-drying method based on brain tissue engineering. The scaffolds were impregnated with rat bone marrow mesenchymal stem cells. A traumatic brain injury rat model was established using the 300 g weight free fall impact method. Bone marrow mesenchymal stem cells/collagen-chitosan scaffolds were implanted into the injured brain. Modified neurological severity scores were used to assess the recovery of neurological function. The Morris water maze was employed to determine spatial learning and memory abilities. Hematoxylin-eosin staining was performed to measure pathological changes in brain tissue. Immunohistochemistry was performed for vascular endothelial growth factor and for 5-bromo-2-deoxyuridine (BrdU)/neuron specific enolase and BrdU/glial fibrillary acidic protein. Our results demonstrated that the transplantation of bone marrow mesenchymal stein cells and collagen-chitosan scaffolds to traumatic brain injury rats remarkably reduced modified neurological severity scores, shortened the average latency of the Morris water maze, increased the number of platform crossings, diminished the degeneration of damaged brain tissue, and increased the positive reaction of vascular endothelial growth factor in the transplantation and surrounding areas. At 14 days after transplantation, increased BrdU/glial fibrillary acidic protein expression and decreased BrdU/neuron specific enolase expression were observed in bone marrow mesenchymal stem cells in the injured area. The therapeutic effect of bone marrow mesenchymal stem cells and collagen-chitosan scaffolds was superior to stereotactic injection of bone marrow mesenchymal stem cells alone. To test the biocompatibility and immunogenicity of bone marrow mesenchymal stem cells and collagen-chitosan scaffolds, immunosuppressive cyclosporine was intravenously injected 12 hours before transplantation and 1-5 days after transplantation. The above indicators were similar to those of rats treated with bone marrow mescnchymal stem cells and collagen-chitosan scaffolds only. These findings indicate that transplantation of bone marrow mesenchymal stem cells in a collagen-chitosan scaffold can promote the recovery of neuropathological injury in rats with traumatic brain injury. This approach has the potential to be developed as a treatment for traumatic brain injury in humans.	[Yan, Feng; Zhang, Hong-Qi; Li, Gui-Lin; Ji, Xun-Ming] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China; [Li, Ming; Ji, Xun-Ming; An, Hong; Ren, Ming] Capital Med Univ, Xuanwu Hosp, China Amer Inst Neurosci, Beijing, Peoples R China; [Hua, Yang] Capital Med Univ, Xuanwu Hosp, Dept Ultrasound, Beijing, Peoples R China; [Shen, Ying] Capital Med Univ, Xuanwu Hosp, Dept Tradit Chinese Med, Beijing, Peoples R China; [Wu, Chuan-Jie; An, Hong] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China		Ji, XM (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China.; Ji, XM (corresponding author), Capital Med Univ, Xuanwu Hosp, China Amer Inst Neurosci, Beijing, Peoples R China.	jixm@ccmu.edu.cn	Ji, Xunming/AAN-3370-2021	yan, feng/0000-0001-8663-6859	Postdoctoral Research Foundation of Beijing of China [2017-ZZ-120]; Natural Science Foundation of Beijing of ChinaBeijing Natural Science Foundation [2164073]; Beijing Municipal Administration of Hospitals' Youth Plan of China [QML20180804]	This study was financially supported by the Postdoctoral Research Foundation of Beijing of China, No. 2017-ZZ-120 (to FY); the Natural Science Foundation of Beijing of China, No. 2164073 (to ML); the Beijing Municipal Administration of Hospitals' Youth Plan of China, No. QML20180804 (to ML).; This study was financially supported by the Postdoctoral Research Foundation of Beijing of China, No. 2017-ZZ-120 (to FY); the Natural Science Foundation of Beijing of China, No. 2164073 (to ML); the Beijing Municipal Administration of Hospitals' Youth Plan of China, No. QML20180804 (to ML). The funders had no roles in the study design, conduction of experiment, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancur MI, 2017, ACS BIOMATER SCI ENG, V3, P420, DOI 10.1021/acsbiomaterials.6b00805; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cantinieaux D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069515; Chedly J, 2017, BIOMATERIALS, V138, P91, DOI 10.1016/j.biomaterials.2017.05.024; Chen SL, 2015, NEURAL REGEN RES, V10, P1777, DOI 10.4103/1673-5374.170301; Fu F, 2017, ZHONGGUO ZUZHI GONGC, V21, P864; Fu F, 2017, NEURAL REGEN RES, V12, P614, DOI 10.4103/1673-5374.205101; Greer K, 2017, BRAIN RES BULL, V134, P38, DOI 10.1016/j.brainresbull.2017.06.016; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Ji CD, 2011, BIOMATERIALS, V32, P9719, DOI 10.1016/j.biomaterials.2011.09.003; Jones Kathryn S, 2017, Neurogenesis (Austin), V4, P1, DOI 10.1080/23262133.2017.1297881; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kim CH, 2007, MANUAL BIOMATERIALS, P91; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; MacLean FL, 2018, APL BIOENG, V2, DOI 10.1063/1.5023709; Mahmood A, 2011, J NEUROTRAUM, V28, P1199, DOI 10.1089/neu.2010.1694; Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078; Moura D, 2016, SCI TECHNOL ADV MAT, V17, P626, DOI 10.1080/14686996.2016.1229104; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Pettikiriarachchi JTS, 2010, AUST J CHEM, V63, P1143, DOI 10.1071/CH10159; Prabaharan M, 2016, SPR SER POLYM COMPOS, P41, DOI 10.1007/978-81-322-2511-9_2; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Xia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076157; Xu Z, 2018, BIOMATERIALS, V157, P125, DOI 10.1016/j.biomaterials.2017.12.010; Yan F, 2015, NEURAL REGEN RES, V10, P1421, DOI 10.4103/1673-5374.163466; Zhang Q, 2013, J BIOACT COMPAT POL, V28, P426, DOI 10.1177/0883911513494620; [赵林 Zhao Lin], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P5923	28	14	15	1	35	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	OCT	2019	14	10					1780	1786	PMID 31169196	10.4103/1673-5374.257533			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	IC3YT	WOS:000470900400025	31169196	Green Published, gold			2022-02-06	
J	Zhang, YM; Wang, JP; Zhang, Y; Wei, J; Wu, RP; Cai, H				Zhang, Yamin; Wang, Jianping; Zhang, Yi; Wei, Jia; Wu, Ruipeng; Cai, Hui			Overexpression of long noncoding RNA Malat1 ameliorates traumatic brain injury induced brain edema by inhibiting AQP4 and the NF-kappa B/IL-6 pathway	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						astrocyte swelling; brain edema; long noncoding RNA; Malat1; traumatic brain injury	EXPRESSION; CELLS	Brain edema is a major traumatic brain injury (TBI)-related neurological complication. In the initiation stage of TBI, brain edema is characterized by astrocyte swelling (cytotoxic edema). We studied the impact of a long noncoding RNA, Malat1, on the TBI-induced astrocyte swelling and brain edema. Our results showed that Malat1 was downregulated in both the TBI rat model and the astrocyte fluid percussion injury (FPI) model, which concurred with brain edema and astrocyte swelling. Overexpression of Malat1 significantly inhibited rat brain edema, meanwhile reducing interleukin-6 (IL-6), nuclear factor-kappa B (NF-kappa B), and aquaporin 4 (AQP4) expression after TBI. In addition, overexpression of Malat1 ameliorated FPI-induced astrocyte swelling and reduced IL-6 release. Quantitative real-time polymerase chain reaction and Western blot analysis also corroborated the inhibitory effects of Malat1 on NF-kappa B and AQP4 expression after FPI. Our results highlighted the protective effects of Malat1 on the TBI-induced brain edema, which were mediated through regulating IL-6, NF-kappa B, and AQP4 expression. Our study could provide a novel approach for TBI treatment.	[Zhang, Yamin; Zhang, Yi; Wu, Ruipeng] Gansu Prov Hosp, Dept Neurol, Lanzhou, Gansu, Peoples R China; [Wang, Jianping] Gansu Prov Hosp, Emergency Dept, Lanzhou, Gansu, Peoples R China; [Wei, Jia] Gansu Prov Hosp, Youth League Comm, Lanzhou, Gansu, Peoples R China; [Cai, Hui] Gansu Prov Hosp, Gen Surg Clin Med Ctr, 204 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China		Cai, H (corresponding author), Gansu Prov Hosp, Gen Surg Clin Med Ctr, 204 Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China.	z691767@163.com					Bender AS, 1998, J NEUROSCI RES, V54, P673, DOI 10.1002/(SICI)1097-4547(19981201)54:5<673::AID-JNR12>3.0.CO;2-P; Biswas S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24907-w; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen JS, 2018, BIOCHEM PHARMACOL, V152, P94, DOI 10.1016/j.bcp.2018.03.019; Cheng ZJ, 2018, J STROKE CEREBROVASC, V27, P3247, DOI 10.1016/j.jstrokecerebrovasdis.2018.07.011; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Guo C, 2018, EUR REV MED PHARMACO, V22, P3703, DOI 10.26355/eurrev_201806_15249; Haemmig S, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00022; Hopp S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0815-8; Jha RM, 2018, NEUROPHARMACOLOGY; Jiang ZZ, 2018, GENE, V665, P201, DOI 10.1016/j.gene.2018.05.005; Kaal ECA, 2004, CURR OPIN ONCOL, V16, P593, DOI 10.1097/01.cco.0000142076.52721.b3; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Li C, 2017, CLIN GENITOURIN CANC, V15, P570, DOI 10.1016/j.clgc.2017.05.001; Li X, 2017, EXP CELL RES, V350, P327, DOI 10.1016/j.yexcr.2016.12.006; Li ZJ, 2017, NEUROSCIENCE, V354, P1, DOI 10.1016/j.neuroscience.2017.04.017; Lindauer U, 2017, BRAIN EDEMA: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE, P3, DOI 10.1016/B978-0-12-803196-4.00001-1; Liu X, 2017, BIOCHEM BIOPH RES CO, V489, P332, DOI 10.1016/j.bbrc.2017.05.126; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; Murai S, 2016, J CLIN NEUROSCI, V33, P148, DOI 10.1016/j.jocn.2016.03.042; Nakano T, 2018, J STROKE CEREBROVASC, V27, P758, DOI 10.1016/j.jstrokecerebrovasdis.2017.10.010; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Puthanveetil P, 2015, J CELL MOL MED, V19, P1418, DOI 10.1111/jcmm.12576; Sun HB, 2017, CLIN CANCER RES, V23, P4376, DOI 10.1158/1078-0432.CCR-16-2185; Sun YZ, 2013, MED HYPOTHESES, V81, P319, DOI 10.1016/j.mehy.2013.04.010; Toraih EA, 2018, BIOMED PHARMACOTHER, V102, P653, DOI 10.1016/j.biopha.2018.03.105; Wick Jeannette Y, 2012, Consult Pharm, V27, P392, DOI 10.4140/TCP.n.2012.392; Wu J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01847; Wu P, 2013, BRAIN RES BULL, V97, P69, DOI 10.1016/j.brainresbull.2013.06.001; Yan X, 2017, BIOMED ENVIRON SCI, V30, P44, DOI 10.3967/bes2017.005; Zhang MY, 2016, INT J CARDIOL, V202, P753, DOI 10.1016/j.ijcard.2015.10.019; Zhong ZH, 2013, NEUROSCI LETT, V555, P24, DOI 10.1016/j.neulet.2013.09.023; Zweckberger K, 2017, BRAIN EDEMA: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE, P457, DOI 10.1016/B978-0-12-803196-4.00023-0	39	14	16	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	OCT	2019	120	10					17584	17592		10.1002/jcb.29025			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IU4IQ	WOS:000483551100116	31218751				2022-02-06	
J	Di Virgilio, TG; Ietswaart, M; Wilson, L; Donaldson, DI; Hunter, AM				Di Virgilio, Thomas G.; Ietswaart, Magdalena; Wilson, Lindsay; Donaldson, David, I; Hunter, Angus M.			Understanding the Consequences of Repetitive Subconcussive Head Impacts in Sport: Brain Changes and Dampened Motor Control Are Seen After Boxing Practice	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						subconcussive head impacts; TBI; transcranial magnetic stimulation; motor unit behavior; boxing	TRANSCRANIAL MAGNETIC STIMULATION; POSTURAL CONTROL; SILENT PERIOD; LONG-TERM; CONCUSSION; CORTEX; INJURY; EXERCISE; FATIGUE; MUSCLE	Objectives: The potential effects of exposure to repetitive subconcussive head impacts through routine participation in sport are not understood. To investigate the effects of repetitive subconcussive head impacts we studied boxers following customary training (sparring) using transcranial magnetic stimulation (TMS), decomposition electromyographic (EMG) and tests of memory. Methods: Twenty amateur boxers performed three 3-min sparring bouts. Parameters of brain function and motor control were assessed prior to sparring and again immediately, 1 h and 24 h post-sparring. Twenty control participants were assessed following mock-sparring. Results: One hour after sparring boxers showed increased corticomotor inhibition, altered motor unit recruitment strategies, and decreased memory performance relative to controls, with values returning to baseline by the 24 h follow up. Conclusion: Repetitive subconcussive head impacts associated with sparring resulted in acute and transient brain changes similar to those previously reported in soccer heading, providing convergent evidence that sport-related head impacts produce a GABAergic response. These acute changes in brain health are reminiscent of effects seen following brain injury, and suggest a potential mechanism underlying the damaging long-term effects of routine repetitive head impacts in sport.	[Di Virgilio, Thomas G.; Hunter, Angus M.] Univ Stirlin, Physiol Exercise & Nutr Res Grp, Stirling, Scotland; [Ietswaart, Magdalena; Wilson, Lindsay; Donaldson, David, I] Univ Stirlin, Fac Nat Sci, Psychol, Stirling, Scotland		Di Virgilio, TG (corresponding author), Univ Stirlin, Physiol Exercise & Nutr Res Grp, Stirling, Scotland.	td13@stir.ac.uk	Donaldson, David I/A-5249-2009; Wilson, Lindsay/A-3659-2009	Donaldson, David I/0000-0002-8036-3455; Wilson, Lindsay/0000-0003-4113-2328; Hunter, Angus/0000-0001-7562-6145; Ietswaart, Magdalena/0000-0003-4576-9393	FP7 grant [602150-2]	LW was supported by FP7 grant number 602150-2 (CENTER-TBI).	[Anonymous], 1992, J NEUROIMAGING; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Chapouthier Georges, 2002, Current Topics in Medicinal Chemistry, V2, P841, DOI 10.2174/1568026023393552; Cheever KM, 2018, INT J SPORTS MED, V39, P141, DOI 10.1055/s-0043-118339; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Clarke RA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.75; Classen J, 1997, BRAIN, V120, P605, DOI 10.1093/brain/120.4.605; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Doherty C, 2017, HUM MOVEMENT SCI, V52, P160, DOI 10.1016/j.humov.2017.02.005; Dulla CG, 2016, NEUROSCIENTIST, V22, P295, DOI 10.1177/1073858415585108; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Gowda SBM, 2018, P NATL ACAD SCI USA, V115, pE2115, DOI 10.1073/pnas.1713869115; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hu XG, 2013, MUSCLE NERVE, V48, P557, DOI 10.1002/mus.23819; Hunter A, 2011, J ELECTROMYOGR KINES, V21, P834, DOI 10.1016/j.jelekin.2011.06.002; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kim GH, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00193; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Major BP, 2015, CLIN EXP PHARMACOL P, V42, P394, DOI 10.1111/1440-1681.12363; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Motawar B, 2012, EXP BRAIN RES, V221, P299, DOI 10.1007/s00221-012-3173-x; Nishimaru H, 2009, ACTA PHYSIOL, V197, P83, DOI 10.1111/j.1748-1716.2009.02020.x; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; O'Leary TJ, 2016, SCAND J MED SCI SPOR, V26, P1287, DOI 10.1111/sms.12582; Pearce AJ, 2016, EBIOMEDICINE, V13, P3, DOI 10.1016/j.ebiom.2016.10.043; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Ramamoorthi K, 2011, TRENDS MOL MED, V17, P452, DOI 10.1016/j.molmed.2011.03.003; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.0.CO;2-M; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sogaard K, 2006, J PHYSIOL-LONDON, V573, P511, DOI 10.1113/jphysiol.2005.103598; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stetkarova I, 2013, CLIN NEUROPHYSIOL, V124, P339, DOI 10.1016/j.clinph.2012.07.005; Stiller JW, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00069; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; Watanabe M, 2002, INT REV CYTOL, V213, P1; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; WILSON SA, 1995, ELECTROMYOGR MOTOR C, V97, P246, DOI 10.1016/0924-980X(95)80001-8; Wirsching A, 2019, J NEUROTRAUM, V36, P548, DOI 10.1089/neu.2018.5836; Ye X, 2015, HUM MOVEMENT SCI, V40, P24, DOI 10.1016/j.humov.2014.11.011; Yoon JH, 2016, J NEUROSCI, V36, P11788, DOI 10.1523/JNEUROSCI.1970-16.2016; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171	63	14	15	1	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	SEP 10	2019	13								294	10.3389/fnhum.2019.00294			10	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	IW8IS	WOS:000485238100001	31551732	gold, Green Published			2022-02-06	
J	Bresler, AY; Hanba, C; Svider, P; Carron, MA; Hsueh, WD; Paskhover, B				Bresler, Amishav Y.; Hanba, Curtis; Svider, Peter; Carron, Michael A.; Hsueh, Wayne D.; Paskhover, Boris			Craniofacial injuries related to motorized scooter use: A rising epidemic	AMERICAN JOURNAL OF OTOLARYNGOLOGY			English	Article						Motorized scooter; National Electronic Injury Surveillance; Craniofacial trauma	HEAD-INJURY	Objectives: Over the last decade, there has been increased interest in utilizing motorized scooters for transportation. The limited regulation of this modernized vehicle raises numerous safety concerns. This analysis examines a national database to describe the yearly incidence of craniofacial injuries and patterns of injury related to motorized scooter use. Methods: The Consumer Product Safety Commission's National Electronic Injury Surveillance system was queried for craniofacial injuries associated with motorized scooter use. Patient demographics, injury type, anatomic location, injury pattern, and helmet status were extracted for analysis. Results: From 2008 to 2017, there were 990 recorded events for craniofacial injuries secondary to motorized scooters extrapolating to an estimated 32,001 emergency department (ED) visits. The annual incidence was noted to triple over that 10-year period. The majority of patients were male (62.1%) and the common age groups at presentation were young children 6-12 years old (33.3%), adolescents 13-18 years old (16.1%) and young adults 19-40 years old (18.0%). The most common injury pattern was a closed head injury (36.1%) followed by lacerations (20.5%). Facial fractures were only present in 5.2% of cases. In cases in which helmet use was recorded, 66% of the patients were not helmeted. Conclusion: The incidence of motorized scooter related craniofacial trauma is rising, resulting in thousands of ED visits annually. Many patients are experiencing morbid traumatic injuries and may not be wearing appropriate protective equipment. This study highlights the importance of public awareness and policy to improve safety and primarily prevent craniofacial trauma.	[Bresler, Amishav Y.; Svider, Peter; Hsueh, Wayne D.; Paskhover, Boris] Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, Newark, NJ USA; [Hanba, Curtis] Univ Minnesota, Dept Otolaryngol Head & Neck Surg, Minneapolis, MN USA; [Carron, Michael A.] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI USA		Bresler, AY (corresponding author), Rutgers New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, Doctors Off Ctr, Suite 8100, Newark, NJ 07208 USA.	ab1631@njms.rutgers.edu					Amanullah S, 2014, PEDIATRICS, V133, P254, DOI 10.1542/peds.2013-2155; Ariel Kaminer, 2010, NY TIMES; Bai L, 2015, TRAFFIC INJ PREV, V16, P424, DOI 10.1080/15389588.2014.952724; Baugh T, OTOLARYNGOLOGY HEAD, V154, P645; Bobian MR, 2016, ANN OTO RHINOL LARYN, V125, P992, DOI 10.1177/0003489416668195; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Dandu KV, 2017, OTOLARYNG HEAD NECK, V156, P853, DOI 10.1177/0194599817695546; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Horner M, J INT NEUROPSYCHOL S, V11, P322; Irfan U, 2018, ELECT SCOOTERS SUDDE; La Torre G, 2007, EUR J PUBLIC HEALTH, V17, P607, DOI 10.1093/eurpub/ckm028; Maxime Croll, 2018, CALIFORNIA LAWS MOPE; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Orces CH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001722; Peng Y, AM J PREV MED, V52, P820; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Raphelson S., 2018, DOCKLESS SCOOTERS GA; Rose Dickey Megan, 2018, ELECT SCOOTERS ARE G; Siman-Tov M, 2017, TRAFFIC INJ PREV, V18, P318, DOI 10.1080/15389588.2016.1246723; Svider PF, 2014, LARYNGOSCOPE, V124, P2257, DOI 10.1002/lary.24686; Van Tassel D, 2014, INT J SPORTS MED, V35, P83, DOI 10.1055/s-0033-1345127	22	14	14	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0196-0709	1532-818X		AM J OTOLARYNG	Am. J. Otolaryngol.	SEP-OCT	2019	40	5					662	666		10.1016/j.amjoto.2019.05.023			5	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	IW7XZ	WOS:000485208600010	31130267				2022-02-06	
J	Saboori, P; Walker, G				Saboori, Parisa; Walker, Graham			Brain Injury and Impact Characteristics	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Jerk; Impact energy; Trapezoidal profile; TBI	HEAD; DEFORMATION	Almost all studies of traumatic brain injuries have only focused on the maximum acceleration associated with the impact. However, it has been noted that other impact characteristics should also be considered. This study has examined the effect on brain deformation [maximum principal strain (MPS)] associated with changing three characteristics of an isosceles trapezoid acceleration profile: initial slope (jerk), maximum acceleration, and impact energy (maximum velocity squared). This involved using a preexisting finite element model of the brain and applying the trapezoidal acceleration impact to the center of the forehead. The results showed the largest values of MPS were found along a line between the coup and contrecoup positions, and that a strong direct relationship existed between maximum acceleration and brain deformation as measured using MPS. In addition, a strong direct relationship was found to exist between impact energy and brain deformation as measured using MPS. However, it was found that there was almost no observable change in MPS with respect to different jerk values, and in fact there was a slight decrease in MPS as jerk values increased. This comported with a shock spectrum analysis of a simple one dimensional multiple degree of freedom system exposed to similar trapezoidal impulses.	[Saboori, Parisa; Walker, Graham] Manhattan Coll, Dept Mech Engn, Bronx, NY 10471 USA		Saboori, P (corresponding author), Manhattan Coll, Dept Mech Engn, Bronx, NY 10471 USA.	parisa.saboori@manhattan.edu		Saboori, Parisa/0000-0003-2355-9387			Alvarez V., 2017, THESIS; An YH, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/2/025020; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bayly PV, 2004, J BIOMECH ENG-T ASME, V126, P523, DOI 10.1115/1.1785811; Chen Y.H., 2011, THESIS; Clark J. M., 2015, IRC1526 IRCOBI; Farid M. H., 2017, IMECHE2017, P70356; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hardy W. N., 1997, CRASHWORTHINESS OCCU; Hoshizaki B., 2013, J NEUROL NEUROPHYSIO, V5, P1, DOI DOI 10.4172/2155-9562.1000181; King AI, 2003, INT RES COUNC BIOM I; KUIJPERS AHWM, 1995, J NEUROTRAUM, V12, P715, DOI 10.1089/neu.1995.12.715; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Mackerle J, 1999, SHOCK VIB, V6, P321, DOI 10.1155/1999/802580; Mao HJ, 2018, BASIC FINITE ELEMENT METHOD AS APPLIED TO INJURY BIOMECHANICS, P469, DOI 10.1016/B978-0-12-809831-8.00012-X; McLean A. J., 1997, HEAD INJURY, P25; Meaney D, 2015, ACCIDENTAL INJURY BI, P247; Melvin J.W., 2015, BIOMECHANICS BRAIN I, P221, DOI [10.1007/978-1-4939-1732-7_9, DOI 10.1007/978-1-4939-1732-7_9]; MILLER RT, 1998, 42 STAPP CAR CRASH C; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Saboori P, 2014, ADV BIOMECH APPL, V1, P253, DOI DOI 10.12989/aba.2014.1.4.253; Saboori P, 2011, THESIS; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P79; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tse K.M., 2014, AM J ENG TECHNOL SOC, V1, P28; Wang F, 2018, BIOMECH MODEL MECHAN, V17, P1165, DOI 10.1007/s10237-018-1021-z; Yang B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/408278	31	14	14	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2019	47	9			SI		1982	1992		10.1007/s10439-019-02199-z			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JD1MH	WOS:000489738300011	30673954				2022-02-06	
J	Zhang, LM; Zhang, DX; Fu, L; Li, Y; Wang, XP; Qi, MM; Li, CC; Song, PP; Wang, XD; Kong, XJ				Zhang, Li-Min; Zhang, Dong-Xue; Fu, Lan; Li, Yan; Wang, Xu-Peng; Qi, Man-Man; Li, Chen-Chen; Song, Pan-Pan; Wang, Xiao-Dong; Kong, Xiang-Jun			Carbon monoxide-releasing molecule-3 protects against cortical pyroptosis induced by hemorrhagic shock and resuscitation via mitochondrial regulation	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Carbon monoxide; Neuroprotection; Pyroptosis; Soluble guanylate-cyclase; Cyclic guanosine monophosphate	TRAUMATIC BRAIN-INJURY; RAT MODEL; SEVOFLURANE; INFLAMMASOME; ISCHEMIA; DEFICITS	Objective: Carbon monoxide (CO) releasing molecule (CORM)-3, a water-soluble CORM, has protective effects against inflammatory and ischemia/reperfusion injury. We determined the effect of CORM-3 against neuronal pyroptosis in a model of hemorrhagic shock and resuscitation (HSR) in rats via mitochondrial regulation. Methods: Rats were treated with CORM-3 (4 mg/kg) in vitro after HSR. We measured cortical CO content 3-24 h after HSR; assessed neuronal pyroptosis, mitochondrial morphology, ROS production, and mitochondrial membrane potential at 12 h after HSR; and evaluated brain magnetic resonance imaging at 24 h after HSR and learning ability 30 days after HSR. We also measured soluble guanylate-cyclase (sGC)-cyclic guanosine monophosphate (cGMP) signaling pathway activity using a blocker of sGC, NS2028, and I-125-cGMP assay. Results: Among rats that underwent HSR, CORM-3-treated rats had more CO in the cortical tissue than sham-and iCORM-3-treated rats. CORM-3-treated rats had significantly less neuronal pyroptosis in the cortical tissue; higher sGC activity and cGMP content; lower ROS production; better mitochondrial morphology, function, and membrane potential; and enhanced learning/memory ability than HSR-treated rats. However, these neuroprotective effects of CORM-3 were partially inhibited by NS2028. Conclusion: CORM-3 may alleviate neuronal pyroptosis and improve neurological recovery in HSR through mitochondrial regulation mediated by the sGC-cGMP pathway. Thus, CO administration could be a promising therapeutic strategy for hemorrhagic shock.	[Zhang, Li-Min; Li, Yan; Wang, Xu-Peng; Qi, Man-Man; Li, Chen-Chen; Song, Pan-Pan; Wang, Xiao-Dong] Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China; [Zhang, Dong-Xue] Cangzhou Cent Hosp, Dept Gerontol, Cangzhou, Peoples R China; [Fu, Lan] Cangzhou Cent Hosp, Dept Radiodiag, Cangzhou, Peoples R China; [Kong, Xiang-Jun] Cangzhou Cent Hosp, Cent Lab, Cangzhou, Peoples R China		Zhang, LM (corresponding author), Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China.	azai2010@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701296]	This work was supported by grants from the National Natural Science Foundation of China (81701296).	Ampawong S, 2017, EXP BIOL MED, V242, P411, DOI 10.1177/1535370216681553; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Cheng YY, 2017, CURR PHARM DESIGN, V23, P3884, DOI 10.2174/1381612823666170413122439; Choi EY, 2015, EUR J PHARMACOL, V764, P22, DOI 10.1016/j.ejphar.2015.06.039; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Egemnazarov B., 2009, AM J PHYSL LUNG CELL, V296; Eroglu O., 2017, INJ INT J CARE INJUR, V48; Feng SY, 2018, J MOL BIOL, V430, P3068, DOI 10.1016/j.jmb.2018.07.002; Fine JM, 2017, J NEUROL SCI, V380, P164, DOI 10.1016/j.jns.2017.07.028; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fujisaki N, 2016, MED GAS RES, V6, P122, DOI 10.4103/2045-9912.191357; Georgoff PE, 2017, J NEUROTRAUM, V34, P2167, DOI 10.1089/neu.2016.4859; Han YC, 2018, REDOX BIOL, V16, P32, DOI 10.1016/j.redox.2018.02.013; He YG, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/935738; Henninger N, 2007, BRAIN RES, V1163, P119, DOI 10.1016/j.brainres.2007.06.006; Hu XW, 2016, J SURG RES, V206, P307, DOI 10.1016/j.jss.2016.08.026; Ida K. K., 2017, BR J ADDICT BR J ANA, V120, P1245; Inoue K, 2008, SHOCK, V29, P252, DOI 10.1097/shk.0b013e3180cab913; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Joe Y, 2015, AM J PATHOL, V185, P2867, DOI 10.1016/j.ajpath.2015.07.002; Kudo Y, 2006, CRIT CARE MED, V34, P2820, DOI 10.1097/01.CCM.0000242522.48734.64; Lee HM, 2010, ACTA ANAESTH SCAND, V54, P328, DOI 10.1111/j.1399-6576.2009.02129.x; Lu YH, 2016, BIOMATERIALS, V90, P27, DOI 10.1016/j.biomaterials.2016.03.003; Mariappan N., 2007, AM J PHYSL HEART CIR, V293; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Nils S., 2013, PLOS ONE, V8; Ryter SW, 2016, TRANSL RES, V167, P7, DOI 10.1016/j.trsl.2015.06.011; Sanna N. M., 2014, EMBO J, V32, P86; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Sekerdag E, 2018, CURR NEUROPHARMACOL, V16, P1396, DOI 10.2174/1570159X16666180302115544; Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502; Wu HY, 2016, CELL PHYSIOL BIOCHEM, V40, P1692, DOI 10.1159/000453218; Wu J., 2017, FRONT PHYSL, V8; Xia PP, 2018, CELL PHYSIOL BIOCHEM, V45, P2351, DOI 10.1159/000488183; Yamanaka R, 2013, FEBS LETT, V587, P2643, DOI 10.1016/j.febslet.2013.06.049; Yang J., 2014, AM J PHYSL RENAL PHY, V306; Zhang DX, 2017, BIOMED PHARMACOTHER, V87, P332, DOI 10.1016/j.biopha.2016.12.115; Zhang LM, 2019, J SURG RES, V235, P591, DOI 10.1016/j.jss.2018.10.046; Zheng G., 2019, EBIOMEDICINE; Zhou XY, 2017, BEHAV BRAIN RES, V322, P70, DOI 10.1016/j.bbr.2016.12.046; Zhu S, 2019, NEUROCHEM INT, V124, P141, DOI 10.1016/j.neuint.2019.01.003	42	14	16	3	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	SEP	2019	141						299	309		10.1016/j.freeradbiomed.2019.06.031			11	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	IU9SG	WOS:000483920100027	31265876				2022-02-06	
J	Shahapal, A; Cho, EB; Yong, HJ; Jeong, I; Kwak, H; Lee, JK; Kim, W; Kim, B; Park, HC; Lee, WS; Kim, H; Hwang, JI; Seong, JY				Shahapal, Anu; Cho, Eun Bee; Yong, Hyo Jeong; Jeong, Inyoung; Kwak, Hoyun; Lee, Jae Keun; Kim, Wonkyum; Kim, Bongcheol; Park, Hae-Chul; Lee, Won Suk; Kim, Hyun; Hwang, Jong-Ik; Seong, Jae Young			FAM19A5 Expression During Embryogenesis and in the Adult Traumatic Brain of FAM19A5-LacZ Knock-in Mice	FRONTIERS IN NEUROSCIENCE			English	Article						FAM19A5; traumatic brain injury; brain development; neuron; oligodendrocyte precursor cells	NEURONAL DIFFERENTIATION; CORTICAL NEUROGENESIS; ALZHEIMERS-DISEASE; CELL PRODUCTION; PROGENITOR; MOUSE; SPECIFICATION; REVEALS; INJURY; GLIA	FAM19A5 is a secretory protein that is predominantly expressed in the brain. Although the FAM19A5 gene has been found to be associated with neurological and/or psychiatric diseases, only limited information is available on its function in the brain. Using FAM19A5-LacZ knock-in mice, we determined the expression pattern of FAM19A5 in developing and adult brains and identified cell types that express FAM19A5 in naive and traumatic brain injury (TBI)-induced brains. According to X-gal staining results, FAM19A5 is expressed in the ventricular zone and ganglionic eminence at a very early stage of brain development, suggesting its functions are related to the generation of neural stem cells and oligodendrocyte precursor cells (OPCs). In the later stages of developing embryos and in adult mice, FAM19A5 expression expanded broadly to particular regions of the brain, including layers 2/3 and 5 of the cortex, cornu amonis (CA) region of the hippocampus, and the corpus callosum. X-gal staining combined with immunostaining for a variety of cell-type markers revealed that FAM19A5 is expressed in many different cell types, including neurons, OPCs, astrocytes, and microglia; however, only some populations of these cell types produce FAM19A5. In a subpopulation of neuronal cells, TBI led to increased X-gal staining that extended to the nucleus, marked by slightly condensed content and increased heterochromatin formation along the nuclear border. Similarly, nuclear extension of X-gal staining occurred in a subpopulation of OPCs in the corpus callosum of the TBI-induced brain. Together, these results suggest that FAM19A5 plays a role in nervous system development from an early stage and increases its expression in response to pathological conditions in subsets of neurons and OPCs of the adult brain.	[Shahapal, Anu; Yong, Hyo Jeong; Lee, Won Suk; Kim, Hyun; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Biomed Sci, Coll Med, Seoul, South Korea; [Cho, Eun Bee; Kwak, Hoyun; Lee, Jae Keun; Kim, Wonkyum; Kim, Bongcheol] Neuracle Sci Co Ltd, Seoul, South Korea; [Jeong, Inyoung; Park, Hae-Chul] Korea Univ, Ansan Hosp, Grad Sch Biomed Sci, Ansan, South Korea		Seong, JY (corresponding author), Korea Univ, Grad Sch Biomed Sci, Coll Med, Seoul, South Korea.	jyseong@korea.ac.kr		Kim, Hyun/0000-0002-7210-5798	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2017R1A2B4006975]; Industrial Technology Innovation Program - Ministry of Trade, Industry & Energy (MOTIE), South Korea [10081300]	This work was supported by grants from the Research Programs (2017R1A2B4006975) of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning and from the Industrial Technology Innovation Program (10081300) funded by the Ministry of Trade, Industry & Energy (MOTIE), South Korea.	Agirman G, 2017, FEBS LETT, V591, P3978, DOI 10.1002/1873-3468.12924; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Bonfanti E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.256; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Chaboub LS, 2016, J NEUROSCI, V36, P11904, DOI 10.1523/JNEUROSCI.1658-16.2016; Chapman H, 2013, DEVELOPMENT, V140, P2289, DOI 10.1242/dev.091090; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; De S, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.152306; de Stahl TD, 2005, GENE CHROMOSOME CANC, V44, P161, DOI 10.1002/gcc.20226; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Draganova K, 2015, STEM CELLS, V33, P170, DOI 10.1002/stem.1820; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; Fichtman B, 2014, MECH AGEING DEV, V135, P24, DOI 10.1016/j.mad.2014.01.003; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Garcia-Cabezas MA, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00107; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldman SA, 2015, DEVELOPMENT, V142, P3983, DOI 10.1242/dev.126409; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Herold C, 2016, MOL PSYCHIATR, V21, P1608, DOI 10.1038/mp.2015.218; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Kang WF, 2009, J NEUROSCI, V29, P14571, DOI 10.1523/JNEUROSCI.3844-09.2009; Kashevarova AA, 2018, MOL CYTOGENET, V11, DOI 10.1186/s13039-018-0375-3; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kim JY, 2016, STEM CELLS, V34, P888, DOI 10.1002/stem.2276; Kotwaliwale CV, 2009, CELL, V136, P211, DOI 10.1016/j.cell.2009.01.004; Levitsky KL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02937; Li WW, 1998, J NEUROSCI, V18, P8853; Malatesta P, 2000, DEVELOPMENT, V127, P5253; McCarthy M, 2001, J NEUROSCI, V21, P6772, DOI 10.1523/JNEUROSCI.21-17-06772.2001; Mez J, 2017, ALZHEIMERS DEMENT, V13, P119, DOI 10.1016/j.jalz.2016.09.002; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Moon Y, 2011, NEUROREPORT, V22, P304, DOI 10.1097/WNR.0b013e3283460265; Morrow T, 2001, DEVELOPMENT, V128, P3585; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Ohtomo R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061743; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Park MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15586-0; Paulsen SJ, 2008, BRAIN RES, V1199, P1, DOI 10.1016/j.brainres.2007.12.074; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; SAKAI Y, 1989, ANAT RECORD, V223, P194, DOI 10.1002/ar.1092230212; Shechter R, 2013, TRENDS MOL MED, V19, P135, DOI 10.1016/j.molmed.2012.11.007; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Strasser C, 2012, NUCLEUS-PHILA, V3, P540, DOI 10.4161/nucl.21982; Suzuki N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14207-0; Tang YT, 2004, GENOMICS, V83, P727, DOI 10.1016/j.ygeno.2003.10.006; Tanner DC, 2011, J NEUROSCI, V31, P6235, DOI 10.1523/JNEUROSCI.5905-10.2011; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Tominaga T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213673; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yaguchi H, 2014, J NEUROL, V261, P224, DOI 10.1007/s00415-013-7134-5; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	64	14	15	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 30	2019	13								917	10.3389/fnins.2019.00917			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IU1KJ	WOS:000483334900001	31543758	Green Published, gold			2022-02-06	
J	Smirl, JD; Jones, KE; Copeland, P; Khatra, O; Taylor, EH; Van Donkelaar, P				Smirl, Jonathan D.; Jones, K. Elisabeth; Copeland, Paige; Khatra, Omeet; Taylor, Edward H.; Van Donkelaar, Paul		Canadian Traumat Brain Injury Res	Characterizing symptoms of traumatic brain injury in survivors of intimate partner violence	BRAIN INJURY			English	Article						Intimate partner violence; domestic violence; IPV screening tools; mild traumatic brain injury; concussion; brain injury severity assessment; BISA; sport concussion assessment tool; SCAT5	SPORT-RELATED CONCUSSION; WOMEN VETERANS; TERMINOLOGY; DEPRESSION; IMPACT; STATE; RISK	Objective: This study examined the extent symptoms associated with potential traumatic brain injury (TBI) in intimate partner violence (IPV) survivors overlap with sport-related concussions (SRC). IPV survivor responses on the Brain Injury Severity Assessment (BISA) tool, an IPV-specific questionnaire developed to assess TBI symptoms; and the widely-used Sport Concussion Assessment Tool (SCAT5), were compared. Additionally, psychopathological assessments of post-traumatic stress disorder (PTSD), depression, and anxiety were completed to account for confounding influences. Design: Eighteen women who had experienced IPV were recruited from high-barrier community-based women's shelters. Results: The total number of reported TBI were higher when employing the BISA compared to SCAT5, the strongest symptom-based correlations associated TBI severity was associated with arousal states ("Fatigue", "Anxious", "Drowsiness", "Just Don't Feel Right") or aspects of memory/cognition ("Difficulty Concentrating", "Difficulty Remembering"). Furthermore, TBI severity was also related to the degree of depression and anxiety, but unrelated to PTSD. Conclusions: Taken together, these findings can contribute to the development of enhanced screening tools and supports to help front-line staff identify TBI as a possible contributor to challenges faced by IPV survivors. By this means, women who have experienced IPV will be more likely to break the cycle of abuse and have more positive long-term health outcomes	[Smirl, Jonathan D.; Jones, K. Elisabeth; Copeland, Paige; Van Donkelaar, Paul] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Khatra, Omeet] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Taylor, Edward H.] Univ British Columbia, Sch Social Work, Kelowna, BC, Canada		Smirl, JD (corresponding author), Univ British Columbia, Sch Hlth & Exercise Sci, Concuss Res Lab, 3333 Univ Way, Kelowna, BC V1V 1V7, Canada.	jonathan.smirl@ubc.ca		Smirl, Jonathan/0000-0003-1054-0038	Canadian Foundation for InnovationCanada Foundation for Innovation; Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC)	This work was supported by the Anonymous Donor; Canadian Foundation for Innovation; Social Sciences and Humanities Research Council of Canada.	Birkley EL, 2016, J TRAUMA STRESS, V29, P397, DOI 10.1002/jts.22129; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Cody MW, 2015, J INTERPERS VIOLENCE; Costello DM, 2018, J CLIN NEUROSCI, V56, P1, DOI 10.1016/j.jocn.2018.07.002; Craparo G, 2014, J SEX MED, V11, P1484, DOI 10.1111/jsm.12505; Cripe SM, 2011, HEADACHE, V51, P208, DOI 10.1111/j.1526-4610.2010.01777.x; Davis Justin, 2015, Mo Med, V112, P187; de Dhaem OB, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0767-5; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Donders J, 2016, ARCH CLIN NEUROPSYCH, V31, P29, DOI 10.1093/arclin/acv048; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fraser S, 2018, B C MED J, V60, P8; Gerber MR, 2014, J WOMENS HEALTH, V23, P302, DOI 10.1089/jwh.2013.4513; Gordon KE, 2010, PEDIATR NEUROL, V43, P253, DOI 10.1016/j.pediatrneurol.2010.05.012; Houry D, 2005, J INTERPERS VIOLENCE, V20, P1467, DOI 10.1177/0886260505278529; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Kempe CB, 2013, CLIN NEUROPSYCHOL, V27, P762, DOI 10.1080/13854046.2013.795245; Kostoglou K, 2016, IEEE ENG MED BIO, P696, DOI 10.1109/EMBC.2016.7590797; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea MA, 2017, NEUROL CLIN, V35, P487, DOI 10.1016/j.ncl.2017.03.005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Prosman GJ, 2014, SCAND J CARING SCI, V28, P3, DOI 10.1111/scs.12025; Rauer AJ, 2012, J FAM PSYCHOL, V26, P470, DOI 10.1037/a0027828; Roth RM, 2005, BRIEF BEHAV RATING I; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Steer, 1993, MANUAL BECK ANXIETY; Taylor EH, 2005, J HUM BEHAV SOC ENVI, V11, P23, DOI 10.1300/J137v11n03_02; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Todd C, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0845-3; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera EM, 2019, J AGGRESS MALTREAT T, V38, P1; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; van Donkelaar P, INT J SPORTS MED; Wong JYH, 2011, NURS RES, V60, P58, DOI 10.1097/NNR.0b013e3182002a7c; Wong J, 2014, CONTEMP NURSE, V46, P170, DOI 10.5172/conu.2014.46.2.170; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00196; Wright AD, 2020, CLIN J SPORT MED, V30, pS53, DOI 10.1097/JSM.0000000000000578; Wright AD, 2018, ACTA NEUROCHIR SUPPL, V126, P303, DOI 10.1007/978-3-319-65798-1_59; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	49	14	14	2	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2019	33	12					1529	1538		10.1080/02699052.2019.1658129		AUG 2019	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ8NK	WOS:000483233600001	31442093				2022-02-06	
J	Krishna, G; Ying, Z; Gomez-Pinilla, F				Krishna, Gokul; Ying, Zhe; Gomez-Pinilla, Fernando			Blueberry Supplementation Mitigates Altered Brain Plasticity and Behavior after Traumatic Brain Injury in Rats	MOLECULAR NUTRITION & FOOD RESEARCH			English	Article						blueberries; brain-derived neurotrophic factor; cognition; oxidative stress; plasticity; traumatic brain injuries	OXIDATIVE STRESS; COGNITIVE FUNCTION; SYNAPTIC PLASTICITY; DIETARY SUPPLEMENTATION; HIPPOCAMPAL PLASTICITY; LIPID-PEROXIDATION; BDNF; MEMORY; CREB; HOMEOSTASIS	Scope Traumatic brain injury (TBI) compromises neuronal function required for hippocampal synaptic plasticity and cognitive function. Despite the high consumption of blueberries, information about its effects on brain plasticity and function under conditions of brain trauma is limited. The efficacy of dietary blueberry (BB) supplementation to mitigate the effects of TBI on plasticity markers and associated behavioral function in a rodent model of concussive injury are assessed. Methods and results Rats were maintained on a diet supplemented with blueberry (BB, 5% w/w) for 2 weeks after TBI. It is found that BB supplementation mitigated a loss of spatial learning and memory performance after TBI, and reduced the effects of TBI on anxiety-like behavior. BB supplementation prevents a reduction of molecules associated with the brain-derived neurotrophic factor (BDNF) system action on learning and memory such as cyclic-AMP response element binding factor (CREB), calcium/calmodulin-dependent protein kinase II (CaMKII). In addition, BB supplementation reverses an increase of the lipid peroxidation byproduct 4-hydroxy-nonenal (4-HNE) after TBI. Importantly, synaptic and neuronal signaling regulators change in proportion with the memory performance, suggesting an association between plasticity markers and behavior. Conclusion Data herein indicate that BB supplementation has a beneficial effect in mitigating the acute aspects of the TBI pathology.	[Krishna, Gokul; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.; Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Gokul, Krishna/H-3365-2019	Gokul, Krishna/0000-0001-5869-2204	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS050465] Funding Source: Medline		Ali T, 2018, MOL NEUROBIOL, V55, P6076, DOI 10.1007/s12035-017-0798-6; Andres-Lacueva C, 2005, NUTR NEUROSCI, V8, P111, DOI 10.1080/10284150500078117; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bensalem J, 2018, J NUTR SCI, V7, DOI 10.1017/jns.2018.10; Boespflug EL, 2018, NUTR NEUROSCI, V21, P297, DOI 10.1080/1028415X.2017.1287833; Casadesus G, 2004, NUTR NEUROSCI, V7, P309, DOI 10.1080/10284150400020482; Castren E, 2017, NEUROBIOL DIS, V97, P119, DOI 10.1016/j.nbd.2016.07.010; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chen DY, 2012, NAT NEUROSCI, V15, P1707, DOI 10.1038/nn.3266; Cisternas P, 2015, BBA-MOL BASIS DIS, V1852, P2379, DOI 10.1016/j.bbadis.2015.08.016; Coban J, 2015, METAB BRAIN DIS, V30, P793, DOI 10.1007/s11011-014-9643-z; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Duffy KB, 2008, NEUROBIOL AGING, V29, P1680, DOI 10.1016/j.neurobiolaging.2007.04.002; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Faria A, 2005, J AGR FOOD CHEM, V53, P6896, DOI 10.1021/jf0511300; Ferrini F, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/429815; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Gite S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26353-0; Goyarzu F, 2004, NUTR NEUROSCI, V7, P75, DOI 10.1080/10284150410001710410; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Joseph JA, 2003, NUTR NEUROSCI, V6, P153, DOI 10.1080/1028415031000111282; Kang JH, 2008, NEUROBIOL AGING, V29, P1394, DOI 10.1016/j.neurobiolaging.2007.03.006; Kent K, 2017, EUR J NUTR, V56, P333, DOI 10.1007/s00394-015-1083-y; Khan MS, 2019, MOL NEUROBIOL, V56, P671, DOI 10.1007/s12035-018-1101-1; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Krishna G, 2017, BBA-MOL BASIS DIS, V1863, P1204, DOI 10.1016/j.bbadis.2017.03.007; Krishna Muralidhara G., 2014, BIOACTIVE NUTRACEUTI; Li Q, 2009, NEUROSCIENCE, V163, P741, DOI 10.1016/j.neuroscience.2009.07.014; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Miller MG, 2018, EUR J NUTR, V57, P1169, DOI 10.1007/s00394-017-1400-8; Moriguchi S, 2012, J NEUROCHEM, V120, P541, DOI 10.1111/j.1471-4159.2011.07608.x; Nagappan G, 2005, TRENDS NEUROSCI, V28, P464, DOI 10.1016/j.tins.2005.07.003; Nair AR, 2017, FOOD FUNCT, V8, P4118, DOI [10.1039/c7fo00815e, 10.1039/C7FO00815E]; Oliveira JF, 2015, TRENDS NEUROSCI, V38, P535, DOI 10.1016/j.tins.2015.07.006; Ortega-Martinez S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00046; Pardo L, 2016, GLIA, V64, P853, DOI 10.1002/glia.22969; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Perez A., 2018, FTS366 USDA EC RES S; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rendeiro C, 2014, NEUROPHARMACOLOGY, V79, P335, DOI 10.1016/j.neuropharm.2013.12.003; Rendeiro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063535; Robison AJ, 2014, TRENDS NEUROSCI, V37, P653, DOI 10.1016/j.tins.2014.07.001; Rodgers KM, 2014, J NEUROTRAUM, V31, P487, DOI [10.1089/NEU.2013.3090, 10.1089/neu.2013.3090]; Romano A, 2017, FREE RADICAL BIO MED, V111, P281, DOI 10.1016/j.freeradbiomed.2016.12.046; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Salinsky M, 2018, EPILEPSIA, V59, P1945, DOI 10.1111/epi.14542; Sharma S, 2009, NEUROSCIENCE, V161, P1037, DOI 10.1016/j.neuroscience.2009.04.042; Slatnar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047880; Spencer JPE, 2008, P NUTR SOC, V67, P238, DOI 10.1017/S0029665108007088; Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z; Stahlberg MA, 2018, BIORXIV, DOI [10.1101/255935, DOI 10.1101/255935]; Szajdek A, 2008, PLANT FOOD HUM NUTR, V63, P147, DOI 10.1007/s11130-008-0097-5; Tan L, 2017, J ALZHEIMERS DIS, V56, P629, DOI [10.3233/JAD-151108, 10.3233/jad-151108]; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Tyagi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057945; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Wengreen HJ, 2007, J NUTR HEALTH AGING, V11, P230; Whyte A. R., 2012, APPETITE, V59, P637; Whyte AR, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060660; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Wu XL, 2010, J NUTR, V140, P1628, DOI 10.3945/jn.110.123927; Yasuhara T, 2008, REJUV RES, V11, P201, DOI 10.1089/rej.2007.0608; Zhang L, 2013, BEHAV BRAIN RES, V256, P72, DOI 10.1016/j.bbr.2013.07.051	72	14	14	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1613-4125	1613-4133		MOL NUTR FOOD RES	Mol. Nutr. Food Res.	AUG	2019	63	15			SI				1801055	10.1002/mnfr.201801055			8	Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology	IN8DZ	WOS:000478912100011	31115168	Green Accepted, Bronze			2022-02-06	
J	Yi, M; Dai, XP; Li, QX; Xu, X; Chen, YY; Wang, DS				Yi, Min; Dai, Xingping; Li, Qiuxia; Xu, Xia; Chen, Yanyi; Wang, Dongsheng			Downregulated lncRNA CRNDE contributes to the enhancement of nerve repair after traumatic brain injury in rats	CELL CYCLE			English	Article						Long non-coding RNA CRNDE; Traumatic brain injury; nerve repair	LONG NONCODING RNAS; CORTICAL INJURY; SYSTEM; MECHANISMS; EXPRESSION; RESPONSES; PROFILE; ROLES; CELLS; MICE	Objective: Long non-coding RNAs (lncRNAs) have recently been demonstrated to be involved in craniocerebral disease, but their expression in traumatic brain injury (TBI) is still unearthed. Therefore, we aimed to elucidate the effect of lncRNA CRNDE on TBI. Methods: Firstly, CRNDE expression was determined in serum of TBI patients and healthy controls. The TBI rat model was established based on Feeney's freefall impact method. The modeled rats were injected with siRNA against CRNDE, and the rats' neurobehavioral function were measured. Besides, expression of inflammatory factors, size, shape and number of hippocampal neurons, neuron apoptosis, Beclin I, LC3-I, LC3-II, glial fibrillary acidic protein (GFAP), BrdU, nerve growth factor (NGF), nestin, and neuronal nuclei (NeuN) expression were detected through different methods. Results: In TBI, CRNDE was found to be upregulated. Downregulated CRNDE improved neurobehavioral function, repressed expression of neuroinflammatory factors, elevated number of Nissl bodies, as well as restricted neuronal apoptosis and autophagy in TBI rats. Besides, downregulated CRNDE also promoted expression of GFAP, BrdU, NGF, nestin, and NeuN, thus induced the differentiation of neurons and the directional growth and regeneration of nerve fibers. Conclusion: Altogether, we found that silencing of CRNDE might be able to promote the nerve repair after TBI in rats.	[Yi, Min; Dai, Xingping; Li, Qiuxia; Xu, Xia; Chen, Yanyi; Wang, Dongsheng] Cent S Univ, Xiangya Hosp, Integrated Tradit Chinese & Western Med, Changsha, Hunan, Peoples R China		Wang, DS (corresponding author), Cent S Univ, Xiangya Hosp, Integrated Tradit Chinese & Western Med, Changsha, Hunan, Peoples R China.	wangdongsheng_223@163.com		Yi, Min/0000-0002-8752-0054	Provincial science and technology innovation platform and talent plan [420010087]	This study was supported by Provincial science and technology innovation platform and talent plan(420010087).	Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Chen RJ, 2016, NEUROSCIENCE, V319, P123, DOI 10.1016/j.neuroscience.2016.01.033; Dong ZG, 2018, BIOMED PHARMACOTHER, V103, P1678, DOI 10.1016/j.biopha.2018.04.192; Ellis Blake C., 2012, Frontiers in Genetics, V3, P270, DOI 10.3389/fgene.2012.00270; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fiorcari S, 2015, HAEMATOLOGICA, V100, P253, DOI 10.3324/haematol.2014.113217; Gao HY, 2017, ONCOTARGETS THER, V10, P205, DOI 10.2147/OTT.S116178; Gudenas BL, 2015, BIOINFORM BIOL INSIG, V9, P21, DOI 10.4137/BBI.S29435; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hu Bao-Ying, 2012, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V28, P179; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Li H, 2017, SIAM J SCI COMPUT, V39, pA114, DOI 10.1137/16M1069596; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Quan ZZ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00175; Roberts TC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0507; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Song H, 2016, EUR REV MED PHARMACO, V20, P2588; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Xie GG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3951783; Xu SY, 2019, NEURAL REGEN RES, V14, P997, DOI 10.4103/1673-5374.250579; Yang LX, 2019, NEURAL REGEN RES, V14, P632, DOI 10.4103/1673-5374.247467; Youssef MRL, 2015, J EGYPT PUBLIC HEAL, V90, P139, DOI 10.1097/01.EPX.0000473569.10092.e7; Zheng J, 2016, MOL THER, V24, P1199, DOI 10.1038/mt.2016.71	35	14	15	2	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4101	1551-4005		CELL CYCLE	Cell Cycle	SEP 17	2019	18	18					2332	2343		10.1080/15384101.2019.1647024		AUG 2019	12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	IS5WI	WOS:000479565400001	31345079	Green Published, Bronze			2022-02-06	
J	Dyer, MR; Alexander, W; Hassoune, A; Chen, QW; Alvikas, J; Liu, YJ; Haldeman, S; Plautz, W; Loughran, P; Li, H; Boone, B; Sadovsky, Y; Sunnd, P; Zuckerbraun, BS; Neal, MD				Dyer, Mitchell R.; Alexander, Wyeth; Hassoune, Adnan; Chen, Qiwei; Alvikas, Jurgis; Liu, Yingjie; Haldeman, Shannon; Plautz, Will; Loughran, Patricia; Li, Hui; Boone, Brian; Sadovsky, Yoel; Sunnd, Prithu; Zuckerbraun, Brian S.; Neal, Matthew D.			Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice	JOURNAL OF THROMBOSIS AND HAEMOSTASIS			English	Article						extracellular vesicles; hemorrhage; platelets; thrombosis; trauma	DEEP-VEIN THROMBOSIS; VENOUS THROMBOSIS; BRAIN-INJURY; MICROPARTICLES; HYDROXYCHLOROQUINE; THROMBOEMBOLISM; INFLAMMATION; COAGULATION; GENERATION; CANCER	Background Traumatic injury can lead to dysregulation of the normal clotting system, resulting in hemorrhagic and thrombotic complications. Platelet activation is robust following traumatic injury and one process of platelet activation is to release of extracellular vesicles (PEV) that carry heterogenous cargo loads and surface ligands. Objectives We sought to investigate and characterize the release and function of PEVs generated following traumatic injury. Methods PEV content and quantity in circulation following trauma in humans and mice was measured using flow cytometry, size exclusion chromatography, and nanoparticle tracking analysis. PEVs were isolated from circulation and the effects on thrombin generation, bleeding time, hemorrhage control, and thrombus formation were determined. Finally, the effect of hydroxychloroquine (HCQ) on PEV release and thrombosis were examined. Results Human and murine trauma results in a significant release of PEVs into circulation compared with healthy controls. These PEVs result in abundant thrombin generation, increased platelet aggregation, decreased bleeding times, and decreased hemorrhage in uncontrolled bleeding. Conversely, PEVs contributed to enhanced venous thrombus formation and were recruited to the developing thrombus site. Interestingly, HCQ treatment resulted in decreased platelet aggregation, decreased PEV release, and reduced deep vein thrombosis burden in mice. Conclusions These data demonstrate that trauma results in significant release of PEVs which are both pro-hemostatic and pro-thrombotic. The effects of PEVs can be mitigated by treatment with HCQ, suggesting the potential use as a form of deep vein thrombosis prophylaxis.	[Dyer, Mitchell R.; Hassoune, Adnan; Chen, Qiwei; Alvikas, Jurgis; Liu, Yingjie; Haldeman, Shannon; Loughran, Patricia; Boone, Brian; Zuckerbraun, Brian S.; Neal, Matthew D.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Alexander, Wyeth; Plautz, Will] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Loughran, Patricia] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA USA; [Li, Hui; Sadovsky, Yoel] Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Li, Hui] Cent S Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Sunnd, Prithu] Univ Pittsburgh, Sch Med, Pittsburgh Heart Lung & Blood Vasc Med Inst, Pittsburgh, PA USA		Neal, MD (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, F1271 2 Presbyterian Hosp, 200 Lothrop, Pittsburgh, PA 15213 USA.	nealm2@upmc.edu	Loughran, Patricia/AAB-1184-2021	Sadovsky, Yoel/0000-0003-2969-6737	U.S. National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 R35 GM119526-01, UM1HL120877-01]; Vascular Medicine Institute at the University of Pittsburgh; Hemophilia Center of Western Pennsylvania; Institute for Transfusion Medicine; American Association for the Surgery for Trauma Research award; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32GM008516]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL128297, R01HL141080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM102146, R35GM119526, T32GM008516] Funding Source: NIH RePORTER	This work is supported by U.S. National Institutes of Health grants 1 R35 GM119526-01 and UM1HL120877-01, support from the Vascular Medicine Institute at the University of Pittsburgh, the Hemophilia Center of Western Pennsylvania, and the Institute for Transfusion Medicine, as well as the American Association for the Surgery for Trauma Research award (all to MDN). This work was additionally supported by the training grant 5T32GM008516 (to MRD) from the National Institute of Health. The authors thank Ms. Lauryn Kohut for her animal expertise.	Aatonen M, 2012, SEMIN THROMB HEMOST, V38, P102, DOI 10.1055/s-0031-1300956; Achuthan S, 2015, J CARDIOVASC PHARM T, V20, P174, DOI 10.1177/1074248414546324; Ay C, 2009, THROMB RES, V123, P724, DOI 10.1016/j.thromres.2008.09.005; Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Belizna C, 2015, AUTOIMMUN REV, V14, P358, DOI 10.1016/j.autrev.2014.12.006; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Boone BA, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4584-2; Bragin DE, 2017, J CEREBR BLOOD F MET, V37, P762, DOI 10.1177/0271678X16684153; Brill A, 2011, BLOOD, V117, P1400, DOI 10.1182/blood-2010-05-287623; Brill JB, 2016, J TRAUMA ACUTE CARE, V80, P625, DOI 10.1097/TA.0000000000000977; Burnouf T, 2014, BLOOD REV, V28, P155, DOI 10.1016/j.blre.2014.04.002; Campello E, 2011, THROMB RES, V127, P473, DOI 10.1016/j.thromres.2011.01.002; Carestia A, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00271; CARTER AE, 1974, BRIT MED J, V3, P94, DOI 10.1136/bmj.3.5923.94; Chirinos JA, 2005, J AM COLL CARDIOL, V45, P1467, DOI 10.1016/j.jacc.2004.12.075; Curry N, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25625; Darwiche SS, 2011, JOVE-J VIS EXP, V50, P1; Davila M, 2008, J THROMB HAEMOST, V6, P1517, DOI 10.1111/j.1538-7836.2008.02987.x; Diaz JA, 2012, ARTERIOSCL THROM VAS, V32, P556, DOI 10.1161/ATVBAHA.111.244608; Dyer M, 2017, JOVE-J VIS EXP, V123, P55554, DOI 10.3791/55554; Dyer MR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20479-x; Edwards MH, 1997, CIRCULATION, V96, P4380; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Forlow SB, 2000, BLOOD, V95, P1317, DOI 10.1182/blood.V95.4.1317.004k30_1317_1323; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Goetzl EJ, 2016, FASEB J, V30, P2058, DOI 10.1096/fj.201500150R; Harr JN, 2013, J TRAUMA ACUTE CARE, V74, P756, DOI 10.1097/TA.0b013e3182826d7e; Heit JA, 2015, NAT REV CARDIOL, V12, P464, DOI 10.1038/nrcardio.2015.83; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449; Hu CF, 2017, CURR MED CHEM, V24, P2241, DOI 10.2174/0929867324666170316115938; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Karcutskie CA, 2017, JAMA SURG, V40; Kim SJ, 2018, SEMIN THROMB HEMOST, V44, P91, DOI 10.1055/s-0037-1607432; Koupenova M, 2018, CIRC RES, V122, P337, DOI 10.1161/CIRCRESAHA.117.310795; Lacroix R, 2013, J THROMB HAEMOST, V11, P24, DOI 10.1111/jth.12268; Mackman N, 2012, J CLIN INVEST, V122, P2331, DOI 10.1172/JCI60229; Merten M, 1999, CIRCULATION, V99, P2577, DOI 10.1161/01.CIR.99.19.2577; Nosal R, 2000, THROMB RES, V98, P411, DOI 10.1016/S0049-3848(00)00200-0; Ogura H, 2001, J TRAUMA, V50, P801, DOI 10.1097/00005373-200105000-00005; Park MS, 2016, THROMB RES, V144, P40, DOI 10.1016/j.thromres.2016.03.026; Park MS, 2015, J TRAUMA ACUTE CARE, V79, P726, DOI 10.1097/TA.0000000000000839; Park MS, 2012, SURGERY, V151, P831, DOI 10.1016/j.surg.2011.12.022; Pienimaeki-Roemer A, 2015, TRANSFUSION, V55, P507, DOI 10.1111/trf.12874; Pierce CA, 2008, J TRAUMA, V64, P932, DOI 10.1097/TA.0b013e318166b808; Rand ML, 2006, J THROMB HAEMOST, V4, P1621, DOI 10.1111/j.1538-7836.2006.02011.x; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Saghazadeh A, 2016, CRIT REV ONCOL HEMAT, V99, P272, DOI 10.1016/j.critrevonc.2016.01.007; Saghazadeh A, 2015, INT IMMUNOPHARMACOL, V28, P655, DOI 10.1016/j.intimp.2015.07.044; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schmidt-Tanguy A, 2013, J THROMB HAEMOST, V11, P1927, DOI 10.1111/jth.12363; Shantsila E, 2010, J THROMB HAEMOST, V8, P2358, DOI 10.1111/j.1538-7836.2010.04007.x; Sharma TS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002867; Shukla M, 2017, J THROMB HAEMOST, V15, P375, DOI 10.1111/jth.13579; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Smith CK, 2014, ARTHRITIS RHEUMATOL, V66, P2532, DOI 10.1002/art.38703; Stark K, 2016, BLOOD, V128, P2435, DOI 10.1182/blood-2016-04-710632; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Thomas GM, 2015, J THROMB HAEMOST, V13, P1310, DOI 10.1111/jth.13002; Thomas GM, 2009, J EXP MED, V206, P1913, DOI 10.1084/jem.20082297; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Vogel S, 2015, J CLIN INVEST, V125, P4638, DOI 10.1172/JCI81660; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Wang JG, 2009, J THROMB HAEMOST, V7, P1092, DOI 10.1111/j.1538-7836.2009.03448.x; WU TK, 1977, SURG GYNECOL OBSTET, V145, P714	66	14	14	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1538-7933	1538-7836		J THROMB HAEMOST	J. Thromb. Haemost.	OCT	2019	17	10					1733	1745		10.1111/jth.14563		JUL 2019	13	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	JB0TC	WOS:000478308300001	31294514	Green Accepted, Bronze			2022-02-06	
J	Chio, JCT; Wang, J; Badner, A; Hong, J; Surendran, V; Fehlings, MG				Chio, Jonathon Chon Teng; Wang, Jian; Badner, Anna; Hong, James; Surendran, Vithushan; Fehlings, Michael G.			The effects of human immunoglobulin G on enhancing tissue protection and neurobehavioral recovery after traumatic cervical spinal cord injury are mediated through the neurovascular unit	JOURNAL OF NEUROINFLAMMATION			English	Article						Spinal cord injury; Human immunoglobulin G; Neuroinflammation; Immunomodulation; Dose-response; Neurovascular unit	SYSTEMIC INFLAMMATORY RESPONSE; INTRAVENOUS IMMUNOGLOBULIN; FUNCTIONAL RECOVERY; ENDOGENOUS INTERLEUKIN-10; VASCULAR DISRUPTION; COMPRESSION INJURY; BRAIN; IVIG; RAT; BARRIER	BackgroundSpinal cord injury (SCI) is a condition with few effective treatment options. The blood-spinal cord barrier consists of pericytes, astrocytes, and endothelial cells, which are collectively termed the neurovascular unit. These cells support spinal cord homeostasis by expressing tight junction proteins. Physical trauma to the spinal cord disrupts the barrier, which leads to neuroinflammation by facilitating immune cell migration to the damaged site in a process involving immune cell adhesion. Immunosuppressive strategies, including methylprednisolone (MPSS), have been investigated to treat SCI. However, despite some success, MPSS has the potential to increase a patient's susceptibility to wound infection and impaired wound healing. Hence, immunomodulation may be a more attractive approach than immunosuppression. Approved for modulating neuroinflammation in certain disorders, including Guillain-Barre syndrome, intravenous administration of human immunoglobulin G (hIgG) has shown promise in the setting of experimental SCI, though the optimal dose and mechanism of action remain undetermined.MethodsFemale adult Wistar rats were subjected to moderate-severe clip compression injury (35g) at the C7-T1 level and randomized to receive a single intravenous (IV) bolus of hIgG (0.02, 0.2, 0.4, 1, 2g/kg), MPSS (0.03g/kg), or control buffer at 15min post-SCI. At 24h and 6weeks post-SCI, molecular, histological, and neurobehavioral effects of hIgG were analyzed.ResultsAt 24h post-injury, human immunoglobulin G co-localized with spinal cord pericytes, astrocytes, and vessels. hIgG (2g/kg) protected the spinal cord neurovasculature after SCI by increasing tight junction protein expression and reducing inflammatory enzyme expression. Improvements in vascular integrity were associated with changes in spinal cord inflammation. Interestingly, hIgG (2g/kg) increased serum expression of inflammatory cytokines and co-localized (without decreasing protein expression) with spinal cord vascular cell adhesion molecule-1, a protein used by immune cells to enter into inflamed tissue. Acute molecular benefits of hIgG (2g/kg) led to greater tissue preservation, functional blood flow, and neurobehavioral recovery at 6weeks post-SCI. Importantly, the effects of hIgG (2g/kg) were superior to control buffer and hIgG (0.4g/kg), and comparable with MPSS (0.03g/kg).ConclusionshIgG (2g/kg) is a promising therapeutic approach to mitigate secondary pathology in SCI through antagonizing immune cell infiltration at the level of the neurovascular unit.	[Chio, Jonathon Chon Teng; Wang, Jian; Hong, James; Fehlings, Michael G.] Univ Hlth Network, Krembil Res Inst, Dept Genet & Dev, Krembil Discovery Tower,60 Leonard Ave,7KD-430, Toronto, ON M5T 2S8, Canada; [Chio, Jonathon Chon Teng; Hong, James; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Badner, Anna] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, 845 Hlth Sci Rd, Irvine, CA 92617 USA; [Chio, Jonathon Chon Teng; Hong, James; Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Spinal Program, Toronto, ON, Canada; [Surendran, Vithushan; Fehlings, Michael G.] Univ Toronto, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Gerry & Tootsie Halbert Chair Neural Repair & Reg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Krembil Neurosci Program, 399 Bathurst St, Toronto, ON M5T 2S8, Canada		Fehlings, MG (corresponding author), Univ Hlth Network, Krembil Res Inst, Dept Genet & Dev, Krembil Discovery Tower,60 Leonard Ave,7KD-430, Toronto, ON M5T 2S8, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Hlth Network, Toronto Western Hosp, Spinal Program, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Gerry & Tootsie Halbert Chair Neural Repair & Reg, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Hlth Network, Toronto Western Hosp, Krembil Neurosci Program, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.	michael.fehlings@uhn.ca	Badner, Anna/N-8035-2019	Badner, Anna/0000-0002-5244-6165; Chio, Jonathon Chon Teng/0000-0002-9914-5538; Fehlings, Michael/0000-0002-5722-6364	Frederick Banting and Charles Best Graduate Scholarship (CIHR)Canadian Institutes of Health Research (CIHR) [N/A] Funding Source: Medline; Gerald and Tootsie Halbert Chair in Neural Repair and Regeneration [N/A] Funding Source: Medline; Baxter Healthcare Corporation [N/A] Funding Source: Medline		Abraham KE, 2004, NEUROSCIENCE, V124, P945, DOI 10.1016/j.neuroscience.2004.01.004; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Badner A, 2019, J NEUROTRAUM, V36, P2298, DOI 10.1089/neu.2018.6081; Badner A, 2016, STEM CELL TRANSL MED, V5, P991, DOI 10.5966/sctm.2015-0295; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Bao F, 2012, J NEUROTRAUM, V29, P1626, DOI 10.1089/neu.2011.2190; Bao F, 2011, EXP NEUROL, V231, P272, DOI 10.1016/j.expneurol.2011.07.001; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Bowes AL, 2014, J NEUROTRAUM, V31, P1753, DOI 10.1089/neu.2014.3429; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brennan FH, 2016, ANN CLIN TRANSL NEUR, V3, P495, DOI 10.1002/acn3.318; Brommer B, 2016, BRAIN, V139, P692, DOI 10.1093/brain/awv375; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Chen M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40528; Cheng P, 2014, NEUROPHARMACOLOGY, V85, P408, DOI 10.1016/j.neuropharm.2014.06.004; Crow AR, 2003, BLOOD, V102, P558, DOI 10.1182/blood-2003-01-0023; Dalakas MC, 2002, NEUROLOGY, V59, pS13, DOI 10.1212/WNL.59.12_suppl_6.S13; de Castro R, 2000, NEUROREPORT, V11, P3551, DOI 10.1097/00001756-200011090-00029; Ditor DS, 2006, J NEUROSURG-SPINE, V5, P343, DOI 10.3171/spi.2006.5.4.343; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Nguyen DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-224; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.x, 10.1111/j.1365-2249.2009.04022.X]; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Fu ES, 2005, J NEUROSURG ANESTH, V17, P82, DOI 10.1097/01.ana.0000163199.10365.38; Genovese T, 2009, J NEUROCHEM, V108, P1360, DOI 10.1111/j.1471-4159.2009.05899.x; Gill V, 2005, CIRCULATION, V112, P2031, DOI 10.1161/CIRCULATIONAHA.105.546150; Gok B, 2009, J CLIN NEUROSCI, V16, P549, DOI 10.1016/j.jocn.2008.04.024; Goldstein EZ, 2016, EXP NEUROL, V283, P550, DOI 10.1016/j.expneurol.2016.05.001; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Guo Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01299; He ZL, 2017, AM J TRANSL RES, V9, P1012; Issekutz AC, 2011, CLIN IMMUNOL, V141, P187, DOI 10.1016/j.clim.2011.08.003; Kabu S, 2015, J CONTROL RELEASE, V219, P141, DOI 10.1016/j.jconrel.2015.08.060; Kjell J, 2016, DIS MODEL MECH, V9, P1125, DOI 10.1242/dmm.025833; Kudo H, 2013, J DERMATOL SCI, V69, P77, DOI 10.1016/j.jdermsci.2012.09.010; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Macmillan HF, 2010, AUTOIMMUNITY, V43, P619, DOI 10.3109/08916931003599062; Massoud AH, 2014, J ALLERGY CLIN IMMUN, V133, P853, DOI 10.1016/j.jaci.2013.09.029; Matsuda A, 2012, EUR J IMMUNOL, V42, P2121, DOI 10.1002/eji.201242398; Morimoto Y, 2014, TOXICOL IND HEALTH, V30, P851, DOI 10.1177/0748233712464807; Neumann J, 2015, ACTA NEUROPATHOL, V129, P259, DOI 10.1007/s00401-014-1355-2; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Nimmerjahn F, 2016, J CLIN IMMUNOL, V36, pS83, DOI 10.1007/s10875-016-0249-6; Noble LJ, 2002, J NEUROSCI, V22, P7526; Noda M, 2011, J BIOL CHEM, V286, P2308, DOI 10.1074/jbc.M110.169839; Paolicelli RC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00129; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Sewell WAC, 2002, IMMUNOLOGY, V107, P387, DOI 10.1046/j.1365-2567.2002.01545.x; Soubeyrand M, 2014, J NEUROTRAUM, V31, P1767, DOI 10.1089/neu.2013.3319; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; St-Amour I, 2013, J CEREBR BLOOD F MET, V33, P1983, DOI 10.1038/jcbfm.2013.160; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tackenberg B, 2009, P NATL ACAD SCI USA, V106, P4788, DOI 10.1073/pnas.0807319106; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Thompson CD, 2013, J NEUROTRAUM, V30, P1311, DOI 10.1089/neu.2012.2651; Tjon ASW, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00197; Trist HM, 2014, J IMMUNOL, V192, P792, DOI 10.4049/jimmunol.1301554; Tzekou A, 2014, J CLIN IMMUNOL, V34, pS132, DOI 10.1007/s10875-014-0021-8; Ueno M, 2016, NAT NEUROSCI, V19, P784, DOI 10.1038/nn.4289; Ulndreaj A, 2017, J NEUROTRAUM, V34, P1209, DOI 10.1089/neu.2016.4498; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Wilcox JT, 2014, STEM CELL TRANSL MED, V3, P1148, DOI 10.5966/sctm.2014-0029; Yano R, 2007, ACTA MED OKAYAMA, V61, P89; Zhang Y, 2013, J NEUROSCI, V33, P12970, DOI 10.1523/JNEUROSCI.1974-13.2013; Zozulya A, 2008, BRAIN RES, V1189, P1, DOI 10.1016/j.brainres.2007.10.099	75	14	15	2	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUL 9	2019	16								141	10.1186/s12974-019-1518-0			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	IJ1UC	WOS:000475683000002	31288834	Green Published, gold			2022-02-06	
J	Hertelendy, P; Varga, DP; Menyhart, A; Bari, F; Farkas, E				Hertelendy, Peter; Varga, Daniel P.; Menyhart, Akos; Bari, Ferenc; Farkas, Eszter			Susceptibility of the cerebral cortex to spreading depolarization in neurological disease states: The impact of aging	NEUROCHEMISTRY INTERNATIONAL			English	Article						Aging; Brain injury; Ischemia; Migraine; Spreading depolarization; Spreading depression	EXTRACELLULAR POTASSIUM CONCENTRATION; NITRIC-OXIDE; NMDA RECEPTOR; SUBARACHNOID HEMORRHAGE; GLUTAMATE RELEASE; BLOOD-FLOW; TISSUE OXYGENATION; CALCIUM-CHANNELS; ARTERY OCCLUSION; ISCHEMIC BRAIN	Secondary injury following acute brain insults significantly contributes to poorer neurological outcome. The spontaneous, recurrent occurrence of spreading depolarization events (SD) has been recognized as a potent secondary injury mechanism in subarachnoid hemorrhage, malignant ischemic stroke and traumatic brain injury. In addition, SD is the underlying mechanism of the aura symptoms of migraineurs. The susceptibility of the nervous tissue to SD is subject to the metabolic status of the tissue, the ionic composition of the extracellular space, and the functional status of ion pumps, voltage-gated and other cation channels, glutamate receptors and excitatory amino acid transporters. All these mechanisms tune the excitability of the nervous tissue. Aging has also been found to alter SD susceptibility, which appears to be highest at young adulthood, and decline over the aging process. The lower susceptibility of the cerebral gray matter to SD in the old brain may be caused by the age-related impairment of mechanisms implicated in ion translocations between the intra- and extracellular compartments, glutamate signaling and surplus potassium and glutamate clearance. Even though the aging nervous tissue is thus less able to sustain SD, the consequences of SD recurrence in the old brain have proven to be graver, possibly leading to accelerated lesion maturation. Taken that recurrent SDs may pose an increased burden in the aging injured brain, the benefit of therapeutic approaches to restrict SD generation and propagation may be particularly relevant for elderly patients.	[Hertelendy, Peter; Varga, Daniel P.; Menyhart, Akos; Bari, Ferenc; Farkas, Eszter] Univ Szeged, Fac Med, Dept Med Phys & Informat, Koranyis Fasor 9, H-6720 Szeged, Hungary; [Hertelendy, Peter; Varga, Daniel P.; Menyhart, Akos; Bari, Ferenc; Farkas, Eszter] Univ Szeged, Fac Sci & Informat, Koranyis Fasor 9, H-6720 Szeged, Hungary; [Hertelendy, Peter] Univ Szeged, Fac Med, Dept Neurol, Semmelweis U 6, H-6725 Szeged, Hungary		Farkas, E (corresponding author), Univ Szeged, Fac Med, Dept Med Phys & Informat, Koranyis Fasor 9, H-6720 Szeged, Hungary.	hertelendy.peter@med.u-szeged.hu; vardan.bio@gmail.com; menyhartakos89@gmall.com; bari.ferenc@med.u-szeged.hu; farkas.eszter.1@med.u-szeged.hu		Menyhart, Akos/0000-0002-1355-3208; Farkas, Eszter/0000-0002-8478-9664; Varga, Daniel Peter/0000-0001-5797-9334	National Research, Development and Innovation Office of HungaryNational Research, Development & Innovation Office (NRDIO) - Hungary [K111923, K120358]; Economic Development and Innovation Operational Programme in Hungary; European Regional Development FundEuropean Commission [GINOP-2.3.2-15-2016-00006]; EUEuropean Commission [EFOP-3.6.1-16-2016-00008]; European UnionEuropean Commission	This work was supported by grants from the National Research, Development and Innovation Office of Hungary (Grant No. K111923 and K120358); the Economic Development and Innovation Operational Programme in Hungary co-financed by the European Union and the European Regional Development Fund (No. GINOP-2.3.2-15-2016-00006); and the EU-funded Hungarian grant No. EFOP-3.6.1-16-2016-00008.	AITKEN PG, 1991, BRAIN RES, V541, P7, DOI 10.1016/0006-8993(91)91067-B; Ayata C, 2000, NEUROSCIENCE, V95, P639; Ayata C, 2009, CEPHALALGIA, V29, P1095, DOI 10.1111/j.1468-2982.2009.01982.x; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Ayata C, 2010, HEADACHE, V50, P725, DOI 10.1111/j.1526-4610.2010.01647.x; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; Benzi G, 1994, J Neural Transm Suppl, V44, P159; Bere Z, 2014, J CEREBR BLOOD F MET, V34, P1695, DOI 10.1038/jcbfm.2014.136; Bodhinathan K, 2010, J NEUROSCI, V30, P1914, DOI 10.1523/JNEUROSCI.5485-09.2010; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BURES J, 1957, ELECTROEN CLIN NEURO, V9, P121, DOI 10.1016/0013-4694(57)90116-5; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Capuani C, 2016, EMBO MOL MED, V8, P967, DOI 10.15252/emmm.201505944; Carlson AP, 2019, J NEUROSURG, V130, P1513, DOI 10.3171/2017.12.JNS171665; Cervetto C, 2013, J NEUROCHEM, V124, P821, DOI 10.1111/jnc.12143; Chakraborty H, 2003, EXP GERONTOL, V38, P705, DOI 10.1016/S0531-5565(03)00066-4; Charpentier C, 1999, STROKE, V30, P1402, DOI 10.1161/01.STR.30.7.1402; Chen G, 2005, J NEUROPHYSIOL, V94, P1287, DOI 10.1152/jn.00224.2005; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; Chen SP, 2017, BRAIN, V140, P1643, DOI 10.1093/brain/awx085; Cholet N, 2002, CEREB CORTEX, V12, P515, DOI 10.1093/cercor/12.5.515; Clark D, 2014, NEUROBIOL AGING, V35, P2803, DOI 10.1016/j.neurobiolaging.2014.06.013; COHADON F, 1986, GERONTOLOGY, V32, P46, DOI 10.1159/000212827; Cook NS., 1990, POTASSIUM CHANNELS S; Costa C, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-62; Cotrina ML, 2001, BRAIN RES, V901, P55, DOI 10.1016/S0006-8993(01)02258-2; Crobeddu E, 2012, STROKE, V43, P697, DOI 10.1161/STROKEAHA.111.638403; CZEH G, 1992, NEUROREPORT, V3, P197, DOI 10.1097/00001756-199202000-00019; CZEH G, 1993, BRAIN RES, V632, P195, DOI 10.1016/0006-8993(93)91154-K; Damodaram S, 2009, HEADACHE, V49, P5, DOI 10.1111/j.1526-4610.2008.01262.x; de Lores Arnaiz Georgina Rodriguez, 2014, Int J Biomed Sci, V10, P85; de Rooij NK, 2013, STROKE, V44, P1288, DOI 10.1161/STROKEAHA.113.001125; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Enyedi P, 2012, MOL CELL ENDOCRINOL, V353, P75, DOI 10.1016/j.mce.2011.11.009; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Farkas E, 2014, J GERONTOL A-BIOL, V69, P1363, DOI 10.1093/gerona/glu066; Farkas E, 2011, NEUROBIOL AGING, V32, P1707, DOI 10.1016/j.neurobiolaging.2009.10.002; Gagolewicz P. J. A., 2017, ELUSIVE CHANNEL DRIV; Goadsby PJ, 2009, CEPHALALGIA, V29, P7, DOI 10.1111/j.1468-2982.2008.01804.x; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Grinberg YY, 2013, J NEUROCHEM, V126, P662, DOI 10.1111/jnc.12267; Guedes RCA, 1996, BRAZ J MED BIOL RES, V29, P1407; Gupta RK, 2013, BIOGERONTOLOGY, V14, P531, DOI 10.1007/s10522-013-9459-y; Gupta RK, 2013, AGE, V35, P59, DOI 10.1007/s11357-011-9330-5; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hajek I, 1996, NEUROCHEM INT, V28, P335, DOI 10.1016/0197-0186(95)00081-X; HANSEN AJ, 1978, ACTA PHYSIOL SCAND, V102, P324, DOI 10.1111/j.1748-1716.1978.tb06079.x; HANSEN AJ, 1980, ACTA PHYSIOL SCAND, V108, P355, DOI 10.1111/j.1748-1716.1980.tb06544.x; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; HANSEN AJ, 1977, ACTA PHYSIOL SCAND, V99, P412, DOI 10.1111/j.1748-1716.1977.tb10394.x; Harada K, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00499; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hertelendy P, 2017, J CEREBR BLOOD F MET, V37, P1763, DOI 10.1177/0271678X16643735; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hille B., 1992, IONIC CHANNELS EXCIT, V2nd; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hoffmann U, 2013, J CEREBR BLOOD F MET, V33, P191, DOI 10.1038/jcbfm.2012.132; Hoffmann U, 2010, J CEREBR BLOOD F MET, V30, P1588, DOI 10.1038/jcbfm.2010.92; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Iwamoto M, 2004, NEUROSCI LETT, V366, P277, DOI 10.1016/j.neulet.2004.05.048; Kao YCJ, 2014, NEUROBIOL DIS, V71, P131, DOI 10.1016/j.nbd.2014.07.005; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; KATSURA K, 1991, J CEREBR BLOOD F MET, V11, P597, DOI 10.1038/jcbfm.1991.109; Kaufmann D, 2017, J CEREBR BLOOD F MET, V37, P1748, DOI 10.1177/0271678X16659496; Kilic K, 2018, ANN NEUROL, V83, P61, DOI 10.1002/ana.25122; Kim Y, 2017, NEUROTHERAPEUTICS, V14, P1148, DOI 10.1007/s13311-017-0536-9; Kocak H, 2002, GERONTOLOGY, V48, P279, DOI 10.1159/000065249; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kudo C, 2008, EXP NEUROL, V212, P201, DOI 10.1016/j.expneurol.2008.03.026; Kumar A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00473; Lalo U, 2011, AGING CELL, V10, P392, DOI 10.1111/j.1474-9726.2011.00682.x; LAURITZEN M, 1983, ANN NEUROL, V13, P633, DOI 10.1002/ana.410130609; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; Liu FD, 2012, NEUROCHEM INT, V61, P1255, DOI 10.1016/j.neuint.2012.10.003; Liu P, 2013, J NEUROSCI, V33, P12810, DOI 10.1523/JNEUROSCI.1237-13.2013; Magge SN, 2010, J NEUROSURG, V112, P1208, DOI 10.3171/2009.9.JNS081670; Magnusson KR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00011; Major S, 2017, J CEREBR BLOOD F MET, V37, P1687, DOI 10.1177/0271678X16639059; Makra P. M., 2018, FRONTIERS PHYS UNPUB; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Mannelli LD, 2015, NEUROPHARMACOLOGY, V97, P133, DOI 10.1016/j.neuropharm.2015.05.037; Mansour H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057038; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; Maslarova A, 2011, STROKE, V42, P2917, DOI 10.1161/STROKEAHA.111.621581; MATSUURA T, 1971, EXP BRAIN RES, V12, P238, DOI 10.1007/BF00237916; Mayevsky A, 1998, ACT NEUR S, V71, P78; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; Menyhart A, 2018, NEUROBIOL DIS, V119, P41, DOI 10.1016/j.nbd.2018.07.026; Menyhart A, 2017, AM J PHYSIOL-HEART C, V313, pH328, DOI 10.1152/ajpheart.00222.2017; Menyhart A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01284-4; Menyhart A, 2015, NEUROBIOL AGING, V36, P3269, DOI 10.1016/j.neurobiolaging.2015.08.014; MILNER PM, 1958, ELECTROEN CLIN NEURO, V10, P705, DOI 10.1016/0013-4694(58)90073-7; Misonou H, 2010, NEUROSCIENTIST, V16, P51, DOI 10.1177/1073858409341085; Murphy S, 2007, BIOCHEM SOC T, V35, P1133, DOI 10.1042/BST0351133; NEDERGAARD M, 1995, J NEUROBIOL, V28, P433, DOI 10.1002/neu.480280404; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; Petzold GC, 2008, STROKE, V39, P1292, DOI 10.1161/STROKEAHA.107.500710; PHILLIPS JM, 1979, BRAIN RES, V173, P567, DOI 10.1016/0006-8993(79)90254-3; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Pinczolits A, 2017, J CEREBR BLOOD F MET, V37, P1896, DOI 10.1177/0271678X17699629; Pusic KM, 2014, GLIA, V62, P1176, DOI 10.1002/glia.22672; RABB CH, 1994, ACTA NEUROCHIR, V127, P27, DOI 10.1007/BF01808542; Reinhart KM, 2018, EXP NEUROL, V305, P121, DOI 10.1016/j.expneurol.2018.04.007; Richter F, 1998, DEV BRAIN RES, V106, P217, DOI 10.1016/S0165-3806(98)00018-2; Richter F, 2002, NEUROSCI LETT, V334, P123, DOI 10.1016/S0304-3940(02)01120-5; Richter F, 2017, J CEREBR BLOOD F MET, V37, P1791, DOI 10.1177/0271678X16641127; Richter F, 2014, ANN NEUROL, V76, P43, DOI 10.1002/ana.24176; Rimmele TS, 2016, NEUROCHEM INT, V98, P19, DOI 10.1016/j.neuint.2016.04.010; Risher WC, 2012, GLIA, V60, P1709, DOI 10.1002/glia.22390; Rovegno M, 2018, BBA-BIOMEMBRANES, V1860, P216, DOI 10.1016/j.bbamem.2017.08.014; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Sanchez-Porras Renan, 2015, Acta Neurochir Suppl, V120, P153, DOI 10.1007/978-3-319-04981-6_26; Satoh M, 1999, BRAIN RES, V822, P142, DOI 10.1016/S0006-8993(99)01141-5; SCHADE JP, 1959, J NEUROPHYSIOL, V22, P243; Selman WR, 2004, BRAIN RES, V999, P167, DOI 10.1016/j.brainres.2003.11.016; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Sesti F, 2016, AGING DIS, V7, P130, DOI 10.14336/AD.2015.0901; Shatillo A, 2015, NEUROPHARMACOLOGY, V93, P164, DOI 10.1016/j.neuropharm.2015.01.028; Shibata M, 2017, J CEREBR BLOOD F MET, V37, P1182, DOI 10.1177/0271678X17690537; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; SOMJEN GG, 1979, ANNU REV PHYSIOL, V41, P159, DOI 10.1146/annurev.ph.41.030179.001111; Spong KE, 2016, J NEUROPHYSIOL, V116, P1117, DOI 10.1152/jn.00352.2016; Steffensen AB, 2015, J NEUROSCI, V35, P12172, DOI 10.1523/JNEUROSCI.0400-15.2015; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Sukhotinsky I, 2010, J CEREBR BLOOD F MET, V30, P1168, DOI 10.1038/jcbfm.2009.285; Sun XL, 2010, CLIN EXP PHARMACOL P, V37, P243, DOI 10.1111/j.1440-1681.2009.05190.x; Szalay G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11499; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tang YT, 2014, J NEUROPHYSIOL, V112, P2572, DOI 10.1152/jn.00205.2014; Theis M, 2003, J NEUROSCI, V23, P766; Tombaugh GC, 1996, J PHYSIOL-LONDON, V493, P719, DOI 10.1113/jphysiol.1996.sp021417; Tong CK, 2000, J NEUROPHYSIOL, V84, P2449, DOI 10.1152/jn.2000.84.5.2449; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; Urenjak J, 2000, N-S ARCH PHARMACOL, V362, P137, DOI 10.1007/s002100000273; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; VANHARREVELD A, 1959, J NEUROCHEM, V3, P300; Verkhratsky A, 2016, CURR OPIN PHARMACOL, V26, P74, DOI 10.1016/j.coph.2015.09.011; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; Villa RF, 2002, NEUROCHEM RES, V27, P861, DOI 10.1023/A:1020381829107; Vinogradova LV, 2018, CEPHALALGIA, V38, P1177, DOI 10.1177/0333102417724151; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Wang MY, 2012, BRIT J PHARMACOL, V165, P235, DOI 10.1111/j.1476-5381.2011.01553.x; Willmot M, 2005, NITRIC OXIDE-BIOL CH, V12, P141, DOI 10.1016/j.niox.2005.01.003; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169; Wu YJ, 2003, J MED CHEM, V46, P3197, DOI 10.1021/jm034073f; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Yao XM, 2015, GLIA, V63, P1860, DOI 10.1002/glia.22853; Zhao X, 2009, NEUROSCIENCE, V162, P933, DOI 10.1016/j.neuroscience.2009.05.018; Zhao XR, 2000, BRAIN RES, V872, P215, DOI 10.1016/S0006-8993(00)02459-8; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	175	14	14	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUL	2019	127						125	136		10.1016/j.neuint.2018.10.010			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	IH2LY	WOS:000474327500015	30336178	Green Accepted			2022-02-06	
J	Yan, J; Bu, XM; Li, ZL; Wu, J; Wang, C; Li, DD; Song, JX; Wang, JJ				Yan, Jing; Bu, Xiaomin; Li, Zhuoling; Wu, Jia; Wang, Cheng; Li, Dandan; Song, Jiaxi; Wang, Junjun			Screening the expression of several miRNAs from TaqMan Low Density Array in traumatic brain injury: miR-219a-5p regulates neuronal apoptosis by modulating CCNA2 and CACUL1	JOURNAL OF NEUROCHEMISTRY			English	Article						biomarker; CACUL1; CCNA2; microRNA; miR-219a-5p; traumatic brain injury	CYCLIN A2; MILD; BIOMARKERS; PROTEIN; MICRORNAS; DIAGNOSIS; PANEL	Circulating microRNAs (miRNAs) have emerged as diagnostic and prognostic biomarkers for traumatic brain injury (TBI). However, a comprehensive characterization of the serum miRNA profile in patients with TBI and the roles of these potential markers in neuronal regulation have rarely been reported. In this study, the levels of 754 serum miRNAs were initially determined in two pooled samples of 15 severe traumatic brain injury (sTBI) patients and 15 healthy controls using a TaqMan Low Density Array. The markedly upregulated miRNAs in sTBI patients were subsequently validated individually by quantitative reverse-transcription PCR (RT-qPCR) in another larger cohort consisting of 81 sTBI patients, 81 mild traumatic brain injury (mTBI) patients and 82 age/sex-matched healthy controls. Seven miRNAs, including miR-103a-3p, miR-219a-5p, miR-302d-3p, miR-422a, miR-518f-3p, miR-520d-3p and miR-627, were significantly upregulated in both sTBI and mTBI patients compared with their expression in controls. Among these miRNAs, miR-219a-5p not only discriminated sTBI and mTBI patients from controls but also discriminated between sTBI and mTBI patients. We further show here that in the neuronal cell injury model, upregulated miR-219a-5p inhibits the expression of CCNA2 and CACUL1 and further regulates akt/Foxo3a and p53/Bcl-2 signaling pathways, causing a notable change in the expression of cleaved caspase-3, thereby inducing neuronal apoptosis. These results indicate that these seven selected miRNAs could serve as novel biomarkers for TBI. In particular, miR-219a-5p is a potentially valuable indicator of the diagnosis, prognosis of TBI and appears to regulate neuronal apoptosis and death.	[Yan, Jing; Bu, Xiaomin; Li, Zhuoling; Wu, Jia; Wang, Cheng; Li, Dandan; Song, Jiaxi; Wang, Junjun] Nanjing Univ, Med Sch, Jinling Hosp, Dept Clin Lab, Nanjing 210002, Jiangsu, Peoples R China; [Yan, Jing] Nanjing Med Univ, Jinling Clin Med Coll, Nanjing, Jiangsu, Peoples R China		Song, JX; Wang, JJ (corresponding author), Nanjing Univ, Med Sch, Jinling Hosp, Dept Clin Lab, Nanjing 210002, Jiangsu, Peoples R China.	strive1225@126.com; wangjunjun9202@163.com	Wang, Cheng/O-7206-2016; jiaxi, song/H-1622-2013	Wang, Cheng/0000-0002-1834-2119; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81572074]; Foundation of Jiangsu Provincial Medical Youth Talent [QNRC2016892]	This study was supported by the grants from the National Natural Science Foundation of China (No. 81572073), Foundation of Jiangsu Provincial Medical Youth Talent (No. QNRC2016892) and National Natural Science Foundation of China (No. 81572074). The authors declare no potential conflicts of interest with the research, authorship, and publication of this article.	Akhter R, 2014, J BIOL CHEM, V289, P10812, DOI 10.1074/jbc.M113.519355; Aquino-Martinez R, 2019, J BONE MINER RES, V34, P135, DOI 10.1002/jbmr.3586; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fukuda T, 2017, BIOCHEM BIOPH RES CO, V482, P863, DOI 10.1016/j.bbrc.2016.11.125; Gygli PE, 2016, AGING-US, V8, P1540, DOI 10.18632/aging.100990; Hass J, 2015, PROG NEURO-PSYCHOPH, V59, P31, DOI 10.1016/j.pnpbp.2015.01.006; Hudish LI, 2016, DEVELOPMENT, V143, P2292, DOI 10.1242/dev.137844; Irimia A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00530; Kanakkanthara A, 2016, SCIENCE, V353, P1549, DOI 10.1126/science.aaf7463; Khalilzadeh B, 2018, MICROCHIM ACTA, V185, DOI 10.1007/s00604-018-2980-6; Kong Y, 2012, INT J BIOCHEM CELL B, V44, P2321, DOI 10.1016/j.biocel.2012.08.006; Kong Y, 2012, J MOL NEUROSCI, V47, P207, DOI 10.1007/s12031-012-9717-5; Li Y, 2018, CANCER SCI, V109, P3093, DOI 10.1111/cas.13765; Lincoln FA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1160-2; Ma J, 2016, AM J TRANSL RES, V8, P1895; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Murai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10965; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Qin XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204051; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sharma K, 2018, MOL ONCOL, V12, P788, DOI 10.1002/1878-0261.12172; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Su TC, 2016, NEUROPHARMACOLOGY, V105, P1, DOI 10.1016/j.neuropharm.2016.01.015; Vedantam A, 2018, J NEUROSURG, V129, P234, DOI 10.3171/2017.3.JNS162720; Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20032; Wu J, 2017, THROMB HAEMOSTASIS, V117, P992, DOI 10.1160/TH16-08-0606; Yan Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15156; Yang F, 2016, ONCOTARGET, V7, P75165, DOI 10.18632/oncotarget.12614; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhao GX, 2015, ONCOTARGET, V6, P38952, DOI 10.18632/oncotarget.5731; Zhi F, 2016, SCI REP-UK, V6, DOI 10.1038/srep32067; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967	39	14	15	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUL	2019	150	2					202	217		10.1111/jnc.14717			16	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	II7WP	WOS:000475402700006	31077370				2022-02-06	
J	Amtmann, D; Bocell, FD; Bamer, A; Heinemann, AW; Hoffman, JM; Juengst, SB; Rosenberg, M; Schneider, JC; Wiechman, S; McMullen, K				Amtmann, Dagmar; Bocell, Fraser D.; Bamer, Alyssa; Heinemann, Allen W.; Hoffman, Jeanne M.; Juengst, Shannon B.; Rosenberg, Marta; Schneider, Jeffery C.; Wiechman, Shelley; McMullen, Kara			Psychometric Properties of the Satisfaction With Life Scale in People With Traumatic Brain, Spinal Cord, or Burn Injury: A National Institute on Disability, Independent Living, and Rehabilitation Research Model System Study	ASSESSMENT			English	Article						measurement invariance; item response theory; Satisfaction With Life Scale; traumatic brain injury; spinal cord injury; burn injury	QUALITY-OF-LIFE; ITEM RESPONSE THEORY; MEASUREMENT INVARIANCE; INTERNAL CONSISTENCY; FIT INDEXES; HEALTH; OUTCOMES; INFORMATION; PERFORMANCE; PREDICTORS	This study evaluated the measurement properties of the Satisfaction With Life Scale (SWLS) in a sample of 17,897 people with spinal cord injury (48%, n = 8,566), traumatic brain injury (44%, n = 7,941), and burn injury (8%, n = 1,390), 1 year following injury. We examined measurement invariance across the groups, unidimensionality, local independence, reliability from a classical test and item response theory (IRT) framework, and fit to a unidimensional IRT model. The results support unidimensionality and local independence of the SWLS. Reliability was adequate from a classical test and IRT perspective. IRT analysis found that the SWLS could be improved by using only five response categories rather than seven and by removing the fifth item, "If I could live my life over, I would change almost nothing." This item functions poorly and reduces instrument reliability. With these revisions, the SWLS is a useful instrument to monitor an important outcome of trauma rehabilitation.	[Amtmann, Dagmar; Bocell, Fraser D.; Bamer, Alyssa; Hoffman, Jeanne M.; Wiechman, Shelley; McMullen, Kara] Univ Washington, Box 354237, Seattle, WA 98195 USA; [Heinemann, Allen W.] Northwestern Univ, Chicago, IL 60611 USA; [Heinemann, Allen W.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Juengst, Shannon B.] Univ Pittsburgh, Pittsburgh, PA USA; [Rosenberg, Marta] Univ Texas Med Branch, Galveston, TX 77555 USA; [Schneider, Jeffery C.] Harvard Med Sch, Boston, MA 02115 USA		Bocell, FD (corresponding author), Univ Washington, Box 354237, Seattle, WA 98195 USA.	fbocell@uw.edu	Schneider, Jeffrey/AAO-2126-2020; Heinemann, Allen W./AAI-2790-2021; Juengst, Shannon B/AAC-5891-2019	Heinemann, Allen W./0000-0003-2782-7326; Juengst, Shannon B/0000-0003-4709-545X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133P120002, 90DP0053, 90DP0031, 90SI5006]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The contents of this publication were developed in part under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR Grant Numbers H133P120002, 90DP0053, 90DP0031, 90SI5006). NIDILRR is a center within the Administration for Community Living and Department of Health and Human Services.	Adams RJ, 2012, EDUC PSYCHOL MEAS, V72, P547, DOI 10.1177/0013164411432166; Bandalos DL, 1996, APPL MEAS EDUC, V9, P151, DOI 10.1207/s15324818ame0902_4; Becchetti L, 2012, SOC INDIC RES, V108, P453, DOI 10.1007/s11205-011-9887-5; Biering-Sorensen F, 2015, SPINAL CORD, V53, P265, DOI 10.1038/sc.2014.246; BOYLE GJ, 1991, PERS INDIV DIFFER, V12, P291, DOI 10.1016/0191-8869(91)90115-R; Bradburn N.M., 1978, P SECT SURV RES METH, P35; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Brown M.W., 1993, SOCIOL METHOD RES, P136; Carle AC, 2011, EXPERT REV PHARM OUT, V11, P677, DOI [10.1586/ERP.11.74, 10.1586/erp.11.74]; Charlifue S, 2011, ARCH PHYS MED REHAB, V92, P457, DOI 10.1016/j.apmr.2010.07.237; Chen WH, 1997, J EDUC BEHAV STAT, V22, P265, DOI 10.3102/10769986022003265; Chen YY, 2016, ARCH PHYS MED REHAB, V97, P1797, DOI 10.1016/j.apmr.2016.02.027; Chen YY, 2011, ARCH PHYS MED REHAB, V92, P391, DOI 10.1016/j.apmr.2010.06.030; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Costa BA, 2003, BURNS, V29, P671, DOI 10.1016/S0305-4179(03)00153-0; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2015, INT J PSYCHOL, V50, P135, DOI 10.1002/ijop.12136; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dijkers MPJM, 1999, ARCH PHYS MED REHAB, V80, P867, DOI 10.1016/S0003-9993(99)90076-X; Dolan P, 2007, PERSPECT PSYCHOL SCI, V2, P71, DOI 10.1111/j.1745-6916.2007.00030.x; DUNN G, 1989, DESIGN ANAL RELIABIL; Gilboa D, 1999, J BURN CARE REHABIL, V20, P340; Goverman J, 2016, BURNS, V42, P1067, DOI 10.1016/j.burns.2016.01.018; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; HAMBLETON RK, 1982, APPL PSYCH MEAS, V6, P373, DOI 10.1177/014662168200600401; Hartoonian N, 2014, ARCH PHYS MED REHAB, V95, P455, DOI 10.1016/j.apmr.2013.10.029; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hill MR, 2010, SPINAL CORD, V48, P438, DOI 10.1038/sc.2009.164; Hu L.T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jacobsson L, 2013, J REHABIL MED, V45, P1010, DOI 10.2340/16501977-1204; Kim D, 2011, APPL PSYCH MEAS, V35, P447, DOI 10.1177/0146621611407909; Klein MB, 2007, J BURN CARE RES, V28, P84, DOI 10.1097/BCR.0b013E31802C888E; Kline P., 1979, PSYCHOMETRICS PSYCHO; Kline R, 2010, PRINCIPLES PRACTICE, V3rd Edn; Kobau R, 2010, APPL PSYCHOL-HLTH WE, V2, P272, DOI 10.1111/j.1758-0854.2010.01035.x; Lee H, 2013, SOC SCI MED, V99, P27, DOI 10.1016/j.socscimed.2013.09.027; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maydeu-Olivares A, 2005, J AM STAT ASSOC, V100, P1009, DOI 10.1198/016214504000002069; Maydeu-Olivares A, 2014, MULTIVAR BEHAV RES, V49, P305, DOI 10.1080/00273171.2014.911075; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Millsap R. E., 2011, STAT APPROACHES MEAS; Moergeli H, 2012, PSYCHOTHER PSYCHOSOM, V81, P305, DOI 10.1159/000330887; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Ng W, 2014, J PERS SOC PSYCHOL, V107, P326, DOI 10.1037/a0036856; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; PATRICK DL, 1988, QUALITY LIFE ASSESSM, P9; Patterson DR, 2000, J BURN CARE REHABIL, V21, P490, DOI 10.1097/00004630-200021060-00004; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Post MW, 2012, ARCH PHYS MED REHAB, V93, P1832, DOI 10.1016/j.apmr.2012.03.025; Post MWM, 1998, SCAND J REHABIL MED, V30, P23; Putzke JD, 2002, ARCH PHYS MED REHAB, V83, P555, DOI 10.1053/apmr.2002.31173; Raykov T, 2004, BEHAV THER, V35, P299, DOI 10.1016/S0005-7894(04)80041-8; Reise SP, 2013, EDUC PSYCHOL MEAS, V73, P5, DOI 10.1177/0013164412449831; Rosengren L, 2015, ACTA NEUROL SCAND, V132, P164, DOI 10.1111/ane.12380; Samejima F., 1969, PSYCHOMETRIC MONOGRA; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; SCHUMAKER JF, 1993, J PSYCHOL, V127, P65, DOI 10.1080/00223980.1993.9915543; SHARP LM, 1983, PUBLIC OPIN QUART, V47, P36, DOI 10.1086/268765; Sijtsma K, 2015, EDUC MEAS-ISSUES PRA, V34, P10, DOI 10.1111/emip.12099; Simpson PL, 1996, J SOC PSYCHOL, V136, P783, DOI 10.1080/00224545.1996.9712255; Steenkamp JBEM, 1998, J CONSUM RES, V25, P78, DOI 10.1086/209528; Stutzer A, 2004, J ECON BEHAV ORGAN, V54, P89, DOI 10.1016/j.jebo.2003.04.003; Tate DG, 2015, ARCH PHYS MED REHAB, V96, P340, DOI 10.1016/j.apmr.2014.09.036; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS44, DOI 10.1016/j.apmr.2011.04.024; Urry HL, 2004, PSYCHOL SCI, V15, P367, DOI 10.1111/j.0956-7976.2004.00686.x; Williamson MLC, 2016, J HEAD TRAUMA REHAB, V31, P167, DOI 10.1097/HTR.0000000000000111; Wilson Jefferson R, 2011, Evid Based Spine Care J, V2, P37, DOI 10.1055/s-0030-1267085	73	14	14	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	JUN	2019	26	4					695	705		10.1177/1073191117693921			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	HZ6YF	WOS:000468997700011	29214853				2022-02-06	
J	Fink, EL; Beers, SR; Houtrow, AJ; Richichi, R; Burns, C; Doughty, L; Ortiz-Aguayo, R; Madurski, CA; Valenta, C; Chrisman, M; Golightly, L; Kiger, M; Patrick, C; Treble-Barna, A; Pollon, D; Smith, CM; Kochanek, P; Rubin, P; Strohm, S; Stanger, M; Orringer, M; Zhou, A; Sisung, C; Hojnacki, K; Lacci, C; Hill, J; Hinkes-Molinaro, L; Walsh, K; Johnson, T; Borrowman, J; Russo, L; Howard, K; Benken, L; Peariso, K; Broomall, E; Frank, E; Clonan, A; Capizzi, L; Miller, C; Phillips, J; Ruffing, M; Evanson, N; Kurowski, B; Taylor, JM; Yunger, T; Music, RW; Betz, E; Wainwright, M; Marshal, L; Pollon, D; Braksick, L; LaPorte, M; Docimo, S; Brown, BE; Rieker, J; Budin, L; Sanders, M; Klepac, D				Fink, Ericka L.; Beers, Sue R.; Houtrow, Amy J.; Richichi, Rudolph; Burns, Cheryl; Doughty, Lesley; Ortiz-Aguayo, Roberto; Madurski, Catherine A.; Valenta, Cynthia; Chrisman, Maddie; Golightly, Lynn; Kiger, Michelle; Patrick, Cheryl; Treble-Barna, Amery; Pollon, Dorothy; Smith, Craig M.; Kochanek, Patrick; Rubin, Pamela; Strohm, Sharon; Stanger, Meg; Orringer, Maxine; Zhou, Amy; Sisung, Charles; Hojnacki, Katie; Lacci, Christina; Hill, Jeanette; Hinkes-Molinaro, Laura; Walsh, Katie; Johnson, Tyler; Borrowman, Julie; Russo, Laura; Howard, Kelli; Benken, Laura; Peariso, Katrina; Broomall, Eileen; Frank, Erin; Clonan, Ann; Capizzi, Lindsey; Miller, Claire; Phillips, Jennifer; Ruffing, Marin; Evanson, Nate; Kurowski, Brad; Taylor, J. Michael; Yunger, Toni; Music, Rebekah W.; Betz, Emily; Wainwright, Mark; Marshal, Linda; Pollon, Dorothy; Braksick, Leslie; LaPorte, Megan; Docimo, Steve; Brown, Brenda Eagan; Rieker, James; Budin, Lee; Sanders, Maurita; Klepac, Dahlia		PICU-Rehabil Study Grp	Early Protocolized Versus Usual Care Rehabilitation for Pediatric Neurocritical Care Patients: A Randomized Controlled Trial	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						critical care; neurologic disorders; outcome; pediatric; rehabilitation	CRITICALLY-ILL CHILDREN; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE; EARLY MOBILIZATION; CRITICAL ILLNESS; MOBILITY PROGRAM; FAMILY BURDEN; RISK-FACTORS; ADMISSION; OUTCOMES	Objectives: Few feasibility, safety, and efficacy data exist regarding ICU-based rehabilitative services for children. We hypothesized that early protocolized assessment and therapy would be feasible and safe versus usual care in pediatric neurocritical care patients. Design: Randomized controlled trial. Setting: Three tertiary care PICUs in the United States. Patients: Fifty-eight children between the ages of 3-17 years with new traumatic or nontraumatic brain insult and expected ICU admission greater than 48 hours. Interventions: Early protocolized (consultation of physical therapy, occupational therapy, and speech and language therapy within 72 hr ICU admission, n = 26) or usual care (consultation per treating team, n = 32). Measurements and Main Results: Primary outcomes were consultation timing, treatment type, and frequency of deferrals and safety events. Secondary outcomes included patient and family functional and quality of life outcomes at 6 months. Comparing early protocolized (n = 26) and usual care groups (n = 32), physical therapy was consulted during the hospital admission in 26 of 26 versus 28 of 32 subjects (p = 0.062) on day 2.4 +/- 0.8 versus 7.7 +/- 4.8 (p = 0.001); occupational therapy in 26 of 26 versus 23 of 32 (p = 0.003), on day 2.3 +/- 0.6 versus 6.9 +/- 4.8 (p = 0.001); and speech and language therapy in 26 of 26 versus 17 of 32 (p = 0.011) on day 2.3 +/- 0.7 versus 13.0 +/- 10.8 (p = 0.026). More children in the early protocolized group had consults and treatments occur in the ICU versus ward for all three services (all p < 0.001). Eleven sessions were discontinued early: nine during physical therapy and two during occupational therapy, none impacting patient outcome. There were no group differences in functional or quality of life outcomes. Conclusions: A protocol for early personalized rehabilitation by physical therapy, occupational therapy, and speech and language therapy in pediatric neurocritical care patients could be safely implemented and led to more ICU-based treatment sessions, accelerating the temporal profile and changing composition of interventions versus usual care, but not altering the total dose of rehabilitation.	[Fink, Ericka L.] Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh UPMC, Dept Crit Care Med, Pittsburgh, PA USA; [Fink, Ericka L.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Beers, Sue R.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Houtrow, Amy J.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Richichi, Rudolph] Stat Anal & Measurement Consultants Inc, Lanexa, VA USA; [Burns, Cheryl] Univ Pittsburgh, Med Ctr, Dept Pediat, Pittsburgh, PA USA; [Doughty, Lesley] Cincinnati Childrens Hosp Med Ctr, Dept Psychiat, Div Crit Care Med, Cincinnati, OH USA; [Ortiz-Aguayo, Roberto] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat & Behav Sci, Philadelphia, PA USA; [Valenta, Cynthia] Jefferson Hosp, Practice & Educ, Jefferson, PA USA; [Chrisman, Maddie] Univ Pittsburgh, Med Ctr, Dept Phys Therapy, Pittsburgh, PA USA; [Golightly, Lynn] UPMC Childrens Hosp, Dept Audiol & Speech Language Pathol, Audiol Commun Disorders, Pittsburgh, PA USA; [Kiger, Michelle] Cincinnati Childrens Hosp Med Ctr, Div Occupat Therapy & Phys Therapy, Cincinnati, OH USA		Fink, EL (corresponding author), Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh UPMC, Dept Crit Care Med, Pittsburgh, PA USA.	finkel@ccm.upmc.edu	Fink, Ericka/AAU-9792-2021; Peariso, Katrina/AAQ-2090-2021		Patient-Centered Outcomes Research Institute (PCORI)Patient-Centered Outcomes Research Institute - PCORI [CER-1310-08343]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS065132]; National Institutes of Health (NIH) National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS096714]; NIH (National Institute of Child Health and Human Development)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U10HD049983]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096714] Funding Source: NIH RePORTER	Supported, in part, by Patient-Centered Outcomes Research Institute (PCORI) Award (CER-1310-08343) (to Dr. Fink), National Institutes of Health (K23 NS065132) (to Dr. Fink), National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke R01 NS096714 (to Dr. Fink), NIH (National Institute of Child Health and Human Development) U10HD049983 (to Dr. Fink).	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Als LC, 2013, CRIT CARE MED, V41, P1094, DOI 10.1097/CCM.0b013e318275d032; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Baumgartner CA, 2008, AACN ADV CRIT CARE, V19, P433, DOI 10.1097/01.AACN.0000340724.80280.31; Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Betters KA, 2017, J CRIT CARE, V41, P303, DOI 10.1016/j.jcrc.2017.08.004; Bone MF, 2014, PEDIATR CRIT CARE ME, V15, P640, DOI 10.1097/PCC.0000000000000199; Brummel NE, 2014, INTENS CARE MED, V40, P370, DOI 10.1007/s00134-013-3136-0; Choong K, 2018, J PEDIATR INTENSIVE, V7, P14, DOI 10.1055/s-0037-1601424; Choong K, 2017, PEDIATR CRIT CARE ME, V18, pE546, DOI 10.1097/PCC.0000000000001329; Choong K, 2015, PEDIATR CRIT CARE ME, V16, P310, DOI 10.1097/PCC.0000000000000362; Choong K, 2014, PEDIATR CRIT CARE ME, V15, pE270, DOI 10.1097/PCC.0000000000000160; Choong K, 2013, CRIT CARE MED, V41, P1745, DOI 10.1097/CCM.0b013e318287f592; Cui LR, 2017, J CRIT CARE, V40, P15, DOI 10.1016/j.jcrc.2017.03.003; Davidson JE, 2012, CRIT CARE MED, V40, P618, DOI 10.1097/CCM.0b013e318236ebf9; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Farrell M, 1989, Intensive Care Nurs, V5, P123, DOI 10.1016/0266-612X(89)90017-5; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Hopkins RO, 2015, J PEDIATR INTENSIVE, V4, P204, DOI 10.1055/s-0035-1563547; Hopkins RO, 2016, AACN ADV CRIT CARE, V27, P187, DOI 10.4037/aacnacc2016244; Jones S, 2006, PEDIATRICS, V118, P2101, DOI 10.1542/peds.2006-1455; Kachmar AG, 2018, PEDIATR CRIT CARE ME, V19, pE164, DOI 10.1097/PCC.0000000000001430; Klein K, 2015, CRIT CARE MED, V43, P865, DOI 10.1097/CCM.0000000000000787; Leon-Carrion J, 2013, BRAIN INJURY, V27, P1119, DOI 10.3109/02699052.2013.804204; Macht M, 2013, CRIT CARE MED, V41, P2396, DOI 10.1097/CCM.0b013e31829caf33; Manning JC, 2018, PEDIATR CRIT CARE ME, V19, P298, DOI 10.1097/PCC.0000000000001476; Marino BS, 2012, CIRCULATION, V126, P1143, DOI 10.1161/CIR.0b013e318265ee8a; Marra A, 2017, CRIT CARE CLIN, V33, P225, DOI 10.1016/j.ccc.2016.12.005; MCALLISTER L, 1993, EUR J DISORDER COMM, V28, P369; McLanahan S, 2012, FUTURE CHILD, V22, P1; Meert KL, 2016, PEDIATR CRIT CARE ME, V17, P498, DOI 10.1097/PCC.0000000000000726; Merritt C, 2018, PEDIATR CRIT CARE ME, V19, pE105, DOI 10.1097/PCC.0000000000001409; Morris PE, 2011, AM J MED SCI, V341, P373, DOI 10.1097/MAJ.0b013e31820ab4f6; O'Neil ME, 2009, PEDIATR PHYS THER, V21, P254, DOI 10.1097/PEP.0b013e3181b17566; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Rees G, 2004, INTENS CARE MED, V30, P1607, DOI 10.1007/s00134-004-2310-9; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Stark AR, 2008, PEDIATRICS, V122, P1119, DOI 10.1542/peds.2008-2174; Taylor A, 2003, INTENS CARE MED, V29, P795, DOI 10.1007/s00134-003-1690-6; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Titsworth WL, 2012, J NEUROSURG, V116, P1379, DOI 10.3171/2012.2.JNS111881; Wieczorek B, 2016, PEDIATR CRIT CARE ME, V17, pE559, DOI 10.1097/PCC.0000000000000983; Williams CN, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4090083; Williams S, 2007, PEDIATR CRIT CARE ME, V8, P18, DOI 10.1097/01.pcc.0000256623.01254.40; World Health Organization, 2007, INT CLASS FUNCT DIS; Zheng K, 2018, PEDIATR CRIT CARE ME, V19, pE350, DOI 10.1097/PCC.0000000000001547	50	14	15	4	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUN	2019	20	6					540	550		10.1097/PCC.0000000000001881			11	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	IQ4HF	WOS:000480711000012	30707210	Green Accepted			2022-02-06	
J	Rice, T; Curtis, R				Rice, Tracy; Curtis, Reagan			Parental knowledge of concussion: Evaluation of the CDC's "Heads up to parents" educational initiative	JOURNAL OF SAFETY RESEARCH			English	Article						Sport-related concussion; Youth sports; Parents; Education; CDC Heads up	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; NEUROPHYSIOLOGICAL ASSESSMENT; CONSENSUS STATEMENT; FOOTBALL PLAYERS; YOUTH; MANAGEMENT; CHILDREN	Background: Potential negative outcomes associated with sport-related concussion drive the need for resources to educate parents about prevention, recognition, and management of concussion in the youth athlete. Parents play a critical role in the recognition and management of concussion for their child. Purpose: This study aims to (a) investigate current knowledge of concussion among parents whose children age 5-18 years play a club sport and (b) identify effects of an online video versus online print educational intervention on concussion knowledge change and learning. Methods: 140 parents whose children played a club sport answered questions regarding their knowledge of sport-related concussion pre- and post-random assignment to an educational intervention: CDC Concussion Awareness video or CDC Concussion Fact Sheet for Parents. Results: Participating parents demonstrated a moderate level of pre-intervention knowledge, but critical gaps in knowledge were identified. Knowledge of concussion improved slightly following intervention regardless of intervention type. Conclusions: This study confirms the presence of gaps in knowledge of concussion in parents whose children play club sports. Without the protection of concussion legislation, those athletes who participate in club sports are at particular risk due to lack of concussion knowledge and education. This study confirms that education can have a positive impact on parental knowledge of concussion. Practical applications: Pre-knowledge of concussion is the greatest predictor of post-knowledge of concussion, therefore pre-assessment of target audience knowledge followed by a custom educational intervention taking into account principles of adult learning, would be the most beneficial to increasing concussion knowledge. (C) 2019 National Safety Council and Elsevier Ltd. All rights reserved.	[Rice, Tracy] West Virginia Univ, Sch Med, Div Phys Therapy, POB 9226, Morgantown, WV 26506 USA; [Curtis, Reagan] West Virginia Univ, Coll Educ & Human Serv, Dept Learning Sci & Human Dev, Allen Hall 507D, Morgantown, WV 26506 USA		Rice, T (corresponding author), West Virginia Univ, Sch Med, Div Phys Therapy, POB 9226, Morgantown, WV 26506 USA.	terice@hsc.wvu.edu	Curtis, Reagan/AAD-3185-2020	Curtis, Reagan/0000-0003-1873-1744			Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Boutin D, 2008, NEUROCASE, V14, P239, DOI 10.1080/13554790802247543; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; C. S. Mott Children's Hospital Web site, 2010, CONC SCH SPORTS PAR; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Centers for Disease C Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1337; Chrisman S. P, 2014, AM J SPORTS MED, V20; Coghlin Craig J, 2009, J Can Chiropr Assoc, V53, P233; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Conder Robert L, 2015, N C Med J, V76, P89; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Edwards JC, 2014, J LAW MED ETHICS, V42, P128, DOI 10.1111/jlme.12126; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Faure C, 2010, AM SECONDARY ED, V39, P5; Field A, 2009, REGRESSION DISCOVERI, P197; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza Christopher C, 2014, Continuum (Minneap Minn), V20, P1545, DOI 10.1212/01.CON.0000458975.78766.11; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Guskiewicz K. M, 2015, KINESIOLOGY REV, V4, P156; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hanson E, 2014, CLIN PEDIATR, V53, P1221, DOI 10.1177/0009922813518429; Haran HP, 2016, J SCI MED SPORT, V19, P194, DOI 10.1016/j.jsams.2015.02.009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Jacobson N. A, 2013, ORTHOP J SPORTS MED, V1, P1; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kay M. C, 2017, ORTHOP J SPORTS MED, V5, P1; Kearney PE, 2017, J SCI MED SPORT, V20, P981, DOI 10.1016/j.jsams.2017.04.019; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Knowles M.S., 2011, ADULT LEARNER, V6th ed.; LaBond Virginia, 2014, NASN Sch Nurse, V29, P194; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Macdonald I, 2016, J NEUROSCI NURS, V48, P297, DOI 10.1097/JNN.0000000000000212; Mann A, 2017, CAN FAM PHYSICIAN, V63, P460; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Miyashita TL, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114554549; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Nanos KN, 2017, MAYO CLIN PROC, V92, P1782, DOI 10.1016/j.mayocp.2017.10.003; National Council of Youth Sports, 2008, REPORTS ON TRENDS AN; Piasek C. Z, 2014, 2014 AAP NAT C EXH A; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Thomas DG, 2018, J EMERG NURS, V44, P52, DOI 10.1016/j.jen.2017.04.012; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Turner RW, 2017, BRAIN INJURY, V31, P1124, DOI 10.1080/02699052.2017.1298003; Weerdenburg K, 2016, PAED CHILD HEALT-CAN, V21, pE22, DOI 10.1093/pch/21.3.e22; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wiersma LD, 2005, RES Q EXERCISE SPORT, V76, P324; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	77	14	14	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	JUN	2019	69						85	93		10.1016/j.jsr.2019.02.007			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	IH4ZJ	WOS:000474500300010	31235239	Green Published			2022-02-06	
J	Scheffler, P; Wolter, NE; Namavarian, A; Propst, EJ; Chan, Y				Scheffler, Patrick; Wolter, Nikolaus E.; Namavarian, Amirpouyan; Propst, Evan J.; Chan, Yvonne			Contact sport related head and neck injuries in pediatric athletes	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Head and neck trauma; Sports; Sports injury; Children	CONCUSSION; PREVENTION; PLAYERS	Objectives: To describe the type and frequency of sports related pediatric head and neck trauma. Methods: The National Electronic Injury Surveillance System (NEISS) was searched for football, basketball, soccer, lacrosse and ice hockey related facial injuries. Cross-sectional analysis of incidence, age, and sex and specific injury diagnoses, mechanisms, and facial locations were performed. We focused on craniofacial and soft tissue injuries and excluded patients with concussion or other neurological injuries. Results: A total of 24,905 cases were identified in the NEISS database, corresponding to an estimated, 764,293 emergency department visits. The most hazardous sports were basketball, accounting for 356,188 visits (46.6%), football with 249,633 visits (32.6%), and soccer with 128,113 (14.7%) visits. Lacrosse and ice hockey accounted for 16,869 (1.9%) and 13,490 (1.5%) visits, respectively. There has been a decrease in injuries over the past 10 years, particularly for football (53%), ice hockey (46%), and lacrosse (41%). Soccer (13%) and basketball (9%) noticed the smallest decreases. Conclusion: Children who play basketball, football and soccer are especially prone to emergency department visits related to the head and neck. Overall, there has been an improvement in number of injuries across the five sports investigated. Sports amenable to head and neck protective equipment saw the largest improvement (football, ice hockey, lacrosse), whereas only small decreases were noted in basketball and soccer. Changes in regulations for sports not amenable to more protective equipment may help decrease adverse events.	[Scheffler, Patrick; Wolter, Nikolaus E.; Namavarian, Amirpouyan; Propst, Evan J.; Chan, Yvonne] Univ Toronto, Fac Med, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Wolter, Nikolaus E.; Propst, Evan J.] Hosp Sick Children, Dept Otolaryngol, Toronto, ON, Canada; [Chan, Yvonne] Trillium Hlth Partners, Div Otolaryngol Head & Neck Surg, Mississauga, ON, Canada		Wolter, NE (corresponding author), Hosp Sick Children, Dept Otolaryngol Head & Neck Surg, 555 Univ Ave,Room 6130, Toronto, ON MSG 1X8, Canada.	patrick.scheffler@mail.utoronto.ca; nikolaus.wolter@sickkids.ca; a.namavarian@mail.utoronto.ca; evan.propst@utoronto.ca; y.chan@utoronto.ca					Acabchuk Rebecca L, 2017, Concussion, V2, pCNC39, DOI 10.2217/cnc-2017-0005; Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Aman M, 2019, KNEE SURG SPORT TR A, V27, P1000, DOI 10.1007/s00167-018-5225-7; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Ferrante Jacqueline, 2012, Morbidity and Mortality Weekly Report, V61, P661; Gandy JR, 2016, LARYNGOSCOPE, V126, P1054, DOI 10.1002/lary.25584; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hojjat H, 2016, ANN OTO RHINOL LARYN, V125, P652, DOI 10.1177/0003489416644617; Hutchinson Mark R, 2003, Instr Course Lect, V52, P25; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Shumway-Cook A, 2012, MOTOR CONTROL TRANSL; Siewers M., 1998, INJURY PROFILE SCHOO, V12, P31; Smith AM, 2000, AM SOC TEST MATER, V1341, P199, DOI 10.1520/STP15240S; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Viozzi CF, 2017, CLIN SPORT MED, V36, P355, DOI 10.1016/j.csm.2016.11.007; Zetterberg H, 2019, J INTERN MED, V285, P624, DOI 10.1111/joim.12863	23	14	14	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	JUN	2019	121						6	9		10.1016/j.ijporl.2019.02.036			4	Otorhinolaryngology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Pediatrics	IA9WA	WOS:000469906400002	30851511				2022-02-06	
J	Shahror, RA; Ali, AAA; Wu, CC; Chiang, YH; Chen, KY				Shahror, Rami Ahmad; Ali, Ahmed Atef Ahmed; Wu, Chung-Che; Chiang, Yung-Hsiao; Chen, Kai-Yun			Enhanced Homing of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 to Injury Site in a Mouse Model of Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						regenerative medicine; mesenchymal stems cells; fibroblast growth factor 21; traumatic brain injury; cell tracking; cell homing; cell therapy; gene therapy	STROMAL CELLS; VALPROIC ACID; MIGRATION; FGF21; TRACKING; NANOPARTICLES; OPTIMIZATION; EXPRESSION; CONTRAST; RECOVERY	Mesenchymal stem cells (MSCs) are emerging as a potential therapeutic intervention for brain injury due to their neuroprotective effects and safe profile. However, the homing ability of MSCs to injury sites still needs to be improved. Fibroblast Growth Factor 21 (FGF21) was recently reported to enhance cells migration in different cells type. In this study, we investigated whether MSCs that overexpressing FGF21 (MSC-FGF21) could exhibit enhanced homing efficacy in brain injury. We used novel Molday IONEverGreen (MIEG) as cell labeling probe that enables a non-invasive, high-sensitive and real-time MRI tracking. Using a mouse model of traumatic brain injury (TBI), MIEG labeled MSCs were transplanted into the contralateral lateral ventricle followed by real-time MRI tracking. FGF21 retained MSC abilities of proliferation and morphology. MSC-FGF21 showed significantly greater migration in transwell assay compared to control MSC. MIEG labeling showed no effects on MSCs' viability, proliferation and differentiation. Magnetic resonance imaging (MRI) revealed that FGF21 significantly enhances the homing of MSC toward injury site. Histological analysis further confirmed the MRI findings. Taken together, these results show that FGF21 overexpression and MIEG labeling of MSC enhances their homing abilities and enables non-invasive real time tracking of the transplanted cells, provides a promising approach for MSC based therapy and tracking in TBI.	[Shahror, Rami Ahmad; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei 110, Taiwan; [Shahror, Rami Ahmad; Chiang, Yung-Hsiao; Chen, Kai-Yun] Natl Hlth Res Inst, Taipei 110, Taiwan; [Shahror, Rami Ahmad; Wu, Chung-Che; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 110, Taiwan; [Shahror, Rami Ahmad; Ali, Ahmed Atef Ahmed; Wu, Chung-Che; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, TMU Neurosci Res Ctr, Taipei 110, Taiwan; [Ali, Ahmed Atef Ahmed] Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei 110, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei 110, Taiwan		Chen, KY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei 110, Taiwan.; Chen, KY (corresponding author), Natl Hlth Res Inst, Taipei 110, Taiwan.; Chen, KY (corresponding author), Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 110, Taiwan.; Chen, KY (corresponding author), Taipei Med Univ, TMU Neurosci Res Ctr, Taipei 110, Taiwan.	rami.shahror@yahoo.com; ahmed.atef@tmu.edu.tw; johnwu@tmu.edu.tw; ychiang@tmu.edu.tw; kychen08@tmu.edu.tw		Ali, Ahmed/0000-0002-0375-6511; Shahror, Rami/0000-0001-6403-9404	Ministry of Science and Technology Grants, Taiwan [MOST 104-2923-B-038-004 -MY2, MOST 107-2314-B-038-063, MOST 107-2314-B-038-042]; Taipei Medical University [TMU 105-AE1-B03, TMU 106-5400-004-400, TMU 106-5310-001-400, DP2-107-21121-01-N-05, DP2-108-21121-01-N-05-01]	This study was supported by the Ministry of Science and Technology Grants, Taiwan (MOST 104-2923-B-038-004 -MY2, MOST 107-2314-B-038-063, and MOST 107-2314-B-038-042) and Taipei Medical University (TMU 105-AE1-B03, TMU 106-5400-004-400, TMU 106-5310-001-400, DP2-107-21121-01-N-05 and DP2-108-21121-01-N-05-01).	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Berman SMC, 2013, MAGN RESON MED, V69, P255, DOI 10.1002/mrm.24216; Betzer O, 2015, SCI REP-UK, V5, DOI 10.1038/srep15400; Billotey C, 2003, MAGN RESON MED, V49, P646, DOI 10.1002/mrm.10418; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; De Becker A, 2016, WORLD J STEM CELLS, V8, P73, DOI 10.4252/wjsc.v8.i3.73; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Himmelreich U, 2008, MINIM INVASIV THER, V17, P132, DOI 10.1080/13645700801969873; Hu SQ, 2017, EXP THER MED, V14, P771, DOI 10.3892/etm.2017.4564; Huang L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt519; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kim SJ, 2016, CONTRAST MEDIA MOL I, V11, P55, DOI 10.1002/cmmi.1658; Kuroda M, 2017, J CLIN INVEST, V127, P3502, DOI 10.1172/JCI94337; Leng Y, 2015, MOL PSYCHIATR, V20, P215, DOI 10.1038/mp.2013.192; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Li YM, 2017, AM J TRANSL RES, V9, P5299; Linares GR, 2016, EXP NEUROL, V281, P81, DOI 10.1016/j.expneurol.2016.04.003; Ma L, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/4837503; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mishra SK, 2015, EXP CELL RES, V339, P427, DOI 10.1016/j.yexcr.2015.11.010; MOLDAY RS, 1982, J IMMUNOL METHODS, V52, P353, DOI 10.1016/0022-1759(82)90007-2; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sarkar D, 2011, BLOOD, V118, pE184, DOI 10.1182/blood-2010-10-311464; Song YH, 2016, MOL MED REP, V13, P3619, DOI 10.3892/mmr.2016.4942; TAYLOR A, 2014, J RURAL COMMUNITY DE, V9, DOI DOI 10.1371/journal.pone.0100259; Tsai LK, 2010, NEUROPSYCHOPHARMACOL, V35, P2225, DOI 10.1038/npp.2010.97; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wang X, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00032; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	42	14	15	1	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JUN 1	2019	20	11							2624	10.3390/ijms20112624			19	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	IE8OX	WOS:000472634100018	31142002	gold, Green Published, Green Submitted			2022-02-06	
J	Foster, CA; D'Lauro, C; Johnson, BR				Foster, Craig A.; D'Lauro, Christopher; Johnson, Brian R.			Pilots and athletes: Different concerns, similar concussion non-disclosure	PLOS ONE			English	Article							SCHOOL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; ICE HOCKEY; EDUCATION; KNOWLEDGE; SYMPTOMS; GENDER; NORMS; RISK; ATTITUDES	Objectives Concussion non-disclosure research has focused almost exclusively on athletes. The focus on athletic populations has been sensible considering athletes' demonstrated susceptibility to sustaining and concealing concussions. Nevertheless, the habitual use of athletic populations has allowed researchers and practitioners to omit the development of generalized perceived costs and perceived rewards as critical determinants of concussion self-disclosure. We hypothesized that perceiving concussion disclosure as generally more costly than rewarding would predict negative attitudes towards disclosure and decreased intent to disclose. We also hypothesized that generalized perceived costs and rewards could explain concussion non-disclosure in different populations, athletes and future pilots specifically, even when those populations perceive concussion self-disclosure as costly for different specific reasons. Methods We examined concussion disclosure using 2,504 cadets at the United States Air Force Academy. Cadets completed anonymous surveys assessing their intention to self-disclose undiagnosed concussions (Anticipated Concussion Disclosure) as well as several variables potentially related to concussion self-disclosure: perceived cost, perceived reward, personal identity, attitudes, normative behavior, social support, and self-efficacy. Results The results demonstrate that concussion non-disclosure develops when a population perceives disclosure as more costly (i.e. directly or emotionally) and less rewarding. Perceived Cost and Perceived Reward variables alone accounted for 50% of the variance in Anticipated Conclusion Disclosure (Adjusted R-2 = 0.50, F(2,2312) = 1,145.31, p < 0.001). As expected, Anticipated Conclusion Disclosure developed for different reasons within different sub-populations. Consistent with existing research, cadet intercollegiate athletes reported being primarily concerned that concussion self-disclosure would cause them to miss practice or game time (t (736.7) = 14.20, p <.001, Cohen's d = 0.96). In contrast, cadet future pilots reported being primarily concerned that concussion self-disclosure would have negative United States Air Force career repercussions (t (1828) = 10.25, p < .001, Cohen's d = 0.50). Conclusions These results suggest that cultures of concussion non-disclosure can develop in any population where disclosure is perceived as having undesirable consequences, not just athletic populations. Concussion researchers and practitioners should devote more attention to the perceived cost-benefit structures that create concussion non-disclosure to address this crucial public health issue more effectively.	[Foster, Craig A.; D'Lauro, Christopher] US Air Force Acad, Dept Behav Sci & Leadership, Colorado Springs, CO 80840 USA; [Johnson, Brian R.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA		D'Lauro, C (corresponding author), US Air Force Acad, Dept Behav Sci & Leadership, Colorado Springs, CO 80840 USA.	christopher.dlauro@gmail.com	D'Lauro, Christopher/X-1518-2019; D'Lauro, Christopher/V-2587-2019	D'Lauro, Christopher/0000-0003-0894-6602; 	National Collegiate Athletic Association (NCAA)-Department of Defense DoD Mind Matters Challenge Award under the Sports Safety Insititue; Sports Safety Institute of the National Collegiate Athletic Association (NCAA) through a Mind Matters research grant; United States Department of Defense through a Mind Matters research grant	The work of all three authors was supported by an National Collegiate Athletic Association (NCAA)-Department of Defense DoD Mind Matters Challenge Award under the auspices of the Sports Safety Insititue. No grant number was provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily reflect those of the United States Air Force Academy or the United States Department of Defense.; We thank Emily Jones for her assistance in developing this manuscript. We thank Lt Col (Ret.) Jerry McGinty and Col. (Ret.) Darren Campbell MD for support and assistance with administration. We thank the entire Summer 2015 USAFA Baseline Concussion team for assistance with administration of surveys. We thank the Sports Safety Institute of the National Collegiate Athletic Association (NCAA) and United States Department of Defense for supporting this research through a Mind Matters research grant. We also thank the cadets who participated so enthusiastically in this research.	Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Capraro V, 2018, JUDGM DECIS MAK, V13, P345; Capraro V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06790; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Combs PR, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967118817515; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Engel C, 2016, APPL ECON LETT, V23, P1157, DOI 10.1080/13504851.2016.1139672; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Halstead ME, 2017, BRIT J SPORT MED, V51, P147, DOI 10.1136/bjsports-2016-096674; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Higgins E.Tory., 1989, ADV EXP SOC PSYCHOL, V22, P93, DOI DOI 10.1016/S0065-2601(08)60306-8; Johnson BR, 2018, MIL MED, V183, P101, DOI 10.1093/milmed/usx106; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lininger M, 2017, ATHLETIC TRAIN SPORT, V9, P71, DOI DOI 10.3928/19425864-20161116-01; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Rand DG, 2017, J EXP SOC PSYCHOL, V73, P164, DOI 10.1016/j.jesp.2017.06.013; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Weber JM, 2004, PERS SOC PSYCHOL REV, V8, P281, DOI 10.1207/s15327957pspr0803_4; 2018, ECON LETT, V170, P19, DOI DOI 10.1016/J.ECONLET.2018.05.022; 2013, CLIN J SPORT MED, V23, P339, DOI DOI 10.1097/JSM.0B013E318291D3B3; 1991, ORGAN BEHAV HUM DECI, V50, P179	54	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2019	14	5							e0215030	10.1371/journal.pone.0215030			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HW0KS	WOS:000466370200018	31042725	gold, Green Published, Green Submitted			2022-02-06	
J	Haider, MN; Leddy, JJ; Wilber, CG; Viera, CB; Bezherano, T; Wilkins, KJ; Miecznikowski, JC; Willer, BS				Haider, Mohammad N.; Leddy, John J.; Wilber, Charles G.; Viera, Caitlin B.; Bezherano, Tai; Wilkins, Kimberly J.; Miecznikowski, Jeffrey C.; Willer, Barry S.			The Predictive Capacity of the Buffalo Concussion Treadmill Test After Sport-Related Concussion in Adolescents	FRONTIERS IN NEUROLOGY			English	Article						Buffalo Concussion Treadmill Test; sport-related concussion; adolescent; post-concussion syndrome; exercise intolerance	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; POSTCONCUSSION SYNDROME; PHYSICAL-EXERCISE; RECOVERY; SYMPTOMS; CHILDREN	The Buffalo Concussion Treadmill Test (BCTT) identifies the heart rate threshold (HRt) of exercise tolerance in concussed patients. A previous study found that an absolute HRt of < 135 bpm was associated with prolonged recovery (> 30 days) from sport-related concussion (SRC). In this study, we assessed the relationship of Delta HR (difference between resting HR and HRt) and recovery from SRC. Using a retrospective cohort design, we compared acutely (< 10 days since injury) concussed adolescents who were prescribed either (1) relative rest (RG, n = 27, 15.2 +/- 1 years, 33% female, median 17 days to recovery, Delta HR = 69.6 +/- 28 bpm), (2) a placebo-stretching program (PG, n = 51, 15.4 +/- 2 years, 49% female, median 17 days to recovery, Delta HR = 60.9 +/- 22 bpm), or (3) sub-threshold aerobic exercise (AG, n = 52, 15.3 +/- 2 years, 46% female, median 13 days to recovery, Delta HR = 62.4 +/- 26 bpm). Linear regression showed that Delta HR significantly correlated with duration of clinical recovery for RG (p = 0.012, R-2 = 0.228) and PG (p = 0.011, R-2 = 0.126) but not for AG (p = 0.084, R-2 = 0.059). Delta HR values were significantly lower in participants with prolonged recovery (> 30 days) in RG (p = 0.01) and PG (p = 0.04). A Delta HR of = 50 bpm on the BCTT is 73% sensitive and 78% specific for predicting prolonged recovery in concussed adolescents who were prescribed the current standard of care (i.e., cognitive and physical rest).	[Haider, Mohammad N.; Leddy, John J.; Wilber, Charles G.; Viera, Caitlin B.; Bezherano, Tai] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Orthoped & Sports Med, Buffalo, NY 14260 USA; [Haider, Mohammad N.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurosci, Buffalo, NY 14260 USA; [Wilkins, Kimberly J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Family Med, Buffalo, NY USA; [Miecznikowski, Jeffrey C.] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Biostat, Buffalo, NY USA; [Willer, Barry S.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA		Haider, MN (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, UBMD Orthoped & Sports Med, Buffalo, NY 14260 USA.; Haider, MN (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurosci, Buffalo, NY 14260 USA.	haider@buffalo.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094444] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R01NS094444. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Bernard C, 2017, BRAIN INJURY, V31, P1414, DOI 10.1080/02699052.2017.1350999; Borg G., 1998, BORGS PERCEIVED EXER; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Chrisman SPD, 2019, JAMA PEDIATR, V173, P315, DOI 10.1001/jamapediatrics.2018.5281; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Conder Robert L, 2015, N C Med J, V76, P89; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Echemendia RJ, 2017, BRIT J SPORT MED, V51, DOI DOI 10.1136/BJSPORTS-2017-097506; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Haider MN, 2020, CLIN J SPORT MED, V30, P513, DOI 10.1097/JSM.0000000000000687; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; OBRIEN IAD, 1986, BRIT HEART J, V55, P348; Sarganas G, 2017, J PEDIATR-US, V187, P174, DOI 10.1016/j.jpeds.2017.05.021; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Whaley MH, 2006, ACSMS GUID EX TEST P; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wustenberg E, 2017, ALLERGO J, V26, P14	46	14	14	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 24	2019	10								395	10.3389/fneur.2019.00395			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HU7VV	WOS:000465492500001	31105634	Green Published, gold			2022-02-06	
J	Hubbard, WB; Joseph, B; Spry, M; Vekaria, HJ; Saatman, KE; Sullivan, PG				Hubbard, W. Brad; Joseph, Binoy; Spry, Malinda; Vekaria, Hemendra J.; Saatman, Kathryn E.; Sullivan, Patrick G.			Acute Mitochondrial Impairment Underlies Prolonged Cellular Dysfunction after Repeated Mild Traumatic Brain Injuries	JOURNAL OF NEUROTRAUMA			English	Article						bioenergetics; closed head injury; concussion; oxidative stress; Seahorse	TEMPORAL WINDOW; LIPID-PEROXIDATION; OXIDATIVE STRESS; MOUSE MODEL; METABOLIC-CHANGES; SEX-DIFFERENCES; TIME-COURSE; VULNERABILITY; CONCUSSION; BIOENERGETICS	Mild traumatic brain injuries (mTBI), accounting for more than 80% of TBIs, can cause cognitive and behavioral impairments, the severity and duration of which increase after additional mTBIs. While mTBI does not cause widespread neuronal death, the mechanisms underlying increased cellular susceptibility to subsequent head impacts remain unknown. To investigate the hypothesis that altered mitochondrial bioenergetics underlie cellular vulnerability to repeated insults, we employed a mouse model of mild closed head injury (CHI) to examine mitochondrial function and oxidative stress, because these mechanisms are often intertwined. Mitochondrial respiration was assayed (Seahorse XFe24 Flux Analyzer) from cortex and hippocampus collected at 6 h, 24 h, 48 h, and 96 h post-injury. State III (adenosine diphosphate [ADP]-mediated) respiration was significantly decreased in the hippocampal mitochondria of the CHI group compared with sham at 48 h post-injury. Further, cortex-derived mitochondria exhibited a decrease in State III respiration at 24 h and 48 h post-injury. No significant differences were observed at 6 h or 96 h post-injury in either region of interest. A second CHI repeated either 48 h or 96 h after the first did not worsen State III respiration at 48 h after the final injury compared with a single CHI, but CHI repeated at a 48 h interval prolonged cortical mitochondrial dysfunction to 96 h after the final injury. Markers of oxidative stress were significantly elevated after two CHIs delivered 48 h apart, but not after single CHI or two CHI delivered 96 h apart. This study establishes that mTBI results in early mitochondrial dysfunction, which may be a determinant for cellular vulnerability to repeated head impacts. Thus, therapies targeting mitochondrial impairment could improve outcomes after repeated mTBI.	[Hubbard, W. Brad; Joseph, Binoy; Spry, Malinda; Vekaria, Hemendra J.; Saatman, Kathryn E.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Saatman, Kathryn E.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [Sullivan, Patrick G.] Lexington VAMC, Lexington, KY USA		Saatman, KE; Sullivan, PG (corresponding author), Univ Kentucky, 741 S Limestone St, Lexington, KY 40536 USA.	k.saatman@uky.edu; patsullivan@uky.edu	Vekaria, Hemendra/AAQ-7450-2020	Vekaria, Hemendra/0000-0001-5945-5235	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA177558] Funding Source: Medline; BLRD VA [I01 BX003405] Funding Source: Medline		Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Ghroubi S, 2016, ANN PHYS REHABIL M S, V59S, pe135; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hall E.D., 2004, NEUROSCIENCE MOL MED; Hall ED, 2015, BRAIN NEUROTRAUMA MO; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Hubbard WB, 2018, ACUTE NEURONAL INJUR, P63, DOI [10.1007/978-3-319-77495-4_4, DOI 10.1007/978-3-319-77495-4_4]; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Kim Susan, 2017, Concussion, V2, pCNC48, DOI 10.2217/cnc-2017-0013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mei ZR, 2017, METAB BRAIN DIS, V32, P1861, DOI 10.1007/s11011-017-0075-4; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nukala VN, 2006, J NEUROSCI METH, V152, P48, DOI 10.1016/j.jneumeth.2005.08.017; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Singh K., 2017, NMR BIOMED, P30; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vekaria HJ, 2017, NEUROCHEM INT, V109, P117, DOI 10.1016/j.neuint.2017.04.004; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yates NJ, 2017, EXP BRAIN RES, V235, P2133, DOI 10.1007/s00221-017-4958-8	71	14	14	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1252	1263		10.1089/neu.2018.5990			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000463812000005	30417732	Green Published			2022-02-06	
J	Zonner, SW; Ejima, K; Bevilacqua, ZW; Huibregtse, ME; Charleston, C; Fulgar, C; Kawata, K				Zonner, Steven W.; Ejima, Keisuke; Bevilacqua, Zachary W.; Huibregtse, Megan E.; Charleston, Carmen; Fulgar, Ciara; Kawata, Keisuke			Association of Increased Serum S100B Levels With High School Football Subconcussive Head Impacts	FRONTIERS IN NEUROLOGY			English	Article						subconcussion; brain injury; blood biomarker; football; youth; concussion; head impact kinematics; astrocyte	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; WHITE-MATTER; NEUROFILAMENT LIGHT; EXERCISE INTENSITY; IN-VIVO; S-100B; PLAYERS; ENCEPHALOPATHY; ELIMINATION	Astrocyte-enriched marker, S100B, shows promise for gauging the severity of acute brain trauma, and understanding subconcussive effects will advance its utility in tracking real-time acute brain damage. The aim of the study was to investigate whether serum 5100B elevations were associated with frequency and magnitude of subconcussive head impacts in adolescents. This prospective cohort study of 17 high-school football players consisted of the following 12 time points: pre-season baseline, 5 in-season pre-post games, and post-season. A sensor-installed mouthguard recorded the number of head impacts, peak linear (PLA) and peak rotational (PRA) head accelerations from every practice and game. During the 5 games, players wore chest-strap heart-rate monitors to estimate players' excess post-exercise oxygen consumption (EPOC), accounting for physical exertion effects. At each time point, blood samples were obtained and assessed for S1008 and creatine kinase levels to account for astrocyte damage/activation and muscle damage, respectively. Using k-means clustering on the impact data, players were categorized into high- or low-impact group. Two players withdrew during the first month of the study. A total of 156 blood samples from 15 players were assessed for S100B and creatine kinase levels and included in the analysis. A median value of 596 head impacts from 15 players were recorded during all practices and games in a season. S100B levels were significantly elevated in all post-game measures compared with the respective pre-game values (median-increase, 0.022 mu g/L; interquartile-range, 0.011-0.043 mu g/L, p < 0.05 for all games). Greater acute S100B increases were significantly associated with greater impact frequency, sum of PLA and PRA, with negligible contributions from physical exertion and muscle damage effects. The high-impact group exhibited greater increases in serum S100B levels at post-games than the low-impact group (high vs. low, 0.043 +/- 0.035 mu g/L vs. 0.019 +/- 0.017 mu g/L, p = 0.002). The degree of acute S100B increases was correlated with subconcussive head impact exposure, suggesting that acute astrocyte damage may be induced in an impact-dependent manner. Acute changes in serum S100B levels may become a useful tool in monitoring real-time brain damage in sports.	[Zonner, Steven W.] Washington Township Med Fdn, Dept Sports Med, Fremont, CA USA; [Ejima, Keisuke] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Bevilacqua, Zachary W.; Huibregtse, Megan E.; Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth, Bloomington, IN 47405 USA; [Charleston, Carmen] Irvington High Sch, Div Washington Sports Med, Fremont, CA USA; [Fulgar, Ciara] Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA; [Kawata, Keisuke] Indiana Univ, Coll Arts & Sci, Program Neurosci, Bloomington, IN 47405 USA		Kawata, K (corresponding author), Indiana Univ, Dept Kinesiol, Sch Publ Hlth, Bloomington, IN 47405 USA.; Kawata, K (corresponding author), Indiana Univ, Coll Arts & Sci, Program Neurosci, Bloomington, IN 47405 USA.	kkawata@indiana.edu			Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health [ISCBIRF 0019939]; IU School of Public Health faculty research grant program [FRGP: 2246237]	This work was partly supported from the Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health (to KK: ISCBIRF 0019939) and IU School of Public Health faculty research grant program (to KK: FRGP: 2246237). Sponsors had no role in the design or execution of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; [Anonymous], 2005, PREDICTION METHOD BA; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baird MF, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/960363; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Borsheim E, 2003, SPORTS MED, V33, P1037; Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; CLARKSON PM, 1988, CLIN SCI, V75, P257, DOI 10.1042/cs0750257; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dang XB, 2014, INT J CLIN EXP PATHO, V7, P3818; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Higgins M, 2007, J ATHL TRAINING, V42, P5; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2018, J NEUROTRAUM, V35, P260, DOI 10.1089/neu.2017.5376; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Laforgia J, 2006, J SPORT SCI, V24, P1247, DOI 10.1080/02640410600552064; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; MacQueen J, 1967, P BERKELEY S MATH ST, V1, P281; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McLeish MJ, 2005, CRIT REV BIOCHEM MOL, V40, P1, DOI 10.1080/10409230590918577; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Michetti F, 2011, CLIN BIOCHEM, V44, P245, DOI 10.1016/j.clinbiochem.2010.10.007; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; NCAA-Research, 2017, EST PROB COMP COLL A; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Pfortmueller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152822; Raabe A, 2001, NEUROSURGERY, V49, P1491, DOI 10.1097/00006123-200112000-00055; Reynolds BB, 2018, BRAIN IMAGING BEHAV, V12, P1332, DOI 10.1007/s11682-017-9790-z; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Rusko H. K., 2003, Medicine & Science in Sports & Exercise, V35, pS183, DOI 10.1097/00005768-200305001-01014; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Smolander J, 2011, CLIN PHYSIOL FUNCT I, V31, P266, DOI 10.1111/j.1475-097X.2011.01011.x; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zonner SW, 2019, JAMA OPHTHALMOL, V137, P265, DOI 10.1001/jamaophthalmol.2018.6193	58	14	14	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 5	2019	10								327	10.3389/fneur.2019.00327			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HS1AD	WOS:000463591900001	31024425	gold, Green Published			2022-02-06	
J	Bader, M; Li, YZ; Lecca, D; Rubovitch, V; Tweedie, D; Glotfelty, E; Rachmany, L; Kim, HK; Choi, HI; Hoffer, BJ; Pick, CG; Greig, NH; Kim, DS				Bader, Miaad; Li, Yazhou; Lecca, Daniela; Rubovitch, Vardit; Tweedie, David; Glotfelty, Elliot; Rachmany, Lital; Kim, Hee Kyung; Choi, Ho-Il; Hoffer, Barry J.; Pick, Chaim G.; Greig, Nigel H.; Kim, Dong Seok			Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Mild traumatic brain injury; PT302; Exenatide; Exendin-4; Glucagon-like peptide-1; Incretin mimetic; Neurodegeneration; Neuroinflammation	GLUCAGON-LIKE PEPTIDE-1; RECEPTOR AGONIST; PARKINSONS-DISEASE; COGNITIVE DEFICITS; ANIMAL-MODEL; DOPAMINERGIC-NEURONS; RODENT MODELS; HEAD-INJURY; EXENDIN-4; GLP-1	Traumatic brain injury (TBI) is a neurodegenerative disorder for which no effective pharmacological treatment is available. Glucagon-like peptide 1 (GLP-1) analogues such as Exenatide have previously demonstrated neurotrophic and neuroprotective effects in cellular and animal models of TBI. However, chronic or repeated administration was needed for efficacy. In this study, the pharmacokinetics and efficacy of PT302, a clinically available sustained-release Exenatide formulation (SR-Exenatide) were evaluated in a concussive mild (m)TBI mouse model. A single subcutaneous (s.c.) injection of PT302 (0.6, 0.12, and 0.024 mg/kg) was administered and plasma Exenatide concentrations were time-dependently measured over 3 weeks. An initial rapid regulated release of Exenatide in plasma was followed by a secondary phase of sustained-release in a dose-dependent manner. Short- and longer-term (7 and 30 day) cognitive impairments (visual and spatial deficits) induced by weight drop mTBI were mitigated by a single post-injury treatment with Exenatide delivered by s.c. injection of PT302 in clinically translatable doses. Immunohistochemical evaluation of neuronal cell death and inflammatory markers, likewise, cross-validated the neurotrophic and neuroprotective effects of SR-Exenatide in this mouse mTBI model. Exenatide central nervous system concentrations were 1.5% to 2.0% of concomitant plasma levels under steady-state conditions. These data demonstrate a positive beneficial action of PT302 in mTBI. This convenient single, sustained-release dosing regimen also has application for other neurological disorders, such as Alzheimer's disease, Parkinson's disease, multiple system atrophy and multiple sclerosis where prior preclinical studies, likewise, have demonstrated positive Exenatide actions.	[Bader, Miaad; Rubovitch, Vardit; Rachmany, Lital; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Li, Yazhou; Lecca, Daniela; Tweedie, David; Glotfelty, Elliot; Greig, Nigel H.; Kim, Dong Seok] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Glotfelty, Elliot; Kim, Dong Seok] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Kim, Hee Kyung; Choi, Ho-Il] Peptron Inc, Daejeon, South Korea; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel		Greig, NH (corresponding author), NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA.	Greign@mail.nih.gov	Glotfelty, Elliot/AAE-6981-2019	Glotfelty, Elliot/0000-0001-5125-8720	Technological Innovation R&D Program - Small and Medium Business Administration (Republic of Korea) [S2174574]; Peptron Inc., Daejeon, Republic of Korea; Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning (MSIP) of Korea [NRF-2014M3A9B5073868]; NINDS, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [094152]; Intramural Research Program of the National Institute on Aging, National Institutes of Health, USA; An and Regine Aprijaskis Fund; Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases at Tel-Aviv University, Tel Aviv, Israel; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000333] Funding Source: NIH RePORTER	This research was supported in part by (i) the Technological Innovation R&D Program (S2174574) funded by the Small and Medium Business Administration (Republic of Korea); (ii) Peptron Inc., Daejeon, Republic of Korea; (iii) the Bio and Medical Technology Development Program (NRF-2014M3A9B5073868) of the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning (MSIP) of Korea, (iv) NINDS, NIH grant NS 094152 to BJH, (v) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, USA, (vi) the An and Regine Aprijaskis Fund, and by a grant from the Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases at Tel-Aviv University, Tel Aviv, Israel. This work was performed in partial fulfillment of the requirements for a Ph.D. degree of MB, Sackler Faculty of Medicine, Tel Aviv University, Israel.	Alcalay RN, 2004, NEUROSCI LETT, V361, P128, DOI 10.1016/j.neulet.2003.12.005; Anderberg RH, 2016, PSYCHONEUROENDOCRINO, V65, P54, DOI 10.1016/j.psyneuen.2015.11.021; Antonsen KK, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019562; Athauda D, 2018, NEUROPHARMACOLOGY, V136, P260, DOI 10.1016/j.neuropharm.2017.09.023; Athauda D, 2018, J PARKINSON DIS, V8, P247, DOI 10.3233/JPD-181329; Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4; Athauda D, 2016, DRUG DISCOV TODAY, V21, P802, DOI 10.1016/j.drudis.2016.01.013; Aviles-Olmos I, 2014, J PARKINSON DIS, V4, P337, DOI 10.3233/JPD-140364; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bassil F, 2017, BRAIN, V140, P1420, DOI 10.1093/brain/awx044; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Benakis C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00461; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chen S., 2018, SCI REP, V8; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Chon S, 2016, DIABETES METAB J, V40, P99, DOI 10.4093/dmj.2016.40.2.99; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Deselms H, 2016, J NEUROSCI METH, V272, P69, DOI 10.1016/j.jneumeth.2016.02.002; DeYoung MB, 2011, DIABETES TECHNOL THE, V13, P1145, DOI 10.1089/dia.2011.0050; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Drucker DJ, 2018, CELL METAB, V27, P740, DOI 10.1016/j.cmet.2018.03.001; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Gallwitz B, 2014, ENDOCRINE, V47, P360, DOI 10.1007/s12020-014-0223-0; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gejl M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00108; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goncalves A, 2016, INVEST OPHTH VIS SCI, V57, P2584, DOI 10.1167/iovs.15-19006; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Gu N, 2014, CLIN THER, V36, P101, DOI 10.1016/j.clinthera.2013.12.002; Gullo F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00500; Hakon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120074; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Heppner KM, 2015, ENDOCRINOLOGY, V156, P255, DOI 10.1210/en.2014-1675; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Holscher C, 2018, NEUROPHARMACOLOGY, V136, P251, DOI 10.1016/j.neuropharm.2018.01.040; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Isacson R, 2011, EUR J PHARMACOL, V650, P249, DOI 10.1016/j.ejphar.2010.10.008; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008; Kappe C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-276; Karnati HK, 2019, J NEUROTRAUM, V36, P975, DOI 10.1089/neu.2018.5898; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; Kim DS, 2017, CELL TRANSPLANT, V26, P1560, DOI 10.1177/0963689717721234; Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132; Koehler JA, 2015, DIABETES, V64, P1046, DOI 10.2337/db14-0883; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee CH, 2018, MOL NEUROBIOL, V55, P3007, DOI 10.1007/s12035-017-0550-2; Lewis A., 2012, COMMUNICATION; Li YW, 2016, REV NEUROSCIENCE, V27, P689, DOI 10.1515/revneuro-2016-0018; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; MATSUO M, 1995, BRAIN RES, V685, P201, DOI 10.1016/0006-8993(95)00490-H; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Vega MM, 2018, EXPERT OPIN DRUG MET, V14, P207, DOI 10.1080/17425255.2018.1420160; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Murakami H, 2000, AM J PHYSIOL-HEART C, V279, pH1022, DOI 10.1152/ajpheart.2000.279.3.H1022; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Nauck M, 2016, DIABETES OBES METAB, V18, P203, DOI 10.1111/dom.12591; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Russell S, 2013, INT J CLIN PHARM-NET, V35, P159, DOI 10.1007/s11096-012-9729-9; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Schmued LC, 2016, BRAIN RES, V1645, P31, DOI 10.1016/j.brainres.2016.03.053; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sun ZL, 2018, CELL PHYSIOL BIOCHEM, V47, P617, DOI 10.1159/000490017; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tamargo IA, 2017, EXP NEUROL, V288, P176, DOI 10.1016/j.expneurol.2016.11.005; Teramoto S, 2011, J CEREBR BLOOD F MET, V31, P1696, DOI 10.1038/jcbfm.2011.51; Tolhurst G, 2009, J PHYSIOL-LONDON, V587, P27, DOI 10.1113/jphysiol.2008.164012; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Verma MK, 2018, EXPERT OPIN THER TAR, V22, P615, DOI 10.1080/14728222.2018.1487952; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wu HY, 2018, J NEUROIMMUNOL, V316, P17, DOI 10.1016/j.jneuroim.2017.12.005; Xie ZY, 2018, NEUROPHARMACOLOGY, V128, P142, DOI 10.1016/j.neuropharm.2017.09.040; Yun S. P., 2018, NAT MED, V1; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	102	14	14	1	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	APR	2019	124						439	453		10.1016/j.nbd.2018.11.023			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HM1NH	WOS:000459217800040	30471415	Green Accepted			2022-02-06	
J	Howell, DR; Myer, GD; Grooms, D; Diekfuss, J; Yuan, WH; Meehan, WP				Howell, David R.; Myer, Gregory D.; Grooms, Dustin; Diekfuss, Jed; Yuan, Weihong; Meehan, William P., III			Examining Motor Tasks of Differing Complexity After Concussion in Adolescents	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Attention; Locomotion; Postural balance; Rehabilitation	TRAUMATIC BRAIN-INJURY; GAIT BALANCE CONTROL; DUAL-TASK; PERFORMANCE; ABNORMALITIES; STABILITY; RECOVERY; WALKING; SPEED; RISK	Objectives: (1) To determine the effects of concussion-related motor impairments at different task complexities in isolation and with a cognitive dual-task and (2) to determine if self-reported balance deficits after concussion are associated with gait, quiet stance, or cognitive dual-task impairments. Design: Cross-sectional study. Setting: Sports medicine clinic. Participants: Adolescent athletes clinically diagnosed with a sport-related concussion and those without concussion. Forty-nine patients with concussion (mean age = 14.9 +/- 1.9y; 51% female; tested 7.0 +/- 3.0d postinjury) and 65 control participants (mean age= -14.9 +/- 1.6y; 52% female) completed the study (N =114). Interventions: Athletes with concussion completed a single-task and dual-task standing and walking protocol within 14 days of injury and were compared to those without concussion. Main Outcome Measures: Outcome measures included gait speed, quiet stance (root mean square [RMS] coronal/sagittal plane sway), and cognitive performance (accuracy). Dual-task costs were calculated as the percentage change between single-task and dual-task conditions. Participants with concussion were then stratified by those who did and did not report subjective balance problems at the time of testing and compared using objective balance and gait metrics. Results: The concussion group walked slower during dual-task gait than controls (0.83 +/- 0.17 m/s vs 0.92 +/- 0.15 m/s; Cohen's d=0.53). Dual-task quiet stance RMS sway values were similar for concussion and control groups in coronal (1.20 +/- 0.52 m/s(-2) vs 1.26 +/- 0.65 m/s(-2); d=0.09) and sagittal (0.56 +/- 0.24 m/s(-2) vs 0.73 +/- 0.44 m/s(-2); d = 0.20) movement planes. The concussion participants with subjectively-reported balance problems had significantly greater walking speed dual-task costs than concussion participants without self-reported balance problems (-25 +/- 10% vs -19 +/- 9%; P = .02). Conclusions: Following concussion, adolescents demonstrate slower gait speeds, but similar quiet stance values relative to those without concussion. The study results indicate that tasks requiring greater motor coordination may elicit greater alterations following a concussion. (C) 2018 by the American Congress of Rehabilitation Medicine	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, 13123 E 16th Ave,B060, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Myer, Gregory D.; Diekfuss, Jed] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, SPORT Ctr, Cincinnati, OH 45229 USA; [Grooms, Dustin] Ohio Univ, Coll Hlth Sci & Profess, Sch Appl Hlth Sci & Wellness, Ohio Musculoskeletal & Neurol Inst, Athens, OH 45701 USA; [Grooms, Dustin] Ohio Univ, Coll Hlth Sci & Profess, Sch Appl Hlth Sci & Wellness, Div Athlet Training, Athens, OH 45701 USA; [Yuan, Weihong] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Radiol, Cincinnati, OH 45229 USA; [Yuan, Weihong] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthoped Surg, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu	Grooms, Dustin/AAO-8917-2021; Diekfuss, Jed/ABD-7372-2020; Myer, Gregory/H-6572-2016	Grooms, Dustin/0000-0001-6102-8224; Diekfuss, Jed/0000-0003-3835-363X; Howell, David/0000-0002-2955-0191; Myer, Gregory/0000-0002-9983-8422	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; ElMindA Ltd.; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament	Unrelated to this study, Dr. Howell has received research support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development, the National Institute of Neurological Disorders and Stroke, and a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd. Dr. Meehan receives royalties from ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A Guide for Coaches and Parents and Concussions; Springer International for the book Head and Neck Injuries in Young Athlete; and Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament.	[Anonymous], 1995, GAIT POSTURE; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kelly VE, 2010, EXP BRAIN RES, V207, P65, DOI 10.1007/s00221-010-2429-6; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moreau NG, 2016, PHYS THER REHABIL J, V96, P1938, DOI 10.2522/ptj.20150401; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Paker N, 2015, J PHYS THER SCI, V27, P3675, DOI 10.1589/jpts.27.3675; Plummer P, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00225; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Rochefort C, 2017, J SCI MED SPORT, V20, P970, DOI 10.1016/j.jsams.2017.04.008; Rochefort C, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117695507; Ruffieux J, 2015, SPORTS MED, V45, P1739, DOI 10.1007/s40279-015-0369-9; Stephens J, 2018, AM J OCCUP THER, V72, DOI 10.5014/ajot.2018.025361; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; Wilkerson GB, 2017, CURR SPORT MED REP, V16, P419, DOI 10.1249/JSR.0000000000000430; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	38	14	14	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4					613	619		10.1016/j.apmr.2018.07.441			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FU	WOS:000462951800004	30193950				2022-02-06	
J	Kwong, MT; Bianchi, F; Malboubi, M; Garcia-Grajales, JA; Homsi, L; Thompson, M; Ye, H; Noels, L; Jerusalem, A				Kwong, Man Ting; Bianchi, Fabio; Malboubi, Majid; Garcia-Grajales, Julian Andres; Homsi, Lina; Thompson, Mark; Ye, Hua; Noels, Ludovic; Jerusalem, Antoine			3D finite element formulation for mechanical-electrophysiological coupling in axonopathy	COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING			English	Article						Mechanical-electrophysiological coupling; Finite element method; Neuronal membrane; Axonal injury; Hodgkin-Huxley; Cable Theory	NETWORK ACTIVITY; ACUTE STRETCH; INJURY; MODEL; NEURONS; AXONS; DEMYELINATION	Traumatic injuries to the central nervous system (brain and spinal cord) have recently been put under the spotlight because of their devastating socio-economical cost. At the cellular scale, recent research efforts have focussed on primary injuries by making use of models aimed at simulating mechanical deformation induced axonal electrophysiological deficits. The overwhelming majority of these models only consider axonal stretching as a loading mode, while other modes of deformation such as crushing or mixed modes - highly relevant in spinal cord injury - are left unmodelled. To this end, we propose here a novel 3D finite element framework coupling mechanics and electrophysiology by considering the electrophysiological Hodgkin-Huxley and Cable Theory models as surface boundary conditions introduced directly in the weak form, hence eliminating the need to geometrically account for the membrane in its electrophysiological contribution. After validation against numerical and experimental results, the approach is leveraged to model an idealised axonal dislocation injury. The results show that the sole consideration of induced longitudinal stretch following transverse loading of a node of Ranvier is not necessarily enough to capture the extent of axonal electrophysiological deficit and that the non-axisymmetric loading of the node participates to a larger extent to the subsequent damage. On the contrary, a similar transverse loading of internodal regions was not shown to significantly worsen with the additional consideration of the non-axisymmetric loading mode. (C) 2018 Elsevier B.V. All rights reserved.	[Kwong, Man Ting; Bianchi, Fabio; Malboubi, Majid; Garcia-Grajales, Julian Andres; Thompson, Mark; Ye, Hua; Jerusalem, Antoine] Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England; [Homsi, Lina; Noels, Ludovic] Univ Liege, Aerosp & Mech Engn Dept, Liege, Belgium; [Garcia-Grajales, Julian Andres] Univ Oxford, Math Inst, Oxford OX2 6GG, England		Jerusalem, A (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.	antoine.jerusalem@eng.ox.ac.uk	Noels, Ludovic/H-3313-2019	Noels, Ludovic/0000-0002-7224-5539; Jerusalem, Antoine/0000-0001-5026-8038	European Union's Seventh Framework Programme, EU (FP7 2007-2013) ERC [306587]; China Regenerative Medicine Limited (CRMI); EPSRC DTP, United Kingdom [1514540]	M.T.K., M.M. and A.J. acknowledge funding from the European Union's Seventh Framework Programme, EU (FP7 2007-2013) ERC Grant Agreement No. 306587. H.Y. would like to acknowledge China Regenerative Medicine Limited (CRMI) for funding and the EPSRC DTP, United Kingdom (Award no. 1514540) for F.B.'s studentship.	Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043; Babbs CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067767; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bianchi F., ENG UNIAXIAL S UNPUB; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cinelli I, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2942; Drapaca CS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00271; FAN SF, 1992, BRAIN RES, V590, P329, DOI 10.1016/0006-8993(92)91116-V; Garcia-Martin JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137859; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; Jow F, 2006, ASSAY DRUG DEV TECHN, V4, P49, DOI 10.1089/adt.2006.4.49; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P1033, DOI 10.1007/s10237-015-0652-6; Kang WH, 2015, J NEUROTRAUM, V32, P1011, DOI 10.1089/neu.2014.3667; Koch Christof, 1999, P1; Loverde JR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00308; Magou GC, 2015, BRAIN RES, V1624, P525, DOI 10.1016/j.brainres.2015.07.056; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; Malboubi M, 2011, MICROELECTRON ENG, V88, P2666, DOI 10.1016/j.mee.2011.02.029; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Pfister BJ, 2006, FEBS LETT, V580, P3525, DOI 10.1016/j.febslet.2006.05.030; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Simulia, 2010, AB 6 10; Smith DH, 1999, J NEUROSCI, V19, P4263; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Tekieh T, 2016, CURR APPL PHYS, V16, P1413, DOI 10.1016/j.cap.2016.07.012; Volman V, 2014, J COMPUT NEUROSCI, V37, P439, DOI 10.1007/s10827-014-0515-7; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; Wu L, 2013, ENG FRACT MECH, V104, P162, DOI 10.1016/j.engfracmech.2013.03.018	36	14	14	0	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0045-7825	1879-2138		COMPUT METHOD APPL M	Comput. Meth. Appl. Mech. Eng.	APR 1	2019	346						1025	1050		10.1016/j.cma.2018.09.006			26	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematics; Mechanics	HI8NR	WOS:000456713400044		Green Submitted			2022-02-06	
J	LaPlaca, MC; Lessing, MC; Prado, GR; Zhou, RZ; Tate, CC; Geddes-Klein, D; Meaney, DF; Zhang, LY				LaPlaca, Michelle C.; Lessing, M. Christian; Prado, Gustavo R.; Zhou, Runzhou; Tate, Ciara C.; Geddes-Klein, Donna; Meaney, David F.; Zhang, Liying			Mechanoporation is a potential indicator of tissue strain and subsequent degeneration following experimental traumatic brain injury	CLINICAL BIOMECHANICS			English	Article						Traumatic brain injury; Membrane permeability; Mechanoporation; Hippocampus; Finite element model; Neuronal degeneration	CONTROLLED CORTICAL IMPACT; FLUORO-JADE-B; SPINAL-CORD; NEURONAL INJURY; POLOXAMER 188; SELECTIVE VULNERABILITY; AXOLEMMAL PERMEABILITY; HIPPOCAMPAL-NEURONS; DEPENDENT CHANGES; RAT HIPPOCAMPUS	Background: An increases in plasma membrane permeability is part of the acute pathology of traumatic brain injury and may be a function of excessive membrane force. This membrane damage, or mechanoporation, allows non-specific flux of ions and other molecules across the plasma membrane, and may ultimately lead to cell death. The relationships among tissue stress and strain, membrane permeability, and subsequent cell degeneration, however, are not fully understood. Methods: Fluorescent molecules of different sizes were introduced to the cerebrospinal fluid space prior to injury and animals were sacrificed at either 10 min or 24 h after injury. We compared the spatial distribution of plasma membrane damage following controlled cortical impact in the rat to the stress and strain tissue patterns in a 3-D finite element simulation of the injury parameters. Findings: Permeable cells were located primarily in the ipsilateral cortex and hippocampus of injured rats at 10 min post-injury; however by 24 h there was also a significant increase in the number of permeable cells. Analysis of colocalization of permeability marker uptake and Fluorojade staining revealed a subset of permeable cells with signs of degeneration at 24 h, but plasma membrane damage was evident in the vast majority of degenerating cells. The regional and subregional distribution patterns of the maximum principal strain and shear stress estimated by the finite element model were comparable to the cell membrane damage profiles following a compressive impact. Interpretation: These results indicate that acute membrane permeability is prominent following traumatic brain injury in areas that experience high shear or tensile stress and strain due to differential mechanical properties of the cell and tissue organization, and that this mechanoporation may play a role in the initiation of secondary injury, contributing to cell death.	[LaPlaca, Michelle C.; Lessing, M. Christian; Prado, Gustavo R.; Tate, Ciara C.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA; [LaPlaca, Michelle C.; Lessing, M. Christian; Prado, Gustavo R.; Tate, Ciara C.] Emory Univ, 313 Ferst Dr, Atlanta, GA 30332 USA; [Zhou, Runzhou; Zhang, Liying] Wayne State Univ, Dept Biomed Engn, 818 W Hancock St, Detroit, MI 48201 USA; [Geddes-Klein, Donna; Meaney, David F.] Univ Penn, Dept Bioengn, 210 South 33rd St, Philadelphia, PA 19104 USA		LaPlaca, MC (corresponding author), Georgia Inst Technol, Georgia Tech & Emory, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.	michelle.laplaca@bme.gatech.edu		Meaney, David/0000-0002-0954-4122	Whitaker Foundation; Institute for Bioengineering and Bioscience at the Georgia Institute of Technology	The authors appreciate the technical support received from Dr. C.M. Simon and analysis assistance from C.K. Giardina. This work was funded by the Whitaker Foundation, the Institute for Bioengineering and Bioscience at the Georgia Institute of Technology.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bukhatwa S, 2009, J NEUROCHEM, V109, P52, DOI 10.1111/j.1471-4159.2009.05956.x; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cho Y, 2010, J NEUROSCI RES, V88, P1433, DOI 10.1002/jnr.22309; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Cooper ST, 2015, PHYSIOL REV, V95, P1205, DOI 10.1152/physrev.00037.2014; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; DAVSON H, 1970, Brain Behavior and Evolution, V93, P665, DOI 10.1093/brain/93.4.665; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; Dixit P., 2016, ARCH COMPUT METHODS, V24, P1; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Egert U, 1998, BRAIN RES PROTOC, V2, P229, DOI 10.1016/S1385-299X(98)00013-0; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hall ED, 2015, BRAIN NEUROTRAUMA MO; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Inman CF, 2005, J IMMUNOL METHODS, V302, P156, DOI 10.1016/j.jim.2005.05.005; Jin XM, 2014, NEURAL REGEN RES, V9, P1876, DOI 10.4103/1673-5374.145475; Kilinc D, 2007, P ANN INT IEEE EMBS, P5395, DOI 10.1109/IEMBS.2007.4353562; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Koob A. O, 2005, J NEUROTRAUMA, V22; Koob Andrew O, 2008, J Biol Eng, V2, P9, DOI 10.1186/1754-1611-2-9; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Laplaca M. C, 2012, ANIMAL MODELS ACUTE, V2, P275; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LaPlaca MC, 2009, SUSCEPTIBILITY NEURO; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; Murphy MA, 2016, MODEL SIMUL MATER SC, V24, DOI 10.1088/0965-0393/24/5/055008; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Ping XJ, 2014, J NEUROTRAUM, V31, P1172, DOI 10.1089/neu.2013.3147; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Povlishock JT, 1996, ACT NEUR S, V66, P81; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; RIESELBACH RE, 1962, NEW ENGL J MED, V267, P1273, DOI 10.1056/NEJM196212202672502; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Slomka N, 2012, ANN BIOMED ENG, V40, P606, DOI 10.1007/s10439-011-0423-1; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Stroetz RW, 2001, J APPL PHYSIOL, V90, P2361, DOI 10.1152/jappl.2001.90.6.2361; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Vlahakis NE, 2002, AM J RESP CRIT CARE, V166, P1282, DOI 10.1164/rccm.200203-207OC; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Yang KH, 2003, INT J VEHICLE DES, V32, P116, DOI 10.1504/IJVD.2003.003240; Zhang L, 2001, Stapp Car Crash J, V45, P369; 2006, J NEUROTRAUMA, V23, P193; 1998, BRAIN RES, V784, P1; 2006, J NEUROSCI, V26, P3130, DOI DOI 10.1523/JNEUROSCI.5119-05.2006	80	14	14	1	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	APR	2019	64				SI		2	13		10.1016/j.clinbiomech.2018.05.016			12	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	HY6ON	WOS:000468249700002	29933966				2022-02-06	
J	Rubovitch, V; Pharayra, A; Har-Even, M; Dvir, O; Mattson, MP; Pick, CG				Rubovitch, V.; Pharayra, A.; Har-Even, M.; Dvir, O.; Mattson, M. P.; Pick, C. G.			Dietary Energy Restriction Ameliorates Cognitive Impairment in a Mouse Model of Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; Cognitive deficits; Axonal regeneration; Intermittent fasting; Caloric restriction	APOPTOTIC CELL-DEATH; CALORIC RESTRICTION; SIRT1; DEFICITS; AGE; BIOENERGETICS; VULNERABILITY; INACTIVATION; EXPRESSION; PROTECTS	Traumatic brain injury (TBI) is one of the most common causes of neurological damage in young people. It was previously reported that dietary restriction, by either intermittent fasting (IF) or daily caloric restriction (CR), could protect neurons against dysfunction and degeneration in animal models of stroke and Parkinson's disease. Recently, several studies have shown that the protein Sirtuin 1 (SIRT1) plays a significant role in the induced neuroprotection following dietary restriction. In the present study, we found a significant reduction of SIRT1 levels in the cortex and hippocampus in a mouse model of mild weight-drop closed head TBI. This reduction was prevented in mice maintained on IF (alternate day fasting) and CR initiated after the head trauma. Hippocampus-dependent learning and memory (measured using a novel object recognition test) was impaired 30days post-injury in mice fed ad libitum, but not in mice in the IF and CR groups. These results suggest a clinical potential for IF and/or CR as an intervention to reduce brain damage and improve functional outcome in TBI patients.	[Rubovitch, V.; Pharayra, A.; Har-Even, M.; Dvir, O.; Pick, C. G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Mattson, M. P.] NIA, Lab Neurosci, Intramural Res Program, Baltimore, MD 21224 USA; [Pick, C. G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Pick, C. G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, IL-69978 Tel Aviv, Israel; [Pick, C. G.] Tel Aviv Univ, Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel		Rubovitch, V (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel.	rubovitc@tauex.tau.ac.il			Ari and Regine Aprijaskis Fund, at Tel-Aviv University; Intramural Research Program of the National Institute on Aging, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)	This research was supported in part by the Ari and Regine Aprijaskis Fund, at Tel-Aviv University and by the Intramural Research Program of the National Institute on Aging, NIH.	Agarwal S, 2005, FREE RADICAL RES, V39, P55, DOI 10.1080/10715760400022343; Anton SD, 2018, OBESITY, V26, P254, DOI 10.1002/oby.22065; Arumugam TV, 2010, ANN NEUROL, V67, P41, DOI 10.1002/ana.21798; Bele MS, 2015, IN VITRO CELL DEV-AN, V51, P546, DOI 10.1007/s11626-015-9867-1; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Brownlow ML, 2014, BEHAV BRAIN RES, V271, P79, DOI 10.1016/j.bbr.2014.06.001; BRUCEKELLER AJ, 2004, ART, V45, P8, DOI DOI 10.1002/1531-8249(199901)45:1; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Dhurandhar EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060437; Donmez Gizem, 2012, Int J Alzheimers Dis, V2012, P509529, DOI 10.1155/2012/509529; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Fann DYW, 2014, EXP NEUROL, V257, P114, DOI 10.1016/j.expneurol.2014.04.017; Gao Y, 2003, J NEUROSCI, V23, P11770; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Hadem IKH, 2019, J CHEM NEUROANAT, V95, P123, DOI 10.1016/j.jchemneu.2017.10.001; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hunt ND, 2006, AGEING RES REV, V5, P125, DOI 10.1016/j.arr.2006.03.006; Ingram DK, 2007, NEUROSCIENCE, V145, P1359, DOI 10.1016/j.neuroscience.2006.10.031; Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003; Li XH, 2013, MOL NEUROBIOL, V48, P490, DOI 10.1007/s12035-013-8437-3; Loncarevic-Vasiljkovic N, 2016, NEUROCHEM INT, V96, P69, DOI 10.1016/j.neuint.2016.02.017; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Martin A, 2015, IMMUNOL RES, V61, P187, DOI 10.1007/s12026-014-8557-5; Mattson MP, 2018, NAT REV NEUROSCI, V19, P81, DOI 10.1038/nrn.2017.156; Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005; Mattson MP, 2012, CELL METAB, V16, P706, DOI 10.1016/j.cmet.2012.08.012; Mattson MP, 2003, J NEUROCHEM, V84, P417, DOI 10.1046/j.1471-4159.2003.01586.x; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Pasinetti GM, 2015, BBA-MOL BASIS DIS, V1852, P1202, DOI 10.1016/j.bbadis.2014.10.006; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rafalski VA, 2013, NAT CELL BIOL, V15, P614, DOI 10.1038/ncb2735; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; Ran MZ, 2015, BRAIN RES, V1610, P61, DOI 10.1016/j.brainres.2015.03.043; Rankin JW, 2006, FREE RADICAL BIO MED, V41, P1001, DOI 10.1016/j.freeradbiomed.2006.06.019; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sasaki T, 2010, ENDOCRINOLOGY, V151, P2556, DOI 10.1210/en.2009-1319; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Solari N, 2018, EUR J NEUROSCI, V48, P2199, DOI 10.1111/ejn.14089; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Stamatovic SM, 2019, NEUROBIOL DIS, V126, P105, DOI 10.1016/j.nbd.2018.09.006; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Thrasivoulou C, 2006, AGING CELL, V5, P247, DOI 10.1111/j.1474-9726.2006.00214.x; Ugochukwu NH, 2007, J NUTR BIOCHEM, V18, P120, DOI 10.1016/j.jnutbio.2006.03.008; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	61	14	15	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	APR	2019	67	4					613	621		10.1007/s12031-019-01271-6			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HS2OU	WOS:000463700900013	30734244	Green Accepted			2022-02-06	
J	Mu, J; Li, MY; Wang, TT; Li, XJ; Bai, ML; Zhang, GH; Kong, JM				Mu, Jiao; Li, Meiyu; Wang, Tingting; Li, Xiujuan; Bai, Meiling; Zhang, Guohui; Kong, Jiming			Myelin Damage in Diffuse Axonal Injury	FRONTIERS IN NEUROSCIENCE			English	Article						diffuse axonal injury; demyelination; oligodendrocyte; axon-myelin unite; corpus callosum; brain stem	TRAUMATIC BRAIN-INJURY; SUBVENTRICULAR ZONE; PROGENITOR CELLS; MULTIPLE-SCLEROSIS; PROLIFERATION; DIFFERENTIATION; DEGENERATION; DIAGNOSIS	Diffuse axonal injury (DAI) is characterized by delayed axonal disconnection. Although the effect of DAI on axonal pathology has been well documented, there is limited information regarding the role of myelin in the pathogenesis of DAI. We used a modified Marmarou method to create a moderate DAI model in adult rat and examined the corpus callosum and brain stem for myelin pathology and dynamic glial responses to DAI. During the first week following DAI, Luxol Fast Blue staining and western blot analysis for MBP showed significant loss of myelin in the corpus callosum and the brain stem. Increased apoptosis of mature oligodendrocyte, as depicted by its marker CC-1, was observed. Conversely, there was an increased number of Olig2-positive cells accompanied by hypertrophic microglia/macrophage and mild reactive astrocytes. Electron microscopy revealed degenerating axons in the corpus callosum and marked myelin abnormalities in the brain stem in the early stage of DAI. Brain stem regions exhibited myelin intrusions or external protrusions with widespread delamination and myelin collapse, leading to degeneration of accompanying axons. Our results show distinct pathologic processes involving axon and myelin between the corpus callosum and the brain stem in DAI. Oligodendrocyte selective vulnerability and subsequent demyelination may contribute to axonal degeneration in the brain stem. Defining the cause of ongoing oligodendrocyte death and promoting myelin regeneration may provide important targets for therapeutic interventions of DAI.	[Mu, Jiao; Li, Meiyu; Wang, Tingting; Li, Xiujuan; Bai, Meiling; Zhang, Guohui; Kong, Jiming] Hebei North Univ, Dept Forens Med, Zhangjiakou, Peoples R China; [Kong, Jiming] Univ Manitoba, Dept Human Anat & Cell Sci, Coll Med, Winnipeg, MB, Canada		Zhang, GH; Kong, JM (corresponding author), Hebei North Univ, Dept Forens Med, Zhangjiakou, Peoples R China.; Kong, JM (corresponding author), Univ Manitoba, Dept Human Anat & Cell Sci, Coll Med, Winnipeg, MB, Canada.	m18931315882_1@163.com; jiming.kong@umanitoba.ca	wang, tingting/AAK-2640-2020	Kong, Jiming/0000-0002-2859-9831	Hebei Natural Science FoundationNatural Science Foundation of Hebei Province [H2017405021]	This study was supported by Hebei Natural Science Foundation (Grant No. H2017405021).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Chen Ge, 2002, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V19, P500; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Deoni SCL, 2011, J NEUROSCI, V31, P784, DOI 10.1523/JNEUROSCI.2106-10.2011; Flygt J, 2017, RESTOR NEUROL NEUROS, V35, P251, DOI 10.3233/RNN-160675; Gallo V, 2008, CURR OPIN NEUROL, V21, P278, DOI 10.1097/WCO.0b013e3282fd1875; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Jang SH, 2016, BRAIN INJURY, V30, P1026, DOI 10.3109/02699052.2016.1146961; Jankovski A, 1998, EUR J NEUROSCI, V10, P3853, DOI 10.1046/j.1460-9568.1998.00397.x; Jia XX, 2012, J TRAUMA ACUTE CARE, V73, P1168, DOI 10.1097/TA.0b013e318246eaf4; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kiray H, 2016, EXP NEUROL, V283, P541, DOI 10.1016/j.expneurol.2016.03.009; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Montanino A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00643; Mu J, 2015, INT J CLIN EXP PATHO, V8, P4388; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Simons M, 2014, J CELL BIOL, V206, P335, DOI 10.1083/jcb.201404154; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Waxman SG, 2004, TRENDS PHARMACOL SCI, V25, P584, DOI 10.1016/j.tips.2004.09.001; Xu LY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0087-0; Zhang J, 2015, J FORENSIC SCI, V60, P759, DOI 10.1111/1556-4029.12743; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhou P, 2017, CNS NEUROSCI THER, V24, P126, DOI [10.1111/cns.12728, DOI 10.1111/CNS.12728]	30	14	15	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAR 19	2019	13								217	10.3389/fnins.2019.00217			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HP4EI	WOS:000461628800001	30941005	gold, Green Published			2022-02-06	
J	Gould, KR; Hicks, AJ; Hopwood, M; Kenardy, J; Krivonos, I; Warren, N; Ponsford, JL				Gould, Kate Rachel; Hicks, Amelia J.; Hopwood, Malcolm; Kenardy, Justin; Krivonos, Iveta; Warren, Narelle; Ponsford, Jennie L.			The lived experience of behaviours of concern: A qualitative study of men with traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; behaviours of concern; challenging behaviour; qualitative design; community rehabilitation	CHALLENGING BEHAVIOR; AGGRESSIVE-BEHAVIOR; PEOPLE; SUPPORTS; ADULTS; TBI; IRRITABILITY; INTERVIEWS; DISORDERS; SURVIVORS	Background and aims: Behaviours of Concern (BoC) are a debilitating consequence of Traumatic Brain Injury (TBI). Whilst perspectives of clinicians, carers and family members on BoC have been previously explored, few qualitative studies have included individuals with TBI. The aim of this study was to explore the lived experience of BoC in individuals with TBI, their close others and clinicians. Method: Eleven males with TBI and BoC were recruited and 25 semi-structured qualitative interviews were conducted (9 individuals with TBI, 9 close others, 7 clinicians). A six-phase thematic analysis approach was utilised. Results: Frequent and persistent BoC were reported and the key themes identified included the brain injury, control, environment, mood, identity, social relationships, and meaningful participation. Whilst the brain injury contributed to BoC in all cases, the way the other themes manifested and interacted was variable. Conclusions: This study enriches our understanding of factors associated with BoC. Themes emerging from this study will inform interventions designed to reduce BoC and ultimately maximise quality of life for individuals with TBI and their families.	[Gould, Kate Rachel; Hicks, Amelia J.; Ponsford, Jennie L.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Gould, Kate Rachel; Hicks, Amelia J.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Sch Psychol Sci, Melbourne, Vic, Australia; [Hopwood, Malcolm; Krivonos, Iveta] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Kenardy, Justin] Univ Queensland, Recover Injury Res Ctr, Brisbane, Qld, Australia; [Kenardy, Justin] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Warren, Narelle] Monash Univ, Fac Arts, Sch Social Sci, Melbourne, Vic, Australia		Gould, KR (corresponding author), Epworth Med Fdn, 50 Burwood Rd, Hawthorn, Vic 3122, Australia.	kate.gould@monash.edu	Hicks, Amelia/AAQ-7743-2020; Gould, Kate Rachel/AAA-5511-2020; Kenardy, Justin A/H-6603-2014; Warren, Narelle/H-9318-2019; Ponsford, Jennie/H-8341-2014	Gould, Kate Rachel/0000-0002-3564-7408; Kenardy, Justin A/0000-0001-9475-8450; Warren, Narelle/0000-0003-2623-4078; Ponsford, Jennie/0000-0003-0430-125X; Hicks, Amelia/0000-0002-1152-0576	Institute for Safety, Compensation and Recovery Research [N-M-13-084]	This work was supported by the Institute for Safety, Compensation and Recovery Research [grant number N-M-13-084].	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barbour RS, 1998, QUAL HEALTH RES, V8, P352, DOI 10.1177/104973239800800306; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Creswell J., 2009, RES DESIGN, V3rd; Curtin M, 2007, AUST OCCUP THER J, V54, P88, DOI 10.1111/j.1440-1630.2007.00661.x; Emerson E., 1995, CHALLENGING BEHAV AN; Feeney T. J., 2010, J BEHAV NEUROSCIENCE, V8, P70; Feeney TJ, 2014, NEUROREHABILITATION, V34, P709, DOI 10.3233/NRE-141088; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hammond FM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000136; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hicks A. J., BRAIN INJURY; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kim E, 2002, NEUROREHABILITATION, V17, P297; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lloyd V, 2006, QUAL HEALTH RES, V16, P1386, DOI 10.1177/1049732306293846; National Trauma Research Institute, 2012, DEV RES PROGR ADDR B; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; QSR International Pty Ltd, 2014, NVIVO VERS 10; Rahman B, 2010, NEUROPSYCHOL REHABIL, V20, P212, DOI 10.1080/09602010903021097; Ryan G. W., 2003, FIELD METHOD, V15, P85, DOI [10.1177/1525-822X02239569, DOI 10.1177/1525822X02239569, 10.1177/1525822X02239569]; Sabaz M., 2012, CHALLENGING BEHAV PR; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Tate RL, 2004, BRAIN INJURY OUTCOME; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Viera AJ, 2005, FAM MED, V37, P360; Wiart L, 2016, ANN PHYS REHABIL MED, V59, P31, DOI 10.1016/j.rehab.2015.12.001; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	45	14	14	1	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 16	2019	29	3					376	394		10.1080/09602011.2017.1307767			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HH1ZY	WOS:000455519600004	28391771				2022-02-06	
J	Liao, RJ; Chen, YC; Cheng, L; Fan, LS; Chen, H; Wan, YS; You, Y; Zheng, YR; Jiang, L; Chen, Z; Zhang, X; Hu, WW				Liao, Rujia; Chen, Youchao; Cheng, Li; Fan, Lishi; Chen, Han; Wan, Yushan; You, Yi; Zheng, Yanrong; Jiang, Lei; Chen, Zhong; Zhang, Xiangnan; Hu, Weiwei			Histamine H1 Receptors in Neural Stem Cells Are Required for the Promotion of Neurogenesis Conferred by H3 Receptor Antagonism following Traumatic Brain Injury	STEM CELL REPORTS			English	Article							HIPPOCAMPAL NEUROGENESIS; CLINICAL-TRIALS; MEMORY; NEUROPROTECTION; CLOBENPROPIT; ISCHEMIA; NEURONS; SYSTEM; MODEL	The neurological recovery following traumatic brain injury (TBI) is limited, largely due to a deficiency in neurogenesis. The present study explores the effects of histamine H3 receptor (H3R) antagonism on TBI and mechanisms related to neurogenesis. H3R antagonism or H3R gene knockout alleviated neurological injury in the late phase of TBI, and also promoted neuroblast differentiation to enhance neurogenesis through activation of the histaminergic system. Histamine H1 receptor, but not H2 receptor, in neural stem cells is shown to be essential for this promotion by using Hrh1(fl/fl);Nestin(CreERT2) and Hrh2(fl/fl);Nestin(CreERT2) mice. Moreover, increase in mature and functional neurons at the penumbra area conferred by H3R antagonism was abrogated in Hrh1(fl/fl);Nestin(CreERT2) mice. Taken together, H3R antagonism provides neuroprotection against TBI in the late phase through the promotion of neurogenesis, and the H1 receptor in neural stem cells is required for this action. H3R may serve as a new target for clinical treatment of TBI.	[Liao, Rujia; Chen, Youchao; Cheng, Li; Fan, Lishi; Chen, Han; Wan, Yushan; You, Yi; Zheng, Yanrong; Jiang, Lei; Chen, Zhong; Zhang, Xiangnan; Hu, Weiwei] Zhejiang Univ, Coll Pharmaceut Sci, Sch Basic Med Sci, NHC & CAMS Key Lab Med Neurobiol,Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China; [Hu, Weiwei] Zhejiang Univ, Pharm Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China		Zhang, X; Hu, WW (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Sch Basic Med Sci, NHC & CAMS Key Lab Med Neurobiol,Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China.; Hu, WW (corresponding author), Zhejiang Univ, Pharm Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China.	xiangnan_zhang@zju.edu.cn; huww@zju.edu.cn	Zhang, xiangnan/C-9649-2010	Zhang, xiangnan/0000-0002-7603-7403; liao, ru-jia/0000-0001-6928-4003	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81473186, 81673405, 81722045]; Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [LR17H310001, LY18H310003]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2018XZZX002-13]; Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences [2017PT31038, 2018PT31041]	This work was supported by the National Natural Science Foundation of China (81473186, 81673405, 81722045), the Zhejiang Provincial Natural Science Foundation of China under grants LR17H310001 and LY18H310003, Fundamental Research Funds for the Central Universities (2018XZZX002-13), and the Non-profit Central Research Institute Fund of the Chinese Academy of Medical Sciences (2017PT31038 and 2018PT31041). We are very grateful to Dr. John Hugh Snyder for language editing.	Arruda-Carvalho M, 2014, J NEUROSCI, V34, P11919, DOI 10.1523/JNEUROSCI.0652-14.2014; Bernardino L, 2012, STEM CELLS, V30, P773, DOI 10.1002/stem.1042; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Chen ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5486; Escobedo-Avila I, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0058-x; Giachino C, 2014, DEVELOPMENT, V141, P83, DOI 10.1242/dev.102608; Glushakov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113689; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Hagg T, 2005, TRENDS NEUROSCI, V28, P589, DOI 10.1016/j.tins.2005.08.009; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Hu WW, 2012, ACS CHEM NEUROSCI, V3, P238, DOI 10.1021/cn200126p; Hu WW, 2017, PHARMACOL THERAPEUT, V175, P116, DOI 10.1016/j.pharmthera.2017.02.039; Huang YW, 2004, BEHAV BRAIN RES, V151, P287, DOI 10.1016/j.bbr.2003.09.002; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li HD, 2016, NEURON, V91, P728, DOI 10.1016/j.neuron.2016.08.004; Liao RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15356; Liu LY, 2007, HIPPOCAMPUS, V17, P634, DOI 10.1002/hipo.20305; Molina-Hernandez A, 2008, J NEUROCHEM, V106, P706, DOI 10.1111/j.1471-4159.2008.05424.x; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Provensi G, 2014, P NATL ACAD SCI USA, V111, P11527, DOI 10.1073/pnas.1322016111; Rodriguez-Martinez G, 2012, NEUROSCIENCE, V216, P10, DOI 10.1016/j.neuroscience.2012.04.049; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schwartz JC, 2011, BRIT J PHARMACOL, V163, P713, DOI 10.1111/j.1476-5381.2011.01286.x; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yan HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4334; Zhang L, 2003, EUR J PHARMACOL, V482, P169, DOI 10.1016/j.ejphar.2003.09.066; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	40	14	15	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2213-6711			STEM CELL REP	Stem Cell Rep.	MAR 5	2019	12	3					532	544		10.1016/j.stemcr.2019.01.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	HN7XX	WOS:000460407800009	30745032	Green Published, gold			2022-02-06	
J	Chang, PP; Williams, AM; Bhatti, UF; Biesterveld, B; Liu, BL; Nikolian, VC; Dennahy, IS; Lee, J; Li, YQ; Alam, HB				Chang, Panpan; Williams, Aaron M.; Bhatti, Umar F.; Biesterveld, Ben E.; Liu, Baoling; Nikolian, Vahagn C.; Dennahy, Isabel S.; Lee, Jessica; Li, Yongqing; Alam, Hasan B.			Valproic Acid and Neural Apoptosis, Inflammation, and Degeneration 30 Days after Traumatic Brain Injury, Hemorrhagic Shock, and Polytrauma in a Swine Model	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							EMERGENCY-DEPARTMENT THORACOTOMY; LONG-TERM CONSEQUENCES; NEUROTROPHIC FACTOR; TRANSCRIPTOMIC CHANGES; INDUCED HYPOTHERMIA; ALZHEIMERS-DISEASE; HEAD-INJURY; CELL-DEATH; RESUSCITATION; ACTIVATION	BACKGROUND: A single-dose (150 mg/kg) of valproic acid (VPA) has been shown to decrease brain lesion size and improve neurologic recovery in preclinical models of traumatic brain injury (TBI). However, the longer-term (30 days) impact of single-dose VPA treatment after TBI has not been well evaluated. STUDY DESIGN: Yorkshire swine were subjected to TBI (cortical impact), hemorrhagic shock, and polytrauma. Animals remained in hypovolemic shock for 2 hours before resuscitation with normal saline (NS; volume = 3 x hemorrhaged volume) or NS thorn VPA (150 mg/kg) (n = 5/cohort). Brain samples were harvested 30 days after injuries. The cerebral cortex adjacent to the site of cortical impact was evaluated using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, immunohistochemistry, and Western blot analysis. Neural apoptosis, inflammation, degeneration, plasticity, and signaling pathways were evaluated. RESULTS: For apoptosis, VPA treatment significantly decreased (p < 0.05) the number of TUNEL (thorn) cells and expression of cleaved-caspase 3. For inflammation and degeneration, expression of ionized calcium binding adaptor molecule-1, glial fibrillary acid protein, amyloid-beta, and phosphorylated-Tau protein were significantly attenuated (p < 0.05) in the VPA-treated animals compared with the NS group. For, plasticity, VPA treatment also increased expression of brain-derived neurotrophic factor significantly (p < 0.05) compared with the NS group. For signaling pathways, nuclear factor-kappa B was decreased significantly (p < 0.05) and cytosolic I kappa B alpha expression was increased significantly (p < 0.05) in the VPA-treated animals compared with the NS group. CONCLUSIONS: Administration of a single dose of VPA (150 mg/kg) can decrease neural apoptosis, inflammation, and degenerative changes, and promote neural plasticity at 30 days after TBI. In addition, VPA acts, in part, via regulation of nuclear factor-kappa B and I kappa B alpha pathways. (C) 2019 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.	[Chang, Panpan] Peking Univ, Peoples Hosp, Trauma Med Ctr, Beijing, Peoples R China; [Chang, Panpan; Williams, Aaron M.; Bhatti, Umar F.; Biesterveld, Ben E.; Liu, Baoling; Nikolian, Vahagn C.; Dennahy, Isabel S.; Lee, Jessica; Li, Yongqing; Alam, Hasan B.] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Biesterveld, Ben/AAM-1087-2021		US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-1-0520]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [F32GM130010] Funding Source: NIH RePORTER	This work was supported by a grant from the US Army Medical Research and Materiel Command, Contract W81XWH-09-1-0520 (principal investigator: Hasan B Alam).	Acosta S.A., 2013, PLOS ONE, V8, P1; Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Arai K, 2001, JPN J PHARMACOL, V87, P195, DOI 10.1254/jjp.87.195; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Butler FK, 2017, EMERG MED CLIN N AM, V35, P391, DOI 10.1016/j.emc.2016.12.005; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gentilello L, 2000, J TRAUMA, V48, P447; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Georgoff PE, 2018, J TRAUMA ACUTE CARE, V84, P642, DOI 10.1097/TA.0000000000001763; Georgoff PE, 2018, CLIN PHARMACOKINET, V57, P209, DOI 10.1007/s40262-017-0553-1; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Guan ZW, 2006, BRAIN BEHAV IMMUN, V20, P64, DOI 10.1016/j.bbi.2005.04.005; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Hansson E, 2016, IBRO REP, V1, P1, DOI 10.1016/j.ibror.2016.06.001; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Irving EA, 1996, NEUROSCI LETT, V213, P189; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Korley FK, 2018, J NEUROTRAUM, V35, P1185, DOI 10.1089/neu.2017.5581; LAPCHAK PA, 1993, NEUROSCIENCE, V53, P297, DOI 10.1016/0306-4522(93)90196-M; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nikolian VC, 2018, J TRAUMA ACUTE CARE, V84, P459, DOI 10.1097/TA.0000000000001765; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Nolan Y, 2003, EXP NEUROL, V184, P794, DOI 10.1016/S0014-4886(03)00301-7; Pierce JES, 1996, J NEUROSCI, V16, P1083; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pugh CR, 1998, BRAIN BEHAV IMMUN, V12, P212, DOI 10.1006/brbi.1998.0524; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Rowell SE, 2016, J NEUROTRAUM, V33, P1054, DOI 10.1089/neu.2014.3478; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Schnydrig S, 2007, NEUROSCI LETT, V429, P69, DOI 10.1016/j.neulet.2007.09.067; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Shackelford S., 2017, J SPEC OPER MED, V17, P130; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Sochocka M, 2017, MOL NEUROBIOL, V54, P8071, DOI 10.1007/s12035-016-0297-1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Weng S, 2018, WORLD NEUROSURG; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430; Zhao Bo, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P236; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	68	14	14	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	MAR	2019	228	3					265	275		10.1016/j.jamcollsurg.2018.12.026			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HM5EA	WOS:000459496700007	30639301	Green Accepted			2022-02-06	
J	DiSanto, D; Kumar, RG; Juengst, SB; Hart, T; O'Neil-Pirozzi, TM; Zasler, ND; Phd, TAN; Dillahunt-Aspillaga, C; Graham, KM; Cotner, BA; Rabinowitz, AR; Dikmen, S; Niemeier, JP; Kesinger, MR; Wagner, AK				DiSanto, Dominic; Kumar, Raj G.; Juengst, Shannon B.; Hart, Tessa; O'Neil-Pirozzi, Therese M.; Zasler, Nathan D.; Novack, Thomas A.; Dillahunt-Aspillaga, Christina; Graham, Kristin M.; Cotner, Bridget A.; Rabinowitz, Amanda R.; Dikmen, Sureyya; Niemeier, Janet P.; Kesinger, Matthew R.; Wagner, Amy K.			Employment Stability in the First 5 Years After Moderate-to-Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	15th Annual Safar Symposium	MAY 22, 2017	Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA		Univ Pittsburgh, Safar Ctr Resuscitat Res	Employment; Mental health; Neuropsychology; Rehabilitation; Traumatic brain injury	WORKING-AGE INDIVIDUALS; COMMUNITY INTEGRATION; UNITED-STATES; PSYCHIATRIC-DISORDERS; SUCCESSFUL RETURN; ACUTE PREDICTORS; JOB STABILITY; OUTCOME 2; DEPRESSION; DISABILITY	Objective: To characterize employment stability and identify predictive factors of employment stability in working-age individuals after moderate-to-severe traumatic brain injury (TBI) that may be clinically addressed. Design: Longitudinal observational study of an inception cohort from the Traumatic Brain Injury Model Systems National Database (TBIMS-NDB) using data at years 1, 2, and 5 post-TBI. Setting: Inpatient rehabilitation centers with telephone follow-up. Participants: Individuals enrolled in the TBIMS-NDB since 2001, aged 18-59, with employment data at 2 or more follow-up interviews at years 1, 2, and 5 (N=5683). Interventions: Not applicable. Main Outcome Measure: Employment stability, categorized using post-TBI employment data as no paid employment (53.25%), stably (27.20%), delayed (10.24%), or unstably (9.31%) employed. Results: Multinomial regression analyses identified predictive factors of employment stability, including younger age, white race, less severe injuries, preinjury employment, higher annual earnings, male sex, higher education, transportation independence postinjury, and no anxiety or depression at 1 year post-TBI. Conclusions: Employment stability serves as an important measure of productivity post-TBI. Psychosocial, clinical, environmental, and demographic factors predict employment stability post-TBI. Notable predictors include transportation independence as well as the presence of anxiety and depression at year 1 post-TBI as potentially modifiable intervention targets. (C) 2018 by the American Congress of Rehabilitation Medicine	[DiSanto, Dominic; Kumar, Raj G.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA; [Kumar, Raj G.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dallas, TX 75390 USA; [Hart, Tessa; Rabinowitz, Amanda R.] Moss Rehabil Res Inst, Montgomery, AL USA; [O'Neil-Pirozzi, Therese M.] Spaulding Harvard Traumat Brain Injury Model Syst, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.; Graham, Kristin M.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zasler, Nathan D.] Int Brain Injury Assoc, Alexandria, VA USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Child & Family Studies, Rehabil & Mental Hlth Counseling Program, Tampa, FL USA; [Dillahunt-Aspillaga, Christina; Cotner, Bridget A.] VA HSR&D Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL USA; [Cotner, Bridget A.] Univ S Florida, Dept Anthropol, Tampa, FL 33620 USA; [Rabinowitz, Amanda R.] Thomas Jefferson Univ, Dept Rehabil, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Psychiat & Behav Sci, Seattle, WA 98195 USA; [Niemeier, Janet P.] Carolinas Med Ctr, Carolinas Rehabil, Charlotte, NC 28203 USA; [Kesinger, Matthew R.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X; Dillahunt-Aspillaga, Christina/0000-0002-1231-2023; DiSanto, Dominic/0000-0002-8815-2169	NIDILRRUnited States Department of Health & Human Services [90DP0031, 90DP0041, 90DPTB0013-01-00, 90DP0044-01, 90DFTB0011-01-00, 90DP0037, 90AR5025]; VA Central Office; VA TBI Model System Program of Research; General Dynamics Health Solutions [W91YTZ-13-C-0015]; Defense and Veterans Brain Injury Center, US Department of Veterans Affairs Health Services Research and Development COIN [1 I50 HX001233-01]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the collection of original data for this article. The content of this article was developed under NIDILRR (grant nos. 90DP0031, 90DP0041, 90DPTB0013-01-00, 90DP0044-01, 90DFTB0011-01-00, 90DP0037) and with postdoctoral fellow support by NIDILRR (grant no. 90AR5025).; Additional support was received from VA Central Office, VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (grant no. W91YTZ-13-C-0015) and from the Defense and Veterans Brain Injury Center, US Department of Veterans Affairs Health Services Research and Development COIN (grant no. 1 I50 HX001233-01).	Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Chien DK, 2017, ACCIDENT ANAL PREV, V98, P101, DOI 10.1016/j.aap.2016.09.025; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Failla MD, 2016, J HEAD TRAUMA REHAB, V31, pE62, DOI 10.1097/HTR.0000000000000214; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Harkness KL, 2002, EUR J PERSONALITY, V16, P271, DOI 10.1002/per.441; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Johansson AEM, 2016, DISABIL REHABIL, V38, P423, DOI 10.3109/09638288.2015.1044034; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Juengst SB, 2017, J NEUROPSYCH CLIN N, V29, P260, DOI 10.1176/appi.neuropsych.16100217; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Juengst SB, 2014, REHABIL PSYCHOL, V59, P242, DOI 10.1037/a0036294; KARPUR A, GUIDE TRAUMATIC BRAI; Kean J, 2011, J HEAD TRAUMA REHAB, V26, P364, DOI 10.1097/HTR.0b013e3181ea4e2c; Ketchum JM, 2012, NEUROREHABILITATION, V30, P13, DOI 10.3233/NRE-2011-0723; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Niemeier JP, 2010, J VOCAT REHABIL, V33, P167, DOI 10.3233/JVR-2010-0525; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tefft N, 2011, J HEALTH ECON, V30, P258, DOI 10.1016/j.jhealeco.2011.01.006; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355	66	14	14	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2019	100	3					412	421		10.1016/j.apmr.2018.06.022			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	HN5BU	WOS:000460198500003	30055162				2022-02-06	
J	Neidecker, J; Sethi, NK; Taylor, R; Monsell, R; Muzzi, D; Spizler, B; Lovelace, L; Ayoub, E; Weinstein, R; Estwanik, J; Reyes, P; Cantu, RC; Jordan, B; Goodman, M; Stiller, JW; Gelber, J; Boltuch, R; Coletta, D; Gagliardi, A; Gelfman, S; Golden, P; Rizzo, N; Wallace, P; Fields, A; Inalsingh, C				Neidecker, John; Sethi, Nitin K.; Taylor, Randolph; Monsell, Raymond; Muzzi, Don; Spizler, Bruce; Lovelace, Larry; Ayoub, Edmund; Weinstein, Rick; Estwanik, Joseph; Reyes, Patricio; Cantu, Robert C.; Jordan, Barry; Goodman, Margaret; Stiller, John W.; Gelber, Jonathan; Boltuch, Robert; Coletta, Domenic; Gagliardi, Angela; Gelfman, Stephen; Golden, Patrick; Rizzo, Nicholas; Wallace, Paul; Fields, Allan; Inalsingh, Calvin			Concussion management in combat sports: consensus statement from the Association of Ringside Physicians	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							HEAD TRAUMA; INJURY; AGREEMENT; BOXERS; DAMAGE; TEAM	Various organisations and experts have published numerous statements and recommendations regarding different aspects of sports-related concussion including definition, presentation, treatment, management and return to play guidelines. 1-7 To date, there have been no written consensus statements specific for combat sports regarding management of combatants who have suffered a concussion or for return to competition after a concussion. In combat sports, head contact is an objective of the sport itself. Accordingly, management and treatment of concussion in combat sports should, and must, be more stringent than for non-combat sports counterparts. The Association of Ringside Physicians (an international, non-profit organisation dedicated to the health and safety of the combat sports athlete) sets forth this consensus statement to establish management guidelines that ringside physicians, fighters, referees, trainers, promoters, sanctioning bodies and other healthcare professionals can use in the ringside setting. We also provide guidelines for the return of a combat sports athlete to competition after sustaining a concussion. This consensus statement does not address the management of moderate to severe forms of traumatic brain injury, such as intracranial bleeds, nor does it address the return to competition for combat sports athletes who have suffered such an injury. These more severe forms of brain injuries are beyond the scope of this statement. This consensus statement does not address neuroimaging guidelines in combat sports.	[Neidecker, John] Orthopaed Specialists North Carolina, Dept Sports Med, Raleigh, NC 26614 USA; [Neidecker, John] Campbell Univ, Sch Osteopath Med, Buies Creek, NC 27506 USA; [Sethi, Nitin K.] New York Presbyterian Hosp, Dept Neurol, New York, NY USA; [Taylor, Randolph] Mem Hermann Healthcare Syst, Houston, TX USA; [Taylor, Randolph] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA; [Monsell, Raymond] Aneurin Bevan Univ, Hlth Board, Newport, Gwent, Wales; [Monsell, Raymond] Royal Coll Surgeons Ireland, Fac Sports & Exercise Med, Dublin, Ireland; [Muzzi, Don] Essentia Hlth, Duluth, MN USA; [Muzzi, Don] Univ Minnesota, Med Sch, Duluth Campus, Duluth, MN 55812 USA; [Spizler, Bruce] Assoc Ringside Physicians Legal Counsel, Baltimore, MD USA; [Lovelace, Larry] INTEGRIS Southwest Med Ctr, Oklahoma City, OK USA; [Ayoub, Edmund] Desert Reg Med Ctr, Palm Springs, CA USA; [Weinstein, Rick] White Plains Hosp Ctr, White Plains, NY USA; [Estwanik, Joseph] Metrolina Orthoped & Sports Med Clin, Charlotte, NC USA; [Reyes, Patricio] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Cantu, Robert C.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Cantu, Robert C.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Jordan, Barry] Burke Rehabil Hosp, New York, NY USA; [Goodman, Margaret] Voluntary Antidoping Assoc, Las Vegas, NV USA; [Stiller, John W.] Univ Maryland, Baltimore Med Sch, Mood & Anxiety Psychiat, Baltimore, MD 21201 USA; [Stiller, John W.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC USA; [Gelber, Jonathan] Connecticut Childrens Med Ctr, Hartford, CT USA; [Gelber, Jonathan] Elite Sports Med, Farmington, CT USA; [Coletta, Domenic] Cape Reg Hlth Syst, Cape May Court House, NJ USA; [Gelfman, Stephen] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY USA; [Golden, Patrick] St Agnes Med Ctr, Fresno, CA USA; [Rizzo, Nicholas] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA; [Wallace, Paul] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA		Neidecker, J (corresponding author), Orthopaed Specialists North Carolina, Dept Sports Med, Raleigh, NC 26614 USA.	neidy13@yahoo.com					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Jensen AR, 2017, SPORTS HEALTH, V9, P64, DOI 10.1177/1941738116664860; Loosemore M, 2015, BRIT J SPORT MED, V49, P1100, DOI 10.1136/bjsports-2015-094755; Lystad RP, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518492; McClain R, 2014, CLIN J SPORT MED, V24, P497, DOI 10.1097/JSM.0000000000000078; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, P176; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mishra VR, 2017, RADIOLOGY, V285, P555, DOI 10.1148/radiol.2017162403; Nalepa B, 2017, PHYSICIAN SPORTSMED, V45, P1; Ngai KM, 2008, BRIT J SPORT MED, V42, P686, DOI 10.1136/bjsm.2007.044891; Otten MH, 2015, OSTEOPATH FAMILY PHY, V7, P13; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Stiller JW, 2014, FRONT PUBLIC HEALTH, V2, P1; Thomas R, 2018, PHYSICIAN SPORTSMED, V25, P1; USA Boxing, 2017, US BOX NAT RUL BOOK; USA Boxing, 2016, MED HDB MED RUL AIBA; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	31	14	14	3	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAR	2019	53	6					328	333		10.1136/bjsports-2017-098799			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IA3WR	WOS:000469494300009	30049779	hybrid, Green Published			2022-02-06	
J	Niu, X; Bai, LJ; Sun, YX; Wang, S; Cao, JL; Sun, CZ; Wang, ZN; Xu, H; Gan, SQ; Fan, G; Huang, WM; Gu, CH; Yin, B; Bai, GH; Xu, XL; Zhang, M				Niu, Xuan; Bai, Lijun; Sun, Yingxiang; Wang, Shan; Cao, Jieli; Sun, Chuanzhu; Wang, Zhuonan; Xu, Hui; Gan, Shuoqiu; Fan, Geng; Huang, Wenmin; Gu, Chenghui; Yin, Bo; Bai, Guanghui; Xu, Xiaoling; Zhang, Ming			Disruption of periaqueductal grey-default mode network functional connectivity predicts persistent post-traumatic headache in mild traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							PAIN MODULATORY SYSTEMS; SUSTAINED ATTENTION; STATE; IMPACT; GRAY; PREVALENCE; DISABILITY; COMPONENT; TRACKING; DEFICITS	Objective Post-traumatic headache (PTH) is one of the most frequent and persistent physical symptoms following mild traumatic brain injury (mTBI) and develop in more than 50% of this population. This study aimed to investigate the periaqueductal grey (PAG)-seeded functional connectivity (FC) in patients with mTBI with acute post-traumatic headache (APTH) and further examine whether the FC can be used as a neural biomarker to identify patients developing chronic pain 3 months postinjury. Methods 70 patients with mTBI underwent neuropsychological measurements and MRI scans within 7 days postinjury and 56 (80%) of patients were followed up at 3 months. 46 healthy controls completed the same protocol on recruitment to the study. PAG-seeded resting-state FC analysis was measured in 54 patients with mTBI with APTH, in comparison with 46 healthy volunteers. Results The mTBI+APTH group presented significantly reduced PAG-seeded FC within the default mode network (DMN), compared with healthy volunteers group. The connectivity strength can also predict patients' complaints on the impact of headache on their lives. Crucially, the initial FC strength between the PAG-right precuneus as well as the PAG-right inferior parietal lobule became the important predictor to identify patients with mTBI developing persistent PTH 3 months postinjury. Conclusions Patients with mTBI+APTH exhibited significant PAG-related FC differences mainly within the DMN. These regions extended beyond traditional pain processing areas and may reflect the diminished top-down attention regulation of pain perception through antinociceptive descending modulation network. The disrupted PAG-DMN FC may be used as an early imaging biomarker to identify patients at risk of developing persistent PTH.	[Niu, Xuan; Sun, Yingxiang; Wang, Zhuonan; Xu, Hui; Gan, Shuoqiu; Xu, Xiaoling; Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian 710049, Shaanxi, Peoples R China; [Bai, Lijun; Wang, Shan; Cao, Jieli; Sun, Chuanzhu; Xu, Hui; Gan, Shuoqiu; Fan, Geng; Huang, Wenmin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ,Dept Biomed Engn, Xian 710049, Shaanxi, Peoples R China; [Gu, Chenghui; Yin, Bo] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Xian, Shaanxi, Peoples R China; [Gu, Chenghui; Yin, Bo; Bai, Guanghui] Wenzhou Med Univ, Yuying Childrens Hosp, Xian, Shaanxi, Peoples R China; [Bai, Guanghui] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Xian, Shaanxi, Peoples R China		Zhang, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian 710049, Shaanxi, Peoples R China.; Bai, LJ (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ,Dept Biomed Engn, Xian 710049, Shaanxi, Peoples R China.	bailijun@xjtu.edu.cn; zhangming01@mail.xjtu.edu.cn	Xu, Hui/AAB-9421-2020; Niu, Xuan/AAD-7351-2022; Wang, Zhuonan/E-3691-2017; Bai, Lijun/C-5119-2015	Xu, Hui/0000-0003-4514-0413; Niu, Xuan/0000-0002-1580-0209; Wang, Zhuonan/0000-0002-5745-4340; Bai, Lijun/0000-0001-8790-5424	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571752, 81771914, 81571640]; Shanxi Nova Program [2014KJXX-34]; National Key Research and Development Plan of China [2016YFC0100300]; Zhejiang Natural Science FoundationNatural Science Foundation of Zhejiang Province [LY15H090016]; Wenzhou Municipal Sci-Tech Bureau [Y20140577]	This research was supported by the National Natural Science Foundation of China under grant numbers 81571752, 81771914 and 81571640, Shanxi Nova Program (2014KJXX-34), the National Key Research and Development Plan of China (2016YFC0100300), the Zhejiang Natural Science Foundation (grant no LY15H090016), and Wenzhou Municipal Sci-Tech Bureau (Y20140577).	BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Flaherty S A, 1996, AANA J, V64, P133; Fortenbaugh FC, 2018, NEUROIMAGE, V171, P148, DOI 10.1016/j.neuroimage.2018.01.002; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kucyi A, 2014, J NEUROSCI, V34, P3969, DOI 10.1523/JNEUROSCI.5055-13.2014; Kucyi A, 2013, P NATL ACAD SCI USA, V110, P18692, DOI 10.1073/pnas.1312902110; Kwong WJ, 2007, CEPHALALGIA, V27, P336, DOI 10.1111/j.1468-2982.2007.01283.x; La Cesa S, 2014, MAGN RESON IMAGING, V32, P236, DOI 10.1016/j.mri.2013.12.003; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Liu P, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13060; Loggia ML, 2013, PAIN, V154, P24, DOI 10.1016/j.pain.2012.07.029; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Miller M D, 1993, Fam Pract Res J, V13, P15; Nachit-Ouinekh F, 2005, EUR J NEUROL, V12, P189, DOI 10.1111/j.1468-1331.2004.00934.x; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Obermann M, 2010, HEADACHE, V50, P710, DOI 10.1111/j.1526-4610.2010.01644.x; PACKARD RC, 1993, HEADACHE, V33, P133, DOI 10.1111/j.1526-4610.1993.hed3303133.x; Parkes L, 2018, NEUROIMAGE, V171, P415, DOI 10.1016/j.neuroimage.2017.12.073; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Ruff RL, 2008, NEW ENGL J MED, V358, P2178; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Shin HE, 2008, J CLIN NEUROL, V4, P158, DOI 10.3988/jcn.2008.4.4.158; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Varndell W, 2017, J CLIN NURS, V26, P7, DOI 10.1111/jocn.13594; Wei SY, 2016, PAIN, V157, P92, DOI 10.1097/j.pain.0000000000000340; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Yu RJ, 2014, NEUROIMAGE-CLIN, V6, P100, DOI 10.1016/j.nicl.2014.08.019; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	49	14	15	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	2019	90	3					326	332		10.1136/jnnp-2018-318886			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	IC7UC	WOS:000471181900182	30554137				2022-02-06	
J	Bramati, IE; Rodrigues, EC; Simoes, EL; Melo, B; Hofle, S; Moll, J; Lent, R; Tovar-Moll, F				Bramati, Ivanei E.; Rodrigues, Erika C.; Simoes, Elington L.; Melo, Bruno; Hofle, Sebastian; Moll, Jorge; Lent, Roberto; Tovar-Moll, Fernanda			Lower limb amputees undergo long-distance plasticity in sensorimotor functional connectivity	SCIENTIFIC REPORTS			English	Article							HUMAN CEREBRAL-CORTEX; CORTICAL REORGANIZATION; MOTOR CORTEX; SOMATOSENSORY CORTEX; CORPUS-CALLOSUM; HUMAN BRAIN; IN-VIVO; PHANTOM; NETWORKS; NEURONS	Amputation in adults is associated with an extensive remapping of cortical topography in primary and secondary sensorimotor areas. Here, we used tactile residual limb stimulation and 3T functional magnetic resonance imaging in humans to investigate functional connectivity changes in the sensorimotor network of patients with long-term lower limb traumatic amputations with phantom sensation, but without pain. We found a pronounced reduction of inter-hemispheric functional connectivity between homologous sensorimotor cortical regions in amputees, including the primary (S1) and secondary (S2) somatosensory areas, and primary (M1) and secondary (M2) motor areas. We additionally observed an intra-hemispheric increased functional connectivity between primary and secondary somatosensory regions, and between the primary and premotor areas, contralateral to amputation. These functional connectivity changes in specialized small-scale sensory-motor networks improve our understanding of the functional impact of lower limb amputation in the brain. Our findings in a selective group of patients with phantom limb sensations, but without pain suggest that disinhibition of neural inputs following traumatic limb amputation disrupts sensorimotor topology, unbalancing functional brain network organization. These findings step up the description of brain plasticity related with phantom sensations by showing that pain is not critical for sensorimotor network changes after peripheral injury.	[Bramati, Ivanei E.; Rodrigues, Erika C.; Melo, Bruno; Hofle, Sebastian; Moll, Jorge; Lent, Roberto; Tovar-Moll, Fernanda] DOr Inst Res & Educ IDOR, BR-22281100 Rio De Janeiro, Brazil; [Bramati, Ivanei E.; Lent, Roberto; Tovar-Moll, Fernanda] Fed Univ Rio de Janeiro UFRJ, Inst Biomed Sci, BR-21941902 Rio De Janeiro, Brazil; [Tovar-Moll, Fernanda] Fed Univ Rio de Janeiro UFRJ, Natl Ctr Struct Biol & Bioimaging, BR-21941902 Rio De Janeiro, Brazil; [Rodrigues, Erika C.] Augusto Motta Univ Unisuam, BR-21041020 Rio De Janeiro, Brazil; [Simoes, Elington L.] Rio de Janeiro State Univ UERJ, BR-20550900 Rio De Janeiro, Brazil		Tovar-Moll, F (corresponding author), DOr Inst Res & Educ IDOR, BR-22281100 Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), Fed Univ Rio de Janeiro UFRJ, Inst Biomed Sci, BR-21941902 Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), Fed Univ Rio de Janeiro UFRJ, Natl Ctr Struct Biol & Bioimaging, BR-21941902 Rio De Janeiro, Brazil.	fernanda.tovarmoll@idor.org	de Carvalho Rodrigues, Erika/AAE-9445-2020; Moll, Fernanda Tovar/AAF-8477-2021; Moll, Fernanda Tovar/N-3320-2018; Moll, Jorge/AAF-8388-2021; Rodrigues, Erika/R-6007-2017	de Carvalho Rodrigues, Erika/0000-0001-5464-2963; Moll, Fernanda Tovar/0000-0002-0292-5985; Moll, Fernanda Tovar/0000-0002-0292-5985; Moll, Jorge/0000-0002-4297-591X; Rodrigues, Erika/0000-0001-5464-2963	National Institute of Translational Neuroscience (INNT); National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Rio de Janeiro Foundation for the Support of Science (FAPERJ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ); CAPES FoundationCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	We thank Rodrigo Basilio for technical advice. We thank Ana Franzoi and Debora O. Lima for assistance with participants' recruitment. Funding sources: National Institute of Translational Neuroscience (INNT), National Council for Scientific and Technological Development (CNPq), Rio de Janeiro Foundation for the Support of Science (FAPERJ), CAPES Foundation.	Aronoff R, 2010, EUR J NEUROSCI, V31, P2221, DOI 10.1111/j.1460-9568.2010.07264.x; Bahia CP, 2019, CEREB CORTEX, V29, P1460, DOI 10.1093/cercor/bhy043; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boesen K, 2004, NEUROIMAGE, V22, P1255, DOI 10.1016/j.neuroimage.2004.03.010; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Clarey JC, 1996, CEREB CORTEX, V6, P196, DOI 10.1093/cercor/6.2.196; Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012; COHEN LG, 1991, BRAIN, V114, P615, DOI 10.1093/brain/114.1.615; COHEN LG, 1991, J CLIN NEUROPHYSIOL, V8, P56, DOI 10.1097/00004691-199101000-00007; Condes-Lara M, 2000, EUR J PAIN-LONDON, V4, P239, DOI 10.1053/eujp.2000.0176; CONTI F, 1994, BEHAV BRAIN RES, V64, P37, DOI 10.1016/0166-4328(94)90117-1; COOK ND, 1984, BRAIN LANG, V23, P116, DOI 10.1016/0093-934X(84)90010-5; Davis KD, 1998, NATURE, V391, P385, DOI 10.1038/34905; DENNIS M, 1976, NEUROPSYCHOLOGIA, V14, P455, DOI 10.1016/0028-3932(76)90074-9; Diers M, 2010, PAIN, V149, P296, DOI 10.1016/j.pain.2010.02.020; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Elbert T, 2004, NEUROSCIENTIST, V10, P129, DOI 10.1177/1073858403262111; Fabri M, 2004, NEUROSCIENCE, V123, P557, DOI 10.1016/j.neuroscience.2003.09.011; Fabri M, 2001, J COGNITIVE NEUROSCI, V13, P1071, DOI 10.1162/089892901753294365; Fabri M, 2014, WORLD J RADIOL, V6, P895, DOI 10.4329/wjr.v6.i12.895; Feng J. T., 2015, BRAIN IMAGING BEHAV, V10, P1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Geyer S, 2004, ADV ANAT EMBRYOL CEL, V174, P1, DOI DOI 10.1007/978-3-642-18910-4_1; Giraux P, 2001, NAT NEUROSCI, V4, P691, DOI 10.1038/89472; Graziano A, 2009, J NEUROSCI, V29, P3738, DOI 10.1523/JNEUROSCI.5388-08.2009; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Grusser SM, 2001, NEUROSCIENCE, V102, P263, DOI 10.1016/S0306-4522(00)00491-7; Hahamy A, 2015, ELIFE, V4, DOI 10.7554/eLife.04605; He XF, 2015, PHYSIOL BEHAV, V151, P502, DOI 10.1016/j.physbeh.2015.08.026; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; Karayannis T, 2007, CEREB CORTEX, V17, P1213, DOI 10.1093/cercor/bhl035; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Liu B, 2013, NEUROSCIENCE, V243, P33, DOI 10.1016/j.neuroscience.2013.03.048; Makin TR, 2015, NEUROIMAGE, V114, P217, DOI 10.1016/j.neuroimage.2015.02.067; Makin TR, 2013, ELIFE, V2, DOI 10.7554/eLife.01273; Makin TR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2571; MANZONI T, 1986, J COMP NEUROL, V252, P245, DOI 10.1002/cne.902520208; Pasaye EH, 2010, NEURORADIOL J, V23, P665, DOI 10.1177/197140091002300604; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Pearson PP, 1999, EXP BRAIN RES, V128, P315, DOI 10.1007/s002210050852; Pearson PP, 2001, EXP BRAIN RES, V138, P8, DOI 10.1007/s002210100678; Pelled G, 2007, NEUROIMAGE, V37, P262, DOI 10.1016/j.neuroimage.2007.03.069; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ragert P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016150; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Romero-Romo JI, 2010, NEURORADIOL J, V23, P671, DOI 10.1177/197140091002300605; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; Silva JPS, 2018, MAGN RESON IMAGING, V51, P151, DOI 10.1016/j.mri.2018.05.006; Simoes EL, 2012, J NEUROSCI, V32, P3211, DOI 10.1523/JNEUROSCI.4592-11.2012; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stancak A, 2002, BRAIN RES, V936, P47, DOI 10.1016/S0006-8993(02)02502-7; Vargas CD, 2009, P NATL ACAD SCI USA, V106, P7197, DOI 10.1073/pnas.0809614106; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xie H, 2013, J CLIN NEUROSCI, V20, P523, DOI 10.1016/j.jocn.2012.03.043	73	14	14	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 21	2019	9								2518	10.1038/s41598-019-39696-z			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2IA	WOS:000459281500087	30792514	gold, Green Published			2022-02-06	
J	Kimura, I; Dohgu, S; Takata, F; Matsumoto, J; Kawahara, Y; Nishihira, M; Sakada, S; Saisho, T; Yamauchi, A; Kataoka, Y				Kimura, Ikuya; Dohgu, Shinya; Takata, Fuyuko; Matsumoto, Junichi; Kawahara, Yohei; Nishihira, Megumi; Sakada, Shohei; Saisho, Takuya; Yamauchi, Atsushi; Kataoka, Yasufumi			Activation of the alpha 7 nicotinic acetylcholine receptor upregulates blood-brain barrier function through increased claudin-5 and occludin expression in rat brain endothelial cells	NEUROSCIENCE LETTERS			English	Article						Blood-brain barrier; Brain endothelial cells; Nicotinic acetylcholine receptor; Claudin-5; Occludin; Permeability	ALZHEIMERS-DISEASE; PERMEABILITY; SUBTYPES; NACHR	The blood-brain barrier (BBB) is formed by brain endothelial cells (BECs) and regulates brain homeostasis by restricting the entry of blood-borne substances into the brain. Recent in vivo studies have shown that administration of nicotinic acetylcholine receptor (nAChR) agonists protects against BBB disruption and neuroin-flammation induced by stroke and traumatic brain injury through the systemic cholinergic anti-inflammatory pathway. In the present study, we focused on the nAChRs expressed on BECs rather than those widely expressed in the central nervous system and peripheral tissues, and examined whether activation of the nAChRs on BECs facilitates BBB function. We used primary cultures of rat brain endothelial cells to evaluate brain endothelial permeability and tight junction (TJ)-related protein expression after a 24-h exposure to PHA543613 (a selective alpha 7 nAChR agonist) or 5-iodo-A-85380 (a selective alpha 4 beta 2 nAChR agonist). We found that PHA543613 decreased sodium fluorescein permeability and increased the expression levels of claudin-5 and occludin, key TJ components. In contrast, 5-iodo-A-85380 had no effect on brain endothelial permeability or TJ protein expression. These findings suggest that the selective activation of alpha 7 nAChRs on BECs has a specific role in upregulating BBB properties through increased claudin-5 and occludin expression.	[Kimura, Ikuya; Dohgu, Shinya; Takata, Fuyuko; Matsumoto, Junichi; Kawahara, Yohei; Nishihira, Megumi; Sakada, Shohei; Saisho, Takuya; Yamauchi, Atsushi; Kataoka, Yasufumi] Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Fukuoka, Fukuoka, Japan		Kataoka, Y (corresponding author), Fukuoka Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Hlth Sci, Jonan Ku, 8-19-1 Nanakuma, Fukuoka, Fukuoka 8140180, Japan.	ikimura@fukuoka-u.ac.jp; dohgu@fukuoka-u.ac.jp; ftakata@fukuoka-u.ac.jp; jmatsumoto@fukuoka-u.ac.jp; pp100201@cis.fukuoka-u.ac.jp; pp130060@cis.fukuoka-u.ac.jp; pp130146@cis.fukuoka-u.ac.jp; pp130266@cis.fukuoka-u.ac.jp; atyama@fukuoka-u.ac.jp; ykataoka@fukuoka-u.ac.jp	Dohgu, Shinya/AAK-9992-2020		Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [16K08429, 26460113, 16K08566, 15K08255]; Fukuoka University Program for supporting research activities of female researchers; Central Research Institute of Fukuoka University [166003, 157007, 166005, 166006, 167111]	This work was supported in part by Grants-in-Aid for Scientific Research to Y.K. (C) 16K08429, to F.T. (C) 26460113, to S.D. (C) 16K08566 and to A.Y. (C) 15K08255 from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/), funds (to F.T.) from Fukuoka University Program for supporting research activities of female researchers (http://www.suisin.fukuoka-u.ac.jp/jyosei/), and funds (to Y.K.) 166003, 157007, (to S.D.) 166005, (to A.Y.) 166006 and (to F.T. and S.D.) 167111, from the Central Research Institute of Fukuoka University (http://www.suisin.fukuoka-u.ac.jp/homel/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Melony Black, PhD, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.	Abbruscato TJ, 2002, J PHARM SCI-US, V91, P2525, DOI 10.1002/jps.10256; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Buckingham SD, 2009, PHARMACOL REV, V61, P39, DOI 10.1124/pr.108.000562; Chan YJ, 2018, EXP CELL RES, V369, P266, DOI 10.1016/j.yexcr.2018.05.025; Colon-Saez JO, 2014, PFLUG ARCH EUR J PHY, V466, P1571, DOI 10.1007/s00424-013-1385-y; Cooke JP, 2008, TRENDS CARDIOVAS MED, V18, P247, DOI 10.1016/j.tcm.2008.11.007; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; del Barrio L, 2011, TOXICOL SCI, V123, P193, DOI 10.1093/toxsci/kfr163; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gahring LC, 2005, AAPS J, V7, pE885, DOI 10.1208/aapsj070486; He Q, 2015, TRENDS PHARMACOL SCI, V33, P395, DOI [10.1038/nbt.3121.ChIP-nexus, DOI 10.1038/NBT.3121.CHIP-NEXUS]; Hutamekalin P, 2008, CELL BIOL INT, V32, P198, DOI 10.1016/j.cellbi.2007.08.026; Krafft PR, 2013, STROKE, V44, P1743, DOI 10.1161/STROKEAHA.111.000427; Lee H, 2014, FRONT BIOSCI-LANDMRK, V19, P272, DOI 10.2741/4206; Mao XB, 2016, ANIM NUTR, V2, P218, DOI 10.1016/j.aninu.2016.05.004; Matsumoto J, 2018, BRAIN RES, V1692, P34, DOI 10.1016/j.brainres.2018.04.023; Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Papke RL, 2010, J PHARMACOL EXP THER, V333, P501, DOI 10.1124/jpet.109.164566; Rakkar K, 2016, BBA-MOL BASIS DIS, V1862, P56, DOI 10.1016/j.bbadis.2015.10.016; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641; Takata F, 2008, NEUROSCI LETT, V441, P163, DOI 10.1016/j.neulet.2008.06.030; Thom MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126755; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Wu JCF, 2009, J CELL BIOCHEM, V108, P433, DOI 10.1002/jcb.22270; Yang TY, 2017, ACTA PHARM SIN B, V7, P611, DOI 10.1016/j.apsb.2017.09.001; Zhang N, 2018, ONCOL REP, V39, P1034, DOI 10.3892/or.2017.6159; Zoli M, 2015, NEUROPHARMACOLOGY, V96, P302, DOI 10.1016/j.neuropharm.2014.11.003; Zwart R, 2014, EUR J PHARMACOL, V726, P77, DOI 10.1016/j.ejphar.2014.01.031	33	14	14	0	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 16	2019	694						9	13		10.1016/j.neulet.2018.11.022			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM7FS	WOS:000459643800002	30452951				2022-02-06	
J	Batsaikhan, B; Wang, JY; Scerba, MT; Tweedie, D; Greig, NH; Miller, JP; Hoffer, BJ; Lin, CT; Wang, JY				Batsaikhan, Buyandelger; Wang, Jing-Ya; Scerba, Michael T.; Tweedie, David; Greig, Nigel H.; Miller, Jonathan P.; Hoffer, Barry J.; Lin, Chih-Tung; Wang, Jia-Yi			Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6-Dithiothalidomide on Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; neurological deficits; 3; 6-dithiothalidomide; neurodegeneration; neuroinflammation; oxidative stress	TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; FACTOR-ALPHA; TNF-ALPHA; INFLAMMATORY CYTOKINES; PIFITHRIN-ALPHA; INHIBITION; EXPRESSION; 3,6'-DITHIOTHALIDOMIDE; NEUROINFLAMMATION	Traumatic brain injury (TBI) is a major cause of mortality and disability worldwide. Long-term deficits after TBI arise not only from the direct effects of the injury but also from ongoing processes such as neuronal excitotoxicity, inflammation, oxidative stress and apoptosis. Tumor necrosis factor- (TNF-) is known to contribute to these processes. We have previously shown that 3,6-dithiothalidomide (3,6-DT), a thalidomide analog that is more potent than thalidomide with similar brain penetration, selectively inhibits the synthesis of TNF- in cultured cells and reverses behavioral impairments induced by mild TBI in mice. In the present study, we further explored the therapeutic potential of 3,6-DT in an animal model of moderate TBI using Sprague-Dawley rats subjected to controlled cortical impact. A single dose of 3,6-DT (28 mg/kg, i.p.) at 5 h after TBI significantly reduced contusion volume, neuronal degeneration, neuronal apoptosis and neurological deficits at 24 h post-injury. Expression of pro-inflammatory cytokines in the contusion regions were also suppressed at the transcription and translation level by 3,6-DT. Notably, neuronal oxidative stress was also suppressed by 3,6-DT. We conclude that 3,6-DT may represent a potential therapy to ameliorate TBI-induced functional deficits.	[Batsaikhan, Buyandelger; Wang, Jing-Ya; Lin, Chih-Tung; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, 250 Wu Xing St, Taipei 11031, Taiwan; [Scerba, Michael T.; Tweedie, David; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Miller, Jonathan P.; Hoffer, Barry J.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA; [Wang, Jia-Yi] Taipei Med Univ, Dept Physiol, Sch Med, Coll Med, Taipei 11031, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, 250 Wu Xing St, Taipei 11031, Taiwan.; Wang, JY (corresponding author), Taipei Med Univ, Dept Physiol, Sch Med, Coll Med, Taipei 11031, Taiwan.	buyndlgr@gmail.com; gaeajyw911real@hotmail.com.tw; mike.scerba@nih.gov; tweedieda@grc.nia.nih.gov; greign@grc.nia.nih.gov; Jonathan.Miller@uhhospitals.org; bjh82@case.edu; sss880205@gmail.com; jywang2010@tmu.edu.tw			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST104-2923-B-038-001-MY3]; Taipei Medical University, Taipei, Taiwan [DP2-107-21121-01-N-05]; National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R56 AG057028]; Intramural Research Program, National Institute on Aging, National Institutes of Health, USA; Lincoln MC Funds; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000994, ZIAAG000469] Funding Source: NIH RePORTER	This research was supported in part by grants from (i) the Ministry of Science and Technology, Taiwan (MOST104-2923-B-038-001-MY3); and DP2-107-21121-01-N-05, Taipei Medical University, Taipei, Taiwan; (ii) National Institutes of Health R56 AG057028, USA; by (iii) the Intramural Research Program, National Institute on Aging, National Institutes of Health, USA; and (iv) Lincoln MC Funds.	Aaltonen KJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030275, 10.1371/journal.pone.0043508]; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; Blach-Olszewska Zofia, 2007, Neuropsychiatr Dis Treat, V3, P365; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Choudhery MS, 2012, CELL BIOL INT, V36, P747, DOI 10.1042/CBI20110183; Decourt B, 2017, CURR ALZHEIMER RES, V14, P403, DOI 10.2174/1567205014666170117141330; EGER K, 1990, ARZNEIMITTEL-FORSCH, V40-2, P1073; Ekici MA, 2014, EUR REV MED PHARMACO, V18, P10; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Greig NH, 2004, ACTA NEUROBIOL EXP, V64, P1; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Hasturk Askin Esen, 2018, Asian J Neurosurg, V13, P1018, DOI 10.4103/ajns.AJNS_29_17; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Ordas I, 2012, CLIN PHARMACOL THER, V91, P635, DOI 10.1038/clpt.2011.328; Qiu P, 2011, EXPERT OPIN INV DRUG, V20, P1555, DOI 10.1517/13543784.2011.623125; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Rowland TL, 1998, IMMUNOPHARMACOLOGY, V40, P11, DOI 10.1016/S0162-3109(98)00010-1; Rowland TL, 1999, IMMUNOL LETT, V68, P325, DOI 10.1016/S0165-2478(99)00055-3; Ryu JK, 2009, NEUROSCIENCE, V163, P601, DOI 10.1016/j.neuroscience.2009.07.006; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Tansey MG, 2010, NEUROBIOL DIS, V37, P491, DOI 10.1016/j.nbd.2009.12.004; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Tobinick E, 2018, EXPERT REV NEUROTHER, V18, P453, DOI 10.1080/14737175.2018.1468253; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Tweedie David, 2011, Open Biochem J, V5, P37, DOI 10.2174/1874091X01105010037; Tweedie D, 2009, J NEUROSCI METH, V183, P182, DOI 10.1016/j.jneumeth.2009.06.034; Wang CX, 2002, PROG NEUROBIOL, V67, P161, DOI 10.1016/S0301-0082(02)00010-2; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Yoon JS, 2013, J NEUROSCI RES, V91, P671, DOI 10.1002/jnr.23190; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhou S, 2013, CURR MED CHEM, V20, P4102; Zhu XX, 2003, J MED CHEM, V46, P5222, DOI 10.1021/jm030152f	61	14	14	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	FEB 1	2019	20	3							502	10.3390/ijms20030502			20	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	HQ4WR	WOS:000462412500046	30682785	Green Published, Green Submitted, gold			2022-02-06	
J	Caglayan, B; Kilic, E; Dalay, A; Altunay, S; Tuzcu, M; Erten, F; Orhan, C; Gunal, MY; Yulug, B; Juturu, V; Sahin, K				Caglayan, Berrak; Kilic, Ertugrul; Dalay, Arman; Altunay, Serdar; Tuzcu, Mehmet; Erten, Fusun; Orhan, Cemal; Gunal, Mehmet Yalcin; Yulug, Burak; Juturu, Vijaya; Sahin, Kazim			Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-kappa B pathways in traumatic brain injury in mice	MOLECULAR BIOLOGY REPORTS			English	Article						Traumatic brain injury; Allyl isothiocyanate; NF-kappa B; Nrf2	INTERCELLULAR-ADHESION MOLECULE-1; INCREASED EXPRESSION; ACTIVATION; NRF2; PATHOPHYSIOLOGY; POPULATION; INDUCTION; MELATONIN; ANTIBODY; DAMAGE	Traumatic brain injury (TBI) is the leading cause of mortality and morbidity in young adults and children in the industrialized countries; however, there are presently no FDA approved therapies. TBI results in oxidative stress due to the overproduction of reactive oxygen species and overwhelming of the endogenous antioxidant mechanisms. Recently, it has been reported that antioxidants including phytochemicals have a protective role against oxidative damage and inflammation after TBI. To analyze the effects of a naturally occurring antioxidant molecule, allyl isothiocyanate (AITC), on the nuclear factor erythroid 2-related factor 2 (Nrf2) and nuclear factor kappa B (NF-kappa B) signaling pathways in TBI, a cryogenic injury model was induced in mice. Here, we showed that AITC administered immediately after the injury significantly decreased infarct volume and blood-brain barrier (BBB) permeability. Protein levels of proinflammatory cytokines interleukin-1 beta (IL1 beta) and interleukin-6 (IL6), glial fibrillary acidic protein (GFAP) and NF-kappa B were decreased, while Nrf2, growth-associated protein 43 (GAP43) and neural cell adhesion molecule levels were increased with AITC when compared with vehicle control. Our results demonstrated that the antioxidant molecule AITC, when applied immediately after TBI, provided beneficial effects on inflammatory processes while improving infarct volume and BBB permeability. Increased levels of plasticity markers, as well as an antioxidant gene regulator, Nrf2, by AITC, suggest that future studies are warranted to assess the protective activities of dietary or medicinal AITC in clinical studies.	[Caglayan, Berrak] Istanbul Medipol Univ, Dept Med Biol, Int Sch Med, Istanbul, Turkey; [Kilic, Ertugrul; Dalay, Arman; Altunay, Serdar] Istanbul Medipol Univ, Dept Physiol, Istanbul, Turkey; [Caglayan, Berrak; Kilic, Ertugrul; Dalay, Arman; Altunay, Serdar; Gunal, Mehmet Yalcin; Yulug, Burak] Istanbul Medipol Univ, Regenerat & Restorat Med Res Ctr, Istanbul, Turkey; [Tuzcu, Mehmet; Erten, Fusun] Firat Univ, Div Biol, Fac Sci, Elazig, Turkey; [Orhan, Cemal; Sahin, Kazim] Firat Univ, Sch Vet Med, Dept Anim Nutr, Elazig, Turkey; [Gunal, Mehmet Yalcin; Yulug, Burak] Istanbul Medipol Univ, Sch Med, Dept Neurol, Istanbul, Turkey; [Juturu, Vijaya] OmniAct Hlth Technol Inc, Res & Dev, Morristown, NJ USA		Sahin, K (corresponding author), Firat Univ, Sch Vet Med, Dept Anim Nutr, Elazig, Turkey.	bcaglayan@medipol.edu.tr; ekilic@medipol.edu.tr; dalayarman@gmail.com; altnyserdar@gmail.com; mtuzcu@firat.edu.tr; fusun_87@yahoo.com; corhan@firat.edu.tr; yalcin.gunal@alanya.edu.tr; burakyulug@gmail.com; v.juturu@omniactives.com; nsahinkm@yahoo.com	Sahin, Kazim/D-5625-2009; Yulug, Burak/O-8322-2016; Kilic, Ertugrul/W-4563-2018; Orhan, Cemal/Q-2086-2015; TUZCU, MEHMET/H-2953-2018; Gunal, Mehmet Yalcin/AAT-9806-2021; Yulug, Burak/AAD-3930-2022; Gunal, Mehmet/AAT-2910-2020; Erten, Fusun/AAZ-3709-2021	Sahin, Kazim/0000-0001-9542-5244; Yulug, Burak/0000-0002-9704-6173; Kilic, Ertugrul/0000-0001-6494-8923; Orhan, Cemal/0000-0003-4138-7689; TUZCU, MEHMET/0000-0002-1329-3143; Gunal, Mehmet/0000-0001-7702-2441; Erten, Fusun/0000-0003-1657-7253; Caglayan, Berrak/0000-0002-5072-132X; ALTUNAY, SERDAR/0000-0002-4051-2559	OmniActive Health Technologies Inc.; Turkish Academy of SciencesTurkish Academy of Sciences	This study was supported by OmniActive Health Technologies Inc. (NJ, USA). This work was also supported in part by the Turkish Academy of Sciences.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Beker MC, 2015, ONCOTARGET, V6, P30604, DOI 10.18632/oncotarget.5773; Beker MC, 2018, MOL NEUROBIOL, V55, P2565, DOI 10.1007/s12035-017-0524-4; BEVILACQUA MP, 1985, AM J PATHOL, V121, P394; Boutin C, 2009, EUR J NEUROSCI, V30, P1209, DOI 10.1111/j.1460-9568.2009.06928.x; BOWES MP, 1993, EXP NEUROL, V119, P215, DOI 10.1006/exnr.1993.1023; Bryant CD, 2008, J NEUROGENET, V22, P315, DOI 10.1080/01677060802357388; Caglayan B, 2017, EXP NEUROL, V296, P23, DOI 10.1016/j.expneurol.2017.06.024; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; de Roos B, 2015, MOL NUTR FOOD RES, V59, P1229, DOI 10.1002/mnfr.201400568; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Ernst IMA, 2011, PHARMACOL RES, V63, P233, DOI 10.1016/j.phrs.2010.11.005; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gorup D, 2015, NEUROSCI LETT, V597, P176, DOI 10.1016/j.neulet.2015.04.042; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Jakubikova J, 2006, J AGR FOOD CHEM, V54, P1656, DOI 10.1021/jf052717h; Jennings M, 1998, LAB ANIM-UK, V32, P233, DOI 10.1258/002367798780559301; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kelestemur T, 2016, NEUROSCI LETT, V612, P92, DOI 10.1016/j.neulet.2015.11.043; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Liddell JR., 2017, J CLIN CELL IMMUNOL, V8, P1, DOI [10.4172/2155-9899.1000489, DOI 10.4172/2155-9899.1000489]; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Peirson SN, 2018, J NEUROSCI METH, V300, P26, DOI 10.1016/j.jneumeth.2017.04.007; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; SALMINEN A, 1995, BIOCHEM BIOPH RES CO, V212, P939, DOI 10.1006/bbrc.1995.2060; Smith T, 1996, BIOCHEM SOC T, V24, pS381, DOI 10.1042/bst024381s; Smith TK, 2004, CARCINOGENESIS, V25, P1409, DOI 10.1093/carcin/bgh149; Sun J, 2008, AM J PHYSIOL-CELL PH, V294, pC1586, DOI 10.1152/ajpcell.00129.2008; Tang L, 2004, J NUTR, V134, P2004, DOI 10.1093/jn/134.8.2004; Trevisan G, 2013, EUR J PHARMACOL, V714, P332, DOI 10.1016/j.ejphar.2013.07.029; Venegoni W, 2017, J ADV NURS, V73, P1331, DOI 10.1111/jan.13259; Vos Pieter E, 2011, Crit Care, V15, P183, DOI 10.1186/cc10290; Wagner AE, 2012, J CELL MOL MED, V16, P836, DOI 10.1111/j.1582-4934.2011.01367.x; Wardyn JD, 2015, BIOCHEM SOC T, V43, P621, DOI 10.1042/BST20150014; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao Guo-min, 2005, J Zhejiang Univ Sci B, V6, P28, DOI 10.1631/jzus.2005.B0028; Yehuda H, 2012, INFLAMM RES, V61, P735, DOI 10.1007/s00011-012-0465-3; You WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060290	60	14	14	0	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851	1573-4978		MOL BIOL REP	Mol. Biol. Rep.	FEB	2019	46	1					241	250		10.1007/s11033-018-4465-4			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP9OI	WOS:000462022300026	30406889				2022-02-06	
J	Castelnovo, LF; Magnaghi, V; Thomas, P				Castelnovo, Luca F.; Magnaghi, Valerio; Thomas, Peter			Expression of membrane progesterone receptors (mPRs) in rat peripheral glial cell membranes and their potential role in the modulation of cell migration and protein expression	STEROIDS			English	Article; Proceedings Paper	10th International Meeting on Rapid Responses to Steroid Hormones	NOV 02-05, 2016	Richmond, VA			Membrane progesterone receptors; Schwann cells; Migration; Myelin associated glycoprotein; Cyclic AMP	SCHWANN-CELLS; SCIATIC-NERVE; MYELIN FORMATION; GENE-EXPRESSION; ESTROGEN; SYSTEM; MAINTENANCE; SIGNALS; ALPHA; BRAIN	The role played by progestogens in modulating Schwann cell pathophysiology is well established. Progestogens exert their effects in these cells through both classical genomic and non-genomic mechanisms, the latter mediated by the GABA-A receptor. However, there is evidence that other receptors may be involved. Membrane progesterone receptors (mPRs) are novel 7-transmembrane receptors coupled to G proteins that have been characterized in different tissues and cells, including the central nervous system (CNS). The mPRs were shown to mediate some of progestogens' neuroprotective effects in the CNS, and to be upregulated in glial cells after traumatic brain injury. Based on this evidence, this paper investigated the possible involvement of mPRs in mediating progestogen actions in S42 Schwann cells. All five mPR isoforms and progesterone receptor membrane component 1 (PGRMC1) were detected in Schwann cells, and were present on the cell membrane. Progesterone and the mPR-specific agonist, Org-OD-02-0 (02) bound to these membranes, indicating the presence of functional mPRs. The mPR agonist 02 rapidly increased cell migration in an in vitro assay, suggesting a putative role of mPRs in the nerve regeneration process. Treatment with pertussis toxin and 8-Br-cAMP blocked 02-induced cell migration, suggesting this progestogen action is mediated by activation of an inhibitory G protein, leading to a decrease in intracellular cAMP levels. In contrast, long-term mPR activation led to increased expression levels of myelin associated glycoprotein (MAG). Taken together, these findings show that mPRs are present and active in Schwann cells and have a role in modulating their physiological processes.	[Castelnovo, Luca F.; Magnaghi, Valerio] Univ Milan, Dept Pharmacol & Biomol Sci, Via G Balzaretti 9, I-20133 Milan, Italy; [Castelnovo, Luca F.; Thomas, Peter] Univ Texas Austin, Marine Sci Univ, 750 Channel View Dr, Port Aransas, TX 78373 USA		Castelnovo, LF (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Via G Balzaretti 9, I-20133 Milan, Italy.	luca.castelnovo@unimi.it	Castelnovo, Luca/AAB-7088-2019; Thomas, Peter/U-9908-2019; Castelnovo, Luca/E-6364-2016	Thomas, Peter/0000-0001-6656-4907; Castelnovo, Luca/0000-0003-4784-1221	H.E.B. endowment	This research was partially funded by an H.E.B. endowment to P.T. The authors would like to thank Dr. Yefei Pang for his advice and Jing Dong for her technical assistance.	Aizen J, 2015, J ENDOCRINOL, V225, P59, DOI 10.1530/JOE-14-0576; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Azcoitia I, 2003, NEUROBIOL AGING, V24, P853, DOI 10.1016/S0197-4580(02)00234-8; Carver CM, 2013, PSYCHOPHARMACOLOGY, V230, P151, DOI 10.1007/s00213-013-3276-5; CELOTTI F, 1992, FRONT NEUROENDOCRIN, V13, P163; Ding YQ, 2016, TISSUE CELL, V48, P503, DOI 10.1016/j.tice.2016.07.002; Faroni A, 2015, ADV DRUG DELIVER REV, V82-83, P160, DOI 10.1016/j.addr.2014.11.010; Faroni Alessandro, 2011, Front Endocrinol (Lausanne), V2, P103, DOI 10.3389/fendo.2011.00103; Glenn TD, 2013, CURR OPIN NEUROBIOL, V23, P1041, DOI 10.1016/j.conb.2013.06.010; Gu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145185; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; Intlekofer KA, 2011, NEUROSCIENCE, V172, P55, DOI 10.1016/j.neuroscience.2010.10.051; Jung-Testas I, 1998, J STEROID BIOCHEM, V65, P243, DOI 10.1016/S0960-0760(97)00191-X; JungTestas I, 1996, J STEROID BIOCHEM, V58, P77, DOI 10.1016/0960-0760(96)00009-X; Kelder J, 2010, STEROIDS, V75, P314, DOI 10.1016/j.steroids.2010.01.010; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Labombarda F, 2010, NEUROSCIENCE, V166, P94, DOI 10.1016/j.neuroscience.2009.12.012; Latasa MJ, 2016, BBA-MOL CELL RES, V1863, P1510, DOI 10.1016/j.bbamcr.2016.04.009; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lopez PHH, 2011, J NEUROCHEM, V116, P900, DOI 10.1111/j.1471-4159.2010.07069.x; Lv J., 2019, STEROIDS, V142, P6; Lv JW, 2015, BIOCHEM BIOPH RES CO, V464, P263, DOI 10.1016/j.bbrc.2015.06.140; Magnaghi V, 1999, MOL BRAIN RES, V70, P36, DOI 10.1016/S0169-328X(99)00124-2; Magnaghi V, 2006, J MOL NEUROSCI, V28, P89, DOI 10.1385/JMN:28:1:89; Magnaghi V, 2001, BRAIN RES REV, V37, P360, DOI 10.1016/S0165-0173(01)00140-0; Magnaghi V, 2010, J NEUROCHEM, V112, P980, DOI 10.1111/j.1471-4159.2009.06512.x; Magnaghi V, 2009, INT REV NEUROBIOL, V87, P295, DOI 10.1016/S0074-7742(09)87015-3; Mantuano E, 2015, J CELL SCI, V128, P3478, DOI 10.1242/jcs.173765; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Melcangi R C, 1992, Endocr Regul, V26, P119; Melcangi RC, 1999, J NEUROSCI RES, V56, P349, DOI 10.1002/(SICI)1097-4547(19990515)56:4<349::AID-JNR3>3.0.CO;2-H; MELCANGI RC, 1990, J STEROID BIOCHEM, V35, P145, DOI 10.1016/0022-4731(90)90159-P; Melcangi RC, 2000, PROG NEUROBIOL, V60, P291, DOI 10.1016/S0301-0082(99)00028-3; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Monje PV, 2010, J BIOL CHEM, V285, P31024, DOI 10.1074/jbc.M110.116970; Pang YF, 2015, AM J PHYSIOL-ENDOC M, V308, pE899, DOI 10.1152/ajpendo.00527.2014; Pang YF, 2013, ENDOCRINOLOGY, V154, P283, DOI 10.1210/en.2012-1772; Pang YF, 2011, STEROIDS, V76, P921, DOI 10.1016/j.steroids.2011.01.008; Perego C, 2012, J CELL PHYSIOL, V227, P1740, DOI 10.1002/jcp.22898; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quarles RH, 2002, CELL MOL LIFE SCI, V59, P1851, DOI 10.1007/PL00012510; Quarles RH, 2007, J NEUROCHEM, V100, P1431, DOI 10.1111/j.1471-4159.2006.04319.x; Roglio I, 2008, NEUROSCIENCE, V155, P673, DOI 10.1016/j.neuroscience.2008.06.034; Schumacher M, 2001, BRAIN RES REV, V37, P343, DOI 10.1016/S0165-0173(01)00139-4; Selzer J.L., 2015, COLD SPRING HARB PER, V7, DOI [10.1101/cshperspect.a020529, DOI 10.1101/CSHPERSPECT.A020529]; Sleiter N, 2009, ENDOCRINOLOGY, V150, P3833, DOI 10.1210/en.2008-0774; Svenningsen AF, 1999, J NEUROSCI RES, V57, P124, DOI 10.1002/(SICI)1097-4547(19990701)57:1<124::AID-JNR13>3.0.CO;2-P; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Taveggia C, 2016, CURR OPIN NEUROBIOL, V39, P24, DOI 10.1016/j.conb.2016.03.006; Thi AD, 1998, J STEROID BIOCHEM, V67, P201; Thomas P., 2019, STEROIDS, V142, P6; Thomas P, 2007, ENDOCRINOLOGY, V148, P705, DOI 10.1210/en.2006-0974; Thomas P, 2014, ENDOCRINOLOGY, V155, P1107, DOI 10.1210/en.2013-1991; Thomas P, 2013, STEROIDS, V78, P583, DOI 10.1016/j.steroids.2013.01.003; Thomas P, 2012, NEUROENDOCRINOLOGY, V96, P162, DOI 10.1159/000339822; TODA K, 1994, J NEUROCHEM, V63, P1646; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang ZH, 2016, GLIA, V64, P374, DOI 10.1002/glia.22934; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100; Zuloaga DG, 2012, ENDOCRINOLOGY, V153, P4432, DOI 10.1210/en.2012-1469	61	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0039-128X	1878-5867		STEROIDS	Steroids	FEB	2019	142				SI		6	13		10.1016/j.steroids.2017.09.009			8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	HO3ID	WOS:000460813500003	28962850				2022-02-06	
J	Nyam, TTE; Ho, CH; Chio, CC; Lim, SW; Wang, JJ; Chang, CH; Kuo, JR; Wang, CC				Nyam, Tee-Tau Eric; Ho, Chung-Han; Chio, Chung-Ching; Lim, Sher-Wei; Wang, Jhi-Joung; Chang, Ching-Hung; Kuo, Jinn-Rung; Wang, Che-Chuan			Traumatic Brain Injury Increases the Risk of Major Adverse Cardiovascular and Cerebrovascular Events: A 13-Year, Population-Based Study	WORLD NEUROSURGERY			English	Article						ACCI; Cardiovascular; Mortality; MACCE; Stroke; Traumatic brain injury	ISCHEMIC-STROKE; DYSFUNCTION; OUTCOMES; MACCE	BACKGROUND: Previous studies have indicated traumatic brain injury (TBI) as a risk factor for stroke and myocardial injury. Whether TBI increases new onset of major adverse cardiovascular and cerebrovascular events (MACCE) is not well established. METHODS: Patients with a diagnosis of TBI from 2000 to 2012 were 1: 2 age-, sex-, and age-adjusted comorbidities matched with normal population cohorts. The MACCE, which included coronary artery disease, heart failure and arrhythmia, ischemic and hemorrhagic stroke, and death, was defined as one inpatient admission with MACCE diagnosis. The maximum follow-up duration to MACCE after the initial TBI diagnosis was 5 years. The baseline comorbidities before TBI, including hypertension, diabetes mellitus, renal disease, and liver disease, also were considered to estimate the risk of MACCE. RESULTS: In total, 16,211 patients with TBI and 32,422 people from the control group were enrolled in the current study. Our results showed that patients with TBI had a 2.77-fold risk of MACCE, 1.72-fold risk of cardiovascular disease, 2.10-fold risk of ischemic stroke, 6.02-fold risk of hemorrhagic stroke, and 3.13-fold risk of mortality compared with the control group (all P < 0.0001) after adjusting the confounding factors. In addition, the trend of cumulated incidence risk among MACCE, cardiovascular disease, ischemic and hemorrhagic stroke, and mortality presented the greatest incidence within the first year after diagnosis and persisted during the 5 years of follow-up. CONCLUSIONS: Our results showed that patients with TBI have a significantly greater risk of MACCE than the control group. We hope this information will remind critical-care physicians and neurosurgeons to keep in mind the long-term effects of TBI on MACCE.	[Nyam, Tee-Tau Eric; Chio, Chung-Ching; Lim, Sher-Wei; Chang, Ching-Hung; Kuo, Jinn-Rung; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com		Ho, Chung-Han/0000-0001-5925-8477	ChiMei Foundation Hospital Research [CMFHR10682]	This research was funded by ChiMei Foundation Hospital Research (CMFHR10682) grants.	Albrecht JS, 2015, J HEAD TRAUMA REHAB, V30, pE62, DOI 10.1097/HTR.0000000000000035; Bahloul M, 2006, AM J CRIT CARE, V15, P462; Bijuklic K, 2017, WIEN KLIN WOCHENSCHR, V129, P243, DOI 10.1007/s00508-016-1148-9; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chang WT, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005466; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cheng CY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001468; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; de Groot B, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009598; Faul M, 2010, TRAUMATIC BRAIN INJU; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Glenn MB, 2010, J HEAD TRAUMA REHAB, V25, P68, DOI 10.1097/HTR.0b013e3181be1eab; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Koppie TM, 2008, CANCER-AM CANCER SOC, V112, P2384, DOI 10.1002/cncr.23462; Kowalski RG, 2017, STROKE, V48, P1802, DOI 10.1161/STROKEAHA.117.017327; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Kwon Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147065; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee YK, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0066-y; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Liu SW, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030230; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Mammo DF, 2017, CARDIOVASC REVASCULA, V18, pS18, DOI 10.1016/j.carrev.2017.03.023; Mantha S, 2011, J THROMB THROMBOLYS, V32, P334, DOI 10.1007/s11239-011-0609-2; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Padhy S, 2017, J CLIN DIAGN RES, V11, pUC13, DOI 10.7860/JCDR/2017/27428.10616; Parsons LS, 2004, P 29 ANN SAS US GROU, P11; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Sabate S, 2011, BRIT J ANAESTH, V107, P879, DOI 10.1093/bja/aer268; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; Shen HN, 2012, PANCREAS, V41, P696, DOI 10.1097/MPA.0b013e31823db941; Xia JG, 2017, CLIN CHIM ACTA, V466, P162, DOI 10.1016/j.cca.2017.01.022	37	14	14	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2019	122						E740	E753		10.1016/j.wneu.2018.10.130			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	HJ6UM	WOS:000457328100089	30391613				2022-02-06	
J	Schaller, SJ; Scheffenbichler, FT; Bose, S; Mazwi, N; Deng, H; Krebs, F; Seifert, CL; Kasotakis, G; Grabitz, SD; Latronico, N; Houle, T; Blobner, M; Eikermann, M				Schaller, Stefan J.; Scheffenbichler, Flora T.; Bose, Somnath; Mazwi, Nicole; Deng, Hao; Krebs, Franziska; Seifert, Christian L.; Kasotakis, George; Grabitz, Stephanie D.; Latronico, Nicola; Houle, Timothy; Blobner, Manfred; Eikermann, Matthias			Influence of the initial level of consciousness on early, goal-directed mobilization: a post hoc analysis	INTENSIVE CARE MEDICINE			English	Article						Early mobilization; Early rehabilitation; Critical care; Functional status; Consciousness; Neurocritical care; Delirium	INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; GLASGOW COMA SCALE; MECHANICALLY VENTILATED PATIENTS; SCORE PREDICTS MORTALITY; TRAUMATIC BRAIN-INJURY; JOINT CONTRACTURES; PASSIVE RANGE; REHABILITATION; RELIABILITY	PurposeEarly mobilization within 72h of intensive care unit (ICU) admission improves functional status at hospital discharge. We aimed to assess the effectiveness of early, goal-directed mobilization in critically ill patients across a broad spectrum of initial consciousness levels.MethodsPost hoc analysis of the international, randomized, controlled, outcome-assessor blinded SOMS trial conducted 2011-2015. Randomization was stratified according to the immediate post-injury Glasgow Coma Scale (GCS) (8 or>8). Patients received either SOMS-guided mobility treatment with a facilitator or standard care. We used general linear models to test the hypothesis that immediate post-randomization GCS modulates the intervention effects on functional independence at hospital discharge.ResultsTwo hundred patients were included in the intention-to-treat analysis. The significant effect of early, goal-directed mobilization was consistent across levels of GCS without evidence of effect modification, for the primary outcome functional independence at hospital discharge (p=0.53 for interaction), as well as average achieved mobility level during ICU stay (mean achieved SOMS level) and functional status at hospital discharge measured with the functional independence measure. In patients with low GCS, delay to first mobilization therapy was longer (0.70.2days vs. 0.2 +/- 0.1days, p=0.008), but early, goal-directed mobilization compared with standard care significantly increased functional independence at hospital discharge in this subgroup of patients with immediate post-randomization GCS8 (OR 3.67; 95% CI 1.02-13.14; p=0.046).Conclusion This post hoc analysis of a randomized controlled trial suggests that early, goal-directed mobilization in patients with an impaired initial conscious state (GCS8) is not harmful but effective.	[Schaller, Stefan J.; Krebs, Franziska; Blobner, Manfred] Tech Univ Munich, Sch Med, Dept Anesthesiol & Intens Care, Klinikum Rechts Isar, Munich, Germany; [Scheffenbichler, Flora T.; Deng, Hao; Grabitz, Stephanie D.; Houle, Timothy] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Bose, Somnath; Eikermann, Matthias] Harvard Med Sch, Dept Anesthesia Crit Care & Pain Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA; [Mazwi, Nicole] Harvard Med Sch, Spaulding Rehabil Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Seifert, Christian L.] Tech Univ Munich, Sch Med, Dept Neurol, Klinikum Rechts Isar, Munich, Germany; [Kasotakis, George] Boston Univ, Dept Surg, Boston, MA 02215 USA; [Latronico, Nicola] Univ Brescia, Spedali Civili Univ Hosp, Dept Anesthesia Crit Care & Emergency Med, Brescia, Italy; [Eikermann, Matthias] Essen Duisburg Univ, Med Fac, Essen, Germany		Eikermann, M (corresponding author), Harvard Med Sch, Dept Anesthesia Crit Care & Pain Med, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.; Eikermann, M (corresponding author), Essen Duisburg Univ, Med Fac, Essen, Germany.	meikerma@bidmc.harvard.edu	Houle, Timothy T/I-7649-2019; Blobner, Manfred/R-4411-2017; Bose, Somnath/AAI-9003-2020; Schaller, Stefan J/L-8054-2019; LATRONICO, Nicola/F-1557-2010	Blobner, Manfred/0000-0002-0370-5247; Bose, Somnath/0000-0001-7310-9881; Schaller, Stefan J/0000-0002-6683-9584; LATRONICO, Nicola/0000-0002-2521-5871; Kasotakis, George/0000-0002-7630-0742; Grabitz, Stephanie D./0000-0002-3071-873X	Jeff and Judy Buzen [222302] Funding Source: Medline		Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Carel C, 2000, J CEREBR BLOOD F MET, V20, P478, DOI 10.1097/00004647-200003000-00006; Clavet H, 2015, DISABIL REHABIL, V37, P207, DOI 10.3109/09638288.2014.913707; Clavet H, 2011, DISABIL REHABIL, V33, P105, DOI 10.3109/09638288.2010.486468; Edwards DJ, 2002, HUM MOVEMENT SCI, V21, P533, DOI 10.1016/S0167-9457(02)00169-0; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Fuest K, 2018, CURR OPIN ANESTHESIO, V31, P144, DOI 10.1097/ACO.0000000000000568; Garzon-Serrano J, 2011, PM&R, V3, P307, DOI 10.1016/j.pmrj.2010.12.022; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kasotakis G, 2012, CRIT CARE MED, V40, P1122, DOI 10.1097/CCM.0b013e3182376e6d; Kevric J, 2011, EMERG MED J, V28, P486, DOI 10.1136/emj.2009.085845; Kim HJ, 2014, J PHYS THER SCI, V26, P149, DOI 10.1589/jpts.26.149; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koch SM, 1996, J CRIT CARE, V11, P176, DOI 10.1016/S0883-9441(96)90028-3; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Langhorne P, 2018, COCHRANE DB SYST REV, V10; Lee JJ, 2012, PHYS THER, V92, P1546, DOI 10.2522/ptj.20110403; Li ZY, 2018, J STROKE CEREBROVASC, V27, P1326, DOI 10.1016/j.jstrokecerebrovasdis.2017.12.021; MAHONEY F I, 1965, Md State Med J, V14, P61; McWilliams D, 2018, J CRIT CARE, V44, P407, DOI 10.1016/j.jcrc.2018.01.001; Meyer MJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003262; Morris PE, 2016, JAMA-J AM MED ASSOC, V315, P2694, DOI 10.1001/jama.2016.7201; Moss M, 2016, AM J RESP CRIT CARE, V193, P1101, DOI 10.1164/rccm.201505-1039OC; Piva S, 2015, J CRIT CARE, V30, P1251, DOI 10.1016/j.jcrc.2015.08.002; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Schaller SJ, 2016, J CRIT CARE, V32, P201, DOI 10.1016/j.jcrc.2015.12.020; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; TEAM Study Investigators, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0765-4; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Titsworth WL, 2012, J NEUROSURG, V116, P1379, DOI 10.3171/2012.2.JNS111881; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; Wright SE, 2018, THORAX, V73, P213, DOI 10.1136/thoraxjnl-2016-209858; Zanni JM, 2010, J CRIT CARE, V25, P254, DOI 10.1016/j.jcrc.2009.10.010	40	14	15	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	FEB	2019	45	2					201	210		10.1007/s00134-019-05528-x			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HK7TI	WOS:000458192100005	30666366				2022-02-06	
J	Wu, HL; Lv, WT; Pan, Q; Kalavaguntaa, PK; Liu, QZ; Qin, GH; Cai, MX; Zhou, LL; Wang, T; Xia, ZJ; Shang, J				Wu, Huali; Lv, Wenting; Pan, Qi; Kalavaguntaa, Praveen Kumar; Liu, Qiongzhen; Qin, Guohong; Cai, Minxuan; Zhou, Liangliang; Wang, Tao; Xia, Zhenjiang; Shang, Jing			Simvastatin therapy in adolescent mice attenuates HFD-induced depression-like behavior by reducing hippocampal neuroinflammation	JOURNAL OF AFFECTIVE DISORDERS			English	Article							HIGH-FAT DIET; TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; NEUROTROPHIC FACTOR; ACUTE ANTIDEPRESSANT; ALZHEIMER-DISEASE; DENTATE GYRUS; UP-REGULATION; WEIGHT-LOSS; ADULT MICE	Background: A high-fat diet (HFD)-induced obesity/hyperlipidemia is accompanied by hormonal and neurochemical changes that can be associated with depression. Emerging studies indicate that simvastatin (SMV, decreasing cholesterol levels) has therapeutic effects on neurological and neuropsychiatric diseases through hippocampal-dependent function. However, the studies on the HFD exposure in adolescent animals, which investigate the neuroprotective effects of SMV on the hippocampal morphology, serotonin (5-HT) system and inflammation, are limited. Hence, the aim of this study was to determine whether SMV attenuates HFD-induced major depressive disorders in adolescent animals and, more specifically, acts as an anti-neuroinflammatory response. Methods: Twenty-four male C57BL/6 mice were fed a control (n = 8), HFD (n = 8) and HFD + SMV (n = 8) for 14 weeks. In HFD + SMV group, SMV (10 mg/kg) was administrated from the 10th week of HFD feeding. The open field test (OFT) and the tail suspension test (TST) were used to examine the effect of SMV on behavioral performance. HE and Nissl staining were conducted to detect hippocampal morphology and neural survival. Expression of the inflammatory cytokine genes was assayed by quantitative polymerase chain reaction (Q-PCR). Results: Firstly, alterations in lipid parameters were minimized after SMV treatment. HFD-induced depression-like behavior, which was evidenced by an increase in immobility time in TST along with considerable decrease in locomotion activity, was significantly attenuated by SMV therapy for 4 weeks. Additionally, SMV could reduce HFD-induced structural abnormality, neuronal injury, serotonergic system disturbance and pro-inflammatory cytokine over-expression in the hippocampus. Neuroimmunological changes in central hippocampus displayed a similar characteristic (only IL-1 beta, IL-6, TNF-alpha) with that in periphery spleen, whereas they appeared in an entirely opposite trend with that in cerebral cortex. Conclusion: Our results suggest that SMV may be a promising treatment for HFD-induced depression-like behavior during adolescent period through brain region-specific neuroninflammatory mechanisms.	[Wu, Huali; Lv, Wenting; Pan, Qi; Kalavaguntaa, Praveen Kumar; Liu, Qiongzhen; Qin, Guohong; Cai, Minxuan; Zhou, Liangliang; Wang, Tao; Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China; [Wu, Huali] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai 201203, Peoples R China; [Lv, Wenting; Pan, Qi; Kalavaguntaa, Praveen Kumar; Liu, Qiongzhen; Qin, Guohong; Cai, Minxuan; Zhou, Liangliang; Wang, Tao; Shang, Jing] China Pharmaceut Univ, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing 211198, Jiangsu, Peoples R China; [Lv, Wenting; Pan, Qi; Kalavaguntaa, Praveen Kumar; Liu, Qiongzhen; Qin, Guohong; Cai, Minxuan; Zhou, Liangliang; Wang, Tao; Shang, Jing] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Nanjing 211198, Jiangsu, Peoples R China; [Xia, Zhenjiang] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Tibetan Med Res, Xining 810008, Qinghai, Peoples R China; [Xia, Zhenjiang; Shang, Jing] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Tibetan Med Pharmacol & Safety Ev, Xining 810008, Qinghai, Peoples R China; [Xia, Zhenjiang; Shang, Jing] Univ Chinese Acad Sci, Beijing 100049, Peoples R China		Shang, J (corresponding author), 639 Long Mian Ave, Nanjing 210009, Jiangsu, Peoples R China.	shangjing21cn@cpu.edu.cn		Kalavagunta, Praveen Kumar/0000-0001-8991-8069	One Hundred Person Project of the Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province [Y229461211]; Science and Technology Plan Projects in Xinjiang Science [2014AB043]; Technology Plan Projects in Qinghai Province [2015-ZJ-733]; Prospective joint research project of Jiangsu Province [BY2016078-02]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81603216]	One Hundred Person Project of the Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province (No. Y229461211), Science and Technology Plan Projects in Xinjiang Science (No. 2014AB043), and Technology Plan Projects in Qinghai Province (No. 2015-ZJ-733) burden on experimental reagent consumption. Prospective joint research project of Jiangsu Province (BY2016078-02) and the National Natural Science Foundation of China (No. 81603216) burden on experimental consumptive materials and publication cost.	Abildgaard A, 2011, PSYCHONEUROENDOCRINO, V36, P623, DOI 10.1016/j.psyneuen.2010.09.004; Akdogan I, 2011, TOXICOL IND HEALTH, V27, P771, DOI 10.1177/0748233710397418; Andre C, 2014, BRAIN BEHAV IMMUN, V41, P10, DOI 10.1016/j.bbi.2014.03.012; Appelberg BG, 2001, J CLIN PSYCHIAT, V62, P448, DOI 10.4088/JCP.v62n0608; Boitard C, 2012, HIPPOCAMPUS, V22, P2095, DOI 10.1002/hipo.22032; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Can OD, 2012, BEHAV PHARMACOL, V23, P582, DOI 10.1097/FBP.0b013e328356c3f2; Chen TT, 2016, NEUROPHARMACOLOGY, V107, P411, DOI 10.1016/j.neuropharm.2016.03.028; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Cottam DR, 2004, OBES SURG, V14, P589, DOI 10.1381/096089204323093345; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Cunha MP, 2013, BRAIN RES BULL, V95, P61, DOI 10.1016/j.brainresbull.2013.01.005; Del Rosario A, 2012, BRIT J NUTR, V108, P1143, DOI 10.1017/S0007114511006738; ElBatsh MM, 2015, CAN J PHYSIOL PHARM, V93, P649, DOI 10.1139/cjpp-2014-0560; Ellul P, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00167; Enge S, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00370; Erion JR, 2014, J NEUROSCI, V34, P2618, DOI 10.1523/JNEUROSCI.4200-13.2014; Ervin R Bethene, 2013, NCHS Data Brief, P1; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Finger BC, 2011, NEUROSCIENCE, V192, P351, DOI 10.1016/j.neuroscience.2011.06.072; Fischer CW, 2015, J NEUROIMMUNOL, V288, P40, DOI 10.1016/j.jneuroim.2015.08.011; Francis H, 2013, APPETITE, V63, P119, DOI 10.1016/j.appet.2012.12.018; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; Ifergan I, 2006, ANN NEUROL, V60, P45, DOI 10.1002/ana.20875; Jena PK, 2018, FASEB J, V32, P2866, DOI 10.1096/fj.201700984RR; Karki K, 2009, STROKE, V40, P3384, DOI 10.1161/STROKEAHA.108.544395; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kilic FS, 2012, NEUROSCIENCES, V17, P39; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Krishna S, 2016, PHYSIOL BEHAV, V157, P196, DOI 10.1016/j.physbeh.2016.02.007; Lavin DN, 2011, OBESITY, V19, P1586, DOI 10.1038/oby.2011.73; Li G, 2007, NEUROLOGY, V69, P878, DOI 10.1212/01.wnl.0000277657.95487.1c; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Lin PY, 2014, PHARMACOL BIOCHEM BE, V124, P174, DOI 10.1016/j.pbb.2014.06.006; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Maric T, 2014, BRAIN BEHAV IMMUN, V36, P35, DOI 10.1016/j.bbi.2013.09.011; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Parle M, 2007, YAKUGAKU ZASSHI, V127, P1125, DOI 10.1248/yakushi.127.1125; Pawlak R, 2002, NEUROSCI LETT, V327, P83, DOI 10.1016/S0304-3940(02)00369-5; Pugh CR, 2001, NEUROSCI BIOBEHAV R, V25, P29, DOI 10.1016/S0149-7634(00)00048-8; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Rahola JG, 2012, CURR NEUROPHARMACOL, V10, P139, DOI 10.2174/157015912800604533; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Ruddick Jon P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000068; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sharma S, 2013, INT J OBESITY, V37, P382, DOI 10.1038/ijo.2012.48; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stone TW, 2012, FEBS J, V279, P1386, DOI 10.1111/j.1742-4658.2012.08487.x; Timirci O, 2010, IN VIVO, V24, P65; Valladolid-Acebes I, 2011, NEUROBIOL LEARN MEM, V95, P80, DOI 10.1016/j.nlm.2010.11.007; Vega GL, 2003, ARCH NEUROL-CHICAGO, V60, P510, DOI 10.1001/archneur.60.4.510; Vitkovic L, 2000, MOL PSYCHIATR, V5, P604, DOI 10.1038/sj.mp.4000813; Wang H., 2017, SCI REP, V7; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Q, 2009, EXP NEUROL, V216, P132, DOI 10.1016/j.expneurol.2008.11.016; Wu H., 2017, METAB BRAIN DIS, V3; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu HL, 2018, METAB BRAIN DIS, V33, P177, DOI 10.1007/s11011-017-0140-z; Xiao Wei, 2016, Zhen Ci Yan Jiu, V41, P528; Yamada K, 2003, PSYCHIAT CLIN NEUROS, V57, P183, DOI 10.1046/j.1440-1819.2003.01099.x; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004; Young-Xu Y, 2003, J AM COLL CARDIOL, V42, P690, DOI 10.1016/S0735-1097(03)00785-X	69	14	14	1	104	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	JAN 15	2019	243						83	95		10.1016/j.jad.2018.09.022			13	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	GW4DE	WOS:000446860300012	30236762				2022-02-06	
J	Lim, LJH; Ho, RCM; Ho, CSH				Lim, Lucas J. H.; Ho, Roger C. M.; Ho, Cyrus S. H.			Dangers of Mixed Martial Arts in the Development of Chronic Traumatic Encephalopathy	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						mixed martial arts; chronic traumatic encephalopathy; neuropsychiatric sequelae	BRAIN-INJURY; CONCUSSION; SEVERITY; RISK	Chronic traumatic encephalopathy (CTE) was first discovered in professional boxers after they exhibited memory impairments, mood and behavioral changes after years of boxing. However, there is now a growing acceptance that CTE can develop in athletes of other sports due to the repetitive head trauma they receive. We present a case of a middle-aged male who presented with worsening memory, poor concentration, and behavioral changes for a year. On further cognitive testing, it was revealed that he had difficulties with short-term memory and processing speed as well as difficulties in organizing and multitasking. He had been practicing mixed martial arts (MMA) for 10 years, and later was an instructor of the sport. Through a detailed examination of his history, it was discovered that he sustained recurrent minor head concussions due to his line of work. To date, there has been limited large-scale research on head trauma in MMA. There is thus an urgent need for more studies in this area as CTE can be a chronic and debilitating illness with incapacitating neuropsychiatric sequelae. This case highlights the importance of public awareness of the risks of MMA and the dangers it poses to the brain, especially with more young people being attracted to this sport.	[Lim, Lucas J. H.; Ho, Roger C. M.; Ho, Cyrus S. H.] Natl Univ Singapore, Dept Psychol Med, Yong Loo Lin Sch Med, Singapore 119074, Singapore; [Ho, Roger C. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Biomed Global Inst Healthcare Res & Technol BIGHE, Singapore 117599, Singapore; [Ho, Roger C. M.] NTTU, Ctr Excellence Behav Med, Ho Chi Minh City 70000, Vietnam; [Ho, Roger C. M.] Huaibei Normal Univ, Fac Educ, 100 Dongshan Rd, Huaibei 235000, Peoples R China		Ho, CSH (corresponding author), Natl Univ Singapore, Dept Psychol Med, Yong Loo Lin Sch Med, Singapore 119074, Singapore.	lucas.lim@mohh.com.sg; pcmrhcm@nus.edu.sg; su_hui_ho@nuhs.edu.sg	Ho, Cyrus SH/AAN-9344-2020; Ho, Roger/ABD-8859-2021; Ho, Roger C./ABD-9061-2021	Ho, Cyrus SH/0000-0002-7092-9566; Ho, Roger C./0000-0001-9629-4493			Acabchuk Rebecca, 2016, Concussion, V1, DOI 10.2217/cnc-2015-0001; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belson K., 2017, NY TIMES; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Cantu R., 1995, BOXING AND MED; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Denk W., 1990, Z RECHTSMED, V103, P367; Frey A, 2004, J TRAUMATOLOGIE SPOR, V21, P100, DOI DOI 10.1016/S0762-915X(04)97390-1; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Jawaid MT, 2017, ANN INDIAN ACAD NEUR, V20, P106, DOI 10.4103/0972-2327.205773; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Lystad RP, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518492; Lystad RP, 2013, BRIT J SPORT MED, V47, P441, DOI 10.1136/bjsports-2012-091666; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Garcia RS, 2010, INT REV SOCIOL SPORT, V45, P39, DOI 10.1177/1012690209352392; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	32	14	14	0	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JAN 2	2019	16	2							254	10.3390/ijerph16020254			8	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	HM0CF	WOS:000459112100089	30658408	Green Published, Green Submitted, gold			2022-02-06	
J	Kong, L; Yao, YJ; Xia, Y; Liang, XC; Ni, YN; Yang, JX				Kong, Liang; Yao, Yingjia; Xia, Yang; Liang, Xicai; Ni, Yingnan; Yang, Jingxian			Osthole alleviates inflammation by down-regulating NF-kappa B signaling pathway in traumatic brain injury	IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY			English	Article						Osthole; inflammation; apoptosis; NF-kappa B signaling pathway; traumatic brain injury	NEURAL STEM-CELLS; ISCHEMIA/REPERFUSION INJURY; NEUROINFLAMMATORY RESPONSES; THERAPEUTIC EFFICIENCY; COGNITIVE IMPAIRMENT; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA; APOPTOTIC PATHWAY; UP-REGULATION; RAT MODEL	Traumatic brain injury (TBI) is a common neurotrosis disorder of the central nervous system (CNS), which has dramatic consequences on the integrity of damaged tissue. In this study, we investigated the neuroprotective effect and anti-inflammatory actions of osthole, a natural coumarin derivative, in both in vivo and in vitro TBI models. We first prepared a mouse model of cortical stab wound brain injury, investigated the capacity for osthole to prevent secondary brain injury and further examined the underlying mechanism. We revealed that osthole significantly improved the neurological function, increased the number of neurons beside injured site. Additionally, osthole treatment reduced the expression of microglia and glial scar, lowered the level of the proinflammatory cytokines interleukin (IL)-6, IL-1 beta, and tumor necrosis factor-alpha (TNF-alpha), and blocked the activation of nuclear factor kappa B (NF-kappa B). Furthermore, the protective effect of osthole was also examined in SH-SY5Y cells subjected to scratch injury. Treatment of osthole prominently suppressed cell apoptosis and inflammatory factors release by blocking injury-induced I kappa B-alpha phosphorylation and NF-kappa B translocation, and upregulated the I kappa B-alpha which functions in the NF-kappa B signaling pathway of SH-SY5Y cells. However, NF-kappa B signaling pathway was inhibited by pyrrolidine dithiocarbamate (PDTC), an NF-kappa B inhibitor, the anti-inflammatory effect of osthole was abolished. In conclusion, our findings demonstrated that osthole attenuated inflammatory response by inhibiting the NF-kappa B pathway in TBI.	[Kong, Liang; Yao, Yingjia; Liang, Xicai; Ni, Yingnan; Yang, Jingxian] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Peoples R China; [Xia, Yang] Univ Oxford, Dept Engn, Oxford, England		Yang, JX (corresponding author), Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Peoples R China.	jingxianyang0520@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81173580]	This work was supported by the National Natural Science Foundation of China [Grant No. 81173580].	Casanova F, 2014, J NEUROSCI METH, V237, P79, DOI 10.1016/j.jneumeth.2014.08.012; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Gao YY, 2017, AM J TRANSL RES, V9, P887; Gao Z, 2014, J PHARMACOL SCI, V124, P54, DOI 10.1254/jphs.13144FP; Guan JH, 2017, BIOCHEM CELL BIOL, V95, P459, DOI 10.1139/bcb-2016-0233; Guo KX, 2014, J MOL NEUROSCI, V54, P41, DOI 10.1007/s12031-014-0243-5; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Hashimoto K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27990-1; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; He YL, 2012, BRAIN RES, V1433, P127, DOI 10.1016/j.brainres.2011.11.027; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; Hosseini SM, 2018, BEHAV BRAIN RES, V347, P26, DOI 10.1016/j.bbr.2018.02.045; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jiang Yanfang, 2010, Mediators Inflamm, V2010, P143026, DOI 10.1155/2010/143026; Jiao YN, 2016, NEUROPHARMACOLOGY, V108, P332, DOI 10.1016/j.neuropharm.2016.04.046; Kania J, 2003, ACTA BIOCHIM POL, V50, P659; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kong L, 2015, BIOL PHARM BULL, V38, P1290, DOI 10.1248/bpb.b15-00142; Kwon SH, 2014, NEUROCHEM INT, V74, P53, DOI 10.1016/j.neuint.2014.04.016; Lanosa Ximena A, 2011, Neuron Glia Biol, V7, P163, DOI 10.1017/S1740925X12000099; Lee JY, 2018, ANN RHEUM DIS, V77, P1480, DOI 10.1136/annrheumdis-2018-213444; Li DJ, 2017, METABOLISM, V68, P31, DOI 10.1016/j.metabol.2016.12.003; Li HL, 2012, MOL MED REP, V6, P774, DOI 10.3892/mmr.2012.1010; Li K, 2016, BIOL PHARM BULL, V39, P336, DOI 10.1248/bpb.b15-00699; Li SH, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00340; Li SH, 2016, J MOL NEUROSCI, V60, P71, DOI 10.1007/s12031-016-0793-9; Li Y, 2017, BIOMED PHARMACOTHER, V85, P177, DOI 10.1016/j.biopha.2016.11.136; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Ma YB, 2017, MOL NEUROBIOL, V54, P3717, DOI 10.1007/s12035-016-9939-6; Mao XX, 2011, BRAIN RES, V1385, P275, DOI 10.1016/j.brainres.2011.02.015; Niu YL, 2018, AM J TRANSL RES, V10, P753; Shao AW, 2016, MOL NEUROBIOL, V53, P18, DOI 10.1007/s12035-014-8986-0; Singh G, 2019, INFLAMMOPHARMACOLOGY, V27, P949, DOI 10.1007/s10787-018-0486-9; Song J, 2016, J MOL NEUROSCI, V60, P115, DOI 10.1007/s12031-016-0784-x; Takarada-Iemata M, 2014, J NEUROCHEM, V130, P374, DOI 10.1111/jnc.12729; Tang C, 2017, STEM CELLS INT, V2017, P1; Tang R, 2018, INT J BIOCHEM CELL B, V99, P64, DOI 10.1016/j.biocel.2018.03.017; Tao XG, 2017, CHINESE MED J-PEKING, V130, P187, DOI 10.4103/0366-6999.198001; Tao ZY, 2017, BIOL PHARM BULL, V40, P1043, DOI 10.1248/bpb.b17-00072; Villapol S, 2013, EXP NEUROL, V250, P353, DOI 10.1016/j.expneurol.2013.10.008; Wang QQ, 2018, CELL PHYSIOL BIOCHEM, V48, P42, DOI 10.1159/000491661; Wang QX, 2014, TOXICOL IN VITRO, V28, P1183, DOI 10.1016/j.tiv.2014.05.006; Wang X, 2018, AM J TRANSL RES, V10, P368; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wei CC, 2017, BRIT J PHARMACOL, V174, P3823, DOI 10.1111/bph.13979; Wu JG, 2018, AM J TRANSL RES, V10, P1109; Xia Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0373-x; Xu H, 2017, EVID-BASED COMPL ALT, V2017, P1, DOI DOI 10.1109/INF0C0M.2017.8056992; Yan YH, 2017, NEUROCHEM RES, V42, P398, DOI 10.1007/s11064-016-2082-y; Yan YH, 2018, BRAIN BEHAV IMMUN, V67, P118, DOI 10.1016/j.bbi.2017.08.011; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Yao YJ, 2015, TOXICOL APPL PHARM, V289, P474, DOI 10.1016/j.taap.2015.10.013; Zhang L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00263; Zhang MK, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0358-z; Zhang X, 2017, INT IMMUNOPHARMACOL, V50, P38, DOI 10.1016/j.intimp.2017.06.007; Zhao H, 2018, MOL NEUROBIOL, V55, P4311, DOI 10.1007/s12035-017-0552-0; Zhao YY, 2017, NEUROCHEM INT, V111, P82, DOI 10.1016/j.neuint.2017.03.017; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	63	14	14	4	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0892-3973	1532-2513		IMMUNOPHARM IMMUNOT	Immunopharmacol. Immunotoxicol.		2019	41	2					349	360		10.1080/08923973.2019.1608560			12	Immunology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy; Toxicology	KG4ZD	WOS:000509955800022	31056982				2022-02-06	
J	Martin-Jimenez, C; Gaitan-Vaca, DM; Areiza, N; Echeverria, V; Ashraf, GM; Gonzalez, J; Sahebkar, A; Garcia-Segura, LM; Barreto, GE				Martin-Jimenez, Cynthia; Milena Gaitan-Vaca, Diana; Areiza, Natalia; Echeverria, Valentina; Ashraf, Ghulam Md; Gonzalez, Janneth; Sahebkar, Amirhossein; Miguel Garcia-Segura, Luis; Barreto, George E.			Astrocytes Mediate Protective Actions of Estrogenic Compounds after Traumatic Brain Injury	NEUROENDOCRINOLOGY			English	Article						Astrocytes; Neuroprotection; Estrogenic compounds; Traumatic brain injury	SPINAL-CORD-INJURY; RECEPTOR MODULATORS SERMS; CENTRAL-NERVOUS-SYSTEM; INDUCED UP-REGULATION; GLUTAMATE TRANSPORTER EXPRESSION; HORMONE-REPLACEMENT THERAPY; CEREBRAL-ARTERY OCCLUSION; ALPHA ER-ALPHA; SELECTIVE ESTROGEN; REACTIVE ASTROCYTES	Traumatic brain injury (TBI) is a serious public health problem. It may result in severe neurological disabilities and in a variety of cellular metabolic alterations for which available therapeutic strategies are limited. In the last decade, the use of estrogenic compounds, which activate protective mechanisms in astrocytes, has been explored as a potential experimental therapeutic approach. Previous works have suggested estradiol (E2) as a neuroprotective hormone that acts in the brain by binding to estrogen receptors (ERs). Several steroidal and nonsteroidal estrogenic compounds can imitate the effects of estradiol on ERs. These include hormonal estrogens, phytoestrogens and synthetic estrogens, such as selective ER modulators or tibolone. Current evidence of the role of astrocytes in mediating protective actions of estrogenic compounds after TBI is reviewed in this paper. We conclude that the use of estrogenic compounds to modulate astrocytic properties is a promising therapeutic approach for the treatment of TBI. (c) 2018 S. Karger AG, Basel	[Martin-Jimenez, Cynthia; Milena Gaitan-Vaca, Diana; Areiza, Natalia; Gonzalez, Janneth; Barreto, George E.] Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Cra 7 40-62, Bogota, DC, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Cs Salud, Concepcion, Chile; [Echeverria, Valentina] Bay Pines VA Healthcare Syst, Res & Dev Serv, Bay Pines, FL USA; [Ashraf, Ghulam Md] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah, Saudi Arabia; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran; [Sahebkar, Amirhossein] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran; [Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, Madrid, Spain; [Miguel Garcia-Segura, Luis] Inst Salud Carlos III, CIBERFES, Madrid, Spain		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Dept Nutr & Bioquim, Fac Ciencias, Cra 7 40-62, Bogota, DC, Colombia.; Garcia-Segura, LM (corresponding author), CSIC, Inst Cajal, Madrid, Spain.	lmgs@cajal.csic.es; gsampaio@javeriana.edu.co	Sahebkar, Amirhossein/B-5124-2018; martin, cynthia/AAC-6016-2021; Valentina Echeverria Moran, BCh/E-7765-2013; Ashraf, Ghulam Md/H-9485-2012; GONZALEZ, JANNETH/AAB-9948-2020; Garcia-Segura, Luis M/U-3711-2017; Barreto, George E./AAD-7420-2020	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Ashraf, Ghulam Md/0000-0002-9820-2078; GONZALEZ, JANNETH/0000-0003-2009-3374; Garcia-Segura, Luis M/0000-0002-2450-2916; Barreto, George E./0000-0002-6644-1971; Gonzalez, Janneth/0000-0003-4482-256X	Colciencias grantDepartamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias [824-2017]	This work is in part funded by Colciencias grant (Contract No. 824-2017) to G.E.B.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Acaz-Fonseca E, 2014, MOL CELL ENDOCRINOL, V389, P48, DOI 10.1016/j.mce.2014.01.009; Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012; Posada-Duque RA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00231; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; Aoki E, 2009, EXP MOL PATHOL, V86, P57, DOI 10.1016/j.yexmp.2008.10.004; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Arimoto JM, 2013, ENDOCRINOLOGY, V154, P2101, DOI 10.1210/en.2012-2046; Aschner M, 2000, NEUROTOXICOLOGY, V21, P1101; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Azcoitia I, 1998, NEUROREPORT, V9, P3075, DOI 10.1097/00001756-199809140-00029; Azcoitia I, 1999, J NEUROSCI RES, V58, P815, DOI 10.1002/(SICI)1097-4547(19991215)58:6<815::AID-JNR8>3.0.CO;2-R; Azcoitia I, 1999, GLIA, V26, P260; Azcoitia I, 1999, J NEUROCYTOL, V28, P699, DOI 10.1023/A:1007025219044; Azcoitia I, 2006, GYNECOL ENDOCRINOL, V22, P63, DOI 10.1080/09513590500519161; Bagheri M, 2012, BRAIN RES, V1429, P145, DOI 10.1016/j.brainres.2011.10.020; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Blurton-Jones M, 2001, J COMP NEUROL, V433, P115, DOI 10.1002/cne.1129; Bolborea M, 2013, TRENDS NEUROSCI, V36, P91, DOI 10.1016/j.tins.2012.12.008; Born G, 1999, ESTROGENS ANTIESTROG, V135; Bourque M, 2012, FRONT NEUROENDOCRIN, V33, P169, DOI 10.1016/j.yfrne.2012.02.003; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Braissant O, 2013, J INHERIT METAB DIS, V36, P595, DOI 10.1007/s10545-012-9546-2; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Brambilla R, 2009, J NEUROCHEM, V110, P765, DOI 10.1111/j.1471-4159.2009.06190.x; Brinton RD, 2004, J ALZHEIMERS DIS, V6, pS27; Brinton RD, 2002, DRUG DEVELOP RES, V56, P380, DOI 10.1002/ddr.10090; Buchanan CD, 2000, BIOL REPROD, V62, P1710, DOI 10.1095/biolreprod62.6.1710; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Cerciat M, 2010, GLIA, V58, P93, DOI 10.1002/glia.20904; Chandra K., 2015, INT J PHYTOPHARMACOL, V7, P383; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Ciriza I, 2004, J NEUROBIOL, V61, P209, DOI 10.1002/neu.20043; Colangelo AM, 2014, NEUROSCI LETT, V565, P59, DOI 10.1016/j.neulet.2014.01.014; Colodner KJ, 2005, J NEUROPATH EXP NEUR, V64, P163, DOI 10.1093/jnen/64.2.163; Colon JM, 2018, EXP NEUROL, V299, P109, DOI 10.1016/j.expneurol.2017.10.006; Cook LG, 2008, NEUROREHABILITATION, V23, P467; Crespo-Castrillo A, 2018, MOL NEUROBIOL, V55, P8651, DOI 10.1007/s12035-018-1008-x; Cvejic J., 2012, STUDIES NATURAL PROD, V38, P1; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Dehghan Fatemeh, 2015, Iranian Biomedical Journal, V19, P165, DOI 10.7508/ibj.2015.03.006; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Dhandapani KM, 2003, ENDOCRINE, V21, P59, DOI 10.1385/ENDO:21:1:59; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Donahue JE, 2000, BRAIN RES, V856, P142, DOI 10.1016/S0006-8993(99)02413-0; DonCarlos Lydia L, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS113, DOI 10.1016/j.psyneuen.2009.04.012; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; dos Santos AQ, 2006, ARCH BIOCHEM BIOPHYS, V453, P161, DOI 10.1016/j.abb.2006.06.025; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Duncan SR, 2018, ESTROGEN EFFECTS TRA; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; Escobedo LVS, 2013, WORLD J EMERG MED, V4, P252, DOI [10.5847/wjem.j.issn.1920-8642.2013.04.002, 10.5847/wjem.j.1920-8642.2013.04.002]; Espinosa-Raya J, 2012, HORM BEHAV, V61, P76, DOI 10.1016/j.yhbeh.2011.10.005; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Figiel M, 2003, EXP NEUROL, V183, P124, DOI 10.1016/S0014-4886(03)00134-1; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Fluck E, 2002, J CLIN PSYCHOPHARM, V22, P62, DOI 10.1097/00004714-200202000-00010; Rodriguez NEF, 2013, BRAIN RES BULL, V98, P64, DOI 10.1016/j.brainresbull.2013.07.007; Fuente-Martin E, 2013, REV ENDOCR METAB DIS, V14, P331, DOI 10.1007/s11154-013-9263-7; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Garcia-Segura LM, 2006, GLIA, V54, P485, DOI 10.1002/glia.20404; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Gavillet M, 2008, GLIA, V56, P975, DOI 10.1002/glia.20671; Gee JR, 2005, INT J BIOCHEM CELL B, V37, P1145, DOI 10.1016/j.biocel.2004.10.004; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; Goldstein JS, 2002, AGEING RES REV, V1, P17, DOI 10.1016/S0047-6374(01)00367-0; Gonzalez-Giraldo Y, 2018, MOL NEUROBIOL, V55, P4453, DOI 10.1007/s12035-017-0667-3; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Guo JB, 2012, FREE RADICAL BIO MED, V52, P2151, DOI 10.1016/j.freeradbiomed.2012.03.005; Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Horner PJ, 2000, J NEUROSCI, V20, P2218; Hosli E, 2000, INT J DEV NEUROSCI, V18, P101, DOI 10.1016/S0736-5748(99)00074-X; Hung KL, 2011, NEUROPHARMACOLOGY, V61, P293, DOI 10.1016/j.neuropharm.2011.04.016; Iglesias J, 2017, MOL NEUROBIOL, V54, P2518, DOI 10.1007/s12035-016-9833-2; Ismailoglu O, 2013, AM J MED SCI, V345, P39, DOI 10.1097/MAJ.0b013e3182522651; Jakab RL, 2001, J COMP NEUROL, V430, P396, DOI 10.1002/1096-9861(20010212)430:3<396::AID-CNE1039>3.0.CO;2-0; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Karki P, 2014, GLIA, V62, P1270, DOI 10.1002/glia.22679; Karki P, 2013, J BIOL CHEM, V288, P28975, DOI 10.1074/jbc.M113.483826; Khaksari M, 2015, BRAIN RES, V1618, P1, DOI 10.1016/j.brainres.2015.05.017; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Khan MM, 2015, J STEROID BIOCHEM, V146, P38, DOI 10.1016/j.jsbmb.2014.05.001; Kim JV, 2006, J IMMUNOL, V177, P5269, DOI 10.4049/jimmunol.177.8.5269; Kim JH, 2014, ENDOCR J, V61, P1055, DOI 10.1507/endocrj.EJ14-0262; Kimelberg HK, 2003, J NEUROSURG, V99, P138, DOI 10.3171/jns.2003.99.1.0138; Klinge CM, 2017, J BIOENERG BIOMEMBR, V49, P307, DOI 10.1007/s10863-017-9704-1; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Kubik LL, 2015, TOXICOL SCI, V144, P7, DOI 10.1093/toxsci/kfu254; LANGUB MC, 1992, ENDOCRINOLOGY, V130, P364, DOI 10.1210/en.130.1.364; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Levi G, 1983, Brain Res, V312, P227; Levison SW, 2000, GLIA, V32, P328, DOI 10.1002/1098-1136(200012)32:3<328::AID-GLIA110>3.0.CO;2-7; Li LB, 2006, J NEUROCHEM, V97, P759, DOI 10.1111/j.1471-4159.2006.03743.x; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Littleton-Kearney MT, 2002, CNS DRUG REV, V8, P309; Liu MH, 2009, NUTR NEUROSCI, V12, P123, DOI 10.1179/147683009X423274; Liu RZ, 2017, INT J MOL MED, V39, P1021, DOI 10.3892/ijmm.2017.2915; Lopez M, 2015, TRENDS ENDOCRIN MET, V26, P411, DOI 10.1016/j.tem.2015.06.003; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; Lu H, 2009, J NEUROL SCI, V278, P91, DOI 10.1016/j.jns.2008.12.007; Ma WW, 2013, NEUROCHEM RES, V38, P1315, DOI 10.1007/s11064-013-1019-y; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Maximov PY, 2013, CURR CLIN PHARMACOL, V8, P135, DOI 10.2174/1574884711308020006; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Mehta SH, 2003, NEUROENDOCRINOLOGY, V77, P44, DOI 10.1159/000068332; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Micevych P, 2010, NEUROENDOCRINOLOGY, V91, P211, DOI 10.1159/000289568; Mickley KR, 2004, NEUROENDOCRINOLOGY, V79, P305, DOI 10.1159/000079710; Milner TA, 2001, J COMP NEUROL, V429, P355; Mirkin S, 2015, MATURITAS, V80, P52, DOI 10.1016/j.maturitas.2014.10.010; Molaie AM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00176; MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201; Moreira AC, 2014, J STEROID BIOCHEM, V143, P61, DOI 10.1016/j.jsbmb.2014.01.016; Moreira PI, 2011, J STEROID BIOCHEM, V123, P8, DOI 10.1016/j.jsbmb.2010.09.004; Moreira PI, 2005, NEUROPHARMACOLOGY, V48, P435, DOI 10.1016/j.neuropharm.2004.10.012; Moreira PI, 2004, BIOCHEM PHARMACOL, V68, P195, DOI 10.1016/j.bcp.2004.03.019; Morissette M, 2008, MOL CELL ENDOCRINOL, V290, P60, DOI 10.1016/j.mce.2008.04.008; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; MUCKE L, 1993, FASEB J, V7, P1226, DOI 10.1096/fasebj.7.13.8405808; Mullier A, 2010, J COMP NEUROL, V518, P943, DOI 10.1002/cne.22273; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Navarrete M, 2011, CELL, V146, P675, DOI 10.1016/j.cell.2011.08.006; Neary JT, 2009, TRENDS NEUROSCI, V32, P189, DOI 10.1016/j.tins.2009.01.002; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Ohab JJ, 2008, NEUROSCIENTIST, V14, P369, DOI 10.1177/1073858407309545; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; Osterstock G, 2014, ENDOCRINOLOGY, V155, P1887, DOI 10.1210/en.2013-1336; Paintlia MK, 2013, J BIOL CHEM, V288, P3831, DOI 10.1074/jbc.M112.405654; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Paterni I, 2014, STEROIDS, V90, P13, DOI 10.1016/j.steroids.2014.06.012; Pawlak J, 2005, GLIA, V50, P270, DOI 10.1002/glia.20162; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez-Alvarez A, 2013, CURR DRUG TARGETS, V14, P1220; Persichini T, 2010, NEUROSCI LETT, V470, P145, DOI 10.1016/j.neulet.2009.12.074; Picazo O, 2003, BRAIN RES, V990, P20, DOI 10.1016/S0006-8993(03)03380-8; Picazo O, 2010, CELL MOL NEUROBIOL, V30, P675, DOI 10.1007/s10571-009-9490-3; Pinkerton JV, 2014, J STEROID BIOCHEM, V142, P142, DOI 10.1016/j.jsbmb.2013.12.011; Pinto-Almazan R, 2014, REV NEUROLOGIA, V58, P441, DOI 10.33588/rn.5810.2013357; Prevot V, 2018, ENDOCR REV, V39, P333, DOI 10.1210/er.2017-00235; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qin HW, 2008, J IMMUNOL, V181, P3167, DOI 10.4049/jimmunol.181.5.3167; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Rossberg MI, 2000, STROKE, V31, P3041, DOI 10.1161/01.STR.31.12.3041; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rzemieniec J, 2015, J STEROID BIOCHEM, V146, P26, DOI 10.1016/j.jsbmb.2014.05.005; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SANTAGATI S, 1994, J NEUROCHEM, V63, P2058; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303; de Medeiros ARS, 2012, REGUL PEPTIDES, V179, P55, DOI 10.1016/j.regpep.2012.08.015; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sato K, 2008, J PHARMACOL SCI, V107, P226, DOI 10.1254/jphs.08039SC; Savaskan E, 2001, BRAIN RES, V908, P113, DOI 10.1016/S0006-8993(01)02610-5; Shi RF, 2014, NEUROCHEM INT, V65, P14, DOI 10.1016/j.neuint.2013.12.002; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Shy H, 2000, INT J DEV NEUROSCI, V18, P289, DOI 10.1016/S0736-5748(99)00097-0; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simpkins JW, 2008, MOL CELL ENDOCRINOL, V290, P51, DOI 10.1016/j.mce.2008.04.013; Simpkins JW, 2008, BRAIN RES REV, V57, P421, DOI 10.1016/j.brainresrev.2007.04.007; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Sirotkin AV, 2014, EUR J PHARMACOL, V741, P230, DOI 10.1016/j.ejphar.2014.07.057; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Stanikova D, 2018, PSYCHONEUROENDOCRINO, V87, P196, DOI 10.1016/j.psyneuen.2017.10.025; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Streit WJ, 2000, J NEUROSCI RES, V61, P10, DOI 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E; Suzumura A, 2013, CURR PROTEIN PEPT SC, V14, P16, DOI 10.2174/1389203711314010004; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Thiede A, 2012, BBA-BIOENERGETICS, V1817, P1747, DOI 10.1016/j.bbabio.2012.02.034; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Tian DS, 2009, J NEUROCHEM, V109, P1658, DOI 10.1111/j.1471-4159.2009.06077.x; Toklu H.Z., 2015, BRAIN NEUROTRAUMA MO; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Verderame M, 2018, STEROIDS, V134, P1, DOI 10.1016/j.steroids.2018.04.001; Verheul HAM, 2006, J STEROID BIOCHEM, V102, P195, DOI 10.1016/j.jsbmb.2006.09.037; Verkhratsky A, 2013, GLIAL PHYSL PATHOPHY, DOI [10.1002/9781118402061, DOI 10.1002/9781118402061]; de Almeida LMV, 2007, CELL MOL NEUROBIOL, V27, P661, DOI 10.1007/s10571-007-9152-2; Volterra A, 2004, GLIA, V47, P249, DOI 10.1002/glia.20080; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Vuceljic Marina, 2006, Vojnosanit Pregl, V63, P545, DOI 10.2298/VSP0606545V; Wang H, 2005, FREE RADICAL BIO MED, V38, P1112, DOI 10.1016/j.freeradbiomed.2005.01.010; Wang YP, 2014, J FORMOS MED ASSOC, V113, P155, DOI 10.1016/j.jfma.2012.04.003; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wicher G, 2015, J STEROID BIOCHEM, V145, P21, DOI 10.1016/j.jsbmb.2014.09.022; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang L, 2002, MOL BRAIN RES, V103, P1; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7; Zhao LQ, 2006, J PHARMACOL EXP THER, V319, P1124, DOI 10.1124/jpet.106.109504; Zhao LQ, 2005, BRAIN RES REV, V49, P472, DOI 10.1016/j.brainresrev.2005.01.009; Zhou WX, 2002, NEUROENDOCRINOLOGY, V75, P24, DOI 10.1159/000048218; Zhou XM, 2014, J SURG RES, V189, P159, DOI 10.1016/j.jss.2014.01.062; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980; [No title captured]	272	14	15	1	10	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-3835	1423-0194		NEUROENDOCRINOLOGY	Neuroendocrinology		2019	108	2					142	160		10.1159/000495078			19	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	HO5PL	WOS:000460980100007	30391959	Bronze			2022-02-06	
J	Mountjoy, M; Miller, J; Junge, A				Mountjoy, Margo; Miller, Jim; Junge, Astrid			Analysis of water polo injuries during 8904 player matches at FINA World Championships and Olympic games to make the sport safer	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						water polo; aquatic sports; sports injury; injury prevention; top-level athletes	RISK; SURVEILLANCE; METHODOLOGY; ILLNESSES; PAIN	Objective To analyse injuries of water polo players reported during four Summer Olympic Games (2004, 2008, 2012, 2016) and four Federation Internationale de Natation World Championships (2009, 2013, 2015, 2017). Methods Injuries during training and matches were reported daily by the team physicians and the local medical staff at the sports venues using an established surveillance system. Results A total of 381 injuries were reported, equivalent to 14.1 injuries per 100 players (95% CI +/- 1.42). The most frequent diagnoses were laceration (12.7%) and contusion (10.9%) of head, followed by (sub-)luxation/sprain of hand (9.5%) and contusion of trunk (6.5%) or hand (6.2%). More than half of the injuries (57.0%) occurred due to contact with another player. A quarter of the injuries (25.4%) were expected to result in absence from training or match; 10 (2.9%) resulted in an estimated time-loss of 3 or more weeks. About three-quarters of injuries (75.6%) occurred during matches, 86 during training. The incidence of match injuries was on average 56.2 injuries per 1000 match hours (95% CI +/- 6.74). The incidence of time-loss match injuries (14.7; 95% CI +/- 3.44) was significantly higher in men than in women. Conclusions A critical review of water polo in-competition rules and the implementation of a Fair Play programme may help to mitigate the high incidence of contact injuries incurred during matches. A water polo-specific concussion education programme including recognition, treatment and return to play is recommended. Finally, a prospective injury surveillance programme would help to better define water polo injuries outside of the competition period.	[Mountjoy, Margo] McMaster Univ Hamilton, Hamilton, ON, Canada; [Mountjoy, Margo; Miller, Jim] Federat Int Natat FINA, Lausanne, Switzerland; [Mountjoy, Margo] IOC, Games Grp Lausanne, Lausanne, Switzerland; [Miller, Jim] Univ Virginia, Dept Med, Charlottesville, VA USA; [Miller, Jim] Virginia Commonwealth Univ, Richmond, VA USA; [Junge, Astrid] Med Sch Hamburg, Hamburg, Germany; [Junge, Astrid] Schulthess Clin, Swiss Concuss Ctr, Zurich, Switzerland		Mountjoy, M (corresponding author), McMaster Med Sch, Kitchener, ON N2G 1C5, Canada.	mmsportdoc@mcmaster.ca		Junge, Astrid/0000-0002-6815-9793	International Olympic Committee (IOC); Federation Internationale de Natation (FINA), Lausanne, Switzerland	The data collection was funded by the International Olympic Committee (IOC) and the Federation Internationale de Natation (FINA), Lausanne, Switzerland. No funding was received for the present study.	Annett P., 2000, NZ J SPORTS MED, V28, P78; Bahr R, 2009, BRIT J SPORT MED, V43, P966, DOI 10.1136/bjsm.2009.066936; Bell L., 2014, SELF REPORTED CONCUS; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Brooks JM, 1999, CLIN SPORT MED, V18, P313, DOI 10.1016/S0278-5919(05)70147-2; Colville JM, 1999, CLIN SPORT MED, V18, P305, DOI 10.1016/S0278-5919(05)70146-0; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; FINA, FINA AQ BRIEF HIST; FINA, FINA WAT POL RUL 201; FINA, FINA WAT POL HIST OR; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Franic M, 2007, CROAT MED J, V48, P281; Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001; Fuller CW, 2007, CLIN J SPORT MED, V17, P182, DOI 10.1097/JSM.0b013e31805930b0; Hersberger S, 2012, DENT TRAUMATOL, V28, P287, DOI 10.1111/j.1600-9657.2011.01083.x; IOC, OL MOV MED COD; IOC, OL CHART; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Miller AH, 2018, J SCI MED SPORT, V21, P368, DOI 10.1016/j.jsams.2017.08.015; Mountjoy M, 2016, BRIT J SPORT MED, V50, P590, DOI 10.1136/bjsports-2015-095686; Mountjoy M, 2015, BRIT J SPORT MED, V49, P37, DOI 10.1136/bjsports-2014-093991; Mountjoy M, 2010, BRIT J SPORT MED, V44, P522, DOI 10.1136/bjsm.2010.071720; National Hockey League, 2018, CONC EV MAN PROT; Prien Annika, 2017, Br J Sports Med, V51, P277, DOI 10.1136/bjsports-2016-096075; Rogge J, 2009, BRIT J SPORT MED, V43, P627, DOI 10.1136/bjsm.2009.062802; Sallis RE, 2001, INT J SPORTS MED, V22, P420, DOI 10.1055/s-2001-16246; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; Spittler J, 2016, CURR SPORT MED REP, V15, P410, DOI 10.1249/JSR.0000000000000305; Steffen K, 2012, BRIT J SPORT MED, V46, P466, DOI 10.1136/bjsports-2012-091168; Stromberg JD, 2017, CURR SPORT MED REP, V16, P363, DOI 10.1249/JSR.0000000000000409; Webster MJ, 2009, J SCI MED SPORT, V12, P3, DOI 10.1016/j.jsams.2007.05.014; Wheeler K, 2013, J SCI MED SPORT, V16, P255, DOI 10.1016/j.jsams.2012.06.006	35	14	15	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2019	53	1					25	31		10.1136/bjsports-2018-099349			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HG8EL	WOS:000455231200011	30194222				2022-02-06	
J	Mundim, MV; Zamproni, LN; Pinto, AAS; Galindo, LT; Xavier, AM; Glezer, I; Porcionatto, M				Mundim, Mayara Vieira; Zamproni, Laura Nicoleti; Sardinha Pinto, Agnes Araujo; Galindo, Layla Testa; Xavier, Andre Machado; Glezer, Isaias; Porcionatto, Marimelia			A new function for Prokineticin 2: Recruitment of SVZ-derived neuroblasts to the injured cortex in a mouse model of traumatic brain injury	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Cortical injury; Prokineticin 2; Subventricular zone; Neural stem cells; Neurogenesis; Brain repair	SUBVENTRICULAR ZONE; CELL PROLIFERATION; CEREBRAL-CORTEX; NEUROGENESIS; MIGRATION; IDENTIFICATION; RECEPTORS; BV8	Traumatic brain injury is an important cause of global morbidity and mortality. After an initial injury, there is a cascade of cellular and molecular events that ultimately lead to cell death. Therapies aim to both counteract these mechanisms and replenish the lost cell population in order to improve recovery. The adult mammal brain has at least two neurogenic regions that maintain physiological functions: the subgranular zone of the dentate gyrus in the hippocampus, which produces neurons that integrate locally, and the subventricular zone (SVZ) adjacent to the lateral ventricles, which produces neuroblasts that migrate through the rostral migratory stream (RMS) to the olfactory bulbs. Brain injuries, as well as neurodegenerative diseases, induce the SVZ to respond by increasing cell proliferation and migration to the injured areas. Here we report that cells migrate from the SVZ and RMS to the injured cortex after traumatic brain injury in mice, and that the physiological RMS migration is not impaired. We also show that Prokineticin 2 (PROK2), a chemokine important for the olfactory bulb neurogenesis, expressed exclusively by cortical microglia in the cortex as early as 24 h after injury. We then show that administration of a PROK2 receptor antagonist decreases the number of SVZ cells that reach the injured cortex, while injection of recombinant PROK2 into the cortex of uninjured mice attracts SVZ cells. We also demonstrate that cells expressing PROK2 in vitro directionally attract SVZ cells. These data suggest that PROK2 could be utilized in regeneration efforts for the acutely injured mammalian cortex.	[Mundim, Mayara Vieira; Zamproni, Laura Nicoleti; Sardinha Pinto, Agnes Araujo; Galindo, Layla Testa; Porcionatto, Marimelia] Univ Fed Sao Paulo, Escola Paulista Med, Lab Neurobiol, Dept Biochem, Rua Pedro de Toledo 669,3o Andar, BR-04039032 Sao Paulo, SP, Brazil; [Xavier, Andre Machado; Glezer, Isaias] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biochem, Rua 3 Maio 100,4o Andar, BR-04044020 Sao Paulo, SP, Brazil		Porcionatto, M (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Lab Neurobiol, Rua Pedro de Toledo 669,3o Andar, BR-04039032 Sao Paulo, SP, Brazil.	marimelia.porcionatto@unifesp.br	Mundim, Mayara V/N-9985-2015; Porcionatto, Marimelia/C-3322-2012; zamproni, laura/AAC-7271-2019; Araujo Sardinha Pinto, Agnes/ABB-4851-2021; Glezer, Isaias/D-2867-2013	Porcionatto, Marimelia/0000-0001-6287-916X; zamproni, laura/0000-0003-2219-6676; Araujo Sardinha Pinto, Agnes/0000-0002-5895-7353; Mundim, Mayara/0000-0002-9771-977X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/00652-5, 2012/06810-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [404646/2012-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (Institutos Nacionais de Ciencia e Tecnologia)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [INCT-Regenera 465656/2014-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]	Financial Support: This work was granted by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP (Research Grants 2012/00652-5; 2012/06810-1), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (Research Grant 404646/2012-3; Institutos Nacionais de Ciencia e Tecnologia, INCT-Regenera 465656/2014-5), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. We thank Dr. James Hillis for the helpful comments.	Abou-Hamdan M, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000095; ALTMAN J, 1963, ANAT REC, V145, P573, DOI 10.1002/ar.1091450409; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Cheng MY, 2006, J COMP NEUROL, V498, P796, DOI 10.1002/cne.21087; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Curtis VF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054916; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dizon M, 2010, DEV NEUROSCI-BASEL, V32, P173, DOI 10.1159/000313468; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Filippo TRM, 2013, STEM CELL RES, V11, P913, DOI 10.1016/j.scr.2013.06.003; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galgano M., 2016, CELL TRANSPLANT, DOI [10.3727/096368916X693806, DOI 10.3727/096368916X693806]; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Giannini E, 2009, P NATL ACAD SCI USA, V106, P14646, DOI 10.1073/pnas.0903720106; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Gordon R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12932; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Lattanzi R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/301292; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maldonado-Perez D, 2007, TRENDS ENDOCRIN MET, V18, P66, DOI 10.1016/j.tem.2006.12.002; Ng KL, 2005, SCIENCE, V308, P1923, DOI 10.1126/science.1112103; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Park D, 2012, CELL TRANSPLANT, V21, P365, DOI 10.3727/096368911X586765; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Radomski KL, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-142; Reis C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6392592; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Severini C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15301; Shimada IS, 2010, STROKE, V41, pE552, DOI 10.1161/STROKEAHA.110.589010; Sun D, 2011, J NEUROTRAUM, V28, P961, DOI 10.1089/neu.2010.1697; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Zhou WB, 2012, REGUL PEPTIDES, V179, P84, DOI 10.1016/j.regpep.2012.08.003	46	14	14	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	JAN	2019	94						1	10		10.1016/j.mcn.2018.10.004			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HJ1BV	WOS:000456897800001	30391355	Green Submitted			2022-02-06	
J	Piao, CS; Holloway, AL; Hong-Routson, S; Wainwright, MS				Piao, Chun-Shu; Holloway, Ashley L.; Hong-Routson, Sue; Wainwright, Mark S.			Depression following traumatic brain injury in mice is associated with down-regulation of hippocampal astrocyte glutamate transporters by thrombin	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Astrocyte; depression; glutamate transporter; thrombin; traumatic brain injury	PROTEASE-ACTIVATED RECEPTORS; TAIL SUSPENSION TEST; BARRIER BREAKDOWN; MAJOR DEPRESSION; EXPRESSION; INHIBITION; STRESS; MODEL; SUSCEPTIBILITY; TRANSMISSION	Depression after traumatic brain injury (TBI) is common but the mechanisms by which TBI causes depression are unknown. TBI decreases glutamate transporters GLT-1 and GLAST and allows extravasation of thrombin. We examined the effects of thrombin on transporter expression in primary hippocampal astrocytes. Application of a PAR-1 agonist caused down-regulation of GLT-1, which was prevented by inhibition of Rho kinase (ROCK). To confirm these mechanisms in vivo, we subjected mice to closed-skull TBI. Thrombin activity in the hippocampus increased one day following TBI. Seven days following TBI, expression of GLT-1 and GLAST was reduced in the hippocampus, and this was prevented by administration of the PAR-1 antagonist SCH79797. Inhibition of ROCK attenuated the decrease in GLT-1, but not GLAST, after TBI. We measured changes in glutamate levels in the hippocampus seven days after TBI using an implanted biosensor. Stress-induced glutamate levels were significantly increased following TBI and this was attenuated by treatment with the ROCK inhibitor fasudil. We quantified depressive behavior following TBI and found that inhibition of PAR-1 or ROCK decreased these behaviors. These results identify a novel mechanism by which TBI results in down-regulation of astrocyte glutamate transporters and implicate astrocyte and glutamate transporter dysfunction in depression following TBI.	[Piao, Chun-Shu; Holloway, Ashley L.; Hong-Routson, Sue; Wainwright, Mark S.] Northwestern Univ, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Feinberg Sch Med, Chicago, IL 60611 USA; [Piao, Chun-Shu; Holloway, Ashley L.; Hong-Routson, Sue; Wainwright, Mark S.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Sch Med, Div Neurol, Chicago, IL 60611 USA; [Hong-Routson, Sue; Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Div Crit Care, Chicago, IL 60611 USA		Wainwright, MS (corresponding author), Seattle Childrens Hosp, Div Neurol, MB 7-460,4800 Sand Point Way NE, Seattle, WA 98105 USA.	mwa110@uw.edu		Wainwright, Mark/0000-0002-4736-7462; Holloway, Ashley/0000-0003-2089-4665	Ruth D. & Ken M Davee Pediatric Neurocritical Care Program; Lyndsey Whittingham Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: These studies were funded by the Ruth D. & Ken M Davee Pediatric Neurocritical Care Program and by the Lyndsey Whittingham Foundation.	Altamura C, 1995, EUR NEUROPSYCHOPHARM, V5, P71, DOI 10.1016/0924-977X(95)00033-L; Anderson CM, 2000, GLIA, V32, P1; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Barzo P, 1997, ACT NEUR S, V70, P243; Bechtholt-Gompf AJ, 2010, NEUROPSYCHOPHARMACOL, V35, P2049, DOI 10.1038/npp.2010.74; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bye N, 2016, EXP NEUROL, V279, P86, DOI 10.1016/j.expneurol.2016.02.012; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Faul M, 2010, TRAUMATIC BRAIN INJU; Friedman A, 2009, EPILEPSY RES, V85, P142, DOI 10.1016/j.eplepsyres.2009.03.005; Ghasemi M, 2009, PSYCHOPHARMACOLOGY, V206, P325, DOI 10.1007/s00213-009-1609-1; Gibson CL, 2014, J NEUROCHEM, V129, P816, DOI 10.1111/jnc.12681; Gomez-Galan M, 2013, MOL PSYCHIATR, V18, P582, DOI 10.1038/mp.2012.10; Gong Y, 2008, ACTA NEUROCHIR SUPPL, V105, P47; Gonzalez MI, 2005, J NEUROCHEM, V94, P1180, DOI 10.1111/j.1471-4159.2005.03330.x; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Gudmundsson P, 2007, AM J GERIAT PSYCHIAT, V15, P832, DOI 10.1097/JGP.0b013e3180547091; Huang CF, 2008, J NEUROIMMUNOL, V204, P118, DOI 10.1016/j.jneuroim.2008.07.004; Huynh THV, 2012, J MED CHEM, V55, P5403, DOI 10.1021/jm300345z; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Itzekson Z, 2014, J MOL NEUROSCI, V53, P87, DOI 10.1007/s12031-013-0200-8; John CS, 2012, NEUROPSYCHOPHARMACOL, V37, P2467, DOI 10.1038/npp.2012.105; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Kesherwani V, 2014, NEUROSCI LETT, V576, P45, DOI 10.1016/j.neulet.2014.05.053; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Lau CL, 2011, BRIT J PHARMACOL, V163, P533, DOI 10.1111/j.1476-5381.2011.01259.x; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Liu WX, 2016, PSYCHOPHARMACOLOGY, V233, P405, DOI 10.1007/s00213-015-4128-2; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Manaenko A, 2013, NEUROBIOL DIS, V50, P13, DOI 10.1016/j.nbd.2012.09.004; Maria NSS, 2017, J NEUROTRAUM, V34, P1692, DOI 10.1089/neu.2016.4747; Mauri MC, 1998, NEUROPSYCHOBIOLOGY, V37, P124, DOI 10.1159/000026491; Medina A, 2013, J PSYCHIATR RES, V47, P1150, DOI 10.1016/j.jpsychires.2013.04.007; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-142; Naylor E, 2011, J ELECTROANAL CHEM, V656, P106, DOI 10.1016/j.jelechem.2010.12.031; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Piao C, 2015, EXP NEUROL, V273, P288, DOI 10.1016/j.expneurol.2015.09.009; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Rincon-Cortes M, 2017, INT J NEUROPSYCHOPH, V20, P823, DOI 10.1093/ijnp/pyx048; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Satoh S, 2010, BRAIN RES BULL, V81, P191, DOI 10.1016/j.brainresbull.2009.08.021; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wan S, 2016, TRANSL STROKE RES, V7, P478, DOI 10.1007/s12975-016-0472-8; Wang H, 2002, GLIA, V37, P53, DOI 10.1002/glia.10012; Wang JH, 2012, STROKE, V43, P2476, DOI 10.1161/STROKEAHA.112.661819; Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27964; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	62	14	14	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2019	39	1					58	73		10.1177/0271678X17742792			16	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	HF8UB	WOS:000454516600005	29135354	Bronze, Green Published			2022-02-06	
S	Schofield, P; Doty, RL		Doty, RL		Schofield, Peterw.; Doty, Richard L.			The influence of head injury on olfactory and gustatory function	SMELL AND TASTE	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; EMISSION COMPUTED-TOMOGRAPHY; OF-PENNSYLVANIA SMELL; METHYLPREDNISOLONE SODIUM SUCCINATE; EVENT-RELATED POTENTIALS; SNIFF MAGNITUDE TEST; BULB VOLUME; POSTTRAUMATIC ANOSMIA; ORBITOFRONTAL CORTEX; ODOR IDENTIFICATION	Head injury, particularly that resulting in brain injury, is a significant public health concern. For example, annual incidence rates of traumatic brain injury, a common consequence of head injury, range from 54 to 60 million people worldwide, including 2.2-3.6 million people whose trauma is moderate to severe. Trauma to the face and brain, including blast injuries common in modern warfare, can result in alterations in the ability to both smell and taste. In the case of smell, these include total loss of function (anosmia), decreased sensitivity (hyposmia), alterations in odor quality (dysosmia), and hallucination (phantosmia). Although taste dysfunction, i.e., altered perception of such basic taste-bud-mediated sensations as sweet, sour, bitter, salty, and savory (umami), can be similarly influenced by head trauma, the effects are typically more subtle and less studied. The present reviewprovides an up-to-date assessment of what is known about the impact of head injury on quantitative measures of taste and smell function, including the influences of severity, type of injury, location of insults, prognosis, and approaches to therapy.	[Schofield, Peterw.] Univ Newcastle, Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia; [Schofield, Peterw.] Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW, Australia; [Doty, Richard L.] Univ Penn, Smell & Taste Ctr, Philadelphia, PA 19104 USA; [Doty, Richard L.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA		Schofield, P (corresponding author), Hunter New England Local Hlth Dist, Neuropsychiat Serv, Newcastle, NSW, Australia.	peter.schofield@health.nsw.gov.au		Schofield, Peter/0000-0001-8298-8590			AMSTERDAM JD, 1987, BIOL PSYCHIAT, V22, P1481, DOI 10.1016/0006-3223(87)90108-9; Arisi GM, 2012, BEHAV BRAIN RES, V227, P356, DOI 10.1016/j.bbr.2011.03.050; Atighechi S, 2013, AM J RHINOL ALLERGY, V27, P403, DOI 10.2500/ajra.2013.27.3931; Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; Bakker K, 2016, J NEUROTRAUM, V33, P777, DOI 10.1089/neu.2015.4075; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Bitter T, 2010, CHEM SENSES, V35, P407, DOI 10.1093/chemse/bjq028; Bonfils P, 2005, ARCH OTOLARYNGOL, V131, P107, DOI 10.1001/archotol.131.2.107; Bromley SM, 2015, HDB OLFACTION GUSTAT, P375; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Caminiti F, 2014, BRAIN INJURY, V28, P1776, DOI 10.3109/02699052.2014.945960; Caminiti F, 2013, BRAIN INJURY, V27, P1715, DOI 10.3109/02699052.2013.823667; Chang CYJ, 1999, AM J OTOL, V20, P96; Clark AL, 2016, J HEAD TRAUMA REHAB, V31, P346, DOI 10.1097/HTR.0000000000000183; Coelho DH, 2016, AURIS NASUS LARYNX, V43, P137, DOI 10.1016/j.anl.2015.08.006; Collet S, 2009, B-ENT, P97; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Coronado VG, 2011, MMWR SURVEILL SUMM, V60; Correia S, 2001, ARCH CLIN NEUROPSYCH, V16, P477, DOI 10.1016/S0887-6177(00)00059-7; CROWE SF, 1996, PSYCHIAT PSYCHOL LAW, V3, P39, DOI DOI 10.1080/13218719609524873; Crowe SF, 2013, J CLIN EXP NEUROPSYC, V35, P298, DOI 10.1080/13803395.2013.771616; Croy I, 2014, J AFFECT DISORDERS, V160, P80, DOI 10.1016/j.jad.2013.12.026; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Daulatzai MA, 2015, J NEURAL TRANSM, V122, P1475, DOI 10.1007/s00702-015-1404-6; de Guise E, 2015, BRAIN INJURY, V29, P730, DOI 10.3109/02699052.2015.1004748; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Desai M, 2015, J CLIN NEUROSCI, V22, P1614, DOI 10.1016/j.jocn.2015.03.035; Doty RL, 2018, J NEUROL, V265, P1654, DOI 10.1007/s00415-018-8891-y; Doty RL, 2017, LANCET NEUROL, V16, P478, DOI 10.1016/S1474-4422(17)30123-0; Doty RL, 2017, PERCEPTION, V46, P257, DOI 10.1177/0301006616685577; Doty RL, 2010, LARYNGOSCOPE, V120, P707, DOI 10.1002/lary.20827; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Doty RL, 2015, HDB OLFACTION GUSTAT, Vthird; Drummond M, 2017, NEUROREHABILITATION, V41, P241, DOI 10.3233/NRE-171477; Drummond M, 2015, BRAIN IMPAIR, V16, P196, DOI 10.1017/BrImp.2015.27; Drummond M, 2013, BRAIN INJURY, V27, P332, DOI 10.3109/02699052.2012.750743; EBY TL, 1988, LARYNGOSCOPE, V98, P717; Eftekhari Mohammad, 2005, BMC Nucl Med, V5, P6, DOI 10.1186/1471-2385-5-6; Eftekhari M, 2006, AM J RHINOL, V20, P577, DOI 10.2500/ajr.2006.20.2906; Fan LY, 2015, J CHIN MED ASSOC, V78, P299, DOI 10.1016/j.jcma.2014.11.009; Fehlings MG, 2017, GLOB SPINE J, V7, p116S, DOI 10.1177/2192568217706366; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fonteyn S, 2014, EUR ANN OTORHINOLARY, V131, P87, DOI 10.1016/j.anorl.2013.03.006; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Frank RA, 2003, PHYSIOL BEHAV, V78, P195, DOI 10.1016/S0031-9384(02)00965-4; Frasnelli J, 2005, EUR ARCH OTO-RHINO-L, V262, P231, DOI 10.1007/s00405-004-0796-y; Frasnelli J, 2004, EUR ARCH OTO-RHINO-L, V261, P411, DOI 10.1007/s00405-003-0703-y; Frasnelli J, 2010, EXP BRAIN RES, V201, P1, DOI 10.1007/s00221-009-1999-7; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Geisler MW, 1999, J CLIN NEUROPHYSIOL, V16, P77, DOI 10.1097/00004691-199901000-00008; Gerami Hooshang, 2011, Acta Med Iran, V49, P13; Ghanizadeh A, 2009, EAT WEIGHT DISORD-ST, V14, pE137, DOI 10.1007/BF03327811; Girotto JA, 2001, PLAST RECONSTR SURG, V108, P312, DOI 10.1097/00006534-200108000-00005; Goektas O, 2009, EUR J RADIOL, V71, P469, DOI 10.1016/j.ejrad.2008.10.039; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Graff-Radford SB, 2003, HEADACHE, V43, P975, DOI 10.1046/j.1526-4610.2003.03189.x; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green P, 2001, NEUROREHABILITATION, V16, P237; Greiffenstein MF, 2002, J CLIN EXP NEUROPSYC, V24, P705, DOI 10.1076/jcen.24.5.705.1011; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Gudziol V, 2009, J SEX MED, V6, P1924, DOI 10.1111/j.1743-6109.2009.01266.x; Gul AI, 2015, KLIN PSIKOFARMAKOL B, V25, P280, DOI 10.5455/bcp.20150207075621; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Habib SS, 2015, JCPSP-J COLL PHYSICI, V25, pS132, DOI 10.2015/JCPSP.S132133; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1987, J PHARMACOL EXP THER, V242, P137; HALL ED, 1984, J NEUROSURG, V61, P124, DOI 10.3171/jns.1984.61.1.0124; Hanlon LA, 2016, J NEUROPATH EXP NEUR, V75, P214, DOI 10.1093/jnen/nlv021; Hawkes CH, 1998, ANN NY ACAD SCI, V855, P608, DOI 10.1111/j.1749-6632.1998.tb10631.x; Hawkes CH, 2017, SMELL TASTE DISORDER; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; HENKIN RI, 1976, AM J MED SCI, V272, P285, DOI 10.1097/00000441-197611000-00006; HENKIN RI, 1969, P NATL ACAD SCI USA, V62, P30, DOI 10.1073/pnas.62.1.30; Henkin RI, 2011, AM J OTOLARYNG, V32, P38, DOI 10.1016/j.amjoto.2009.10.001; Herzog CD, 2002, NEUROSCIENCE, V113, P569, DOI 10.1016/S0306-4522(02)00203-8; Hillis AE, 2014, BRAIN, V137, P981, DOI 10.1093/brain/awt317; HOLCOMB JD, 1995, DEV BIOL, V172, P307, DOI 10.1006/dbio.1995.0025; Hong SC, 2012, ACTA OTO-LARYNGOL, V132, pS27, DOI 10.3109/00016489.2012.659759; Hummel T, 2013, J NEUROL, V260, P1004, DOI 10.1007/s00415-012-6741-x; Hummel T, 2010, ARCH OTOLARYNGOL, V136, P347, DOI 10.1001/archoto.2010.27; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Ibarretxe-Bilbao N, 2010, MOVEMENT DISORD, V25, P1888, DOI 10.1002/mds.23208; Jackson JH, 1864, LOND HOSP REP, V1, P70; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; Jiang RS, 2015, OTOLARYNG HEAD NECK, V152, P954, DOI 10.1177/0194599815571272; Jiang RS, 2010, EUR ARCH OTO-RHINO-L, V267, P1563, DOI 10.1007/s00405-010-1240-0; Jiang RS, 2009, AM J RHINOL ALLERGY, V23, P582, DOI 10.2500/ajra.2009.23.3370; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; Jonker FA, 2015, REV NEUROSCIENCE, V26, P1, DOI 10.1515/revneuro-2014-0043; Joung YI, 2007, J KOREAN NEUROSURG S, V42, P1; Keilhoff Gerburg, 2006, Neuropsychopharmacology, V31, P1165; Keller A, 2013, BMC EAR NOSE THROAT, V13, DOI 10.1186/1472-6815-13-8; Kelly JP, 1997, PHARMACOL THERAPEUT, V74, P299, DOI 10.1016/S0163-7258(97)00004-1; Kern RC, 2004, LARYNGOSCOPE, V114, P2200, DOI 10.1097/01.mlg.0000149458.21501.6f; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; Kettenmann B, 1997, CHEM SENSES, V22, P493, DOI 10.1093/chemse/22.5.493; Kobal G, 1998, LARYNGOSCOPE, V108, P1033, DOI 10.1097/00005537-199807000-00015; Kobayashi M, 2009, CHEM SENSES, V34, P573, DOI 10.1093/chemse/bjp038; Kohli P, 2016, CHEM SENSES, V41, P479, DOI 10.1093/chemse/bjw061; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Kratskin IL, 1999, BRAIN RES, V847, P240, DOI 10.1016/S0006-8993(99)02076-4; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kuo CL, 2015, J LARYNGOL OTOL, V129, P1201, DOI 10.1017/S0022215115002911; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Leopold D, 2002, CHEM SENSES, V27, P611, DOI 10.1093/chemse/27.7.611; Levenson CW, 2011, ADV NUTR, V2, P96, DOI 10.3945/an.110.000174; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; Li YN, 2017, PROCEEDINGS OF THE THIRTEENTH INTERNATIONAL SYMPOSIUM ON GLOBAL MANUFACTURING AND CHINA (GMC'17), P32; Liu G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013246; Liu Y, 2014, EUR J NEUROSCI, V39, P1632, DOI 10.1111/ejn.12531; Lotsch J, 2006, BEHAV BRAIN RES, V170, P78, DOI 10.1016/j.bbr.2006.02.013; Lotsch J, 2016, CHEM SENSES, V41, P339, DOI 10.1093/chemse/bjw006; London B, 2008, ANN NEUROL, V63, P159, DOI 10.1002/ana.21293; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; Mann NM, 2006, CLIN NUCL MED, V31, P458, DOI 10.1097/01.rlu.0000227010.72925.6d; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; McCaffrey RJ, 2000, J NEUROPSYCH CLIN N, V12, P29, DOI 10.1176/jnp.12.1.29; McManus LJ, 2012, J LARYNGOL OTOL, V126, P8, DOI 10.1017/S0022215111002039; McNeill E, 2007, J LARYNGOL OTOL, V121, P713, DOI 10.1017/S0022215107006615; Miao XT, 2015, EUR ARCH OTO-RHINO-L, V272, P1945, DOI 10.1007/s00405-014-3278-x; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mucignat-Caretta C, 2009, AM J PHYSIOL-LUNG C, V297, pL1073, DOI 10.1152/ajplung.00014.2009; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Mueller Christian A, 2009, J Med Case Rep, V3, P9283, DOI 10.4076/1752-1947-3-9283; Nagraj SK, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010470.pub2; Negoias S, 2010, NEUROSCIENCE, V169, P415, DOI 10.1016/j.neuroscience.2010.05.012; Neuland C, 2011, LARYNGOSCOPE, V121, P867, DOI 10.1002/lary.21387; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nordin S, 2008, CURR OPIN ALLERGY CL, V8, P10, DOI 10.1097/ACI.0b013e3282f3f473; Ogawa T, 1999, ACTA OTO-LARYNGOL, P50; Ogle W, 1870, Med Chir Trans, V53, P263; Ohlsson M, 2004, J NEURO-OPHTHALMOL, V24, P11, DOI 10.1097/00041327-200403000-00003; Ono MY, 2011, BRAIN INJURY, V25, P237, DOI 10.3109/02699052.2010.541893; Oral E, 2013, NEUROSCIENCE, V240, P63, DOI 10.1016/j.neuroscience.2013.02.026; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Pause BM, 2001, J PSYCHIAT RES, V35, P271, DOI 10.1016/S0022-3956(01)00029-2; Pence TS, 2014, JAMA OTOLARYNGOL, V140, P951, DOI 10.1001/jamaoto.2014.1675; Pentzek M, 2007, AGING CLIN EXP RES, V19, P255; Philpott C., 2014, ANN R COLL SURG ENGL, V96, P156, DOI DOI 10.1308/RCSBULL.2014.96.5.156; Philpott CM, 2006, OTOLARYNG HEAD NECK, V134, P488, DOI 10.1016/j.otohns.2005.10.041; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pope K, 2007, NEUROSCI LETT, V422, P13, DOI 10.1016/j.neulet.2007.05.041; Price S, 1986, CLIN MEASUREMENT TAS, P443; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Quint C, 2002, ACTA OTO-LARYNGOL, V122, P877, DOI 10.1080/003655402/000028054; Reden J, 2007, EUR ARCH OTO-RHINO-L, V264, P139, DOI 10.1007/s00405-006-0157-0; Reden J, 2012, LARYNGOSCOPE, V122, P1906, DOI 10.1002/lary.23405; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Roberts Richard J, 2010, Indian J Psychol Med, V32, P93, DOI 10.4103/0253-7176.78504; Rombaux P, 2007, LARYNGOSCOPE, V117, P1096, DOI 10.1097/MLG.0b013e31804d1d0d; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sabaru I, 2015, ROM J RHINOL, V5, P153; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schofield PW, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0479-z; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Seddon HJ, 1943, BRAIN, V66, P237, DOI 10.1093/brain/66.4.237; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Seubert J, 2013, CEREB CORTEX, V23, P2448, DOI 10.1093/cercor/bhs230; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shill HA, 2016, MOV DISORD CLIN PRAC, V3, P43, DOI 10.1002/mdc3.12220; Sigurdardottir S, 2016, NEUROPSYCHOLOGY, V30, P98, DOI 10.1037/neu0000206; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Silas J, 2011, AM J OTOLARYNG, V32, P177, DOI 10.1016/j.amjoto.2010.07.005; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Sivam A, 2016, CHEM SENSES, V41, P293, DOI 10.1093/chemse/bjv088; Solomon GS, 1998, J NEUROPSYCH CLIN N, V10, P64, DOI 10.1176/jnp.10.1.64; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; Soter A, 2008, LARYNGOSCOPE, V118, P611, DOI 10.1097/MLG.0b013e318161e53a; Soudry Y, 2011, EUR ANN OTORHINOLARY, V128, P18, DOI 10.1016/j.anorl.2010.09.007; Steinsapir KD, 2000, RESTOR NEUROL NEUROS, V17, P157; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Swann IJ, 2006, EMERG MED J, V23, P618, DOI 10.1136/emj.2005.029017; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Tourbier IA, 2007, CHEM SENSES, V32, P515, DOI 10.1093/chemse/bjm020; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Varney NR, 1998, J HEAD TRAUMA REHAB, V13, P63; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Watanabe K, 1995, Nihon Jibiinkoka Gakkai Kaiho, V98, P80; Wehling E, 2015, RHINOLOGY, V53, P89, DOI [10.4193/Rhino14.081, 10.4193/Rhin14.081]; Wehling E, 2011, ARCH CLIN NEUROPSYCH, V26, P260, DOI 10.1093/arclin/acr019; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Wise JB, 2006, ANN OTO RHINOL LARYN, V115, P124, DOI 10.1177/000348940611500208; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475; YOUNG W, 1982, J NEUROSURG, V57, P667, DOI 10.3171/jns.1982.57.5.0667; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; Yuan TF, 2014, PROG NEURO-PSYCHOPH, V54, P26, DOI 10.1016/j.pnpbp.2014.05.013; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012	207	14	14	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-444-63856-4; 978-0-444-63855-7	HAND CLINIC			2019	164						409	429		10.1016/B978-0-444-63855-7.00023-X			21	Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BR0OY	WOS:000629812900025	31604560				2022-02-06	
J	Singleton, Q; Vaibhav, K; Braun, M; Patel, C; Khayrullin, A; Mendhe, B; Lee, BR; Kolhe, R; Kaiser, H; Awad, ME; Fariyike, T; Elsayed, R; Elsalanty, M; Isales, CM; Liu, YT; Hamrick, MW; Dhandapani, KM; Fulzele, S				Singleton, Quante; Vaibhav, Kumar; Braun, Molly; Patel, Chandani; Khayrullin, Andrew; Mendhe, Bharati; Lee, Byung R.; Kolhe, Ravindra; Kaiser, Helen; Awad, Mohamed E.; Fariyike, Tunde; Elsayed, Ranya; Elsalanty, Mohammed; Isales, Carlos M.; Liu, Yutao; Hamrick, Mark W.; Dhandapani, Krishnan M.; Fulzele, Sadanand			Bone Marrow Derived Extracellular Vesicles Activate Osteoclast Differentiation in Traumatic Brain Injury Induced Bone Loss	CELLS			English	Article						traumatic brain injury; bone loss; traumatic brain injury; extracellular vesicles; extracellular vesicles	NECROSIS-FACTOR-ALPHA; MINERAL DENSITY; CONSEQUENCES; REHABILITATION; POLARIZATION; PREVALENCE; EXPRESSION; REDUCTION; IMPACT; ADULTS	Traumatic brain injury (TBI) is a major source of worldwide morbidity and mortality. Patients suffering from TBI exhibit a higher susceptibility to bone loss and an increased rate of bone fractures; however, the underlying mechanisms remain poorly defined. Herein, we observed significantly lower bone quality and elevated levels of inflammation in bone and bone marrow niche after controlled cortical impact-induced TBI in in vivo CD-1 mice. Further, we identified dysregulated NF-kappa B signaling, an established mediator of osteoclast differentiation and bone loss, within the bone marrow niche of TBI mice. Ex vivo studies revealed increased osteoclast differentiation in bone marrow-derived cells from TBI mice, as compared to sham injured mice. We also found bone marrow derived extracellular vesicles (EVs) from TBI mice enhanced the colony forming ability and osteoclast differentiation efficacy and activated NF-kappa B signaling genes in bone marrow-derived cells. Additionally, we showed that miRNA-1224 up-regulated in bone marrow-derived EVs cargo of TBI. Taken together, we provide evidence that TBI-induced inflammatory stress on bone and the bone marrow niche may activate NF-kappa B leading to accelerated bone loss. Targeted inhibition of these signaling pathways may reverse TBI-induced bone loss and reduce fracture rates.	[Singleton, Quante; Patel, Chandani; Lee, Byung R.; Isales, Carlos M.; Fulzele, Sadanand] Augusta Univ, Dept Orthoped Surg, Augusta, GA 30912 USA; [Vaibhav, Kumar; Braun, Molly; Fariyike, Tunde; Dhandapani, Krishnan M.] Augusta Univ, Dept Neurosurg, Augusta, GA 30912 USA; [Khayrullin, Andrew; Mendhe, Bharati; Kaiser, Helen; Liu, Yutao; Hamrick, Mark W.] Augusta Univ, Cell Biol & Anat, Augusta, GA 30912 USA; [Kolhe, Ravindra; Elsayed, Ranya; Elsalanty, Mohammed] Augusta Univ, Dept Pathol, Augusta, GA 30912 USA; [Awad, Mohamed E.] Augusta Univ, Dept Oral Biol, Augusta, GA 30912 USA; [Isales, Carlos M.; Hamrick, Mark W.; Fulzele, Sadanand] Georgia Regents Univ, Inst Regenerat & Reparat Med, Augusta, GA 30912 USA		Fulzele, S (corresponding author), Augusta Univ, Dept Orthoped Surg, Augusta, GA 30912 USA.; Dhandapani, KM (corresponding author), Augusta Univ, Dept Neurosurg, Augusta, GA 30912 USA.; Fulzele, S (corresponding author), Georgia Regents Univ, Inst Regenerat & Reparat Med, Augusta, GA 30912 USA.	qsingleton@augusta.edu; kvaibhav@augusta.edu; mobraun@augusta.edu; chapatel@augusta.edu; akhayrullin@augusta.edu; bmendhe@augusta.edu; blee@augusta.edu; rkolhe@augusta.edu; hkaiser@augusta.edu; moawad@augusta.edu; bfariyike@augusta.edu; relsayed@augusta.edu; melsalanty@augusta.edu; cisales@augusta.edu; yutliu@augusta.edu; mhamrick@augusta.edu; kdhandapani@augusta.edu; sfulzele@augusta.edu	Awad, Mohamed E./ABC-8407-2020; Awad, Mohamed/U-1799-2019; Vaibhav, Kumar/H-4120-2019	Dhandapani, Krishnan/0000-0001-7044-1117; KOLHE, RAVINDRA/0000-0002-8283-2403; Awad, Mohamed E./0000-0001-7525-5364; Vaibhav, Kumar/0000-0002-4206-3830; Singleton, Quante/0000-0002-2910-1353	National Institutes on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01 AG 036675]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS097825, NS110378]; National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD094606]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG036675] Funding Source: NIH RePORTER	This work was supported by grants from the National Institutes on Aging P01 AG 036675 to SF, MWH, and CS; National Institute of Health NS097825; NS110378 to KMD; and National Institute of Child Health & Human Development HD094606 to KV. The authors declare no competing financial and non-financial interests.	Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Banham-Hall N, 2013, PHYSIOTHERAPY, V99, P328, DOI 10.1016/j.physio.2012.12.009; Brady RD, 2016, J MUSCULOSKEL NEURON, V16, P369; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Braun M, 2017, J IMMUNOL, V198, P3615, DOI 10.4049/jimmunol.1601948; Bretz NP, 2013, J BIOL CHEM, V288, P36691, DOI 10.1074/jbc.M113.512806; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Cefalu CA, 2004, CURR MED RES OPIN, V20, P341, DOI 10.1185/030079903125003062; Chao CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132685; Crescitelli R., 2013, J ORAL TISSUE ENG, V2, P20677; Davis C, 2017, TISSUE ENG PT A, V23, P1231, DOI [10.1089/ten.tea.2016.0525, 10.1089/ten.TEA.2016.0525]; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Dias C, 2015, NEUROCRIT CARE, V22, P192, DOI 10.1007/s12028-014-0045-1; Divittorio G, 2006, PHARMACOTHERAPY, V26, P104, DOI 10.1592/phco.2006.26.1.104; Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227; Ginaldi Lia, 2005, Immun Ageing, V2, P14, DOI 10.1186/1742-4933-2-14; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Hilz MJ, 2017, J NEUROL, V264, P1956, DOI 10.1007/s00415-017-8581-1; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; Kagiya T, 2013, J PERIODONTAL RES, V48, P373, DOI 10.1111/jre.12017; Kanis JA, 2017, J CLIN DENSITOM, V20, P444, DOI 10.1016/j.jocd.2017.06.013; Kisser JE, 2016, J NEUROL SCI, V365, P9, DOI 10.1016/j.jns.2016.03.033; Kolhe R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01905-y; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JI, 2005, BRAIN INJURY, V19, P1207, DOI 10.1080/02699050500309338; Lee Young Joo, 2015, Obstet Gynecol Sci, V58, P46, DOI 10.5468/ogs.2015.58.1.46; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Marton N, 2017, CELL MOL LIFE SCI, V74, P3599, DOI 10.1007/s00018-017-2535-8; Niu YN, 2011, IMMUNOLOGY, V133, P8, DOI 10.1111/j.1365-2567.2010.03374.x; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Rau CS, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121203; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sangani R, 2013, EXP MOL PATHOL, V95, P298, DOI 10.1016/j.yexmp.2013.08.007; Smith E, 2016, IRISH J MED SCI, V185, P473, DOI 10.1007/s11845-016-1399-5; Smith E, 2011, J CLIN DENSITOM, V14, P85, DOI 10.1016/j.jocd.2010.12.002; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Van Deun J, 2017, NAT METHODS, V14, P228, DOI 10.1038/nmeth.4185; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; Xu JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114627; Yu HR, 2014, BRAIN INJURY, V28, P244, DOI 10.3109/02699052.2013.859735	49	14	15	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	JAN	2019	8	1							63	10.3390/cells8010063			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	HM8PD	WOS:000459742400062	30658394	gold, Green Submitted, Green Published			2022-02-06	
J	Brett, BL; Kuhn, AW; Yengo-Kahn, AM; Solomon, GS; Zuckerman, SL				Brett, Benjamin L.; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.			Risk Factors Associated With Sustaining a Sport-related Concussion: An Initial Synthesis Study of 12,320 Student-Athletes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Childhood brain insult	HIGH-SCHOOL; PROFESSIONAL FOOTBALL; INJURY RATES; HEAD-INJURY; EPIDEMIOLOGY; COLLEGIATE; SYMPTOMS; MANAGEMENT; CHILDREN; YOUTH	Objective: The empirical identification of risk factors associated with sport-related concussion (SRC) may improve the management of student-athletes. The current study attempted to identify and quantify bio-cognitive risk factors associated with sustaining a SRC. Methods: Cross-sectional ambispective study; level of evidence, 3. Neurocognitive testing of 12,320 middle school, high school and collegiate athletes was completed at preseason baseline and post-SRC. Univariate and multivariable logistic regressions were used to determine which pre-injury variables accurately predicted the occurrence of SRC. A quantitative risk score for each variable was developed. Results: Five of 13 variables maintained significance in the multivariable model with the associated weighted point scores: SRC history (21), prior headache treatment (6), contact sport (5), youth level of play (7), and history of ADHD/LD (2). Six stratified groups were formed based on probability of SRC, which produced an area under the curve (AUC) of 0.71 (95% CI 0.69-0.72, p < .001). Though the model was a significant predictor of SRC (X-2 = 1,112.75, p < .001), the effect size was small and accounted for only 16% of the overall variance. Conclusions: An initial aggregate model of weighted bio-cognitive factors associated with increased odds of sustaining a SRC was developed. Previously validated factors were confirmed, yet a large source of variance remained unexplained. These findings emphasize the need to expand the host factors studied when assessing SRC risk, and that the existing, empirically based bio-cognitive factors do not adequately quantify the risk of SRC.	[Brett, Benjamin L.] Vet Affairs Connecticut Healthcare Syst, Dept Psychol, West Haven, CT USA; [Brett, Benjamin L.; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Brett, Benjamin L.] Univ Memphis, Dept Counseling Educ Psychol & Res, Memphis, TN 38152 USA; [Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu	Kuhn, Andrew W/AAM-4820-2020; Yengo-Kahn, Aaron/AAV-7647-2020	Kuhn, Andrew W/0000-0003-1836-7575; Yengo-Kahn, Aaron/0000-0002-5989-3064			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; [Anonymous], 2012, IMM POSTC ASS COGN T; Ban VS, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS15609; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Berry WD, 1985, MULTIPLE REGRESSION; Brain S., 2015, YOUTH SPORTS STAT; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Center for Disease Control and Prevention (CDC), 2015, FAQS BAS TEST; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hampel F. R., 1986, WILEY SERIES PROBABI; Hinkle D. E, 2002, APPL STAT BEHAV SCI, V5th; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Institute of Medicine, 2013, SPORTS RELATED CONCU; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Knox CL, 2006, PEDIATRICS, V118, P549, DOI 10.1542/peds.2005-2913; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall S, 2015, INJURY EPIDEMIOLOGY, V2, P1; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; National Collegiate Athletic Association, 2014, 2014 15 SPORTS MED H; National Federation of State High School Assoction (NFHS), 2014, HIGH SCH PART INCR 2; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	55	14	14	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2018	33	8					984	992		10.1093/arclin/acy006			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HG9LJ	WOS:000455329500005	29471410	Bronze			2022-02-06	
J	Russo, E; Citraro, R				Russo, Emilio; Citraro, Rita			Pharmacology of epileptogenesis and related comorbidities in the WAG/Rij rat model of genetic absence epilepsy	JOURNAL OF NEUROSCIENCE METHODS			English	Article; Proceedings Paper	Mediterranean Conference of Neuroscience	JUN, 2017	St Julians, MALTA			Epileptogenesis; Genetic animal model; Antiepileptic drugs; Comorbidities; Depression; Cognitive impairment	DEPRESSIVE-LIKE BEHAVIOR; MTOR SIGNALING PATHWAY; SPIKE-WAVE DISCHARGES; LONG-TERM TREATMENT; WHEY-PROTEIN RICH; ANIMAL-MODEL; RODENT MODELS; ANTIEPILEPTIC DRUGS; GENERALIZED ABSENCE; ALPHA-LACTOALBUMIN	Animal studies currently represent the best source of information also in the field of epileptogenesis research. Many animal models have been proposed and studied so far both from the pathophysiological and pharmacological point of view. Furthermore, they are widely used for the identification of potentially clinically valuable biomarkers. The WAG/Rij rat model, similarly to other genetic animal strains, represents a suitable animal model of absence epileptogenesis accompanied by depressive-like and cognitive comorbidities. Generally, animal models of epileptogenesis are characterized by an identifiable initial insult (e.g. traumatic brain injury), a latent phase lasting up to the appearance of the first spontaneous seizure and a chronic phase characterized by recurrent spontaneous seizures. In most of genetic models: the initial insult should be defined as the mutation causing epilepsy, which is not clearly defined in the WAG/Rij rat model; the latent phase ends at the appearance of the first spontaneous seizure, which is about 2-3 months of age in WAG/Rij rats and thereafter the chronic phase. WAG/Rij rats also display depressive-like comorbidity around the age of 4 months, which is apparently linked to the development of absence seizures considering both its ontogeny and the fact that drugs affecting absence seizures development also block the development of depressive-like behavior. Finally, WAG/Rij rats also display cognitive impairment in some memory tasks, however, this has not been yet definitively linked to absence seizures development and may represent an epiphenomenon. This review is focused on the effects of pharmacological treatments against epileptogenesis and their effects on comorbidities.	[Russo, Emilio; Citraro, Rita] Univ Catanzaro, Sch Med, Sci Hlth Dept, Viale Europa Germaneto, I-88100 Catanzaro, Italy		Russo, E (corresponding author), Univ Catanzaro, Sch Med, Sci Hlth Dept, Viale Europa Germaneto, I-88100 Catanzaro, Italy.	erusso@unicz.it	Russo, Emilio/G-5241-2010	Russo, Emilio/0000-0002-1279-8123	Italian Ministry of Health: Bando Ricerca Finalizzata 2013	This work was partially supported by a grant obtained from the Italian Ministry of Health: Bando Ricerca Finalizzata 2013.	Ates N, 2005, DEV BRAIN RES, V154, P137, DOI 10.1016/j.devbrainres.2004.10.001; Avanzini G, 2012, EPILEPSIA, V53, P771, DOI 10.1111/j.1528-1167.2012.03462.x; Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; Berg AT, 2014, EPILEPSIA, V55, P551, DOI 10.1111/epi.12551; Birioukova LM, 2005, EPILEPSY RES, V63, P89, DOI 10.1016/j.eplepsyres.2004.12.001; Blumenfeld H, 2008, EPILEPSIA, V49, P400, DOI 10.1111/j.1528-1167.2007.01458.x; Brooks-Kayal AR, 2013, EPILEPSIA, V54, P44, DOI 10.1111/epi.12298; Caplan R, 2008, EPILEPSIA, V49, P1838, DOI 10.1111/j.1528-1167.2008.01680.x; Cardamone L, 2013, BRIT J PHARMACOL, V168, P1531, DOI 10.1111/bph.12052; Cardamone L, 2014, NEUROBIOL DIS, V63, P194, DOI 10.1016/j.nbd.2013.11.020; Citraro R, 2006, NEUROPHARMACOLOGY, V51, P1058, DOI 10.1016/j.neuropharm.2006.06.014; Citraro R, 2017, EPILEPSIA, V58, P231, DOI 10.1111/epi.13629; Citraro R, 2016, PHARMACOL RES, V107, P333, DOI 10.1016/j.phrs.2016.03.039; Citraro R, 2015, BRIT J PHARMACOL, V172, P3177, DOI 10.1111/bph.13121; Citraro R, 2015, BRAIN RES BULL, V113, P1, DOI 10.1016/j.brainresbull.2015.02.004; Citraro R, 2014, EPILEPSIA, V55, P1284, DOI 10.1111/epi.12686; Citraro R, 2014, EXPERT OPIN THER TAR, V18, P319, DOI 10.1517/14728222.2014.874416; Citraro R, 2011, EPILEPSY RES, V95, P60, DOI 10.1016/j.eplepsyres.2011.02.013; Coenen AML, 2003, BEHAV GENET, V33, P635, DOI 10.1023/A:1026179013847; de Bruin NMWJ, 2000, NEUROSCI RES, V38, P165, DOI 10.1016/S0168-0102(00)00154-1; de Vries EE, 2016, NEUROSCI BIOBEHAV R, V63, P177, DOI 10.1016/j.neubiorev.2016.02.007; Dezsi G, 2013, EPILEPSIA, V54, P635, DOI 10.1111/epi.12118; Epps SA, 2013, BIOCHEM PHARMACOL, V85, P135, DOI 10.1016/j.bcp.2012.08.016; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Gao F, 2012, PHARMACOL BIOCHEM BE, V103, P187, DOI 10.1016/j.pbb.2012.08.025; Gauguier D, 2004, EPILEPSIA, V45, P908, DOI 10.1111/j.0013-9580.2004.13104.x; Giblin KA, 2010, NEUROSCIENTIST, V16, P253, DOI 10.1177/1073858409354385; Gol M, 2017, EUR J PHARM SCI, V96, P72, DOI 10.1016/j.ejps.2016.09.016; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Jafarian M, 2015, NEUROSCIENCE, V298, P161, DOI 10.1016/j.neuroscience.2015.04.033; Jarre G, 2017, CEREB CORTEX, V27, P4607, DOI 10.1093/cercor/bhx174; Kaminski RM, 2003, POL J PHARMACOL, V55, P741; Kanner AM, 2009, NEUROL CLIN, V27, P865, DOI 10.1016/j.ncl.2009.08.002; Karson A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-51; Kovacs Z, 2012, BRAIN RES BULL, V89, P102, DOI 10.1016/j.brainresbull.2012.07.010; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Landmark CJ, 2016, EPILEPSY BEHAV, V61, P287, DOI 10.1016/j.yebeh.2016.01.029; Leo A, 2016, MOL MED MTOR TRANSLA, P123, DOI [10.1016/B978-0-12-802733-2.00006-2, DOI 10.1016/B978-0-12-802733-2.00006-2]; Leo A, 2017, NEUROTHERAPEUTICS, V14, P1134, DOI 10.1007/s13311-017-0550-y; Leo A, 2017, CNS NEUROL DISORD-DR, V16, P311, DOI 10.2174/1871527315666161104163031; Mazarati A, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022798; Midzianovskaia IS, 2001, BRAIN RES, V911, P62, DOI 10.1016/S0006-8993(01)02705-6; Midzyanovskaya IS, 2006, BRAIN RES BULL, V69, P631, DOI 10.1016/j.brainresbull.2006.03.008; Prager B, 2015, TRENDS MOL MED, V21, P354, DOI 10.1016/j.molmed.2015.03.006; Rudolf G, 2004, EPILEPSIA, V45, P301, DOI 10.1111/j.0013-9580.2004.50303.x; Russo E, 2012, NEUROSCIENCE, V226, P282, DOI 10.1016/j.neuroscience.2012.09.021; Russo E, 2008, INT J DEV NEUROSCI, V26, P739, DOI 10.1016/j.ijdevneu.2008.07.002; Russo E, 2008, EPILEPSY BEHAV, V13, P295, DOI 10.1016/j.yebeh.2008.04.018; Russo E, 2016, NEUROSCI BIOBEHAV R, V71, P388, DOI 10.1016/j.neubiorev.2016.09.017; Russo E, 2014, BRAIN BEHAV IMMUN, V42, P157, DOI 10.1016/j.bbi.2014.06.016; Russo E, 2014, NEUROL SCI, V35, P1793, DOI 10.1007/s10072-014-1842-1; Russo E, 2013, NEUROPHARMACOLOGY, V69, P25, DOI 10.1016/j.neuropharm.2012.09.019; Russo E, 2013, PHARMACOL RES, V70, P1, DOI 10.1016/j.phrs.2012.12.002; Russo E, 2012, MOL NEUROBIOL, V46, P662, DOI 10.1007/s12035-012-8314-5; Russo E, 2012, EXPERT OPIN INV DRUG, V21, P1371, DOI 10.1517/13543784.2012.705277; Russo E, 2011, BEHAV BRAIN RES, V225, P373, DOI 10.1016/j.bbr.2011.07.030; Russo E, 2011, EPILEPSIA, V52, P1341, DOI 10.1111/j.1528-1167.2011.03112.x; Russo E, 2010, EPILEPSIA, V51, P1560, DOI 10.1111/j.1528-1167.2009.02400.x; Sarkisova KY, 2018, GENES BRAIN BEHAV, V17, DOI 10.1111/gbb.12477; Sarkisova K Yu, 2017, Dokl Biol Sci, V473, P39, DOI 10.1134/S0012496617020077; Sarkisova K Yu, 2008, Neurosci Behav Physiol, V38, P119, DOI 10.1007/s11055-008-0017-z; Sarkisova K, 2011, PROG NEURO-PSYCHOPH, V35, P854, DOI 10.1016/j.pnpbp.2010.11.010; Sarkisova KY, 2010, EPILEPSIA, V51, P146, DOI 10.1111/j.1528-1167.2009.02260.x; Sarkisova KY, 2006, BEHAV BRAIN RES, V166, P9, DOI 10.1016/j.bbr.2005.07.024; Scicchitano F, 2015, CURR DRUG TARGETS, V16, P747, DOI 10.2174/1389450116666150330114850; Sierra-Marcos A, 2015, EUR J NEUROL, V22, P402, DOI 10.1111/ene.12428; Sitnikova E, 2015, BRAIN RES, V1594, P305, DOI 10.1016/j.brainres.2014.10.067; Sitnikova E, 2011, BRAIN RES, V1377, P109, DOI 10.1016/j.brainres.2010.12.067; Teskey GC, 2004, EPILEPSY RES, V59, P25, DOI 10.1016/j.eplepsyres.2004.03.001; van de Bovenkamp-Janssen MC, 2004, J NEUROBIOL, V58, P467, DOI 10.1002/neu.10291; van Luijtelaar G, 2014, CURR MED CHEM, V21, P704; van Luijtelaar G, 2012, NEUROPHYSIOLOGY+, V43, P478, DOI 10.1007/s11062-012-9252-6; van Luijtelaar G, 2017, CURR PHARM DESIGN, V23, P5577, DOI 10.2174/1381612823666171017170226; van Luijtelaar G, 2013, NEUROBIOL DIS, V60, P126, DOI 10.1016/j.nbd.2013.08.013; van Vliet EA, 2011, EPILEPSIA, V52, P1319, DOI 10.1111/j.1528-1167.2011.03073.x; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; WARTER JM, 1988, NEUROPHARMACOLOGY, V27, P269, DOI 10.1016/0028-3908(88)90043-3; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; White HS, 2014, NEUROTHERAPEUTICS, V11, P373, DOI 10.1007/s13311-013-0250-1; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057445	80	14	14	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	DEC 1	2018	310				SI		54	62		10.1016/j.jneumeth.2018.05.020			9	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HC0LM	WOS:000451489900007	29857008				2022-02-06	
J	Zeiler, FA; Kim, DJ; Cabeleira, M; Calviello, L; Smielewski, P; Czosnyka, M				Zeiler, Frederick A.; Kim, Dong-Joo; Cabeleira, Manuel; Calviello, Leanne; Smielewski, Peter; Czosnyka, Marek			Impaired cerebral compensatory reserve is associated with admission imaging characteristics of diffuse insult in traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Compensatory reserve; Diffuse injury; Imaging; Monitoring; TBI	MAGNETIC-RESONANCE ELASTOGRAPHY; MORPHOLOGICAL FEATURES; PULSE AMPLITUDE; PRESSURE; CLASSIFICATION	BackgroundContinuous assessment of cerebral compensatory reserve is possible using the moving correlation between pulse amplitude of intra-cranial pressure (AMP) and intra-cranial pressure (ICP), called RAP. Little is known about the behavior and associations of this index in adult traumatic brain injury (TBI). The goal of this study is to evaluate the association between admission cerebral imaging findings and RAP over the course of the acute intensive care unit stay.MethodsWe retrospectively reviewed 358 adult TBI patients admitted to the Addenbrooke's Hospital, University of Cambridge, from March 2005 to December 2016. Only non-craniectomy patients were studied. Using archived high frequency physiologic signals, RAP was derived and analyzed over the first 48h and first 10days of recording in each patient, using grand mean, percentage of time above various thresholds, and integrated area under the curve (AUC) of RAP over time. Associations between these values and admission computed tomography (CT) injury characteristics were evaluated.ResultsThe integrated AUC, based on various thresholds of RAP, was statistically associated with admission CT markers of diffuse TBI and cerebral edema. Admission CT findings of cortical gyral effacement, lateral ventricle compression, diffuse cortical subarachnoid hemorrhage (SAH), thickness of cortical SAH, presence of bilateral contusions, and subcortical diffuse axonal injury (DAI) were all associated with AUC of RAP over time. Joncheere-Terpstra testing indicated a statistically significant increase in mean RAP AUC across ordinal categories of the abovementioned associated CT findings.ConclusionsRAP is associated with cerebral CT injury patterns of diffuse injury and edema, providing some confirmation of its potential measurement of cerebral compensatory reserve in TBI.	[Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Sect Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Cabeleira, Manuel; Calviello, Leanne; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg,Sect Brain Phys, Cambridge CB2 0QQ, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.	umzeiler@myumanitoba.ca; dongjookim@korea.ac.kr; mc916@cam.ac.uk; lac76@cam.ac.uk; ps10011@cam.ac.uk; mc141@medschl.cam.ac.uk		czosnyka, marek/0000-0003-2446-8006; Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada - Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI17C1790]	FAZ has received salary support for dedicated research time, during which this project was completed. Such salary support came from the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada - Harry S. Morton Travelling Fellowship in Surgery, and the University of Manitoba Clinician Investigator Program.; DJK and MC were supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI17C1790).	AVEZAAT CJJ, 1986, NEUROSURG REV, V9, P113, DOI 10.1007/BF01743061; Bianciardi M, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0184; Boulet T, 2011, J NEUROSCI METH, V201, P296, DOI 10.1016/j.jneumeth.2011.08.019; Calviello L, 2018, NEUROCRIT CARE, V28, P212, DOI 10.1007/s12028-017-0475-7; Cardim D, 2017, NEUROCRIT CARE, V26, P330, DOI 10.1007/s12028-016-0356-5; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; Czosnyka Z, 2008, ACTA NEUROCHIR SUPPL, V102, P137, DOI 10.1007/978-3-211-85578-2_28; Donnelly J, 2017, J CEREBR BLOOD F MET, V37, P694, DOI 10.1177/0271678X16639060; Glenn Thomas C, 2012, Acta Neurochir Suppl, V114, P11, DOI 10.1007/978-3-7091-0956-4_3; Hamilton R, 2009, IEEE ENG MED BIO, P4331, DOI 10.1109/IEMBS.2009.5332749; Howells T, 2012, INTENS CARE MED, V38, P1061, DOI 10.1007/s00134-012-2571-7; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Kasprowicz M, 2010, J NEUROSCI METH, V190, P310, DOI 10.1016/j.jneumeth.2010.05.015; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Kolipaka A, 2018, CLIN IMAG, V51, P114, DOI 10.1016/j.clinimag.2018.02.005; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Pineda B, 2018, ACTA NEUROCHIR SUPPL, V126, P297, DOI 10.1007/978-3-319-65798-1_58; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Scalzo F, 2008, IEEE ENG MED BIO, P5411, DOI 10.1109/IEMBS.2008.4650438; UK Health Departments, 2011, GOV ARR RES ETH COMM; VANEIJNDHOVEN JHM, 1986, NEUROSURGERY, V19, P507, DOI 10.1227/00006123-198610000-00004; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2018, J NEUROTRAUM, V35, P1569, DOI 10.1089/neu.2017.5595	29	14	15	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	DEC	2018	160	12					2277	2287		10.1007/s00701-018-3681-y			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HB3XI	WOS:000450984500001	30251196	Green Published, hybrid			2022-02-06	
J	Kinoshita, T; Yamakawa, K; Yoshimura, J; Watanabe, A; Matsumura, Y; Ito, K; Ohbe, H; Hayashida, K; Kushimoto, S; Matsumoto, J; Fujimi, S				Kinoshita, Takahiro; Yamakawa, Kazuma; Yoshimura, Jumpei; Watanabe, Atsushi; Matsumura, Yosuke; Ito, Kaori; Ohbe, Hiroyuki; Hayashida, Kei; Kushimoto, Shigeki; Matsumoto, Junichi; Fujimi, Satoshi		Japanese Assoc Hybrid Emergency	First clinical experiences of concurrent bleeding control and intracranial pressure monitoring using a hybrid emergency room system in patients with multiple injuries	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Concurrent treatment; Functional outcome; HERS; Mortality; Polytrauma	TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE; HEAD-INJURY; COAGULOPATHY; HYPOTENSION	BackgroundThe outcomes of multiple injury patients with concomitant torso hemorrhage and traumatic brain injury (TBI) are very poor. The hybrid emergency room system (HERS) is a trauma management system designed to complete resuscitation, computed tomography (CT), surgery, angioembolization, and intracranial pressure (ICP) monitoring all in one trauma resuscitation room without patient transfer. We aimed to review the outcomes of polytrauma patients who underwent concurrent bleeding control and ICP monitoring using the HERS.MethodsIn this retrospective observational study, we enrolled patients who underwent concurrent bleeding control and ICP monitoring using the HERS between August 2011 and June 2018. Initial data on vital signs, Injury Severity Score (ISS), probability of survival (Ps) calculated by the Trauma and Injury Severity Score (TRISS), intervention type, 28-day mortality, and Extended Glasgow Outcome Scale at 6months after injury were collected. Continuous variables were expressed as the median (25th and 75th percentiles) and categorical variables as numbers (%).ResultsTen patients were included in the analysis. The injury severity of the patients was as high as an ISS of 58 (50-64) and TRISS Ps of 0.15 (0.02-0.36). Seven of the 10 (70%) patients had hemodynamic instability within 30min from arrival. The recorded durations from arrival to events were CT examination 9 (6-16) min, bleeding control procedure 29 (22-42) min, and neurosurgical intervention 39 (31-53) min. Four of the 10 patients (40%) survived to discharge, and two of them (20%) were able to live independently at 6months after injury.ConclusionsThe concurrent performance of bleeding control procedure and ICP monitoring would be feasible in HERS settings among polytrauma patients with exsanguinating hemorrhage and TBI.	[Kinoshita, Takahiro; Yamakawa, Kazuma; Yoshimura, Jumpei; Watanabe, Atsushi; Fujimi, Satoshi] Osaka Gen Med Ctr, Div Trauma & Surg Crit Care, Sumiyoshi Ku, 3-1-56 Bandai Higashi, Osaka 5588558, Japan; [Matsumura, Yosuke] Chiba Univ, Dept Emergency & Crit Care Med, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2600856, Japan; [Ito, Kaori] Teikyo Univ, Div Acute Care Surg, Dept Emergency Med, Sch Med,Itabashi Ku, 2-11-1 Kaga, Tokyo 1738606, Japan; [Ohbe, Hiroyuki; Kushimoto, Shigeki] Tohoku Univ, Div Emergency & Crit Care Med, Grad Sch Med, Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan; [Hayashida, Kei] Keio Univ, Sch Med, Dept Emergency & Crit Care Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Matsumoto, Junichi] St Marianna Univ, Sch Med, Dept Emergency & Crit Care Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan		Kinoshita, T (corresponding author), Osaka Gen Med Ctr, Div Trauma & Surg Crit Care, Sumiyoshi Ku, 3-1-56 Bandai Higashi, Osaka 5588558, Japan.	ogmc.dmat.t.kinoshita@gmail.com	Yamakawa, Kazuma/AAD-3436-2022; Watanabe, Atsushi/AAU-8018-2020; Matsumura, Yosuke/AAP-5800-2021; Ohbe, Hiroyuki/ABB-6008-2021	Yamakawa, Kazuma/0000-0003-2999-4021; Matsumura, Yosuke/0000-0003-4830-3791; Ohbe, Hiroyuki/0000-0001-8544-2569			American College of Surgeons Committee on trauma, 2018, ATLS ADV TRAUM LIF S, V10; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kinoshita T, 2019, ANN SURG, V269, P370, DOI 10.1097/SLA.0000000000002527; Kinoshita T, 2018, WORLD NEUROSURG, V118, pE792, DOI 10.1016/j.wneu.2018.07.053; Kirkpatrick AW, 2014, INJURY, V45, P1413, DOI 10.1016/j.injury.2014.01.021; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Rieger M, 2009, J TRAUMA, V66, P648, DOI 10.1097/TA.0b013e31816275f3; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wada D, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-52; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	19	14	14	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	NOV 29	2018	13								56	10.1186/s13017-018-0218-x			7	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	HC3VZ	WOS:000451732300001	30519279	gold, Green Published			2022-02-06	
J	Vande Vyvere, T; Wilms, G; Claes, L; Leon, FM; Nieboer, D; Verheyden, J; van den Hauwe, L; Pullens, P; Maas, AIR; Parizel, PM				Vande Vyvere, Thijs; Wilms, Guido; Claes, Lene; Leon, Francisco Martin; Nieboer, Daan; Verheyden, Jan; van den Hauwe, Luc; Pullens, Pim; Maas, Andrew I. R.; Parizel, Paul M.		CENTER-TBI Investigators	Central versus Local Radiological Reading of Acute Computed Tomography Characteristics in Multi-Center Traumatic Brain Injury Research	JOURNAL OF NEUROTRAUMA			English	Article						agreement; central radiology review; traumatic brain injury	COMMON DATA ELEMENTS; PROGNOSTIC VALUE; HEAD-INJURY; CT; HEMORRHAGE; DIAGNOSIS; FEATURES; SCAN	Observer variability in local radiological reading is a major concern in large-scale multi-center traumatic brain injury (TBI) studies. A central review process has been advocated to minimize this variability. The aim of this study is to compare central with local reading of TBI imaging datasets and to investigate the added value of central review. A total of 2050 admission computed tomography (CT) scans from subjects enrolled in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study were analyzed for seven main CT characteristics. Kappa statistics were used to calculate agreement between central and local evaluations and a center-specific analysis was performed. The McNemar test was used to detect whether discordances were significant. Central interobserver and intra-observer agreement was calculated in a subset of patients. Good agreement was found between central and local assessment for the presence or absence of structural pathology (CT+, CT-, kappa = 0.73) and most CT characteristics (kappa = 0.62 to 0.71), except for traumatic axonal injury lesions (kappa = 0.37). Despite good kappa values, discordances were significant in four of seven CT characteristics (i.e., midline shift, contusion, traumatic subarachnoid hemorrhage, and cisternal compression; p = 0.0005). Central reviewers showed substantial to excellent interobserver and intra-observer agreement (kappa = 0.73 to kappa = 0.96), contrasted by considerable variability in local radiological reading. Compared with local evaluation, a central review process offers a more consistent radiological reading of acute CT characteristics in TBI. It generates reliable, reproducible data and should be recommended for use in multi-center TBI studies.	[Vande Vyvere, Thijs; van den Hauwe, Luc; Parizel, Paul M.] Antwerp Univ Hosp, Dept Radiol, Antwerp, Belgium; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Antwerp, Belgium; Univ Antwerp, Antwerp, Belgium; [Wilms, Guido; Claes, Lene; Leon, Francisco Martin; Verheyden, Jan; van den Hauwe, Luc] Icometrix, Res & Dev, Leuven, Belgium; [Wilms, Guido] Univ Hosp Leuven, Dept Radiol, Leuven, Belgium; [Wilms, Guido] Katholieke Univ Leuven, Leuven, Belgium; [Nieboer, Daan] Erasmus Univ, Dept Publ Hlth, Rotterdam, Netherlands; [Pullens, Pim] Ghent Univ Hosp, Dept Radiol, Ghent, Belgium		Vande Vyvere, T (corresponding author), Poelsnepstr 11, B-9000 Ghent, Belgium.	thijs.vandevyvere@uantwerpen.be	Lagares, Alfonso/B-2969-2011; Boogert, Hugo F den/B-2782-2016; Posti, Jussi P./Y-2908-2019; Vande Vyvere, Thijs/AAB-5180-2022; Poca, Maria A./B-8475-2008; Maas, Andrew IR/C-5584-2013; Gomez, Pedro/N-5051-2019; Cooper, D. James/G-7961-2013; Santos, Edgar/AAV-2506-2021; Badenes, Rafael/K-6628-2019; Sahuquillo, Juan/B-3577-2008; Lanyon, Linda/L-9238-2019; Golubovic, Jagos/AAD-1270-2019; Volovici, Victor/AAZ-8901-2020; Radoi, Andreea/N-5613-2019; Castano-Leon, Ana M/ABF-6322-2020; Raj, Rahul/K-7693-2012	Lagares, Alfonso/0000-0003-3996-0554; Posti, Jussi P./0000-0002-5925-5193; Vande Vyvere, Thijs/0000-0003-4032-5443; Poca, Maria A./0000-0002-3831-0536; Maas, Andrew IR/0000-0003-1612-1264; Gomez, Pedro/0000-0002-4185-5238; Cooper, D. James/0000-0002-5872-9051; Santos, Edgar/0000-0002-8976-5549; Badenes, Rafael/0000-0001-7017-0150; Sahuquillo, Juan/0000-0003-0713-5875; Lanyon, Linda/0000-0002-0885-1825; Golubovic, Jagos/0000-0001-5524-246X; Volovici, Victor/0000-0002-5798-5360; Radoi, Andreea/0000-0002-0677-3544; Castano-Leon, Ana M/0000-0002-7918-5049; Raj, Rahul/0000-0003-4243-9591; Stewart, William/0000-0003-2199-2582; Dippel, Diederik/0000-0002-9234-3515; Coles, Jonathan/0000-0003-4013-679X; Kolias, Angelos/0000-0003-3992-0587; , Johnny/0000-0003-4138-2589; Sanchez-Porras, Renan/0000-0002-9084-8114; Parizel, Paul M./0000-0002-0221-2854; Blaabjerg, Morten/0000-0001-6007-1861; Newcombe, Virginia/0000-0001-6044-9035; Esser, Patrick/0000-0002-3227-0115; Dawes, Helen/0000-0002-2933-5213; Sakowitz, Oliver/0000-0003-3248-6335; Van Essen, Thomas/0000-0003-4657-5283; Wessels, lars/0000-0001-8056-9659; Rossi, Sandra/0000-0002-9963-8121	European Commission 7th Framework program [602150]; Hannelore Kohl Foundation (Germany); non-profit organization One Mind	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project supported by the European Commission 7th Framework program (602150). Funding of additional elements has been provided by the Hannelore Kohl Foundation (Germany) and by the non-profit organization One Mind.	Azian AA, 2001, ACTA NEUROCHIR, V143, P711, DOI 10.1007/s007010170051; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Chesnut R M, 1991, Neurosurg Clin N Am, V2, P267; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Ford R, 2009, EUR J CANCER, V45, P268, DOI 10.1016/j.ejca.2008.10.031; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Harburg L, 2017, BRAIN INJURY, V31, P174, DOI 10.1080/02699052.2016.1225989; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Huff JS, 2014, AM J EMERG MED, V32, P606, DOI 10.1016/j.ajem.2014.03.010; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Karantanas AH, 2005, C EXTRA CASES, V29, P1; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kisat M, 2012, J SURG RES, V173, P31, DOI 10.1016/j.jss.2011.04.059; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193278; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Marion DW, 2006, NEUROSURGERY, V58, P655; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Provenzale J, 2007, EMERG RADIOL, V14, P1, DOI 10.1007/s10140-007-0587-z; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; US Department of Health and Human Services Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER), 2004, CLIN MED GUID IND DE; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	34	14	14	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1080	1092		10.1089/neu.2018.6061		NOV 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6CG	WOS:000450729800001	30259789	Green Submitted			2022-02-06	
J	Chitturi, J; Li, Y; Santhakumar, V; Kannurpatti, SS				Chitturi, Jyothsna; Li, Ying; Santhakumar, Vijayalakshmi; Kannurpatti, Sridhar S.			Early behavioral and metabolomic change after mild to moderate traumatic brain injury in the developing brain	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; Sensorimotor behavior; Metabolomics; Glycolysis; TCA cycle; Mass spectrometry; Liquid chromatography; Pediatric; Glycolysis; Fluid percussion	N-ACETYL-ASPARTATE; METHYL-D-ASPARTATE; IMMATURE; RATS; SEVERITY; NEUROTOXICITY; METABOANALYST; DISTURBANCES; DYSFUNCTION; INHIBITION	Pathophysiology of developmental traumatic brain injury (TBI) is unique due to intrinsic differences in the developing brain. Energy metabolic studies of the brain during early development (P13 to P30) have indicated acute oxidative energy metabolic decreases below 24 h after TBI, which generally recovered by 48 h. However, marked neurodegeneration and altered neural functional connectivity have been observed at later stages into adolescence. As secondary neurodegeneration is most prominent during the first week after TBI in the rat model, we hypothesized that the subacute TBI-metabolome may contain predictive markers of neurodegeneration. Sham and TBI metabolomes were examined at 72 h after a mild to moderate intensity TBI in male Sprague-Dawley rats aged P31. Sensorimotor behavior was assessed at 24, 48 and 72 h after injury, followed by 72-hour postmortem brain removal for metabolomics using Liquid Chromatography/Mass Spectrometry (LC-MS) measurement. Broad TBI-induced metabolomic shifts occurred with relatively higher intensity in the injury-lateralized (ipsilateral) hemisphere. Intensity of metabolomic perturbation correlated with the extent of sensorimotor behavioral deficit. N-acetyl-aspartate (NAA) levels at 72 h after TBI, predicted the extent of neurodegeneration assessed histochemically 7-days post TBI. Results from the multivariate untargeted approach clearly distinguished metabolomic shifts induced by TBI. Several pathways including amino acid, fatty acid and energy metabolism continued to be affected at 72 h after TBI, whose collective effects may determine the overall pathological response after TBI in early development including neurodegeneration.	[Chitturi, Jyothsna; Kannurpatti, Sridhar S.] Rutgers New Jersey Med Sch, Dept Radiol, Adm Complex Bldg 5 ADMC5,30 Bergen St Room 575, Newark, NJ 07101 USA; [Li, Ying; Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, MSB-H-512,512,185 S Orange Ave, Newark, NJ 07103 USA; [Santhakumar, Vijayalakshmi] Univ Calif Riverside, Mol Cell & Syst Biol, Spieth 1308,3401 Watkins Dr, Riverside, CA 92521 USA		Kannurpatti, SS (corresponding author), Univ Med & Dent New Jersey, Dept Radiol, Rutgers Biomed & Hlth Sci, ADMC 5,Room 575,30 Bergen St, Newark, NJ 07101 USA.	jc2248@njms.rutgers.edu; yl691@njms.rutgers.edu; santhavi@njms.rutgers.edu; kannursr@njms.rutgers.edu	Chitturi, Jyothsna/AAR-3986-2020; Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187	New Jersey Commission on Brain Injury Research [CBIR15IRG010]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097750]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861, R01NS097750] Funding Source: NIH RePORTER	This study was supported by funding from the New Jersey Commission on Brain Injury Research (CBIR15IRG010; SK), and National Institutes of Health (R01NS097750; VS). The authors thank Drs. Guoan Zhang and Zhe Cheng from the Proteomics and Metabolomics Core Facility, Weill Cornell Medicine, New York, NY for assistance in sample preparation and performance of the LC-MS measurements.	Al-Samsam RH, 2000, J NEUROTRAUM, V17, P31, DOI 10.1089/neu.2000.17.31; Alessandri B, 2000, NEUROL RES, V22, P705; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1044-3; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0957-1; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Daley M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1131-5; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Glenn Thomas C, 2013, Acta Neurochir Suppl, V118, P115, DOI 10.1007/978-3-7091-1434-6_20; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; MCDONALD JW, 1988, ANN NEUROL, V24, P337; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Murugan M, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00019; NETOPILOVA M, 1995, EPILEPSY RES, V20, P179, DOI 10.1016/0920-1211(94)00068-8; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Parent M, 2019, J NEUROTRAUM, V36, P601, DOI 10.1089/neu.2018.5741; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Quinn M, 2014, DIGEST LIVER DIS, V46, P527, DOI 10.1016/j.dld.2014.01.159; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schubring SR, 2012, NEUROSCI LETT, V506, P322, DOI 10.1016/j.neulet.2011.11.036; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; TALLAN HH, 1956, J BIOL CHEM, V219, P257; Tang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096944; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zadori D, 2012, J NEUROL SCI, V322, P187, DOI 10.1016/j.jns.2012.06.004; Zheng F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182025; Zheng XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24125	52	14	14	1	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2018	120						75	86		10.1016/j.neuint.2018.08.003			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GX5VR	WOS:000447819600008	30098378	Green Accepted, Bronze			2022-02-06	
J	Hwang, JH; Kumar, RV; Kang, SY; Jung, HW; Park, YK				Hwang, Ji Hye; Kumar, Vinoth R.; Kang, Seok Yong; Jung, Hyo Won; Park, Yong-Ki			Effects of Flower Buds Extract of Tussilago farfara on Focal Cerebral Ischemia in Rats and Inflammatory Response in BV2 Microglia	CHINESE JOURNAL OF INTEGRATIVE MEDICINE			English	Article						Tussilago farfara; focal cerebral ischemia; inflammation; microglia; tussilagone	TRAUMATIC BRAIN-INJURY; STROKE; CELLS; SESQUITERPENOIDS; NEURONS; DISEASE; NEUROTOXICITY; RECOGNITION; MECHANISMS; EXPRESSION	Objective: To investigate the effects of the flower buds extract of Tussilago farfara Linne (Farfarae Flos; FF) on focal cerebral ischemia through regulation of inflammatory responses in activated microglia. Methods: Brain ischemia was induced in Sprague-Dawley rats by a transient middle cerebral artery occlusion (tMCAO) for 90 min and reperfusion for 24 h. Twenty rats were randomly divided into 4 groups (n=5 per group): normal, tMCAO-induced ischemic control, tMCAO plus FF extract 300 mg/kg-treated, and tMCAO plus MK-801 1 mg/kg-treated as reference drug. FF extract (300 mg/kg, p.o.) or MK-801 (1 mg/kg, i.p.) was administered after reperfusion. Brain infarction was measured by 2,3,5,-triphenyltetrazolium chloride staining. Neuronal damage was observed by haematoxylin eosin, Nissl staining and immunohistochemistry using anti-neuronal nuclei (NeuN), anti-glial fibrillary acidic protein (GFAP), and anti-CD11b/c (OX42) antibodies in ischemic brain. The expressions of inducible nitric oxide synthase (iNOS), tumor necrosis factor (TNF- alpha ), and hypoxia-inducible factor-1 alpha (HIF-1 alpha) were determined by Western blot. BV2 microglial cells were treated with FF extract or its main bioactive compound, tussilagone with or without lipopolysaccharide (LPS). Nitric oxide (NO) production was measured in culture medium by Griess assay. The expressions of iNOS, COX-2 and pro-inflammatory cytokines mRNA were analyzed by reverse transcription-polymerase chain reaction. The expression of iNOS, and COX-2 proteins, the phosphorylation of ERK1/2, JNK, and p38 MAPK and the nuclear expression of NF-kappa B p65 in BV2 cells were determined by Western blot. Results: FF extract significantly decreased brain infarctions in ischemic rats (P<0.01). The neuronal death and the microglia/astrocytes activation in ischemic brains were inhibited by FF extract. FF extract also suppressed iNOS, TNF-alpha, and HIF-1 alpha expression in ischemic brains. FF extract (0.2 and 0.5 mg/mL, P<0.01) and tussilagone 20 and 50 mu mol/L, P<0.01) significantly decreased LPS-induced NO production in BV2 microglia through downregulation of iNOS mRNA and protein expression. FF extract and tussilagone significantly inhibited LPS-induced expression of TNF-alpha, IL-1 beta, and IL-6 mRNA, and also suppressed the phosphorylation of ERK1/2, JNK and p38 MAPK and the nuclear expression of NF- kappa B in a dose-dependent manner. Conclusion: FF extract has a neuroprotective effect in ischemic stroke by the decrease of brain infarction, and the inhibition of neuronal death and microglial activation-mediated inflammatory responses.	[Hwang, Ji Hye] Gachon Univ, Dept Acupuncture & Moxibust Med, Coll Korean Med, Seongnam 13120, South Korea; [Kumar, Vinoth R.; Kang, Seok Yong; Jung, Hyo Won; Park, Yong-Ki] Dongguk Univ, Dept Herbol, Coll Korean Med, Gyeongju 38066, South Korea		Park, YK (corresponding author), Dongguk Univ, Dept Herbol, Coll Korean Med, Gyeongju 38066, South Korea.	yongki@dongguk.ac.kr	Rethineswaran, Vinoth Kumar/AAE-5917-2019; Hwang, Ji Hye/R-9219-2017	Hwang, Ji Hye/0000-0002-6304-1972	Ministry of Food and Drug Safety, Republic of KoreaMinistry of Food & Drug Safety (MFDS) [12172MFDS989]	Supported by the grant from Ministry of Food and Drug Safety in 2014 (No. 12172MFDS989), Republic of Korea	Amantea D, 2014, CURR MED CHEM, V21, P2098, DOI 10.2174/0929867321666131227162634; Ayala GX, 2005, EUR J NEUROSCI, V22, P3067, DOI 10.1111/j.1460-9568.2005.04509.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boje K.M., 1992, BRAIN RES, V853, P236; Bora KS, 2011, PHARM BIOL, V49, P175, DOI 10.3109/13880209.2010.506489; Cho JS, 2005, BIOL PHARM BULL, V28, P440; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Fluri F, 2015, DRUG DES DEV THER, V9, P3445, DOI 10.2147/DDDT.S56071; Gao HM, 2003, J NEUROSCI, V23, P1228, DOI 10.1523/JNEUROSCI.23-04-01228.2003; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hoozemans JJM, 2003, CURR DRUG TARGETS, V4, P461, DOI 10.2174/1389450033490902; Hwangbo C, 2009, INT IMMUNOPHARMACOL, V9, P1578, DOI 10.1016/j.intimp.2009.09.016; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ip FCF, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1417-1; Jang H, 2016, ARCH PHARM RES, V39, P127, DOI 10.1007/s12272-015-0667-7; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jordan J, 2008, CURR PHARM DESIGN, V14, P3549, DOI 10.2174/138161208786848766; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kim MS, 2016, J MED FOOD, V19, P196, DOI 10.1089/jmf.2015.3512; Kocaeli H, 2005, SURG NEUROL, V64, P22, DOI 10.1016/j.surneu.2005.07.034; Kokoska L, 2002, J ETHNOPHARMACOL, V82, P51, DOI 10.1016/S0378-8741(02)00143-5; Li H, 2014, BIOCHEM BIOPH RES CO, V443, P132, DOI 10.1016/j.bbrc.2013.11.062; Li W, 2012, FITOTERAPIA, V83, P318, DOI 10.1016/j.fitote.2011.11.011; Lim HJ, 2008, ARCH PHARM RES, V31, P645, DOI 10.1007/s12272-001-1207-4; Lim HJ, 2015, J ENZYM INHIB MED CH, V30, P852, DOI 10.3109/14756366.2014.965701; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Park Y, 2014, INT IMMUNOPHARMACOL, V22, P400, DOI 10.1016/j.intimp.2014.07.023; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Scali C, 2003, NEUROSCIENCE, V117, P909, DOI 10.1016/S0306-4522(02)00839-4; Seo UM, 2015, CHEM PHARM BULL, V63, P546, DOI 10.1248/cpb.c15-00204; Svensson C, 2010, BRAIN RES, V1322, P1, DOI 10.1016/j.brainres.2010.01.082; Tzeng Shun-Fen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P335, DOI 10.2174/1568010054022051; Zhi HJ, 2012, PHYTOCHEM ANALYSIS, V23, P492, DOI 10.1002/pca.2346	34	14	17	0	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0415	1993-0402		CHIN J INTEGR MED	Chin. J. Integr. Med.	NOV	2018	24	11					844	852		10.1007/s11655-018-2936-4			9	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	GX5OG	WOS:000447797700008	30090976				2022-02-06	
J	Cogan, AM; Carlson, M				Cogan, Alison M.; Carlson, Mike			Deciphering participation: an interpretive synthesis of its meaning and application in rehabilitation	DISABILITY AND REHABILITATION			English	Article						Participation; community integration; engagement; healthcare; clinical practice; rehabilitation	TRAUMATIC BRAIN-INJURY; DISABILITY-AND-HEALTH; INTERNATIONAL-CLASSIFICATION; OCCUPATIONAL-THERAPY; PATIENT PARTICIPATION; SOCIAL-PARTICIPATION; DECISION-MAKING; SELF-EFFICACY; INPATIENT REHABILITATION; COMMUNITY PARTICIPATION	Purpose: Participation is widely recognized as an important outcome for rehabilitation. However, it lacks a universally accepted definition. The purpose of this review is to synthesize the literature about participation in rehabilitation in order to clarify the term and increase its usefulness for rehabilitation providers and researchers. Methods: We undertook an interpretive synthesis of the literature, drawing from a broad and varied selection of the vast number of publications on the subject of participation. The search and analysis was iterative and continued until saturation of themes was achieved. Results and Conclusions: Seventy-six articles were included in our analysis. We argue that three essential dimensions - performance, subjective experience, and interpersonal connection - constitute participation. We further divide participation into community-based and interventional contexts. Interventional participation is circumscribed by the treatment setting, whereas community-based encompasses all other areas. Participation in either interventional or community-based contexts is largely determined by the available opportunities from which a person can choose, with such opportunities affected by conditions that are either internal or external to the individual. As defined in this framework, participation is not inherently good or bad; rather, its effect is determined by a person's unique life circumstances and the impact may not always be apparent. We posit this model as a resource for future research as well as clinical reasoning.	[Cogan, Alison M.; Carlson, Mike] Univ Southern Calif, Mrs TH Chan Div Occupat Sci & Occupat Therapy, 1540 Alcazar St,CHP-133, Los Angeles, CA 90089 USA		Cogan, AM (corresponding author), Univ Southern Calif, Mrs TH Chan Div Occupat Sci & Occupat Therapy, 1540 Alcazar St,CHP-133, Los Angeles, CA 90089 USA.	acogan@usc.edu	Cogan, Alison/AAS-3101-2021	Cogan, Alison/0000-0002-6800-1988			Allen M. L., 2015, ADM POLICY MENTAL HL, V44, P431; American Academy of Physical Medicine Rehabilitation, 2016, WHAT COND PHYS TREAT; [Anonymous], 2013, US ICF PRACT MAN US; Austin W, 2005, ETHICS BEHAV, V15, P197, DOI 10.1207/s15327019eb1503_1; Babulal Ganesh M, 2015, BMC Psychol, V3, P36, DOI 10.1186/s40359-015-0093-0; Babulal GM, 2015, TOP STROKE REHABIL, V22, P144, DOI 10.1179/1074935714Z.0000000012; Badley EM, 2008, SOC SCI MED, V66, P2335, DOI 10.1016/j.socscimed.2008.01.026; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Baum CM, 2011, ARCH PHYS MED REHAB, V92, P169, DOI 10.1016/j.apmr.2010.12.010; Baumgartner JN, 2014, INT J EPIDEMIOL, V43, P354, DOI 10.1093/ije/dyt224; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; Berg K, 2016, DISABIL REHABIL, V38, P870, DOI 10.3109/09638288.2015.1066453; Bernabeo E, 2013, HEALTH AFFAIR, V32, P250, DOI 10.1377/hlthaff.2012.1120; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Bosmans MWG, 2015, J BEHAV MED, V38, P642, DOI 10.1007/s10865-015-9638-1; Bright FAS, 2015, DISABIL REHABIL, V37, P643, DOI 10.3109/09638288.2014.933899; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Brown M, 2010, ARCH PHYS MED REHAB, V91, pS34, DOI 10.1016/j.apmr.2009.11.030; Brymer E, 2013, PSYCHOL SPORT EXERC, V14, P865, DOI 10.1016/j.psychsport.2013.07.004; Buntin MB, 2007, ARCH PHYS MED REHAB, V88, P1488, DOI 10.1016/j.apmr.2007.07.023; Cardol M, 2002, DISABIL REHABIL, V24, P970, DOI 10.1080/09638280210151996; Carman KL, 2013, HEALTH AFFAIR, V32, P223, DOI 10.1377/hlthaff.2012.1133; Catrine A, 2010, INT J NURS TERMIN CL, V21, P21, DOI 10.1111/j.1744-618X.2009.01141.x; Center for Advancing Health, 2010, NEW DEF PAT ENG WHAT; Chan DK, 2009, ARCH PHYS MED REHAB, V90, P1977, DOI 10.1016/j.apmr.2009.05.024; Chang FH, 2014, ARCH PHYS MED REHAB, V95, P1791, DOI 10.1016/j.apmr.2014.05.008; Chang FH, 2013, ARCH PHYS MED REHAB, V94, P771, DOI 10.1016/j.apmr.2012.10.031; Charlton CR, 2008, J AM ACAD NURSE PRAC, V20, P382, DOI 10.1111/j.1745-7599.2008.00336.x; CLARK F, 1993, AM J OCCUP THER, V47, P1067, DOI 10.5014/ajot.47.12.1067; CLARK FA, 1991, AM J OCCUP THER, V45, P300, DOI 10.5014/ajot.45.4.300; Crabtree Jeffrey L, 2003, Occup Ther Health Care, V17, P1, DOI 10.1080/J003v17n02_01; Crepeau EB, 2016, DISABIL REHABIL, V38, P2419, DOI 10.3109/09638288.2015.1129443; Dalemans RJP, 2010, INT J LANG COMM DIS, V45, P537, DOI 10.3109/13682820903223633; de Haes H, 2009, PATIENT EDUC COUNS, V74, P287, DOI 10.1016/j.pec.2008.12.006; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; Desrosiers J, 2008, NEUROREHAB NEURAL RE, V22, P288, DOI 10.1177/1545968307307116; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Dixon-Woods M., 2006, QUAL RES, V6, P27, DOI [https://doi.org/10.1177/1468794106058867, DOI 10.1177/1468794106058867]; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Doble Susan E, 2008, Can J Occup Ther, V75, P184; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Eakman AM, 2010, INT J AGING HUM DEV, V70, P299, DOI 10.2190/AG.70.4.b; EHRLICH I, 1973, J POLIT ECON, V81, P521, DOI 10.1086/260058; Eisenhart M, 1998, REV EDUC RES, V68, P391, DOI 10.3102/00346543068004391; Eldh AC, 2006, NURS ETHICS, V13, P503, DOI 10.1191/0969733006nej898oa; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Erikson A, 2010, J REHABIL MED, V42, P831, DOI 10.2340/16501977-0608; Eyssen IC, 2011, ARCH PHYS MED REHAB, V92, P983, DOI 10.1016/j.apmr.2011.01.006; Faber MJ, 2014, INT J CARE COORD, V17, P72, DOI 10.1177/2053435414540616; Fiscella K, 2002, MED CARE, V40, P52, DOI 10.1097/00005650-200201000-00007; Fougeyrollas P, 1998, INT J REHABIL RES, V21, P127, DOI 10.1097/00004356-199806000-00002; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Fry PS, 2000, AGING MENT HEALTH, V4, P375, DOI 10.1080/713649965; Galvaan R., 2012, OCCUPATIONAL SCI, P152; Guptill C, 2012, J OCCUP SCI, V19, P258, DOI 10.1080/14427591.2012.670901; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Hammell KRW, 2014, CAN J OCCUP THER, V81, P39, DOI 10.1177/0008417413520489; Hammell KRW, 2013, SCAND J OCCUP THER, V20, P174, DOI 10.3109/11038128.2012.752032; Hammell Karen Whalley, 2004, Can J Occup Ther, V71, P296; Hartley MT, 2016, REHABIL RES POL EDUC, V30, P32, DOI 10.1891/2168-6653.30.1.32; Heaton J, 2012, INT J INTEGR CARE, V12; Heinemann AW, 2010, ARCH PHYS MED REHAB, V91, pS72, DOI 10.1016/j.apmr.2009.11.031; Hemmingsson H, 2005, AM J OCCUP THER, V59, P569, DOI 10.5014/ajot.59.5.569; Hendricks J, 2011, HDB AGING HDB AGING, P301; Hicks E, 2012, J AGING STUD, V26, P140, DOI 10.1016/j.jaging.2011.10.004; Hocking C, 2009, J OCCUP SCI, V16, P140, DOI 10.1080/14427591.2009.9686655; Houston Susan, 2013, J Clin Ethics, V24, P98; Hoving C, 2010, PATIENT EDUC COUNS, V78, P275, DOI 10.1016/j.pec.2010.01.015; Jackson J, 2010, DISABIL REHABIL, V32, P567, DOI 10.3109/09638280903183829; Jellema S, 2016, ARCH PHYS MED REHAB, V97, P991, DOI 10.1016/j.apmr.2016.01.015; Joseph-Williams N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3178; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; Kjellberg A, 2012, SCAND J OCCUP THER, V19, P421, DOI 10.3109/11038128.2011.627378; Kortte KB, 2007, ARCH PHYS MED REHAB, V88, P877, DOI 10.1016/j.apmr.2007.03.030; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Law M, 1990, Can J Occup Ther, V57, P82; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; Levasseur Melanie, 2007, Can J Occup Ther, V74 Spec No., P233; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Leven N.V.T., 2002, SCAND J OCCUP THER, V9, P148; LITTLE BR, 1983, ENVIRON BEHAV, V15, P273, DOI 10.1177/0013916583153002; Lund ML, 2005, J REHABIL MED, V37, P3, DOI 10.1080/16501970410031246; Magasi S, 2009, J REHABIL MED, V41, P936, DOI 10.2340/16501977-0450; Mallinson T, 2010, ARCH PHYS MED REHAB, V91, pS29, DOI 10.1016/j.apmr.2010.04.027; Manary MP, 2013, NEW ENGL J MED, V368, P201, DOI 10.1056/NEJMp1211775; Marszalek J, 2017, ARTHRIT CARE RES, V69, P491, DOI 10.1002/acr.22969; Mazzi MA, 2013, PATIENT EDUC COUNS, V90, P347, DOI 10.1016/j.pec.2011.06.010; Muhlbacher AC, 2013, APPL HEALTH ECON HEA, V11, P163, DOI 10.1007/s40258-013-0023-3; NELSON DL, 1988, AM J OCCUP THER, V42, P633, DOI 10.5014/ajot.42.10.633; Nordenfelt L, 2006, DISABIL REHABIL, V28, P1461, DOI 10.1080/09638280600925886; Ozelie R, 2009, J SPINAL CORD MED, V32, P283, DOI 10.1080/10790268.2009.11760782; Palmadottir G., 2006, BR J OCCUP THER, V69, P394, DOI DOI 10.1177/030802260606900902; Partington S, 2009, SPORT PSYCHOL, V23, P170, DOI 10.1123/tsp.23.2.170; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pierce D, 2001, AM J OCCUP THER, V55, P138, DOI 10.5014/ajot.55.2.138; Piskur B, 2014, CLIN REHABIL, V28, P211, DOI 10.1177/0269215513499029; Pyatak EA, 2013, ARCH PHYS MED REHAB, V94, P1190, DOI 10.1016/j.apmr.2012.12.009; Reed K, 2010, J OCCUP SCI, V17, P140, DOI 10.1080/14427591.2010.9686688; Reed KD, 2011, CAN J OCCUP THER, V78, P303, DOI 10.2182/cjot.2011.78.5.5; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Rettke H, 2015, REHABIL NURS, V40, P209, DOI 10.1002/rnj.157; Ridgway E, 2016, EUR J CANCER CARE, V25, P348, DOI 10.1111/ecc.12258; Rieckmann P, 2015, MULT SCLER RELAT DIS, V4, P202, DOI 10.1016/j.msard.2015.02.005; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Roberts K, 2002, J ADV NURS, V40, P413, DOI 10.1046/j.1365-2648.2002.02389.x; Saegert S, 2004, AM J COMMUN PSYCHOL, V34, P219, DOI 10.1007/s10464-004-7416-2; Schoeb V, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.516; Schyve PM, 2007, J GEN INTERN MED, V22, P360, DOI 10.1007/s11606-007-0365-3; Seekins T, 2012, DISABIL HEALTH J, V5, P224, DOI 10.1016/j.dhjo.2012.05.002; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Jesus TS, 2016, CLIN REHABIL, V30, P315, DOI 10.1177/0269215515585133; Skidmore ER, 2010, ARCH PHYS MED REHAB, V91, P203, DOI 10.1016/j.apmr.2009.10.026; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Suri H, 2011, QUAL RES J, V11, P63, DOI 10.3316/QRJ1102063; Suri H, 2009, REV EDUC RES, V79, P395, DOI 10.3102/0034654308326349; Thompson AGH, 2007, SOC SCI MED, V64, P1297, DOI 10.1016/j.socscimed.2006.11.002; Townsend A, 2006, CHRONIC ILLN, V2, P185, DOI 10.1179/174592006X129518; Turner-Cobb JM, 2015, PSYCHOL HEALTH, V30, P495, DOI 10.1080/08870446.2014.991735; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Van Brakel WH, 2006, DISABIL REHABIL, V28, P193, DOI 10.1080/09638280500192785; Verdonschot MML, 2009, J INTELL DISABIL RES, V53, P54, DOI 10.1111/j.1365-2788.2008.01128.x; Vogel BA, 2009, PATIENT EDUC COUNS, V77, P391, DOI 10.1016/j.pec.2009.09.005; Wade D, 2015, CLIN REHABIL, V29, P1145, DOI 10.1177/0269215515601175; Wain HR, 2008, ARCH PHYS MED REHAB, V89, P1366, DOI 10.1016/j.apmr.2007.11.050; Weed M, 2008, INT J SOC RES METHOD, V11, P13, DOI 10.1080/13645570701401222; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Wilcock A., 1993, J OCCUP SCI, V1, P17; Williamson L, 2014, AM J BIOETHICS, V14, P4, DOI 10.1080/15265161.2014.900139; World Health Organization, 2002, COMM LANG FUNCT DIS; Zachariae R, 2003, BRIT J CANCER, V88, P658, DOI 10.1038/sj.bjc.6600798; Zeuner R, 2015, HEALTH EXPECT, V18, P2465, DOI 10.1111/hex.12216	136	14	14	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 23	2018	40	22					2692	2703		10.1080/09638288.2017.1342282			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GX4PP	WOS:000447717100011	28633542				2022-02-06	
J	Davies, DJ; Clancy, M; Dehghani, H; Lucas, SJE; Forcione, M; Yakoub, KM; Belli, A				Davies, David James; Clancy, Michael; Dehghani, Hamid; Lucas, Samuel John Edwin; Forcione, Mario; Yakoub, Kamal Makram; Belli, Antonio			Cerebral Oxygenation in Traumatic Brain Injury: Can a Non-Invasive Frequency Domain Near-Infrared Spectroscopy Device Detect Changes in Brain Tissue Oxygen Tension as Well as the Established Invasive Monitor?	JOURNAL OF NEUROTRAUMA			English	Article						brain tissue oxygen tension; cerebral hypoxia; cerebral non-invasive monitoring; critical care; frequency domain near-infrared spectroscopy; traumatic brain injury	PRESSURE	The cost and highly invasive nature of brain monitoring modality in traumatic brain injury patients currently restrict its utility to specialist neurological intensive care settings. We aim to test the abilities of a frequency domain near-infrared spectroscopy (FD-NIRS) device in predicting changes in invasively measured brain tissue oxygen tension. Individuals admitted to a United Kingdom specialist major trauma center were contemporaneously monitored with an FD-NIRS device and invasively measured brain tissue oxygen tension probe. Area under the curve receiver operating characteristic (AUROC) statistical analysis was utilized to assess the predictive power of FD-NIRS in detecting both moderate and severe hypoxia (20 and 10mm Hg, respectively) as measured invasively. Sixteen individuals were prospectively recruited to the investigation. Severe hypoxic episodes were detected in nine of these individuals, with the NIRS demonstrating a broad range of predictive abilities (AUROC 0.68-0.88) from relatively poor to good. Moderate hypoxic episodes were detected in seven individuals with similar predictive performance (AUROC 0.576-0.905). A variable performance in the predictive powers of this FD-NIRS device to detect changes in brain tissue oxygen was demonstrated. Consequently, this enhanced NIRS technology has not demonstrated sufficient ability to replace the established invasive measurement.	[Davies, David James; Clancy, Michael; Forcione, Mario; Yakoub, Kamal Makram; Belli, Antonio] Univ Hosp Birmingham NHS Fdn Trust, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Dehghani, Hamid] Univ Birmingham, Sch Comp Sci, Birmingham, W Midlands, England; [Lucas, Samuel John Edwin] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England		Davies, DJ (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, NIHR, SRMRC, Old Queen Elizabeth Hosp, Heritage Bldg, Birmingham B15 2TH, W Midlands, England.	david.davies@uhb.nhs.uk	Lucas, Samuel/AAR-8980-2021; Belli, Antonio/I-3799-2015; Lucas, Samuel/J-4124-2014; Forcione, Mario/K-2852-2018	Lucas, Samuel/0000-0002-8713-2457; Belli, Antonio/0000-0002-3211-9933; Lucas, Samuel/0000-0002-8713-2457; Forcione, Mario/0000-0002-4045-8011; Dehghani, Hamid/0000-0003-4117-0412			Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clancy M., 2015, DIFFUSE OPT IMAGING, P9538; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Genbrugge C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0837-5; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; GOPINATH SP, 1993, J NEUROSURG, V79, P43, DOI 10.3171/jns.1993.79.1.0043; Guyot LL, 1998, ACT NEUR S, V71, P47; Helliwell R., 2009, BR J NEUROSCI NURS, V5, P22; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; KNOPP JA, 1972, BIOCHIM BIOPHYS ACTA, V279, P393, DOI 10.1016/0304-4165(72)90158-4; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; McMahon N, 2012, ANAESTHESIA, V67, P1343, DOI 10.1111/j.1365-2044.2012.07302.x; Minagawa-Kawai Y, 2008, DEV NEUROBIOL, V68, P712, DOI 10.1002/dneu.20618; Munch E, 1998, ACTA NEUROCHIR, V140, P1113, DOI 10.1007/s007010050224; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Sen AN, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031409; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Sussman ES, 2014, J NEUROSURG, V120, P931, DOI 10.3171/2013.12.JNS131685; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Vos JJ, 2014, BRIT J ANAESTH, V113, P67, DOI 10.1093/bja/aeu091; Weatherall A, 2012, ACTA ANAESTH SCAND, V56, P172, DOI 10.1111/j.1399-6576.2011.02591.x; White BR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3368999; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278	30	14	16	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1175	1183		10.1089/neu.2018.5667		OCT 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6CL	WOS:000447717900001	29877139	Green Published			2022-02-06	
J	Barker, LC; Stewart, DE; Vigod, SN				Barker, Lucy Church; Stewart, Donna E.; Vigod, Simone N.			Intimate Partner Sexual Violence: An Often Overlooked Problem	JOURNAL OF WOMENS HEALTH			English	Article						intimate partner violence; sexual violence; intimate partner sexual violence; spouse abuse; mental health	TRAUMATIC BRAIN-INJURY; WOMENS MENTAL-HEALTH; DOMESTIC VIOLENCE; ASSAULT; SYMPTOMS; VICTIMS; IMPACT; ABUSE; CONSEQUENCES; PREVALENCE	Background: Intimate partner sexual violence (IPSV) is a common but often overlooked form of intimate partner violence (IPV) that may have unique consequences for those who experience it. We aimed to explore how outcomes associated with IPSV differ from outcomes associated with other forms of intimate partner and sexual violence. Methods: We conducted a narrative review of the English-language literature, including original research studies and reports that focused on outcomes associated with IPSV. We aimed to quantify the risk for health outcomes associated with exposure to IPSV in comparison with exposure to other forms of interpersonal violence or nonexposure to interpersonal violence. Results: Twenty-eight publications were reviewed, most were small observational studies focused on women exposed to IPSV. Reported outcomes were related to mental health (n=20 studies), physical and sexual health (n=19 studies), and health of children with a parent exposed to IPSV (n=1 study). Compared with other forms of interpersonal violence, exposure to IPSV was associated with greater risk for posttraumatic stress disorder and depressive symptoms, problematic substance use, suicidality, pain and other somatic symptoms, adverse sexual health problems, specific physical injuries including strangulation, and death by homicide. Children with an exposed parent were at higher risk for internalizing symptoms such as depression, anxiety, and somatization. Conclusions: Sexual violence in intimate partner relationships is common and has distinct consequences compared with other forms of interpersonal violence including elevated risks for suicidality and death by homicide. It should be given special consideration within the assessment and management of interpersonal violence.	[Barker, Lucy Church; Stewart, Donna E.; Vigod, Simone N.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Stewart, Donna E.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Vigod, Simone N.] Womens Coll Hosp & Res Inst, Dept Psychiat, Toronto, ON, Canada		Vigod, SN (corresponding author), Womens Coll Hosp, Womens Mental Hlth Program, Reprod Life Stages Program, 76 Grenville St Rm 7234, Toronto, ON M5S 1B2, Canada.	simone.vigod@wchospital.ca	Stewart, Donna Eileen E/J-2844-2016	Stewart, Donna Eileen E/0000-0002-8157-7746			Ali FA, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-77; American Psychological Association, 2017, CLIN PRACT GUID TREA; Bagwell-Gray ME, 2015, TRAUMA VIOLENCE ABUS, V16, P316, DOI 10.1177/1524838014557290; Bennice Jennifer A, 2003, Violence Vict, V18, P87, DOI 10.1891/vivi.2003.18.1.87; Breiding MJ., 2015, INTIMATE PARTNER VIO; Breiding MJ, 2002, MORBIDITY MORTALITY; Campbell JC, 2007, TRAUMA VIOLENCE ABUS, V8, P246, DOI 10.1177/1524838007303505; CAMPBELL JC, 1989, AM J NURS, V89, P946, DOI 10.2307/3426372; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Cavanaugh CE, 2011, SUICIDE LIFE-THREAT, V41, P372, DOI 10.1111/j.1943-278X.2011.00035.x; Chen PH, 2009, J HEALTH CARE POOR U, V20, P569, DOI 10.1353/hpu.0.0145; Decker MR, 2014, J ADOLESCENT HEALTH, V55, pS58, DOI 10.1016/j.jadohealth.2014.08.022; Deitz MF, 2015, VIOLENCE AGAINST WOM, V21, P598, DOI 10.1177/1077801215573330; Dude AM, 2011, AIDS BEHAV, V15, P142, DOI 10.1007/s10461-009-9526-1; Feinstein BA, 2011, PSYCHOL TRAUMA-US, V3, P192, DOI 10.1037/a0021652; Ferris LE, 1997, CAN MED ASSOC J, V156, P1015; Graham-Bermann SA, 2006, VIOLENCE AGAINST WOM, V12, P663, DOI 10.1177/1077801206290216; Heise LL, 2015, LANCET GLOB HEALTH, V3, pE332, DOI 10.1016/S2214-109X(15)00013-3; Henry RS, 2018, J INTERPERS VIOLENCE, V1; Henry Tara, 2010, J Forensic Nurs, V6, P57, DOI 10.1111/j.1939-3938.2010.01069.x; Honda T, 2018, J WOMENS HEALTH, V27, P716, DOI 10.1089/jwh.2016.6276; Isaac NE, 2001, DOCUMENTING DOMESTIC; Ishida K, 2010, SOC SCI MED, V71, P1653, DOI 10.1016/j.socscimed.2010.08.007; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Katz J, 2017, J INTERPERS VIOLENCE, V32, P3301, DOI 10.1177/0886260515597441; Katzman MA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-S1-S1; Kelly TC, 2012, PARTN ABUSE, V3, P107, DOI 10.1891/1946-6560.3.1.107; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lewis T, 2016, CHILD ABUSE NEGLECT, V51, P31, DOI 10.1016/j.chiabu.2015.11.016; Markowitz J., 2010, PRACTICE GUIDELINE T; McFarlane J, 2005, OBSTET GYNECOL, V105, P99, DOI 10.1097/01.AOG.0000146641.98665.b6; McFarlane Judith, 2005, Issues Ment Health Nurs, V26, P953; Messing JT, 2014, HEALTH SOC WORK, V39, P181, DOI 10.1093/hsw/hlu026; Mihorean K, 2005, TRENDS SELF REPORTED; Nowinski SN, 2012, AGGRESS VIOLENT BEH, V17, P36, DOI 10.1016/j.avb.2011.09.005; Overstreet NM, 2013, BASIC APPL SOC PSYCH, V35, P109, DOI 10.1080/01973533.2012.746599; Park J, 2016, AM J OBSTET GYNECOL, V214, P74, DOI 10.1016/j.ajog.2015.08.045; Patten SB, 2016, CAN J PSYCHIAT, V61, P504, DOI 10.1177/0706743716660034; Pengpid S, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0526-z; Pico-Alfonso MA, 2006, J WOMENS HEALTH, V15, P599, DOI 10.1089/jwh.2006.15.599; Puri M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-29; Sakhonchik A, 2015, CLOSING GAPIMPROVING; Seyller M, 2016, OBSTET GYNECOL, V127, P516, DOI 10.1097/AOG.0000000000001288; Shorey RC, 2011, J INTERPERS VIOLENCE, V26, P1834, DOI 10.1177/0886260510372949; Sinha M., 2013, FAMILY VIOLENCE CANA; Stephenson R, 2006, INT FAM PLAN PERSPEC, V32, P201, DOI 10.1363/3220106; Stewart DE, 2013, CAN J PSYCHIAT, V58, P496; Stewart DE, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-015-0644-3; Substance Abuse and Mental Health Services Administration, 2016, TRAUM INF APPR TRAUM; Symes L, 2014, J CLIN NURS, V23, P2909, DOI 10.1111/jocn.12542; Temple JR, 2007, VIOLENCE AGAINST WOM, V13, P285, DOI 10.1177/1077801206297437; Thoennes, 2000, EXTENT NATURE CONSEQ; Tsui V, 2010, J COMMUNITY PSYCHOL, V38, P769, DOI 10.1002/jcop.20394; Ullman SE, 2015, J AGGRESS MALTREAT T, V24, P117, DOI 10.1080/10926771.2015.996312; Wandera SO, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1564-1; Weaver Terri L, 2007, Health Care Women Int, V28, P478, DOI 10.1080/07399330701226453; World Health Organization, 2014, HLTH CAR WOM SUBJ IN; World Health Organization (WHO), 2005, WHO MULT STUD WOM HL; Zilkens RR, 2016, J FORENSIC LEG MED, V43, P1, DOI 10.1016/j.jflm.2016.06.005	60	14	14	4	37	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1540-9996	1931-843X		J WOMENS HEALTH	J. Womens Health	MAR	2019	28	3					363	374		10.1089/jwh.2017.6811		OCT 2018	12	Public, Environmental & Occupational Health; Medicine, General & Internal; Obstetrics & Gynecology; Women's Studies	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine; Obstetrics & Gynecology; Women's Studies	JJ7RY	WOS:000447615700001	30335574				2022-02-06	
J	Zhang, Y; Liu, YX; Xiao, QX; Liu, Q; Deng, R; Bien, J; Deng, IB; Al-Hawwas, M; Yu, FX				Zhang, Ying; Liu, Yue-Xin; Xiao, Qiu-Xia; Liu, Qing; Deng, Rui; Bien, Jiang; Deng, Isaac Bul; Al-Hawwas, Mohammed; Yu, Feng-Xu			Microarray Expression Profiles of lncRNAs and mRNAs in Postoperative Cognitive Dysfunction	FRONTIERS IN NEUROSCIENCE			English	Article						postoperative cognitive dysfunction; lncRNA; mRNA; Gene Ontology; genetic dysregulation; microarray analysis; bioinformatics analysis	LONG NONCODING RNAS; TRAUMATIC BRAIN-INJURY; TAU HYPERPHOSPHORYLATION; ALZHEIMERS-DISEASE; ELDERLY-PATIENTS; AGED RATS; SURGERY; GENE; NEUROINFLAMMATION; ANESTHESIA	Postoperative cognitive dysfunction (POCD) is serious disorder in the central nervous system common in aged patients after anesthesia. Although its clinical symptoms are well recognized, however, the molecular etiology of the POCD remains unrevealed. Similarly, neither gold standard molecular diagnosis nor effective treatment is available for POCD until the present. Therefore, we aimed to explore the molecular mechanism of this disorder through investigating lncRNAs and mRNAs associated with POCD human patients and investigate their underlying regulatory pathways. In this study, we recruited 200 patients requiring hip or knee replacement surgery. Their neurological functions were assessed at two time points, 1 day before the surgery and 30 days post-surgery. In parallel, serum samples were collected from the participants to analyze lncRNAs and mRNAs differential expression profile between POCD and non-POCD patients using microarray analysis. To further investigate the role differentially expressed mRNA and lncRNAs, Gene Ontology (GO), pathway analyses on mRNAs and lncRNA-mRNA interaction network were performed. As a result, 68 lncRNAs and 115 mRNAs were dysregulated in the POCD group compared to non-POCD group. Among them, the top 10 upregulated lncRNAs and 10 downregulated lncRNAs were listed for enrichment analysis. Interestingly, we found that these lncRNA and mRNA are involved in biological process, molecular function, and cellular component in addition to various signaling pathways, suggesting that the pathogenesis of POCD involves lncRNAs and mRNAs differential expression. Consequently, the genetic dysregulation between the non-POCD and POCD patients participates in the occurrence and development of POCD, and could be served as diagnostic biomarkers and drug targets for POCD treatment.	[Zhang, Ying; Liu, Yue-Xin; Xiao, Qiu-Xia; Liu, Qing; Deng, Rui; Bien, Jiang] Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Dept Anesthesiol, Luzhou, Peoples R China; [Deng, Isaac Bul; Al-Hawwas, Mohammed] Univ South Australia, Sch Pharm & Med Sci, Sansom Inst Div Hlth Sci, Adelaide, SA, Australia; [Yu, Feng-Xu] Southwest Med Univ, Affiliated Hosp, Dept Cardiothorac Surg, Luzhou, Peoples R China		Yu, FX (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Cardiothorac Surg, Luzhou, Peoples R China.	yuluchuan@163.com		AL-HAWWAS, MOHAMMED/0000-0003-1778-4393			Aprahamian I, 2010, INT PSYCHOGERIATR, V22, P64, DOI 10.1017/S1041610209991141; Arora SS, 2014, INT J NEUROSCI, V124, P236, DOI 10.3109/00207454.2013.833919; Bekker Alex Y, 2003, Best Pract Res Clin Anaesthesiol, V17, P259, DOI 10.1016/S1521-6896(03)00005-3; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Chen RJ, 2016, NEUROSCIENCE, V319, P123, DOI 10.1016/j.neuroscience.2016.01.033; Clark MB, 2011, SEMIN CELL DEV BIOL, V22, P366, DOI 10.1016/j.semcdb.2011.01.001; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Duan XX, 2018, J THORAC CARDIOV SUR, V155, P958, DOI 10.1016/j.jtcvs.2017.07.073; Gong Y. X., 1992, HDB CHINESE ADAPTED; Gudenas BL, 2015, BIOINFORM BIOL INSIG, V9, P21, DOI 10.4137/BBI.S29435; Guennewig B, 2014, INT REV NEUROBIOL, V116, P153, DOI 10.1016/B978-0-12-801105-8.00007-2; Han CL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0496-y; Hartholt KA, 2012, Z GERONTOL GERIATR, V45, P411, DOI 10.1007/s00391-012-0326-2; Hu N, 2014, BRAIN RES, V1551, P13, DOI 10.1016/j.brainres.2014.01.015; Hu Y, 2017, INT J MOL MED, V39, P57, DOI 10.3892/ijmm.2016.2819; Isin M, 2015, CLIN CHIM ACTA, V444, P280, DOI 10.1016/j.cca.2015.02.046; Johansson P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176760; Kang MK, 2008, CELL PROLIFERAT, V41, P377, DOI 10.1111/j.1365-2184.2008.00537.x; Kong ZH, 2017, J MOL NEUROSCI, V63, P385, DOI 10.1007/s12031-017-0989-7; Krenk L, 2010, ACTA ANAESTH SCAND, V54, P951, DOI 10.1111/j.1399-6576.2010.02268.x; Liang YR, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0582-1; Liu XL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195659; Lou YH, 2018, INT J MOL MED, V42, P91, DOI 10.3892/ijmm.2018.3588; Lu SM, 2015, BRAIN BEHAV IMMUN, V44, P221, DOI 10.1016/j.bbi.2014.10.011; Lyu Q, 2017, CELL TRANSPLANT, V26, P1622, DOI 10.1177/0963689717723014; Maass PG, 2014, J MOL MED, V92, P337, DOI 10.1007/s00109-014-1131-8; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Mathew JP, 2003, STROKE, V34, P508, DOI 10.1161/01.STR.0000053844.09493.58; Min SW, 2018, J NEUROSCI, V38, P3680, DOI 10.1523/JNEUROSCI.2369-17.2018; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2011, CURR OPIN CRIT CARE, V17, P376, DOI 10.1097/MCC.0b013e328348bece; Muret K, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-016-0275-0; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Pappa Maria, 2017, Electron Physician, V9, P3768, DOI 10.19082/3768; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Renard P, 1997, BIOCHEM PHARMACOL, V53, P149, DOI 10.1016/S0006-2952(96)00645-4; Valentin LSS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152308; Santen GWE, 2013, HUM MUTAT, V34, P1519, DOI 10.1002/humu.22394; Shang JL, 2018, INT J MOL MED, V41, P2715, DOI 10.3892/ijmm.2018.3484; Silbert BS, 2014, BRIT J ANAESTH, V113, P784, DOI 10.1093/bja/aeu163; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Taniguchi M, 2017, NEURON, V96, P130, DOI 10.1016/j.neuron.2017.09.015; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Tian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141596; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vacas S, 2014, ANESTHESIOLOGY, V120, P1160, DOI 10.1097/ALN.0000000000000045; Van Blitterswijk M, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.016; van Dijk D, 2007, Ned Tijdschr Geneeskd, V151, P1163; van Harten AE, 2012, ANAESTHESIA, V67, P280, DOI 10.1111/j.1365-2044.2011.07008.x; Verma T, 2017, BIOMED PHARMACOTHER, V96, P736, DOI 10.1016/j.biopha.2017.09.150; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Wang DQ, 2018, MOL THER-NUCL ACIDS, V10, P269, DOI 10.1016/j.omtn.2017.12.011; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wei CW, 2017, ONCOTARGET, V8, P55901, DOI 10.18632/oncotarget.18362; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wu J, 2017, MOL MED REP, V16, P1846, DOI 10.3892/mmr.2017.6840; Wu ZP, 2018, EXP THER MED, V15, P878, DOI 10.3892/etm.2017.5480; Wynne A, 2010, CURR NEUROPHARMACOL, V8, P268, DOI 10.2174/157015910792246191; Xu J, 2012, CELL MOL NEUROBIOL, V32, P1343, DOI 10.1007/s10571-012-9860-0; Yan W, 2018, BIOCHEM BIOPH RES CO, V496, P1019, DOI 10.1016/j.bbrc.2017.12.149; Yi SQ, 2015, THORAC CARDIOV SURG, V63, P618, DOI 10.1055/s-0034-1393704; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zhang Q, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0501-0; Zhang X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0592-9; Zhang YN, 2016, MOL MED REP, V14, P2778, DOI 10.3892/mmr.2016.5556; Zhao FY, 2015, SCI REP-UK, V5, DOI 10.1038/srep13850; Zhao YH, 2017, ONCOTARGET, V8, P64827, DOI 10.18632/oncotarget.17472; Zhou XY, 2017, BRAIN RES BULL, V132, P190, DOI 10.1016/j.brainresbull.2017.06.001; Zizioli D, 2016, NEUROBIOL DIS, V85, P35, DOI 10.1016/j.nbd.2015.10.010	73	14	14	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	OCT 8	2018	12								694	10.3389/fnins.2018.00694			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GW1DR	WOS:000446611900001	30349449	gold, Green Published			2022-02-06	
J	Chan, DD; Knutsen, AK; Lu, YC; Yang, SH; Magrath, E; Wang, WT; Bayly, PV; Butman, JA; Pham, DL				Chan, Deva D.; Knutsen, Andrew K.; Lu, Yuan-Chiao; Yang, Sarah H.; Magrath, Elizabeth; Wang, Wen-Tung; Bayly, Philip, V; Butman, John A.; Pham, Dzung L.			Statistical Characterization of Human Brain Deformation During Mild Angular Acceleration Measured In Vivo by Tagged Magnetic Resonance Imaging	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						brain biomechanics; magnetic resonance imaging; in vivo; angular acceleration; computational models	MOTION ESTIMATION; SHEAR-WAVES; HEAD; INJURY; STRAIN; MODEL; ELASTOGRAPHY; NEURODEGENERATION; DISPLACEMENT; IMPACT	Understanding of in vivo brain biomechanical behavior is critical in the study of traumatic brain injury (TBI) mechanisms and prevention. Using tagged magnetic resonance imaging, we measured spatiotemporal brain deformations in 34 healthy human volunteers under mild angular accelerations of the head. Two-dimensional (2D) Lagrangian strains were examined throughout the brain in each subject. Strain metrics peaked shortly after contact with a padded stop, corresponding to the inertial response of the brain after head deceleration. Maximum shear strain of at least 3% was experienced at peak deformation by an area fraction (median +/- standard error) of 23.5 +/- 1.8% of cortical gray matter, 15.9 +/- 1.4% of white matter, and 4.0 +/- 1.5% of deep gray matter. Cortical gray matter strains were greater in the temporal cortex on the side of the initial contact with the padded stop and also in the contralateral temporal, frontal, and parietal cortex. These tissue-level deformations from a population of healthy volunteers provide the first in vivo measurements of full-volume brain deformation in response to known kinematics. Although strains differed in different tissue type and cortical lobes, no significant differences between male and female head accelerations or strain metrics were found. These cumulative results highlight important kinematic features of the brain's mechanical response and can be used to facilitate the evaluation of computational simulations of TBI.	[Chan, Deva D.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Knutsen, Andrew K.; Lu, Yuan-Chiao; Yang, Sarah H.; Magrath, Elizabeth; Wang, Wen-Tung; Pham, Dzung L.] Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, 10 Ctr Dr,MSC 1182, Bethesda, MD 20892 USA; [Bayly, Philip, V] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Butman, John A.] NIH, Radiol & Imaging Sci, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA		Pham, DL (corresponding author), Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, 10 Ctr Dr,MSC 1182, Bethesda, MD 20892 USA.	dzung.pham@nih.gov	Butman, John/J-2780-2013; Pham, Dzung/AAR-8263-2020; Chan, Deva/F-1496-2010; Butman, John A/A-2694-2008	Butman, John/0000-0002-1547-9195; Chan, Deva/0000-0003-1508-1045; 	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951]; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; National Institutes of Health Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (R01NS055951).; The Department of Defense in the Center for Neuroscience and Regenerative Medicine.; The National Institutes of Health Intramural Research Program.	Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; AXEL L, 1989, RADIOLOGY, V171, P841, DOI 10.1148/radiology.171.3.2717762; Badachhape AA, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036146; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bayly PV, 2004, J BIOMECH ENG-T ASME, V126, P523, DOI 10.1115/1.1785811; Bell ED, 2017, J MECH BEHAV BIOMED, V65, P627, DOI 10.1016/j.jmbbm.2016.09.028; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Gomez A, 2017, MICCAI COMPUTATIONAL, P18; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Krave U, 2011, J NEUROTRAUM, V28, P57, DOI 10.1089/neu.2010.1431; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Liu XF, 2010, IEEE T MED IMAGING, V29, P1560, DOI 10.1109/TMI.2010.2045509; Mao HJ, 2011, J NEUROTRAUM, V28, P2263, DOI 10.1089/neu.2010.1600; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; McGarry MDJ, 2015, MED PHYS, V42, P947, DOI 10.1118/1.4905048; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Osman NF, 2000, PHYS MED BIOL, V45, P1665, DOI 10.1088/0031-9155/45/6/318; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Provance AJ, 2016, ORTHOPEDICS, V39, P24, DOI 10.3928/01477447-20151218-13; Roy S, 2015, IEEE J BIOMED HEALTH, V19, P1598, DOI 10.1109/JBHI.2015.2439242; Rutz AK, 2008, MAGN RESON MED, V59, P755, DOI 10.1002/mrm.21363; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Samadi-Dooki A, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036486; Sanchez EJ, 2017, J NEUROTRAUM, V34, P2410, DOI 10.1089/neu.2016.4681; Schmidt JL, 2016, J BIOMECH, V49, P1042, DOI 10.1016/j.jbiomech.2016.02.018; SKULLERUD K, 1985, ACTA NEUROL SCAND, V71, P5; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Taber LA, 2004, NONLINEAR THEORY ELA; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tschiffely AE, 2015, J NEUROSCI RES, V93, P1769, DOI 10.1002/jnr.23641; Tweten DJ, 2017, MAGN RESON MED, V78, P2360, DOI 10.1002/mrm.26600; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Xing FX, 2017, IEEE T MED IMAGING, V36, P2116, DOI 10.1109/TMI.2017.2723021; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	55	14	14	1	9	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	OCT	2018	140	10							101005	10.1115/1.4040230			13	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	GW9BT	WOS:000447277300005	30029236	Green Published			2022-02-06	
J	Davidow, D; Quarrie, K; Viljoen, W; Burger, N; Readhead, C; Lambert, M; Jones, B; Hendricks, S				Davidow, Demi; Quarrie, Ken; Viljoen, Wayne; Burger, Nicholas; Readhead, Clint; Lambert, Mike; Jones, Ben; Hendricks, Sharief			Tackle technique of rugby union players during head impact tackles compared to injury free tackles	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Injury prevention; Head impact; Team sports; Training; Measurement	VIDEO ANALYSIS; PREVENTION; CONCUSSIONS; STRATEGIES; CONTACT; EVENTS; LEAGUE	Objectives: The majority of head injuries in rugby union occur during tackles in which the head receives an impact. Head impacted tackles may be a result of poor tackle technique. Therefore, the purpose of this study was to analyse ball-carrier and tackler technique proficiency in head impacted tackles and compare the technique proficiency to successfully completed tackles in real-match situations. Design: Retrospective video analysis. Methods: Video footage of head impacts with the 'head impacted player' (n = 157) and the opposing player 'impacting player' (n = 156) were scored for contact technique using a list of technical criteria and compared to contact technique scores of role and tackle-type matched injury-free, successful tackles (n = 170). Results: Ball-carriers contacting their head during front-on head impacted tackles (mean 6.4, 95% CI 5.6-7.1 AU, out of a total score of 14) scored significantly less than the 'impacting player' (mean 8.1, 95%CI 7.1-9.1 AU, p < 0.01, ES = 0.5, small) and successful ball-carriers (successful ball-carrier mean 9.4, 95% CI 8.9-9.9 AU, p <0.0001, ES = 1.1, moderate). Tackler contact proficiency scores during successful front-on tackles (mean 12.3, 95%CI 11.6-12.9 AU, out of a total score of 16) were significantly greater than tackler contact proficiency scores for the 'head impacted player' (mean 9.8, 95%CI 8.6-10.9, p < 0.001, ES = 0.8, moderate) and 'impacting player' (mean 9.3, 95%CI 8.4-10.1, p <0.0001, ES = 1.0, moderate). Conclusions: Both the ball-carrier and tackler have a technical deficiency when there is a head impact in matches. The implication of this finding is that players and coaches need to acknowledge that both the ball-carrier and tackler are responsible for each other's safety during the tackle. (C) 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Davidow, Demi; Viljoen, Wayne; Burger, Nicholas; Readhead, Clint; Lambert, Mike; Hendricks, Sharief] Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, Rondebosch, South Africa; [Quarrie, Ken] New Zealand Rugby, Wellington, New Zealand; [Viljoen, Wayne; Readhead, Clint] South African Rugby Union, Cape Town, South Africa; [Lambert, Mike] Vrije Univ Amsterdam, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Lambert, Mike] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Jones, Ben; Hendricks, Sharief] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Jones, Ben] Yorkshire Carnegie Rugby Union Football Club, Leeds, W Yorkshire, England; [Jones, Ben] Rugby Football League, Leeds, W Yorkshire, England		Hendricks, S (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, Rondebosch, South Africa.; Hendricks, S (corresponding author), Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.	sharief.hendricks@uct.ac.za	Hendricks, Sharief/U-3278-2019	Hendricks, Sharief/0000-0002-3416-6266; Quarrie, Ken/0000-0003-1703-8489; Davidow, Demi/0000-0001-7934-8218; Viljoen, Wayne/0000-0002-9432-6153; Jones, Ben/0000-0002-4274-6236			Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Burger N, 2017, AM J SPORT MED, V45, P278, DOI 10.1177/0363546516677548; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Hendricks S, 2017, J SPORTS SCI, P1, DOI 10.1080/02640414.2017.1322216; Hendricks S, 2017, BRIT J SPORT MED, V51, P829, DOI 10.1136/bjsports-2016-096347; Hendricks S, 2015, INT J SPORTS SCI COA, V10, P949, DOI 10.1260/1747-9541.10.5.949; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; Mc Fie S, 2016, CLIN J SPORT MED, V26, P398, DOI 10.1097/JSM.0000000000000276; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Patricios J, 2014, CURR SPORT MED REP, V13, P142, DOI 10.1249/JSR.0000000000000049; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Sewry N, 2015, INT J SPORTS SCI COA, V10, P1115, DOI 10.1260/1747-9541.10.6.1115; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P16, DOI 10.1177/1747954117711866; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tierney GJ, 2018, J SCI MED SPORT, V21, P221, DOI 10.1016/j.jsams.2017.06.023; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Williams S, 2016, SCAND J MED SCI SPOR, V26, P101, DOI 10.1111/sms.12402; World Rugby, 2016, YEAR IN REV, P44	30	14	14	0	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	OCT	2018	21	10					1025	1031		10.1016/j.jsams.2018.04.003			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GX9CQ	WOS:000448096500010	29803736				2022-02-06	
J	Kalmbach, DA; Conroy, DA; Falk, H; Rao, V; Roy, D; Peters, ME; Van Meter, TE; Korley, FK				Kalmbach, David A.; Conroy, Deirdre A.; Falk, Hayley; Rao, Vani; Roy, Durga; Peters, Matthew E.; Van Meter, Timothy E.; Korley, Frederick K.			Poor sleep is linked to impeded recovery from traumatic brain injury	SLEEP			English	Article						TBI; insomnia; short sleep; functional impairment; global functioning; sleep latency	POSTTRAUMATIC-STRESS-DISORDER; GLASGOW OUTCOME SCALE; WAKE DISTURBANCES; HEAD-INJURY; COMA SCALE; INSOMNIA; VETERANS; DURATION; QUALITY; IMPACT	Study Objectives: While disruptions in sleep are common after mild traumatic brain injury (TBI), the longitudinal relationships between sleep problems and global functioning after injury are poorly understood. Here, we prospectively investigate risk for functional impairment during the first 6 months of TBI recovery based on sleep onset insomnia symptoms and short sleep. Methods: Patients presenting to the Emergency Department (ED) at Johns Hopkins Hospital within 24 hours of head injury and evaluated for TBI were eligible for our study. Demographic and injury-related information were collected in the ED. Patients then completed in-person surveys and phone interviews to provide follow-up data on global functioning, sleep, and depressive symptoms at 1, 3, and 6 months post-injury. A total of 238 patients provided sufficient data for analysis, and hypotheses were tested using mixed effects modeling. Results: Sleep quality and global functioning improved over the 6 months of TBI recovery, but patients were at increased risk for functional impairment when sleeping poorly (odds ratio [OR] = 7.69, p < .001). Sleep onset insomnia symptoms and short sleep both independently corresponded to poor global functioning. Functional impairment was highest among those with both insomnia and short sleep (43%-79%) compared to good sleepers (15%-25%) and those with short sleep (29%-33%) or insomnia alone (33%-64%). A bidirectional relationship between sleep quality and functioning was observed. Conclusions: Functionally impaired patients diagnosed predominantly with mild TBI exhibit high rates of insomnia and short sleep, which may impede TBI recovery. Monitoring sleep after head injury may identify patients with poor prognoses and allow for early intervention to improve functional outcomes. Statement of Significance Poor sleep is endemic to patients with traumatic brain injury (TBI) and may a represent critical threat to recovery from TBI. In our study, poorly sleeping TBI patients were more functionally impaired during the first 6 post-injury months than good sleepers. The highest rates of impairment were observed among patients with both sleep onset insomnia symptoms and concomitant short sleep. Critically, the relationship between sleep quality and global functioning was bidirectional, such that higher sleep disturbance predicted greater functional impairment months later, and vice versa. Given the roles of insomnia symptoms and short sleep in functional impairment during the post-acute recovery period, early detection of sleep problems may identify patients with poor prognosis, and intervention may improve recovery from TBI.	[Kalmbach, David A.; Conroy, Deirdre A.] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI USA; [Falk, Hayley; Korley, Frederick K.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA; [Rao, Vani; Roy, Durga; Peters, Matthew E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Van Meter, Timothy E.] ImmunArray Inc, Program Neurol Dis, Richmond, VA USA		Korley, FK (corresponding author), Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA.	korley@med.umich.edu			ImmunArray; National Heart Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL110952]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL110952] Funding Source: NIH RePORTER	HeadSMART was funded by ImmunArray. D.A.K.'s effort was supported by the National Heart Lung and Blood Institute (T32HL110952).	Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chiu HY, 2014, INT J NURS STUD, V51, P892, DOI 10.1016/j.ijnurstu.2013.10.020; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Feldner M.T., 2015, SLEEP AND AFFECT, DOI [10.1016/B978-0-12-417188-6.00010-4, DOI 10.1016/B978-0-12-417188-6.00010-4]; Fernandez-Mendoza J, 2015, J SLEEP RES, V24, P390, DOI 10.1111/jsr.12285; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Harvey AG, 2000, BRIT J CLIN PSYCHOL, V39, P275, DOI 10.1348/014466500163284; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P108, DOI 10.1097/HTR.0000000000000206; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Kalmbach D. A., 2017, SLEEP, V40; Kalmbach DA, 2016, SLEEP, V39, P2101, DOI 10.5665/sleep.6306; Kalmbach DA, 2016, SLEEP, V39, P449, DOI 10.5665/sleep.5462; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Peters ME, 2017, BRAIN INJURY, V31, P370, DOI 10.1080/02699052.2016.1231344; Pillai V, 2015, SLEEP, V38, P127, DOI 10.5665/sleep.4338; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Sandsmark DK, 2016, J HEAD TRAUMA REHAB, V31, P101, DOI 10.1097/HTR.0000000000000217; Sivertsen B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-720; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Vgontzas AN, 2013, SLEEP MED REV, V17, P241, DOI 10.1016/j.smrv.2012.09.005; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	62	14	14	1	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	OCT	2018	41	10							zsy147	10.1093/sleep/zsy147			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GY0BI	WOS:000448174000017	30053263	Bronze, Green Published			2022-02-06	
J	Lee, SH; Choi, BY; Kho, AR; Jeong, JH; Hong, DK; Kang, DH; Kang, BS; Song, HK; Choi, HC; Suh, SW				Lee, Song Hee; Choi, Bo Young; Kho, A. Ra; Jeong, Jeong Hyun; Hong, Dae Ki; Kang, Dong Hyeon; Kang, Beom Seok; Song, Hong Ki; Choi, Hui Chul; Suh, Sang Won			Inhibition of NADPH Oxidase Activation by Apocynin Rescues Seizure-Induced Reduction of Adult Hippocampal Neurogenesis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						epilepsy; pilocarpine; neuron death; NADPH-oxidase inhibitor; oxidative stress; neurogenesis	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; HYPOGLYCEMIC NEURONAL DEATH; DENTATE GYRUS; OXIDATIVE STRESS; STATUS EPILEPTICUS; PILOCARPINE MODEL; SUPEROXIDE; RAT; DAMAGE	Apocynin, also known as acetovanillone, is a natural organic compound structurally related to vanillin. Apocynin is known to be an inhibitor of NADPH (Nicotinamide adenine dinucleotide phosphate) oxidase activity and is highly effective in suppressing the production of superoxide. The neuroprotective effects of apocynin have been investigated in numerous brain injury settings, such as stroke, traumatic brain injury (TBI), and epilepsy. Our lab has demonstrated that TBI or seizure-induced oxidative injury and neuronal death were reduced by apocynin treatment. Several studies have also demonstrated that neuroblast production is transiently increased in the hippocampus after seizures. Here, we provide evidence confirming the hypothesis that long-term treatment with apocynin may enhance newly generated hippocampal neuronal survival by reduction of superoxide production after seizures. A seizure was induced by pilocarpine [(25 mg/kg intraperitoneal (i.p.)] injection. Apocynin was continuously injected for 4 weeks after seizures (once per day) into the intraperitoneal space. We evaluated neuronal nuclear antigen (NeuN), bromodeoxyuridine (BrdU), and doublecortin (DCX) immunostaining to determine whether treatment with apocynin increased neuronal survival and neurogenesis in the hippocampus after seizures. The present study indicates that long-term treatment of apocynin increased the number of NeuN(+) and DCX+ cells in the hippocampus after seizures. Therefore, this study suggests that apocynin treatment increased neuronal survival and neuroblast production by reduction of hippocampal oxidative injury after seizures.	[Lee, Song Hee; Choi, Bo Young; Kho, A. Ra; Jeong, Jeong Hyun; Hong, Dae Ki; Kang, Dong Hyeon; Kang, Beom Seok; Suh, Sang Won] Hallym Univ, Dept Physiol, Coll Med, Chunchon 24252, South Korea; [Song, Hong Ki; Choi, Hui Chul] Hallym Univ, Coll Med, Neurol, Chunchon 24252, South Korea; [Song, Hong Ki; Choi, Hui Chul; Suh, Sang Won] Hallym Inst Epilepsy Res, Chunchon 24252, South Korea		Suh, SW (corresponding author), Hallym Univ, Dept Physiol, Coll Med, Chunchon 24252, South Korea.; Song, HK; Choi, HC (corresponding author), Hallym Univ, Coll Med, Neurol, Chunchon 24252, South Korea.; Song, HK; Choi, HC; Suh, SW (corresponding author), Hallym Inst Epilepsy Res, Chunchon 24252, South Korea.	sshlee@hallym.ac.kr; bychoi@hallym.ac.kr; rnlduadkfk136@hallym.ac.kr; jd1422@hanmail.net; zxnm01220@gmail.com; ehdgus2728@naver.com; ttiger1993@gmail.com; hksong0@hanmail.net; dohchi@naver.com; swsuh@hallym.ac.kr		Choi, Bo Young/0000-0002-9579-3503; Hong, Dae Ki/0000-0002-8937-1064; Hong, Dae-Ki/0000-0003-3769-3456	National Research Foundation of Korea (NRF)National Research Foundation of Korea [NRF-2017R1D1A1A09081190]; Hallym University Research Fund [HRF-201801-014]	This study was supported by funding from the National Research Foundation of Korea (NRF) (NRF-2017R1D1A1A09081190) to Sang Won Suh. This study was also supported by Hallym University Research Fund (HRF-201801-014).	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Cameron HA, 2015, ANNU REV PSYCHOL, V66, P53, DOI 10.1146/annurev-psych-010814-015006; Cattaneo F, 2014, INT J MOL SCI, V15, P19700, DOI 10.3390/ijms151119700; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Choi BY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0325-5; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Dingledine R, 2014, ADV EXP MED BIOL, V813, P109, DOI 10.1007/978-94-017-8914-1_9; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Freitas RM, 2005, FEBS J, V272, P1307, DOI 10.1111/j.1742-4658.2004.04537.x; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Fujikawa DG, 2000, EPILEPSIA, V41, pS9, DOI 10.1111/j.1528-1157.2000.tb01549.x; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Hakami NY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00150; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Hattiangady B, 2008, EPILEPSIA, V49, P26, DOI 10.1111/j.1528-1167.2008.01635.x; Huang TT, 2012, SEMIN CELL DEV BIOL, V23, P738, DOI 10.1016/j.semcdb.2012.04.003; Kim JE, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.331; Kim JH, 2013, BRAIN RES, V1499, P163, DOI 10.1016/j.brainres.2013.01.007; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048543; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Kralic JE, 2005, EUR J NEUROSCI, V22, P1916, DOI 10.1111/j.1460-9568.2005.04386.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Li NJ, 2005, AM J PHYSIOL-RENAL, V289, pF1048, DOI 10.1152/ajprenal.00416.2004; Liu JZ, 2010, SEIZURE-EUR J EPILEP, V19, P165, DOI 10.1016/j.seizure.2010.01.010; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Mora GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005759; Parent JM, 2002, PROG BRAIN RES, V135, P121; PERSINGER MA, 1988, PHYSIOL BEHAV, V44, P27, DOI 10.1016/0031-9384(88)90342-3; Pestana RRF, 2010, NEUROSCI LETT, V484, P187, DOI 10.1016/j.neulet.2010.08.049; RACINE RJ, 1972, BRAIN RES, V47, P262, DOI 10.1016/0006-8993(72)90268-5; Rotheneichner P, 2013, EPILEPSIA, V54, P40, DOI 10.1111/epi.12274; Russo R, 2018, NEUROBIOL AGING, V68, P123, DOI 10.1016/j.neurobiolaging.2018.02.025; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Simonyi Agnes, 2012, Front Biosci (Elite Ed), V4, P2183; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; van Rijckevorsel K, 2006, SEIZURE-EUR J EPILEP, V15, P227, DOI 10.1016/j.seizure.2006.02.019; Vejrazka M, 2005, BBA-GEN SUBJECTS, V1722, P143, DOI 10.1016/j.bbagen.2004.12.008; Wang J, 2018, FREE RADICAL BIO MED, V123, P62, DOI 10.1016/j.freeradbiomed.2018.05.069; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; WASTERLAIN CG, 1993, EPILEPSIA, V34, pS37, DOI 10.1111/j.1528-1157.1993.tb05905.x	48	14	15	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	OCT	2018	19	10							3087	10.3390/ijms19103087			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	GY9HB	WOS:000448951000242	30304850	Green Published, gold, Green Submitted			2022-02-06	
J	Qi, LF; Xue, XH; Sun, JJ; Wu, QJ; Wang, HR; Guo, Y; Sun, BL				Qi, Lifeng; Xue, Xinhong; Sun, Jijun; Wu, Qingjian; Wang, Hongru; Guo, Yan; Sun, Baoliang			The Promising Effects of Transplanted Umbilical Cord Mesenchymal Stem Cells on the Treatment in Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Cell factors; traumatic brain injury; umbilical cord mesenchymal stem cell	NEURAL PROGENITOR CELLS; LONG-TERM SURVIVAL; ANIMAL-MODEL; DELIVERY; CULTURE; STROKE	Many studies have reported the recovery ability of umbilical cord-derived mesenchymal stem cells (UC-MSCs) for neural diseases. In this study, the authors explored the roles of UC-MSCs to treat the traumatic brain injury. Umbilical cord-derived mesenchymal stem cells were isolated from healthy neonatal rat umbilical cord immediately after delivery. The traumatic brain injury (TBI) model was formed by the classical gravity method. The authors detected the behavior changes and measured the levels of inflammatory factors, such as interleukin-1 beta and tumor necrosis factor-alpha by enzyme linked immunosorbent assay (ELISA) at 1, 2, 3, 4 weeks after transplantation between TBI treated and untreated with UC-MSCs. Simultaneously, the expression of glial cell line-derived neurotrophic factor (GDNF) and brain derived neurotrophic factor (BDNF) were measured by real-time-polymerase chain reaction and ELISA. The authors found that the group of transplantation UC-MSCs has a significant improvement than other group treated by phosphate buffered saline. In the behavioral test, the Neurological Severity Scores of UC-MSCs thorn TBI group were lower than TBI group (P<0.05), but not obviously higher than control group at 2, 3, and 4week, respectively. The inflammatory factors are significantly reduced comparison with TBI group (P<0.05), but both GDNF and BDNF were higher than TBI group (P<0.05). The results indicated that UC-MSCs might play an important role in TBI recovery through inhibiting the release of inflammatory factors and increasing the expression of GDNF and BDNF.	[Qi, Lifeng] Shandong Univ, Sch Med, Dept Neurol, Jinan, Shandong, Peoples R China; [Qi, Lifeng; Xue, Xinhong; Sun, Jijun; Wang, Hongru; Guo, Yan] Liaocheng Peoples Hosp, Dept Neurol, Liaocheng 252000, Peoples R China; [Qi, Lifeng; Xue, Xinhong; Sun, Jijun; Wang, Hongru; Guo, Yan] Taishan Med Univ, Liaocheng Clin Sch, Liaocheng 252000, Peoples R China; [Wu, Qingjian] Jining 1 Peoples Hosp, Dept Emergency, Jining 272011, Shandong, Peoples R China; [Sun, Baoliang] Taishan Med Univ, Affiliated Hosp, Key Lab Cerebral Microcirculat Univ Shandong, Dept Neurol, Tai An, Shandong, Peoples R China		Sun, BL (corresponding author), Liaocheng Peoples Hosp, Dept Neurol, Liaocheng 252000, Peoples R China.; Sun, BL (corresponding author), Taishan Med Univ, Liaocheng Clin Sch, Liaocheng 252000, Peoples R China.; Wu, QJ (corresponding author), Jining 1 Peoples Hosp, Dept Emergency, Jining 272011, Shandong, Peoples R China.	wqw110@163.com; blsun88@163.com	Qi, LI/AAF-3389-2019				Argenta LC, 2012, NEUROSURGERY, V70, P1281, DOI 10.1227/NEU.0b013e3182446760; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Barilani M, 2015, STEM CELLS DEV, V24, P104, DOI 10.1089/scd.2014.0160; Benito C, 2017, J NEUROSCI, V37, P4255, DOI 10.1523/JNEUROSCI.3481-16.2017; Bieback K, 2016, METHODS MOL BIOL, V1416, P245, DOI 10.1007/978-1-4939-3584-0_14; Boltze J, 2012, CELL TRANSPLANT, V21, P1199, DOI 10.3727/096368911X589609; Bossolasco P, 2005, EXP NEUROL, V193, P312, DOI 10.1016/j.expneurol.2004.12.013; Cai Xin-Zhen, 2015, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V23, P1697, DOI 10.7534/j.issn.1009-2137.2015.06.031; Cerri S, 2015, STEM CELL TRANSL MED, V4, P1073, DOI 10.5966/sctm.2015-0023; Chen XD, 2018, CELL IMMUNOL, V326, P8, DOI 10.1016/j.cellimm.2017.06.006; Danielyan L, 2011, REJUV RES, V14, P3, DOI 10.1089/rej.2010.1130; Fuller GW, 2016, NEUROEPIDEMIOLOGY, V47, P1, DOI 10.1159/000445997; Gu Jian, 2014, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V22, P166, DOI 10.7534/j.issn.1009-2137.2014.01.032; Heo JS, 2013, NEUROSCIENCE, V238, P305, DOI 10.1016/j.neuroscience.2013.02.011; Huang B, 2012, J CONTROL RELEASE, V162, P464, DOI 10.1016/j.jconrel.2012.07.034; Kim DS, 2009, STEM CELLS DEV, V18, P511, DOI 10.1089/scd.2008.0050; Kronig M, 2015, ONCOTARGET, V6, P1302; Li H, 2015, CELL BIOL INT, V39, P84, DOI 10.1002/cbin.10355; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; Mortazavi Y, 2016, CELL J, V18; Noh YH, 2011, PEDIATR HEMAT ONCOL, V28, P682, DOI 10.3109/08880018.2011.599477; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Pham PV, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-56; Rafieemehr H, 2015, IRAN J ALLERGY ASTHM, V14, P596; Salehpour F, 2016, WORLD NEUROSURG, V87, P132, DOI 10.1016/j.wneu.2015.11.048; Spielman LJ, 2017, EUR J CELL BIOL, V96, P240, DOI 10.1016/j.ejcb.2017.03.004; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Takano S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5706359; Udupa AN, 2015, PEDIATR ANESTH, V25, P309, DOI 10.1111/pan.12588; Uruma G, 2013, ANN NUCL MED, V27, P187, DOI 10.1007/s12149-012-0674-4; Wei N, 2013, CELL TRANSPLANT, V22, P977, DOI 10.3727/096368912X657251	31	14	14	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	OCT	2018	29	7					1689	1692		10.1097/SCS.0000000000005042			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HD3SX	WOS:000452441400046	30234712	hybrid, Green Published			2022-02-06	
J	Reynolds, BB; Stanton, AN; Soldozy, S; Goodkin, HP; Wintermark, M; Druzgal, TJ				Reynolds, Bryson B.; Stanton, Amanda N.; Soldozy, Sauson; Goodkin, Howard P.; Wintermark, Max; Druzgal, T. Jason			Investigating the effects of subconcussion on functional connectivity using mass-univariate and multivariate approaches	BRAIN IMAGING AND BEHAVIOR			English	Article						Subconcussion; Fmri; Multivariate; Regional homogeneity; Degree centrality	SUPPORT VECTOR MACHINE; HEAD IMPACT EXPOSURE; TRAUMATIC BRAIN-INJURY; REGIONAL HOMOGENEITY; CLASSIFICATION; CONCUSSION; NETWORK; BIOMECHANICS; ACTIVATION; INTEGRITY	There are concerns about the effects of subconcussive head impacts in sport, but the effects of subconcussion on brain connectivity are not well understood. We hypothesized that college football players experience changes in brain functional connectivity not found in athletes competing in lower impact sports or healthy controls. These changes may be spatially heterogeneous across participants, requiring analysis methods that go beyond mass-univariate approaches commonly used in functional MRI (fMRI). To test this hypothesis, we analyzed resting-state fMRI data from college football (n=15), soccer (n=12), and lacrosse players (n=16), and controls (n=29) collected at preseason and postseason time points. Regional homogeneity (ReHo) and degree centrality (DC) were calculated as measures of local and long-range functional connectivity, respectively. Standard voxel-wise analysis and paired support vector machine (SVM) classification studied subconcussion's effects on local and global functional connectivity. Voxel-wise analyses yielded minimal findings, but SVM classification had high accuracy for college football's ReHo (87%, p=0.009) and no other group. The findings suggest subconcussion results in spatially heterogeneous changes in local functional connectivity that may only be detectible with multivariate analyses. To determine if voxel-wise and SVM analyses had similar spatial patterns, region-average t-statistic and SVM weight values were compared using a measure of ranking distance. T-statistic and SVM weight rankings exhibited significantly low ranking distance values for all groups and metrics, demonstrating that the analyses converged on a similar underlying effect. Overall, this research suggests that subconcussion in football may produce local functional connectivity changes similar to concussion.	[Reynolds, Bryson B.; Stanton, Amanda N.; Soldozy, Sauson] Univ Virginia, Div Neuroradiol, Dept Radiol & Med Imaging, Charlottesville, VA 22908 USA; [Reynolds, Bryson B.; Druzgal, T. Jason] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Goodkin, Howard P.] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA; [Goodkin, Howard P.; Druzgal, T. Jason] Univ Virginia, UVA Brain Inst, Charlottesville, VA 22908 USA; [Wintermark, Max] Stanford Univ, Stanford, CA 94305 USA		Druzgal, TJ (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.; Druzgal, TJ (corresponding author), Univ Virginia, UVA Brain Inst, Charlottesville, VA 22908 USA.	jasondruzgal@gmail.com		Stanton, Amanda/0000-0003-2985-7799; Goodkin, Howard/0000-0003-0528-4949; Druzgal, Jason/0000-0001-7240-9487; Reynolds, Bryson/0000-0001-9196-1461	University of Virginia Health System Research Award; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2 T32 GM 8328-21]; University of Virginia Department of Radiology and Medical Imaging; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB001628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008328] Funding Source: NIH RePORTER	This study was funded by a University of Virginia Health System Research Award, NIH 2 T32 GM 8328-21, and the University of Virginia Department of Radiology and Medical Imaging.	Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Avants BB, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.3; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Braun ML, 2008, J MACH LEARN RES, V9, P1875; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Chanraud S, 2011, CEREB CORTEX, V21, P2272, DOI 10.1093/cercor/bhq297; Cheng H, 2014, J PSYCHOPHARMACOL, V28, P1030, DOI 10.1177/0269881114550354; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Formisano E, 2008, MAGN RESON IMAGING, V26, P921, DOI 10.1016/j.mri.2008.01.052; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson B.D., 2014, CONCUSSIONS ATHLETIC, P331, DOI [10.1007/978-1-4939-0295-8_19, DOI 10.1007/978-1-4939-0295-8_19]; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lempel R, 2005, INFORM RETRIEVAL, V8, P245, DOI 10.1007/s10791-005-5661-0; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mahmoudi A, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/961257; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Meier TB, 2012, NEUROIMAGE, V60, P601, DOI 10.1016/j.neuroimage.2011.12.052; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Rack-Gomer AL, 2009, NEUROIMAGE, V46, P56, DOI 10.1016/j.neuroimage.2009.02.001; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schrouff J, 2013, INT WORKSHOP PATTERN, P124, DOI 10.1109/PRNI.2013.40; Schrouff J, 2013, NEUROINFORMATICS, V11, P319, DOI 10.1007/s12021-013-9178-1; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sripada CS, 2013, NEUROIMAGE, V81, P213, DOI 10.1016/j.neuroimage.2013.05.016; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stoffers D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142014; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Telesford QK, 2011, BRAIN CONNECT, V1, P295, DOI [10.1089/brain.2011.0055, 10.1089/brain.2011.0038]; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Vapnik V., 2000, NATURE STAT LEARNING; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Voss MW, 2016, NEUROIMAGE, V131, P113, DOI 10.1016/j.neuroimage.2015.10.044; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Xu JQ, 2013, NEUROIMAGE, V83, P991, DOI 10.1016/j.neuroimage.2013.07.055; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	77	14	14	4	11	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2018	12	5					1332	1345		10.1007/s11682-017-9790-z			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HD7UY	WOS:000452760300011	29188492	Green Accepted			2022-02-06	
J	Tsai, YR; Chang, CF; Lai, JH; Wu, JCC; Chen, YH; Kang, SJ; Hoffer, BJ; Tweedie, D; Luo, WM; Greig, NH; Chiang, YH; Chen, KY				Tsai, Yan-Rou; Chang, Cheng-Fu; Lai, Jing-Huei; Wu, John Chung-Che; Chen, Yen-Hua; Kang, Shuo-Jhen; Hoffer, Barry J.; Tweedie, David; Luo, Weiming; Greig, Nigel H.; Chiang, Yung-Hsiao; Chen, Kai-Yun			Pomalidomide Ameliorates H2O2-Induced Oxidative Stress Injury and Cell Death in Rat Primary Cortical Neuronal Cultures by Inducing Anti-Oxidative and Anti-Apoptosis Effects	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						pomalidomide; neuroprotection; oxidative stress; ischemia; stroke; neurodegeneration	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; NEURODEGENERATIVE DISEASES; CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; ZEBRAFISH EMBRYOS; DAMAGE; ACTIVATION; NEUROINFLAMMATION; NEUROPROTECTION	Due to its high oxygen demand and abundance of peroxidation-susceptible lipid cells, the brain is particularly vulnerable to oxidative stress. Induced by a redox state imbalance involving either excessive generation of reactive oxygen species (ROS) or dysfunction of the antioxidant system, oxidative stress plays a central role in a common pathophysiology that underpins neuronal cell death in acute neurological disorders epitomized by stroke and chronic ones such as Alzheimer's disease. After cerebral ischemia, for example, inflammation bears a key responsibility in the development of permanent neurological damage. ROS are involved in the mechanism of post-ischemic inflammation. The activation of several inflammatory enzymes produces ROS, which subsequently suppress mitochondrial activity, leading to further tissue damage. Pomalidomide (POM) is a clinically available immunomodulatory and anti-inflammatory agent. Using H2O2-treated rat primary cortical neuronal cultures, we found POM displayed neuroprotective effects against oxidative stress and cell death that associated with changes in the nuclear factor erythroid derived 2/superoxide dismutase 2/catalase signaling pathway. POM also suppressed nuclear factor kappa-light-chain-enhancer (NF-B) levels and significantly mitigated cortical neuronal apoptosis by regulating Bax, Cytochrome c and Poly (ADP-ribose) polymerase. In summary, POM exerted neuroprotective effects via its anti-oxidative and anti-inflammatory actions against H2O2-induced injury. POM consequently represents a potential therapeutic agent against brain damage and related disorders and warrants further evaluation.	[Tsai, Yan-Rou; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei 11031, Taiwan; [Tsai, Yan-Rou; Chiang, Yung-Hsiao; Chen, Kai-Yun] Natl Hlth Res Inst, Taipei 11031, Taiwan; [Tsai, Yan-Rou; Chang, Cheng-Fu; Lai, Jing-Huei; Wu, John Chung-Che; Chen, Yen-Hua; Kang, Shuo-Jhen; Hoffer, Barry J.; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 11031, Taiwan; [Chang, Cheng-Fu] Taipei City Hosp, Zhongxiao Branch, Dept Neurosurg, Taipei 11556, Taiwan; [Chang, Cheng-Fu; Lai, Jing-Huei; Wu, John Chung-Che; Chen, Yen-Hua; Kang, Shuo-Jhen; Chiang, Yung-Hsiao] Taipei Med Univ, Dept Surg, Coll Med, Taipei 11031, Taiwan; [Wu, John Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 11031, Taiwan; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Tweedie, David; Luo, Weiming; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Bethesda, MD 20892 USA		Chiang, YH; Chen, KY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei 11031, Taiwan.; Chiang, YH; Chen, KY (corresponding author), Natl Hlth Res Inst, Taipei 11031, Taiwan.; Chiang, YH; Chen, KY (corresponding author), Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 11031, Taiwan.; Chiang, YH (corresponding author), Taipei Med Univ, Dept Surg, Coll Med, Taipei 11031, Taiwan.; Chiang, YH (corresponding author), Taipei Med Univ Hosp, Dept Neurosurg, Taipei 11031, Taiwan.	aggytsai@hotmail.com; chang3@ms3.hinet.net; m105095006@tmu.edu.tw; dr.jcwu@gmail.com; swallows3366@gmail.com; terbiun@gmail.com; bhoffer@intra.nida.nih.gov; tweedieda@grc.nia.nih.gov; luowe@grc.nia.nih.gov; greign@grc.nia.nih.gov; ychiang@tmu.edu.tw; kychen08@tmu.edu.tw			Ministry of Science and Technology [MOST-102-2314-B-038-025-MY3, MOST-105-2314-532-008, MOST 107-2314-B-038-042]; Taipei Medical University [TMU102-AE1-B27, TMU105-AE1-B03]; Intramural Research Program of the National Institute on Aging, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000469, ZIAAG000994] Funding Source: NIH RePORTER	This study was supported in part by (i) the Ministry of Science and Technology, Grant numbers MOST-102-2314-B-038-025-MY3, MOST-105-2314-532-008 and MOST 107-2314-B-038-042, (ii) Taipei Medical University TMU102-AE1-B27 and TMU105-AE1-B03 and (iii) the Intramural Research Program of the National Institute on Aging, NIH.	Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Ahn J, 2006, CLIN CANCER RES, V12, P7063, DOI 10.1158/1078-0432.CCR-06-0039; Becker RE, 2018, ALZHEIMERS DEMENT, V14, P431, DOI 10.1016/j.jalz.2017.11.007; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chanan-Khan AA, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.38; Chang CF, 2002, NEUROPHARMACOLOGY, V43, P418, DOI 10.1016/S0028-3908(02)00092-8; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Clark IA, 2018, BRIT J PHARMACOL, V175, P3859, DOI 10.1111/bph.14471; Collins, 2017, NEUROL TODAY, V17, P01, DOI DOI 10.1097/01.NT.0000527316.80068.88; Deb P., 2010, PATHOPHYSIOLOGY, V17, P197, DOI [DOI 10.1016/J.PATHOPHYS.2009.12.001, DOI 10.1016/J.PATH0PHYS.2009.12.001.PUBMED]; dela Pena I, 2017, J STROKE, V19, P50, DOI 10.5853/jos.2016.01515; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; European Medicines Agency, ASS REP POM CELG; Evans MD, 2004, BIOESSAYS, V26, P533, DOI 10.1002/bies.20027; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Han Z, 2016, EUR J PHARMACOL, V777, P129, DOI 10.1016/j.ejphar.2016.03.006; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hoffmann M, 2013, CANCER CHEMOTH PHARM, V71, P489, DOI 10.1007/s00280-012-2040-6; Hu Y, 2015, INT J MOL SCI, V16, P24895, DOI 10.3390/ijms161024895; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kalaria RN, 2018, NEUROPHARMACOLOGY, V134, P226, DOI 10.1016/j.neuropharm.2017.12.030; KALARIA RN, 1993, ANN NY ACAD SCI, V695, P190, DOI 10.1111/j.1749-6632.1993.tb23050.x; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kalogeris T, 2014, REDOX BIOL, V2, P702, DOI 10.1016/j.redox.2014.05.006; Knecht T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122756; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kunz A, 2008, J NEUROSCI, V28, P1649, DOI 10.1523/JNEUROSCI.5205-07.2008; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Li YZ, 2017, EXP NEUROL, V288, P104, DOI 10.1016/j.expneurol.2016.11.010; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liska Grant M, 2018, Cond Med, V1, P151; Liu PK, 1996, J NEUROSCI, V16, P6795; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Mahony C, 2013, P NATL ACAD SCI USA, V110, P12703, DOI 10.1073/pnas.1307684110; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Neuhaus AA, 2017, BRAIN, V140, P2079, DOI 10.1093/brain/awx126; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9; Popa-Wagner A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020356; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Santos Claudia Y, 2017, Alzheimers Dement (Amst), V7, P69, DOI 10.1016/j.dadm.2017.01.005; Sugawara T, 2003, ANTIOXID REDOX SIGN, V5, P597, DOI 10.1089/152308603770310266; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Terpos E, 2013, ONCOTARGETS THER, V6, P531, DOI 10.2147/OTT.S34498; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Vargesson N, 2013, P NATL ACAD SCI USA, V110, pE4820, DOI 10.1073/pnas.1318475110; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Wang Y, 2001, STROKE, V32, P2170, DOI 10.1161/hs0901.095650; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Weinberger JM, 2006, J NEUROL SCI, V249, P101, DOI 10.1016/j.jns.2006.06.010; World Health Organization, TOP 10 CAUS DEATH; Zhang JX, 2017, INT J MOL MED, V39, P603, DOI 10.3892/ijmm.2017.2882; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	63	14	14	3	10	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	OCT	2018	19	10							3252	10.3390/ijms19103252			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	GY9HB	WOS:000448951000407	30347766	gold, Green Published, Green Submitted			2022-02-06	
J	Tao, L; Zhang, L; Gao, R; Jiang, F; Cao, JB; Liu, HX				Tao, Li; Zhang, Li; Gao, Rong; Jiang, Feng; Cao, Jianbo; Liu, Huixiang			Andrographolide Alleviates Acute Brain Injury in a Rat Model of Traumatic Brain Injury: Possible Involvement of Inflammatory Signaling	FRONTIERS IN NEUROSCIENCE			English	Article						andrographolide; inflammation; apoptosis; traumatic brain injury; neuroprotection	NF-KAPPA-B; MICROGLIAL ACTIVATION; FUNCTIONAL RECOVERY; INOS EXPRESSION; NEUROINFLAMMATION; PATHWAY; RESPONSES; DISEASE; NEURON; NEURODEGENERATION	Neuroinflammation plays an important role in secondary injury after traumatic brain injury (TBI). Andrographolide (Andro), a diterpenoid lactone isolated from Andrographis paniculata, has been demonstrated to exhibit anti-inflammatory activity in neurodegenerative disorders. This study therefore aimed to investigate the potential neuroprotective effects of Andra after TBI and explore the underlying mechanisms. In our study, we used a weight-dropped model to induce TBI in Sprague-Dawley rats, the neurological deficits were assessed using modified neurological severity scores, Fluoro-Jade B (FJB) and terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) staining were employed to examine neuronal degeneration and apoptosis after TBI, immunofluorescence was designed to investigate microglial activation. Quantitative Real-time PCR and ELISA were conducted to detect the expression levels of pro-inflammatory cytokines, Western blot was used to examine the expression level of proteins of relative signaling pathway. Our results showed that after Andro administration, the neurological deficit was attenuated, and the cerebral edema and apoptosis in brain tissues were also decreased following TBI. Both microglial activation and the expression of pro-inflammatory cytokines were significantly inhibited by Andro after TBI. Moreover, Andro inhibited NF-kappa B p65 subunit translocation and decreased the expression levels of phosphorylated extracellular signal regulated kinase (ERK) and p38 MAPK after TBI. Altogether, this study suggests that Andro could improve neurobehavioral function by inhibiting NF-kappa B and MAPK signaling pathway in TBI, which might provide a new approach for treating brain injury.	[Tao, Li; Cao, Jianbo] Zhangjiagang First Peoples Hosp, Dept Pharm, Suzhou, Peoples R China; [Tao, Li; Cao, Jianbo] Zhangjiagang First Peoples Hosp, Translat Med Ctr, Suzhou, Peoples R China; [Zhang, Li; Gao, Rong; Jiang, Feng; Liu, Huixiang] Zhangjiagang First Peoples Hosp, Dept Neurosurg, Suzhou, Peoples R China		Cao, JB (corresponding author), Zhangjiagang First Peoples Hosp, Dept Pharm, Suzhou, Peoples R China.; Cao, JB (corresponding author), Zhangjiagang First Peoples Hosp, Translat Med Ctr, Suzhou, Peoples R China.; Liu, HX (corresponding author), Zhangjiagang First Peoples Hosp, Dept Neurosurg, Suzhou, Peoples R China.	Caojianbo65@126.com; liuhuixianglab@sina.com					Batkhuu J, 2002, BIOL PHARM BULL, V25, P1169, DOI 10.1248/bpb.25.1169; Chan SJ, 2010, BRIT J PHARMACOL, V161, P668, DOI 10.1111/j.1476-5381.2010.00906.x; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chern CM, 2011, PLANTA MED, V77, P1669, DOI 10.1055/s-0030-1271019; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jin Q, 2014, BRAIN BEHAV IMMUN, V40, P131, DOI 10.1016/j.bbi.2014.03.003; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu DY, 2006, BIOCHEM PHARMACOL, V72, P992, DOI 10.1016/j.bcp.2006.06.038; Luo CL, 2013, BRAIN RES, V1502, P1, DOI 10.1016/j.brainres.2013.01.037; Lutton EM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03309-4; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Shen YC, 2002, BRIT J PHARMACOL, V135, P399, DOI 10.1038/sj.bjp.0704493; Skaper SD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00072; Skaper SD, 2017, NEUROSCIENTIST, V23, P478, DOI 10.1177/1073858416687249; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Tao L, 2014, J PHARMACOL SCI, V125, P364, DOI 10.1254/jphs.14025FP; Ullah N, 2011, NEUROPHARMACOLOGY, V61, P1248, DOI 10.1016/j.neuropharm.2011.06.031; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang TG, 2004, J PHARMACOL EXP THER, V308, P975, DOI 10.1124/jpet.103.059683; Wang YJ, 2007, CELL RES, V17, P933, DOI 10.1038/cr.2007.89; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Zhang HJ, 2018, INT J MOL MED, V42, P279, DOI 10.3892/ijmm.2018.3600; Zhao YY, 2017, NEUROCHEM INT, V111, P82, DOI 10.1016/j.neuint.2017.03.017; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	37	14	15	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 20	2018	12								657	10.3389/fnins.2018.00657			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU2QZ	WOS:000445116300001	30294256	gold, Green Published			2022-02-06	
J	Bronson, H; Vaudreuil, R; Bradt, J				Bronson, Hannah; Vaudreuil, Rebecca; Bradt, Joke			Music Therapy Treatment of Active Duty Military: An Overview of Intensive Outpatient and Longitudinal Care Programs	MUSIC THERAPY PERSPECTIVES			English	Article						Military; Music Therapy; TBI; PTSD; Creative Arts Therapies	MENTAL-HEALTH; BRAIN; REHABILITATION; MODEL	In recent years, there has been increased demand for music therapy services within military treatment facilities to treat combat-related injuries. This demand is partly due to increased research output related to music interventions in neuro-rehabilitation as well as an increased prevalence of signature injuries including traumatic brain injury and posttraumatic stress disorder for which interdisciplinary patient-centered care is recommended. The complexity of traumatic brain injury, posttraumatic stress, and military service itself presents challenges for music therapists when creating patient-centered program models. As military healthcare increases access to new treatments as a standard of care, it is important for music therapists to provide descriptions of effective treatment models in military settings. Outlining established music therapy models of care is essential to the successful addition of music therapy in the treatment of service members' complex injuries. This paper outlines current program models at two facilities, the National Intrepid Center of Excellence at Walter Reed National Military Medical Center and Intrepid Spirit Center at Fort Belvoir.	[Bronson, Hannah; Vaudreuil, Rebecca] Creat Forces NEA Mil Healing Arts Network, Washington, DC USA; [Bradt, Joke] Drexel Univ, Dept Creat Arts Therapies, Philadelphia, PA 19104 USA		Bronson, H (corresponding author), Creat Forces, Washington, DC 20506 USA.	Hannah.e.bronson.ctr@mail.mil	bradt, joke/C-5930-2014	bradt, joke/0000-0001-7313-9829	National Endowment for the Arts, Creative Forces: NEA Military Healing Arts Network	The authors of this paper would like to thank the National Endowment for the Arts, Creative Forces: NEA Military Healing Arts Network for their funding support. In addition, gratitude is extended to leadership and colleagues at NICoE/Intrepid Spirit Center at Fort Belvoir for ongoing support of music therapy.	American Music Therapy Association, 2014, MUS THER MIL POP; American Music Therapy Association & Certification Board for Music Therapist, 2015, SCOP MUS THER PRACT; Baker FA, 2013, ART PSYCHOTHER, V40, P20, DOI 10.1016/j.aip.2012.09.004; Bensimon M, 2008, ART PSYCHOTHER, V35, P34, DOI 10.1016/j.aip.2007.09.002; Bradt J, 2006, CREATIVE ARTS THERAP; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; DAVIS WB, 1993, J MUSIC THER, V30, P34, DOI 10.1093/jmt/30.1.34; de l'Etoile S, 2000, J MUSIC THER, V37, P51; Defense and Veterans Brain Injury Center, 2017, RES REV MILD TRAUM B; DEGRABA T, 2014, NEUROLOGY S10, V82, P5; Denning LA., 2014, PREVENTING PSYCHOL D; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Fort Belvoir Community Hospital, 2017, TRAUM BRAIN INJ CLIN; Gabrielsson A., 2001, MUSIC EMOTION THEORY, P223, DOI DOI 10.1525/MP.2004.21.4.561; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Hunt AM, 2015, MUSIC THER PERSPECT, V33, P142, DOI 10.1093/mtp/miv024; Irle K, 2014, MUSIC THER PERSPECT, V32, P178, DOI 10.1093/mtp/miu019; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Leszcz M., 1995, THEORY PRACTICE GROU; Magee WL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub3; McCraty R., 2006, COHERENT HEART HEART; MUSICANT S, 1994, AM J DANCE THER, V16, P91, DOI 10.1007/BF02358569; National Endowments for the Arts, 2017, CREAT FORC NEA MIL H; Pearce M, 2012, TOP COGN SCI, V4, P468, DOI 10.1111/j.1756-8765.2012.01226.x; Rorke MA, 1996, J MUSIC THER, V33, P189, DOI 10.1093/jmt/33.3.189; Rudhyar G, 1982, MAGIC TONE ART MUSIC; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Sarkamo T, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00103; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Sihvonen AJ, 2017, LANCET NEUROL, V16, P648, DOI 10.1016/S1474-4422(17)30168-0; Solli HP, 2013, J MUSIC THER, V50, P244, DOI 10.1093/jmt/50.4.244; Spencer JR, 2013, THESIS; Stegemoller EL, 2014, J MUSIC THER, V51, P211, DOI 10.1093/jmt/thu023; TAYLOR DB, 1981, J MUSIC THER, V18, P62, DOI 10.1093/jmt/18.2.62; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thaut M. H., 2014, HDB NEUROLOGIC MUSIC; Tyson F., 1981, PSYCHIAT MUSIC THERA; van der Kolk B, 1998, PSYCHIAT CLIN NEUROS, V52, pS52; van der Kolk B.A., 2014, BODY KEEPS SCORE BRA; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	43	14	14	2	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0734-6875	2053-7387		MUSIC THER PERSPECT	Music Ther. Perspect.	FAL	2018	36	2					195	206		10.1093/mtp/miy006			12	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	HI5RF	WOS:000456510900008		hybrid			2022-02-06	
J	Huang, SX; Qiu, GZ; Cheng, FR; Pei, Z; Yang, Z; Deng, XH; Zhu, JH; Chen, L; Chen, CC; Lin, WF; Liu, Y; Liu, ZS; Zhu, FQ				Huang, Shu-Xuan; Qiu, Guozhen; Cheng, Fu-Rong; Pei, Zhong; Yang, Zhi; Deng, Xu-Hui; Zhu, Jin-Hua; Chen, Lue; Chen, Chun-Chun; Lin, Wei-Feng; Liu, Yuan; Liu, Zhengshan; Zhu, Fei-Qi			Berberine Protects Secondary Injury in Mice with Traumatic Brain Injury Through Anti-oxidative and Anti-inflammatory Modulation	NEUROCHEMICAL RESEARCH			English	Article						Traumatic brain injury; Berberine; Oxidative stress; Inflammatory; Secondary injury	NITRIC-OXIDE SYNTHASE; CEREBRAL-ISCHEMIA; NEURONAL DEATH; RATS; MODEL; NEUROPROTECTION; ACTIVATION; DISEASE; DAMAGE; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) is one of the major causes of death and disability worldwide. Novel and effective therapy is needed to prevent the secondary spread of damage beyond the initial injury. The aim of this study was to investigate whether berberine has a neuroprotective effect on secondary injury post-TBI, and to explore its potential mechanism in this protection. The mice were randomly divided into Sham-saline, TBI-saline and TBI-Berberine (50 mg/kg). TBI was induced by Feeney's weight-drop technique. Saline or berberine was administered via oral gavage starting 1 h post-TBI and continuously for 21 days. Motor coordination, spatial learning and memory were assessed using beam-walking test and Morris water maze test, respectively. Brain sections were processed for lesion volume assessment, and expression of neuronal nuclei (NeuN), cyclooxygenase 2 (COX-2), inducible nitric oxide synthase (iNOS), 8-hydroxy-2-deoxyguanosine (8-OHdG), ionized calcium-binding adapter molecule 1 (Iba1) and glial fibrillary acidic protein (GFAP) were detected via immunohistochemistry and immunofluorescence. There were statistically significant improvement in motor coordination, spatial learning and memory in the TBI-Berberine group, compared to the TBI-saline group. Treatment with berberine significantly reduced cortical lesion volume, neuronal loss, COX-2, iNOS and 8-OHdG expression in both the cortical lesion border zone (LBZ) and ipsilateral hippocampal CA1 region (CA1), compared to TBI-saline. Berberine treatment also significantly decreased Iba1- and GFAP-positive cell number in both the cortical LBZ and ipsilateral CA1, relative to saline controls. These results indicated that berberine exerted neuroprotective effects on secondary injury in mice with TBI probably through anti-oxidative and anti-inflammatory properties.	[Qiu, Guozhen; Chen, Chun-Chun; Zhu, Fei-Qi] Shenzhen Univ, Cognit Impairment Ward, Neurol Dept, Affiliated Hosp 3, 47 Youyi Rd, Shenzhen 518001, Guangdong, Peoples R China; [Huang, Shu-Xuan; Yang, Zhi; Deng, Xu-Hui; Zhu, Jin-Hua; Lin, Wei-Feng; Zhu, Fei-Qi] Shantou Univ, Dept Neurol, Affiliated Yuebei Peoples Hosp, Shaoguan 512026, Guangdong, Peoples R China; [Huang, Shu-Xuan] Guangzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China; [Cheng, Fu-Rong] Luohu Dist Hlth & Family Planning Bur, Shenzhen 518001, Guangdong, Peoples R China; [Pei, Zhong] Sun Yat Sen Univ, Dept Neurol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Chen, Lue] Southern Med Univ, Dept Neurol, Affiliated Shunde Peoples Hosp 1, Foshan 528300, Guangdong, Peoples R China; [Liu, Yuan] Third Hosp Hangzhou, Dept Neurol, Hangzhou 310009, Zhejiang, Peoples R China; [Liu, Zhengshan] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Liu, Zhengshan] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA		Zhu, FQ (corresponding author), Shenzhen Univ, Cognit Impairment Ward, Neurol Dept, Affiliated Hosp 3, 47 Youyi Rd, Shenzhen 518001, Guangdong, Peoples R China.; Zhu, FQ (corresponding author), Shantou Univ, Dept Neurol, Affiliated Yuebei Peoples Hosp, Shaoguan 512026, Guangdong, Peoples R China.	zfqzsu2004@aliyun.com	Zhu, Feiqi/AAE-2897-2020		Natural Science Foundation of Guangdong Province ChinaNational Natural Science Foundation of Guangdong Province [S2013010015786, 2015A030310294]; Natural Science Foundation of Shaoguan City, Guangdong Province, China [2010-01]	This work was supported by the Natural Science Foundation of Guangdong Province China (S2013010015786), (2015A030310294) and the Natural Science Foundation of Shaoguan City, Guangdong Province, China (2010-01).	Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chen CY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092271, 10.1371/journal.pone.0108021, 10.1371/journal.pone.0106248]; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Durairajan SSK, 2012, NEUROBIOL AGING, V33, P2903, DOI 10.1016/j.neurobiolaging.2012.02.016; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Franklin JL, 2011, ANTIOXID REDOX SIGN, V14, P1437, DOI 10.1089/ars.2010.3596; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Haces ML, 2010, NEUROSCIENCE, V165, P28, DOI 10.1016/j.neuroscience.2009.10.003; Hong JS, 2012, J NEUROSCI RES, V90, P489, DOI 10.1002/jnr.22756; Hsieh HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484613; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; IKRAM M, 1975, PLANTA MED, V28, P353, DOI 10.1055/s-0028-1097869; Im JY, 2006, FREE RADICAL BIO MED, V41, P960, DOI 10.1016/j.freeradbiomed.2006.06.001; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kumar A, 2016, PSYCHOPHARMACOLOGY, V233, P137, DOI 10.1007/s00213-015-4095-7; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee IA, 2010, EUR J PHARMACOL, V648, P162, DOI 10.1016/j.ejphar.2010.08.046; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Mendez DR, 2004, J TRAUMA, V56, P1235, DOI 10.1097/01.TA.0000130759.62286.0E; Merrill DA, 2001, J COMP NEUROL, V438, P445, DOI 10.1002/cne.1327; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Siow YL, 2011, FOOD RES INT, V44, P2409, DOI 10.1016/j.foodres.2010.12.038; Thau-Zuchman O, 2012, J NEUROTRAUM, V29, P375, DOI 10.1089/neu.2010.1673; Wang JP, 2018, MOL MED REP, V17, P6881, DOI 10.3892/mmr.2018.8674; Wang XL, 2005, LIFE SCI, V77, P3058, DOI 10.1016/j.lfs.2005.02.033; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Ye MZ, 2009, J PHARM PHARMACOL, V61, P831, DOI [10.1211/jpp/61.07.0001, 10.1211/jpp.61.07.0001]; Zhang DF, 2016, PAK J PHARM SCI, V29, P1365; Zhang J, 2009, SAUDI MED J, V30, P760; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78; Zilles K, 2012, CORTEX RAT STEREOTAX	53	14	16	1	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	SEP	2018	43	9					1814	1825		10.1007/s11064-018-2597-5			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GQ2AV	WOS:000441447600011	30027364				2022-02-06	
J	Isacescu, J; Danckert, J				Isacescu, Julia; Danckert, James			Exploring the relationship between boredom proneness and self-control in traumatic brain injury (TBI)	EXPERIMENTAL BRAIN RESEARCH			English	Article						Boredom; Attention; Self-control; Traumatic brain injury; Aggression	ORBITOFRONTAL CORTEX; SUSTAINED ATTENTION; CONSCIOUS AWARENESS; AGGRESSION; DEPRESSION; FAILURES; REWARD; LAPSES; MIND; SENSITIVITY	Characterized as an agitated state in which the individual is motivated to engage in their environment but all attempts to do so fail to satisfy, boredom represents a disengaged attentional state that is associated with negative affect and poor self-control. There have been anecdotal reports of increased levels of boredom post-traumatic brain injury (TBI). For the first time, we provide objective evidence that TBI patients do indeed experience higher levels of boredom proneness. Hierarchical regression analyses showed that the presence and severity of head injury were a significant positive predictor of levels of boredom proneness and a negative predictor of self-control. As with healthy controls, TBI patients showed a strong negative correlation between boredom proneness and self-control-those with lower levels of self-control exhibited higher levels of boredom proneness. This was despite the fact that our TBI patients reported higher overall levels of self-control (probably concomitant with their older mean age). The TBI patients also showed strong positive correlations between boredom proneness and measures of physical aggression and anger. Together, this suggests that patients with TBI may be more susceptible to increased levels of boredom proneness and other negative affective states that arise as a consequence of failures of self-control.	[Isacescu, Julia; Danckert, James] Univ Waterloo, Dept Psychol, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada		Danckert, J (corresponding author), Univ Waterloo, Dept Psychol, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	jdancker@uwaterloo.ca					AHMED SMS, 1990, PERCEPT MOTOR SKILL, V71, P963, DOI 10.2466/pms.1990.71.3.963; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bailey NW, 2015, BIOL PSYCHOL, V106, P1, DOI 10.1016/j.biopsycho.2015.01.011; Bench SW, 2013, BEHAV SCI-BASEL, V3, P459, DOI 10.3390/bs3030459; Bengtsson TT, 2012, J CONTEMP ETHNOGR, V41, P526, DOI 10.1177/0891241612449356; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carriere JSA, 2008, CONSCIOUS COGN, V17, P835, DOI 10.1016/j.concog.2007.04.008; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; Cohen J, 2003, APPL MULTIPLE REGRES, P2012; Dahlen ER, 2004, PERS INDIV DIFFER, V37, P1615, DOI 10.1016/j.paid.2004.02.016; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; DeCoster J., 2007, APPL LINEAR REGRESSI; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Eastwood, 2010, INT GAMBL STUD, V10, P91, DOI [10.1080/14459791003754414, DOI 10.1080/14459791003754414, 10.1080/1445979100 3754414]; Eastwood JD, 2012, PERSPECT PSYCHOL SCI, V7, P482, DOI 10.1177/1745691612456044; Elliott R, 2003, J NEUROSCI, V23, P303; Elpidorou A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01245; Fahlman SA, 2013, ASSESSMENT, V20, P68, DOI 10.1177/1073191111421303; FARMER R, 1986, J PERS ASSESS, V50, P4, DOI 10.1207/s15327752jpa5001_2; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Goetz T, 2014, MOTIV EMOTION, V38, P401, DOI 10.1007/s11031-013-9385-y; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldberg Y, 2013, BEHAV SCI-BASEL, V3, P434, DOI 10.3390/bs3030434; Goldberg YK, 2011, J SOC CLIN PSYCHOL, V30, P647, DOI 10.1521/jscp.2011.30.6.647; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Isacescu J, COGN EMOT; ISOAHOLA SE, 1991, J LEISURE RES, V23, P260, DOI 10.1080/00222216.1991.11969857; Joireman J, 2003, J PERS SOC PSYCHOL, V84, P1287, DOI 10.1037/0022-3514.84.6.1287; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Juengst SB, 2014, AM J PHYS MED REHAB, V93, P1086, DOI 10.1097/PHM.0000000000000163; KASS SJ, 1990, PSYCHOLOGY, V27, P7; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Malkovsky E, 2012, EXP BRAIN RES, V221, P59, DOI 10.1007/s00221-012-3147-z; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P619, DOI 10.1080/13803395.2011.553586; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; Melton AMA, 2009, J PSYCHOL, V143, P493, DOI 10.3200/JRL.143.5.493-508; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; Pekrun R, 2014, J EDUC PSYCHOL, V106, P696, DOI 10.1037/a0036006; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Seli P, 2015, PSYCHOL RES-PSYCH FO, V79, P750, DOI 10.1007/s00426-014-0617-x; Shah JY, 2003, ONT SYMP P, V9, P247; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Sigurdardottir S, 2014, BRAIN INJURY, V28, P1542, DOI 10.3109/02699052.2014.934285; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; STARK KD, 1987, J ABNORM CHILD PSYCH, V15, P91, DOI 10.1007/BF00916468; Struk AA, 2016, COGNITION EMOTION, V30, P1388, DOI 10.1080/02699931.2015.1064363; Struk AA, 2017, ASSESSMENT, V24, P346, DOI 10.1177/1073191115609996; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; TEASDALE G, 1974, LANCET, V2, P81; Vodanovich SJ, 2005, J PERS ASSESS, V85, P295, DOI 10.1207/s15327752jpa8503_05; VODANOVICH SJ, 1990, J SOC BEHAV PERS, V5, P297; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274	71	14	16	2	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	SEP	2018	236	9			SI		2493	2505		10.1007/s00221-016-4674-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GP4FV	WOS:000440815700006	27215775				2022-02-06	
J	Kerr, ZY; Putukian, M; Chang, CJ; DiStefano, LJ; Currie, DW; Pierpoint, LA; Knowles, SB; Wasserman, EB; Dompier, TP; Comstock, RD; Marshall, SW				Kerr, Zachary Y.; Putukian, Margot; Chang, Cindy J.; DiStefano, Lindsay J.; Currie, Dustin W.; Pierpoint, Lauren A.; Knowles, Sarah B.; Wasserman, Erin B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in US High School Boys' Soccer (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Men's Soccer (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; student-athletes; injury prevention	RANDOMIZED CONTROLLED-TRIAL; FEMALE VOLLEYBALL PLAYERS; PREVENTION PROGRAM; MEDICAL COVERAGE; ANKLE SPRAINS; RISK-FACTORS; FOOTBALL; RATES; SYSTEM; METAANALYSIS	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of boys' and men's soccer injury data. Objective: To describe the epidemiology of injuries sustained in high school boys' soccer in the 2005-2006 through 2013-2014 academic years and collegiate men's soccer in the 2004-2005 through 2013-2014 academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from soccer teams of high school boys (annual average = 100) and collegiate men (annual average = 41). Patients or Other Participants: Boys' or men's soccer players who participated in practices and competitions during the 2005-2006 through 2013-2014 academic years in high school and the 2004-2005 through 2013-2014 academic years in college, respectively. Main Outcome Measure(s): Athletic trainers collected timeloss (>= 24 hours) injury and exposure data. Injury rates per 1000 athlete-exposures (AEs), injury rate ratios (IRRs) with 95% confidence intervals (Cis), and injury proportions by body site and diagnosis were calculated. Results: High School Reporting Information Online documented 2912 time-loss injuries during 1 592 238 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 4765 time-loss injuries during 686 918 AEs. The injury rate was higher in college than in high school (6.94 versus 1.83/1000 AEs; IRR = 3.79; 95% CI = 3.62, 3.97). Injury rates increased with smaller school size for high schools and were higher in Division I than in Divisions II and III. The injury rate was higher during competitions than during practices in both high school (IRR = 3.55; 95% CI = 3.30, 3.83) and college (IRR = 3.45; 95% CI = 3.26, 3.65). Most injuries were to the lower extremity. However, concussion was a common injury, particularly in collegiate goalkeepers and at all positions for high school players. Concussions accounted for more than one-fifth of injuries in high school games. Conclusions: Injury-prevention interventions should be tailored to reflect variations in the incidence and type of injury by level of competition, event type, and position.	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Putukian, Margot] Princeton Univ, Univ Hlth Serv, Princeton, NJ 08544 USA; [Putukian, Margot] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Chang, Cindy J.] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Chang, Cindy J.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [DiStefano, Lindsay J.; Comstock, R. Dawn] Univ Connecticut, Dept Kinesiol, Storrs, CT USA; [Currie, Dustin W.; Pierpoint, Lauren A.] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Knowles, Sarah B.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu		Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000674, R49CE001172] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025754] Funding Source: NIH RePORTER	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The ISP was funded by the NCAA. The HS RIO was funded in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. The authors also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	Agel J, 2007, J ATHL TRAINING, V42, P270; Al Attar WSA, 2017, SPORTS MED, V47, P907, DOI 10.1007/s40279-016-0638-2; Arnason A, 2004, AM J SPORT MED, V32, p5S, DOI 10.1177/0363546503258912; Askling C, 2003, SCAND J MED SCI SPOR, V13, P244, DOI 10.1034/j.1600-0838.2003.00312.x; Aukerman DF, 2006, SOUTH MED J, V99, P132, DOI 10.1097/01.smj.0000199749.22741.5e; Bahr R, 1997, SCAND J MED SCI SPOR, V7, P172, DOI 10.1111/j.1600-0838.1997.tb00135.x; Bizzini M, 2015, BRIT J SPORT MED, V49, P577, DOI 10.1136/bjsports-2015-094765; Brink MS, 2010, BRIT J SPORT MED, V44, P809, DOI 10.1136/bjsm.2009.069476; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Carek P J, 1999, J S C Med Assoc, V95, P420; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Education Commission of the States, STAT ADDR CONC YOUTH; Federation Internationale de Football Association (FIFA), 265 MILL PLAYING FOO; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Freckleton G, 2013, BRIT J SPORT MED, V47, P351, DOI 10.1136/bjsports-2011-090664; Grooms DR, 2013, J ATHL TRAINING, V48, P782, DOI 10.4085/1062-6050-48.4.08; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Halson SL, 2014, SPORTS MED, V44, pS139, DOI 10.1007/s40279-014-0253-z; Kaminski TW, 2013, J ATHL TRAINING, V48, P528, DOI 10.4085/1062-6050-48.4.02; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2011, J ATHL TRAINING, V46, P489; McCriskin BJ, 2015, WORLD J ORTHOP, V6, P161, DOI 10.5312/wjo.v6.i2.161; McGuine TA, 2011, AM J SPORT MED, V39, P1840, DOI 10.1177/0363546511406242; National Collegiate Athletic Association, STUD ATHL PART 1981; National Collegiate Athletic Association, 2014 15 SPORTS MED H; National Federation of State High School Associations, PART STAT; Pedowitz DI, 2008, AM J SPORT MED, V36, P324, DOI 10.1177/0363546507308358; Petersen J, 2011, AM J SPORT MED, V39, P2296, DOI 10.1177/0363546511419277; Powell JW, 2004, J ATHL TRAINING, V39, P56; Powell JW, 1999, J ATHL TRAINING, V34, P277; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rutherford DS, 1999, CLIN J SPORT MED, V9, P209, DOI 10.1097/00042752-199910000-00005; Silvers-Granelli H, 2015, AM J SPORT MED, V43, P2628, DOI 10.1177/0363546515602009; Stasinopoulos D, 2004, BRIT J SPORT MED, V38, P182, DOI 10.1136/bjsm.2002.003947; United States Census Bureau, CENS REG US; Van Reijen M, 2017, J SCI MED SPORT, V20, P549, DOI 10.1016/j.jsams.2016.12.001; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	41	14	14	0	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2018	53	9					893	905		10.4085/1062-6050-166-17			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GY4NU	WOS:000448540500009	30372638	gold, Green Published			2022-02-06	
J	Oldham, MA; Flaherty, JH; Maldonado, JR				Oldham, Mark A.; Flaherty, Joseph H.; Maldonado, Jose R.			Refining Delirium: A Transtheoretical Model of Delirium Disorder with Preliminary Neurophysiologic Subtypes	AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						Delirium model; neurophysiology; subtypes; encephalopathy; neurocognitive disorder; cognitive decline	TRAUMATIC BRAIN-INJURY; POSTOPERATIVE DELIRIUM; COGNITIVE DECLINE; HYPERAMMONEMIC ENCEPHALOPATHY; GENERAL-ANESTHESIA; SLEEP-DEPRIVATION; VASCULAR DEMENTIA; MOTOR SUBTYPES; RISK-FACTORS; METAANALYSIS	The development of delirium indicates neurophysiologic disruption and predicts unfavorable outcomes. This relationship between delirium and its outcomes has inspired a generation of studies aimed at identifying, predicting, and preventing both delirium and its associated sequelae. Despite this, evidence on delirium prevention and management remains limited. No medication is approved for the prevention or treatment of delirium or for its associated psychiatric symptoms. This unmet need for effective delirium treatment calls for a refined approach. First, we explain why a one-size-fitsall approach based on a unitary biological model of delirium has contributed to variance in delirium studies and prevents further advance in the field. Next, in parallel with the shift from dementia to "major neurocognitive disorder," we propose a transtheoretical model of "delirium disorder" composed of interactive elements-precipitant, neurophysiology, delirium phenotype, and associated psychiatric symptoms. We explore how these relate both to the biopsychosocial factors that promote healthy cognition ("procognitive factors") and to consequent neuropathologic sequelae. Finally, we outline a preliminary delirium typology of specific neurophysiologic disturbances. Our model of delirium disorder offers several avenues for novel insights and clinical advance: it univocally differentiates delirium disorder from the phenotype of delirium, highlights delirium neurophysiology as a treatment target, separates the core features of delirium from associated psychiatric symptoms, suggests how procognitive factors influence the core elements of delirium disorder, and makes intuitive predictions about how delirium disorder leads to neuropathologic sequelae and cognitive impairment. Ultimately, this model opens several avenues for modern neuroscience to unravel this disease of antiquity.	[Oldham, Mark A.] Univ Rochester, Med Ctr, Dept Psychiat, 300 Crittenden Blvd,Box PSYCH, Rochester, NY 14642 USA; [Flaherty, Joseph H.] Geriatrics, Envis Questcare Phys Serv, Dallas, TX USA; [Maldonado, Jose R.] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA		Oldham, MA (corresponding author), Univ Rochester, Med Ctr, Dept Psychiat, 300 Crittenden Blvd,Box PSYCH, Rochester, NY 14642 USA.	mark_oldham@URMC.rochester.edu	Maldonado, Jose R/B-5964-2011				Abraha I, 2016, J NUTR HEALTH AGING, V20, P927, DOI 10.1007/s12603-016-0719-9; Abraha I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123090; Agar MR, 2017, JAMA INTERN MED, V177, P34, DOI 10.1001/jamainternmed.2016.7491; Al-Qadheeb NS, 2014, CRIT CARE MED, V42, P1442, DOI 10.1097/CCM.0000000000000224; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anderson BJ, 2014, CRIT CARE MED, V42, P1558, DOI 10.1097/CCM.0000000000000265; Avidan MS, 2011, J ALZHEIMERS DIS, V24, P201, DOI 10.3233/JAD-2011-101680; Basner M, 2013, CURR OPIN NEUROBIOL, V23, P854, DOI 10.1016/j.conb.2013.02.008; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brusilow S W, 1996, Adv Pediatr, V43, P127; Butterworth RF, 2016, METAB BRAIN DIS, V31, P1211, DOI 10.1007/s11011-015-9746-1; Chae JHJ, 2015, J PSYCHIATR PRACT, V21, P402, DOI 10.1097/PRA.0000000000000105; Choi SH, 2012, AM J PSYCHIAT, V169, P498, DOI 10.1176/appi.ajp.2012.11060976; Cizginer S, 2017, J GERIATR PSYCH NEUR, V30, P337, DOI 10.1177/0891988717732152; Cole MG, 2009, AGE AGEING, V38, P19, DOI 10.1093/ageing/afn253; Dauncey MJ, 2014, EUR J CLIN NUTR, V68, P1179, DOI 10.1038/ejcn.2014.173; Davis DHJ, 2017, JAMA PSYCHIAT, V74, P244, DOI 10.1001/jamapsychiatry.2016.3423; Dharmarajan K, 2017, J AM GERIATR SOC, V65, P1026, DOI 10.1111/jgs.14743; Engel GL, 2004, J NEUROPSYCH CLIN N, V16, P526, DOI 10.1176/appi.neuropsych.16.4.526; Foroughi CK, 2016, P NATL ACAD SCI USA, V113, P7470, DOI 10.1073/pnas.1601243113; Gatz M, 2005, PLOS MED, V2, P38, DOI 10.1371/journal.pmed.0020007; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Goel N, 2013, PROG MOL BIOL TRANSL, V119, P155, DOI 10.1016/B978-0-12-396971-2.00007-5; Gupta N, 2008, J PSYCHOSOM RES, V65, P215, DOI 10.1016/j.jpsychores.2008.05.020; Hall RJ, 2018, INT J GERIATR PSYCH, V33, P1479, DOI 10.1002/gps.4720; Harwood RH, 2018, INT J GERIATR PSYCH, V33, P1512, DOI 10.1002/gps.4696; Heckers S, 2015, JAMA PSYCHIAT, V72, P1165, DOI 10.1001/jamapsychiatry.2015.2250; Heidland A, 2010, J RENAL NUTR, V20, pS44, DOI 10.1053/j.jrn.2010.05.011; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hilton DA, 2015, NEUROPATHOLOGY SIMPL, P17; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Inouye SK, 2015, J AM GERIATR SOC, V63, P142, DOI 10.1111/jgs.13281; Inouye SK, 2014, ANN INTERN MED, V160, P526, DOI 10.7326/M13-1927; Isabelle C, 1999, AM J HEALTH-SYST PH, V56, P555, DOI 10.1093/ajhp/56.6.555; Kendler KS, DSM5 WORK GROUPS; King F, 2015, CASE REP NEUROL, V7, P242, DOI 10.1159/000441892; Klein PMC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6652; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Kuehn BM, 2017, JAMA-J AM MED ASSOC, V317, P1303, DOI 10.1001/jama.2017.0653; Lewis C, 2012, CURR MED RES OPIN, V28, P1039, DOI 10.1185/03007995.2012.694362; Lipowski ZJ, 1980, DELIRIUM ACUTE BRAIN; Lipowski ZJ., 1990, DELIRIUM ACUTE CONFU; Logan RW, 2012, MOL CELL ENDOCRINOL, V349, P82, DOI 10.1016/j.mce.2011.06.039; MacLullich AMJ, 2008, J PSYCHOSOM RES, V65, P229, DOI 10.1016/j.jpsychores.2008.05.019; Maldonado JR, 2018, INT J GERIATR PSYCH, V33, P1428, DOI 10.1002/gps.4823; Maldonado JR, 2017, CRIT CARE CLIN, V33, P461, DOI 10.1016/j.ccc.2017.03.013; Maldonado JR, 2013, AM J GERIAT PSYCHIAT, V21, P1190, DOI 10.1016/j.jagp.2013.09.005; Marcantonio ER, 2006, J GERONTOL A-BIOL, V61, P1281, DOI 10.1093/gerona/61.12.1281; Marcantonio ER, 2003, J AM GERIATR SOC, V51, P4, DOI 10.1034/j.1601-5215.2002.51002.x; Meagher DJ, 2011, J PSYCHOSOM RES, V71, P395, DOI 10.1016/j.jpsychores.2011.06.001; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Morley JE, 2014, J AM MED DIR ASSOC, V15, P689, DOI 10.1016/j.jamda.2014.07.015; Nadelson MR, 2015, BRIT J ANAESTH, V114, P344, DOI 10.1093/bja/aeu476; Neufeld KJ, 2016, J AM GERIATR SOC, V64, P705, DOI 10.1111/jgs.14076; Newman MW, 2015, GEN HOSP PSYCHIAT, V37, P408, DOI 10.1016/j.genhosppsych.2015.05.003; Oldham MA, 2016, CRIT CARE MED, V44, P207, DOI 10.1097/CCM.0000000000001282; Pandharipande P, 2010, CRIT CARE, V14, DOI 10.1186/cc8999; Pisani MA, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2010.02.009; Piva Simone, 2015, Cardiovascular & Hematological Disorders - Drug Targets, V15, P10; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Quinn TJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000110; Riebl SK, 2013, ACSMS HEALTH FIT J, V17, P21, DOI 10.1249/FIT.0b013e3182a9570f; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Rudberg MA, 1997, AGE AGEING, V26, P169, DOI 10.1093/ageing/26.3.169; Ruthirakuhan Myuri, 2012, J Aging Res, V2012, P384875, DOI 10.1155/2012/384875; Salluh JIF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2538; Sanford AM, 2014, CURR OPIN CLIN NUTR, V17, P45, DOI 10.1097/MCO.0000000000000022; Scheydt S, 2017, INT J MENT HEALTH NU, V26, P110, DOI 10.1111/inm.12303; Schultz D., 1965, SENSORY RESTRICTION; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sepulveda E, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0878-6; Sfera A, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00018; Shafi MM, 2017, J AM GERIATR SOC, V65, P1114, DOI 10.1111/jgs.14748; Shim J, 2015, PSYCHOSOMATICS, V56, P644, DOI 10.1016/j.psym.2015.05.002; Shioiri A, 2016, AM J GERIAT PSYCHIAT, V24, P528, DOI 10.1016/j.jagp.2015.09.002; Shirvani N, 2015, J AM GERIATR SOC, V63, P2645, DOI 10.1111/jgs.13851; Siddiqi N, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005563.pub2; Singhal AB, 2002, J NEUROL SCI, V196, P37, DOI 10.1016/S0022-510X(02)00019-9; Skelly DT, 2019, MOL PSYCHIATR, V24, P1533, DOI 10.1038/s41380-018-0075-8; Slor CJ, 2013, J PSYCHOSOM RES, V74, P444, DOI 10.1016/j.jpsychores.2012.12.007; Stein DJ, 2010, PSYCHOL MED, V40, P1759, DOI 10.1017/S0033291709992261; Stillman CM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00626; Thomas T, 2015, BRAIN, V138, P1059, DOI 10.1093/brain/awv025; Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1; TRZEPACZ PT, 1994, PSYCHOSOMATICS, V35, P374, DOI 10.1016/S0033-3182(94)71759-X; Tsang AH, 2016, J ENDOCRINOL, V230, pR1, DOI 10.1530/JOE-16-0051; van de Rest O, 2015, ADV NUTR, V6, P154, DOI 10.3945/an.114.007617; van Meenen LCC, 2014, J AM GERIATR SOC, V62, P2383, DOI 10.1111/jgs.13138; Vossler DG, 2002, EPILEPSIA, V43, P154, DOI 10.1046/j.1528-1157.2002.25001.x; WEISMAN AD, 1958, NEW ENGL J MED, V258, P1284, DOI 10.1056/NEJM195806262582602; Wong RY, 2017, J AM MED DIR ASSOC, V18, P282, DOI 10.1016/j.jamda.2017.01.002	92	14	14	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1064-7481	1545-7214		AM J GERIAT PSYCHIAT	Am. J. Geriatr. Psychiatr.	SEP	2018	26	9					913	924		10.1016/j.jagp.2018.04.002			12	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	GQ9PG	WOS:000442112700001	30017237				2022-02-06	
J	Pietropaoli, S; Leonetti, A; Cervetto, C; Venturini, A; Mastrantonio, R; Baroli, G; Persichini, T; Colasanti, M; Maura, G; Marcoli, M; Mariottini, P; Cervelli, M				Pietropaoli, Stefano; Leonetti, Alessia; Cervetto, Chiara; Venturini, Arianna; Mastrantonio, Roberta; Baroli, Giulia; Persichini, Tiziana; Colasanti, Marco; Maura, Guido; Marcoli, Manuela; Mariottini, Paolo; Cervelli, Manuela			Glutamate Excitotoxicity Linked to Spermine Oxidase Overexpression	MOLECULAR NEUROBIOLOGY			English	Article						EAAT; Oxidative stress; Polyamine metabolism; Seizures; Sulfasalazine; System x(c)(-) transporter	TRAUMATIC BRAIN-INJURY; ORNITHINE-DECARBOXYLASE; MOLECULAR PHARMACOLOGY; MOUSE MODEL; ACTIVATION; POLYAMINES; RELEASE; TRANSPORTERS	Excitotoxic stress has been associated with several different neurological disorders, and it is one of the main causes of neuronal degeneration and death. To identify new potential proteins that could represent key factors in excitotoxic stress and to study the relationship between polyamine catabolism and excitotoxic damage, a novel transgenic mouse line overexpressing spermine oxidase enzyme in the neocortex (Dach-SMOX) has been engineered. These transgenic mice are more susceptible to excitotoxic injury and display a higher oxidative stress, highlighted by 8-Oxo-2'-deoxyguanosine increase and activation of defense mechanisms, as demonstrated by the increase of nuclear factor erythroid 2-related factor 2 (Nrf-2) in the nucleus. In Dach-SMOX astrocytes and neurons, an alteration of the phosphorylated and non-phosphorylated subunits of glutamate receptors increases the kainic acid response in these mice. Moreover, a decrease in excitatory amino acid transporters and an increase in the system x(c)(-) transporter, a Nrf-2 target, was observed. Sulfasalazine, a system x(c)(-) transporter inhibitor, was shown to revert the increased susceptibility of Dach-SMOX mice treated with kainic acid. We demonstrated that astrocytes play a crucial role in this process: neuronal spermine oxidase overexpression resulted in an alteration of glutamate excitability, in glutamate uptake and efflux in astrocytes involved in the synapse. Considering the involvement of oxidative stress in many neurodegenerative diseases, Dach-SMOX transgenic mouse can be considered as a suitable in vivo genetic model to study the involvement of spermine oxidase in excitotoxicity, which can be considered as a possible therapeutic target.	[Pietropaoli, Stefano; Leonetti, Alessia; Mastrantonio, Roberta; Baroli, Giulia; Persichini, Tiziana; Colasanti, Marco; Mariottini, Paolo; Cervelli, Manuela] Univ Rome Roma Tre, Dept Sci, Viale Marconi 446, I-00146 Rome, Italy; [Cervetto, Chiara; Venturini, Arianna; Maura, Guido; Marcoli, Manuela] Univ Genoa, Dept Pharm, Sect Pharmacol & Toxicol, Viale Cembrano 4, I-16148 Genoa, Italy; [Maura, Guido; Marcoli, Manuela] Univ Genoa, Ctr Excellence Biomed Res, Viale Benedetto 15 5, I-16132 Genoa, Italy		Cervelli, M (corresponding author), Univ Rome Roma Tre, Dept Sci, Viale Marconi 446, I-00146 Rome, Italy.	stefano.pietropaoli@uniroma3.it; alessia.leonetti@uniroma3.it; cervetto@difar.unige.it; venturini@difar.unige.it; robena.mastrantonio@uniroma3.it; giulia.baroli@uniroma3.it; tiziana.persichini@uniroma3.it; marco.colasanti@uniroma3.it; maura@pharmatox.unige.it; marcoli@pharmatox.unige.it; paolo.mariottini@uniroma3.it; manuela.cervelli@uniroma3.it	Cervelli, Manuela/ABC-6913-2020; Cervetto, Chiara/G-6404-2010	Cervelli, Manuela/0000-0001-8535-8279; Cervetto, Chiara/0000-0001-8290-3008; Pietropaoli, Stefano/0000-0002-8423-9187	Roma Tre University [CAL/2016]; Ph.D. School (Department of Science)	This work was supported by the Roma Tre University contribution to the laboratories [CAL/2016] to M.C. and P.M. and by the Ph.D. School (Department of Science) contribution 2016 to S.P. and A.L.	Balkhi HM, 2014, INT J ADV RES, V2, P361; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Cabungcal JH, 2013, BIOL PSYCHIAT, V73, P574, DOI 10.1016/j.biopsych.2012.09.020; Ceci R, 2017, FREE RADICAL BIO MED, V103, P216, DOI 10.1016/j.freeradbiomed.2016.12.040; Cervelli M, 2004, EUR J BIOCHEM, V271, P760, DOI 10.1111/j.1432-1033.2004.03979.x; Cervelli M, 2016, AMINO ACIDS, V48, P2283, DOI 10.1007/s00726-016-2273-5; Cervelli M, 2014, AMINO ACIDS, V46, P521, DOI 10.1007/s00726-013-1572-3; Cervelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064810; Cervelli M, 2013, J MOL EVOL, V76, P365, DOI 10.1007/s00239-013-9570-3; Cervelli M, 2012, AMINO ACIDS, V42, P441, DOI 10.1007/s00726-011-1014-z; Cervelli M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-555; Cervetto C, 2017, J NEUROCHEM, V140, P268, DOI 10.1111/jnc.13885; Cervetto C, 2016, NEUROMOL MED, V18, P50, DOI 10.1007/s12017-015-8377-3; Cervetto C, 2015, NEUROPHARMACOLOGY, V99, P396, DOI 10.1016/j.neuropharm.2015.08.011; Cervetto C, 2012, NEUROCHEM INT, V60, P768, DOI 10.1016/j.neuint.2012.02.034; Cervetto C, 2010, J PHARMACOL EXP THER, V332, P210, DOI 10.1124/jpet.109.154955; Chaturvedi R, 2012, GUT MICROBES, V3, P48, DOI 10.4161/gmic.19345; de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF487, DOI 10.1152/ajprenal.1999.277.4.F487; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Mastrantonio R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149802; Murray-Stewart T, 2016, ONCOGENE, V35, P5480, DOI 10.1038/onc.2016.91; PASCHEN W, 1992, CEREBROVAS BRAIN MET, V4, P59; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Pellegrini-Giampietro DE, 2003, TRENDS NEUROSCI, V26, P9, DOI 10.1016/S0166-2236(02)00004-8; Polticelli F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-90; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rea G, 2004, IUBMB LIFE, V56, P167, DOI 10.1080/15216540410001673996; Rosenblum LT, 2017, EXP NEUROL, V292, P145, DOI 10.1016/j.expneurol.2017.03.014; Shigeri Y, 2004, BRAIN RES REV, V45, P250, DOI 10.1016/j.brainresrev.2004.04.004; Smirnova OA, 2012, BIOCHIMIE, V94, P1876, DOI 10.1016/j.biochi.2012.04.023; Tavladoraki P, 2011, AMINO ACIDS, V40, P1115, DOI 10.1007/s00726-010-0735-8; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Uemura T, 2016, BIOCHEM BIOPH RES CO, V473, P630, DOI 10.1016/j.bbrc.2016.03.137; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097	42	14	14	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	SEP	2018	55	9					7259	7270		10.1007/s12035-017-0864-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO9UK	WOS:000440453100012	29397558				2022-02-06	
J	Reif, S; Adams, RS; Ritter, GA; Williams, TV; Larson, MJ				Reif, Sharon; Adams, Rachel Sayko; Ritter, Grant A.; Williams, Thomas, V; Larson, Mary Jo			Prevalence of Pain Diagnoses and Burden of Pain Among Active Duty Soldiers, FY2012	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; OPERATIONS ENDURING FREEDOM; POLYTRAUMA-CLINICAL-TRIAD; TRAUMATIC BRAIN-INJURY; LOW-BACK-PAIN; IRAQI FREEDOM; HEALTH-CARE; RISK-FACTORS; US VETERANS; MANAGEMENT	Introduction: Soldiers are at risk for acute and chronic pain due to the mental and physical challenges of military duties and ongoing training for force readiness. With the burden of pain on any individual attributable across pain sources, a broad perspective that goes beyond prior characterizations of pain is important. We aim to further the understanding of pain's effects among non-deployed active duty soldiers and the Military Health System (MHS), by describing prevalence of 10 painful conditions, reported pain levels, duration of pain and impact of pain on military duty limitations. Methods: Data are from the MHS Data Repository including outpatient MHS direct care encounters, claims for outpatient purchased care from civilian providers, and vital records, for all soldiers continuously enrolled in TRICARE and not deployed in FY 2012. Ten pain-related diagnostic categories were conceptually derived for this analysis and identified using ICD-9-CM diagnostic codes. We report the FY 2012 prevalence at the soldier-level (N = 297,120) for each pain category as a primary diagnosis, as well as in any diagnostic position, and at the soldier-level for reported pain level, duration, and military duty limitations. Institutional Review Board approval was obtained prior to analyses. Results: Overall, 63% of soldiers had at least one pain diagnosis and 59% had a primary pain diagnosis during FY 2012. Back and neck pain (22%), non-traumatic joint disorders (28%), and other musculoskeletal pain (30%) were the most frequent categories for primary diagnosis. Nearly two-thirds of soldiers had a primary pain diagnosis in more than one category, and 23% in four or more categories. Moderate or severe pain levels were reported at least once during the year by 55% of soldiers who had a primary pain diagnosis. In the subsample of soldiers with primary pain in the first quarter, duration and chronicity of pain diagnoses varied by pain category: the back and neck pain category was the most common for both persistent pain occurring in each quarter of FY 2012 (23%) and chronic pain lasting for at least 3 mo (62%). In most pain categories, the majority of soldiers were released without duty limitations. Conclusion: These data provide a deeper understanding of pain diagnoses and burden of pain among active duty soldiers. A substantial proportion of soldiers with pain diagnoses were seen for pain self-reported as only mild, or that did not result in significant restrictions in military duty limitations. However, given the prevalence of multiple pain diagnoses and common reports of moderate or severe pain and long duration, complex interventions may be required to minimize the effect of pain on force readiness. This encounters-based analysis is likely an underestimate of presence of pain, and does not include contextual factors that could better describe the true effect of pain among this population.	[Reif, Sharon; Adams, Rachel Sayko; Ritter, Grant A.; Larson, Mary Jo] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St, Waltham, MA 02453 USA; [Williams, Thomas, V] Def Hlth Agcy, 7700 Arlington Blvd, Falls Church, VA 22042 USA; [Williams, Thomas, V] Univ Chicago, NORC, 4350 East West Highway, Bethesda, MD 20814 USA		Reif, S (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St, Waltham, MA 02453 USA.		Adams, Rachel/AAH-4653-2020		National Center for Complementary and Integrative Health (NCCIH) [R01 AT008404]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AT008404] Funding Source: NIH RePORTER	This study was funded by the National Center for Complementary and Integrative Health (NCCIH; R01 AT008404).	Agency for Healthcare Research and Quality - Healthcare Cost and Utilization Project (HCUP), 2014, CLIN CLASS SOFTW CCS; Armed Forces Health Surveillance Branch. Update: malaria U. S. Armed Forces, 2015, MED SURVEILLANCE MON, V23, P2; Blyth FM, 2004, PAIN, V111, P51, DOI 10.1016/j.pain.2004.05.020; Buckenmaier CC, 2013, PAIN MED, V14, P110, DOI 10.1111/j.1526-4637.2012.01516.x; Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Cicero TJ, 2009, PAIN, V144, P20, DOI 10.1016/j.pain.2009.01.026; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Clark ME, 2004, PAIN MED, V5, P333, DOI 10.1111/j.1526-4637.2004.04059.x; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Cohen SP, 2005, ANESTH ANALG, V101, P1098, DOI 10.1213/01.ane.0000169332.45209.cf; Cook KF, 2014, PAIN MANAG, V4, P277, DOI [10.2217/PMT.14.25, 10.2217/pmt.14.25]; Department of Defense-Office of the Secretary of Defense, 2016, IMPL COMPR POL PAIN; Department of Veterans Affairs - Office of Inspector General, 2014, HEALTHC INSP VA PATT; Edlund MJ, 2007, PAIN, V129, P355, DOI 10.1016/j.pain.2007.02.014; Eilat-Tsanani S, 2010, SPINE, V35, pE995, DOI 10.1097/BRS.0b013e3181c6edbb; Ernat J, 2012, MIL MED, V177, P1348, DOI 10.7205/MILMED-D-12-00183; Fillingim RB, 2014, J PAIN, V15, P241, DOI 10.1016/j.jpain.2014.01.004; Gallagher RM, 2014, PRINCIPLES ADDICTION, P1435; George SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030597; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Goulet JL, 2013, MED CARE, V51, P245, DOI 10.1097/MLR.0b013e318277f1ad; Haskell SG, 2009, PAIN MED, V10, P1167, DOI 10.1111/j.1526-4637.2009.00714.x; Interagency Pain Research Coordinating Committee, 2015, NAT PAIN STRAT COMP; International Association for the Study of Pain (IASP), 2002, CLASSIFICATION CHRON; International Association for the Study of Pain (IASP), PAIN TRETM SERV; IOM (Institute of Medicine), 2011, REL PAIN AM BLUEPR T; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Knox J, 2011, SPINE, V36, P1492, DOI 10.1097/BRS.0b013e3181f40ddd; Larson MJ, 2007, ADDICTION, V102, P752, DOI 10.1111/j.1360-0443.2007.01759.x; Lee C, 2014, PAIN MED, V15, pS76, DOI 10.1111/pme.12408; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McGeary CA, 2014, HDB MUSCULOSKETETAL, P143; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; National Institutes of Health, 2011, NIH MEDLINE PLUS; Office of The Army Surgeon General, 2010, PAIN MAN TASK FORC P; Otis JD, 2010, PSYCHOL SERV, V7, P126, DOI 10.1037/a0020512; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Rosenquist RW, 2010, ANESTHESIOLOGY, V112, P810, DOI 10.1097/ALN.0b013e3181c43103; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006; Veterans Health Administration, 2017, CHRON PAIN PRIM; Veterans Health Administration, 2000, PAIN 5 VIT SIGN TOOL; Villano CL, 2007, J REHABIL RES DEV, V44, P167, DOI 10.1682/JRRD.2006.05.0052; Von Korff M, 2007, CLIN J PAIN, V23, P400, DOI 10.1097/AJP.0b013e31804ac020; VONKORFF M, 1988, PAIN, V32, P173, DOI 10.1016/0304-3959(88)90066-8	46	14	14	1	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2018	183	9-10					E330	E337		10.1093/milmed/usx200			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GR8XG	WOS:000443018900015	29547946	Bronze, Green Published, Green Accepted			2022-02-06	
J	Ross, DE; Ochs, AL; Tate, DF; Tokac, U; Seabaugh, J; Abildskov, TJ; Bigler, ED				Ross, David E.; Ochs, Alfred L.; Tate, David F.; Tokac, Umit; Seabaugh, John; Abildskov, Tracy J.; Bigler, Erin D.			High correlations between MRI brain volume measurements based on NeuroQuant (R) and FreeSurfer	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Brain imaging; Reliability; Bayesian regression; Machine learning	RELIABILITY; INJURY	NeuroQuant (R) ( NQ) and FreeSurfer (FS) are commonly used computer-automated programs for measuring MRI brain volume. Previously they were reported to have high intermethod reliabilities but often large intermethod effect size differences. We hypothesized that linear transformations could be used to reduce the large effect sizes. This study was an extension of our previously reported study. We performed NQ and FS brain volume measurements on 60 subjects (including normal controls, patients with traumatic brain injury, and patients with Alzheimer's disease). We used two statistical approaches in parallel to develop methods for transforming FS volumes into NQ volumes: traditional linear regression, and Bayesian linear regression. For both methods, we used regression analyses to develop linear transformations of the FS volumes to make them more similar to the NQ volumes. The FS-to-NQ transformations based on traditional linear regression resulted in effect sizes which were small to moderate. The transformations based on Bayesian linear regression resulted in all effect sizes being trivially small. To our knowledge, this is the first report describing a method for transforming FS to NQ data so as to achieve high reliability and low effect size differences. Machine learning methods like Bayesian regression may be more useful than traditional methods.	[Ross, David E.; Ochs, Alfred L.; Seabaugh, John] Virginia Inst Neuropsychiat, 364 Browns Hill Court, Midlothian, VA 23114 USA; [Ross, David E.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Ochs, Alfred L.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA; [Tate, David F.; Tokac, Umit] Univ Missouri St Louis, Berkeley, MO USA; [Abildskov, Tracy J.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Abildskov, Tracy J.; Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA		Ross, DE (corresponding author), Virginia Inst Neuropsychiat, 364 Browns Hill Court, Midlothian, VA 23114 USA.	dross@VaNeuropsychiatry.org	Tate, David F/I-3963-2013	Tate, David F/0000-0003-0213-1920; Ochs, Alfred/0000-0003-3932-876X	Virginia Institute of Neuropsychiatry, University of Missouri at St. Louis; Brigham Young University; ADNI (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 AG024904]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.Biogen; Bristol-Myers Squibb CompanyBristol-Myers Squibb; Eisai Inc.Eisai Co Ltd; Elan Pharmaceuticals, Inc.; Eli Lilly and CompanyEli Lilly; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; GE HealthcareGeneral ElectricGE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.Johnson & JohnsonJohnson & Johnson USA; Medpace, Inc.; Merck Co., Inc.Merck & Company; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals CorporationNovartis; Pfizer Inc.Pfizer; Piramal Imaging; ServierServier; Synarc Inc.; Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	Funding was internal for work done at the Virginia Institute of Neuropsychiatry, University of Missouri at St. Louis, and Brigham Young University.; Data collection and sharing for this project was funded by the ADNI (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (http://www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuroimaging at the University of Southern California.	BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; Cohen J., 1988, STAT POWER ANAL; Crowley SJ, 2018, J INT NEUROPSYCH SOC, V24, P206, DOI 10.1017/S1355617717000868; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Groome D, 2016, INTRO APPL COGNITIVE; Iscan Z, 2015, HUM BRAIN MAPP, V36, P3472, DOI 10.1002/hbm.22856; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jovicich J, 2013, NEUROIMAGE, V83, P472, DOI 10.1016/j.neuroimage.2013.05.007; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lee SY, 2004, MULTIVAR BEHAV RES, V39, P653, DOI 10.1207/s15327906mbr3904_4; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ochs AL, 2015, J NEUROIMAGING, V25, P721, DOI 10.1111/jon.12229; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; R Core Team, 2016, R LANG ENV STAT COMP; Reid MW, 2017, J NEUROIMAGING, V27, P365, DOI 10.1111/jon.12431; Revelle W., 2010, PACKAGE PSYCH; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420	21	14	14	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	AUG 30	2018	278						69	76		10.1016/j.pscychresns.2018.05.007			8	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	GM0ZC	WOS:000437789300010	29880256				2022-02-06	
J	Cappelli, G; Noccetti, S; Arcara, G; Bambini, V				Cappelli, Gloria; Noccetti, Sabrina; Arcara, Giorgio; Bambini, Valentina			Pragmatic competence and its relationship with the linguistic and cognitive profile of young adults with dyslexia	DYSLEXIA			English	Article						figurative language; inference; narratives; pragmatics	TRAUMATIC BRAIN-INJURY; MIND; LANGUAGE; SKILLS; NEUROPRAGMATICS; COMMUNICATION; DISORDERS; ABILITIES; CHILDREN	The study assessed the pragmatic skills of 19 well-compensated Italian-speaking young adults with dyslexia compared with controls. A comprehensive pragmatic assessment tool was employed, targeting production and comprehension (Assessment of Pragmatic Abilities and Cognitive Substrates [APACS]). Participants were also administered a series of standardized tests to assess verbal and non-verbal cognitive abilities, including executive functions and social cognition tests. Data were analysed with the aim of understanding whether pragmatic abilities are compromised in dyslexia and of exploring associations between pragmatic performance and other cognitive domains. The performance of the dyslexia group was poorer than that of the control group in both expressive and receptive modalities. Data showed diffuse problems across several domains, with the greatest challenge posed by inferring nonliteral meanings, which indicates that pragmatic inefficiency is an important aspect of the linguistic and communicative profile of dyslexia in adulthood. Explorative correlations highlighted a relation between pragmatic performance and reading and vocabulary abilities, as well as between pragmatics and working memory. This suggests that pragmatic difficulties are strongly tied to the most distinctive aspects of dyslexia, namely, phonological awareness, verbal short-term memory, pseudo-word repetition, whereas the link with high-level executive functions and Theory of Mind is negligible.	[Cappelli, Gloria; Noccetti, Sabrina] Univ Pisa, Dept Philol Literature & Linguist, Pisa, Italy; [Arcara, Giorgio] San Camillo Hosp IRCCS, Venice, Italy; [Bambini, Valentina] Univ Sch Adv Studies IUSS Pavia, Ctr Neurocognit & Theoret Syntax NEtS, Pavia, Italy		Bambini, V (corresponding author), Sch Adv Studies IUSS Pavia, Ctr Neurocognit Epistemol & Theoret Syntax NEtS, Piazza Vittoria 15, I-27100 Pavia, Italy.	valentina.bambini@iusspavia.it	Bambini, Valentina/K-6643-2016; CAPPELLI, GLORIA/M-6942-2017	Bambini, Valentina/0000-0001-5770-228X; CAPPELLI, GLORIA/0000-0002-2047-2596; NOCCETTI, SABRINA/0000-0003-1188-3817			Adamczyk P, 2016, SCHIZOPHR RES, V176, P331, DOI 10.1016/j.schres.2016.08.015; Arcara G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00070; Ariel M, 2010, RES SURV LINGUIST, P1; Baddeley A. D., 1998, WORKING MEMORY; Baker SF, 2007, INT J LAW PSYCHIAT, V30, P492, DOI 10.1016/j.ijlp.2007.09.010; Bambini V, 2016, COMPR PSYCHIAT, V71, P106, DOI 10.1016/j.comppsych.2016.08.012; Bambini V, 2016, BRAIN LANG, V153, P1, DOI 10.1016/j.bandl.2015.12.002; Bambini V, 2010, ITAL J LINGUIST, V22, P1; Bambini V, 2011, BRAIN RES BULL, V86, P203, DOI 10.1016/j.brainresbull.2011.07.015; Bara BG, 2010, COGNITIVE PRAGMATICS, DOI [10.7551/mitpress/9780262014113.001.0001, DOI 10.7551/MITPRESS/9780262014113.001.0001]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertelli B., 2006, VAUMELF; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Bosco FM, 2012, J COMMUN DISORD, V45, P181, DOI 10.1016/j.jcomdis.2012.01.005; Bryan K., 1995, RIGHT HEMISPHERE LAN, V2nd ed.; Cain K, 2001, MEM COGNITION, V29, P850, DOI 10.3758/BF03196414; Cappelli G., 2016, MULTIMODALITY COMMUN, P37; Cardillo R, 2018, APPL NEUROPSYCH-CHIL, V7, P245, DOI 10.1080/21622965.2017.1297946; Carotenuto A, 2018, ARCH CLIN NEUROPSYCH, V33, P194, DOI 10.1093/arclin/acx061; Chinn S.J., 1995, DYSLEXIA STRESS, P49; Cornoldi C., 2010, MT AVANZATE 2; Dodich A, 2015, NEUROL SCI, V36, P1907, DOI 10.1007/s10072-015-2281-3; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Fawcett A. J., 1998, DYSLEXIA ADULT SCREE; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GATHERCOLE SE, 1992, DEV PSYCHOL, V28, P887, DOI 10.1037//0012-1649.28.5.887; Griffiths CCB, 2007, DYSLEXIA, V13, P276, DOI 10.1002/dys.333; Hales G., 1995, DYSLEXIA AND STRESS, P73; Kalandadze T, 2018, AUTISM, V22, P99, DOI 10.1177/1362361316668652; Kormos J., 2012, TEACHING LANGUAGES S; Lallier M, 2009, BRAIN RES, V1302, P132, DOI 10.1016/j.brainres.2009.07.037; Lam K.-H., 2014, ASIA PACIFIC J DEV D, V1, P4, DOI DOI 10.3850/S2345734114000027; Levinson Stephen., 1983, PRAGMATICS; Lorusso M.L., 2009, APL MEDEA ABILITA PR; MacCullagh L, 2017, DYSLEXIA, V23, P3, DOI 10.1002/dys.1544; Marotta L., 2008, TEST CMFVALUTAZIONE; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Matthews D., 2014, PRAGMATIC DEV 1 LANG, DOI [10.1075/tilar.10, DOI 10.1075/TILAR.10]; Melogno S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070085; Miles T.R., 2007, DYSLEXIA COLL; Nicolson R. I., 2008, DYSLEXIA LEARNING BR, DOI [10. 7551/mitpress/9780262140997. 001. 0001, DOI 10.7551/MITPRESS/9780262140997.001.0001]; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Orsini A., 2013, WAIS 4; Parola A, 2018, PSYCHIAT RES, V260, P144, DOI 10.1016/j.psychres.2017.11.051; Ransby MJ, 2003, J LEARN DISABIL-US, V36, P538, DOI 10.1177/00222194030360060501; Rinaldi M. C., 2006, BLEDBATTERIA LINGUAG; Ruffino M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00331; Simmons F, 2000, Dyslexia, V6, P178, DOI 10.1002/1099-0909(200007/09)6:3<178::AID-DYS171>3.0.CO;2-9; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Sperber D., 1995, RELEVANCE COMMUNICAT; Spotorno N, 2012, NEUROIMAGE, V63, P25, DOI 10.1016/j.neuroimage.2012.06.046; Stella G., 2000, P P V T R PEABODY PI; Stemmer B, 2000, BRAIN LANG, V71, P233, DOI 10.1006/brln.1999.2257; Suraniti S., 2009, TEST RECEPTION GRAMM; Thoma P, 2006, NEUROSCI BIOBEHAV R, V30, P1182, DOI 10.1016/j.neubiorev.2006.09.001; Vulchanova M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00024; Wampers M, 2018, SCHIZOPHR RES, V195, P97, DOI 10.1016/j.schres.2017.08.053	58	14	14	4	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1076-9242	1099-0909		DYSLEXIA	Dyslexia	AUG	2018	24	3					294	306		10.1002/dys.1588			13	Education, Special; Psychology, Educational; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Psychology; Rehabilitation	GP4HD	WOS:000440820300007	29993159				2022-02-06	
J	Chen, L; Jones, ALC; Mair, G; Patel, R; Gontsarova, A; Ganesalingam, J; Math, N; Dawson, A; Aweid, B; Cohen, D; Mehta, A; Wardlaw, J; Rueckert, D; Bentley, P				Chen, Liang; Jones, Anoma Lalani Carlton; Mair, Grant; Patel, Rajiv; Gontsarova, Anastasia; Ganesalingam, Jeban; Math, Nikhil; Dawson, Angela; Aweid, Basaam; Cohen, David; Mehta, Amrish; Wardlaw, Joanna; Rueckert, Daniel; Bentley, Paul		IST-3 Collaborative Grp	Rapid Automated Quantification of Cerebral Leukoaraiosis on CT Images: A Multicenter Validation Study	RADIOLOGY			English	Article							ACUTE ISCHEMIC-STROKE; WHITE-MATTER CHANGES; TISSUE-PLASMINOGEN ACTIVATOR; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; VISUAL RATING-SCALES; INTRAVENOUS THROMBOLYSIS; MR-IMAGES; HEMORRHAGE; SEGMENTATION	Purpose: To validate a random forest method for segmenting cerebral white matter lesions (WMLs) on computed tomographic (CT) images in a multicenter cohort of patients with acute ischemic stroke, by comparison with fluid-attenuated recovery (FLAIR) magnetic resonance (MR) images and expert consensus. Materials and Methods: A retrospective sample of 1082 acute ischemic stroke cases was obtained that was composed of unselected patients who were treated with thrombolysis or who were undergoing contemporaneous MR imaging and CT, and a subset of International Stroke Thrombolysis-3 trial participants. Automated delineations of WML on images were validated relative to experts' manual tracings on CT images, and co-registered FLAIR MR imaging, and ratings were performed by using two conventional ordinal scales. Analyses included correlations between CT and MR imaging volumes, and agreements between automated and expert ratings. Results: Automated WML volumes correlated strongly with expert-delineated WML volumes at MR imaging and CT (r(2) = 0.85 and 0.71 respectively; P<.001). Spatial-similarity of automated maps, relative to WML MR imaging, was not significantly different to that of expert WML tracings on CT images. Individual expert WML volumes at CT correlated well with each other (r(2) = 0.85), but varied widely (range, 91% of mean estimate; median estimate, 11 mL; range of estimated ranges, 0.2-68 mL). Agreements (kappa) between automated ratings and consensus ratings were 0.60 (Wahlund system) and 0.64 (van Swieten system) compared with agreements between individual pairs of experts of 0.51 and 0.67, respectively, for the two rating systems (P < .01 for Wahlund system comparison of agreements). Accuracy was unaffected by established infarction, acute ischemic changes, or atrophy (P>.05). Automated preprocessing failure rate was 4%; rating errors occurred in a further 4%. Total automated processing time averaged 109 seconds (range, 79-140 seconds). Conclusion: An automated method for quantifying CT cerebral white matter lesions achieves a similar accuracy to experts in unselected and multicenter cohorts. (c) RSNA, 2018	[Chen, Liang; Rueckert, Daniel] Imperial Coll London, Charing Cross Hosp, Biomed Imaging Anal Grp, Comp Sci, Fulham Palace Rd,10L21, London W6 8RF, England; [Chen, Liang; Jones, Anoma Lalani Carlton; Gontsarova, Anastasia; Ganesalingam, Jeban; Math, Nikhil; Dawson, Angela; Aweid, Basaam; Mehta, Amrish; Bentley, Paul] Imperial Coll London, Charing Cross Hosp, Div Brain Sci, Fulham Palace Rd,10L21, London W6 8RF, England; [Mair, Grant; Wardlaw, Joanna] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Patel, Rajiv; Cohen, David] London North West Healthcare NHS Trust, Northwick Pk Hosp, Dept Radiol, London, England		Bentley, P (corresponding author), Imperial Coll London, Charing Cross Hosp, Div Brain Sci, Fulham Palace Rd,10L21, London W6 8RF, England.	p.bentley@ic.ac.uk	Wardlaw, Joanna M/Y-3456-2019; Chen, Liang/X-9808-2019; Carlton Jones, Lalani/AAA-1656-2022; Mair, Grant/M-9071-2016	Wardlaw, Joanna M/0000-0002-9812-6642; Mair, Grant/0000-0003-2189-443X; Bentley, Paul/0000-0001-8036-7010; Cohen, David/0000-0001-7318-8567	National Institute for Health ResearchNational Institute for Health Research (NIHR) [II-LA-0814-20007]; National Institute for Health Research i4i Program [II-LA-0814-20007]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-4002, MC_G1002455, G0400069] Funding Source: UKRI	Study supported by National Institute for Health Research (II-LA-0814-20007). This publication is independent research funded by the National Institute for Health Research i4i Program II-LA-0814-20007. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Alachkar M, 2014, PSYCHIATR BULL, V38, P137, DOI 10.1192/pb.38.3.137a; Bentley P, 2014, EUR J NEUROL, V21, P1226, DOI 10.1111/ene.12464; Bentley P, 2014, NEUROIMAGE-CLIN, V4, P635, DOI 10.1016/j.nicl.2014.02.003; Charidimou A, 2016, STROKE, V47, P2364, DOI 10.1161/STROKEAHA.116.014096; Chen L, 2015, LECT NOTES COMPUT SC, V9349, P523, DOI 10.1007/978-3-319-24553-9_64; Farrell C, 2009, EUR RADIOL, V19, P177, DOI 10.1007/s00330-008-1119-2; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Gillebert CR, 2014, NEUROIMAGE-CLIN, V4, P540, DOI 10.1016/j.nicl.2014.03.009; Hanning U, 2017, CLIN NEURORADIOL; Henninger N, 2014, NEUROCRIT CARE, V21, P483, DOI 10.1007/s12028-014-9980-0; Herweh C, 2016, INT J STROKE, V11, P438, DOI 10.1177/1747493016632244; Kuruvilla T, 2014, PSYCHIATR BULL, V38, P24, DOI 10.1192/pb.bp.113.043398; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Ledig C, 2014, PROC CVPR IEEE, P3065, DOI 10.1109/CVPR.2014.392; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516; Lou M, 2010, STROKE, V41, P34, DOI 10.1161/STROKEAHA.109.564955; Maier O, 2017, MED IMAGE ANAL, V35, P250, DOI 10.1016/j.media.2016.07.009; Pantoni L, 2002, STROKE, V33, P2827, DOI 10.1161/01.STR.0000038424.70926.5E; Riello R, 2003, INT J GERIATR PSYCH, V18, P577, DOI 10.1002/gps.893; Rossi R, 2005, DEMENT GERIATR COGN, V19, P61, DOI 10.1159/000082350; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Ryu WS, 2017, BRAIN, V140, P158, DOI 10.1093/brain/aww259; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Sanossian N, 2017, J NEUROIMAGING, V27, P59, DOI 10.1111/jon.12369; Scheltens P, 1998, EUR NEUROL, V39, P80, DOI 10.1159/000007921; Simoni M, 2012, NEUROLOGY, V79, P1215, DOI 10.1212/WNL.0b013e31826b951e; Vanbelle S, 2008, J STAT COMPUT SIM, V78, P1009, DOI 10.1080/00949650701410249; VANSWIETEN JC, 1990, J NEUROL NEUROSUR PS, V53, P1080, DOI 10.1136/jnnp.53.12.1080; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wardlaw JM, 2015, LANCET NEUROL, V14, P485, DOI 10.1016/S1474-4422(15)00012-5; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Whiteley WN, 2012, STROKE, V43, P2904, DOI 10.1161/STROKEAHA.112.665331; Willer L, 2015, J STROKE CEREBROVASC, V24, P1126, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.018	33	14	15	1	4	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	AUG	2018	288	2					573	581		10.1148/radiol.2018171567			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	GQ6HN	WOS:000441808100036	29762091	Bronze, Green Submitted			2022-02-06	
J	Pan, MX; Tang, JC; Liu, R; Feng, YG; Wan, Q				Pan, Meng-Xian; Tang, Jun-Chun; Liu, Rui; Feng, Yu-Gong; Wan, Qi			Effects of estrogen receptor GPR30 agonist G1 on neuronal apoptosis and microglia polarization in traumatic brain injury rats	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						GPR30; Traumatic brain injury; Microglia; Neuron	EPIDEMIOLOGY; ACTIVATION; DISEASE; ALPHA	Purpose: To investigate the effects of estrogen G protein-coupled receptor 30 (GPR30) agonist G1 on hippocampal neuronal apoptosis and microglial polarization in rat traumatic brain injury (TBI). Methods: Male SD rats were randomly divided into sham group, TBI thorn vehicle group, TBI thorn G1 group. Experimental moderate TBI was induced using Feeney's weigh-drop method. G1 (100 mu g/kg) or vehicle was intravenously injected from femoral vein at 30 min post-injury. Rats were sacrificed at 24 h after injury for detection of neuronal apoptosis and microglia polarization. Neuronal apoptosis was assayed by immunofluorescent staining of active caspase-3. M1 type microglia markers (iNOS and IL-1 beta) and M2 type markers (Arg1 and IL-4) were examined by immunoblotting or ELISA. Total protein level of Akt and phosphorylated Akt were assayed by immunoblotting. Results: G1 significantly reduced active caspase-3 positive neurons in hippocampus. Meanwhile G1 increased the ratio of Arg1/iNOS. IL-1 beta production was decreased but IL-4 was increased after G1 treatment. G1 treatment also increased the active form of Akt. Conclusions: GPR30 agonist G1 inhibited neuronal apoptosis and favored microglia polarization to M2 type. (c) 2018 Chinese Medical Association. Production and hosting by Elsevier B.V.	[Pan, Meng-Xian; Tang, Jun-Chun; Liu, Rui; Wan, Qi] Wuhan Univ, Sch Med, Sch Basic Med Sci, Collaborat Innovat Ctr Brain Sci,Dept Physiol, 185 Donghu St, Wuhan 430071, Hubei, Peoples R China; [Feng, Yu-Gong; Wan, Qi] Qingdao Univ, Inst Neuroregenerat & Neurorehabil, Dept Neurosurg, Qingdao 266071, Peoples R China		Wan, Q (corresponding author), Wuhan Univ, Sch Med, Sch Basic Med Sci, Collaborat Innovat Ctr Brain Sci,Dept Physiol, 185 Donghu St, Wuhan 430071, Hubei, Peoples R China.	qwanwh@hotmail.com			Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81470599]	This work was supported by Natural Science Foundation of China (NSFC; 81470599).	Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Cheng ZQ, 2016, JOURNAL PRACT, V10, P744, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Djordjevic J, 2016, CURR ALZHEIMER RES, V13, P730, DOI 10.2174/1567205013666160222110320; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Ezaki J, 2016, NEUROL RES, V38, P994, DOI 10.1080/01616412.2016.1228746; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fuente-Martin E, 2013, REV ENDOCR METAB DIS, V14, P331, DOI 10.1007/s11154-013-9263-7; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Kosaka Y, 2012, TRANSL STROKE RES, V3, P500, DOI 10.1007/s12975-012-0211-8; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lu CL, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13121; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Morris GP, 2013, NEUROBIOL LEARN MEM, V105, P40, DOI 10.1016/j.nlm.2013.07.002; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang ZF, 2017, BIOCHEM BIOPH RES CO, V482, P948, DOI 10.1016/j.bbrc.2016.11.138; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020077; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Zhang JW, 2013, CANCER LETT, V339, P279, DOI 10.1016/j.canlet.2012.10.037; Zhang L, 2018, INT J MOL MED, V41, P2839, DOI 10.3892/ijmm.2018.3470	28	14	16	1	3	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	AUG	2018	21	4					224	228		10.1016/j.cjtee.2018.04.003			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	GP7RD	WOS:000441101300007	30017543	gold, Green Published			2022-02-06	
J	Peters, AJ; Villasana, LE; Schnell, E				Peters, Austin J.; Villasana, Laura E.; Schnell, Eric			Ketamine Alters Hippocampal Cell Proliferation and Improves Learning in Mice after Traumatic Brain Injury	ANESTHESIOLOGY			English	Article							ADULT NEUROGENESIS; NMDA; ACTIVATION; NEURONS; SYNAPTOGENESIS; ANESTHESIA; EXPRESSION; RECEPTORS; MICROGLIA; PROPOFOL	Background: Traumatic brain injury induces cellular proliferation in the hippocampus, which generates new neurons and glial cells during recovery. This process is regulated by N-methyl-d-aspartate-type glutamate receptors, which are inhibited by ketamine. The authors hypothesized that ketamine treatment after traumatic brain injury would reduce hippocampal cell proliferation, leading to worse behavioral outcomes in mice. Methods: Traumatic brain injury was induced in mice using a controlled cortical impact injury, after which mice (N = 118) received either ketamine or vehicle systemically for 1 week. The authors utilized immunohistochemical assays to evaluate neuronal, astroglial, and microglial cell proliferation and survival 3 days, 2 weeks, and 6 weeks postintervention. The Morris water maze reversal task was used to assess cognitive recovery. Results: Ketamine dramatically increased microglial proliferation in the granule cell layer of the hippocampus 3 days after injury (injury + vehicle, 2,800 +/- 2,700 cells/mm(3), n = 4; injury + ketamine, 11,200 +/- 6,600 cells/mm(3), n = 6; P = 0.012). Ketamine treatment also prevented the production of astrocytes 2 weeks after injury (sham + vehicle, 2,400 +/- 3,200 cells/mm(3), n = 13; injury + vehicle, 10,500 +/- 11,300 cells/mm(3), n = 12; P = 0.013 vs. sham + vehicle; sham + ketamine, 3,500 +/- 4,900 cells/mm(3), n = 14; injury + ketamine, 4,800 +/- 3,000 cells/mm(3), n = 13; P = 0.955 vs. sham + ketamine). Independent of injury, ketamine temporarily reduced neurogenesis (vehicle-exposed, 105,100 +/- 66,700, cells/mm(3), n = 25; ketamine-exposed, 74,300 +/- 29,200 cells/mm(3), n = 27; P = 0.031). Ketamine administration improved performance in the Morris water maze reversal test after injury, but had no effect on performance in sham-treated mice. Conclusions: Ketamine alters hippocampal cell proliferation after traumatic brain injury. Surprisingly, these changes were associated with improvement in a neurogenesis-related behavioral recall task, suggesting a possible benefit from ketamine administration after traumatic brain injury in mice. Future studies are needed to determine generalizability and mechanism.	[Peters, Austin J.; Villasana, Laura E.; Schnell, Eric] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR USA; [Schnell, Eric] Vet Affairs Portland Hlth Care Syst, Anesthesiol Serv, Portland, OR USA		Schnell, E (corresponding author), VA Portland Hlth Care Syst, 3170 SW US Vet Hosp Rd,P3ANES, Portland, OR 97239 USA.	schneler@ohsu.edu		Schnell, Eric/0000-0002-5623-5015	Foundation for Anesthesia Education and Research (Schaumburg, Illinois); BIRCWH K12 award through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Bethesda, Maryland); Office of Research on Women's Health (Bethesda, Maryland) [K12 HD 043488]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Washington, D.C.)US Department of Veterans Affairs; Biomedical Laboratory Research and Development (Washington, D.C.) CDA-2 Award [005-10S]; Department of Veterans Affairs Merit Review AwardUS Department of Veterans Affairs [I01-BX002949]; Oregon Health and Science University (Portland, Oregon) Anesthesiology and Perioperative Medicine departmental funds; Oregon Clinical and Translational Research Institute (Portland, Oregon) [TL1TR000129]; National Institute for Neurological Disorders and Stroke (Bethesda, Maryland) [P30 NS061800]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD043488] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS061800] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002949] Funding Source: NIH RePORTER	Primary funding for this project was provided by a Foundation for Anesthesia Education and Research (Schaumburg, Illinois) Research Fellowship Grant (to Dr. Peters). Additional funding was provided by a BIRCWH K12 award made possible through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Bethesda, Maryland) and the Office of Research on Women's Health (Bethesda, Maryland; grant No. K12 HD 043488; to Dr. Villasana), a Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Washington, D.C.), Biomedical Laboratory Research and Development (Washington, D.C.) CDA-2 Award 005-10S (to Dr. Schnell), a Department of Veterans Affairs Merit Review Award I01-BX002949 (to Dr. Schnell), and Oregon Health and Science University (Portland, Oregon) Anesthesiology and Perioperative Medicine departmental funds. Supplementary equipment and developmental funds were provided by the Oregon Clinical and Translational Research Institute (Portland, Oregon) grant No. TL1TR000129 and National Institute for Neurological Disorders and Stroke (Bethesda, Maryland) grant No. P30 NS061800.	Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Arruda-Carvalho M, 2011, J NEUROSCI, V31, P15113, DOI 10.1523/JNEUROSCI.3432-11.2011; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Bell JD, 2017, ANESTH ANALG, V124, P1237, DOI 10.1213/ANE.0000000000001856; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Blaiss C, 2011, J NEUROSCI, V454, P42; Bond A, 2015, STEM CELLS, V116, P1477; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Chang LC, 2013, CNS NEUROSCI THER, V19, P390, DOI 10.1111/cns.12077; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clarke M, 2017, NEUROPHARMACOLOGY, V112, P210, DOI 10.1016/j.neuropharm.2016.04.021; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Duman RS, 2012, PHILOS T R SOC B, V367, P2475, DOI 10.1098/rstb.2011.0357; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Gradari S, 2016, HIPPOCAMPUS, V26, P857, DOI 10.1002/hipo.22568; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hattiangady B, 2008, EPILEPSIA, V49, P26, DOI 10.1111/j.1528-1167.2008.01635.x; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Loix S, 2011, ACTA ANAESTH BELG, V62, P47; Mei XP, 2009, J NEUROCHEM, V109, P1691, DOI 10.1111/j.1471-4159.2009.06087.x; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morrens J, 2012, GLIA, V60, P159, DOI 10.1002/glia.21247; Parent JM, 2007, EPILEPSIA, V48, P69, DOI 10.1111/j.1528-1167.2007.01355.x; Petrus DS, 2009, EUR J NEUROSCI, V29, P244, DOI 10.1111/j.1460-9568.2008.06579.x; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Shibakawa YS, 2005, BRIT J ANAESTH, V95, P803, DOI 10.1093/bja/aei256; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Sleigh J, 2014, TRENDS ANAESTH CRIT, V4, P76, DOI 10.1016/j.tacc.2014.03.002; Soumier A, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0116-15.2016; Tan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021328; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tung A, 2008, ANESTH ANALG, V106, P1772, DOI 10.1213/ane.0b013e31816f2004; Verkhratsky A, 2007, NEUROSCIENTIST, V13, P28, DOI 10.1177/1073858406294270; Villasana LE, 2014, EXP NEUROL, V261, P156, DOI 10.1016/j.expneurol.2014.05.016; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wesseling H, 2015, J PROTEOME RES, V14, P411, DOI 10.1021/pr5009493; Winkelheide U, 2009, ACTA ANAESTH SCAND, V53, P528, DOI 10.1111/j.1399-6576.2009.01905.x; Yeung LY, 2009, TOXICOL LETT, V191, P275, DOI 10.1016/j.toxlet.2009.09.006; Yuhas Y, 2017, J NEUROIMMUNOL, V305, P75, DOI 10.1016/j.jneuroim.2016.12.017; Zanos P, 2016, NATURE, V533, P481, DOI 10.1038/nature17998	50	14	14	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	AUG	2018	129	2					278	295		10.1097/ALN.0000000000002197			18	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GN3QP	WOS:000438922500012	29734230	Green Accepted			2022-02-06	
J	Wang, Y; Lan, Q				Wang, Y.; Lan, Q.			Long non-coding RNA AFAP1-AS1 accelerates invasion and predicts poor prognosis of glioma	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Glioma; LncRNA; AFAP1-AS1; Prognosis	MALIGNANT GLIOMA; HIGH EXPRESSION; CARCINOMA; CANCER; PROLIFERATION; METASTASIS; ADULTS	OBJECTIVE: The role of A FAP1-AS1 in glioma is not fully known. This study aims at investigating the expression of AFAP1-AS1 in glioma and its underlying mechanism. PATIENTS AND METHODS: AFAP1-AS1 expressions in brain tissues from 52 cases of glioma and 5 cases of traumatic brain injury were assessed using quantitative fluorescence polymerase chain reaction (PCR). The clinicopathological features of glioma were first recorded. The correlation between AFAP1-AS1 expression and prognosis of glioma was discussed. AFAP1-AS1 expressions in the glioma cell lines were further detected. After knockdown of AFAP1-AS1 in U87MG and U251 glioma cells, cell invasion was assessed by transwell assay. MMP2 and MMP9 expressions in glioma cells, which were important indicators of cell invasive-ness, were determined by Western blot. RESULTS: AFAP1-AS1 was upregulated in the glioma tissues compared with that in the control tissues. and the expression level was correlated with glioma grading and KPS scores. After knockdown of AFAP1-AS1, the invasion capacities of the glioma cells declined significantly, and the expressions of invasion-related proteins MMP2 and MMP9 also decreased significantly. CONCLUSIONS: lncRNA AFAP1-AS1 can considerably facilitate the invasion of glioma cells and acts as an independent predictor of malignancy and prognosis, which may also serve as a potential therapeutic target.	[Wang, Y.; Lan, Q.] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China; [Wang, Y.] Nantong Univ, Affiliated Hosp 2, Dept Neurosurg, Nan Tong, Peoples R China		Lan, Q (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China.	lanqingdoc@163.com			Scientific Research Programme of Nantong [GJZ16001]	The study was sponsored by a grant from the Scientific Research Programme of Nantong (No.: GJZ16001).	Bo H, 2015, ONCOTARGET, V6, P20404, DOI 10.18632/oncotarget.4057; Fang YW, 2016, GENOM PROTEOM BIOINF, V14, P42, DOI 10.1016/j.gpb.2015.09.006; Feng Y, 2017, EUR REV MED PHARMACO, V21, P3842; Han X, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0094-3; Lu X, 2016, TUMOR BIOL, V37, P9699, DOI 10.1007/s13277-016-4858-8; Luo HL, 2016, CANCER MED-US, V5, P2879, DOI 10.1002/cam4.848; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Simonetti G, 2014, NEUROL SCI, V35, P977, DOI 10.1007/s10072-014-1829-y; Soffietti R, 2014, CNS DRUGS, V28, P1127, DOI 10.1007/s40263-014-0215-x; Wang W, 2017, TURK NEUROSURG, V27, P174, DOI 10.5137/1019-5149.JTN.15462-15.0; Wu RF, 2016, MOL GENET GENOMICS, V291, P1013, DOI 10.1007/s00438-016-1179-y; Ye YB, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0490-4; Zeng ZY, 2016, TUMOR BIOL, V37, P729, DOI 10.1007/s13277-015-3860-x; Zhang JY, 2016, INT J ONCOL, V48, P1590, DOI 10.3892/ijo.2016.3385; Zhou XL, 2016, MOL CARCINOGEN, V55, P2095, DOI 10.1002/mc.22454	16	14	15	0	1	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	AUG	2018	22	16					5223	5229					7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GU2OD	WOS:000445108700026	30178845				2022-02-06	
J	Li, HJ; Pan, YB; Sun, ZL; Sun, YY; Yang, XT; Feng, DF				Li, Hong-Jiang; Pan, Yuan-Bo; Sun, Zhao-Liang; Sun, Yi-Yu; Yang, Xi -Tao; Feng, Dong-Fu			Inhibition of miR-21 ameliorates excessive astrocyte activation and promotes axon regeneration following optic nerve crush	NEUROPHARMACOLOGY			English	Article						Optic nerve crush; Astrocyte activation; microRNA-21; EGFR pathway; Glial scar; Axonal regeneration	SPINAL-CORD-INJURY; CHONDROITIN SULFATE PROTEOGLYCANS; TRAUMATIC BRAIN-INJURY; GLIAL SCAR FORMATION; GROWTH-FACTOR; REACTIVE ASTROCYTES; NEUROTROPHIC FACTOR; COLORECTAL-CANCER; SIGNALING PATHWAY; TISSUE INHIBITOR	Optic nerve injury is a leading cause of irreversible visual impairment worldwide and can even cause blindness. Excessive activation of astrocytes has negative effects on the repair and recovery of retinal ganglion cells following optic nerve injury. However, the molecular and cellular mechanisms underlying astrocyte activation after optic nerve injury remain largely unknown. In the present study, we explored the effects of microRNA-21 (miR-21) on axon regeneration and flash visual evoked potential (F-VEP) and the underlying mechanisms of these effects based on astrocyte activation in the rat model of optic nerve crush (ONC). To the best of our knowledge, this article is the first to report that inhibition of miR-21 enhances axonal regeneration and promotes functional recovery in F-VEP in the rat model of ONC. Furthermore, inhibition of miR-21 attenuates excessive astrocyte activation and glial scar formation, thereby promoting axonal regeneration by regulating the epidermal growth factor receptor (EGFR) pathway. In addition, we observed that the expression of tissue inhibitor of metalloproteinase-3, a target gene of miR-21, was inhibited during this process. Taken together, these findings demonstrate that inhibition of miR-21 regulates the EGFR pathway, ameliorating excessive astrocyte activation and glial scar progression and promoting axonal regeneration and alleviating impairment in F-VEP function in a model of ONC. This study's results suggest that miR-21 may represent a therapeutic target for optic nerve injury. (C) 2018 Elsevier Ltd. All rights reserved.	[Li, Hong-Jiang; Pan, Yuan-Bo; Sun, Zhao-Liang; Sun, Yi-Yu; Yang, Xi -Tao; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Neurosurg, Sch Med, Shanghai 201999, Peoples R China; [Li, Hong-Jiang; Pan, Yuan-Bo; Sun, Zhao-Liang; Sun, Yi-Yu; Yang, Xi -Tao; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Inst Traumat Med, Sch Med, Shanghai 201999, Peoples R China		Feng, DF (corresponding author), 280 Mo He Rd, Shanghai 201999, Peoples R China.	drneuro@163.com		Pan, Yuan-Bo/0000-0002-4082-9898	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772059, 81401587]	This work was supported by the National Natural Science Foundation of China [grant number: 81772059, 81401587].	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bao LL, 2013, CANCER LETT, V337, P226, DOI 10.1016/j.canlet.2013.05.007; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Chen CH, 2016, EXP NEUROL, V278, P27, DOI 10.1016/j.expneurol.2016.01.023; Cizkova D, 1997, PHYSIOL RES, V46, P487; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Cua RC, 2013, GLIA, V61, P972, DOI 10.1002/glia.22489; Dezawa M, 1999, BRAIN RES BULL, V48, P573, DOI 10.1016/S0361-9230(99)00035-0; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feng DF, 2010, NEUROL RES, V32, P476, DOI 10.1179/016164110X12556180206158; Fischer D, 2012, PROG RETIN EYE RES, V31, P688, DOI 10.1016/j.preteyeres.2012.06.005; Fitch MT, 1999, J NEUROSCI, V19, P8182; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gao HS, 2012, REGEN MED, V7, P865, DOI [10.2217/RME.12.97, 10.2217/rme.12.97]; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Heiduschka P, 2008, GRAEF ARCH CLIN EXP, V246, P1559, DOI 10.1007/s00417-008-0895-3; Iwamura Y, 2003, BRAIN RES BULL, V61, P393, DOI 10.1016/S0361-9230(03)00142-4; Joly S, 2014, EUR J NEUROSCI, V40, P3021, DOI 10.1111/ejn.12677; Kang K, 2014, GLIA, V62, P1328, DOI 10.1002/glia.22684; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Koyama Y, 2007, NEUROSCIENCE, V147, P620, DOI 10.1016/j.neuroscience.2007.04.047; Li HJ, 2017, CURR NEUROPHARMACOL, V15, P861, DOI 10.2174/1570159X14666161227150250; Li ZW, 2011, NEUROCHEM INT, V58, P812, DOI 10.1016/j.neuint.2011.03.007; Lin B, 2014, EXP THER MED, V7, P66, DOI 10.3892/etm.2013.1371; Liu B, 2004, GLIA, V46, P153, DOI 10.1002/glia.10358; Liu B, 2004, DEV BIOL, V273, P297, DOI 10.1016/j.ydbio.2004.06.006; Liu B, 2006, J NEUROSCI, V26, P7532, DOI 10.1523/JNEUROSCI.1004-06.2006; Lui VWY, 2002, ANTICANCER RES, V22, P1; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Moore DL, 2010, J NEURO-OPHTHALMOL, V30, P347, DOI 10.1097/WNO.0b013e3181e755af; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagao Y, 2012, MODERN PATHOL, V25, P112, DOI 10.1038/modpathol.2011.142; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Pernet V, 2006, BRAIN, V129, P1014, DOI 10.1093/brain/awl015; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Su ZD, 2011, J NEUROTRAUM, V28, P1089, DOI 10.1089/neu.2010.1597; Sun D, 2013, GLIA, V61, P1218, DOI 10.1002/glia.22507; Vega-Melendez GS, 2014, J NEUROSCI RES, V92, P13, DOI 10.1002/jnr.23303; Wang RB, 2017, EXP EYE RES, V159, P49, DOI 10.1016/j.exer.2017.03.008; Xiong BH, 2013, INT J ONCOL, V42, P219, DOI 10.3892/ijo.2012.1707; Yang XT, 2015, J NEUROSCI RES, V93, P539, DOI 10.1002/jnr.23487; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807	57	14	15	2	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	JUL 15	2018	137						33	49		10.1016/j.neuropharm.2018.04.028			17	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	GP3TM	WOS:000440776100004	29709341				2022-02-06	
J	Otsuka, T; Imura, T; Nakagawa, K; Shrestha, L; Takahashi, S; Kawahara, Y; Sueda, T; Kurisu, K; Yuge, L				Otsuka, Takashi; Imura, Takeshi; Nakagawa, Kei; Shrestha, Looniva; Takahashi, Shinya; Kawahara, Yumi; Sueda, Taijiro; Kurisu, Kaoru; Yuge, Louis			Simulated Microgravity Culture Enhances the Neuroprotective Effects of Human Cranial Bone-Derived Mesenchymal Stem Cells in Traumatic Brain Injury	STEM CELLS AND DEVELOPMENT			English	Article						simulated microgravity; mesenchymal stem cells; neuroprotection	HEPATOCYTE GROWTH-FACTOR; MARROW STROMAL CELLS; TGF-BETA; HGF; DIFFERENTIATION; PROLIFERATION; CYTOKINES; BLOOD; ANGIOGENESIS; PROGENITORS	Fundamental cures of central nervous system (CNS) diseases are rarely achieved due to the low regenerative ability of the CNS. Recently, cell-based therapy using mesenchymal stem cells (MSCs) has been explored as an effective treatment for CNS diseases. Among the various tissue-derived MSCs, we have isolated human cranial bone-derived MSCs (cMSCs) in our laboratory. In addition, we have focused on simulated microgravity (MG) as a valuable culture environment of MSCs. However, detailed mechanisms underlying functional recovery from transplantation of MSCs cultured under MG conditions remain unclear. In this study, we investigated the therapeutic mechanisms of transplantation of cMSCs cultured under MG conditions in traumatic brain injury (TBI) model mice. Human cMSCs were cultured under 1G and MG conditions, and cMSCs cultured under MG conditions expressed significantly higher messenger RNA (mRNA) levels of hepatocyte growth factor (HGF) and transforming growth factor beta (TGF-). In TBI model mice, the transplantation of cMSCs cultured under MG conditions (group MG) showed greater motor functional improvement compared with only phosphate-buffered saline administration (group PBS). Moreover, the protein expression levels of tumor necrosis factor alpha (TNF-) and the Bcl-2-associated X protein (Bax)/b cell leukemia/lymphoma 2 protein (Bcl-2) ratio were significantly lower at brain injury sites in mice of group MG than those of group PBS. In addition, an in vitro study showed that the conditioned medium of cMSCs cultured under MG conditions significantly suppressed the cell death of NG108-15 cells exposed to oxidative or inflammatory stress through anti-inflammatory and antiapoptosis effects. These findings demonstrate that culturing cMSCs under simulated MG increases the neuroprotective effects, suggesting that simulated MG cultures may be a useful method for cell-based therapy strategies for CNS diseases.	[Otsuka, Takashi; Imura, Takeshi; Nakagawa, Kei; Shrestha, Looniva; Yuge, Louis] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Bioenvironm Adaptat Sci, Hiroshima, Japan; [Takahashi, Shinya; Sueda, Taijiro] Hiroshima Univ Hosp, Dept Cardiovasc Surg, Hiroshima, Japan; [Kawahara, Yumi; Yuge, Louis] Space Biolabs Co Ltd, Hiroshima, Japan; [Kurisu, Kaoru] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima, Japan		Yuge, L (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Bioenvironm Adaptat Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	ryuge@hiroshima-u.ac.jp	Hiyama, Eiso/A-2013-2019	Hiyama, Eiso/0000-0001-9179-5037			Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Beck LS, 1991, GROWTH FACTORS, V5, DOI 10.3109/08977199109000293; Bendinelli P, 2010, J CELL PHYSIOL, V225, P757, DOI 10.1002/jcp.22274; BENVENISTE EN, 1995, INT J DEV NEUROSCI, V13, P341, DOI 10.1016/0736-5748(94)00061-7; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caton A, 2000, DEVELOPMENT, V127, P1751; Chen NF, 2013, J PAIN, V14, P1671, DOI 10.1016/j.jpain.2013.08.010; Chen NN, 2016, NEUROCHEM RES, V41, P3052, DOI 10.1007/s11064-016-2024-8; Chen Y, 2006, CELL MOL LIFE SCI, V63, P1649, DOI 10.1007/s00018-006-6019-5; Cho SR, 2009, CELL TRANSPLANT, V18, P1359, DOI 10.3727/096368909X475329; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cook D, 2013, ADV EXP MED BIOL, V786, P213, DOI 10.1007/978-94-007-6621-1_12; Dai YL, 2003, BLOOD, V102, P1178, DOI 10.1182/blood-2002-12-3771; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Echeverry S, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-16; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Gutierrez H, 2004, DEVELOPMENT, V131, P3717, DOI 10.1242/dev.01209; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; He F, 2008, COLLOID SURFACE B, V61, P290, DOI 10.1016/j.colsurfb.2007.09.009; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Hossain MA, 2002, J NEUROCHEM, V81, P365, DOI 10.1046/j.1471-4159.2002.00837.x; Hu ZX, 2010, EUR J PHARMACOL, V645, P23, DOI 10.1016/j.ejphar.2010.07.011; Huang CY, 2012, ARCH DERMATOL RES, V304, P589, DOI 10.1007/s00403-012-1278-5; Imura T, 2017, STEM CELL RES THER, V7, P375; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jiang JG, 1997, MOL CELL BIOL, V17, P5758, DOI 10.1128/MCB.17.10.5758; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kes VB, 2008, CLIN BIOCHEM, V41, P1330, DOI 10.1016/j.clinbiochem.2008.08.080; Komatsu K, 2010, BRAIN RES, V1334, P84, DOI 10.1016/j.brainres.2010.04.006; Li H, 2007, CELL MOL IMMUNOL, V4, P407; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109305; Mitsuhara T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt184; MOSES HL, 1981, CANCER RES, V41, P2842; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Neirinckx V, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0202-2; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Pomies P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160092; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Shang JW, 2011, J NEUROSCI RES, V89, P86, DOI 10.1002/jnr.22524; Shinagawa K, 2015, NEUROSCI LETT, V606, P161, DOI 10.1016/j.neulet.2015.08.056; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Sun W, 2002, MOL BRAIN RES, V103, P36, DOI 10.1016/S0169-328X(02)00168-7; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wang PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049720; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; WEIDNER KM, 1990, J CELL BIOL, V111, P2097, DOI 10.1083/jcb.111.5.2097; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; YANG EY, 1990, J CELL BIOL, V111, P731, DOI 10.1083/jcb.111.2.731; Yenari MA, 2006, STROKE, V37, P1087, DOI 10.1161/01.STR.0000206281.77178.ac; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921; Zhang P, 2016, BIOMED PHARMACOTHER, V83, P658, DOI 10.1016/j.biopha.2016.07.040	57	14	14	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	SEP	2018	27	18			SI		1287	1297		10.1089/scd.2017.0299		JUL 2018	11	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	GT4OJ	WOS:000438206400001	29790427	Green Submitted			2022-02-06	
J	Zan, J; Zhang, H; Lu, MY; Beng, HM; Zhong, KL; Sun, XO; Tan, W				Zan, Jie; Zhang, Hao; Lu, Min-yi; Beng, Hui-min; Zhong, Kai-lun; Sun, Xiao-ou; Tan, Wen			Isosteviol sodium injection improves outcomes by modulating TLRs/NF-B-dependent inflammatory responses following experimental traumatic brain injury in rats	NEUROREPORT			English	Article						inflammatory; isosteviol sodium; nuclear factor kappa-light-chain-enhancer of activated B cells; toll-like receptors; traumatic brain injury	TOLL-LIKE RECEPTORS; NEURAL STEM-CELLS; NF-KAPPA-B; CEREBRAL-ARTERY OCCLUSION; INNATE IMMUNE-RESPONSE; POSSIBLE INVOLVEMENT; CORTICAL CONTUSION; SIGNALING PATHWAYS; ISCHEMIA INJURY; PATHOPHYSIOLOGY	Previous studies have shown that isosteviol sodium (STVNa) protects against permanent cerebral ischemia injury by inhibition of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B)-mediated inflammatory responses. Overwhelming evidence shows that toll-like receptors (TLRs) are the upstream regulators of NF-B. On the basis of the similarity of the pathology caused by traumatic brain injury (TBI) and stroke, we speculated that STVNa may have a therapeutic effect against TBI through regulation of the TLRs/NF-B signaling-mediated inflammatory response. Thus, we studied the potential therapeutic effects of STVNa and the underlying mechanisms. Male rats, subjected to controlled cortical impact (CCI) injury, were injected intraperitoneally with STVNa (5, 10, 20, 40, and 80mg/kg, daily for 3 or 7 days) after trauma. Neurobehavioral scores, relative numbers of cortical lesions, and histology were examined. We also measured the mRNA and protein expression levels of TLRs/NF-B signaling pathway-related genes including TLR2, TLR4, and NF-B by quantitative real-time-PCR and western blotting, respectively, and concentrations of tumor necrosis factor- and interleukin-1 by an enzyme-linked immunosorbent assay. The results indicated that STVNa (20mg/kg) showed significant neuroprotective effects 3 and 7 days after TBI, including the reduction of cortical lesions, improvement of the neurological severity score, significantly increased number of restored neurons, decreased number of astrocytes, and lower concentrations of tumor necrosis factor- and interleukin-1. Results from quantitative real-time-PCR and western blotting also show that the mRNA and protein expression levels of TLR2, TLR4, and NF-B were significantly lower in STVNa-treated rats compared with the vehicle-treated rats. The administration of STVNa attenuates the TLR/NF-B signaling pathway-mediated inflammatory responses in the injured rat brain, and this may be the mechanism by which STVNa improves the outcome following TBI.	[Zan, Jie; Zhang, Hao; Lu, Min-yi; Zhong, Kai-lun; Sun, Xiao-ou; Tan, Wen] Guangdong Univ Technol, Inst Biomed & Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Zhang, Hao; Beng, Hui-min] South China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China		Tan, W (corresponding author), Guangdong Univ Technol, Inst Biomed & Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	went@gdut.edu.cn		Zhang, Hao/0000-0003-1165-8943; Zhang, Hao/0000-0003-3798-2979	Science and Technology Planning Project of Guangdong Province [2015B010109004]; Science and Technology Planning Project of Guangzhou [123000068]; Natural Science Foundation of Guangdong Province of ChinaNational Natural Science Foundation of Guangdong Province [2017A030310404]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017M622642]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31601089]	This study was supported in part by the Science and Technology Planning Project of Guangdong Province (no. 2015B010109004), the 2017 PhD Start-up Fund of the Natural Science Foundation of Guangdong Province of China (2017A030310404), the China Postdoctoral Science Foundation (no. 2017M622642), the Science and Technology Planning Project of Guangzhou (no.123000068), and the National Natural Science Foundation of China (31601089).	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bagge A, 2012, BIOCHEM BIOPH RES CO, V426, P266, DOI 10.1016/j.bbrc.2012.08.082; Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Chakrabarti M, 2016, REV NEUROSCIENCE, V27, P271, DOI 10.1515/revneuro-2015-0032; Chan P, 1998, LIFE SCI, V63, P1679, DOI 10.1016/S0024-3205(98)00439-1; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Douen AG, 2004, BRAIN RES, V1008, P139, DOI 10.1016/j.brainres.2003.08.070; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; Fandino-Rivera J, 2004, REV NEUROLOGIA, V38, P912, DOI 10.33588/rn.3810.2003035; Gregersen S, 2004, METABOLISM, V53, P73, DOI 10.1016/j.metabol.2003.07.013; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hu H, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1379162; Hua F, 2009, BRAIN RES, V1262, P100, DOI 10.1016/j.brainres.2009.01.018; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Itoh T, 2006, NEUROCHEM RES, V31, P1381, DOI 10.1007/s11064-006-9186-8; Itoh T, 2013, J NEURAL TRANSM, V120, P361, DOI 10.1007/s00702-012-0895-7; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Jain KK, 2011, NEUROPROTECTION TRAU, P1082; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Lai WS, 2017, PHARM DEV TECHNOL, V22, P275, DOI 10.1080/10837450.2016.1226900; Lai YC, 2006, DEV NEUROSCI-BASEL, V28, P336, DOI 10.1159/000094159; Lee Sung Joong, 2002, Current Drug Targets - Inflammation and Allergy, V1, P181; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; SOEJARTO DD, 1982, J NAT PROD, V45, P590, DOI 10.1021/np50023a013; Sun J, 2004, ANN CLIN LAB SCI, V34, P181; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Xu DY, 2008, PLANTA MED, V74, P816, DOI 10.1055/s-2008-1074557; Yu WH, 2012, PHYTOTHER RES, V26, P1838, DOI 10.1002/ptr.4662; Zhang H, 2017, J STROKE CEREBROVASC, V26, P2603, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.023; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	47	14	16	2	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JUL 4	2018	29	10					794	803		10.1097/WNR.0000000000001033			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GJ4KE	WOS:000435349200002	29683870	Green Published			2022-02-06	
J	Navarro, SM; Pettit, RW; Haeberle, HS; Frangiamore, SJ; Rahman, NM; Farrow, LD; Schickendantz, MS; Ramkumar, PN				Navarro, Sergio M.; Pettit, Rowland W.; Haeberle, Heather S.; Frangiamore, Salvatore J.; Rahman, Nadeem M.; Farrow, Lutul D.; Schickendantz, Mark S.; Ramkumar, Prem N.			Short-Term Impact of Concussion in the NHL: An Analysis of Player Longevity, Performance, and Financial Loss	JOURNAL OF NEUROTRAUMA			English	Article						economic decision analysis; head injuries/concussion; ice hockey; medical aspects of sports; performance	FOOTBALL LEAGUE PLAYERS; MENS ICE HOCKEY; RETURN; TIME	Many studies have focused on the long-term impact of concussions in professional sports, but few have investigated short-term effects. This study examines concussion effects on individual players in the National Hockey League (NHL) by assessing career length, performance, and salary. Contracts, transactions, injury reports, and performance statistics from 2008-17 were obtained from the official NHL online publication. Players who sustained a concussion were compared with the 2008-17 non-concussed player pool. Career length was analyzed using Kaplan-Meier survival curves and stratification of player age, experience, and longevity. Player performance and salary changes were evaluated between the years before versus after concussion. Performance and salary changes were compared against non-concussed NHL athletes before/after their career midpoints. Of the 2194 eligible NHL players in the 9-year period, 309 sustained 399 concussions resulting in injury protocol. The probability of playing a full NHL season post-concussion was significantly decreased compared with the non-concussed pool (p<0.05), specifically 65.0% versus 81.2% at 1 year into a player's career, 49.8% versus 67.4% at 2 years, and 14.6% versus 43.7% at 5 years. Performance was reduced at all non-goalie positions post-concussion (p<0.05). Players scored 2.5 points/year less following a concussion. The total annualized financial impact from salary reductions after 1 concussion was $57.0 million, with a decrease of $292,000 per year in contract value per athlete. This retrospective study demonstrates that NHL concussions resulting in injury protocol activation lead to shorter career lengths, earnings reductions, and decreased performance when compared with non-concussed controls.	[Navarro, Sergio M.; Pettit, Rowland W.; Haeberle, Heather S.] Baylor Coll Med, Dept Orthoped Surg, Houston, TX 77030 USA; [Frangiamore, Salvatore J.; Farrow, Lutul D.; Schickendantz, Mark S.; Ramkumar, Prem N.] Summa Hlth, Dept Orthoped Surg, Akron, OH USA; [Rahman, Nadeem M.] Cleveland Clin, Dept Anesthesiol, Cleveland, OH 44106 USA		Ramkumar, PN (corresponding author), 2049 E 100th St, Cleveland, OH 44195 USA.	premramkumar@gmail.com	Navarro, Sergio M/K-8923-2019; Navarro, Sergio M/B-4287-2019	Navarro, Sergio M/0000-0003-3455-1567; Navarro, Sergio M/0000-0003-3455-1567; Pettit, Rowland/0000-0003-0011-8714; Haeberle, Heather/0000-0001-8341-8389			Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bonfield CM, 2014, PROG NEUROL SURG, V28, P161, DOI 10.1159/000358777; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Colon GAT, 2017, QUAL HEALTH RES, V27, P1077, DOI 10.1177/1049732316669339; de Beer J., 2008, CAN LEG ED ANN REV, V2, P61; Donaldson L, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041016; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Fino P.C., 2017, CLIN J SPORT MED; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hutchison MG, 2014, BRIT J SPORT MED, V48, P125, DOI 10.1136/bjsports-2012-092059; Izraelski Jason, 2014, J Can Chiropr Assoc, V58, P346; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; LaPrade RF, 2004, AM SOC TEST MATER, V1446, P40, DOI 10.1520/STP11607S; Ling H, 2017, NEUROPATH APPL NEURO, V43, P467, DOI 10.1111/nan.12425; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; Padaki AS, 2016, AM J SPORT MED, V44, P2263, DOI 10.1177/0363546516634679; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Plancher KD, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114550623; Samson K., 2012, NEUROL TODAY, V12, P13; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19	25	14	14	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2391	2399		10.1089/neu.2017.5611		JUL 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437231100001	29648975				2022-02-06	
J	Abu Hamdeh, S; Waara, ER; Moller, C; Soderberg, L; Basun, H; Alafuzoff, I; Hillered, L; Lannfelt, L; Ingelsson, M; Marklund, N				Abu Hamdeh, Sami; Waara, Erik Rollman; Moller, Christer; Soderberg, Linda; Basun, Hans; Alafuzoff, Irina; Hillered, Lars; Lannfelt, Lars; Ingelsson, Martin; Marklund, Niklas			Rapid amyloid-beta oligomer and protofibril accumulation in traumatic brain injury	BRAIN PATHOLOGY			English	Article						Alzheimer's disease; amyloid-; amyloid oligomers; traumatic brain injury	PITTSBURGH COMPOUND B; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; NEUROLOGICAL STATUS; AXONAL INJURY; PROTEIN; PATHOLOGY; MICRODIALYSIS; MEMORY	Deposition of amyloid- (A) is central to Alzheimer's disease (AD) pathogenesis and associated with progressive neurodegeneration in traumatic brain injury (TBI). We analyzed predisposing factors for A deposition including monomeric A40, A42 and A oligomers/protofibrils, A species with pronounced neurotoxic properties, following human TBI. Highly selective ELISAs were used to analyze N-terminally intact and truncated A40 and A42, as well as A oligomers/protofibrils, in human brain tissue, surgically resected from severe TBI patients (n=12; mean age 49.5 +/- 19 years) due to life-threatening brain swelling/hemorrhage within one week post-injury. The TBI tissues were compared to post-mortem AD brains (n=5), to post-mortem tissue of neurologically intact (NI) subjects (n=4) and to cortical biopsies obtained at surgery for idiopathic normal pressure hydrocephalus patients (iNPH; n=4). The levels of A40 and A42 were not elevated by TBI. The levels of A oligomers/protofibrils in TBI were similar to those in the significantly older AD patients and increased compared to NI and iNPH controls (P<0.05). Moreover, TBI patients carrying the AD risk genotype Apolipoprotein E epsilon3/4 (APOE epsilon 3/4; n=4) had increased levels of A oligomers/protofibrils (P<0.05) and of both N-terminally intact and truncated A42 (P<0.05) compared to APOE epsilon 3/4-negative TBI patients (n=8). Neuropathological analysis showed insoluble A aggregates (commonly referred to as A plaques) in three TBI patients, all of whom were APOE epsilon 3/4 carriers. We conclude that soluble intermediary A aggregates form rapidly after TBI, especially among APOE epsilon 3/4 carriers. Further research is needed to determine whether these aggregates aggravate the clinical short- and long-term outcome in TBI.	[Abu Hamdeh, Sami; Hillered, Lars; Marklund, Niklas] Uppsala Univ, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden; [Waara, Erik Rollman; Moller, Christer; Soderberg, Linda; Basun, Hans; Lannfelt, Lars] BioArctic Neurosci AB, Stockholm, Sweden; [Basun, Hans; Lannfelt, Lars; Ingelsson, Martin] Dept Publ Hlth & Caring Sci, Geriatr, Stockholm, Sweden; [Alafuzoff, Irina] Dept Immunol Genet & Pathol, Clin & Expt Pathol, Stockholm, Sweden		Marklund, N (corresponding author), Uppsala Univ, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden.	niklas.marklund@neuro.uu		Marklund, Niklas/0000-0002-9797-5626	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; Swedish Institute; Selander Foundation	This work was financed by the Swedish Research Council under the framework of EU-ERA-NET NEURON CnsAFlame (to NM), Swedish Brain Foundation, Swedish Research Council (to MI), Swedish Institute and the Selander Foundation (NM + LH). We acknowledge Dr Kristina Guiliana Cesarini for help with cortical biopsies of idiopathic normal pressure hydrocephalus patients and Charlotte Sahlin for assisting in establishing the APOE genotyping assay.	Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bouter Y, 2013, ACTA NEUROPATHOL, V126, P189, DOI 10.1007/s00401-013-1129-2; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Casoli T, 2007, ANN NY ACAD SCI, V1096, P170, DOI 10.1196/annals.1397.082; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elobeid A, 2016, J NEUROPATH EXP NEUR, V75, P316, DOI 10.1093/jnen/nlw002; Elobeid A, 2015, J NEUROPATH EXP NEUR, V74, P470, DOI 10.1097/NEN.0000000000000191; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hays CC, 2016, CELL MOL NEUROBIOL, V36, P167, DOI 10.1007/s10571-015-0261-z; HIXSON JE, 1990, J LIPID RES, V31, P545; Holtta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066381; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Koshida S, 2010, CLIN CHIM ACTA, V411, P391, DOI 10.1016/j.cca.2009.12.006; Leuzy A, 2016, BRAIN, V139, P2540, DOI 10.1093/brain/aww160; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Magnusson K, 2013, J ALZHEIMERS DIS, V37, P29, DOI 10.3233/JAD-130029; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mauri M, 2006, FUNCT NEUROL, V21, P223; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Paranjape GS, 2012, ACS CHEM NEUROSCI, V3, P302, DOI 10.1021/cn2001238; Pluta R, 2013, MOL NEUROBIOL, V47, P425, DOI 10.1007/s12035-012-8360-z; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sahlin C, 2007, J NEUROCHEM, V101, P854, DOI 10.1111/j.1471-4159.2006.04443.x; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sehlin D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10759; Sehlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032014; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Tucker S, 2015, J ALZHEIMERS DIS, V43, P575, DOI 10.3233/JAD-140741; Yang T, 2017, J NEUROSCI, V37, P152, DOI 10.1523/JNEUROSCI.1698-16.2016	48	14	14	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JUL	2018	28	4					451	462		10.1111/bpa.12532			12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	GO1WE	WOS:000439749700001	28557010	Green Published			2022-02-06	
J	Dreer, LE; Ketchum, JM; Novack, TA; Bogner, J; Felix, ER; Corrigan, JD; Johnson-Greene, D; Hammond, FM				Dreer, Laura E.; Ketchum, Jessica M.; Novack, Thomas A.; Bogner, Jennifer; Felix, Elizabeth R.; Corrigan, John D.; Johnson-Greene, Doug; Hammond, Flora M.			Obesity and Overweight Problems Among Individuals 1 to 25 Years Following Acute Rehabilitation for Traumatic Brain Injury: A NIDILRR Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						health behaviors; lifestyle; obesity; overweight; traumatic brain injury; weight	BODY-MASS INDEX; PARTICIPATION ASSESSMENT; SCALE; NUTRITION; OUTCOMES	Objective: Examine the prevalence of weight classifications and factors related to obesity/overweight among persons 1 to 25 years following traumatic brain injury (TBI) using the Traumatic Brain Injury Model Systems national database. Design: Multicenter, cross-sectional, observational design. Setting: Traumatic Brain Injury Model Systems inpatient rehabilitation facilities. Participants: Persons (N = 7287) 1, 2, 5, 10, 15, 20, or 25 years after TBI who required inpatient acute rehabilitation. Main Outcome Measures: Body mass index, demographic characteristics, functional, health, satisfaction with life, and global outcomes. Results: Overall postinjury weight prevalence rates were 23% obese, 36% overweight, 39% normal, and 3% underweight. Higher rates for obesity and overweight problems were associated with increasing time since injury. Younger (18-19 years) and older (80+ years) age, those in a vegetative state, and those reporting excellent health were less likely to be obese. Individuals with a history of hypertension, heart failure, or diabetes were more likely to be obese. Conclusions: Being obese or overweight presents a health risk in the years following rehabilitation for TBI. The findings support the need for longitudinal studies and highlight the advisability of monitoring weight and promoting healthy lifestyle behaviors over time in survivors of TBI.	[Dreer, Laura E.] Univ Alabama Birmingham, UAB Traumat Brain Injury Model Syst, Dept Ophthalmol, Birmingham, AL USA; [Dreer, Laura E.; Novack, Thomas A.] Univ Alabama Birmingham, UAB Traumat Brain Injury Model Syst, Dept Phys Med & Rehabil, Birmingham, AL USA; [Ketchum, Jessica M.] Craig Hosp, Res Dept, Englewood, CO USA; [Ketchum, Jessica M.] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Bogner, Jennifer; Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Felix, Elizabeth R.; Johnson-Greene, Doug] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33136 USA; [Felix, Elizabeth R.] Bruce W Carter Dept Vet Affairs Med Ctr, Res Serv, Miami, FL USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, Indianapolis, IN 46202 USA		Dreer, LE (corresponding author), Univ Alabama Birmingham, Callahan Eye Hosp, Dept Ophthalmol, 1720 Univ Blvd,Room H-405, Birmingham, AL 35243 USA.	lauradreer@uabmc.edu	Corrigan, John D./E-2921-2011; Ketchum, Jessica/AAE-8200-2020; Felix, Elizabeth/AAD-6356-2021	Felix, Elizabeth/0000-0002-6239-715X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0044, 90DP0036, 90DP0040, 90DP0084, 90DP0034, 90DP0046]	The contents of this (insert type of publication, eg, book, report, film) were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant numbers 90DP0044 [PI: Novack], 90DP0036 [PI: Hammond], 90DP0040 [PI: Corrigan], 90DP0084 [PI: Harrison-Felix], 90DP0034 [PI: Harrison-Felix], and 90DP0046 [PI: Johnson-Greene]. The NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this (insert type of publication, eg, book, report, film) do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Centers for Disease Control and Prevention, 2016, HLTH WEIGHT; Centers for Disease Control and Prevention, DIS OB; Chabok SY, 2014, EUR J TRAUMA EMERG S, V40, P51, DOI 10.1007/s00068-013-0314-2; Churilla JR, 2016, SOUTH MED J, V109, P615, DOI 10.14423/SMJ.0000000000000537; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Ditillo M, 2014, J TRAUMA ACUTE CARE, V76, P176, DOI 10.1097/TA.0b013e3182ab0d7c; Duraski SA, 2014, REHABIL NURS, V39, P140, DOI 10.1002/rnj.138; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kumar MA, 2012, NEUROCRIT CARE, V16, P286, DOI 10.1007/s12028-011-9576-x; Le D, 2015, AM J PHYS MED REHAB, V94, P627, DOI 10.1097/PHM.0000000000000222; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; National Heart Lung and Blood Institute, 2013, MAN OV OB AD SYST EV; Neville AL, 2004, ARCH SURG-CHICAGO, V139, P983, DOI 10.1001/archsurg.139.9.983; Ogden Cynthia L, 2015, NCHS Data Brief, P1; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rimmer JH, 2011, PHYS THER, V91, P1728, DOI 10.2522/ptj.20100410; Rosnow RL, 2003, CAN J EXP PSYCHOL, V57, P221, DOI 10.1037/h0087427; Sarafidis PA, 2013, NAT REV NEPHROL, V9, P51, DOI 10.1038/nrneph.2012.260; Stapleton RD, 2014, CLIN CHEST MED, V35, P655, DOI 10.1016/j.ccm.2014.08.005; Tolli A, 2017, J ENDOCRINOL INVEST, V40, P193, DOI 10.1007/s40618-016-0546-1; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	30	14	14	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2018	33	4					246	256		10.1097/HTR.0000000000000408			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GR6GT	WOS:000442745900011	29975254	Bronze			2022-02-06	
J	Humble, SS; Wilson, LD; Wang, L; Long, DA; Smith, MA; Siktberg, JC; Mirhoseini, MF; Bhatia, A; Pruthi, S; Day, MA; Muehlschlegel, S; Patel, MB				Humble, Stephen S.; Wilson, Laura D.; Wang, Li; Long, Drew A.; Smith, Miya A.; Siktberg, Jonathan C.; Mirhoseini, Mina F.; Bhatia, Aashim; Pruthi, Sumit; Day, Matthew A.; Muehlschlegel, Susanne; Patel, Mayur B.			Prognosis of diffuse axonal injury with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	31st Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma(EAST)	JAN 09-13, 2018	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Traumatic brain injury; axonal injury; magnetic resonance imaging; outcomes; neurocritical care	CORPUS-CALLOSUM; INSURANCE STATUS; HEAD TRAUMA; SCALE; STEM	BACKGROUND Determine the prognostic impact of magnetic resonance imaging (MRI)-defined diffuse axonal injury (DAI) after traumatic brain injury (TBI) on functional outcomes, quality of life, and 3-year mortality. METHODS This retrospective single center cohort included adult trauma patients (age > 17 years) admitted from 2006 to 2012 with TBI. Inclusion criteria were positive head computed tomography with brain MRI within 2 weeks of admission. Exclusion criteria included penetrating TBI or prior neurologic condition. Separate ordinal logistic models assessed DAI's prognostic value for the following scores: (1) hospital-discharge Functional Independence Measure, (2) long-term Glasgow Outcome Scale-Extended, and (3) long-term Quality of Life after Brain Injury-Overall Scale. Cox proportional hazards modeling assessed DAI's prognostic value for 3-year survival. Covariates included age, sex, race, insurance status, Injury Severity Score, admission Glasgow Coma Scale Score, Marshall Head computed tomography Class, clinical DAI on MRI (Y/N), research-level anatomic DAI Grades I-III (I, cortical; II, corpus callosum; III, brainstem), ventilator days, time to follow commands, and time to long-term follow-up (for logistic models). RESULTS Eligibility criteria was met by 311 patients, who had a median age of 40 years (interquartile range [IQR], 23-57 years), Injury Severity Score of 29 (IQR, 22-38), intensive care unit stay of 6 days (IQR, 2-11 days), and follow-up of 5 years (IQR, 3-6 years). Clinical DAI was present on 47% of MRIs. Among 300 readable MRIs, 56% of MRIs had anatomic DAI (25% Grade I, 18% Grade II, 13% Grade III). On regression, only clinical (not anatomic) DAI was predictive of a lower Functional Independence Measure score (odds ratio, 2.5; 95% confidence interval, 1.28-4.76], p = 0.007). Neither clinical nor anatomic DAI were related to survival, Glasgow Outcome Scale-Extended, or Quality of Life after Brain Injury-Overall Scale scores. CONCLUSION In this longitudinal cohort, clinical evidence of DAI on MRI may only be useful for predicting short-term in-hospital functional outcome. Given no association of DAI and long-term TBI outcomes, providers should be cautious in attributing DAI to future neurologic function, quality of life, and/or survival. LEVEL OF EVIDENCE Epidemiological, level III; Therapeutic, level IV.	[Humble, Stephen S.; Smith, Miya A.; Siktberg, Jonathan C.; Mirhoseini, Mina F.; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Hlth Serv Res,Vanderbilt Brain Ins, Sect Surg Sci,Div Trauma & Surg Crit Care,Dept Su, Nashville, TN USA; [Humble, Stephen S.; Smith, Miya A.; Siktberg, Jonathan C.; Mirhoseini, Mina F.; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Hlth Serv Res,Vanderbilt Brain Ins, Sect Surg Sci,Div Trauma & Surg Crit Care,Dept Ne, Nashville, TN USA; [Humble, Stephen S.] UTHSC, Coll Med, Memphis, TN USA; [Wilson, Laura D.] Univ Tulsa, Dept Commun Sci & Disorders, Oxley Coll Hlth Sci, Tulsa, OK 74104 USA; [Wilson, Laura D.; Patel, Mayur B.] Vanderbilt Univ, Sch Med, Dept Hearing & Speech Sci, Nashville, TN 37212 USA; [Wang, Li] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Long, Drew A.; Siktberg, Jonathan C.; Bhatia, Aashim; Pruthi, Sumit; Day, Matthew A.; Patel, Mayur B.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Long, Drew A.] San Antonio Mil Med Ctr, Dept Emergency Med, Ft Sam Houston, TX USA; [Smith, Miya A.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Smith, Miya A.] Meharry Med Coll, Nashville, TN 37208 USA; [Bhatia, Aashim; Pruthi, Sumit; Day, Matthew A.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Muehlschlegel, Susanne] Univ Massachusetts, Med Ctr, Dept Neurol, Med Sch, Worcester, MA 01655 USA; [Patel, Mayur B.] Tennessee Valley Care Syst, Surg Serv, Gen Surg Sect, Geriatr Res Educ & Clin Ctr Serv,Dept Vet Affairs, Nashville, TN USA		Patel, MB (corresponding author), 1211,21st Ave,South 404,Med Arts Bldg, Nashville, TN 37212 USA.	mayur.b.patel@vanderbilt.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01GM120484, R01HL111111]; Vanderbilt Faculty Research Scholars Program; REDCap from NCATS/NIH [UL1 TR000445]; Vanderbilt Institute for Clinical and Translational Research award via CTSA [VR9296, UL1TR000011, VR1584, VR5351, VR12073, VR22411]; Department of Defense, Joint Program Committee-6, Combat Casualty Care [W81XWH-16-R-0033]; PfizerPfizer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002243, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL111111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM120484] Funding Source: NIH RePORTER	National Institutes of Health R01GM120484 and R01HL111111 (mbp); Vanderbilt Faculty Research Scholars Program (mbp); REDCap, UL1 TR000445 from NCATS/NIH (all authors), Vanderbilt Institute for Clinical and Translational Research award (VR9296) via CTSA grant UL1TR000011 (NCRR/NCATS/NIH).; M.B.P. has been or is supported by the Vanderbilt Institute for Clinical and Translational Research awards (VR1584, VR5351, VR12073, VR22411) via CTSA grant UL1TR000011 (NCRR/NCATS/NIH); Department of Defense, Joint Program Committee-6, Combat Casualty Care, W81XWH-16-R-0033 (subcontract); and speaker fee from Pfizer. M.B.P. has served on the EAST Guidelines Committee, Mentoring Committee, Manuscript and Literature Review Committee, and Board of Directors.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Bell TM, 2013, J TRAUMA ACUTE CARE, V75, P728, DOI 10.1097/TA.0b013e3182a53aaa; Chelly H, 2011, J TRAUMA, V71, P838, DOI 10.1097/TA.0b013e3182127baa; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Matsukawa H, 2011, J NEUROSURG, V115, P1019, DOI 10.3171/2011.6.JNS11513; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	17	14	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2018	85	1					155	159		10.1097/TA.0000000000001852			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GL8GZ	WOS:000437457000023	29462087	Green Accepted			2022-02-06	
J	Kardouni, JR; Shing, TL; Mckinnon, CJ; Scofield, DE; Proctor, SP				Kardouni, Joseph R.; Shing, Tracie L.; Mckinnon, Craig J.; Scofield, Dennis E.; Proctor, Susan P.			Risk for Lower Extremity Injury After Concussion: A Matched Cohort Study in Soldiers	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						concussion; lower extremity injury; military; tactical athlete	STABILITY FOLLOWING CONCUSSION; MUSCULOSKELETAL INJURY; POSTURAL CONTROL; DIVIDED ATTENTION; DYNAMIC STABILITY; FOOTBALL PLAYERS; GAIT; INCREASES; RETURN; SPORT	BACKGROUND: Rates of lower extremity musculoskeletal injury are reportedly higher in professional and collegiate athletes following concussions. However, there is a paucity of evidence on this relationship in individuals who are not high-level athletes. OBJECTIVES: To examine the risk of acute lower extremity musculoskeletal injury in soldiers within 2 years of an incident concussion, compared to matched nonconcussed soldiers. METHODS: This was a matched-cohort study that used the medical encounter and personnel data of active-duty US Army soldiers from 2005 to 2011. Incident concussions were identified using International Classification of Diseases-Ninth Revision codes in medical encounter data of all soldiers from 2005 to 2009. One nonconcussed soldier in the US Army during the same month was matched by age, sex, rank, length of service, deployment status, and military career field to each concussed soldier. Hazard ratio (HR) and 95% confidence interval (CI) were calculated for the risk of lower extremity injury within 2 years of the incident concussion. Monthly HRs were compared to identify differences in injury rates between the groups, and an HR for the period of greatest difference was also calculated. RESULTS: A total of 23 044 individuals (11 522 concussed and 11 522 nonconcussed) were included in the study. Within 2 years of concussion, the hazard of lower extremity injury was 38% greater in concussed compared to nonconcussed soldiers (HR, 1.38; 95% CI: 1.30, 1.46), while the 15-month hazard was 45% greater (HR, 1.45; 95% CI: 1.36, 1.56). CONCLUSION: The rate of lower extremity musculoskeletal injury among this population of physically active adults is higher following concussion, and the risk remains elevated for more than a year following injury.	[Kardouni, Joseph R.; Shing, Tracie L.; Mckinnon, Craig J.; Scofield, Dennis E.; Proctor, Susan P.] US Army, Res Inst Environm Med, Natick, MA 01760 USA; [Proctor, Susan P.] VA Boston Healthcare Syst, Res Serv, Boston, MA USA; [Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA		Kardouni, JR (corresponding author), US Army, Res Inst Environm Med, Mil Performance Div, 10 Gen Greene Ave,Bldg 42, Natick, MA 01760 USA.	joseph.r.kardouni.mil@mail.mil	Scofield, Dennis/AAC-6775-2019	Scofield, Dennis/0000-0003-4478-9640			Allison PD, 1995, SURVIVAL ANAL USING; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Fulton J, 2014, INT J SPORTS PHYS TH, V9, P583; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00045; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Rothman K.J., 2008, Modern epidemiology, V3rd; Scofield DE, 2015, STRENGTH COND J, V37, P2, DOI 10.1519/SSC.0000000000000149; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009	28	14	14	1	7	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	JUL	2018	48	7					533	540		10.2519/jospt.2018.8053			8	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	GL6MR	WOS:000437301400004	29739302				2022-02-06	
J	McCredie, VA; Alali, AS; Scales, DC; Rubenfeld, GD; Cuthbertson, BH; Nathens, AB				McCredie, Victoria A.; Alali, Aziz S.; Scales, Damon C.; Rubenfeld, Gordon D.; Cuthbertson, Brian H.; Nathens, Avery B.			Impact of ICU Structure and Processes of Care on Outcomes After Severe Traumatic Brain Injury: A Multicenter Cohort Study	CRITICAL CARE MEDICINE			English	Article						clinical protocols; delivery of healthcare; intensive care unit structure; neurocritical care; process of care; traumatic brain injury	SPECIALIST NEUROCRITICAL CARE; AMERICAN-COLLEGE; MORTALITY; EPIDEMIOLOGY; MANAGEMENT; WITHDRAWAL; UNITS; RISK	Objectives: It is uncertain whether dedicated neurocritical care units are associated with improved outcomes for critically ill neurologically injured patients in the era of collaborative protocol-driven care. We examined the association between dedicated neurocritical care units and mortality and the effects of standardized management protocols for severe traumatic brain injury. Design: We surveyed trauma medical directors from centers participating in the American College of Surgeons Trauma Quality Improvement Program to obtain information about ICU structure and processes of care. Survey data were then linked to the Trauma Quality Improvement Program registry, and random-intercept hier-archical multivariable modeling was used to evaluate the association between dedicated neurocritical care units, the presence of standardized management protocols and mortality. Setting: Trauma centers in North America participating in Trauma Quality Improvement Program. Patients: Data were analyzed from 9,773 adult patients with isolated severe traumatic brain injury admitted to 134 Trauma Quality Improvement Program centers between 2011 and 2013. Interventions: None. Measurements and Main Results: Only 50 ICUs (37%) were dedicated neurocritical care units, whereas 84 (63%) were general ICUs. Rates of standardized management protocols were similar comparing dedicated neurocritical care units and general ICUs. Among severe TBI patients admitted to trauma centers enrolled in Trauma Quality Improvement Program, care in a dedicated neurocritical care unit did not improve risk-adjusted in-hospital survival (odds ratio, 0.97; 95% CI, 0.80-1.19; p = 0.79). However, the presence of a standardized management protocol for these patients was associated with lower risk-adjusted in-hospital mortality (odds ratio, 0.77; 95% CI, 0.63-0.93; p = 0.009). Conclusions: Compared with dedicated neurocritical care models, standardized management protocols for severe traumatic brain injured patients are process-targeted intervention strategies that may improve clinical outcomes.	[McCredie, Victoria A.; Alali, Aziz S.; Scales, Damon C.; Rubenfeld, Gordon D.; Cuthbertson, Brian H.] Univ Toronto, Interdept Div Crit Care Med, Dept Med, Toronto, ON, Canada; [McCredie, Victoria A.] Univ Hlth Network, Div Crit Care Med, Dept Med, Toronto, ON, Canada; [McCredie, Victoria A.; Scales, Damon C.; Nathens, Avery B.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Scales, Damon C.; Rubenfeld, Gordon D.; Cuthbertson, Brian H.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Cuthbertson, Brian H.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON, Canada; [Nathens, Avery B.] Univ Toronto, Toronto, ON, Canada		McCredie, VA (corresponding author), Univ Toronto, Interdept Div Crit Care Med, Dept Med, Toronto, ON, Canada.; McCredie, VA (corresponding author), Univ Hlth Network, Div Crit Care Med, Dept Med, Toronto, ON, Canada.	Victoria.McCredie@uhn.ca			de Souza Chair in Trauma Research	Supported, in part, by a de Souza Chair in Trauma Research.	Alali AS, 2017, J NEUROTRAUM, V34, P2760, DOI 10.1089/neu.2017.4997; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; American College of : Surgeons Committee on Trauma, 2007, RES OPT CAR INJ PAT; Austin PC, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1195; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada, 2010, TRIC POL STAT ETH CO; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Costa DK, 2015, CRIT CARE MED, V43, P2275, DOI 10.1097/CCM.0000000000001259; Damian MS, 2013, INTENS CARE MED, V39, P1405, DOI 10.1007/s00134-013-2960-6; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; Kozar RA, 2014, J TRAUMA ACUTE CARE, V76, P634, DOI 10.1097/TA.0000000000000130; Kramer AH, 2014, CURR OPIN CRIT CARE, V20, P174, DOI 10.1097/MCC.0000000000000076; Kramer AH, 2013, CAN J ANESTH, V60, P966, DOI 10.1007/s12630-013-0001-0; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Lott JP, 2009, AM J RESP CRIT CARE, V179, P676, DOI 10.1164/rccm.200808-1281OC; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; Mittlbock M, 1996, STAT MED, V15, P1987, DOI 10.1002/(SICI)1097-0258(19961015)15:19<1987::AID-SIM318>3.0.CO;2-9; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049	35	14	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUL	2018	46	7					1139	1149		10.1097/CCM.0000000000003149			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ4AZ	WOS:000435290400050	29629983				2022-02-06	
J	Hou, LL; Zhou, X; Gan, F; Liu, ZX; Zhou, YJ; Qjan, G; Huang, KH				Hou, Lili; Zhou, Xuan; Gan, Fang; Liu, Zixuan; Zhou, Yajiao; Qjan, Gang; Huang, Kehe			Combination of Selenomethionine and N-Acetylcysteine Alleviates the Joint Toxicities of Aflatoxin B1 and Ochratoxin A by ERK MAPK Signal Pathway in Porcine Alveolar Macrophages	JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY			English	Article						combination; selenomethionine; N-acetylcysteine; aflatoxin B1; ochratoxin A; mitogen-activated protein kinases	HEMATOPOIETIC STEM-CELLS; TRAUMATIC BRAIN-INJURY; DORSAL-ROOT GANGLION; OXIDATIVE STRESS; IMMUNE TOXICITY; FUMONISIN B-1; PK15 CELLS; VITAMIN-E; P38 MAPK; IN-VITRO	Our previous studies showed that aflatoxin B1 (AFB1) and ochratoxin A (OTA) could trigger joint immune toxicity. Little is known about the combined effects of selenomethionine (SeMet) and N-acetylcysteine (NAC) on the joint toxicities of the two toxins. In this study, results showed that SeMet or NAC alone or in combination significantly alleviated the downswing of cell viability, glutathione production, and phagorytosis induced by AFB1 and OTA in porcine alveolar macrophages. The uptrend of lactate dehydrogenase activities, apoptosis, reactive oxygen species levels, and the relative mRNA of inflammatory cytokines triggered by the two toxins was decreased. Combination of them was more effective than single application. Knockdown of p38, c-JUN N-terminal kinase (JNK), or extracellular signal-regulated kinase (ERK) via use of the corresponding specific siRNA could alleviate the joint toxicities of AFB1 and OTA. However, the ERK but not p38 or JNK pathway was involved in the protection of SeMet and NAC against the immunotoxicity. In conclusion, combination of SeMet and NAC might be a new therapeutic orientation for preventing the joint toxicities induced by AFB1 and OTA.	[Hou, Lili; Zhou, Xuan; Gan, Fang; Liu, Zixuan; Zhou, Yajiao; Qjan, Gang; Huang, Kehe] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Hou, Lili; Zhou, Xuan; Gan, Fang; Liu, Zixuan; Zhou, Yajiao; Qjan, Gang; Huang, Kehe] Nanjing Agr Univ, Inst Nutr & Metab Disorders Domest Anim & Fowls, Nanjing 210095, Jiangsu, Peoples R China		Huang, KH (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China.; Huang, KH (corresponding author), Nanjing Agr Univ, Inst Nutr & Metab Disorders Domest Anim & Fowls, Nanjing 210095, Jiangsu, Peoples R China.	khhuang@njau.edu.cn	Qian, Gang/N-5350-2019	Qian, Gang/0000-0002-8081-1350	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31772811, 31602123, 31472253]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20160736]; Priority Academic Program Development of Jiangsu Higher Education Institutions (Jiangsu, China)	This work was funded by the National Natural Science Foundation of China (31772811, 31602123, 31472253), Natural Science Foundation of Jiangsu Province (BK20160736), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Jiangsu, China).	Abul-Hassan KS, 2004, MUTAT RES-GEN TOX EN, V565, P45, DOI 10.1016/j.mrgentox.2004.09.004; Ansar S, 2016, BIOL TRACE ELEM RES, V169, P129, DOI 10.1007/s12011-015-0403-7; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen XX, 2012, FREE RADICAL BIO MED, V53, P395, DOI 10.1016/j.freeradbiomed.2012.04.035; Costa S, 2008, WORLD MYCOTOXIN J, V1, P469, DOI 10.3920/WMJ2007.1007; COTGREAVE IA, 1987, BIOCHEM PHARMACOL, V36, P2899, DOI 10.1016/0006-2952(87)90200-0; Creppy EE, 1999, J TOXICOL-TOXIN REV, V18, P277, DOI 10.3109/15569549909009258; [冯永东 Feng Yongdong], 2004, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V27, P582; FRANKE KURT W., 1938, CEREAL CHEM, V15, P1; Gan F, 2017, CHEMOSPHERE, V182, P630, DOI 10.1016/j.chemosphere.2017.05.030; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Golli-Bennour Emna El, 2010, J Biochem Mol Toxicol, V24, P42, DOI 10.1002/jbt.20310; Hao S, 2016, J AGR FOOD CHEM, V64, P1385, DOI 10.1021/acs.jafc.5b05621; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Horvath A, 2002, TOXICON, V40, P273, DOI 10.1016/S0041-0101(01)00219-7; Hou LL, 2018, CHEMOSPHERE, V199, P718, DOI 10.1016/j.chemosphere.2018.02.009; Hou YQ, 2013, AMINO ACIDS, V45, P513, DOI 10.1007/s00726-012-1295-x; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Joshi D, 2014, J TRACE ELEM MED BIO, V28, P218, DOI 10.1016/j.jtemb.2013.12.006; JUNOD AF, 1987, AGENTS ACTIONS, V22, P176, DOI 10.1007/BF01968835; Kaur P, 2009, TOXICOL IN VITRO, V23, P378, DOI 10.1016/j.tiv.2008.12.024; Khatoon A, 2013, J IMMUNOTOXICOL, V10, P25, DOI 10.3109/1547691X.2012.686533; Klaric MK, 2008, ARCH TOXICOL, V82, P247, DOI 10.1007/s00204-007-0245-y; Lai JT, 2009, CLIN NUTR, V28, P338, DOI 10.1016/j.clnu.2009.01.011; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Li JL, 2010, BIOMETALS, V23, P695, DOI 10.1007/s10534-010-9334-0; Liu BH, 2002, TOXICOL APPL PHARM, V180, P197, DOI 10.1006/taap.2002.9406; Liu YH, 2018, J NUTR BIOCHEM, V58, P138, DOI 10.1016/j.jnutbio.2018.04.011; Monaghan D, 2014, BIOCHEM BIOPH RES CO, V443, P761, DOI 10.1016/j.bbrc.2013.12.041; Mu H, 2008, ATHEROSCLEROSIS, V201, P67, DOI 10.1016/j.atherosclerosis.2007.12.049; Naziroglu M, 2013, NEUROSCIENCE, V242, P151, DOI 10.1016/j.neuroscience.2013.03.032; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Ozgul C, 2012, PHYSIOL BEHAV, V106, P122, DOI 10.1016/j.physbeh.2012.01.014; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Parveen F, 2014, BIOL TRACE ELEM RES, V157, P266, DOI 10.1007/s12011-014-9887-9; PATTERSON BH, 1989, AM J PHYSIOL, V257, pR556, DOI 10.1152/ajpregu.1989.257.3.R556; PERETZ A, 1991, AM J CLIN NUTR, V53, P1323, DOI 10.1093/ajcn/53.5.1323; Pinotti L, 2016, TOXINS, V8, DOI 10.3390/toxins8020045; PITT JI, 1987, APPL ENVIRON MICROB, V53, P266, DOI 10.1128/AEM.53.2.266-269.1987; Sodhi S, 2006, VET RES COMMUN, V30, P935, DOI 10.1007/s11259-006-2503-5; Spagnuolo G, 2006, BIOMATERIALS, V27, P1803, DOI 10.1016/j.biomaterials.2005.10.022; Stalk N. M., 2016, BIOL TRACE ELEM RES, V169, P121; SWANSON CA, 1991, AM J CLIN NUTR, V54, P917, DOI 10.1093/ajcn/54.5.917; Vila-Donat P, 2018, FOOD CHEM TOXICOL, V114, P246, DOI 10.1016/j.fct.2018.02.044; Wang HW, 2014, FOOD CHEM TOXICOL, V71, P217, DOI 10.1016/j.fct.2014.05.032; Wang Y, 2012, TOXICOL LETT, V209, P186, DOI 10.1016/j.toxlet.2011.12.011; Wielogorska E, 2016, WORLD MYCOTOXIN J, V9, P419, DOI 10.3920/WMJ2015.1919; Xu HB, 2017, CHEM-BIOL INTERACT, V272, P107, DOI 10.1016/j.cbi.2017.05.016; Yang M, 2013, J CELL BIOCHEM, V114, P111, DOI 10.1002/jcb.24308; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004; Yu ZQ, 2015, BIOL TRACE ELEM RES, V168, P242, DOI 10.1007/s12011-015-0344-1; Zhai H, 2005, EUR J PHARMACOL, V516, P112, DOI 10.1016/j.ejphar.2005.04.035	53	14	15	2	42	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0021-8561	1520-5118		J AGR FOOD CHEM	J. Agric. Food Chem.	JUN 13	2018	66	23					5913	5923		10.1021/acs.jafc.8b01858			11	Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Chemistry; Food Science & Technology	GJ6WT	WOS:000435525800022	29799741				2022-02-06	
J	Munoz-Galdeano, T; Reigada, D; del Aguila, A; Velez, I; Caballero-Lopez, MJ; Maza, RM; Nieto-Diaz, M				Munoz-Galdeano, Teresa; Reigada, David; del Aguila, Angela; Velez, Irene; Caballero-Lopez, Marcos J.; Maza, Rodrigo M.; Nieto-Diaz, Manuel			Cell Specific Changes of Autophagy in a Mouse Model of Contusive Spinal Cord Injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						neural cell; LC3; Beclin 1; autophagic flux; cell death	PROMOTES FUNCTIONAL RECOVERY; LYSOSOMAL STORAGE DISORDERS; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; UP-REGULATION; PRIMARY NEURONS; BECLIN 1; NEURODEGENERATIVE DISEASE; ALZHEIMERS-DISEASE	Autophagy is an essential process of cellular waist clearance that becomes altered following spinal cord injury (SCI). Details on these changes, including timing after injury, underlying mechanisms, and affected cells, remain controversial. Here we present a characterization of autophagy in the mice spinal cord before and after a contusive SCI. In the undamaged spinal cord, analysis of LC3 and Beclin 1 autophagic markers reveals important differences in basal autophagy between neurons, oligodendrocytes, and astrocytes and even within cell populations. Following moderate contusion, western blot analyses of LC3 indicates that autophagy increases to a maximum at 7 days post injury (dpi), whereas unaltered Beclin 1 expression and increase of p62 suggests a possible blockage of autophagosome clearance. Immunofluorescence analyses of LC3 and Beclin 1 provide additional details that reveal a complex, cell-specific scenario. Autophagy is first activated (1 dpi) in the severed axons, followed by a later (7 dpi) accumulation of phagophores and/or autophagosomes in the neuronal soma without signs of increased initiation. Oligodendrocytes and reactive astrocytes also accumulate phagophores and autophagosomes at 7 dpi, but whereas the accumulation in astrocytes is associated with an increased autophagy initiation, it seems to result from a blockage of the autophagic flux in oligodendrocytes. Comparison with previous studies highlights the complex and heterogeneous autophagic responses induced by the SCI, leading in many cases to contradictory results and interpretations. Future studies should consider this complexity in the design of therapeutic interventions based on the modulation of autophagy to treat SCI.	[Munoz-Galdeano, Teresa; Reigada, David; del Aguila, Angela; Velez, Irene; Caballero-Lopez, Marcos J.; Maza, Rodrigo M.; Nieto-Diaz, Manuel] Hosp Nacl Paraplejicos SESCAM, UDI HNP, Lab Mol Neuroprotect, Toledo, Spain; [del Aguila, Angela] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA		Nieto-Diaz, M (corresponding author), Hosp Nacl Paraplejicos SESCAM, UDI HNP, Lab Mol Neuroprotect, Toledo, Spain.	mnietodiaz@sescam.jccm.es	Maza, Rodrigo Martinez/ABH-3989-2020; Diaz, Manuel Nieto/ABD-7144-2020; Munoz-Galdeano, Teresa/ABF-8881-2020; Nieto-Diaz, Manuel/R-5163-2017; Reigada, David/AAU-5910-2020	Maza, Rodrigo Martinez/0000-0002-7249-9205; Munoz-Galdeano, Teresa/0000-0003-3526-819X; Nieto-Diaz, Manuel/0000-0002-7244-794X; Reigada, David/0000-0001-9041-0705	Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI12/02828]; European Regional Development Fund/European Social Fund; Tatiana Perez de Guzman el Bueno Foundation	This study has been funded by Instituto de Salud Carlos III through the project PI12/02828, co-funded by European Regional Development Fund/European Social Fund (Investing in your future) and a 2017-2019 grant from the Tatiana Perez de Guzman el Bueno Foundation. We thank Dr. Noboru Mizushima (Tokyo Medical and Dental University, Tokyo, Japan) and Dr. Patricia Boya (Department of Cellular and Molecular Biology, Centro de Investigaciones Biologicas, Madrid, Spain) for the GFP-Lc3 mice; Drs. Eeva Liisa Eskelinen (Department of Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Finland), and Isei Tanida (Department of Cell Biology and Neurosciences, Juntendo University Graduate School of Medicine, Tokyo, Japan) for their helpful suggestions on autophagosomes identification images. We thank for their technical and logistic support to the Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion (FUHNPAIIN) and the microscopy and cytometry facilities of the UDI-HNP.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Alirezaei M, 2010, AUTOPHAGY, V6, P702, DOI 10.4161/auto.6.6.12376; Baba H, 2009, J VASC SURG, V50, P381, DOI 10.1016/j.jvs.2009.03.042; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bercury KK, 2014, J NEUROSCI, V34, P4466, DOI 10.1523/JNEUROSCI.4314-13.2014; Berliocchi L, 2015, MOL PAIN, V11, DOI 10.1186/1744-8069-11-3; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; BUNGE MB, 1973, J CELL BIOL, V56, P713, DOI 10.1083/jcb.56.3.713; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Castillo K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.421; Chen HC, 2013, J SURG RES, V179, pE203, DOI 10.1016/j.jss.2012.02.023; Chen HC, 2012, SPINE, V37, P470, DOI 10.1097/BRS.0b013e318221e859; Chen Z, 2014, MOL MED REP, V9, P2091, DOI 10.3892/mmr.2014.2124; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Engedal N, 2013, AUTOPHAGY, V9, P1475, DOI 10.4161/auto.25900; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; Fan H, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0081-8; Gao K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/260161; Goldshmit Y, 2015, MOL CELL NEUROSCI, V68, P82, DOI 10.1016/j.mcn.2015.04.006; Hao HH, 2013, NEUROSCI BULL, V29, P484, DOI 10.1007/s12264-013-1355-6; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hou HP, 2014, J NEUROSURG-SPINE, V20, P568, DOI 10.3171/2014.1.SPINE13237; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, AUTOPHAGY, V5, P390, DOI 10.4161/auto.5.3.7724; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korenic A, 2015, NEUROSCI LETT, V595, P128, DOI 10.1016/j.neulet.2015.04.020; Kulbe JR, 2014, BRAIN RES, V1542, P12, DOI 10.1016/j.brainres.2013.10.032; Lee Jin-A, 2012, Exp Neurobiol, V21, P1, DOI 10.5607/en.2012.21.1.1; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Lieberman AP, 2012, AUTOPHAGY, V8, P719, DOI 10.4161/auto.19469; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu NK, 2006, J NEUROTRAUM, V23, P1794, DOI 10.1089/neu.2006.23.1794; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Lytle JM, 2007, EUR J NEUROSCI, V25, P1711, DOI 10.1111/j.1460-9568.2007.05390.x; Maday S, 2016, BRAIN RES, V1649, P143, DOI 10.1016/j.brainres.2016.03.047; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Maday S, 2014, DEV CELL, V30, P71, DOI 10.1016/j.devcel.2014.06.001; Maday S, 2012, AUTOPHAGY, V8, P858, DOI 10.4161/auto.20055; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Matus S, 2014, AUTOPHAGY, V10, P710, DOI 10.4161/auto.28434; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Motori E, 2013, CELL METAB, V18, P844, DOI 10.1016/j.cmet.2013.11.005; Nikoletopoulou V, 2015, CELL DEATH DIFFER, V22, P398, DOI 10.1038/cdd.2014.204; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Owens T, 2008, J NEUROPATH EXP NEUR, V67, P1113, DOI 10.1097/NEN.0b013e31818f9ca8; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; R Development Core Team, 2011, R LANG ENV STAT COMP; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Ribas VT, 2015, BRAIN PATHOL, V25, P157, DOI 10.1111/bpa.12170; Rodriguez-Muela N, 2012, CELL DEATH DIFFER, V19, P162, DOI 10.1038/cdd.2011.88; Rodriguez-Muela N, 2012, AUTOPHAGY, V8, P286, DOI 10.4161/auto.8.2.18982; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Satoh J, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-68; Schwarz L, 2012, J MOL NEUROSCI, V47, P256, DOI 10.1007/s12031-012-9733-5; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Smith CM, 2013, J NEUROSCI, V33, P8088, DOI 10.1523/JNEUROSCI.0233-13.2013; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tanabe F, 2011, AUTOPHAGY, V7, P1462, DOI 10.4161/auto.7.12.17892; Tang PF, 2014, MOL NEUROBIOL, V49, P276, DOI 10.1007/s12035-013-8518-3; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tian FF, 2010, AUTOPHAGY, V6, P1107, DOI 10.4161/auto.6.8.13427; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Wang P, 2018, CELL MOL NEUROBIOL, V38, P679, DOI 10.1007/s10571-017-0527-8; Wang WG, 2015, INT J CLIN EXP PATHO, V8, P2375; Wang ZY, 2014, APOPTOSIS, V19, P933, DOI 10.1007/s10495-014-0976-1; Yin F, 2014, NEURAL REGEN RES, V9, P1665, DOI 10.4103/1673-5374.141801; Young W, 2002, PROG BRAIN RES, V137, P231; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Zhang D, 2017, MOL NEUROBIOL, V54, P3327, DOI 10.1007/s12035-016-9895-1; Zhang E, 2013, BRAIN RES, V1519, P31, DOI 10.1016/j.brainres.2013.04.055; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Zhang MT, 2017, J NEUROCHEM, V143, P244, DOI 10.1111/jnc.14154; Zhang Q, 2014, CHIN J TRAUMATOL, V17, P193, DOI 10.3760/cma.j.issn.1008-1275.2014.04.002; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zhao HS, 2017, NEUROSCIENCE, V348, P241, DOI 10.1016/j.neuroscience.2017.02.027; Zhou YL, 2016, NEUROCHEM RES, V41, P813, DOI 10.1007/s11064-015-1756-1	107	14	17	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JUN 12	2018	12								164	10.3389/fncel.2018.00164			26	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GJ1DS	WOS:000434995000001	29946241	gold, Green Published			2022-02-06	
J	Rao, KVR; Iring, S; Younger, D; Kuriakose, M; Skotak, M; Alay, E; Gupta, RK; Chandra, N				Rao, Kakulavarapu V. Rama; Iring, Stephanie; Younger, Daniel; Kuriakose, Matthew; Skotak, Maciej; Alay, Eren; Gupta, Raj K.; Chandra, Namas			A Single Primary Blast-Induced Traumatic Brain Injury in a Rodent Model Causes Cell-Type Dependent Increase in Nicotinamide Adenine Dinucleotide Phosphate Oxidase Isoforms in Vulnerable Brain Regions	JOURNAL OF NEUROTRAUMA			English	Article						astrocytes; blast injury; 4-hydroxynonenal; microglia; neuron; NADPH oxidase; oxidative stress; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; NADPH-OXIDASE; OXIDATIVE STRESS; FREE-RADICALS; LIPID-PEROXIDATION; ACTIVATED MICROGLIA; SCALING RULES; INHIBITION; NOX2; INFLAMMATION	Blast-induced traumatic brain injury (bTBI) is a leading cause of morbidity in soldiers on the battlefield and in training sites with long-term neurological and psychological pathologies. Previous studies from our laboratory demonstrated activation of oxidative stress pathways after blast injury, but their distribution among different brain regions and their impact on the pathogenesis of bTBI have not been explored. The present study examined the protein expression of two isoforms: nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 1 and 2 (NOX1, NOX2), corresponding superoxide production, a downstream event of NOX activation, and the extent of lipid peroxidation adducts of 4-hydroxynonenal (4HNE) to a range of proteins. Brain injury was evaluated 4h after the shock-wave exposure, and immunofluorescence signal quantification was performed in different brain regions. Expression of NOX isoforms displayed a differential increase in various brain regions: in hippocampus and thalamus, there was the highest increase of NOX1, whereas in the frontal cortex, there was the highest increase of NOX2 expression. Cell-specific analysis of changes in NOX expression with respect to corresponding controls revealed that blast resulted in a higher increase of NOX1 and NOX 2 levels in neurons compared with astrocytes and microglia. Blast exposure also resulted in increased superoxide levels in different brain regions, and such changes were reflected in 4HNE protein adduct formation. Collectively, this study demonstrates that primary blast TBI induces upregulation of NADPH oxidase isoforms in different regions of the brain parenchyma and that neurons appear to be at higher risk for oxidative damage compared with other neural cells.	[Rao, Kakulavarapu V. Rama; Iring, Stephanie; Younger, Daniel; Kuriakose, Matthew; Skotak, Maciej; Alay, Eren; Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med CIBM3, 111 Lock St, Newark, NJ 07102 USA; [Gupta, Raj K.] US Army, Med Res & Mat Command, Dept Def Blast Injury Res Program Coordinating Of, Ft Detrick, MD USA		Rao, KVR (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med CIBM3, 111 Lock St, Newark, NJ 07102 USA.	kakulava@njit.edu; namas.chandra@njit.edu	Skotak, Maciej/H-4769-2019	Skotak, Maciej/0000-0003-2584-7294; Alay, Eren/0000-0003-2523-0366	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [14059001, W81XWH-15-1-0303]	This work was supported by grant no. 14059001, W81XWH-15-1-0303, entitled "Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tubes" received from the U.S. Army Medical Research and Materiel Command. Authors greatly acknowledge the assistance of Arun Ravula, Debanjan Haldar, Jose Rodriguez, Yonatan Sheer, Madison Taylor, Smit Shah for tissue sectioning and experimental data analysis.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Arlt S, 2002, CURR OPIN LIPIDOL, V13, P289, DOI 10.1097/00041433-200206000-00009; Banakou E, 2010, COMP BIOCHEM PHYS C, V152, P346, DOI 10.1016/j.cbpc.2010.06.001; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bochicchio GV, 2008, AM SURGEON, V74, P267; BROWN SA, 1992, J AM VET MED ASSOC, V200, P1849; Butterfield DA, 2016, PROTEOM CLIN APPL, V10, P1191, DOI 10.1002/prca.201600003; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Carbone F, 2015, ANTIOXID REDOX SIGN, V23, P460, DOI 10.1089/ars.2013.5778; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Chandra N., 2015, BRAIN NEUROTRAUMA MO; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Coyoy A, 2013, NEUROCHEM INT, V62, P998, DOI 10.1016/j.neuint.2013.03.009; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; FERNANDEZ V, 1985, ENDOCRINOLOGY, V117, P496, DOI 10.1210/endo-117-2-496; Friedman J, 2011, OXID STRESS APPL BAS, P19, DOI 10.1007/978-1-60327-514-9_2; Fu YH, 2013, BRAIN STRUCT FUNCT, V218, P1337, DOI 10.1007/s00429-012-0462-x; Guilarte TR, 2016, TRENDS PHARMACOL SCI, V37, P334, DOI 10.1016/j.tips.2016.02.008; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2011, BRAIN BEHAV EVOLUT, V78, P302, DOI 10.1159/000330825; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; JESBERGER JA, 1991, INT J NEUROSCI, V57, P1, DOI 10.3109/00207459109150342; Kim JH, 2013, BRAIN RES, V1499, P163, DOI 10.1016/j.brainres.2013.01.007; Koppula S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/823902; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Lucke-Wold BP, 2015, TRANSL RES, V166, P509, DOI 10.1016/j.trsl.2015.08.005; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; Mattson MP, 1996, PERSPECT DEV NEUROBI, V3, P79; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Ferreira APO, 2014, PSYCHOPHARMACOLOGY, V231, P1935, DOI 10.1007/s00213-013-3336-x; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Park KW, 2008, J NEUROSCI RES, V86, P1053, DOI 10.1002/jnr.21571; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Schaur RJ, 2015, BIOMOLECULES, V5, P2247, DOI 10.3390/biom5042247; Schiavone S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.36; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Singleton J.A., 2013, BMJ OPEN, P3; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Sorce S, 2010, J NEUROSCI, V30, P11317, DOI 10.1523/JNEUROSCI.1491-10.2010; Stanger O, 2001, CLIN PHYSIOL, V21, P718, DOI 10.1046/j.1365-2281.2001.00381.x; Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4; Tan X., 2013, ASME 2013 INT MECH E; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wang XK, 2005, MOL BRAIN RES, V140, P120, DOI 10.1016/j.molbrainres.2005.07.018; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; Yoshioka H, 2011, J CEREBR BLOOD F MET, V31, P868, DOI 10.1038/jcbfm.2010.166; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009	77	14	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	17					2077	2090		10.1089/neu.2017.5358		JUN 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ7LU	WOS:000435148500001	29648986	Green Published, Green Submitted, Bronze			2022-02-06	
J	Chang, JL; Hinrich, AJ; Roman, B; Norrbom, M; Rigo, F; Marr, RA; Norstrom, EM; Hastings, ML				Chang, Jennifer L.; Hinrich, Anthony J.; Roman, Brandon; Norrbom, Michaela; Rigo, Frank; Marr, Robert A.; Norstrom, Eric M.; Hastings, Michelle L.			Targeting Amyloid-beta Precursor Protein, APP, Splicing with Antisense Oligonucleotides Reduces Toxic Amyloid-beta Production	MOLECULAR THERAPY			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; DOWN-SYNDROME; EXPRESSION; DEMENTIA; MICE; IDENTIFICATION; PHARMACOLOGY; DUPLICATION; COMPLEXITY	Alterations in amyloid beta precursor protein (APP) have been implicated in cognitive decline in Alzheimer's disease (AD), which is accelerated in Down syndrome/Trisomy 21 (DS/TS21), likely due to the extra copy of the APP gene, located on chromosome 21. Proteolytic cleavage of APP generates amyloid-beta (A beta) peptide, the primary component of senile plaques associated with AD. Reducing A beta production is predicted to lower plaque burden and mitigate AD symptoms. Here, we designed a splice-switching antisense oligonucleotide (SSO) that causes skipping of the APP exon that encodes proteolytic cleavage sites required for A beta peptide production. The SSO induced exon skipping in Down syndrome cell lines, resulting in a reduction of A beta. Treatment of mice with the SSO resulted in widespread distribution in the brain accompanied by APP exon skipping and a reduction of A beta. Overall, we show that an alternatively spliced isoform of APP encodes a cleavage-incompetent protein that does not produce A beta peptide and that promoting the production of this isoform with an SSO can reduce Ab in vivo. These findings demonstrate the utility of using SSOs to induce a spliced isoform of APP to reduce Ab as a potential approach for treating AD.	[Chang, Jennifer L.; Hinrich, Anthony J.; Hastings, Michelle L.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Ctr Genet Dis, Dept Cell Biol & Anat, N Chicago, IL 60064 USA; [Chang, Jennifer L.; Hinrich, Anthony J.; Hastings, Michelle L.] Rosalind Franklin Univ Med & Sci, Sch Grad & Postdoctoral Studies, N Chicago, IL 60064 USA; [Roman, Brandon; Norstrom, Eric M.] Depaul Univ, Dept Biol Sci, Chicago, IL 60614 USA; [Norrbom, Michaela; Rigo, Frank] Ionis Pharmaceut, Carlsbad, CA 92010 USA; [Marr, Robert A.] Rosalind Franklin Univ Med & Sci, Dept Neurosci, N Chicago, IL 60064 USA		Hastings, ML (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, Chicago Med Sch, 3333 Green Bay Dr, N Chicago, IL 60064 USA.	michelle.hastings@rosalindfranklin.edu	Hastings, MICHELLE L./AAK-6627-2021	Hastings, Michelle/0000-0002-4253-9261	RFUMS internal research funding; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10 OD 010662]	We thank Francine Jodelka for technical assistance and Gopal Thinakaran for the CTM-1 antibody. This work was financially supported by RFUMS internal research funding and NIH S10 OD 010662.	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Antonarakis SE, 2017, NAT REV GENET, V18, P147, DOI 10.1038/nrg.2016.154; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bennett CF, 2017, ANNU REV PHARMACOL, V57, P81, DOI 10.1146/annurev-pharmtox-010716-104846; Bird SM, 2016, NEUROSCI BIOBEHAV R, V64, P215, DOI 10.1016/j.neubiorev.2016.01.004; Castro P, 2017, J NEUROL, V264, P804, DOI 10.1007/s00415-016-8308-8; Chakravarthy M, 2017, THERANOSTICS, V7, P3933, DOI 10.7150/thno.21529; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Chauhan NB, 2007, NEUROSCIENCE, V146, P143, DOI 10.1016/j.neuroscience.2007.01.008; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; De Strooper B, 2014, CELL, V159, P721, DOI 10.1016/j.cell.2014.10.016; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Deyts C, 2016, TRENDS PHARMACOL SCI, V37, P390, DOI 10.1016/j.tips.2016.01.005; Doran E, 2017, J ALZHEIMERS DIS, V56, P459, DOI 10.3233/JAD-160836; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gaiteri C, 2016, NAT REV NEUROL, V12, P413, DOI 10.1038/nrneurol.2016.84; Glascock J, 2017, GENE THER, V24, P498, DOI 10.1038/gt.2017.39; Hafez DM, 2012, NEUROSCIENCE, V223, P465, DOI 10.1016/j.neuroscience.2012.07.038; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Havens MA, 2016, NUCLEIC ACIDS RES, V44, P6549, DOI 10.1093/nar/gkw533; Havens MA, 2013, WIRES RNA, V4, P247, DOI 10.1002/wrna.1158; Hinrich AJ, 2016, EMBO MOL MED, V8, P328, DOI 10.15252/emmm.201505846; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Khvorova A, 2017, NAT BIOTECHNOL, V35, P238, DOI 10.1038/nbt.3765; Kumar VB, 2000, PEPTIDES, V21, P1769, DOI 10.1016/S0196-9781(00)00339-9; Lanoiselee HM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002270; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marr R.A., 2014, FRONT AGING NEUROSCI, V6; McClorey G, 2015, CURR OPIN PHARMACOL, V24, P52, DOI 10.1016/j.coph.2015.07.005; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Mockett BG, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00030; Muller UC, 2017, NAT REV NEUROSCI, V18, P281, DOI 10.1038/nrn.2017.29; Norstrom E, 2017, DISCOV MED, V23, P269; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Rigo F, 2014, J PHARMACOL EXP THER, V350, P46, DOI 10.1124/jpet.113.212407; Rohn TT, 2000, J NEUROCHEM, V74, P2331, DOI 10.1046/j.1471-4159.2000.0742331.x; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Stahl R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00410; Szaruga M, 2015, J EXP MED, V212, P2003, DOI 10.1084/jem.20150892; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tcw J., 2017, COLD SPRING HARB PER, V7, DOI DOI 10.1101/CSHPERSPECT.A024539; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Van Cauwenberghe C, 2016, GENET MED, V18, P421, DOI 10.1038/gim.2015.117; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Veugelen S, 2016, NEURON, V90, P410, DOI 10.1016/j.neuron.2016.03.010; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wan LL, 2017, CELL, V170, P5, DOI 10.1016/j.cell.2017.06.028; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Xia D, 2015, NEURON, V85, P967, DOI 10.1016/j.neuron.2015.02.010; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	76	14	14	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	JUN 6	2018	26	6					1539	1551		10.1016/j.ymthe.2018.02.029			13	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	GO1DH	WOS:000439687900016	29628304	hybrid, Green Published			2022-02-06	
J	Graupensperger, SA; Benson, AJ; Evans, MB				Graupensperger, Scott A.; Benson, Alex J.; Evans, M. Blair			Everyone Else Is Doint It: The Association Between Social Identity and Susceptibility to Peer Influence in NCAA Athletes	JOURNAL OF SPORT & EXERCISE PSYCHOLOGY			English	Article						alcohol; concussion; conformity; hazing; health-risk behavior; substance use	SPORT PARTICIPATION; ALCOHOL-CONSUMPTION; SUBSTANCE USE; YOUTH SPORT; SELF-ESTEEM; NORMS; DRINKING; BEHAVIOR; ADOLESCENTS; TEAM	The authors examined athletes' conformity to teammates' risky behaviors through a performance-based manipulation paradigm. They hypothesized that athletes who strongly identified with their team would be at increased risk of conforming to teammates' behaviors. Athletes (N=379) from 23 intact National Collegiate Athletic Association (NCAA) teams completed surveys (e.g., social identity) and reported the extent to which they would engage in risky behavior scenarios (e.g., drinking and driving). Then, researchers displayed ostensible responses that were manipulated to appear as though teammates reported high engagement in the risky behaviors. Finally, athletes again responded to the hypothetical scenarios and a conformity index was created. Results indicated that social identity, at both individual and group levels, positively predicted conformity- indicating that athletes with stronger social identities are more susceptible to peer influence. Although these findings highlight a pernicious aspect of social identity, they also provide insight into how group-level processes could be leveraged to prevent risky behaviors in student-athletes.	[Graupensperger, Scott A.; Evans, M. Blair] Penn State Univ, Dept Kinesiol, State Coll, PA 16801 USA; [Benson, Alex J.] Western Univ, Dept Psychol, London, ON, Canada		Graupensperger, SA (corresponding author), Penn State Univ, Dept Kinesiol, State Coll, PA 16801 USA.	sag40@psu.edu		Benson, Alex/0000-0002-5978-065X; Evans, Blair/0000-0003-0668-4928	NCAA Graduate Student Research Grant; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1 TR002016]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR002016, UL1TR002014] Funding Source: NIH RePORTER	This project was funded by an NCAA Graduate Student Research Grant to support the study of intercollegiate athletics. The first author is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (award number TL1 TR002016).	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Armstrong S, 2009, J AM COLL HEALTH, V57, P521, DOI 10.3200/JACH.57.5.521-526; Benson AJ, 2017, SPORT EXERC PERFORM, V6, P129, DOI 10.1037/spy0000090; Bensons AJ, 2017, J SPORT EXERCISE PSY, V39, P13, DOI 10.1123/jsep.2016-0182; Bernstein I.H., 1994, PSYCHOMETRIC THEORY, V3; Blackhart GC, 2012, BEHAV RES METHODS, V44, P24, DOI 10.3758/s13428-011-0132-6; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; Brisola-Santos MB, 2016, AM J ADDICTION, V25, P518, DOI 10.1111/ajad.12425; Bruner MW, 2018, J YOUTH ADOLESCENCE, V47, P1113, DOI 10.1007/s10964-017-0769-2; Bruner MW, 2018, PSYCHOL SPORT EXERC, V35, P181, DOI 10.1016/j.psychsport.2017.12.006; Bruner MW, 2017, RES Q EXERCISE SPORT, V88, P209, DOI 10.1080/02701367.2017.1296100; Bruner MW, 2015, J APPL SPORT PSYCHOL, V27, P351, DOI 10.1080/10413200.2015.1010661; Buckman JF, 2013, DRUG ALCOHOL DEPEN, V131, P50, DOI 10.1016/j.drugalcdep.2013.04.023; Burnett S, 2011, NEUROSCI BIOBEHAV R, V35, P1654, DOI 10.1016/j.neubiorev.2010.10.011; Cameron JE, 2004, SELF IDENTITY, V3, P239, DOI 10.1080/13576500444000047; Carron A. V., 2012, GROUP DYNAMICS SPORT, V4th; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Daniels E, 2006, SEX ROLES, V55, P875, DOI 10.1007/s11199-006-9138-4; De los Reyes A, 2004, J CLIN CHILD ADOLESC, V33, P325, DOI 10.1207/s15374424jccp3302_14; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Egan KL, 2016, J PSYCHOACTIVE DRUGS, V48, P166, DOI 10.1080/02791072.2016.1186305; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Evans MB, 2012, CAN PSYCHOL, V53, P301, DOI 10.1037/a0030202; Fishbach A, 2016, SOC PERSONAL PSYCHOL, V10, P298, DOI 10.1111/spc3.12251; Gaertner L, 2002, J PERS SOC PSYCHOL, V83, P574, DOI 10.1037//0022-3514.83.3.574; Gayles JG, 2009, J HIGH EDUC-UK, V80, P315, DOI 10.1080/00221546.2009.11779015; Grossbard J, 2009, J APPL SPORT PSYCHOL, V21, P247, DOI 10.1080/10413200903019145; Helms SW, 2014, DEV PSYCHOL, V50, P2697, DOI 10.1037/a0038178; Hogg MA, 2017, GROUP PROCESS INTERG, V20, P570, DOI 10.1177/1368430217690909; Hogg MA, 2016, PEACE PSYCHOL BOOK S, P3, DOI 10.1007/978-3-319-29869-6_1; Hummer JF, 2009, ADDICT BEHAV, V34, P573, DOI 10.1016/j.addbeh.2009.03.021; Kim HY, 2017, PERS SOC PSYCHOL B, V43, P814, DOI 10.1177/0146167217699581; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Labrie JW, 2009, DRUG ALCOHOL REV, V28, P40, DOI 10.1111/j.1465-3362.2008.00012.x; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; MacDonald G., 2012, HDB SELF IDENTITY, P354; Nail PR, 2000, PSYCHOL BULL, V126, P454, DOI 10.1037/0033-2909.126.3.454; Neighbors C, 2010, PSYCHOL ADDICT BEHAV, V24, P522, DOI 10.1037/a0019944; Nelson TF, 2001, MED SCI SPORT EXER, V33, P43; Nichols AL, 2008, J GEN PSYCHOL, V135, P151, DOI 10.3200/GENP.135.2.151-166; Nook EC, 2016, PERS SOC PSYCHOL B, V42, P1045, DOI 10.1177/0146167216649932; Ntoumanis N, 2014, SPORTS MED, V44, P1603, DOI 10.1007/s40279-014-0240-4; Olthuis JV, 2011, J CLIN SPORT PSYCHOL, V5, P24, DOI 10.1123/jcsp.5.1.24; Pinheiro J., 2017, NLME LINEAR NONLINEA; Prinstein MJ, 2011, DEV PSYCHOL, V47, P1167, DOI 10.1037/a0023274; Rees T, 2015, SPORTS MED, V45, P1083, DOI 10.1007/s40279-015-0345-4; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; *Seitz C.M., 2014, J ALCOHOL DRUG EDUC, V58, P7, DOI 10.1123/jcsp.2018-0083; Sheeran P, 2017, HEALTH PSYCHOL, V36, P1065, DOI 10.1037/hea0000553; Tajfel Henri, 1981, HUMAN GROUPS SOCIAL; Taylor EA, 2017, J APPL SPORT MANAG, V9, P56, DOI 10.18666/JASM-2017-V9-I1-7470; Teunissen HA, 2016, J ADOLESCENCE, V53, P45, DOI 10.1016/j.adolescence.2016.08.017; Turrisi R, 2007, PSYCHOL ADDICT BEHAV, V21, P453, DOI 10.1037/0893-164X.21.4.453; Webber TA, 2017, EXP CLIN PSYCHOPHARM, V25, P31, DOI 10.1037/pha0000105; Zhou J, 2014, ALCOHOL ALCOHOLISM, V49, P604, DOI 10.1093/alcalc/agu061	56	14	14	3	33	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0895-2779	1543-2904		J SPORT EXERCISE PSY	J. Sport Exerc. Psychol.	JUN	2018	40	3					117	127		10.1123/jsep.2017-0339			11	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	GN8EY	WOS:000439392800001	30001165	Green Accepted			2022-02-06	
J	Groth, CM; Acquisto, NM; Khadem, T				Groth, Christine M.; Acquisto, Nicole M.; Khadem, Tina			Current practices and safety of medication use during rapid sequence intubation	JOURNAL OF CRITICAL CARE			English	Article						Intensive Care Unit (KU); Emergency department; Rapid sequence incubation (RSI); Medications; Adverse effects	EMERGENCY-DEPARTMENT; ETOMIDATE; SEPSIS; CONTROVERSIES; INDUCTION; MIDAZOLAM; MORTALITY; KETAMINE; TRIAL	Purpose: Characterize medication practices during and immediately after rapid sequence intubation (RSI) by provider/location and evaluate adverse drug events. Materials and methods: This was a multicenter, observational, cross-sectional study of adult and pediatric intensive care unit and emergency department patients over a 24-h period surrounding first intubation. Results: A total of 404 patients from 34 geographically diverse institutions were included (mean age 58 +/- 22 years, males 59%, pediatric 8%). During RSI, 21%, 87%, and 77% received pre-induction, induction, and paralysis, respectively. Significant differences in medication use by provider type were seen. Etomidate was administered to 58% with sepsis, but was not associated with adrenal insufficiency. Ketamine was associated with hypotension post-RSI [RR = 1.78 (1.36-2.35)] and use was low with traumatic brain injury/stroke (1.5%). Succinylcholine was given to 67% of patients with baseline bradycardia and was significantly associated with bradycardia post-RSI [RR = 1.81 (1.11-2.94)]. An additional 13% given succinylcholine had contraindications. Sedation practices post-RSI were not consistent with current practice guidelines and most receiving a non-depolarizing paralytic did not receive adequate sedation post-RSI. Conclusions: Medication practices during RSI vary amongst provider and medications are often used inappropriately. There is opportunity for optimization of medication use during RSI. (C) 2018 Elsevier Inc. All rights reserved.	[Groth, Christine M.; Acquisto, Nicole M.; Khadem, Tina] Univ Rochester, Med Ctr, Coordinating Site,601 Elmwood Ave Box 638, Rochester, NY 14642 USA		Groth, CM (corresponding author), Univ Rochester, Med Ctr, Coordinating Site,601 Elmwood Ave Box 638, Rochester, NY 14642 USA.	christine_groth@urmc.rochester.edu; nicole_acquisto@urmc.rochester.edu; khademt@upmc.edu		Acquisto, Nicole/0000-0002-7649-9624			[Anonymous], WOLT KLUW CLIN DRUG; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Chan CM, 2012, CRIT CARE MED, V40, P2945, DOI 10.1097/CCM.0b013e31825fec26; Choi YF, 2004, EMERG MED J, V21, P700, DOI 10.1136/emj.2002.004143; Edwin SB, 2010, ANN PHARMACOTHER, V44, P1307, DOI 10.1345/aph.1M664; El-Orbany M, 2010, ANESTH ANALG, V110, P1318, DOI 10.1213/ANE.0b013e3181d5ae47; Hildreth AN, 2008, J TRAUMA, V65, P573, DOI 10.1097/TA.0b013e31818255e8; Ingrande J, 2010, BRIT J ANAESTH, V105, pI16, DOI 10.1093/bja/aeq312; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jacoby J, 2006, ANN EMERG MED, V47, P525, DOI 10.1016/j.annemergmed.2005.12.009; Kendrick DB, 2009, PEDIATR EMERG CARE, V25, P393, DOI 10.1097/PEC.0b013e3181a7923b; Korinek JD, 2014, EUR J EMERG MED, V21, P206, DOI 10.1097/MEJ.0b013e3283606b89; LIGIER B, 1991, SURG GYNECOL OBSTET, V173, P477; Mace SE, 2008, EMERG MED CLIN N AM, V26, P1043, DOI 10.1016/j.emc.2008.10.002; McPhee LC, 2013, CRIT CARE MED, V41, P774, DOI 10.1097/CCM.0b013e318274190d; Patanwala AE, 2014, ACAD EMERG MED, V21, P87, DOI 10.1111/acem.12292; Patanwala AE, 2011, ACAD EMERG MED, V18, P11, DOI 10.1111/j.1553-2712.2010.00954.x; Silber SH, 1997, AM J EMERG MED, V15, P263, DOI 10.1016/S0735-6757(97)90010-3; Zelicof-Paul A, 2005, CURR OPIN PEDIATR, V17, P355, DOI 10.1097/01.mop.0000162365.64140.b7	19	14	15	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	JUN	2018	45						65	70		10.1016/j.jcrc.2018.01.017			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4VX	WOS:000432695500011	29413725				2022-02-06	
J	Maggio, MG; De Luca, R; Torrisi, M; De Cola, MC; Buda, A; Rosano, M; Visani, E; Pidala, A; Bramanti, P; Calabro, RS				Maggio, Maria Grazia; De Luca, Rosaria; Torrisi, Michele; De Cola, Maria Cristina; Buda, Antonio; Rosano, Mariagrazia; Visani, Enrico; Pidala, Alessandra; Bramanti, Placido; Calabro, Rocco Salvatore			Is there a correlation between family functioning and functional recovery in patients with acquired brain injury? An exploratory study	APPLIED NURSING RESEARCH			English	Article						Acquired brain injury; Caregiver burden; Family functioning	HEALTH	Background Acquired Brain injury (ABI) is a very critical event in a family, as it is a highly distressing and traumatic experience, imposing a very deep reorganization of the whole family. Objective: This study aims to evaluate the possible correlation between the family aspects and the patients' functional outcomes after rehabilitation. Methods: Fifteen patient-caregiver pairs were enrolled in the study. All the patients were assessed by using specific neuropsychological and functional scales, including the Family Adaptability and Cohesion Evaluation Scales, before and after treatment. Results: The results reveal that when the caregiver is the son or the spouse (p = 0,71), the perception of the emotional and physical burden is stronger, while the scores related to the burden were lower in the presence of other kinds of relationship. The family functioning seems to be connected to the burden level for the caregivers. Furthermore, there is a significant correlation between the improvements observed in the patients during their rehabilitative training and the family dynamics. Conclusions: in our opinion, the family plays a key role in allowing a suitable compliance of the patient to the treatments, and supports the processes of adaptive reorganization.	[Maggio, Maria Grazia; De Luca, Rosaria; Torrisi, Michele; De Cola, Maria Cristina; Buda, Antonio; Pidala, Alessandra; Bramanti, Placido; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy; [Rosano, Mariagrazia] Italian Inst Relat Psychotherapy IIPR, Messina, Italy; [Visani, Enrico] Italian Inst Relat Psychotherapy IIPR, Rome, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy.	salbro77@tiscali.it	calabro, rocco salvatore/L-9570-2019; De Cola, Maria C/B-7714-2017; Maggio, Maria Grazia/ABA-1852-2020; Bramanti, Placido/K-5117-2016; Calabro, Rocco S/K-7520-2016	calabro, rocco salvatore/0000-0002-8566-3166; De Cola, Maria C/0000-0002-7509-3833; /0000-0003-0757-2389			DELUCA R, 2016, NEUROPSYCHOL REHABIL, V25, P1, DOI DOI 10.1080/09602011.2016.1211937; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; JACKSON DD, 1966, ARCH GEN PSYCHIAT, V15, P410; Kreutzer JS, 2016, NEUROREHABILITATION, V38, P271, DOI 10.3233/NRE-161318; Leathem J, 1996, BRAIN INJURY, V10, P27; Leibach GG, 2014, NEUROREHABILITATION, V34, P167, DOI 10.3233/NRE-131013; Loriedo C, 2004, FACES 4 MODELLO CIRC; Maitz E., 1990, PSYCHOSOCIAL SEQUELA; MINUCHIN S, 1979, J AM ACAD CHILD PSY, V18, P76, DOI 10.1016/S0002-7138(09)60479-9; Moi G., 2013, RIV I PSICOTERAPIA S, V3; OLSON DH, 1983, FAM PROCESS, V22, P69, DOI 10.1111/j.1545-5300.1983.00069.x; Onnis L., 2002, MED FAMIGLIA COMUNIT; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; PATTERSON JM, 1994, FAM PROCESS, V33, P287, DOI 10.1111/j.1545-5300.1994.00287.x; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Rolland J. S., 2002, J FAM THER, V21, P242; Rolland JS, 2005, FAM PROCESS, V44, P283, DOI 10.1111/j.1545-5300.2005.00060.x; Rolland JS, 1994, FAMILIES ILLNESS DIS; Rolland JS, 2011, NORMAL FAMILY PROCES; Scabini Eugenia, 1985, ORG FAMIGLIA TRA CRI; Selvini Palazzoli M., 2006, ANORESSIA MENTALE DA; Walsh F, 2003, FAM PROCESS, V42, P1, DOI 10.1111/j.1545-5300.2003.00001.x	22	14	14	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0897-1897	1532-8201		APPL NURS RES	Appl. Nurs. Res.	JUN	2018	41						11	14		10.1016/j.apnr.2018.03.005			4	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	GJ5NB	WOS:000435427100003	29853207				2022-02-06	
J	Murray, GD; Brennan, PM; Teasdale, GM				Murray, Gordon D.; Brennan, Paul M.; Teasdale, Graham M.			Simplifying the use of prognostic information in traumatic brain injury. Part 2: Graphical presentation of probabilities	JOURNAL OF NEUROSURGERY			English	Article						Glasgow Coma Scale; head injury; traumatic brain injury; trauma; prognosis; charts	SEVERE HEAD-INJURY; RISK PREDICTION MODELS; COMA SCALE SCORE; COMPUTERIZED-TOMOGRAPHY; DECOMPRESSIVE CRANIECTOMY; OUTCOME PREDICTION; CLASSIFICATION; IMPACT; VALIDATION; MANAGEMENT	OBJECTIVE Clinical features such as those included in the Glasgow Coma Scale (GCS) score, pupil reactivity, and patient age, as well as CT findings, have clear established relationships with patient outcomes due to neurotrauma. Nevertheless, predictions made from combining these features in probabilistic models have not found a role in clinical practice. In this study, the authors aimed to develop a method of displaying probabilities graphically that would be simple and easy to use, thus improving the usefulness of prognostic information in neurotrauma. This work builds on a companion paper describing the GCS-Pupils score (GCS-P) as a tool for assessing the clinical severity of neurotrauma. METHODS Information about early GCS score, pupil response, patient age, CT findings, late outcome according to the Glasgow Outcome Scale, and mortality were obtained at the individual adult patient level from the CRASH (Corticosteroid Randomisation After Significant Head Injury; n = 9045) and IMPACT (International Mission for Prognosis and Clinical Trials in TBI; n = 6855) databases. These data were combined into a pooled data set for the main analysis. Logistic regression was first used to model the combined association between the GCS-P and patient age and outcome, following which CT findings were added to the models. The proportion of variability in outcomes "explained" by each model was assessed using Nagelkerke's R-2. RESULTS The authors observed that patient age and GCS-P have an additive effect on outcome. The probability of mortality 6 months after neurotrauma is greater with increasing age, and for all age groups the probability of death is greater with decreasing GCS-P. Conversely, the probability of favorable recovery becomes lower with increasing age and lessens with decreasing GCS-P. The effect of combining the GCS-P with patient age was substantially more informative than the GCS-P, age, GCS score, or pupil reactivity alone. Two-dimensional charts were produced displaying outcome probabilities, as percentages, for 5-year increments in age between 15 and 85 years, and for GCS-Ps ranging from 1 to 15; it is readily seen that the movement toward combinations at the top right of the charts reflects a decreasing likelihood of mortality and an increasing likelihood of favorable outcome. Analysis of CT findings showed that differences in outcome are very similar between patients with or without a hematoma, absent cisterns, or subarachnoid hemorrhage. Taken in combination, there is a gradation in risk that aligns with increasing numbers of any of these abnormalities. This information provides added value over age and GCS-P alone, supporting a simple extension of the earlier prognostic charts by stratifying the original charts in the following 3 CT groupings: none, only 1, and 2 or more CT abnormalities. CONCLUSIONS The important prognostic features in neurotrauma can be brought together to display graphically their combined effects on risks of death or on prospects for independent recovery. This approach can support decision making and improve communication of risk among health care professionals, patients, and their relatives. These charts will not replace clinical judgment, but they will reduce the risk of influences from biases.	[Murray, Gordon D.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Brennan, Paul M.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Teasdale, Graham M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland		Murray, GD (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Sch Med, Edinburgh, Midlothian, Scotland.	gordon.murray@ed.ac.uk		Brennan, Paul/0000-0002-7347-830X			BARLOW P, 1986, NEUROSURGERY, V19, P989, DOI 10.1227/00006123-198612000-00014; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRAHAMS D, 1989, LANCET, V2, P632; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Brust-Renck Priscila G, 2013, Rev Hum Factors Ergon, V8, P235; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Corbett W, 1987, MED APPL MICROCOMPUT; Counsell C, 2001, CEREBROVASC DIS, V12, P159, DOI 10.1159/000047699; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Garcia-Retamero R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00932; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Latronico N, 2015, CRIT CARE MED, V43, P505, DOI 10.1097/CCM.0000000000000795; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moore NA, 2013, BRIT J NEUROSURG, V27, P340, DOI 10.3109/02688697.2012.754402; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	54	14	14	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2018	128	6					1621	1634		10.3171/2017.12.JNS172782			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GP2IM	WOS:000440653000003	29631517	Green Submitted, Bronze			2022-02-06	
J	Terry, DP; Miller, LS				Terry, Douglas P.; Miller, L. Stephen			Repeated mild traumatic brain injuries is not associated with volumetric differences in former high school football players	BRAIN IMAGING AND BEHAVIOR			English	Article						Concussion; Mild traumatic brain injury; MRI; Brain volume; Atrophy; Cognition	HEAD-INJURY; NEUROCOGNITIVE PERFORMANCE; INTRACRANIAL VOLUME; ALZHEIMERS-DISEASE; AXONAL DAMAGE; CONCUSSION; ABNORMALITIES; ATROPHY; SEGMENTATION; DISORDER	We investigated potential brain volumetric differences in a sample of former high school football players many years after these injuries. Forty community-dwelling males ages 40-65 who played high school football, but not college or professional sports, were recruited. The experimental group (n = 20) endorsed experiencing two or more mTBIs on an empirically validated mTBI assessment tool (median = 3, range = 2-15). The control group (n = 20) denied ever experiencing an mTBI. Participants completed a self-report index of current mTBI symptomatology and underwent high-resolution T1-weighted MRI scanning, which were analyzed using the Freesurfer software package. A priori regions of interest (ROIs) included total intracranial volume (ICV), total gray matter, total white matter, bilateral anterior cingulate cortex, bilateral hippocampi, and lateral ventricles. ROIs were corrected for head size using a normalization method that took ICV into account. Despite an adequate sample size and being matched on age, education, estimated premorbid IQ, current concussive symptomatology, there were no statistically significant volumetric group differences across all of the ROIs. These data suggest that multiple mTBIs from high school football may not be associated with measurable brain atrophy later in life. Accounting for the severity of injury and chronicity of sport exposure may be especially important when measuring long-term neuroanatomical differences.	[Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Network, Boston, MA USA; [Terry, Douglas P.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA; [Miller, L. Stephen] Univ Georgia, Dept Psychol, 110 Hooper St,Psychol Bldg,Room 163, Athens, GA 30602 USA; [Miller, L. Stephen] Univ Georgia, Biomed & Hlth Sci Inst, BioImaging Res Ctr, Athens, GA 30602 USA		Miller, LS (corresponding author), Univ Georgia, Dept Psychol, 110 Hooper St,Psychol Bldg,Room 163, Athens, GA 30602 USA.; Miller, LS (corresponding author), Univ Georgia, Biomed & Hlth Sci Inst, BioImaging Res Ctr, Athens, GA 30602 USA.	dterry@mgh.harvard.edu; lsmiller@uga.edu			John and Mary Franklin Foundation; University of Georgia BioImaging Research Center	This study was funded by partial support to D.P. Terry by the John and Mary Franklin Foundation and the University of Georgia BioImaging Research Center.	Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Canu E, 2010, J ALZHEIMERS DIS, V19, P963, DOI 10.3233/JAD-2010-1295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; CDC, 2010, INJ PREV CONTR TRAUM; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Du AT, 2006, NEUROBIOL AGING, V27, P733, DOI 10.1016/j.neurobiolaging.2005.03.021; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; Gioia G, 2006, ACUTE CONCUSSION EVA; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Head D, 2008, NEUROPSYCHOLOGY, V22, P491, DOI 10.1037/0894-4105.22.4.491; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kendler KS, 2008, PSYCHOL MED, V38, P1001, DOI 10.1017/S0033291707001821; Kramer JH, 2007, NEUROPSYCHOLOGY, V21, P412, DOI 10.1037/0894-4105.21.4.412; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Moffitt TE, 2007, ARCH GEN PSYCHIAT, V64, P651, DOI 10.1001/archpsyc.64.6.651; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Ross DE, 2014, NEUROIMAGE, V102, P565, DOI 10.1016/j.neuroimage.2014.07.043; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Sanfilipo MP, 2004, NEUROIMAGE, V22, P1732, DOI 10.1016/j.neuroimage.2004.03.037; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Terry D. P., 2016, NAT AC NEUR ANN C OC; Terry DP, 2015, ARCH CLIN NEUROPSYCH, V30, P341, DOI 10.1093/arclin/acv020; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Wierenga CE, 2007, NEUROPSYCHOL REV, V17, P127, DOI 10.1007/s11065-007-9025-y; Wilde EA, 2016, BRAIN INJURY, V30, P1442, DOI 10.1080/02699052.2016.1219063; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	57	14	14	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2018	12	3					631	639		10.1007/s11682-017-9719-6			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GI6PB	WOS:000434491400002	28434160				2022-02-06	
J	Ouellet, MC; Beaulieu-Bonneau, S; Sirois, MJ; Savard, J; Turgeon, AF; Moore, L; Swaine, B; Roy, J; Giguere, M; Laviolette, V				Ouellet, Marie-Christine; Beaulieu-Bonneau, Simon; Sirois, Marie-Josee; Savard, Josee; Turgeon, Alexis F.; Moore, Lynne; Swaine, Bonnie; Roy, Joanne; Giguere, Myriam; Laviolette, Valerie			Depression in the First Year after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						depression; longitudinal cohort study; mental health; mood disorders; traumatic brain injury	PSYCHIATRIC-DISORDERS; MINOR DEPRESSION; MILD; PREDICTORS; SYMPTOMS; MODERATE; TRAJECTORIES; IMPAIRMENT; AWARENESS; DISTRESS	The aims of this study were to document the frequency of major and minor depressive episodes in the first year after traumatic brain injury (TBI), taking into account TBI severity and pre-morbid history of major depression, and to describe trajectories of depressive episodes. Participants were 227 adults who were hospitalized post-TBI (76% male; mean age=41 years; 50% mild, 33% moderate, and 17% severe TBI). Major and minor depressive episodes were assessed with the Mini International Neuropsychiatric Interview at three time points (4, 8, and 12 months after TBI). Overall, 29% of participants had a major depressive episode in at least one of the three assessments, with fairly stable rates across assessments. Participants with mild TBI were more likely than those with moderate/severe TBI to be diagnosed with major depression, as were individuals with a positive pre-morbid history of depression compared to those without such history. In addition, 13% of participants had a minor depressive episode in at least one of the three assessments. Rates of minor depression significantly decreased from 4 to 8-12 months post-injury. Results also revealed a wide variety of trajectories of depressive episodes across assessments. Of note, 52% of major depression cases still fulfilled diagnostic criteria 4 months later, whereas 38% of minor depression cases deteriorated to major depression at the following assessment. These findings suggest that depression is highly prevalent after TBI, and monitoring of patients with subthreshold depressive symptoms is warranted in order to prevent the development of full-blown major depressive episodes.	[Ouellet, Marie-Christine; Beaulieu-Bonneau, Simon; Giguere, Myriam; Laviolette, Valerie] CIRRIS, H-1608,525 Blvd Hamel, Quebec City, PQ G1M 2S8, Canada; [Ouellet, Marie-Christine; Beaulieu-Bonneau, Simon; Savard, Josee; Laviolette, Valerie] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Ouellet, Marie-Christine; Sirois, Marie-Josee; Savard, Josee; Turgeon, Alexis F.; Moore, Lynne] Univ Laval, CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada; [Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada; [Swaine, Bonnie] Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ, Canada; [Swaine, Bonnie] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Roy, Joanne] Univ Laval, CHU Quebec, Quebec City, PQ, Canada		Ouellet, MC (corresponding author), CIRRIS, H-1608,525 Blvd Hamel, Quebec City, PQ G1M 2S8, Canada.	marie-christine.ouellet@psy.ulaval.ca		Beaulieu-Bonneau, Simon/0000-0002-9544-5023; Ouellet, Marie-Christine/0000-0003-3477-1893; Sirois, Marie-josee/0000-0001-9775-6960	Fonds de recherche du Quebec Sante (FRQ-S) [16375]	The authors thank all participants who volunteered to take part in the study, Patricia Chabot, RN, and Nancy Lemieux, RN, who identified potential participants, Andree-Anne Paradis-Giroux, PhD, for coordinating the final part of the data collection, Jean Leblond, PhD, for statistical advice, the graduate students who conducted interviews (Sarah Lavoie-Dugre, DPsy, Guillaume Lamontagne, DPsy, Danielle Tessier, DPsy, Alexandra Champoux-Tremblay, DPsy, and Stephanie Ropars, DPsy), and the undergraduate students who collaborated with data entry. This study was supported by a grant from the Fonds de recherche du Quebec Sante (FRQ-S; 16375).	Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2010, IBM SPSS STAT WIND V; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bulloch AGM, 2015, GEN HOSP PSYCHIAT, V37, P507, DOI 10.1016/j.genhosppsych.2015.06.007; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Demakis GJ, 2010, APPL NEUROPSYCHOL, V17, P183, DOI 10.1080/09084282.2010.499752; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann Jesse, 2013, Arch Phys Med Rehabil, V94, P801, DOI 10.1016/j.apmr.2012.04.001; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Ghisletta P, 2004, J EDUC BEHAV STAT, V29, P421, DOI 10.3102/10769986029004421; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gwet KL, 2008, BRIT J MATH STAT PSY, V61, P29, DOI 10.1348/000711006X126600; Hardeveld F, 2010, ACTA PSYCHIAT SCAND, V122, P184, DOI 10.1111/j.1600-0447.2009.01519.x; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hegel MT, 2006, GEN HOSP PSYCHIAT, V28, P205, DOI 10.1016/j.genhosppsych.2006.02.008; Jean-Bay E, 2000, J Neurosci Nurs, V32, P169; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Mah K, 2018, DISABIL REHABIL, V40, P960, DOI 10.1080/09638288.2016.1277402; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; Ministere de la sante et des services sociaux du Quebec & Societe d'assurance automobile du Quebec, 2005, OR MIN TRAUM CRAN LE; National Institute for Health and Care Excellence (NICE), 2009, CLIN GUID; Pearson C., 2013, MENTAL SUBSTANCE USE; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Seel R., 2010, US NEUROL, V6, P41; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; TEASDALE G, 1974, LANCET, V2, P81; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; von Holst H., 2004, J REHABIL MED, V43, P1650; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7	49	14	15	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1620	1629		10.1089/neu.2017.5379		MAY 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000432679100001	29566597				2022-02-06	
J	Piro, JR; Suidan, GL; Quan, J; Pi, YQ; O'Neill, SM; Ilardi, M; Pozdnyakov, N; Lanz, TA; Xi, HL; Bell, RD; Samad, TA				Piro, Justin R.; Suidan, Georgette L.; Quan, Jie; Pi, YeQing; O'Neill, Sharon M.; Ilardi, Marissa; Pozdnyakov, Nikolay; Lanz, Thomas A.; Xi, Hualin; Bell, Robert D.; Samad, Tarek A.			Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Monoacylglycerol lipase; 2-arachidonoylglycerol; Neuroinflammation; Blood-brain barrier; Neurovasculature	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MATRIX METALLOPROTEINASES; ISCHEMIC-STROKE; ENDOCANNABINOID SYSTEM; BACTERIAL-MENINGITIS; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; SPINAL-CORD; MOUSE MODEL	Background: Acute neurological insults caused by infection, systemic inflammation, ischemia, or traumatic injury are often associated with breakdown of the blood-brain barrier (BBB) followed by infiltration of peripheral immune cells, cytotoxic proteins, and water. BBB breakdown and extravasation of these peripheral components into the brain parenchyma result in inflammation, oxidative stress, edema, excitotoxicity, and neurodegeneration. These downstream consequences of BBB dysfunction can drive pathophysiological processes and play a substantial role in the morbidity and mortality of acute and chronic neurological insults, and contribute to long-term sequelae. Preserving or rescuing BBB integrity and homeostasis therefore represents a translational research area of high therapeutic potential. Methods: Induction of general and localized BBB disruption in mice was carried out using systemic administration of LPS and focal photothrombotic ischemic insult respectively, in the presence and absence of the monoacylglycerol lipase (MAGL) inhibitor, CPD-4645. The effects of CPD-4645 treatment were assessed by gene expression analysis performed on neurovascular-enriched brain fractions, cytokine and inflammatory mediator measurement, and functional assessment of BBB permeability. The mechanism of action of CPD-4645 was studied pharmacologically using inverse agonists/antagonists of the cannabinoid receptors CB1 and CB2. Results: Here, we demonstrate that the neurovasculature exhibits a unique transcriptional signature following inflammatory insults, and pharmacological inhibition of MAGL using a newly characterized inhibitor rescues the transcriptional profile of brain vasculature and restores its functional homeostasis. This pronounced effect of MAGL inhibition on blood-brain barrier permeability is evident following both systemic inflammatory and localized ischemic insults. Mechanistically, the protective effects of the MAGL inhibitor are partially mediated by cannabinoid receptor signaling in the ischemic brain insult. Conclusions: Our results support considering MAGL inhibitors as potential therapeutics for BBB dysfunction and cerebral edema associated with inflammatory brain insults.	[Piro, Justin R.; Suidan, Georgette L.; Quan, Jie; Pi, YeQing; O'Neill, Sharon M.; Ilardi, Marissa; Pozdnyakov, Nikolay; Lanz, Thomas A.; Xi, Hualin; Bell, Robert D.; Samad, Tarek A.] Pfizer Worldwide Res & Dev, Cambridge, MA 02139 USA; [Piro, Justin R.; Xi, Hualin] Abbvie Inc, 200 Sidney St, Cambridge, MA 02139 USA; [Suidan, Georgette L.; Pi, YeQing; O'Neill, Sharon M.; Lanz, Thomas A.] Biogen, 225 Binney St, Cambridge, MA 02142 USA; [Ilardi, Marissa] NYU, Sch Med, 550 1St Ave, New York, NY 10016 USA; [Samad, Tarek A.] Sanofi R&D, 49 New York Ave, Framingham, MA 01701 USA		Piro, JR; Samad, TA (corresponding author), Pfizer Worldwide Res & Dev, Cambridge, MA 02139 USA.	JPiro1000@gmail.com; samad.tarek@gmail.com		Lanz, Thomas/0000-0003-2483-3122	Pfizer Global ResearchPfizer	This work was supported by Pfizer Global Research.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Bahr BA, 2006, EXPERT OPIN INV DRUG, V15, P351, DOI 10.1517/13543784.15.4.351; Bales KR, 2016, BRAIN, V139, P563, DOI 10.1093/brain/awv313; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Boroujerdi A, 2013, EXP NEUROL, V250, P43, DOI 10.1016/j.expneurol.2013.09.009; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Cross AK, 2006, BRAIN RES, V1088, P19, DOI 10.1016/j.brainres.2006.02.136; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; Erickson MA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-150; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Gottschall PE, 2015, MATRIX BIOL, V44-46, P70, DOI 10.1016/j.matbio.2015.01.014; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Jaeger LB, 2009, BRAIN BEHAV IMMUN, V23, P507, DOI 10.1016/j.bbi.2009.01.017; Jin AY, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-12; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Kisucka J, 2009, BLOOD, V113, P6015, DOI 10.1182/blood-2008-10-186650; Lapilover EG, 2012, NEUROBIOL DIS, V48, P495, DOI 10.1016/j.nbd.2012.06.024; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lemarchant S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-133; Leppert D, 2000, CLIN INFECT DIS, V31, P80, DOI 10.1086/313922; Leppert D, 2001, BRAIN RES REV, V36, P249, DOI 10.1016/S0165-0173(01)00101-1; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Nygardas PT, 2002, CLIN EXP IMMUNOL, V128, P245, DOI 10.1046/j.1365-2249.2002.01855.x; Palasik W, 2005, EUR NEUROL, V53, P188, DOI 10.1159/000086355; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Pihlaja R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0305-9; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; Rieckmann P, 1997, ANN NEUROL, V41, P326, DOI 10.1002/ana.410410307; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roberts J, 2017, J CEREBR BLOOD F MET, V37, P85, DOI 10.1177/0271678X15616979; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Suidan GL, 2013, ARTERIOSCL THROM VAS, V33, P2112, DOI 10.1161/ATVBAHA.113.301362; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Terrone G, 2018, EPILEPSIA, V59, P79, DOI 10.1111/epi.13950; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Wagsater D, 2008, ATHEROSCLEROSIS, V196, P514, DOI 10.1016/j.atherosclerosis.2007.05.018; Westling J, 2004, BIOCHEM J, V377, P787, DOI 10.1042/bj20030896; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P706, DOI 10.1038/jcbfm.2014.247; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	52	14	15	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAY 14	2018	15								142	10.1186/s12974-018-1166-9			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	GF8YA	WOS:000432260900002	29759062	gold, Green Published			2022-02-06	
J	Crichton, A; Anderson, V; Oakley, E; Greenham, M; Hearps, S; Delzoppo, C; Beauchamp, MH; Hutchison, JS; Guerguerian, AM; Boutis, K; Babl, FE				Crichton, Alison; Anderson, Vicki; Oakley, Ed; Greenham, Mardee; Hearps, Stephen; Delzoppo, Carmel; Beauchamp, Miriam H.; Hutchison, James S.; Guerguerian, Anne-Marie; Boutis, Kathy; Babl, Franz E.		Biomarker Quality Life Children	Fatigue Following Traumatic Brain Injury in Children and Adolescents: A Longitudinal Follow-Up 6 to 12 Months After Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescent; brain injuries; child; fatigue; longitudinal studies; preschool child; sleep-wake disorders	QUALITY-OF-LIFE; SICKLE-CELL-DISEASE; MINOR HEAD-INJURY; MULTIDIMENSIONAL FATIGUE; PEDIATRIC-PATIENTS; RELIABILITY; PEDSQL(TM); SCALE; CONCUSSION; PREDICTION	Background: Longitudinal fatigue data in children suffering from traumatic brain injury (TBI) are lacking. Objectives: To examine the effects of time postinjury (6-12 months) and injury severity on fatigue after childhood TBI. Secondarily, we compared fatigue 12 months postinjury against published control data. Setting: Three tertiary children's hospitals across Australia (n = 1) and Canada (n = 2). Participants: Parents (n = 109) of children (mean [M] = 9.9 years at injury; range, 1.0-16.9 years) admitted to one of 3 participating hospitals with mild (n = 69) or moderate/severe (n = 37) TBI. Design: Longitudinal prospective study. Measures:Primary: Pediatric Quality of Life Multidimensional Fatigue Scale (total, general, sleep/rest, and cognitive), rated by parents 6 and 12 months postinjury. Secondary: Pediatric Injury Functional Outcome Scale (fatigue and sleep items, rated on recruitment and 6 and 12 months postinjury). Demographic and children data were collected at recruitment. Results: Mixed-models analysis demonstrated nonsignificant effects of time (6 vs 12 months postinjury) on multidimensional fatigue scores. Cognitive fatigue worsened over time. Moderate/severe TBI was associated with worse fatigue 12 months postinjury (general, P = .03; cognitive, P = .02). Across all severities, fatigue 12 months postinjury was significantly worse compared with control data (total fatigue, P < .001; all domains, all Ps < .025). Conclusion: Fatigue remains significant at 12 months since injury, particularly for those with moderate/severe TBI.	[Crichton, Alison; Anderson, Vicki; Oakley, Ed; Greenham, Mardee; Delzoppo, Carmel; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Crichton, Alison] Monash Childrens, Victorian Peadiat Rehabil Serv, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Dept Psychol, Melbourne, Vic, Australia; [Crichton, Alison; Greenham, Mardee] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.] Univ Melbourne, Dept Peadiat, Melbourne, Vic, Australia; [Oakley, Ed; Delzoppo, Carmel; Babl, Franz E.] RCH, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Hutchison, James S.; Guerguerian, Anne-Marie] Hosp Sick Children HSK, Neurosci & Mental Hlth Res Program, Toronto, ON, Canada; [Hutchison, James S.; Guerguerian, Anne-Marie; Boutis, Kathy] Hosp Sick Children HSK, Toronto, ON, Canada; [Hutchison, James S.; Boutis, Kathy] Univ Toronto, Toronto, ON, Canada		Crichton, A (corresponding author), Murdoch Childrens Res Inst, Crit Care & Neurosci Theme, 50 Flemington Rd, Parkville, Vic 3052, Australia.	ali.crichton@mcri.edu.au	Greenham, Mardee/AAR-1711-2020; Hearps, Stephen/L-6853-2016	Hearps, Stephen/0000-0003-2984-1172	Ontario Neurotrauma Foundation, Toronto, Canada; Victorian Neurotrauma Initiative, Melbourne, Australia; Moving Ahead Seed Grant; National Health and Medical Research Council Postgraduate Scholarship, Canberra, Australia [GNT 1075048]; Neurosciences Victoria Brain and Mind Scholarship, Melbourne, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; National Health and Medical Research Council Centre for Research Excellence Grant in Paediatric Emergency Medicine, Canberra, Australia; Royal Children's Hospital Foundation grant	This work is supported by a jointly awarded grant from The Ontario Neurotrauma Foundation, Toronto, Canada, and The Victorian Neurotrauma Initiative, Melbourne, Australia (Vicki Anderson and Jamie Hutchison, awarded 2011); a Moving Ahead Seed Grant (Alison Crichton, awarded 2012); a National Health and Medical Research Council Postgraduate Scholarship, Canberra, Australia (Alison Crichton, awarded 2014, GNT 1075048); a Neurosciences Victoria Brain and Mind Scholarship, Melbourne, Australia (Alison Crichton, awarded 2012); the Victorian Government's Infrastructure Support Program, Melbourne, Australia, and in part funded by a National Health and Medical Research Council Centre for Research Excellence Grant in Paediatric Emergency Medicine, Canberra, Australia. Franz E. Babl was in part funded by a Royal Children's Hospital Foundation grant.	Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Briggs-Gowan M., 2006, BRIEF INFANT TODDLER; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; CARTER BD, 1995, PEDIATRICS, V95, P179; CHAPMAN SB, 2007, BRAIN INJ PROF, V3, P10; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chiang YC, 2008, CANCER NURS, V31, pE1, DOI 10.1097/01.NCC.0000305732.03464.29; Cohen J., 2013, STAT POWER ANAL BEHA; Crichton A, 2015, PEDIATRICS, V135, pE1015, DOI 10.1542/peds.2014-2440; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Dampier C, 2010, PEDIATR BLOOD CANCER, V55, P485, DOI 10.1002/pbc.22497; Eddy L, 2007, J SPEC PEDIATR NURS, V12, P105, DOI 10.1111/j.1744-6155.2007.00099.x; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Falk AC, 2013, SCAND J CARING SCI, V27, P51, DOI 10.1111/j.1471-6712.2012.00999.x; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gold JI, 2009, CLIN J PAIN, V25, P407, DOI 10.1097/AJP.0b013e318192bfb1; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hilger T, 2009, ADV CLIN EXP MED, V18, P169; Hinds PS, 2013, PEDIATR BLOOD CANCER, V60, P402, DOI 10.1002/pbc.24233; Holland AA, 2014, CHILD NEUROPSYCHOL, V20, P71, DOI 10.1080/09297049.2012.748888; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Jonsson CCA, 2014, INT J REHABIL RES, V37, P317, DOI 10.1097/MRR.0000000000000073; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; MacAllister WS, 2009, MULT SCLER J, V15, P1502, DOI 10.1177/1352458509345902; Meeske K, 2004, CANCER, V101, P2116, DOI 10.1002/cncr.20609; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Nagane M, 2004, PSYCHOL REP, V95, P48, DOI 10.2466/PR0.95.5.48-52; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Overweg-Plandsoen WCG, 1999, EUR J PEDIATR, V158, P249, DOI 10.1007/s004310051061; Palmer SN, 2007, PEDIATR BLOOD CANCER, V49, P287, DOI 10.1002/pbc.21026; Panepinto JA, 2014, PEDIATR BLOOD CANCER, V61, P171, DOI 10.1002/pbc.24776; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Ryan NP, 2016, CORTEX, V83, P222, DOI 10.1016/j.cortex.2016.07.020; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Selewski DT, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-29; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Sumpter R, 2011, BRAIN INJURY, V25, P1288, DOI 10.3109/02699052.2011.613090; Taylor H. G., 2010, PEDIAT TRAUMATIC BRA, P145; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	56	14	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					200	209		10.1097/HTR.0000000000000330			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500125	28926479				2022-02-06	
J	Dobney, DM; Grilli, L; Kocilowicz, H; Beaulieu, C; Straub, M; Friedman, D; Gagnon, IJ				Dobney, Danielle M.; Grilli, Lisa; Kocilowicz, Helen; Beaulieu, Christine; Straub, Meghan; Friedman, Debbie; Gagnon, Isabelle J.			Is There an Optimal Time to Initiate an Active Rehabilitation Protocol for Concussion Management in Children? A Case Series	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain concussion; exercise therapy; mild traumatic brain injury; postconcussion syndrome	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; POSTCONCUSSION SYNDROME; EXERCISE; ADOLESCENTS; RECOVERY; IMPAIRMENT; SYMPTOMS; OUTCOMES; ANXIETY	Objective: To estimate the time frame during which initiating an active rehabilitation intervention (aerobic exercise, balance, and sport specific skills) after concussion contributed to improvement in symptoms at follow-up in children and adolescents who are slow to recover (symptoms persisting beyond 2 weeks) from concussion. Setting: Concussion clinic at a tertiary care pediatric teaching hospital. Participants: A total of 677 children and adolescents with concussion aged 7 to 18 years. Design: Case series of participants starting active rehabilitation less than 2, 2, 3, 4, 5, or 6 or more weeks postconcussion. Main Measure: Symptom severity measured by the 22-item Post-Concussion Scale (PCS)-revised. Results: All patients experienced significant improvement of symptoms while participating in active rehabilitation, irrespective of the start time postonset. Patients initiating active rehabilitation at 2 (P < .001) or 3 (P = .039) weeks postinjury demonstrated lower symptom severity at follow-up than those starting at 6 weeks or later. Patients starting at 2 weeks had lower symptom severity than patients starting less than 2 (P = .02), 4 (P = .20), or 5 weeks postinjury (P = .04). Lastly, patients starting less than 2 and 6 weeks or more postinjury yielded equivalent outcomes. Conclusions: The findings support the use of active rehabilitation in children and adolescents who are slow to recover from concussion. Participants starting active rehabilitation less than 2 weeks and up to 6 or more weeks postconcussion demonstrated significant symptom improvements, but improvement was observed in all groups, regardless of the time to start active rehabilitation.	[Dobney, Danielle M.; Gagnon, Isabelle J.] McGill Univ, Sch Phys & Occupat Therapy, Fac Med, Montreal, PQ H3G 1Y5, Canada; [Grilli, Lisa; Kocilowicz, Helen; Beaulieu, Christine; Straub, Meghan; Friedman, Debbie; Gagnon, Isabelle J.] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Ctr Trauma, Montreal, PQ, Canada; [Friedman, Debbie] Publ Hlth Agcy Canada, Canadian Hosp Injury Reporting & Prevent Program, Montreal, PQ, Canada; [Friedman, Debbie; Gagnon, Isabelle J.] McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada		Dobney, DM (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, Fac Med, Montreal, PQ H3G 1Y5, Canada.	danielle.dobney@mail.mcgill.ca		Gagnon, Isabelle/0000-0003-2043-1644	Montreal Children's Hospital Trauma Program; Research Institute of the McGill University Health Center; Fonds de recherche du Quebec-Sante (FRQS); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	We would like to thank the children and their families for participating in this study and The Montreal Children's Hospital Trauma Program professionals for their support. As well, we wish to thank the Research Institute of the McGill University Health Center for its support of this research.; Supported by Fonds de recherche du Quebec-Sante (FRQS) and Canadian Institutes of Health Research (CIHR).	Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Berlin AA, 2006, PSYCHOSOM MED, V68, P224, DOI 10.1097/01.psy.0000204628.73273.23; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Imhoff Sarah, 2016, J Sports Med (Hindawi Publ Corp), V2016, P5127374, DOI 10.1155/2016/5127374; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McCrory P, 2009, S AFR J SPORTS MED, V21; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; PETRUZZELLO SJ, 1991, SPORTS MED, V11, P143, DOI 10.2165/00007256-199111030-00002; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Winkler R, 2015, J HEAD TRAUMA REHAB, V30, P324, DOI 10.1097/HTR.0000000000000114	38	14	14	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					E11	E17		10.1097/HTR.0000000000000339			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500002	28926482				2022-02-06	
J	Gu, F; Parada, I; Yang, T; Longo, FM; Prince, DA				Gu, Feng; Parada, Isabel; Yang, Tao; Longo, Frank M.; Prince, David A.			Partial TrkB receptor activation suppresses cortical epileptogenesis through actions on parvalbumin interneurons	NEUROBIOLOGY OF DISEASE			English	Article						Epilepsy; BDNF; Neocortical injury; Trophic; Anti-epileptogenesis	TEMPORAL-LOBE EPILEPSY; EXCITATORY SYNAPTIC-TRANSMISSION; CULTURED HIPPOCAMPAL-NEURONS; IMPAIRED GABAERGIC INHIBITION; ACTIVITY-DEPENDENT REGULATION; FAST-SPIKING INTERNEURONS; RAT VISUAL-CORTEX; NEUROTROPHIC FACTOR; RETT-SYNDROME; MOUSE MODEL	Post-traumatic epilepsy is one of the most common and difficult to treat forms of acquired epilepsy worldwide. Currently, there is no effective way to prevent post-traumatic epileptogenesis. It is known that abnormalities of interneurons, particularly parvalbumin-containing interneurons, play a critical role in epileptogenesis following traumatic brain injury. Thus, enhancing the function of existing parvalbumin interneurons might provide a logical therapeutic approach to prevention of post-traumatic epilepsy. The known positive effects of brain-derived neurotrophic factor on intemeuronal growth and function through activation of its receptor tropomyosin receptor kinase B, and its decrease after traumatic brain injury, led us to hypothesize that enhancing trophic support might improve parvalbumin interneuronal function and decrease epileptogenesis. To test this hypothesis, we used the partial neocortical isolation ('undercut', UC) model of posttraumatic epileptogenesis in mature rats that were treated for 2 weeks, beginning on the day of injury, with LM22A-4, a newly designed partial agonist at the tropomyosin receptor kinase B. Effects of treatment were assessed with Western blots to measure pAKT/AKT; immunocytochemistry and whole cell patch clamp recordings to examine functional and structural properties of GABAergic interneurons; field potential recordings of epileptiform discharges in vitro; and video EEG recordings of PTZ-induced seizures in vivo. Results showed that LM22A-4 treatment 1) increased pyramidal cell perisomatic immunoreactivity for VGAT, GAD65 and parvalbumin; 2) increased the density of close appositions of VGAT/gephyrin immunoreactive puncta (putative inhibitory synapses) on pyramidal cell somata; 3) increased the frequency of mIPSCs in pyramidal cells; and 4) decreased the incidence of spontaneous and evoked epileptiform discharges in vitro. 5) Treatment of rats with PTX BD4-3, another partial TrkB receptor agonist, reduced the incidence of bicuculline-induced ictal episodes in vitro and PTZ induced electrographic and behavioral ictal episodes in vivo. 6) Inactivation of TrkB receptors in undercut TrkB(F616A) mice with 1NMPP1 abolished both LM22A-4-induced effects on mIPSCs and on increased perisomatic VGAT-IR. Results indicate that chronic activation of the tropomyosin receptor kinase B by a partial agonist after cortical injury can enhance structural and functional measures of GABAergic inhibition and suppress posttraumatic epileptogenesis. Although the full agonist effects of brain-derived neurotrophic factor and tropomyosin receptor kinase B activation in epilepsy models have been controversial, the present results indicate that such trophic activation by a partial agonist may potentially serve as an effective therapeutic option for prophylactic treatment of posttraumatic epileptogenesis, and treatment of other neurological and psychiatric disorders whose pathogenesis involves impaired parvalbumin intemeuronal function.	[Gu, Feng; Parada, Isabel; Yang, Tao; Longo, Frank M.; Prince, David A.] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA		Prince, DA (corresponding author), Stanford Med Ctr, 300 Pasteur Dr,Room M016, Stanford, CA 94028 USA.	daprince@stanford.edu			National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS082644, NS039579]; George and Irene Pimley Research Fund; Jean Perkins Foundation	This study was supported by Grants NS082644 and NS039579 from the National Institutes of Neurological Disorders and Stroke (D.A.P), the George and Irene Pimley Research Fund (D. A.P.), and the Jean Perkins Foundation (F.M. L).	Abidin I, 2008, J PHYSIOL-LONDON, V586, P1885, DOI 10.1113/jphysiol.2007.148627; Aguado F, 2003, DEVELOPMENT, V130, P1267, DOI 10.1242/dev.00351; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Aronica E, 2017, EPILEPSIA, V58, P27, DOI 10.1111/epi.13783; Baldelli P, 2005, J NEUROSCI, V25, P3358, DOI 10.1523/JNEUROSCI.4227-04.2005; Baldelli P, 2002, EUR J NEUROSCI, V16, P2297, DOI 10.1046/j.1460-9568.2002.02313.x; Bartolomei F, 2017, EPILEPSIA, V58, P1131, DOI 10.1111/epi.13791; Bausch SB, 2005, EPILEPSY BEHAV, V7, P390, DOI 10.1016/j.yebeh.2005.07.019; Berghuis P, 2006, J NEUROBIOL, V66, P1437, DOI 10.1002/neu.20319; Bolton MM, 2000, J NEUROSCI, V20, P3221, DOI 10.1523/JNEUROSCI.20-09-03221.2000; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Cai ZX, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2016.00129; Carmignoto G, 1997, J PHYSIOL-LONDON, V498, P153, DOI 10.1113/jphysiol.1997.sp021848; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; Chapleau CA, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/578057; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Croll SD, 1999, NEUROSCIENCE, V93, P1491, DOI 10.1016/S0306-4522(99)00296-1; CROLL SD, 1994, EUR J NEUROSCI, V6, P1343, DOI 10.1111/j.1460-9568.1994.tb00325.x; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; DeFelipe J, 1999, BRAIN, V122, P1807, DOI 10.1093/brain/122.10.1807; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; Eftekhari S, 2016, BASIC CLIN NEUROSCI, V7, P115, DOI 10.15412/J.BCN.03070205; Elmariah SB, 2004, J NEUROSCI, V24, P2380, DOI 10.1523/JNEUROSCI.4112-03.2004; Faria LC, 2012, NEUROBIOL DIS, V45, P821, DOI 10.1016/j.nbd.2011.11.006; Faria LC, 2010, J NEUROPHYSIOL, V104, P280, DOI 10.1152/jn.00351.2010; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Giblin KA, 2010, NEUROSCIENTIST, V16, P253, DOI 10.1177/1073858409354385; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Gill R, 2013, EUR J NEUROSCI, V38, P3554, DOI 10.1111/ejn.12367; Glaze DG, 2010, NEUROLOGY, V74, P909, DOI 10.1212/WNL.0b013e3181d6b852; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; Graber KD, 2006, MODELS OF SEIZURES AND EPILEPSY, P477, DOI 10.1016/B978-012088554-1/50040-2; Gu B, 2015, NEURON, V88, P484, DOI 10.1016/j.neuron.2015.09.032; Gu F, 2017, NEUROBIOL DIS, V108, P100, DOI 10.1016/j.nbd.2017.08.008; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; Han J, 2012, STROKE, V43, P1918, DOI 10.1161/STROKEAHA.111.641878; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hashemi E, 2017, CEREB CORTEX, V27, P1931, DOI 10.1093/cercor/bhw021; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; He J, 2005, CELL PHYSIOL BIOCHEM, V16, P69, DOI 10.1159/000087733; Henderson KW, 2014, J NEUROSCI, V34, P13492, DOI 10.1523/JNEUROSCI.0005-14.2014; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Holm MM, 2009, J NEUROSCI, V29, P12412, DOI 10.1523/JNEUROSCI.2978-09.2009; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Jiang B, 2004, EUR J NEUROSCI, V20, P709, DOI 10.1111/j.1460-9568.2004.03523.x; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Jiao YY, 2011, P NATL ACAD SCI USA, V108, P12131, DOI 10.1073/pnas.1105296108; Jin X, 2003, J NEUROSCI, V23, P5662; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang SK, 2015, EUR J NEUROSCI, V42, P2792, DOI 10.1111/ejn.13094; Khoshkhoo S, 2017, NEURON, V93, P291, DOI 10.1016/j.neuron.2016.11.043; Kohara K, 2003, J NEUROSCI, V23, P6123, DOI 10.1523/JNEUROSCI.23-14-06123.2003; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; Kron M, 2014, DIS MODEL MECH, V7, P1047, DOI 10.1242/dmm.016030; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Kuriu T, 2012, MOL CELL NEUROSCI, V49, P184, DOI 10.1016/j.mcn.2011.11.002; Lemtiri-Chlieh F, 2010, J NEUROPHYSIOL, V104, P1923, DOI 10.1152/jn.00472.2010; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Li HF, 2011, NEUROSCI LETT, V497, P172, DOI 10.1016/j.neulet.2011.02.042; Li W, 2017, DIS MODEL MECH, V10, P837, DOI 10.1242/dmm.029959; Li YX, 1998, J NEUROSCI, V18, P10231; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Lippmann K, 2017, J CEREBR BLOOD F MET, V37, P1803, DOI 10.1177/0271678X16652631; Liu GM, 2013, NEURON, V79, P31, DOI 10.1016/j.neuron.2013.04.027; Ma YY, 2012, NEUROBIOL DIS, V47, P102, DOI 10.1016/j.nbd.2012.03.027; Marty S, 1997, TRENDS NEUROSCI, V20, P198, DOI 10.1016/S0166-2236(96)01026-0; Marty S, 1996, J NEUROSCI, V16, P675; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; McNamara J. O., 2012, JASPERS BASIC MECH E; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Numakawa T, 2002, J BIOL CHEM, V277, P6520, DOI 10.1074/jbc.M109139200; Palizvan MR, 2004, NEUROSCIENCE, V126, P955, DOI 10.1016/j.neuroscience.2004.03.053; Paradiso B, 2009, P NATL ACAD SCI USA, V106, P7191, DOI 10.1073/pnas.0810710106; Peng ZC, 2013, J NEUROSCI, V33, P14392, DOI 10.1523/JNEUROSCI.2045-13.2013; Ping XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158231; Pitkanen A., 2012, JASPERS BASIC MECH E, V4th; Prince DA, 2016, PROG BRAIN RES, V226, P209, DOI 10.1016/bs.pbr.2016.03.013; Prince D. A., 2012, JASPERS BASIC MECH E, V4, P315; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Puskarjov M, 2015, NEUROPHARMACOLOGY, V88, P103, DOI 10.1016/j.neuropharm.2014.09.005; Reibel S, 2003, HIPPOCAMPUS, V13, P557, DOI 10.1002/hipo.10110; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Sakata K, 2009, P NATL ACAD SCI USA, V106, P5942, DOI 10.1073/pnas.0811431106; Salin PA, 1996, J NEUROPHYSIOL, V75, P1589, DOI 10.1152/jn.1996.75.4.1589; Sanchez-Munoz I, 2011, BRAIN RES, V1375, P28, DOI 10.1016/j.brainres.2010.12.031; Schmid DA, 2012, J NEUROSCI, V32, P1803, DOI 10.1523/JNEUROSCI.0865-11.2012; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Simmons DA, 2013, J NEUROSCI, V33, P18712, DOI 10.1523/JNEUROSCI.1310-13.2013; Steullet P, 2017, MOL PSYCHIATR, V22, P936, DOI 10.1038/mp.2017.47; Takahashi DK, 2016, NEUROBIOL DIS, V91, P166, DOI 10.1016/j.nbd.2016.03.003; Tripp A, 2012, AM J PSYCHIAT, V169, P1194, DOI 10.1176/appi.ajp.2012.12020248; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Uematsu M, 2008, CEREB CORTEX, V18, P315, DOI 10.1093/cercor/bhm056; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wang XD, 2009, J NEUROSCI, V29, P5508, DOI 10.1523/JNEUROSCI.4288-08.2009; Wardle RA, 2003, J NEUROSCI, V23, P8722; Yu GZ, 2015, INT J CLIN EXP PATHO, V8, P6526; Zhang W, 2009, J NEUROSCI, V29, P7846, DOI 10.1523/JNEUROSCI.6199-08.2009; Zhu WJ, 2001, ANN NEUROL, V50, P188, DOI 10.1002/ana.1074	120	14	15	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	MAY	2018	113						45	58		10.1016/j.nbd.2018.01.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GD6SU	WOS:000430639500005	29408225	hybrid			2022-02-06	
J	Reid, MW; Cooper, DB; Lu, LH; Iverson, GL; Kennedy, JE				Reid, Matthew W.; Cooper, Douglas B.; Lu, Lisa H.; Iverson, Grant L.; Kennedy, Jan E.			Adversity and Resilience Are Associated with Outcome after Mild Traumatic Brain Injury in Military Service Members	JOURNAL OF NEUROTRAUMA			English	Article						military service members; persistent or chronic symptoms; PTSD; stress	POSTTRAUMATIC-STRESS-DISORDER; EARLY-LIFE ADVERSITY; PSYCHOMETRIC PROPERTIES; SOCIAL SUPPORT; UNITED-STATES; PREDICTORS; HEALTH; RISK; PTSD; SYMPTOMS	The objective of this study was to assess the associations between resilience, adversity, post-concussion symptoms, and post-traumatic stress symptom reporting after mild traumatic brain injury (mTBI). We hypothesized that resilience would be associated with less symptom reporting, and adversity would be associated with greater symptom reporting. This was a cross-sectional study of retrospective data collected for an ongoing TBI repository. United States military service members who screened positive for mTBI during a primary care visit completed the Trauma History Screen (THS), Connor-Davidson Resilience Scale (CD-RISC), Neurobehavioral Symptom Inventory (NSI), and post-traumatic stress disorder (PTSD) Checklist-Civilian Version (PCL-C). Data collected from February 2015 to August 2016 were used for the present study. Only participants with complete data for the above measures were included, yielding a sample size of 165 participants. Adversity (THS) and resilience (CD-RISC) scores were each correlated significantly with post-concussion (NSI) and traumatic stress (PCL-C) total and subscale scores in the hypothesized direction. Interactions between adversity and resilience were absent for all measures except the NSI sensory subscale. Four traumatic event types were significantly associated positively with most NSI and PCL-C total and subscale scores, but the age at which traumatic events were first experienced showed few and mixed significant associations. In conclusion, resilience and adversity were significantly associated with symptom endorsement after mTBI. Screening for cumulative adversity may identify individuals at greater risk of developing persistent post-concussion symptoms and/or PTSD, and interventions that increase resilience may reduce symptom severity.	[Reid, Matthew W.; Lu, Lisa H.; Kennedy, Jan E.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Reid, Matthew W.; Lu, Lisa H.; Kennedy, Jan E.] JBSA Ft Sam Houston, Neurol Clin, Ft Sam Houston, TX USA; [Cooper, Douglas B.] Univ Texas Hlth Sci Ctr San Antonio, Def & Vet Brain Injury Ctr, San Antonio Polytrauma Rehabil Ctr, South Texas Vet Hlth Care Syst,Dept Psychiat, San Antonio, TX 78229 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Home Base A Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA		Reid, MW (corresponding author), San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, Neurol Clin, JBSA, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	Matthew.w.reid2.ctr@mail.mil		Iverson, Grant/0000-0001-7348-9570			Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; Ahern NR, 2006, Compr Child Adoles N, V29, P103, DOI 10.1080/01460860600677643; Albrecht A, 2017, NEUROSCI BIOBEHAV R, V74, P21, DOI 10.1016/j.neubiorev.2017.01.005; Amstadter AB, 2014, BRIT J PSYCHIAT, V205, P275, DOI 10.1192/bjp.bp.113.130906; Ashokan A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4928081; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Berens AE, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0895-4; Bezdjian S, 2017, PSYCHOL ASSESSMENT, V29, P479, DOI 10.1037/pas0000370; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bradshaw M, 2017, HEALTH PSYCHOL, V36, P682, DOI 10.1037/hea0000487; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Briere J, 2008, J TRAUMA STRESS, V21, P223, DOI 10.1002/jts.20317; Brown MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065524; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Castro-Vale I, 2016, NEUROSCI BIOBEHAV R, V63, P143, DOI 10.1016/j.neubiorev.2016.02.005; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Doom J.R., 2015, INT ENCY SOCIAL BEHA, V2nd Edn, P577, DOI [10.1016/B978-0-08-097086-8.23012-2, DOI 10.1016/B978-0-08-097086-8.23012-2]; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Fuller-Thomson E, 2009, CANCER, V115, P3341, DOI 10.1002/cncr.24372; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Gonzalez SP, 2016, PSYCHOL SPORT EXERC, V23, P31, DOI 10.1016/j.psychsport.2015.10.005; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Horn SR, 2016, EXP NEUROL, V284, P119, DOI 10.1016/j.expneurol.2016.07.002; Iverson GL., 2012, PTSD MILD TRAUMATIC; Kelly-Irving M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-767; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kittleson MM, 2006, ARCH INTERN MED, V166, P2356, DOI 10.1001/archinte.166.21.2356; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Liu RT, 2015, J ABNORM PSYCHOL, V124, P80, DOI 10.1037/abn0000043; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Mak WWS, 2011, J COUNS PSYCHOL, V58, P610, DOI 10.1037/a0025195; Maniam J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00073; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; May CL, 2016, PSYCHOL TRAUMA-US, V8, P233, DOI 10.1037/tra0000077; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Meyers JE, 2014, APPL NEUROPSYCH-ADUL, V21, P60, DOI 10.1080/09084282.2012.737881; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Nusslock R, 2016, BIOL PSYCHIAT, V80, P23, DOI 10.1016/j.biopsych.2015.05.017; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Raymond C., 2017, PROG NEUROPSYCHOPHAR; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schulz A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00993; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Shields ME, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3491-1; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Szyf M, 2013, CAN J PSYCHIAT, V58, P697, DOI 10.1177/070674371305801208; Tsai J, 2012, PSYCHIATRY, V75, P135, DOI 10.1521/psyc.2012.75.2.135; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Turner RJ, 1995, J HEALTH SOC BEHAV, V36, P360, DOI 10.2307/2137325; van der Kolk BA, 2005, J TRAUMA STRESS, V18, P389, DOI 10.1002/jts.20047; Vasa RA, 2015, BRAIN INJURY, V29, P921, DOI 10.3109/02699052.2015.1005670; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wagnild G. M., 2009, RESILIENCE SCALE USE; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Weiss J M, 1972, Ciba Found Symp, V8, P253; Woodson J., 2015, TRAUMATIC BRAIN INJU; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yehuda R, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.57	85	14	14	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	10					1146	1155		10.1089/neu.2017.5424			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GF8DL	WOS:000432198500006	29357779				2022-02-06	
J	Santos, MM; Qureshi, MM; Budohoski, KP; Mangat, HS; Ngerageza, JG; Scholler, K; Shabani, HK; Zubkov, MR; Hartl, R				Santos, Maria M.; Qureshi, Mubashir M.; Budohoski, Karol P.; Mangat, Halinder S.; Ngerageza, Japhet G.; Schoeller, Karsten; Shabani, Hamisi K.; Zubkov, Micaella R.; Hartl, Roger			The Growth of Neurosurgery in East Africa: Challenges	WORLD NEUROSURGERY			English	Article						Brain drain; Burden of disease; East Africa; Global neurosurgery; Workforce crisis	MIDDLE-INCOME-COUNTRIES; TERTIARY REFERRAL CENTER; TRAUMATIC BRAIN-INJURY; GLOBAL HEALTH; SURGERY; TANZANIA; ANESTHESIA; HOSPITALS; CAPACITY; BURDEN	As the second of 3 articles in this series, the aim of this article is to provide readers with an understanding of the development of neurosurgery in East Africa (foundations), the challenges that arise in providing neurosurgical care in developing countries (challenges), and an overview of traditional and novel approaches to overcoming these challenges and improving health care in the region (innovations). Recognizing the challenges that need to be addressed is the first step to implementing efficient and qualified surgery delivery systems in low- and middle-income countries. We reviewed the major challenges facing health care in East Africa and grouped them into 5 categories: 1) burden of surgical disease and workforce crisis; 2) global health view of surgery as "the neglected stepchild"; 3) need for recognizing the surgical system as an interdependent network and importance of organizational and equipment deficits; 4) lack of education in the community, failure of primary care systems, and net result of overwhelming tertiary care systems; 5) personal and professional burnout as well as brain drain of promising human resources from low- and middle-income countries in East Africa and similar regions across the world. Each major challenge was detailed and analyzed by authors who have worked or are currently working in the region, providing a personal perspective.	[Santos, Maria M.] Weill Cornell Med, Ctr Global Hlth, New York, NY USA; [Santos, Maria M.; Ngerageza, Japhet G.; Shabani, Hamisi K.] Muhimbili Orthoped Neurosurg Inst, Dept Neurosurg, Dar Es Salaam, Tanzania; [Qureshi, Mubashir M.] Aga Khan Univ Hosp, Dept Neurosurg, Nairobi, Kenya; [Budohoski, Karol P.] Univ Cambridge, Dept Neurosurg, Addenbrookes Hosp, Cambridge, England; [Budohoski, Karol P.] Univ Cambridge, Natl Inst Healthcare Res, Global Hlth Res Grp Neurotrauma, Cambridge, England; [Mangat, Halinder S.] New York Presbyterian Hosp, Weill Cornell Med, Dept Neurol, Div Stroke & Crit Care, New York, NY USA; [Zubkov, Micaella R.; Hartl, Roger] Weill Cornell Med, Dept Neurol Surg, Weill Cornell Brain & Spine Ctr, New York, NY 10065 USA; [Schoeller, Karsten] Justus Liebig Univ Giessen, Dept Neurosurg, Giessen, Germany		Hartl, R (corresponding author), Weill Cornell Med, Dept Neurol Surg, Weill Cornell Brain & Spine Ctr, New York, NY 10065 USA.	roger@hartlmd.net	Mangat, HALINDER/AAN-9153-2020	Mangat, HALINDER/0000-0003-3426-2001	Leonard and Evelyn Lauder Foundation; Eric Javits Family Foundation; William Beecher Scoville Foundation; Colin McDonald Family	Funding was received from the Leonard and Evelyn Lauder Foundation, Eric Javits Family Foundation, William Beecher Scoville Foundation, Colin McDonald Family, and patient donations.	[Anonymous], 2013, 2013 ANN STAT REP SP; [Anonymous], 2016, WORLD POPULATION REV; Bianchi, 2012, J ANESTH CLIN RES, V3, P207, DOI DOI 10.1007/S00268-012-1629-6; Coburger J, 2014, WORLD NEUROSURG, V82, pE1, DOI 10.1016/j.wneu.2012.09.019; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Furlan JC, 2013, CAN J NEUROL SCI, V40, P454, DOI 10.1017/S0317167100014529; Hartl R, 2010, WORLD NEUROSURG, V73, P259, DOI 10.1016/j.wneu.2010.02.047; HAMEL JL, 1988, TROP DOCT, V18, P139, DOI 10.1177/004947558801800317; Hoffman S, 2012, REV CONCEPTUAL BARRI; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kushner AL, 2010, ARCH SURG-CHICAGO, V145, P154, DOI 10.1001/archsurg.2009.263; Lagarde E, 2007, PLOS MED, V4, P967, DOI 10.1371/journal.pmed.0040170; Lantz A, 2015, LANCET GLOB HEALTH, V3, pS11, DOI 10.1016/S2214-109X(15)70084-7; LeBrun DG, 2014, SURGERY, V155, P365, DOI 10.1016/j.surg.2013.10.008; Linden AF, 2012, WORLD J SURG, V36, P1056, DOI 10.1007/s00268-012-1482-7; Luboga S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000200; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Mangat HS, 2018, WORLD NEUROSURG, V113, P411, DOI 10.1016/j.wneu.2018.01.086; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Merriam Webster Inc, 2016, MERR WEBST DICT; Mitchell KB, 2013, CAN J SURG, V56, P199, DOI 10.1503/cjs.028911; Mock C, 2008, CLIN ORTHOP RELAT R, V466, P2306, DOI 10.1007/s11999-008-0416-z; Ozgediz D, 2005, ARCH SURG-CHICAGO, V140, P795, DOI 10.1001/archsurg.140.8.795; Ozgediz D, 2008, B WORLD HEALTH ORGAN, V86, P646, DOI 10.2471/BLT.07.050435; Perry L, 2011, MED BIOL ENG COMPUT, V49, P719, DOI 10.1007/s11517-011-0786-3; Poz, 2014, MIGRATION HLTH WORKE; Rehmani R., 2004, JPMA Journal of the Pakistan Medical Association, V54, P233; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sambo G., 2014, STATUS BLOOD SAFETY; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Tagny CT, 2010, TRANSFUSION MED, V20, P1, DOI 10.1111/j.1365-3148.2009.00958.x; Warf BC, 2010, WORLD NEUROSURG, V73, P296, DOI 10.1016/j.wneu.2010.02.009; Whitworth JAG, 2008, LANCET, V372, P1590, DOI 10.1016/S0140-6736(08)61660-8; WHO, 1997, GUID HLTH CAR EQ DON; WHO, 2012, WHO STRAT RES HLTH; Winkler AS, 2010, WORLD NEUROSURG, V73, P264, DOI 10.1016/j.wneu.2010.03.037; World Health Organization, 2006, WORLD HLTH REPORT 20	37	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2018	113						425	435		10.1016/j.wneu.2018.01.084			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8JD	WOS:000432942700182	29702966				2022-02-06	
J	Theadom, A; Barker-Collo, S; Jones, K; Dudley, M; Vincent, N; Feigin, V				Theadom, Alice; Barker-Collo, Suzanne; Jones, Kelly; Dudley, Margaret; Vincent, Norah; Feigin, Valery			A pilot randomized controlled trial of on-line interventions to improve sleep quality in adults after mild or moderate traumatic brain injury	CLINICAL REHABILITATION			English	Article						Traumatic brain injury; sleep; cognitive behavioural therapy; education	COGNITIVE-BEHAVIORAL THERAPY; HEAD-INJURY; INSOMNIA; METAANALYSIS; SYMPTOMS; DISTURBANCES; PREVALENCE; DISORDERS; EFFICACY; LIFE	Objective: To explore feasibility and potential efficacy of on-line interventions for sleep quality following a traumatic brain injury (TBI). Design: A two parallel-group, randomized controlled pilot study. Setting: Community-based. Subjects: In all, 24 participants (mean age: 35.9 11.8 years) who reported experiencing sleep difficulties between 3 and 36 months after a mild or moderate TBI. Interventions: Participants were randomized to receive either a cognitive behaviour therapy or an education intervention on-line. Both interventions were self-completed for 20-30 minutes per week over a six-week period. Main measures: The Pittsburgh Sleep Quality Index assessed self-reported sleep quality with actigraphy used as an objective measure of sleep quality. The CNS Vital Signs on-line neuropsychological test assessed cognitive functioning and the Rivermead Post-concussion Symptoms and Quality of Life after Brain Injury questionnaires were completed pre and post intervention. Results: Both programmes demonstrated feasibility for use post TBI, with 83.3% of participants completing the interventions. The cognitive behaviour therapy group experienced significant reductions (F = 5.47, p = 0.04) in sleep disturbance (mean individual change = -4.00) in comparison to controls post intervention (mean individual change = -1.50) with a moderate effect size of 1.17. There were no significant group differences on objective sleep quality, cognitive functioning, post-concussion symptoms or quality of life. Conclusion: On-line programmes designed to improve sleep are feasible for use for adults following mild-to-moderate TBI. Based on the effect size identified in this pilot study, 128 people (64 per group) would be needed to determine clinical effectiveness.	[Theadom, Alice; Jones, Kelly; Feigin, Valery] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Sci, AR417 AUT North Shore Campus,Private Bag 92006, Auckland 1142, New Zealand; [Barker-Collo, Suzanne; Dudley, Margaret] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Jones, Kelly] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [Vincent, Norah] Univ Manitoba, Dept Clin Hlth Psychol, Winnipeg, MB, Canada		Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Sci, AR417 AUT North Shore Campus,Private Bag 92006, Auckland 1142, New Zealand.	alice.theadom@aut.ac.nz	Feigin, Valery/AAF-2313-2019; Jones, Kelly/I-5199-2019	Vincent, Norah/0000-0002-2255-2346; Feigin, Valery L./0000-0002-6372-1740	Health Research Council of New ZealandHealth Research Council of New Zealand [14/598]	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This study was funded by the Health Research Council of New Zealand (grant no. 14/598).	Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Babor TF, 2001, AUDIT ALCOHOL USE DI; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Buscemi N, 2007, J GEN INTERN MED, V22, P1335, DOI 10.1007/s11606-007-0251-z; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chung F, 2009, CURR OPIN ANESTHESIO, V22, P405, DOI 10.1097/ACO.0b013e32832a96e2; Ferri R, 2007, EUR J NEUROL, V14, P1016, DOI 10.1111/j.1468-1331.2007.01862.x; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Gualtieri CT, 2004, AM NEUR ASS ANN M; Hopkins W., 2002, SCALE MAGNITUDES EFF; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morin CM, 2005, BEHAV RES THER, V43, P1, DOI 10.1016/j.brat.2003.12.002; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Saghaei M, 2011, J BIOMED SCI ENG, V04, P734, DOI [DOI 10.4236/JBISE.2011.411090, 10.4236/jbise.2011.411090, DOI 10.4236/jbise.2011.411090]; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Stepanski EJ, 2003, SLEEP MED REV, V7, P215, DOI 10.1053/smrv.2001.0246; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Vincent N, 2013, J CLIN SLEEP MED, V9, P227, DOI 10.5664/jcsm.2484; Vincent N, 2009, SLEEP, V32, P807, DOI 10.1093/sleep/32.6.807; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	33	14	14	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	MAY	2018	32	5					619	629		10.1177/0269215517736671			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GF6BZ	WOS:000432053100006	29072086				2022-02-06	
J	Esenaliev, RO; Petrov, IY; Petrov, Y; Guptarak, J; Boone, DR; Mocciaro, E; Weisz, H; Parsley, MA; Sell, SL; Hellmich, H; Ford, JM; Pogue, C; DeWitt, D; Prough, DS; Micci, MA				Esenaliev, Rinat O.; Petrov, Irene Y.; Petrov, Yuriy; Guptarak, Jutatip; Boone, Debbie R.; Mocciaro, Emanuele; Weisz, Harris; Parsley, Margaret A.; Sell, Stacy L.; Hellmich, Helen; Ford, Jonathan M.; Pogue, Connor; DeWitt, Douglas; Prough, Donald S.; Micci, Maria-Adelaide			Nano-Pulsed Laser Therapy Is Neuroprotective in a Rat Model of Blast-Induced Neurotrauma	JOURNAL OF NEUROTRAUMA			English	Article						blast injury; near-infrared light; neuroprotection; non-invasive transcranial laser therapy; optoacoustics; traumatic brain injury	TRAUMATIC BRAIN-INJURY; VENOUS-BLOOD OXYGENATION; LONG-TERM POTENTIATION; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; CELL-PROLIFERATION; AQUEOUS-SOLUTIONS; LIGHT; MECHANISMS	We have developed a novel, non-invasive nano-pulsed laser therapy (NPLT) system that combines the benefits of near-infrared laser light (808 nm) and ultrasound (optoacoustic) waves, which are generated with each short laser pulse within the tissue. We tested NPLT in a rat model of blast-induced neurotrauma (BINT) to determine whether transcranial application of NPLT provides neuroprotective effects. The laser pulses were applied on the intact rat head 1h after injury using a specially developed fiber-optic system. Vestibulomotor function was assessed on post-injury days (PIDs) 1-3 on the beam balance and beam walking tasks. Cognitive function was assessed on PIDs 6-10 using a working memory Morris water maze (MWM) test. BDNF and caspase-3 messenger RNA (mRNA) expression was measured by quantitative real-time PCR (qRT-PCR) in laser-captured cortical neurons. Microglia activation and neuronal injury were assessed in brain sections by immunofluorescence using specific antibodies against CD68 and active caspase-3, respectively. In the vestibulomotor and cognitive (MWM) tests, NPLT-treated animals performed significantly better than the untreated blast group and similarly to sham animals. NPLT upregulated mRNA encoding BDNF and downregulated the pro-apoptotic protein caspase-3 in cortical neurons. Immunofluorescence demonstrated that NPLT inhibited microglia activation and reduced the number of cortical neurons expressing activated caspase-3. NPLT also increased expression of BDNF in the hippocampus and the number of proliferating progenitor cells in the dentate gyrus. Our data demonstrate a neuroprotective effect of NPLT and prompt further studies aimed to develop NPLT as a therapeutic intervention after traumatic brain injury (TBI).	[Esenaliev, Rinat O.; Guptarak, Jutatip; Boone, Debbie R.; Mocciaro, Emanuele; Weisz, Harris; Parsley, Margaret A.; Sell, Stacy L.; Hellmich, Helen; Ford, Jonathan M.; Pogue, Connor; DeWitt, Douglas; Prough, Donald S.; Micci, Maria-Adelaide] Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA; [Esenaliev, Rinat O.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Esenaliev, Rinat O.; Petrov, Irene Y.; Petrov, Yuriy] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA		Micci, MA (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	mmicci@utmb.edu	Mocciaro, Emanuele/AAA-7650-2020; Prough, Donald S/G-5793-2013; Esenaliev, Rinat/Y-4361-2019	Prough, Donald S/0000-0001-7994-532X; Esenaliev, Rinat/0000-0002-2848-5906; Mocciaro, Emanuele/0000-0002-4287-8933	Moody Project for Translational Traumatic Brain Injury Research	These studies were completed as part of an interdisciplinary research team funded by The Moody Project for Translational Traumatic Brain Injury Research.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Briley D, 2016, SCI REP-UK, V6, DOI 10.1038/srep27812; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; DOBROV EN, 1989, PHOTOCHEM PHOTOBIOL, V49, P595, DOI 10.1111/j.1751-1097.1989.tb08429.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; ESENALIEV RO, 1994, APPL PHYS B-LASERS O, V59, P73, DOI 10.1007/BF01081730; ESENALIEV RO, 1993, LASER SURG MED, V13, P470, DOI 10.1002/lsm.1900130412; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hoge CW, 2008, AM J EPIDEMIOL, V168, P1095, DOI 10.1093/aje/kwn261; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; KARU T, 1994, J PHOTOCH PHOTOBIO B, V24, P155, DOI 10.1016/1011-1344(94)07016-4; Karu TI, 1996, LASER SURG MED, V18, P171, DOI 10.1002/(SICI)1096-9101(1996)18:2<171::AID-LSM7>3.0.CO;2-P; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lopes CDF, 2017, BIOMATERIALS, V121, P83, DOI 10.1016/j.biomaterials.2016.12.025; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCarthy TJ, 2010, PHOTOMED LASER SURG, V28, P663, DOI 10.1089/pho.2009.2581; MESTER E, 1976, ACTA CHIR HUNG, V17, P49; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miyamoto N, 2015, J NEUROSCI, V35, P14002, DOI 10.1523/JNEUROSCI.1592-15.2015; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Ohl F, 1999, COGNITIVE BRAIN RES, V7, P379, DOI 10.1016/S0926-6410(98)00042-1; Oraevsky AA, 1996, LASER SURG MED, V18, P231, DOI 10.1002/(SICI)1096-9101(1996)18:3<231::AID-LSM3>3.0.CO;2-T; Pang AL, 2017, CELL TRANSPLANT, V26, P1262, DOI 10.1177/0963689717715168; Petrov A, 2014, PHOTOACOUSTICS, V2, P75, DOI 10.1016/j.pacs.2014.04.001; Petrov IY, 2012, OPT EXPRESS, V20, P4159, DOI 10.1364/OE.20.004159; Petrov IY, 2012, BIOMED OPT EXPRESS, V3, P125, DOI 10.1364/BOE.3.000125; Petrov Y., 2017, P SPIE, P10064; Petrova IY, 2009, OPT EXPRESS, V17, P7285, DOI 10.1364/OE.17.007285; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Ramagiri Sruthi, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P1, DOI 10.1515/jbcpp-2015-0021; Rao MS, 1999, ANAT RECORD, V257, P137; Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Su WS, 2015, ONCOTARGET, V6, P42290, DOI 10.18632/oncotarget.5978; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Thunshelle C, 2016, PHOTOMED LASER SURG, V34, P587, DOI 10.1089/pho.2015.4051; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; Van Kanegan MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25626; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Yoon SH, 2012, PEDIATR NEUROSURG, V48, P102, DOI 10.1159/000343011; Zhao MR, 2007, BIOL PSYCHIAT, V62, P381, DOI 10.1016/j.biopsych.2006.10.019; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	73	14	14	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	13					1510	1522		10.1089/neu.2017.5249		APR 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GJ4CQ	WOS:000431108300001	29562823	Green Submitted, Bronze, Green Published			2022-02-06	
J	Cuzzocrea, S; Doyle, T; Campolo, M; Paterniti, I; Esposito, E; Farr, SA; Salvemini, D				Cuzzocrea, Salvatore; Doyle, Timothy; Campolo, Michela; Paterniti, Irene; Esposito, Emanuela; Farr, Susan A.; Salvemini, Daniela			Sphingosine 1-Phosphate Receptor Subtype 1 (S1PR1) as a Therapeutic Target for Brain Trauma	JOURNAL OF NEUROTRAUMA			English	Article						CCI; S1PR1; TBI	MICROTUBULE-ASSOCIATED PROTEIN-2; FINGOLIMOD FTY720; LYMPHOCYTE EGRESS; MOUSE MODEL; STEM-CELLS; INJURY; SPHINGOSINE-1-PHOSPHATE; NEUROPROTECTION; TRAFFICKING; EXPRESSION	Traumatic brain injury (TBI) provokes secondary pathological mechanisms, including ischemic and inflammatory processes. The new research in sphingosine 1-phosphate (S1P) receptor modulators has opened the door for an effective mechanism of reducing central nervous system (CNS) inflammatory lesion activity. Thus, the aim of this study was to characterize the immunomodulatory effect of the functional S1PR1 antagonist, siponimod, in phase III clinical trials for autoimmune disorders and of the competitive sphingosine 1-phosphate receptor subtype 1 (S1PR1) antagonist, TASP0277308, in pre-clinical development in an in vivo model of TBI in mice. We used the well-characterized model of TBI caused by controlled cortical impact. Mice were injected intraperitoneally with siponimod or TASP0277308 (1mg/kg) at 1 and 4h post-trauma. Our results demonstrated that these agents exerted significant beneficial effects on TBI pre-clinical scores in term of anti-inflammatory and immunomodulatory effects, in particular, attenuation of astrocytes and microglia activation, cytokines release, and rescue of the reduction of adhesion molecules (i.e., occludin and zonula occludens-1). Moreover, these compounds were able to decrease T-cell activation visible by reduction of CD4(+) and CD8(+), reduce the lesioned area (measured by 2,3,5-triphenyltetrazolium chloride staining), and to preserve tissue architecture, microtubule stability, and neural plasticity. Moreover, our findings provide pre-clinical evidence for the use of low-dose oral S1PR1 antagonists as neuroprotective strategies for TBI and broaden our understanding of the underlying S1PR1-driven neuroinflammatory processes in the pathophysiology of TBI. Altogether, our results showed that blocking the S1PR1 axis is an effective therapeutic strategy to mitigate neuropathological effects engaged in the CNS by TBI.	[Cuzzocrea, Salvatore; Campolo, Michela; Paterniti, Irene; Esposito, Emanuela] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres, Messina, Italy; [Cuzzocrea, Salvatore; Doyle, Timothy; Salvemini, Daniela] St Louis Univ, Dept Physiol & Pharmacol, St Louis, MO 63103 USA; [Farr, Susan A.] VA Med Ctr St Louis, St Louis, MO USA; [Farr, Susan A.] St Louis Univ, Div Geriatr Med, St Louis, MO 63103 USA		Salvemini, D (corresponding author), St Louis Univ, Dept Physiol & Pharmacol, St Louis, MO 63103 USA.	salvemd@slu.edu	Campolo, Michela/K-6432-2016	Cuzzocrea, Salvatore/0000-0001-6131-3690; Farr, Susan/0000-0002-0481-2570			Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Barcia C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00058; Bigaud M, 2014, BBA-MOL CELL BIOL L, V1841, P745, DOI 10.1016/j.bbalip.2013.11.001; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Campolo M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0196-1; Chi HB, 2011, TRENDS PHARMACOL SCI, V32, P16, DOI 10.1016/j.tips.2010.11.002; Chiba K, 2005, PHARMACOL THERAPEUT, V108, P308, DOI 10.1016/j.pharmthera.2005.05.002; Chiba K, 2010, INFLAMM REGEN, V30, P160; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi JW, 2009, MULT SCLER, V15, pS58; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Croitoru-Lamoury J, 2007, J INTERF CYTOK RES, V27, P53, DOI 10.1089/jir.2006.0037; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dietrich W.D., 2009, ENCY NEUROSCIENCE, V1, P2727; Ding W, 2012, ANIM REPROD SCI, V131, P172, DOI 10.1016/j.anireprosci.2012.02.013; Esposito E, 2014, PHARMACOL RES, V86, P26, DOI 10.1016/j.phrs.2014.05.009; Esposito E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-66; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Fu Y, 2014, JAMA NEUROL, V71, P1092, DOI 10.1001/jamaneurol.2014.1065; Fujii Y, 2012, J IMMUNOL, V188, P206, DOI 10.4049/jimmunol.1101537; Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272; Gentile A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0686-4; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gonzalez-Cabrera Pedro J, 2014, F1000Prime Rep, V6, P109, DOI 10.12703/P6-109; Gonzalez-Cabrera PJ, 2012, MOL PHARMACOL, V81, P166, DOI 10.1124/mol.111.076109; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Huh JW, 2003, J NEUROTRAUM, V20, P975, DOI 10.1089/089771503770195821; Janes K, 2014, J BIOL CHEM, V289, P21082, DOI 10.1074/jbc.M114.569574; Jung CG, 2007, GLIA, V55, P1656, DOI 10.1002/glia.20576; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; Kappos L, 2016, JAMA NEUROL, V73, P1089, DOI 10.1001/jamaneurol.2016.1451; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kimura A, 2007, STEM CELLS, V25, P115, DOI 10.1634/stemcells.2006-0223; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li M, 2015, CHINESE MED J-PEKING, V128, P1072, DOI 10.4103/0366-6999.155094; Lin CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118473; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; Mencl S, 2014, J NEUROIMMUNOL, V274, P125, DOI 10.1016/j.jneuroim.2014.07.010; Milstien S, 2007, ACTA PAEDIATR, V96, P40, DOI 10.1111/j.1651-2227.2007.00206.x; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Nishimura H, 2010, J HISTOCHEM CYTOCHEM, V58, P847, DOI 10.1369/jhc.2010.956409; Noda H, 2013, J NEUROIMMUNOL, V256, P13, DOI 10.1016/j.jneuroim.2012.12.005; Obinata H, 2012, SEMIN IMMUNOPATHOL, V34, P73, DOI 10.1007/s00281-011-0287-3; Ohuchi H, 2008, DEV DYNAM, V237, P3280, DOI 10.1002/dvdy.21736; Pan SF, 2013, ACS MED CHEM LETT, V4, P333, DOI 10.1021/ml300396r; Pellegrini-Giampietro DE, 1999, EUR J NEUROSCI, V11, P3637, DOI 10.1046/j.1460-9568.1999.00786.x; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Rouach N, 2006, EUR J NEUROSCI, V23, P1453, DOI 10.1111/j.1460-9568.2006.04671.x; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Saha AK, 2011, ACS MED CHEM LETT, V2, P97, DOI 10.1021/ml100227q; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Schabitz WR, 1999, STROKE, V30, P427, DOI 10.1161/01.STR.30.2.427; Selmaj K, 2013, LANCET NEUROL, V12, P756, DOI 10.1016/S1474-4422(13)70102-9; Snelder N, 2014, DRUG METAB DISPOS, V42, P1367, DOI 10.1124/dmd.113.056770; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Subei AM, 2015, CNS DRUGS, V29, P565, DOI 10.1007/s40263-015-0261-z; Takatsuru Y, 2013, J NEUROSCI, V33, P4683, DOI 10.1523/JNEUROSCI.2657-12.2013; Toman RE, 2002, NEUROCHEM RES, V27, P619, DOI 10.1023/A:1020219915922; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xie JH, 2003, J IMMUNOL, V170, P3662, DOI 10.4049/jimmunol.170.7.3662; Yamagata K, 2003, GLIA, V41, P199, DOI 10.1002/glia.10180; Yoshino T, 2011, CELL MOL NEUROBIOL, V31, P1009, DOI 10.1007/s10571-011-9698-x; Zhao CQ, 2008, J LIPID RES, V49, P2323, DOI 10.1194/jlr.M800143-JLR200	86	14	16	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	13					1452	1466		10.1089/neu.2017.5391		APR 2018	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GJ4CQ	WOS:000430578400001	29310513				2022-02-06	
J	Barberini, DJ; Aleman, M; Aristizabal, F; Spriet, M; Clark, KC; Walker, NJ; Galuppo, LD; Amorim, RM; Woolard, KD; Borjesson, DL				Barberini, Danielle Jaqueta; Aleman, Monica; Aristizabal, Fabio; Spriet, Mathieu; Clark, Kaitlin C.; Walker, Naomi J.; Galuppo, Larry D.; Amorim, Rogerio Martins; Woolard, Kevin D.; Borjesson, Dori L.			Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses	STEM CELL RESEARCH & THERAPY			English	Article						Mesenchymal stem cells; Intrathecal; Neurology; Scintigraphy; Adipose tissue; Cerebrospinal fluid	SPINAL-CORD-INJURY; EQUINE PROTOZOAL MYELOENCEPHALITIS; TRAUMATIC BRAIN-INJURY; BONE-MARROW; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; IN-VIVO; NEUROLOGICAL DISEASES; DISTAL LIMB; FOLLOW-UP	Background: It is currently unknown if the intrathecal administration of a high dose of allogeneic mesenchymal stem cells (MSCs) is safe, how MSCs migrate throughout the vertebral canal after intrathecal administration, and whether MSCs are able to home to a site of injury. The aims of the study were: 1) to evaluate the safety of intrathecal injection of 100 million allogeneic adipose-derived MSCs (ASCs); 2) to assess the distribution of ASCs after atlanto-occipital (AO) and lumbosacral (LS) injection in healthy horses; and 3) to determine if ASCs homed to the site of injury in neurologically diseased horses. Methods: Six healthy horses received 100 x 10(6) allogeneic ASCs via AO (n = 3) or LS injection (n = 3). For two of these horses, ASCs were radiolabeled with technetium and injected AO (n = 1) or LS (n = 1). Neurological examinations were performed daily, and blood and cerebrospinal fluid (CSF) were evaluated prior to and at 30 days after injection. Scintigraphic images were obtained immediately postinjection and at 30 mins, 1 h, 5 h, and 24 h after injection. Three horses with cervical vertebral compressive myelopathy (CVCM) received 100 x 106 allogeneic ASCs labeled with green fluorescent protein (GFP) via AO injection and were euthanized 1-2 weeks after injection for a full nervous system necropsy. CSF parameters were compared using a paired student's t test. Results: There were no significant alterations in blood, CSF, or neurological examinations at any point after either AO or LS ASC injections into healthy horses. The radioactive signal could be identified all the way to the lumbar area after AO ASC injection. After LS injection, the signal extended caudally but only a minimal radioactive signal extended further cranially. GFP-labeled ASCs were not present at the site of disease at either 1 or 2 weeks following intrathecal administration. Conclusions: The intrathecal injection of allogeneic ASCs was safe and easy to perform in horses. The AO administration of ASCs resulted in better distribution within the entire subarachnoid space in healthy horses. ASCs could not be found after 7 or 15 days of injection at the site of injury in horses with CVCM.	[Barberini, Danielle Jaqueta; Clark, Kaitlin C.; Walker, Naomi J.; Woolard, Kevin D.; Borjesson, Dori L.] Univ Calif Davis, Vet Inst Regenerat Cures, Davis, CA 95616 USA; [Barberini, Danielle Jaqueta; Clark, Kaitlin C.; Walker, Naomi J.; Woolard, Kevin D.; Borjesson, Dori L.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Aleman, Monica] Univ Calif Davis, Dept Med & Epidemiol, Davis, CA 95616 USA; [Aristizabal, Fabio; Spriet, Mathieu; Galuppo, Larry D.] Univ Calif Davis, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Amorim, Rogerio Martins] Sao Paulo State Univ Julio de Mesquita Filho UNES, Dept Vet Clin, Botucatu, SP, Brazil		Borjesson, DL (corresponding author), Univ Calif Davis, Vet Inst Regenerat Cures, Davis, CA 95616 USA.; Borjesson, DL (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	dlborjesson@ucdavis.edu	Spriet, Mathieu/AAT-6986-2021; Amorim, Rogerio Martins/C-1713-2012	Amorim, Rogerio Martins/0000-0003-3750-5857	Center for Equine Health; State of California satellite wagering fund; Sao Paulo Research Foundation (FAPESP/CAPES), Brazil [2014/20550-8]	This project was supported by a generous gift from the Haas Family and by the Center for Equine Health with funds provided by the State of California satellite wagering fund and contributions by private donors. Danielle J. Barberini was supported by grant #2014/20550-8, Sao Paulo Research Foundation (FAPESP/CAPES), Brazil. The funding agencies played no role in the development of the study, collection, analysis and interpretation of the data, in the writing of the manuscript, or in the decision to submit the manuscript for publication.	Aleman M, 2007, JAVMA-J AM VET MED A, V230, P378, DOI 10.2460/javma.230.3.378; Audigie F, 2004, VET RADIOL ULTRASOUN, V45, P340, DOI 10.1111/j.1740-8261.2004.04065.x; Bauer G, 2008, MOL THER, V16, P1308, DOI 10.1038/mt.2008.93; Carrade DD, 2012, CELL MED, V4, P1, DOI 10.3727/215517912X647217; Carvalho AM, 2014, EQUINE VET J, V46, P635, DOI 10.1111/evj.12173; Chen BKK, 2015, TRANSFUSION, V55, P1013, DOI 10.1111/trf.12938; Cohen JA, 2013, J NEUROL SCI, V333, P43, DOI 10.1016/j.jns.2012.12.009; Cole C, 2014, TREATMENT EQUINE NER, P192; Dang SP, 2014, AUTOPHAGY, V10, P1301, DOI 10.4161/auto.28771; Danielyan L, 2009, EUR J CELL BIOL, V88, P315, DOI 10.1016/j.ejcb.2009.02.001; Dubey JP, 2015, VET PARASITOL, V209, P1, DOI 10.1016/j.vetpar.2015.01.026; Galleu A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7828; Gershwin LJ, 2012, VACCINE, V30, P7615, DOI 10.1016/j.vaccine.2012.10.029; Glavaski-Joksimovic A, 2013, EXP NEUROL, V247, P25, DOI 10.1016/j.expneurol.2013.03.016; Harris VK, 2012, J NEUROL SCI, V313, P167, DOI 10.1016/j.jns.2011.08.036; Hu DZ, 2004, CHINESE MED J-PEKING, V117, P1576; Jarocha D, 2015, CELL TRANSPLANT, V24, P661, DOI 10.3727/096368915X687796; Johnson AL, 2013, J VET INTERN MED, V27, P596, DOI 10.1111/jvim.12061; Johnson PJ, 2000, EQUINE VET EDUC, V12, P7, DOI 10.1111/j.2042-3292.2000.tb01755.x; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Jung DI, 2009, J NEUROL SCI, V285, P67, DOI 10.1016/j.jns.2009.05.027; Karussis D, 2013, J NEUROL SCI, V324, P1, DOI 10.1016/j.jns.2012.09.031; Kerkis I, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0248-1; Kishk NA, 2013, J CLIN NEUROSCI, V20, P304, DOI 10.1016/j.jocn.2012.04.013; Laroni A, 2015, IMMUNOL LETT, V168, P183, DOI 10.1016/j.imlet.2015.08.007; Lee HJ, 2012, NEUROBIOL AGING, V33, P588, DOI 10.1016/j.neurobiolaging.2010.03.024; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Levine JM, 2008, JAVMA-J AM VET MED A, V233, P1453, DOI 10.2460/javma.233.9.1453; Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612; Liang J, 2009, MULT SCLER J, V15, P644, DOI 10.1177/1352458509104590; Lin P, 2014, MOL THER, V22, P160, DOI 10.1038/mt.2013.221; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Liu J, 2013, CYTOTHERAPY, V15, P185, DOI 10.1016/j.jcyt.2012.09.005; Liu M, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0319-y; Lunn D. P., 1989, Equine Veterinary Education, V1, P94, DOI 10.1111/j.2042-3292.1989.tb01355.x; Maia L, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0361-5; MAYHEW IG, 1975, CORNELL VET, V65, P500; Mazzini L, 2010, EXP NEUROL, V223, P229, DOI 10.1016/j.expneurol.2009.08.007; Meyerrose TE, 2008, STEM CELLS, V26, P1713, DOI 10.1634/stemcells.2008-0008; Meyerrose TE, 2007, STEM CELLS, V25, P220, DOI 10.1634/stemcells.2006-0243; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004; Owens SD, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5830103; Pease A, 2012, VET RADIOL ULTRASOUN, V53, P92, DOI 10.1111/j.1740-8261.2011.01855.x; Pezzanite LM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0053-x; Pusterla N, 2014, VET J, V200, P332, DOI 10.1016/j.tvjl.2014.03.014; Reed SM, 2016, J VET INTERN MED, V30, P491, DOI 10.1111/jvim.13834; Reed S, 2008, EQUINE NEUROLOGY, P283; Sahraian MA, 2014, ARCH NEUROSCI, V1, P71, DOI 10.5812/archneurosci.13687; Sato M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3735; Satti HS, 2016, CYTOTHERAPY, V18, P518, DOI 10.1016/j.jcyt.2016.01.004; Schwarz B, 2006, EQUINE VET EDUC, V18, P243, DOI 10.1111/j.2042-3292.2006.tb00456.x; Shyu WC, 2006, J NEUROSCI, V26, P3444, DOI 10.1523/JNEUROSCI.5165-05.2006; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; Singh Udai P, 2010, Front Biosci (Schol Ed), V2, P993; Sole A, 2013, EQUINE VET J, V45, P726, DOI 10.1111/evj.12063; Sole A, 2012, EQUINE VET J, V44, P594, DOI 10.1111/j.2042-3306.2011.00530.x; Spriet M, 2015, VET RADIOL ULTRASOUN, V56, P327, DOI 10.1111/vru.12243; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Vernau W, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P769, DOI 10.1016/B978-0-12-370491-7.00026-X; Villanova M, 2015, AM J PHYS MED REHAB, V94, P410, DOI 10.1097/PHM.0000000000000309; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Xia P, 2015, INT ORTHOP, V39, P2363, DOI 10.1007/s00264-015-2785-8; Yousefifard M, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0295-2; Zeira O, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0402-9; Zhang J, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0240-9	67	14	16	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-6512			STEM CELL RES THER	Stem Cell Res. Ther.	APR 10	2018	9								96	10.1186/s13287-018-0849-6			11	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	GC4DX	WOS:000429735100002	29631634	Green Published, gold			2022-02-06	
J	Folweiler, KA; Samuel, S; Metheny, HE; Cohen, AS				Folweiler, Kaitlin A.; Samuel, Sandy; Metheny, Hannah E.; Cohen, Akiva S.			Diminished Dentate Gyrus Filtering of Cortical Input Leads to Enhanced Area Ca3 Excitability after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						area CA3; dentate gyrus; LFPI; mTBI; object-place recognition memory; perforant path	MEDIAL PREFRONTAL CORTEX; CLOSED-HEAD INJURY; PATTERN SEPARATION; GRANULE CELLS; RECOGNITION MEMORY; LONG-TERM; HIPPOCAMPAL SUBREGIONS; COGNITIVE IMPAIRMENTS; SYNAPTIC PLASTICITY; NEUROTOXIC LESIONS	Mild traumatic brain injury (mTBI) disrupts hippocampal function and can lead to long-lasting episodic memory impairments. The encoding of episodic memories relies on spatial information processing within the hippocampus. As the primary entry point for spatial information into the hippocampus, the dentate gyrus is thought to function as a physiological gate, or filter, of afferent excitation before reaching downstream area Cornu Ammonis (CA3). Although injury has previously been shown to alter dentate gyrus network excitability, it is unknown whether mTBI affects dentate gyrus output to area CA3. In this study, we assessed hippocampal function, specifically the interaction between the dentate gyrus and CA3, using behavioral and electrophysiological techniques in ex vivo brain slices 1 week following mild lateral fluid percussion injury (LFPI). Behaviorally, LFPI mice were found to be impaired in an object-place recognition task, indicating that spatial information processing in the hippocampus is disrupted. Extracellular recordings and voltage-sensitive dye imaging demonstrated that perforant path activation leads to the aberrant spread of excitation from the dentate gyrus into area CA3 along the mossy fiber pathway. These results suggest that after mTBI, the dentate gyrus has a diminished capacity to regulate cortical input into the hippocampus, leading to increased CA3 network excitability. The loss of the dentate filtering efficacy reveals a potential mechanism by which hippocampal-dependent spatial information processing is disrupted, and may contribute to memory dysfunction after mTBI.	[Folweiler, Kaitlin A.; Samuel, Sandy; Metheny, Hannah E.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Folweiler, Kaitlin A.; Samuel, Sandy; Metheny, Hannah E.; Cohen, Akiva S.] Univ Penn, Dept Anesthesiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Folweiler, Kaitlin A.; Cohen, Akiva S.] Univ Penn, Neurosci Grad Grp, Philadelphia, PA 19104 USA		Folweiler, KA (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Dept Anesthesiol & Crit Care Med, 3615 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	kfolw@pennmedicine.upenn.edu			NIH/National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37 HD059288]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288] Funding Source: NIH RePORTER	We thank Drs. Sanghee Yun and Brian Johnson for constructive suggestions on previous drafts of the manuscript. The grant sponsor was NIH/National Institute of Child Health and Human Development (NICHD); the grant number is R37 HD059288 (A.S.C.)	Acsady L, 1998, J NEUROSCI, V18, P3386; ALGER BE, 1976, BRAIN RES, V110, P463, DOI 10.1016/0006-8993(76)90858-1; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; ANDERSEN P, 1966, ACTA PHYSIOL SCAND, V66, P448, DOI 10.1111/j.1748-1716.1966.tb03223.x; ANDERSON WW, 1987, J NEUROPHYSIOL, V57, P1; Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bejanin A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00107; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; BERGER TW, 1981, BRAIN RES, V224, P329, DOI 10.1016/0006-8993(81)91138-0; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Bourgeois EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108686; Buckmaster PS, 1996, J COMP NEUROL, V366, P270, DOI 10.1002/(SICI)1096-9861(19960304)366:2<270::AID-CNE7>3.0.CO;2-2; Bussey TJ, 2000, BEHAV BRAIN RES, V111, P187, DOI 10.1016/S0166-4328(00)00155-8; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; CHERUBINI E, 1988, BRAIN RES, V445, P91, DOI 10.1016/0006-8993(88)91077-3; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; Darwish H, 2014, BRAIN INJURY, V28, P1362; DELLER T, 1995, J COMP NEUROL, V352, P55, DOI 10.1002/cne.903520105; Dengler CG, 2016, PROG BRAIN RES, V226, P155, DOI 10.1016/bs.pbr.2016.04.005; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Ennaceur A, 1997, BEHAV BRAIN RES, V88, P181, DOI 10.1016/S0166-4328(97)02297-3; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; FRICKE RA, 1984, J NEUROPHYSIOL, V51, P195, DOI 10.1152/jn.1984.51.2.195; FROTSCHER M, 1991, J COMP NEUROL, V312, P145, DOI 10.1002/cne.903120111; FROTSCHER M, 1985, J NEUROCYTOL, V14, P245, DOI 10.1007/BF01258450; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; GOODMAN JH, 1992, HIPPOCAMPUS, V2, P13, DOI 10.1002/hipo.450020103; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Hannesson DK, 2004, J NEUROSCI, V24, P4596, DOI 10.1523/JNEUROSCI.5517-03.2004; Hashimotodani Y, 2017, NEURON, V95, P928, DOI 10.1016/j.neuron.2017.07.028; HEINEMANN U, 1992, EPILEPSY RES, P273; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; Howard AL, 2007, J NEUROPHYSIOL, V97, P2394, DOI 10.1152/jn.00509.2006; Hsu D, 2007, PROG BRAIN RES, V163, P601, DOI 10.1016/S0079-6123(07)63032-5; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P1064, DOI 10.1002/hipo.20464; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Johnson BN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00435; Kahn J., 2016, 46 ANN M SOC NEUR PR; Kesner RP, 2015, NEUROBIOL LEARN MEM, V118, P42, DOI 10.1016/j.nlm.2014.11.004; Kesner RP, 2013, BEHAV PROCESS, V93, P148, DOI 10.1016/j.beproc.2012.09.018; Kesner RP, 2003, BEHAV BRAIN RES, V146, P159, DOI 10.1016/j.bbr.2003.09.024; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Krook-Magnuson E, 2015, J PHYSIOL-LONDON, V593, P2379, DOI 10.1113/JP270056; Langston RF, 2010, HIPPOCAMPUS, V20, P1139, DOI 10.1002/hipo.20714; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lee I, 2005, BEHAV NEUROSCI, V119, P145, DOI 10.1037/0735-7044.119.1.145; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; LOTHMAN EW, 1992, EPILEPSY RES, P301; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Marucci G, 2010, CLIN NEUROPATHOL, V29, P32; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Nenov MN, 2014, J NEUROSCI, V34, P1028, DOI 10.1523/JNEUROSCI.3413-13.2014; Neuberger EJ, 2014, J NEUROSCI RES, V92, P1350, DOI 10.1002/jnr.23401; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Oliveira AMM, 2010, LEARN MEMORY, V17, P155, DOI 10.1101/lm.1625310; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; SCHARFMAN HE, 1992, EPILEPSY RES, P93; Scharfman HE, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00106; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SORIANO E, 1993, J COMP NEUROL, V333, P435, DOI 10.1002/cne.903330309; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; TAMAMAKI N, 1993, HIPPOCAMPUS, V3, P471, DOI 10.1002/hipo.450030408; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEYLER TJ, 1976, BRAIN RES, V115, P413, DOI 10.1016/0006-8993(76)90358-9; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Toth Z, 1997, J NEUROSCI, V17, P8106; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tsirka V, 2010, INT J NEUROSCI, V120, P184, DOI 10.3109/00207450903585308; Tsuda S, 2016, NEUROREPORT, V27, P724, DOI 10.1097/WNR.0000000000000598; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Vascak M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00157; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; WILLIAMSON A, 1993, BRAIN RES, V622, P194, DOI 10.1016/0006-8993(93)90819-9; Wilson DI, 2013, HIPPOCAMPUS, V23, P352, DOI 10.1002/hipo.22095; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Witter MP, 2007, LEARN MEMORY, V14, P705, DOI 10.1101/lm.725207; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wright BJ, 2014, J NEUROSCI, V34, P9743, DOI 10.1523/JNEUROSCI.0814-14.2014; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Yamashita Shin, 2011, Kurume Medical Journal, V58, P47; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271; ZIMMER J, 1971, J COMP NEUROL, V142, P393, DOI 10.1002/cne.901420402; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	126	14	14	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	11					1304	1317		10.1089/neu.2017.5350		APR 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GG7EW	WOS:000429536500001	29338620	Green Published			2022-02-06	
J	Thibeault, CM; Thorpe, S; O'Brien, MJ; Canac, N; Ranjbaran, M; Patanam, I; Sarraf, A; LeVangie, J; Scalzo, F; Wilk, SJ; Diaz-Arrastia, R; Hamilton, RB				Thibeault, Corey M.; Thorpe, Samuel; O'Brien, Michael J.; Canac, Nicolas; Ranjbaran, Mina; Patanam, Ilyas; Sarraf, Artin; LeVangie, James; Scalzo, Fabien; Wilk, Seth J.; Diaz-Arrastia, Ramon; Hamilton, Robert B.			A Cross-Sectional Study on Cerebral Hemodynamics After Mild Traumatic Brain Injury in a Pediatric Population	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; vascular reactivity; cerebral blood flow autoregulation; blood flow; cerebral blood flow velocity	SPORTS-RELATED CONCUSSION; NITRIC-OXIDE SYNTHASE; BLOOD-FLOW ALTERATIONS; TRANSCRANIAL DOPPLER; HEAD-INJURY; VASCULAR INJURY; REACTIVITY; PATHOPHYSIOLOGY; PULSATILITY; EXPRESSION	The microvasculature is prominently affected by traumatic brain injury (TBI), including mild TBI (concussion). Assessment of cerebral hemodynamics shows promise as biomarkers of TBI, and may help inform development of therapies aimed at promoting neurologic recovery. The objective of this study was to assess the evolution in cerebral hemodynamics observable with transcranial Doppler (TCD) ultrasound in subjects suffering from a concussion at different intervals during recovery. Pediatric subjects between the ages of 14 and 19 years clinically diagnosed with a concussion were observed at different points post-injury. Blood flow velocity in the middle cerebral artery was measured with TCD. After a baseline period, subjects participated in four breath holding challenges. Pulsatility index (PI), resistivity index (RI), the ratio of the first two pulse peaks (P2R), and the mean velocity (MV) were computed from the baseline section. The breath hold index (BHI) was computed from the challenge sections. TCD detected two phases of hemodynamic changes after concussion. Within the first 48 h, PI, RI, and P2R show a significant difference from the controls (U = -3.10; P < 0.01, U = -2.86; P < 0.01, and U = 2.62; P < 0.01, respectively). In addition, PI and P2R were not correlated (rp = -0.36; P = 0.23). After 48 h, differences in pulsatile features were no longer observable. However, BHI was significantly increased when grouped as 2-3, 4-5, and 6-7 days post-injury (U = 2.72; P < 0.01, U = 2.46; P = 0.014, and U = 2.38; P = 0.018, respectively). To our knowledge, this is the first longitudinal study of concussions using TCD. In addition, these results are the first to suggest the multiple hemodynamic changes after a concussion are observable with TCD and could ultimately lead to a better understanding of the underlying pathophysiology. In addition, the different hemodynamic responses to a concussion as compared to severe traumatic brain injuries highlight the need for specific diagnostic and therapeutic treatments of mild head injuries in adolescents.	[Thibeault, Corey M.; Thorpe, Samuel; O'Brien, Michael J.; Canac, Nicolas; Ranjbaran, Mina; Patanam, Ilyas; LeVangie, James; Wilk, Seth J.; Hamilton, Robert B.] Neural Analyt Inc, Los Angeles, CA 90064 USA; [Sarraf, Artin] Citadel LLC, Greenwich, CT USA; [Scalzo, Fabien] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Scalzo, Fabien] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Diaz-Arrastia, Ramon] Univ Penn Hosp, Penn Presbyterian Med Ctr, Philadelphia, PA USA		Thibeault, CM (corresponding author), Neural Analyt Inc, Los Angeles, CA 90064 USA.	corey@neuralanalytics.com	Scalzo, Fabien/AAM-6328-2020	Scalzo, Fabien/0000-0001-9755-8104	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R43NS092209-01, 2R44NS092209-02]; Neural Analytics, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS092209, R43NS092209] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health grants 1R43NS092209-01 and 2R44NS092209-02, as well as internal funding from Neural Analytics, Inc. The NIH had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bouzat P, 2016, ANESTHESIOLOGY, V125, P346, DOI 10.1097/ALN.0000000000001165; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; GILLER CA, 1990, J NEUROSURG, V72, P901, DOI 10.3171/jns.1990.72.6.0901; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hamilton R, 2012, J APPL PHYSIOL, V113, P1560, DOI 10.1152/japplphysiol.00357.2012; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim S, 2013, IEEE T BIO-MED ENG, V60, P1126, DOI 10.1109/TBME.2012.2227477; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lim MH, 2009, STROKE, V40, P3216, DOI 10.1161/STROKEAHA.109.558403; Mandera M, 2002, CHILD NERV SYST, V18, P124, DOI 10.1007/s00381-002-0572-5; MARKUS HS, 1992, STROKE, V23, P668, DOI 10.1161/01.STR.23.5.668; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Settakis G, 2002, J NEUROIMAGING, V12, P252, DOI 10.1177/10528402012003007; Tegeler CH, 2013, J NEUROIMAGING, V23, P466, DOI 10.1111/j.1552-6569.2012.00711.x; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zaaroor M, 2007, INDIAN J NEUROTRAUM, V4, P25, DOI 10.1016/S0973-0508(07)80007-4; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	35	14	14	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 5	2018	9								200	10.3389/fneur.2018.00200			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GB7PQ	WOS:000429267000001	29674994	Green Published, gold			2022-02-06	
J	Chaikittisilpa, N; Krishnamoorthy, V; Lele, AV; Qiu, Q; Vavilala, MS				Chaikittisilpa, Nophanan; Krishnamoorthy, Vijay; Lele, Abhijit V.; Qiu, Qian; Vavilala, Monica S.			Characterizing the relationship between systemic inflammatory response syndrome and early cardiac dysfunction in traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; systemic inflammatory response syndrome; inflammation; stress cardiomyopathy; echocardiography	TUMOR-NECROSIS-FACTOR; SUBARACHNOID HEMORRHAGE; MYOCARDIAL DYSFUNCTION; SYSTOLIC DYSFUNCTION; CEREBROSPINAL-FLUID; SEVERE SEPSIS; SEPTIC SHOCK; INTERLEUKIN-6; CARDIOMYOPATHY; SEVERITY	Systolic dysfunction was recently described following traumatic brain injury (TBI), and systemic inflammation may be a contributing mechanism. Our aims were to 1) examine the association between the early systemic inflammatory response syndrome (SIRS) and systolic cardiac dysfunction following TBI, and 2) describe the longitudinal change in SIRS criteria, cardiac function, and hemodynamic parameters during the first week of hospitalization. We used a secondary analysis of a prospective cohort study examining cardiac function (with transthoracic echocardiography on the first day and serially over the first week of hospitalization) in 32 moderate-severe isolated TBI patients, and quantified the admission and daily SIRS response to injury. We determined the association of admission SIRS and systolic dysfunction following TBI. Admission SIRS was present in 7 (21%) patients and was associated with systolic dysfunction on multivariable analysis (relative risk 4.01; 95% 1.16-13.79, p = .028). Both SIRS criteria and systolic cardiac function improved over the first week of hospitalization. In conclusion, early SIRS is common among patients with moderate-severe TBI, and the presence of SIRS criteria on admission is associated with systolic cardiac dysfunction following TBI.	[Chaikittisilpa, Nophanan; Krishnamoorthy, Vijay; Lele, Abhijit V.; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Chaikittisilpa, Nophanan; Krishnamoorthy, Vijay; Qiu, Qian; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA		Vavilala, MS (corresponding author), Harborview Injury Prevent & Res Ctr, 401 Broadway,Box 359960, Seattle, WA 98104 USA.	vavilala@u.washington.edu			Department of Anesthesiology and Pain Medicine, University of WashingtonUniversity of Washington; Harborview Injury Prevention and Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS095321] Funding Source: NIH RePORTER	We gratefully acknowledge the support from the Department of Anesthesiology and Pain Medicine, University of Washington and Harborview Injury Prevention and Research Center.	Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Audebert HJ, 2004, STROKE, V35, P2128, DOI 10.1161/01.STR.0000137607.61697.77; Boehme AK, 2013, STROKE, V44, P2321, DOI 10.1161/STROKEAHA.113.001371; Boissier F, 2017, INTENS CARE MED, V43, P633, DOI 10.1007/s00134-017-4698-z; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bone RC, 1996, CRIT CARE MED, V24, P163, DOI 10.1097/00003246-199601000-00026; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; Cheah CF, 2017, NEUROCRIT CARE, V26, P284, DOI 10.1007/s12028-016-0334-y; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Court O, 2002, CRIT CARE, V6, P500, DOI 10.1186/cc1822; Elrifai AM, 1996, STROKE, V27, P737, DOI 10.1161/01.STR.27.4.737; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Flierl MA, 2008, MOL MED, V14, P327, DOI 10.2119/2007-00130.Flierl; Flynn A, 2010, HEART FAIL REV, V15, P605, DOI 10.1007/s10741-010-9176-4; Giannoudis PV, 1998, BRIT J SURG, V85, P986; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hochstadt A, 2011, J CARDIOTHOR VASC AN, V25, P526, DOI 10.1053/j.jvca.2010.11.026; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Horton JW, 2007, SHOCK, V28, P326, DOI 10.1097/01.shk.0000238064.54332.c8; Huang SJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12741; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; ICHIJO T, 1994, BRAIN RES BULL, V34, P547, DOI 10.1016/0361-9230(94)90139-2; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Li Y. N., 2013, ELECTRON J DIFFER EQ, V2013, P1, DOI DOI 10.1038/SREP01377; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Marshall JC, 2000, SHOCK, V14, P586, DOI 10.1097/00024382-200014060-00002; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Masuda T, 2002, STROKE, V33, P1671, DOI 10.1161/01.STR.0000016327.74392.02; Mazzeo AT, 2014, BRIT J ANAESTH, V112, P803, DOI 10.1093/bja/aeu046; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Mica L, 2012, EUR J TRAUMA EMERG S, V38, P665, DOI 10.1007/s00068-012-0227-5; Mierzewska-Schmidt M, 2015, ANAESTH INTENSIVE TH, V47, P175, DOI 10.5603/AIT.2015.0017; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; Niederbichler AD, 2006, SHOCK, V25, P176, DOI 10.1097/01.shk.0000192123.91166.e1; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Pulido JN, 2012, MAYO CLIN PROC, V87, P620, DOI 10.1016/j.mayocp.2012.01.018; Qian R, 2015, AM J CARDIOVASC DIS, V5, P72; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; SEVERN A, 1992, J IMMUNOL, V148, P3441; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Taniguchi T, 1999, CRIT CARE MED, V27, P1262, DOI 10.1097/00003246-199907000-00005; van Diepen S, 2013, CRIT CARE MED, V41, P2080, DOI 10.1097/CCM.0b013e31828a67b2; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646; Zhang HC, 2007, AM J PHYSIOL-HEART C, V292, pH2408, DOI 10.1152/ajpheart.01150.2006	59	14	16	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		661	670		10.1002/jnr.24100			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV2DK	WOS:000424374300016	28573763	Green Accepted			2022-02-06	
J	Chandrasekar, A; Aksan, B; Heuvel, FO; Forstner, P; Sinske, D; Rehman, R; Palmer, A; Ludolph, A; Huber-Lang, M; Bockers, T; Mauceri, D; Knoll, B; Roselli, F				Chandrasekar, Akila; Aksan, Bahar; Heuvel, Florian Olde; Foerstner, Philip; Sinske, Daniela; Rehman, Rida; Palmer, Annette; Ludolph, Albert; Huber-Lang, Markus; Boeckers, Tobias; Mauceri, Daniela; Knoell, Bernd; Roselli, Francesco			Neuroprotective effect of acute ethanol intoxication in TBI is associated to the hierarchical modulation of early transcriptional responses	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Ethanol intoxication; Immediate early genes; Transcription; Neuroprotection; c-Fos	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; GENE-EXPRESSION; C-FOS; ALCOHOL EXPOSURE; GATED CURRENTS; BLOOD-ALCOHOL; CELL-DEATH; MICE; PLASTICITY	Ethanol intoxication is a risk factor for traumatic brain injury (TBI) but clinical evidence suggests that it may actually improve the prognosis of intoxicated TBI patients.& para;& para;We have employed a closed, weight-drop TBI model of different severity (2 cm or 3 cm falling height), preceded (- 30 min) or followed (+ 20 min) by ethanol administration (5 g/Kg). This protocol allows us to study the interaction of binge ethanol intoxication in TBI, monitoring behavioral changes, histological responses and the transcriptional regulation of a series of activity-regulated genes (immediate early genes, IEGs). We demonstrate that ethanol pretreatment before moderate TBI (2 cm) significantly reduces neurological impairment and accelerates recovery. In addition, better preservation of neuronal numbers and cFos + cells was observed 7 days after TBI. At transcriptional level, ethanol reduced the upregulation of a subset of IEGs encoding for transcription factors such as Atf3, c-Fos, FosB, Egr1, Egr3 and Npas4 but did not affect the upregulation of others (e.g. Gadd45b and Gadd45c). While a subset of IEGs encoding for effector proteins (such as Bdnf, InhbA and Dusp5) were downregulated by ethanol, others (such as 11-6) were unaffected. Notably, the majority of genes were sensitive to ethanol only when administered before TBI and not afterwards (the exceptions being c-Fos, Egr1 and Dusp5). Furthermore, while severe TBI (3 cm) induced a qualitatively similar (but quantitatively larger) transcriptional response to moderate TBI, it was no longer sensitive to ethanol pretreatment. Thus, we have shown that a subset of the TBI-induced transcriptional responses were sensitive to ethanol intoxication at the instance of trauma (ultimately resulting in beneficial outcomes) and that the effect of ethanol was restricted to a certain time window (pre TBI treatment) and to TBI severity (moderate). This information could be critical for the translational value of ethanol in TBI and for the design of clinical studies aimed at disentangling the role of ethanol intoxication in TBI.	[Chandrasekar, Akila; Heuvel, Florian Olde; Rehman, Rida; Ludolph, Albert; Roselli, Francesco] Ulm Univ, Dept Neurol, Ulm, Germany; [Aksan, Bahar; Mauceri, Daniela] Heidelberg Univ, IZN, Dept Neurobiol, Heidelberg, Germany; [Foerstner, Philip; Sinske, Daniela; Knoell, Bernd] Ulm Univ, Inst Physiol Chem, Ulm, Germany; [Palmer, Annette; Huber-Lang, Markus] Ulm Univ, Inst Clin & Expt Trauma Immunol, Ulm, Germany; [Boeckers, Tobias] Ulm Univ, Dept Anat & Cell Biol, Ulm, Germany		Roselli, F (corresponding author), Ulm Univ, Ctr Biomed Res ZBF, Dept Neurol, Helmholtzstr 8-2 R1-44, D-89081 Ulm De, Germany.	francesco.roselli@uni-ulm.de	Rehman, Rida/AAR-4811-2020; roselli, francesco/O-8847-2019; Mauceri, Daniela/C-4969-2014; Huber-Lang, Markus/AAJ-2209-2020	Rehman, Rida/0000-0003-0518-5051; roselli, francesco/0000-0001-9935-6899; Mauceri, Daniela/0000-0003-1225-4633; 	Deutsche Forschungs Gemeinschaft (DFG)German Research Foundation (DFG); ERANET-NEURON initiative "External Insults to the Nervous System", MICRONET consortium; Baustein Program of Ulm University; Ulm University-Bundeswehr Krankenhaus Ulm research initiative; DFGGerman Research Foundation (DFG)European Commission [SFB1158, FOR2325]	The work by FR and BK has been supported by the Deutsche Forschungs Gemeinschaft (DFG) as part of the Collaborative Research Center 1149 "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma". FR is also supported by the ERANET-NEURON initiative "External Insults to the Nervous System" as part of the MICRONET consortium and by the Baustein Program of Ulm University. BK is supported by an Ulm University-Bundeswehr Krankenhaus Ulm research initiative. The work performed by DM is supported by DFG grants SFB1158 and FOR2325. DM is a member of the Excellence Cluster CellNetworks at Heidelberg University.	Ahlgren H, 2014, J BIOL CHEM, V289, P9970, DOI 10.1074/jbc.M113.502914; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Berry C, 2011, AM SURGEON, V77, P1416; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Botta P, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00010; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chandrasekar A, 2017, INT IMMUNOPHARMACOL, V51, P66, DOI 10.1016/j.intimp.2017.08.002; Cho JS, 2016, ALCOHOL CLIN EXP RES, V40, P1290, DOI 10.1111/acer.13065; Corbett BF, 2017, CELL REP, V20, P344, DOI 10.1016/j.celrep.2017.06.040; Criswell HE, 2004, BRAIN RES, V1015, P107, DOI 10.1016/j.brainres.2004.04.050; Criswell HE, 2003, J PHARMACOL EXP THER, V304, P192, DOI 10.1124/jpet.102.041590; Cummings P, 2006, INJURY PREV, V12, P148, DOI 10.1136/ip.2005.010975; Czigner A, 2004, INT J MOL MED, V14, P247; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Gey M, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160091; Gill R, 2013, EUR J NEUROSCI, V38, P3554, DOI 10.1111/ejn.12367; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Grassi D, 2017, CEREB CORTEX, V27, P4166, DOI 10.1093/cercor/bhx095; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; He Q, 2013, J NEUROPHYSIOL, V109, P1333, DOI 10.1152/jn.00350.2012; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Honkaniemi J, 1999, EUR J NEUROSCI, V11, P10, DOI 10.1046/j.1460-9568.1999.00401.x; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P403, DOI 10.1097/TA.0000000000000504; Karelina K, 2017, BRAIN BEHAV IMMUN, V60, P304, DOI 10.1016/j.bbi.2016.11.009; Katada R, 2009, J NEUROTRAUM, V26, P2015, DOI 10.1089/neu.2008.0552; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kidger AM, 2017, P NATL ACAD SCI USA, V114, pE317, DOI 10.1073/pnas.1614684114; Kigar SL, 2015, BRAIN BEHAV IMMUN, V46, P60, DOI 10.1016/j.bbi.2015.02.018; Kumar S, 2009, PSYCHOPHARMACOLOGY, V205, P529, DOI 10.1007/s00213-009-1562-z; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Losing P, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0310-2; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Ma J, 2017, CELL MOL NEUROBIOL, V37, P111, DOI 10.1007/s10571-016-0351-6; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; Mellstrom B, 2014, MOL CELL BIOL, V34, P877, DOI 10.1128/MCB.00360-13; Morris TA, 2000, MOL BRAIN RES, V79, P138, DOI 10.1016/S0169-328X(00)00112-1; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nomaru H, 2014, GLIA, V62, P1284, DOI 10.1002/glia.22680; Oshitari T, 2002, INVEST OPHTH VIS SCI, V43, P2442; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rawat V, 2016, MOL NEUROBIOL, V53, P1165, DOI 10.1007/s12035-014-9058-1; Relja B, 2013, SCAND J GASTROENTERO, V48, P448, DOI 10.3109/00365521.2013.772228; Renaudineau S, 2009, P NATL ACAD SCI USA, V106, P11771, DOI 10.1073/pnas.0900484106; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Shin GT, 2012, INFLAMM RES, V61, P1195, DOI 10.1007/s00011-012-0515-x; Teng SX, 2015, BRAIN BEHAV IMMUN, V45, P145, DOI 10.1016/j.bbi.2014.11.006; Vaagenes IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120356; Wagner N, 2017, ALCOHOL CLIN EXP RES, V41, P1559, DOI 10.1111/acer.13446; Wang L, 2012, NEUROSCIENCE, V220, P100, DOI 10.1016/j.neuroscience.2012.06.010; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; Wang YP, 2014, NEUROREPORT, V25, P954, DOI 10.1097/WNR.0000000000000219; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; YUAN X-Q, 1990, Journal of Neurotrauma, V7, P141, DOI 10.1089/neu.1990.7.141; Yutsudo N, 2013, NEUROPSYCHOPHARMACOL, V38, P895, DOI 10.1038/npp.2012.260; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang X. F., 2014, J ANHUI AGR SCI, V7, P2014, DOI DOI 10.1039/C3EE43278E; Zimprich A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00125	76	14	14	1	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2018	302						34	45		10.1016/j.expneurol.2017.12.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GD1MZ	WOS:000430265300004	29306704				2022-02-06	
J	Eckner, JT; Goshtasbi, A; Curtis, K; Kapshai, A; Myyra, E; Franco, LM; Favre, M; Jacobson, JA; Ashton-Miller, JA				Eckner, James T.; Goshtasbi, Alireza; Curtis, Kayla; Kapshai, Aliaksandra; Myyra, Erik; Franco, Lea M.; Favre, Michael; Jacobson, Jon A.; Ashton-Miller, James A.			Feasibility and Effect of Cervical Resistance Training on Head Kinematics in Youth Athletes: A Pilot Study	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Concussion; Neck Strength; Sports Medicine; Resistance Training	SEGMENT DYNAMIC STABILIZATION; NECK MUSCLE ACTIVATION; UNITED-STATES; STRENGTH; CONCUSSION; FOOTBALL; SPORTS; EPIDEMIOLOGY; BIOMECHANICS; PLAYERS	Greater neck girth and strength may be associated with a lower risk of sport-related concussion due to mitigation of head accelerations by the neck. However, neck strengthening exercise remains unstudied in youth athletes. Therefore, this pilot study assessed the feasibility and effect of targeted neck strengthening exercises in youth athletes. Seventeen participants were allocated to perform 8-wk manual resistance-based neck strengthening (n = 13) or control resistance exercise (n = 4) programs. Before and after the intervention, participants completed laboratory-based assessments of neck size, strength, and head kinematics during standardized test loading in each plane of motion. Descriptive statistics were calculated to compare pre-post changes between the two groups. All participants safely and successfully completed the intervention. Neck girth and strength increased in both groups, with greater increases in the neck strengthening group. Across all planes of motion, overall changes in head linear and angular velocity decreased in both groups, with greater decreases in V in the neck strengthening group and greater decreases in in controls. These results suggest the potential for resistance exercise training to reduce youth athletes' risk for sport-related concussion by increasing neck girth and strength. Additional research is needed to determine optimal neck strengthening programs.	[Eckner, James T.; Myyra, Erik; Franco, Lea M.] Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48109 USA; [Goshtasbi, Alireza; Curtis, Kayla; Kapshai, Aliaksandra; Ashton-Miller, James A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Curtis, Kayla] DISHER, Ann Arbor, MI USA; [Myyra, Erik] Towson Univ, Towson, MD USA; [Favre, Michael] Univ Michigan, Dept Athlet, Ann Arbor, MI 48109 USA; [Jacobson, Jon A.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA		Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48109 USA.			Goshtasbi, Alireza/0000-0002-9575-6091	University of Michigan Injury Center; Mid-Career Investigator Research Grant from the Foundation for Physical Medicine and Rehabilitation; Career Development Award from the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K23 HD078502-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078502, K12HD001097] Funding Source: NIH RePORTER	This work was funded by a pilot grant from the University of Michigan Injury Center and a Mid-Career Investigator Research Grant from the Foundation for Physical Medicine and Rehabilitation. In addition, Dr. Eckner received partial effort support from a Career Development Award from the National Institutes of Health (1K23 HD078502-01A1). The authors do not stand to benefit financially from this work.	Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Caswell SV., 2014, INT J ATHL THER TRAI, V19, P22; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; DEWALD JPA, 1995, BRAIN, V118, P495, DOI 10.1093/brain/118.2.495; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Hamilton DF, 2012, BONE JOINT RES, V1, P152, DOI 10.1302/2046-3758.17.2000079; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; KESHNER EA, 1989, EXP BRAIN RES, V75, P335; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavallee AV, 2013, J BIOMECH, V46, P527, DOI 10.1016/j.jbiomech.2012.09.029; Mansell J, 2005, J ATHL TRAINING, V40, P310; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; National Federation of State High School Associations, 2016, 2014 15 HIGH SCH ATH; Portero R, 2011, ISOKINET EXERC SCI, V19, P7, DOI 10.3233/IES-2011-0390; REID SE, 1981, AVIAT SPACE ENVIR MD, V52, P78; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Staudte H W, 1994, Eur Spine J, V3, P155, DOI 10.1007/BF02190578; Thelen DG, 1996, J AM GERIATR SOC, V44, P804, DOI 10.1111/j.1532-5415.1996.tb03737.x; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Triplett N, 2009, STRENGTH CONDITIONIN; Vasavada AN, 2002, EXP BRAIN RES, V147, P437, DOI 10.1007/s00221-002-1275-6; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0	29	14	14	2	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	APR	2018	97	4					292	297		10.1097/PHM.0000000000000843			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GA1MM	WOS:000428080300016	29557889	Green Accepted			2022-02-06	
J	Elbogen, EB; Wagner, HR; Kimbrel, NA; Brancu, M; Naylor, J; Graziano, R; Crawford, E				Elbogen, Eric B.; Wagner, H. Ryan; Kimbrel, Nathan A.; Brancu, Mira; Naylor, Jennifer; Graziano, Robert; Crawford, Eric		VA Mid-Atlantic MIRECC Workgrp	Risk Factors for Concurrent Suicidal Ideation and Violent Impulses in Military Veterans	PSYCHOLOGICAL ASSESSMENT			English	Article						suicide; violence; veterans; risk assessment; PTSD	POSTTRAUMATIC-STRESS-DISORDER; AFGHANISTAN WAR VETERANS; IRAQ/AFGHANISTAN-ERA VETERANS; STRUCTURED CLINICAL INTERVIEW; SERVICEMEMBERS ARMY STARRS; VIETNAM COMBAT VETERANS; SUBSTANCE-USE DISORDERS; TRAUMATIC BRAIN-INJURY; ABUSE SCREENING-TEST; PSYCHIATRIC COMORBIDITY	Suicide and violence are significant problems in a subset of Iraq/Afghanistan-era veterans. This study investigates how posttraumatic stress disorder (PTSD) and resilience in veterans are associated with suicidal ideation and violent impulses while controlling for known covariates of both adverse outcomes. Structured clinical interviews were conducted of N = 2,543 Iraq/Afghanistan-era U.S. veterans. Compared with veterans denying suicidal ideation or violent impulses (n = 1,927), veterans endorsing both (n = 171) were more likely to meet diagnostic criteria for PTSD, report childhood abuse, combat exposure, physical pain symptoms, and drug misuse, and less likely to endorse self-direction/life purpose. Veterans reporting concurrent suicidal ideation and violent impulses had higher odds of misusing drugs and reporting pain symptoms relative to veterans reporting suicidal ideation only (n = 186) and had lower odds of endorsing self-direction/life purpose compared with veterans reporting violent impulses only (n = 259). The findings underscore the importance of examining drug abuse, physical pain symptoms, and self-direction/life purpose, as well as PTSD and history of trauma, in the context of clinical assessment and empirical research aimed at optimizing risk management of suicide and violence in military veterans.	[Elbogen, Eric B.; Wagner, H. Ryan; Kimbrel, Nathan A.; Brancu, Mira; Naylor, Jennifer; Crawford, Eric] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Elbogen, Eric B.; Wagner, H. Ryan; Kimbrel, Nathan A.; Brancu, Mira; Naylor, Jennifer] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Graziano, Robert] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA		Elbogen, EB (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA.	eric.elbogen@duke.edu		Graziano, Robert/0000-0002-9105-0614	VA Mid-Atlantic Mental Illness Research, Education and Clinical Center; National Center for Complementary and Integrative Health [R34 AT008399-01]; Clinical Science Research and Development Service of the VA Office of Research and Development [IK2 CX000525]; Department of Veterans Affairs Rehabilitation Research and Development Career Development AwardUS Department of Veterans Affairs [11K2RX000908]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R34AT008399] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX000525] Funding Source: NIH RePORTER	We would like to extend our sincere thanks to the participants who volunteered for this study. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. Preparation of this report was supported by the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center and a grant from National Center for Complementary and Integrative Health (R34 AT008399-01). Kimbrel was supported by a Career Development Award (IK2 CX000525) from the Clinical Science Research and Development Service of the VA Office of Research and Development. Naylor was funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (11K2RX000908). The Mid-Atlantic MIRECC Workgroup contributors for this paper include: Jean C. Beckham, Patrick S. Calhoun, Eric Dedert, John A. Fairbank, Kimberly T. Green, Robin A. Hurley, Jason D. Kilts, Angela Kirby, Christine E. Marx, Gregory McCarthy, Scott D. McDonald, Marinell Miller-Mumford, Scott D. Moore, Rajendra A. Morey, Treven C. Pickett, Jared Rowland, Jennifer J. Runnals, Cindy Swinkels, Steven T. Szabo, Katherine H. Taber, Larry A. Tupler, Elizabeth E. Van Voorhees, Richard D. Weiner, Ruth E. Yoash-Gantz.	Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; Babor TF, 2001, AUDIT ALCOHOL USE DI; Beck A., 1996, BECK DEPRESSION INVE; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; Beckham JC, 2000, AGGRESS VIOLENT BEH, V5, P451, DOI 10.1016/S1359-1789(98)00018-4; Begic D, 2001, MIL MED, V166, P671, DOI 10.1093/milmed/166.8.671; Brancu M., INT J METHO IN PRESS; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Clancy CP, 2006, J CLIN PSYCHIAT, V67, P1346, DOI 10.4088/JCP.v67n0904; Cochrane-Brink KA, 2000, GEN HOSP PSYCHIAT, V22, P445, DOI 10.1016/S0163-8343(00)00106-7; Conner KR, 2014, J AFFECT DISORDERS, V166, P1, DOI 10.1016/j.jad.2014.04.067; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; Ejdesgaard BA, 2015, MIL MED, V180, P61, DOI 10.7205/MILMED-D-13-00353; Elbogen EB, 2014, PSYCHOL SERV, V11, P220, DOI 10.1037/a0035088; Elbogen EB, 2014, BRIT J PSYCHIAT, V204, P368, DOI 10.1192/bjp.bp.113.134627; Elbogen EB, 2010, CLIN PSYCHOL REV, V30, P595, DOI 10.1016/j.cpr.2010.03.009; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2015, AN VA HLTH CAR UT OP; Fanning JR, 2013, J PSYCHIATR RES, V47, P1766, DOI 10.1016/j.jpsychires.2013.07.015; Fazel S, 2014, LANCET PSYCHIAT, V1, P44, DOI 10.1016/S2215-0366(14)70223-8; Ferrada-Noli M, 1998, J TRAUMA STRESS, V11, P103, DOI 10.1023/A:1024461216994; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Folkman S, 2008, ANXIETY STRESS COPIN, V21, P3, DOI 10.1080/10615800701740457; Gallaway MS, 2012, AGGRESSIVE BEHAV, V38, P357, DOI 10.1002/ab.21436; GANZINI L, 1995, INT J GERIATR PSYCH, V10, P945, DOI 10.1002/gps.930101106; Glenn D Michael, 2002, Violence Vict, V17, P473, DOI 10.1891/vivi.17.4.473.33685; Goldstein G, 2012, PSYCHIAT RES, V199, P37, DOI 10.1016/j.psychres.2012.03.029; Green KT, 2014, ASSESSMENT, V21, P443, DOI 10.1177/1073191114524014; Guerra VS, 2011, J ANXIETY DISORD, V25, P12, DOI 10.1016/j.janxdis.2010.06.025; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hellmuth JC, 2012, J TRAUMA STRESS, V25, P527, DOI 10.1002/jts.21732; HENDIN H, 1991, AM J PSYCHIAT, V148, P586; Hoffman D. F., 2016, PRESENTED N CAROLINA; Ilgen MA, 2010, SUICIDE LIFE-THREAT, V40, P597, DOI 10.1521/suli.2010.40.6.597; Ilgen MA, 2010, J STUD ALCOHOL DRUGS, V71, P473, DOI 10.15288/jsad.2010.71.473; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kaplan MS, 2007, J EPIDEMIOL COMMUN H, V61, P619, DOI 10.1136/jech.2006.054346; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kimbrel NA, 2016, PSYCHIAT RES, V243, P97, DOI 10.1016/j.psychres.2016.06.011; Kimbrel NA, 2014, PSYCHIAT RES, V220, P397, DOI 10.1016/j.psychres.2014.07.064; KINNEY RK, 1991, SPINE, V16, P940, DOI 10.1097/00007632-199108000-00013; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lehmann LS, 1999, PSYCHIATR SERV, V50, P384, DOI 10.1176/ps.50.3.384; Lenhardt JM, 2012, J TRAUMA STRESS, V25, P461, DOI 10.1002/jts.21717; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; LUND M, 1984, J CLIN PSYCHOL, V40, P1323, DOI 10.1002/1097-4679(198411)40:6<1323::AID-JCLP2270400607>3.0.CO;2-I; MacManus D, 2012, PSYCHOL MED, V42, P1663, DOI 10.1017/S0033291711002327; Miller MW, 2008, J REHABIL RES DEV, V45, P359, DOI 10.1682/JRRD.2007.06.0085; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; National Center for Veterans Analysis and Statistics (NCVAS), 2015, PROF POST 9 11 VET 2; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Owens GP, 2014, J INTERPERS VIOLENCE, V29, P1318, DOI 10.1177/0886260513506274; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P720, DOI 10.1016/j.jpsychires.2010.11.015; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Plagge JM, 2013, PAIN MED, V14, P1164, DOI 10.1111/pme.12155; Rasic D, 2011, J PSYCHIATR RES, V45, P848, DOI 10.1016/j.jpsychires.2010.11.014; Rosellini AJ, 2016, PSYCHOL MED, V46, P303, DOI 10.1017/S0033291715001774; SALTSTONE R, 1994, ADDICT BEHAV, V19, P455, DOI 10.1016/0306-4603(94)90001-9; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Sherman MD, 2006, J MARITAL FAM THER, V32, P479, DOI 10.1111/j.1752-0606.2006.tb01622.x; SKINNER HA, 1986, BRIT J ADDICT, V81, P479; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Snir A, 2017, ARCH SUICIDE RES, V21, P595, DOI 10.1080/13811118.2016.1227740; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stappenbeck CA, 2014, PSYCHOL TRAUMA-US, V6, P65, DOI 10.1037/a0031468; STEER RA, 1993, BEHAV RES THER, V31, P229, DOI 10.1016/0005-7967(93)90090-H; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Sullivan CP, 2014, LAW HUMAN BEHAV, V38, P1, DOI 10.1037/lhb0000035; Taft CT, 2005, J CONSULT CLIN PSYCH, V73, P151, DOI 10.1037/0022-006X.73.1.151; Teten AL, 2009, J TRAUMA STRESS, V22, P307, DOI 10.1002/jts.20422; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; van der Kolk BA, 2005, J TRAUMA STRESS, V18, P389, DOI 10.1002/jts.20047; Wells TS, 2013, J AFFECT DISORDERS, V148, P77, DOI 10.1016/j.jad.2012.11.052; Werbeloff N, 2016, J AFFECT DISORDERS, V205, P387, DOI 10.1016/j.jad.2016.08.015; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Yehuda R, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.57; Youssef NA, 2013, ANN CLIN PSYCHIATRY, V25, P59	87	14	14	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	APR	2018	30	4					425	435		10.1037/pas0000490			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GD3RW	WOS:000430422200001	28627921	Green Accepted, Bronze			2022-02-06	
J	Hellewell, SC; Mondello, S; Conquest, A; Shaw, G; Madorsky, I; Deng, JV; Little, L; Kobeissy, F; Bye, N; Bellomo, R; Cooper, DJ; Vallance, S; Board, J; Morganti-Kossmann, MC				Hellewell, Sarah C.; Mondello, Stefania; Conquest, Alison; Shaw, Gerry; Madorsky, Irina; Deng, Jay V.; Little, Lorraine; Kobeissy, Firas; Bye, Nicole; Bellomo, Rinaldo; Cooper, David J.; Vallance, Shirley; Board, Jasmine; Morganti-Kossmann, Maria C.			Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial	CRITICAL CARE MEDICINE			English	Article						biomarker; erythropoietin; phosphorylated neurofilament heavy-chain; traumatic brain injury; ubiquitin carboxy-terminal hydrolase L1	C-TERMINAL HYDROLASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; INTRACRANIAL LESIONS; DOUBLE-BLIND; PNF-H; NF-H; SUBUNIT; BLOOD; RECOVERY; THERAPY	Objective: To determine profiles of serum ubiquitin carboxy-terminal hydrolase L1 and phosphorylated neurofilament heavy-chain, examine whether erythropoietin administration reduce their concentrations, and whether biomarkers discriminate between erythropoietin and placebo treatment groups. Design: Single-center, prospective observational study. Setting: A sub-study of the erythropoietin-traumatic brain injury clinical trial, conducted at the Alfred Hospital, Melbourne, Australia. Patients: Forty-four patients with moderate-to-severe traumatic brain injury. Interventions: Epoetin alfa 40,000 IU or 1 mL sodium chloride 0.9 as subcutaneous injection within 24 hours of traumatic brain injury. Measurements and Main Results: Ubiquitin carboxy-terminal hydrolase L1, phosphorylated neurofilament heavy-chain, and erythropoietin concentrations were measured in serum by enzyme-linked immunosorbent assay from D0 (within 24 hr of injury, prior to erythropoietin/vehicle administration) to D5. Biomarker concentrations were compared between injury severities, diffuse versus focal traumatic brain injury and erythropoietin or placebo treatment groups. Ubiquitin carboxy-terminal hydrolase L1 peaked at 146.0 ng/mL on D0, significantly decreased to 84.30 ng/mL on D1, and declined thereafter. Phosphorylated neurofilament heavy-chain levels were lowest at D0 and peaked on D5 at 157.9 ng/mL. D0 ubiquitin carboxy-terminal hydrolase L1 concentrations were higher in diffuse traumatic brain injury. Peak phosphorylated neurofilament heavy-chain levels on D3 and D4 correlated with Glasgow Outcome Score-Extended, predicting poor outcome. Erythropoietin did not reduce concentrations of ubiquitin carboxy-terminal hydrolase L1 or phosphorylated neurofilament heavy-chain. Conclusions: Serum ubiquitin carboxy-terminal hydrolase L1 and phosphorylated neurofilament heavy-chain increase after traumatic brain injury reflecting early neuronal and progressive axonal injury. Consistent with lack of improved outcome in traumatic brain injury patients treated with erythropoietin, biomarker concentrations and profiles were not affected by erythropoietin. Pharmacokinetics of erythropoietin suggest that the dose given was possibly too low to exert neuroprotection.	[Hellewell, Sarah C.] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada; [Hellewell, Sarah C.; Bye, Nicole] Alfred Hosp, Dept Surg, Melbourne, Vic, Australia; [Hellewell, Sarah C.; Conquest, Alison; Bellomo, Rinaldo; Cooper, David J.] Monash Univ, Dept Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Shaw, Gerry; Madorsky, Irina; Deng, Jay V.] EnCor Biotechnol Inc, Gainesville, FL USA; [Little, Lorraine; Cooper, David J.; Vallance, Shirley; Board, Jasmine; Morganti-Kossmann, Maria C.] Australian New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Kobeissy, Firas] Univ Florida, McKnight Brain Inst, Dept Psychiat & Neurosci, Gainesville, FL USA; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care Res, Melbourne, Vic, Australia; [Cooper, David J.] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Morganti-Kossmann, Maria C.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Morganti-Kossmann, Maria C.] Univ Arizona, Dept Child Hlth, Barrow Neurol Inst, Phoenix, AZ USA		Hellewell, SC (corresponding author), Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada.; Hellewell, SC (corresponding author), Alfred Hosp, Dept Surg, Melbourne, Vic, Australia.; Hellewell, SC (corresponding author), Monash Univ, Dept Med Nursing & Hlth Sci, Melbourne, Vic, Australia.	hellewel@ualberta.ca	Mondello, Stefania/A-1813-2012; Cooper, D. James/G-7961-2013; Kobeissy, Firas/E-7042-2017; , Gerry/X-2377-2019	Mondello, Stefania/0000-0002-8587-3614; Cooper, D. James/0000-0002-5872-9051; Kobeissy, Firas/0000-0002-5008-6944; Morganti-Kossmann, Cristina/0000-0002-0807-2063; Hellewell, Sarah/0000-0002-2179-2209	Centre of Excellence in Traumatic Brain Injury Research (CETBIR) Postdoctoral Fellowship; National Health and Medical Research Council (NHMRC) AustraliaNational Health and Medical Research Council of Australia; Transport Accident Commission (TAC); Monash University from the NHMRC; TAC grants; Victorian Neurotrauma Initiative	Dr. Hellewell was supported by a Centre of Excellence in Traumatic Brain Injury Research (CETBIR) Postdoctoral Fellowship.; Drs. Little and Cooper's institutions received funding from National Health and Medical Research Council (NHMRC) Australia. Dr. Little's institution received funding from the Transport Accident Commission (TAC), and she disclosed that she project-managed the EPO-TBI RCT and received a salary via Monash University from the NHMRC and TAC grants for her work. Drs. Bellomo and Cooper disclosed off-label product use of erythropoietin in traumatic brain injury. Dr. Cooper's institution received funding from Victorian Neurotrauma Initiative. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adamcio B, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-37; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Berger RP, 2011, PM&R, V3, pS31, DOI 10.1016/j.pmrj.2011.03.016; Bian XX, 2010, NEUROL MED-CHIR, V50, P361, DOI 10.2176/nmc.50.361; Blennow K, 2014, NEUROPSYCHOPHARMACOL, V39, P189, DOI 10.1038/npp.2013.154; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Brophy G, 2009, J NEUROTRAUM, V26, pA14; Cai JY, 2013, CLIN CHIM ACTA, V424, P182, DOI 10.1016/j.cca.2013.06.019; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2011, MOL MED, V17, P1306, DOI 10.2119/molmed.2011.00259; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; HARRIS J, 1991, J NEUROSCI RES, V30, P47, DOI 10.1002/jnr.490300107; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Kiiski H, 2016, J NEUROL SCI, V361, P144, DOI 10.1016/j.jns.2015.12.046; Kobeissy F.H, 2015, BRAIN NEUROTRAUMA MO; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shibahashi K, 2016, J NEUROTRAUM, V33, P1826, DOI 10.1089/neu.2015.4237; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sosna J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-76; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang KKW, 2013, PROC SPIE, V8723, DOI 10.1117/12.2020030; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510	46	14	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2018	46	4					554	561		10.1097/CCM.0000000000002938			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ7IZ	WOS:000427775500032	29278529				2022-02-06	
J	Hudson, TJ; Painter, JT; Gressler, LE; Lu, LY; Williams, JS; Booth, BM; Martin, BC; Sullivan, MD; Edlund, MJ				Hudson, Teresa J.; Painter, Jacob T.; Gressler, Laura E.; Lu, Liya; Williams, J. Silas; Booth, Brenda M.; Martin, Bradley C.; Sullivan, Mark D.; Edlund, Mark J.			Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury	PAIN MEDICINE			English	Article						Opioid; Traumatic Brain Injury; Veteran; Pain	CHRONIC NONCANCER PAIN; PERSISTENT PAIN; IRAQI FREEDOM; PRESCRIPTION; COMORBIDITY; AFGHANISTAN; PREVALENCE; DEPRESSION; DISORDERS; TRENDS	Objective. These analyses examined opioid initiation and chronic use among Iraq (OIF) and Afghanistan (OEF/OND) veterans with a new diagnosis of traumatic brain injury (TBI) in the Veterans Health Administration (VHA). Methods. Data were obtained from national VHA data repositories. Analyses included OEF/OIF/OND veterans with a new TBI diagnosis in 2010-2012 who used the VHA at least twice, had not received a VHA opioid prescription in the 365 days before diagnosis, and had at least 365 days of data available after TBI diagnosis. Results. Analyses included 35,621 veterans. Twenty-one percent initiated opioids; among new initiators, 23% used chronically. The mean dose was 24.0mg morphine equivalent dose (MED) daily (SD=24.26); mean days supplied was 60.52 (SD=74.69). Initiation was significantly associated with age 36-45 years (odds ratio [OR] = 1.09, 95% CI=1.01-1.17, P=0.04), female gender (OR=1.22, P<0.001), having back pain (OR=1.38, P<0.0001), arthritis/joint pain (OR=1.24, P<0.0001), or neuropathic pain (OR=1.415, P<0.02). In veterans age 36-45 years, those living in small rural areas had higher odds of chronic opioid use (OR=1.31, P<0.0001, and OR=1.33, P=0.006, respectively) and back pain (OR=1.36, P=0.003). Headache/migraine pain was associated with decreased odds of chronic opioid use (OR=0.639, P=0.003). Conclusions. Prevalence of opioid use is relatively low among OEF/OIF/OND veterans with newly diagnosed TBI who are using VHA. Among those who initiated opioids, about 25% use them chronically. Prescribing was mostly limited to moderate doses, with most veterans using opioids for approximately two months of the 12-month study period.	[Hudson, Teresa J.; Painter, Jacob T.; Gressler, Laura E.; Williams, J. Silas] Cent Arkansas Vet Healthcare Syst, Ctr Mental Healthcare & Outcomes Res, HSR&D, Little Rock, AR USA; [Hudson, Teresa J.; Lu, Liya; Booth, Brenda M.] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA; [Painter, Jacob T.; Gressler, Laura E.; Martin, Bradley C.] Univ Arkansas Med Sci, Dept Pharm Practice, Div Pharmaceut Outcome & Policy, Little Rock, AR 72205 USA; [Sullivan, Mark D.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Edlund, Mark J.] RTI Int, Behav & Urban Hlth Epidemiol Program, Durham, NC USA; [Edlund, Mark J.] St Lukes Hlth Syst, Behav Hlth Serv, Twin Falls, ID USA		Hudson, TJ (corresponding author), Cent Arkansas Vet Healthcare Syst, Ctr Mental Healthcare & Outcomes Res, HSR&D, 2200 Ft Roots Dr, North Little Rock, AR 72114 USA.	hudsonteresaj@uams.edu			National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01 DA030300]; VA HSR&D Center for Mental Healthcare and Outcomes Research	This research was supported by the National Institute on Drug Abuse (grant No. R01 DA030300). Dr. Hudson also receives support from the VA HSR&D Center for Mental Healthcare and Outcomes Research.	Agency Medical Directors Group, 2010, INT GUID OP DOS CHR; Ashburn MA, 2003, PRINC AN US TREATM A; Atluri S, 2014, PAIN PHYSICIAN, V17, pE119; Baumblatt JAG, 2014, JAMA INTERN MED, V174, P796, DOI 10.1001/jamainternmed.2013.12711; Beaudoin FL, 2014, AM J EMERG MED, V32, P580, DOI 10.1016/j.ajem.2014.02.030; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Braden JB, 2008, J PAIN, V9, P1026, DOI 10.1016/j.jpain.2008.06.002; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Burgess DJ, 2014, J PAIN, V15, P447, DOI 10.1016/j.jpain.2013.12.010; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cicero TJ, 2008, PAIN, V139, P127, DOI 10.1016/j.pain.2008.03.021; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Congress of the United States Congressional Budget Office, 2012, VET HLTH ADM TREATM; Dobscha SK, 2013, CLIN J PAIN, V29, P102, DOI 10.1097/AJP.0b013e3182490bdb; Edlund MJ, 2014, PAIN, V155, P2337, DOI 10.1016/j.pain.2014.08.033; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2014, AN VA HLTH CAR UT AM; Fabrizio KS, 2010, NURS CLIN N AM, V45, P569, DOI 10.1016/j.cnur.2010.06.003; Frayne SM, 2012, SOURCEBOOK WOMEN VET, V2; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Haskell SG, 2009, PAIN MED, V10, P1167, DOI 10.1111/j.1526-4637.2009.00714.x; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hudson TJ, 2008, J PAIN SYMPTOM MANAG, V36, P280, DOI 10.1016/j.jpainsymman.2007.10.003; Kaur S, 2007, J GEN INTERN MED, V22, P228, DOI 10.1007/s11606-006-0048-5; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Macey TA, 2011, PAIN MED, V12, P1502, DOI 10.1111/j.1526-4637.2011.01226.x; Minneapolis Veterans Affairs Medical Center Minnesota Evidence Synthesis Program Center for Chronic Disease Outcomes Research., ASS TREATM IND HIST; Morasco BJ, 2011, J GEN INTERN MED, V26, P965, DOI 10.1007/s11606-011-1734-5; Morasco BJ, 2010, PAIN, V151, P625, DOI 10.1016/j.pain.2010.08.002; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; O'Neil ME, 2013, 05225 VA ESP; Rural Health Research Center, 2012, RUCA DAT US RUC DAT; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sullivan MD, 2008, PAIN, V138, P440, DOI 10.1016/j.pain.2008.04.027; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Taber KH, 2010, PTSD RES Q, V21, P1; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor B, 2012, 0520102 PLY; Taylor BC, 2014, 0520102 QUERI PLY; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; US Department of Justice Drug Enforcement Administration Office of Diversion Control., CONTR SUBST SCH; US Department of Veterans Affairs Office of Acquisition and Logistics (OAL), 2013, US DEP VET AFF OFF S; Vanderlip ER, 2014, PAIN, V155, P2673, DOI 10.1016/j.pain.2014.09.034; Veterans Health Administration Department of Defense, 2010, VA DOD CLIN PRACT GU; Vieweg W Victor R, 2005, Prim Care Companion J Clin Psychiatry, V7, P86; Weimer MB, 2013, PAIN MED, V14, P1839, DOI 10.1111/pme.12177; Wu Phipson C, 2010, J Opioid Manag, V6, P133	53	14	14	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	APR	2018	19	4					774	787		10.1093/pm/pnx208			14	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	GT1VU	WOS:000444265700017	29036680	Green Published, hybrid			2022-02-06	
J	Moskowitz, EE; Burlew, CC; Moore, EE; Pieracci, FM; Fox, CJ; Campion, EM; Lawless, RA; Cohen, MJ				Moskowitz, Eliza E.; Burlew, Clay Cothren; Moore, Ernest E.; Pieracci, Fredric M.; Fox, Charles J.; Campion, Eric M.; Lawless, Ryan A.; Cohen, Mitchell J.			Preperitoneal pelvic packing is effective for hemorrhage control in open pelvic fractures	AMERICAN JOURNAL OF SURGERY			English	Article						Preperitoneal pelvic packing; Pelvic fractures; Open pelvic fractures; Trauma; Hemorrhage; Shock	HEMODYNAMICALLY UNSTABLE PATIENTS; LIFE-THREATENING HEMORRHAGE; MANAGEMENT; MORTALITY; ANGIOEMBOLIZATION; MULTICENTER; IMPROVEMENT; CARE	Background: Open pelvic fractures are life-threatening injuries. Preperitoneal pelvic packing (PPP) has been suggested to be ineffective for hemorrhage control in open pelvic fractures. We hypothesize that PPP is effective at hemorrhage control in patients with open pelvic fractures and reduces mortality. Methods: Patients undergoing PPP from 2005 to 2015 were analyzed. Patients with open pelvic fractures were defined as direct communication of the bony injury with overlying soft tissue, vagina, or rectum. Results: During the 10-year study, 126 patients underwent PPP; 14 (11%) sustained an open pelvic fracture. After PPP, 1 patient (7%) underwent angioembolization with a documented arterial blush. PPP controlled pelvic hemorrhage in all patients. Overall mortality rate was 7% with one death due to traumatic brain injury. Conclusions: PPP is effective for hemorrhage control in patients with open pelvic fractures. PPP should be used in a standard protocol for hemodynamically unstable patients with pelvic fractures regardless of associated perineal injuries. (C) 2017 Elsevier Inc. All rights reserved.	[Burlew, Clay Cothren] Denver Hlth Med Ctr, Dept Surg, 777 Bannock St, Denver, CO 80204 USA; Univ Colorado Denver, Denver, CO USA		Burlew, CC (corresponding author), Denver Hlth Med Ctr, Dept Surg, 777 Bannock St, Denver, CO 80204 USA.	clay.cothren@dhha.org		Campion, Eric/0000-0002-4563-7748			Bircher M., 2005, EUR J TRAUMA, V6, P526; BIRCHER M, 2004, EUR J TRAUMA, V30, P74; Black Emily Anne, 2011, Iowa Orthop J, V31, P193; Brenneman FD, 1997, J TRAUMA, V42, P773, DOI 10.1097/00005373-199705000-00003; Burlew CC, 2017, J TRAUMA ACUTE CARE, V82, P233, DOI 10.1097/TA.0000000000001324; Burlew CC, 2011, J AM COLL SURGEONS, V212, P628, DOI 10.1016/j.jamcollsurg.2010.12.020; Cannada LK, 2013, J TRAUMA ACUTE CARE, V74, P901, DOI 10.1097/TA.0b013e3182827496; Cannada Lisa K, 2011, Am J Orthop (Belle Mead NJ), V40, P415; Cheng M, 2015, EMERG MED J, V32, P214, DOI 10.1136/emermed-2012-202009; Chiara O, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0077-2; Dente CJ, 2005, AM J SURG, V190, P830, DOI 10.1016/j.amjsurg.2005.05.050; Dong JL, 2011, INJURY, V42, P1003, DOI 10.1016/j.injury.2011.01.032; Giordano Vincenzo, 2016, Open Orthop J, V10, P772, DOI 10.2174/1874325001610010772; Grotz MRW, 2005, INJURY, V36, P1, DOI 10.1016/j.injury.2004.05.029; Heetveld MJ, 2004, WORLD J SURG, V28, P904, DOI 10.1007/s00268-004-7357-9; Jones AL, 1997, ORTHOP CLIN N AM, V28, P345, DOI 10.1016/S0030-5898(05)70293-5; Li QH, 2016, INJURY, V47, P395, DOI 10.1016/j.injury.2015.10.008; Magnone S, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-18; Marzi I, 2014, SCAND J SURG, V103, P104, DOI 10.1177/1457496914525604; Perkins ZB, 2014, BONE JOINT J, V96B, P1090, DOI 10.1302/0301-620X.96B8.33383; Tai DKC, 2011, J TRAUMA, V71, pE79, DOI 10.1097/TA.0b013e31820cede0; Velmahos GC, 2013, TRAUMA	22	14	16	0	7	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	APR	2018	215	4					675	677		10.1016/j.amjsurg.2017.11.024			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GA2US	WOS:000428181800024	29179908				2022-02-06	
J	Nogueira, ML; Hamraz, M; Abolhassani, M; Bigan, E; Lafitte, O; Steyaert, JM; Dubois, B; Schwartz, L				Nogueira, Marcel Levy; Hamraz, Minoo; Abolhassani, Mohammad; Bigan, Erwan; Lafitte, Olivier; Steyaert, Jean-Marc; Dubois, Bruno; Schwartz, Laurent			Mechanical stress increases brain amyloid beta, tau, and alpha-synuclein concentrations in wild-type mice	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease; Parkinson's disease; Animal models; Mechanical stress; Repetitive mild traumatic brain injury; Amyloid; Tau; alpha-synuclein	CHRONIC TRAUMATIC ENCEPHALOPATHY; CONTROLLED CORTICAL IMPACT; LONG-TERM ACCUMULATION; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; MOUSE MODEL; NEURODEGENERATIVE DISEASES; COGNITIVE IMPAIRMENT; INJURY MODEL; HEAD-INJURY	Introduction: Exposure to traumatic brain injury is a core risk factor that predisposes an individual to sporadic neurodegenerative diseases. We provide evidence that mechanical stress increases brain levels of hallmark proteins associated with neurodegeneration. Methods: Wild-type mice were exposed to multiple regimens of repetitive mild traumatic brain injury, generating a range of combinations of impact energies, frequencies, and durations of exposure. Brain concentrations of amyloid beta 1-42 (A beta(1-42)), total tau, and alpha-synuclein were measured by sandwich enzyme-linked immunosorbent assay. Results: There was a highly significant main effect of impact energy, frequency, and duration of exposure on A beta(1-42), tau, and alpha-synuclein levels (P<.001), and a significant interaction between impact energy and duration of exposure for A beta(1-42) and tau (P<.001), but not for alpha-synuclein. Discussion: Dose-dependent and cumulative influence of repetitive mild traumatic brain injury-induced mechanical stress may trigger and/or accelerate neurodegeneration by pushing protein concentration over the disease threshold. (C) 2017 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.	[Nogueira, Marcel Levy; Dubois, Bruno] Hop La Pitie Salpetriere, AP HP, Dept Neurol, IM2A, Paris, France; [Nogueira, Marcel Levy; Dubois, Bruno] Inst Cerveau & Moelle Epiniere ICM, Inst Rech Translat Neurosci IHU A ICM, Paris, France; [Hamraz, Minoo; Abolhassani, Mohammad] Nosco Pharmaceut, Paris, France; [Bigan, Erwan; Steyaert, Jean-Marc] Univ Paris Saclay, Lab Informat LIX, Ecole Polytech, UMR 7161, Palaiseau, France; [Lafitte, Olivier] Univ Paris 13, LAGA, UMR 7539, Sorbonne Paris Cite, Villetaneuse, France; [Dubois, Bruno] Inst Cerveau & Moelle Epiniere ICM, CNRS, INSERM, UMR S975, Paris, France; [Schwartz, Laurent] AP HP, Paris, France		Nogueira, ML (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Neurol, IM2A, Paris, France.; Nogueira, ML (corresponding author), Inst Cerveau & Moelle Epiniere ICM, Inst Rech Translat Neurosci IHU A ICM, Paris, France.	marcel.levy@psl.aphp.fr					Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chetelat G, 2013, NAT REV NEUROL, V9, P123, DOI [10.1038/nrneurol.2013.21, 10.1038/nrneurol.2013.21-c2]; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Houpt TA, 2013, AM J PHYSIOL-REG I, V305, pR793, DOI 10.1152/ajpregu.00549.2012; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Nogueira ML, 2016, ALZHEIMERS DEMENT, V12, P324, DOI 10.1016/j.jalz.2015.10.005; Nogueira ML, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00197; Pannuzzo M, 2013, PHYS CHEM CHEM PHYS, V15, P8940, DOI 10.1039/c3cp44539a; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Surgucheva I, 2014, MOL CELL NEUROSCI, V63, P114, DOI 10.1016/j.mcn.2014.10.005; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00223; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; van Raaij ME, 2008, BIOPHYS J, V95, P4871, DOI 10.1529/biophysj.107.127464; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	51	14	14	2	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	APR	2018	14	4					444	453		10.1016/j.jalz.2017.11.003			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC6LN	WOS:000429903200002	29244999				2022-02-06	
J	Cacialli, P; D'angelo, L; Kah, O; Coumailleau, P; Gueguen, MM; Pellegrini, E; Lucini, C				Cacialli, Pietro; D'angelo, Livia; Kah, Olivier; Coumailleau, Pascal; Gueguen, Marie-Madeleine; Pellegrini, Elisabeth; Lucini, Carla			Neuronal expression of brain derived neurotrophic factor in the injured telencephalon of adult zebrafish	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						brain; brain traumatic; fish; injury; lesion; neurotrophins; regeneration; repair; RRID AB_477413; RRID AB_477585; RRID AB_221448; RRID; AB_2633275	MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; FACTOR BDNF; ANATOMICAL DISTRIBUTION; PROGENITOR CELLS; UP-REGULATION; RAT-BRAIN; NEUROGENESIS; REGENERATION; FOREBRAIN	The reparative ability of the central nervous system varies widely in the animal kingdom. In the mammalian brain, the regenerative mechanisms are very limited and newly formed neurons do not survive longer, probably due to a non-suitable local environment. On the opposite, fish can repair the brain after injury, with fast and complete recovery of damaged area. The brain of zebrafish, a teleost fish widely used as vertebrate model, also possesses high regenerative properties after injury. Taking advantage of this relevant model, the aim of the present study was to investigate the role of brain-derived neurotrophic factor (BDNF) in the regenerative ability of adult brain, after stab wound telencephalic injury. BDNF is involved in many brain functions and plays key roles in the repair process after traumatic brain lesions. It has been reported that BDNF strengthens the proliferative activity of neuronal precursor cells, facilitates the neuronal migration toward injured areas, and shows survival properties due to its anti-apoptotic effects. BDNF mRNA levels, assessed by quantitative PCR and in situ hybridization at 1, 4, 7, and 15 days after the lesion, were increased in the damaged telencephalon, mostly suddenly after the lesion. Double staining using in situ hybridization and immunocytochemistry revealed that BDNF mRNA was restricted to cells identified as mature neurons. BDNF mRNA expressing neurons mostly increased in the area around the lesion, showing a peak 1 day after the lesion. Taken together, these results highlight the role of BDNF in brain repair processes and reinforce the value of zebrafish for the study of regenerative neurogenesis.	[Cacialli, Pietro; D'angelo, Livia; Lucini, Carla] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Cacialli, Pietro; Kah, Olivier; Coumailleau, Pascal; Gueguen, Marie-Madeleine; Pellegrini, Elisabeth] Univ Rennes 1, Res Inst Hlth Environm & Occupat, SFR Biosit, Inserm,UMR 1085, Rennes, France		Lucini, C (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy.; Pellegrini, E (corresponding author), Univ Rennes 1, Res Inst Hlth Environm & Occupat, SFR Biosit, Inserm,UMR 1085, Rennes, France.	carla.lucini@unina.it; elisabeth.pellegrini@univ-rennes1.fr	Lucini, Carla/E-6828-2013; Pellegrini, Elisabeth/K-1705-2015; cacialli, pietro/AAO-1662-2020; kah, olivier/K-7624-2012	Lucini, Carla/0000-0003-2216-6338; Pellegrini, Elisabeth/0000-0003-4821-0966; cacialli, pietro/0000-0003-1250-0793; 	INSERMInstitut National de la Sante et de la Recherche Medicale (Inserm)European Commission; University of Rennes 1 (France)	We greatly appreciated the help of the staff of the zebrafish Biosit facility (Laboratoire de Physiologie et Genetique des Poissons, INRA, Rennes. We thank Mr Antonio Calamo for his skillful assistance during elaboration of all graphics and images. We are thankful for INSERM and University of Rennes 1 (France) for funding our research supported this research.	Abbate F, 2014, NEUROSCI LETT, V563, P66, DOI 10.1016/j.neulet.2014.01.031; Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Alder J, 2016, BRAIN INJURY, V30, P48, DOI 10.3109/02699052.2015.1088963; Alunni A, 2016, DEVELOPMENT, V143, P741, DOI 10.1242/dev.122796; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Broglio C, 2005, BRAIN RES BULL, V66, P277, DOI 10.1016/j.brainresbull.2005.03.021; Cacialli P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158057; CASTREN E, 1995, NEUROSCIENCE, V64, P71, DOI 10.1016/0306-4522(94)00386-J; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; Coumailleau P, 2014, J NEUROENDOCRINOL, V26, P226, DOI 10.1111/jne.12142; D'Angelo L, 2016, ANN ANAT, V205, P75, DOI 10.1016/j.aanat.2016.02.001; D'Angelo L, 2014, J COMP NEUROL, V522, P1004, DOI 10.1002/cne.23457; Dalton VS, 2009, NEUROSCI LETT, V461, P275, DOI 10.1016/j.neulet.2009.06.038; De Felice E, 2014, J ANAT, V224, P564, DOI 10.1111/joa.12168; Deinhardt K, 2014, NEUROPHARMACOLOGY, V76, P603, DOI 10.1016/j.neuropharm.2013.04.054; Diotel N, 2013, HORM BEHAV, V63, P193, DOI 10.1016/j.yhbeh.2012.04.003; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Ferrer I, 1997, J NEUROPATH EXP NEUR, V56, P790; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; Gatta C, 2016, J MORPHOL, V277, P725, DOI 10.1002/jmor.20530; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Huang S, 1998, MECH DEVELOP, V71, P23, DOI 10.1016/S0925-4773(97)00199-8; KhorshidAhmad T, 2016, MOL NEUROBIOL, V53, P1092, DOI 10.1007/s12035-014-9074-1; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kyritsis N, 2014, TRENDS CELL BIOL, V24, P128, DOI 10.1016/j.tcb.2013.08.004; Lum T, 2001, INT J DEV NEUROSCI, V19, P569, DOI 10.1016/S0736-5748(01)00041-7; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Meeker RB, 2015, NEURAL REGEN RES, V10, P721, DOI 10.4103/1673-5374.156967; Migaud M, 2016, THERIOGENOLOGY, V86, P313, DOI 10.1016/j.theriogenology.2016.04.044; Molendijk ML, 2014, MOL PSYCHIATR, V19, P791, DOI 10.1038/mp.2013.105; Montalbano G, 2016, ANN ANAT, V204, P36, DOI 10.1016/j.aanat.2015.11.003; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Quartu M, 2010, BRAIN RES, V1363, P49, DOI 10.1016/j.brainres.2010.09.106; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Salas C, 2003, BRAIN BEHAV EVOLUT, V62, P72, DOI 10.1159/000072438; SchmidtKastner R, 1996, NEUROSCIENCE, V74, P161, DOI 10.1016/0306-4522(96)00093-0; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Silhol M, 2005, NEUROSCIENCE, V132, P613, DOI 10.1016/j.neuroscience.2005.01.008; Skaggs K, 2014, GLIA, V62, P2061, DOI 10.1002/glia.22726; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Vajn K, 2013, NEUROSCI BULL, V29, P402, DOI 10.1007/s12264-013-1361-8; Vissio PG, 2008, TISSUE CELL, V40, P261, DOI 10.1016/j.tice.2008.01.001; Wang Y, 2013, INT J NEUROSCI, V123, P191, DOI 10.3109/00207454.2012.744755; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232; Wysokinski A, 2016, NORD J PSYCHIAT, V70, P267, DOI 10.3109/08039488.2015.1087592; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 2011, EUR J NEUROSCI, V34, P917, DOI 10.1111/j.1460-9568.2011.07854.x	62	14	14	1	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	MAR 1	2018	526	4					569	582		10.1002/cne.24352			14	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	FS5JC	WOS:000419829600001	29124763	Green Submitted			2022-02-06	
J	Coxe, K; Hamilton, K; Harvey, HH; Xiang, J; Ramirez, MR; Yang, JZ				Coxe, Kathryn; Hamilton, Kelsey; Harvey, Hosea H.; Xiang, Joe; Ramirez, Marizen R.; Yang, Jingzhen			Consistency and Variation in School-Level Youth Sports Traumatic Brain Injury Policy Content	JOURNAL OF ADOLESCENT HEALTH			English	Article						TBI; Content analysis; Written policy; High school	UNITED-STATES; CONCUSSION; EDUCATION; LAWS	Purpose: The purpose of the study was to examine the consistency and variation in content of high school written traumatic brain injury (TBI) policies in relation to the three key tenets of youth sports TBI laws. Methods: A content analysis was conducted on written TBI policies retrieved from 71 high schools currently participating in High School Reporting Information Online. Each policy was independently analyzed by two trained coders. The number and percent of the policies reflecting the three key tenets of state youth sports TBI laws were described and compared on policy enforcement (i.e., strictness of language), policy description (i.e., details and definitions of the requirements), and policy implementation steps (i.e., specific steps for implementing the requirements). Direct quotes were identified to support quantitative findings. Results: All 71 high school TBI policies contained at least two of the three main TBI law tenets, where 98.6% (n = 70) included the return to play tenet, 83.1% (n = 59) included the removal from play tenet, and 59.2% (n = 42) specified the distribution of TBI information sheets to student-athletes and their parents. Nearly half of the policies (49.3%, n = 35) required parents' signature while only 39.4% (n = 28) required students' signature on the TBI information sheet. The language exhibited wide variance across the 71 TBI policies regarding policy enforcement, policy description, and policy implementation specifications. Conclusions: All 71 TBI policies covered at least two of the three youth sports TBI law tenets, but with considerable variation. Future research should assess variations by schools within the same state and their impact on TBI rates in school athletics. (C) 2017 Society for Adolescent Health and Medicine. All rights reserved.	[Coxe, Kathryn; Xiang, Joe; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43215 USA; [Coxe, Kathryn] Ohio Dept Mental Hlth & Addict Serv, Dept Qual Planning & Res, Columbus, OH USA; [Hamilton, Kelsey] Kent State Univ, Coll Publ Hlth, Kent, OH 44242 USA; [Harvey, Hosea H.] Temple Univ, Beasley Sch Law, Philadelphia, PA 19122 USA; [Xiang, Joe] Ohio Univ, Ctr Intervent Res Sch, Athens, OH 45701 USA; [Ramirez, Marizen R.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA; [Yang, Jingzhen] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA		Yang, JZ (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43215 USA.	Ginger.Yang@nationwidechildrens.org	Coxe, Kathryn/AAJ-8041-2021	Coxe, Kathryn/0000-0002-7813-1081	Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF) [30822]	This work was supported by the Robert Wood Johnson Foundation (grant #30822). The interpretations and conclusions in this article do not necessarily represent those of the funding organization.	Amberg P., 2012, MARQUETTE SPORTS LAW, V23, P171; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; California Interscholastic Federation, 2016, CONC; Centers for Disease Control and Prevention, IMPL RET PLAY LEARN; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Devore CD, 2013, PEDIATRICS, V131, P178, DOI 10.1542/peds.2012-2995; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Esquivel A, 2013, SPORTS HEALTH, V5, P258, DOI 10.1177/1941738113476850; Fairfax County Public Schools Office of Government Relations, 2016, GEN ASS SUMM STUD AC; Gibson TB, 2014, JAMA PEDIAT, V169, pE1; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glassman SJ, 2011, NEW HAMPSHIRE BAR J, V52, P26; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harvey HH, 2015, J LAW MED ETHICS, V43, P87, DOI 10.1111/jlme.12225; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kerr ZY, 2013, AM J LIFESTYLE MED, V7, P138, DOI 10.1177/1559827612450683; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Lowrey KM., 2015, J BUS TECHNOL LAW, V10, P61; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McGowen K, RETURN TO LEARN ACAD; National Conference of State Legislatures, TRAUM BRAIN INJ LEG; Program for Injury Prevention. Education & Research (PIPER), ED RES PIPER HIGH SC; Public Health Law Research, 2015, YOUTH SPORTS TRAUM B; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Robert Wood Johnson Foundation & Thompson, COD YOUTH SPORTS TRA; Smart Growth America & The National Complete Streets Coalition, BEST COMPL STREETS P; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Trojian T, 2015, INJ EPIDEMIOL, V2, P1; Zhang N, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2870; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	36	14	14	3	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	MAR	2018	62	3					255	264		10.1016/j.jadohealth.2017.07.003			10	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	FX2BD	WOS:000425861300004	28970062	Bronze			2022-02-06	
J	Gera, G; Chesnutt, J; Mancini, M; Horak, FB; King, LA				Gera, Geetanjali; Chesnutt, Jim; Mancini, Martina; Horak, Fay B.; King, Laurie A.			Inertial Sensor-Based Assessment of Central Sensory Integration for Balance After Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium (MHSRS)	2016	FL				ERROR SCORING SYSTEM; VESTIBULAR CONSEQUENCES; BLAST EXPOSURE; CONCUSSION; ORGANIZATION; SENSITIVITY; DISORDERS; STABILITY; DIZZINESS; SYMPTOMS	Introduction: Optimal balance control requires a complex integration of sensory information from the visual, vestibular, and proprioceptive systems. The goal of this study is to determine if the instrumented modified Clinical Test of Sensory Integration and Balance (mCTSIB) was impaired acutely after mild traumatic brain injury (mTBI) when postural sway under varying sensory conditions was measured with a wearable inertial sensor. Materials and Methods: Postural sway was assessed in athletes who had sustained a mTBI within the past 2-3 d (n = 38) and control athletes (n = 81). Postural sway was quantified with a wearable inertial sensor (Opal; APDM, Inc.) during four varying sensory conditions of quiet stance: (1) eyes open (EO) firm surface, (2) eyes closed (EC) firm surface, (3) eyes open (EO) foam surface, and (4) eyes closed (EC) foam surface. Sensory reweighting deficits were computed by comparing the postural sway area in eyes closed versus eyes open conditions for firm and foam condition. Results: Postural sway was higher for mTBI compared with the control group during three of the four conditions of instrumented mCTSIB (EO firm, EC firm, and EC foam; p < 0.05). Sensory reweighting deficits were evident for mTBI individuals compared with control group on foam surface (EC firm vs EO firm; p < 0.05) and not on firm surface (EC firm vs EO firm; p = 0.63). Conclusions: The results from this study highlight the importance of detecting postural sway deficits during sensorimotor integration in mild TBI individuals.	[Gera, Geetanjali; Mancini, Martina; Horak, Fay B.; King, Laurie A.] Univ Kentucky, Dept Rehabil Sci, 900 South Limestone, Lexington, KY 40536 USA; [Chesnutt, Jim] Oregon Hlth & Sci Univ, Dept Orthoped & Rehabil, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Horak, Fay B.] Vet Affairs Portland Healthcare Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA		Gera, G (corresponding author), Univ Kentucky, Dept Rehabil Sci, 900 South Limestone, Lexington, KY 40536 USA.				Oregon Clinical and Translational Research Institute from the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH) [KL2TR000152]; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH [UL1TR000128, R21HD080398]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD080398] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000128, KL2TR000152] Funding Source: NIH RePORTER	This project was supported by the Oregon Clinical and Translational Research Institute (KL2TR000152) from the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH); (UL1TR000128) and Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH under Award Number (R21HD080398).	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Faul M, 2010, TRAUMATIC BRAIN INJU; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Freeman L, 2017, J GERIATR PHYS THER; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; King LA, 2012, J NEUROL PHYS THER, V36, P25, DOI 10.1097/NPT.0b013e31824620d1; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Neville C, 2015, MED DEVICES-EVID RES, V8, P447, DOI 10.2147/MDER.S91719; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Peterka Robert J, 2011, Front Neurol, V2, P57, DOI 10.3389/fneur.2011.00057; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wallmann HW, 2001, J GERONTOL A-BIOL, V56, pM580, DOI 10.1093/gerona/56.9.M580; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607	29	14	14	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183			S			327	332		10.1093/milmed/usx162			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GC0JM	WOS:000429463600046	29635623	Green Published, Green Accepted			2022-02-06	
J	Liu, C; Zhang, CW; Zhou, Y; Wong, WQ; Lee, LC; Ong, WY; Yoon, SO; Hong, WJ; Fu, XY; Soong, TW; Koo, EH; Stanton, LW; Lim, KL; Xiao, ZC; Dawe, GS				Liu, Chao; Zhang, Cheng-Wu; Zhou, Yi; Wong, Wan Qing; Lee, Liying Corinne; Ong, Wei Yi; Yoon, Sung Ok; Hong, Wanjin; Fu, Xin-Yuan; Soong, Tuck Wah; Koo, Edward H.; Stanton, Lawrence W.; Lim, Kah-Leong; Xiao, Zhi-Cheng; Dawe, Gavin S.			APP upregulation contributes to retinal ganglion cell degeneration via JNK3	CELL DEATH AND DIFFERENTIATION			English	Article							AMYLOID PRECURSOR PROTEIN; OPTIC-NERVE TRANSECTION; INTRACELLULAR DOMAIN; TRANSGENIC MICE; AXONAL INJURY; ADULT-RATS; PATHOLOGICAL FEATURES; OCULAR HYPERTENSION; ALZHEIMERS-DISEASE; POSSIBLE TARGET	Axonal injury is a common feature of central nervous system insults. Upregulation of amyloid precursor protein (APP) is observed following central nervous system neurotrauma and is regarded as a marker of central nervous system axonal injury. However, the underlying mechanism by which APP mediates neuronal death remains to be elucidated. Here, we used mouse optic nerve axotomy (ONA) to model central nervous system axonal injury replicating aspects of retinal ganglion cell (RGC) death in optic neuropathies. APP and APP intracellular domain (AICD) were upregulated in retina after ONA and APP knockout reduced Tuj1(+) RGC loss. Pathway analysis of microarray data combined with chromatin immunoprecipitation and a luciferase reporter assay demonstrated that AICD interacts with the JNK3 gene locus and regulates JNK3 expression. Moreover, JNK3 was found to be upregulated after ONA and to contribute to Tuj1(+) RGC death. APP knockout reduced the ONA-induced enhanced expression of JNK3 and phosphorylated JNK (pJNK). Gamma-secretase inhibitors prevented production of AICD, reduced JNK3 and pJNK expression similarly, and protected Tuj1(+) RGCs from ONA-induced cell death. Together these data indicate that ONA induces APP expression and that gamma-secretase cleavage of APP releases AICD, which upregulates JNK3 leading to RGC death. This pathway may be a novel target for neuronal protection in optic neuropathies and other forms of neurotrauma.	[Liu, Chao; Wong, Wan Qing; Dawe, Gavin S.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, 16 Med Dr, Singapore 117600, Singapore; [Liu, Chao; Zhou, Yi; Wong, Wan Qing; Ong, Wei Yi; Fu, Xin-Yuan; Soong, Tuck Wah; Lim, Kah-Leong; Dawe, Gavin S.] Natl Univ Singapore, Life Sci Inst, Ctr Life Sci, Neurobiol & Ageing Programme, 28 Med Dr, Singapore 117456, Singapore; [Liu, Chao; Wong, Wan Qing; Dawe, Gavin S.] Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, Ctr Life Sci, 28 Med Dr, Singapore 117456, Singapore; [Liu, Chao; Lee, Liying Corinne; Soong, Tuck Wah; Koo, Edward H.; Lim, Kah-Leong] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Physiol, 2 Med Dr, Singapore 117597, Singapore; [Zhang, Cheng-Wu] Nanjing Tech Univ Nanjing Tech, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Key Lab Flexible Elect KLOFE, 30 South Puzhu Rd, Nanjing 211816, Jiangsu, Peoples R China; [Zhang, Cheng-Wu] Nanjing Tech Univ Nanjing Tech, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, IAM, 30 South Puzhu Rd, Nanjing 211816, Jiangsu, Peoples R China; [Zhang, Cheng-Wu; Lim, Kah-Leong] Natl Neurosci Inst, Neurodegenerat Res Lab, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore; [Zhou, Yi; Fu, Xin-Yuan] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, 8 Med Dr, Singapore 117596, Singapore; [Wong, Wan Qing; Stanton, Lawrence W.] Genome Inst Singapore, Stem Cell & Regenerat Biol Grp, 60 Biopolis St, Singapore 138672, Singapore; [Ong, Wei Yi] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Anat, 4 Med Dr, Singapore 117594, Singapore; [Yoon, Sung Ok] Ohio State Univ, Dept Biol Chem & Pharmacol, Wexner Med Ctr, Columbus, OH 43210 USA; [Hong, Wanjin] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore; [Koo, Edward H.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, 12 Sci Dr 2, Singapore 117549, Singapore; [Xiao, Zhi-Cheng] Monash Univ Clayton, Dept Anat & Dev Biol, Melbourne, Vic 3800, Australia; [Xiao, Zhi-Cheng] Kunming Med Coll, Inst Mol & Clin Med, Key Lab Stem Cell & Regenerat Med, Kunming 650031, Yunnan, Peoples R China		Dawe, GS (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, 16 Med Dr, Singapore 117600, Singapore.; Dawe, GS (corresponding author), Natl Univ Singapore, Life Sci Inst, Ctr Life Sci, Neurobiol & Ageing Programme, 28 Med Dr, Singapore 117456, Singapore.; Dawe, GS (corresponding author), Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, Ctr Life Sci, 28 Med Dr, Singapore 117456, Singapore.; Xiao, ZC (corresponding author), Monash Univ Clayton, Dept Anat & Dev Biol, Melbourne, Vic 3800, Australia.; Xiao, ZC (corresponding author), Kunming Med Coll, Inst Mol & Clin Med, Key Lab Stem Cell & Regenerat Med, Kunming 650031, Yunnan, Peoples R China.	zhicheng.xiao@monash.edu; gavindawe@nus.edu.sg	Lim, Kah-Leong/AAY-3308-2020; Liu, Chao/AAL-6454-2021; Lim, Kah/L-5426-2019	Dawe, Gavin/0000-0001-6119-701X; xiao, zhicheng/0000-0001-5172-762X; Lim, Kah-Leong/0000-0002-5440-2588	National Medical Research Council, Ministry of Health, SingaporeNational Medical Research Council, Singapore [NMRC/1059/2006]; NMRC NUHS Centre Grant-Memory, Ageing, and Cognition Centre [NMRC/CG/013/2013]	This work was supported by the National Medical Research Council, Ministry of Health, Singapore, with grant NMRC/1059/2006 and with NMRC NUHS Centre Grant-Memory, Ageing, and Cognition Centre Seed Funding, NMRC/CG/013/2013. We thank Miss Maying Tsemay Tse for the APP-null mice required for the additional experiments necessary for revision of the manuscript. We thank Dr M. Goedert (Cambridge, UK) for the rabbit anti-AICD antibody (BR188). We thank Mr Woon Fei Ho for excellent technical and administrative assistance. We thank Dr Zhong-Can Chen for assisting in generating the SH-SY5Y-APP cell line and Ms Jayakody Pathirannehelage Tharindunee Jayakody for technical assistance in detecting JNK3 expression in SH-SY5Y cells. We thank Dr Huck-Hui Ng and Dr Yun-Shen Chan for helpful advice on luciferase assays.	Anderson JJ, 2005, BIOCHEM PHARMACOL, V69, P689, DOI 10.1016/j.bcp.2004.11.015; Arnhold M, 2016, CLIN AUTON RES, V26, P211, DOI 10.1007/s10286-016-0358-6; Asai M, 2011, FASEB J, V25, P3720, DOI 10.1096/fj.11-182154; Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chaon BC, 2015, CURR OPIN OPHTHALMOL, V26, P445, DOI 10.1097/ICU.0000000000000198; Chintala SK, 2015, INVEST OPHTH VIS SCI, V56, P505, DOI 10.1167/iovs.14-15539; Choi WS, 2010, J NEUROPATH EXP NEUR, V69, P511, DOI 10.1097/NEN.0b013e3181db8100; Christensen DP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0519-5; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Fernandes KA, 2012, NEUROBIOL DIS, V46, P393, DOI 10.1016/j.nbd.2012.02.003; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Ghosal K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.020; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Haenold R, 2014, J CELL SCI, V127, P3052, DOI 10.1242/jcs.140731; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He Y, 2015, NEURAL REGEN RES, V10, P432, DOI 10.4103/1673-5374.153692; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Kato T, 2008, J INTERF CYTOK RES, V28, P235, DOI 10.1089/jir.2007.0075; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kipfer-Kauer A, 2010, CURR EYE RES, V35, P828, DOI 10.3109/02713683.2010.494240; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kwong JMK, 2006, EXP EYE RES, V82, P576, DOI 10.1016/j.exer.2005.08.017; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Levin LA, 2007, CAN J OPHTHALMOL, V42, P403, DOI 10.3129/i07-046; Liu C, 2015, J BIOL CHEM, V290, P12048, DOI 10.1074/jbc.M114.617092; Lukas TJ, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-5; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; Magharious Mark M, 2011, J Vis Exp, DOI 10.3791/2241; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Margevicius DR, 2015, NEUROBIOL AGING, V36, P2370, DOI 10.1016/j.neurobiolaging.2015.04.013; Martin JH, 1996, MOL BRAIN RES, V35, P47, DOI 10.1016/0169-328X(95)00181-Q; MISANTONE LJ, 1984, J NEUROCYTOL, V13, P449, DOI 10.1007/BF01148334; MOHIT AA, 1995, NEURON, V14, P67, DOI 10.1016/0896-6273(95)90241-4; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P6095, DOI 10.1167/iovs.15-17195; Osborne NN, 2004, EYE, V18, P1075, DOI 10.1038/sj.eye.6701588; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Repici M, 2006, ADV EXP MED BIOL, V588, P145; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Sanchez-Migallon MC, 2016, INVEST OPHTH VIS SCI, V57, P81, DOI 10.1167/iovs.15-17841; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Tezel G, 2003, INVEST OPHTH VIS SCI, V44, P3025, DOI 10.1167/iovs.02-1136; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	60	14	15	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	MAR	2018	25	4					661	676		10.1038/s41418-017-0005-3			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FZ9IJ	WOS:000427923400005	29238071	hybrid, Green Published			2022-02-06	
J	Norheim, N; Kissinger-Knox, A; Cheatham, M; Webbe, F				Norheim, Nicole; Kissinger-Knox, Alicia; Cheatham, Megan; Webbe, Frank			Performance of college athletes on the 10-item word list of SCAT5	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article								Objectives The Sport Concussion Assessment Tool-5 (SCAT5) was published in 2017; however, normative performance within the college athlete population on the optional 10-item word list has not been described. This study reports normative values for immediate memory trials, total immediate memory score and delayed recall of the 10-item word list. Methods The SCAT5 was administered as part of the preparticipation medical testing to 514 collegiate studentathletes, aged 17-23 (M=19.65, SD=1.40; 64% male) prior to the 2017-2018 athletic season. Results On the SCAT5's optional 10-item word list, with a total possible immediate memory score of 30, participants recalled an average of 20.57 (SD=3.22) words over three learning trials, with an average for trial 3 of 8.13 (SD=1.32). The average delayed memory score was 6.59 (SD=1.85). Small but significant demographic comparisons were found. Women scored higher on both immediate and delayed recall, non-native speakers scored higher on delayed recall, and Black/African-American athletes scored lower than White athletes on immediate, and lower than White and Hispanic/Latino athletes on delayed recall. Conclusion The 10-item word list on the SCAT5 eliminates the ceiling effect observed on the five-item word list of the SCAT3, therefore, increasing its clinical utility in the diagnosis of sports-related concussions. Significant demographic differences suggest use of category-specific norms for sex, native language and race/ ethnicity.	[Norheim, Nicole; Kissinger-Knox, Alicia; Cheatham, Megan; Webbe, Frank] Florida Inst Technol, Dept Psychol, Melbourne, FL 32901 USA		Webbe, F (corresponding author), Florida Inst Technol, Dept Psychol, Melbourne, FL 32901 USA.	webbe@fit.edu		Webbe, Frank/0000-0002-4370-5698			[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; BLEECKER ML, 1988, J CLIN PSYCHOL, V44, P403, DOI 10.1002/1097-4679(198805)44:3<403::AID-JCLP2270440315>3.0.CO;2-0; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fernandes MA, 2007, CAN J EXP PSYCHOL, V61, P128, DOI 10.1037/cjep2007014; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Kisser JE, 2012, ARCH CLIN NEUROPSYCH, V27, P749, DOI 10.1093/arclin/acs082; KRAMER JH, 1988, J CLIN PSYCHOL, V44, P907, DOI 10.1002/1097-4679(198811)44:6<907::AID-JCLP2270440610>3.0.CO;2-8; Kramer JH, 1997, NEUROPSYCHOLOGY, V11, P577, DOI 10.1037/0894-4105.11.4.577; Lundervold AJ, 2019, J ATTEN DISORD, V23, P1188, DOI 10.1177/1087054715580842; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; NOTT CR, 1968, J VERB LEARN VERB BE, V7, P1065, DOI 10.1016/S0022-5371(68)80069-6; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832	18	14	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	MAR	2018	4	1							e000412	10.1136/bmjsem-2018-000412			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VJ4QA	WOS:000596798200110	30167321	Green Published, gold			2022-02-06	
J	Rui, Q; Ni, HB; Gao, F; Dang, BQ; Li, D; Gao, R; Chen, G				Rui, Qin; Ni, Haibo; Gao, Fan; Dang, Baoqi; Li, Di; Gao, Rong; Chen, Gang			LRRK2 Contributes to Secondary Brain Injury Through a p38/Drosha Signaling Pathway After Traumatic Brain Injury in Rats	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						LRRK2; p38; Drosha; traumatic brain injury; secondary brain injury	SUBARACHNOID HEMORRHAGE; PARKINSONS; ACTIVATION; INHIBITION; PATHOPHYSIOLOGY; PHOSPHORYLATION; DYSFUNCTION; MECHANISMS; MICRORNA	Leucine-rich repeat kinase 2 (LRRK2) is widely expressed in the brain and exerts neurotoxicity in Parkinson's disease. The p38/Drosha signaling activation has been reported to increase cell death under stress. This study was designed to investigate the potential role and mechanism of LRRK2 in secondary brain injury after traumatic brain injury (TBI). A total of 130 male Sprague-Dawley rats were examined using a weight-drop model of TBI. The rats received the specific LRRK2 inhibitor PF-06447475 or LRRK2 pDNA alone or in combination with Drosha pDNA. Real-time PCR, western blot, immunofluorescence, neuronal apoptosis, brain water content, and neurological score analyses were conducted. Our results showed that after TBI, endogenous LRRK2 expression and p38 phosphorylation were increased, whereas Drosha expression was inhibited. Administration of the LRRK2 inhibitor PF-06447475 significantly reduced neuronal apoptosis, brain water content, and blood-brain barrier permeability 12 h after TBI and ameliorated neurological deficits 72 h after TBI, which was concomitant with decreased p38 phosphorylation and increased Drosha expression. Conversely, LRRK2 overexpression induced the opposite effect. Moreover, the neurotoxic effects of LRRK2 on TBI were also eliminated by Drosha overexpression. Altogether, these findings demonstrate the importance of TBI-induced LRRK2 upregulation during the induction of post-traumatic neurological injury, which may be partially mediated through a p38/Drosha signaling pathway.	[Rui, Qin; Gao, Rong] First Peoples Hosp Zhangjiagang, Dept Lab, Suzhou, Peoples R China; [Ni, Haibo] First Peoples Hosp Zhangjiagang, Dept Neurosurg, Suzhou, Peoples R China; [Gao, Fan; Dang, Baoqi] Nanjing Univ Chinese Med, Dept Rehabil, Zhangjiagang Hosp Tradit Chinese Med, Suzhou, Peoples R China; [Li, Di] First Peoples Hosp Zhangjiagang, Dept Translat Med Ctr, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, Suzhou, Peoples R China; [Chen, Gang] Soochow Univ, Brain & Nerve Res Lab, Affiliated Hosp 1, Suzhou, Peoples R China		Gao, R (corresponding author), First Peoples Hosp Zhangjiagang, Dept Lab, Suzhou, Peoples R China.; Li, D (corresponding author), First Peoples Hosp Zhangjiagang, Dept Translat Med Ctr, Suzhou, Peoples R China.	lidilab@sina.com; lidi715@163.com					Aguado LC, 2017, NATURE, V547, P114, DOI 10.1038/nature22990; Atashrazm F, 2016, CLIN PHARMACOL-ADV A, V8, P177, DOI 10.2147/CPAA.S102191; Bae JR, 2015, BMB REP, V48, P243, DOI 10.5483/BMBRep.2015.48.5.032; Casili G, 2018, J NEUROTRAUM, V35, P1437, DOI 10.1089/neu.2017.5260; Cookson MR, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0564-y; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Devyatov AA, 2017, B EXP BIOL MED+, V163, P195, DOI 10.1007/s10517-017-3764-4; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Feng DY, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12395; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gillardon F, 2012, NEUROSCIENCE, V208, P41, DOI 10.1016/j.neuroscience.2012.02.001; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Ho DH, 2017, BIOCHEM BIOPH RES CO, V482, P1088, DOI 10.1016/j.bbrc.2016.11.163; Hong SG, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003706; Hsu CH, 2010, NEURODEGENER DIS, V7, P68, DOI 10.1159/000285509; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Islam MS, 2017, BIOCHEM SOC T, V45, P163, DOI 10.1042/BST20160264; Kang UB, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600092; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Kim KY, 2015, BIOCHEM BIOPH RES CO, V464, P236, DOI 10.1016/j.bbrc.2015.06.125; Kim T, 2017, J CEREBR BLOOD F MET, V37, P1910, DOI 10.1177/0271678X17694186; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lee H, 2017, BIOCHEM SOC T, V45, P131, DOI 10.1042/BST20160262; Li D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0841-6; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Mechtler P, 2017, RNA BIOL, V14, P1508, DOI 10.1080/15476286.2017.1342934; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Parisiadou L, 2014, NAT NEUROSCI, V17, P367, DOI 10.1038/nn.3636; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Shen HT, 2015, STROKE, V46, P2607, DOI 10.1161/STROKEAHA.115.009729; Tang Zhaohua, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P928; Tsika E, 2012, CURR NEUROL NEUROSCI, V12, P251, DOI 10.1007/s11910-012-0265-8; Verma M, 2014, BBA-MOL BASIS DIS, V1842, P1273, DOI 10.1016/j.bbadis.2013.11.005; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Wang Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep33577; Wei L, 2014, CLIN EXP PHARMACOL P, V41, P134, DOI 10.1111/1440-1681.12186; Wu J, 2016, STROKE, V47, P1319, DOI 10.1161/STROKEAHA.115.011552; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yang P, 2016, EXP NEUROL, V283, P157, DOI 10.1016/j.expneurol.2016.06.010; Yang Q, 2015, MOL CELL, V57, P721, DOI 10.1016/j.molcel.2015.01.004; Yokota Takanori, 2009, Brain and Nerve (Tokyo), V61, P167; You WC, 2016, J NEUROL SCI, V367, P224, DOI 10.1016/j.jns.2016.06.021; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020; Zhao ZL, 2017, PROTEIN CELL, V8, P801, DOI 10.1007/s13238-017-0414-6	46	14	14	0	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	MAR 1	2018	12								51	10.3389/fncel.2018.00051			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FX9FE	WOS:000426401200001	29545743	Green Published, gold			2022-02-06	
J	Woolcott, CR; Torrey, S; Turner, PV; Serpa, L; Schwean-Lardner, K; Widowski, TM				Woolcott, Caitlin R.; Torrey, Stephanie; Turner, Patricia V.; Serpa, Lilia; Schwean-Lardner, Karen; Widowski, Tina M.			Evaluation of Two Models of Non-Penetrating Captive Bolt Devices for On-Farm Euthanasia of Turkeys	ANIMALS			English	Article						animal welfare; euthanasia; turkey; insensibility; brain death	TRAUMATIC BRAIN-INJURY; MECHANICAL CERVICAL DISLOCATION; CARBON-DIOXIDE; BLUNT TRAUMA; BROILER-CHICKENS; POULTRY; RESPONSES; ELECTROENCEPHALOGRAM; UNCONSCIOUSNESS; ACCELEROMETERS	On-farm euthanasia is a critical welfare issue in the poultry industry and can be particularly difficult to perform on mature turkeys due to their size. We evaluated the efficacy of two commercially available non-penetrating captive bolt devices, the Zephyr-EXL and the Turkey Euthanasia Device (TED), on 253 turkeys at three stages of production: 4-5, 10, and 15-20 weeks of age. Effectiveness of each device was measured using both ante-and post-mortemmeasures. Application of the Zephyr-EXL resulted in a greater success rate (immediate abolishment of brainstem reflexes) compared to the TED (97.6% vs. 89.3%, p = 0.0145). Times to last movement (p = 0.102) and cardiac arrest (p = 0.164) did not differ between devices. Ante-and post-mortem measures of trauma and hemorrhage were highly correlated. Skull fractures and gross subdural hemorrhage (SDH) were present in 100% of birds euthanized with both the Zephyr-EXL and TED devices. Gross SDH scores were greater in birds killed with the Zephyr-EXL than the TED (p < 0.001). Microscopic SDH scores indicated moderate to severe hemorrhage in 92% of turkeys for the Zephyr-EXL and 96% of turkeys for the TED, with no difference between devices (p = 0.844). Overall, both devices were highly effective inducing immediate insensibility through traumatic brain injury and are reliable, single-step methods for on-farm euthanasia of turkeys.	[Woolcott, Caitlin R.; Torrey, Stephanie; Serpa, Lilia; Widowski, Tina M.] Univ Guelph, Dept Anim Biosci, Guelph, ON N1G 2W1, Canada; [Woolcott, Caitlin R.; Torrey, Stephanie; Turner, Patricia V.; Serpa, Lilia; Widowski, Tina M.] Univ Guelph, Campbell Ctr Study Anim Welf, Guelph, ON N1G 2W1, Canada; [Turner, Patricia V.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Schwean-Lardner, Karen] Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 5A8, Canada		Widowski, TM (corresponding author), Univ Guelph, Dept Anim Biosci, Guelph, ON N1G 2W1, Canada.; Widowski, TM (corresponding author), Univ Guelph, Campbell Ctr Study Anim Welf, Guelph, ON N1G 2W1, Canada.	caitwoolcott@gmail.com; storrey@uoguelph.ca; pvturner@uoguelph.ca; lilia.serpa20@gmail.com; karen.schwean@usask.ca; twidowsk@uoguelph.ca		Torrey, Stephanie/0000-0002-8157-9207; Turner, Patricia/0000-0003-1547-0139; Woolcott, Caitlin/0000-0002-3336-5060	Chicken Farmers of Saskatchewan; Egg Farmers of Canada; Hybrid Turkeys; Natural Sciences and Engineering Research Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Ontario Ministry of Agriculture and Rural Affairs (OMAFRA); Turkey Farmers of Canada through the Canadian Poultry Research Council; Turkey Farmers of Ontario through the Poultry Industry Council	This research is part of a large, multi-species project collectively funded by Chicken Farmers of Saskatchewan, Egg Farmers of Canada, Hybrid Turkeys, Natural Sciences and Engineering Research Council (NSERC) of Canada, the Ontario Ministry of Agriculture and Rural Affairs (OMAFRA), Turkey Farmers of Canada through the Canadian Poultry Research Council, and Turkey Farmers of Ontario through the Poultry Industry Council. Bock Industries, Inc., provided in-kind support.	Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; AVMA (American Veterinary Medical Association) Panel on Euthanasia, 2013, AVMA GUIDELINES EUTH; Bader S, 2014, J APPL POULTRY RES, V23, P546, DOI 10.3382/japr.2014-00977; Benson ER, 2012, RES VET SCI, V93, P960, DOI 10.1016/j.rvsc.2011.12.008; BLACKMORE DK, 1979, VET REC, V105, P372, DOI 10.1136/vr.105.16.372; Bock Industries Inc, 2016, CAPT BOLT DEV HUM LI; Brennan LK, 2009, J NEUROS-PEDIATR, V3, P232, DOI 10.3171/2008.11.PEDS0835; Cartner SC, 2007, COMPARATIVE MED, V57, P570; Casey-Trott TM, 2014, J ANIM SCI, V92, P5166, DOI 10.2527/jas.2014-7980; Casey-Trott TM, 2013, J ANIM SCI, V91, P5477, DOI 10.2527/jas.2013-6320; Casey-Trott TM, 2012, THESIS; Cors JC, 2015, POULTRY SCI, V94, P147, DOI 10.3382/ps/peu038; Dalton HA, 2013, WORLD POULTRY SCI J, V69, P865, DOI 10.1017/S004393391300086X; Dawson MD, 2007, J APPL POULTRY RES, V16, P583, DOI 10.3382/japr.2007-00023; Dawson MD, 2009, J APPL POULTRY RES, V18, P135, DOI 10.3382/japr.2008-00072; Duggan G, 2014, J APPL POULTRY RES, V23, P280, DOI 10.3382/japr.2013-00860; Erasmus MA, 2010, VET REC, V167, P850, DOI 10.1136/vr.c5051; Erasmus MA, 2010, J APPL POULTRY RES, V19, P288, DOI 10.3382/japr.2009-00103; Erasmus MA, 2010, POULTRY SCI, V89, P1345, DOI 10.3382/ps.2009-00445; Erasmus MA, 2009, THESIS; Finnie JW, 2003, AUST VET J, V81, P153, DOI 10.1111/j.1751-0813.2003.tb11078.x; Finnie JW, 2001, AUST VET J, V79, P628, DOI 10.1111/j.1751-0813.2001.tb10785.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gerritzen MA, 2004, POULTRY SCI, V83, P1294, DOI 10.1093/ps/83.8.1294; Gerritzen M, 2007, APPL ANIM BEHAV SCI, V108, P179, DOI 10.1016/j.applanim.2006.11.014; Gibson TJ, 2018, BRIT POULTRY SCI, V59, P13, DOI 10.1080/00071668.2017.1401215; GREGORY NG, 1990, VET REC, V126, P570; Grist A, 2017, ANIM WELFARE, V26, P111, DOI 10.7120/09627286.26.1.111; Heard D, 2000, Vet Clin North Am Exot Anim Pract, V3, P587; Martin JE, 2016, ANIM WELFARE, V25, P227, DOI 10.7120/09627286.25.2.227; Martin J.M., 2015, THESIS; Merskey H, 1994, CLASSIFICATION CHRON, P207, DOI DOI 10.1002/ANA.20394; National Farm Animal Care Council, 2016, COD PRACT CAR HANDL; National Turkey Federation, 2016, AN CAR GUID; RAJ ABM, 1992, BRIT VET J, V148, P147, DOI 10.1016/0007-1935(92)90106-B; Raj ABM, 2001, BRIT POULTRY SCI, V42, P295, DOI 10.1080/00071660120055232; Sandercock DA, 2014, PHYSIOL BEHAV, V133, P252, DOI 10.1016/j.physbeh.2014.05.030; Sparrey J, 2014, WORLD POULTRY SCI J, V70, P737, DOI 10.1017/S0043933914000816; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60; Turner PV, 2012, POULTRY SCI, V91, P1558, DOI 10.3382/ps.2012-02139; Veltri CJ, 2005, J FIELD ORNITHOL, V76, P127, DOI 10.1648/0273-8570-76.2.127; Verhoeven MTW, 2015, ANIMAL, V9, P320, DOI 10.1017/S1751731114002596; Walsh JL, 2017, ANIMALS, V7, DOI 10.3390/ani7120100; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	45	14	15	0	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-2615			ANIMALS	Animals	MAR	2018	8	3							42	10.3390/ani8030042			17	Agriculture, Dairy & Animal Science; Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Veterinary Sciences; Zoology	GA7GC	WOS:000428502800012	29558419	Green Published, gold			2022-02-06	
J	Shi, ZH; Qiu, WS; Xiao, GM; Cheng, J; Zhang, N				Shi, Zhenhua; Qiu, Wusi; Xiao, Guomin; Cheng, Jun; Zhang, Ning			Resveratrol Attenuates Cognitive Deficits of Traumatic Brain Injury by Activating p38 Signaling in the Brain	MEDICAL SCIENCE MONITOR			English	Article						Apoptosis; Brain Injuries; Cognitive Dissonance; Oxidative Stress	RAT MODEL; OXIDATIVE STRESS; APOPTOSIS; PATHWAYS	Background: Traumatic brain injury (TBI) is characterized by cognitive deficits, which was associated with brain oxidative stress and apoptosis. Resveratrol (RSV) is an anti-apoptotic and anti-oxidative. This study aimed to investigate neuroprotective effects and involved molecular mechanisms in TBI. Material/Methods: RSV and p38 inhibitor were administrated to TBI rats. Cognitive deficits were evaluated by Morris water maze assay. Reactive oxygen species (ROS) and apoptosis were detected in rat brains by fluorescent staining. Western blotting was used to assess the phosphorylation of p38 and the expression levels of Nrf2, HO1, and activated caspase-3. Results: RSV administration attenuated cognitive deficits of TBI rats. The ROS generation and apoptosis in the brain of TBI rats were suppressed by RSV treatment. Moreover, RSV treatment recovered activation of p38/Nrf2/HO1 signaling pathway. The co-administration of p38 inhibitor impaired RSV's attenuating effects on cognitive deficits, brain apoptosis, and ROS generation. Conclusions: RSV attenuated cognitive deficits of TBI by inhibiting oxidative stress-mediated apoptosis via targeting p38/Nrf2 signaling.	[Shi, Zhenhua; Qiu, Wusi; Xiao, Guomin; Cheng, Jun] Hangzhou Normal Univ, Affiliated Hosp, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Zhang, Ning] Hangzhou Normal Univ, Affiliated Hosp, Dept Intens Care Unit ICU, Hangzhou, Zhejiang, Peoples R China		Zhang, N (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Dept Intens Care Unit ICU, Hangzhou, Zhejiang, Peoples R China.	kenshaoliaolua@163.com			Hangzhou Committee of Science and Technology [20150733Q18]	This study was supported by foundation approved by Hangzhou Committee of Science and Technology (No. 20150733Q18)	Albani D, 2010, BIOFACTORS, V36, P370, DOI 10.1002/biof.118; Beretta S, 2017, CELL TRANSPLANT, V26, P1247, DOI 10.1177/0963689717714107; Berman AY, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0038-6; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; Fan ZG, 2017, EUR J PHARMACOL, V804, P7, DOI 10.1016/j.ejphar.2017.04.003; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Hao QF, 2016, MOL MED REP, V14, P3683, DOI 10.3892/mmr.2016.5714; Howard SW, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-017-2768-0; Ikwegbue PC, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010002; Jiang YS, 2017, AQUAT TOXICOL, V187, P55, DOI 10.1016/j.aquatox.2017.03.011; Jin XH, 2017, MOL MED REP, V16, P3519, DOI 10.3892/mmr.2017.6962; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Li HF, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070778; Li YY, 2017, INT J MOL MED, V40, P1347, DOI 10.3892/ijmm.2017.3123; Li ZZ, 2017, AM J TRANSL RES, V9, P5653; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Liu Q, 2018, INT J NEUROSCI, V15, P1; Liu Z., 2017, J AM HEART ASS, V6; Mohammadi RK, 2017, BIOMED PHARMACOTHER, V91, P220, DOI 10.1016/j.biopha.2017.04.078; Qin HL, 2017, MED SCI MONITOR, V23, P6099, DOI 10.12659/MSM.905429; Radi E, 2014, J ALZHEIMERS DIS, V42, pS125, DOI 10.3233/JAD-132738; Rauf A, 2017, FOOD FUNCT, V8, P4284, DOI [10.1039/C7FO01300K, 10.1039/c7fo01300k]; van Raamsdonk JM, 2017, ONCOTARGET, V8, P10777, DOI 10.18632/oncotarget.14650; Wang PB, 2018, EUR J PHARMACOL, V820, P173, DOI 10.1016/j.ejphar.2017.12.013; Wei JY, 2018, INT J MOL MED, V41, P1608, DOI 10.3892/ijmm.2018.3378; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Xiao YT, 2017, CELL PHYSIOL BIOCHEM, V41, P623, DOI 10.1159/000457933; Zhang W, 2015, CENT EUR J IMMUNOL, V40, P35, DOI 10.5114/ceji.2015.50831; Zhou ZW, 2017, NEURAL REGEN RES, V12, P1322, DOI 10.4103/1673-5374.213553	30	14	14	2	8	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	FEB 22	2018	24						1097	1103		10.12659/MSM.909042			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FX1PA	WOS:000425823000001	29467361	Green Published, Green Submitted			2022-02-06	
J	Skotak, M; Alay, E; Chandra, N				Skotak, Maciej; Alay, Eren; Chandra, Namas			On the accurate Determination of shock Wave Time-Pressure Profile in the experimental Models of Blast-induced neurotrauma	FRONTIERS IN NEUROLOGY			English	Article						shock wave; shock tube; peak overpressure; impulse; sampling frequency; electrostatic charges; baseline drift	TRAUMATIC BRAIN-INJURY; OVERPRESSURE; RAT; INFLAMMATION; EXPOSURE; TUBE	Measurement issues leading to the acquisition of artifact-free shock wave pressure-time profiles are discussed. We address the importance of in-house sensor calibration and data acquisition sampling rate. Sensor calibration takes into account possible differences between calibration methodology in a manufacturing facility, and those used in the specific laboratory. We found in-house calibration factors of brand new sensors differ by less than 10% from their manufacturer supplied data. Larger differences were noticeable for sensors that have been used for hundreds of experiments and were as high as 30% for sensors close to the end of their useful lifetime. These observations were despite the fact that typical overpressures in our experiments do not exceed 50 psi for sensors that are rated at 1,000 psi maximum pressure. We demonstrate that sampling rate of 1,000 kHz is necessary to capture the correct rise time values, but there were no statistically significant differences between peak overpressure and impulse values for low-intensity shock waves (Mach number <2) at lower rates. We discuss two sources of experimental errors originating from mechanical vibration and electromagnetic interference on the quality of a waveform recorded using state-of-the-art high-frequency pressure sensors. The implementation of preventive measures, pressure acquisition artifacts, and data interpretation with examples, are provided in this paper that will help the community at large to avoid these mistakes. In order to facilitate inter-laboratory data comparison, common reporting standards should be developed by the blast TBI research community. We noticed the majority of published literature on the subject limits reporting to peak overpressure; with much less attention directed toward other important parameters, i.e., duration, impulse, and dynamic pressure. These parameters should be included as a mandatory requirement in publications so the results can be properly compared with others.	[Skotak, Maciej; Alay, Eren; Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA		Chandra, N (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	namas.chandra@njit.edu	Skotak, Maciej/H-4769-2019	Skotak, Maciej/0000-0003-2584-7294; Alay, Eren/0000-0003-2523-0366	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [14059001];  [W91CRB-16-C-0025]	This work was supported by grant no. 14059001 entitled "Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tubes" received from the U.S. Army Medical Research and Materiel Command. The headform testing was funded by award no. W91CRB-16-C-0025 (PEO Soldier).	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Alay E, 2018, SHOCK WAVES, V28, P51, DOI 10.1007/s00193-017-0762-4; Aronson P, 1963, PRESSURE PULSE GENER; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Bennett S, 2015, J MIL VETERANS HEALT, V23, P27; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Courtney AC, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3702803; Courtney E, 2014, DEF TECHNOL, V10, P245, DOI 10.1016/j.dt.2014.04.003; de Vries J, 2007, P COMBUST INST, V31, P3163, DOI 10.1016/j.proci.2006.07.206; DePalma R. G., 2011, P NATO RTO MP HFM 20; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fox GW, 1933, PHYSICS-J GEN APPL P, V4, P10, DOI 10.1063/1.1745137; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmberg A., 2010, DEV CHARACTERIZATION; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Lally J., 2003, Sensors, V20, P15; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Mathieu O, 2013, P COMBUST INST, V34, P3211, DOI 10.1016/j.proci.2012.05.008; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Ostertag MH, 2013, ASME 2013 INT MECH E, pA17; Phillips Y. Y., 1991, CONVENTIONAL WARFARE, P221; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Richmond DR, 1966, DASA1853 DEP DEF; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Walter PL, 2004, SOUND VIB, V38, P10; Wiri S, 2016, SHOCK WAVES, V26, P279, DOI 10.1007/s00193-016-0644-1; WOOSTER WA, 1953, REP PROG PHYS, V16, P62, DOI 10.1088/0034-4885/16/1/302; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	47	14	14	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 6	2018	9								52	10.3389/fneur.2018.00052			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV0GJ	WOS:000424233700001	29467718	gold, Green Published			2022-02-06	
J	Fischer, JT; Hannay, HJ; Alfano, CA; Swank, PR; Ewing-Cobbs, L				Fischer, Jesse T.; Hannay, H. Julia; Alfano, Candice A.; Swank, Paul R.; Ewing-Cobbs, Linda			Sleep Disturbances and Internalizing Behavior Problems Following Pediatric Traumatic Injury	NEUROPSYCHOLOGY			English	Article						injury; internalizing problems; outcome; sleep; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; SCHOOL-AGE-CHILDREN; QUALITY-OF-LIFE; 1ST 6 MONTHS; BRAIN-INJURY; ANXIETY DISORDERS; YOUNG-CHILDREN; HEAD-INJURY; LONGITUDINAL ASSOCIATIONS; PSYCHIATRIC-DISORDERS	Objective: This prospective longitudinal study investigated sleep disturbance (SD) and internalizing problems after traumatic injury, including traumatic brain injury (TBI) or extracranial/bodily injury (EI) in children and adolescents, relative to typically developing (TD) children. We also examined longitudinal relations between SD and internalizing problems postinjury. Method: Participants (N = 87) ages 8-15 included youth with TBI, EI, and TD children. Injury groups were recruited from a Level 1 trauma center after sustaining vehicle-related injuries. Parent-reported SD and internalizing problems were assessed at preinjury/baseline, and 6 and 12 months postinjury. Linear mixed models evaluated the relation of group and time of assessment on outcomes. Results: Controlling for age, the combined traumatic injury group experienced significantly higher postinjury levels of SD (p = .042) and internalizing problems (p = .024) than TD children; however, TBI and EI injury groups did not differ from each other. Injury severity was positively associated with SD in the EI group only, but in both groups SD was associated with additional postinjury sequelae, including fatigue and externalizing behavior problems. Internalizing problems predicted subsequent development of SD but not vice versa. The relation between injury and SD 1 year later was consistent with mediation by internalizing problems at 6 months postinjury. Conclusions: Children with both types of traumatic injury demonstrated higher SD and internalizing problems than healthy children. Internalizing problems occurring either prior to or following pediatric injury may be a risk factor for posttraumatic SD. Consequently, internalizing problems may be a promising target of intervention to improve both SD and related adjustment concerns.	[Fischer, Jesse T.; Alfano, Candice A.] Univ Houston, Dept Psychol, Houston, TX 77004 USA; [Hannay, H. Julia] Univ Houston, Texas Inst Measurement Evaluat & Stat, Houston, TX 77004 USA; [Swank, Paul R.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, 7000 Fannin St Suite 2401, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, 7000 Fannin St Suite 2401, Houston, TX 77030 USA		Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat, 7000 Fannin St Suite 2401, Houston, TX 77030 USA.; Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, 7000 Fannin St Suite 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu	Alfano, Candice/ABD-4455-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health Grant R01 NS046308 awarded to Linda Ewing-Cobbs. The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting institute.	Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alfano CA, 2007, J AM ACAD CHILD PSY, V46, P224, DOI 10.1097/01.chi.0000242233.06011.8e; Alfano CA, 2006, SLEEP MED, V7, P467, DOI 10.1016/j.sleep.2006.05.002; Alfano CA, 2009, CHILD YOUTH CARE FOR, V38, P327, DOI 10.1007/s10566-009-9081-y; Amin RS, 2002, AM J RESP CRIT CARE, V165, P1395, DOI 10.1164/rccm.2105118; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Beebe DW, 2008, J CHILD PSYCHOL PSYC, V49, P915, DOI 10.1111/j.1469-7610.2008.01885.x; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Borse NN, 2008, CDC CHILDHOOD INJURY; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; BUCKLEY SL, 1994, J PEDIATR ORTHOPED, V14, P449, DOI 10.1097/01241398-199407000-00005; Calhoun SL, 2017, J ABNORM CHILD PSYCH, V45, P337, DOI 10.1007/s10802-016-0166-4; Cohen R, 2013, PEDIATR NEUROL, V49, P465, DOI 10.1016/j.pediatrneurol.2013.06.010; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; Ding R, 2006, J PEDIATR ORTHOPED, V26, P157, DOI 10.1097/01.bpo.0000218521.98244.7e; El-Sheikh M, 2015, MONOGR SOC RES CHILD, V80, P15, DOI 10.1111/mono.12142; Ewing-Cobbs L, 2017, PSYCHONEUROENDOCRINO, V84, P66, DOI 10.1016/j.psyneuen.2017.06.003; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Gozal D, 2008, CURR OPIN PEDIATR, V20, P654, DOI 10.1097/MOP.0b013e328316ec2d; Gregory AM, 2005, J ABNORM CHILD PSYCH, V33, P157, DOI 10.1007/s10802-005-1824-0; Gregory AM, 2004, J AM ACAD CHILD PSY, V43, P744, DOI 10.1097/01.chi/0000122798.47863.a5; Gregory AM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00015; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Hollingshead A. B, 1975, 4 FACTOR INDEX UNPUB; IBM Corp, 2016, IBM SPSS STAT WINDOW; Johnson EO, 2000, PSYCHIAT RES, V94, P93, DOI 10.1016/S0165-1781(00)00145-1; Kelly RJ, 2014, DEV PSYCHOL, V50, P1137, DOI 10.1037/a0034501; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Koulouglioti C, 2008, PUBLIC HEALTH NURS, V25, P106, DOI 10.1111/j.1525-1446.2008.00687.x; Kovachy B, 2013, J CLIN SLEEP MED, V9, P503, DOI 10.5664/jcsm.2678; Kravitz Melva, 1993, Journal of Burn Care and Rehabilitation, V14, P83, DOI 10.1097/00004630-199301000-00018; Langeland W, 2008, NEUROSCI BIOBEHAV R, V32, P161, DOI 10.1016/j.neubiorev.2007.07.002; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 2015, J PEDIATR REHAB MED, V8, P345, DOI 10.3233/PRM-150352; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Mayes T, 2013, J BURN CARE RES, V34, pE15, DOI 10.1097/BCR.0b013e318272178e; McMakin DL, 2015, CURR OPIN PSYCHIATR, V28, P483, DOI 10.1097/YCO.0000000000000204; Mellman TA, 2001, DEPRESS ANXIETY, V14, P226, DOI 10.1002/da.1071; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Mindell JA, 1999, CHILD ADOL PSYCH CL, V8, P695; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P457; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ong SH, 2006, J AFFECT DISORDERS, V96, P1, DOI 10.1016/j.jad.2006.05.025; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Owens J., 2009, DEV BEHAV PEDIAT, V4th, P619; Owens Judith A, 2005, Behav Sleep Med, V3, P18, DOI 10.1207/s15402010bsm0301_4; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reynolds KC, 2016, J PEDIATR PSYCHOL, V41, P971, DOI 10.1093/jpepsy/jsw014; Romeo DM, 2013, EUR J PAEDIATR NEURO, V17, P374, DOI 10.1016/j.ejpn.2012.12.009; Roth-Isigkeit A, 2005, PEDIATRICS, V115, pE152, DOI 10.1542/peds.2004-0682; Ruff Robert L, 2016, F1000Res, V5, DOI 10.12688/f1000research.9017.1; Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414; Sadeh A, 2000, DEV PSYCHOL, V36, P291, DOI 10.1037/0012-1649.36.3.291; Sadeh A, 2009, SLEEP, V32, P1602, DOI 10.1093/sleep/32.12.1602; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; SAS Institute Inc, 2013, BAS SAS 9 4 PROC GUI; Shanahan L, 2014, J AM ACAD CHILD PSY, V53, P550, DOI 10.1016/j.jaac.2013.12.029; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Shirtcliff EA, 2008, DEV PSYCHOBIOL, V50, P690, DOI 10.1002/dev.20336; Spruyt K, 2004, SLEEP, V27, P495, DOI 10.1093/sleep/27.3.495; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; TEASDALE G, 1974, LANCET, V2, P81; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Willis TA, 2015, SLEEP MED CLIN, V10, P125, DOI 10.1016/j.jsmc.2015.02.002; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642; Zatzick DF, 2006, J AM ACAD CHILD PSY, V45, P1188, DOI 10.1097/01.chi.0000231975.21096.45	94	14	14	0	13	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	FEB	2018	32	2					161	175		10.1037/neu0000420			15	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FY7LU	WOS:000427044500004	29528681	Green Accepted, Bronze			2022-02-06	
J	Keasey, MP; Jia, CH; Pimentel, LF; Sante, RR; Lovins, C; Hagg, T				Keasey, Matthew P.; Jia, Cuihong; Pimentel, Lylyan F.; Sante, Richard R.; Lovins, Chiharu; Hagg, Theo			Blood vitronectin is a major activator of LIF and IL-6 in the brain through integrin-FAK and uPAR signaling	JOURNAL OF CELL SCIENCE			English	Article						FAK; IL-6; Integrin; LIF; Vitronectin; uPAR	LEUKEMIA INHIBITORY FACTOR; FOCAL ADHESION KINASE; FACTOR MESSENGER-RNA; NECROSIS-FACTOR-ALPHA; CELL SELF-RENEWAL; UROKINASE RECEPTOR; INFLAMMATORY RESPONSES; EXTRACELLULAR-MATRIX; BINDING-SITE; SPINAL-CORD	We defined how blood-derived vitronectin (VTN) rapidly and potently activates leukemia inhibitory factor (LIF) and pro-inflammatory interleukin 6 (IL-6) in vitro and after vascular injury in the brain. Treatment with VTN (but not fibrinogen, fibronectin, laminin-111 or collagen-I) substantially increased LIF and IL-6 within 4 h in C6-astroglioma cells, while VTN-/- mouse plasma was less effective than that from wild-type mice. LIF and IL-6 were induced by intracerebral injection of recombinant human (rh)VTN in mice, but induction seen upon intracerebral hemorrhage was less in VTN-/- mice than in wild-type littermates. In vitro, VTN effects were inhibited by RGD, alpha v beta 3 and alpha v beta 5 integrin-blocking peptides and antibodies. VTN activated focal adhesion kinase (FAK; also known as PTK2), whereas pharmacological-or siRNA-mediated inhibition of FAK, but not PYK2, reduced the expression of LIF and IL-6 in C6 and endothelial cells and after traumatic cell injury. Dominant-negative FAK (Y397F) reduced the amount of injury-induced LIF and IL-6. Pharmacological inhibition or knockdown of uPAR (also known as PLAUR), which binds VTN, also reduced cytokine expression, possibly through a common target of uPAR and integrins. We propose that VTN leakage into tissues promotes inflammation. Integrin-FAK signaling is therefore a novel IL-6 and LIF regulation mechanism relevant to the inflammation and stem cell fields.	[Keasey, Matthew P.; Jia, Cuihong; Pimentel, Lylyan F.; Sante, Richard R.; Lovins, Chiharu; Hagg, Theo] East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Pimentel, Lylyan F.] Univ Fed Pernambuco, Keizo Asami Lab LIKA, Recife, PE, Brazil		Hagg, T (corresponding author), East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.	haggt1@etsu.edu		Jia, Cuihong/0000-0002-9693-0012	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG29493, C06RR0306551]; Quillen College of Medicine at East Tennessee State University; Conselho Nacional de Desenvolvimento Cientifico e TecnologicoConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [454077/2014-9]; Fundacao do Amparo a Ciencia e Tecnologia [AMD-0291-2.00/14]; Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior [88881.133822/2016-01]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR030651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG029493] Funding Source: NIH RePORTER	Funding was provided by National Institutes of Health (NIH) (R01 grant AG29493, and in part by C06RR0306551) and the Quillen College of Medicine at East Tennessee State University. L.F.P. was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (454077/2014-9), Fundacao do Amparo a Ciencia e Tecnologia (AMD-0291-2.00/14) and Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (88881.133822/2016-01). Deposited in PMC for release after 12 months.	Antonov AS, 2011, J CELL PHYSIOL, V226, P469, DOI 10.1002/jcp.22356; Bang JY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005264; Banner LR, 1997, EXP NEUROL, V147, P1, DOI 10.1006/exnr.1997.6536; BANNER LR, 1994, P NATL ACAD SCI USA, V91, P7109, DOI 10.1073/pnas.91.15.7109; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; BORISH L, 1986, J IMMUNOL, V137, P1897; Butler B, 2005, J BIOL CHEM, V280, P14556, DOI 10.1074/jbc.M411765200; Carlson CD, 1996, GLIA, V18, P141, DOI 10.1002/(SICI)1098-1136(199610)18:2<141::AID-GLIA6>3.0.CO;2-3; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cattavarayane S, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0051-y; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; Choi Y, 2010, PROTEOMICS, V10, P72, DOI 10.1002/pmic.200900146; Degryse B, 2005, J BIOL CHEM, V280, P24792, DOI 10.1074/jbc.M413954200; del Zoppo GJ, 2012, J CEREBR BLOOD F MET, V32, P919, DOI 10.1038/jcbfm.2012.11; Delimont D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099083; DERIGS HG, 1993, LEUKEMIA, V7, P630; Dowsing BJ, 2001, J NEUROTRAUM, V18, P1279, DOI 10.1089/089771501317095313; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Gertz K, 2012, BRAIN, V135, P1964, DOI 10.1093/brain/aws075; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; Herrera-Molina R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034295; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Jang YC, 2000, SURGERY, V127, P696, DOI 10.1067/msy.2000.105858; Kang SS, 2013, TRANSL STROKE RES, V4, P533, DOI 10.1007/s12975-013-0265-2; Kang SS, 2012, J NEUROSCI, V32, P9277, DOI 10.1523/JNEUROSCI.1746-12.2012; Kang WS, 2008, BRAIN RES, V1228, P208, DOI 10.1016/j.brainres.2008.06.106; Keasey MP, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-35; Kerr BJ, 2004, EXP NEUROL, V188, P391, DOI 10.1016/j.expneurol.2004.04.012; Krueger M, 2015, J CEREBR BLOOD F MET, V35, P292, DOI 10.1038/jcbfm.2014.199; Lacroix S, 2002, J COMP NEUROL, V454, P213, DOI 10.1002/cne.10407; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Leavesley DI, 2013, IUBMB LIFE, V65, P807, DOI 10.1002/iub.1203; Lee Y, 2004, J BIOMOL SCREEN, V9, P687, DOI 10.1177/1087057104268125; Li RW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503; Liu YK, 1997, FEBS LETT, V420, P112, DOI 10.1016/S0014-5793(97)01498-1; Longo A, 2015, MOLECULES, V20, P9879, DOI 10.3390/molecules20069879; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Magnussen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105929; Magnussen SN, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3349-7; Matsuoka I, 1997, BRAIN RES, V776, P170, DOI 10.1016/S0006-8993(97)01015-9; Mauer J, 2015, TRENDS IMMUNOL, V36, P92, DOI 10.1016/j.it.2014.12.008; Memmo LM, 1998, J CELL SCI, V111, P425; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2007, J IMMUNOL, V178, P8158, DOI 10.4049/jimmunol.178.12.8158; Milner R, 2009, GLIA, V57, P714, DOI 10.1002/glia.20799; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mracsko E, 2014, STROKE, V45, P2107, DOI 10.1161/STROKEAHA.114.005801; MURPHY GM, 1995, NEUROSCI LETT, V184, P48, DOI 10.1016/0304-3940(94)11165-F; Nagamoto-Combs K, 1999, J NEUROCHEM, V72, P1871, DOI 10.1046/j.1471-4159.1999.0721871.x; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Ochel HJ, 1999, MOL GENET METAB, V66, P24, DOI 10.1006/mgme.1998.2774; OSTBERG CO, 1995, FEBS LETT, V367, P93, DOI 10.1016/0014-5793(95)00509-8; Pan WH, 2008, AM J PHYSIOL-CELL PH, V294, pC1436, DOI 10.1152/ajpcell.00489.2007; Peruzzi B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1651; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Schlaepfer DD, 2007, J BIOL CHEM, V282, P17450, DOI 10.1074/jbc.M610672200; SEIFFERT D, 1995, DEV DYNAM, V203, P71, DOI 10.1002/aja.1002030108; SEIFFERT D, 1991, P NATL ACAD SCI USA, V88, P9402, DOI 10.1073/pnas.88.21.9402; Shimamura N, 2006, STROKE, V37, P1902, DOI 10.1161/01.STR.0000226991.27540.f2; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Sugiura S, 2000, EUR J NEUROSCI, V12, P457, DOI 10.1046/j.1460-9568.2000.00922.x; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Tofaris GK, 2002, J NEUROSCI, V22, P6696; Tomasini-Johansson BR, 1998, BRIT J RHEUMATOL, V37, P620; Tornatore TF, 2011, AM J PHYSIOL-HEART C, V300, pH902, DOI 10.1152/ajpheart.00319.2010; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; Vandenberghe M, 2013, P NATL ACAD SCI USA, V110, pE4839, DOI 10.1073/pnas.1310394110; Vogiagis D, 1999, J ENDOCRINOL, V160, P181, DOI 10.1677/joe.0.1600181; Wang J, 2006, J NEUROCHEM, V96, P148, DOI 10.1111/j.1471-4159.2005.03521.x; WEI Y, 1994, J BIOL CHEM, V269, P32380; Welser-Alves JV, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-157; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008; Zheng XX, 1995, P NATL ACAD SCI USA, V92, P12426, DOI 10.1073/pnas.92.26.12426; Zigmond RE, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00062	92	14	15	0	8	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	FEB	2018	131	3							jcs202580	10.1242/jcs.202580			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FX2UF	WOS:000425917200002	29222114	hybrid, Green Published			2022-02-06	
J	King, DA; Hume, PA; Gissane, C; Kieser, DC; Clark, TN				King, Doug A.; Hume, Patria A.; Gissane, Conor; Kieser, David C.; Clark, Trevor N.			Head impact exposure from match participation in women's rugby league over one season of domestic competition	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Head impact; Rugby league; Peak linear acceleration; Peak rotational acceleration	HIGH-SCHOOL FOOTBALL; INSTRUMENTED MOUTHGUARD; PLAYERS; INJURY; CONCUSSION; RISK; BIOMECHANICS; MAGNITUDE; THRESHOLD	Objectives: To quantify the magnitude, frequency, duration and distribution of head impact exposure in a women's rugby league competition. Design: Prospective cohort study. Methods: Twenty-one players had a wireless impact measuring device (X2Biosystems XPatch) behind their right ear during match participation. Head impact data were collected and downloaded for analysis. Median peak linear and rotational accelerations and impact locations between player positions were assessed using a Friedman repeated measures ANOVA on ranks with a Wilcoxon signed-rank test for post hoc analysis with a Bonferroni correction. Results: A total of 1659 impacts to the head >10g were recorded (range 10g-91g) over the nine competition matches. There was a mean of 184 +/- 18 impacts per-match resulting in a mean of 14 +/- 12 impacts per player per-match. The No. 8 prop recorded a mean of 29 +/- 27 impacts per-match, the No. 12 second-row forward recorded the highest median peak resultant linear acceleration (16g) per-match and the No. 11 second-row forward recorded the highest median peak resultant rotational acceleration (3696 rad/s(2)). Conclusions: Our cohort of 21 female rugby league athletes were exposed to repetitive sub-concussive head impact exposure with an average of 14 impacts per-player per-match. Forwards were exposed to more impacts per-match than backs and these impacts were of higher magnitude. Most impacts occurred on the side of the head and were sustained during the second half of the game. Clinicians, coaches and players should be aware of the rates and magnitude of head impacts in female rugby league athletes. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[King, Doug A.; Hume, Patria A.] Auckland Univ Technol, Fac Hlth & Environm Sci, AUT Millennium, SPRINZ, Auckland, New Zealand; [Gissane, Conor] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England; [Kieser, David C.] Univ Otago, Dept Orthopaed Surg & Musculoskeletal Med, Dunedin, New Zealand; [Clark, Trevor N.] Australian Coll Phys Educ, Fac Human Performance, Sydney, NSW, Australia		King, DA (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, AUT Millennium, SPRINZ, Auckland, New Zealand.	dking@aut.ac.nz	Gissane, Conor/I-3661-2019; Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017	Gissane, Conor/0000-0003-4677-3853; Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128; Kieser, David/0000-0001-6060-6627; Clark, Dr Trevor/0000-0002-2853-0068; King, Doug/0000-0003-0135-0937	AUT University	The XPatches were purchased from X2Biosystems as part of the lead authors 2nd PhD funding through AUT University. No funding was provided for the conducting of this research nor were any external agencies involved.	Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco J, 2010, J ATHL TRAINING, V45, P459; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Gabbett T, 2008, J SCI MED SPORT, V11, P585, DOI 10.1016/j.jsams.2007.07.004; Gabbett TJ, 2007, J STRENGTH COND RES, V21, P875; Gabbett TJ, 2005, J SPORT SCI, V23, P961, DOI 10.1080/02640410400023381; Gabbett TJ, 2005, AM J SPORT MED, V33, P428, DOI 10.1177/0363546504268407; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P36, DOI 10.1136/bjsm.37.1.36; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gissane C, 2001, CLEVE MED J, V4, P147; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; King D, 2017, INT J SPORTS SCI COA, V12, P359, DOI 10.1177/1747954117710512; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King DA, 2009, NZ J SPORTS MED, V36, P6; King D, 2017, SPORTS MED, V47, P197, DOI 10.1007/s40279-016-0576-z; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King D, 2010, INT J PERF ANAL SPOR, V10, P241, DOI 10.1080/24748668.2010.11868519; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; King DA, 2010, SPORTS MED, V40, P163, DOI 10.2165/11319740-000000000-00000; Lennon A., 2015, DEP EXERCISE SPORT S, P44; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	50	14	14	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	FEB	2018	21	2					139	146		10.1016/j.jsams.2017.10.026			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FX5TZ	WOS:000426144600008	29122475	Green Accepted			2022-02-06	
J	Shi, S; Gupta, R; Moore, JM; Griessenauer, CJ; Adeeb, N; Motiei-Langroudi, R; Thomas, AJ; Ogilvy, CS				Shi, Siyu; Gupta, Raghav; Moore, Justin M.; Griessenauer, Christoph J.; Adeeb, Nimer; Motiei-Langroudi, Rouzbeh; Thomas, Ajith J.; Ogilvy, Christopher S.			De novo AVM formation following venous sinus thrombosis and prior AVM resection in adults: report of 2 cases	JOURNAL OF NEUROSURGERY			English	Article						de novo AVM; venous sinus thrombosis; adult; angiogenesis; vascular disorders	CEREBRAL ARTERIOVENOUS-MALFORMATION; MOYAMOYA-DISEASE; CHILD	Brain arteriovenous malformations (AVMs) are traditionally considered congenital lesions, arising from aberrant vascular development during the intrauterine period. Rarely, however, AVMs develop in the postnatal period. Individual case reports of de novo AVM formation in both pediatric and adult patients have challenged the traditional dogma of a congenital origin. Instead, for these cases, a dynamic picture is emerging of AVM growth and development, initially triggered by ischemic and/or traumatic events, coupled with genetic predispositions. A number of pathophysiological descriptions involving aberrant angiogenic responses following trauma, hemorrhage, or inflammation have been proposed, although the exact etiology of these lesions remains to be elucidated. Here, the authors present 2 cases of de novo AVM formation in adult patients. The first case involves the development of an AVM following a venous sinus thrombosis and to the authors' knowledge is the first of its kind to be reported in the literature. They also present a case in which an elderly patient with a previously ruptured AVM developed a second AVM in the contralateral hemisphere 11 years later. In addition to presenting these cases, the authors propose a possible mechanism for de novo AVM development in adult patients following ischemic injury.	[Shi, Siyu; Gupta, Raghav; Moore, Justin M.; Griessenauer, Christoph J.; Adeeb, Nimer; Motiei-Langroudi, Rouzbeh; Thomas, Ajith J.; Ogilvy, Christopher S.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, Div Neurosurg, 110 Francis St, Boston, MA 02215 USA		Ogilvy, CS (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, Div Neurosurg, 110 Francis St, Boston, MA 02215 USA.	cogilvy@bidmc.harvard.edu	Thomas, Ajith/AAX-9054-2020	Thomas, Ajith/0000-0003-4412-3152			Aboian MS, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09161; Akimoto H, 2003, NEUROSURGERY, V52, P228, DOI 10.1097/00006123-200301000-00030; Ali MJ, 2003, PEDIATR NEUROSURG, V39, P32, DOI 10.1159/000070878; Alvarez H, 2012, J NEUROSURG-PEDIATR, V9, P327, DOI 10.3171/2011.12.PEDS11312; Bulsara KR, 2002, NEUROSURGERY, V50, P1137, DOI 10.1097/00006123-200205000-00036; Friedman JA, 2000, J NEUROSURG, V93, P1058, DOI 10.3171/jns.2000.93.6.1058; Fujimura M, 2014, J NEUROSURG-PEDIATR, V13, P647, DOI 10.3171/2014.3.PEDS13610; Gonzalez LF, 2005, J NEUROSURG, V102, P726, DOI 10.3171/jns.2005.102.4.0726; Hao Q, 2010, TRANSL STROKE RES, V1, P197, DOI 10.1007/s12975-010-0020-x; Hashimoto T, 2000, NEUROSURGERY, V47, P910, DOI 10.1097/00006123-200010000-00022; Jeffree RL, 2009, PEDIATR NEUROSURG, V45, P296, DOI 10.1159/000235604; Kilbourn KJ, 2014, NEUROSURG REV, V37, P685, DOI 10.1007/s10143-014-0557-3; Koch MJ, 2016, J CLIN NEUROSCI, V28, P162, DOI 10.1016/j.jocn.2015.11.021; Lasjaunias P., 2007, SURG NEUROANGIOGRAPH, V3; Lawton MT, 1997, J NEUROSURG, V87, P267, DOI 10.3171/jns.1997.87.2.0267; Mahajan A, 2010, NEUROSURG REV, V33, P115, DOI 10.1007/s10143-009-0227-z; Mathon B, 2013, NEUROLOGY, V81, P398, DOI 10.1212/WNL.0b013e31829c5cd5; Morales-Valero SF, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.6.FOCUS14234; Morales-Valero SF, 2014, NEUROSURG FOCUS, V39, pE14; Mullan S, 1996, J NEUROSURG, V85, P1, DOI 10.3171/jns.1996.85.1.0001; Neil Jayson A, 2014, Surg Neurol Int, V5, P148, DOI 10.4103/2152-7806.142796; O'Shaughnessy BA, 2005, J NEUROSURG, V102, P238, DOI 10.3171/jns.2005.102.2.0238; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Ozsarac Murat, 2012, J Emerg Med, V43, pe17, DOI 10.1016/j.jemermed.2009.05.035; SALCMAN M, 1992, SURG NEUROL, V38, P121, DOI 10.1016/0090-3019(92)90089-6; Schmit BP, 1996, J NEUROSURG, V84, P677, DOI 10.3171/jns.1996.84.4.0677; Stevens J, 2009, AM J NEURORADIOL, V30, P111, DOI 10.3174/ajnr.A1255; Yeo JJY, 2015, CHILD NERV SYST, V31, P609, DOI 10.1007/s00381-014-2609-y	28	14	14	0	11	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2018	128	2					506	510		10.3171/2016.9.JNS161710			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FU4JX	WOS:000423820500022	28186446	Bronze			2022-02-06	
J	Nguyen, T; Fan, T; George, SR; Perreault, ML				Tuan Nguyen; Fan, Theresa; George, Susan R.; Perreault, Melissa L.			Disparate Effects of Lithium and a GSK-3 Inhibitor on Neuronal Oscillatory Activity in Prefrontal Cortex and Hippocampus	FRONTIERS IN AGING NEUROSCIENCE			English	Article						GSK-3; lithium; neuronal oscillations; coherence; hippocampus; prefrontal cortex; spatial memory	GLYCOGEN-SYNTHASE KINASE-3; FRAGILE-X-SYNDROME; EUTHYMIC BIPOLAR DISORDER; HUMAN THETA-OSCILLATIONS; TRANSGENIC MOUSE MODEL; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; WORKING-MEMORY TASK; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY	Glycogen synthase kinase-3 (GSK-3) plays a critical role in cognitive dysfunction associated with Alzheimer's disease (AD), yet the mechanism by which GSK-3 alters cognitive processes in other disorders, such as schizophrenia, remains unknown. In the present study, we demonstrated a role for GSK-3 in the direct regulation of neuronal oscillations in hippocampus (HIP) and prelimbic cortex (PL). A comparison of the GSK-3 inhibitors SB 216763 and lithium demonstrated disparate effects of the drugs on spatial memory and neural oscillatory activity in HIP and PL. SB 216763 administration improved spatial memory whereas lithium treatment had no effect. Analysis of neuronal local field potentials in anesthetized animals revealed that whereas both repeated SB 216763 (2.5 mg/kg) and lithium (100 mg/kg) induced a theta frequency spike in HIP at approximately 10 Hz, only SB 216763 treatment induced an overall increase in theta power (4-12 Hz) compared to vehicle. Acute administration of either drug suppressed slow (32-59 Hz) and fast (61-100 Hz) gamma power. In PL, both drugs induced an increase in theta power. Repeated SB 216763 increased HIP-PL coherence across all frequencies except delta, whereas lithium selectively suppressed delta coherence. These findings demonstrate that GSK-3 plays a direct role in the regulation of theta oscillations in regions critically involved in cognition, and highlight a potential mechanism by which GSK-3 may contribute to cognitive decline in disorders of cognitive dysfunction.	[Tuan Nguyen; Fan, Theresa; George, Susan R.; Perreault, Melissa L.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [George, Susan R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Perreault, Melissa L.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada		Perreault, ML (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada.; Perreault, ML (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	perreaum@uoguelph.ca	George, Susan/W-7494-2019; George, Susan R/P-9669-2018; Perreault, Melissa L/N-2867-2017	Perreault, Melissa L/0000-0002-5775-8950	W. Garfield Weston Foundation [RR150081]	This work was supported by a grant from the W. Garfield Weston Foundation (to MP and SG) (grant #: RR150081).	Al Banchaabouchi M, 2004, PHARMACOL BIOCHEM BE, V79, P607, DOI 10.1016/j.pbb.2004.09.015; Ances BM, 2008, INT REV PSYCHIATR, V20, P89, DOI 10.1080/09540260701877670; Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250; Balaraman Y, 2006, CELL MOL LIFE SCI, V63, P1226, DOI 10.1007/s00018-005-5597-y; Basar E, 2016, INT J PSYCHOPHYSIOL, V103, P135, DOI 10.1016/j.ijpsycho.2015.02.004; Basar Erol, 2013, Suppl Clin Neurophysiol, V62, P19; Basar-Eroglu C, 2007, INT J PSYCHOPHYSIOL, V64, P39, DOI 10.1016/j.ijpsycho.2006.07.007; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Blasi G, 2013, AM J PSYCHIAT, V170, P868, DOI 10.1176/appi.ajp.2012.12070908; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133; Bradley CA, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00013; Broersen LM, 2000, PROG BRAIN RES, V126, P79; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Chan MH, 2012, SCHIZOPHR RES, V136, P96, DOI 10.1016/j.schres.2012.01.024; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Cohen MX, 2011, CURR BIOL, V21, P1900, DOI 10.1016/j.cub.2011.09.036; Contestabile A, 2013, J CLIN INVEST, V123, P348, DOI 10.1172/JCI64650; Crofton EJ, 2017, NEUROPHARMACOLOGY, V117, P49, DOI 10.1016/j.neuropharm.2017.01.020; Daglas R, 2016, EUR PSYCHIAT, V31, P20, DOI 10.1016/j.eurpsy.2015.09.460; Dai MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044117; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; de Vasconcellos APS, 2005, NEUROBIOL LEARN MEM, V84, P102, DOI 10.1016/j.nlm.2005.05.002; Decloedt EH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005401; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Forlenza OV, 2016, CURR ALZHEIMER RES, V13, P879, DOI 10.2174/1567205013666160219112854; Franklin AV, 2014, BIOL PSYCHIAT, V75, P198, DOI 10.1016/j.biopsych.2013.08.003; GIVENS B, 1994, J NEUROSCI, V14, P3578; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Gong EJ, 2011, NEUROBIOL DIS, V44, P223, DOI 10.1016/j.nbd.2011.07.005; Graybeal C, 2011, NAT NEUROSCI, V14, P1507, DOI 10.1038/nn.2954; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Guadagna S, 2012, NEUROPHARMACOLOGY, V62, P2208, DOI 10.1016/j.neuropharm.2012.01.014; Guo WX, 2012, HUM MOL GENET, V21, P681, DOI 10.1093/hmg/ddr501; Guo WP, 2010, BIOCHEM CELL BIOL, V88, P649, DOI 10.1139/O09-189; Harris AZ, 2015, ANNU REV NEUROSCI, V38, P171, DOI 10.1146/annurev-neuro-071714-034111; Helfrich RF, 2016, TRENDS COGN SCI, V20, P916, DOI 10.1016/j.tics.2016.09.007; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; Huang HC, 2006, CURR DRUG TARGETS, V7, P1389, DOI 10.2174/1389450110607011389; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Igarashi KM, 2015, CURR OPIN NEUROBIOL, V35, P163, DOI 10.1016/j.conb.2015.09.005; James TF, 2015, BBA-GEN SUBJECTS, V1850, P832, DOI 10.1016/j.bbagen.2015.01.011; JOFFE RT, 1988, J CLIN PSYCHOPHARM, V8, P425; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kalweit AN, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00036; Keri S, 2009, NEUROCHEM INT, V55, P606, DOI 10.1016/j.neuint.2009.06.002; King MK, 2013, GENES BRAIN BEHAV, V12, P723, DOI 10.1111/gbb.12071; King MR, 2013, J NEUROSCI RES, V91, P506, DOI 10.1002/jnr.23192; Kinney GG, 1999, J PHARMACOL EXP THER, V291, P99; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korotkova T, 2018, NEUROSCI BIOBEHAV R, V85, P65, DOI 10.1016/j.neubiorev.2017.09.004; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Lee J, 2017, NEUROSCIENCE, V358, P124, DOI 10.1016/j.neuroscience.2017.06.039; Lemercier CE, 2017, SCHIZOPHR RES, V188, P118, DOI 10.1016/j.schres.2017.01.017; Letendre SL, 2006, AIDS, V20, P1885, DOI 10.1097/01.aids.0000244208.49123.1b; Li M, 2011, SCHIZOPHR RES, V133, P165, DOI 10.1016/j.schres.2011.09.013; Li YC, 2009, J NEUROSCI, V29, P15551, DOI 10.1523/JNEUROSCI.3336-09.2009; LINNOILA M, 1986, J CLIN PSYCHOPHARM, V6, P356; Lipina TV, 2013, NEUROPHARMACOLOGY, V64, P205, DOI 10.1016/j.neuropharm.2012.06.032; Lipina TV, 2012, NEUROPHARMACOLOGY, V62, P1252, DOI 10.1016/j.neuropharm.2011.02.020; Lipina TV, 2011, SYNAPSE, V65, P234, DOI 10.1002/syn.20839; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Lodge DJ, 2009, J NEUROSCI, V29, P2344, DOI 10.1523/JNEUROSCI.5419-08.2009; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Maksimovic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100188; Malhi GS, 2013, CNS DRUGS, V27, P135, DOI 10.1007/s40263-013-0039-0; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Maqbool M, 2016, EUR J MED CHEM, V107, P63, DOI 10.1016/j.ejmech.2015.10.018; Martinez A, 2008, J ALZHEIMERS DIS, V15, P181; Mas-Herrero E, 2016, NEUROIMAGE, V143, P166, DOI 10.1016/j.neuroimage.2016.08.024; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Matsunaga S, 2015, J ALZHEIMERS DIS, V48, P403, DOI 10.3233/JAD-150437; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; Medina M, 2010, CURR PHARM DESIGN, V16, P2790, DOI 10.2174/138161210793176581; Mesbah-Oskui L, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2015.11; Miller AMP, 2017, NEUROBIOL LEARN MEM, V145, P59, DOI 10.1016/j.nlm.2017.08.010; Missonnier P, 2010, J NEURAL TRANSM, V117, P489, DOI 10.1007/s00702-010-0384-9; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Monks PJ, 2004, BIPOLAR DISORD, V6, P550, DOI 10.1111/j.1399-5618.2004.00147.x; Muyllaert D, 2008, GENES BRAIN BEHAV, V7, P57, DOI 10.1111/j.1601-183X.2007.00376.x; Nakazono T, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00048; Nocjar C, 2007, NEUROSCIENCE, V150, P774, DOI 10.1016/j.neuroscience.2007.09.063; Noh MY, 2013, BIOCHEM BIOPH RES CO, V435, P274, DOI 10.1016/j.bbrc.2013.04.065; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Nunes MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142267; Nunes MA, 2013, CURR ALZHEIMER RES, V10, P104; O'Neill PK, 2013, J NEUROSCI, V33, P14211, DOI 10.1523/JNEUROSCI.2378-13.2013; Onishi T, 2011, J NEUROCHEM, V119, P1330, DOI 10.1111/j.1471-4159.2011.07532.x; Pardo M, 2017, EUR J NEUROSCI, V45, P490, DOI 10.1111/ejn.13446; Parsaei L, 2016, BRAIN RES BULL, V127, P1, DOI 10.1016/j.brainresbull.2016.07.007; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pfennig A, 2014, INT J BIPOLAR DISORD, V2, DOI 10.1186/s40345-014-0016-7; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rama S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10163; ROUX F, 2014, SCI ENG ETHICS, V18, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schifitto G, 2009, J NEUROVIROL, V15, P176, DOI 10.1080/13550280902758973; Schmiedt C, 2005, COGNITIVE BRAIN RES, V25, P936, DOI 10.1016/j.cogbrainres.2005.09.015; Scott L, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.010; Senturk V, 2007, BIPOLAR DISORD, V9, P136, DOI 10.1111/j.1399-5618.2007.00481.x; Sereno L, 2009, NEUROBIOL DIS, V35, P359, DOI 10.1016/j.nbd.2009.05.025; Seres I, 2010, NEUROCHEM INT, V56, P906, DOI 10.1016/j.neuint.2010.03.018; Sharifzadeh M, 2005, EUR J PHARMACOL, V511, P159, DOI 10.1016/j.ejphar.2005.01.041; Shavkunov AS, 2013, J BIOL CHEM, V288, P19370, DOI 10.1074/jbc.M112.445924; SHAW ED, 1987, J ABNORM PSYCHOL, V96, P64, DOI 10.1037/0021-843X.96.1.64; Spiegelberg BD, 2005, J BIOL CHEM, V280, P5400, DOI 10.1074/jbc.M407890200; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stip E, 2000, J AFFECT DISORDERS, V60, P147, DOI 10.1016/S0165-0327(99)00178-0; Syed H, 2015, MOL MED REP, V12, P7649, DOI 10.3892/mmr.2015.4351; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; Tamura M, 2016, NEURON, V89, P1100, DOI 10.1016/j.neuron.2016.01.025; Tang H, 2013, MOL NEUROBIOL, V48, P404, DOI 10.1007/s12035-013-8414-x; Tesche CD, 1999, J COGNITIVE NEUROSCI, V11, P424, DOI 10.1162/089892999563517; Tian MJ, 2012, FEBS LETT, V586, P3737, DOI 10.1016/j.febslet.2012.09.004; Tsaltas E, 2007, BEHAV BRAIN RES, V177, P51, DOI 10.1016/j.bbr.2006.11.003; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vasconcellos APS, 2003, PHYSIOL BEHAV, V79, P143, DOI 10.1016/S0031-9384(03)00113-6; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Villette V, 2010, J NEUROSCI, V30, P10991, DOI 10.1523/JNEUROSCI.6284-09.2010; Wang X, 2016, BIOCHEM BIOPH RES CO, V473, P428, DOI 10.1016/j.bbrc.2016.03.024; Watase K, 2007, PLOS MED, V4, P836, DOI 10.1371/journal.pmed.0040182; WEINGARTNER H, 1985, PSYCHOPHARMACOLOGY, V86, P472, DOI 10.1007/BF00427911; Wickens RH, 2017, BEHAV PHARMACOL, V28, P262, DOI 10.1097/FBP.0000000000000283; Wildburger NC, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00080; Wingo AP, 2009, J CLIN PSYCHIAT, V70, P1588, DOI 10.4088/JCP.08r04972; Yanagita T, 2009, NEUROPHARMACOLOGY, V57, P311, DOI 10.1016/j.neuropharm.2009.05.006; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Yuskaitis CJ, 2010, BIOCHEM PHARMACOL, V79, P632, DOI 10.1016/j.bcp.2009.09.023; Zhang XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21948; Zhang X, 2011, J ALZHEIMERS DIS, V24, P739, DOI 10.3233/JAD-2011-101875; Zhao R, 2016, SYNAPSE, V70, P461, DOI 10.1002/syn.21922; Zheng WH, 2013, NEUROREPORT, V24, P560, DOI 10.1097/WNR.0b013e3283623725	148	14	14	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	JAN 12	2018	9								434	10.3389/fnagi.2017.00434			15	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	FS6DD	WOS:000419887200001	29375364	Green Published, gold			2022-02-06	
J	Taylor, AN; Tio, DL; Paydar, A; Sutton, RL				Taylor, Anna N.; Tio, Delia L.; Paydar, Afshin; Sutton, Richard L.			Sex Differences in Thermal, Stress, and Inflammatory Responses to Minocycline Administration in Rats with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cytokines; hyperthermia; minocycline; stress; TBI	IMMUNE FUNCTION; HYPERTHERMIA; CYTOKINES; INCREASE; FEMALE; MODEL; IL-6	Persistent inflammation, mediated in part by increases in cytokines, is a hallmark of traumatlc brain injury (TBI). Minocycline has been shown to inhibit post-TBI neuroinflammation in male rats and mice, but has not been tested in females. Here, we studied sex differences in thermal, stress, and inflammatory responses to TBI and minocycline. Female rats were ovariectomized under isoflurane anesthesia at 33-36 days of age. At 45-55 days of age, male and female rats were implanted intraperitoneally (i.p.) with calibrated transmitters for monitoring body temperature. Moderate cortical contusion injury (CCI) or sham surgery was performed when the rats attained 60-70 days of age. One hour after surgery, rats were injected i.p. with minocycline (50mg/kg) or saline (0.3mL); injections were repeated once daily for the next 3 days. At 28 days after CCI or sham surgery, 30min restraint stress was initiated and blood samples were obtained by tail venipuncture before the onset of restraint and at 30, 60, and 90min after stress onset. At 35 days after CCI or sham surgery, rats were decapitated and blood was collected for corticosterone (CORT) and cytokine analysis. The brains were removed and ipsilateral cortical tissue and hippocampus were dissected and subsequently assayed for interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-. Hyperthermia occurred during days 1-6 post-CCI in male rats, but only on the day of CCI in female rats, and minocycline prevented its occurrence in both sexes. Minocycline facilitated suppression of the CORT response to restraint stress in both sexes. In females, but not males, hippocampal IL-6 content increased post-CCI compared with sham-injured controls, whereas IL-1 content was augmented by minocycline. Hippocampal TNF- was unaffected by CCI and minocycline. These results demonstrate sex differences in immediate thermal and long-lasting stress and cytokine responses to CCI, and only short-term protective effects of minocycline on hyperthermia.	[Taylor, Anna N.; Tio, Delia L.] UCLA, David Geffen Sch Med, Dept Neurobiol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA; [Paydar, Afshin; Sutton, Richard L.] UCLA, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA		Taylor, AN (corresponding author), UCLA, David Geffen Sch Med, Dept Neurobiol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	ataylor@mednet.ucla.edu					Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Engler H, 2016, BRAIN BEHAV IMMUN, V52, P18, DOI 10.1016/j.bbi.2015.08.013; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; KITAY JI, 1961, ENDOCRINOLOGY, V68, P818, DOI 10.1210/endo-68-5-818; Kovesdi E., 2012, FRONT NEUROL, V3, P1; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Levkovitz Y, 2015, EUR NEUROPSYCHOPHARM, V25, P124, DOI 10.1016/j.euroneuro.2014.11.012; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Scharfman HE, 2017, J NEUROSCI RES, V95, P563, DOI 10.1002/jnr.23927; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Sorrells SF, 2014, NEUROENDOCRINOLOGY, V100, P129, DOI 10.1159/000367849; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	32	14	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2018	35	4					630	638		10.1089/neu.2017.5238		JAN 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FV3OH	WOS:000419868000001	29179648				2022-02-06	
J	Bird, ET; Bowden, AE; Seeley, MK; Fullwood, DT				Bird, Evan T.; Bowden, Anton E.; Seeley, Matthew K.; Fullwood, David T.			Materials selection of flexible open-cell foams in energy absorption applications	MATERIALS & DESIGN			English	Article						Energy absorption; Materials selection; Foam; Football helmet; Ashby methods	HIGH-SCHOOL FOOTBALL; POLYMERIC FOAMS; HELMETS; PERFORMANCE; CONCUSSION	Foam must be engineered to absorb a particular range of energy in various impact-related applications. Since energy absorption is dependent upon the unique stress-strain response of each foam specimen, it is difficult to quantify analytically; thus, energy absorption cannot be easily compared across materials. Current methods accomplish this using an experimental approach, individually testing foam materials, densities, and geometries to quantify how each influences energy absorption. Such methods require large amounts of time and money to characterize a narrow range of foams. This paper facilitates foam selection by deriving generalized energy absorption material indices. Assuming Euler buckling of columns in the open-cell foam structure, this paper applies equations derived by Maiti et al. to a typical impact scenario wherein the indices are extracted. Using existing Ashby charts, these indices allow polymers to be ranked by the mass and cost each would require as a foamed structure to satisfy specific energy absorption constraints. The presented method allows the energy absorption of a wide range of flexible foams to be compared and relieves the need for extensive factor-specific testing. This method is applied to football helmet foam selection; however, it can be used for many applications where energy absorption is of interest. (C) 2017 Elsevier Ltd. All rights reserved	[Bird, Evan T.; Bowden, Anton E.; Fullwood, David T.] Brigham Young Univ, Dept Mech Engn, Provo, UT 84602 USA; [Seeley, Matthew K.] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA		Fullwood, DT (corresponding author), Brigham Young Univ, Dept Mech Engn, Provo, UT 84602 USA.	dfullwood@byu.edu			National Science FoundationNational Science Foundation (NSF) [CMMI 1538447]; REU supplements; Directorate For EngineeringNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1538447] Funding Source: National Science Foundation	This work was funded by the National Science Foundation [grant number CMMI 1538447] and related REU supplements. This paper represents work done by students of the Brigham Young University Mechanical Engineering Department's Design and Materials Applications class over the last three years. The authors would like to specifically thank Parker Rosquist, Cory Newton, and David Wood for their contributions to the methods presented in this work.	Ashby M. F., 1993, J PHYS, VIV; ASHBY MF, 1989, ACTA METALL MATER, V37, P1273, DOI 10.1016/0001-6160(89)90158-2; Ashby MF., 2011, MAT SELECTION MECH D, V4th ed.; Avalle M, 2001, INT J IMPACT ENG, V25, P455, DOI 10.1016/S0734-743X(00)00060-9; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Caswell SV, 2007, MATERIALS IN SPORTS EQUIPMENT, VOL 2, P87, DOI 10.1533/9781845693664.1.87; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Cournoyer J, 2016, J ATHL TRAINING, V51, P258, DOI 10.4085/1062-6050-51.4.08; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; DeMarco AL, 2010, ACCIDENT ANAL PREV, V42, P1778, DOI 10.1016/j.aap.2010.04.019; Ghaedizadeh A., 2017, MAT DES; Gibson L. J., 1999, CELLULAR SOLIDS STRU; Gimbel G, 2008, INT J SPORT SCI ENG, V2, P154; Gong L, 2005, INT J SOLIDS STRUCT, V42, P1355, DOI 10.1016/j.ijsolstr.2004.07.023; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Honarmandi Peyman, 2015, International Journal of Experimental and Computational Biomechanics, V3, P267; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Liu DS, 2003, ENG FAIL ANAL, V10, P581, DOI 10.1016/S1350-6307(03)00040-2; Maiti SK, 1984, ACTA METALL, V11, P1963; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1113, DOI 10.1136/bjsports-2015-095093; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; Mills NJ., 2003, MAT SPORTS EQUIPMENT, V1, P20; Ozturk UE, 2009, MATER DESIGN, V30, P15, DOI 10.1016/j.matdes.2008.04.054; Post A., 2014, P I MECH ENG P-J SPO; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Saha MC, 2005, MAT SCI ENG A-STRUCT, V406, P328, DOI 10.1016/j.msea.2005.07.006; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P422, DOI 10.1016/S0924-0136(02)00047-X; Wanner A, 2010, MATER DESIGN, V31, P2834, DOI 10.1016/j.matdes.2009.12.052	30	14	16	5	66	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-1275	1873-4197		MATER DESIGN	Mater. Des.	JAN 5	2018	137						414	421		10.1016/j.matdes.2017.10.054			8	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	FM0PO	WOS:000414669500041					2022-02-06	
J	Welton, KL; Kraeutler, MJ; Pierpoint, LA; Bartley, JH; McCarty, EC; Comstock, RD				Welton, K. Linnea; Kraeutler, Matthew J.; Pierpoint, Lauren A.; Bartley, Justin H.; McCarty, Eric C.; Comstock, R. Dawn			Injury Recurrence Among High School Athletes in the United States A Decade of Patterns and Trends, 2005-2006 Through 2015-2016	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						recurrent injury; reinjury; injury; High School RIO; epidemiology	CRUCIATE LIGAMENT RECONSTRUCTION; LOWER-EXTREMITY INJURIES; FOOTBALL PLAYERS; SURVEILLANCE SYSTEM; PROSPECTIVE COHORT; NORTH-CAROLINA; TIME TRENDS; BASKETBALL; CONCUSSION; EPIDEMIOLOGY	Background: As participation in high school athletics increases, so does the number of adolescents experiencing sports-related injury. Understanding injury patterns is an important component to developing and evaluating prevention and rehabilitation programs. Purpose: To analyze recurrent injury rates and patterns among high school athletes, to compare recurrent injuries with new injuries, and to evaluate injury trends over time. Study Design: Descriptive epidemiology study. Methods: High school sports injury data on 24 sports were collected from 2005-2006 through 2015-2016 via the High School RIO (Reporting Information Online) surveillance system. Injury rates were calculated as number of injuries per 10,000 athletic exposures (AEs). Injury rate ratios and injury proportion ratios (IPRs) were calculated to compare differences among subgroups. Results: Overall, 78,005 injuries were sustained during 40,195,806 AEs, for an injury rate of 19.41 per 10,000 AEs. Of these, 69,821 (89.5%) were new injuries, and 8184 (10.5%) were recurrent. The ankle was the most commonly injured body part among recurrent injuries, while the head/face was the most common body part that sustained new injuries. Ligament sprains were more often recurrent, while concussions were more commonly diagnosed as new, although concussions represented 16.7% of recurrent injuries. Trends for recurrent injuries over time were relatively stable. The proportion of athletes who had > 3 weeks of time loss or medical disqualification (15.8% vs 13.3%; IPR, 1.19; 95% CI, 1.13-1.26) or who voluntarily withdrew from sport (2.5% vs 1.1%; IPR, 2.33; 95% CI, 2.00-2.73) was significantly greater for recurrent injuries than new injuries. Furthermore, a greater proportion of recurrent injuries resulted in surgery (8.1% vs 6.0%; IPR, 1.34; 95% CI, 1.24-1.46). Conclusion: Although only 10.5% of all injuries were recurrent, they more frequently resulted in missing > 3 weeks of playing time and were more often managed surgically when compared with new injuries. The rate of recurrent injuries has not increased over the past decade.	[Welton, K. Linnea; Kraeutler, Matthew J.; Pierpoint, Lauren A.; Bartley, Justin H.; McCarty, Eric C.; Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Orthoped, CU Sports Med & Performance Ctr, Boulder, CO 80309 USA; [Kraeutler, Matthew J.] Seton Hall Hackensack Meridian Sch Med, Dept Orthopaed, 400 S Orange Ave, S Orange, NJ 07079 USA; [Welton, K. Linnea; Bartley, Justin H.; McCarty, Eric C.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Pierpoint, Lauren A.; Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA		Kraeutler, MJ (corresponding author), Seton Hall Hackensack Meridian Sch Med, Dept Orthopaed, 400 S Orange Ave, S Orange, NJ 07079 USA.	matthewkraeutlermd@gmail.com	mccarty, eric/AAA-1821-2019	mccarty, eric/0000-0002-8948-5862	Biomet; Mitek; Smith Nephew; Stryker; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01, R49/CE002106-01]; NFHS; NOCSAE; DonJoy Orthotics; EyeBlack; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001172, R49CE000674, R49CE002106] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: E.C.M. receives royalties from Biomet and Elsevier; is a paid consultant for Biomet; and receives research support from Biomet, Mitek, Smith & Nephew, and Stryker. The HS RIO surveillance study was funded in part by the Centers for Disease Control and Prevention (grant Nos. R49/CE000674-01, R49/CE001172-01, and R49/CE002106-01) as well as research funding contributions of the NFHS, NOCSAE, DonJoy Orthotics, and EyeBlack.	Agel J, 2007, J ATHL TRAINING, V42, P202; Anand BS, 2016, AM J SPORT MED, V44, P580, DOI 10.1177/0363546515618381; Andriolo L, 2015, KNEE SURG SPORT TR A, V23, P2825, DOI 10.1007/s00167-015-3702-9; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Chandran A, 2016, AM J SPORT MED, V44, P3237, DOI 10.1177/0363546516659879; Collins CL, 2008, PEDIATRICS, V121, P1181, DOI 10.1542/peds.2007-2572; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Currie DW, 2017, AM J SPORT MED, V45, P3368, DOI 10.1177/0363546517725068; Dragoo JL, 2010, SPORTS MED, V40, P981, DOI 10.2165/11535910-000000000-00000; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; Grassi A, 2015, BRIT J SPORT MED, V49, P1295, DOI 10.1136/bjsports-2014-094089; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Ingram JG, 2008, AM J SPORT MED, V36, P1116, DOI 10.1177/0363546508314400; Knowles SB, 2006, AM J EPIDEMIOL, V164, P1209, DOI 10.1093/aje/kwj337; Kofotolis N, 2007, J ATHL TRAINING, V42, P388; Kraeutler MJ, 2017, J BONE JOINT SURG AM, V99, DOI 10.2106/JBJS.17.00412; Kraeutler MJ, 2017, SPORTS HLTH; LaBella CR, 2011, ARCH PEDIAT ADOL MED, V165, P1033, DOI 10.1001/archpediatrics.2011.168; Lefevre N, 2017, AM J SPORT MED, V45, P34, DOI 10.1177/0363546516660075; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Maletis GB, 2013, AM J SPORT MED, V41, P2090, DOI 10.1177/0363546513493589; McKeon JMM, 2014, J SCI MED SPORT, V17, P23, DOI 10.1016/j.jsams.2013.04.006; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; National Federation of State High School Associations, HIGH SCH SPORTS PART; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Pasanen K, 2017, SCAND J MED SCI SPOR, V27, P643, DOI 10.1111/sms.12818; Paterno MV, 2012, CLIN J SPORT MED, V22, P116, DOI 10.1097/JSM.0b013e318246ef9e; Pierpoint LA, 2016, SUMMARY REPORTS NATL; Powell JW, 1999, J ATHL TRAINING, V34, P277; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Roos KG, 2017, AM J SPORT MED, V45, P201, DOI 10.1177/0363546516660980; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shanley E, 2011, J ATHL TRAINING, V46, P648; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; Takahashi S, 2017, RES SPORTS MED, V25, P266, DOI 10.1080/15438627.2017.1314290; Taylor JB, 2015, SPORTS HEALTH, V7, P392, DOI 10.1177/1941738115593441; Verhagen EALM, 2004, BRIT J SPORT MED, V38, P477, DOI 10.1136/bjsm.2003.005785; Wiggins AJ, 2016, AM J SPORT MED, V44, P1861, DOI 10.1177/0363546515621554	43	14	14	1	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	JAN 2	2018	6	1							2325967117745788	10.1177/2325967117745788			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FR5XC	WOS:000419138900001	29318177	Green Published, gold			2022-02-06	
S	Alluri, H; Shaji, CA; Davis, ML; Tharakan, B		Tharakan, B		Alluri, Himakarnika; Shaji, Chinchusha Anasooya; Davis, Matthew L.; Tharakan, Binu			A Mouse Controlled Cortical Impact Model of Traumatic Brain Injury for Studying Blood-Brain Barrier Dysfunctions	TRAUMATIC AND ISCHEMIC INJURY: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Blood-brain barrier; Controlled cortical impact; Traumatic brain injury; Intravital microscopy; Evans Blue; Edema; Intracranial pressure; Central nervous system; Hyperpermeability; Endothelial permeability	INTRAVITAL MICROSCOPY; ADULTS	Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. It is a silently growing epidemic with multifaceted pathogenesis, and current standards of treatments aim to target only the symptoms of the primary injury, while there is a tremendous need to explore interventions that can halt the progression of the secondary injuries. The use of a reliable animal model to study and understand the various aspects the pathobiology of TBI is extremely important in therapeutic drug development against TBI-associated complications. The controlled cortical impact (CCI) model of TBI described here, uses a mechanical impactor to inflict a mechanical injury into the mouse brain. This method is a reliable and reproducible approach to inflict mild, moderate or severe injuries to the animal for studying TBI-associated blood-brain barrier (BBB) dysfunctions, neuronal injuries, brain edema, neurobehavioral changes, etc. The present method describes how the CCI model could be utilized for determining the BBB dysfunction and hyperpermeability associated with TBI. Blood-brain barrier disruption is a hallmark feature of the secondary injury that occur following TBI, frequently associated with leakage of fluid and proteins into the extravascular space leading to vasogenic edema and elevation of intracranial pressure. The method described here focuses on the development of a CCI-based mouse model of TBI followed by the evaluation of BBB integrity and permeability by intravital microscopy as well as Evans Blue extravasation assay.	[Alluri, Himakarnika; Shaji, Chinchusha Anasooya; Davis, Matthew L.; Tharakan, Binu] Texas A&M Univ, Coll Med, Baylor Scott & White Res Inst, Dept Surg,Hlth Sci Ctr, Temple, TX 76508 USA		Alluri, H (corresponding author), Texas A&M Univ, Coll Med, Baylor Scott & White Res Inst, Dept Surg,Hlth Sci Ctr, Temple, TX 76508 USA.						Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Cuccurullo S, 2012, AM J PHYS MED REHABI, V91, P727; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Kasper C, 2015, ANN REV NURSING RES, V33; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marques PE, 2012, AFR J MICROBIOL RES, V6, P1603, DOI 10.5897/AJMR11.1645; Masedunskas A, 2013, JOVE-J VIS EXP, DOI 10.3791/50558; Nidavani R.B., 2014, J APPL PHARM SCI, V4, P106, DOI [10.7324/JAPS.2014.41119, DOI 10.7324/JAPS.2014.41119]; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Scott BNV, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-68; Shen Q, 2009, CELL HEALTH CYTOSKEL, V1, P43; Taqueti VR, 2013, INTEGR BIOL-UK, V5, P278, DOI 10.1039/c2ib20194a; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuan SY, 2002, VASC PHARMACOL, V39, P213, DOI 10.1016/S1537-1891(03)00010-7	23	14	15	2	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-7526-6; 978-1-4939-7524-2	METHODS MOL BIOL	Methods Mol. Biol.		2018	1717						37	52		10.1007/978-1-4939-7526-6_4	10.1007/978-1-4939-7526-6		16	Biochemical Research Methods; Biochemistry & Molecular Biology; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Research & Experimental Medicine	BK3CS	WOS:000434764100005	29468582				2022-02-06	
J	Baker-Sparr, C; Hart, T; Bergquist, T; Bogner, J; Dreer, L; Juengst, S; Mellick, D; O'Neil-Pirozzi, TM; Sander, AM; Whiteneck, GG				Baker-Sparr, Christina; Hart, Tessa; Bergquist, Thomas; Bogner, Jennifer; Dreer, Laura; Juengst, Shannon; Mellick, David; O'Neil-Pirozzi, Therese M.; Sander, Angelle M.; Whiteneck, Gale G.			Internet and Social Media Use After Traumatic Brain Injury: A Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; communication; community reintegration; Internet; social media; social participation	COLLEGE-STUDENTS; ASSISTIVE TECHNOLOGY; SUBSTANCE USE; FACEBOOK USE; DEPRESSION; NETWORKING; PEOPLE; TBI; INTERVENTION; INDIVIDUALS	Objectives: To characterize Internet and social media use among adults with moderate to severe traumatic brain injury (TBI) and to compare demographic and socioeconomic factors associated with Internet use between those with and without TBI. Setting: Ten Traumatic Brain Injury Model Systems centers. Participants: Persons with moderate to severe TBI (N = 337) enrolled in the TBI Model Systems National Database and eligible for follow-up from April 1, 2014, to March 31, 2015. Design: Prospective cross-sectional observational cohort study. Main Measures: Internet usage survey. Results: The proportion of Internet users with TBI was high (74%) but significantly lower than those in the general population (84%). Smartphones were the most prevalent means of Internet access for persons with TBI. The majority of Internet users with TBI had a profile account on a social networking site (79%), with more than half of the sample reporting multiplatform use of 2 or more social networking sites. Conclusion: Despite the prevalence of Internet use among persons with TBI, technological disparities remain in comparison with the general population. The extent of social media use among persons with TBI demonstrates the potential of these platforms for social engagement and other purposes. However, further research examining the quality of online activities and identifying potential risk factors of problematic use is recommended.	[Baker-Sparr, Christina; Mellick, David; Whiteneck, Gale G.] Craig Hosp, Englewood, CO USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Bergquist, Thomas] Mayo Clin, Coll Med, Rochester, MN USA; [Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Dreer, Laura] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Juengst, Shannon] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [O'Neil-Pirozzi, Therese M.] Harvard Med Sch, Spaulding Rehabil Hosp, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Sander, Angelle M.] Baylor Coll Med, TIRR Mem Hermann, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Harris Hlth Syst, Houston, TX 77030 USA		Baker-Sparr, C (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	cbaker-sparr@craighospital.org	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0028, 90DP0030, 90DP0034, 90DP0037, 90DP0040, 90DP0041, H133A120085, H133A120096]	This work was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) grants 90DP0028, 90DP0030, 90DP0034, 90DP0037, 90DP0040, 90DP0041, H133A120085, andH133A120096. Public data set provided by the Pew Research Center. Pew Research bears no responsibility for interpretations presented or conclusions reached on the basis of analysis of the data. The authors express appreciation to the data collection personnel who interviewed participants at each collaborating site.	[Anonymous], 2009, TRAUM BRAIN INJ MOD; Banjanin N, 2015, COMPUT HUM BEHAV, V43, P308, DOI 10.1016/j.chb.2014.11.013; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Carey JC, 2008, CYBERPSYCHOL BEHAV, V11, P188, DOI 10.1089/cpb.2007.0025; Casale S, 2016, ADDICT BEHAV, V59, P84, DOI 10.1016/j.addbeh.2016.03.014; Crisp R., 1994, J APPL REHABILITATIO, V25, P16; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; Dobransky K., 2006, Information Communication & Society, V9, P313, DOI 10.1080/13691180600751298; Duggan M., 2015, SOCIAL MEDIA UPDATE; Duggan M., 2015, DEMOGRAPHICS SOCIAL; Egan J, 2005, BRAIN INJURY, V19, P555, DOI 10.1080/02699050400013659; Evald L, 2015, NEUROPSYCHOL REHABIL, V25, P283, DOI 10.1080/09602011.2014.970557; Fichten CS, 2001, J POSTSECONDARY ED D, V15, P28; File T., 2014, COMPUTER INTERNET US; Fox S., 2011, AM LIVING DISABILITY; Fox S., 2014, WEB 25 US; Gamez-Guadix M, 2013, J ADOLESCENT HEALTH, V53, P446, DOI 10.1016/j.jadohealth.2013.03.030; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Hoofien D, 2001, BRAIN INJURY, V15, P189; Israel G. D., 1992, DETERMINING SAMPLE S; Jelenchick LA, 2013, J ADOLESCENT HEALTH, V52, P128, DOI 10.1016/j.jadohealth.2012.05.008; Leung L, 2012, NEW MEDIA SOC, V14, P117, DOI 10.1177/1461444811410406; Li Q, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00370; Manago AM, 2012, DEV PSYCHOL, V48, P369, DOI 10.1037/a0026338; NCDDR, 2001, RES EXCH, V6; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Pantic I, 2012, PSYCHIAT DANUB, V24, P90; Perrin A., 2015, AM INTERNET ACCESS 2; Rainie L., 2012, JUST IN TIME INFORM; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Rucker J, 2015, ACTA PAEDIATR, V104, P504, DOI 10.1111/apa.12971; Suris JC, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14061; Tandoc EC, 2015, COMPUT HUM BEHAV, V43, P139, DOI 10.1016/j.chb.2014.10.053; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Traumatic Brain Injury Model Systems National data and Statistical Center, 2016, TBI MOD SYST PRES; Tsaousides T, 2011, BRAIN INJURY, V25, P1155, DOI 10.3109/02699052.2011.613086; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; Wartberg L, 2016, PSYCHIAT RES, V240, P272, DOI 10.1016/j.psychres.2016.04.057; Wellman B, 2001, AM BEHAV SCI, V45, P436, DOI 10.1177/00027640121957286; Wright BA., 1983, PHYS DISABILITY PSYC; Zickuhr K, 2012, DIGITAL DIFFERENCES, P13	43	14	14	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					E9	E17		10.1097/HTR.0000000000000305			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300002	28422898	Green Accepted			2022-02-06	
J	Bertenthal, D; Yaffe, K; Barnes, DE; Byers, AL; Gibson, CJ; Seal, KH				Bertenthal, Daniel; Yaffe, Kristine; Barnes, Deborah E.; Byers, Amy L.; Gibson, Carolyn J.; Seal, Karen H.		Chronic Effects Of Neurotrauma C	Do postconcussive symptoms from traumatic brain injury in combat veterans predict risk for receiving opioid therapy for chronic pain?	BRAIN INJURY			English	Article						Neuropsychological; Pain; Post concussional syndrome; Cognitive; Opioids	MENTAL-HEALTH DISORDERS; CHRONIC NONCANCER PAIN; AFGHANISTAN VETERANS; RACIAL-DIFFERENCES; PATIENT RACE; CARE-SYSTEM; ASSOCIATION; IRAQ; PRESCRIPTION; DISPARITIES	Objectives: Opioid therapy is contraindicated in patients with traumatic brain injury (TBI) with neuropsychological impairment, yet guidelines do not consistently predict practice. We evaluated independent risk for initiation of opioid therapy among combat veterans with chronic pain diagnoses and persistent postconcussive symptoms.Methods: We assembled a retrospective cohort of 53124 Iraq and Afghanistan veterans in Veterans Affairs (VA) healthcare between October 2007 and March 2015 who received chronic pain diagnoses, completed a Comprehensive TBI Evaluation (CTBIE) and had not received opioid therapy in the prior year. Primary exposure variables were self-reported severe or very severe Emotional, Vestibular, Cognitive and Somatic/Sensory symptoms measured using the Neurobehavioral Symptom Inventory. Outcome measures were initiation of short-term and long-term opioid therapy within the year following CTBIE.Results: Self-reported severe and very severe postconcussive symptoms predicted initiation of long-term and short-term opioid use for chronic pain in both unadjusted and adjusted analyses. In adjusted analyses, all four postconcussive symptom domains significantly predicted initiation of long-term opioid therapy, with Emotional symptoms being the strongest predictor [ARR=1.68 (1.52, 1.86)].Conclusions: Increased opioid prescribing in veterans with self-reported severe persistent postconcussive symptoms indicates a need to educate prescribers and make non-opioid pain management options available for veterans with TBI and neuropsychological sequelae.	[Bertenthal, Daniel; Yaffe, Kristine; Barnes, Deborah E.; Byers, Amy L.; Gibson, Carolyn J.; Seal, Karen H.] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA USA; [Yaffe, Kristine; Barnes, Deborah E.; Byers, Amy L.; Seal, Karen H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine; Barnes, Deborah E.; Byers, Amy L.; Seal, Karen H.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Gibson, Carolyn J.; Seal, Karen H.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA		Bertenthal, D (corresponding author), San Francisco VA Hlth Care Syst, MIRECC, 4150 Clement St,Box 116-A, San Francisco, CA 94121 USA.	Daniel.bertenthal@va.gov			Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	This work was supported by grant funding from: Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135. The authors report no conflicts of interest. The views, opinions and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy or decision, unless so designated by other official documentation.	Anderson KO, 2009, J PAIN, V10, P1187, DOI 10.1016/j.jpain.2009.10.002; [Anonymous], 2015, STAT SE COMP PROGR V; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Burgess DJ, 2014, PAIN MED, V15, P965, DOI 10.1111/pme.12378; Burgess DJ, 2014, J PAIN, V15, P447, DOI 10.1016/j.jpain.2013.12.010; Burgess DJ, 2013, CLIN J PAIN, V29, P118, DOI 10.1097/AJP.0b013e31826a86ae; Campbell LC, 2012, J PAIN, V13, P611, DOI 10.1016/j.jpain.2012.02.004; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper LA, 2012, AM J PUBLIC HEALTH, V102, P979, DOI 10.2105/AJPH.2011.300558; Defense and Veterans Brain Injury Center, 2014, NEUROBEHAVIORAL SYMP; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; Dobscha SK, 2009, J PAIN, V10, P1078, DOI 10.1016/j.jpain.2009.04.018; Donnelly K, 2018, CLIN NEUROPSYCHOL, V32, P436, DOI 10.1080/13854046.2017.1390163; Drwecki BB, 2011, PAIN, V152, P1001, DOI 10.1016/j.pain.2010.12.005; Edlund MJ, 2010, CLIN J PAIN, V26, P1, DOI 10.1097/AJP.0b013e3181b99f35; Harris KM, 2005, HEALTH SERV RES, V40, P117, DOI 10.1111/j.1475-6773.2005.00345.x; Hirsh AT, 2015, J PAIN, V16, P558, DOI 10.1016/j.jpain.2015.03.003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hudson TJ, 2018, PAIN MED, V19, P774, DOI 10.1093/pm/pnx208; Hudson TJ, 2017, PAIN, V158, P1039, DOI 10.1097/j.pain.0000000000000874; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Kleinbaum D. G., 2010, STAT BIOL HLTH, DOI [10.1007/978-1-4419-1742-3, DOI 10.1007/978-1-4419-1742-3]; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Samuelson KW, 2017, J TRAUMA STRESS, V30, P521, DOI 10.1002/jts.22223; SAS Institute Inc, 2014, SAS COMP PROGR VERS; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Smedley BD, 2003, CONFR RAC ETHN DISP; StataCorp LP, 2015, BAS REF MAN VERS 14; Sullivan MD, 2006, ARCH INTERN MED, V166, P2087, DOI 10.1001/archinte.166.19.2087; Sullivan MD, 2006, J GEN INTERN MED, V21, P360, DOI 10.1111/j.1525-1497.2006.00352.x; US Department of Veterans Affairs/US Department of Defense, 2017, VA DOD CLIN PRACT GU; VA Information Resource Center, 2011, VIREC TECHN REP VA R; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Veterans Health Administration, 2017, SCREEN EV TRAUM BRAI	42	14	14	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1188	1196		10.1080/02699052.2018.1493535			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200005	29985653				2022-02-06	
J	Cullen, B; Pownall, J; Cummings, J; Baylan, S; Broomfield, N; Haig, C; Kersel, D; Murray, H; Evans, JJ				Cullen, Breda; Pownall, Jaycee; Cummings, Joanne; Baylan, Satu; Broomfield, Niall; Haig, Caroline; Kersel, Denyse; Murray, Heather; Evans, Jonathan J.			Positive PsychoTherapy in ABI Rehab (PoPsTAR): A pilot randomised controlled trial	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; stroke; positive psychology; psychotherapy; randomised controlled trial	TRAUMATIC BRAIN-INJURY; BEHAVIORAL-THERAPY; DEPRESSION; METAANALYSIS; PSYCHOLOGY; PEOPLE; STROKE; REHABILITATION; INTERVENTIONS; POSTSTROKE	Psychological distress is common following acquired brain injury (ABI), but the evidence base for psychotherapeutic interventions is small and equivocal. Positive psychotherapy aims to foster well-being by increasing experiences of pleasure, engagement and meaning. In this pilot trial, we investigated the feasibility and acceptability of brief positive psychotherapy in adults with ABI and emotional distress. Participants were randomised to brief positive psychotherapy plus usual treatment, or usual treatment only. Brief positive psychotherapy was delivered over eight individual out-patient sessions, by one research psychologist. A blinded assessor administered the Depression Anxiety Stress Scales (DASS-21) and the Authentic Happiness Inventory (AHI) at 5, 9 and 20 weeks post-baseline. Of 27 participants randomised (median age 57; 63% male; 82% ischaemic stroke survivors; median 5.7 months post-injury), 14 were assigned to positive psychotherapy, of whom 8 completed treatment. The intervention was feasible to deliver with excellent fidelity, and was acceptable to participants. Retention at 20 weeks was 63% overall. A full-scale trial would need to retain n=39 per group to end-point, to detect a significant difference in change scores on the DASS-21 Depression scale of 7 points (two-tailed alpha=.05, power=.80). Trials including an active control arm would require larger sample sizes. We conclude that a full-scale trial to investigate efficacy is warranted.	[Cullen, Breda; Pownall, Jaycee; Cummings, Joanne; Baylan, Satu; Broomfield, Niall; Evans, Jonathan J.] Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Cummings, Joanne] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland; [Broomfield, Niall] NHS Greater Glasgow & Clyde, Stroke Psychol Serv, Glasgow, Lanark, Scotland; [Haig, Caroline; Murray, Heather] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Kersel, Denyse] NHS Greater Glasgow & Clyde, Community Treatment Ctr Brain Injury, Glasgow, Lanark, Scotland		Evans, JJ (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Acad Ctr, Mental Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland.	jonathan.evans@glasgow.ac.uk	Cullen, Breda/C-9154-2012; Cullen, Breda/N-3449-2019	Cullen, Breda/0000-0002-7259-9505; Cullen, Breda/0000-0002-7259-9505; Broomfield, Niall/0000-0003-2599-3435	Scottish Executive Health Department, Chief Scientist Office [CZH/4/778]; Chief Scientist Office [CZH/4/778] Funding Source: researchfish	This study was funded by the Scottish Executive Health Department, Chief Scientist Office [ref. CZH/4/778]. Support with sample recruitment was received through the Scottish Stroke Research Network.	Andrewes HE, 2014, BRAIN INJURY, V28, P965, DOI 10.3109/02699052.2014.888764; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Bolier L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-119; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Broomfield NM, 2011, CLIN PSYCHOL PSYCHOT, V18, P202, DOI 10.1002/cpp.711; Burton CAC, 2013, INT J STROKE, V8, P545, DOI 10.1111/j.1747-4949.2012.00906.x; Enderby P, 2013, FRENCHAY APHASIA SCR; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Hackett ML, 2014, INT J STROKE, V9, P1017, DOI 10.1111/ijs.12357; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kneebone II, 2016, COGN BEHAV PRACT, V23, P99, DOI 10.1016/j.cbpra.2015.02.001; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Malec J., 2005, MAYO PORTLAND ADAPTA; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Peterson C., 2004, BRIEF STRENGTHS TEST; Peterson C., 2005, AUTHENTIC HAPPINESS; Petticrew, 2008, DEV EVALUATING COMPL; Pohjasvaara T, 2001, EUR J NEUROL, V8, P315, DOI 10.1046/j.1468-1331.2001.00182.x; Randolph C., 1998, REPEATABLE BATTERY A; Rashid T, 2013, CURRENT PSYCHOTHERAP, P461; Rogan C, 2013, NEUROPSYCHOL REHABIL, V23, P639, DOI 10.1080/09602011.2013.799076; Schiffrin HH, 2010, J HAPPINESS STUD, V11, P33, DOI 10.1007/s10902-008-9104-7; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Seligman MP, 2011, FLOURISH; Sherer M, 2004, AWARENESS QUESTIONNA; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Swift JK, 2012, J CONSULT CLIN PSYCH, V80, P547, DOI 10.1037/a0028226; Thomas SA, 2013, CLIN REHABIL, V27, P398, DOI 10.1177/0269215512462227; Thornton M, 2003, J GERONTOL B-PSYCHOL, V58, pS127, DOI 10.1093/geronb/58.2.S127; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Wechsler D., 2011, TEST PREMORBID FUNCT; Wechsler D., 2010, WECHSLER ADULT INTEL; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WIERZBICKI M, 1993, PROF PSYCHOL-RES PR, V24, P190, DOI 10.1037/0735-7028.24.2.190	38	14	14	6	30	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	1					17	33		10.1080/09602011.2015.1131722			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FR0UL	WOS:000418779100002	26726854	Green Accepted			2022-02-06	
J	Donnelly, K; Donnelly, JP; Warner, GC; Kittleson, CJ; King, PR				Donnelly, Kerry; Donnelly, James P.; Warner, Gary C.; Kittleson, C. James; King, Paul R.			Longitudinal study of objective and subjective cognitive performance and psychological distress in OEF/OIF Veterans with and without traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury; Veterans health; cognitive dysfunction; PTSD; depression	POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL OUTCOMES; SOLDIERS; CONCUSSION; ASSOCIATION; DYSFUNCTION; DEPLOYMENT; PERSONNEL; SYMPTOMS; SEQUELAE	Objective: To describe changes in post-deployment objective and subjective cognitive performance in combat Veterans over 18months, relative to traumatic brain injury (TBI) status and psychological distress. Method: This prospective cohort study examined 500 Veterans from Upstate New York at four time points, six months apart. TBI status was determined by a structured clinical interview. Neuropsychological instruments focused on attention, memory, and executive functions. Subjective cognitive complaints were assessed with the Neurobehavioral Symptom Inventory (NSI). A psychological distress composite included measures of post-traumatic stress disorder (PTSD), depression, and generalized anxiety. Results: Forty-four percent of the sample was found to have sustained military-related TBI, 97% of which were classified as mild (mTBI), with a mean time since injury of 41months. Veterans with TBI endorsed moderate cognitive symptoms on the NSI. In contrast to these subjective complaints, mean cognitive test performance was within normal limits at each time point in all domains, regardless of TBI status. Multilevel models examined effects of TBI status, time, and psychological distress. Psychological distress was a strong predictor of all cognitive domains, especially the subjective domain. Substantial proportions of both TBI+ and TBI- groups remained in the clinically significant range at the initial and final assessment for all three distress measures, but the TBI+ group had higher proportions of clinically significant cases. Conclusions: Objective cognitive performance was generally within normal limits for Veterans with mTBI across all assessments. Psychological distress was elevated and significantly related to both objective and subjective cognitive performance.	[Donnelly, Kerry; King, Paul R.] VA Western New York Healthcare Syst, Buffalo, NY 14215 USA; [Donnelly, James P.] Canisius Coll, Dept Counseling & Human Serv, Buffalo, NY 14208 USA; [Warner, Gary C.] Canandaigua VA Med Ctr, Canandaigua, NY USA; [Kittleson, C. James] Bath VA Med Ctr, Bath, NY USA		Donnelly, K (corresponding author), VA Western New York Healthcare Syst, Buffalo, NY 14215 USA.	Kerry.Donnelly@va.gov	Donnelly, James/AAI-4840-2020		VA Health Services Research DevelopmentUS Department of Veterans Affairs [SDR 06-162]	This work was supported by VA Health Services Research & Development under Grant [SDR 06-162].	Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; BECK A, 1993, BECK ANXIETY INDEX; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 2013, STAT POWER ANAL BEHA; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Congressional Budget Office, 2012, VET HLTH ADM TREATM; Cumming G, 2016, INTRO NEW STAT; Delis DC, 2001, D KEFS TECHNICAL MAN; DELIS DC, 2000, CVLT 2 MANUAL; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; GREEN P, 2007, MED SYMPTOM VALIDITY; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; King PR, 2014, ARCH CLIN NEUROPSYCH, V29, P391, DOI 10.1093/arclin/acu011; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lew H. L., 2009, J REHABILITATION RES, V46, P6; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Twisk J., 2013, APPL LONGITUDINAL DA; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Weathers F.W., 1993, 9 ANN C ISTSS; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; [No title captured]; [No title captured]; [No title captured]	50	14	14	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	3					436	455		10.1080/13854046.2017.1390163			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FZ4KL	WOS:000427561000007	29052464				2022-02-06	
J	Evald, L				Evald, Lars			Prospective memory rehabilitation using smartphones in patients with TBI	DISABILITY AND REHABILITATION			English	Article						Assistive technology; prospective memory; neurorehabilitation; memory disorders; compensatory strategy; Internet calendar	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; COGNITIVE REHABILITATION; EFNS GUIDELINES; PAGING SYSTEM; AID; PEOPLE; INDIVIDUALS; TECHNOLOGY; PDAS	Purpose: The aim of the present study was to investigate the effectiveness of a prospective memory aid that combines smartphones with Internet-based calendars among community-dwelling patients with traumatic brain injury.Method: An uncontrolled pre- and post-assessment design was employed to study the use of unmodified, low-cost, off-the-shelf smartphones combined with Internet-calendars as a compensatory memory strategy in community-dwelling patients with traumatic brain injury. Thirteen participants received a 6-week group-based intervention with pre-, post- and 2-month follow-up-assessments by questionnaires and by daily assessment of target behaviors for 2-week periods.Results: Participants reported significantly fewer retro- and prospective memory problems on questionnaires after the intervention and at follow-up with large effect sizes. The performance of target behaviors, however, improved insignificantly with moderate effect sizes. There were no changes in quality of life or symptoms of emotional distress.Conclusions: This study adds to a growing body of evidence that smartphones are a useful compensatory aid in rehabilitation of prospective memory that should routinely be considered in rehabilitation of traumatic brain injury patients.Implication for rehabilitationSmartphones are easy-to-use and accessible assistive technology for compensatory memory rehabilitation to most traumatic brain injury patients.By using low-cost, off-the-shelf devices, the technology becomes available to a broader range of patients.By combining smartphones with Internet-based and cross-platform services (e.g., calendars, contacts) the participants are less device-dependent and less vulnerable to data loss.Smartphones should routinely be considered as compensatory aid in rehabilitation of prospective memory of traumatic brain injured patients.	[Evald, Lars] Cent Denmark Reg, Hammel Neurorehabil Ctr, Hammel, Denmark; [Evald, Lars] Univ Res Clin, Hammel, Denmark; [Evald, Lars] Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark; [Evald, Lars] Aarhus Univ, MINDLAB, CFIN, CNRU, Aarhus, Denmark; [Evald, Lars] Aarhus Univ Hosp, Aarhus, Denmark		Evald, L (corresponding author), Hammel Neurorehabil & Univ Res Ctr, Voldbyvej 15, DK-8450 Hammel, Denmark.	lars.evald@midt.rm.dk	Evald, Lars/Q-4384-2019	Evald, Lars/0000-0001-6255-2562			[Anonymous], 1958, EXAMEN CLIN PSYCHOL; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Culbertson WC., 2001, TOWER LONDON DREXEL; De Joode E. A., 2012, NEUROPSYCHOL REHABIL, V23, P133, DOI DOI 10.1080/09602011.2012.726632; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Dowds MM, 2011, J HEAD TRAUMA REHAB, V26, P339, DOI 10.1097/HTR.0b013e3181f2bf1d; Ellis J., 1996, PROSPECTIVE MEMORY T; Evald L, 2015, NEUROPSYCHOL REHABIL, V25, P283, DOI 10.1080/09602011.2014.970557; Ferguson S, 2015, BRAIN INJURY, V29, P583, DOI 10.3109/02699052.2014.1002109; Gade A, 1984, PSYKOLOGISK TIDSSKRI; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gentry T, 2008, AM J OCCUP THER, V62, P18, DOI 10.5014/ajot.62.1.18; Gillette Y, 2004, NEUROREHABILITATION, V19, P233; Gillette Y, 2008, PSYCHOL SCHOOLS, V45, P665, DOI 10.1002/pits.20316; Golden CJ, 1978, STROOP COLOR WORD TE; Golden CJ., 2002, STROOP COLOR WORD TE; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; JOrgensen K, 2012, DANSKE NORMER NEUROP; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Meyers JE., 1995, REY COMPLEX FIGURE T; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; NIELSEN H, 1989, SCAND J PSYCHOL, V30, P37, DOI 10.1111/j.1467-9450.1989.tb01066.x; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Smith A., 1991, SYMBOL DIGIT MODALIT; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Spreen O., 1969, NEUROSENSORY CTR COM; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; Sundhedsstyrelsen, 2011, HJERN EN MED TEKN HO; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Svoboda E, 2010, NEUROPSYCHOL REHABIL, V20, P562, DOI 10.1080/09602011003669918; Svoboda E, 2009, J INT NEUROPSYCH SOC, V15, P629, DOI 10.1017/S1355617709090791; Taylor L B, 1969, Clin Neurosurg, V16, P269; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Uttl B, 2011, CAN J EXP PSYCHOL, V65, P57, DOI 10.1037/a0022843; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Waldron B., 2012, IRISH J PSYCHOL, V33, P29, DOI [10.1080/03033910.2012.659044, DOI 10.1080/03033910.2012.659044]; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WHO, 1996, INTR ADM SCOR GEN VE; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006; Yasuda K, 2002, NEUROPSYCHOL REHABIL, V12, P155, DOI 10.1080/09602010143000239; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	14	14	1	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	19					2250	2259		10.1080/09638288.2017.1333633			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GO4ZI	WOS:000440026500004	28589735				2022-02-06	
J	Feng, LY; Sharma, A; Niu, F; Huang, Y; Lafuente, JV; Muresanu, DF; Ozkizilcik, A; Tian, ZR; Sharma, HS				Feng, Lianyuan; Sharma, Aruna; Niu, Feng; Huang, Yin; Vicente Lafuente, Jose; Muresanu, Dafin Fior; Ozkizilcik, Asya; Tian, Z. Ryan; Sharma, Hari Shanker			TiO2-Nanowired Delivery of DL-3-n-butylphthalide (DL-NBP) Attenuates Blood-Brain Barrier Disruption, Brain Edema Formation, and Neuronal Damages Following Concussive Head Injury	MOLECULAR NEUROBIOLOGY			English	Article						DL-3-n-butylphthalide (DL-NBP); Concussive head injury (CHI); Blood-brain barrier; Brain edema; Neuronal injury; TiO2 nanodelivery; Neuroprotection	NANOWIRED DRUG-DELIVERY; US MILITARY PERSONNEL; SPINAL-CORD; OXIDATIVE STRESS; UP-REGULATION; I-131 SODIUM; NEUROPROTECTION; ANTIOXIDANT; TRAUMA; MODEL	DL-3-n-butylphthalide (DL-NBP) is one of the constituents of Chinese celery extract that is used to treat stroke, dementia, and ischemic diseases. However, its role in traumatic brain injury is less well known. In this investigation, neuroprotective effects of DL-NBP in concussive head injury (CHI) on brain pathology were explored in a rat model. CHI was inflicted in anesthetized rats by dropping a weight of 114.6 g from a height of 20 cm through a guide tube on the exposed right parietal bone inducing an impact of 0.224 N and allowed them to survive 4 to 24 h after the primary insult. DL-NBP was administered (40 or 60 mg/kg, i.p.) 2 and 4 h after injury in 8-h survival group and 8 and 12 h after trauma in 24-h survival group. In addition, TiO2-nanowired delivery of DL-NBP (20 or 40 mg/kg, i.p.) in 8 and 24 h CHI rats was also examined. Untreated CHI showed a progressive increase in blood-brain barrier (BBB) breakdown to Evans blue albumin (EBA) and radioiodine (I[131]-), edema formation, and neuronal injuries. The magnitude and intensity of these pathological changes were most marked in the left hemisphere. Treatment with DL-NBP significantly reduced brain pathology in CHI following 8 to 12 h at 40-mg dose. However, 60-mg dose is needed to thwart brain pathology at 24 h following CHI. On the other hand, TiO2-DL-NBP was effective in reducing brain damage up to 8 or 12 h using a 20-mg dose and only 40-mg dose was needed for neuroprotection in CHI at 24 h. These observations are the first to suggest that (i) DL-NBP is quite effective in reducing brain pathology and (ii) nanodelivery of DL-NBP has far more superior effects in CHI, not reported earlier.	[Feng, Lianyuan] Bethune Int Peace Hosp, Dept Neurol, Zhongshan Rd West, Shijiazhuang, Hebei, Peoples R China; [Sharma, Aruna; Sharma, Hari Shanker] Uppsala Univ, Dept Surg Sci Anesthesiol & Intens Care Med, Cerebrovasc Res Lab, SE-75185 Uppsala, Sweden; [Sharma, Hari Shanker] Uppsala Univ, Univ Hosp, Int Expt CNS Injury & Repair IECNSIR, Frodingsgatan 12,Bldg 28, SE-75421 Uppsala, Sweden; [Niu, Feng; Huang, Yin] CSPC NBP Pharmaceut Med, Zhongshan Rd West, Shijiazhuang, Hebei, Peoples R China; [Vicente Lafuente, Jose] Univ Basque Country UPV EHU, Dept Neurosci, LaNCE, Leioa, Bizkaia, Spain; [Muresanu, Dafin Fior] RoNeuro Inst Neurol Res & Diagnost, 37 Mircea Eliade St, Cluj Napoca 400364, Romania; [Muresanu, Dafin Fior] Univ Med & Pharm, Dept Clin Neurosci, Cluj Napoca, Romania; [Vicente Lafuente, Jose] BioCruces Hlth Res Inst, Nanoneurosurg Grp, Baracaldo 48903, Bizkaia, Spain; [Vicente Lafuente, Jose] Univ Autonoma Chile, Fac Hlth Sci, Santiago, Chile; [Ozkizilcik, Asya] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA; [Tian, Z. Ryan] Univ Arkansas, Dept Chem & Biochem, J William Fulbright Coll Arts & Sci, Fayetteville, AR 72701 USA		Sharma, HS (corresponding author), Uppsala Univ, Dept Surg Sci Anesthesiol & Intens Care Med, Cerebrovasc Res Lab, SE-75185 Uppsala, Sweden.; Sharma, HS (corresponding author), Uppsala Univ, Univ Hosp, Int Expt CNS Injury & Repair IECNSIR, Frodingsgatan 12,Bldg 28, SE-75421 Uppsala, Sweden.	Sharma@surgsci.uu.se	Tian, Z. Ryan/R-6671-2016; Muresanu, Fior-Dafin/AAI-8120-2021; Lafuente, Jose-Vicente/O-6395-2014	Tian, Z. Ryan/0000-0002-5644-8483; Lafuente, Jose-Vicente/0000-0001-7246-0987; Ozkizilcik, Asya/0000-0002-6261-9533	Ministry of Science and Technology, People Republic of ChinaMinistry of Science and Technology, China; Air Force Office of Scientific Research (EOARD, London, UK)United States Department of DefenseAir Force Office of Scientific Research (AFOSR); Air Force Material Command, USAF [FA8655-05-1-3065]; Alzheimer's AssociationAlzheimer's Association [IIRG-09-132087]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG028679]; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [2710-HSS]; Goran Gustafsson Foundation, Stockholm, Sweden; Astra Zeneca, Molndal, SwedenAstraZeneca; University Grants Commission, New Delhi, IndiaUniversity Grants Commission, India; Ministry of Science and Technology, Govt. of India; Indian Medical Research Council, New Delhi, India; India-EU Co-operation Program; Government of Basque Country; University of Basque Country, Spain [UFI 11/32, PPG 17/51]; Society for Neuroprotection and Neuroplasticity (SSNN), Romania;  [IT 901/16]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG028679] Funding Source: NIH RePORTER	Supported by grants from the Ministry of Science and Technology, People Republic of China, the Air Force Office of Scientific Research (EOARD, London, UK), and Air Force Material Command, USAF, under grant number FA8655-05-1-3065; the Alzheimer's Association (IIRG-09-132087), the National Institutes of Health (R01 AG028679); Swedish Medical Research Council (Nr 2710-HSS), Goran Gustafsson Foundation, Stockholm, Sweden (HSS), Astra Zeneca, Molndal, Sweden (HSS/AS), The University Grants Commission, New Delhi, India (HSS/AS), Ministry of Science and Technology, Govt. of India (HSS/AS), Indian Medical Research Council, New Delhi, India (HSS/AS) and India-EU Co-operation Program (RP/AS/HSS) and IT 901/16 (JVL), Government of Basque Country and UFI 11/32 and PPG 17/51 (JVL) University of Basque Country, Spain, and Society for Neuroprotection and Neuroplasticity (SSNN), Romania. We thank Suraj Sharma, Uppsala, Sweden for computer and graphic support. The U.S. Government is authorized to reproduce and distribute reprints for Government purpose notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the US Government.	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Bryan CJ, 2013, BRAIN INJURY, V27, P1333, DOI 10.3109/02699052.2013.823651; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chong ZZ, 2000, CHINESE MED J-PEKING, V113, P613; Chong ZZ, 1999, ACTA PHARMACOL SIN, V20, P509; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Deahl MP, 2011, INT REV PSYCHIATR, V23, P201, DOI 10.3109/09540261.2011.557059; DEY P K, 1984, Indian Journal of Physiology and Pharmacology, V28, P177; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122, DOI 10.1152/ajplegacy.1949.157.1.122; Emilien G, 1996, ACTA NEUROL BELG, V96, P89; Feng XH, 2012, NEUROPHARMACOLOGY, V62, P1004, DOI 10.1016/j.neuropharm.2011.10.009; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; French LM, 2014, J NEUROTRAUM, V31, P1607, DOI 10.1089/neu.2014.3401; Gilhooly Jonathan, 2015, Handb Clin Neurol, V127, P379, DOI 10.1016/B978-0-444-52892-6.00024-6; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; He WF, 2011, NEURAL REGEN RES, V6, P2773, DOI 10.3969/j.issn.1673-5374.2011.35.009; Huang JZ, 2010, NEUROSCI LETT, V475, P89, DOI 10.1016/j.neulet.2010.03.053; Jia JP, 2016, ALZHEIMERS DEMENT, V12, P89, DOI 10.1016/j.jalz.2015.04.010; Kerr HA, 2013, CLIN SPORT MED, V32, P273, DOI 10.1016/j.csm.2012.12.008; Koss KM, 2016, ACTA BIOMATER, V44, P2, DOI 10.1016/j.actbio.2016.08.026; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Li JM, 2010, BRAIN RES, V1359, P216, DOI 10.1016/j.brainres.2010.08.061; Li L, 2009, BRAIN RES, V1290, P91, DOI 10.1016/j.brainres.2009.07.020; Li Qi-Fu, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P84; Li YM, 2015, BRAIN INJURY, V29, P981, DOI 10.3109/02699052.2014.989405; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Lu L, 2016, BIOMACROMOLECULES, V17, P1425, DOI 10.1021/acs.biomac.6b00040; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; Maguen S, 2012, J TRAUMA STRESS, V25, P3, DOI 10.1002/jts.21669; Muresanu DF, 2015, MOL NEUROBIOL, V52, P837, DOI 10.1007/s12035-015-9298-8; NIH, 2011, GUIDE CARE USE LAB A, Veighth; OLSSON Y, 1990, ACTA NEUROPATHOL, V79, P595, DOI 10.1007/BF00294236; Paskaski M, 2008, NEUROCHEM INT, V53, P103, DOI 10.1016/j.neuint.2008.06.005; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Ruozi B, 2014, CNS NEUROL DISORD-DR, V13, P1475, DOI 10.2174/1871527313666140806145540; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Sharma A, 2016, CNS NEUROL DISORD-DR, V15, P1092, DOI 10.2174/1871527315666160819123059; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P295, DOI 10.1196/annals.1403.022; Sharma HS, 2013, AMINO ACIDS, V45, P1055, DOI 10.1007/s00726-013-1584-z; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P197, DOI 10.1196/annals.1403.014; Sharma HS, 2016, CNS NEUROL DISORD-DR, V15, P1045, DOI 10.2174/1871527315666160902145145; Sharma HS, 2012, WIRES NANOMED NANOBI, V4, P184, DOI 10.1002/wnan.172; Sharma HS, 2011, J NEURAL TRANSM, V118, P87, DOI 10.1007/s00702-010-0486-4; SHARMA HS, 1990, BRAIN RES, V517, P215, DOI 10.1016/0006-8993(90)91029-G; SHARMA HS, 1995, RESTOR NEUROL NEUROS, V7, P207, DOI 10.3233/RNN-1994-7403; SHARMA HS, 1990, ACT NEUR S, V51, P383; SHARMA HS, 1986, J NEUROL SCI, V72, P61, DOI 10.1016/0022-510X(86)90036-5; Tian ZR, 2012, CNS NEUROL DISORD-DR, V11, P86; Wang CY, 2016, NEUROBIOL AGING, V38, P32, DOI 10.1016/j.neurobiolaging.2015.10.024; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Xiong NA, 2012, NEUROBIOL AGING, V33, P1777, DOI 10.1016/j.neurobiolaging.2011.03.007; Xue LX, 2016, EXP THER MED, V11, P2015, DOI 10.3892/etm.2016.3139; Zhang LH, 2012, CURR NEUROVASC RES, V9, P167, DOI 10.2174/156720212801618956; Zhang LH, 2012, NEUROCHEM RES, V37, P911, DOI 10.1007/s11064-011-0663-3; Zhang T, 2010, NEUROL RES, V32, P390, DOI 10.1179/016164110X12670144526264; Zhao HR, 2016, J STROKE CEREBROVASC, V25, P752, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.018; Zhao J, 2016, LIFE SCI, V165, P16, DOI 10.1016/j.lfs.2016.09.009; Zhao WH, 2014, NEURAL REGEN RES, V9, P719, DOI 10.4103/1673-5374.131576	65	14	18	1	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2018	55	1					350	358		10.1007/s12035-017-0746-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FV6PC	WOS:000424702600034	28856586				2022-02-06	
J	Karagiorgou, O; Evans, JJ; Cullen, B				Karagiorgou, Olga; Evans, Jonathan J.; Cullen, Breda			Post-traumatic growth in adult survivors of brain injury: a qualitative study of participants completing a pilot trial of brief positive psychotherapy	DISABILITY AND REHABILITATION			English	Article						Acquired brain injury; post-traumatic growth; positive psychology; psychotherapy; qualitative	PSYCHOLOGY; VALIDITY	Purpose: Post-traumatic growth (PTG) can occur following acquired brain injury (ABI). It has been proposed that people experiencing psychological distress following ABI may benefit from a positive psychotherapy intervention (PPT) aimed at increasing well-being; PPT may also influence PTG. We aimed to investigate PTG experiences in participants of a positive psychotherapy pilot trial. Methods: ABI survivors who had received PPT or treatment as usual (TAU) were interviewed individually after the end of the trial. Thematic analysis was conducted, to code transcripts for known themes from PTG literature as well as newly emerging themes. Results: Four participants (age = 46-62; n = 3 male; months since injury = 11-20) from the PPT group and three (age = 58-74; n = 2 male; months since injury = 9-22) from the TAU group were interviewed. Six themes were shared across both groups: personal strength, appreciation of life, relating to others, optimism/positive attitude, feeling fortunate compared to others, and positive emotional/behavioral changes. Two themes were expressed by PPT participants only: lifestyle improvements and new possibilities. One TAU participant reported spiritual change. Conclusions: A greater understanding of the development of PTG following ABI may help rehabilitation clinicians to promote better adjustment by focusing on clients' potential for positive change and enhancing their capacity for growth.	[Karagiorgou, Olga; Evans, Jonathan J.; Cullen, Breda] Univ Glasgow, Inst Hlth & Wellbeing, Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Karagiorgou, Olga] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland		Cullen, B (corresponding author), Univ Glasgow, Queen Elizabeth Univ Hosp, Off Block, Glasgow G51 4TF, Lanark, Scotland.	breda.cullen@glasgow.ac.uk	Cullen, Breda/C-9154-2012; Cullen, Breda/N-3449-2019	Cullen, Breda/0000-0002-7259-9505; Cullen, Breda/0000-0002-7259-9505	Dr Mortimer and Theresa Sackler Foundation; Scottish Executive Health Department [CZH/4/778]; Chief Scientist Office [CZH/4/778] Funding Source: researchfish	Breda Cullen is supported by The Dr Mortimer and Theresa Sackler Foundation. The PoPsTAR trial was funded by the Scottish Executive Health Department (Chief Scientist Office) under grant CZH/4/778. The funders had no role in the study design; collection, analysis, and interpretation of data; writing of the report; or decision to submit for publication. The authors declare that there are no other competing interests to disclose.	Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cullen B, 2018, NEUROPSYCHOL REHABIL, V28, P17, DOI 10.1080/09602011.2015.1131722; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Joseph S, 2012, PSYCHOL TRAUMA-US, V4, P420, DOI 10.1037/a0024740; Karagiorgou O, 2016, J LOSS TRAUMA, V21, P589, DOI 10.1080/15325024.2016.1161427; Lennon A, 2014, BRAIN INJURY, V28, P27, DOI 10.3109/02699052.2013.848378; Seligman M., 2011, FLOURISH NEW UNDERST; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Shakespeare-Finch J, 2013, J LOSS TRAUMA, V18, P572, DOI 10.1080/15325024.2012.734207; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	14	14	14	2	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	6					655	659		10.1080/09638288.2016.1274337			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FY5XL	WOS:000426911500005	28068845	Green Accepted			2022-02-06	
J	Lambregts, SAM; Smetsers, JEM; Verhoeven, IMAJ; de Kloet, AJ; van de Port, IGL; Ribbers, GM; Catsman-Berrevoets, CE				Lambregts, S. A. M.; Smetsers, J. E. M.; Verhoeven, I. M. A. J.; de Kloet, A. J.; van de Port, I. G. L.; Ribbers, G. M.; Catsman-Berrevoets, C. E.			Cognitive function and participation in children and youth with mild traumatic brain injury two years after injury	BRAIN INJURY			English	Article						Acquired Brain Injury; adolescents; young adults; long-term	NEUROCOGNITIVE OUTCOMES; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; CHILDHOOD; RECOVERY; ADOLESCENTS; PERFORMANCE; RESERVE; SCALE; TBI	Background: 10-20% of children and youth with mild traumatic brain injury (mTBI) suffer from long-term cognitive impairments with, supposedly, a negative impact on most domains of functioning. Objectives: To describe cognitive functioning and participation in children and youth two-years post-mTBI and to determine associated risk factors. Methods: Cross-sectional study among 73 patients (aged 6-22 years), hospital diagnosed with mTBI. Linear regression modelling was used to investigate the effect of potential predictors on cognitive functioning as measured with a neuropsychological assessment (NPA), two-years post-injury. Extent of participation was assessed using the Child and Adolescent Scale of Participation and correlation analysis was conducted to examine its association with level of cognitive functioning. Results: 7-15% of all participants had impaired cognitive functions, especially in the domains of processing speed, inhibitory control, cognitive flexibility, visuospatial constructional ability and visuospatial memory. Lower level of education and pre-injury cognitive problems were predictive for a lower level of long-term cognitive functioning. Slower inhibition speed, impaired visuospatial and verbal working memory were associated with reduced participation. Discussion and conclusions: Persisting cognitive problems two years after mTBI were mostly related to the lower level of education and to pre-injury cognitive problems. Although participation of the patients was reported by parents to be relatively high, slower inhibition speed, impaired visuospatial and verbal working memory were associated with reduced participation.	[Lambregts, S. A. M.; Ribbers, G. M.] Erasmus MC Univ, Med Ctr, Dept Rehabil Med, Rotterdam, Netherlands; [Lambregts, S. A. M.; van de Port, I. G. L.] Revant Rehabil Ctr, Dept Rehabil Med, Breda, Netherlands; [Smetsers, J. E. M.] Univ Utrecht, Dept Neuropsychol, Utrecht, Netherlands; [Verhoeven, I. M. A. J.; de Kloet, A. J.] The Hague Univ Appl Sci, Expertise Grp, The Hague, Netherlands; [de Kloet, A. J.] Sophia Rehabil Ctr, Dept Rehabil Med, The Hague, Netherlands; [Ribbers, G. M.] Rijndam Rehabil Inst, Dept Rehabil Med, Rotterdam, Netherlands; [Catsman-Berrevoets, C. E.] Erasmus MC Univ, Med Ctr, Dept Pediat Neurol, Rotterdam, Netherlands		Lambregts, SAM (corresponding author), Evant Rehabil Ctr, Brabantlaan 1, NL-4817 JW Breda, Netherlands.	s.lambregts@revant.nl	Ribbers, Gerard/N-3623-2019; Ribbers, Gerard M/C-1454-2014	Ribbers, Gerard M/0000-0002-6114-349X	Revalidatiefonds [2010/0029]; Johanna KinderFonds and Kinderrevalidatie Fonds Adriaanstichting (JKF/KFA Grant) [2009/0075]	The authors report no declarations of interest. This study was supported by the Revalidatiefonds (Grant 2010/0029), Johanna KinderFonds and Kinderrevalidatie Fonds Adriaanstichting (JKF/KFA Grant 2009/0075).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; de Kloet AJ, 2015, BRAIN INJURY, P1; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; De Sonneville L., 2014, HDB AMSTERDAMSE NEUR; De Sonneville L. M. J., 2005, TIJDSCHRIFT NEUROPSY, V1, P27; de Sonneville LMJ, 1999, COMP PSYCH, V6, P187; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P554, DOI 10.1136/adc.2009.161083; Gerstman B.B., 2009, BASIC BIOSTATISTICS; Hackman DA, 2014, CHILD DEV, V85, P1433, DOI 10.1111/cdev.12242; Hageman G., 2010, MANAGEMENT PATIENTS; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; LIBERMAN J, 1994, J CLIN PSYCHOL, V50, P615, DOI 10.1002/1097-4679(199407)50:4<615::AID-JCLP2270500419>3.0.CO;2-R; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Stern Y, 2013, FOLIA PHONIATR LOGO, V65, P49, DOI 10.1159/000353443; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; TOMPKINS CA, 1990, BRAIN COGNITION, V13, P86, DOI 10.1016/0278-2626(90)90042-M; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wechsler D, 2005, MANUAL WECHSLER INTE; World Health Organization, 2007, INT CLASS FUNCT DIS; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	57	14	14	1	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	2					230	241		10.1080/02699052.2017.1406990			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WF	WOS:000427073600009	29190153				2022-02-06	
J	Lee, JJ; Segar, DJ; Morrison, JF; Mangham, WM; Lee, S; Asaad, WF				Lee, Jonathan J.; Segar, David J.; Morrison, John F.; Mangham, William M.; Lee, Shane; Asaad, Wael F.			Subdural hematoma as a major determinant of short-term outcomes in traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						head injury; traumatic brain injury; subdural hematoma; trauma	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; CLASSIFICATION-SYSTEM; ODDS RATIOS; PREDICTION; SEVERITY; SCORE; AGE	OBJECTIVE Early radiographic findings in patients with traumatic brain injury (TBI) have been studied in hopes of better predicting injury severity and outcome. However, prior attempts have generally not considered the various types of intracranial hemorrhage in isolation and have typically not excluded patients with potentially confounding extracranial injuries. Therefore, the authors examined the associations of various radiographic findings with short-term outcome to assess the potential utility of these findings in future prognostic models. METHODS The authors retrospectively identified 1716 patients who had experienced TBI without major extracranial injuries, and categorized them into the following TBI subtypes: subdural hematoma (SDH), traumatic subarachnoid hemorrhage, intraparenchymal hemorrhage (which included intraventricular hemorrhage), and epidural hematoma. They specifically considered isolated forms of hemorrhage, in which only 1 subtype was present. RESULTS In general, the presence of an isolated SDH was more likely to result in worse outcomes than the presence of other isolated forms of traumatic intracranial hemorrhage. Discharge to home was less likely and perihospital mortality rates were generally higher in patients with SDH. These findings were not simply related to age and were not fully captured by the admission Glasgow Coma Scale (GCS) score. The presence of SDH had a much higher sensitivity for poor outcome than the presence of other TBI subtypes, and was more sensitive for these poor outcomes than having a low GCS score (3-8). CONCLUSIONS In these ways, SDH was the most important finding associated with poor outcome, and the authors show that consideration of SDH, specifically, can augment age and GCS score in classification and prognostic models for TBI. https://thejns.org/doi/abs/10.3171/2016.5.JNS16255	[Lee, Jonathan J.; Segar, David J.; Morrison, John F.; Mangham, William M.; Asaad, Wael F.] Brown Univ, Warren Alpert Med Sch, Providence, RI USA; [Morrison, John F.; Asaad, Wael F.] Rhode Isl Hosp, Dept Neurosurg, 593 Eddy St, Providence, RI 02903 USA; [Lee, Shane] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA; [Lee, Shane] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Asaad, Wael F.] Rhode Isl Hosp, Norman Prince Neurosci Inst, Providence, RI 02903 USA		Asaad, WF (corresponding author), Rhode Isl Hosp, Dept Neurosurg, 593 Eddy St, Providence, RI 02903 USA.	wael_asaad@brown.edu	; Asaad, Wael/I-8485-2012	Segar, David/0000-0001-9369-1856; Asaad, Wael/0000-0003-4406-9096; Lee, Shane/0000-0001-7264-5658	Department of Neurosurgery; Alpert Medical School of Brown University; Rhode Island Hospital	We thank the Department of Neurosurgery, the Alpert Medical School of Brown University, and Rhode Island Hospital for their support.	ACourt C, 2012, BR J GEN PRACT, V62, pe220; Altman DG, 1998, BRIT MED J, V317, P1318, DOI 10.1136/bmj.317.7168.1318; AMACHER AL, 1987, NEUROSURGERY, V20, P954; [Anonymous], 1990, PRACTICAL STAT MED R; BRAAKMAN R, 1992, ACTA NEUROCHIR, V116, P161, DOI 10.1007/BF01540870; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Chieregato A, 2010, ACTA ANAESTH SCAND, V54, P696, DOI 10.1111/j.1399-6576.2010.02234.x; D'Amato L, 2007, J Neurosurg Sci, V51, P107; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Epstein DS, 2014, BR J NEUROSURG; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Holcomb WL, 2001, OBSTET GYNECOL, V98, P685, DOI 10.1016/S0029-7844(01)01488-0; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Lee JJ, 2014, J NEUROTRAUM, V31, P595, DOI 10.1089/neu.2013.3152; Lee YB, 2011, KOREAN J NEUROTRAUMA, V7, P12; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; TEASDALE G, 1978, ANESTHESIOLOGY, V49, P225, DOI 10.1097/00000542-197809000-00023; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294; Varano P, 2015, J TRAUMA ACUTE CARE, V78, P1039, DOI 10.1097/TA.0000000000000604	41	14	14	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2018	128	1					236	249		10.3171/2016.5.JNS16255			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FR3AW	WOS:000418939300029	28186445				2022-02-06	
J	Martin, JL; Wu, D				Martin, Jean-Louis; Wu, Dan			Pedestrian fatality and impact speed squared: Cloglog modeling from French national data	TRAFFIC INJURY PREVENTION			English	Article						Crash; pedestrian; impact speed; fatality; statistical modeling	MOTOR-VEHICLE COLLISIONS; ROAD CRASH CASUALTIES; LIGHT TRUCK VEHICLES; INJURY SEVERITY; PASSENGER CARS; HEAD-INJURY; RISK; FRANCE; PROTECTION; POLICE	Objective: The present study estimates pedestrians' risk of death according to impact speed when hit by a passenger car in a frontal collision.Methods: Data were coded for all fatal crashes in France in 2011 and for a random sample of 1/20th of all road injuries for the same year and weighted to take into account police underreporting of mild injury. A cloglog model was used to optimize risk adjustment for high collision speeds. The fit of the model on the data was also improved by using the square of the impact speed, which best matches the energy dissipated in the collision.Results: Modeling clearly demonstrated that the risk of death was very close to 1 when impact speeds exceeded 80km/h. For speeds less than 40km/h, because data representative of all crashes resulting in injury were used, the estimated risk of death was fairly low. However, although the curve seemed deceptively flat below 50km/h, the risk of death in fact rose 2-fold between 30 and 40km/h and 6-fold between 30 and 50km/h. For any given speed, the risk of death was much higher for more elderly subjects, especially those over 75years of age. These results concern frontal crashes involving a passenger car. Collisions involving trucks are far less frequent, but half result in the pedestrian being run over, incurring greater mortality.Conclusions: For impact speeds below 60km/h, the shape of the curve relating probability of death to impact speed was very similar to those reported in recent rigorous studies. For higher impact speeds, the present model allows the curve to rise ever more steeply, giving a much better fit to observed data. The present results confirm that, when a pedestrian is struck by a car, impact speed is a major risk factor, thus providing a supplementary argument for strict speed limits in areas where pedestrians are highly exposed.	[Martin, Jean-Louis; Wu, Dan] Univ Lyon 1, UMRESTTE UMR T 9405, IFSTTAR, Lyon, France		Martin, JL (corresponding author), Univ Lyon 1, UMRESTTE UMR T 9405, IFSTTAR, Lyon, France.; Martin, JL (corresponding author), Univ Lyon 1, IFSTTAR, UMRESTTE, 25 Ave Francois Mitterrand, F-69675 Bron, France.	jean-louis.martin@ifsttar.fr	Martin, Jean-Louis/X-6588-2019	Martin, Jean-Louis/0000-0002-3426-9601	French National Research AgencyFrench National Research Agency (ANR)	Funding was provided by the French National Research Agency.	Alhajyaseen WKM, 2013, ACCIDENT ANAL PREV, V50, P175, DOI 10.1016/j.aap.2012.04.006; Amoros E, 2008, EUR J PUBLIC HEALTH, V18, P360, DOI 10.1093/eurpub/ckn018; Amoros E, 2007, J TRAUMA, V62, P482, DOI 10.1097/01.ta.0000202546.49273.f9; Amoros E, 2006, ACCIDENT ANAL PREV, V38, P627, DOI 10.1016/j.aap.2005.11.006; Ashton S, 1982, P 24 STAPP CAR CRASH, P609; Badea-Romero A, 2013, ACCIDENT ANAL PREV, V50, P1140, DOI 10.1016/j.aap.2012.09.024; Ballesteros MF, 2004, ACCIDENT ANAL PREV, V36, P73, DOI 10.1016/S0001-4575(02)00129-X; Consentino F, 2010, COMPUT STAT DATA AN, V54, P2284, DOI 10.1016/j.csda.2010.04.009; Crandall JR, 2002, BRIT MED J, V324, P1145, DOI 10.1136/bmj.324.7346.1145; Crocetta G, 2015, ACCIDENT ANAL PREV, V79, P56, DOI 10.1016/j.aap.2015.03.009; Davis GA, 2001, TRANSPORT RES REC, P108, DOI 10.3141/1773-13; del Fueyo RS, 2015, PEDESTRIAN FATAL HEA; Demetriades D, 2004, J AM COLL SURGEONS, V199, P382, DOI 10.1016/j.jamcollsurg.2004.03.027; Depriester J-P, 2005, COMPARISON SEVERAL M; Desapriya E, 2010, TRAFFIC INJ PREV, V11, P48, DOI 10.1080/15389580903390623; Elvik R., 1999, TRANSPORT RES REC, V1665, P33; Fugger TF, 2000, IMECHE CONF TRANS, V2000, P107; Goshu A.T., 2013, AM J THEORETICAL APP, V2, P268, DOI [10.11648/j.ajtas.20130206.25, DOI 10.11648/J.AJTAS.20130206.25]; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Gupta Vishal, 2013, Stapp Car Crash J, V57, P139; Hamacher M, 2009, 21 INT C ENH SAF VEH; Han Y, 2012, TRAFFIC INJ PREV, V13, P507, DOI 10.1080/15389588.2012.661111; Hannawald L, 2004, EQUAL EFFECTIVENESS; Helmer T, 2010, IRCOBI C HAN GERM 20; Henary Basem Y, 2003, Annu Proc Assoc Adv Automot Med, V47, P105; Henary Basem Y, 2006, Traffic Inj Prev, V7, P182, DOI 10.1080/15389580500516414; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Kim JK, 2008, ACCIDENT ANAL PREV, V40, P1695, DOI 10.1016/j.aap.2008.06.005; Kroyer HRG, 2014, ACCIDENT ANAL PREV, V62, P143, DOI 10.1016/j.aap.2013.09.007; Kutner MH., 2004, APPL LINEAR STAT MOD; Mallory Ann, 2012, Ann Adv Automot Med, V56, P13; Martin JL, 2008, ACCIDENT ANAL PREV, V40, P1811, DOI 10.1016/j.aap.2008.07.001; Martin JL, 2011, 55 ANN AAAM C 2011 P; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; Observatoire National Interministeriel de Securite Routiere (ONISR), 2014, SEC ROUT FRANC BIL L; Okamoto Yutaka, 2003, Traffic Inj Prev, V4, P74, DOI 10.1080/15389580309856; OTTE D, 1999, P INT IRCOBI C BIOM, P329; Pulugurtha SS, 2011, ACCIDENT ANAL PREV, V43, P439, DOI 10.1016/j.aap.2010.09.014; Rau H, 2000, VERKEHRSUNFALL FAHRZ, V12, P341; Richards D.C., 2010, RELATIONSHIP SPEED R; Richards D, 2012, ACCIDENT ANAL PREV, V47, P16, DOI 10.1016/j.aap.2012.01.009; Richmond SA, 2014, ACCIDENT ANAL PREV, V71, P222, DOI 10.1016/j.aap.2014.05.022; Richmond SA, 2014, INJURY PREV, V20, P155, DOI 10.1136/injuryprev-2012-040717; Rosen E, 2011, ACCIDENT ANAL PREV, V43, P25, DOI 10.1016/j.aap.2010.04.003; Rosen E, 2009, ACCIDENT ANAL PREV, V41, P536, DOI 10.1016/j.aap.2009.02.002; Roudsari Bahman S, 2005, Traffic Inj Prev, V6, P185; Roudsari BS, 2004, INJURY PREV, V10, P154, DOI 10.1136/ip.2003.003814; Rubin D.B., 1987, MULTIPLE IMPUTATION; Tefft BC, 2013, ACCIDENT ANAL PREV, V50, P871, DOI 10.1016/j.aap.2012.07.022; Toor A, 2003, THEORETICAL VS EMPIR; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Watanabe Ryosuke, 2012, Stapp Car Crash J, V56, P269; WHO, 2013, PED SAF ROAD SAF MAN; World Health Organization, 2015, WHO GLOB STAT REP RO; Zegeer CV, 2012, ACCIDENT ANAL PREV, V44, P3, DOI 10.1016/j.aap.2010.12.007; Zhu MT, 2013, INJURY PREV, V19, P227, DOI 10.1136/injuryprev-2012-040594	56	14	16	2	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2018	19	1					94	101		10.1080/15389588.2017.1332408			8	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	FN0UP	WOS:000415696600016	28557669	Green Submitted			2022-02-06	
J	McCaul, C; Boone, KB; Ermshar, A; Cottingham, M; Victor, TL; Ziegler, E; Zeller, MA; Wright, M				McCaul, Courtney; Boone, Kyle B.; Ermshar, Annette; Cottingham, Maria; Victor, Tara L.; Ziegler, Elizabeth; Zeller, Michelle A.; Wright, Matthew			Cross-validation of the Dot Counting Test in a large sample of credible and non-credible patients referred for neuropsychological testing	CLINICAL NEUROPSYCHOLOGIST			English	Article						Dot Counting Test; Performance Validity; non-credible performance; freestanding performance validity test	TRAUMATIC BRAIN-INJURY; WORD RECOGNITION TEST; B TEST; SPECIFICITY; PERFORMANCE; SCORES; SENSITIVITY; MEMORY; INTELLIGENCE; UTILITY	Objective: To cross-validate the Dot Counting Test in a large neuropsychological sample. Method: Dot Counting Test scores were compared in credible (n = 142) and non-credible (n = 335) neuropsychology referrals. Results: Non-credible patients scored significantly higher than credible patients on all Dot Counting Test scores. While the original E-score cut-off of >= 17 achieved excellent specificity (96.5%), it was associated with mediocre sensitivity (52.8%). However, the cut-off could be substantially lowered to >= 13.80, while still maintaining adequate specificity (>= 90%), and raising sensitivity to 70.0%. Examination of non-credible subgroups revealed that Dot Counting Test sensitivity in feigned mild traumatic brain injury (mTBI) was 55.8%, whereas sensitivity was 90.6% in patients with non-credible cognitive dysfunction in the context of claimed psychosis, and 81.0% in patients with non-credible cognitive performance in depression or severe TBI. Thus, the Dot Counting Test may have a particular role in detection of non-credible cognitive symptoms in claimed psychiatric disorders. Alternative to use of the E-score, failure on >= 1 cut-offs applied to individual Dot Counting Test scores (>= 6.0" for mean grouped dot counting time, >= 10.0" for mean ungrouped dot counting time, and >= 4 errors), occurred in 11.3% of the credible sample, while nearly two-thirds (63.6%) of the non-credible sample failed one of more of these cut-offs. Conclusions: An E-score cut-off of 13.80, or failure on >= 1 individual score cut-offs, resulted in few false positive identifications in credible patients, and achieved high sensitivity (64.0-70.0%), and therefore appear appropriate for use in identifying neurocognitive performance invalidity.	[McCaul, Courtney; Boone, Kyle B.; Ermshar, Annette] Alliant Int Univ, Calif Sch Forens Studies, Los Angeles, CA 91803 USA; [Cottingham, Maria] Vet Adm Tennessee Valley Healthcare Syst, Mental Hlth Care Line, Nashville, TN USA; [Victor, Tara L.] Calif State Univ Dominguez Hills, Dept Psychol, Carson, CA 90747 USA; [Ziegler, Elizabeth] Spokane Vet Adm, Spokane, WA USA; [Zeller, Michelle A.] West Los Angeles Vet Adm Med Ctr, Los Angeles, CA USA; [Wright, Matthew] Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA		Boone, KB (corresponding author), Alliant Int Univ, Calif Sch Forens Studies, Los Angeles, CA 91803 USA.	kboone@kyleboonephd.com	Victor, Tara/K-6581-2019				Arentsen TJ, 2013, CLIN NEUROPSYCHOL, V27, P1060, DOI 10.1080/13854046.2013.803603; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Ben-Porath Y., 2012, INTERPRETING MMPI 2; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Burton V, 2012, ARCH CLIN NEUROPSYCH, V27, P262, DOI 10.1093/arclin/acs026; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1224, DOI 10.1080/13854046.2014.987167; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Herzberg D., 2002, REY DOT COUNTING TES; Keary TA, 2013, J INT NEUROPSYCH SOC, V19, P314, DOI 10.1017/S1355617712001397; Kemp S, 2008, J PSYCHOSOM RES, V65, P319, DOI 10.1016/j.jpsychores.2008.02.010; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Marshall P, 2007, CLIN NEUROPSYCHOL, V21, P826, DOI 10.1080/13854040600801001; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Roberson CJ, 2013, CLIN NEUROPSYCHOL, V27, P495, DOI 10.1080/13854046.2012.737027; Robles L, 2015, J CLIN EXP NEUROPSYC, V37, P614, DOI 10.1080/13803395.2015.1039961; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Sherman D. S., 2002, CLIN NEUROPSYCHOL, V13, P545; Smith K, 2014, CLIN NEUROPSYCHOL, V28, P1048, DOI 10.1080/13854046.2014.931465; Soble JR, 2018, J CLIN EXP NEUROPSYC, V40, P317, DOI 10.1080/13803395.2017.1342773; Solomon RE, 2010, CLIN NEUROPSYCHOL, V24, P1243, DOI 10.1080/13854046.2010.514864; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Vilar-Lopez R, 2008, ARCH CLIN NEUROPSYCH, V23, P365, DOI 10.1016/j.acn.2008.01.007; Weiss R., 2010, INT J FORENSIC MENT, V9, P300, DOI [https://doi.org/10.1080/14999013.2010.526680, DOI 10.1080/14999013.2010.526680]	30	14	14	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	6					1054	1067		10.1080/13854046.2018.1425481			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GO3SJ	WOS:000439914700002	29345192				2022-02-06	
J	McPherson, K; Fadyl, J; Theadom, A; Channon, A; Levack, W; Starkey, N; Wilkinson-Meyers, L; Kayes, N				McPherson, Kathryn; Fadyl, Joanna; Theadom, Alice; Channon, Alexis; Levack, William; Starkey, Nicola; Wilkinson-Meyers, Laura; Kayes, Nicola		TBI Experiences Res Grp	Living Life After Traumatic Brain Injury: Phase 1 of a Longitudinal Qualitative Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adults; brain trauma; experience; qualitative; rehabilitation; traumatic brain injury	NEW-ZEALAND; INTERPRETIVE DESCRIPTION; HEALTH-CARE; REHABILITATION; POPULATION; RESILIENCE; RECOVERY; IDENTITY; SELF; EXPERIENCES	Objective: To explore what helps and hinders recovery and adaptation after disabling traumatic brain injury (TBI) and make recommendations for improving service responsiveness. Design: A longitudinal qualitative descriptive study across all TBI severities. Setting: Community. Participants: Forty people with TBI, and 22 significant others, 6 to 9 months following a TBI. Main Measures: Semistructured interviews, analyzed using qualitative description, focused on (a) key areas of importance or concern and (b) strategies or actions that people found helpful or that hindered recovery. Results: Traumatic brain injury produced a complex set of challenges in keeping up with life, and understanding what having a TBI means for, and to, me. This period encompassed a tangled fit and misfit in life as brain injury did not occur in isolation. People had to actively change some aspects of life and yet allow other changes to happen. Valued supports from others included being looked out for and having someone to help drive the process. Conclusion: Improved services delivery and better outcomes may result if we respond to the person within his or her context; listen, believe, and acknowledge the person's story through our actions; and avoid assumptions about aspects of life that mean most to people and who/what may help best.	[McPherson, Kathryn] Hlth Res Council New Zealand, 110 Stanley St, Auckland 1010, New Zealand; [McPherson, Kathryn; Fadyl, Joanna; Channon, Alexis; Kayes, Nicola] AUT Univ, Ctr Person Ctr Res, Auckland, New Zealand; [Theadom, Alice] AUT Univ, Ctr Person Ctr Res, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Levack, William] Univ Otago, Wellington, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [Wilkinson-Meyers, Laura] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand		McPherson, K (corresponding author), Hlth Res Council New Zealand, 110 Stanley St, Auckland 1010, New Zealand.	kmcpherson@hrc.govt.nz	Levack, William Mark Magnus/F-9607-2018; Starkey, Nicola/AAJ-3795-2020	Levack, William Mark Magnus/0000-0001-6631-908X; Starkey, Nicola/0000-0002-4370-8186; McPherson, Kath/0000-0003-0487-8497; Feigin, Valery L./0000-0002-6372-1740	Health Research Council of New ZealandHealth Research Council of New Zealand	Funding for the research was provided by the Health Research Council of New Zealand. The authors thank the participants for their time and energy in sharing their experiences. Input into design or processes during the project was offered by numerous colleagues in addition to those named above including Kay Shannon, Kirsten Thomas, Dawn Willix-Payne, Claire Townson, Elisa Lavelle, Margaret Dudley, and Thivasha Naidoo-Melis. The authors particularly thank the organizations that facilitated participant recruitment, and the community reference group (Stephen Jenkins, MatireHarwood, Alison Forster, and Suzanne Mudge). Greta Smith contributed financial management, data modeling, and administrative support. The authors thank the members of the Centre for Person Centred Research of AUT who contributed feedback during the study on emerging findings.	Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; CHARMAZ K, 1990, SOC SCI MED, V30, P1161, DOI 10.1016/0277-9536(90)90256-R; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Charmaz K, 1999, QUAL HEALTH RES, V9, P362, DOI 10.1177/104973299129121910; Chwalisz K, 2008, REHABIL PSYCHOL, V53, P387, DOI 10.1037/a0012998; Clendon Jill, 2006, Contemp Nurse, V23, P243; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dillahunt-Aspillaga C., 2014, SGRJARC, V45, P25; Douglas J, 2015, RETHINKING REHABILIT; Douglas J, 2015, INT J SPEECH-LANG PA, V17, P199, DOI 10.3109/17549507.2015.1016113; Ellis-Hill C, 2009, DISABIL REHABIL, V31, P61, DOI 10.1080/09638280701775289; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fadyl JK, 2017, NURS INQ, V24, DOI 10.1111/nin.12170; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Glaser B., 1967, DISCOVERY GROUNDED T; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Leplege A., 2015, RETHINKING REHABILIT; Levack WMM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004630; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; McPherson KM, 2012, PHYS THER REV, V17, P382, DOI 10.1179/1743288X12Y.0000000044; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; MCPHERSON KM, 2007, MANAGEMENT NEUROLOGI; Moloczij N, 2008, HEALTH SOC CARE COMM, V16, P501, DOI 10.1111/j.1365-2524.2008.00771.x; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Murray SA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3702; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Robison J, 2009, DISABIL REHABIL, V31, P1555, DOI 10.1080/09638280802639327; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Thorne S, 1997, RES NURS HEALTH, V20, P169; Thorne S, 2004, QUAL HEALTH RES, V14, P5, DOI 10.1177/1049732303259618; Williams V, 2010, PRIM CARE RESP J, V19, P45, DOI 10.4104/pcrj.2009.00044; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	53	14	14	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					E44	E52		10.1097/HTR.0000000000000321			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300006	28520671				2022-02-06	
J	Merritt, VC; Bradson, ML; Meyer, JE; Arnett, PA				Merritt, Victoria C.; Bradson, Megan L.; Meyer, Jessica E.; Arnett, Peter A.			Evaluating the test-retest reliability of symptom indices associated with the ImPACT post-concussion symptom scale (PCSS)	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						ImPACT; post-concussion symptoms; reliable change; sports concussion; test-retest reliability	POSTCONCUSSION-LIKE SYMPTOMS; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; SEX-DIFFERENCES; NEUROPSYCHOLOGICAL ASSESSMENT; NEUROCOGNITIVE PERFORMANCE; FOOTBALL PLAYERS; BASE-LINE; COLLEGIATE; PREDICTORS	Objective: The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) is a commonly used tool in sports concussion assessment. While test-retest reliabilities have been established for the ImPACT cognitive composites, few studies have evaluated the psychometric properties of the ImPACT's Post-Concussion Symptom Scale (PCSS). The purpose of this study was to establish the test-retest reliability of symptom indices associated with the PCSS.Participants and Methods: Participants included 38 undergraduate students (50.0% male) who underwent neuropsychological testing as part of their participation in their psychology department's research subject pool. The majority of the participants were Caucasian (94.7%) and had no history of concussion (73.7%). All participants completed the ImPACT at two time points, approximately 6weeks apart. The PCSS was the main outcome measure, and eight symptom indices were calculated (a total symptom score, three symptom summary indices, and four symptom clusters).Results: Pearson correlations (r) and intraclass correlation coefficients (ICCs) were computed as measures of test-retest reliability. Overall, reliabilities ranged from low to high (r=.44 to .80; ICC=.44 to .77). The cognitive symptom cluster exhibited the highest test-retest reliability (r=.80, ICC=.77), followed by the positive symptom total (PST) index, an indicator of the total number of symptoms endorsed (r=.71, ICC=.69). In contrast, the commonly used total symptom score showed lower test-retest reliability (r=.67, ICC=.62). Paired-samples ttests revealed no significant differences between test and retest for any of the symptom variables (all p>.01). Finally, reliable change indices (RCI) were computed to determine whether differences observed between test and retest represented clinically significant change. RCI values were provided for each symptom index at the 80%, 90%, and 95% confidence intervals.Conclusion: These results suggest that evaluating additional symptom indices beyond the total symptom score from the PCSS is beneficial. Findings from this study can be applied to athlete samples to assess reliable change in symptoms following concussion.	[Merritt, Victoria C.; Bradson, Megan L.; Meyer, Jessica E.; Arnett, Peter A.] Penn State Univ, Dept Psychol, 372 Moore Bldg, University Pk, PA 16802 USA		Merritt, VC (corresponding author), Penn State Univ, Dept Psychol, 372 Moore Bldg, University Pk, PA 16802 USA.	vcabarnes@gmail.com		Merritt, Victoria/0000-0001-5683-4168			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; ANASTASI A, 1998, PSYCHOL TESTING; Brett BL, 2017, J CLIN EXP NEUROPSYC, V39, P286, DOI 10.1080/13803395.2016.1224322; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell M. R, 2016, ADM INTERPRETATION M; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P., 2017, BRIT J SPORT MED, DOI [10.1136/brsports-2017-098699, DOI 10.1136/BRSPORTS-2017-098699]; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Pardini D., 2004, BR J SPORTS MED, V38, P661; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shoukri MM, 2004, STAT METHODS MED RES, V13, P251, DOI 10.1191/0962280204sm365ra; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spreen O., 2006, COMPENDIUM NEUROPSYC; Topolovec-Vranic J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141699; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Tsushima WT, 2016, ARCH CLIN NEUROPSYCH, V31, P105, DOI 10.1093/arclin/acv066; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Watkins M. P., 1993, FDN CLIN RES APPL PR; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Ziegler M, 2009, PSYCHOL SPORT EXERC, V10, P344, DOI 10.1016/j.psychsport.2008.12.004	66	14	16	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2018	40	4					377	388		10.1080/13803395.2017.1353590			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GA3XR	WOS:000428264300006	28728465				2022-02-06	
J	Salisbury, JP; Keshav, NU; Sossong, AD; Sahin, NT				Salisbury, Joseph P.; Keshav, Neha U.; Sossong, Anthony D.; Sahin, Ned T.			Concussion Assessment With Smartglasses: Validation Study of Balance Measurement Toward a Lightweight, Multimodal, Field-Ready Platform	JMIR MHEALTH AND UHEALTH			English	Article						postural balance; wearable technology; accelerometry; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; RANDOMIZED CLINICAL-TRIAL; ERROR SCORING SYSTEM; SOCIAL COMMUNICATION; AUDITORY BIOFEEDBACK; NIH TOOLBOX; ICE HOCKEY; MILITARY; REHABILITATION; RELIABILITY	Background: Lightweight and portable devices that objectively measure concussion-related impairments could improve injury detection and critical decision-making in contact sports and the military, where brain injuries commonly occur but remain underreported. Current standard assessments often rely heavily on subjective methods such as symptom self-reporting. Head-mounted wearables, such as smartglasses, provide an emerging platform for consideration that could deliver the range of assessments necessary to develop a rapid and objective screen for brain injury Standing balance assessment, one parameter that may inform a concussion diagnosis, could theoretically be performed quantitatively using current off-the-shelf smartglasses with an internal accelerometer. However, the validity of balance measurement using smartglasses has not been investigated. Objective: This study aimed to perform preliminary validation of a smartglasses-based balance accelerometer measure (BAM) compared with the well-described and characterized waist-based BAM. Methods: Forty-two healthy individuals (26 male, 16 female; mean age 23.8 [SD 5.2] years) participated in the study. Following the BAM protocol, each subject performed 2 trials of 6 balance stances while accelerometer and gyroscope data were recorded from smartglasses (Glass Explorer Edition). Test-retest reliability and correlation were determined relative to waist-based BAM as used in the National Institutes of Health's Standing Balance Toolbox. Results: Balance measurements obtained using a head-mounted wearable were highly correlated with those obtained through a waist-mounted accelerometer (Spearman rho, rho=.85). Test-retest reliability was high (intraclass correlation coefficient, ICC2,1=0.85, 95% CI 0.81-0.88) and in good agreement with waist balance measurements (ICC2,1=0.84, 95% CI 0.80-0.88). Considering the normalized path length magnitude across all 3 axes improved interdevice correlation (rho=.90) while maintaining test-retest reliability (ICC2,1=0.87, 95% CI 0.83-0.90). All subjects successfully completed the study, demonstrating the feasibility of using a head-mounted wearable to assess balance in a healthy population. Conclusions: Balance measurements derived from the smartglasses-based accelerometer were consistent with those obtained using a waist-mounted accelerometer. Additional research is necessary to determine to what extent smartglasses-based accelerometry measures can detect balance dysfunction associated with concussion. However, given the potential for smartglasses to perform additional concussion-related assessments in an integrated, wearable platform, continued development and validation of a smartglasses-based balance assessment is warranted. This approach could lead to a wearable platform for real-time assessment of concussion-related impairments that could be further augmented with telemedicine capabilities to integrate professional clinical guidance. Smartglasses may be superior to fully immersive virtual reality headsets for this application, given their lighter weight and reduced likelihood of potential safety concerns.	[Salisbury, Joseph P.; Sossong, Anthony D.; Sahin, Ned T.] TIAX LLC, Neural Sensing & Biometr Div, Lexington, MA USA; [Salisbury, Joseph P.; Keshav, Neha U.; Sossong, Anthony D.; Sahin, Ned T.] Brain Power LLC, Empowerment Lab, 1 Broadway 14th Fl, Cambridge, MA 02142 USA; [Sossong, Anthony D.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Sossong, Anthony D.] Harvard Med Sch, Boston, MA USA; [Sahin, Ned T.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA		Sahin, NT (corresponding author), Brain Power LLC, Empowerment Lab, 1 Broadway 14th Fl, Cambridge, MA 02142 USA.	sahin@post.harvard.edu	Salisbury, Joseph/L-3294-2019	Salisbury, Joseph/0000-0002-9448-9024; Sossong, Anthony/0000-0001-9969-234X; Keshav, Neha/0000-0003-4307-2955	United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-14-C-0007]; Office of the Assistant Secretary of Defense for Health Affairs, through the Autism Research Program [W81XWH-17-1-0449]	This study is based upon work supported by the United States Army Medical Research and Materiel Command under Contract No. W81XWH-14-C-0007 (awarded to TIAX, LLC). Additional work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Autism Research Program under Award No. W81XWH-17-1-0449. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. The authors thank Alyk Moomaw for her help in preparing the manuscript. The authors thank Google, Inc for generous support and the Glass team at X (formerly Google X) for technical guidance on Glass development.	Abdullah KG, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0535-3; Amick R.Z., 2015, J MOB TECHNOL MED, V4, P40, DOI [10.7309/jmtm.4.2.6, DOI 10.7309/JMTM.4.2.6]; ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; Baumel A, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0776-6; Burghart M., 2017, CURRENT RES CONCUSSI, V4, pE1, DOI DOI 10.1055/S-0036-1597914; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll Linda, 2012, CONCUSSION CRISIS AN; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Connelly C, 2017, INJURY, V48, P64, DOI 10.1016/j.injury.2016.08.025; Coughlin S. S., 2012, POSTTRAUMATIC STRESS; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; Dozza M, 2005, ARCH PHYS MED REHAB, V86, P1401, DOI 10.1016/j.apmr.2004.12.036; Dozza M, 2007, EXP BRAIN RES, V178, P37, DOI 10.1007/s00221-006-0709-y; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Gil-Gomez JA, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-30; Global Industry Analysts Inc., STRAT SMART AUGM REA; Goble DJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-12; Guskiewicz Kevin, 2014, Neurosurgery, V75 Suppl 4, pS113, DOI 10.1227/NEU.0000000000000494; Hoge CW, 2005, AM J PSYCHIAT, V162, P585, DOI 10.1176/appi.ajp.162.3.585; Johnson MAL, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0311-8; Keshav NU, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.8534; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kinsella BG, 2017, FRONT ROBOT AI, V4, DOI 10.3389/frobt.2017.00031; Kraus J. F., 1999, REHABILITATION ADULT, P3; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kvedar JC, 2016, NAT BIOTECHNOL, V34, P239, DOI 10.1038/nbt.3495; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange B, 2011, IEEE ENG MED BIO, P1831, DOI 10.1109/IEMBS.2011.6090521; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Liu RP, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00145; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; LUPTON SD, 1990, J IMMUNOL, V144, P3592; Lutz Otto Hans-Martin, 2017, Current Directions in Biomedical Engineering, V3, P53, DOI 10.1515/cdbme-2017-0012; Madhushri P, 2016, IEEE ENG MED BIO, P3117, DOI 10.1109/EMBC.2016.7591389; Madhushri P, 2016, INFORMATION, V7, DOI 10.3390/info7030047; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; Marchetti GF, 2013, J VESTIBUL RES-EQUIL, V23, P227, DOI 10.3233/VES-130490; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Mellone S, 2012, GAIT POSTURE, V36, P163, DOI 10.1016/j.gaitpost.2012.02.006; Mitrasinovic S, 2015, TECHNOL HEALTH CARE, V23, P381, DOI 10.3233/THC-150910; Myers L., 2006, ENCY STAT SCI; Ozdalga E, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1994; Paavola JM, 2013, J NOV PHYSIOTHER, V3, P129, DOI 10.4172/2165-7025.1000129; Patterson JA, 2014, INT J SPORTS PHYS TH, V9, P135; Phillips T, 2015, SPORT J, V8; Prosperini L, 2013, NEUROREHAB NEURAL RE, V27, P516, DOI 10.1177/1545968313478484; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; Rine RM, 2013, NEUROLOGY, V80, pS25, DOI 10.1212/WNL.0b013e3182872c6a; Rogers M.E., 2013, INT J APPL SCI TECHN, V3, P97, DOI DOI 10.13140/2.1.1568.8324; Saldana SJ, 2017, CLIN INTERV AGING, V12, DOI 10.2147/CIA.S141251; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Shah Nirtal, 2016, JMIR Rehabil Assist Technol, V3, pe4, DOI 10.2196/rehab.4511; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Slotkin J., 2012, NIH TOOLBOX TECHNICA; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; Thompson JWG, 2012, J CLIN SPORT PSYCHOL, V6, P22, DOI 10.1123/jcsp.6.1.22; Vargha A, 1998, J EDUC BEHAV STAT, V23, P170, DOI 10.3102/10769986023002170; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Venugopalan J, 2013, IEEE ENG MED BIO, P4625, DOI 10.1109/EMBC.2013.6610578; Vincenzo JL, 2016, AGING CLIN EXP RES, V28, P679, DOI 10.1007/s40520-015-0471-8; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wright WG, 2017, DISABIL REHABIL, V39, P1564, DOI 10.1080/09638288.2016.1226432; Youssef AR, 2017, EXPERT REV MED DEVIC, V14, P481, DOI 10.1080/17434440.2017.1325319; Zar J.H., 1998, ENCY BIOSTATISTICS; Zhao Y, 2016, J NEUROL, V263, P1156, DOI 10.1007/s00415-016-8115-2; Zoeller T, INTRACLASS CORRELATI	76	14	14	0	6	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	2291-5222			JMIR MHEALTH UHEALTH	JMIR mHealth uHealth	JAN	2018	6	1							e15	10.2196/mhealth.8478			12	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	GH8XB	WOS:000433951300025	29362210	Green Submitted, Green Published, gold			2022-02-06	
J	Soliman, I; Johnson, GGRJ; Gillman, LM; Zeiler, FA; Faqihi, F; Aletreby, WT; Balhamar, A; Mahmood, NN; Mumtaz, SA; Alharthy, A; Lazaridis, C; Karakitsos, D				Soliman, Ibrahim; Johnson, Garrett G. R. J.; Gillman, Lawrence M.; Zeiler, Frederick A.; Faqihi, Fahad; Aletreby, Waleed Tharwat; Balhamar, Abdullah; Mahmood, Nasir Nasim; Mumtaz, Shahzad Ahmad; Alharthy, Abdulrahman; Lazaridis, Christos; Karakitsos, Dimitrios			New Optic Nerve Sonography Quality Criteria in the Diagnostic Evaluation of Traumatic Brain Injury	CRITICAL CARE RESEARCH AND PRACTICE			English	Article							RAISED INTRACRANIAL-PRESSURE; SHEATH DIAMETER; UNIQUE MODEL; ULTRASONOGRAPHY; MANAGEMENT	Background. New sonographic quality criteria to optimize optic nerve sheath diameter (ONSD) measurements were suggested. The latter were correlated to elevated intracranial pressure (ICP) in traumatic brain injury (TBI). Aim. We investigated whether ONSD measurements were correlated to simultaneous ICP measurements in severe TBI. Methods. Forty patients with severe TBI (Marshall Scale >= II and GCS <= 8) participated in the study. All patients had an intraparenchymal ICP catheter inserted, while ONSD was measured bilaterally, upon admission and over the next 48 hours, based on the new sonographic criteria. A total of 400 ONSD measurements were performed, while mean ONSD values of both eyes were used in the analysis. Results. ONSD measurements were strongly correlated to ICP values (r = 0.74, p < 0.0001). Receiver operator curve (ROC) analysis revealed that the ONSD cutoff value for predicting elevated ICP was 6.4mm when using the mean of both eyes (AUC = 0.88, 95% CI = 0.80 to 0.95; sensitivity = 85.3%, specificity = 82.6%). Linear regression analysis nested models revealed that sex (p = 0.006) and height (p = 0.04) were significant predictors of ONSD values. Conclusion. When applying the new sonographic quality criteria, ONSD is strongly correlated to ICP in severe TBI. Whether to use such criteria to monitor ONSD as a proxy for ICP trend in TBI remains to be further explored.	[Soliman, Ibrahim; Faqihi, Fahad; Aletreby, Waleed Tharwat; Balhamar, Abdullah; Mahmood, Nasir Nasim; Mumtaz, Shahzad Ahmad; Alharthy, Abdulrahman; Karakitsos, Dimitrios] King Saud Med City, Crit Care Dept, Neurocrit Care Unit, Riyadh, Saudi Arabia; [Johnson, Garrett G. R. J.] Univ Manitoba, Rady Fac Hlth Sci, Undergrad Med Educ, Winnipeg, MB, Canada; [Gillman, Lawrence M.; Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Lazaridis, Christos] Baylor Coll Med, Dept Neurol, Div Neurocrit Care, Houston, TX 77030 USA; [Lazaridis, Christos] Baylor Coll Med, Dept Neurosurg, Div Neurocrit Care, Houston, TX 77030 USA; [Karakitsos, Dimitrios] USC, Keck Sch Med, Dept Crit Care, Los Angeles, CA USA		Soliman, I (corresponding author), King Saud Med City, Crit Care Dept, Neurocrit Care Unit, Riyadh, Saudi Arabia.	ibrahimrefaat@hotmail.com	Aletreby, Waleed/AAH-7349-2019	Aletreby, Waleed/0000-0001-8387-1829; Johnson, Garrett/0000-0001-5507-9543; Zeiler, Frederick/0000-0003-1737-0510			Asghar A, 2015, ANAESTH PAIN INTENSI, V19, P282; Attaallah A. F., 2013, TRAUMA, P125; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Goeres P, 2016, J CRIT CARE, V31, P168, DOI 10.1016/j.jcrc.2015.10.009; Johnson GGRJ, 2016, CRIT ULTRASOUND J, V8, DOI 10.1186/s13089-016-0053-9; Karakitsos D, 2006, TRANSPL P, V38, P3700, DOI 10.1016/j.transproceed.2006.10.185; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Lee SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002439; Maude RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081013; ODwyer L. M., 2014, 2015046 REL US DEP E; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Sargsyan AE, 2014, CRITICAL CARE ULTRAS; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Wang LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117939; Wright D.W., 2007, J NEUROTRAUM, V24, pS37; Zeiler FA, 2014, CAN J NEUROL SCI, V41, P430, DOI 10.1017/S0317167100018448; Zeiler FA, 2016, CRIT ULTRASOUND J, V8, DOI 10.1186/s13089-016-0044-x; Zeiler FA, 2013, CAN J NEUROL SCI, V40, P225, DOI 10.1017/S0317167100013779	30	14	15	0	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1305	2090-1313		CRIT CARE RES PRACT	Crit. Care Res. Pract.		2018	2018								3589762	10.1155/2018/3589762			7	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GH0AO	WOS:000433064000001	29854448	Green Published, gold, Green Submitted			2022-02-06	
J	Tester, NJ; Foss, JJ				Tester, Nicole J.; Foss, Joanne Jackson			Sleep as an Occupational Need	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							COGNITIVE-BEHAVIORAL THERAPY; MULTIPLE-SCLEROSIS FATIGUE; TRAUMATIC BRAIN-INJURY; IMPACT; INSOMNIA; DISTURBANCES; INSTRUMENT; DISORDERS; EXERCISE; CHILDREN	In the same way the human body requires food, hydration, and oxygen, it also requires sleep. Even among healthy people, the amount and quality of sleep substantially influence health and quality of life because sleep helps regulate physiological functioning. Given the impact of sleep on participation, the American Occupational Therapy Association reclassified sleep from an activity of daily living to an occupational domain. Poor sleep is a frequent medical complaint, especially among populations with neurological impairment. Occupational therapy practitioners should consider routinely screening for factors affecting their clients' sleep. By addressing such factors, as well as related routines and habits, practitioners can enhance the effectiveness of rehabilitation, promote health and well-being, and increase engagement and life quality. Practitioners should acknowledge the importance of sleep in practice, and the study of sleep should be prioritized by researchers in the field to meet client needs and establish evidence for interventions.	[Tester, Nicole J.] Univ Florida Hlth Rehabil, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA; [Foss, Joanne Jackson] Univ Florida, Dept Occupat Therapy, Gainesville, FL USA		Tester, NJ (corresponding author), Univ Florida Hlth Rehabil, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA.	NTES1202@shands.ufl.edu		Tester, Nicole/0000-0001-8481-915X			Abrantes AM, 2012, J GERIATR PSYCH NEUR, V25, P138, DOI 10.1177/0891988712455237; Altevogt B.M., 2006, SLEEP DISORDERS SLEE, P137; American Occupational Therapy Association, 2008, AM J OCCUP THER, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.62.6.625]; American Occupational Therapy Association, 2017, OCC THER ROL SLEEP; Ancoli-Israel S, 2006, AM J MANAG CARE, V12, pS221; Brown L. K., 2008, J CLIN SLEEP MED, V4, P381; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Centers for Disease Control and Prevention, 2015, INS SLEEP IS PUBL HL; Cmiel CA, 2004, AM J NURS, V104, P40, DOI 10.1097/00000446-200402000-00019; Nascimento CMC, 2014, GERIATR GERONTOL INT, V14, P259, DOI 10.1111/ggi.12082; De Mello MT, 2002, SPINAL CORD, V40, P646, DOI 10.1038/sj.sc.3101381; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Gansor S., 2015, AOTA ANN C EXP NASH; Gentry T., 2013, OT PRACTICE, V18, P9, DOI DOI 10.7138/OTP.2013.181F1; Green A., 2008, BRIT J OCCUPATIONAL, V71, P339, DOI DOI 10.1177/030802260807100808; Hu RF, 2010, CRIT CARE, V14, DOI 10.1186/cc8965; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Leland NE, 2014, OTJR-OCCUP PART HEAL, V34, P141, DOI 10.3928/15394492-20140513-01; Matuska K, 2007, AM J OCCUP THER, V61, P62, DOI 10.5014/ajot.61.1.62; Meyer A., 1922, ARCH OCCUP THER, V1, P1, DOI [DOI 10.1192/BJP.68.283.421, 10.1300/J004v02n03_05, DOI 10.1300/J004V02N03_05]; O'Connell A, 2008, AUST OCCUP THER J, V55, P212, DOI 10.1111/j.1440-1630.2007.00717.x; O'Donoghue N, 2012, BRIT J OCCUP THER, V75, P509, DOI 10.4276/030802212X13522194759932; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet M.-C., 2010, INT ENCY REHABILITAT; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Reynolds S, 2012, OTJR-OCCUP PART HEAL, V32, P246, DOI 10.3928/15394492-20110513-02; Sturkenboom I, 2011, GUIDELINES OCCUPATIO; van Kessel K, 2008, PSYCHOSOM MED, V70, P205, DOI 10.1097/PSY.0b013e3181643065; Vanage SM, 2003, AM J OCCUP THER, V57, P315, DOI 10.5014/ajot.57.3.315; Weaver TE, 1997, SLEEP, V20, P835; Wiseman-Hakes C, 2011, BRAIN INJURY, V25, P1256, DOI 10.3109/02699052.2011.608215; World Federation of Occupational Therapists, 2012, DEF OCC THER	33	14	14	1	12	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2018	72	1							7201347010	10.5014/ajot.2018.020651			4	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	FW4HJ	WOS:000425273500021	29280728				2022-02-06	
J	Tierney, GJ; Joodaki, H; Krosshaug, T; Forman, JL; Crandall, JR; Simms, CK				Tierney, Gregory J.; Joodaki, Hamed; Krosshaug, Tron; Forman, Jason L.; Crandall, Jeff R.; Simms, Ciaran K.			Assessment of model-based image-matching for future reconstruction of unhelmeted sport head impact kinematics	SPORTS BIOMECHANICS			English	Article						Concussion; rugby; image processing	RUGBY UNION; INSTRUMENTED MOUTHGUARD; PROFESSIONAL FOOTBALL; HUMAN MOTION; INJURY; CONCUSSION; ACCELERATION; VELOCITY	Player-to-player contact inherent in many unhelmeted sports means that head impacts are a frequent occurrence. Model-Based Image-Matching (MBIM) provides a technique for the assessment of three-dimensional linear and rotational motion patterns from multiple camera views of a head impact event, but the accuracy is unknown for this application. The goal of this study is to assess the accuracy of the MBIM method relative to reflective marker-based motion analysis data for estimating six degree of freedom head displacements and velocities in a staged pedestrian impact scenario at 40 km/h. Results showed RMS error was under 20 mm for all linear head displacements and 0.01-0.04 rad for head rotations. For velocities, the MBIM method yielded RMS errors between 0.42 and 1.29 m/s for head linear velocities and 3.53-5.38 rad/s for angular velocities. This method is thus beneficial as a tool to directly measure six degree of freedom head positional data from video of sporting head impacts, but velocity data is less reliable. MBIM data, combined in future with velocity/acceleration data from wearable sensors could be used to provide input conditions and evaluate the outputs of multibody and finite element head models for brain injury assessment of sporting head impacts.	[Tierney, Gregory J.; Simms, Ciaran K.] Trinity Coll Dublin, Dept Mech & Mfg Engn, Trinity Ctr Bioengn, Dublin, Ireland; [Joodaki, Hamed; Forman, Jason L.; Crandall, Jeff R.] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA USA; [Krosshaug, Tron] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Oslo, Norway		Tierney, GJ (corresponding author), Trinity Coll Dublin, Dept Mech & Mfg Engn, Trinity Ctr Bioengn, Dublin, Ireland.	gtierne@tcd.ie	Krosshaug, Tron/AAT-2390-2021; Simms, Ciaran/K-3100-2019	Simms, Ciaran/0000-0001-5564-1620	Irish Research CouncilIrish Research Council for Science, Engineering and Technology	Acknowledgement should be given to The Irish Research Council for funding this study.	Allison M. A., 2013, INT RES COUNC BIOM I; Alvarez M., 2007, IEEE 10 INT S WORKL; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Collins H, 2012, PUBLIC UNDERST SCI, V21, P904, DOI 10.1177/0963662511407991; Elliott JR, 2012, P I MECH ENG K-J MUL, V226, P266, DOI 10.1177/1464419311430176; Forman J. L., 2015, INT RES COUNC BIOM I; Forman Jason L, 2015, Stapp Car Crash J, V59, P401; Frechede B., 2007, ENH SAF VEH LYON FRA; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Kerrigan J. R., 2005, EXP SAF VEH C WASH D; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Krosshaug T, 2005, J BIOMECH, V38, P919, DOI 10.1016/j.jbiomech.2004.04.033; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Mok KM, 2011, GAIT POSTURE, V34, P71, DOI 10.1016/j.gaitpost.2011.03.014; Newman J., 1999, INT RES COUNC BIOM I; O'Reilly O. M., 2008, INTERMEDIATE DYNAMIC, DOI [10.1017/CBO9780511791352, DOI 10.1017/CBO9780511791352]; Parent DP, 2011, INT J CRASHWORTHINES, V16, P633, DOI 10.1080/13588265.2011.616114; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Richards JG, 1999, HUM MOVEMENT SCI, V18, P589, DOI 10.1016/S0167-9457(99)00023-8; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tierney G. J., 2015, INT RES COUNC BIOM I; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yamazaki J, 2015, MED SCI SPORT EXER, V47, P1113, DOI 10.1249/MSS.0000000000000511	37	14	14	1	19	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.		2018	17	1					33	47		10.1080/14763141.2016.1271905			15	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	FU5GG	WOS:000423880500003		Green Accepted			2022-02-06	
J	Tsyben, A; Guilfoyle, M; Timofeev, I; Anwar, F; Allanson, J; Outtrim, J; Menon, D; Hutchinson, P; Helmy, A				Tsyben, Anastasia; Guilfoyle, Mathew; Timofeev, Ivan; Anwar, Fahim; Allanson, Judith; Outtrim, Joanne; Menon, David; Hutchinson, Peter; Helmy, Adel			Spectrum of outcomes following traumatic brain injury-relationship between functional impairment and health-related quality of life	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Quality of life; SF-36; Glasgow Outcome Scale	HEAD-INJURY; PROSPECTIVE COHORT; MODERATE; PREDICTORS; VALIDITY; ADULTS; SCALE; SENSITIVITY; DISABILITY; COSTS	The outcome following traumatic brain injury (TBI) is heterogeneous and poorly defined and physical disability scales like the extended Glasgow Outcome Score (GOSE) while providing valuation information in terms of broad categorisation of outcome are unlikely to capture the full spectrum of deficits. Quality of life questionnaires such as SF-36 are emerging as potential tools to help characterise factors important to patients' recovery. This study assessed the association between physical disability and subjective health rating. The relationship is of value as it may help evaluate the impact of TBI on patients' lives and facilitate the delivery of appropriate neuro-rehabilitation services. A single-centre retrospective study was undertaken to assess the relationship between physical outcome as measured by GOSE and quality of life captured by the SF-36 questionnaire. Cronbach's alpha was calculated for each of the eight SF-36 domains to measure internal consistency of the test. Multivariate analysis of variance was conducted to look at the association between GOSE and the physical (PCS) and mental (MCS) component scores on the SF-36. Finally, we performed a generalised linear mixed model (GLMM) to assess the relative contribution of GOSE score, age at the time of trauma, sex and TBI duration towards MCS and PCS rating. There is a statistically significant difference in the MCS and PCS scores based on patients' GOSE scores. The mean scores of the eight SF-36 domains showed significant association with GOSE. GLMM demonstrated that GOSE was the strongest predictor of PCS and MCS. Age was an important variable in the PCS score while time following trauma was a significant predictor of MCS rating. This study highlights that patients' physical outcome following TBI is a strong predictor of the subjective mental and physical health. Nevertheless, there remains tremendous variability in individual SF-36 scores for each GOSE category, highlighting that additional factors play a role in determining quality of life.	[Tsyben, Anastasia; Guilfoyle, Mathew; Timofeev, Ivan; Hutchinson, Peter; Helmy, Adel] Addenbrookes Hosp, Dept Neurosurg, Hills Rd, Cambridge CB2 0QQ, England; [Tsyben, Anastasia; Guilfoyle, Mathew; Timofeev, Ivan; Hutchinson, Peter; Helmy, Adel] Cambridge Biomed Campus, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Anwar, Fahim; Allanson, Judith] Addenbrookes Hosp, Dept Neurorehabil, Cambridge, England; [Outtrim, Joanne; Menon, David] Cambridge Biomed Campus, Dept Med, Div Anaesthesia, Cambridge, England		Tsyben, A (corresponding author), Addenbrookes Hosp, Dept Neurosurg, Hills Rd, Cambridge CB2 0QQ, England.; Tsyben, A (corresponding author), Cambridge Biomed Campus, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.	anastasia.tsyben@cantab.net	Anwar, Fahim/ABH-5525-2020; Timofeev, Ivan/AAE-7019-2019; Helmy, Adel/AAS-3084-2020	Anwar, Fahim/0000-0002-1176-0975; Helmy, Adel/0000-0002-0531-0556; Timofeev, Ivan/0000-0002-1168-0393	National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Center; NIHRNational Institute for Health Research (NIHR); European Union Framework Program 7 grant (CENTER-TBI) [602150]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0802251] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090, ACF-2006-14-004] Funding Source: researchfish	This study was supported by National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Center to PH and AH, an NIHR Senior Investigator Award to DM and an NIHR Research Professorship to PH. Authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150). AH is supported by MRC (G0802251).	ASHLEY MJ, 1990, J INSURANCE MED, V22, P156; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Callaway DW, 2007, EMERG MED CLIN N AM, V25, P837, DOI 10.1016/j.emc.2007.06.005; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cotelli M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00038; Edwards SGM, 2002, BRIT MED J, V324, P1493, DOI 10.1136/bmj.324.7352.1493; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fayers PM, 2005, ASSESSING QUALITY LI; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hajfey WJ, 1991, HEAD TRAUMA REHABIL; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Johnstone B, 1999, J HEAD TRAUMA REHAB, V14, P220, DOI 10.1097/00001199-199906000-00003; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Likert R.A., 1932, TECHNIQUE MEASUREMEN, V140, P1; McCauley SR, 2013, J NEUROTRAUM, V30, P1506, DOI 10.1089/neu.2013.2925; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Subramanian L, 2011, J NEUROSCI, V31, P16309, DOI 10.1523/JNEUROSCI.3498-11.2011; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; Ware JE, 1993, F 36 HLTH SURVEY MAN; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wood RL, 2013, NEUROREHABILITATION, V32, P699, DOI 10.3233/NRE-130895	43	14	14	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2018	160	1					107	115		10.1007/s00701-017-3334-6			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	FQ3UW	WOS:000418283800015	28988342	Green Published, hybrid			2022-02-06	
J	Vincent, AS; Roebuck-Spencer, TM; Fuenzalida, E; Gilliland, K				Vincent, Andrea S.; Roebuck-Spencer, Tresa M.; Fuenzalida, Eugenia; Gilliland, Kirby			Test-retest reliability and practice effects for the ANAM General Neuropsychological Screening battery	CLINICAL NEUROPSYCHOLOGIST			English	Article						ANAM; neuropsychology; psychometrics; computerized testing	TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE ASSESSMENT TOOLS; SPORT-RELATED CONCUSSION; MILITARY SAMPLE; METRICS ANAM; PERFORMANCE; RECOVERY; ENVIRONMENT; IMPAIRMENT; VALIDATION	Objective: As the use of computer-based neurocognitive assessment is rapidly expanding, the need to systematically study and document key psychometric properties of these measures has become increasingly more salient. To meet this aim, this study examined test-retest reliability and practice effects for the Automated Neuropsychological Assessment Metrics General Neuropsychological Screening battery (ANAM GNS) in a sample of 94 community dwelling adults. Method: ANAM GNS was administered and then repeated (alternate form) after 30days. Test-retest reliability, practice effects, and the standard error of measurement were calculated. Using these estimates, reliable change indices were calculated to determine degree of performance change needed to exceed chance and measurement error (with 90% confidence interval). Results: The test-retest reliability for the ANAM composite score was .91. Performance significantly improved upon retest, but the effect size was small consistent with minimal practice effects. The threshold indicating change beyond chance or measurement error with 90% certainty was .9 (z-score). Conclusions: Findings suggest that the ANAM GNS has excellent test-retest reliability upon retest at 30days. Small practice effects can be expected. Change greater than .9 standard deviations in the ANAM composite score is likely to represent meaningful clinical change. This paper presents initial psychometric data from the ANAM GNS and supports its use as a reliable measure of cognition.	[Vincent, Andrea S.; Roebuck-Spencer, Tresa M.; Fuenzalida, Eugenia; Gilliland, Kirby] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73019 USA		Vincent, AS (corresponding author), Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73019 USA.	avincent@ou.edu					Abramson IS, 2000, J INT NEUROPSYCH SOC, V6, P365, DOI 10.1017/S1355617700633131; Anastasi A., 1988, PSYCHOL TESTING; [Anonymous], 2013, ANAM TECHN MAN; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Benedetto J. M., 1995, 9502 ERPL MANK STAT; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Cohen J., 2013, STAT POWER ANAL BEHA; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Coolican H., 1994, RES METHODS STAT PSY; CSRC, 2013, ANAM GNS BATT ADM MA; Cumming G., 2013, UNDERSTANDING NEW ST; Dretsch M, 2015, APPL NEUROPSYCH-ADUL, V22, P304, DOI 10.1080/23279095.2014.926454; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; GOEL V, 1995, NEUROPSYCHOLOGIA, V33, P623, DOI 10.1016/0028-3932(95)90866-P; Haran FJ, 2016, J HEAD TRAUMA REHAB, V31, P329, DOI 10.1097/HTR.0000000000000172; Harris W. C., 1997, COGNITIVE MEASUREMEN; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; McDiarmid Melissa A, 2002, Mil Med, V167, P123; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Proctor SP, 2015, MIL MED, V180, P660, DOI 10.7205/MILMED-D-14-00298; Rahill AA, 1996, AVIAT SPACE ENVIR MD, V67, P640; Randolph C, 2005, J ATHL TRAINING, V40, P139; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Roebuck-Spencer TM, 2008, MIL PSYCHOL, V20, P187, DOI 10.1080/08995600802118825; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Urbina S, 1997, PSYCHOL TESTING; US Census Bureau, QUICKFACTS POP EST; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007; Woodard J., 2002, J INT NEUROPSYCHOLOG, V8, P175; Woodhouse J, 2013, CLIN NEUROPSYCHOL, V27, P376, DOI 10.1080/13854046.2012.762427	58	14	15	3	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	3					479	494		10.1080/13854046.2017.1368716			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FZ4KL	WOS:000427561000010	28832273				2022-02-06	
J	Wang, JY; Li, HYZ; Ren, YC; Yao, Y; Hu, J; Zheng, MZ; Ding, YM; Chen, YY; Shen, YL; Wang, LL; Zhu, YJ				Wang, Jingyu; Li, Heyangzi; Ren, Yucheng; Yao, Ying; Hu, Jue; Zheng, Mingzhi; Ding, Yuemin; Chen, Ying-ying; Shen, Yueliang; Wang, Lin-lin; Zhu, Yongjian			Local Delivery of beta-Elemene Improves Locomotor Functional Recovery by Alleviating Endoplasmic Reticulum Stress and Reducing Neuronal Apoptosis in Rats with Spinal Cord Injury	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						beta-elemene; Spinal cord injury; Motor neurons; ER stress; Apoptosis	UNFOLDED-PROTEIN RESPONSE; ISCHEMIA-REPERFUSION INJURY; SIGNALING-PATHWAY; STEM-CELLS; MESENCHYMAL TRANSITION; GLIOBLASTOMA CELLS; OXIDATIVE STRESS; EPITHELIAL-CELLS; TRAUMATIC BRAIN; IN-VITRO	Background/Aims: Spinal cord injury (SCI) is a serious global problem that leads to permanent motor and sensory deficits. This study explores the anti-apoptotic and neuroprotective effects of the natural extract beta-elemene in vitro and in a rat model of SCI. Methods: CCK-8 assay was used to evaluate cell viability and lactate dehydrogenase assay was used to evaluate cytotoxicity. A model of cell injury was established using cobalt chloride. Apoptosis was evaluated using a fluorescence-activated cell sorting assay of annexin V-FITC and propidium iodide staining. A rat SCI model was created via the modified Allen's method and Basso, Beattie, and Bresnahan (BBB) scores were used to assess locomotor function. Inflammatory responses were assessed via enzyme-linked immunosorbent assay (ELISA). Apoptotic and surviving neurons in the ventral horn were respectively observed via terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining and Nissl staining. Western blotting was used to measure protein expression. Results: beta-elemene (20 mu g/ml) promoted cell viability by activating phosphorylation of the PI3K-AKT-mTOR pathway. beta-elemene reduced CoCl 2 induced cellular death and apoptosis by suppressing the expression levels of CHOP, cleavedcaspase 12, 78-kilodalton glucose-regulated protein, cleaved-caspase 3, and the Bax/Bcl-2 ratio. In the rat model of SCI, Nissl and TUNEL staining showed that beta-elemene promoted motor neuron survival and reduced neuronal apoptosis in the spinal cord ventral horn. BBB scores showed that beta-elemene significantly promoted locomotor behavioral recovery after SCI. In addition, beta-elemene reduced the ELISA-detected secretion of interleukin (IL)-6 and IL-1 beta. Conclusion: beta-elemene reduces neuronal apoptosis by alleviating endoplasmic reticulum stress in vitro and in vivo. In addition, beta-elemene promotes locomotor function recovery and tissue repair in SCI rats. Thus, our study provides a novel encouraging strategy for the potential treatment of beta-elemene in SCI patients. (c) 2018 The Author(s) Published by S. Karger AG, Basel.	[Wang, Jingyu; Yao, Ying; Zhu, Yongjian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Heyangzi; Ren, Yucheng; Chen, Ying-ying; Shen, Yueliang; Wang, Lin-lin] Zhejiang Univ, Sch Med, Dept Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Hu, Jue; Zheng, Mingzhi] Zhejiang Med Coll, Dept Pharmacol, Hangzhou, Zhejiang, Peoples R China; [Ding, Yuemin] Zhejiang Univ City Coll, Sch Med, Hangzhou, Zhejiang, Peoples R China		Wang, LL; Zhu, YJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310058, Zhejiang, Peoples R China.	wanglinlin@zju.edu.cn; neurosurgery@zju.edu.cn	yongjian, zhu/AAR-5445-2021	Wang, Jingyu/0000-0003-0433-9549	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81572229, 81673777, 81371953]	This study was supported by the National Natural Science Foundation of China (No. 81572229, 81673777, and 81371953).	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Anna Z, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3978595; Aufenberg C, 2005, J NEUROTRAUM, V22, P1018, DOI 10.1089/neu.2005.22.1018; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bell MT, 2013, CIRCULATION, V128, pS152, DOI 10.1161/CIRCULATIONAHA.112.000024; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi YH, 2017, CELL PHYSIOL BIOCHEM, V43, P481, DOI 10.1159/000480474; Chen JC, 2015, CHIN J NAT MEDICINES, V13; Chen JC, 2014, BIOORG MED CHEM LETT, V24, P3407, DOI 10.1016/j.bmcl.2014.05.078; Chong WC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040771; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dobkin BH, 2004, ANNU REV MED, V55, P255, DOI 10.1146/annurev.med.55.091902.104338; Fu PP, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00255; Gao YN, 2017, CELL PHYSIOL BIOCHEM, V43, P1503, DOI 10.1159/000481974; de la Cadena SG, 2016, APOPTOSIS, V21, P763, DOI 10.1007/s10495-016-1247-0; Gu CL, 2017, NEUROSCI LETT, V636, P282, DOI 10.1016/j.neulet.2016.11.032; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; He JC, 2017, CELL PHYSIOL BIOCHEM, V44, P1224, DOI 10.1159/000485452; He ZL, 2017, AM J TRANSL RES, V9, P1075; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Cornejo VH, 2013, IUBMB LIFE, V65, P962, DOI 10.1002/iub.1224; Ji S, 2017, J CANCER, V8, P555, DOI 10.7150/jca.17205; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Li XQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21010; Liang D, 2012, J CANCER RES CLIN, V138, P1865, DOI 10.1007/s00432-012-1256-5; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Lopez-Sanchez LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099143; Mu L, 2016, INT J ONCOL, V49, P1427, DOI 10.3892/ijo.2016.3626; Nicola FD, 2017, BRAIN RES, V1663, P95, DOI 10.1016/j.brainres.2017.03.015; Ohri SS, 2012, J NEUROTRAUM, V29, P579, DOI 10.1089/neu.2011.1940; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Sadidi M, 2009, BIOCHIMIE, V91, P577, DOI 10.1016/j.biochi.2009.01.010; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Taiyab A, 2016, INVEST OPHTH VIS SCI, V57, P5736, DOI 10.1167/iovs.16-20162; Tohda C, 2011, PHARMACOL THERAPEUT, V132, P57, DOI 10.1016/j.pharmthera.2011.05.006; Wang C, 2016, NEUROCHEM INT, V97, P15, DOI 10.1016/j.neuint.2016.04.015; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wu JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00626-6; Yang GL, 2016, MOL MED REP, V13, P2583, DOI 10.3892/mmr.2016.4836; Yao XL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010473; Yao YQ, 2008, CANCER LETT, V264, P127, DOI 10.1016/j.canlet.2008.01.049; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Ying CJ, 2017, BIOMED PHARMACOTHER, V90, P796, DOI 10.1016/j.biopha.2017.04.013; Zhang DP, 2016, CELL PHYSIOL BIOCHEM, V39, P1152, DOI 10.1159/000447822; Zhang J, 2018, J CELL PHYSIOL, V233, P7071, DOI 10.1002/jcp.26630; Zhu LL, 2017, CELL PHYSIOL BIOCHEM, V44, P388, DOI 10.1159/000484919; Zhu TZ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0727-2; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	52	14	18	4	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2018	49	2					595	609		10.1159/000492996			15	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	GT0KA	WOS:000444125900014	30165357	gold			2022-02-06	
J	Adeleye, AO; Ogun, MI				Adeleye, Amos O.; Ogun, Millicent I.			Clinical Epidemiology of Head Injury from Road-Traffic Trauma in a Developing Country in the Current Era	FRONTIERS IN NEUROLOGY			English	Article						road-traffic injury; head injury; motor-vehicle crash; motorcycle crash; Nigeria; developing countries	BRAIN-INJURY; NIGERIA; CARE; PREDICTION; MODERATE	Objectives: Africa and other Asian low middle-income countries account for the greatest burden of the global road-traffic injury (RTI)-related head injury (HI). This study set out to describe the incidence, causation, and severity of RTI-related HI and associated injuries in a Nigerian academic neurosurgical practice. Methods: This is a retrospective cross-sectional analysis of RTI-related HI from a prospective HI registry in an academic neurosurgery practice in Nigeria. Results: All-terrain RTI accounted for 80.6% (833/1,034) of HI over a 7-year study period. All age groups were involved, mean 33.06 years (SD 18.30), mode 21-30, 231/833 (27.7%). The male: female ratio was 631: 202, approximate to 3: 1. The road trauma occurred exclusively from motorcycle-and motor-vehicle crash (MCC/MVC), MCC caused 56.8% (473/833) of these; the victims were vulnerable road users (VRU) in 74%, and > 90% belong in the low socioeconomic class. Using the Glasgow Coma Scale grading, the HI was moderate/severe in 52%; loss of consciousness occurred in 93%, the Abbreviated Injury Severity-head > 3 in 74%, and computed tomography (CT) Rotterdam score > 3 in 52%. Significant extracranial injuries occurred in many organ systems, 421/833 (50.5%) having Injury Severity Score (ISS) > 25. Surgical lesions included extensive brain contusions in 157 (18.8%); acute extradural hematoma in 34 (4.1%); acute subdural hematoma in 32 (3.8%); and traumatic intracerebral hemorrhage in 27 (3.2%), but only 97 (11.6%) received operative care for various logistic reasons. The in-hospital outcome was good in 71.3% and poor in 28.7%; the statistically significant (p < 0.001) determinants of this outcome profile were the severity of the HI, the CT Rotterdam score, and the ISS. Conclusion: In this study from Nigeria, RTI-related HI emanates from significant trauma to vulnerable road users and are caused exclusively by motorcycles and motor vehicles.	[Adeleye, Amos O.] Univ Ibadan, Coll Med, Dept Surg, Div Neurol Surg, Ibadan, Nigeria; [Adeleye, Amos O.] UCH, Dept Neurol Surg, Ibadan, Nigeria; [Ogun, Millicent I.] UCH, Clin Nursing Dept, Ibadan, Nigeria		Adeleye, AO (corresponding author), Univ Ibadan, Coll Med, Dept Surg, Div Neurol Surg, Ibadan, Nigeria.; Adeleye, AO (corresponding author), UCH, Dept Neurol Surg, Ibadan, Nigeria.	femdoy@yahoo.com					Adeleye A O, 2017, Ann Ib Postgrad Med, V15, P34; Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Adeleye AO, 2010, TURK NEUROSURG, V20, P430, DOI 10.5137/1019-5149.JTN.3038-10.1; Adeolu AA, 2013, WORLD NEUROSURG, V80, P251, DOI 10.1016/j.wneu.2012.11.063; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Chandran A, 2012, TRAFFIC INJ PREV, V13, P11, DOI 10.1080/15389588.2011.633289; Chichom-Mefire A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2290-4; El-Gindi S., 2001, REV ESPANOLA NEUROPS, V3, P3; Faried A, 2017, WORLD NEUROSURG, V100, P195, DOI 10.1016/j.wneu.2016.12.133; Guerrier G, 2015, AUST NZ J PUBL HEAL, V39, P188, DOI 10.1111/1753-6405.12362; Ibrahim NA, 2017, PREHOSP DISASTER MED, V32, P424, DOI 10.1017/S1049023X17006410; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kareem Abdul, 2003, Malays J Med Sci, V10, P31; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MUHAMMAD I, 1990, E AFR MED J, V67, P447; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; OHAEGBULAM SC, 1978, AFR J MED MED SCI, V7, P23; Peden Margie, 2005, Int J Inj Contr Saf Promot, V12, P85, DOI 10.1080/15660970500086130; Solagberu BA, 2006, INJURY PREV, V12, P266, DOI 10.1136/ip.2005.011221; Solagberu BA, 2015, TRAFFIC INJ PREV, V16, P184, DOI 10.1080/15389588.2014.921817; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Tripathi M, 2014, NEUROL INDIA, V62, P610, DOI 10.4103/0028-3886.149382	25	14	14	0	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 15	2017	8								695	10.3389/fneur.2017.00695			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ0UH	WOS:000418071700001	29326652	Green Published, gold			2022-02-06	
J	Moran, R; Covassin, T				Moran, R.; Covassin, T.			Risk factors associated with baseline King-Devick performance	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Concussion; Sports; Youth; Sex; Age	SPORTS-RELATED CONCUSSION; SEX-DIFFERENCES; REFERENCE VALUES; HIGH-SCHOOL; SYMPTOMS; CHILDREN; PLAYERS; BALANCE; VISION; GENDER	Objective: This study examined the effect of baseline risk factors on the King-Devick (K-D) test in youth athletes, including of age, sex, and history of concussion. Methods: A total of 422 youth football and soccer athletes between the ages of 8 and 14 completed a baseline K-D test prior to the start of their respective seasons. Participant age, sex, and history of concussion were analyzed for K-D performance (i.e., errors and baseline time). A series of Mann-Whitney U tests were conducted to determine the effects of risk factors on performance. Correlations and regression analyses were conducted to assess the relationship between risk factors and K-D time and errors. Results: Differences in age (p < 0.001) and sex (p < 0.001) were reported on K-D time and errors. A history of concussion did not have an effect on K-D time (p = 0.15) or errors (p range = 0.15-0.17). Overall, weak to moderate correlations were observed between risk factors and K-D performance (r range = 0.43-0.23). Baseline K-D time and total errors improved with increasing participant age (p < 0.001). Sex was also able to predict K-D time and errors (p < 0.001). History of concussion was not able to predict K-D time (p = 0.18) or errors (p > 0.05). Conclusions: This study demonstrates the influence of risk factors such as sex and age on baseline K-D assessment. Associated risk factors at baseline further emphasize the need for individualized, multifaceted assessment for sport-related concussion diagnosis and management.	[Moran, R.] Univ Alabama, Athlet Training Res Lab, Dept Hlth Sci, Tuscaloosa, AL USA; [Covassin, T.] Michigan State Univ, Sports Injury Res Lab, Dept Kinesiol, E Lansing, MI 48824 USA		Moran, R (corresponding author), 481 Russell Hall,Box 870311, Tuscaloosa, AL 35487 USA.	rnmoran@ches.ua.edu			Michigan State University University Department of Kinesiology and Graduate School	This study was supported by the Michigan State University University Department of Kinesiology and Graduate School.	Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Burton LA, 2005, DEV NEUROPSYCHOL, V28, P493, DOI 10.1207/s15326942dn2801_3; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Halpern DF, 1997, AM PSYCHOL, V52, P1091, DOI 10.1037/0003-066X.52.10.1091; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X	18	14	14	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	DEC 15	2017	383						101	104		10.1016/j.jns.2017.10.039			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FT9UQ	WOS:000423498200023	29246592				2022-02-06	
J	Donders, J; Pendery, A				Donders, Jacobus; Pendery, Adriene			Clinical Utility of the Patient Health Questionnaire-9 in the Assessment of Major Depression After Broad-Spectrum Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							RISK-FACTORS; SYMPTOM VALIDITY; FORM MMPI-2-RF; ANXIETY; PREVALENCE; VALIDATION; PREDICTORS; SCALES	Objective: To determine the predictive validity of the Patient Health Questionnaire-9 (PHQ-9) when screening for symptoms of depression after traumatic brain injury. Design: Retrospective analysis of data collected as part of routine clinical outpatient care over a period of 30 months. Setting: Regional rehabilitation facility. Participants: Persons (N=137) with mild to severe traumatic brain injury who were referred for neuropsychological evaluation within 1 to 12 months. Interventions: Not applicable. Main Outcome Measures: PHQ-9 and Minnesota Multiphasic Personality Inventory-2-Restructured Form. Results: PHQ-9 scores >= 10 had a sensitivity of 91.7 and a specificity of 60.2 for predicting a diagnosis of major depression. Correlations between scores of PHQ-9 and Minnesota Multiphasic Personality Inventory-2-Restructured Form Demoralization (.64) and Low Positive Emotions (.48) scales ranged from large to medium. Premorbid outpatient psychiatric treatment was the most consistent predictor of PHQ-9 elevations as well as final diagnoses of major depression. Conclusions: The PHQ-9 has adequate clinical utility as a screening instrument for depression in outpatients with traumatic brain injury. Elevations on this instrument cannot, however, be automatically attributed to neuropathology, especially not in the context of premorbid psychiatric dysfunction. Clinicians should conduct more thorough follow-up assessment in those with highly elevated PHQ-9 scores. (C) 2017 by the American Congress of Rehabilitation Medicine	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Grand Rapids, MI USA; [Pendery, Adriene] Calvin Coll, Grand Rapids, MI USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com	tan, janie/AAH-9283-2021				Ben-Porath Y., 2012, INTERPRETING MMPI 2; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; de Man-van Ginkel JM, 2012, STROKE, V43, P854, DOI 10.1161/STROKEAHA.111.640276; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; First M., 2015, STRUCTURED CLIN INTE; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Haber JC, 2014, S AFR J PSYCHOL, V44, P439, DOI 10.1177/0081246314532788; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Myors B., 2004, STAT POWER ANAL SIMP; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Pennello G, 2016, J BIOPHARM STAT, V26, P1083, DOI 10.1080/10543406.2016.1226335; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Sakakibara BM, 2009, SPINAL CORD, V47, P841, DOI 10.1038/sc.2009.93; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tarescavage AM, 2015, PSYCHOL ASSESSMENT, V27, P433, DOI 10.1037/pas0000056; Tarescavage AM, 2015, J AFFECT DISORDERS, V174, P549, DOI 10.1016/j.jad.2014.12.018; Tellegen, 2008, MINNESOTA MULTIPHASI; Watson C, 2011, J PSYCHOPATHOL BEHAV, V33, P368, DOI 10.1007/s10862-010-9212-7; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095	32	14	14	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2017	98	12					2514	2519		10.1016/j.apmr.2017.05.019			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FO5FK	WOS:000416878700022	28647552				2022-02-06	
J	Faude, O; Rossler, R; Junge, A; Funten, KAD; Chomiak, J; Verhagen, E; Beaudouin, F; Dvorak, J; Feddermann-Demont, N				Faude, O.; Rossler, R.; Junge, A.; Fuenten, K. Aus Der; Chomiak, J.; Verhagen, E.; Beaudouin, F.; Dvorak, J.; Feddermann-Demont, N.			Head injuries in childrens footballresults from two prospective cohort studies in four European countries	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						concussion; heading; soccer; traumatic brain injury; youth	CONSENSUS STATEMENT; SOCCER INJURIES; CONCUSSION; MANAGEMENT; SPORT; EPIDEMIOLOGY; PLAYERS; YOUTH; RISK	Head injuries are considered harmful in children. We analyzed head and neck injuries in organized football in 7- to 12-year-old children. Data for this analysis were obtained from a prospective cohort study over two consecutive football seasons in two European countries, and a randomized intervention trial over one season in four European countries. Football exposure and injuries were documented through an online database. Detailed information regarding injury characteristics and medical follow-up was retrieved from coaches, children and parents by phone. Thirty-nine head injuries and one neck injury (5% of all 791 injuries) were documented during 9933 player-seasons (total football exposure 688045 hours). The incidence was 0.25 [95%CI 0.15, 0.35] head/neck injuries per 1000 match hours (N=23 match injuries) and 0.03 [95%CI 0.02, 0.03] per 1000 training hours. Eleven concussions (27.5%), nine head contusions (22.5%), eight lacerations or abrasions (20%), two nose fractures (2.5%), and two dental injuries (2.5%) occurred. The remaining eight injuries were nose bleeding or other minor injuries. Thirty injuries (75%) resulted from contact with another player, and ten injuries were due to collision with an object, falling or a hit by the ball. Whereas 70% of all head injuries (N=28) were due to frontal impacts, 73% of concussions (N=8) resulted from an impact to the occiput. The incidence and severity of head injuries in childrens football are low. Coaches and parents, however, should be sensitized regarding the potential of concussions, particularly after an impact to the occiput.	[Faude, O.; Rossler, R.] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland; [Junge, A.] Med Sch Hamburg, Hamburg, Germany; [Junge, A.; Dvorak, J.; Feddermann-Demont, N.] Swiss Concuss Ctr SCC, Zurich, Switzerland; [Junge, A.; Dvorak, J.; Feddermann-Demont, N.] Schulthess Clin, Zurich, Switzerland; [Fuenten, K. Aus Der; Beaudouin, F.] Saarland Univ, FIFA Med Ctr Excellence, Inst Sports & Prevent Med, Saarbrucken, Germany; [Chomiak, J.] Charles Univ Prague, Fac Med 1, Dept Orthopaed, Prague, Czech Republic; [Chomiak, J.] Hosp Na Bulovce, FIFA Med Ctr Excellence, Prague, Czech Republic; [Verhagen, E.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Feddermann-Demont, N.] Univ Hosp, Interdisciplinary Ctr Vertigo & Neurol Visual Dis, Dept Neurol, Zurich, Switzerland; [Feddermann-Demont, N.] Univ Zurich, Zurich, Switzerland		Faude, O (corresponding author), Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland.	oliver.faude@unibas.ch	Verhagen, Evert/A-1502-2013; Rossler, Roland/C-3857-2016	Verhagen, Evert/0000-0001-9227-8234; Rossler, Roland/0000-0002-6763-0694; Faude, Oliver/0000-0002-2832-7780; Junge, Astrid/0000-0002-6815-9793	FIFA	FIFA	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Blond L, 1999, BRIT J SPORT MED, V33, P110, DOI 10.1136/bjsm.33.2.110; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Feddermann-Demont N, 2014, J SPORT SCI, V32, P1217, DOI 10.1080/02640414.2014.918273; FIFA Communications Division, 2007, FIFA BIG COUNT 2006; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Giannotti M, 2011, PEDIATR EMERG CARE, V27, P81, DOI 10.1097/PEC.0b013e3182094340; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Giza Eric, 2005, Med Sport Sci, V49, P140, DOI 10.1159/000085395; Gomez JE, 2013, J ADOLESCENT HEALTH, V53, P311, DOI 10.1016/j.jadohealth.2013.06.018; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Rossler R, 2016, J SPORT SCI, V34, P549, DOI 10.1080/02640414.2015.1099715; Rossler R, 2016, AM J SPORT MED, V44, P309, DOI 10.1177/0363546515614816; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Tarnutzer AA, 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2016-096593<original-structure ref=info:doi/10.1136/bjsports-2016-096593></original-structure>, DOI 10.1136/BJSPOTS-2016-096593]; TEASDALE G, 1974, LANCET, V2, P81	30	14	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	DEC	2017	27	12					1986	1992		10.1111/sms.12839			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FO0DA	WOS:000416411800048	28054391				2022-02-06	
J	Haltmeier, T; Benjamin, E; Siboni, S; Dilektasli, E; Inaba, K; Demetriades, D				Haltmeier, Tobias; Benjamin, Elizabeth; Siboni, Stefano; Dilektasli, Evren; Inaba, Kenji; Demetriades, Demetrios			Prehospital intubation for isolated severe blunt traumatic brain injury: worse outcomes and higher mortality	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; Prehospital endotracheal intubation; Prehospital care; Outcome; Matched-pair analysis	SEVERE HEAD-INJURY; EMERGENCY TRACHEAL INTUBATION; RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; UNRECOGNIZED MISPLACEMENT; AIRWAY MANAGEMENT; SUCCESS RATES; VENTILATION; PRESSURE; TUBES	Purpose Prehospital endotracheal intubation (ETI) for traumatic brain injury (TBI) is a controversial issue. The aim of this study was to investigate the effect of prehospital ETI in patients with TBI. Methods Cohort-matched study using the US National Trauma Data Bank (NTDB) 2008-2012. Patients with isolated severe blunt TBI (AIS head >= 3, AIS chest/abdomen < 3) and a field GCS <= 8 were extracted from NTDB. A 1:1 matching of patients with and without prehospital ETI was performed. Matching criteria were sex, age, exact field GCS, exact AIS head, field hypotension, field cardiac arrest, and the brain injury type (according PREDOT-code). The matched cohorts were compared with univariable and multivariable regression analysis. Results A total of 27,714 patients were included. Matching resulted in 8139 cases with and 8139 cases without prehospital ETI. Prehospital ETI was associated with significantly longer scene (median 9 vs. 8 min, p < 0.001) and transport times (median 26 vs. 19 min, p < 0.001), lower Emergency Department (ED) GCS scores (in patients without sedation; mean 3.7 vs. 3.9, p = 0.026), more ventilator days (mean 7.3 vs. 6.9, p = 0.006), longer ICU (median 6.0 vs. 5.0 days, p < 0.001) and total hospital length of stay (median 10.0 vs. 9.0 days, p < 0.001), and higher in-hospital mortality (31.4 vs. 27.5 %, p < 0.001). In regression analysis prehospital ETI was independently associated with lower ED GCS scores (RC -4.213, CI -4.562/-3.864, p < 0.001) and higher in-hospital mortality (OR 1.399, CI 1.205/1.624, p < 0.001). Conclusion In this large cohort-matched analysis, prehospital ETI in patients with isolated severe blunt TBI was independently associated with lower ED GCS scores and higher mortality.	[Haltmeier, Tobias; Benjamin, Elizabeth; Siboni, Stefano; Dilektasli, Evren; Inaba, Kenji; Demetriades, Demetrios] Los Angeles Cty, Dept Surg, Div Acute Care Surg & Surg Crit Care, 1200 N State St,Inpatient Tower C Rm C5L100, Los Angeles, CA 90033 USA; [Haltmeier, Tobias; Benjamin, Elizabeth; Siboni, Stefano; Dilektasli, Evren; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, Med Ctr, 1200 N State St,Inpatient Tower C Rm C5L100, Los Angeles, CA 90033 USA		Demetriades, D (corresponding author), Los Angeles Cty, Dept Surg, Div Acute Care Surg & Surg Crit Care, 1200 N State St,Inpatient Tower C Rm C5L100, Los Angeles, CA 90033 USA.; Demetriades, D (corresponding author), Univ Southern Calif, Med Ctr, 1200 N State St,Inpatient Tower C Rm C5L100, Los Angeles, CA 90033 USA.	demetria@usc.edu	Siboni, Stefano/AAF-5456-2019; Benjamin, Elizabeth/AAD-2457-2020	Siboni, Stefano/0000-0003-0532-3135; Haltmeier, Tobias/0000-0001-6049-9235			[Anonymous], 2000, ADV CARDIOVASCULAR 6; [Anonymous], 2015, EVIDENCE BASED GUIDE; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Black KL, 2002, J HEAD TRAUMA REHAB, V17, P489, DOI 10.1097/00001199-200212000-00001; Bledsoe Bryan E, 2009, JEMS, V34, P88, DOI 10.1016/S0197-2510(09)70075-0; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Breckwoldt J, 2012, RESUSCITATION, V83, P434, DOI 10.1016/j.resuscitation.2011.10.011; Bulger EM, 2007, ANN EMERG MED, V49, P293, DOI 10.1016/j.annemergmed.2006.06.038; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; BURNEY RG, 1975, ANESTH ANALG, V54, P687; Burton John H, 2003, Prehosp Emerg Care, V7, P352, DOI 10.1080/10903120390936554; Cady CE, 2005, AM J EMERG MED, V23, P868, DOI 10.1016/j.ajem.2005.07.013; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dinsmore J., 2013, TRAUMATIC BRAIN INJU; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Falcone R E, 1996, Air Med J, V15, P163, DOI 10.1016/S1067-991X(96)90024-3; Geisser W, 2009, ANAESTHESIA, V64, P973, DOI 10.1111/j.1365-2044.2009.06007.x; Harris T, 2011, EMERG MED J, V28, P225, DOI 10.1136/emj.2009.088302; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Huang YH, 2013, INJURY, V44, P1226, DOI 10.1016/j.injury.2012.12.029; Jemmett ME, 2003, ACAD EMERG MED, V10, P961, DOI 10.1197/S1069-6563(03)00315-4; Karamanos E, 2014, PREHOSP DISASTER MED, V29, P32, DOI 10.1017/S1049023X13008947; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Lockey D, 2014, BRIT J ANAESTH, V113, P220, DOI 10.1093/bja/aeu227; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Oestern HJ, 2013, GEN TRAUMA CARE RELA; Perkins ZB, 2013, J TRAUMA ACUTE CARE, V74, P1074, DOI 10.1097/TA.0b013e3182827305; Peters J, 2015, EUR J EMERG MED, V22, P391, DOI 10.1097/MEJ.0000000000000161; Prekker ME, 2014, CRIT CARE MED, V42, P1372, DOI 10.1097/CCM.0000000000000213; Rognas L, 2014, EUR J EMERG MED, V21, P418, DOI 10.1097/MEJ.0000000000000103; Samaha T, 1996, ANN FR ANESTH, V15, P36, DOI 10.1016/0750-7658(96)89400-7; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Shafi S, 2005, J TRAUMA, V59, P1140, DOI 10.1097/01.ta.0000196434.88182.77; Shafi S, 2005, J TRAUMA, V59, P5; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Sollid SJM, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-30; Surgeons ACo, 2015, NATL TRAUMA DATA BAN; Timmermann A, 2007, ANESTH ANALG, V104, P619, DOI 10.1213/01.ane.0000253523.80050.e9; Trauma TEAftSo, 2015, EM TRACH INT IMM FOL; Ufberg JW, 2005, AM J EMERG MED, V23, P379, DOI 10.1016/j.ajem.2005.02.005; Vandromme MJ, 2011, J TRAUMA, V71, P1615, DOI 10.1097/TA.0b013e31822a30a1; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Wirtz DD, 2007, PREHOSP EMERG CARE, V11, P213, DOI 10.1080/10903120701205935; Yeh DD, 2012, ANZ J SURG, V82, P484, DOI 10.1111/j.1445-2197.2012.06130.x	60	14	14	0	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2017	43	6					731	739		10.1007/s00068-016-0718-x			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FO1PF	WOS:000416534600002	27567923				2022-02-06	
J	Lee, SH; Choi, BY; Lee, SH; Kho, AR; Jeong, JH; Hong, DK; Suh, SW				Lee, Sang Hwon; Choi, Bo Young; Lee, Song Hee; Kho, A. Ra; Jeong, Jeong Hyun; Hong, Dae Ki; Suh, Sang Won			Administration of Protocatechuic Acid Reduces Traumatic Brain Injury-Induced Neuronal Death	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; protocatechuic acid; neuron death; oxidative injury; microglial activation	OXIDATIVE STRESS; SUPEROXIDE-PRODUCTION; BARRIER DISRUPTION; LIPID-PEROXIDATION; DAMAGE; GLUTATHIONE; INHIBITION; IMPAIRMENT; RADICALS; RATS	Protocatechuic acid (PCA) was first purified from green tea and has shown numerous biological activities, including anti-apoptotic, anti-inflammatory, and anti-atherosclerotic effects. The effect of PCA on traumatic brain injury (TBI)-induced neuronal death has not previously been evaluated. TBI is defined as damage to the brain resulting from external mechanical force, such as rapid acceleration or deceleration, impact, blast waves, or penetration by a projectile. TBI causes neuronal death in the hippocampus and cerebral cortex. The present study aimed to evaluate the therapeutic potential of PCA on TBI-induced neuronal death. Here, TBI was induced by a controlled cortical impact model using rats. PCA (30 mg/kg) was injected into the intraperitoneal (ip) space immediately after TBI. Neuronal death was evaluated with Fluoro Jade-B (FJB) staining at 24 h after TBI. Oxidative injury was detected by 4-hydroxy-2-nonenal (4HNE), glutathione (GSH) concentration was analyzed by glutathione adduct with N-ethylmaleimide (GS-NEM) staining at 24 h after TBI, and microglial activation in the hippocampus was detected by CD11b immunohistochemistry at one week after TBI. We found that the proportion of degenerating neurons, oxidative injury, GSH depletion, and microglia activation in the hippocampus and cortex were all reduced by PCA treatment following TBI. Therefore, our study suggests that PCA may have therapeutic potential in preventing TBI-induced neuronal death.	[Lee, Sang Hwon; Choi, Bo Young; Lee, Song Hee; Kho, A. Ra; Jeong, Jeong Hyun; Hong, Dae Ki; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon 24252, South Korea		Suh, SW (corresponding author), Hallym Univ, Coll Med, Dept Physiol, Chunchon 24252, South Korea.	bluesea3616@naver.com; bychoi@hallym.ac.kr; sshlee@hallym.ac.kr; rnlduadkfk136@hallym.ac.kr; jd1422@hanmail.net; zxnm01220@gmail.com; swsuh@hallym.ac.kr		Hong, Dae-Ki/0000-0003-3769-3456; Choi, Bo Young/0000-0002-9579-3503; Hong, Dae Ki/0000-0002-8937-1064	National Research Foundation of Korea (NRF)National Research Foundation of Korea [NRF-2017R1C1B1004226]; Brain Research Program through the NRF - Ministry of Science, information and communication technology (ICT), and Future Planning [NRF-2017M3C7A1028937]	This study was supported by the National Research Foundation of Korea (NRF) (NRF-2017R1C1B1004226) to Bo Young Choi. This work was also supported by the Brain Research Program through the NRF funded by the Ministry of Science, information and communication technology (ICT), and Future Planning (NRF-2017M3C7A1028937) to Sang Won Suh.	ALTHAUS JS, 1993, MOL CHEM NEUROPATHOL, V20, P147, DOI 10.1007/BF02815368; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Chao CY, 2009, FOODBORNE PATHOG DIS, V6, P201, DOI 10.1089/fpd.2008.0187; CHENG Y, 1994, NEUROCHEM RES, V19, P1557, DOI 10.1007/BF00969006; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Choi BY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102189; Choi BY, 2014, INT J MOL SCI, V15, P19444, DOI 10.3390/ijms151119444; Choi BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081523; Ciftci O, 2013, TOXICOL IND HEALTH, V29, P806, DOI 10.1177/0748233712442735; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Guan S, 2009, TOXICOL IN VITRO, V23, P201, DOI 10.1016/j.tiv.2008.11.008; Hall ED, 1995, J NEUROL SCI, V134, P79, DOI 10.1016/0022-510X(95)00211-J; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; KIHARA T, 1995, J NEUROCHEM, V65, P282; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Krzysztoforska K, 2019, NUTR NEUROSCI, V22, P72, DOI 10.1080/1028415X.2017.1354543; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lee HM, 2017, INT J BIOCHEM CELL B, V90, P81, DOI 10.1016/j.biocel.2017.07.019; Lende Amol B., 2011, Inflammopharmacology, V19, P255, DOI 10.1007/s10787-011-0086-4; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Li CM, 2012, PHARM BIOL, V50, P413, DOI 10.3109/13880209.2011.608193; Li XC, 2012, MOLECULES, V17, P13457, DOI 10.3390/molecules171113457; Liu JZ, 2010, SEIZURE-EUR J EPILEP, V19, P165, DOI 10.1016/j.seizure.2010.01.010; Love S, 1999, BRAIN PATHOL, V9, P119; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; PELLEGRINIGIAMPIETRO DE, 1990, J NEUROSCI, V10, P1035, DOI 10.1523/jneurosci.10-03-01035.1990; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Scazzocchio B, 2011, DIABETES, V60, P2234, DOI 10.2337/db10-1461; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shi GF, 2006, NEUROSCI LETT, V403, P206, DOI 10.1016/j.neulet.2006.02.057; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Singh P, 2003, NEUROL INDIA, V51, P215; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2003, J NEUROSCI, V23, P10681; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Tang XAN, 2010, J NEUROSCI METH, V190, P240, DOI 10.1016/j.jneumeth.2010.05.004; Wang HY, 2015, NEUROCHEM RES, V40, P1655, DOI 10.1007/s11064-015-1646-6; Wang Z, 2015, NEUROL RES, V37, P159, DOI 10.1179/1743132814Y.0000000421; Wei MM, 2013, INT IMMUNOPHARMACOL, V15, P780, DOI 10.1016/j.intimp.2013.01.010; WINTER AN, 2017, OXID MED CELL LONGEV, V2017, DOI DOI 10.1155/2017/6297080; Yin X, 2015, SCI REP-UK, V5, DOI 10.1038/srep14507; Zhang HN, 2009, BIOL PHARM BULL, V32, P1866, DOI 10.1248/bpb.32.1866	50	14	14	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2017	18	12							2510	10.3390/ijms18122510			13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	FR2KU	WOS:000418896700014	29168791	gold, Green Submitted, Green Published			2022-02-06	
J	Li, T; Zhang, YM; Han, D; Hua, R; Guo, BN; Hu, SQ; Yan, XL; Xu, T				Li, Tan; Zhang, Yong-mei; Han, Dong; Hua, Rong; Guo, Bing-nan; Hu, Shu-qun; Yan, Xian-liang; Xu, Tie			Involvement of IL-17 in Secondary Brain Injury After a Traumatic Brain Injury in Rats	NEUROMOLECULAR MEDICINE			English	Article						IL-17; TBI; Secondary brain injury; Inflammation; IL-23/IL-17 axis	CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNITY; TH17 CELLS; T-CELLS; INTERLEUKIN-23; INFLAMMATION; IL-23; NEUROPROTECTION; EXPRESSION; CNS	The pro-inflammatory activity of interleukin 17, which is produced by the IL-23/IL-17 axis, has been associated with the pathogenesis of traumatic brain injury (TBI). The study investigated the potential role of IL-17 in secondary brain injury of TBI in a rat model. Our data showed that the levels of IL-17 increased from 6 h to 7 days and peaked at 3 days, in both the CNS and serum, which were consistent with the severity of secondary brain injury. The IL-23 inhibitor suberoylanilide hydroxamic acid (SAHA) treatment markedly decreased the expressions of IL-17 and apoptosis-associated proteins cleaved caspase-3 and increased the protein ratio of Bcl-2 (B cell lymphoma/leukemia-2)/Bax (Bcl-2-associated X protein). Meanwhile, neuronal apoptosis was reduced, and neural function was improved after SAHA treatment. This study suggests that IL-17 is involved in secondary brain injury after TBI. Administering an IL-23 inhibitor and thereby blocking the IL-23/IL-17 axis may be beneficial in the treatment of TBI.	[Li, Tan; Han, Dong; Hua, Rong; Guo, Bing-nan; Hu, Shu-qun; Yan, Xian-liang; Xu, Tie] Xuzhou Med Univ, Inst Emergency Rescue Med, Xuzhou 221002, Peoples R China; [Hua, Rong; Yan, Xian-liang; Xu, Tie] Xuzhou Med Univ, Emergency Ctr, Affiliated Hosp, Xuzhou 221002, Peoples R China; [Zhang, Yong-mei] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Peoples R China; [Li, Tan] Nanjing Univ Tradit Chinese Med, Jiangsu Prov Hosp TCM 2, Nanjing 210017, Jiangsu, Peoples R China		Hu, SQ; Yan, XL; Xu, T (corresponding author), Xuzhou Med Univ, Inst Emergency Rescue Med, Xuzhou 221002, Peoples R China.; Yan, XL; Xu, T (corresponding author), Xuzhou Med Univ, Emergency Ctr, Affiliated Hosp, Xuzhou 221002, Peoples R China.	hushuqun88@126.com; docyxl@163.com; xutie889@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271267]; "333 Program'' of Jiangsu Province [BRA2015068]; Jiangsu social development or Natural Science Foundation [BE2016645, BK20161153, BK20161171, BE2017641]; Xuzhou Natural Science Foundation [KC15J0060, KC15SX009]; Jiangsu Educational Science Foundation [KJS1410]; Jiangsu Provincial Commission of Health and Family Planning, Genera Programs [H201527]	This research was supported by the National Natural Science Foundation of China (81271267), "333 Program'' of Jiangsu Province (BRA2015068), Jiangsu social development or Natural Science Foundation (BE2016645, BK20161153, BK20161171, BE2017641), Xuzhou Natural Science Foundation (KC15J0060, KC15SX009), Jiangsu Educational Science Foundation (KJS1410), Jiangsu Provincial Commission of Health and Family Planning, Genera Programs (H201527).	Alam MS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9407; Baird AM, 2013, LUNG CANCER, V79, P83, DOI 10.1016/j.lungcan.2012.10.003; Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; Behairi N, 2015, NEUROIMMUNOMODULAT, V22, P385, DOI 10.1159/000435885; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Brough D, 2015, IUBMB LIFE, V67, P323, DOI 10.1002/iub.1377; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cui CM, 2015, MOL MED REP, V12, P2323, DOI 10.3892/mmr.2015.3611; Dobreva ZG, 2016, IMMUNOPHARM IMMUNOT, V38, P281, DOI 10.1080/08923973.2016.1188940; DU Chao-Yang, 2017, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V25, P147, DOI 10.7534/j.issn.1009-2137.2017.01.026; Ghosh M, 2012, GLIA, V60, P1839, DOI 10.1002/glia.22401; Huang Ji-Chong, 2017, Zhongguo Dang Dai Er Ke Za Zhi, V19, P81; Huppert J, 2010, FASEB J, V24, P1023, DOI 10.1096/fj.09-141978; Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006; Iwamoto M, 2013, CANCER CHEMOTH PHARM, V72, P493, DOI 10.1007/s00280-013-2220-z; Jafarzadeh A, 2015, IRAN J IMMUNOL, V12, P288, DOI IJIv12i4A6; Jiang HQ, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0343-8; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P698, DOI 10.1097/TA.0000000000000584; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Krizova L, 2017, AUTOIMMUNITY, V50, P102, DOI 10.1080/08916934.2016.1272598; Kroenke MA, 2011, BRAIN BEHAV IMMUN, V25, P932, DOI 10.1016/j.bbi.2010.10.001; Kuwabara T, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3908061; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lei Ling, 2016, Clin Exp Rheumatol, V34 Suppl 100, P14; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li SY, 2017, ELECTRON J QUAL THEO, P1, DOI 10.14232/ejqtde.2017.1.48; Lin Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.284; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; McDermott AJ, 2016, IMMUNOLOGY, V147, P114, DOI 10.1111/imm.12545; Mioni G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00269; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/s1474-4422(16)00070-3, 10.1016/S1474-4422(16)00070-3]; Pacifici R, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00057; Pan RQ, 2015, BLOOD, V126, P363, DOI 10.1182/blood-2014-10-604975; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Song W, 2011, LEUKEMIA, V25, P161, DOI 10.1038/leu.2010.244; Steinman L, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003898; van den Berg WB, 2013, SEMIN ARTHRITIS RHEU, V43, P158, DOI 10.1016/j.semarthrit.2013.04.006; Wines BD, 2017, IMMUNOL CELL BIOL, V95, P272, DOI 10.1038/icb.2016.93; Wu JH, 2017, ONCOL LETT, V13, P770, DOI 10.3892/ol.2016.5476; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yan F, 2017, MOL NEUROBIOL, V54, P1808, DOI 10.1007/s12035-016-9790-9; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhong Q, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004340; Zong SH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/786947	53	14	16	3	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	DEC	2017	19	4					541	554		10.1007/s12017-017-8468-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM4RO	WOS:000415009400008	28916896				2022-02-06	
J	Liu, XF; Zhao, ZQ; Ji, RH; Zhu, J; Sui, QQ; Knight, GE; Burnstock, G; He, C; Yuan, HB; Xiang, ZH				Liu, Xiaofeng; Zhao, Zhengqing; Ji, Ruihua; Zhu, Jiao; Sui, Qian-Qian; Knight, Gillian E.; Burnstock, Geoffrey; He, Cheng; Yuan, Hongbin; Xiang, Zhenghua			Inhibition of P2X7 receptors improves outcomes after traumatic brain injury in rats	PURINERGIC SIGNALLING			English	Article						Traumatic brain injury; P2X7R; Microglial cells; Microvesicles; Neuroinflammation	MICROGLIAL ACTIVATION; EXTRACELLULAR ATP; WATER-MAZE; ASTROGLIOSIS; INVOLVEMENT; RELEASE; EPIDEMIOLOGY; ANTAGONIST; ASTROCYTES; EXPRESSION	Traumatic brain injury (TBI) is the leading cause of death and disability for people under the age of 45 years worldwide. Neuropathology after TBI is the result of both the immediate impact injury and secondary injury mechanisms. Secondary injury is the result of cascade events, including glutamate excitotoxicity, calcium overloading, free radical generation, and neuroinflammation, ultimately leading to brain cell death. In this study, the P2X7 receptor (P2X7R) was detected predominately in microglia of the cerebral cortex and was up-regulated on microglial cells after TBI. The microglia transformed into amoeba-like and discharged many microvesicle (MV)-like particles in the injured and adjacent regions. A P2X7R antagonist (A804598) and an immune inhibitor (FTY720) reduced significantly the number of MV-like particles in the injured/adjacent regions and in cerebrospinal fluid, reduced the number of neurons undergoing apoptotic cell death, and increased the survival of neurons in the cerebral cortex injured and adjacent regions. Blockade of the P2X7R and FTY720 reduced interleukin-1 beta expression, P38 phosphorylation, and glial activation in the cerebral cortex and improved neurobehavioral outcomes after TBI. These data indicate that MV-like particles discharged by microglia after TBI may be involved in the development of local inflammation and secondary nerve cell injury.	[Liu, Xiaofeng; Zhu, Jiao; Sui, Qian-Qian; He, Cheng; Xiang, Zhenghua] Second Mil Med Univ, Dept Neurobiol, Neurosci Res Ctr, MOE Key Lab Mol Neurobiol,Changzheng Hosp,Minist, Shanghai 200433, Peoples R China; [Zhao, Zhengqing] Second Mil Med Univ Shanghai, Dept Neurol, Neurosci Res Ctr, Changzheng Hosp, Shanghai, Yangpu Qu, Peoples R China; [Ji, Ruihua; Yuan, Hongbin] Second Mil Med Univ, Changzheng Hosp, Dept Anesthesiol, 415 Fengyang Rd, Shanghai 200003, Peoples R China; [Knight, Gillian E.; Burnstock, Geoffrey] UCL, Auton Neurosci Ctr, Sch Med, Rowland Hill St, London NW3 2PF, England; [Burnstock, Geoffrey] Univ Melbourne, Dept Pharmacol, Parkville, Vic, Australia		Xiang, ZH (corresponding author), Second Mil Med Univ, Dept Neurobiol, Neurosci Res Ctr, MOE Key Lab Mol Neurobiol,Changzheng Hosp,Minist, Shanghai 200433, Peoples R China.; Yuan, HB (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Anesthesiol, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	jfjczyy@aliyun.com; xiang-zhenghua@163.com		, yuan/0000-0001-8468-4005	National Natural Science Foundation of the People's Republic of ChinaNational Natural Science Foundation of China (NSFC) [81471260]; Qingnian Science Foundation of Changzheng Hospital, Shanghai, People's Republic of China [2016CZQN05]	This work was supported by the National Natural Science Foundation of the People's Republic of China (81471260 to Z. Xiang) and by the Qingnian Science Foundation of Changzheng Hospital, Shanghai, People's Republic of China (2016CZQN05 to R. Ji).	Abbracchio Maria P, 2006, Novartis Found Symp, V276, P91; ABBRACCHIO MP, 1994, PHARMACOL THERAPEUT, V64, P445, DOI 10.1016/0163-7258(94)00048-4; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Bianco F, 2005, J IMMUNOL, V174, P7268, DOI 10.4049/jimmunol.174.11.7268; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Burnstock G, 2015, CURR MED CHEM, V22, P819, DOI 10.2174/0929867321666140706130415; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chavez-Valdez R, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/257563; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Dawson G, 2011, BIOCHEM BIOPH RES CO, V404, P321, DOI 10.1016/j.bbrc.2010.11.115; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ferrari D, 1997, NEUROPHARMACOLOGY, V36, P1295, DOI 10.1016/S0028-3908(97)00137-8; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; FILIPPINI A, 1990, J BIOL CHEM, V265, P334; Franke H, 2007, PURINERG SIGNAL, V3, P435, DOI 10.1007/s11302-007-9082-y; Franke H, 2006, INT J DEV NEUROSCI, V24, P123, DOI 10.1016/j.ijdevneu.2005.11.016; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GIULIAN D, 1988, J NEUROSCI, V8, P2485; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jimenez-Pacheco A, 2013, EPILEPSIA, V54, P1551, DOI 10.1111/epi.12257; Kim JE, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-65; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li J, 2017, PURINERG SIGNAL, V13, P13, DOI 10.1007/s11302-016-9537-0; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Ryu JK, 2008, NEUROREPORT, V19, P1715, DOI 10.1097/WNR.0b013e3283179333; Sadallah S, 2011, CLIN EXP IMMUNOL, V163, P26, DOI 10.1111/j.1365-2249.2010.04271.x; Sharp AJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-33; Sikora A, 1999, J IMMUNOL, V163, P558; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Turola E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00149; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wang YC, 2015, MOL MED REP, V12, P2149, DOI 10.3892/mmr.2015.3607; Woiciechowsky C, 2004, MED SCI MONITOR, V10, pBR325; Xiang ZH, 2006, J NEUROSCI RES, V83, P91, DOI 10.1002/jnr.20709; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zimmermann H, 1999, PROG BRAIN RES, V120, P371	57	14	16	3	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1573-9538	1573-9546		PURINERG SIGNAL	Purinergic Signal.	DEC	2017	13	4					529	544		10.1007/s11302-017-9579-y			16	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FO7UL	WOS:000417082600011	28823092	Green Published, Green Submitted			2022-02-06	
J	Makola, M; Ris, MD; Mahone, EM; Yeates, KO; Cecil, KM				Makola, Monwabisi; Ris, M. Douglas; Mahone, E. Mark; Yeates, Keith Owen; Cecil, Kim M.			Long-term effects of radiation therapy on white matter of the corpus callosum: a diffusion tensor imaging study in children	PEDIATRIC RADIOLOGY			English	Article						Brain; Brain tumor; Children; Corpus callosum; Diffusion tensor imaging; Magnetic resonance imaging; Radiation; White matter	INDUCED COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; PROCESSING SPEED; MEDULLOBLASTOMA; ANISOTROPY; INTEGRITY; TUMORS; MRI; CHILDHOOD	Despite improving survival rates, children are at risk for long-term cognitive and behavioral difficulties following the diagnosis and treatment of a brain tumor. Surgery, chemotherapy and radiation therapy have all been shown to impact the developing brain, especially the white matter. The purpose of this study was to determine the long-term effects of radiation therapy on white matter integrity, as measured by diffusion tensor imaging, in pediatric brain tumor patients 2 years after the end of radiation treatment, while controlling for surgical interventions. We evaluated diffusion tensor imaging performed at two time points: a baseline 3 to 12 months after surgery and a follow-up approximately 2 years later in pediatric brain tumor patients. A region of interest analysis was performed within three regions of the corpus callosum. Diffusion tensor metrics were determined for participants (n=22) who underwent surgical tumor resection and radiation therapy and demographically matched with participants (n=22) who received surgical tumor resection only. Analysis revealed that 2 years after treatment, the radiation treated group exhibited significantly lower fractional anisotropy and significantly higher radial diffusivity within the body of the corpus callosum compared to the group that did not receive radiation. The findings indicate that pediatric brain tumor patients treated with radiation therapy may be at greater risk of experiencing long-term damage to the body of the corpus callosum than those treated with surgery alone.	[Makola, Monwabisi] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Ris, M. Douglas] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Mahone, E. Mark] Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD USA; [Mahone, E. Mark] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada; [Cecil, Kim M.] Cincinnati Childrens Hosp Med Ctr, Imaging Res Ctr, MLC 5033,3333 Burnet Ave, Cincinnati, OH 45229 USA; [Cecil, Kim M.] Univ Cincinnati, Coll Med, Dept Radiol, Cincinnati, OH USA; [Cecil, Kim M.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Cecil, Kim M.] Univ Cincinnati, Coll Med, Neurosci Grad Program, Cincinnati, OH USA; [Cecil, Kim M.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH USA		Cecil, KM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Imaging Res Ctr, MLC 5033,3333 Burnet Ave, Cincinnati, OH 45229 USA.; Cecil, KM (corresponding author), Univ Cincinnati, Coll Med, Dept Radiol, Cincinnati, OH USA.; Cecil, KM (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.; Cecil, KM (corresponding author), Univ Cincinnati, Coll Med, Neurosci Grad Program, Cincinnati, OH USA.; Cecil, KM (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH USA.	kim.cecil@cchmc.org	Yeates, Keith/AAJ-4223-2020	Cecil, Kim/0000-0001-8233-5485; Yeates, Keith/0000-0001-7680-2892	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 CA112182, R01 ES027724]; Intellectual & Development Disabilities Research Center, at Kennedy Krieger Institute [U54 HD079123]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA112182] Funding Source: NIH RePORTER	Funding to support this work came from the National Institutes of Health grant numbers R01 CA112182, R01 ES027724 and the Intellectual & Development Disabilities Research Center, at Kennedy Krieger Institute, grant number U54 HD079123.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Borghesani PR, 2013, NEUROPSYCHOLOGIA, V51, P1435, DOI 10.1016/j.neuropsychologia.2013.03.005; Burns TC, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS161; Chapman CH, 2012, INT J RADIAT ONCOL, V82, P2033, DOI 10.1016/j.ijrobp.2011.01.068; Conklin HM, 2013, J NEURO-ONCOL, V113, P333, DOI 10.1007/s11060-013-1123-5; de Blank PMK, 2016, PEDIATR BLOOD CANCER, V63, P818, DOI 10.1002/pbc.25896; Dietrich J, 2008, ONCOLOGIST, V13, P1285, DOI 10.1634/theoncologist.2008-0130; Ferrer E, 2013, DEVELOPMENTAL SCI, V16, P941, DOI 10.1111/desc.12088; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Genova HM, 2013, J CLIN EXP NEUROPSYC, V35, P631, DOI 10.1080/13803395.2013.806649; Greene-Schloesser D, 2013, CLIN CANCER RES, V19, P2294, DOI 10.1158/1078-0432.CCR-11-2903; Hope TR, 2015, J MAGN RESON IMAGING, V41, P414, DOI 10.1002/jmri.24533; Ishii A, 2009, P NATL ACAD SCI USA, V106, P14605, DOI 10.1073/pnas.0905936106; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kerchner GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050425; Khong PL, 2003, AM J NEURORADIOL, V24, P734; Kourtidou P, 2013, J HEAD TRAUMA REHAB, V28, P433, DOI 10.1097/HTR.0b013e3182585d06; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee YW, 2012, BIOMOL THER, V20, P357, DOI 10.4062/biomolther.2012.20.4.357; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Mulhern RK, 2001, J CLIN ONCOL, V19, P472, DOI 10.1200/JCO.2001.19.2.472; Nagesh V, 2008, INT J RADIAT ONCOL, V70, P1002, DOI 10.1016/j.ijrobp.2007.08.020; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI 10.1093/neuonc/nov189; Palmer SL, 2013, J CLIN ONCOL, V31, P3494, DOI 10.1200/JCO.2012.47.4775; Patel SK, 2017, PEDIATR NEUROSURG, V52, P436, DOI 10.1159/000454717; Patel S, 2014, CHILD NERV SYST, V30, P147, DOI 10.1007/s00381-013-2307-1; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Price RE, 2001, J MED PRIMATOL, V30, P81, DOI 10.1034/j.1600-0684.2001.300202.x; Qiu D, 2007, INT J RADIAT ONCOL, V69, P846, DOI 10.1016/j.ijrobp.2007.04.041; Ris MD, 2001, J CLIN ONCOL, V19, P3470, DOI 10.1200/JCO.2001.19.15.3470; Rueckriegel SM, 2010, INT J RADIAT ONCOL, V76, P859, DOI 10.1016/j.ijrobp.2009.02.054; SCHULTHEISS TE, 1992, INT J RADIAT ONCOL, V23, P1089, DOI 10.1016/0360-3016(92)90920-D; Siasios I, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.6.FOCUS16192; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Systat Software I, 2014, SIGMAPLOT WINDOWS; Uh J, 2015, INT J RADIAT ONCOL, V93, P64, DOI 10.1016/j.ijrobp.2015.05.017; VOGEL FS, 1958, J NEUROPATH EXP NEUR, V17, P138, DOI 10.1097/00005072-195801000-00006; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H; Yuan W, 2009, AM J NEURORADIOL, V30, P1792, DOI 10.3174/ajnr.A1663	45	14	14	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	DEC	2017	47	13					1809	1816		10.1007/s00247-017-3955-1			8	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	FN2NV	WOS:000415831000014	28844078	Green Accepted			2022-02-06	
J	Nerenberg, KA; Park, AL; Vigod, SN; Saposnik, G; Berger, H; Hladunewich, MA; Gandhi, S; Silversides, CK; Ray, JG				Nerenberg, Kara A.; Park, Alison L.; Vigod, Simone N.; Saposnik, Gustavo; Berger, Howard; Hladunewich, Michelle A.; Gandhi, Shital; Silversides, Candice K.; Ray, Joel G.			Long-term Risk of a Seizure Disorder After Eclampsia	OBSTETRICS AND GYNECOLOGY			English	Article							HIPPOCAMPAL SCLEROSIS; SOLUBLE ENDOGLIN; COMPLICATIONS; PREECLAMPSIA; EPILEPSY; HEALTH	OBJECTIVE: To evaluate the incidence rate and relative risk of a seizure disorder after eclampsia. METHODS: We evaluated 1,565,733 births in a retrospective data linkage cohort study in Ontario, Canada, from April 1, 2002, to March 31, 2014. We included females aged 15-50 years and excluded patients with epilepsy, conditions predisposing to seizure, and those who died within 30 days of the delivery discharge date. The exposure was defined as a hypertensive disorder of pregnancy, namely 1) eclampsia, 2) preeclampsia, or 3) gestational hypertension. The referent was an unaffected pregnancy. The primary outcome was the risk of seizure disorder starting 31 days after a hospital birth discharge. Risk was expressed as an incidence rate and a hazard ratio (HR) with 95% CI. The predefined study hypothesis was that women with eclampsia would have an increased risk of future seizure disorder. RESULTS: There were 1,615 (0.10%) pregnancies exclusively affected by eclampsia, 17,264 (1.1%) with preeclampsia, 60,863 (3.9%) with gestational hypertension, and 1,485,991 (94.9%) unaffected. A future seizure disorder was significantly more likely after a pregnancy with eclampsia (4.58/10,000 person-years) than a pregnancy without a hypertensive disorder of pregnancy (0.72/10,000 person-years; crude HR 6.09, 95% CI 2.73-13.60). The adjusted HR was minimally attenuated from 6.09 to 5.42 (95% CI 2.42-12.12) after multivariable adjustment for confounders at the index birth as well as adjusting for traumatic brain injury, stroke, cerebral tumor, aneurysm or hemorrhage, and multiple sclerosis. The risk of seizure disorder was doubled in pregnancies affected by preeclampsia (adjusted HR 1.96, 95% CI 1.21-3.17), but not by gestational hypertension (adjusted HR 1.01, 95% CI 0.71-1.43). CONCLUSION: Women with eclampsia should be reassured that, although the relative risk of a seizure disorder is higher than unaffected women, the absolute risk is extremely low (approximately one seizure/2,200 person-years).	Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada; Univ Calgary, Cumming Sch Med, Dept Obstet & Gynecol, Calgary, AB, Canada; Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Inst, Toronto, ON, Canada; Univ Toronto, Dept Psychiat, Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Toronto, St Michaels Hosp, Womens Coll Hosp Res Inst, Dept Med, Toronto, ON, Canada; Univ Toronto, St Michaels Hosp, Womens Coll Hosp Res Inst, Dept Obstet & Gynecol, Toronto, ON, Canada; Univ Toronto, Sunnybrook Hosp, Dept Med, Toronto, ON, Canada; Univ Toronto, Mt Sinai Hosp, Dept Med, Sunnybrook Hosp Res Inst, Toronto, ON, Canada; Univ Toronto, Toronto Gen Hosp, Dept Med, Toronto, ON, Canada		Nerenberg, KA (corresponding author), Foothills Prov Gen Hosp, Dept Med, HSC 1410,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	kara.nerenberg@ucalgary.ca	Berger, Howard/N-6424-2019; Saposnik, Gustavo/M-3937-2017; Silversides, Candice K/D-8967-2017	Saposnik, Gustavo/0000-0002-5950-9886; Berger, Howard/0000-0003-3842-213X	University of Toronto's Department of Medicine; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)Ministry of Health and Long-Term Care, Ontario; Applied Research Chair in Reproductive and Child Health Services and Policy Research from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	This study was funded by the University of Toronto's Department of Medicine. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Dr Ray is supported by an Applied Research Chair in Reproductive and Child Health Services and Policy Research from the Canadian Institutes of Health Research.	Al-Safi Z, 2011, OBSTET GYNECOL, V118, P1102, DOI 10.1097/AOG.0b013e318231934c; Allison PD, 2010, SURVIVAL ANAL USING, V2nd; Andersgaard AB, 2008, GYNECOL OBSTET INVES, V67, P49, DOI 10.1159/000161569; Aukes AM, 2012, BJOG-INT J OBSTET GY, V119, P1117, DOI 10.1111/j.1471-0528.2012.03406.x; Aukes AM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.033; Cunningham FG, 2000, AM J OBSTET GYNECOL, V182, P94, DOI 10.1016/S0002-9378(00)70496-0; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Lawn N, 2004, NEUROLOGY, V62, P1352, DOI 10.1212/01.WNL.0000120544.64972.10; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Liu JN, 2012, KIDNEY INT, V81, P341, DOI 10.1038/ki.2011.388; Liu SL, 2011, OBSTET GYNECOL, V118, P987, DOI 10.1097/AOG.0b013e31823311c1; Macdonald RL, 2009, ANN NEUROL, V66, P2, DOI 10.1002/ana.21763; Magee LA, 2014, PREGNANCY HYPERTENS, V4, P105, DOI 10.1016/j.preghy.2014.01.003; Melamed N, 2014, J OBSTET GYNAECOL CA, V36, P642, DOI 10.1016/S1701-2163(15)30545-4; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Ray JG, 2012, HEART, V98, P1136, DOI 10.1136/heartjnl-2011-301548; SEXTON JA, 1976, J KENTUCKY MED ASSOC, V74, P595; Shah AK, 2008, J NEUROL SCI, V271, P158, DOI 10.1016/j.jns.2008.04.010; Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99; SIBAI BM, 1992, AM J OBSTET GYNECOL, V166, P1757, DOI 10.1016/0002-9378(92)91566-S; Solinas C, 2003, NEUROLOGY, V60, P1534, DOI 10.1212/01.WNL.0000061479.59789.10; SUTER C, 1957, NEUROLOGY, V7, P105, DOI 10.1212/WNL.7.2.105; Vaisbuch E, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.049; Wasseff S, 2009, MED HYPOTHESES, V72, P49, DOI 10.1016/j.mehy.2008.08.017; Wiegman MJ, 2012, OBSTET GYNECOL, V119, P959, DOI 10.1097/AOG.0b013e31824da5a8; Zeeman GG, 2009, SEMIN PERINATOL, V33, P166, DOI 10.1053/j.semperi.2009.02.003; Zwart JJ, 2008, OBSTET GYNECOL, V112, P820, DOI 10.1097/AOG.0b013e3181875eb3	29	14	14	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7844			OBSTET GYNECOL	Obstet. Gynecol.	DEC	2017	130	6					1327	1333		10.1097/AOG.0000000000002364			7	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	FR5UT	WOS:000419132400022	29112665				2022-02-06	
J	Richardson, JD; Ketcheson, F; King, L; Shnaider, P; Marlborough, M; Thompson, A; Elhai, JD				Richardson, J. Don; Ketcheson, F.; King, L.; Shnaider, P.; Marlborough, M.; Thompson, A.; Elhai, J. D.			Psychiatric comorbidity pattern in treatment-seeking veterans	PSYCHIATRY RESEARCH			English	Article						Posttraumatic stress disorder; Major depression; Canadian Forces	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; CANADIAN ARMED-FORCES; TRAUMATIC BRAIN-INJURY; LATENT CLASS ANALYSIS; PEACEKEEPING VETERANS; MILITARY PERSONNEL; CARE UTILIZATION; PTSD; AFGHANISTAN	This study investigated comorbidity patterns in treatment-seeking veterans and currently-serving Canadian Forces members of an outpatient mental health clinic from September 2006-September 2014. Using a retrospective cohort design, latent class analysis was conducted to determine latent classes of comorbidity (including posttraumatic stress disorder [PTSD], major depressive disorder [MDD], generalized anxiety disorder, panic disorder, and alcohol use disorder [AUD]). Multiple logistic regression was used to determine which covariates (age, gender, number of deployments, and service duration) were predictors of latent class membership. Among the 486 participants, 79.2% had more than one probable mental health condition. The most common co morbidity was PTSD and MDD (61.5%), followed by PTSD and GAD (52.3%). Among those with PTSD, almost all (95%) had a subsequent condition, predominantly MDD (82.6% of those with PTSD had MDD). A two-class model was the best fitting model with a high comorbidity and a low comorbidity class. Older age and shorter service duration significantly increased the probability of being in the high comorbidity class when not controlling for member status. Results showed that treatment-seeking veterans and military personnel have high rates of comorbidity, particularly alongside PTSD. Therefore, it is critical for clinicians to be able to assess and treat comorbidity.	[Ketcheson, F.; King, L.; Marlborough, M.] Parkwood Hosp, Operat Stress Injury Clin, London, ON, Canada; [Richardson, J. Don] Western Univ, London, ON, Canada; [Richardson, J. Don] McMaster Univ, Hamilton, ON, Canada; [Shnaider, P.] St Josephs Healthcare Hamilton, Hamilton, ON, Canada; [Thompson, A.] Canadian Forces Hlth Serv Grp, Dept Natl Def, Ottawa, ON, Canada; [Elhai, J. D.] Univ Toledo, Toledo, OH USA		Richardson, JD (corresponding author), Parkwood Inst, Arthur J Hobbins Bldg Zone D,550 Wellington Rd, London, ON N6C 0A7, Canada.	jdonrichardson@gmail.com	Elhai, Jon D/U-1901-2017; Richardson, J Don/X-5123-2018	Elhai, Jon D/0000-0001-5205-9010; Richardson, J Don/0000-0002-2927-6735; Shnaider, Philippe/0000-0003-4879-7306			Aakre JM, 2014, PSYCHIAT SERV, V65, P1066, DOI 10.1176/appi.ps.201300117; Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armour C, 2015, PSYCHIAT RES, V228, P1, DOI 10.1016/j.psychres.2015.03.011; Babor TF, 2001, AUDIT ALCOHOL USE DI; Bergman B.P., 2016, J CLIN PSYCHIAT, pe1; Boulos D, 2013, CAN MED ASSOC J, V185, pE545, DOI 10.1503/cmaj.122120; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Contractor A.A., 2015, J PSYCHIAT RES; Forbes D, 2010, J TRAUMA STRESS, V23, P340, DOI 10.1002/jts.20526; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Haley RW, 1998, AM J EPIDEMIOL, V148, P315, DOI 10.1093/oxfordjournals.aje.a009645; Haskell SG, 2011, WOMEN HEALTH ISS, V21, P92, DOI 10.1016/j.whi.2010.08.001; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine, 2013, RET HOM IR AFGH ASS; Kessler R.C., 2014, JAMA PSYCHIAT; Kozaric-Kovacic D, 2005, MIL MED, V170, P223, DOI 10.7205/MILMED.170.3.223; Litz BT, 1997, AM J PSYCHIAT, V154, P178; Lockwood E, 2014, PSYCHOL INJ LAW, V7, P108, DOI 10.1007/s12207-014-9189-8; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; McMillan K.A., 2017, J NERV MENT DISORD; Murdoch M, 2003, MED CARE, V41, P536, DOI 10.1097/00005650-200304000-00009; Naifeh JA, 2010, PSYCHOL ASSESSMENT, V22, P666, DOI 10.1037/a0019783; Nelson C, 2011, MIL MED, V176, P156, DOI 10.7205/MILMED-D-10-00252; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Orsillo SM, 1996, J NERV MENT DIS, V184, P307, DOI 10.1097/00005053-199605000-00007; Pearson C., 2014, STAT CANADA; Resnick SG, 2008, J REHABIL RES DEV, V45, P427, DOI 10.1682/JRRD.2007.06.0093; Richardson JD, 2006, J CLIN PSYCHIAT, V67, P1240, DOI 10.4088/JCP.v67n0810; Richardson JD, 2014, J CLIN PSYCHIAT, V75, pE1299, DOI 10.4088/JCP.13m08796; Rosellini AJ, 2015, DEPRESS ANXIETY, V32, P493, DOI 10.1002/da.22364; Rusu C, 2016, CAN J PSYCHIAT, V61, p46S, DOI 10.1177/0706743716628856; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; St Cyr K, 2014, PSYCHIAT RES, V218, P148, DOI 10.1016/j.psychres.2014.03.038; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Weathers F., 1993, PTSD CHECLDIST PCL R; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wisco BE, 2014, J CLIN PSYCHIAT, V75, P1338, DOI 10.4088/JCP.14m09328; Zamorski MA, 2016, CAN J PSYCHIAT, V61, p26S, DOI 10.1177/0706743716628854	43	14	15	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	DEC	2017	258						488	493		10.1016/j.psychres.2017.08.091			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FN7FQ	WOS:000416184500076	28899613				2022-02-06	
J	Snell, DL; Iverson, GL; Panenka, WJ; Silverberg, ND				Snell, Deborah L.; Iverson, Grant L.; Panenka, William J.; Silverberg, Noah D.			Preliminary Validation of the World Health Organization Disability Assessment Schedule 2.0 for Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						mTBI; outcome measures; 12 item WHODAS 2.0	POST-CONCUSSION SYMPTOMS; CHRONIC PAIN; PREDICTION; INTERVIEW; 12-ITEM; VERSION; MINI	The purpose of this study is to examine the reliability, factor structure, and validity of the World Health Organization Disability Assessment Schedule (WHODAS 2.0 12 item version) in a sample of patients who were slow to recover from a mild traumatic brain injury (mTBI). Participants were 79 adults with mTBI recruited from one of four specialty outpatient clinics in Vancouver, Canada. The WHODAS 2.0 12 item version is a disease-nonspecific measure of disability representing six International Classification of Disability, Functioning, and Health activity and participation domains including cognition, mobility, self-care, interpersonal functioning, life activities, and participation. Results of analyses showed that the WHODAS 2.0 had high internal consistency and adequate construct and concurrent validity. A three factor structure emerged in this sample. The scale differentiated between patients with good and those with poor outcomes based on post-concussion syndrome, psychiatric, and pain status. Participants with multiple comorbidities reported the most disability on the WHODAS. Concurrent validity was also supported by lower WHODAS scores in participants who had returned to work versus those who had not. To our knowledge, this is the first study to evaluate the psychometric properties of the WHODAS 2.0 in a sample of people with mTBI. In summary, the WHODAS was sensitive to post-concussion syndrome after mTBI, as well as to health conditions that commonly co-occur with mTBI (e.g., mental health problems and chronic pain).	[Snell, Deborah L.] Univ Otago, Burwood Hosp, Canterbury Dist Hlth Board, Concuss Clin,Dept Orthopaed Surg & Musculoskeleta, Christchurch, New Zealand; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Panenka, William J.] Univ British Columbia, Dept Psychiat, British Columbia Neuropsychiat Program, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Rehabil Res Program, GF Strong Rehab Ctr,Rehabil Res Program, Vancouver, BC, Canada		Silverberg, ND (corresponding author), Univ British Columbia, Div Phys Med & Rehabil, Rehabil Res Program, GF Strong Rehab Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Panenka, William/0000-0001-7143-6512; Iverson, Grant/0000-0001-7348-9570	Specific Priorities Research Grant from WorkSafeBC [RS2014-SP03]; Clinician Scientist Career Development Award from the Vancouver Coastal Health Research Institute	We thank research assistants Mary Ellen Johnson and Sabrina Khan as well as the clinical staff at our recruitment sites, including Kelsey Davies, Jennifer Loffree, Grace Boutilier, and Trish Mahoney (GF Strong Rehab Centre); Deanna Yells, Heather MacNeil, and Rod Macdonald (Fraser Health Concussion Clinic); Denise Silva and Lesley Norris (Back in Motion); and Karilyn Lao, Wayne Tang, and Cyrus Huang (LifeMark). This study was funded by a Specific Priorities Research Grant from WorkSafeBC (# RS2014-SP03). Dr. Silverberg receives salary support from a Clinician Scientist Career Development Award from the Vancouver Coastal Health Research Institute.	Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P343, DOI 10.1080/13854046.2013.774438; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; de Guise E, 2016, APPL NEUROPSYCH-ADUL, V23, P213, DOI 10.1080/23279095.2015.1038747; Derrett S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044909; Dixon J.K., 2005, STAT METHODS HLTH CA, P321; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Friedland D, 2016, J NEUROL NEUROSUR PS, V87, P1068, DOI 10.1136/jnnp-2015-312193; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; IBM Corporation, 2016, BM SPSS STAT MAC VER; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; MacLeod MA, 2016, INT J METH PSYCH RES, V25, P243, DOI 10.1002/mpr.1523; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Resnik L, 2017, ARCH PHYS MED REHAB, V98, P561, DOI 10.1016/j.apmr.2016.08.463; Saltychev M, 2017, CLIN REHABIL, V31, P262, DOI 10.1177/0269215516631385; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Sjonnesen K, 2016, CAN J PSYCHIAT, V61, P227, DOI 10.1177/0706743716632514; Smedema SM, 2016, J REHABIL, V82, P28; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Theadom A., 2017, ARCH PHYS MED REHABI; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Ustun T, 2010, MEASURING HLTH DISAB; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Weeks M, 2016, CAN J PSYCHIAT, V61, p56S, DOI 10.1177/0706743716628853; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2001, ICF INT CLASFUNCT	41	14	15	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3256	3261		10.1089/neu.2017.5234			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000416341700006	28895491				2022-02-06	
J	Tsao, JW; Stentz, LA; Rouhanian, M; Howard, RS; Perry, BN; Haran, FJ; Pasquina, PF; Wolde, M; Taylor, CE; Lizardo, R; Liu, S; Flores, E; Creason, AH; Sher, K				Tsao, Jack W.; Stentz, Lauren A.; Rouhanian, Minoo; Howard, Robin S.; Perry, Briana N.; Haran, F. Jay; Pasquina, Paul F.; Wolde, Mikias; Taylor, Carolyn E.; Lizardo, Radhames; Liu, Scott; Flores, Eusebio, III; Creason, Alia H.; Sher, Katalina			Effect of concussion and blast exposure on symptoms after military deployment	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; LOW-LEVEL BLAST; PERSONNEL; SLEEP; IRAQ	Objective: To examine whether blast exposure alone and blast-associated concussion result in similar neurologic and mental health symptoms. Methods: A 14-item questionnaire was administered to male US Marines on their return from deployment in Iraq and/or Afghanistan. Results: A total of 2,612 Marines (median age 22 years) completed the survey. Of those, 2,320 (88.9%) reported exposure to >= 1 blast during their current and/or prior deployments. In addition, 1,022 (39.1%) reported >= 1 concussion during the current deployment, and 731 (28.0%) had experienced at least 1 prior lifetime concussion. Marines were more likely to have sustained a concussion during the current deployment if they had a history of 1 (odds ratio [OR] 1.5, 95% confidence interval [CI] 1.2-2.0) or >= 1 (OR 2.3, 95% CI 1.7-3.0) prior concussion. The most common symptoms were trouble sleeping (38.4%), irritability (37.9%), tinnitus (33.8%), and headaches (33.3%). Compared to those experiencing blast exposure without injury, Marines either experiencing a concussion during the current deployment or being moved or injured by a blast had an increased risk of postinjury symptoms. Conclusions: There appears to be a continuum of increasing total symptoms from no exposure to blast exposure plus both current deployment concussion and past concussion. Concussion had a greater influence than blast exposure alone on the presence of postdeployment symptoms. A high blast injury score can be used to triage those exposed to explosive blasts for evaluation.	[Tsao, Jack W.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Tsao, Jack W.] Le Bonheur Childrens Hosp, Childrens Fdn Res Ctr, Memphis, TN 38103 USA; [Tsao, Jack W.; Haran, F. Jay; Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Stentz, Lauren A.; Rouhanian, Minoo; Howard, Robin S.; Perry, Briana N.; Pasquina, Paul F.; Wolde, Mikias; Taylor, Carolyn E.; Sher, Katalina] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Lizardo, Radhames] Naval Med Ctr San Diego, San Diego, CA USA; [Flores, Eusebio, III] Neurosci Consultants PLC, Naval Med Ctr Portsmouth, Reston, VA USA; [Creason, Alia H.] Informat Innovators Inc, Springfield, VA USA		Tsao, JW (corresponding author), Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA.; Tsao, JW (corresponding author), Le Bonheur Childrens Hosp, Childrens Fdn Res Ctr, Memphis, TN 38103 USA.; Tsao, JW (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	jtsao@uthsc.edu		Taylor, Carolyn/0000-0002-1862-4773	US Navy Bureau of Medicine and Surgery	This study was supported by the US Navy Bureau of Medicine and Surgery.	Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Defense and Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBL; Dionne JP, 2011, INCREASED BLAST INJU; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jones Edgar, 2005, SHELL SHOCK PTSD MIL; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vandrey R, 2014, INT REV PSYCHIATR, V26, P237, DOI 10.3109/09540261.2014.901300; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Yankaskas K, 2013, HEARING RES, V295, P3, DOI 10.1016/j.heares.2012.04.016	21	14	14	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 7	2017	89	19					2010	2016		10.1212/WNL.0000000000004616			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FP5QW	WOS:000417675300017	29030450				2022-02-06	
J	Alotaibi, NM; Wang, JZ; Pasarikovski, CR; Guha, D; Al-Mufti, F; Mamdani, M; Saposnik, G; Schweizer, TA; Macdonald, RL				Alotaibi, Naif M.; Wang, Justin Z.; Pasarikovski, Christopher R.; Guha, Daipayan; Al-Mufti, Fawaz; Mamdani, Muhammad; Saposnik, Gustavo; Schweizer, Tom A.; Macdonald, R. Loch			Management of raised intracranial pressure in aneurysmal subarachnoid hemorrhage: time for a consensus?	NEUROSURGICAL FOCUS			English	Article						aneurysm; subarachnoid hemorrhage; aSAH; intracranial pressure; ICP; management	CEREBRAL PERFUSION-PRESSURE; CRITICAL-CARE MANAGEMENT; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; THERAPEUTIC HYPOTHERMIA; HYPERTONIC SALINE; BARBITURATE COMA; CLINICAL CHARACTERISTICS; GRADE; VASOSPASM	Elevated intracranial pressure (ICP) is a well-recognized phenomenon in aneurysmal subarachnoid hemorrhage (aSAH) that has been demonstrated to lead to poor outcomes. Despite significant advances in clinical research into aSAH, there are no consensus guidelines devoted specifically to the management of elevated ICP in the setting of aSAH. To treat high ICP in aSAH, most centers extrapolate their treatment algorithms from studies and published guidelines for traumatic brain injury. Herein, the authors review the current management strategies for treating raised ICP within the aSAH population, emphasize key differences from the traumatic brain injury population, and highlight potential directions for future research in this controversial topic.	[Alotaibi, Naif M.; Guha, Daipayan; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Alotaibi, Naif M.; Wang, Justin Z.; Pasarikovski, Christopher R.; Guha, Daipayan; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Alotaibi, Naif M.] King Fahad Med City, Natl Neurosci Inst, Dept Neurosurg, Riyadh, Saudi Arabia; [Al-Mufti, Fawaz] Robert Wood Johnson Univ Hosp, Dept Neurol & Crit Care, New Brunswick, NJ USA; [Mamdani, Muhammad] Univ Toronto, Inst Clin Evaluat Sci, Li Ka Shing Ctr Healthcare Analyt Res & Training, Toronto, ON, Canada; [Saposnik, Gustavo; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, Neurosci Res Program, Keenan Res Ctr, Li Ka Shing Knowledge Inst,St Michaels Hosp, Toronto, ON, Canada; [Saposnik, Gustavo] Univ Toronto, St Michaels Hosp, Stroke Outcomes & Decis Neurosci Res Unit, Toronto, ON, Canada		Alotaibi, NM (corresponding author), Univ Toronto, Div Neurosurg, 399 Bathurst St,WW 4-427, Toronto, ON M5T 2S8, Canada.	naif.alotaibi@mail.utoronto.ca	Al-Mufti, Fawaz/AAZ-3360-2020; Saposnik, Gustavo/M-3937-2017; Guha, Daipayan/AAV-1008-2021	Al-Mufti, Fawaz/0000-0003-4461-7005; Saposnik, Gustavo/0000-0002-5950-9886; Guha, Daipayan/0000-0002-2052-4819; Alotaibi, Naif/0000-0002-8227-347X	Brain Aneurysm Foundation; Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada	Dr. Macdonald receives grant support from the Brain Aneurysm Foundation, Canadian Institutes for Health Research, and the Heart and Stroke Foundation of Canada. Dr. Saposnik is supported by the 2017-2021 Heart and Stroke Foundation of Canada Mid-Career Scientist Award.	Alotaibi NM, 2017, J NEUROSURG, V127, P1315, DOI 10.3171/2016.9.JNS161383; Alotaibi NM, 2016, WORLD NEUROSURG, V89, P587, DOI 10.1016/j.wneu.2015.11.072; Anei R, 2010, NEUROL MED-CHIR, V50, P879, DOI 10.2176/nmc.50.879; BAILES JE, 1990, J NEUROSURG, V72, P559, DOI 10.3171/jns.1990.72.4.0559; Bentsen G, 2006, CRIT CARE MED, V34, P2912, DOI 10.1097/01.CCM.0000245665.46789.7C; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bracard S, 2002, AM J NEURORADIOL, V23, P953; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen H, 2012, CAN J NEUROL SCI, V39, P483, DOI 10.1017/S0317167100013998; Chouhan RS, 2006, J ANAESTH CLIN PHARM, V22, P21; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cossu G, 2016, MINERVA ANESTESIOL, V82, P684; Cross DT, 1998, AM J NEURORADIOL, V19, P1319; Czorlich P, 2017, EUR J NEUROL, V24, P645, DOI 10.1111/ene.13265; D'Souza S, 2015, J NEUROSURG ANESTH, V27, P222, DOI 10.1097/ANA.0000000000000130; Dereeper E, 2002, J CRIT CARE, V17, P58, DOI 10.1053/jcrc.2002.33032; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Etminan N, 2017, HAND CLINIC, V140, P195, DOI 10.1016/B978-0-444-63600-3.00012-X; Fei L, 2007, CLIN DRUG INVEST, V27, P827, DOI 10.2165/00044011-200727120-00004; Finfer SR, 1999, INTENS CARE MED, V25, P406, DOI 10.1007/s001340050866; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Frontera JA, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/263974; Gigante P, 2010, BRIT J NEUROSURG, V24, P625, DOI 10.3109/02688697.2010.505989; Gomis P, 2010, J NEUROSURG, V112, P681, DOI 10.3171/2009.4.JNS081377; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hays AN, 2011, NEUROCRIT CARE, V14, P222, DOI 10.1007/s12028-010-9477-4; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; Hollig A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0954-1; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holzer M, 2002, NEW ENGL J MED, V346, P549; Huang Xue-cai, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P389; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Keller E, 2005, ACT NEUR S, V94, P65; Kim YI, 2008, J KOREAN NEUROSURG S, V44, P141, DOI 10.3340/jkns.2008.44.3.141; Kimme P, 2004, BRIT J ANAESTH, V93, P343, DOI 10.1093/bja/aeh206; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Lane PL, 2000, CAN J SURG, V43, P442; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; Li LYR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008445.pub2; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7; Mak CHK, 2013, VASC HEALTH RISK MAN, V9, P353, DOI 10.2147/VHRM.S34046; Manoel ALD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1193-9; Marko NF, 2012, CRIT CARE, V16, DOI 10.1186/cc11182; Mocco J, 2007, Neurosurg Focus, V22, pE7; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; NELSON E, 1982, J CLIN PHARMACOL, V22, P141, DOI 10.1002/j.1552-4604.1982.tb02662.x; NORNES H, 1973, J NEUROSURG, V39, P226, DOI 10.3171/jns.1973.39.2.0226; Olson DM, 2013, J NEUROSURG, V119, P974, DOI 10.3171/2013.6.JNS122403; Otani N, 2011, WORLD NEUROSURG, V75, P73, DOI 10.1016/j.wneu.2010.10.021; Pasarikovski CR, 2017, WORLD NEUROSURG, V105, P1, DOI 10.1016/j.wneu.2017.05.085; 허동화, 2003, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V33, P142; Ransom ER, 2007, NEUROCRIT CARE, V6, P174, DOI 10.1007/s12028-007-0019-7; Rogers M, 2017, J NEUROSCI NURS, V49, P85, DOI 10.1097/JNN.0000000000000257; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Sauvigny T, 2018, J NEUROSURG, V128, P819, DOI 10.3171/2016.11.JNS162263; Scirica BM, 2013, CIRCULATION, V127, P244, DOI 10.1161/CIRCULATIONAHA.111.076851; Seule MA, 2009, NEUROSURGERY, V64, P86, DOI 10.1227/01.NEU.0000336312.32773.A0; Springborg JB, 2005, BRIT J ANAESTH, V94, P259, DOI 10.1093/bja/aei004; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Thongrong C, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.02.027; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Tuzgen S, 2012, J NEUROSCI RURAL PRA, V3, P251, DOI 10.4103/0976-3147.102598; Wan A, 2016, J NEUROSURG, V125, P1344, DOI 10.3171/2015.10.JNS151036; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Weerakkody RA, 2010, ACTA NEUROCHIR, V152, P1763, DOI 10.1007/s00701-010-0748-9; Zhao B, 2017, J NEUROSURG SCI, V61, P403, DOI 10.23736/S0390-5616.16.03457-3; Zoerle T, 2015, CRIT CARE MED, V43, P168, DOI 10.1097/CCM.0000000000000670	74	14	15	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E13	10.3171/2017.7.FOCUS17426			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800005	29088956	gold			2022-02-06	
J	Alshweki, A; Perez-Munuzuri, A; Lopez-Suarez, O; Bana, A; Couce, ML				Alshweki, Ayham; Perez-Munuzuri, Alejandro; Lopez-Suarez, Olalla; Bana, Ana; Couce, Maria L.			Relevance of urinary S100B protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia	MEDICINE			English	Article						hypoxic-ischemic encephalopathy; neuron-specific enolase; serum S-100B protein; therapeutic hypothermia; urinary S-100B protein	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; EARLY IDENTIFICATION; BODY HYPOTHERMIA; NEWBORN; DAMAGE; SERUM; BLOOD	The initial diagnosis of neonatal hypoxic-ischemic encephalopathy is based on nervous system clinical manifestations. The use of biomarkers to monitor brain injury and evaluate neuroprotective effects allows early intervention and treatment. This study was designed to determine the short-term prognostic significance of urinary S100B calcium-binding protein (S100B) in asphyxiated newborns treated with hypothermia.An observational prospective study was conducted over a period of 5 years in 31 newborns with hypoxic-ischemic encephalopathy who received therapeutic hypothermia. The patients were divided into 2 groups: Group A (13 newborns with a normal neurological examination before discharge) and Group B (18 newborns who died during admission or had an abnormal neurologic examination before discharge). Urinary S100B was the main variable, serum S100B and neuron-specific enolase (NSE) were considered as secondary variables, and all of them were assessed on the first 3 days of life. The newborns were subsequently divided into groups with normal and abnormal electrophysiological and imaging findings.Mean urinary S100B levels were significantly higher in group B than group A on day 1 (10.5814.82 vs 4.65 +/- 9.16g/L, P=.031) and day 2 (5.16 +/- 7.63 vs 0.88 +/- 2.53, P=.002). The optimal cutoff for urinary S100B on day 1 was >1.11g/L of (sensitivity, 100%; specificity 60%) for the prediction of neonatal death and<0.66g/L (sensitivity 83% and specificity 70%) for the prediction of a normal neurological examination before discharge. It was not possible to calculate cutoffs with a similar accuracy for serum S100B or NSE. Urinary S100B on day 1 was higher in patients with abnormal magnetic resonance imaging findings (7.89 +/- 8.09 vs 4.49 +/- 9.14, P=.039) and abnormal positron emission tomography findings (8.60 +/- 9.29 vs 4.30 +/- 8.28, P=.038). There were no significant differences in S100B levels between patients with normal and abnormal electroencephalography results.Urinary S100B measured in the first days of life can predict neonatal death and short-term prognosis in asphyxiated newborns treated with hypothermia. The method is convenient, noninvasive, and has a higher sensitivity and specificity than measurement of serum S100B or NSE.	[Alshweki, Ayham; Perez-Munuzuri, Alejandro; Lopez-Suarez, Olalla; Bana, Ana; Couce, Maria L.] Santiago de Compostela Univ Hosp, IDIS Hlth Res Inst Santiago de Compostela, Dept Pediat, Neonatal Unit,CIBERER, Santiago De Compostela, Spain		Alshweki, A (corresponding author), Complejo Hosp Univ Santiago de Compostela, Santiago De Compostela 15706, A Coruna, Spain.	drayham@live.com	Couce, Maria Luz/R-8981-2019	Couce, Maria Luz/0000-0003-4861-9905; Perez-Munuzuri, Alejandro/0000-0003-1434-7470			Anand N, 2005, CEREBROVASC DIS, V20, P213, DOI 10.1159/000087701; BABLOK W, 1988, J CLIN CHEM CLIN BIO, V26, P783; Benbadis SR, 2006, SLEEP: A COMPREHENSIVE HANDBOOK, P989; Cornette L, 2012, FACTS VIEWS VIS OBGY, V4, P133; Drury PP, 2010, SEMIN FETAL NEONAT M, V15, P287, DOI 10.1016/j.siny.2010.05.005; Dubowitz L, 2005, MENT RETARD DEV D R, V11, P52, DOI 10.1002/mrdd.20048; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Ergenekon E, 2016, J CLIN NEONATOL, V5, P8, DOI 10.4103/2249-4847.173271; Gancia P, 2012, J MATERN-FETAL NEO M, V25, P94, DOI 10.3109/14767058.2012.715023; Gazzolo D, 2004, CRIT CARE MED, V32, P131, DOI 10.1097/01.CCM.0000104116.91462.CD; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Gazzolo D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004298; Giuseppe D, 2009, CURR NEUROVASC RES, V6, P110, DOI 10.2174/156720209788185614; Graham EM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00196; Hassell KJ, 2015, ARCH DIS CHILD-FETAL, V100, pF541, DOI 10.1136/archdischild-2014-306284; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kannan S, 2010, SEMIN PERINATOL, V34, P39, DOI 10.1053/j.semperi.2009.10.004; Lima JE, 2004, BRAZ J MED BIOL RES, V37, P19, DOI 10.1590/S0100-879X2004000100003; Liu L, 2010, NEONATOLOGY, V97, P41, DOI 10.1159/000227292; Lv HY, 2015, CLIN CHIM ACTA, V450, P282, DOI 10.1016/j.cca.2015.08.021; Ma H, 2012, CURR MOL MED, V12, P1282, DOI 10.2174/156652412803833517; Magalhaes M, 2015, SAO PAULO MED J, V133, P314, DOI 10.1590/1516-3180.2013.7740026; Marks K, 2010, ISR MED ASSOC J, V12, P494; Mosalli R, 2012, J CLIN NEONATOL, V1, P101, DOI 10.4103/2249-4847.96777; Oh W, 2008, J PEDIATR-US, V153, P375, DOI 10.1016/j.jpeds.2008.03.041; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Ruetzler K, 2006, BIOL NEONATE, V89, P260, DOI 10.1159/000090120; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Shankaran S, 2012, J PEDIATR-US, V160, P567, DOI 10.1016/j.jpeds.2011.09.018; Sie LTL, 2000, NEUROPEDIATRICS, V31, P128, DOI 10.1055/s-2000-7496; Silveira RC, 2015, J PEDIAT-BRAZIL, V91, pS78, DOI 10.1016/j.jped.2015.07.004; STRAUSS J, 2008, EUR J NUCL MED MOL I, V35, P1581, DOI 10.1007/s00259-008-0826-x; STRAUSS RG, 1995, IMMUNOL INVEST, V24, P341, DOI 10.3109/08820139509062784; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Wassink G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00040	38	14	16	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV	2017	96	44							e8453	10.1097/MD.0000000000008453			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FM5UQ	WOS:000415106800042	29095291	Green Published			2022-02-06	
J	Keenan, HT; Cook, LJ; Olson, LM; Bardsley, T; Campbell, KA				Keenan, Heather T.; Cook, Lawrence J.; Olson, Lenora M.; Bardsley, Tyler; Campbell, Kristine A.			Social Intuition and Social Information in Physical Child Abuse Evaluation and Diagnosis	PEDIATRICS			English	Article							DECISION-MAKING; DISPARITIES; STRATEGIES; INFANTS; INJURY	BACKGROUND: Poor and minority children with injuries concerning for abuse are evaluated and diagnosed for abuse differentially. We hypothesized that 2 steps in the decision-making process would influence evaluation and diagnosis: social intuition from meeting the family and objective social information associated with child abuse risk. METHODS: Between 2009 and 2013, 32 child abuse pediatricians (CAPs) submitted 730 child abuse consultations including original medical evaluations and diagnoses. CAPs evaluated and diagnosed each other's cases. Comparisons of evaluations and diagnoses were made by levels of social understanding available to the CAP: meeting the family (social intuition and information), reading the case (social information), and reading the case without social information. Evaluations were compared with a consensus gold standard by using logistic regression modeling adjusting for child and CAP characteristics. Diagnostic categories were compared by level of social understanding and diagnostic certainty by using contingency tables. RESULTS: CAPs without access to social intuition were approximately twice as likely to perform gold standard evaluations for neurotrauma and long bone fracture compared with CAPs who met families. Diagnostic agreement fell from 73.3% (95% confidence interval [CI]: 70.1%-76.5%) when social information was present to 66.5% (95% CI: 63.1%-70.0%) when social information was restricted. In cases with less certainty, agreement dropped to 51.3% (95% CI: 46.0%-56.7%). CONCLUSIONS: Social intuition and information play a role in the physical child abuse decision-making process, which may contribute to differential diagnosis. Simple interventions including decision tools, check lists, and peer review may structure evaluations to ensure children's equal treatment.	[Keenan, Heather T.; Cook, Lawrence J.; Olson, Lenora M.; Bardsley, Tyler; Campbell, Kristine A.] Univ Utah, Dept Pediat, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA		Keenan, HT (corresponding author), Univ Utah, Dept Pediat, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu			Eunice Kennedy Shriver Institute of Child Health and Human Development of the National Institutes of Health [R01 HD061373]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061373] Funding Source: NIH RePORTER	Supported by the Eunice Kennedy Shriver Institute of Child Health and Human Development of the National Institutes of Health grant R01 HD061373 (principal investigator Dr Keenan). Funded by the National Institutes of Health (NIH).	Association of American Medical Colleges, 2004, STAT NEW AAMC DEF UN; Campbell KA, 2015, PEDIATRICS, V136, P35, DOI 10.1542/peds.2014-4192; Cavalcanti RB, 2014, ACAD MED, V89, P107, DOI 10.1097/ACM.0000000000000074; Chaiyachati BH, 2016, CHILD ABUSE NEGLECT, V51, P87, DOI 10.1016/j.chiabu.2015.11.001; Croskerry P, 2013, BMJ QUAL SAF, V22, pii65, DOI 10.1136/bmjqs-2012-001713; Croskerry P, 2013, NEW ENGL J MED, V368, P2445, DOI 10.1056/NEJMp1303712; Croskerry Pat, 2012, Healthc Q, V15 Spec No, P50; Dovidio JF, 2012, AM J PUBLIC HEALTH, V102, P945, DOI 10.2105/AJPH.2011.300601; Ely JW, 2011, ACAD MED, V86, P307, DOI 10.1097/ACM.0b013e31820824cd; Eva KW, 2007, MED EDUC, V41, P1152, DOI 10.1111/j.1365-2923.2007.02923.x; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kostopoulou O, 2012, MED DECIS MAKING, V32, P831, DOI 10.1177/0272989X12447241; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Laskey AL, 2012, J PEDIATR-US, V160, P1003, DOI 10.1016/j.jpeds.2011.11.042; Rangel EL, 2009, J PEDIATR SURG, V44, P1229, DOI 10.1016/j.jpedsurg.2009.02.044; Redelmeier DA, 2005, ANN INTERN MED, V142, P115, DOI 10.7326/0003-4819-142-2-200501180-00010; Starling SP, 2013, CHILD ABUSE NEGLECT, V37, P456, DOI 10.1016/j.chiabu.2013.01.002; Thenappan A, 2017, PEDIATR BLOOD CANCER, V64, P254, DOI 10.1002/pbc.26201; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031	20	14	14	1	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	2017	140	5							e20171188	10.1542/peds.2017-1188			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	FL3JO	WOS:000414119600030	29074609	Green Published, Bronze			2022-02-06	
J	Liu, PL; Zhang, ZJ; Wang, QD; Guo, RD; Mei, W				Liu, Peilin; Zhang, Zijuan; Wang, Qingde; Guo, Rundong; Mei, Wei			Lithium Chloride Facilitates Autophagy Following Spinal Cord Injury via ERK-dependent Pathway	NEUROTOXICITY RESEARCH			English	Article						Lithiumchloride; Autophagy flux; Spinal cord injury; ERK	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; ORAL LITHIUM; CANCER CELLS; PROTEIN; APOPTOSIS; NEURONS; MICE; LINE; CYTOTOXICITY	Spinal cord injury (SCI) is one major cause of death and results in long-term disability even in the most productive periods of human lives with few efficacious drugs. Autophagy is a potential therapeutic target for SCI. In the present study, we examined the role of lithium in functional recovery in the rat model of SCI and explored the related mechanism. Locomotion tests were employed to assess the functional recovery after SCI, Western blotting and RT-PCT to determine the level of p-ERK and LC3-II as well as p62, immunofluorescence imaging to localize LC3 and p62. Here, we found that both the expression of LC3-II and p62 were increased after SCI. However, lithium chloride enhanced the level of LC3-II while abrogated the abundance of p62. Furthermore, lithium treatment facilitated ERK activation in vivo, and inhibition of MEK/ERK signaling pathway suppressed lithium-evoked autophagy flux. Taken together, our results illustrated that lithium facilitated functional recovery by enhancing autophagy flux.	[Liu, Peilin; Wang, Qingde; Guo, Rundong; Mei, Wei] Zhengzhou Orthopaed Hosp, Dept Spine Surg, Zhengzhou, Henan, Peoples R China; [Zhang, Zijuan] Henan Univ Chinese Med, Sch Basic Med Sci, Expt Teaching Ctr, Zhengzhou, Henan, Peoples R China		Mei, W (corresponding author), Zhengzhou Orthopaed Hosp, Dept Spine Surg, Zhengzhou, Henan, Peoples R China.	zzhospital03@126.com					Bartholomeusz C, 2008, CANCER RES, V68, P9302, DOI 10.1158/0008-5472.CAN-08-2592; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Chang JW, 2011, J NEUROCHEM, V116, P659, DOI 10.1111/j.1471-4159.2010.07158.x; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cohen-Kaplan V, 2016, ONCOTARGET, V7, P83833, DOI 10.18632/oncotarget.13805; Cohen-Kaplan V, 2016, P NATL ACAD SCI USA, V113, pE7490, DOI 10.1073/pnas.1615455113; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Del Grosso A, 2016, J NEUROSCI RES, V94, P1246, DOI 10.1002/jnr.23910; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Fabrizi C, 2017, J APPL TOXICOL, V37, P207, DOI 10.1002/jat.3344; Gong X, 2016, AM J TRANSL RES, V8, P2127; Guttuso T, 2016, J NEUROL SCI, V368, P221, DOI 10.1016/j.jns.2016.07.027; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hou LL, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0222-y; Hull M, 2014, J CELL BIOCHEM, V115, P71, DOI 10.1002/jcb.24634; Kim EC, 2013, BRIT J OPHTHALMOL, V97, P1068, DOI 10.1136/bjophthalmol-2012-302881; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lenzi P, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00078; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Matsuzaki T, 2015, INT J DEV NEUROSCI, V41, P63, DOI 10.1016/j.ijdevneu.2014.11.006; Mattingly RR, 2006, J PHARMACOL EXP THER, V316, P456, DOI 10.1124/jpet.105.091454; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; O'Donovan TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134676; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Pardo R, 2003, J NEUROCHEM, V87, P417, DOI 10.1046/j.1471-4159.2003.02015.x; Raja M, 2015, MOVEMENT DISORD, V30, P1438, DOI 10.1002/mds.26260; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shimada K, 2012, NEUROBIOL DIS, V46, P101, DOI 10.1016/j.nbd.2011.12.050; SMITH RG, 1994, P NATL ACAD SCI USA, V91, P3393, DOI 10.1073/pnas.91.8.3393; Wang C, 2016, BIOCHEM BIOPH RES CO, V477, P534, DOI 10.1016/j.bbrc.2016.05.148; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wang YA, 2017, AUTOPHAGY, V13, P212, DOI 10.1080/15548627.2016.1245262; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Wong DJL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-194; Wong YW, 2011, SPINAL CORD, V49, P94, DOI 10.1038/sc.2010.69; Yang ML, 2012, SPINAL CORD, V50, P141, DOI 10.1038/sc.2011.126; Zassadowski F, 2015, LEUKEMIA, V29, P2277, DOI 10.1038/leu.2015.159; Zhang DL, 2017, MULTIMED TOOLS APPL, V76, P7175, DOI 10.1007/s11042-016-3359-5; Zhang ZJ, 2016, CELL PHYSIOL BIOCHEM, V40, P1529, DOI 10.1159/000453203	46	14	19	0	19	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	NOV	2017	32	4					535	543		10.1007/s12640-017-9758-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH2DV	WOS:000410949900001	28593525				2022-02-06	
J	Mishra, VR; Zhuang, XW; Sreenivasan, KR; Banks, SJ; Yang, ZS; Bernick, C; Cordes, D				Mishra, Virendra R.; Zhuang, Xiaowei; Sreenivasan, Karthik R.; Banks, Sarah J.; Yang, Zhengshi; Bernick, Charles; Cordes, Dietmar			Multimodal MR Imaging Signatures of Cognitive Impairment in Active Professional Fighters	RADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; MATTER TRACT DAMAGE; WHITE-MATTER; HEAD TRAUMA; DIFFUSION; PERFORMANCE; INFERENCE; FEATURES; BOXERS; MODELS	Purpose: To investigate whether combining multiple magnetic resonance (MR) imaging modalities such as T1-weighted and diffusion-weighted MR imaging could reveal imaging biomarkers associated with cognition in active professional fighters. Materials and Methods: Active professional fighters (n = 297; 24 women and 273 men) were recruited at one center. Sixty-two fighters (six women and 56 men) returned for a follow-up examination. Only men were included in the main analysis of the study. On the basis of computerized testing, fighters were separated into the cognitively impaired and nonimpaired groups on the basis of computerized testing. T1-weighted and diffusion-weighted imaging were performed, and volume and cortical thickness, along with diffusion-derived metrics of 20 major white matter tracts were extracted for every subject. A classifier was designed to identify imaging biomarkers related to cognitive impairment and was tested in the follow-up dataset. Results: The classifier allowed identification of seven imaging biomarkers related to cognitive impairment in the cohort of active professional fighters. Areas under the curve of 0.76 and 0.69 were obtained at baseline and at follow-up, respectively, with the optimized classifier. The number of years of fighting had a significant (P = 8.8 3 10(27)) negative association with fractional anisotropy of the forceps major (effect size [d] = 0.34) and the inferior longitudinal fasciculus (P = .03; d = 0.17). A significant difference was observed between the impaired and nonimpaired groups in the association of fractional anisotropy in the forceps major with number of fights (P = .03, d = 0.38) and years of fighting (P = 6 3 1028, d = 0.63). Fractional anisotropy of the inferior longitudinal fasciculus was positively associated with psychomotor speed (P = .04, d = 0.16) in nonimpaired fighters but no association was observed in impaired fighters. Conclusion: Without enforcement of any a priori assumptions on the MR imaging-derived measurements and with a multivariate approach, the study revealed a set of seven imaging biomarkers that were associated with cognition in active male professional fighters. (C) RSNA, 2017	[Mishra, Virendra R.; Zhuang, Xiaowei; Sreenivasan, Karthik R.; Banks, Sarah J.; Yang, Zhengshi; Bernick, Charles; Cordes, Dietmar] Cleveland Clin Lou Ruvo Ctr Brain Hlth, Dept Imaging Res, 888 W Bonneville Ave, Las Vegas, NV 89106 USA		Mishra, VR (corresponding author), Cleveland Clin Lou Ruvo Ctr Brain Hlth, Dept Imaging Res, 888 W Bonneville Ave, Las Vegas, NV 89106 USA.	mishrav@ccf.org	Sreenivasan, Karthik/ABA-7605-2020; Mishra, Virendra R./ABE-1942-2020; Yang, Zhengshi/AAM-6739-2021	Sreenivasan, Karthik/0000-0002-6486-302X; Mishra, Virendra R./0000-0002-0452-6400; Banks, Sarah/0000-0001-7536-2370; Cordes, Dietmar/0000-0001-6574-5546	Lincy Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P20GM109025 COBRE]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109025] Funding Source: NIH RePORTER	Study supported by Lincy Foundation and the National Institutes of Health Institutional Development Award (5P20GM109025 COBRE).	Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Broomhead D. S., 1988, Complex Systems, V2, P321; Chanraud S, 2010, NEUROPSYCHOL REV, V20, P209, DOI 10.1007/s11065-010-9129-7; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Dunst B, 2014, BRAIN COGNITION, V91, P71, DOI 10.1016/j.bandc.2014.08.006; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hartberg CB, 2011, J INT NEUROPSYCH SOC, V17, P1080, DOI 10.1017/S1355617711001081; Hartley T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00338; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Joel D, 2015, P NATL ACAD SCI USA, V112, P15468, DOI 10.1073/pnas.1509654112; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meng DW, 2017, RADIOLOGY, V282, P502, DOI 10.1148/radiol.2016152685; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Papoulis A., 1991, PROBABILITY RANDOM V; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sarro L, 2011, AM J NEURORADIOL, V32, P1866, DOI 10.3174/ajnr.A2658; Schinka JA, 2010, AM J GERIAT PSYCHIAT, V18, P684, DOI 10.1097/JGP.0b013e3181e56d5a; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uher T, 2014, J NEUROL, V261, P1735, DOI 10.1007/s00415-014-7413-9; Winkler AM, 2016, NEUROIMAGE, V141, P502, DOI 10.1016/j.neuroimage.2016.05.068; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	49	14	14	0	4	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	NOV	2017	285	2					555	567		10.1148/radiol.2017162403			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Radiology, Nuclear Medicine & Medical Imaging	FK4NL	WOS:000413472000023	28741982	Green Published, Bronze			2022-02-06	
J	Tjong, VK; Baker, HP; Cogan, CJ; Montoya, M; Lindley, TR; Terry, MA				Tjong, Vehniah K.; Baker, Hayden P.; Cogan, Charles J.; Montoya, Melissa; Lindley, Tory R.; Terry, Michael A.			Concussions in NCAA Varsity Football Athletes: A Qualitative Investigation of Player Perception and Return to Sport	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS GLOBAL RESEARCH AND REVIEWS			English	Article							TRAUMATIC BRAIN-INJURY; DEPRESSION; SYMPTOMS; EDUCATION; IMPACT	Background: The objective of this study was to understand the experiences and perspectives of varsity football athletes on return to play following a concussion injury. Methods: Two experienced interviewers conducted qualitative, semistructured interviews of college-level football players who had sustained at least one concussion during their varsity careers. Results: Twenty varsity football players who averaged 2.3 concussions each (range, 1-5) were interviewed regarding peer pressure, the culture of football, and player awareness as factors affecting return to sport following a concussion. Less common secondary factors included risk management, severity and timing of the injury, and team support. Conclusions: Psychological stressors, the culture of football, and increased awareness were the most influential factors affecting collegiate football players' deciding to return to sport following a concussion.	[Tjong, Vehniah K.; Cogan, Charles J.; Montoya, Melissa; Lindley, Tory R.; Terry, Michael A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Baker, Hayden P.] Univ Illinois, Coll Med, Chicago, IL USA		Tjong, VK (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.			Baker, Hayden/0000-0002-9306-7006			American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th; Ardern CL, 2013, BRIT J SPORT MED, V47, P1120, DOI 10.1136/bjsports-2012-091203; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, pe333; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Diehl E, 2010, JL HLTH, V23, P85; Flanigan DC, 2013, ARTHROSCOPY, V29, P1322, DOI 10.1016/j.arthro.2013.05.015; Galgano MA, 2016, CUREUS, V8, DOI 10.7759/cureus.532; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Harmon Kimberly G, 2016, J Pediatr, V168, P253, DOI 10.1016/j.jpeds.2015.10.071; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Lingard L, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39602.690162.47; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Miyashita TL, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114554549; Mizobuchi Yoshifumi, 2016, Korean J Neurotrauma, V12, P1, DOI 10.13004/kjnt.2016.12.1.1; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morrey MA, 1999, CLIN J SPORT MED, V9, P63, DOI 10.1097/00042752-199904000-00004; Multani N, 2016, J NEUROL, V263, P1342, DOI 10.1007/s00415-016-8172-6; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Podlog L, 2006, J APPL SPORT PSYCHOL, V18, P44, DOI 10.1080/10413200500471319; Richmond TS, 2009, PSYCHOL MED, V39, P1709, DOI 10.1017/S0033291709005376; Roiger T, 2015, J ATHL TRAINING, V50, P256, DOI 10.4085/1062-6050-49.3.83; Simpson JR, 2014, J AM ACAD PSYCHIATRY, V42, P159; Smith AM, 1996, SPORTS MED, V22, P391, DOI 10.2165/00007256-199622060-00006; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Strauss A, 1990, BASIS QUALITATIVE RE; Sullivan L, 2016, INT J ADOLESC MED HL, V29; Takahata Keisuke, 2016, Brain Nerve, V68, P849, DOI 10.11477/mf.1416200517; Tjong VK, 2014, AM J SPORT MED, V42, P336, DOI 10.1177/0363546513508762; Wright MJ, 2016, J CLIN EXP NEUROPSYC, V38, P561, DOI 10.1080/13803395.2016.1139057	45	14	14	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2474-7661			JAAOS GLOB RES REV	J. Am. Acad. Orthop. Surg. Glob. Res. Rev.	NOV	2017	1	8							e070	10.5435/JAAOSGlobal-D-17-00070			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VI1JX	WOS:000461095500007	30211371	gold, Green Published			2022-02-06	
J	Toglia, J; Askin, G; Gerber, LM; Taub, MC; Mastrogiovanni, AR; O'Dell, MW				Toglia, Joan; Askin, Gulce; Gerber, Linda M.; Taub, Michael C.; Mastrogiovanni, Andrea R.; O'Dell, Michael W.			Association Between 2 Measures of Cognitive Instrumental Activities of Daily Living and Their Relation to the Montreal Cognitive Assessment in Persons With Stroke	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Activities of daily living; Cognitive dysfunction; Cognitive impairment; Executive function; Functional outcome; IADL; Rehabilitation; Stroke; Stroke Rehabilitation	MENTAL-STATE-EXAMINATION; FUNCTION PERFORMANCE-TEST; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; OLDER-ADULTS; INPATIENT REHABILITATION; AFTER-DISCHARGE; OUTCOMES; IMPAIRMENT; VALIDITY	Objectives: To explore the relation between a computer adaptive functional cognitive questionnaire and a performance-based measure of cognitive instrumental activities of daily living (C-IADL) and to determine whether the Montreal Cognitive Assessment (MoCA) at admission can identify those with C-IADL difficulties at discharge.& para;& para;Design: Prospective cohort study.& para;& para;Setting: Acute inpatient rehabilitation unit of an academic medical center.& para;& para;Participants: Inpatients (N = 148) with a diagnosis of stroke (mean age, 68y; median, 13d poststroke) who had mild cognitive and neurological deficits.& para;& para;Interventions: Not applicable.& para;& para;Main Outcome Measures: Admission cognitive status was assessed by the MoCA. C-IADL at discharge was assessed by the Executive Function Performance Test (EFPT) bill paying task and Activity Measure of Post-Acute Care (AM-PAC) Applied Cognition scale.& para;& para;Results: Greater cognitive impairment on the MoCA was associated with more assistance on the EFPT bill paying task (rho=-.63; P<.01) and AM-PAC Applied Cognition scale (rho=-.43; P<.01). This relation was nonsignificant for higher MoCA scores and EFPT bill paying task scores. The AM-PAC Applied Cognition scale and the EFPT bill paying task had low agreement in classifying functional performance (Cohen's kappa=.20). A receiver operating characteristic curve identified optimal MoCA cutoff scores of 20 and 21 for classifying EFPT bill paying task status and AM- PAC Applied Cognition scale status, respectively. For values above 20 and 21, sensitivity increased whereas specificity decreased for classifying functional deficits. Approximately one third of the participants demonstrated C-IADL deficits on at least 1 C-IADL measure at discharge despite having a MoCA score of >= 26 at admission.& para;& para;Conclusions: Questionnaire and performance-based methods of assessment appear to yield different estimates of C-IADL. Low MoCA scores (<20) are more likely to identify those with C-IADL deficits on the EFPT bill paying task. The results suggest that C-IADL should be assessed in those who have mild or no cognitive difficulties at admission. (C) 2017 by the American Congress of Rehabilitation Medicine.	[Toglia, Joan] Mercy Coll, Sch Hlth & Nat Sci, 555 Broadway, Dobbs Ferry, NY 10522 USA; [Toglia, Joan; Mastrogiovanni, Andrea R.; O'Dell, Michael W.] Weill Cornell Med Ctr, NewYork Presbyterian, Dept Rehabil Med, New York, NY USA; [Askin, Gulce; Gerber, Linda M.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY USA; [Taub, Michael C.; O'Dell, Michael W.] Weill Cornell Med, New York, NY USA		Toglia, J (corresponding author), Mercy Coll, Sch Hlth & Nat Sci, 555 Broadway, Dobbs Ferry, NY 10522 USA.	Jtoglia@mercy.edu	Toglia, Joan/AAN-6674-2021	Toglia, Joan/0000-0002-6902-6853	Peter Jay Sharp Foundation; Clinical and Translational Science Center, National Center for Advancing Translational Sciences [UL1-TR000457-06]	Supported by the Peter Jay Sharp Foundation and in part by the Clinical and Translational Science Center, National Center for Advancing Translational Sciences (grant no. UL1-TR000457-06).	Andres PL, 2003, AM J PHYS MED REHAB, V82, P614, DOI 10.1097/01.PHM.0000073818.34847.F0; Baum CM, 2017, NEUROPSYCHOL REHABIL, V27, P603, DOI 10.1080/09602011.2016.1176934; Baum CM, 2008, TEST MANUAL EXECUTIV; Burton CZ, 2015, SCHIZOPHR RES, V161, P399, DOI 10.1016/j.schres.2014.12.002; Cederfeldt M, 2011, BRIT J OCCUP THER, V74, P443, DOI 10.4276/030802211X13153015305673; Coster WJ, 2006, J REHABIL MED, V38, P237, DOI 10.1080/16501970600609774; Coster WJ, 2004, ARCH PHYS MED REHAB, V85, P2030, DOI 10.1016/j.apmr.2004.05.002; Cumming TB, 2013, ACTA NEUROL SCAND, V128, P122, DOI 10.1111/ane.12084; Dolinar RMD, 2016, CAN J RURAL MED, V21, P101; Dong YH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003105; Durant January, 2016, Alzheimers Dement (Amst), V4, P43, DOI 10.1016/j.dadm.2016.06.001; FITZGERALD JF, 1993, J GERONTOL, V48, pS28, DOI 10.1093/geronj/48.1.S28; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Gold DA, 2012, J CLIN EXP NEUROPSYC, V34, P11, DOI 10.1080/13803395.2011.614598; Grant I., 2010, NEUROPSYCHOLOGY EVER, P93; Greenaway MC, 2012, INT PSYCHOGERIATR, V24, P987, DOI 10.1017/S1041610211002717; Haley SM, 2006, AM J PHYS MED REHAB, V85, P747, DOI 10.1097/01.phm.0000228524.31576.15; Haley SM, 2006, J CLIN EPIDEMIOL, V59, P1174, DOI 10.1016/j.jclinepi.2006.02.010; Haley SM, 2006, ARCH PHYS MED REHAB, V87, P1033, DOI 10.1016/j.apmr.2006.04.020; Hanger HC, 2010, INTERN MED J, V40, P45, DOI 10.1111/j.1445-5994.2008.01844.x; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Livengood M, 2010, BRAIN INJURY, V24, P598, DOI 10.3109/02699051003652815; McAlister C, 2016, J CLIN EXP NEUROPSYC, V38, P925, DOI 10.1080/13803395.2016.1177490; McDonough CM, 2016, AM J PHYS MED REHAB, V95, P62, DOI 10.1097/PHM.0000000000000340; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Morrison MT, 2014, AM J OCCUP THER, V69; Nielsen KT, 2015, SCAND J OCCUP THER, V22, P13, DOI 10.3109/11038128.2014.961547; Schmitter-Edgecombe M, 2011, J INT NEUROPSYCH SOC, V17, P853, DOI 10.1017/S1355617711000865; Tan JE, 2009, CLIN NEUROPSYCHOL, V23, P479, DOI 10.1080/13854040802368684; Toglia J, 2015, WEEKLY CALENDAR PLAN; Toglia J, 2011, ARCH PHYS MED REHAB, V92, P792, DOI 10.1016/j.apmr.2010.12.034; Van Heugten CM, 2015, CLIN REHABIL, V29, P694, DOI 10.1177/0269215514553012; Voelbel GT, 2011, OTJR-OCCUP PART HEAL, V31, pS30, DOI 10.3928/15394492-20101108-06; Wesson J, 2016, NEUROSCI BIOBEHAV R, V68, P335, DOI 10.1016/j.neubiorev.2016.05.024; Wolf TJ, 2010, WORK, V36, P405, DOI 10.3233/WOR-2010-1045; Wong GKC, 2014, EUR J NEUROL, V21, P725, DOI 10.1111/ene.12363; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	37	14	14	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2017	98	11					2280	2287		10.1016/j.apmr.2017.04.007			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FL5KK	WOS:000414275500022	28478128				2022-02-06	
J	Zhu, W; Chi, N; Zou, P; Chen, HG; Tang, GT; Zhao, W				Zhu, Wei; Chi, Nan; Zou, Peng; Chen, Hongguang; Tang, Guotai; Zhao, Wei			Effect of docosahexaenoic acid on traumatic brain injury in rats	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						B-cell lymphoma 2; B-cell lymphoma 2-associated X protein; caspase-3; docosahexaenoic acid; traumatic brain injury	CEREBRAL-ISCHEMIA; FATTY-ACIDS; CELL-DEATH; OMEGA-3-FATTY-ACIDS; DHA; SUPPLEMENTATION; HOMEOSTASIS; APOPTOSIS; CASPASE-3; SEQUELAE	The present study aimed to investigate the protective effects of docosahexaenoic acid (DHA) on traumatic brain injury (TBI) in rats. A model of TBI was induced by lateral fluid percussion injury in adult rats and rats were randomly divided into the TBI-model group, TBI-low DHA group and TBI-high DHA group, while other healthy rats were assigned to the sham-operated group. Motor recovery was tested with beam-walking trials at 2, 7 and 15 days post-TBI. Cognitive recovery was tested with Morris water maze trials at 15 days post-TBI. The expression levels of caspase-3, B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax) were measured by western blotting. DHA protected against motor deficits induced by TBI in beam walking tests. All TBI-model groups had longer escape latency and swimming distances than the sham groups. Compared with the TBI-low DHA group, the TBI-high DHA group demonstrated shorter escape latency and swimming distances. DHA inhibited the expression of caspase-3 and the inhibition effect was more obvious at a high dosage. Furthermore, DHA dose-dependently rescued neurons by upregulating the Bcl-2: Bax ratio. DHA supplementation was a viable strategy to mitigate injury from TBI.	[Zhu, Wei; Chi, Nan; Zou, Peng; Chen, Hongguang; Tang, Guotai; Zhao, Wei] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Neurosurg, 20 Yuhuangding East Rd, Yantai 264000, Shandong, Peoples R China		Zhu, W (corresponding author), Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Neurosurg, 20 Yuhuangding East Rd, Yantai 264000, Shandong, Peoples R China.	zhuwei20162016@126.com					Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bousquet M, 2011, AGEING RES REV, V10, P453, DOI 10.1016/j.arr.2011.03.001; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; Chen WQ, 2005, INVEST OPHTH VIS SCI, V46, P4342, DOI 10.1167/iovs.05-0601; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cole GM, 2010, NUTR REV, V68, pS102, DOI 10.1111/j.1753-4887.2010.00345.x; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Florent S, 2006, J NEUROCHEM, V96, P385, DOI 10.1111/j.1471-4159.2005.03541.x; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hara A, 1996, VIRCHOWS ARCH, V429, P249; Kalmijn S, 1997, AM J EPIDEMIOL, V145, P33, DOI 10.1093/oxfordjournals.aje.a009029; Kao TK, 2006, NEUROCHEM INT, V48, P166, DOI 10.1016/j.neuint.2005.10.008; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Lauterbach MD, 2015, NEUROPSYCH DIS TREAT, V11, P1601, DOI 10.2147/NDT.S80457; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martin A, 2011, MOL IMAGING BIOL, V13, P10, DOI 10.1007/s11307-010-0324-y; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nguemeni C, 2010, PHARMACOL RES, V61, P226, DOI 10.1016/j.phrs.2009.12.007; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pusceddu MM, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw078; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Salakou S, 2007, IN VIVO, V21, P123; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Wei L, 2005, NEUROBIOL DIS, V19, P183, DOI 10.1016/j.nbd.2004.12.016; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Xiao DaLiao, 2008, Int J Med Sci, V5, P295	35	14	14	1	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	NOV	2017	14	5					4411	4416		10.3892/etm.2017.5054			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FM4GS	WOS:000414973100063	29075341	gold, Green Published			2022-02-06	
J	Canchi, S; Kelly, K; Hong, Y; King, MA; Subhash, G; Sarntinoranont, M				Canchi, Saranya; Kelly, Karen; Hong, Yu; King, Michael A.; Subhash, Ghatu; Sarntinoranont, Malisa			Controlled single bubble cavitation collapse results in jet-induced injury in brain tissue	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Single bubble cavitation; Blast neurotrauma; DIC; Rodent model; Strain maps	POSSIBLE DAMAGE MECHANISM; SHOCK-WAVES; RAT-BRAIN; DYNAMICS; ULTRASOUND; INDUCTION	Multiscale damage due to cavitation is considered as a potential mechanism of traumatic brain injury (TBI) associated with explosion. In this study, we employed a TBI relevant hippocampal ex vivo slice model to induce bubble cavitation. Placement of single reproducible seed bubbles allowed control of size, number, and tissue location to visualize and measure deformation parameters. Maximum strain value was measured at 45 mu s after bubble collapse, presented with a distinct contour and coincided temporally and spatially with the liquid jet. Composite injury maps combined this maximum strain value with maximum measured bubble size and location along with histological injury patterns. This facilitated the correlation of bubble location and subsequent jet direction to the corresponding regions of high strain which overlapped with regions of observed injury. A dynamic threshold strain range for tearing of cerebral cortex was estimated to be between 0.5 and 0.6. For a seed bubble placed underneath the hippocampus, cavitation induced damage was observed in hippocampus (local), proximal cerebral cortex (marginal) and the midbrain/forebrain (remote) upon histological evaluation. Within this test model, zone of cavitation injury was greater than the maximum radius of the bubble. Separation of apposed structures, tissue tearing, and disruption of cellular layers defined early injury patterns that were not detected in the blast-exposed half of the brain slice. Ultrastructural pathology of the neurons exposed to cavitation was characterized by disintegration of plasma membrane along with loss of cellular content. The developed test system provided a controlled experimental platform to study cavitation induced high strain deformations on brain tissue slice. The goal of the future studies will be to lower underpressure magnitude and cavitation bubble size for more sensitive evaluation of injury.	[Canchi, Saranya; Hong, Yu; Subhash, Ghatu; Sarntinoranont, Malisa] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Kelly, Karen] Univ Florida, ICBR Electron Microscope Facil, Gainesville, FL USA; [King, Michael A.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA; [King, Michael A.] North Florida South Georgia VA Med Ctr, Gainesville, FL USA		Sarntinoranont, M (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.	msarnt@ufl.edu	Subhash, Ghatu/J-4851-2017	Subhash, Ghatu/0000-0002-5996-0909	Army Research Office [W911NF-10-1-0276]; North Florida/South Georgia Veterans Health System, Gainesville, FL	This research was funded by the Army Research Office award no. W911NF-10-1-0276. This work was supported by resources provided by the North Florida/South Georgia Veterans Health System, Gainesville, FL. The contents do not represent the views of the U.S Department of Veterans Affairs or the United States Government. The authors would like to thank Dr. Yuquing Li for technical assistance with EM data and Dr. Stephen J. Blackband for allowing us to use his laboratory facilities.	Adhikari U, 2016, PHYS CHEM CHEM PHYS, V18, P32638, DOI 10.1039/c6cp06704b; Arieli R, 2013, RESP PHYSIOL NEUROBI, V188, P49, DOI 10.1016/j.resp.2013.04.013; Barrow MS, 2004, J FLUID ENG-T ASME, V126, P162, DOI 10.1115/1.1667889; BENEDICT JV, 1970, J BASIC ENG-T ASME, V92, P597, DOI 10.1115/1.3425083; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Brujan EA, 2001, J FLUID MECH, V433, P283, DOI 10.1017/S0022112000003335; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; CLEMEDSON C. J., 1954, MILITARY SURGEON, V114, P424; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Dalecki D, 2000, ULTRASOUND MED BIOL, V26, P1327, DOI 10.1016/S0301-5629(00)00297-0; DEAR JP, 1988, NATURE, V332, P505, DOI 10.1038/332505a0; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; Hong Y., 2015, EXP MECH, P1; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Krasovitski B, 2011, P NATL ACAD SCI USA, V108, P3258, DOI 10.1073/pnas.1015771108; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Liu QL, 2006, MECH MATER, V38, P1105, DOI 10.1016/j.mechmat.2006.01.001; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; LUBOCK P, 1980, J BIOMECH, V13, P1041, DOI 10.1016/0021-9290(80)90048-2; Mason W., 1971, P SOC EXP BIOL MED, V136; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Moosavi-Nejad SF, 2006, CANCER SCI, V97, P296, DOI 10.1111/j.1349-7006.2006.00172.x; Morrison B, 2003, J NEUROTRAUM, V20, P1079; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; NUSHOLTZ GS, 1995, J NEUROTRAUM, V12, P707, DOI 10.1089/neu.1995.12.707; Ohl CD, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.214502; Ohl CD, 2006, BIOPHYS J, V91, P4285, DOI 10.1529/biophysj.106.075366; Pan B, 2012, OPT LASER ENG, V50, P586, DOI 10.1016/j.optlaseng.2011.05.005; Pan B, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/6/062001; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Papadopoulou V, 2014, ADV COLLOID INTERFAC, V206, P239, DOI 10.1016/j.cis.2014.01.017; Papadopoulou V, 2013, ADV COLLOID INTERFAC, V191, P22, DOI 10.1016/j.cis.2013.02.002; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Penn-Barwell JG, 2015, CURR REV MUSCULOSKE, V8, P312, DOI 10.1007/s12178-015-9289-4; PHILIPP A, 1993, J ACOUST SOC AM, V93, P2496, DOI 10.1121/1.406853; Pishchalnikov YA, 2003, J ENDOUROL, V17, P435, DOI 10.1089/089277903769013568; Rau KR, 2004, APPL PHYS LETT, V84, P2940, DOI 10.1063/1.1705728; Rayleigh, 1917, PHILOS MAG, V34, P94, DOI 10.1080/14786440808635681; Saijo A., 2011, NEUROIMAGE S1, V54, pS83; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; SHIMA A, 1981, J FLUID ENG-T ASME, V103, P370; Skyba DM, 1998, CIRCULATION, V98, P290, DOI 10.1161/01.CIR.98.4.290; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Subhash G., 2000, SPLIT HOPKINSON PRES, P497; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Tsokos M, 2003, AM J RESP CRIT CARE, V168, P549, DOI 10.1164/rccm.200304-528OC; VERGUNST H, 1989, ANN SURG, V210, P565, DOI 10.1097/00000658-198911000-00001; von See C, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-6; Wu JR, 2002, ULTRASOUND MED BIOL, V28, P125, DOI 10.1016/S0301-5629(01)00497-5; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhong P, 2001, ULTRASOUND MED BIOL, V27, P119, DOI 10.1016/S0301-5629(00)00322-7	63	14	14	0	33	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	OCT	2017	74						261	273		10.1016/j.jmbbm.2017.06.018			13	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	FG4RP	WOS:000410253500029	28645069				2022-02-06	
J	Chen, H; Yuan, F; Chen, SW; Guo, Y; Wang, G; Deng, ZF; Tian, HL				Chen, Hao; Yuan, Fang; Chen, Shi-Wen; Guo, Yan; Wang, Gan; Deng, Zhi-Feng; Tian, Heng-Li			Predicting posttraumatic hydrocephalus: derivation and validation of a risk scoring system based on clinical characteristics	METABOLIC BRAIN DISEASE			English	Article						Posttraumatic hydrocephalus; Traumatic brain injury; Prognostic model; Risk score; Validation	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; INTERHEMISPHERIC HYGROMA	Posttraumatic hydrocephalus (PTH) is a disorder of disturbed cerebrospinal fluid (CSF) dynamics after traumatic brain injury (TBI). It can lead to brain metabolic impairment and dysfunction and has a high risk of clinical deterioration and worse outcomes. The incidence and risk factors for the development of PTH after decompressive craniectomy (DC) has been assessed in previous studies, but rare studies identify patients with higher risk for PTH among all TBI patients. This study aimed to develop and validate a risk scoring system to predict PTH after TBI. Demographics, injury severity, duration of coma, radiologic findings, and DC were evaluated to determine the independent predictors of PTH during hospitalization until 6 months following TBI through logistic regression analysis. A risk stratification system was created by assigning a number of points for each predictor and validated in an independent cohort. The model accuracy was assessed by the area under the receiver operating characteristic curve (AUC). Of 526 patients in the derivation cohort, 57 (10.84%) developed PTH during 6 months follow up. Age > 50 yrs (Odd ratio [OR] = 1.91, 95% confidence interval [CI] 1.09-3.75, 4 points), duration of coma ae<yen>1 w (OR = 5.68, 95% CI 2.57-13.47, 9 points), Fisher grade III (OR = 2.19, 95% CI 1.24-4.36, 5 points) or IV (OR = 3.87, 95% CI 1.93-8.43, 7 points), bilateral DC (OR = 6.13, 95% CI 2.82-18.14, 9 points), and extra herniation after DC (OR = 2.36, 95% CI 1.46-4.92, 5 points) were independently associated with PTH. Rates of PTH for the low- (0-12 points), intermediate- (13-22 points) and high-risk (23-34 points) groups were 1.16%, 35.19% and 78.57% (p < 0.0001). The corresponding rates in the validation cohort, where 17/175 (9.71%) developed PTH, were 1.35%, 37.50% and 81.82% (p < 0.0001). The risk score model exhibited good-excellent discrimination in both cohorts, with AUC of 0.839 versus 0.894 (derivation versus validation) and good calibration (Hosmer-Lemshow p = 0.56 versus 0.68). This model will be useful to identify patients at high risk for PTH who may be candidates for preventive interventions, and to improve their outcomes.	[Chen, Hao; Yuan, Fang; Chen, Shi-Wen; Guo, Yan; Wang, Gan; Deng, Zhi-Feng; Tian, Heng-Li] Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 6, Dept Neurosurg, 600 Yishan Rd, Shanghai 200233, Peoples R China		Tian, HL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Affiliated Peoples Hosp 6, Dept Neurosurg, 600 Yishan Rd, Shanghai 200233, Peoples R China.	tianhlsh@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471245, 81501657]	This study was supported by the National Natural Science Foundation of China (grant 81471245 and 81501657).	Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen H, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/134905; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Czosnyka M, 2001, J NEUROSURG, V94, P482, DOI 10.3171/jns.2001.94.3.0482; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Guyot LL, 2000, NEUROL RES, V22, P25; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kondziella D, 2008, J NEUROCHEM, V106, P1515, DOI 10.1111/j.1471-4159.2008.05422.x; Licata C, 2001, J Neurosurg Sci, V45, P141; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Nor MAM, 2013, MALAYS J MED SCI, V20, P95; Relkin N, 2005, NEUROSURGERY, V57, P4, DOI 10.1227/01.NEU.0000168185.29659.C5; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Symss NP, 2013, J NEUROSURG-PEDIATR, V11, P170, DOI 10.3171/2012.3.PEDS0934; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Yoshioka H, 2000, SURG NEUROL, V53, P119, DOI 10.1016/S0090-3019(99)00185-8; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	32	14	18	1	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	OCT	2017	32	5					1427	1435		10.1007/s11011-017-0008-2			9	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	FG9BD	WOS:000410732300009	28391551				2022-02-06	
J	Jang, H; Huang, S; Hammer, DX; Wang, L; Rafi, H; Ye, MJ; Welle, CG; Fisher, JAN				Jang, Hyounguk; Huang, Stanley; Hammer, Daniel X.; Wang, Lin; Rafi, Harmain; Ye, Meijun; Welle, Cristin G.; Fisher, Jonathan A. N.			Alterations in neurovascular coupling following acute traumatic brain injury	NEUROPHOTONICS			English	Article						brain injury; diffuse correlation spectroscopy; neurophotonics; neurophysiology	CEREBRAL-BLOOD-FLOW; SOMATOSENSORY-EVOKED-POTENTIALS; LOW-FREQUENCY OSCILLATIONS; CORTICAL IMPACT INJURY; SPREADING DEPRESSION; OXYGEN-CONSUMPTION; CORTEX ACTIVATION; NEURAL ACTIVATION; GOLDEN HOUR; MODEL	Following acute traumatic brain injury (TBI), timely transport to a hospital can significantly improve the prognosis for recovery. There is, however, a dearth of quantitative biomarkers for brain injury that can be rapidly acquired and interpreted in active, field environments in which TBIs are frequently incurred. We explored potential functional indicators for TBI that can be noninvasively obtained through portable detection modalities, namely optical and electrophysiological approaches. By combining diffuse correlation spectroscopy with colocalized electrophysiological measurements in a mouse model of TBI, we observed concomitant alterations in sensory-evoked cerebral blood flow (CBF) and electrical potentials following controlled cortical impact. Injury acutely reduced the peak amplitude of both electrophysiological and CBF responses, which mostly recovered to baseline values within 30 min, and intertrial variability for these parameters was also acutely altered. Notably, the postinjury dynamics of the CBF overshoot and undershoot amplitudes differed significantly; whereas the amplitude of the initial peak of stimulus-evoked CBF recovered relatively rapidly, the ensuing undershoot did not appear to recover within 30 min of injury. Additionally, acute injury induced apparent low-frequency oscillatory behavior in CBF (<1 Hz). Histological assessment indicated that these physiological alterations were not associated with any major, persisting anatomical changes. Several time-domain features of the blood flow and electrophysiological responses showed strong correlations in recovery kinetics. Overall, our results reveal an array of stereotyped, injury-induced alterations in electrophysiological and hemodynamic responses that can be rapidly obtained using a combination of portable detection techniques. (C) The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License.	[Jang, Hyounguk; Wang, Lin; Rafi, Harmain; Fisher, Jonathan A. N.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Jang, Hyounguk; Huang, Stanley; Hammer, Daniel X.; Ye, Meijun; Welle, Cristin G.; Fisher, Jonathan A. N.] US FDA, Div Biomed Phys, Silver Spring, MD 20903 USA; [Welle, Cristin G.] Univ Colorado Denver, Dept Neurosurg, Aurora, CO USA; [Welle, Cristin G.] Univ Colorado Denver, Dept Bioengn, Aurora, CO USA		Fisher, JAN (corresponding author), New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA.; Fisher, JAN (corresponding author), US FDA, Div Biomed Phys, Silver Spring, MD 20903 USA.	fisherworks@gmail.com		Rafi, Harmain/0000-0003-2113-3366	National Science FoundationNational Science Foundation (NSF) [1541612, 1641133]; New York Medical College	The mention of commercial products, their sources, or their use in connection with material reported herein is not to be construed as either an actual or implied endorsement of such products by the Department of Health and Human Services. The authors thank Dr. A. Parthasarathy, Dr. W. Baker, Dr. T. Durduran, Dr. A. G. Yodh, Dr. G. Yu, Dr. D. Busch, Dr. A. Koller, Dr. D. Ress, and Dr. J. Pfefer for helpful discussions, and Dr. S. Vasudevan for technical assistance. The work was supported by the National Science Foundation (Award Nos. 1541612 and 1641133) as well as intramural recruitment funds from New York Medical College.	Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Ances BM, 2000, J CEREBR BLOOD F MET, V20, P921, DOI 10.1097/00004647-200006000-00004; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budinich CS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/378307; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DELZOPPO GJ, 1994, CEREBROVAS BRAIN MET, V6, P47; DIEHL RR, 1991, NEUROSCI LETT, V127, P5, DOI 10.1016/0304-3940(91)90880-3; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Durduran T, 2004, OPT LETT, V29, P1766, DOI 10.1364/OL.29.001766; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T, 2004, J CEREBR BLOOD F MET, V24, P518, DOI 10.1097/00004647-200405000-00005; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Faul M, 2010, TRAUMATIC BRAIN INJU; Fisher JAN, 2016, IEEE T NEUR SYS REH, V24, P1003, DOI 10.1109/TNSRE.2016.2529663; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge RD, 1999, NEUROIMAGE, V9, P573, DOI 10.1006/nimg.1999.0443; Huang S., 2017, IEEE T BIOM IN PRESS; Irimia A, 2013, CLIN NEUROL NEUROSUR, V115, P2159, DOI 10.1016/j.clineuro.2013.08.003; Itoh Y, 2012, J CEREBR BLOOD F MET, V32, P1167, DOI 10.1038/jcbfm.2012.5; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Kim JH, 2016, NEUROIMAGE, V124, P394, DOI 10.1016/j.neuroimage.2015.08.068; Kim JH, 2013, J CEREBR BLOOD F MET, V33, P1429, DOI 10.1038/jcbfm.2013.90; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leontiev O, 2013, NEUROIMAGE, V68, P221, DOI 10.1016/j.neuroimage.2012.11.050; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Li TQ, 1999, NEUROIMAGE, V10, P562, DOI 10.1006/nimg.1999.0496; Li TQ, 2000, J MAGN RESON IMAGING, V12, P757, DOI 10.1002/1522-2586(200011)12:5<757::AID-JMRI14>3.0.CO;2-4; Lindquist MA, 2009, NEUROIMAGE, V45, pS187, DOI 10.1016/j.neuroimage.2008.10.065; Ma Y, 2011, J NEUROSCI METH, V201, P355, DOI 10.1016/j.jneumeth.2011.08.025; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahmud MS, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.050901; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Mountcastle V. B., 1998, PERCEPTUAL NEUROSCIE; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mullinger KJ, 2013, P NATL ACAD SCI USA, V110, P13636, DOI 10.1073/pnas.1221287110; Nag S, 2009, ACTA NEUROPATHOL, V118, P197, DOI 10.1007/s00401-009-0541-0; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nishimura N, 2010, J CEREBR BLOOD F MET, V30, P1914, DOI 10.1038/jcbfm.2010.157; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P142, DOI 10.1016/S0013-4694(97)00117-X; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Placek MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181851; Ress David, 2009, Front Neuroenergetics, V1, P3, DOI 10.3389/neuro.14.003.2009; Roche-Labarbe N, 2014, NEUROIMAGE, V85, P279, DOI 10.1016/j.neuroimage.2013.01.035; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SAKATANI K, 1990, STROKE, V21, P124, DOI 10.1161/01.STR.21.1.124; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Srinivasan VJ, 2010, OPT LETT, V35, P43, DOI 10.1364/OL.35.000043; Staba RJ, 2004, J PHYSIOL-LONDON, V561, P205, DOI 10.1113/jphysiol.2004.075325; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu D, 2010, NEUROSCI LETT, V485, P157, DOI 10.1016/j.neulet.2010.08.086; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhou C, 2006, OPT EXPRESS, V14, P1125, DOI 10.1364/OE.14.001125; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814	81	14	14	1	8	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	2329-423X	2329-4248		NEUROPHOTONICS	Neurophotonics	OCT-DEC	2017	4	4							045007	10.1117/1.NPh.4.4.045007			15	Neurosciences; Optics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Optics	FX5QS	WOS:000426135300002	29296629	Green Submitted, Green Published, hybrid			2022-02-06	
J	Nijdam-Jones, A; Rivera, D; Rosenfeld, B; Arango-Lasprilla, JC				Nijdam-Jones, Alicia; Rivera, Diego; Rosenfeld, Barry; Carlos Arango-Lasprilla, Juan			A Cross-Cultural Analysis of the Test of Memory Malingering Among Latin American Spanish-Speaking Adults	LAW AND HUMAN BEHAVIOR			English	Article						memory malingering; Latin America; feigning; cross-cultural	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; TRAUMATIC BRAIN-INJURY; TOMM NORMATIVE DATA; POOR EFFORT; POPULATION; VALIDITY; DEPRESSION; ISSUES	Cognitive efforts tests, such as the Test of Memory Malingering (TOMM; Tombaugh, 1997), are widely used internationally, yet there is a dearth of research that has assessed the utility of these measures in different cultures, countries, and languages. This study evaluated the specificity of the TOMM Trial 2 among a sample of 3,590 Spanish-speaking adults residing in 8 Latin American countries (Argentina, Bolivia, Chile, Colombia, Mexico, Paraguay, Peru, and Puerto Rico). Trial 2 TOMM scores were negatively associated with participants' age and positively associated with level of education. Country development, as measured by the United Nations Human Development Index, was also positively associated with TOMM scores. With the widespread use of cognitive efforts tests, this study offers useful insights into the utility of the TOMM in the assessment of Spanish speakers and highlights potential cultural biases that may impact test performance. Furthermore, this study raises concerns about the cross-cultural applicability of the TOMM, particularly when using cut scores established and evaluated primarily on North American, English-speaking samples. Forensic psychologists should be cautious when interpreting TOMM performance with Spanish-speaking adults from Latin American countries because it appears that there are cross-cultural differences that influence test performance. Public Significance Statement The potential for symptom or deficit exaggeration in the context of forensic evaluations supports the need for reliable and valid measures of cognitive effort. With the widespread use of cognitive effort tests and the potential for cultural biases when tests are adapted to a new language or culture, this study offers useful insights into the utility of one such test, the TOMM, in the assessment of Spanish speakers in Latin America. The present study suggests that forensic psychologists should be cautious when interpreting TOMM performance with Spanish-speaking adults from eight Latin American countries because scores varied markedly between countries, and there were significant associations between participants' age, education, and country's development with TOMM scores.	[Nijdam-Jones, Alicia; Rosenfeld, Barry] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA; [Rivera, Diego] Cruces Univ Hosp, BioCruces Hlth Res Inst, Baracaldo, Bizkaia, Spain; [Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp, BioCruces Hlth Res Inst, Grp Psicol & Salud, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain; [Carlos Arango-Lasprilla, Juan] IKERBASQUE Basque Fdn Sci, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Cruces Univ Hosp, BioCruces Hlth Res Inst, Grp Psicol & Salud, Plaza Cruces S-N, Baracaldo 48903, Bizkaia, Spain.	jcalasprilla@gmail.com	Blanco, Leire/O-5114-2017; Arango-Lasprilla, Juan Carlos/AAB-5407-2019; Rivera, Diego/U-8872-2017	Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; Rivera, Diego/0000-0001-7477-1893; Nijdam-Jones, Alicia/0000-0002-5242-3406			American Educational Research Association American Psychological Association & National Council on Measurement in Education, 2014, STAND ED PSYCH TEST; American Psychological Association, 2010, AM PSYCH ASS ETH PRI; Arango-Lasprilla J., 2015, NEUROPSICOLOGIA COLO; Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; Burton V, 2012, ARCH CLIN NEUROPSYCH, V27, P262, DOI 10.1093/arclin/acs026; Cohen J., 2013, STAT POWER ANAL BEHA; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Fuentes-Ramirez R. R., 2014, CARIBBEAN STUD, V42, P253, DOI DOI 10.1353/CRB.2014.0010; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Guardia-Olmos J, 2015, NEUROREHABILITATION, V37, P493, DOI 10.3233/NRE-151277; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; MAHONEY F I, 1965, Md State Med J, V14, P61; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Nijdam-Jones A., 2017, PSYCHOL ASSESSMENT; Orive M, 2010, J PSYCHOSOM RES, V69, P399, DOI 10.1016/j.jpsychores.2010.04.007; Pena ED, 2007, CHILD DEV, V78, P1255, DOI 10.1111/j.1467-8624.2007.01064.x; Prieto De Estebecorena M.-J., 2007, THESIS; Ramirez RM, 2004, REV NEUROLOGIA, V38, P28, DOI 10.33588/rn.3801.2003533; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rivera D, 2015, NEUROREHABILITATION, V37, P719, DOI 10.3233/NRE-151287; Rosenfeld B, 2000, ARCH CLIN NEUROPSYCH, V15, P349, DOI 10.1016/S0887-6177(99)00025-6; Saez PA, 2014, APPL NEUROPSYCH-ADUL, V21, P108, DOI 10.1080/09084282.2013.768996; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Strutt AM, 2012, BRAIN INJURY, V26, P853, DOI 10.3109/02699052.2012.655366; Tombaugh T. N., 2011, TOMM TEST SIMULACIN; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; United Nations Development Programme, 2015, HUMAN DEV REPORT 201; Vilar-Lopez R, 2008, ARCH CLIN NEUROPSYCH, V23, P365, DOI 10.1016/j.acn.2008.01.007; Vilar-Lopez R, 2007, ARCH CLIN NEUROPSYCH, V22, P379, DOI 10.1016/j.acn.2007.01.012; Villasenor-Cabrera T, 2010, QUAL QUANT, V44, P1105, DOI 10.1007/s11135-009-9263-6	34	14	14	0	12	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0147-7307	1573-661X		LAW HUMAN BEHAV	Law Hum. Behav.	OCT	2017	41	5					422	428		10.1037/lhb0000250			7	Law; Psychology, Social	Social Science Citation Index (SSCI)	Government & Law; Psychology	FI6IS	WOS:000412098900002	28639802				2022-02-06	
J	Chan, YL; Saad, S; Machaalani, R; Oliver, BG; Vissel, B; Pollock, C; Jones, NM; Chen, H				Chan, Yik L.; Saad, Sonia; Machaalani, Rita; Oliver, Brian G.; Vissel, Bryce; Pollock, Carol; Jones, Nicole M.; Chen, Hui			Maternal Cigarette Smoke Exposure Worsens Neurological Outcomes in Adolescent Offspring with Hypoxic-Ischemic Injury	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						mitophagy; apoptosis; cognition; motor behavior	TRAUMATIC BRAIN-INJURY; DELAYED NEURONAL DEATH; TRANSGENERATIONAL INHERITANCE; OXIDATIVE STRESS; NEONATAL RAT; PREGNANCY; NICOTINE; EXPRESSION; DEFICITS; IMPACT	Hypoxic-ischemic (HI) encephalopathy occurs in approximately 6 per 1000 term newborns leading to devastating neurological consequences, such as cerebral palsy and seizures. Maternal smoking is one of the prominent risk factors contributing to HI injury. Mitochondrial integrity plays a critical role in neural injury and repair during HI. We previously showed that maternal cigarette smoke exposure (SE) can reduce brain mitochondrial fission and autophagosome markers in male offspring. This was accompanied by increased brain cell apoptosis (active caspase-3) and DNA fragmentation (TUNEL staining). Here, we aimed to investigate whether maternal SE leads to more severe neurological damage after HI brain injury in male offspring. Female BALB/c mice (8 weeks) were exposed to cigarette smoke prior to mating, during gestation, and lactation. At postnatal day 10, half of the pups from each litter underwent left carotid artery occlusion, followed by exposure to 8% oxygen (92% nitrogen). At postnatal day 40-44, maternal SE reduced grip strength in grip traction and foot fault tests, which were also reduced by HI injury to similar levels regardless of the maternal group. Limb coordination was impaired by maternal SE which was not worsened by HI injury. Maternal SE increased anxiety level in the offspring, which was normalized by HI injury. Apoptosis markers were increased in different brain regions by maternal SE, with the cortex having further increased TUNEL by HI injury, along with increased markers of inflammation and mitophagy. We conclude that maternal SE can worsen HI-induced cellular damage in male offspring well into adolescence.	[Chan, Yik L.; Saad, Sonia; Oliver, Brian G.; Vissel, Bryce; Chen, Hui] Univ Technol Sydney, Sch Life Sci, Fac Sci, Sydney, NSW, Australia; [Chan, Yik L.; Oliver, Brian G.] Univ Sydney, Woolcock Inst Med Res, Resp Cellular & Mol Biol, Sydney, NSW, Australia; [Saad, Sonia; Pollock, Carol] Royal North Shore Hosp, Kolling Inst, Renal Res Grp, St Leonards, NSW, Australia; [Machaalani, Rita] Univ Sydney, Dept Med, Sydney, NSW, Australia; [Vissel, Bryce] Univ Technol Sydney, Ctr Neurosci & Regenerat Med, Fac Sci, Sydney, NSW, Australia; [Jones, Nicole M.] Univ New South Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW, Australia		Chan, YL; Chen, H (corresponding author), Univ Technol Sydney, Sch Life Sci, Fac Sci, Sydney, NSW, Australia.; Chan, YL (corresponding author), Univ Sydney, Woolcock Inst Med Res, Resp Cellular & Mol Biol, Sydney, NSW, Australia.	yik.chan@uts.edu.au; hui.chen-1@uts.edu.au	Chen, Hui/R-6137-2019; Chen, Hui/D-2005-2014; Oliver, Brian/E-7939-2010; Jones, Nicole/C-8216-2015	Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752; Oliver, Brian/0000-0002-7122-9262; Chan, Yik Lung/0000-0002-9605-4200; Vissel, Bryce/0000-0001-8860-8050; Saad, Sonia/0000-0001-8067-8046; Jones, Nicole/0000-0001-6738-6022			Akar F, 2014, MED SCI MONIT BASIC, V20, P27, DOI 10.12659/MSMBR.890438; ALBERTSSON AM, 2014, J NEUROINFLAMM, V11; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Baek SH, 2014, STROKE, V45, P2438, DOI 10.1161/STROKEAHA.114.005183; Bale TL, 2015, NAT REV NEUROSCI, V16, P332, DOI 10.1038/nrn3818; Bereiter-Hahn J., 1990, International Review of Cytology, V122, P1, DOI 10.1016/S0074-7696(08)61205-X; Brennan PA, 1999, ARCH GEN PSYCHIAT, V56, P215, DOI 10.1001/archpsyc.56.3.215; BUREAU MA, 1983, PEDIATRICS, V72, P22; Chan YL, 2016, CLIN EXP PHARMACOL P, V43, P1168, DOI 10.1111/1440-1681.12659; Chan YL, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00033; Chan YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25881; Cheeta S, 2001, NEUROPSYCHOPHARMACOL, V25, P601, DOI 10.1016/S0893-133X(01)00258-5; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; COLE PV, 1972, J OBSTET GYN BR COMM, V79, P782; Cotten C Michael, 2010, Expert Rev Obstet Gynecol, V5, P227, DOI 10.1586/eog.10.7; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Eriksson C, 1999, NEUROSCIENCE, V93, P915, DOI 10.1016/S0306-4522(99)00178-5; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Fergusson DM, 1998, ARCH GEN PSYCHIAT, V55, P721, DOI 10.1001/archpsyc.55.8.721; Habek D, 2002, FETAL DIAGN THER, V17, P367, DOI 10.1159/000065387; Hei MY, 2012, BRAZ J MED BIOL RES, V45, P13, DOI [10.1590/S0100-879X2011007500161, 10.1590/S0100-879X2012000100003]; Holley AK, 2011, INT J MOL SCI, V12, P7114, DOI 10.3390/ijms12107114; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; Jacobsen LK, 2006, NEUROPSYCHOPHARMACOL, V31, P1550, DOI 10.1038/sj.npp.1300981; Jones NM, 2008, PEDIATR RES, V63, P620, DOI 10.1203/PDR.0b013e31816d9117; Jones NM, 2001, J CEREBR BLOOD F MET, V21, P1105, DOI 10.1097/00004647-200109000-00008; Kaminsky LM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.026; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Knopik VS, 2009, DEV NEUROPSYCHOL, V34, P1, DOI 10.1080/87565640802564366; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Kravitz AV, 2015, BRAIN RES, V1628, P186, DOI 10.1016/j.brainres.2015.03.048; Lambe M, 2006, EPIDEMIOLOGY, V17, P524, DOI 10.1097/01.ede.0000231561.49208.be; Larsson M, 2011, J EPIDEMIOL COMMUN H, V65, P1151, DOI 10.1136/jech.2008.085241; Li Y, 2012, STROKE, V43, P2483, DOI 10.1161/STROKEAHA.112.664698; Li Y, 2012, PROG NEUROBIOL, V98, P145, DOI 10.1016/j.pneurobio.2012.05.010; Liu FD, 2013, ACTA PHARMACOL SIN, V34, P1121, DOI 10.1038/aps.2013.89; Liu J, 2010, J TROP PEDIATRICS, V56, P178, DOI 10.1093/tropej/fmp098; Machaalani R, 2014, TOXICOL APPL PHARM, V276, P204, DOI 10.1016/j.taap.2014.02.015; Moylan S, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0257-4; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Mueller BR, 2007, PHYSIOL BEHAV, V91, P55, DOI 10.1016/j.physbeh.2007.01.017; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211; Orlebeke JF, 1999, ARCH ENVIRON HEALTH, V54, P15, DOI 10.1080/00039899909602231; Osadchy A, 2009, J OBSTET GYNAECOL CA, V31, P744, DOI 10.1016/S1701-2163(16)34281-5; PHILIPP K, 1984, GYNECOL OBSTET INVES, V17, P179, DOI 10.1159/000299145; Quinn HR, 2008, NEUROPSYCHOPHARMACOL, V33, P1113, DOI 10.1038/sj.npp.1301475; Reinboth BS, 2016, EXP NEUROL, V283, P264, DOI 10.1016/j.expneurol.2016.06.024; Rocha-Ferreira E, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4901014; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; Sanchez V, 2015, DRUG ALCOHOL DEPEN, V156, P193, DOI 10.1016/j.drugalcdep.2015.09.022; Savard A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0330-8; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Shi RY, 2014, CNS NEUROSCI THER, V20, P1045, DOI 10.1111/cns.12325; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; SOCOL ML, 1982, AM J OBSTET GYNECOL, V142, P214, DOI 10.1016/S0002-9378(16)32339-0; Streja E, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.023; SUGIOKA K, 1988, BIOCHIM BIOPHYS ACTA, V936, P377, DOI 10.1016/0005-2728(88)90014-X; Sukjamnong S, 2017, AM J PHYSIOL-LUNG C, V313, pL416, DOI 10.1152/ajplung.00134.2017; Tang YC, 2016, PROTEIN CELL, V7, P699, DOI 10.1007/s13238-016-0307-0; Thanos PK, 2015, SYNAPSE, V69, P356, DOI 10.1002/syn.21822; Trasti N, 1999, EARLY HUM DEV, V55, P137, DOI 10.1016/S0378-3782(99)00017-1; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Ubaldi M, 2016, PROG BRAIN RES, V224, P251, DOI 10.1016/bs.pbr.2015.07.018; Valente EM, 2009, FUTUR NEUROL, V4, P575, DOI 10.2217/FNL.09.39; Vassoler FM, 2014, NEUROSCIENCE, V264, P198, DOI 10.1016/j.neuroscience.2013.07.064; Vivekanandarajah A, 2016, NEUROTOXICOLOGY, V53, P53, DOI 10.1016/j.neuro.2015.12.017; Wang DB, 2013, J NEUROSCI, V33, P1357, DOI 10.1523/JNEUROSCI.3365-12.2013; Wang YJ, 2016, J PSYCHIATR RES, V79, P1, DOI 10.1016/j.jpsychires.2016.04.001; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yohn NL, 2015, PROG BIOPHYS MOL BIO, V118, P21, DOI 10.1016/j.pbiomolbio.2015.03.002; Yuan TF, 2016, MOL NEUROBIOL, V53, P6367, DOI 10.1007/s12035-015-9526-2	78	14	14	1	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	SEP 26	2017	10								306	10.3389/fnmol.2017.00306			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FI1WN	WOS:000411726500001	29018327	Green Published, gold			2022-02-06	
J	Lee, JH; Howell, DR; Meehan, WP; Iverson, GL; Gardner, AJ				Lee, Jin H.; Howell, David R.; Meehan, William P., III; Iverson, Grant L.; Gardner, Andrew J.			Effects of Exercise on Sport Concussion Assessment Tool-Third Edition Performance in Professional Athletes	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						SCAT3; concussion; sideline assessment; athletes	ERROR SCORING SYSTEM; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; INDIVIDUALS; SYMPTOMS; EXERTION; ZURICH; INJURY; SCAT3	Background: The Sport Concussion Assessment Tool-Third Edition (SCAT3) is currently considered the standard sideline assessment for concussions. In-game exercise, however, may affect SCAT3 performance and the diagnosis of concussions. Purpose: To examine the influence of exercise on SCAT3 performance in professional male athletes. Study Design: Controlled laboratory study. Methods: We examined the SCAT3 performance of 82 professional male athletes under 2 conditions: at rest and after exercise. Results: Athletes reported significantly fewer total symptoms (mean, 1.0 +/- 1.5 vs 1.6 +/- 2.3 total symptoms, respectively; P = .008; Cohen d = 0.34), committed significantly fewer errors on the modified Balance Error Scoring System (mean, 3.5 +/- 3.5 vs 4.6 +/- 4.1 errors, respectively; P = .017; d = 0.31), and required significantly less time to complete the tandem gait test (mean, 9.5 +/- 1.4 vs 9.9 +/- 1.7 seconds, respectively; P = .02; d = 0.30) during the at-rest condition compared with the postexercise condition. Conclusion: The interpretation of in-game (sideline) SCAT3 results should consider the effects of postexercise fatigue levels on an athlete's performance, particularly if preseason baseline data have been collected when the athlete was well rested.	[Lee, Jin H.; Howell, David R.; Meehan, William P., III; Iverson, Grant L.; Gardner, Andrew J.] Univ Newcastle, Newcastle, NSW, Australia; [Lee, Jin H.] Univ Queensland, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia; [Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Howell, David R.] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Emergency Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Sports Concuss Clin, Boston, MA USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Clin, Boston, MA USA; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Stroke & Brain Injury, Newcastle, NSW, Australia; [Gardner, Andrew J.] John Hunter Hosp, Sports Concuss Clin, Newcastle, NSW, Australia		Gardner, AJ (corresponding author), Calvary Mater Hosp, McCauley Bldg,Level 5, Waratah, NSW 2298, Australia.	Andrew.Gardner@neurogard.com.au		Gardner, Andrew/0000-0001-5031-5586; Iverson, Grant/0000-0001-7348-9570	National Hockey League Alumni Association through Corey C. Griffin NHL Alumni Pro-Am Tournament; Football Players Health Study at Harvard University - National Football League Players Association; ImPACT Applications; CNS Vital Signs; Psychological Assessment Resources; Mooney-Reed Charitable Foundation; Australian Football League; New South Wales Sporting Injuries Committee; Brain Foundation (Australia); Hunter Medical Research Institute (HMRI); HMRI; University of Newcastle's Priority Research Centre for Stroke and Brain Injury	One or more of the authors has declared the following potential conflicts of interest or source of funding: W.P.M. receives royalties from ABC-CLIO, Springer Publishing, and Wolters Kluwer and receives philanthropic research support from the National Hockey League Alumni Association through the Corey C. Griffin NHL Alumni Pro-Am Tournament; he is also supported by a grant from the Football Players Health Study at Harvard University, which is funded by the National Football League Players Association. G.L.I. has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild traumatic brain injuries (TBIs) and sport-related concussions at meetings, scientific conferences, and symposiums. He also has a clinical and consulting practice in forensic neuropsychology involving patients who have sustained mild TBIs (including athletes); has received research support from several test publishing companies including ImPACT Applications, CNS Vital Signs, and Psychological Assessment Resources; and receives unrestricted philanthropic support from the Mooney-Reed Charitable Foundation and ImPACT Applications. A.J.G. has a clinical practice in neuropsychology involving patients who have sustained sport-related concussions (including current and former athletes); has operated as a contracted concussion consultant to the Australian Rugby Union from July 2016; has received travel funding from the Australian Football League to present at the Concussion in Football Conference in 2013 and 2017; has received previous grants from the New South Wales Sporting Injuries Committee, the Brain Foundation (Australia), and the Hunter Medical Research Institute (HMRI), supported by Jennie Thomas; and is currently funded through the HMRI, supported by Anne Greaves, and the University of Newcastle's Priority Research Centre for Stroke and Brain Injury.	[Anonymous], 2013, Br J Sports Med, V47, P259; Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; Borg G., 1998, BORGS PERCEIVED EXER; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Coutts A, 2003, J SPORT SCI, V21, P97, DOI 10.1080/0264041031000070831; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Lee H, 2015, J SCI MED SPORT, V18, P245, DOI 10.1016/j.jsams.2014.04.003; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Morissette MP, 2014, CURR RES CONCUSSION, V1, P19; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Susco TM, 2004, J ATHL TRAINING, V39, P241; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	24	14	14	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	SEP 15	2017	5	9							2325967117727261	10.1177/2325967117727261			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FH3VK	WOS:000411078000001	28944251	Green Published, gold, Green Submitted			2022-02-06	
J	Poveda, B; Osborne-Crowley, K; Laidlaw, K; Macleod, F; Power, K				Poveda, Blanca; Osborne-Crowley, Katherine; Laidlaw, Kenneth; Macleod, Fiona; Power, Kevin			Social Cognition, Behaviour and Relationship Continuity in Dementia of the Alzheimer Type	BRAIN IMPAIRMENT			English	Article						social cognition; Alzheimer's disease; dementia; theory of mind; emotion recognition	TRAUMATIC BRAIN-INJURY; VARIANT FRONTOTEMPORAL DEMENTIA; MINI-MENTAL STATE; NEUROPSYCHIATRIC INVENTORY; EMOTION PERCEPTION; FACIAL EXPRESSIONS; SEMANTIC DEMENTIA; DISEASE; RECOGNITION; PSYCHOPATHOLOGY	Social cognition can be impaired in a range of neuro-degenerative conditions, yet the impact of these difficulties on behaviour and social relationships is not yet fully understood. This study assessed social cognition in 27 participants with Dementia of the Alzheimer Type (DAT) and their co-residing partners (N = 27) and explored the relationships between social cognition, cognitive ability, relationship continuity and behaviour following diagnosis. In line with previous research, participants with dementia scored lower on social cognition tasks compared to their partners. Behaviour changes such as apathy, disinhibition and agitation in participants with dementia were significantly related to relationship continuity; however, no significant associations were found with measures of social cognition. The results of this study are discussed within a therapeutic context and in line with current guidelines and policies.	[Poveda, Blanca] Astley Ainslie Hosp, Clin Neuropsychol Dept, NHS Lothian, Edinburgh, Midlothian, Scotland; [Osborne-Crowley, Katherine] Univ South Wales, Sch Psychol, Syndney, Australia; [Laidlaw, Kenneth] Univ East Anglia, Norwich Med Sch, Fac Med & Hlth Sci, Norwich Res Pk, Norwich, Norfolk, England; [Macleod, Fiona] Stracathro Hosp, NHS Tayside Older People, Psychol Therapies Serv, Brechin, Scotland; [Power, Kevin] Univ Stirling, Stirling, Scotland		Poveda, B (corresponding author), Astley Ainslie Hosp, Clin Neuropsychol Dept, NHS Lothian, Edinburgh, Midlothian, Scotland.	blanca.poveda@nhslothian.nhs.scot.uk		Osborne-Crowley, Katherine/0000-0003-0295-1849	Scottish Dementia Clinical Research Network; Chief Scientist Office	This research was conducted as part of the Doctorate in Clinical Psychology at the University of Edinburgh. This work was supported by the Scottish Dementia Clinical Research Network, who received funding from Scottish Ministers through the Chief Scientist Office. The views expressed in this publication are those of the authors and not necessarily those of Scottish Ministers or the Chief Scientist Office.	Adolphs R., 2001, CURRENT OPINIONS NEU, V11, P11231; Alzheimers Society, 2012, OPT TREATM CAR PEOPL; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Bozeat S, 2000, J NEUROL NEUROSUR PS, V69, P178, DOI 10.1136/jnnp.69.2.178; Bucks RS, 2004, AGING MENT HEALTH, V8, P222, DOI 10.1080/13607860410001669750; Burke JR, 1999, POSTGRAD MED, V106, P131, DOI 10.3810/pgm.1999.10.15.748; Burnham H, 2004, DEMENT GERIATR COGN, V18, P75, DOI 10.1159/000077813; Chow TW, 2009, ARCH NEUROL-CHICAGO, V66, P888, DOI 10.1001/archneurol.2009.92; Coen RF, 1997, INT J GERIATR PSYCH, V12, P331, DOI 10.1002/(SICI)1099-1166(199703)12:3<331::AID-GPS495>3.0.CO;2-J; COHEN CA, 1993, GERONTOLOGIST, V33, P714, DOI 10.1093/geront/33.6.714; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Department of Health, 2009, LIVING WELL DEMENTIA; Duff K, 2011, ARCH CLIN NEUROPSYCH, V26, P701, DOI 10.1093/arclin/acr083; Ekman P., 1976, PICTURES FACIAL AFFE; FEHER EP, 1992, ARCH NEUROL-CHICAGO, V49, P87, DOI 10.1001/archneur.1992.00530250091022; Field A., 2017, DISCOVERING STAT USI, V5th; Finkel S I, 1996, Int Psychogeriatr, V8 Suppl 3, P497; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher-Thompson D, 2001, J GERONTOL B-PSYCHOL, V56, pS140, DOI 10.1093/geronb/56.3.S140; Garand L, 2007, WESTERN J NURS RES, V29, P976, DOI 10.1177/0193945907303086; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Hargrave R, 2002, J NEUROPSYCH CLIN N, V14, P64, DOI 10.1176/appi.neuropsych.14.1.64; Hebert R, 2001, J GERONTOL A-BIOL, V56, pM693, DOI 10.1093/gerona/56.11.M693; Henry JD, 2008, NEUROPSYCHOLOGIA, V46, P1363, DOI 10.1016/j.neuropsychologia.2007.12.012; Hodges JR, 1999, NEUROPSYCHOLOGY, V13, P31, DOI 10.1037/0894-4105.13.1.31; Honan C. A., 2016, CLIN NEUROPSYCHOL, V30, P1; Hsieh S, 2013, J GERIATR PSYCH NEUR, V26, P174, DOI 10.1177/0891988713495448; Jalbert JJ, 2008, EPIDEMIOL REV, V30, P15, DOI 10.1093/epirev/mxn008; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Kipps CM, 2009, NEUROCASE, V15, P182, DOI 10.1080/13554790802632892; Koff E, 1999, J INT NEUROPSYCH SOC, V5, P32, DOI 10.1017/S1355617799511053; Kumfor F, 2014, J NEUROL NEUROSUR PS, V85, P1076, DOI 10.1136/jnnp-2013-307098; Lavenu I, 1999, ALZ DIS ASSOC DIS, V13, P96, DOI 10.1097/00002093-199904000-00007; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S., 2002, AWARENESS SOCIAL INF; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M., 2006, J INT NEUROPSYCH SOC, V14, P318; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Morris R. G., 2000, ADV PSYCHIAT TREAT, V6, P362, DOI [10.1192/apt.6.5.362, DOI 10.1192/APT.6.5.362]; O'Donnell B F, 1992, J Geriatr Psychiatry Neurol, V5, P45; Osborne-Crowley K, 2016, NEUROPSYCHOLOGY, V30, P820, DOI 10.1037/neu0000293; Osborne-Crowley K, 2016, J CLIN EXP NEUROPSYC, V38, P341, DOI 10.1080/13803395.2015.1115824; Phillips LH, 2010, PSYCHOL AGING, V25, P38, DOI 10.1037/a0017369; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Riley GA, 2013, INT PSYCHOGERIATR, V25, P263, DOI 10.1017/S1041610212001743; Roberts VJ, 1996, NEUROLOGY, V47, P1482, DOI 10.1212/WNL.47.6.1482; Rosen HJ, 2004, ALZ DIS ASSOC DIS, V18, P202; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Shany-Ur T, 2012, CORTEX, V48, P1329, DOI 10.1016/j.cortex.2011.08.003; Shimokawa A, 2001, BRAIN COGNITION, V47, P423, DOI 10.1006/brcg.2001.1318; STEELE C, 1990, AM J PSYCHIAT, V147, P1049; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Van Hoesen G. W., 2000, CEREB CORTEX, V10, P1047; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	64	14	14	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2017	18	2			SI		175	187		10.1017/BrImp.2016.35			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	FD5GN	WOS:000407559000001		Bronze, Green Submitted			2022-02-06	
J	Risen, SR; Reesman, J; Yenokyan, G; Slomine, BS; Suskauer, SJ				Risen, Sarah R.; Reesman, Jennifer; Yenokyan, Gayane; Slomine, Beth S.; Suskauer, Stacy J.			The Course of Concussion Recovery in Children 6-12 Years of Age: Experience From an Interdisciplinary Rehabilitation Clinic	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; SYMPTOM DURATION; HEAD-INJURY; HIGH-SCHOOL; EMERGENCY-DEPARTMENT; PROLONGED RECOVERY; PREDICTORS; SPORT; ADOLESCENTS	Background: Current concussion evidence is derived largely from teenagers and adults. Concussion in younger children occurs within the context of neuromaturation, with differing age-based pathophysiological responses to injury. Therefore, our current understanding of concussion in older children and adults is unlikely to directly apply to younger children. Objective: To describe patient variables, clinical course, and factors associated with time to discharge from concussion care in children 6-12 years of age with concussion treated in an interdisciplinary rehabilitation-based concussion clinic. Design: Retrospective chart review. Setting: Interdisciplinary concussion clinic at an academically affiliated rehabilitation center. Patients: Children aged 6-12 years (n = 105; mean 10.8 years of age, 70% male) seen within 60 days of concussive injury. Main Outcome Measurements: Descriptive statistics explored demographic, injury, and clinical features. The primary outcome measure, time to discharge from concussion care, was estimated with survival-analysis methods based on the date of discharge from the clinic. Multivariate models were used to examine factors associated with longer time to discharge. Results: Median time to discharge was 34 days postinjury (range 5-192 days); 75% of children were discharged within 60 days of injury. A minority reported persisting symptoms at discharge. Younger age and increased symptom burden at initial evaluation predicted longer time to discharge. Conclusions: Although children 6-12 years old treated in a specialty concussion clinic show variability in time to discharge from concussion care, most were discharged within 2 months after injury. Risk factors for prolonged recovery, such as younger age and greater symptom burden at initial visit, can be used when counseling families and planning interventions. There may be varying contributions, including psychosocial stressors, to ongoing symptoms in children who experience persisting symptoms after other concussion-related concerns have resolved. Future work focused on the subset of children who report persisting symptoms will be useful for developing an evidence base related to their care.	[Risen, Sarah R.; Reesman, Jennifer] Johns Hopkins Univ, Kennedy Krieger Inst, Sch Med, Baltimore, MD 21205 USA; [Risen, Sarah R.] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21205 USA; [Risen, Sarah R.] Baylor Coll Med, Pediat Neurol & Dev Med, Houston, TX 77030 USA; [Risen, Sarah R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Reesman, Jennifer; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Yenokyan, Gayane] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Suskauer, Stacy J.] Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21230 USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21218 USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21230 USA.; Suskauer, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA.; Suskauer, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21218 USA.	Suskauer@kennedykrieger.org		Reesman, Jennifer/0000-0002-0884-3323	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HD007414-20]; Johns Hopkins School of Public Health; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HD007414-20]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [1UL1TR001079]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007414] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001079] Funding Source: NIH RePORTER	Disclosures related to this publication: grant, NIH Grant T32HD007414-20 (money to institution); Disclosures related to this publication: grant, Johns Hopkins School of Public Health (money to institution); All phases of this study were supported by a grant from the National Institutes of Health, #T32HD007414-20. Support for statistical analysis came from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through grant number 1UL1TR001079.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Dillard C, 2017, DISABIL REHABIL, V39, P544, DOI 10.3109/09638288.2016.1152602; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Kriz PK, 2016, J PEDIATR-US, V171, P234, DOI 10.1016/j.jpeds.2015.12.006; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Phillips MM, 2016, PHYS MED REH CLIN N, V27, P455, DOI 10.1016/j.pmr.2015.12.005; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rane S, 2014, J INT NEUROPSYCH SOC, V20, P19; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; StataCorp, 2013, STAT STAT SOFTW REL; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	38	14	14	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	SEP	2017	9	9					874	883		10.1016/j.pmrj.2016.12.005			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FL7PN	WOS:000414440500005	28082178	Green Accepted			2022-02-06	
J	Smoliga, JM; Zavorsky, GS				Smoliga, James M.; Zavorsky, Gerald S.			Team Logo Predicts Concussion Risk Lessons in Protecting a Vulnerable Sports Community from Misconceived, but Highly Publicized Epidemiologic Research	EPIDEMIOLOGY			English	Article							HIGHER ALTITUDES; FOOTBALL	Background: Observational research has linked altitude to concussion risk, but the physiologic and epidemiologic bases for this association remain questionable. Methods: We performed a retrospective cohort study by analyzing four seasons of National Football League data from a widely used database (Concussion Watch) to determine if previous claims that altitude >= 196 m reduced concussion risk were replicable and whether an arbitrary predictor variable (animal vs. non-animal team logo) was related to concussion risk. Relative risk (RR) and 95% confidence intervals (95% CIs) were computed. Results: The previous association with altitude was reproduced for earlier seasons, but not replicable for recent seasons (RR = 0.92 [ 95% CI = 0.70, 1.22]). Across four combined seasons, "higher altitude" (RR = 0.78 [ 0.64, 0.96]) and animal logo (RR = 0.75 [0.63, 0.89]) were similarly associated with reduced concussion risk. Conclusions: Inconsistent epidemiologic effects, combined with weak physiologic rationale, suggest links between altitude and concussion are coincidental. Interdisciplinary critique of concussion research is necessary to ensure that marketing claims and clinical recommendations are scientifically justified.	[Smoliga, James M.] High Point Univ, Dept Phys Therapy, One Univ Pkwy, High Point, NC 27268 USA; [Zavorsky, Gerald S.] Georgia State Univ, Dept Resp Therapy, Atlanta, GA 30303 USA		Smoliga, JM (corresponding author), High Point Univ, Dept Phys Therapy, One Univ Pkwy, High Point, NC 27268 USA.	jsmoliga@highpoint.edu	Zavorsky, Gerald S./I-7753-2013; Zavorsky, Gerald/AAI-1422-2021	Zavorsky, Gerald S./0000-0002-4473-1601; 			Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Branch J, 2016, NY TIMES; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carson D, 2015, T BRADY ONCE ENDORSE; Frontline, 2015, CONCUSSION WATCH; Iannetta J, 2015, US SOCCERS A KRIEGER; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Lawrence DW, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116639222; Lohmander LS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7835; Lynn RC, 2015, LANCET NEUROL, V14, P14, DOI 10.1016/S1474-4422(14)70308-4; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Nuzzo R, 2015, NATURE, V526, P182, DOI 10.1038/526182a; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Orcutt M, 2016, NEW COLLAR PROMISES; Pearce N, 2014, LANCET NEUROL, V13, P969, DOI 10.1016/S1474-4422(14)70146-2; Schwarz A., 2016, NY TIMES; Schwarz A, 2016, N F L S FLAWED CONCU; Singal J, 2016, U MARYLAND HAS BURGE; Smoliga JM, 2017, J APPL PHYSIOL, V122, P215, DOI 10.1152/japplphysiol.00661.2016; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; United States Food and Drug Administration, 2015, CAN DIET SUPPL TREAT; Willett WC, 2008, EPIDEMIOLOGY, V19, P655, DOI 10.1097/EDE.0b013e318181b877; Young S.S., 2011, SIGNIF, V8, P116, DOI [10.1111/j.1740-9713.2011.00506.x, DOI 10.1111/J.1740-9713.2011.00506.X]; Zavorsky GS, 2017, JAMA NEUROL, V74, P485, DOI 10.1001/jamaneurol.2016.6068; Zavorsky GS, 2016, JAMA NEUROL, V73, P1368, DOI 10.1001/jamaneurol.2016.0795	28	14	14	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1044-3983	1531-5487		EPIDEMIOLOGY	Epidemiology	SEP	2017	28	5					753	757		10.1097/EDE.0000000000000694			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FC2PA	WOS:000406679200024	28570384				2022-02-06	
J	Tepe, V; Smalt, C; Nelson, J; Quatieri, T; Pitts, K				Tepe, Victoria; Smalt, Christopher; Nelson, Jeremy; Quatieri, Thomas; Pitts, Kenneth			Hidden Hearing Injury: The Emerging Science and Military Relevance of Cochlear Synaptopathy	MILITARY MEDICINE			English	Article							MEDIAL-OLIVOCOCHLEAR REFLEX; TRAUMATIC BRAIN-INJURY; NOISE EXPOSURE; SPEECH; NEUROPATHY; DAMAGE; DYSFUNCTION; ACCELERATION; DEGENERATION; PERCEPTION	Introduction: The phenomenon recently described as "hidden hearing loss" was the subject of a meeting co-hosted by the Department of Defense Hearing Center of Excellence and MIT Lincoln Laboratory to consider the potential relevance of noise-related synaptopathic injury to military settings and performance, service-related injury scenarios, and military medical priorities. Participants included approximately 50 researchers and subject matter experts from academic, federal, and military laboratories. Here we present a synthesis of discussion topics and concerns, as well as specific research objectives identified to develop militarily relevant knowledge. Materials and Methods: We consider findings from studies to date that have demonstrated cochlear synaptopathy and neurodegenerative processes apparently linked to noise exposure in animal models. We explore the potential relevance of these findings to the prediction and prevention of military hearing injuries, and to comorbid injuries in the neurological domain. Results: Noise-induced cochlear synaptopathic injury is not detected by conventional audiometric assessment of threshold sensitivity. Animal studies suggest there may be a generous window of opportunity for intervention to mitigate or prevent cochlear neurodegenerative processes, e.g., by administration of neurotrophins or antioxidants. However, it is not yet known if the mechanisms that underlie "hidden hearing loss" also occur in human beings or, if so, how to identify them early, and how and when to intervene. Conclusion: Neurological injuries resulting from noise exposures via the auditory system have potentially significant implications for military Service Member performance, long-term Veteran health, and noise exposure standards. Mediated via auditory pathways, such injuries have possible relationship to clinical impairments including speech perception, and may be a largely overlooked contributor to cognitive symptoms associated with other military service-related injuries such as blast exposure and brain trauma. The potential health and performance consequences of noise-induced cochlear synaptopathic injury are easily overlooked, especially if it is assumed that hearing threshold sensitivity loss is the major concern. There should be a renewed impetus to further characterize and model synaptopathic mechanisms of auditory injury; study its potential impact on human auditory function, cognition, and performance metrics of military relevance; and develop solutions for auditory protection (including noise dosimetry) and treatment if appropriate following noise or blast exposure in military scenarios. We identify specific problems, solution objectives, and research objectives. Recommended research calls for a multidisciplinary approach to address cochlear nerve synaptopathy, central (brain) dysfunction, noise exposure measurement and metrics, and clinical assessment.	[Tepe, Victoria; Nelson, Jeremy] JBSA Lackland, Hearing Ctr Excellence, Dept Def, 2200 Bergquist Dr, Lackland AFB, TX 78236 USA; [Smalt, Christopher; Quatieri, Thomas] MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02420 USA; [Pitts, Kenneth] US Army, Inst Environm Med, 15 Kansas St, Natick, MA 01760 USA		Tepe, V (corresponding author), JBSA Lackland, Hearing Ctr Excellence, Dept Def, 2200 Bergquist Dr, Lackland AFB, TX 78236 USA.			Nelson, Jeremy/0000-0003-4428-8694	US Army Research Institute of Environmental Medicine (USARIEM) [FA8721-05-C-0002, FA8702-15-D-0001]	We extend our thanks to COL (retired) Karl Friedl (University of California San Francisco) for his thoughts in the development of this report, and to Dr. Sharon Kujawa (Massachusetts Eye and Ear) for her very helpful comments and corrections. The DoD Hearing Center of Excellence also wishes to thank researchers and staff at MIT Lincoln Laboratory for their collaboration, and for the use of their meeting facilities. Contributions to this paper from Dr. Smalt and Dr. Quatieri were sponsored by the US Army Research Institute of Environmental Medicine (USARIEM) under Air Force Contract No. FA8721-05-C0002 and/or FA8702-15-D-0001.	Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Anderson S, 2011, EAR HEARING, V32, P750, DOI 10.1097/AUD.0b013e31822229d3; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Aydelott J, 2010, TRENDS AMPLIF, V14, P218, DOI 10.1177/1084713810393751; Bernstein LR, 2016, J ACOUST SOC AM, V140, P3540, DOI 10.1121/1.4966113; Bharadwaj HM, 2015, J NEUROSCI, V35, P2161, DOI 10.1523/JNEUROSCI.3915-14.2015; Bharadwaj HM, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00026; Bramhall NF, 2017, EAR HEARING, V38, pE1, DOI 10.1097/AUD.0000000000000370; Bressler S, 2014, J ACOUST SOC AM, V135, P2415; Brungart DS, 2014, J ACOUST SOC AM, V136, P777, DOI 10.1121/1.4887440; Buckey JC, 2015, NOISE HEALTH, V17, P263, DOI 10.4103/1463-1741.165037; Campbell K, 2015, ADA616584 TR US ARM; Casali JG, 2009, NOISE HEALTH, V11, P69, DOI 10.4103/1463-1741.48564; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Clasing JE, 2014, INT J AUDIOL, V53, pS43, DOI 10.3109/14992027.2013.860489; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Department of Health and Human Services National Institutes of Health, 2016, NOIS IND SYN HUM AUD; Earl B. R., 2015, AUDIOL TODAY, V27, P16; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; Fulton Susan E., 2015, Seminars in Hearing, V36, P140, DOI 10.1055/s-0035-1555117; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gannouni N, 2015, J NEUROSCI RES, V93, P848, DOI 10.1002/jnr.23567; Hamernik RP, 2007, J ACOUST SOC AM, V122, P2245, DOI 10.1121/1.2775160; Hebert S, 2009, INT J HYG ENVIR HEAL, V212, P37, DOI 10.1016/j.ijheh.2007.11.005; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Jensen JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125160; Kopke R, 2015, HEARING RES, V323, P40, DOI 10.1016/j.heares.2015.01.002; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kraus N., 2016, HEAR J, V69, P38, DOI [10.1097/01.HJ.0000483269.59643.1a, DOI 10.1097/01.HJ.0000483269.59643.1A]; Kryter K, 1950, J SPEECH HEAR DISORD; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Le Prell C, 2015, FREE RADICALS ENT PA; Le Prell CG, 2007, FREE RADICAL BIO MED, V42, P1454, DOI 10.1016/j.freeradbiomed.2007.02.008; Le Prell CG, 2016, OTOL NEUROTOL, V37, pE295, DOI 10.1097/MAO.0000000000001069; Le Prell CG, 2012, EAR HEARING, V33, pE44, DOI 10.1097/AUD.0b013e31825f9d89; Le Prell CG, 2012, ADV EXP MED BIOL, V730, P191, DOI 10.1007/978-1-4419-7311-5_43; Le Prell CG, 2011, TRANSL RES, V158, P38, DOI 10.1016/j.trsl.2011.02.006; LEI SF, 1994, J ACOUST SOC AM, V96, P1435, DOI 10.1121/1.410287; Lemke U, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00998; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li CM, 2014, JAMA OTOLARYNGOL, V140, P293, DOI 10.1001/jamaoto.2014.42; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; Liberman MC, 2014, J ACOUST SOC AM, V135, P2311, DOI DOI 10.1523/JNEUROSCI.2845-09.2009; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Lobarinas E., 2016, ABS ASS RES OTOLARYN, P68; Makary CA, 2011, JARO-J ASSOC RES OTO, V12, P711, DOI 10.1007/s10162-011-0283-2; Marshall L, 2014, J ACOUST SOC AM, V136, P2697, DOI 10.1121/1.4896745; Mehraei G, 2016, J NEUROSCI, V36, P3755, DOI 10.1523/JNEUROSCI.4460-15.2016; Mentel K, 2013, P HUM FACTORS ERGON, V57, P1204; Moser T, 2016, NAT REV NEUROL, V12, P135, DOI 10.1038/nrneurol.2016.10; Moser T, 2013, OTOL NEUROTOL, V34, P995, DOI 10.1097/MAO.0b013e3182814d4a; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; National Institute on Deafness and Other Communication Disorders (NIDCD), 2015, SYN NOIS IND HEAR LO; National Institutes of Health, 2016, NOIS IND COCHL SYN B; Nelson J, 2016, HEAR RES; Niwa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31754; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Parthasarathy A, 2014, JARO-J ASSOC RES OTO, V15, P649, DOI 10.1007/s10162-014-0460-1; Paul BT, 2017, HEARING RES, V344, P170, DOI 10.1016/j.heares.2016.11.010; Pengfei S, 2016, IEEE EMBS INT C BIOM; Peters L., 1990, 1190 US ARM HUM ENG; Plack CJ, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514550621; Prendergast G., 2016, ABS ASS RES OTOLARYN, V39, P202; PRICE GR, 1991, J ACOUST SOC AM, V90, P219, DOI 10.1121/1.401291; Qiu W, 2013, J ACOUST SOC AM, V133, P2856, DOI 10.1121/1.4799813; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; SCHUKNECHT H F, 1955, J Laryngol Otol, V69, P75, DOI 10.1017/S0022215100050465; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Seung HS, 2011, NATURE, V471, P170, DOI 10.1038/471170a; Shaheen LA, 2015, JARO-J ASSOC RES OTO, V16, P727, DOI 10.1007/s10162-015-0539-3; Sheffield B., 2015, P HUM FACT ERG SOC A, V59, P1346; Shirwany N, 2015, FREE RADICALS ENT PA; Smalt C, 2016, J ACOUST SOC AM, V140, P3151, DOI DOI 10.1121/1.4969883; Smalt CJ, 2017, HEARING RES, V349, P42, DOI 10.1016/j.heares.2016.11.008; Smalt CJ, 2014, JARO-J ASSOC RES OTO, V15, P159, DOI 10.1007/s10162-013-0430-z; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Suzuki J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24907; Tepe V, 2013, PSYCHIAT ANN, V43; Tun PA, 2009, PSYCHOL AGING, V24, P761, DOI 10.1037/a0014802; Valero MD, 2016, HEARING RES, V332, P29, DOI 10.1016/j.heares.2015.11.005; Veterans Benefits Administration, 2015, VBA ANN BEN REP FISC; Viana LM, 2015, HEARING RES, V327, P78, DOI 10.1016/j.heares.2015.04.014; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564; Wang Y, 2012, JARO-J ASSOC RES OTO, V13, P505, DOI 10.1007/s10162-012-0329-0; WARD WD, 1991, J ACOUST SOC AM, V90, P164, DOI 10.1121/1.401310; Wells TS, 2015, NOISE HEALTH, V17, P34, DOI 10.4103/1463-1741.149574; Wild CJ, 2012, J NEUROSCI, V32, P14010, DOI 10.1523/JNEUROSCI.1528-12.2012; Wilson RH, 2005, J REHABIL RES DEV, V42, P79, DOI 10.1682/JRRD.2005.06.0096; Wilson RH, 2002, J REHABIL RES DEV, V39, P105; Wilson RH, 2007, J SPEECH LANG HEAR R, V50, P844, DOI 10.1044/1092-4388(2007/059); Wilson RH, 2008, J AM ACAD AUDIOL, V19, P548, DOI 10.3766/jaaa.19.7.4; ZILANY MSA, 2007, P 3 INT IEEE EMBS C; Zundorf IC, 2014, BRAIN, V137, P1410, DOI 10.1093/brain/awu044	105	14	15	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP-OCT	2017	182	9-10					E1785	E1795		10.7205/MILMED-D-17-00025			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT7AW	WOS:000423306300010	28885938	Bronze			2022-02-06	
J	de Castro, MRT; Ferreira, APD; Busanello, GL; da Silva, LRH; da Silveira, MEP; Fiorin, FD; Arrifano, G; Crespo-Lopez, ME; Barcelos, RP; Cuevas, MJ; Bresciani, G; Gonzalez-Gallego, J; Fighera, MR; Royes, LFF				Torres de Castro, Mauro Robson; de Oliveira Ferreira, Ana Paula; Busanello, Guilherme Lago; Hart da Silva, Luis Roberto; Porto da Silveira Junior, Mauro Eduardo; Fiorin, Fernando da Silva; Arrifano, Gabriela; Crespo-Lopez, Maria Elena; Barcelos, Romulo Pillon; Cuevas, Maria J.; Bresciani, Guilherme; Gonzalez-Gallego, Javier; Fighera, Michele Rechia; Freire Royes, Luiz Fernando			Previous physical exercise alters the hepatic profile of oxidative-inflammatory status and limits the secondary brain damage induced by severe traumatic brain injury in rats	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							CONTROLLED CORTICAL IMPACT; INSULIN-RESISTANCE; LIPID-PEROXIDATION; POSTTRAUMATIC EPILEPSY; NA+,K+-ATPASE ACTIVITY; SYSTEMIC RESPONSE; FLUID PERCUSSION; INDUCED SEIZURES; SKELETAL-MUSCLE; HEAD TRAUMA	Although systemic responses have been described after traumatic brain injury (TBI), little is known regarding potential interactions between brain and peripheral organs after neuronal injury. Accordingly, we aimed to investigate whether a peripheral oxidative/inflammatory response contributes to neuronal dysfunction after TBI, as well as the prophylactic role of exercise training. Animals were submitted to fluid percussion injury after 6 weeks of swimming training. Previous exercise training increased mRNA expression of X receptor alpha and ATP-binding cassette transporter, and decreased inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 expression per se in liver. Interestingly, exercise training protected against hepatic inflammation (COX-2, iNOS, TNF-alpha and IL-6), oxidative stress (decreases in non-protein sulfhydryl and glutathione, as well as increases in 2',7'-dichlorofluorescein diacetate oxidation and protein carbonyl), which altered hepatic redox status (increases in myeloperoxidase and superoxide dismutase activity, as well as inhibition of catalase activity) mitochondrial function (decreases in methyl-tetrazolium and Delta psi, as well as inhibition of citrate synthase activity) and ion gradient homeostasis (inhibition of Na+, K+-ATPase activity inhibition) when analysed 24 h after TBI. Previous exercise training also protected against dysglycaemia, impaired hepatic signalling (increase in phosphorylated c-Jun NH2-terminal kinase, phosphorylated decreases in insulin receptor substrate and phosphorylated AKTexpression), high levels of circulating and neuronal cytokines, the opening of the blood-brain barrier, neutrophil infiltration and Na+, K+-ATPase activity inhibition in the ipsilateral cortex after TBI. Moreover, the impairment of protein function, neurobehavioural (neuromotor dysfunction and spatial learning) disability and hippocampal cell damage in sedentary rats suggests that exercise training also modulates peripheral oxidative/inflammatory pathways in TBI, which corroborates the ever increasing evidence regarding health-related outcomes with respect to a physically active lifestyle.	[Torres de Castro, Mauro Robson; Busanello, Guilherme Lago; Hart da Silva, Luis Roberto; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Programa Posgrad Educ Fis, Santa Maria, RS, Brazil; [Torres de Castro, Mauro Robson; Busanello, Guilherme Lago; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, Santa Maria, RS, Brazil; [de Oliveira Ferreira, Ana Paula] Univ Fed Santa Maria, Programa Posgrad Farmacol, Santa Maria, RS, Brazil; [Porto da Silveira Junior, Mauro Eduardo; Fiorin, Fernando da Silva; Barcelos, Romulo Pillon; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol Bioquim Toxicol, Santa Maria, RS, Brazil; [Arrifano, Gabriela; Crespo-Lopez, Maria Elena] UFPA, Lab Farmacol Mol, ICB, Belem, Para, Brazil; [Cuevas, Maria J.; Gonzalez-Gallego, Javier] Univ Leon, Inst Biomed IBIOMED, Leon, Spain; [Cuevas, Maria J.; Gonzalez-Gallego, Javier] Univ Leon, CIBERehd, Leon, Spain; [Bresciani, Guilherme] PUCV, Escuela Educ Fis, Valparaiso, Chile		Royes, LFF (corresponding author), Univ Fed Santa Maria, Dept Metodos & Tecnicas Desportivas, Ctr Educ Fis & Desportos, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	da Silva Fiorin, Fernando/AAQ-9472-2021; Gonzalez-Gallego, Javier/D-8219-2012; DE PAULA FONSECA ARRIFANO, GABRIELA/E-3451-2014; Fighera, Michele R/J-9576-2014; Crespo-Lopez, Maria Elena/X-7912-2018; Barcelos, Romulo/J-8231-2015	da Silva Fiorin, Fernando/0000-0002-6517-7160; Gonzalez-Gallego, Javier/0000-0002-4386-9342; DE PAULA FONSECA ARRIFANO, GABRIELA/0000-0003-2817-3539; Crespo-Lopez, Maria Elena/0000-0002-1335-6853; Bresciani, Guilherme/0000-0003-1526-5573; Fighera, Michele/0000-0002-3111-7530; Barcelos, Romulo/0000-0002-6366-6366	CNPq/FAPERGSConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [Pronem 11/2082-4]; CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [CNPq: 306309/2013-0]; Instituto de Salud Carlos III, SpainInstituto de Salud Carlos III	The present study was supported by CNPq/FAPERGS (grants: Pronem 11/2082-4). M. R. Fighera and L. F. F. Royes are recipients of CNPq fellowships (CNPq: 306309/2013-0). CIBERehd is funded by Instituto de Salud Carlos III, Spain.	El-Kader SMA, 2014, AFR HEALTH SCI, V14, P551, DOI 10.4314/ahs.v14i3.8; AEBI H, 1984, METHOD ENZYMOL, V105, P121; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Ang ET, 2007, CURR MED CHEM, V14, P2564, DOI 10.2174/092986707782023280; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bao F, 2011, EXP NEUROL, V231, P272, DOI 10.1016/j.expneurol.2011.07.001; Barcelos RP, 2017, FREE RADICAL RES, P1; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; Botezelli JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31106; Boveris A, 2008, FREE RADICAL BIO MED, V44, P224, DOI 10.1016/j.freeradbiomed.2007.08.015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY PP, 1982, BLOOD, V60, P618; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cohen G, 1997, P NATL ACAD SCI USA, V94, P4890, DOI 10.1073/pnas.94.10.4890; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dong GZ, 2014, EUR J PHARMACOL, V740, P634, DOI 10.1016/j.ejphar.2014.06.017; ELLMAN GL, 1967, J LAB CLIN MED, V70, P518; Filippin LI, 2011, INFLAMM RES, V60, P347, DOI 10.1007/s00011-010-0277-2; Fiorin FD, 2016, J NEUROTRAUM, V33, P1317, DOI 10.1089/neu.2015.4068; Fiske CH, 1927, SCIENCE, V65, P401, DOI 10.1126/science.65.1686.401; Fu YH, 2014, INT IMMUNOPHARMACOL, V22, P379, DOI 10.1016/j.intimp.2014.07.015; Garcia-Mediavilla MV, 2005, J HEPATOL, V43, P606, DOI 10.1016/j.jhep.2005.04.019; Ghanbari-Niaki A, 2007, BIOCHEM BIOPH RES CO, V361, P841, DOI 10.1016/j.bbrc.2007.07.100; Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2; Gomez-Pinilla F, 2008, SURG NEUROL, V70, P333, DOI 10.1016/j.surneu.2008.05.023; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Handelman GJ, 1998, ANAL BIOCHEM, V258, P339, DOI 10.1006/abio.1998.2592; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hoene M, 2010, EXERC IMMUNOL REV, V16, P163; Huang GJ, 2012, EUR J MED CHEM, V48, P371, DOI 10.1016/j.ejmech.2011.12.008; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; INIGUEZ C, 1985, J NEUROSCI METH, V13, P77, DOI 10.1016/0165-0270(85)90045-7; Jamme I, 1995, NEUROREPORT, V7, P333; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kazeminasab F, 2013, EUR J APPL PHYSIOL, V113, P2285, DOI 10.1007/s00421-013-2658-z; Kazeminasab S, 2012, PSYCHIAT RES, V200, P1086, DOI 10.1016/j.psychres.2012.04.006; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Kostyuk VA, 2010, ANTIOXID REDOX SIGN, V13, P607, DOI 10.1089/ars.2009.2976; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896; Lenzlinger PM, 2004, RESTOR NEUROL NEUROS, V22, P73; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lima FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055668; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Ljungqvist O, 2000, SURGERY, V128, P757, DOI 10.1067/msy.2000.107166; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lubrano Carla, 2015, Oxid Med Cell Longev, V2015, P490613, DOI 10.1155/2015/490613; Mansoor O, 1996, P NATL ACAD SCI USA, V93, P2714, DOI 10.1073/pnas.93.7.2714; Mansoor O, 1997, AM J PHYSIOL-ENDOC M, V273, pE898, DOI 10.1152/ajpendo.1997.273.5.E898; Marquezi ML, 2003, INT J SPORT NUTR EXE, V13, P65, DOI 10.1123/ijsnem.13.1.65; Mirzayan MJ, 2008, NEUROL RES, V30, P457, DOI 10.1179/174313208X276907; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Moinard C, 2008, J NEUROTRAUM, V25, P124, DOI 10.1089/neu.2007.0391; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Moschen AR, 2008, CURR OPIN CLIN NUTR, V11, P620, DOI 10.1097/MCO.0b013e32830b5d09; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Motta L, 2013, J SMALL ANIM PRACT, V54, P213, DOI 10.1111/jsap.12028; Motta VF, 2016, J SPORT MED PHYS FIT, V56, P655; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; O'Connell KM, 2012, MIL MED, V177, P546, DOI 10.7205/MILMED-D-11-00422; Olsen AL, 2007, ANTIVIR RES, V75, P104, DOI 10.1016/j.antiviral.2006.11.013; Packer L, 2008, FREE RADICAL BIO MED, V44, P123, DOI 10.1016/j.freeradbiomed.2007.05.031; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Radak Z, 2008, AGEING RES REV, V7, P34, DOI 10.1016/j.arr.2007.04.004; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Rao V, 2008, J NEUROPSYCH CLIN N, V20, P118, DOI 10.1176/jnp.2008.20.1.118; Ray Katrina, 2012, Nat Rev Gastroenterol Hepatol, V9, P244, DOI 10.1038/nrgastro.2012.61; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; Salvemini Daniela, 1995, Am J Ther, V2, P616; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Shi J, 2016, ONCOTARGET; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siems WG, 1996, FREE RADICAL BIO MED, V20, P215, DOI 10.1016/0891-5849(95)02041-1; Sigala F, 2004, TOXICOLOGY, V196, P155, DOI 10.1016/j.tox.2003.12.005; Silva VS, 2013, J INORG BIOCHEM, V128, P208, DOI 10.1016/j.jinorgbio.2013.06.011; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; Spillmann F, 2014, ATHEROSCLEROSIS, V232, P1, DOI 10.1016/j.atherosclerosis.2013.10.001; SRERE PA, 1969, ARCH BIOCHEM BIOPHYS, V129, P708, DOI 10.1016/0003-9861(69)90231-8; Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Toldy A, 2005, BRAIN RES BULL, V65, P487, DOI 10.1016/j.brainresbull.2005.02.028; Tsatsoulis A, 2013, METABOLISM, V62, P622, DOI 10.1016/j.metabol.2012.11.004; Tsuzuki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132029; Tunon MJ, 2011, J PINEAL RES, V50, P38, DOI 10.1111/j.1600-079X.2010.00807.x; Unterberg AW, 1997, ACT NEUR S, V70, P106; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; VIGUIE CA, 1993, J APPL PHYSIOL, V75, P566, DOI 10.1152/jappl.1993.75.2.566; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Wang GX, 2001, LIFE SCI, V69, P2801, DOI 10.1016/S0024-3205(01)01354-6; Wang XC, 2014, WORLD J GASTROENTERO, V20, P17914, DOI 10.3748/wjg.v20.i47.17914; Wang Yan-bin, 2010, Zhonghua Yi Xue Za Zhi, V90, P1716; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; WANNAMETHEE G, 1992, BRIT MED J, V304, P597, DOI 10.1136/bmj.304.6827.597; Xu J, 2008, ENDOCRINOLOGY, V149, P2369, DOI 10.1210/en.2007-0922; Yan LJ, 1996, ARCH BIOCHEM BIOPHYS, V327, P330, DOI 10.1006/abbi.1996.0130; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Yang SG, 2013, J NEUROSCI RES, V91, P230, DOI 10.1002/jnr.23159; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	120	14	14	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3751	1469-7793		J PHYSIOL-LONDON	J. Physiol.-London	SEP 1	2017	595	17					6023	6044		10.1113/JP273933			22	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	FF2HY	WOS:000408719700026	28726269	Green Published, Bronze			2022-02-06	
J	Hu, YN; Lu, JH; Xu, XJ; Lyu, JY; Zhang, HX				Hu, Ya'nan; Lu, Junhou; Xu, Xiaojing; Lyu, Jingya; Zhang, Huanxiang			Regulation of focal adhesion turnover in SDF-1 alpha-stimulated migration of mesenchymal stem cells in neural differentiation	SCIENTIFIC REPORTS			English	Article							HEMATOPOIETIC PROGENITOR CELLS; ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; TYROSINE PHOSPHORYLATION; CHEMOTACTIC RESPONSES; KINASE; ACTIVATION; ACTIN; PAXILLIN; DYNAMICS	Directed migration of the transplanted mesenchymal stem cells ( MSCs) to the lesion sites plays a pivotal role in the efficacy of cell-based therapy. Our previous study demonstrates that MSCs under varying neural differentiation states possess different migratory capacities in response to chemoattractants. However, the underlying mechanism has not been fully addressed. Herein, we show that the assembly and turnover of focal adhesions, the phosphorylation of FAK and paxillin, and the reorganisation of F-actin in MSCs are closely related to their differentiation states in response to SDF-1 alpha. Upon SDF-1 alpha stimulation, FAs turnover more rapidly with the most obvious reduction in the existing time of FAs in MSCs of 24-h preinduction that exhibit the most effective migration towards SDF-1 alpha. Further, we confirm that PI3K/Akt and MAPK pathways participate in the regulation of SDF-1 alpha-induced cell migration and FA assembly, and moreover, that the regulatory effects vary greatly depending on the differentiation states. Collectively, these results demonstrate that FA assembly and turnover, which is accompanied with F-actin reorganisation in response to SDF-1 alpha, correlates closely with the differentiation states of MSCs, which might contribute to the different chemotactic responses of these cells, and thus help develop new strategy to improve the efficacy of MSCs-based therapy.	[Hu, Ya'nan; Lu, Junhou; Xu, Xiaojing; Lyu, Jingya; Zhang, Huanxiang] Soochow Univ, Coll Med, Dept Cell Biol, Jiangsu Key Lab Stem Cell Res, Suzhou 215123, Peoples R China		Zhang, HX (corresponding author), Soochow Univ, Coll Med, Dept Cell Biol, Jiangsu Key Lab Stem Cell Res, Suzhou 215123, Peoples R China.	hzhang@suda.edu.cn		Lyu, Jingya/0000-0002-1270-625X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31371407, 31071220]; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China (No. 31371407 and 31071220) and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Alexanian AR, 2008, STEM CELLS DEV, V17, P1123, DOI 10.1089/scd.2007.0212; Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; Bellis SL, 1997, BIOCHEM J, V325, P375, DOI 10.1042/bj3250375; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hu CJ, 2013, J SURG RES, V183, P427, DOI 10.1016/j.jss.2013.01.019; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang Z, 2008, CELL SIGNAL, V20, P2002, DOI 10.1016/j.cellsig.2008.07.014; Iwasaki T, 2002, INT J CANCER, V97, P330, DOI 10.1002/ijc.1609; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Leiker M, 2008, CELL TRANSPLANT, V17, P911, DOI 10.3727/096368908786576444; Liu J, 2011, J NEUROSCI RES, V89, P1173, DOI 10.1002/jnr.22623; Ma JH, 2015, NEUROL RES, V37, P50, DOI 10.1179/1743132814Y.0000000399; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Petit V, 2000, J CELL BIOL, V148, P957, DOI 10.1083/jcb.148.5.957; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Segarra J, 2006, J BIOL CHEM, V281, P4771, DOI 10.1074/jbc.M508298200; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shen Y, 1999, MOL BIOL CELL, V10, P2507, DOI 10.1091/mbc.10.8.2507; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Stehbens SJ, 2014, METHOD CELL BIOL, V123, P335, DOI 10.1016/B978-0-12-420138-5.00018-5; Togel FE, 2011, KIDNEY INT SUPPL, V1, P87, DOI 10.1038/kisup.2011.20; Tomar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044041; Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Tureckova J, 2009, TRANSL ONCOL, V2, P281, DOI 10.1593/tlo.09160; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Wang SJ, 2012, J CELL BIOL, V199, P331, DOI 10.1083/jcb.201202041; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Won YW, 2014, BIOMATERIALS, V35, P5627, DOI 10.1016/j.biomaterials.2014.03.070; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu WS, 2008, CANCER METAST REV, V27, P303, DOI 10.1007/s10555-008-9112-4; Xu XJ, 2014, CELL MOL NEUROBIOL, V34, P1047, DOI 10.1007/s10571-014-0082-5; Yu JXA, 2010, CELL ADHES MIGR, V4, P342, DOI 10.4161/cam.4.3.11406; Yu YC, 2007, EUR J CANCER PREV, V16, P430, DOI 10.1097/01.cej.0000236259.88146.a4; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342; Zhao XK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19276; Zheng B, 2013, J CELL PHYSIOL, V228, P149, DOI 10.1002/jcp.24114; ZICHA D, 1991, J CELL SCI, V99, P769	56	14	14	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 30	2017	7								10013	10.1038/s41598-017-09736-7			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF0WS	WOS:000408622400107	28855566	Green Published, gold			2022-02-06	
J	Sanchez, MIGL; Waugh, HS; Tsatsanis, A; Wong, BX; Crowston, JG; Duce, JA; Trounce, IA				Sanchez, M. Isabel G. Lopez; Waugh, Hayley S.; Tsatsanis, Andrew; Wong, Bruce X.; Crowston, Jonathan G.; Duce, James A.; Trounce, Ian A.			Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CYTOCHROME-OXIDASE; GENE-EXPRESSION; NMDA-RECEPTOR; NEUROPROTECTION; DYSFUNCTION; PEPTIDE; ACCUMULATION; MUTATION	Amyloid precursor protein (APP) and its extracellular domain, soluble APP alpha (sAPP alpha) play important physiological and neuroprotective roles. However, rare forms of familial Alzheimer's disease are associated with mutations in APP that increase toxic amyloidogenic cleavage of APP and produce amyloid beta (A beta) at the expense of sAPPa and other non-amyloidogenic fragments. Although mitochondrial dysfunction has become an established hallmark of neurotoxicity, the link between A beta and mitochondrial function is unclear. In this study we investigated the effects of increased levels of neuronal APP or A beta on mitochondrial metabolism and gene expression, in human SH-SY5Y neuroblastoma cells. Increased non-amyloidogenic processing of APP, but not A beta, profoundly decreased respiration and enhanced glycolysis, while mitochondrial DNA (mtDNA) transcripts were decreased, without detrimental effects to cell growth. These effects cannot be ascribed to A beta toxicity, since higher levels of endogenous A beta in our models do not cause oxidative phosphorylation (OXPHOS) perturbations. Similarly, chemical inhibition of beta-secretase decreased mitochondrial respiration, suggesting that non-amyloidogenic processing of APP may be responsible for mitochondrial changes. Our results have two important implications, the need for caution in the interpretation of mitochondrial perturbations in models where APP is overexpressed, and a potential role of sAPPa or other non-amyloid APP fragments as acute modulators of mitochondrial metabolism.	[Sanchez, M. Isabel G. Lopez; Waugh, Hayley S.; Crowston, Jonathan G.; Trounce, Ian A.] Ctr Eye Res Australia, 75 Commercial Rd, Melbourne, Vic 3004, Australia; [Sanchez, M. Isabel G. Lopez; Waugh, Hayley S.; Crowston, Jonathan G.; Trounce, Ian A.] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia; [Tsatsanis, Andrew; Wong, Bruce X.; Duce, James A.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Wong, Bruce X.; Duce, James A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Oxidat Biol Unit, 30 Royal Parade, Parkville, Vic 3052, Australia		Trounce, IA (corresponding author), Ctr Eye Res Australia, 75 Commercial Rd, Melbourne, Vic 3004, Australia.; Trounce, IA (corresponding author), Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia.	i.trounce@unimelb.edu.au	Sanchez, Isabel G Lopez/A-5472-2019; Trounce, Ian A/F-8338-2010; Wong, Bruce/AAY-5884-2020	Sanchez, Isabel G Lopez/0000-0002-1528-5964; Trounce, Ian A/0000-0002-1070-8892; Wong, Bruce/0000-0002-1687-4138	BrightFocus FoundationBrightFocus Foundation [G2009020]; DHB Foundation	This research was supported by the BrightFocus Foundation Thomas R. Lee award (G2009020) and DHB Foundation. CERA receives Operational Infrastructure Support from the Victorian Government, Australia.	Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Bour A, 2004, NEUROBIOL LEARN MEM, V81, P27, DOI 10.1016/S1074-7427(03)00071-6; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Clarke J, 2007, EUR J NEUROSCI, V26, P1845, DOI 10.1111/j.1460-9568.2007.05807.x; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Forman MS, 1997, J BIOL CHEM, V272, P32247, DOI 10.1074/jbc.272.51.32247; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; HAASS C, 1993, J BIOL CHEM, V268, P3021; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Harkany T, 2000, NEUROSCIENCE, V101, P101, DOI 10.1016/S0306-4522(00)00296-7; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Kish SJ, 1999, J NEUROCHEM, V72, P700, DOI 10.1046/j.1471-4159.1999.0720700.x; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Krako N, 2013, J ALZHEIMERS DIS, V37, P747, DOI 10.3233/JAD-130728; Lim SC, 2016, FASEB J, V30, P2236, DOI 10.1096/fj.201500137R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mann DMA, 1996, AM J PATHOL, V148, P1257; Milosch N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.352; Morais VA, 2010, J ALZHEIMERS DIS, V20, pS255, DOI 10.3233/JAD-2010-100345; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; MUTISYA EM, 1994, J NEUROCHEM, V63, P2179; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; Parks JK, 2001, J NEUROCHEM, V76, P1050, DOI 10.1046/j.1471-4159.2001.00112.x; Pierce JES, 1996, J NEUROSCI, V16, P1083; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Rhein V, 2009, CELL MOL NEUROBIOL, V29, P1063, DOI 10.1007/s10571-009-9398-y; Rhein V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012359; Sanchez MIGL, 2016, PHARMACOL THERAPEUT, V165, P132, DOI 10.1016/j.pharmthera.2016.06.004; Sanchez MIGL, 2015, MOL ENDOCRINOL, V29, P14, DOI 10.1210/me.2014-1077; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Schaefer PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168157; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Van Bergen NJ, 2014, MITOCHONDRION, V15, P24, DOI 10.1016/j.mito.2014.03.003; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; Yang TT, 2009, MECH AGEING DEV, V130, P592, DOI 10.1016/j.mad.2009.07.002	63	14	14	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 29	2017	7								9835	10.1038/s41598-017-10233-0			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9QL	WOS:000408538100077	28852095	Green Published, gold			2022-02-06	
J	Hayakawa, M; Maekawa, K; Kushimoto, S; Kato, H; Sasaki, J; Ogura, H; Matsuoka, T; Uejima, T; Morimura, N; Ishikura, H; Hagiwara, A; Takeda, M; Kaneko, N; Saitoh, D; Kudo, D; Kanemura, T; Shibusawa, T; Furugori, S; Nakamura, Y; Shiraishi, A; Murata, K; Mayama, G; Yaguchi, A; Kim, S; Takasu, O; Nishiyama, K				Hayakawa, Mineji; Maekawa, Kunihiko; Kushimoto, Shigeki; Kato, Hiroshi; Sasaki, Junichi; Ogura, Hiroshi; Matsuoka, Tetsuya; Uejima, Toshifumi; Morimura, Naoto; Ishikura, Hiroyasu; Hagiwara, Akiyoshi; Takeda, Munekazu; Kaneko, Naoyuki; Saitoh, Daizoh; Kudo, Daisuke; Kanemura, Takashi; Shibusawa, Takayuki; Furugori, Shintaro; Nakamura, Yoshihiko; Shiraishi, Atsushi; Murata, Kiyoshi; Mayama, Gou; Yaguchi, Arino; Kim, Shiei; Takasu, Osamu; Nishiyama, Kazutaka			Hyperfibrinolysis in severe isolated traumatic brain injury may occur without tissue hypoperfusion: a retrospective observational multicentre study	CRITICAL CARE			English	Article						Coagulopathy; Disseminated intravascular coagulation; Hypoperfusion; Hyperfibrinolysis; Traumatic brain injury	DISSEMINATED INTRAVASCULAR COAGULATION; HEAD-INJURY; LACTATE-DEHYDROGENASE; ACUTE COAGULOPATHY; PREDICTIVE-VALUE; MULTIPLE TRAUMA; LUNG INJURY; T-PA; FIBRINOLYSIS; DIAGNOSIS	Background: Hyperfibrinolysis is a critical complication in severe trauma. Hyperfibrinolysis is traditionally diagnosed via elevated D-dimer or fibrin/fibrinogen degradation product levels, and recently, using thromboelastometry. Although hyperfibrinolysis is observed in patients with severe isolated traumatic brain injury (TBI) on arrival at the emergency department (ED), it is unclear which factors induce hyperfibrinolysis. The present study aimed to investigate the factors associated with hyperfibrinolysis in patients with isolated severe TBI. Methods: We conducted a multicentre retrospective review of data for adult trauma patients with an injury severity score >= 16, and selected patients with isolated TBI (TBI group) and extra-cranial trauma (non-TBI group). The TBI group included patients with an abbreviated injury score (AIS) for the head >= 4 and an extra-cranial AIS < 2. The non-TBI group included patients with an extra-cranial AIS >= 3 and head AIS < 2. Hyperfibrinolysis was defined as a D-dimer level >= 38 mg/L on arrival at the ED. We evaluated the relationships between hyperfibrinolysis and injury severity/tissue injury/tissue perfusion in TBI patients by comparing them with non-TBI patients. Results: We enrolled 111 patients in the TBI group and 126 in the non-TBI group. In both groups, patients with hyperfibrinolysis had more severe injuries and received transfusion more frequently than patients without hyperfibrinolysis. Tissue injury, evaluated on the basis of lactate dehydrogenase and creatine kinase levels, was associated with hyperfibrinolysis in both groups. Among patients with TBI, the mortality rate was higher in those with hyperfibrinolysis than in those without hyperfibrinolysis. Tissue hypoperfusion, evaluated on the basis of lactate level, was associated with hyperfibrinolysis in only the non-TBI group. Although the increase in lactate level was correlated with the deterioration of coagulofibrinolytic variables (prolonged prothrombin time and activated partial thromboplastin time, decreased fibrinogen levels, and increased D-dimer levels) in the non-TBI group, no such correlation was observed in the TBI group. Conclusions: Hyperfibrinolysis is associated with tissue injury and trauma severity in TBI and non-TBI patients. However, tissue hypoperfusion is associated with hyperfibrinolysis in non-TBI patients, but not in TBI patients. Tissue hypoperfusion may not be a prerequisite for the occurrence of hyperfibrinolysis in patients with isolated TBI.	[Hayakawa, Mineji; Maekawa, Kunihiko] Hokkaido Univ Hosp, Emergency & Crit Care Ctr, Kita Ku, N14W5, Sapporo, Hokkaido 0608648, Japan; [Kushimoto, Shigeki; Kudo, Daisuke] Tohoku Univ, Grad Sch Med, Div Emergency & Crit Care Med, Sendai, Miyagi, Japan; [Kato, Hiroshi; Kanemura, Takashi] Natl Hosp Org, Disaster Med Ctr, Dept Crit Care & Traumatol, Tokyo, Japan; [Sasaki, Junichi; Shibusawa, Takayuki] Keio Univ, Sch Med, Dept Emergency & Crit Care Med, Tokyo, Japan; [Ogura, Hiroshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka, Japan; [Matsuoka, Tetsuya] Rinku Gen Med Ctr, Senshu Trauma & Crit Care Ctr, Osaka, Japan; [Uejima, Toshifumi] Kinki Univ, Fac Med, Dept Emergency & Crit Care Med, Osaka, Japan; [Morimura, Naoto] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Ishikura, Hiroyasu; Nakamura, Yoshihiko] Fukuoka Univ, Fac Med, Dept Emergency & Crit Care Med, Fukuoka, Japan; [Hagiwara, Akiyoshi; Mayama, Gou] Natl Ctr Global Hlth & Med, Dept Emergency Med & Crit Care, Tokyo, Japan; [Takeda, Munekazu; Yaguchi, Arino] Tokyo Womens Med Univ, Dept Crit Care & Emergency Med, Tokyo, Japan; [Kaneko, Naoyuki] Fukaya Red Cross Hosp, Trauma & Emergency Ctr, Saitama, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Saitama, Japan; [Furugori, Shintaro] Yokohama City Univ, Grad Sch Med, Dept Emergency Med, Yokohama, Kanagawa, Japan; [Shiraishi, Atsushi; Murata, Kiyoshi] Tokyo Med & Dent Univ Hosp Med, Trauma & Acute Crit Care Med Ctr, Tokyo, Japan; [Kim, Shiei] Nippon Med Sch, Dept Emergency Crit Care Med, Tokyo, Japan; [Takasu, Osamu] Kurume Univ, Sch Med, Dept Emergency & Crit Care Med, Kurume, Fukuoka, Japan; [Nishiyama, Kazutaka] Juntendo Univ, Urayasu Hosp, Dept Emergency & Crit Care Med, Chiba, Japan		Hayakawa, M (corresponding author), Hokkaido Univ Hosp, Emergency & Crit Care Ctr, Kita Ku, N14W5, Sapporo, Hokkaido 0608648, Japan.	mineji@dream.com	Sasaki, Junichi/E-6992-2016; Kudo, Daisuke/AAE-4019-2020; Hayakawa, Mineji/G-2263-2012	Sasaki, Junichi/0000-0002-5190-8524; Kudo, Daisuke/0000-0001-8213-5176; 	Japan Society for the Promotion of Science KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25462810, 24592731]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15K10964] Funding Source: KAKEN	This study was supported in part by the Japan Society for the Promotion of Science KAKENHI (grant numbers 25462810 and 24592731).	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Bilgic I, 2014, AM J EMERG MED, V32, P705, DOI 10.1016/j.ajem.2014.03.052; Feng JF, 2009, CLIN CHEM LAB MED, V47, P590, DOI 10.1515/CCLM.2009.127; Gando S, 1997, CRIT CARE MED, V25, P1820, DOI 10.1097/00003246-199711000-00019; Gando S, 2013, J THROMB HAEMOST, V11, P826, DOI 10.1111/jth.12190; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Gando S, 2016, SEMIN THROMB HEMOST, V42, P155, DOI 10.1055/s-0035-1564831; Hagiwara A, 2016, SHOCK, V45, P495, DOI 10.1097/SHK.0000000000000536; Hayakawa M, 2016, SHOCK, V45, P308, DOI 10.1097/SHK.0000000000000542; Hayakawa M, 2013, SHOCK, V39, P514, DOI 10.1097/SHK.0b013e318293980d; Huber D, 2002, BLOOD, V99, P3637, DOI 10.1182/blood.V99.10.3637; KANEMITSU F, 1988, J CHROMATOGR-BIOMED, V429, P399, DOI 10.1016/S0378-4347(00)83880-3; Karakus A, 2012, ULUS TRAVMA ACIL CER, V18, P289, DOI 10.5505/tjtes.2012.81488; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; KOOISTRA T, 1994, INT J HEMATOL, V59, P233; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Kudo D, 2017, AM J EMERG MED, V35, P62, DOI 10.1016/j.ajem.2016.10.002; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P87, DOI 10.1097/TA.0b013e3182598c70; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MAEKAWA M, 1988, J CHROMATOGR-BIOMED, V429, P373, DOI 10.1016/S0378-4347(00)83879-7; Medved L, 2003, THROMB HAEMOSTASIS, V89, P409; Naganathar S, 2015, J TRAUMA ACUTE CARE, V79, P71, DOI 10.1097/TA.0000000000000694; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Ostrowski SR, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-64; RAO CJ, 1978, J NEUROL NEUROSUR PS, V41, P948, DOI 10.1136/jnnp.41.10.948; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; RISBERG B, 1986, CRIT CARE MED, V14, P917, DOI 10.1097/00003246-198611000-00001; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Schrieber M, 2007, J TRAUMA, V63, P1261; Story DA, 2004, BRIT J ANAESTH, V92, P54, DOI 10.1093/bja/aeh018; Suehiro E, 2014, CLIN NEUROL NEUROSUR, V127, P97, DOI 10.1016/j.clineuro.2014.10.007; Theusinger OM, 2015, ANESTH ANALG, V120, P627, DOI 10.1213/ANE.0000000000000561; Theusinger OM, 2011, ANESTH ANALG, V113, P1003, DOI 10.1213/ANE.0b013e31822e183f; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Wada H, 2008, SEMIN THROMB HEMOST, V34, P33, DOI 10.1055/s-2008-1066021; Yasui H, 2016, AM J PHYSIOL-LUNG C, V311, pL74, DOI 10.1152/ajplung.00429.2015; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	47	14	15	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	AUG 23	2017	21								222	10.1186/s13054-017-1811-1			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE7RV	WOS:000408405500001	28830477	Green Published, gold			2022-02-06	
J	Liu, XX; Qiu, JH; Alcon, S; Hashim, J; Meehan, WP; Mannix, R				Liu, Xixia; Qiu, Jianhua; Alcon, Sasha; Hashim, Jumana; Meehan, William P., III; Mannix, Rebekah			Environmental Enrichment Mitigates Deficits after Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal model; concussion; enrichment; mild traumatic brain injury; synaptic plasticity	ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; RATS; RECOVERY; EXPRESSION; SUBUNIT; MICE; PHOSPHORYLATION; INCREASES; NEURODEGENERATION	Although environmental enrichment has been shown to improve functional and histologic outcomes in pre-clinical moderate-to-severe traumatic brain injury (TBI), there are a paucity of pre-clinical data regarding enrichment strategies in the setting of repetitive mild traumatic brain injury (rmTBI). Given the vast numbers of athletes and those in the military who sustain rmTBI, the mounting evidence of the long-term and progressive sequelae of rmTBI, and the lack of targeted therapies to mitigate these sequelae, successful enrichment interventions in rmTBI could have large public health significance. Here, we evaluated enrichment strategies in an established pre-clinical rmTBI model. Seventy-one male C57BL/6 mice were randomized to two different housing conditions, environmental enrichment (EE) or normal condition (NC), then subjected to rmTBI injury (seven injuries in 9 days) or sham injury (anesthesia only). Functional outcomes in all four groups (NC-TBI, EE-TBI, NC-sham, and EE-sham) were assessed by motor, exploratory/anxiety, and mnemonic behavioral tests. At the synaptic level, N-methyl D-aspartate receptor (NMDAR) subunit expression of phosphorylated glutamate receptor 1 (GluR1), phosphorylated Ca2+/calmodulin-dependent protein kinase II (CaMKII), and calpain were evaluated by western blot. Compared to injured NC-TBI mice, EE-TBI mice had improved memory and decreased anxiety and exploratory activity post-injury. Treatment with enrichment also corresponded to normal NMDAR subunit expression, decreased GluR1 phosphorylation, decreased phosphorylated CaMKII, and normal calpain expression post-rmTBI. These data suggest that enrichment strategies may improve functional outcomes and mitigate synaptic changes post-rmTBI. Given that enrichment strategies are feasible in the clinical setting, particularly for athletes and soldiers for whom the risk of repetitive injury is greatest, these data suggest that clinical trials may be warranted.	[Liu, Xixia] Peoples Hosp Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China; [Qiu, Jianhua; Alcon, Sasha; Hashim, Jumana; Meehan, William P., III; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Qiu, Jianhua; Meehan, William P., III; Mannix, Rebekah] Harvard Med Sch, Boston, MA USA; [Meehan, William P., III] Sports Concuss Clin, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	Rebekah.Mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020		ABC-Clio publishing; Harvard Catalyst (the National Football League Players Association); National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD040128]; CHB IDDRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758] Funding Source: NIH RePORTER	Dr. Meehan receives royalties from ABC-Clio publishing for the sale of his book, Kids, Sports, and Concussion: A guide for coaches and parents, and from Springer International for the book Head and Neck Injuries in Young Athlete and from and royalties from Wolters Kluwer for working as an author for UpToDate. He is under contract with ABC-Clio publishing for a future book entitled, Concussions. His research is funded, in part, by a grant from Harvard Catalyst (the National Football League Players Association mechanism) and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament.; Dr. Mannix is funded, in part, by the NICHD T32 HD040128, a grant from Harvard Catalyst (the National Football League Players Association mechanism), and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament.; The research presented in this article is supported by CHB IDDRC.	Anggono V, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8256196; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Chang XL, 2016, MOL NEUROBIOL, V53, P3349, DOI 10.1007/s12035-015-9264-5; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; Doshi Shachee, 2009, Front Biosci (Schol Ed), V1, P466, DOI 10.2741/s38; Dupont G., 2003, SENSITIVITY CAM KINA; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; GENTILE AM, 1987, BEHAV NEURAL BIOL, V47, P321, DOI 10.1016/S0163-1047(87)90435-3; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jang A, 2013, CURR ALZHEIMER RES, V10, P829; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Mines Marjelo A, 2011, Int J Alzheimers Dis, V2011, P861072, DOI 10.4061/2011/861072; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Shin SS, 2013, J NEUROTRAUM, V30, P259, DOI 10.1089/neu.2012.2462; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Woo CC, 2015, BEHAV NEUROSCI, V129, P412, DOI 10.1037/bne0000068; Zhang XQ, 2016, MOL MED REP, V14, P2231, DOI 10.3892/mmr.2016.5470; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739	53	14	15	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2445	2455		10.1089/neu.2016.4823			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400007	28376667	Green Published			2022-02-06	
J	Yuan, WH; Leach, J; Maloney, T; Altaye, M; Smith, D; Gubanich, PJ; Foss, KDB; Thomas, S; DiCesare, CA; Kiefer, AW; Myer, GD				Yuan, Weihong; Leach, James; Maloney, Thomas; Altaye, Mekibib; Smith, David; Gubanich, Paul J.; Foss, Kim D. Barber; Thomas, Staci; DiCesare, Christopher A.; Kiefer, Adam W.; Myer, Gregory D.			Neck Collar with Mild Jugular Vein Compression Ameliorates Brain Activation Changes during a Working Memory Task after a Season of High School Football	JOURNAL OF NEUROTRAUMA			English	Article						fMRI; football head impact; N-Back task; neck collar; working memory	HEAD IMPACT EXPOSURE; COMPENSATORY CORTICAL ACTIVATION; SPORTS-RELATED CONCUSSION; MULTIPLE-SCLEROSIS; AXONAL INJURY; EPIDEMIOLOGY; ROBUST; REORGANIZATION; OPTIMIZATION; REGISTRATION	Emerging evidence indicates that repetitive head impacts, even at a sub-concussive level, may result in exacerbated or prolonged neurological deficits in athletes. This study aimed to: 1) quantify the effect of repetitive head impacts on the alteration of neuronal activity based on functional magnetic resonance imaging (fMRI) of working memory after a high school football season; and 2) determine whether a neck collar that applies mild jugular vein compression designed to reduce brain energy absorption in head impact through "slosh" mitigation can ameliorate the altered fMRI activation during a working memory task. Participants were recruited from local high school football teams with 27 and 25 athletes assigned to the non-collar and collar group, respectively. A standard N-Back task was used to engage working memory in the fMRI at both pre- and post-season. The two study groups experienced similar head impact frequency and magnitude during the season (all p > 0.05). fMRI blood oxygen level dependent (BOLD) signal response (a reflection of the neuronal activity level) during the working memory task increased significantly from pre- to post-season in the non-collar group (corrected p < 0.05), but not in the collar group. Areas displaying less activation change in the collar group (corrected p < 0.05) included the precuneus, inferior parietal cortex, and dorsal lateral prefrontal cortex. Additionally, BOLD response in the non-collar group increased significantly in direct association with the total number of impacts and total g-force (p < 0.05). Our data provide initial neuroimaging evidence for the effect of repetitive head impacts on the working memory related brain activity, as well as a potential protective effect that resulted from the use of the purported brain slosh reducing neck collar in contact sports.	[Yuan, Weihong; Maloney, Thomas] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Leach, James] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Altaye, Mekibib] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Smith, David; Gubanich, Paul J.; Foss, Kim D. Barber; Thomas, Staci; DiCesare, Christopher A.; Kiefer, Adam W.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Foss, Kim D. Barber; Thomas, Staci; DiCesare, Christopher A.; Kiefer, Adam W.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, SPORT Ctr, Cincinnati, OH 45229 USA; [Yuan, Weihong; Leach, James; Altaye, Mekibib] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Gubanich, Paul J.; Kiefer, Adam W.; Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Foss, Kim D. Barber] Mt St Joseph Univ, Dept Athlet Training, Div Hlth Sci, Cincinnati, OH USA; [Foss, Kim D. Barber] Rocky Mt Univ Hlth Profess, Provo, UT USA; [Kiefer, Adam W.] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Univ Penn, Dept Orthopaed, Philadelphia, PA 19104 USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Myer, GD (corresponding author), Cincinnati Childrens Hosp, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	Greg.Myer@cchmc.org	Kiefer, Adam/F-1756-2018; DiCesare, Christopher/AAA-3327-2021; DiCesare, Christopher/ABH-9573-2020; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Maloney, Thomas/0000-0002-2643-9009; Myer, Gregory/0000-0002-9983-8422	Heidt Family Foundation; Robert S. Heidt, Sr. - Wellington Foundation; Q30 Sports Sciences, LLC	This work was supported The Heidt Family Foundation, Robert S. Heidt, Sr. - Wellington Foundation and Q30 Sports Sciences, LLC. The Clinical Trial Registration number is NCT02696200.	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Audoin B, 2003, HUM BRAIN MAPP, V20, P51, DOI 10.1002/hbm.10128; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Ernst T, 2002, NEUROLOGY, V59, P1343, DOI 10.1212/01.WNL.0000031811.45569.B0; Fridman L, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-30; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mainero C, 2006, J NEUROL SCI, V245, P93, DOI 10.1016/j.jns.2005.08.024; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Montenigro P. H., 2016, J NEUROTRAUMA; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pantano P, 2006, J NEUROIMAGING, V16, P104, DOI 10.1111/j.1552-6569.2006.00029.x; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Schneider D. K., 2016, BR J SPORTS MED; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tirabassi J., 2016, AM J SPORTS MED; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Xu JS, 2006, PSYCHIAT RES-NEUROIM, V148, P103, DOI 10.1016/j.pscychresns.2006.09.005; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	51	14	14	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2432	2444		10.1089/neu.2016.4834			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400006	28437225				2022-02-06	
J	Bangma, DF; Fuermaier, ABM; Tucha, L; Tucha, O; Koerts, J				Bangma, Dorien F.; Fuermaier, Anselm B. M.; Tucha, Lara; Tucha, Oliver; Koerts, Janneke			The effects of normal aging on multiple aspects of financial decision-making	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE PATIENTS; IOWA GAMBLING TASK; TRAUMATIC BRAIN-INJURY; ADULT AGE-DIFFERENCES; OLDER-ADULTS; LIFE-SPAN; INDIVIDUAL-DIFFERENCES; EXTERNAL VALIDATION; ALZHEIMERS-DISEASE	Objectives Financial decision-making (FDM) is crucial for independent living. Due to cognitive decline that accompanies normal aging, older adults might have difficulties in some aspects of FDM. However, an improved knowledge, personal experience and affective decision-making, which are also related to normal aging, may lead to a stable or even improved age-related performance in some other aspects of FDM. Therefore, the present explorative study examines the effects of normal aging on multiple aspects of FDM. Methods One-hundred and eighty participants (range 18-87 years) were assessed with eight FDM tests and several standard neuropsychological tests. Age effects were evaluated using hierarchical multiple regression analyses. The validity of the prediction models was examined by internal validation (i.e. bootstrap resampling procedure) as well as external validation on another, independent, sample of participants (n = 124). Multiple regression and correlation analyses were applied to investigate the mediation effect of standard measures of cognition on the observed effects of age on FDM. Results On a relatively basic level of FDM (e.g., paying bills or using FDM styles) no significant effects of aging were found. However more complex FDM, such as making decisions in accordance with specific rules, becomes more difficult with advancing age. Furthermore, an older age was found to be related to a decreased sensitivity for impulsive buying. These results were confirmed by the internal and external validation analyses. Mediation effects of numeracy and planning were found to explain parts of the association between one aspect of FDM (i.e. Competence in decision rules) and age; however, these cognitive domains were not able to completely explain the relation between age and FDM. Conclusion Normal aging has a negative influence on a complex aspect of FDM, however, other aspects appear to be unaffected by normal aging or improve.	[Bangma, Dorien F.; Fuermaier, Anselm B. M.; Tucha, Lara; Tucha, Oliver; Koerts, Janneke] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands		Koerts, J (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	janneke.koerts@rug.nl	Tucha, Oliver/AAD-1403-2019	Fuermaier, Anselm/0000-0002-2331-0840; Bangma, Dorien/0000-0003-4187-3679			Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Barkley R., 2008, ADHD ADULTS WHAT SCI; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beatty SE, 1998, J RETAILING, V74, P169, DOI 10.1016/S0022-4359(99)80092-X; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Beitz KM, 2014, J EXP PSYCHOL GEN, V143, P1677, DOI 10.1037/a0035823; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Bouma A., 2012, HDB NEUROPSYCHOLOGIS, P717; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Braver T. S., 2008, HDB AGING COGNITION, P311; Brickenkamp R., 2007, D2 AANDACHTS CONCENT; Brickenkamp R., 1998, D2 TEST ATTENTION; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Chen YW, 2014, EDUC GERONTOL, V40, P825, DOI 10.1080/03601277.2014.900263; Coley A., 2003, J FASH MARK MANAG, V7, P282, DOI [10.1108/13612020310484834, DOI 10.1108/13612020310484834]; Davis C, 2008, J INT NEUROPSYCH SOC, V14, P1063, DOI 10.1017/S1355617708081204; de Bruin WB, 2015, MED DECIS MAKING, V35, P22, DOI 10.1177/0272989X14542485; De Bruin WB, 2012, J BEHAV DECIS MAKING, V25, P352, DOI 10.1002/bdm.712; de Bruin WB, 2007, J PERS SOC PSYCHOL, V92, P938, DOI 10.1037/0022-3514.92.5.938; Del Missier F, 2013, J EXP PSYCHOL LEARN, V39, P1344, DOI 10.1037/a0032379; Del Missier F, 2010, THINK REASONING, V16, P69, DOI 10.1080/13546781003630117; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Denburg NL, 2015, AGING DECISION MAKIN, P79; Dennis, 2008, HDB AGING COGNITION, P1, DOI DOI 10.4324/9780203837665.CH1; Dijksterhuis A, 2006, SCIENCE, V311, P1005, DOI 10.1126/science.1121629; Dijksterhuis A, 2004, J PERS SOC PSYCHOL, V87, P586, DOI 10.1037/0022-3514.87.5.586; Dreer LE, 2012, REHABIL PSYCHOL, V57, P5, DOI 10.1037/a0025818; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Fehr E., 2014, NEUROECONOMICS DECIS, P63; Fein G, 2007, J INT NEUROPSYCH SOC, V13, P480, DOI 10.1017/S135561770707052X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fry J, 2009, S AFR J PSYCHOL, V39, P122, DOI 10.1177/008124630903900111; Grasman R. P. P. P., 2005, DHTML IMPLEMENTATION; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P149, DOI 10.1007/BF01499323; HARREN VA, 1979, J VOCAT BEHAV, V14, P119, DOI 10.1016/0001-8791(79)90065-4; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hess TM, 2015, AGING DECISION MAKIN, P189, DOI DOI 10.1016/B978-0-12-417148-0.00010-8; Hindmarch T, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-54; Karlawish J, 2013, NEUROLOGY, V81, P801, DOI 10.1212/WNL.0b013e3182a05ba5; Kennerley SW, 2011, BEHAV NEUROSCI, V125, P297, DOI 10.1037/a0023575; Kershaw MM, 2008, PSYCHIAT PSYCHOL LAW, V15, P40, DOI 10.1080/13218710701873965; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; Lockenhoff CE, 2011, PSYCHOL AGING, V26, P274, DOI 10.1037/a0023280; LOEWENSTEIN DA, 1989, J GERONTOL, V44, pP114, DOI 10.1093/geronj/44.4.P114; Loewenstein G., 2015, DECISION, V2, P55, DOI [10.1037/dec0000029, DOI 10.1037/DEC0000029]; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Loo R, 2000, PERS INDIV DIFFER, V29, P895, DOI 10.1016/S0191-8869(99)00241-X; Lui VWC, 2013, J GERIATR PSYCH NEUR, V26, P69, DOI 10.1177/0891988713481268; Luteijn F., 2004, GIT 2 GRONINGER INTE; Maillet D, 2013, AGEING RES REV, V12, P479, DOI 10.1016/j.arr.2012.11.001; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Martin RC, 2008, MOVEMENT DISORD, V23, P1867, DOI 10.1002/mds.22170; Martin RC, 2013, PARKINSONISM RELAT D, V19, P986, DOI 10.1016/j.parkreldis.2013.06.017; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Mather M., 2006, REV DECISION MAKING, P145; MEYER BJF, 1995, PSYCHOL AGING, V10, P84, DOI 10.1037/0882-7974.10.1.84; Mikels JA, 2013, EMOTION, V13, P189, DOI 10.1037/a0030441; Mikels JA, 2011, EMOTION, V11, P743, DOI 10.1037/a0023986; Nieuwenstein MR, 2015, JUDGM DECIS MAK, V10, P1; Orgeta V, 2009, AGING MENT HEALTH, V13, P818, DOI 10.1080/13607860902989661; Parker AM, 2005, J BEHAV DECIS MAKING, V18, P1, DOI 10.1002/bdm.481; Pereira FS, 2010, J INT NEUROPSYCH SOC, V16, P297, DOI 10.1017/S1355617709991330; Peters E, 2007, PERSPECT PSYCHOL SCI, V2, P1, DOI 10.1111/j.1745-6916.2007.00025.x; Pirogovsky E, 2014, NEUROPSYCHOLOGY, V28, P229, DOI 10.1037/neu0000045; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reyna VF, 2009, PSYCHOL BULL, V135, P943, DOI 10.1037/a0017327; Roelofs J, 2013, J PSYCHOPATHOL BEHAV, V35, P93, DOI 10.1007/s10862-012-9309-2; ROOK DW, 1987, J CONSUM RES, V14, P189, DOI 10.1086/209105; SALTHOUSE TA, 1995, J GERONTOL B-PSYCHOL, V50, pP297, DOI 10.1093/geronb/50B.6.P297; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schmand B, 2008, Tijdschr Gerontol Geriatr, V39, P64; SCOTT SG, 1995, EDUC PSYCHOL MEAS, V55, P818, DOI 10.1177/0013164495055005017; Sherod MG, 2009, J INT NEUROPSYCH SOC, V15, P258, DOI 10.1017/S1355617709090365; Spicer D. P., 2005, J MANAGERIAL PSYCHOL, V20, P137, DOI 10.1108/02683940510579777; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Suto WMI, 2005, J INTELL DISABIL RES, V49, P199, DOI 10.1111/j.1365-2788.2005.00635.x; Triebel KL, 2009, NEUROLOGY, V73, P928, DOI 10.1212/WNL.0b013e3181b87971; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; Van der Elst W, 2006, PSYCHOL ASSESSMENT, V18, P424, DOI 10.1037/1040-3590.18.4.424; van der Elst W, 2006, J CLIN EXP NEUROPSYC, V28, P998, DOI 10.1080/13803390591004428; Vellinga A, 2005, AGING MENT HEALTH, V9, P40, DOI 10.1080/13607860512331334059; Verplanken B, 2001, EUR J PERSONALITY, V15, pS71, DOI 10.1002/per.423; Webber LS., 2002, PSYCHIAT PSYCHOL LAW, V9, P248, DOI [10.1375/pplt.2002.9.2.248, DOI 10.1375/PPLT.2002.9.2.248]; Webber LS., 2004, PSYCHIAT PSYCHOL LAW, V11, P338, DOI [10.1375/pplt.2004.11.2.338, DOI 10.1375/PPLT.2004.11.2.338]; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D. WAIS-IV-NL, 2012, WAIS 4 NL WECHLER AD; Whelan R, 2009, PSYCHOL REC, V59, P247, DOI 10.1007/BF03395661; Wood RL, 2013, J INT NEUROPSYCH SOC, V19, P181, DOI 10.1017/S135561771200118X	98	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182620	10.1371/journal.pone.0182620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9YJ	WOS:000407196700055	28792973	Green Published, gold, Green Submitted			2022-02-06	
J	Xu, ZM; Liu, YL; Yang, DX; Yuan, F; Ding, J; Chen, H; Tian, HL				Xu, Zhiming; Liu, Yingliang; Yang, Dianxu; Yuan, Fang; Ding, Jun; Chen, Hao; Tian, Hengli			Sesamin protects SH-SY5Y cells against mechanical stretch injury and promoting cell survival	BMC NEUROSCIENCE			English	Article						Sesamin; Apoptosis; Oxidative stress; Mechanical stretch injury	TRAUMATIC BRAIN-INJURY; INDUCED OXIDATIVE STRESS; PARKINSONS-DISEASE; CORTICAL-NEURONS; MITOCHONDRIAL DYSFUNCTION; DELAYED DEPOLARIZATION; SUPEROXIDE-DISMUTASE; MODEL; DEATH; ASTROCYTES	Background: Sesamin is a well-known antioxidant extracted from sesame seeds that exhibits various curative effects. The present study investigated whether sesamin would protect neuroblastoma SH-SY5Y cells against mechanical stretch injury-induced increases in reactive oxygen species (ROS) and apoptosis. Additionally, the mechanisms underlying these actives were investigated. Following exposure to mechanical stretch injury, cells were incubated for further investigations. Lactate dehydrogenase and Cell Counting Kit-8 assays were used to assess cell viability, and a terminal deoxynucleotidyl transferase dUTP nick end labeling assay and flow cytometric analysis were performed to evaluate changes in mitochondrial membrane potential (Delta Psi m). Furthermore, intracellular levels of ROS production were measured by 20, 70-dichlorofluorescein diacetate staining, the mRNA levels of matrix metallopeptidase 9 (MMP-9) were evaluated using real-time polymerase chain reaction analysis, and the determinations had also been made on related proteins by Western blot analysis. Results: Exposure to mechanical stretch injury significantly decreased cell viability but this decrease was attenuated by pretreatment with sesamin (50 mu M). Sesamin also significantly inhibited mechanical stretch injury-induced increases in intracellular ROS production, attenuated declines Delta Psi m, diminished the expressions of pro-apoptotic proteins, and decreased cell apoptosis. Stretch injury increased Bax and cleaved caspase 3 levels, enhanced the gene expression of MMP-9, increased the phosphorylation levels of Akt, p38, and JNK and decreased Bcl-2 levels in the cells. However, pretreatment with sesamin reduced the mechanical stretch injury-induced overexpression of MMP-9. Conclusions: Sesamin protected SH-SY5Y cells against stretch injury by attenuating increases in ROS levels and suppressing apoptosis. Accordingly, sesamin seems to be a potentially therapeutic agent in the treatment of traumatic brain injury.	[Xu, Zhiming; Liu, Yingliang; Yang, Dianxu; Yuan, Fang; Ding, Jun; Chen, Hao; Tian, Hengli] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, 600 Yi Shan Rd, Shanghai 200030, Peoples R China		Tian, HL (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, 600 Yi Shan Rd, Shanghai 200030, Peoples R China.	tianhlsh@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471245, 81501048, 81271383]	This work was supported by grants from National Natural Science Foundation of China (Nos. 81471245, 81501048) in the process of study design, experiment implementation and data collection. Data interpretation and article writing were supported by the grant from National Natural Science Foundation of China (No. 81271383).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Ali ZA, 2014, J CLIN INVEST, V124, P5159, DOI 10.1172/JCI77484; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Hou RCW, 2004, NEUROSCI LETT, V367, P10, DOI 10.1016/j.neulet.2004.05.073; Hou RCW, 2003, NEUROREPORT, V14, P1815, DOI 10.1097/00001756-200310060-00011; Hou RCW, 2003, J NEUROSCI RES, V74, P123, DOI 10.1002/jnr.10749; Hsieh HL, 2014, MOL NEUROBIOL, V50, P520, DOI 10.1007/s12035-013-8628-y; Hsieh PF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-57; Jeng KCG, 2005, IMMUNOL LETT, V97, P101, DOI 10.1016/j.imlet.2004.10.004; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kim MJ, 2015, BIOMATERIALS, V64, P45, DOI 10.1016/j.biomaterials.2015.06.015; Kim MJ, 2013, FREE RADICAL BIO MED, V63, P432, DOI 10.1016/j.freeradbiomed.2013.06.005; Kim SY, 2010, NEUROCHEM INT, V56, P437, DOI 10.1016/j.neuint.2009.11.019; Lahaie-Collins V, 2008, OXID MED CELL LONGEV, V1, P54, DOI 10.4161/oxim.1.1.6958; Lamb RG, 1997, J NEUROCHEM, V68, P1904; Lee YP, 2012, FEBS J, V279, P1929, DOI 10.1111/j.1742-4658.2012.08574.x; Loh Kok Poh, 2006, Current Alzheimer Research, V3, P327; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Pfister Bryan, 2004, Mech Chem Biosyst, V1, P233; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Song H, 2016, NEUROSCI LETT, V622, P95, DOI 10.1016/j.neulet.2016.04.048; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Tian PC, 2016, HUM EXP TOXICOL, V35, P124, DOI 10.1177/0960327115578974; Vali S, 2007, NEUROSCIENCE, V149, P917, DOI 10.1016/j.neuroscience.2007.08.028; von Leden RE, 2017, J NEUROTRAUM, V34, P755, DOI 10.1089/neu.2016.4486; Wang F, 2014, NEUROTOXICOLOGY, V41, P54, DOI 10.1016/j.neuro.2014.01.002; Wang ZR, 2016, ASIAN PAC J TROP MED, V9, P269, DOI 10.1016/j.apjtm.2016.01.027; Webster Gregory D, 2008, Biomed Sci Instrum, V44, P483; Xia Q, 2011, J NEUROCHEM, V117, P38, DOI 10.1111/j.1471-4159.2010.07162.x; Xu XH, 2015, BRAIN RES, V1614, P38, DOI 10.1016/j.brainres.2015.04.014; Zhang H, 2011, BRAIN RES, V1370, P89, DOI 10.1016/j.brainres.2010.11.019	36	14	14	1	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	AUG 7	2017	18								57	10.1186/s12868-017-0378-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD5OO	WOS:000407579900001	28784087	Green Published, gold			2022-02-06	
J	Cabella, B; Donnelly, J; Cardim, D; Liu, XY; Cabeleira, M; Smielewski, P; Haubrich, C; Hutchinson, PJA; Kim, DJ; Czosnyka, M				Cabella, Brenno; Donnelly, Joseph; Cardim, Danilo; Liu, Xiuyun; Cabeleira, Manuel; Smielewski, Peter; Haubrich, Christina; Hutchinson, Peter J. A.; Kim, Dong-Joo; Czosnyka, Marek			An Association Between ICP-Derived Data and Outcome in TBI Patients: The Role of Sample Size	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Outcome prediction; Statistical inference; Intracranial pressure; Autoregulation	TRAUMATIC BRAIN-INJURY; CONFIDENCE-INTERVALS; POWER	Background Many demographic and physiological variables have been associated with TBI outcomes. However, with small sample sizes, making spurious inferences is possible. This paper explores the effect of sample sizes on statistical relationships between patient variables (both physiological and demographic) and outcome. Methods Data from head-injured patients with monitored arterial blood pressure, intracranial pressure (ICP) and outcome assessed at 6 months were included in this retrospective analysis. A univariate logistic regression analysis was performed to obtain the odds ratio for unfavorable outcome. Three different dichotomizations between favorable and unfavorable outcomes were considered. A bootstrap method was implemented to estimate the minimum sample sizes needed to obtain reliable association between physiological and demographic variables with outcome. Results In a univariate analysis with dichotomized outcome, samples sizes should be generally larger than 100 for reproducible results. Pressure reactivity index, ICP, and ICP slow waves offered the strongest relationship with outcome. Relatively small sample sizes may overestimate effect sizes or even produce conflicting results. Conclusion Low power tests, generally achieved with small sample sizes, may produce misleading conclusions, especially when they are based only on p values and the dichotomized criteria of rejecting/not-rejecting the null hypothesis. We recommend reporting confidence intervals and effect sizes in a more complete and contextualized data analysis.	[Cabella, Brenno; Donnelly, Joseph; Cardim, Danilo; Liu, Xiuyun; Cabeleira, Manuel; Smielewski, Peter; Haubrich, Christina; Hutchinson, Peter J. A.; Kim, Dong-Joo; Czosnyka, Marek] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea		Cabella, B (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge, England.	cabellab@gmail.com	Cardim, Danilo Augusto/B-8447-2012; Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018; Cabella, Brenno C.T./G-6169-2012; Liu, Xiuyun/V-4427-2017	Cardim, Danilo Augusto/0000-0002-9261-1321; Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Cabella, Brenno C.T./0000-0003-2214-645X; Liu, Xiuyun/0000-0001-9540-4865; Smielewski, Peter/0000-0001-5096-3938	National Institutes of Health Research (Cambridge Centre)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHR Health Technology Co-operative; CNPQConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [203792/2014-9]; Woolf Fisher Trust; Cambridge Commonwealth European and International Trust Scholarship; Gates Cambridge Trust; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [12/35/57, NIHR-RP-R3-12-013] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025, G0600986] Funding Source: UKRI	Many thanks to Addenbrooke's Hospital Neurocritical Care and University of Cambridge Department of Anaesthesia Staff for long-standing support in computerized bedside monitoring of TBI patients. This work was supported by National Institutes of Health Research (Cambridge Centre) and NIHR Health Technology Co-operative. B.C. is supported by a CNPQ Scholarship (Research Project 203792/2014-9). J.D. is supported by a Woolf Fisher Trust Scholarship. D.C. is supported by a Cambridge Commonwealth European and International Trust Scholarship. X.L. is supported by a Gates Cambridge Trust Scholarship.	Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; Cumming G, 2012, AUST J PSYCHOL, V64, P138, DOI 10.1111/j.1742-9536.2011.00037.x; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; JENNETT B, 1975, LANCET, V1, P480; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Le Roux P, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0331-2; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maxwell SE, 2008, ANNU REV PSYCHOL, V59, P537, DOI 10.1146/annurev.psych.59.103006.093735; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; ROYALL RM, 1986, AM STAT, V40, P313, DOI 10.2307/2684616; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708	18	14	14	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2017	27	1					103	107		10.1007/s12028-016-0319-x			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FB7GX	WOS:000406310200015	27822739	hybrid, Green Published, Green Accepted			2022-02-06	
J	Campiglio, L; Bianchi, F; Cattalini, C; Belvedere, D; Rosci, CE; Casellato, CL; Secchi, M; Saetti, MC; Baratelli, E; Innocenti, A; Cova, I; Gambini, C; Romano, L; Oggioni, G; Pagani, R; Gardinali, M; Priori, A				Campiglio, Laura; Bianchi, Francesca; Cattalini, Claudio; Belvedere, Daniela; Rosci, Chiara Emilia; Casellato, Chiara Livia; Secchi, Manuela; Saetti, Maria Cristina; Baratelli, Elena; Innocenti, Alessandro; Cova, Ilaria; Gambini, Chiara; Romano, Luca; Oggioni, Gaia; Pagani, Rossella; Gardinali, Marco; Priori, Alberto			Mild brain injury and anticoagulants Less is enough	NEUROLOGY-CLINICAL PRACTICE			English	Article							MINOR HEAD-INJURY; TRAUMATIC INTRACRANIAL HEMORRHAGE; LONG-TERM ANTICOAGULATION; PREINJURY WARFARIN; RISK; MANAGEMENT; COMPLICATIONS; METAANALYSIS; ASSOCIATION; VALIDATION	Background: Despite the higher theoretical risk of traumatic intracranial hemorrhage (ICH) in anticoagulated patients with mild head injury, the value of sequential head CT scans to identify bleeding remains controversial. This study evaluated the utility of 2 sequential CT scans at a 48-hour interval (CT1 and CT2) in patients with mild head trauma (Glasgow Coma Scale 13-15) taking oral anticoagulants. Methods: We retrospectively evaluated the clinical records of all patients on chronic anticoagulation treatment admitted to the emergency department for mild head injury. Results: A total of 344 patients were included, and 337 (97.9%) had a negative CT1. CT2 was performed on 284 of the 337 patients with a negative CT1 and was positive in 4 patients (1.4%), but none of the patients developed concomitant neurologic worsening or required neurosurgery. Conclusions: Systematic routine use of a second CT scan in mild head trauma in patients taking anticoagulants is expensive and clinically unnecessary.	[Campiglio, Laura; Bianchi, Francesca; Cattalini, Claudio; Belvedere, Daniela; Rosci, Chiara Emilia; Casellato, Chiara Livia; Secchi, Manuela; Saetti, Maria Cristina; Baratelli, Elena; Innocenti, Alessandro; Cova, Ilaria; Gambini, Chiara; Romano, Luca; Oggioni, Gaia; Pagani, Rossella; Priori, Alberto] Milan Univ, San Paolo Univ Hosp, ASST Santi Paolo & Carlo, Dept Hlth Sci,Neurol Clin 3, Milan, Italy; [Campiglio, Laura; Bianchi, Francesca; Cattalini, Claudio; Belvedere, Daniela; Rosci, Chiara Emilia; Casellato, Chiara Livia; Secchi, Manuela; Saetti, Maria Cristina; Baratelli, Elena; Innocenti, Alessandro; Cova, Ilaria; Gambini, Chiara; Romano, Luca; Oggioni, Gaia; Pagani, Rossella; Priori, Alberto] Milan Univ, San Paolo Univ Hosp, ASST Santi Paolo & Carlo, Neurol Unit, Milan, Italy; [Gardinali, Marco] Milan Univ, San Paolo Univ Hosp, ASST Santi Paolo & Carlo, Emergency Unit, Milan, Italy; Univ Milan, Res Ctr Neurotechnol & Expt Brain Therapeut, Milan, Italy; [Priori, Alberto] Fdn IRCCS Ca Granda, Milan, Italy		Priori, A (corresponding author), Milan Univ, San Paolo Univ Hosp, ASST Santi Paolo & Carlo, Dept Hlth Sci,Neurol Clin 3, Milan, Italy.; Priori, A (corresponding author), Milan Univ, San Paolo Univ Hosp, ASST Santi Paolo & Carlo, Neurol Unit, Milan, Italy.; Priori, A (corresponding author), Fdn IRCCS Ca Granda, Milan, Italy.	alberto.priori@unimi.it	Cova, Ilaria/K-9454-2016; Priori, Alberto/K-9603-2016	Cova, Ilaria/0000-0001-7831-6791; Priori, Alberto/0000-0002-1549-3851; SAETTI, MARIA CRISTINA/0000-0001-5867-5981			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8; Atzema C, 2004, ANN EMERG MED, V44, P47, DOI 10.1016/j.annemergmed.2004.02.032; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Batchelor J, 2002, EMERG MED J, V19, P515, DOI 10.1136/emj.19.6.515; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P1787, DOI 10.1136/jnnp.2004.041384; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Faul M, 2010, TRAUMATIC BRAIN INJU; Francel P, 1996, NEUROLOGICAL SURG; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kaen A, 2012, J TRAUMA, V59, P451; Karni A, 2001, AM SURGEON, V67, P1098; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; NICE, 2014, NICE CLIN GUID 176; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rusticali B, 2008, MINERVA ANESTESIOL, V74, P583; Sackville T, 2010, COMP PRICE REPORT ME; Schoonman GG, 2014, EUR J NEUROL, V21, P1021, DOI 10.1111/ene.12429; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; The Management of Concussion/mTBI Work Group, VA DOD CLIN PRACT GU; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061; Volans AP, 1998, J ACCID EMERG MED, V15, P159	41	14	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0402	2163-0933		NEUROL-CLIN PRACT	Neurol.-Clin. Pract.	AUG	2017	7	4					296	305		10.1212/CPJ.0000000000000375			10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	FT9RB	WOS:000423488100009	29185534	Green Published			2022-02-06	
J	Gugliandolo, A; Caio, C; Mezzatesta, ML; Rifici, C; Bramanti, P; Stefani, S; Mazzon, E				Gugliandolo, Agnese; Caio, Carla; Mezzatesta, Maria Lina; Rifici, Carmela; Bramanti, Placido; Stefani, Stefania; Mazzon, Emanuela			Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury A case report	MEDICINE			English	Article						ceftazidime-avibactam; chest trauma; Enterobacteriaceae; Klebsiella pneumoniae; traumatic brain injury	CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; BLOOD-STREAM INFECTIONS; BETA-LACTAMASES; COMBINATION; BACTEREMIA; MORTALITY; EMERGENCE; THERAPY; STRAINS; OPTIONS	Rationale: Carbapenem-resistant Enterobacteriaceae infections are a serious health care problem, because of the high mortality. Carbapenem resistance is mainly caused by carbapenemases production, including Klebsiella pneumoniae carbapenemase (KPC). Ceftazidime-avibactam is a new cephalosporin/beta-lactamase inhibitor combination for the treatment of complicated urinary, intra-abdominal infections, and nosocomial pneumonia caused by gram negative, or other serious gram-negative infections. Patient concerns: We showed the case of a 27-year-old patient, hospitalized for traumatic brain injury and chest trauma, with KPC-producing Klebsiella pneumoniae infection. Diagnoses: Blood and bronchial aspirate culture analysis detected an infection caused by MDR Klebsiella pneumoniae, resistant to meropenem, ertapenem, piperacillin/tazobactam, amoxicillin/clavulanic acid, aztreonam, ceftazidime, cefotaxime, cefepime, amikacin, ciprofloxacin, trimethoprim/sulfamethoxazole, colistin while it showed an intermediate sensitivity to gentamicin and was sensitive to ceftazidime-avibactam. Molecular analyses revealed that the isolate belonged to the epidemic clone sequence type 258 (ST258) carrying blaKPC-3, blaTEM-1, and blaSHV-11genes. Interventions: After various combined antibiotic therapies without improvements, he was treated with ceftazidime-avibactam, on a compassionate-use basis. Outcomes: With ceftazidime-avibactam monotherapy clinical and microbiological clearance was obtained. A week after the end of the therapy microbiological analysis was repeated and a positive rectal swab for KPC-Klebsiella pneumoniae was found, becoming negative after 1 month. Moreover, the patient did not show any relapses for up to 18 weeks. Lessons: This case indicates that ceftazidime-avibactam monotherapy could be efficacious against KPC positive Klebsiella pneumoniae infections.	[Gugliandolo, Agnese; Rifici, Carmela; Bramanti, Placido; Mazzon, Emanuela] IRCCS Ctr Neurolesi Bonino Pulejo, Via Provinciale Palermo, I-98124 Messina, Italy; [Caio, Carla; Mezzatesta, Maria Lina; Stefani, Stefania] Univ Catania, Sect Microbiol, Dept Biomed & Biotechnol Sci, Catania, Italy		Mazzon, E (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Via Provinciale Palermo, I-98124 Messina, Italy.	emazzon.irccs@gmail.com	Rifici, Carmela/ABH-4398-2020; Bramanti, Placido/K-5117-2016; Mazzon, Emanuela/AAL-4334-2020; Gugliandolo, Agnese/AAA-5466-2019	Gugliandolo, Agnese/0000-0002-7868-3353; mazzon, emanuela/0000-0002-5073-717X			Camargo JF, 2015, ANTIMICROB AGENTS CH, V59, P5903, DOI 10.1128/AAC.00655-15; da Silva RM, 2012, EXPERT OPIN BIOL TH, V12, P663, DOI 10.1517/14712598.2012.681369; Daikos GL, 2014, ANTIMICROB AGENTS CH, V58, P2322, DOI 10.1128/AAC.02166-13; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Doi Y, 2015, SEMIN RESP CRIT CARE, V36, P74, DOI 10.1055/s-0035-1544208; Falcone M, 2016, J ANTIMICROB CHEMOTH, V71, P2713, DOI 10.1093/jac/dkw239; Gona F, 2014, CLIN MICROBIOL INFEC, V20, pO633, DOI 10.1111/1469-0691.12577; Gootz TD, 2009, ANTIMICROB AGENTS CH, V53, P1998, DOI 10.1128/AAC.01355-08; Hackel M, 2016, ANTIMICROB AGENTS CH, V60, P4677, DOI 10.1128/AAC.02841-15; Jacobs DM, 2016, INT J ANTIMICROB AG, V48, P225, DOI 10.1016/j.ijantimicag.2016.06.002; Krapp F, 2017, INT J ANTIMICROB AG, V49, P770, DOI 10.1016/j.ijantimicag.2017.01.018; Lee CH, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.025; Lee CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00895; Levasseur P, 2015, ANTIMICROB AGENTS CH, V59, P1931, DOI 10.1128/AAC.04218-14; Levasseur P, 2014, ANTIMICROB AGENTS CH, V58, P6490, DOI 10.1128/AAC.03579-14; Mezzatesta ML, 2016, MICROB DRUG RESIST, V22, P360, DOI 10.1089/mdr.2015.0160; Mezzatesta ML, 2013, J ANTIMICROB CHEMOTH, V68, P1932, DOI 10.1093/jac/dkt116; Monari C, 2016, ADV EXP MED BIOL, V901, P91, DOI 10.1007/5584_2015_5018; Pagani L, 2003, J CLIN MICROBIOL, V41, P4264, DOI 10.1128/JCM.41.9.4264-4269.2003; Perilli M, 2008, MICROB DRUG RESIST, V14, P45, DOI 10.1089/mdr.2008.0765; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Sharma R, 2016, CLIN THER, V38, P431, DOI 10.1016/j.clinthera.2016.01.018; Trecarichi EM, 2017, VIRULENCE, V8, P470, DOI 10.1080/21505594.2017.1292196; Tumbarello M, 2015, J ANTIMICROB CHEMOTH, V70, P2133, DOI 10.1093/jac/dkv086; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Tuon FF, 2017, BRAZ J INFECT DIS, V21, P1, DOI 10.1016/j.bjid.2016.09.008; Veillette JJ, 2016, PHARMACOTHERAPY, V36, pE172, DOI 10.1002/phar.1840; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Wu G, 2016, CLIN INFECT DIS, V63, P1147, DOI 10.1093/cid/ciw491; Zacharczuk K, 2011, ANTIMICROB AGENTS CH, V55, P443, DOI 10.1128/AAC.00386-10	31	14	15	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	AUG	2017	96	31							e7664	10.1097/MD.0000000000007664			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD0GC	WOS:000407216800024	28767588	Green Published, gold			2022-02-06	
J	Molloy, JH; Murphy, I; Gissane, C				Molloy, John H.; Murphy, Ian; Gissane, Conor			The King-Devick (K-D) test and concussion diagnosis in semi-professional rugby union players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						King-Devick test; Sport concussion assessment tool; Brain concussion; Post-concussion syndrome; Vision tests; Rugby	VISUAL SCREENING TOOL	Objectives: To determine the utility of the King-Devick (K-D) test in identifying sports-related concussion in semi-professional rugby players. Design: Descriptive cohort study. Methods: 176 male players were recruited from a semi-professional rugby union competition in New Zealand (NZ). Baseline K-D scores were obtained in the pre-season. Post-match K-D and Pitch Side Concussion Assessment Version 2 (PSCA2) scores were obtained in those with suspected concussion. Post-match K-D scores were also administered to selected control players. Results: 19 concussions in 18 players were analysed. In addition, 33 controls were used for analysis. A positive K-D test was identified in 53% of players with concussion post-match. Conversely, a positive test was identified in 33% of controls. The sensitivity and specificity of the K-D test was calculated as 53% and 69% respectively. The positive predictive value and negative predictive value was 48% and 73% respectively. The PSCA2 correctly identified 74% of concussions. The K-D test identified 3 cases not identified by the PSCA2. When the PSCA2 and K-D were combined, 89% of concussions were correctly identified. Conclusions: The K-D test does not appear to be effective if used as a stand-alone test for the diagnosis of concussion. However, if used alongside current side-line cognitive and balance tests, it may assist in more accurately diagnosing sports-related concussion. Further research should look to utilise the K-D test in in-match protocols to establish if this improves the diagnostic accuracy of in-match protocols for sports-related concussion. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Molloy, John H.] Australasian Coll Sport & Exercise Phys, Melbourne, Vic, Australia; [Murphy, Ian] New Zealand Rugby Union, Wellington, New Zealand; [Gissane, Conor] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England		Molloy, JH (corresponding author), Australasian Coll Sport & Exercise Phys, Melbourne, Vic, Australia.	drjohnmolloy@gmail.com	Gissane, Conor/I-3661-2019	Gissane, Conor/0000-0003-4677-3853			Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K.M., 2015, J NEURO-OPHTHALMOL, P1; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Marindes Z, 2014, NEUROL CLIN PRACT, P1; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; WorldRugby, 2015, WORLD RUGB CONC MAN	13	14	14	1	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	AUG	2017	20	8					708	711		10.1016/j.jsams.2017.02.002			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FC5PE	WOS:000406893400002	28258820	Green Accepted			2022-02-06	
J	Ottomanelli, L; Goetz, LL; Barnett, SD; Njoh, E; Dixon, TM; Holmes, SA; LePage, JP; Ota, D; Sabharwal, S; White, KT				Ottomanelli, Lisa; Goetz, Lance L.; Barnett, Scott D.; Njoh, Eni; Dixon, Thomas M.; Holmes, Sally Ann; LePage, James P.; Ota, Doug; Sabharwal, Sunil; White, Kevin T.			Individual Placement and Support in Spinal Cord Injury: A Longitudinal Observational Study of Employment Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Employment, supported; Rehabilitation; Rehabilitation, vocational; Spinal cord injuries; Veterans	QUALITY-OF-LIFE; VOCATIONAL INTERESTS; VETERANS; WORK; INTERVENTIONS; FIDELITY; PROGRAM; PEOPLE; RETURN; REHABILITATION	Objective: To determine the effects of a 24-month program of Individual Placement and Support (IPS) supported employment (SE) on employment outcomes for veterans with spinal cord injury (SCI). Design: Longitudinal, observational multisite study of a single-arm, nonrandomized cohort. Setting: SCI centers in the Veterans Health Administration (n=7). Participants: Veterans with SCI (N=213) enrolled during an episode of either inpatient hospital care (24.4%) or outpatient care (75.6%). More than half the sample (59.2%) had a history of traumatic brain injury (TBI). Intervention: IPS SE for 24 months. Main Outcome Measure: Competitive employment. Results: Over the 24-month period, 92 of 213 IPS participants obtained competitive jobs for an overall employment rate of 43.2%. For the subsample of participants without TBI enrolled as outpatients (n=69), 36 obtained competitive jobs for an overall employment rate of 52.2%. Overall, employed participants averaged 38.2 +/- 29.7 weeks of employment, with an average time to first employment of 348.3 +/- 220.0 days. Nearly 25% of first jobs occurred within 4 to 6 months of beginning the program. Similar employment characteristics were observed in the subsample without TBI history enrolled as outpatients. Conclusions: Almost half of the veterans with SCI participating in the 24-month IPS program as part of their ongoing SCI care achieved competitive employment, consistent with their expressed preferences at the start of the study. Among a subsample of veterans without TBI history enrolled as outpatients, employment rates were >50%. Time to first employment was highly variable, but quite long in many instances. These findings support offering continued IPS services as part of ongoing SCI care to achieve positive employment outcomes. (C) 2017 by the American Congress of Rehabilitation Medicine	[Ottomanelli, Lisa; Barnett, Scott D.; Njoh, Eni; White, Kevin T.] James A Haley Vet Hosp, Vet Affairs Hlth Serv Res & Dev, Ctr Innovat Disabil & Rehabil Res, Tampa, FL 33612 USA; [Ottomanelli, Lisa] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Tampa, FL USA; [Goetz, Lance L.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Goetz, Lance L.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Dixon, Thomas M.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland, OH USA; [Holmes, Sally Ann] Michael E DeBakey VA Med Ctr, Houston, TX USA; [LePage, James P.] Vet Affairs North Texas Healthcare Syst, Dallas, TX USA; [LePage, James P.] Univ Texas Southwestern Med Sch, Dept Psychiat, Dallas, TX USA; [Ota, Doug] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Ota, Doug] Stanford Univ, Div Phys Med & Rehabil, Stanford, CA 94305 USA; [Sabharwal, Sunil] Vet Affairs Boston Hlth Care Syst, Boston, MA USA; [Sabharwal, Sunil] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA		Ottomanelli, L (corresponding author), James A Haley Vet Hosp, 8900 Grand Oak Circle, Tampa, FL 33637 USA.	lisa.ottomanelli-slone@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [O7824R]	Supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service (project no. O7824R).	Anderson D, 2007, J VOCAT REHABIL, V27, P57; Becker DR, 2011, AM J PSYCHIATR REHAB, V14, P230, DOI 10.1080/15487768.2011.598083; Becker DR, 2006, EVID-BASED MENT HEAL, V9, P22, DOI 10.1136/ebmh.9.1.22; Bond GR, 2008, PSYCHIATR REHABIL J, V31, P300, DOI 10.2975/31.4.2008.300.305; Bond GR, 1997, REHABIL COUNS BULL, V40, P265; Bond GR, 2001, PSYCHIATR SERV, V52, P313, DOI 10.1176/appi.ps.52.3.313; Bond GR, 2004, PSYCHIATR REHABIL J, V27, P345, DOI 10.2975/27.2004.345.359; BOND GR, 2001, J MENTAL HLTH, V10, P383, DOI DOI 10.1080/09638230124258; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Drake RE, 2012, INDIVIDUAL PLACEMENT; Ferdiana A, 2014, J REHABIL MED, V46, P984, DOI 10.2340/16501977-1873; Franceschini M, 2012, SPINAL CORD, V50, P238, DOI 10.1038/sc.2011.131; GUTTMANN L, 1954, P ROY SOC MED, V47, P1099, DOI 10.1177/003591575404701226; Kennedy P, 2006, SPINAL CORD, V44, P95, DOI 10.1038/sj.sc.3101787; Kennedy P, 2016, SPINAL CORD, V54, P141, DOI 10.1038/sc.2015.122; Krause JS, 2010, J VOCAT REHABIL, V33, P89, DOI 10.3233/JVR-2010-0518; Krause James S, 2015, Top Spinal Cord Inj Rehabil, V21, P189, DOI 10.1309/sci2103-189; Krause JS, 2014, REHABIL PSYCHOL, V59, P321, DOI 10.1037/a0037265; Krause JS, 2012, ARCH PHYS MED REHAB, V93, P373, DOI 10.1016/j.apmr.2011.09.006; Krause JS, 2011, ARCH PHYS MED REHAB, V92, P626, DOI 10.1016/j.apmr.2010.11.026; KRAUSE JS, 1992, REHABIL COUNS BULL, V35, P218; Krause JS, 1999, ARCH PHYS MED REHAB, V80, P1492; Latimer EA, 2004, PSYCHIAT SERV, V55, P401, DOI 10.1176/appi.ps.55.4.401; Leduc BE, 2002, DISABIL REHABIL, V24, P196, DOI 10.1080/09638280110067603; Marini I, 2008, J VOCAT REHABIL, V28, P1; Marshall T, 2014, PSYCHIAT SERV, V65, P16, DOI 10.1176/appi.ps.201300262; Meade Michelle A, 2015, Top Spinal Cord Inj Rehabil, V21, P1, DOI 10.1310/sci2101-1; Ottomanelli L, 2016, HDB RETURN WORK RES, P519; Ottomanelli Lisa, 2015, Top Spinal Cord Inj Rehabil, V21, P31, DOI 10.1310/sci2101-31; Ottomanelli L, 2014, ARCH PHYS MED REHAB, V95, P784, DOI 10.1016/j.apmr.2013.11.012; Ottomanelli L, 2013, QUAL LIFE RES, V22, P2133, DOI 10.1007/s11136-013-0353-5; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Ottomanelli L, 2009, J REHABIL RES DEV, V46, P919, DOI 10.1682/JRRD.2008.10.0145; Ottomanelli L, 2009, J SPINAL CORD MED, V32, P503, DOI 10.1080/10790268.2009.11754553; Roels EH, 2016, SPINAL CORD, V54, P2, DOI 10.1038/sc.2015.133; Rohe DE, 1999, REHABIL PSYCHOL, V44, P160, DOI 10.1037/0090-5550.44.2.160; Sinnott PL, 2014, ARCH PHYS MED REHAB, V95, P1254, DOI 10.1016/j.apmr.2014.01.010; Trenaman LM, 2014, SPINAL CORD, V52, P788, DOI 10.1038/sc.2014.149; Trenaman L, 2015, J SPINAL CORD MED, V38, P422, DOI 10.1179/2045772315Y.0000000031; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; WEST M, 1991, ARCH PHYS MED REHAB, V72, P127; World Health Organization & ISCOS, 2014, INT PERSP SPIN CORD	42	14	14	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2017	98	8					1567	1575		10.1016/j.apmr.2016.12.010			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FD1OF	WOS:000407305900009	28115071				2022-02-06	
J	Peters, J; Van Wageningen, B; Hoogerwerf, N; Tan, E				Peters, Joost; Van Wageningen, Bas; Hoogerwerf, Nico; Tan, Edward			Near-Infrared Spectroscopy: A Promising Prehospital Tool for Management of Traumatic Brain Injury	PREHOSPITAL AND DISASTER MEDICINE			English	Article						diagnostic equipment; infrared spectrophotometry; prehospital emergency care; traumatic brain injury	CT-SCAN; CHILDREN; DEVICE; INFRASCANNER; HEMATOMAS	Introduction: Early identification of traumatic brain injury (TBI) is essential. Near-infrared spectroscopy (NIRS) can be used in prehospital settings for non-invasive monitoring and the diagnosis of patients who may require surgical intervention. Methods: The handheld NIRS Infrascanner (InfraScan Inc.; Philadelphia, Pennsylvania USA) uses eight symmetrical scan points to detect intracranial bleeding. A scanner was tested in a physician-staffed helicopter Emergency Medical Service (HEMS). The results were compared with those obtained using in-hospital computed tomography (CT) scans. Scan time, ease-of-use, and change in treatment were scored. Results: A total of 25 patients were included. Complete scans were performed in 60% of patients. In 15 patients, the scan was abnormal, and in one patient, the scan resulted in a treatment change. Compared with the results of CT scanning, the Infrascanner obtained a sensitivity of 93.3% and a specificity of 78.6%. Most patients had severe TBI with indication for transport to a trauma center prior to scanning. In one patient, the scan resulted in a treatment change. Evaluation of patients with less severe TBI is needed to support the usefulness of the Infrascanner as a prehospital triage tool. Conclusion: Promising results were obtained using the InfraScan NIRS device in prehospital screening for intracranial hematomas in TBI patients. High sensitivity and good specificity were found. Further research is necessary to determine the beneficial effects of enhanced prehospital screening on triage, survival, and quality of life in TBI patients.	[Peters, Joost; Van Wageningen, Bas; Tan, Edward] Radboud Univ Nijmegen, Med Ctr, Dept Trauma Surg, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands; [Peters, Joost; Van Wageningen, Bas; Hoogerwerf, Nico; Tan, Edward] Radboud Univ Nijmegen, Med Ctr, Helicopter Emergency Med Serv, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands; [Hoogerwerf, Nico] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands		Peters, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Surg, Geert Grootepl Zuid 10, NL-6525 GA Nijmegen, Netherlands.	Joost.Peters@radboudumc.nl	Tan, E.C.T.H./L-4681-2015; Peters, Joost/L-4573-2015; Hoogerwerf, Nico/L-4388-2015	Tan, E.C.T.H./0000-0002-9978-249X; Peters, Joost/0000-0002-5774-2617; Hoogerwerf, Nico/0000-0003-1815-6989			Bajoghli M, 2010, INT J PREVENTIVE MED, V1, P220; Blume Heidi K, 2012, Evid Based Med, V17, pe11, DOI 10.1136/ebmed-2012-100574; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Braun T, 2014, UNFALLCHIRURG; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Bressan S, 2014, CHILD NERV SYST, V30, P477, DOI [10.1007/s00381-014-2368-9, 10.1007/s00381-013-2314-2]; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Hoogmartens O, 2014, PREHOSP EMERG CARE, V18, P265, DOI 10.3109/10903127.2013.856506; Hoshiko S, 2014, PEDIATR RADIOL, V44, P522, DOI 10.1007/s00247-014-2881-8; Katzenberger RJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04790; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; Tan EC, 2015, NETHERLANDS MIL MED, V68, P22	18	14	15	0	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-023X	1945-1938		PREHOSP DISASTER MED	Prehospital Disaster Med.	AUG	2017	32	4					414	418		10.1017/S1049023X17006367			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FO3EO	WOS:000416701000010	28351447				2022-02-06	
J	Radabaugh, HL; LaPorte, MJ; Greene, AM; Bondi, CO; Lajud, N; Kline, AE				Radabaugh, Hannah L.; LaPorte, Megan J.; Greene, Anna M.; Bondi, Corina O.; Lajud, Naima; Kline, Anthony E.			Refining environmental enrichment to advance rehabilitation based research after experimental traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Behavioral outcome; Controlled cortical impact; Environmental enrichment; Functional recovery; Learning and memory; Morris water maze; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; RANDOMIZED CONTROLLED-TRIAL; RECEPTOR AGONIST 8-OH-DPAT; COGNITIVE FLEXIBILITY; HISTOLOGICAL BENEFITS; TREATMENT REGIMEN; CLINICAL-TRIALS; FEMALE RATS; RECOVERY; DEFICITS	The typical environmental enrichment (EE) paradigm, which consists of continuous exposure after experimental traumatic brain injury (TBI), promotes behavioral and histological benefits. However, rehabilitation is often abbreviated in the clinic and administered in multiple daily sessions. While recent studies have demonstrated that a once daily 6-hr bout of EE confers benefits comparable to continuous EE, breaking the therapy into two shorter sessions may increase novelty and ultimately enhance recovery. Hence, the aim of the study was to test the hypothesis that functional and histological outcomes will be significantly improved by daily preclinical neurorehabilitation consisting of two 3-hr periods of EE vs. a single 6-hr session. Anesthetized adult male rats received a controlled cortical impact of moderate-to-severe injury (2.8 mm tissue deformation at 4 m/s) or sham surgery and were then randomly assigned to groups receiving standard (STD) housing, a single 6-hr session of EE, or two 3-hr sessions of EE daily for 3 weeks. Motor function (beam-balance/traversal) and acquisition of spatial learning/memory retention (Morris water maze) were assessed on post-operative days 1-5 and 14-19, respectively. Cortical lesion volume was quantified on day 21. Both EE conditions improved motor function and acquisition of spatial learning, and reduced cortical lesion volume relative to STD housing (p < 0.05), but did not differ from one another in any endpoint (p > 0.05). The findings replicate previous work showing that 6-hr of EE daily is sufficient to confer behavioral and histological benefits after TBI and extend the findings by demonstrating that the benefits are comparable regardless of how the 6-hrs of EE are accrued. The relevance of the finding is that it can be extrapolated to the clinic and may benefit patients who cannot endure a single extended period of neurorehabilitation. (C) 2017 Elsevier Inc. All rights reserved.	[Radabaugh, Hannah L.; LaPorte, Megan J.; Greene, Anna M.; Bondi, Corina O.; Lajud, Naima; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Radabaugh, Hannah L.; LaPorte, Megan J.; Greene, Anna M.; Bondi, Corina O.; Lajud, Naima; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Lajud, Naima] Inst Mexicano Seguro Social Morelia, Ctr Invest Biomed Michoacan, Div Neurociencias, Morelia, Michoacan, Mexico; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15213 USA		Kline, AE (corresponding author), Univ Pittsburgh, John G Rangos Res Ctr, Childrens Hosp Pittsburgh, Psychol,Phys Med & Rehabil,Crit Care Med,Sch Med, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Ctr Neurosci, Sch Med, Childrens Hosp Pittsburgh,John G Rangos Res Ctr, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, HD069620-S1, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; UMPC Rehabilitation Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS099683, R01NS060005, R01NS084967, R03NS094950] Funding Source: NIH RePORTER	This work was supported, in part, by NIH grants HD069620, HD069620-S1, NS060005, NS084967 (AEK), NS094950, NS099683 (COB), the University of Pittsburgh Physicians/UPMC Academic Foundation, and the UMPC Rehabilitation Institute (COB).	Adelson PD, 1998, ACT NEUR S, V71, P104; Barry NC, 2015, J CLIN EXP NEUROPSYC, V37, P994, DOI 10.1080/13803395.2015.1038981; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Carlson SW, 2017, EXP NEUROL, V289, P55, DOI 10.1016/j.expneurol.2016.12.006; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; De Bartolo P, 2008, NEUROSCIENCE, V154, P444, DOI 10.1016/j.neuroscience.2008.03.069; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hart T, 2016, ARCH PHYS MED REHAB, V97, P2045, DOI 10.1016/j.apmr.2016.07.012; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Homeman G., 2009, BRAIN INJURY, V23, P907; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Leary JB, 2017, J NEUROTRAUM, V34, P444, DOI 10.1089/neu.2016.4438; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Richter KM, 2015, J CLIN EXP NEUROPSYC, V37, P571, DOI 10.1080/13803395.2015.1030358; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Zeleznikow-Johnston A, 2017, NEUROPHARMACOLOGY, V117, P219, DOI 10.1016/j.neuropharm.2017.02.009; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	50	14	14	1	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2017	294						12	18		10.1016/j.expneurol.2017.04.013			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY6FA	WOS:000404076700002	28457905	Green Accepted			2022-02-06	
J	Turner, S; Langdon, J; Shaver, G; Graham, V; Naugle, K; Buckley, T				Turner, Samantha; Langdon, Jody; Shaver, George; Graham, Victoria; Naugle, Kelly; Buckley, Thomas			Comparison of Psychological Response Between Concussion and Musculoskeletal Injury in Collegiate Athletes	SPORT EXERCISE AND PERFORMANCE PSYCHOLOGY			English	Article						profile of mood states; state-trait anxiety inventory; concussion; recovery	SPORT-RELATED CONCUSSION; MANAGEMENT PRACTICE PATTERNS; CONSENSUS STATEMENT; POSTURAL CONTROL; BRAIN-INJURY; DEPRESSION; RECOVERY; SYMPTOMS; RELIABILITY; PREVALENCE	The psychological response to musculoskeletal injuries has been well documented; however, research on the psychological response to concussion is limited. The Profile of Mood States (POMS) and the State-Trait Anxiety Inventory (STAI) have recently been used to assess the psychological recovery of concussions (CONC). Although some studies indicate that psychological response is different for musculoskeletal injuries and concussion, there is currently not enough information to indicate this difference occurs at specific clinical milestones. The purpose of this study was to compare the psychological responses of student-athletes who have been diagnosed with a concussion to those of athletes diagnosed with musculoskeletal injuries with similar recovery duration. Fifteen collegiate athletes who sustained a musculoskeletal injury were recruited and matched with 15 previously collected concussion participants. The main outcome measures were the scores of POMS constructs: tension-anxiety, anger-hostility, fatigue-inertia, depression-dejection, vigor-activity, confusion- bewilderment, and total mood disturbance and STAI (state anxiety only). Two-way MANOVAs were run to determine the effects of group and time on POMS and STAI constructs. There were no significant interactions identified, but follow-up ANOVAs identified a main effect for time for most POMS subscales, with POMS scores improving over time in both groups. Analyses also revealed that tension-anxiety, vigor-activity and the STAI were not affected by time or group. The findings of this study that both groups' psychological response to injury improves over time and at similar clinical milestones suggests reduction in sports and team-related activities may play a substantial role in the psychological response to either concussion or musculoskeletal injury.	[Turner, Samantha] Keiser Univ, Athlet Dept, Ft Lauderdale, FL USA; [Langdon, Jody] Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA 30460 USA; [Shaver, George] Georgia Southern Univ, Dept Psychol, Statesboro, GA 30460 USA; [Graham, Victoria] Sport Safety Consulting, Cromwell, CT USA; [Naugle, Kelly] Indiana Univ Purdue Univ Indianapolis, Sch Phys Educ & Tourism Management, Indianapolis, IN USA; [Buckley, Thomas] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA		Langdon, J (corresponding author), Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA 30460 USA.	jlangdon@georgiasouthern.edu	Langdon, Jody/AAY-4638-2021; Naugle, Kelly/AAQ-1628-2021; Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Langdon, Jody/0000-0002-5589-1694	National Institute of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS070744-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS070744] Funding Source: NIH RePORTER	This study was supported by the National Institute of Health/National Institute of Neurological Disorders and Stroke (1R15NS070744-01A1). The funding source had no role in the study design, data collection and interpretation, or decision to submit this article for publication.	Abend R, 2014, J BEHAV THER EXP PSY, V45, P447, DOI 10.1016/j.jbtep.2014.06.004; ANTONY MM, 2001, PRACTITIONERS GUIDE; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Gouttebarge V., 2016, CLIN J SPORT MED, V12, P12; GROVE JR, 1992, INT J SPORT PSYCHOL, V23, P93; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring L, 2012, J CLIN SPORT PSYCHOL, V6, P247, DOI 10.1123/jcsp.6.3.247; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Moore RD, 2016, BRAIN IMAGING BEHAV, V10, P1108, DOI 10.1007/s11682-015-9473-6; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Neal TL, 2013, J ATHL TRAINING, V48, P716, DOI 10.4085/1062-6050-48.4.13; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Singh R, 2016, J NEUROL NEUROSUR PS, V87, P670, DOI 10.1136/jnnp-2015-311369; Spielberger CD, 1970, MANUAL STATE TRAIT A; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Udry E, 1997, J SPORT EXERCISE PSY, V19, P368, DOI 10.1123/jsep.19.4.368; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Vincent HK, 2015, PM&R, V7, P978, DOI 10.1016/j.pmrj.2015.03.007; Wiese-Bjornstal D., 2015, KINESIOLOGY REV, V4, P169; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	47	14	14	2	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	2157-3905	2157-3913		SPORT EXERC PERFORM	Sport Exerc. Perform. Psychol.	AUG	2017	6	3					277	288		10.1037/spy0000099			12	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	FD8RW	WOS:000407792800007	29250458	Green Accepted, Bronze, Green Submitted			2022-02-06	
J	Antonakakis, M; Dimitriadis, SI; Zervakis, M; Papanicolaou, AC; Zouridakis, G				Antonakakis, Marios; Dimitriadis, Stavros I.; Zervakis, Michalis; Papanicolaou, Andrew C.; Zouridakis, George			RECONFIGURATION OF DOMINANT COUPLING MODES IN MILD TRAUMATIC BRAIN INJURY MEDIATED BY delta-BAND ACTIVITY: A RESTING STATE MEG STUDY	NEUROSCIENCE			English	Article						magnetoencephalography (MEG); mild traumatic brain injury (mTBI); cross-frequency coupling; intrinsic networks; brain network models	RICH-CLUB ORGANIZATION; SMALL-WORLD NETWORKS; FUNCTIONAL CONNECTIVITY; IMAGING APPROACH; FREQUENCY; MAGNETOENCEPHALOGRAPHY; DYNAMICS; THETA; REORGANIZATION; FLUCTUATIONS	During the last few years, rich-club (RC) organization has been studied as a possible brain-connectivity organization model for large-scale brain networks. At the same time, empirical and simulated data of neurophysiological models have demonstrated the significant role of intra-frequency and inter-frequency coupling among distinct brain areas. The current study investigates further the importance of these couplings using recordings of resting state magnetoencephalographic activity obtained from 30 mild traumatic brain injury (mTBI) subjects and 50 healthy controls. Intra-frequency and inter-frequency coupling modes are incorporated in a single graph to detect group differences within individual rich-club subnetworks (type I networks) and networks connecting RC nodes with the rest of the nodes (type II networks). Our results show a higher probability of inter-frequency coupling for (delta-gamma(1)), (delta-gamma(2)), (theta-beta), (theta-gamma(2)), (alpha-gamma(2)), (gamma(1)-gamma(2)) and intra-frequency coupling for (gamma(1)-gamma(1)) and (delta-delta) for both type I and type II networks in the mTBI group. Additionally, mTBI and control subjects can be correctly classified with high accuracy (98.6%), whereas a general linear regression model can effectively predict the subject group using the ratio of type I and type II coupling in the (delta, theta), (delta, beta), (delta, gamma(1)), and (delta, gamma(2)) frequency pairs. These findings support the presence of an RC organization simultaneously with dominant frequency interactions within a single functional graph. Our results demonstrate a hyperactivation of intrinsic RC networks in mTBI subjects compared to controls, which can be seen as a plausible compensatory mechanism for alternative frequency-dependent routes of information flow in mTBI subjects. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Antonakakis, Marios] Westfalian Wilhelms Univ Muenster, Inst Biomagnetism & Biosignal Anal, D-48149 Munster, Germany; [Antonakakis, Marios; Zervakis, Michalis] Tech Univ Crete, Sch Elect & Comp Engn, Digital Image & Signal Proc Lab, Khania 73100, Greece; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Dimitriadis, Stavros I.] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff, S Glam, Wales; [Papanicolaou, Andrew C.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Papanicolaou, Andrew C.] Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Papanicolaou, Andrew C.] Le Bonheur Childrens Hosp, Neurosci Inst, Memphis, TN USA; [Zouridakis, George] Univ Houston, Biomed Imaging Lab, Dept Engn Technol, 4730 Calhoun Rd Room 300, Houston, TX USA; [Zouridakis, George] Univ Houston, Biomed Imaging Lab, Dept Engn Technol, 4730 Calhoun Rd Room 300, Houston, TX USA		Antonakakis, M (corresponding author), Westfalian Wilhelms Univ Muenster, Inst Biomagnetism & Biosignal Anal, D-48149 Munster, Germany.	marios.antonakakis@uni-muenster.de; stidimitriadis@gmail.com; michalis@display.tuc.gr; apapanic@uthsc.edu; zouridakis@uh.edu	Antonakakis, Marios/ABD-8218-2020; DIMITRIADIS, STAVROS I/AAN-8992-2020; Zouridakis, George/R-8876-2019	Antonakakis, Marios/0000-0003-1173-7895; DIMITRIADIS, STAVROS I/0000-0002-0000-5392; Zouridakis, George/0000-0002-7770-9857	Department of Defense Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH-08-2-0135]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K004360/1]; EU-UK	The current study is part of a larger project, the Integrated Clinical Protocol, conducted by the Investigators and staff of The Mission Connect Mild Traumatic Brain Injury Translational Research Consortium and supported by the Department of Defense Congressionally Directed Medical Research Program W81XWH-08-2-0135. SID was supported by MRC grant MR/K004360/1 (Behavioural and Neurophysiological Effects of Schizophrenia Risk Genes: A Multi-locus, Pathway Based Approach) and by EU-UK COFUND FELLOWSHIP.	Alawieh A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13513; Antonakakis M, 2016, C P IEEE ENG MED BIO; Antonakakis M, 2016, IEEE CONF IMAGING SY, P156, DOI 10.1109/IST.2016.7738215; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Antonakakis M, 2015, IEEE ENG MED BIO, P7426, DOI 10.1109/EMBC.2015.7320108; Arakaki X, 2017, BRAIN INJURY, V31, P1016; Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Assistant Secretary D. O. D, 2007, TRAUM BRAIN INJ DEF; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Crossley NA, 2016, SCHIZOPHRENIA BULL, V42, P434, DOI 10.1093/schbul/sbv146; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimitriadis SI, 2015, COGN NEURODYNAMICS, V9, P371, DOI 10.1007/s11571-015-9330-8; Dimitriadis SI, 2013, NEUROIMAGE, V83, P307, DOI 10.1016/j.neuroimage.2013.06.036; Dimitriadis SI, 2013, IEEE ENG MED BIO, P2940, DOI 10.1109/EMBC.2013.6610156; Dimitriadis SI, 2013, BRAIN TOPOGR, V26, P397, DOI 10.1007/s10548-013-0276-z; Dimitriadis S, 2016, IEEE T NEUR SYS REH, V24, P1017, DOI 10.1109/TNSRE.2016.2516107; Dimitriadis SI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00163; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dimitriadis SI, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00350; Dimitriadis SI, 2015, ANN BIOMED ENG, V43, P977, DOI 10.1007/s10439-014-1143-0; Dimitriadis SI, 2009, BRAIN TOPOGR, V22, P119, DOI 10.1007/s10548-008-0071-4; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Escudero J, 2011, ANN BIOMED ENG, V39, P2274, DOI 10.1007/s10439-011-0312-7; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HORN RA, 1990, SIAM J MATRIX ANAL A, V11, P481, DOI 10.1137/0611034; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Levin H. S., 2009, MISSION CONNECT MILD, DOI 10.21236/ADA550012; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Li LY, 2017, BRAIN INJURY, V31, P965; Li LY, 2015, IEEE ENG MED BIO, P6963, DOI 10.1109/EMBC.2015.7319994; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Martin-Buro MC, 2016, HUM BRAIN MAPP, V37, P179, DOI 10.1002/hbm.23027; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Misic B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003427; Mvula E, 2017, BRAIN INJURY, V31, P956; Niyogi P., 2005, ADV NEURAL INF PROCE, V18; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palva JM, 2011, PROG BRAIN RES, V193, P335, DOI 10.1016/B978-0-444-53839-0.00022-3; Pang EW, 2016, ANN CLIN TRANSL NEUR, V3, P124, DOI 10.1002/acn3.280; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Senden M, 2014, NEUROIMAGE, V96, P174, DOI 10.1016/j.neuroimage.2014.03.066; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vertes PE, 2015, J CHILD PSYCHOL PSYC, V56, P299, DOI 10.1111/jcpp.12365; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Watanabe T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16152; Xu XX, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00027; Zouridakis G., 2016, 20 INT C BIOM BIOMAG; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	69	14	14	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 25	2017	356						275	286		10.1016/j.neuroscience.2017.05.032			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EZ9MZ	WOS:000405055800025	28576727	Green Accepted, Green Submitted			2022-02-06	
J	Ware, JB; Hart, T; Whyte, J; Rabinowitz, A; Detre, JA; Kim, J				Ware, Jeffrey B.; Hart, Tessa; Whyte, John; Rabinowitz, Amanda; Detre, John A.; Kim, Junghoon			Inter-Subject Variability of Axonal Injury in Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; diffusion tensor imaging; traumatic axonal injury; traumatic brain injury	WHITE-MATTER MICROSTRUCTURE; MR-IMAGES; TENSOR; MODEL; MODERATE; REGISTRATION; ORIENTATION; PERFORMANCE; INFERENCE; SCLEROSIS	Traumatic brain injury (TBI) is a leading cause of cognitive morbidity worldwide for which reliable biomarkers are needed. Diffusion tensor imaging (DTI) is a promising biomarker of traumatic axonal injury (TAI); however, existing studies have been limited by a primary reliance on group-level analytic methods not well suited to account for inter-subject variability. In this study, 42 adults with TBI of at least moderate severity were examined 3 months following injury and compared with 35 healthy controls. DTI data were used for both traditional group-level comparison and subject-specific analysis using the distribution-corrected Z-score (DisCo-Z) approach. Inter-subject variation in TAI was assessed in a threshold-invariant manner using a threshold-weighted overlap map derived from subject-specific analysis. Receiver operator curve analysis was used to examine the ability of subject-specific DTI analysis to identify TBI subjects with significantly impaired processing speed in comparison with region of interest-based fractional anisotropy (FA) measurements and clinical characteristics. Traditional group-wise analysis demonstrated widespread reductions of white matter FA within the TBI group (voxel-wise p<0.05, corrected), despite relatively low consistency of subject-level effects secondary to widespread variation in the spatial distribution of TAI. Subject-specific mapping of TAI with the DisCo-Z approach was the best predictor of impaired processing speed, achieving high classification accuracy (area under the curve [AUC]=0.94). In moderate-to-severe TBI, there is substantial inter-subject variation in TAI, with extent strongly correlated to post-traumatic deficits in processing speed. Significant group-level effects do not necessarily represent consistent effects at the individual level. Better accounting for inter-subject variability in neurobiological manifestations of TBI may substantially improve the ability to detect and classify patterns of injury.	[Ware, Jeffrey B.] Hosp Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Detre, John A.] Hosp Univ Penn, Dept Neurol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Hart, Tessa; Whyte, John; Rabinowitz, Amanda; Kim, Junghoon] Moss Rehabil Res Inst, Philadelphia, PA USA; [Kim, Junghoon] CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, 160 Convent Ave, New York, NY 10031 USA		Kim, J (corresponding author), CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, 160 Convent Ave, New York, NY 10031 USA.	jkim@med.cuny.edu	Kim, Junghoon John/I-6702-2019	Kim, Junghoon John/0000-0001-5729-8993; Whyte, John/0000-0002-4381-1474; Ware, Jeffrey/0000-0002-3495-9733	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS065980, 2T32EB004311-11]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065980] Funding Source: NIH RePORTER	We would like to acknowledge and thank H. Branch Coslett, MD, and Wooyoung Choi, BA, for their assistance in lesion segmentation for this paper. This work was supported by the National Institutes of Health grants 5R01NS065980 (principal investigator[PI]: J.K.) and 2T32EB004311-11 (PI: Mitchell Schnall, MD, PhD).	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Cremers LGM, 2016, NEUROBIOL AGING, V39, P108, DOI 10.1016/j.neurobiolaging.2015.11.021; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Keihaninejad S, 2013, NEUROIMAGE, V72, P153, DOI 10.1016/j.neuroimage.2013.01.044; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Peng HL, 2009, NEUROIMAGE, V46, P967, DOI 10.1016/j.neuroimage.2009.03.046; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rokem A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123272; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Seghier ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep20170; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shen K, 2015, P NATL ACAD SCI USA, V112, P6473, DOI 10.1073/pnas.1503436112; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Strauss S. B., 2016, A J N R AM J NEURORA; STRICH SJ, 1961, LANCET, V2, P443; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; WANG Y, 2017, BIOMED ENG ONLINE, V16; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhang H, 2007, LECT NOTES COMPUT SC, V4792, P211; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	52	14	14	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2243	2253		10.1089/neu.2016.4817			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000007	28314375	Green Published			2022-02-06	
J	Budnick, HC; Tyroch, AH; Milan, SA				Budnick, Hailey C.; Tyroch, Alan H.; Milan, Stacey A.			Ethnic disparities in traumatic brain injury care referral in a Hispanic-majority population	JOURNAL OF SURGICAL RESEARCH			English	Article							INPATIENT REHABILITATION; RACIAL DISPARITIES; INSURANCE STATUS; FAMILY NEEDS; OUTCOMES; DISCHARGE; INTENSITY; TBI; EPIDEMIOLOGY; CAREGIVERS	Background: Functional outcomes after traumatic brain injury (TBI) can be significantly improved by discharge to posthospitalization care facilities. Many variables influence the discharge disposition of the TBI patient, including insurance status, patient condition, and patient prognosis. The literature has demonstrated an ethnic disparity in posthospitalization care referral, with Hispanics being discharged to rehabilitation and nursing facilities less often than non-Hispanics. However, this relationship has not been studied in a Hispanicmajority population, and thus, this study seeks to determine if differences in neurorehabilitation referrals exist among ethnic groups in a predominately Hispanic region. Methods: This study is a retrospective cohort that includes 1128 TBI patients who presented to University Medical Center El Paso, Texas, between the years 2005 and 2015. The patients' age, sex, race, residence, admission Glasgow Coma Scale (GCS), GCS motor, Injury Severity Score (ISS), hospital and intensive care unit length of stay (LOS), mechanism of injury, and discharge disposition were analyzed in univariate and multivariate models. Results: Our study population had an insurance rate of 55.5%. Insurance status and markers of injury severity (hospital LOS, intensive care unit LOS, ISS, GCS, and GCS motor) were predictive of discharge disposition to rehabilitation facilities. The study population was 70% Hispanic, yet Hispanics were discharged to rehabilitation facilities (relative risk: 0.56, P:0.001) and to long- term acute care/nursing facilities (relative risk: 0.35, P < 0.0001) less than non- Hispanics even after LOS, ISS, ethnicity, insurance status, and residence were adjusted for in multivariate analysis. Conclusions: This study suggests that patients of different ethnicities but comparable traumatic severity and insurance status receive different discharge dispositions post-TBI even in regions in which Hispanics are the demographic majority. (C) 2017 Elsevier Inc. All rights reserved.	[Budnick, Hailey C.; Tyroch, Alan H.; Milan, Stacey A.] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, 900 Myrtle Ave 2107, El Paso, TX 79901 USA		Budnick, HC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Surg, 900 Myrtle Ave 2107, El Paso, TX 79901 USA.	hailey.budnick@ttuhsc.edu					Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Cooper Z, 2012, J HEALTH CARE POOR U, V23, P857, DOI 10.1353/hpu.2012.0064; Faul M, 2010, TRAUMATIC BRAIN INJU; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Kane WG, 2014, J HEAD TRAUMA REHAB, V29, pE10, DOI 10.1097/HTR.0000000000000028; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rubin MA, 2014, J CRIT CARE, V29, P49, DOI 10.1016/j.jcrc.2013.08.023; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Salottolo K, 2017, J CRIT CARE, V38, P197, DOI 10.1016/j.jcrc.2016.11.034; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; US Census Bureau, 2015, PAS COUNT; Valdivieso-Mora E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01632; Zanaty M, 2015, J NEUROSURG, P1	30	14	14	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUL	2017	215						231	238		10.1016/j.jss.2017.03.062			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	FA3RZ	WOS:000405363400034	28688653				2022-02-06	
J	Durber, CM; Yeates, KO; Taylor, HG; Walz, NC; Stancin, T; Wade, SL				Durber, Chelsea M.; Yeates, Keith Owen; Taylor, H. Gerry; Walz, Nicolay Chertkoff; Stancin, Terry; Wade, Shari L.			The Family Environment Predicts Long-Term Academic Achievement and Classroom Behavior Following Traumatic Brain Injury in Early Childhood	NEUROPSYCHOLOGY			English	Article						home environment; academic achievement; behavioral functioning; parents	YOUNG-CHILDREN; OUTCOMES; SCHOOL; RECOVERY; TBI; SKILLS	Objective: This study examined how the family environment predicts long-term academic and behavioral functioning in school following traumatic brain injury (TBI) in early childhood. Method: Using a concurrent cohort, prospective design, 15 children with severe TBI, 39 with moderate TBI, and 70 with orthopedic injury (OI) who were injured when they were 3-7 years of age were compared on tests of academic achievement and parent and teacher ratings of school performance and behavior on average 6.83 years postinjury. Soon after injury and at the longer term follow-up, families completed measures of parental psychological distress, family functioning, and quality of the home environment. Hierarchical linear regression analyses examined group differences in academic outcomes and their associations with measures of the early and later family environment. Results: The severe TBI group, but not the moderate TBI group, performed worse than did the OI group on all achievement tests, parent ratings of academic performance, and teacher ratings of internalizing problems. Higher quality early and late home environments predicted stronger academic skills and better classroom behavior for children with both TBI and OI. The early family environment more consistently predicted academic achievement, whereas the later family environment more consistently predicted classroom functioning. The quality of the home environment predicted academic outcomes more strongly than did parental psychological distress or family functioning. Conclusion: TBI in early childhood has long-term consequences for academic achievement and school performance and behavior. Higher quality early and later home environments predict better school outcomes for both children with TBI and children with OI.	[Durber, Chelsea M.] Univ Calgary, Werklund Sch Educ, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cleveland, OH USA; [Walz, Nicolay Chertkoff] Univ Cincinnati, Coll Med, Dept Pediat, Div Behav Med & Clin Psychol, Cincinnati, OH 45221 USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] MetroHlth Med Ctr, Cleveland, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Div Pediat Rehabil, Cincinnati, OH 45221 USA		Yeates, KO (corresponding author), Univ Calgary, Dept Psychol, Adm Bldg 254,2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kyeates@ucalgary.ca	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; U.S. Public Health Service National Institutes of HealthUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; State of Ohio Emergency Medical Services; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER	The research reported here was supported by National Institute of Child Health and Human Development Grant R01 HD42729, in part by U.S. Public Health Service National Institutes of Health Grant M01 RR 08084, and by trauma research grants from the State of Ohio Emergency Medical Services. The project described was also supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 8 UL1 TR000077-04.	Achenbach, 1991, MANUAL TEACHERS REPO; Achenbach T.M., 2001, MANUAL ASEBA PRESCHO; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Al-Nhar T., 1999, ED PSYCHOL, V19, P37; Aldrich EM, 2012, CAN J SCH PSYCHOL, V27, P291, DOI 10.1177/0829573512455016; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADLEY RH, 1993, GENET SOC GEN PSYCH, V119, P439; Bradley RH, 2000, J RES ADOLESCENCE, V10, P247, DOI 10.1207/SJRA1003_1; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Caldwell B., 1984, HOME OBSERVATION MEA; Camara-Costa H, 2016, ARCH PEDIATRIE, V23, P136, DOI 10.1016/j.arcped.2015.11.007; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Ciping D., 2015, EARLY CHILDHOOD RES, V33, P12; Derogatis L, 1983, BRIEF SYMPTOM INVENT, V13, P595, DOI DOI 10.1017/S0033291700048017; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Hawley C A, 2005, Pediatr Rehabil, V8, P117; Kellaghan T., 1993, HOME ENV SCH LEARNIN; Marjoribanks K., 2005, EDUC PSYCHOL-US, V25, P647, DOI [10.1080/01443410500344704, DOI 10.1080/01443410500344704]; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Melhuish EC, 2008, J SOC ISSUES, V64, P95, DOI 10.1111/j.1540-4560.2008.00550.x; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Silberg T, 2015, BRAIN INJURY, V29, P481, DOI 10.3109/02699052.2014.984758; SUGLAND BW, 1995, J FAM ISSUES, V16, P632, DOI 10.1177/019251395016005007; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; TEASDALE G, 1974, LANCET, V2, P81; Thaler NS, 2012, APPL NEUROPSYCH-CHIL, V1, P30, DOI 10.1080/21622965.2012.665776; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Woodcock R. W., 2001, WOODCOCKJOHNSON 3 TE; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_	40	14	14	2	21	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2017	31	5					499	507		10.1037/neu0000351			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EY1GE	WOS:000403713200003	28541083	Green Accepted, Bronze			2022-02-06	
J	Gaskin, J; Gomes, J; Darshan, S; Krewski, D				Gaskin, J.; Gomes, J.; Darshan, S.; Krewski, D.			Burden of neurological conditions in Canada	NEUROTOXICOLOGY			English	Article							PARKINSONS-DISEASE; COST; PROGRESSION; DISORDERS; DEMENTIA	Neurological conditions are among the leading causes of disability in the Canadian population and are associated with a large public health burden. An increase in life expectancy and a declining birth rate has resulted in an aging Canadian population, and the proportion of age-adjusted mortality due to non-communicable diseases has been steadily increasing. These conditions are frequently associated with chronic disability and an increasing burden of care for patients, their families and caregivers. The National Population Health Study of Neurological Conditions (NPHSNC) aims to improve knowledge about neurological conditions and their impacts on individuals, their families, caregivers and health care system. The Systematic Review of Determinants of Neurological Conditions, a specific objective within the NPHSNC, is a compendium of systematic reviews on risk factors affecting onset and progression of the following 14 priority neurological conditions: Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), brain tumours (BT), cerebral palsy (CP), dystonia, epilepsy, Huntington's disease (HD), hydrocephalus, multiple sclerosis (MS), muscular dystrophies (MD), neurotrauma, Parkinson's disease (PD), spina bifida (SB), and Tourette's syndrome (TS). The burden of neurological disease is expected to increase as the population ages, and this trend is presented in greater detail for Alzheimer's and Parkinson's disease because the incidence of these two common neurological diseases increases significantly with age over 65 years. This article provides an overview of burden of neurological diseases in Canada to set the stage for the in-depth systematic reviews of the 14 priority neurological conditions presented in subsequent articles in this issue. (C) 2016 Published by Elsevier B.V.	[Gaskin, J.; Gomes, J.; Darshan, S.; Krewski, D.] Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON, Canada; [Gomes, J.] Univ Ottawa, Fac Hlth Sci, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Gomes, J.] Univ Ottawa, Environm Hlth Res Unit, Ottawa, ON, Canada; [Gaskin, J.; Krewski, D.] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; Risk Sci Int, Ottawa, ON, Canada		Gaskin, J (corresponding author), Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON, Canada.; Gaskin, J (corresponding author), Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada.	jgaskin@uottawa.ca	Gomes, James/R-8363-2017	Gomes, James/0000-0002-9818-5984; Gaskin, Janet/0000-0001-5326-4921	Neurological Health Charities Canada; Public Health Agency of Canada; Neurological Health Charities Canada; Public Health Agency of Canada	Support for the project was provided by the Public Health Agency of Canada in association with Neurological Health Charities Canada. D. Krewski is the Natural Sciences and Engineering Research Council of Canada Chair in Risk Science at the University of Ottawa.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Black SE, 2010, INT J GERIATR PSYCH, V25, P807, DOI 10.1002/gps.2421; Chin JH, 2014, NEUROLOGY, V83, P349, DOI 10.1212/WNL.0000000000000610; CIHI, 2007, BURD NEUR DIS DIS IN; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Guttman M, 2003, MOVEMENT DISORD, V18, P313, DOI 10.1002/mds.10333; Hebert R, 2001, J GERONTOL A-BIOL, V56, pM693, DOI 10.1093/gerona/56.11.M693; Herrmann N, 2010, CAN J PSYCHIAT, V55, P768, DOI 10.1177/070674371005501204; Herrmann N, 2006, INT J GERIATR PSYCH, V21, P972, DOI 10.1002/gps.1594; Hersi M, 2017, NEUROTOXICOLOGY, V61, P12, DOI 10.1016/j.neuro.2016.06.017; Jones CA, 2012, PARKINSONISM RELAT D, V18, P327, DOI 10.1016/j.parkreldis.2011.11.018; Krewski D, 2017, NEUROTOXICOLOGY, V61, P266, DOI 10.1016/j.neuro.2017.04.002; Little J, 2017, NEUROTOXICOLOGY, V61, P243, DOI [10.1016/j.neuro.2016.09.018, 10.1016/j.neuro.2016.09.01]; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCDOWELL I, 1994, CAN MED ASSOC J, V150, P899; Public Health Agency of Canada (PHAC), 2014, EC BURD ILLN CAN 200, P111; Public Health Agency of Canada (PHAC), 2014, MAPP CONN UND NEUR C, P110; Public Health Agency of Canada (PHAC), 2012, NAT POP HLTH STUD NE; Statistics Canada, 2016, CAN DEM GLANC; Tator C, 2007, CAN J NEUROL SCI, V34, P268, DOI 10.1017/S0317167100006673; Turcotte, 2013, FAMILY CAREGIVING WH; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; WHO (World Health Organization), 1993, ICD CLASS MENT BEH D, V10th; Wong S.L., 2014, HLTH REPORTS; World Health Organization, 2016, MENT HLTH STRENGTH O	26	14	14	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	JUL	2017	61				SI		2	10		10.1016/j.neuro.2016.05.001			9	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	FI3IG	WOS:000411851800003	27153747				2022-02-06	
J	Harch, PG; Andrews, SR; Fogarty, EF; Lucarini, J; Van Meter, KW				Harch, Paul G.; Andrews, Susan R.; Fogarty, Edward F.; Lucarini, Juliette; Van Meter, Keith W.			Case control study: hyperbaric oxygen treatment of mild traumatic brain injury persistent post-concussion syndrome and post-traumatic stress disorder	MEDICAL GAS RESEARCH			English	Article						hyperbaric oxygen; traumatic brain injury; persistent post concussion syndrome; post traumatic stress disorder; single photon emission computed tomography; cognitive assessment; brain injury treatment; combat veterans	CEREBRAL BLOOD-FLOW; PHASE-I; DECOMPRESSION ILLNESS; SERVICE MEMBERS; GENE-EXPRESSION; THERAPY; PRESSURE; BLAST; SYMPTOMS; QUALITY	Mild traumatic brain injury (TBI) persistent post-concussion syndrome (PPCS) and post-traumatic stress disorder (PTSD) are epidemic in United States Iraq and Afghanistan War veterans. Treatment of the combined diagnoses is limited. The aim of this study is to assess safety, feasibility, and effectiveness of hyperbaric oxygen treatments (HBOT) for mild TBI PPCS and PTSD. Thirty military subjects aged 18 -65 with PPCS with or without PTSD and from one or more blast-induced mild-moderate traumatic brain injuries that were a minimum of 1 year old and occurred after 9/11/2001 were studied. The measures included symptom lists, physical exam, neuropsychological and psychological testing on 29 subjects (1 dropout) and SPECT brain imaging pre and post HBOT. Comparison was made using SPECT imaging on 29 matched Controls. Side effects (30 subjects) experienced due to the HBOT: reversible middle ear barotrauma (n = 6), transient deterioration in symptoms (n = 7), reversible bronchospasm (n = 1), and increased anxiety (n = 2; not related to confinement); unrelated to HBOT: ureterolithiasis (n = 1), chest pain (n = 2). Significant improvement (29 subjects) was seen in neurological exam, symptoms, intelligence quotient, memory, measures of attention, dominant hand motor speed and dexterity, quality of life, general anxiety, PTSD, depression (including reduction in suicidal ideation), and reduced psychoactive medication usage. At 6-month follow-up subjects reported further symptomatic improvement. Compared to Controls the subjects' SPECT was significantly abnormal, significantly improved after 1 and 40 treatments, and became statistically indistinguishable from Controls in 75% of abnormal areas. HBOT was found to be safe and significantly effective for veterans with mild to moderate TBI PPCS with PTSD in all four outcome domains: clinical medicine, neuropsychology, psychology, and SPECT imaging. Veterans also experienced a significant reduction in suicidal ideation and reduction in psychoactive medication use.	[Harch, Paul G.; Andrews, Susan R.; Lucarini, Juliette; Van Meter, Keith W.] Louisiana State Univ, Sch Med, New Orleans, LA 70112 USA; [Fogarty, Edward F.] Univ North Dakota, Sch Med, Bismarck, ND USA		Harch, PG (corresponding author), Louisiana State Univ, Sch Med, New Orleans, LA 70112 USA.	paulharchmd@gmail.com			Marine Corps Law Enforcement Foundation; Semper Fi Fund; Coalition to Salute Americas Heroes; Harch Hyperbaric Research Fund of the Baromedical Research Institute of New Orleans; Van Kampen Foundation; N.Y. Community Trust; Louis and Candace Hughes Trust; Sutton Foundation; Caulkins Family; New Orleans Natural Resource Group; Health Freedom Foundation; Tim and Libby Brown Foundation	The Marine Corps Law Enforcement Foundation, The Semper Fi Fund, The Coalition to Salute Americas Heroes, John and Resa Wing, the Harch Hyperbaric Research Fund of the Baromedical Research Institute of New Orleans, Frederick Lowther, Mr. Chris Anderson of the Van Kampen Foundation, Stanley Horton, John Staley IV, N.Y. Community Trust, Louis and Candace Hughes Trust, James Rooney, Marshall Wallach, Mr. Poindexter, Richard and Meg Lyon, The Sutton Foundation, The Caulkins Family, George Wood, Mr. Caleb Gates, New Orleans Natural Resource Group, Rubie and Bryan Bell, Margaret Hoffmann, John and Virginia Weinmann, Peter Roy Carney, John Fox, Dr. Warren Thomas, Joan C. White, James Wallace, Isabel Sanders, Edgar Jannotta, Thomas Petrie, Health Freedom Foundation, Tim and Libby Brown Foundation, Lisa Ethier, Operation Homefront Louisiana, Mr. Theodore Solomon, and Shoney's Restaurant (Gretna, LA). Twenty-five doses of the SPECT agent Ethyl Cysteinate Dimer were donated by Dupont Merck Pharma Radiopharmaceuticals, North Billerica, MA, USA for use in LSU IRB #3511, Tc99m ECD SPECT Brain Imaging in Neurologically Normal Individuals and Neurologically and Cognitively Abnormal Nitrogen Tetroxide Exposed Patients.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2008, US NAVY DIVING MANUA, V1, P42; Armistead-Jehle P, 2012, J NEUROTRAUM, V29, P2513, DOI 10.1089/neu.2012.2400; Barratt DM, 2002, NEUROLOGIST, V8, P186, DOI 10.1097/00127893-200205000-00005; Beauregard M, 2009, NORD J PSYCHIAT, V63, P5, DOI 10.1080/08039480802421182; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Centers for Medicare and Medicaid Services, 2006, CTR MED MED SERV P 1; Chen Y, 2009, NEUROCHEM RES, V34, P1047, DOI 10.1007/s11064-008-9873-8; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; CLARK JM, 1993, PHYSL MED DIVING, P121; Congress of the United States Congressional Budget Office, 2012, CBO STUD VET HLTH AD; Dougherty G, 1996, MED ENG PHYS, V18, P557, DOI 10.1016/1350-4533(96)00011-2; Duncan LE, LARGEST GWAS PTSD N; Figueroa XA, 2016, NEUROLOGY, V87, P1400, DOI 10.1212/WNL.0000000000003146; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Garcia AJ, 2010, J APPL PHYSIOL, V109, P804, DOI 10.1152/japplphysiol.91429.2008; GAVIN DR, 1989, BRIT J ADDICT, V84, P301; Godman CA, 2010, CELL STRESS CHAPERON, V15, P431, DOI 10.1007/s12192-009-0159-0; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Greenberg LM., 1996, TEST VARIABLES ATTEN; GUR RC, 1982, SCIENCE, V217, P659, DOI 10.1126/science.7089587; Harch P.G., 2002, P 2 INT S HYP OXYG C; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch PG, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0030-6; Harch PG, 2013, J NEUROTRAUM, V30, P1995, DOI 10.1089/neu.2012.2799; Harch PG, 2013, UNDERSEA HYPERBAR M, V40, P469; Harch PG, 2012, J NEUROTRAUM, V29, P2516, DOI 10.1089/neu.2012.2608; Harch PG, 2012, J NEUROTRAUM, V29, P2425, DOI 10.1089/neu.2012.2544; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harch Paul G, 2009, Cases J, V2, P6538, DOI 10.4076/1757-1626-2-6538; Harch PG, 1996, TXB HYPERBARIC MED, P480; Harch PG, 2017, TXB HYPERBARIC MED, V20, P269; Harch PG, 2009, TXB HYPERBARIC MED, P505; Harch PG, 1996, UNDERSEA HYPERB ME S, V23, P48; Harch PG, 2004, TXB HYPERBARIC MED, P223; Harch PG, 2009, TXB HYPERBARIC MED, P235; Harch PG, 1996, TREATMENT DECOMPRESS, P203; HARCH PG, 1994, UNDERSEA HYPERB ME S, V21, P30; HARCH PG, 1999, TXB HYPERBARIC MED, P319; Harch PG, 2015, HYPERBARIC OXYGEN TH; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jarcho JM, 2009, CLIN PHARMACOL THER, V86, P352, DOI 10.1038/clpt.2009.126; Kendall AC, 2013, UNDERSEA HYPERBAR M, V40, P115; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lesak M, 2004, NEUROPSYCHOLOGICAL A, P776; Lesak M. D., 2004, NEUROPSYCHOLOGICAL A; LIDVALL HF, 1975, LANCET, V1, P100; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Marx RE, 1988, PROBLEM WOUNDS ROLE, P65; MEYER JS, 1968, CIRCULATION, V37, P1036, DOI 10.1161/01.CIR.37.6.1036; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Mulvaney SW, 2014, MIL MED, V179, P1133, DOI 10.7205/MILMED-D-14-00151; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Oh S, 2008, CELL STRESS CHAPERON, V13, P447, DOI 10.1007/s12192-008-0041-5; PALMER AC, 1992, NEUROPATH APPL NEURO, V18, P113, DOI 10.1111/j.1365-2990.1992.tb00773.x; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; PTSD Checklist-Military, 2009, PTSD CHECKLIST MILIT; Quitkin FM, 1999, AM J PSYCHIAT, V156, P829, DOI 10.1176/ajp.156.6.829; RAICHLE ME, 1976, ARCH NEUROL-CHICAGO, V33, P523, DOI 10.1001/archneur.1976.00500080001001; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Robb MA, 2016, JAMA-J AM MED ASSOC, V315, P1107, DOI 10.1001/jama.2016.2240; Rossignol DA, 2007, MED HYPOTHESES, V68, P1208, DOI 10.1016/j.mehy.2006.09.064; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Scorza KA, 2013, UNDERSEA HYPERBARIC; Shandley S, 2017, UNDERSEA HYPERBAR M, V44, P257; Shields TG, 1997, OCCUP ENVIRON MED, V54, P247, DOI 10.1136/oem.54.4.247; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; SYMONDS C, 1962, LANCET, V1, P1; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thorsen E, 1998, EUR RESPIR J, V12, P1442, DOI 10.1183/09031936.98.12061442; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; VANMETER KW, 1994, ANN EMERG MED, V24, P283, DOI 10.1016/S0196-0644(05)83748-5; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Weaver LK, 2014, HYPERBARIC OXYGEN TH; WechslerD, 2001, WECHSLER TEST ADULT; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wolf EG, 2015, UNDERSEA HYPERBAR M, V42, P313; Wolf EG, 2012, UNDERSEA HYPERBAR M, V39, P1075; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Wolfson, 1993, HALSTEAD REITAN NEUR; Wortzel HS, 2012, J NEUROTRAUM, V29, P2421, DOI 10.1089/neu.2012.2426; Wright JK, 2009, UNDERSEA HYPERBAR M, V36, P391; Zhang T, 2010, BRAIN INJURY, V24, P1350, DOI 10.3109/02699052.2010.504525	104	14	15	3	6	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	JUL-SEP	2017	7	3					156	+		10.4103/2045-9912.215745			93	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	FK3DK	WOS:000413365100003	29152209	Green Published			2022-02-06	
J	Liu, DZ; Waldau, B; Ander, BP; Zhan, XH; Stamova, B; Jickling, GC; Lyeth, BG; Sharp, FR				Liu, Da Zhi; Waldau, Ben; Ander, Bradley P.; Zhan, Xinhua; Stamova, Boryana; Jickling, Glen C.; Lyeth, Bruce G.; Sharp, Frank R.			Inhibition of Src family kinases improves cognitive function after intraventricular hemorrhage or intraventricular thrombin	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Intraventricular hemorrhage; Src family kinases; Fyn; spatial memory deficits; PP2	PHASE-II TRIAL; INTRACEREBRAL HEMORRHAGE; BRAIN; ACTIVATION; PROTECTS; INJURY; RHO	Intraventricular hemorrhage causes spatial memory loss, but the mechanism remains unknown. Our recent studies demonstrated that traumatic brain injury activates Src family kinases, which cause spatial memory loss. To test whether the spatial memory loss was due to blood in the ventricles, which activated Src family kinases, we infused autologous whole blood or thrombin into the lateral ventricles of adult rats to model non-traumatic intraventricular hemorrhage. Hippocampal neuron loss was examined 1day to 5 weeks later. Spatial memory function was assessed 29 to 33 days later using the Morris water maze. Five weeks after the ventricular injections of blood or thrombin, there was death of most hippocampal neurons and significant memory deficits compared with sham operated controls. These data show that intraventricular thrombin is sufficient to kill hippocampal neurons and produce spatial memory loss. In addition, systemic administration of the non-specific Src family kinase inhibitor PP2 or intraventricular injection of siRNA-Fyn, a Src family kinase family member, prevented hippocampal neuronal loss and spatial memory deficits following intraventricular hemorrhage. The data support the conclusions that thrombin mediates the hippocampal neuronal cell death and spatial memory deficits produced by intraventricular blood and that these can be blocked by non-specific inhibition of Src family kinases or by inhibiting Fyn.	[Liu, Da Zhi; Ander, Bradley P.; Zhan, Xinhua; Stamova, Boryana; Jickling, Glen C.; Sharp, Frank R.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Liu, Da Zhi; Ander, Bradley P.; Zhan, Xinhua; Stamova, Boryana; Jickling, Glen C.; Sharp, Frank R.] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA; [Waldau, Ben; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA		Liu, DZ (corresponding author), UC Davis Med Ctr, Dept Neurol, MIND Inst, Wet Labs, Room 2417,2805 50th St, Sacramento, CA 95817 USA.	dzliu@ucdavis.edu	Jickling, Glen/J-8790-2019; Stamova, Boryana/ABA-2981-2020	Jickling, Glen/0000-0003-3543-0820; Lyeth, Bruce/0000-0003-4811-1474	American Heart AssociationAmerican Heart Association; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS089901, R01NS066845]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS089901, R01NS066845] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by American Heart Association Beginning Grant in Aid (DZL), NIH grants R01NS089901 (DZL) and R01NS066845 (FRS).	AKIYAMA H, 1992, NEUROSCI LETT, V146, P152, DOI 10.1016/0304-3940(92)90065-F; Ardizzone TD, 2004, STROKE, V35, P2587, DOI 10.1161/01.STR.0000143451.14228.ff; Ardizzone TD, 2007, STROKE, V38, P1621, DOI 10.1161/STROKEAHA.106.478966; Badjatia N, 2005, NEUROLOGIST, V11, P311, DOI 10.1097/01.nrl.0000178757.68551.26; Chen QW, 2015, STROKE, V46, P2902, DOI 10.1161/STROKEAHA.115.009713; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Diemer NH, 1997, MATURATION PHENOMENON IN CEREBRAL ISCHEMIA II, P53; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Eifler AC, 2011, METHODS MOL BIOL, V726, P325, DOI 10.1007/978-1-61779-052-2_21; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P1534, DOI 10.1136/jnnp.2004.055145; Gucalp A, 2011, CLIN BREAST CANCER, V11, P306, DOI 10.1016/j.clbc.2011.03.021; Hanley DF, 2009, STROKE, V40, P1533, DOI 10.1161/STROKEAHA.108.535419; Herold CI, 2011, CLIN CANCER RES, V17, P6061, DOI 10.1158/1078-0432.CCR-11-1071; Jeon BT, 2013, NEUROTOX RES, V23, P238, DOI 10.1007/s12640-012-9339-2; Joshi AD, 2014, AM J RESP CELL MOL, V50, P170, DOI 10.1165/rcmb.2012-0496OC; Liu DZ, 2014, J NEUROTRAUM, V31, P1268, DOI 10.1089/neu.2013.3250; Liu DZ, 2008, NEUROBIOL DIS, V30, P201, DOI 10.1016/j.nbd.2008.01.006; Liu DZ, 2012, SCI WORLD J, DOI 10.1100/2012/491737; Liu DZ, 2011, ACTA NEUROCHIR SUPPL, V111, P77, DOI 10.1007/978-3-7091-0693-8_13; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Liu DZ, 2010, NEUROBIOL DIS, V37, P549, DOI 10.1016/j.nbd.2009.11.013; Liu DZ, 2011, J CYTOL HISTOL, V2, pe101; Lu W, 2015, J BIOL CHEM, V290, P22945, DOI 10.1074/jbc.M115.663450; Misra A, 2003, J PHARM PHARM SCI, V6, P252; Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rodriguez PL, 2007, CELL SIGNAL, V19, P2361, DOI 10.1016/j.cellsig.2007.07.021; ROSS CA, 1988, P NATL ACAD SCI USA, V85, P9831, DOI 10.1073/pnas.85.24.9831; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trepanier CH, 2012, FEBS J, V279, P12, DOI 10.1111/j.1742-4658.2011.08391.x; UMEMORI H, 1992, MOL BRAIN RES, V16, P303, DOI 10.1016/0169-328X(92)90239-8; Wang H, 2003, J NEUROCHEM, V84, P1349, DOI 10.1046/j.1471-4159.2003.01637.x; Wong GKC, 2009, ACTA NEUROCHIR, V151, P1601, DOI 10.1007/s00701-009-0425-z	37	14	14	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	2017	37	7					2359	2367		10.1177/0271678X16666291			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	EY3XE	WOS:000403907700005	27624844	Green Published, Bronze			2022-02-06	
J	Mahoney, PF; Carr, DJ; Delaney, RJ; Hunt, N; Harrison, S; Breeze, J; Gibb, I				Mahoney, P. F.; Carr, D. J.; Delaney, R. J.; Hunt, N.; Harrison, S.; Breeze, J.; Gibb, I.			Does preliminary optimisation of an anatomically correct skull-brain model using simple simulants produce clinically realistic ballistic injury fracture patterns?	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Head; Military helmet; Assessment; 7.62 x 39 mm bullet; AK47	SURROGATES; BONE	Ballistic head injury remains a significant threat to military personnel. Studying such injuries requires a model that can be used with a military helmet. This paper describes further work on a skull-brain model using skulls made from three different polyurethane plastics and a series of skull 'fills' to simulate brain (3, 5, 7 and 10% gelatine by mass and PermaGel (TM)). The models were subjected to ballistic impact from 7.62 x 39 mm mild steel core bullets. The first part of the work compares the different polyurethanes (mean bullet muzzle velocity of 708 m/s), and the second part compares the different fills (mean bullet muzzle velocity of 680 m/s). The impact events were filmed using high speed cameras. The resulting fracture patterns in the skulls were reviewed and scored by five clinicians experienced in assessing penetrating head injury. In over half of the models, one or more assessors felt aspects of the fracture pattern were close to real injury. Limitations of the model include the skull being manufactured in two parts and the lack of a realistic skin layer. Further work is ongoing to address these.	[Mahoney, P. F.] ICT Ctr, Royal Ctr Def Med, Res Pk, Birmingham B15 2SQ, W Midlands, England; [Mahoney, P. F.; Carr, D. J.] Cranfield Univ, Def Acad United Kingdom, Ctr Def Engn, Swindon SN6 8LA, Wilts, England; [Delaney, R. J.] South West Forens Pathol Grp Practice, POB 388, Bristol BS9 0DB, Avon, England; [Hunt, N.] Forens Pathol Serv, Grove Technol Pk, Wantage OX12 9FA, Oxon, England; [Harrison, S.; Breeze, J.] RCDM, Acad Dept Mil Surg & Trauma, Birmingham, W Midlands, England; [Gibb, I.] HM Naval Base, Med Ctr, Xray Dept, HMS Nelson, Portsmouth PO1 3HH, Hants, England		Mahoney, PF (corresponding author), ICT Ctr, Royal Ctr Def Med, Res Pk, Birmingham B15 2SQ, W Midlands, England.; Mahoney, PF (corresponding author), Cranfield Univ, Def Acad United Kingdom, Ctr Def Engn, Swindon SN6 8LA, Wilts, England.	p.f.mahoney@cranfield.ac.uk	; Carr, Debra/K-6845-2013	Harrisson, Stuart/0000-0003-4995-4270; Breeze, John/0000-0002-2352-1365; Carr, Debra/0000-0002-9476-2166			Betz P, 1997, FORENSIC SCI INT, V86, P155, DOI 10.1016/S0379-0738(97)02121-X; Bir C, 2016, FORENSIC SCI INT, V261, P1, DOI 10.1016/j.forsciint.2016.01.023; Carr D, 2015, INT J LEGAL MED, V129, P505, DOI 10.1007/s00414-014-1073-2; COE JI, 1982, AM J FOREN MED PATH, V3, P215, DOI 10.1097/00000433-198209000-00006; Di Maio VJ, 2016, GUNSHOT WOUNDS PRACT; Dormody, 1994, J AGR ED, V35, P49, DOI DOI 10.5032/JAE.1994.04031; Falland-Cheung L, 2015, FORENSIC SCI MED PAT, V11, P552, DOI 10.1007/s12024-015-9718-0; Hejna P, 2011, INT J LEGAL MED, V125, P587, DOI 10.1007/s00414-011-0553-x; Karger B, 2008, FORENSIC PATHOL REV, V5, P139, DOI 10.1007/978-1-59745-110-9_9; Keene DD, 2016, J ROY ARMY MED CORPS, V162, P355, DOI 10.1136/jramc-2015-000490; Leestma IE, 2014, FORENSIC NEUROPATHOL, P655; Lu HC, 2015, J SURG RES, V199, P698, DOI 10.1016/j.jss.2015.01.006; Mabbott A, 2016, INT J LEGAL MED, V130, P1353, DOI 10.1007/s00414-015-1309-9; Mabbott A, 2013, 27TH INTERNATIONAL SYMPOSIUM ON BALLISTICS, VOLS. 1 AND 2, P648; Puskas CM, 2003, J FORENSIC SCI, V48, P1219; Raymond DE, 2015, J FORENSIC SCI, V60, P370, DOI 10.1111/1556-4029.12693; Rennick SL, 2005, J FORENSIC SCI, V50, P1016; Russell R, 2014, J ROY ARMY MED CORPS, V160, P150, DOI 10.1136/jramc-2013-000215; Sarron JC, 2004, J TRAUMA, V57, P236, DOI 10.1097/01.TA.0000133575.48065.3F; Saukko P, 2016, KNIGHTS FORENSIC PAT, P241; Smith JE, 2014, INJURY, V45, P874, DOI 10.1016/j.injury.2013.12.004; Smith MJ, 2015, LEGAL MED-TOKYO, V17, P427, DOI 10.1016/j.legalmed.2015.06.007; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; Viel G, 2009, FORENSIC SCI MED PAT, V5, P22, DOI 10.1007/s12024-008-9062-8	24	14	14	2	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUL	2017	131	4					1043	1053		10.1007/s00414-017-1557-y			11	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	EZ4DP	WOS:000404662500020	28271364	Green Published			2022-02-06	
J	Nikoo, M; Gadermann, A; To, MJ; Krausz, M; Hwang, SW; Palepu, A				Nikoo, Mohammadali; Gadermann, Anne; To, Matthew J.; Krausz, Michael; Hwang, Stephen W.; Palepu, Anita			Incidence and Associated Risk Factors of Traumatic Brain Injury in a Cohort of Homeless and Vulnerably Housed Adults in 3 Canadian Cities	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						homeless; incidence; prevalence; risk factor; traumatic brain injury	PSYCHIATRIC-DISORDERS; COGNITIVE DYSFUNCTION; MENTAL-ILLNESS; ALCOHOL; POPULATION; VETERANS; HEALTH; INDIVIDUALS; ADOLESCENCE; IMPAIRMENT	Objective: To examine the factors associated with incident traumatic brain injury (TBI) among homeless and vulnerably housed persons over a 3-year follow-up period. Setting and participants: Data were obtained from the Health andHousing in Transition study, which tracked the health and housing status of 1190 homeless or vulnerably housed individuals in 3 Canadian cities for 3 years. Design and Main Measures: Main measure was self-reported incident TBI during the follow-up period. Factors associated with TBI were ascertained using mixed-effects logistic regression. Results: During first, second, and third years of follow-up, 187 (19.4%), 166 (17.1%), and 172 (17.9%) participants reported a minimum of 1 incident TBI, respectively. Among 825 participants with available data for all 3 years of follow-up, 307 (37.2%) reported at least 1 incident TBI during the 3-year follow-up period. Lifetime prevalence of TBI, endorsing a history of mental health diagnoses at baseline, problematic alcohol and drug use, younger age, poorer mental health, and residential instability were associated with increased risk of incident TBI during follow-up period. Conclusion: Mental health support and addressing residential instability and problematic substance use may reduce further risk of TBI and its associated poor health and social outcomes in this population.	[Nikoo, Mohammadali] Univ British Columbia, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Inst Mental Hlth, David Strangway Bldg 430-5950,Univ Blvd, Vancouver, BC V6T 1Z3, Canada; [Gadermann, Anne] Univ British Columbia, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Krausz, Michael] Univ British Columbia, Inst Mental Hlth, Addict Res, Vancouver, BC, Canada; [Palepu, Anita] Univ British Columbia, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Div Gen Internal Med, Vancouver, BC, Canada; [To, Matthew J.; Hwang, Stephen W.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON, Canada		Nikoo, M (corresponding author), Univ British Columbia, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Inst Mental Hlth, David Strangway Bldg 430-5950,Univ Blvd, Vancouver, BC V6T 1Z3, Canada.	mnikoo@cheos.ubc.ca			Canadian Institute of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	Canadian Institute of Health Research (CIHR) has funded the Health and Housing in Transition study (HHiT). We thank the following individuals from our community partner organizations: Laura Cowan, Liz Evans, Stephanie Gee, Clare Hacksel, Erika Khandor, and Wendy Muckle. The authors also thank the study coordinators and interviewers in each of the 3 cities as well as the shelter, drop-in, and municipal and provincial staff for their assistance with participant recruitment and follow-up. We thank theHealth and Housing in Transition study participants for their contribution to these data. We also thank Marc Vogel, Fiona Choi, and Kerry Jang and Monica Norena for their contribution to the idea formulation and discussion to develop this manuscript.	Andersen J, 2014, DISABIL REHABIL, V36, P2210, DOI 10.3109/09638288.2014.895870; Aron L, 2002, 1996 NATL SURVEY HOM; Barnes SM, 2015, J HEALTH CARE POOR U, V26, P92, DOI 10.1353/hpu.2015.0010; Brady KT, 2005, AM J PSYCHIAT, V162, P1483, DOI 10.1176/appi.ajp.162.8.1483; Chandler RA, 2009, BIOL PSYCHIAT, V66, P840, DOI 10.1016/j.biopsych.2009.05.011; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Donovan DM, 2006, ADDICTION, V101, P1696, DOI 10.1111/j.1360-0443.2006.01606.x; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Grant M., 1992, AUDIT ALCOHOL USE DI; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2011, INT J PUBLIC HEALTH, V56, P609, DOI 10.1007/s00038-011-0283-3; Karriker-Jaffe KJ, 2008, J ABNORM CHILD PSYCH, V36, P1227, DOI 10.1007/s10802-008-9245-5; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; Maisto SA, 2000, PSYCHOL ASSESSMENT, V12, P186, DOI 10.1037/1040-3590.12.2.186; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McMillan TM, 2015, J NEUROTRAUM, V32, P116, DOI 10.1089/neu.2014.3387; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; Nikoo N, 2015, J HLTH DISPARITIES R, V8, P17; Nordstrom A, 2013, BMJ, V346; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Olson-Madden J. H., 2012, REHABIL RES PRACT, V2012; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Statistics Canada, 2009, CAN COMM HLTH SURV C; Stergiopoulos V, 2015, ACTA PSYCHIAT SCAND, V131, P256, DOI 10.1111/acps.12391; Teasdale TW, 1997, BRIT MED J, V315, P569; The Health and Housing in Transition (HHiT) Study Team, 2015, STUD TEAM HOUS DEF H; To MJ, 2015, J HEAD TRAUMA REHAB, V30, P270, DOI 10.1097/HTR.0000000000000044; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Tsemberis S, 2007, J COMMUNITY PSYCHOL, V35, P29, DOI 10.1002/jcop.20132; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; UCLA: Statistical Consulting Group, 2016, R DAT AN EX MIX EFF; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Ware JE, 2002, SF 12 SCORE SF 12 PH; Winn JL, 2013, PSYCHOL SERV, V10, P233, DOI 10.1037/a0031051	42	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					E19	E26		10.1097/HTR.0000000000000262			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200003	28489699				2022-02-06	
J	Oldham, JR; DiFabio, MS; Kaminski, TW; DeWolf, RM; Buckley, TA				Oldham, Jessie R.; DiFabio, Melissa S.; Kaminski, Thomas W.; DeWolf, Ryan M.; Buckley, Thomas A.			Normative Tandem Gait in Collegiate Student-Athletes: Implications for Clinical Concussion Assessment	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						brain; mild traumatic brain injury; balance; postural control	ERROR SCORING SYSTEM; TRAUMATIC BRAIN-INJURY; POSTURAL-CONTROL; BALANCE CONTROL; PERFORMANCE; DEFICITS; SPORT; STABILITY; RECOVERY; EXERCISE	Background: Impaired balance is common after concussion. The third edition of the Sport Concussion Assessment Tool (SCAT-3) recommends the Balance Error Scoring System (BESS) and/or tandem gait for postconcussion balance assessment. The limitations of the BESS are well documented; however, tandem gait has received little attention throughout concussion literature. The purpose of this study was to provide normative data for tandem gait in collegiate student-athletes based on sport type, concussion history, and gender. Hypothesis: Tandem gait will be influenced by concussion history, sport, and gender. Study Design: Cohort study. Level of Evidence: Level 3. Methods: Four hundred collegiate student-athletes from both collision/contact (n = 200) and limited contact/noncontact (n = 200) sports performed 4 tandem gait trials, consistent with SCAT-3 guidelines. The dependent variables included the best of the 4 trials (BEST), the mean of the 4 trials (MEAN), and the mean of each of the trials individually (ORDER). Separate multivariate analyses of variance were performed for each of the independent variables to determine effect on BEST and MEAN trial times. Significant main effects were followed up with a 1-way analysis of variance (ANOVA). A separate 1-way ANOVA was used to assess ORDER differences. Results: The mean BEST was 10.37 +/- 1.76 seconds, and the MEAN was 11.32 +/- 0.70 seconds. There were no significant differences in BEST or MEAN tandem gait times, respectively, between those with and without concussion history (P = 0.41 and P = 0.69, respectively), sport type (P = 0.57 and P = 0.42, respectively), or gender (P = 0.73 and P = 0.49, respectively). There were significant differences (P < 0.05) between ORDER of the 4 tandem gait trials across the population, with improved times at each trial. Conclusion: The results of this study provide a normative data set for tandem gait in healthy collegiate student-athletes and suggest that common determinants of balance, including concussion history, collision sport participation, and gender do not appear to influence performance, but ORDER could have significant clinical implications.	[Oldham, Jessie R.; DiFabio, Melissa S.; Kaminski, Thomas W.; DeWolf, Ryan M.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [DiFabio, Melissa S.; Buckley, Thomas A.] Univ Delaware, Biomech & Movement Sci, Newark, DE USA		Buckley, TA (corresponding author), Univ Delaware, Human Performance Lab, 541 South Coll Ave, Newark, DE 19716 USA.	tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Oldham, Jessie/0000-0003-2801-2110	National Athletic Trainers' Association Research and Education Foundation; CARE [NCAA/DoD CARE W81XWH-14-2-0151]	The following author declared potential conflicts of interest: Thomas A. Buckley, EdD, ATC, has grants/grants pending from National Athletic Trainers' Association Research and Education Foundation. This study was funded by CARE, grant number NCAA/DoD CARE W81XWH-14-2-0151.	[Anonymous], 2013, Br J Sports Med, V47, P259; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Giorgetti M M, 1998, Physiother Res Int, V3, P274, DOI 10.1002/pri.150; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guyton A. C., 1986, TXB MED PHYSL; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; HORSTMANN GA, 1988, NEUROSCI LETT, V95, P179, DOI 10.1016/0304-3940(88)90653-2; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hubble JP, 1997, MOVEMENT DISORD, V12, P969, DOI 10.1002/mds.870120620; Kammerlind AS, 2005, EUR J PHYSIOTHER, V7, P96, DOI 10.1080/14038190510010403; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mayhew JL, 2010, J STRENGTH COND RES, V24, P447, DOI 10.1519/JSC.0b013e3181c08860; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Perry J, 1992, GAIT ANAL NORMAL PAT; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Shumway-Cook A, 2001, MOTOR CONTROL THEORY, V2; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Vander A. J., 1990, HUMAN PHYSL MECH BOD, V5th ed; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	40	14	14	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JUL-AUG	2017	9	4					305	311		10.1177/1941738116680999			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FH9XL	WOS:000411570600002	27899680	Green Published			2022-02-06	
J	Stevens, LF; Lapis, Y; Tang, X; Sander, AM; Dreer, LE; Hammond, FM; Kreutzer, JS; O'Neil-Pirozzi, TM; Nakase-Richardson, R				Stevens, Lillian Flores; Lapis, Yanna; Tang, Xinyu; Sander, Angelle M.; Dreer, Laura E.; Hammond, Flora M.; Kreutzer, Jeffrey S.; O'Neil-Pirozzi, Therese M.; Nakase-Richardson, Risa			Relationship Stability After Traumatic Brain Injury Among Veterans and Service Members: A VA TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; couples; marital status; polytrauma; relationship stability; Veterans	HEAD-INJURY; MARITAL STABILITY; MILITARY SERVICE; CAREGIVERS; MARRIAGE; REHABILITATION; PERSPECTIVES; INDIVIDUALS; POLYTRAUMA; FAMILIES	Objective: To explore stability of relationships and predictors of change in relationship status 2 years following TBI/polytrauma. Setting: Five Department of Veterans Affairs Polytrauma Rehabilitation Centers (VA PRCs). Participants: A total of 357 active duty service members and Veterans enrolled in the Veterans Affairs Polytrauma Rehabilitation Centers Traumatic Brain Injury Model Systems database with complete marital status information at 2 years postinjury. Design: Prospective, longitudinal, multisite. Main Measures: Relationship status change was defined as change in marital status (single/never married; married; divorced/separated) at 2-year follow-up, compared with status at enrollment. Results: At the time of enrollment, 134 participants (38%) were single/never married; 151 (42%) were married, and 72 (20%) were divorced/separated. Of those married at enrollment, 78% remained married at year 2 while 22% underwent negative change. Multivariable analyses revealed that age and education at the time of injury and mental health utilization prior to injury were significant predictors of relationship change. Among those who were single/ divorced/ separated at the time of enrollment, 87% remained so at year 2 while 13% underwent positive change. Injury during deployment significantly predicted positive relationship change. Conclusions: The unmalleable, preinjury characteristics identified may be used as potential triggers for education, prevention, surveillance, and couples therapy, if needed.	[Stevens, Lillian Flores; Lapis, Yanna] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Stevens, Lillian Flores] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian Flores; Lapis, Yanna; Kreutzer, Jeffrey S.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Stevens, Lillian Flores] Hunter Holmes McGuire Vet Affairs Med Ctr, DVBIC, Richmond, VA USA; [Tang, Xinyu] Univ Arkansas Med Sci, Biostat Program, Dept Pediat, Little Rock, AR 72205 USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [O'Neil-Pirozzi, Therese M.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Tampa, FL USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, VA HSR&D Ctr Innovat Disabil Rehabil & Res CINDRR, Tampa, FL USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, DVBIC, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Tampa, FL USA		Stevens, LF (corresponding author), Hunter Holmes McGuire Vet Affairs Med Ctr, Mental Hlth Serv, 1201 Broad Rock Blvd 116B, Richmond, VA 23249 USA.	lillian.stevens@va.gov			U.S. Department of Veterans Affairs Health Services Research and Development COIN grant (CINDRR) [1 I50 HX001233-01]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90RT5007, 90DP0028, 90DP0060, 90DP0044-01-00, 90DP0036, 90DP00303, 90DP0039-02-01]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000060, U48DP000039, U48DP000028, U48DP000036] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I50HX001233] Funding Source: NIH RePORTER	The authors acknowledge the support of U.S. Department of Veterans Affairs Health Services Research and Development COIN grant (1 I50 HX001233-01; CINDRR) for assistance in manuscript preparation.; The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center within the Defense Health Agency.; The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (grant numbers 90RT5007 [PI: Sander], 90DP0028 [PI: Sherer], and 90DP0060 [PI: Arciniegas]; 90DP0044-01-00 [PI: Novak], 90DP0036 [PI: Hammond], 90DP00303 [PI: Kreutzer], and # 90DP0039-02-01 [PI: Giacino]). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health & Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, and HHS, and endorsement by the Federal Government should not be assumed.	ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Baptist JA, 2011, CONTEMP FAM THER, V33, P199, DOI 10.1007/s10591-011-9162-6; Bin Zubair U, 2015, J ROY ARMY MED CORPS, V161, P127, DOI 10.1136/jramc-2014-000253; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Call VRA, 1996, J MARRIAGE FAM, V58, P219, DOI 10.2307/353390; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Cohen J, 2009, ARMED FORCES SOC, V36, P19, DOI 10.1177/0095327X09332146; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Cutrona CE, 2011, J CONSULT CLIN PSYCH, V79, P814, DOI 10.1037/a0025874; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; GIMBEL C, 1994, J MARRIAGE FAM, V56, P691, DOI 10.2307/352879; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Gosling J, 1999, BRAIN INJURY, V13, P785; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hogan PF, 2010, ARMED FORCES SOC, V36, P420, DOI 10.1177/0095327X09351228; Karney BR, 2012, J FAM ISSUES, V33, P1572, DOI 10.1177/0192513X12439690; Karney BR., 2007, FAMILIES STRESS ASSE; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2016, NEUROREHABILITATION, V38, P271, DOI 10.3233/NRE-161318; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Melvin KC, 2015, RES NURS HEALTH, V38, P7, DOI 10.1002/nur.21630; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; Paley B, 2013, CLIN CHILD FAM PSYCH, V16, P245, DOI 10.1007/s10567-013-0138-y; Panting A, 1972, REHABILITATION, V38, P33; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Raley RK, 2015, FUTURE CHILD, V25, P89, DOI 10.1353/foc.2015.0014; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rosand GMB, 2014, SOC PSYCH PSYCH EPID, V49, P109, DOI 10.1007/s00127-013-0681-3; Ruger W, 2002, ARMED FORCES SOC, V29, P85, DOI 10.1177/0095327X0202900105; Sander AM, 2016, ARCH PHYS MED REHAB, V97, P753, DOI 10.1016/j.apmr.2016.01.009; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Segal Mady W., 1989, ORG FAMILY WORK FAMI, P3; *SUBST AB MENT HLT, 1998, NAT HOUS SURV DRUG A; Sutton G.W., 2005, INDIVIDUAL DIFFERENC, V3; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Wade TJ, 2004, J HEALTH SOC BEHAV, V45, P155, DOI 10.1177/002214650404500203; Wang L, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0517-7; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	55	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					234	244		10.1097/HTR.0000000000000324			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200011	28520674	Green Accepted			2022-02-06	
J	Jackson, ML; Srivastava, AK; Cox, CS				Jackson, Margaret L.; Srivastava, Amit K.; Cox, Charles S., Jr.			Preclinical progenitor cell therapy in traumatic brain injury: a meta-analysis	JOURNAL OF SURGICAL RESEARCH			English	Article						Meta-analysis; Traumatic brain injury; Progenitor cells; Animal TBI model; Preclinical studies	MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; ACTIVATED MICROGLIAL/MACROPHAGE RESPONSE; RAT MODEL; FUNCTIONAL RECOVERY; COGNITIVE FUNCTION; TRANSPLANTATION; MICE; PATHOPHYSIOLOGY; EFFICACY	Background: No treatment is available to reverse injury associated with traumatic brain injury (TBI). Progenitor cell therapies show promise in both preclinical and clinical studies.We conducted a meta-analysis of preclinical studies using progenitor cells to treat TBI. Methods: EMBASE, MEDLINE, Cochrane Review, Biosis, and Google Scholar were searched for articles using prespecified search strategies. Studies meeting inclusion criteria underwent data extraction. Analysis was performed using Review Manager 5.3 according to a fixed-effects model, and all studies underwent quality scoring. Results: Of 430 abstracts identified, 38 met inclusion criteria and underwent analysis. Average quality score was 4.32 of 8 possible points. No study achieved a perfect score. Lesion volume (LV) and neurologic severity score (NSS) outcomes favored cell treatment with standard mean difference (SMD) of 0.86 (95% CI: 0.64-1.09) and 1.36 (95% CI: 1.11-1.60),respectively.Rotarod and Morris water maze outcomes also favored treatment with improvements in SMD of 0.34 (95% CI: 0.02-0.65) and 0.46 (95% CI: 0.17-74), respectively. Although LV and NSS were robust to publication bias assessments, rotarod and Morris water maze tests were not.Heterogeneity (I-2) ranged from 74%-85% among the analyses, indicating a high amount of heterogeneity among studies. Precision as a function of quality score showed a statistically significant increase in the size of the confidence interval as quality improved. Conclusions: Our meta-analysis study reveals an overall positive effect of progenitor cell therapies on LV and NSS with a trend toward improved motor function and spatial learning in different TBI animal models. (C) 2017 Elsevier Inc. All rights reserved.	[Jackson, Margaret L.; Srivastava, Amit K.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA		Jackson, ML (corresponding author), UTHlth McGovern Med Sch, Dept Pediat Surg, 6431 Fannin St, Houston, TX 77030 USA.	margaret.l.jackson@uth.tmc.edu	Srivastava, Amit/L-7019-2019	Srivastava, Amit/0000-0001-7554-7201	Department of Health and Human Services [5T32GM008792-13, 4T3200GM8792-14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	This work was supported by the Department of Health and Human Services, grant numbers 5T32GM008792-13 and 4T3200GM8792-14.	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Anbari F, 2014, NEURAL REGEN RES, V9, P919, DOI 10.4103/1673-5374.133133; Arien-Zakay H, 2014, J NEUROTRAUM, V31, P1405, DOI 10.1089/neu.2013.3270; Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Bonilla C, 2014, CYTOTHERAPY, V16, P1501, DOI 10.1016/j.jcyt.2014.07.007; Chang J, 2015, EXP NEUROL, V273, P225, DOI 10.1016/j.expneurol.2015.08.020; Chen SH, 2014, CELL TRANSPLANT, V23, P959, DOI 10.3727/096368913X667006; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cox Jr CS, 2016, STEM CELLS; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fu XM, 2015, CELL TRANSPLANT, V24, P1533, DOI 10.3727/096368914X679345; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gibb SL, 2015, STEM CELLS, V33, P3530, DOI 10.1002/stem.2189; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Han EY, 2013, CURR STEM CELL RES T, V8, P172; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Higgins JP, 2010, COLLABORATION SMGOTC; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hong SQ, 2011, NEUROCHEM RES, V36, P2391, DOI 10.1007/s11064-011-0567-2; Jiang JD, 2012, NEURAL REGEN RES, V7, P46, DOI 10.3969/j.issn.1673-5374.2012.01.008; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A., 2003, NEUROSURGERY, V53, P702; Mahmood A, 2013, J NEUROSURG, V118, P381, DOI 10.3171/2012.11.JNS12753; McIntosh TK, 1996, LAB INVEST, V74, P315; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Moher D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-13; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Muthuraju S, 2012, BASAL GANGLIA, V2, P143, DOI 10.1016/j.baga.2012.06.004; Muthuraju S, 2013, J BIOSCIENCES, V38, P93, DOI 10.1007/s12038-012-9290-7; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Osanai T, 2012, NEUROSURGERY, V70, P435, DOI 10.1227/NEU.0b013e318230a795; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Silachev DN, 2015, B EXP BIOL MED+, V159, P528, DOI 10.1007/s10517-015-3009-3; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Turtzo LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126551; van der Worp HB, 2011, J MOL CELL CARDIOL, V51, P449, DOI 10.1016/j.yjmcc.2011.04.008; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Xu HS, 2014, EUR REV MED PHARMACO, V18, P520; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhao J, 2012, J NEUROTRAUM, V29, P1209, DOI 10.1089/neu.2011.1858; Zhao JJ, 2012, NEURAL REGEN RES, V7, P741, DOI 10.3969/j.issn.1673-5374.2012.10.004; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310	76	14	14	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 15	2017	214						38	48		10.1016/j.jss.2017.02.078			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FA3RX	WOS:000405363200006	28624058	Green Accepted			2022-02-06	
J	Albanese, BJ; Boffa, JW; Macatee, RJ; Schmidt, NB				Albanese, Brian J.; Boffa, Joseph W.; Macatee, Richard J.; Schmidt, Norman B.			Anxiety sensitivity mediates gender differences in post-concussive symptoms in a clinical sample	PSYCHIATRY RESEARCH			English	Article						Cognitive risk factors; Traumatic brain injury; Post-concussive symptoms; Gender	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; DISTRESS TOLERANCE; METAANALYSIS; VALIDATION; DIMENSIONS; DISORDERS; COMBAT; INDEX; US	Traumatic brain injury (TBI) is both prevalent and potentially disabling. Extant literature has demonstrated women to report greater post-concussive symptoms (PCS) compared to men, highlighting the necessity of investigations into malleable, gender-linked risk factors for PCS that hold promise for reducing this gender disparity. Anxiety Sensitivity (AS) and Distress Tolerance (DT) are gender-linked risk factors that may be related to PCS. Despite a breadth of research supporting elevated AS and reduced DT in women, no study to date has investigated whether AS and DT mediate gender differences in PCS. The current sample was composed of 59 participants selected from a larger study based on their report of a past TBI. Findings indicated that AS, but not DT, significantly mediated gender differences in PCS. The present results suggest that AS is a cognitive risk factor that can partially account for the gender disparity in the expression of PCS. AS may influence an individual's interpretation of PCS as dangerous, thereby amplifying the perception of PCS severity. This suggests that efforts to reduce the burden of TBI may benefit from targeting AS in prevention and treatment paradigms, especially among women.	[Albanese, Brian J.; Boffa, Joseph W.; Macatee, Richard J.; Schmidt, Norman B.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA		Schmidt, NB (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	schmidt@psy.fsu.edu	Schmidt, Norman B/C-6426-2015	Schmidt, Norman B/0000-0003-4125-9601	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH093311] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH093311] Funding Source: NIH RePORTER		Allan N.P., 2015, J ANXIETY DISORD; Armstrong KA, 2002, BEHAV COGN PSYCHOTH, V30, P227, DOI 10.1017/S1352465802002114; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Deacon BJ, 2003, BEHAV RES THER, V41, P1427, DOI 10.1016/S0005-7967(03)00065-2; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farris SG, 2015, PSYCHOL ASSESSMENT, V27, P1123, DOI 10.1037/pas0000112; First M.B., 1994, STRUCTURED CLIN INTE; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gratz KL, 2011, COMPR PSYCHIAT, V52, P63, DOI 10.1016/j.comppsych.2010.04.009; Hayes A.F., 2012, PROCESS VERSATILE CO; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Leyro TM, 2010, PSYCHOL BULL, V136, P576, DOI 10.1037/a0019712; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Naragon-Gainey K, 2010, PSYCHOL BULL, V136, P128, DOI 10.1037/a0018055; Olatunji BO, 2009, PSYCHOL BULL, V135, P974, DOI 10.1037/a0017428; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reiss S., 1985, THEORETICAL ISSUES B, P107; Richardson JD, 2014, PSYCHIAT RES, V218, P118, DOI 10.1016/j.psychres.2014.04.008; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schmidt NB, 2000, COGNITIVE THER RES, V24, P533, DOI 10.1023/A:1005562011960; Schmidt NB, 2014, J CONSULT CLIN PSYCH, V82, P1023, DOI 10.1037/a0036651; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2006, NEUROLOGY, V66, pA235; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Simons JS, 2005, MOTIV EMOTION, V29, P83, DOI 10.1007/s11031-005-7955-3; Stewart SH, 1997, J ANXIETY DISORD, V11, P179, DOI 10.1016/S0887-6185(97)00005-4; TAYLOR S, 2003, J COGN PSYCHOTHER, V17, P179, DOI DOI 10.1891/088983903780906147; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; Walsh TM, 2004, J ANXIETY DISORD, V18, P695, DOI 10.1016/S0887-6185(03)00043-4; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; Zvolensky MJ, 2001, BEHAV RES THER, V39, P477, DOI 10.1016/S0005-7967(00)00010-3	46	14	15	1	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	JUN	2017	252						242	246		10.1016/j.psychres.2017.01.099			5	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EX3FX	WOS:000403119100039	28285252	Green Accepted			2022-02-06	
J	King, D; Hecimovich, M; Clark, T; Gissane, C				King, D.; Hecimovich, M.; Clark, T.; Gissane, C.			Measurement of the head impacts in a sub-elite Australian Rules football team with an instrumented patch: An exploratory analysis	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Biomechanics; concussion; linear acceleration; rotational acceleration	HIGH-SCHOOL FOOTBALL; CHRONIC TRAUMATIC ENCEPHALOPATHY; RUGBY UNION PLAYERS; RISK-FACTORS; PROFESSIONAL FOOTBALL; BRAIN-INJURY; CONCUSSION; ACCELERATION; BIOMECHANICS; SPORT	An investigation was made of the frequency, magnitude, and distribution of head impacts in Australian Football League players over a season of matches. In a prospective cohort analysis of impact magnitude, frequency, and distribution on data collected with a wireless head impact sensor worn behind the ear of 23 players, a total of 4903 impacts were recorded. Players experienced on average 407 +/- 143 impacts over the duration of the study resulting in 30 +/- 38 impacts per-player per-match. Linear accelerations ranged from 10 g to 153 g with a mean, median, and 95th percentile value of 17 g, 13 g, and 40 g, respectively. Rotational accelerations ranged from 130 rad/s(2) to 21,890 rad/s(2) with a mean, median, and 95th percentile value of 2426 rad/s(2), 1556 rad/s(2), and 7571 rad/s(2), respectively. This study obtained initial measurements on the frequency, magnitude, distribution, and risk weighted exposure of head impacts in Australia Rules Football in order to better inform medical personnel in the identification and evaluation of at-risk players for concussion. The location of impacts varied considerably with the back of the head recording more total impacts than the front, side, and top. Midfielders sustained more impacts per-player, per-match, and had higher median resultant linear accelerations than forwards and defenders. The results of this study, in which most impacts were within the low severity limit for linear, rotational, HITSP, and RWECP, indicate that Australian Rules football needs to include more encompassing methods of examination of player exposure.	[King, D.] Auckland Univ Technol, Fac Hlth & Environm Sci, Auckland, New Zealand; [Hecimovich, M.] Univ Northern Iowa, Div Athlet Training, Cedar Falls, IA USA; [Clark, T.] Australian Coll Phys Educ, Fac Sport Performance, Sydney, NSW, Australia; [Gissane, C.] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England		King, D (corresponding author), Hutt Valley Dist Hlth Board, Emergency Dept, Private Bag 31-907, Lower Hutt, New Zealand.	dking@aut.ac.nz		Clark, Dr Trevor/0000-0002-2853-0068	West Australian Football Commission	We would like to thank the West Australian Football Commission and, in particular, Troy Kirkham for their support of this research project. We also recognize the work of Myles Murphy, Head Physiotherapist, and student Mason Gittins. According to the definition given by the International Committee of Medical Journal Editors (ICMJE), the authors listed above qualify for authorship on the basis of making one or more of the substantial contributions to the intellectual content of the manuscript.	Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Crisco J, 2010, J ATHL TRAINING, V45, P459; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Fortington Lauren V, 2015, Inj Epidemiol, V2, P20; Fortington LV, 2016, J SCI MED SPORT, V19, P18, DOI 10.1016/j.jsams.2014.12.008; Gastin PB, 2013, J SCI MED SPORT, V16, P589, DOI 10.1016/j.jsams.2013.01.007; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gray AJ, 2010, SPORTS MED, V40, P347, DOI 10.2165/11531400-000000000-00000; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hopkins WG, 2007, CLIN J SPORT MED, V17, P208, DOI 10.1097/JSM.0b013e3180592a68; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hrysomallis C., 2006, WEIGHT TRAINING AUST; Hrysomallis C, 2013, SPORTS MED, V43, P339, DOI 10.1007/s40279-013-0034-0; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King D, 2010, INT J PERF ANAL SPOR, V10, P241, DOI 10.1080/24748668.2010.11868519; King D, 2012, RES SPORTS MED, V20, P86, DOI 10.1080/15438627.2012.660824; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McManus A, 2004, J SCI MED SPORT, V7, P384, DOI 10.1016/S1440-2440(04)80033-1; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Orchard J, 1998, J Sci Med Sport, V1, P83, DOI 10.1016/S1440-2440(98)80016-9; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard J, 2014, AFL INJURY REPORT; Orchard JW, 2013, AM J SPORT MED, V41, P734, DOI 10.1177/0363546513476270; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Robertson S, 2016, J SPORT SCI, V34, P637, DOI 10.1080/02640414.2015.1066026; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Stevenson MR, 2000, BRIT J SPORT MED, V34, P188, DOI 10.1136/bjsm.34.3.188; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	59	14	14	0	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	JUN	2017	12	3					359	370		10.1177/1747954117710512			12	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	EX3SF	WOS:000403152000009		Green Accepted			2022-02-06	
J	Krebs, E; Gerardo, CJ; Park, LP; Vissoci, JRN; Byiringiro, JC; Byiringiro, F; Rulisa, S; Staton, CA; Thielman, NM				Krebs, Elizabeth; Gerardo, Charles J.; Park, Lawrence P.; Vissoci, Joao Ricardo Nickenig; Byiringiro, Jean Claude; Byiringiro, Fidele; Rulisa, Stephen; Staton, Catherine A.; Thielman, Nathan M.			Mortality-Associated Characteristics of Patients with Traumatic Brain Injury at the University Teaching Hospital of Kigali, Rwanda	WORLD NEUROSURGERY			English	Article						Rwanda; Traumatic brain injury	LOW-INCOME COUNTRIES; ALCOHOL; EPIDEMIOLOGY; IMPACT; CARE	OBJECTIVE: Traumatic brain injury (TBI) is a leading cause of death and disability. Patients with TBI in low and middle-income countries have worse outcomes than patients in high-income countries. We evaluated important clinical indicators associated with mortality for patients with TBI at University Teaching Hospital of Kigali, Kigali, Rwanda. METHODS: A prospective consecutive sampling of patients with TBI presenting to University Teaching Hospital of Kigali Accident and Emergency Department was screened for inclusion criteria: reported head trauma, alteration in consciousness, headache, and visible head trauma. Exclusion criteria were age <10 years, >48 hours after injury, and repeat visit. Data were assessed for association with death using logistic regression. Significant variables were included in a multivariate logistic regression model and refined via backward elimination. RESULTS: Between October 7, 2013, and April 6, 2014, 684 patients were enrolled; 14 (2%) were excluded because of incomplete data. Of patients, 81% were male with mean age of 31 years (range, 10-89 years; SD 11.8). Most patients (80%) had mild TBI (Glasgow Coma Scale [GCS] score 13-15); 10% had moderate (GCS score 9-12) and 10% had severe (GCS score 3-8) TBI. Multivariate logistic regression determined that GCS score <13, hypoxia, bradycardia, tachycardia, and age >50 years were significantly associated with death. CONCLUSIONS: GCS score <13, hypoxia, bradycardia, tachycardia, and age >50 years were associated with mortality. These findings inform future research that may guide clinicians in prioritizing care for patients at highest risk of mortality.	[Krebs, Elizabeth; Gerardo, Charles J.; Park, Lawrence P.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.; Thielman, Nathan M.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Krebs, Elizabeth; Gerardo, Charles J.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA; [Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Dept Neurosurg, Div Global Neurosurg & Neurosci, Med Ctr, Durham, NC USA; [Park, Lawrence P.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA; [Byiringiro, Jean Claude; Byiringiro, Fidele; Rulisa, Stephen] Univ Teaching Hosp Kigali, Kigali, Rwanda; [Rulisa, Stephen] Univ Rwanda, Coll Med & Hlth Sci, Sch Med & Pharm, Kigali, Rwanda; [Krebs, Elizabeth] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA		Krebs, E (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC USA.; Krebs, E (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA.; Krebs, E (corresponding author), Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA.	krebse@gmail.com	Rulisa, Stephen/E-3914-2018; BYIRINGIRO, JEAN CLAUDE/T-9719-2019; Thielman, Nathan/R-5142-2019	Rulisa, Stephen/0000-0002-5357-7626; BYIRINGIRO, JEAN CLAUDE/0000-0002-6445-1797; Thielman, Nathan/0000-0001-8152-2879; Staton, Catherine/0000-0002-6468-2894; Krebs, Elizabeth/0000-0003-4905-9700	National Institutes of Health Office of the DirectorUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC); Office of AIDS ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Cancer Center; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI); National Heart, Blood, and Lung InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI); National Institute of Dental and Craniofacial ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR); National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); National Institute of Allergy and Infectious DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health Office of Women's Health and Research at Vanderbilt University [R24 TW007988]; Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01 TW010000-01A1]; Duke University Division of Emergency Medicine; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R25TW009337, D43TW009337, K01TW010000, R24TW007988] Funding Source: NIH RePORTER	We thank the physicians and staff at UTHK A& E, Dr. Severien Muneza for his neurosurgical expertise, Assumpta Muzayire for her work as study coordinator and Cecile Kateretse and Eliane Maria Spiecker who both provided administrative support. EK acknowledges support from the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental and Craniofacial Research, National Institute on Drug Abuse, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, and National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Recovery and Reinvestment Act. CAS acknowledges salary support funding from the Fogarty International Center (K01 TW010000-01A1) and the Duke University Division of Emergency Medicine.	Alexander T, 2009, S AFR J SURG, V47, P120; Allen Ingabire JC, 2015, RWANDA MED J, V72, P5; Brasel KJ, 2007, J TRAUMA, V62, P812, DOI 10.1097/TA.0b013e31803245a1; Brown H., 2007, B WORLD HEALTH ORGAN, V85; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Henry JA, 2012, J TRAUMA ACUTE CARE, V73, P261, DOI 10.1097/TA.0b013e31824bde1e; Hitimana J., 2009, East and Central African Journal of Surgery, V14, P50; Hu TM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/121786; Husum H, 2003, J TRAUMA, V54, P1188, DOI 10.1097/01.TA.0000073609.12530.19; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Malone DL, 2001, J TRAUMA, V51, P458, DOI 10.1097/00005373-200109000-00006; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MOH, 2012, HUM RES HLTH RPOGR R; Murad MK, 2012, PREHOSP DISASTER MED, V27, P36, DOI 10.1017/S1049023X11006819; Ogbonna M, 2015, NEUROSCI J, V2015, P1; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Razzak JA, 2005, EMERG MED CLIN N AM, V23, P85, DOI 10.1016/j.emc.2004.09.008; Reed AR, 2002, SAMJ S AFR MED J, V92, P221; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Stubig T, 2012, ALCOHOL, V46, P681, DOI 10.1016/j.alcohol.2012.07.002; Tieves Kelly S, 2005, WMJ, V104, P22; Tives KS, 2001, WMJ, V104, p[22, 54]; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Twagirayezu E., 2008, East and Central African Journal of Surgery, V13, P73; WHO, 2007, ALC INJ EM DEP SUMM; *WORLD BANK, 2012, WORLD DEV REP 2012, DOI DOI 10.1596/978-0-8213-8439-8; World Health Organization, 2010, HELM US SAV LIV INCR; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x	39	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2017	102						571	582		10.1016/j.wneu.2017.03.001			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FA5HA	WOS:000405472500072	28336445	Green Accepted			2022-02-06	
J	McDonough, TL; Paolicchi, JM; Heier, LA; Das, N; Engel, M; Perlman, JM; Grinspan, ZM				McDonough, Tiffani L.; Paolicchi, Juliann M.; Heier, Linda A.; Das, Nikkan; Engel, Murray; Perlman, Jeffrey M.; Grinspan, Zachary M.			Prediction of Future Epilepsy in Neonates With Hypoxic-Ischemic Encephalopathy Who Received Selective Head Cooling	JOURNAL OF CHILD NEUROLOGY			English	Article						epilepsy; cohort studies; all epilepsy / seizures; cohort studies; risk factors in epidemiology; childhood stroke	HYPOTHERMIA TREATMENT; MODERATE HYPOTHERMIA; ASPHYXIATED INFANTS; TERM INFANTS; FOLLOW-UP; SEIZURES; ELECTROENCEPHALOGRAPHY; TRIAL; OUTCOMES; NEWBORNS	Epilepsy outcomes after therapeutic hypothermia for neonates with hypoxic-ischemic encephalopathy are understudied. The authors used multivariable logistic regression to predict epilepsy in neonates after selective head cooling. Sensitivity analyses used magnetic resonance imaging (MRI) and electroencephalogram (EEG) interpretations by different clinicians. Fifty neonates had 2-year follow-up. Nine developed epilepsy. Predictors included pH <= 6.8 on day of birth (adjusted odds ratio [OR] 19 [95% confidence interval (CI) 1-371]), burst suppression on EEG on day 4 (8.2 [1.3-59]), and MRI deep gray matter injury (OR 33 [2.4-460]). These factors stratify neonates into low (0-1 factors; 3% [0%-14%] risk), medium (2 factors; 56% [21%-86%] risk), and high-risk groups (3 factors; 100% [29%-100%] risk) for epilepsy. The stratification was robust to varying clinical interpretations of the MRI and EEG. Neonates with hypoxic-ischemic encephalopathy who undergo selective head cooling appear at risk of epilepsy if they have 2 to 3 identified factors. If validated, this rule may help counsel families and identify children for close clinical follow-up.	[McDonough, Tiffani L.] Columbia Univ, Med Ctr, Div Child Neurol, New York, NY USA; [Paolicchi, Juliann M.] Hackensack Med Ctr, Hackensack, NJ 07604 USA; [Heier, Linda A.] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Radiol, New York, NY USA; [Das, Nikkan] Weill Cornell Med Coll, New York, NY USA; [Engel, Murray; Grinspan, Zachary M.] Weill Cornell Med Ctr, Div Child Neurol, New York, NY USA; [Perlman, Jeffrey M.] New York Presbyterian Hosp, Div Neonatol, Weill Cornell Med Ctr, New York, NY USA; [Grinspan, Zachary M.] Weill Cornell Med Coll, Div Hlth Policy & Econ, Dept Healthcare Policy & Res, 402 East 67th St Room LA 220, New York, NY 10065 USA		Grinspan, ZM (corresponding author), Weill Cornell Med Coll, Div Hlth Policy & Econ, Dept Healthcare Policy & Res, 402 East 67th St Room LA 220, New York, NY 10065 USA.	zag9005@med.cornell.edu		Grinspan, Zachary/0000-0001-6705-0932	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K12NS066274] Funding Source: NIH RePORTER		Ambalavanan N, 2006, PEDIATRICS, V118, P2084, DOI 10.1542/peds.2006-1591; Azzopardi D, 1999, EARLY HUM DEV, V55, P113, DOI 10.1016/S0378-3782(99)00010-9; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P143; Cheong JLY, 2012, ARCH PEDIAT ADOL MED, V166, P634, DOI 10.1001/archpediatrics.2012.284; Cseko AJ, 2013, ACTA PAEDIATR, V102, P707, DOI 10.1111/apa.12226; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Glass HC, 2011, PEDIATR RES, V70, P535, DOI 10.1203/PDR.0b013e31822f24c7; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Guillet R, 2012, PEDIATR RES, V71, P205, DOI 10.1038/pr.2011.30; Hallberg B, 2010, ACTA PAEDIATR, V99, P531, DOI 10.1111/j.1651-2227.2009.01653.x; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; Jung DE, 2015, PEDIATR NEUROL, V53, P135, DOI 10.1016/j.pediatrneurol.2015.04.009; Kwon JM, 2011, J CHILD NEUROL, V26, P322, DOI 10.1177/0883073810380915; Low E, 2012, ARCH DIS CHILD-FETAL, V97, pF267, DOI 10.1136/archdischild-2011-300716; Lumley T., 2009, **DATA OBJECT**; Martinez-Biarge M, 2011, NEUROLOGY, V76, P2055, DOI 10.1212/WNL.0b013e31821f442d; McCarthy AL, 2015, PEDIATR RES, V78, P304, DOI 10.1038/pr.2015.99; Merchant N, 2015, DEV MED CHILD NEUROL, V57, P8, DOI 10.1111/dmcn.12726; Newell R, 2013, EJ NEONATOL RES, V3, P38; Pisani F, 2015, EUR J PAEDIATR NEURO, V19, P6, DOI 10.1016/j.ejpn.2014.10.001; Pisani F, 2012, PEDIATR RES, V72, P186, DOI 10.1038/pr.2012.66; Pisani F, 2009, BRAIN DEV-JPN, V31, P64, DOI 10.1016/j.braindev.2008.04.001; R Foundation for Statistical Computing, 2011, R LANG ENV STAT COMP; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; ROBERTSON C, 1985, DEV MED CHILD NEUROL, V27, P473; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Shellhaas RA, 2008, J PEDIATR-US, V153, P369, DOI 10.1016/j.jpeds.2008.03.004; Stevenson D, 2009, FETAL NEONATAL BRAIN; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.3.CO;2-S; Takenouchi T, 2010, RESUSCITATION, V81, P1637, DOI 10.1016/j.resuscitation.2010.08.001; Twomey E, 2010, PEDIATR RADIOL, V40, P1526, DOI 10.1007/s00247-010-1692-9; Volpe J. J., 2008, NEUROLOGY NEWBORN; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wusthoff CJ, 2017, EPILEPSIA, V58, P429, DOI 10.1111/epi.13661; Wusthoff CJ, 2011, J CHILD NEUROL, V26, P724, DOI 10.1177/0883073810390036; Yap V, 2009, PEDIATR NEUROL, V41, P327, DOI 10.1016/j.pediatrneurol.2009.05.004	38	14	14	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JUN	2017	32	7					630	637		10.1177/0883073817698628			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	EV1XV	WOS:000401545900004	28359187				2022-02-06	
J	Oyesanya, TO; Brown, RL; Turkstra, LS				Oyesanya, Tolu O.; Brown, Roger L.; Turkstra, Lyn S.			Caring for Patients with traumatic brain injury: a survey of nurses' perceptions	JOURNAL OF CLINICAL NURSING			English	Article						latent class analysis; nursing attitudes; nursing care; nursing education; structural equationmodelling; survey research; traumatic brain injuries	KNOWLEDGE; REHABILITATION; MILITARY; CLUSTERS; ALPHA; MODEL	Aims and objectivesThe purpose of this study was to determine nurses' perceptions about caring for patients with traumatic brain injury. BackgroundAnnually, it is estimated that over 10 million people sustain a traumatic brain injury around the world. Patients with traumatic brain injury and their families are often concerned with expectations about recovery and seek information from nurses. Nurses' perceptions of care might influence information provided to patients and families, particularly if inaccurate knowledge and perceptions are held. Thus, nurses must be knowledgeable about care of these patients. MethodsA cross-sectional survey, the Perceptions of Brain Injury Survey (PBIS), was completed electronically by 513 nurses between October and December 2014. Data were analysed with structural equationmodelling, factor analysis, and pairwise comparisons. ResultsUsing latent class analysis, authors were able to divide nurses into three homogeneous sub-groups based on perceived knowledge: low, moderate and high. Findings showed that nurses who care for patients with traumatic brain injury the most have the highest perceived confidence but the lowest perceived knowledge. Nurses also had significant variations in training. ConclusionsAs there is limited literature on nurses' perceptions of caring for patients with traumatic brain injury, these findings have implications for training and educating nurses, including direction for development of nursing educational interventions. Relevance to clinical practiceAs the incidence of traumatic brain injury is growing, it is imperative that nurses be knowledgeable about care of patients with these injuries. The traumatic brain injury PBIS can be used to determine inaccurate perceptions about caring for patients with traumatic brain injury before educating and training nurses.	[Oyesanya, Tolu O.; Brown, Roger L.] Univ Wisconsin Madison, Sch Nursing, 5130 Signe Skott Cooper Hall,701 Highland Ave, Madison, WI 53705 USA; [Turkstra, Lyn S.] Univ Wisconsin Madison, Dept Commun Sci & Disorders, Madison, WI USA		Oyesanya, TO (corresponding author), Univ Wisconsin Madison, Sch Nursing, 5130 Signe Skott Cooper Hall,701 Highland Ave, Madison, WI 53705 USA.	toyesanya@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921; Oyesanya, Tolu/0000-0001-8821-4510	University of Wisconsin-Madison, School of Nursing; NIH/NIGMS Initiative for Maximizing Student Development [R25GM083252]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	This research was supported by the University of Wisconsin-Madison, School of Nursing and the NIH/NIGMS Initiative for Maximizing Student Development (PI, M. Carnes) Grant# R25GM083252.	Borenstein M, 2009, INTRO METAANALYSIS, P33, DOI [10.2196/jmir.2636, DOI 10.2196/JMIR.2636]; Brain Injury Association of America, 2014, GUID REH CHRON DIS M; Brain Injury Association of America, 2015, LIV BRAIN INJ; Brain Injury Association of America, 2012, BIAA FREQ ASK QUEST; Cannon HM, 2014, DEV BUSINESS SIMULAT, V37; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; CLOGG CC, 1995, HDB STAT MODELING SO, DOI DOI 10.1007/978-1-4899-1292-3_6; Coco K, 2011, J NEUROSCI NURS, V43, P337, DOI 10.1097/JNN.0b013e318234ea0b; Cook RS, 2013, J NEUROSCI NURS, V45, P108, DOI 10.1097/JNN.0b013e318282906e; COOPER H. M., 2009, HDB RES SYNTHESIS ME, V2nd; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Couper MP, 2008, PUBLIC OPIN QUART, V72, P831, DOI 10.1093/poq/nfn066; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kroonenberg PM., 1982, J EDUC STAT, V7, P69, DOI [10.3102/10769986007002069, DOI 10.3102/10769986007002069]; Linden MA, 2012, NURS RES, V61, P58, DOI 10.1097/NNR.0b013e31823ca253; Long AF, 2002, J ADV NURS, V37, P70, DOI 10.1046/j.1365-2648.2002.02059.x; MCDONALD RP, 1970, BRIT J MATH STAT PSY, V23, P1, DOI 10.1111/j.2044-8317.1970.tb00432.x; McQuillan K. A., 2002, TRAUMA NURSING RESUS, P394; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Muthen L.K., 2010, MPLUS USERS GUIDE ST; NOVICK MR, 1967, PSYCHOMETRIKA, V32, P1, DOI 10.1007/BF02289400; Oyesanya TO, NURSES PERCEPTIONS C; Pieper P., 2011, J TRAUMA NURS, V18, P11, DOI [10.1097/JTN.0b013e31820e3f31, DOI 10.1097/JTN.0B013E31820E3F31]; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; SUHR DD, 2006, EXPLORATORY CONFIRMA, P1; Thoroddsen A, 2010, INT J NURS TERMIN CL, V21, P69, DOI 10.1111/j.1744-618X.2010.01148.x; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Tyler J, 1999, TEACHING STRATEGIES; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6	40	14	14	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	JUN	2017	26	11-12					1562	1574		10.1111/jocn.13457			13	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	EU4IG	WOS:000400992400013	27346166	Green Accepted			2022-02-06	
J	Zhao, ZA; Li, P; Ye, SY; Ning, YL; Wang, H; Peng, Y; Yang, N; Zhao, Y; Zhang, ZH; Chen, JF; Zhou, YG				Zhao, Zi-Ai; Li, Ping; Ye, Shi-Yang; Ning, Ya-Lei; Wang, Hao; Peng, Yan; Yang, Nan; Zhao, Yan; Zhang, Zhuo-Hang; Chen, Jiang-Fan; Zhou, Yuan-Guo			Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A(2A) receptor inactivation	SCIENTIFIC REPORTS			English	Article							CORTICAL IMPACT MODEL; HEAD-INJURY; NERVE-TERMINALS; TAU; AQUAPORIN-4; IMPAIRMENT; CLEARANCE; MICE; PROPAGATION; DISEASE	Traumatic brain injury (TBI) can induce cognitive dysfunction due to the regional accumulation of hyperphosphorylated tau protein (p-tau). However, the factors that cause p-tau to concentrate in specific brain regions remain unclear. Here, we show that AQP4 polarization in the perivascular astrocytic end feet was impaired after TBI, which was most prominent in the ipsilateral brain tissue surrounding the directly impacted region and the contralateral hippocampal CA1 area and was accompanied by increased local p-tau, changes in dendritic spine density and morphology, and upregulation of the adenosine A(2A) receptor (A(2A)R). The critical role of the A(2A)R signaling in these pathological changes was confirmed by alleviation of the impairment of AQP4 polarity and accumulation of p-tau in the contralateral CA1 area in A(2A)R knockout mice. Given that p-tau can be released to the extracellular space and that the astroglial water transport via AQP4 is involved in tau clearance from the brain interstitium, our results suggest that regional disruption of AQP4 polarity following TBI may reduce the clearance of the toxic interstitial solutes such as p-tau and lead to changes in dendritic spine density and morphology. This may explain why TBI patients are more vulnerable to cognitive dysfunction.	[Zhao, Zi-Ai; Li, Ping; Ye, Shi-Yang; Ning, Ya-Lei; Peng, Yan; Yang, Nan; Zhao, Yan; Zhang, Zhuo-Hang; Zhou, Yuan-Guo] Third Mil Med Univ, Res Inst Surg, State Key Lab Trauma Burn & Combined Injury, Mol Biol Ctr, Chongqing 400042, Peoples R China; [Zhao, Zi-Ai; Li, Ping; Ye, Shi-Yang; Ning, Ya-Lei; Wang, Hao; Peng, Yan; Yang, Nan; Zhao, Yan; Zhang, Zhuo-Hang; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; [Wang, Hao] Third Mil Med Univ, Res Inst Surg, Dept Neurosurg, Chongqing 400042, Peoples R China; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol & Pharmacol, Boston, MA 02118 USA		Zhou, YG (corresponding author), Third Mil Med Univ, Res Inst Surg, State Key Lab Trauma Burn & Combined Injury, Mol Biol Ctr, Chongqing 400042, Peoples R China.; Zhou, YG (corresponding author), Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China.	zhourick@hotmail.com	Li, ping/J-6507-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471109]	This work was supported by the National Natural Science Foundation of China (No. 81471109).	Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Chakraborti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040844; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2014, INT REV NEUROBIOL, V119, P257, DOI 10.1016/B978-0-12-801022-8.00012-X; Chen XJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00467; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gubitz AK, 1996, J NEUROCHEM, V67, P374; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Han ZQ, 2000, BIOCHEM BIOPH RES CO, V273, P328, DOI 10.1006/bbrc.2000.2944; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Laurent C, 2016, MOL PSYCHIATR, V21, P97, DOI 10.1038/mp.2014.151; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nielsen S, 1997, J NEUROSCI, V17, P171; Ning YL, 2013, J CEREBR BLOOD F MET, V33, P1789, DOI 10.1038/jcbfm.2013.127; Orr AG, 2015, NAT NEUROSCI, V18, P423, DOI 10.1038/nn.3930; Phan A, 2012, NEUROPSYCHOPHARMACOL, V37, P2299, DOI 10.1038/npp.2012.82; Phan A, 2011, ENDOCRINOLOGY, V152, P1492, DOI 10.1210/en.2010-1273; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rodrigues RJ, 2005, J NEUROCHEM, V92, P433, DOI 10.1111/j.1471-4159.2004.02887.x; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xu L, 2015, BBA-MOL BASIS DIS, V1852, P1298, DOI 10.1016/j.bbadis.2015.03.009; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zeppenfeld DM, 2017, JAMA NEUROL, V74, P91, DOI 10.1001/jamaneurol.2016.4370	47	14	14	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 22	2017	7								2254	10.1038/s41598-017-02505-6			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV4TE	WOS:000401754200041	28533515	Green Published, gold			2022-02-06	
J	Dreer, LE; Crowley, MT; Cash, A; O'Neill, JA; Cox, MK				Dreer, Laura E.; Crowley, Maria T.; Cash, Augusta; O'Neill, Jilian A.; Cox, Molly K.			Examination of Teacher Knowledge, Dissemination Preferences, and Classroom Management of Student Concussions: Implications for Return-to-Learn Protocols	HEALTH PROMOTION PRACTICE			English	Article						concussions; teachers; return-to-learn	SCHOOL; RECOMMENDATIONS; RECOVERY	Objectives. To determine teacher knowledge of (1) concussion symptomatology, (2) dissemination preferences, and (3) classroom management practices of student concussions. Study Design. A cross-sectional survey assessing concussion-related information was completed by teachers/instructors in the state of Alabama. Results. One-hundred and thirty participants completed the survey. Only a quarter perceived they were "very" or "extremely" confident enough to recognize signs related to a concussion (22.3%), and only 12.4% reported they were "very knowledgeable" about concussions. The majority were able to recognize more common concussion symptoms/challenges: headaches (95.4%), trouble concentrating (86.2%), memory (82.3%), balance problems/dizziness (82.3%), changes vision/hearing (76.2%), difficulty completing tasks (70.8%), difficulty making decisions (66.2%), changes in sleep (61.5%), and fatigue (60.8%); only half recognized emotional symptoms (e.g., mood) or symptoms associated with more prolonged recovery. Concussion informants were school nurses (74.4%), followed by parents (46.2%), students (46.2%), and coaches/athletic trainers (45.4%). A little under half of participants received concussion information as part of their job (41.9%). About 14.1% of teachers reported that someone had come to their school to talk with them as a group about concussions, and 82% felt they needed more information. Of the 37% who taught a concussed student, 83% reported they altered the classroom management strategies. Conclusions. In general, teachers were able to recognize the more commonly experienced concussion symptoms as well as management strategies. However, they appear to want greater concussion information and training. Given the daily influence of teachers on student tasks involving cognitive exertion, incorporation of formal concussion education for teachers is warranted.	[Dreer, Laura E.; O'Neill, Jilian A.; Cox, Molly K.] Univ Alabama Birmingham, 1720 Univ Blvd, Birmingham, AL USA; [Crowley, Maria T.; Cash, Augusta] Alabama Dept Rehabil Serv, Birmingham, AL USA		Dreer, LE (corresponding author), Univ Alabama Birmingham, 1720 Univ Blvd, Birmingham, AL USA.; Dreer, LE (corresponding author), Psychol & Neuropsychol Clin Res Serv, Suite H-405, Birmingham, AL 35243 USA.	lauradreer@uabmc.edu			Health Resources and Services Administration of the U.S. Department of Health and Human Services [H21MC26930]; Wise Up! Initiative of the Al and Sharyne Wallace Foundation	Funding from the Health Resources and Services Administration of the U.S. Department of Health and Human Services (H21MC26930) and the Wise Up! Initiative of the Al and Sharyne Wallace Foundation.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Centers for Disease Control and Prevention, 2015, HEADS SCH KNOW YOUR; Centers for Disease Control and Prevention, 2015, HEADS SCH CONC FACT; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Dreer L. E, 2006, REHABIL PSYCHOL, V53, P486; Dreer Laura E, 2014, J Health Dispar Res Pract, V7, P14; Dreer LE, 2016, CURR EYE RES, V41, P50, DOI 10.3109/02713683.2014.1002045; Dreer LE, 2013, OPTOMETRY VISION SCI, V90, P883, DOI 10.1097/OPX.0000000000000009; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer GL, 2015, J PEDIATR-US, V166, P594, DOI 10.1016/j.jpeds.2014.09.038; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McAvoy K, 2014, REAP BENEFITS GOOD C; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod Tamara C Valovich, 2014, NASN Sch Nurse, V29, P232; Piebes SK, 2009, J SCH NURS, V25, P270, DOI 10.1177/1059840509339782; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Werther K., 2014, COLORADO DEP ED CONC	29	14	15	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1524-8399	1552-6372		HEALTH PROMOT PRACT	Health Promot. Pract.	MAY	2017	18	3					428	436		10.1177/1524839916650865			9	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	ES7SN	WOS:000399751100014	27234985				2022-02-06	
J	Eapen, BC; Georgekutty, J; Subbarao, B; Bavishi, S; Cifu, DX				Eapen, Blessen C.; Georgekutty, Jason; Subbarao, Bruno; Bavishi, Sheital; Cifu, David X.			Disorders of Consciousness	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Disorder of consciousness; Rehabilitation; Coma; Vegetative state; Minimally conscious state; Traumatic brain injury	COMA RECOVERY SCALE; VEGETATIVE STATE; BRAIN-INJURY; STIMULATION; METHYLPHENIDATE; DISABILITY; AMANTADINE; ZOLPIDEM; OUTCOMES; TRIAL	Disorder of consciousness (DOC) is a state of prolonged altered consciousness, which can be categorized into coma, vegetative state, or minimally conscious state based on neurobehavioral function. The pathophysiology of DOC is poorly understood but recent advances in neuroimaging and advanced electrophysiological techniques may provide an improved understanding for the neural network involved with consciousness. The primary aim of DOC rehabilitation programs is to promote arousal while preventing secondary medical complications while providing education and training to families. Treatment interventions include both pharmacologic and nonpharmacologic programs, but there are currently no consensus treatment guidelines for individuals with DOC.	[Eapen, Blessen C.; Subbarao, Bruno] South Texas Vet Healthcare Syst, Polytrauma Rehabil Ctr, 7400 Merton Minter, San Antonio, TX 78229 USA; [Georgekutty, Jason] Kessler Inst Rehabil, 201 Pleasant Hill Rd, Chester, NJ 07930 USA; [Bavishi, Sheital] Ohio State Univ, Dept Phys Med & Rehabil, Traumat Brain Injury Rehabil Program, Wexner Med Ctr, 480 Med Ctr Dr, Columbus, OH 43210 USA; [Cifu, David X.] Virginia Commonwealth Univ, Dept PM&R, US Dept Vet Affairs, VA DoD Chron Effects NeuroTrauma Consortium, 1223 E Marshall St,POB 980677, Richmond, VA 23284 USA		Eapen, BC (corresponding author), South Texas Vet Healthcare Syst, Polytrauma Rehabil Ctr, 7400 Merton Minter, San Antonio, TX 78229 USA.	blessen.eapen2@va.gov		Cifu, David/0000-0003-1600-9387			Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; [Anonymous], 1995, Neurology, V45, P1012; BAUER G, 1979, J NEUROL, V221, P77, DOI 10.1007/BF00313105; Bernat JL, 2009, ANNU REV MED, V60, P381, DOI 10.1146/annurev.med.60.060107.091250; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cavanna AE, 2011, BEHAV NEUROL, V24, P107, DOI [10.3233/BEN-2011-0322, 10.1155/2011/645159]; Cavanna AE, 2011, BEHAV NEUROL, V24, P3, DOI [10.1155/2011/374507, 10.3233/BEN-2011-0311]; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Eapen BC, 2017, EXP NEUROL, V287, P479, DOI 10.1016/j.expneurol.2016.08.004; Eapen Blessen C, 2015, Semin Neurol, V35, pe1, DOI 10.1055/s-0035-1549094; Fisher CE, 2010, J LAW MED ETHICS, V38, P374, DOI 10.1111/j.1748-720X.2010.00496.x; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Gray M, 2011, J TRAUMA, V71, P1465, DOI 10.1097/TA.0b013e31821f82f5; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P335, DOI 10.1097/WNF.0b013e3181b40678; Krimchansky BZ, 2004, BRAIN INJURY, V18, P1099, DOI 10.1080/02699050310001646206; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; ODell MW, 1996, NEUROREHABILITATION, V6, P45, DOI 10.3233/NRE-1996-6106; Page SJ, 2015, ARCH PHYS MED REHAB, V96, pS89, DOI 10.1016/j.apmr.2014.09.019; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Plum F, 1966, DIAGNOSIS STUPOR COM, P5; RADER MA, 1994, BRAIN INJURY, V8, P309, DOI 10.3109/02699059409150982; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; Reynolds JC, 2013, RESUSCITATION, V84, P818, DOI 10.1016/j.resuscitation.2012.11.014; Rosenbaum Amy M, 2015, Handb Clin Neurol, V127, P395, DOI 10.1016/B978-0-444-52892-6.00025-8; Schnakers C, 2008, BRAIN INJURY, V22, P926, DOI 10.1080/02699050802530565; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Tucker C, 2016, NEUROCRIT CARE, V24, P488, DOI 10.1007/s12028-015-0227-5; Vanhaudenhuyse A, 2007, Rev Med Liege, V62 Spec No, P15; Whyte J, 2014, AM J PHYS MED REHAB, V93, P101, DOI 10.1097/PHM.0000000000000069; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8; Zasler ND, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1	52	14	20	2	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					245	258		10.1016/j.pmr.2016.12.003			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU5AJ	WOS:000401043700005	28390511				2022-02-06	
J	Hertelendy, P; Menyhart, A; Makra, P; Sule, Z; Kiss, T; Toth, G; Ivankovits-Kiss, O; Bari, F; Farkas, E				Hertelendy, Peter; Menyhart, Akos; Makra, Peter; Sule, Zoltan; Kiss, Tamas; Toth, Gergely; Ivankovits-Kiss, Orsolya; Bari, Ferenc; Farkas, Eszter			Advancing age and ischemia elevate the electric threshold to elicit spreading depolarization in the cerebral cortex of young adult rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Age; cerebral blood flow; electrophysiology; spreading depolarization; threshold	ANEURYSMAL SUBARACHNOID HEMORRHAGE; BLOOD-FLOW; BRAIN TRAUMA; DEPRESSION; INJURY; MODULATION; STROKE; DAMAGE; HYPOPERFUSION; PROPAGATION	Spreading depolarizations of long cumulative duration have been implicated in lesion development and progression in patients with stroke and traumatic brain injury. Spreading depolarizations evolve less likely in the aged brain, but it remains to be determined at what age the susceptibility to spreading depolarizations starts to decline, especially in ischemia. Spreading depolarizations were triggered by epidural electric stimulation prior and after ischemia induction in the cortex of 7-30 weeks old anesthetized rats (n=38). Cerebral ischemia was achieved by occlusion of both common carotid arteries. Spreading depolarization occurrence was confirmed by the acquisition of DC potential and electrocorticogram. Cerebral blood flow variations were recorded by laser-Doppler flowmetry. Dendritic spine density in the cortex was determined in Golgi-COX stained sections. Spreading depolarization initiation required increasingly greater electric charge with older age, a potential outcome of consolidation of cortical connections, indicated by altered dendritic spine distribution. The threshold of spreading depolarization elicitation increased with ischemia in all age groups, which may be caused by tissue acidosis and increased K+ conductance, among other factors. In conclusion, the brain appears to be the most susceptible to spreading depolarizations at adolescent age; therefore, spreading depolarizations may occur in young patients of ischemic or traumatic brain injury at the highest probability.	[Hertelendy, Peter; Menyhart, Akos; Makra, Peter; Kiss, Tamas; Toth, Gergely; Ivankovits-Kiss, Orsolya; Bari, Ferenc; Farkas, Eszter] Univ Szeged, Fac Med, Dept Med Phys & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary; [Hertelendy, Peter; Menyhart, Akos; Makra, Peter; Kiss, Tamas; Toth, Gergely; Ivankovits-Kiss, Orsolya; Bari, Ferenc; Farkas, Eszter] Univ Szeged, Fac Sci & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary; [Sule, Zoltan] Univ Szeged, Fac Med, Dept Anat Histol & Embryol, Szeged, Hungary		Farkas, E (corresponding author), Univ Szeged, Fac Med, Dept Med Phys & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary.; Farkas, E (corresponding author), Univ Szeged, Fac Sci & Informat, Koranyi Fasor 9, H-6720 Szeged, Hungary.	farkas.eszter.1@med.u-szeged.hu		Farkas, Eszter/0000-0002-8478-9664; Menyhart, Akos/0000-0002-1355-3208; Kiss, Tamas/0000-0001-5339-5227	Hungarian Scientific Research FundOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [K111923]; Hungarian Brain Research Program [KTIA_13_NAP-A-I/13]; Bolyai Janos Research Scholarship of the Hungarian Academy of SciencesHungarian Academy of Sciences [BO/00327/14/5];  [TAMOP-4.2.2.D-15/1/KONV-2015-0024]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the Hungarian Scientific Research Fund (Grant No. K111923); the Hungarian Brain Research Program (Grant No. KTIA_13_NAP-A-I/13); TAMOP-4.2.2.D-15/1/KONV-2015-0024; and the Bolyai Janos Research Scholarship of the Hungarian Academy of Sciences (BO/00327/14/5, to EF).	Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; Cippola MJ., 2009, CEREBRAL CIRCULATION; Clark D, 2014, NEUROBIOL AGING, V35, P2803, DOI 10.1016/j.neurobiolaging.2014.06.013; Dickstein DL, 2013, NEUROSCIENCE, V251, P21, DOI 10.1016/j.neuroscience.2012.09.077; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Faber JE, 2011, ARTERIOSCL THROM VAS, V31, P1748, DOI 10.1161/ATVBAHA.111.227314; Farkas E, 2011, NEUROBIOL AGING, V32, P1707, DOI 10.1016/j.neurobiolaging.2009.10.002; Feuerstein D, 2014, J CEREBR BLOOD F MET, V34, P1117, DOI 10.1038/jcbfm.2014.53; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; HERRERAS O, 1993, BRAIN RES, V610, P276, DOI 10.1016/0006-8993(93)91411-K; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hoffmann U, 2013, J CEREBR BLOOD F MET, V33, P191, DOI 10.1038/jcbfm.2012.132; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; Lanzino G, 1996, J NEUROSURG, V85, P410, DOI 10.3171/jns.1996.85.3.0410; Lapi D, 2015, J VASC RES, V52, P22, DOI 10.1159/000381096; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Maslarova A, 2011, STROKE, V42, P2917, DOI 10.1161/STROKEAHA.111.621581; Menyhart A, 2015, NEUROBIOL AGING, V36, P3269, DOI 10.1016/j.neurobiolaging.2015.08.014; Nedergaard M, 1996, ADV NEUROL, V71, P75; Richter F, 1998, DEV BRAIN RES, V106, P217, DOI 10.1016/S0165-3806(98)00018-2; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sukhotinsky I, 2008, J CEREBR BLOOD F MET, V28, P1369, DOI 10.1038/jcbfm.2008.35; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tong CK, 2000, J NEUROPHYSIOL, V84, P2449, DOI 10.1152/jn.2000.84.5.2449; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932	40	14	14	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2017	37	5					1763	1775		10.1177/0271678X16643735			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ET8CG	WOS:000400525200015	27189902	Green Published, Green Accepted, Bronze			2022-02-06	
J	Pinczolits, A; Zdunczyk, A; Dengler, NF; Hecht, N; Kowoll, CM; Dohmen, C; Graf, R; Winkler, MKL; Major, S; Hartings, JA; Dreier, JP; Vajkoczy, P; Woitzik, J				Pinczolits, Alexandra; Zdunczyk, Anna; Dengler, Nora F.; Hecht, Nils; Kowoll, Christina M.; Dohmen, Christian; Graf, Rudolf; Winkler, Maren K. L.; Major, Sebastian; Hartings, Jed A.; Dreier, Jens P.; Vajkoczy, Peter; Woitzik, Johannes			Standard-sampling microdialysis and spreading depolarizations in patients with malignant hemispheric stroke	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Malignant hemispheric stroke; cortical spreading depolarization; spreading depression; cerebral ischemia; microdialysis; glutamate	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; INTRACEREBRAL MICRODIALYSIS; PERIINFARCT DEPOLARIZATIONS; ANOXIC DEPOLARIZATION; DC SHIFTS; DEPRESSION; GLUTAMATE; CORTEX; EXCITOTOXICITY	Spreading depolarizations (SD) occur in high frequency in patients with malignant hemispheric stroke (MHS). Experimentally, SDs cause marked increases in glutamate and lactate, whereas glucose decreases. Here, we studied extracellular brain glutamate, glucose, lactate, pyruvate and the lactate/pyruvate ratio in relationship to SDs after MHS. We inserted two microdialysis probes in peri-infarct tissue at 5 and 15 mm to the infarct in close proximity to a subdural electrode strip. During 2356.6 monitoring hours, electrocorticography (ECoG) revealed 697 SDs in 16 of 18 patients. Ninety-nine SDs in electrically active tissue (spreading depressions, SDd) were single (SDds) and 485 clustered (SDdc), whereas 10 SDs with at least one electrode in electrically inactive tissue (isoelectric SDs, SDi) were single (SDis) and 103 clustered (SDic). More SDs and a significant number of clustered SDs occurred during the first 36 h post-surgery when glutamate was significantly elevated (> 100 mu M). In a grouped analysis, we observed minor glutamate elevations with more than two SDs per hour. Glucose slightly decreased during SDic at 5 mm from the infarct. Directions of SD-related metabolic changes correspond to the experimental setting but the long sampling time of standard microdialysis precludes a more adequate account of the dynamics revealed by ECoG.	[Pinczolits, Alexandra; Zdunczyk, Anna; Dengler, Nora F.; Hecht, Nils; Vajkoczy, Peter; Woitzik, Johannes] Charite, Dept Neurosurg, Berlin, Germany; [Pinczolits, Alexandra; Zdunczyk, Anna; Dengler, Nora F.; Hecht, Nils; Winkler, Maren K. L.; Major, Sebastian; Dreier, Jens P.; Vajkoczy, Peter; Woitzik, Johannes] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Kowoll, Christina M.; Dohmen, Christian] Univ Cologne, Dept Neurol, Cologne, Germany; [Kowoll, Christina M.; Dohmen, Christian; Graf, Rudolf] Max Planck Inst Neurol Res, Cologne, Germany; [Winkler, Maren K. L.; Major, Sebastian; Dreier, Jens P.] Charite, Dept Neurol, Berlin, Germany; [Hartings, Jed A.] Univ Cincinnati, Coll Med, Dept Neurosurg, Mayfield Clin, Cincinnati, OH 45267 USA		Woitzik, J (corresponding author), Dept Neurosurg, Charite Univ Med Berlin Campus,Hindenburgdamm 30, D-12200 Berlin, Germany.	johannes.woitzik@charite.de	Major, Sebastian/I-1838-2019	Major, Sebastian/0000-0003-0970-1308; Dengler, Nora F./0000-0001-7783-8053; Zdunczyk, Anna/0000-0002-9836-6080; Hartings, Jed/0000-0001-8583-3471; Woitzik, Johannes/0000-0002-1865-4606	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG-WO 1704/1-1, DFG-WO 1704/1-2, DFG DR 323/5-1]; Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)Federal Ministry of Education & Research (BMBF) [01 EO 0801]; Era-Net Neuron [01EW1212]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: J. Woitzik received research support from the Deutsche Forschungsgemeinschaft (DFG-WO 1704/1-1; DFG-WO 1704/1-2). A. Pinczolits is funded by the Deutsche Forschungsgemeinschaft (DFG-WO 1704/1-1). JP. Dreier received research support from the Deutsche Forschungsgemeinschaft (DFG DR 323/5-1), Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 0801), and Era-Net Neuron 01EW1212.	AYAD M, 1994, J NEUROSURG ANESTH, V6, P98; Balanca B, 2017, J CEREBR BLOOD F MET, V37, P1670, DOI 10.1177/0271678X16657571; Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2007, EXP BIOL MED, V232, P204; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2013, STROKE, V44, P490, DOI 10.1161/STROKEAHA.112.660589; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; FABRICIUS M, 1993, BRAIN RES, V612, P61, DOI 10.1016/0006-8993(93)91644-8; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hecht N, 2016, J CEREBR BLOOD F MET, V36, P1022, DOI 10.1177/0271678X15612487; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Kang EJ, 2013, NEUROBIOL DIS, V52, P204, DOI 10.1016/j.nbd.2012.12.007; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Liu JYW, 2012, BRAIN, V135, P3115, DOI 10.1093/brain/aws147; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; Nozari A, 2010, ANN NEUROL, V67, P221, DOI 10.1002/ana.21871; Obrenovitch TP, 1996, ACT NEUR S, V67, P21; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Sahuquillo Juan, 2014, PLoS One, V9, pe102540, DOI 10.1371/journal.pone.0102540; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; Somjen GG., 2004, IONS IN THE BRAIN, P338; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; SYMON L, 1977, ACTA NEUROL SCAND, V56, P110; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; WAHL F, 1994, J NEUROCHEM, V63, P1003; Woitzik J, 2014, STROKE, V45, P1183, DOI 10.1161/STROKEAHA.113.004475; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Woitzik J, 2012, J CEREBR BLOOD F MET, V32, P203, DOI 10.1038/jcbfm.2011.169	56	14	14	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2017	37	5					1896	1905		10.1177/0271678X17699629			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ET8CG	WOS:000400525200025	28350195	Green Published, Bronze			2022-02-06	
J	Richter, A; Barman, A; Wustenberg, T; Soch, J; Schanze, D; Deibele, A; Behnisch, G; Assmann, A; Klein, M; Zenker, M; Seidenbecher, C; Schott, BH				Richter, Anni; Barman, Adriana; Wuestenberg, Torsten; Soch, Joram; Schanze, Denny; Deibele, Anna; Behnisch, Gusalija; Assmann, Anne; Klein, Marieke; Zenker, Martin; Seidenbecher, Constanze; Schott, Bjoern H.			Behavioral and Neural Manifestations of Reward Memory in Carriers of Low-Expressing versus High-Expressing Genetic Variants of the Dopamine D2 Receptor	FRONTIERS IN PSYCHOLOGY			English	Article						dopamine D2 receptor; TaqIA; C957T; episodic memory; reward; fMRI; intermediate phenotype	LONG-TERM-MEMORY; TRAUMATIC BRAIN-INJURY; AVAILABILITY IN-VIVO; C957T POLYMORPHISM; A1 ALLELE; BINDING CHARACTERISTICS; NICOTINE DEPENDENCE; ALCOHOL DEPENDENCE; HEALTHY-VOLUNTEERS; INHIBITORY CONTROL	Dopamine is critically important in the neural manifestation of motivated behavior, and alterations in the human dopaminergic system have been implicated in the etiology of motivation-related psychiatric disorders, most prominently addiction. Patients with chronic addiction exhibit reduced dopamine D2 receptor (DRD2) availability in the striatum, and the DRD2 TaqIA (rs1800497) and C957T (rs6277) genetic polymorphisms have previously been linked to individual differences in striatal dopamine metabolism and clinical risk for alcohol and nicotine dependence. Here, we investigated the hypothesis that the variants of these polymorphisms would show increased reward-related memory formation, which has previously been shown to jointly engage the mesolimbic dopaminergic system and the hippocampus, as a potential intermediate phenotype for addiction memory. To this end, we performed functional magnetic resonance imaging (fMRI) in 62 young, healthy individuals genotyped for DRD2 TaqIA and C957T variants. Participants performed an incentive delay task, followed by a recognition memory task 24 h later. We observed effects of both genotypes on the overall recognition performance with carriers of low-expressing variants, namely TaqIA A1 carriers and C957T C homozygotes, showing better performance than the other genotype groups. In addition to the better memory performance, C957T C homozygotes also exhibited a response bias for cues predicting monetary reward. At the neural level, the C957T polymorphism was associated with a genotype-related modulation of right hippocampal and striatal fMRI responses predictive of subsequent recognition confidence for reward-predicting items. Our results indicate that genetic variations associated with DRD2 expression affect explicit memory, specifically for rewarded stimuli. We suggest that the relatively better memory for rewarded stimuli in carriers of low-expressing DRD2 variants may reflect an intermediate phenotype of addiction memory.	[Richter, Anni; Barman, Adriana; Soch, Joram; Deibele, Anna; Behnisch, Gusalija; Assmann, Anne; Klein, Marieke; Seidenbecher, Constanze; Schott, Bjoern H.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Wuestenberg, Torsten; Schott, Bjoern H.] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Schanze, Denny; Zenker, Martin] Otto von Guericke Univ, Inst Human Genet, Magdeburg, Germany; [Assmann, Anne; Schott, Bjoern H.] Univ Magdeburg, Dept Neurol, Magdeburg, Germany; [Seidenbecher, Constanze; Schott, Bjoern H.] Ctr Behav Brain Sci, Magdeburg, Germany		Richter, A (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	anni.richter@lin-magdeburg.de	Schott, Bjorn H/U-5626-2017; Klein, Marieke/G-9870-2015	Schott, Bjorn H/0000-0002-8237-4481; Klein, Marieke/0000-0001-8784-5679; Wustenberg, Torsten/0000-0001-8408-2864; Soch, Joram/0000-0002-8879-5666	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 779, TP A8]; Leibniz Graduate School Synaptogenetics	This project was supported by the Deutsche Forschungsgemeinschaft (SFB 779, TP A8) and the Leibniz Graduate School Synaptogenetics (Ph.D. stipend to AB, Master stipend to MK).	Aarts E, 2014, PSYCHOL SCI, V25, P1003, DOI 10.1177/0956797613517240; Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Apitz T, 2013, NEUROPSYCHOPHARMACOL, V38, P2409, DOI 10.1038/npp.2013.141; Barman A, 2015, SOC COGN AFFECT NEUR, V10, P1537, DOI 10.1093/scan/nsv044; Barman A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00260; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bartres-Faz D, 2002, NEUROREPORT, V13, P1121, DOI 10.1097/00001756-200207020-00010; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Colzato LS, 2013, NEUROPSYCHOLOGIA, V51, P1377, DOI 10.1016/j.neuropsychologia.2013.01.014; Costa A, 2011, SYNAPSE, V65, P998, DOI 10.1002/syn.20927; CUBEDDU LX, 1990, ANN NY ACAD SCI, V604, P452, DOI 10.1111/j.1749-6632.1990.tb32011.x; de Jong JW, 2015, NEUROPSYCHOPHARMACOL, V40, P2085, DOI 10.1038/npp.2015.60; Doehring A, 2009, PHARMACOGENET GENOM, V19, P407, DOI 10.1097/FPC.0b013e328320a3fd; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Duzel E, 2011, HIPPOCAMPUS, V21, P803, DOI 10.1002/hipo.20834; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Elfman KW, 2008, J EXP PSYCHOL LEARN, V34, P752, DOI 10.1037/0278-7393.34.4.752; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Everitt BJ, 2014, EUR J NEUROSCI, V40, P2163, DOI 10.1111/ejn.12644; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; GRANDY DK, 1989, AM J HUM GENET, V45, P778; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; Hirvonen MM, 2009, PROG NEURO-PSYCHOPH, V33, P630, DOI 10.1016/j.pnpbp.2009.02.021; Jocham G, 2009, J NEUROSCI, V29, P3695, DOI 10.1523/JNEUROSCI.5195-08.2009; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Jou J, 2013, PSYCHOL RES-PSYCH FO, V77, P671, DOI 10.1007/s00426-012-0472-6; Kienast T., 2006, CNS & Neurological Disorders-Drug Targets, V5, P109, DOI 10.2174/187152706784111560; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Krebs RM, 2009, NEUROPSYCHOLOGIA, V47, P2272, DOI 10.1016/j.neuropsychologia.2009.01.015; Laakso A, 2005, PHARMACOGENET GENOM, V15, P387, DOI 10.1097/01213011-200506000-00003; Laruelle M, 1998, MOL PSYCHIATR, V3, P261, DOI 10.1038/sj.mp.4000343; Li SC, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.08.001; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; Machulska A, 2016, J PSYCHIATR RES, V76, P44, DOI 10.1016/j.jpsychires.2015.11.015; Markett S, 2013, NEUROIMAGE, V64, P167, DOI 10.1016/j.neuroimage.2012.08.059; Markett S, 2011, COGN AFFECT BEHAV NE, V11, P644, DOI 10.3758/s13415-011-0058-6; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Miller MB, 1999, PSYCHOL REV, V106, P398, DOI 10.1037/0033-295X.106.2.398; Morton LM, 2006, PHARMACOGENET GENOM, V16, P901, DOI 10.1097/01.fpc.0000230417.20468.d0; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; Papenberg G, 2013, J COGNITIVE NEUROSCI, V25, P571, DOI 10.1162/jocn_a_00359; Persson J, 2015, HUM BRAIN MAPP, V36, P1325, DOI 10.1002/hbm.22704; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Richter A, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00140; Richter A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00250; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Samochowiec J, 2014, NEUROPSYCHOBIOLOGY, V70, P77, DOI 10.1159/000364826; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Schott BH, 2007, BRAIN, V130, P2412, DOI 10.1093/brain/awm147; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Shumay E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022754; Spencer TJ, 2013, BIOL PSYCHIAT, V74, P84, DOI 10.1016/j.biopsych.2012.11.010; Swagell CD, 2012, ALCOHOL ALCOHOLISM, V47, P397, DOI 10.1093/alcalc/ags047; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Voisey J, 2012, PSYCHIAT RES, V196, P285, DOI 10.1016/j.psychres.2011.09.024; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wittmann BC, 2013, NEUROPSYCHOLOGIA, V51, P2469, DOI 10.1016/j.neuropsychologia.2013.09.031; WOLF ME, 1990, ANN NY ACAD SCI, V604, P323, DOI 10.1111/j.1749-6632.1990.tb32003.x; Yacubian J, 2007, NEUROIMAGE, V38, P557, DOI 10.1016/j.neuroimage.2007.08.007; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Zimmermann P., 1993, TESTBATTERIE AUFMERK	75	14	17	0	11	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAY 1	2017	8								654	10.3389/fpsyg.2017.00654			13	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	EU6XD	WOS:000401178300001	28507526	Green Published, gold			2022-02-06	
J	Soble, JR; Critchfield, EA; O'Rourke, JJF				Soble, Jason R.; Critchfield, Edan A.; O'Rourke, Justin J. F.			Neuropsychological Evaluation in Traumatic Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Neuropsychology; Assessment; Cognition; Brain-behavior relationships; Psychometrics; Outcome; Rehabilitation	NORMAL-PRESSURE HYDROCEPHALUS; HEAD-INJURY; COGNITIVE PERFORMANCE; LIKELIHOOD RATIOS; DIAGNOSIS; VALIDITY; AMNESIA	Clinical neuropsychology is a subspecialty of professional psychology that is concerned with the scientific study and clinical application of brain-behavior relationships. Broadly defined, a neuropsychological evaluation is a flexible clinical tool that involves integration of objective, psychometric test data along with various other sources of clinical information to comprehensively elucidate the cognitive, behavioral, and emotional sequelae after traumatic brain injury (TBI). In addition to characterizing TBI sequelae, evidenced based neuropsychological assessment can contribute to TBI patient care by aiding with prognostic assessment, measuring interval change/recovery overtime (eg, resolution of posttraumatic amnesia), informing and implementing rehabilitation strategies, and evaluating the effectiveness of interventions.	[Soble, Jason R.; Critchfield, Edan A.; O'Rourke, Justin J. F.] South Texas Vet Healthcare Syst, Psychol Serv 116B, 7400 Merton Minter, San Antonio, TX 78229 USA		Soble, JR (corresponding author), South Texas Vet Healthcare Syst, Psychol Serv 116B, 7400 Merton Minter, San Antonio, TX 78229 USA.	jason.soble@va.gov					American Psychological Association, CLIN NEUROPSYCHOLOGY; Barr WB, 2008, TXB CLIN NEUROPSYCHO, P3; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; Bush SS, 2011, ENCY CLIN NEUROPSYCH, P1589; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Eapen Blessen C, 2015, Semin Neurol, V35, pe1, DOI 10.1055/s-0035-1549094; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hannay HJ, 1998, ARCH CLIN NEUROPSYCH, V13, P157, DOI 10.1016/S0887-6177(98)00003-1; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilman KM, 2003, CLIN NEUROPSYCHOLOGY; Hellstrom P, 2007, NEUROSURGERY, V61, P1219, DOI 10.1227/01.NEU.0000280167.18344.85; Iverson GL, 2012, NEUROPSYCHOLOGICAL A, P360; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2015, AM PSYCHOL, V70, P779, DOI 10.1037/a0039835; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maassen GH, 2009, J CLIN EXP NEUROPSYC, V31, P339, DOI 10.1080/13803390802169059; Mateer CA, 2008, TXB CLIN NEUROPSYCHO, P996; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Sandhaug M, 2011, J NEUROLOGICAL RES, V1, P48; Schoenberg MR, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P1, DOI 10.1007/978-0-387-76978-3; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith GE, 2008, Textbook of clinical neuropsychology, P38; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; The Center for Outcome Measurement in Brain Injury, COMBI FEAT SCAL; Tranel D, 2008, TXB CLIN NEUROPSYCHO, P25; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Vanneste JAL, 2000, J NEUROL, V247, P5, DOI 10.1007/s004150050003	44	14	14	0	22	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					339	+		10.1016/j.pmr.2016.12.009			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU5AJ	WOS:000401043700011	28390517				2022-02-06	
J	Yang, Y; Mackey, DC; Liu-Ambrose, T; Leung, PM; Feldman, F; Robinovitch, SN				Yang, Yijian; Mackey, Dawn C.; Liu-Ambrose, Teresa; Leung, Pet-Ming; Feldman, Fabio; Robinovitch, Stephen N.			Clinical Risk Factors for Head Impact During Falls in Older Adults: A Prospective Cohort Study in Long-Term Care	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						falls; head impact; long-term care; older adults; traumatic brain injury	TRAUMATIC BRAIN-INJURIES; UPPER EXTREMITY; SERIOUS INJURY; HIP FRACTURE; CIRCUMSTANCES; PERFORMANCE; MEDICATION; MORTALITY; PATIENT; GENDER	Objective: To examine risk factors associated with head impact during falls in older adults in long-term care (LTC). Setting: Two LTC facilities in British Columbia, Canada. Participants: 160 LTC residents. Design: Prospective cohort study. Main Measures: Between 2007 and 2014, we video captured 520 falls experienced by participants. Each fall video was analyzed to determine whether impact occurred to the head. Using generalized estimating equation models, we examined how head impact was associated with other fall characteristics and health status prior to the fall. Results: Head impact occurred in 33% of falls. Individuals with mild cognitive impairment were at higher risk for head impact (odds ratio = 2.8; 95% confidence interval, 1.5-5.0) than those with more severe cognitive impairment. Impaired vision was associated with 2.0-fold (1.3-3.0) higher odds of head impact. Women were 2.2 times (1.4-3.3) more likely than men to impact their head during a fall. Conclusion: Head impact is common during falls in LTC, with less cognitively impaired, female residents who suffered from visual impairment, being most likely to impact their head. Future research should focus on improving our ability to detect neural consequences of head impact and evaluating the effect of interventions for reducing the risk for fall-related head injuries in LTC.	[Yang, Yijian; Leung, Pet-Ming; Feldman, Fabio; Robinovitch, Stephen N.] Simon Fraser Univ, Technol Injury Prevent Seniors Program, Burnaby, BC, Canada; [Yang, Yijian; Mackey, Dawn C.; Feldman, Fabio; Robinovitch, Stephen N.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Robinovitch, Stephen N.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada; [Yang, Yijian; Mackey, Dawn C.; Liu-Ambrose, Teresa; Robinovitch, Stephen N.] Univ British Columbia, Ctr Hip Hlth & Mobil, Robert HN Ho Res Ctr, 7-F 2635 Laurel St, Vancouver, BC V5Z 1M9, Canada; [Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Liu-Ambrose, Teresa] Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Leung, Pet-Ming; Feldman, Fabio] Fraser Hlth Author, Surrey, BC, Canada		Yang, Y (corresponding author), Univ British Columbia, Ctr Hip Hlth & Mobil, Robert HN Ho Res Ctr, 7-F 2635 Laurel St, Vancouver, BC V5Z 1M9, Canada.	yijiany@sfu.ca	Yang, Yijian/G-1580-2016; Liu-Ambrose, Teresa/W-2332-2019	Yang, Yijian/0000-0002-5831-186X; Liu-Ambrose, Teresa/0000-0002-8297-5308; Robinovitch, Stephen/0000-0003-3881-6227	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR) [AMG-100487, TIR-103945, TEI-138295]; AGE-WELL Core Research Program [AW CRP 2015-WP5.2]; Canada Research Chair programCanada Research Chairs	This study was funded by grants from the Canadian Institutes for Health Research (funding reference nos. AMG-100487, TIR-103945, and TEI-138295), and the AGE-WELL Core Research Program (AW CRP 2015-WP5.2). The Canada Research Chair program supported Stephen N. Robinovitch and Teresa Liu-Ambrose. The authors thank the staff and residents of New Vista Society Care Home and Delta View Life Enrichment Centre and Habilitation Centre for their partnership in this study.	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Aziz O, 2014, GAIT POSTURE, V39, P506, DOI 10.1016/j.gaitpost.2013.08.034; Bagala F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037062, 10.1371/journal.pone.0034473]; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Bowers B, 2008, REHABIL NURS, V33, P253, DOI 10.1002/j.2048-7940.2008.tb00237.x; Boye NDA, 2014, INJURY, V45, P1224, DOI 10.1016/j.injury.2014.03.021; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; DeGoede KM, 2003, J BIOMECH, V36, P413, DOI 10.1016/S0021-9290(02)00396-2; Drahota AK, 2013, AGE AGEING, V42, P633, DOI 10.1093/ageing/aft067; Greenspan SL, 1998, AM J MED, V104, P539, DOI 10.1016/S0002-9343(98)00115-6; Groen BE, 2010, MARTIAL ARTS TECHNIQ; Hamden K, 2014, AM J EMERG MED, V32, P890, DOI 10.1016/j.ajem.2014.04.051; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Hawes C, 1997, AGE AGEING, V26, P19, DOI 10.1093/ageing/26.suppl_2.19; Hsiao ET, 1998, J BIOMECH, V31, P1; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; Inui TS, 2014, J TRAUMA ACUTE CARE, V76, P642, DOI 10.1097/TA.0000000000000138; Karon SL, 2007, J HEAD TRAUMA REHAB, V22, P350, DOI 10.1097/01.HTR.0000300230.13490.11; Knoefel F, 2013, J AM MED DIR ASSOC, V14, P303, DOI 10.1016/j.jamda.2012.12.077; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Kulmala J, 2008, AGING CLIN EXP RES, V20, P25; Laing AC, 2009, ACCIDENT ANAL PREV, V41, P642, DOI 10.1016/j.aap.2009.03.001; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Mustard CA, 1997, AM J EPIDEMIOL, V145, P738, DOI 10.1093/aje/145.8.738; Neutel CI, 2002, PHARMACOEPIDEM DR S, V11, P97, DOI 10.1002/pds.686; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Riccardi A, 2013, AM J EMERG MED, V31, P37, DOI 10.1016/j.ajem.2012.05.023; Robinovitch SN, 2004, J BIOMECH, V37, P1329, DOI 10.1016/j.jbiomech.2003.12.015; Schlicht EJ, 2007, EXP BRAIN RES, V182, P47, DOI 10.1007/s00221-007-0970-8; Schonnop R, 2013, CAN MED ASSOC J, V185, pE803, DOI 10.1503/cmaj.130498; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Shankar S., 2006, PROTECTIVE RESPONSES; Sran MA, 2010, J GERONTOL A-BIOL, V65, P312, DOI 10.1093/gerona/glp153; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Tabbarah M, 2002, J GERONTOL A-BIOL, V57, pM228, DOI 10.1093/gerona/57.4.M228; TINETTI ME, 1987, J AM GERIATR SOC, V35, P644, DOI 10.1111/j.1532-5415.1987.tb04341.x; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z; Watt SJ, 2000, EXP BRAIN RES, V135, P411, DOI 10.1007/s002210000545; Weerdesteyn V, 2008, J ELECTROMYOGR KINES, V18, P235, DOI 10.1016/j.jelekin.2007.06.010; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wright AD, 2012, MED ENG PHYS, V34, P1071, DOI 10.1016/j.medengphy.2011.11.012; Yang YJ, 2015, J AM MED DIR ASSOC, V16, P388, DOI 10.1016/j.jamda.2014.12.003; Yang YJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-40	49	14	14	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					168	177		10.1097/HTR.0000000000000257			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900003	27603766				2022-02-06	
J	Abas, S; Erdozain, AM; Keller, B; Rodriguez-Arevalo, S; Callado, LF; Garcia-Sevilla, JA; Escolano, C				Abas, Sonia; Erdozain, Amaia M.; Keller, Benjamin; Rodriguez-Arevalo, Sergio; Callado, Luis F.; Garcia-Sevilla, Jesus A.; Escolano, Carmen			Neuroprotective Effects of a Structurally New Family of High Affinity Imidazoline l(2) Receptor Ligands	ACS CHEMICAL NEUROSCIENCE			English	Article						(2-Imidazolin-4-yl)phosphonates; imidazoline I-2 receptors; neuroprotection	IDAZOXAN BINDING-SITES; TRAUMATIC BRAIN-INJURY; APOPTOTIC PATHWAYS; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; PREFRONTAL CORTEX; POSTMORTEM BRAIN; SUICIDE VICTIMS; OPIATE ABUSERS; P25	The imidazoline l(2) receptors (I-2-IRs) are widely distributed in the brain, and l(2)-IR ligancls may have therapeutic potential as neuroprotective agents. Since structural data for l(2)-IR remains unknown, the discovery of selective l(2)-IR ligands devoid of alpha(2)-drenoceptor (alpha(2)-AR) affinity is likely to provide valuable tools in defining the pharmacological characterization of these receptors. We report the pharmacological characterization of a new family of (2-imidazolin-4-yl)phosphonates. Radioligand binding studies showed that they displayed a higher affinity for I-2-IRs than idazoxan, and high l(2)/alpha(2) selectivity. In vivo studies in mice showed that acute treatments with lb and 2c significantly increased p-FADD/FADD ratio (an index of cell survival) in the hippocampus when compared with vehicle treated controls. Additionally, acute and repeated treatments with 2c, but not with lb, markedly reduced hippocampal p35 cleavage into neurotoxic p25. The present results indicate a neuroprotective potential of (2-imidazolin-4-yl)phosphonates acting at l(2)-IRs.	[Abas, Sonia; Rodriguez-Arevalo, Sergio; Escolano, Carmen] Univ Barcelona, Dept Pharmacol Toxicol & Med Chem, Fac Pharm & Food Sci, Lab Med Chem,Associated Unit CSIC, Av Joan 23 27-31, E-08028 Barcelona, Spain; [Abas, Sonia; Rodriguez-Arevalo, Sergio; Escolano, Carmen] Univ Barcelona, Inst Biomed IBUB, Av Joan 23 27-31, E-08028 Barcelona, Spain; [Erdozain, Amaia M.; Callado, Luis F.] Univ Basque Country, Dept Pharmacol, UPV EHU, E-48940 Leioa, Bizkaia, Spain; [Erdozain, Amaia M.; Callado, Luis F.] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Keller, Benjamin; Garcia-Sevilla, Jesus A.] Univ Balearic Isl UIB, ILab Neuropharmacol, IUNICS IdISPa, Cra Valldemossa Km 7-5, E-07122 Palma De Mallorca, Spain		Escolano, C (corresponding author), Univ Barcelona, Dept Pharmacol Toxicol & Med Chem, Fac Pharm & Food Sci, Lab Med Chem,Associated Unit CSIC, Av Joan 23 27-31, E-08028 Barcelona, Spain.; Escolano, C (corresponding author), Univ Barcelona, Inst Biomed IBUB, Av Joan 23 27-31, E-08028 Barcelona, Spain.	cescolano@ub.edu	Callado, Luis F/A-7024-2008; Erdozain, Amaia/AAD-1883-2021; Erdozain, Amaia M/Q-9664-2018; Blanco, Leire/O-5114-2017; escolano, carmen/F-3073-2016	Callado, Luis F/0000-0001-9941-012X; escolano, carmen/0000-0002-9117-8239; Erdozain, Amaia Maite/0000-0003-0207-9122; Abas Prades, Sonia/0000-0002-3005-3539	Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional (MINECO-FEDER) [SAF2011-29918, SAF-201348586-R, SAF2014-55903-R, SAF2016-77703-C2-1-R, BFU2015-66030-R]; Generalitat de CatalunyaGeneralitat de CatalunyaGeneral Electric [2014-SGR-0155]; Basque GovernmentBasque Government [IT616/13]; Redes Ternaticas de Investigacion Cooperativa en Salud - Red de Trastornos Adictivos (RETICS-RTA) [RD12/0028/0011]; Instituto de Salud Carlos III (ISCIII, MINECO/FEDER) SpainInstituto de Salud Carlos III; Institut d'Estudis Catalans (Barcelona, Catalonia, Spain); Basque GovernmentBasque Government	This study was supported by the Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional (MINECO-FEDER) (Projects SAF2011-29918, SAF-201348586-R, SAF2014-55903-R, SAF2016-77703-C2-1-R, BFU2015-66030-R), Generalitat de Catalunya (Grant 2014-SGR-0155), and the Basque Government (IT616/13). B.K. was supported by a predoctoral contract from Redes Ternaticas de Investigacion Cooperativa en Salud - Red de Trastornos Adictivos (RETICS-RTA, RD12/0028/0011), Instituto de Salud Carlos III (ISCIII, MINECO/FEDER), Spain. JAG.-S. is a member of the Institut d'Estudis Catalans (Barcelona, Catalonia, Spain). A.M.E. was recipient of a postdoctoral fellowship from the Basque Government.	Abas S, 2015, TETRAHEDRON, V71, P2872, DOI 10.1016/j.tet.2015.03.065; Alvaro-Bartolome M, 2011, NEUROSCIENCE, V196, P1, DOI 10.1016/j.neuroscience.2011.08.074; BOUSQUET P, 1984, J PHARMACOL EXP THER, V230, P232; Callado LF, 2004, J NEUROL NEUROSUR PS, V75, P785, DOI 10.1136/jnnp.2003.020446; CHAN SLF, 1994, BRIT J PHARMACOL, V112, P1065, DOI 10.1111/j.1476-5381.1994.tb13191.x; Craven JA, 1997, CLIN EXP PHARMACOL P, V24, P204, DOI 10.1111/j.1440-1681.1997.tb01808.x; Dardonville C, 2004, MED RES REV, V24, P639, DOI 10.1002/med.20007; Ernsberger P, 1995, Ann N Y Acad Sci, V763, P22, DOI 10.1111/j.1749-6632.1995.tb32388.x; Garau C, 2013, J PSYCHOPHARMACOL, V27, P123, DOI 10.1177/0269881112450785; Garcia-Fuster MJ, 2008, NEUROSCIENCE, V157, P105, DOI 10.1016/j.neuroscience.2008.09.002; Garcia-Sevilla JA, 1998, NEUROSCI LETT, V247, P95, DOI 10.1016/S0304-3940(98)00265-1; GarciaSevilla JA, 1996, ARCH GEN PSYCHIAT, V53, P803; GargalidisMoudanos C, 1997, NEUROCHEM INT, V30, P31, DOI 10.1016/S0197-0186(96)00035-6; Grijalba B, 1996, EUR J PHARMACOL, V310, P83, DOI 10.1016/0014-2999(96)00381-0; ILLIEVICH UM, 1994, ANESTH ANALG, V78, P905; Keller B, 2016, J PSYCHOPHARMACOL, V30, P875, DOI 10.1177/0269881116652579; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Li JX, 2011, EUR J PHARMACOL, V658, P49, DOI 10.1016/j.ejphar.2011.02.038; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MartinGomez JI, 1996, NEUROREPORT, V7, P1393, DOI 10.1097/00001756-199605310-00013; McDonald GR, 2010, PHARMACOL RES, V62, P475, DOI 10.1016/j.phrs.2010.09.001; MEANA JJ, 1993, BIOL PSYCHIAT, V34, P498; Mitsios N, 2007, BRAIN PATHOL, V17, P11, DOI 10.1111/j.1750-3639.2006.00031.x; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Ramos-Miguel A, 2009, NEUROSCIENCE, V161, P23, DOI 10.1016/j.neuroscience.2009.03.028; Ramos-Miguel A, 2010, EUR NEUROPSYCHOPHARM, V20, P49, DOI 10.1016/j.euroneuro.2009.08.005; Regunathan S, 1999, ANN NY ACAD SCI, V881, P410, DOI 10.1111/j.1749-6632.1999.tb09389.x; RUIZ J, 1993, NEUROSCI LETT, V160, P109, DOI 10.1016/0304-3940(93)90925-B; Thorn DA, 2012, BRIT J PHARMACOL, V166, P1936, DOI 10.1111/j.1476-5381.2012.01894.x; Yousuf MA, 2016, J NEUROCHEM, V138, P317, DOI 10.1111/jnc.13620	32	14	16	0	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	APR	2017	8	4					737	742		10.1021/acschemneuro.6b00426			6	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	ET0QL	WOS:000399968400008	28029766				2022-02-06	
J	Albrecht, JS; Mullins, DC; Smith, GS; Rao, V				Albrecht, Jennifer S.; Mullins, Daniel C.; Smith, Gordon S.; Rao, Vani			Psychotropic Medication Use among Medicare Beneficiaries Following Traumatic Brain Injury	AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						Traumatic brain injury; psychotropic medications; older adults; neuropsychiatric disorders	OLDER-ADULTS; PHARMACOLOGICAL MANAGEMENT; UNITED-STATES; DEPRESSION; FALLS; PATTERNS; RISK; CARE; AGE	Objectives: To characterize psychotropic medication use before and after traumatic brain injury (TBI) hospitalization among older adults. A secondary objective is to determine how receipt of indicated pharmacologic treatment for anxiety and post-traumatic stress disorder (PTSD) differs following TBI. Design: Retrospective cohort. Setting: United States. Participants: Medicare beneficiaries aged >= 65 years hospitalized with TBI between 2006 and 2010 with continuous drug coverage for 12 months before and after TBI (N = 60,276). Measurements: We obtained monthly psychotropic medication use by drug class and specific drugs from Medicare Part D drug event files. ICD-9 codes were used to define anxiety (300.0x) and PTSD (309.81). Results: Average monthly prevalence of psychotropic medication use among all patients hospitalized for TBI was 44.8%; antidepressants constituted 73%. Prevalence of psychotropic medication use increased from 2006 to 2010. Following TBI, psychotropic medication use increased slightly (OR: 1.05; 95% CI: 1.03, 1.06.) Tricyclic antidepressant use decreased post-TBI (OR: 0.76; 95% CI: 0.73, 0.79) whereas use of the sedating antidepressants mirtazapine (OR: 1.31; 95% CI: 1.25, 1.37) and trazadone (OR: 1.11; 95% CI: 1.06, 1.17) increased. Antipsychotic (OR: 1.15; 95% CI: 1.12, 1.19) use also increased post-TBI. Beneficiaries newly diagnosed with anxiety (OR: 0.42; 95% CI: 0.36, 0.48) and/or PTSD (OR: 0.39; 95% CI: 0.18, 0.84) post-TBI were less likely to receive indicated pharmacologic treatment. Conclusions: Older adults hospitalized with TBI have a high prevalence of psychotropic medication use yet are less likely to receive indicated pharmacological treatment for newly diagnosed anxiety and PTSD following TBI.	[Albrecht, Jennifer S.; Smith, Gordon S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA; [Mullins, Daniel C.] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, Natl Study Ctr Trauma & Emergency Med Serv, Shock Trauma & Anesthesiol Res Organized Res Ctr, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA; [Rao, Vani] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA.	jalbrecht@epi.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274; Smith, Gordon/0000-0002-2911-3071	AHRQUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1K01HS024560]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AA18707]; DODUnited States Department of Defense [W81XWH-13-1-0469]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018707, R01AA018313] Funding Source: NIH RePORTER	Dr. Albrecht was supported by AHRQ grant 1K01HS024560. Dr. Smith was supported by NIH grant R01AA18707. Dr. Rao was supported by DOD grant W81XWH-13-1-0469. The authors declare no conflicts of interest.	Akincigil A, 2011, J AM GERIATR SOC, V59, P1042, DOI 10.1111/j.1532-5415.2011.03447.x; Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Albrecht JS, 2015, J NEUROTRAUM, V32, P1223, DOI 10.1089/neu.2014.3651; Centers for Medicaid and Medicare Services, 2012, CHRON COND MED BEN C; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Faul M, 2010, TRAUMATIC BRAIN INJU; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Klap R, 2003, AM J GERIAT PSYCHIAT, V11, P517, DOI 10.1176/appi.ajgp.11.5.517; Lee HCB, 2003, INT REV PSYCHIATR, V15, P359, DOI 10.1080/09540260310001606746; Marcum ZA, 2016, ANN PHARMACOTHER, V50, P525, DOI 10.1177/1060028016644466; Marr A., 2004, CENTRAL NERVOUS SYST; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maust DT, 2014, J AM GERIATR SOC, V62, P358, DOI 10.1111/jgs.12640; Menant JC, 2016, J AM GERIATR SOC, V64, P1073, DOI 10.1111/jgs.14104; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sanglier T, 2011, J AM GERIATR SOC, V59, P1197, DOI 10.1111/j.1532-5415.2011.03457.x; Shippee ND, 2014, AHRQ PUBLICATION; Sterke CS, 2012, BRIT J CLIN PHARMACO, V73, P812, DOI 10.1111/j.1365-2125.2011.04124.x; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Thurman DJ., 1995, GUIDELINES SURVEILLA; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	35	14	14	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1064-7481	1545-7214		AM J GERIAT PSYCHIAT	Am. J. Geriatr. Psychiatr.	APR	2017	25	4					415	424		10.1016/j.jagp.2016.11.018			10	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	ET6XE	WOS:000400435800016	28111062	Green Accepted, Bronze, Green Submitted			2022-02-06	
J	Feddermann-Demont, N; Junge, A; Weber, KP; Weller, M; Dvorak, J; Tarnutzer, AA				Feddermann-Demont, Nina; Junge, Astrid; Weber, Konrad P.; Weller, Michael; Dvorak, Jiri; Tarnutzer, Alexander A.			Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients	BRAIN AND BEHAVIOR			English	Article						amyotrophic lateral sclerosis; football (soccer); head trauma; ice hockey; physical activity	MOTOR-NEURON DISEASE; PHYSICAL-ACTIVITY; HEAD-INJURY; SOCCER PLAYERS; POPULATION; TRAUMA; ALS	ObjectivesAmyotrophic lateral sclerosis (ALS) has been reported to occur with increased incidence amongst physically active people. The role of extrinsic risk factors as physical activity, head trauma and drug/pesticide-exposure in the pathophysiology of ALS and especially in the context of practising sports remains controversial. Materials and MethodsWe retrospectively studied exposure to extrinsic factors in 92 ALS patients in the presymptomatic stage. Metabolic equivalents (METs) were calculated and the association of physical activity, drug intake, head trauma and participation in specific sports (football [soccer], ice hockey) with age at symptom-onset was evaluated. ResultsNinety-five percent of patients considered themselves physically active before symptom-onset. Total MET-values varied broadly and there was no correlation between vigorous physical activity and age at symptom-onset. Mild traumatic brain injury (prevalence=16.7%) was the most frequent diagnosis after head/neck injury. A history of 1 head/neck injuries was associated with a younger age at symptom-onset (61.811.0 vs. 54.1 +/- 13.0, p=.013). In former football and ice hockey players the rate of vigorous physical activities was increased (p<.05), whereas total MET-values, frequency of head injuries and analgesic intake were not different compared to other ALS patients. ConclusionsHistory of head injuries was the only extrinsic risk factor associated with accelerated neurodegeneration in ALS. There was no evidence for extrinsic factors predisposing former football and ice hockey players to ALS. Our data therefore support the hypothesis that not increased physical activity per se, but other unknown environmental factors and/or genetic profile or lifestyle-promoting physical fitness increases ALS susceptibility.	[Feddermann-Demont, Nina; Weber, Konrad P.; Weller, Michael; Tarnutzer, Alexander A.] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland; [Feddermann-Demont, Nina; Weber, Konrad P.; Weller, Michael; Tarnutzer, Alexander A.] Univ Zurich, Zurich, Switzerland; [Feddermann-Demont, Nina; Junge, Astrid; Weber, Konrad P.; Dvorak, Jiri; Tarnutzer, Alexander A.] Schulthess Clin, Swiss Concuss Ctr, Zurich, Switzerland; [Feddermann-Demont, Nina; Junge, Astrid; Dvorak, Jiri] FIFA Med Assessment & Res Ctr F MARC, Zurich, Switzerland; [Junge, Astrid; Dvorak, Jiri] Schulthess Clin, Zurich, Switzerland; [Junge, Astrid] MSH, Hamburg, Germany; [Weber, Konrad P.] Univ Hosp Zurich, Dept Ophthalmol, Zurich, Switzerland; [Dvorak, Jiri] Federat Int Football Assoc, Zurich, Switzerland		Tarnutzer, AA (corresponding author), Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland.; Tarnutzer, AA (corresponding author), Univ Zurich, Zurich, Switzerland.	alexander.tarnutzer@access.uzh.ch	Weber, Konrad P/A-1941-2013; Tarnutzer, Alexander/H-3236-2019	Weber, Konrad P/0000-0003-2526-4582; Tarnutzer, Alexander/0000-0002-6984-6958; Weller, Michael/0000-0002-1748-174X; Junge, Astrid/0000-0002-6815-9793	Federation Internationale de Football Association (FIFA)	The study was funded by the Federation Internationale de Football Association (FIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al-Chalabi A, 2005, BRAIN, V128, P451, DOI 10.1093/brain/awh426; Alonso A, 2009, EUR J NEUROL, V16, P745, DOI 10.1111/j.1468-1331.2009.02586.x; Armon C, 2007, J NEUROL SCI, V262, P45, DOI 10.1016/j.jns.2007.06.021; Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Beghi E, 2007, NEUROLOGY, V68, P141, DOI 10.1212/01.wnl.0000250339.14392.bb; Beghi E, 2013, AMYOTROPH LAT SCL FR, V14, P501, DOI 10.3109/21678421.2013.809764; Beghi E, 2010, AMYOTROPH LATERAL SC, V11, P289, DOI 10.3109/17482960903384283; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chio A, 2001, NEUROLOGY, V56, P239; Cronin S, 2007, NEUROLOGY, V68, P1002, DOI 10.1212/01.wnl.0000258551.96893.6f; Fondell E, 2012, AMYOTROPH LATERAL SC, V13, P573, DOI 10.3109/17482968.2012.703209; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Frantseva M, 2002, PROG BRAIN RES, V137, P171; Gotkine M, 2014, AMYOTROPH LAT SCL FR, V15, P534, DOI 10.3109/21678421.2014.932383; Hamidou B, 2014, EUR J EPIDEMIOL, V29, P459, DOI 10.1007/s10654-014-9923-2; Harwood CA, 2009, AMYOTROPH LATERAL SC, V10, P191, DOI 10.1080/17482960802549739; Huisman MHB, 2013, J NEUROL NEUROSUR PS, V84, P976, DOI 10.1136/jnnp-2012-304724; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P201, DOI 10.1001/archneur.55.2.201; LONGSTRETH WT, 1991, MED HYPOTHESES, V34, P144, DOI 10.1016/0306-9877(91)90183-Y; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Popat RA, 2007, AMYOTROPH LATERAL SC, V8, P157, DOI 10.1080/17482960601179456; Pupillo E, 2012, EUR J NEUROL, V19, P1509, DOI 10.1111/j.1468-1331.2012.03723.x; Pupillo E, 2014, ANN NEUROL, V75, P708, DOI 10.1002/ana.24150; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Seelen M, 2014, J NEUROL, V261, P1949, DOI 10.1007/s00415-014-7445-1; Strickland D, 1996, ACTA NEUROL SCAND, V94, P45, DOI 10.1111/j.1600-0404.1996.tb00038.x; SUVA Medical, 2014, VERS ARB REH; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; Turner MR, 2012, J NEUROL NEUROSUR PS, V83, P395, DOI 10.1136/jnnp-2011-301161; Turner MR, 2010, J NEUROL SCI, V288, P45, DOI 10.1016/j.jns.2009.10.010; Uenal H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093932; Vanacore N, 2006, PARKINSONISM RELAT D, V12, P327, DOI 10.1016/j.parkreldis.2005.11.007; Veldink JH, 2005, NEUROLOGY, V64, P241, DOI 10.1212/01.WNL.0000149513.82332.5C	39	14	15	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	APR	2017	7	4							e00630	10.1002/brb3.630			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	ES3TQ	WOS:000399452500001	28413696	Green Published, Green Accepted, gold			2022-02-06	
J	Franchow, EI; Suchy, Y				Franchow, E. I.; Suchy, Yana			Expressive Suppression Depletes Executive Functioning in Older Adulthood	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Affect suppression; Emotional suppression; Emotion regulation; Executive control; Depletion; Cognitive aging	TRAUMATIC BRAIN-INJURY; DEMENTIA RATING-SCALE; EMOTION REGULATION; LIFE-SPAN; ALZHEIMERS-DISEASE; SELF-CONTROL; INTRAINDIVIDUAL VARIABILITY; INSTRUMENTAL ACTIVITIES; COGNITIVE IMPAIRMENT; ECOLOGICAL VALIDITY	Objectives: Accurate detection of executive dysfunction in neuropsychological assessments is complicated by the fact that executive functioning (EF) is vulnerable to temporary disruption (i.e., lapses), with more frequent lapses in older adulthood. Effortful regulation of affect (i.e., expressive suppression) is a well-known source of executive lapses in younger adults, but the generalizability of this depleting effect to older adults is unknown. The purpose of this study was to (1) determine whether EF is subject to depletion via expressive suppression and (2) to examine whether this effect is unique to EF, or whether it also applies to lower-order component processes in older adults. Methods: Ninety-seven non-demented, community-dwelling older adults were randomly assigned to either an expressive suppression group or control group. We compared performance of the groups on a battery of tests measuring EF and component processes both before and after exposure to emotionally evocative stimuli. Results: Consistent with the hypothesized depletion effect, suppressing participants showed an attenuated practice effect on post-manipulation EF relative to controls, while performance on lower-order component processes was unaffected by suppression. Conclusions: These results suggest that depletion contributes to executive lapses in older adulthood.	[Franchow, E. I.; Suchy, Yana] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA		Franchow, EI (corresponding author), Dept Psychol, 380 S 1530 E Room 502, Salt Lake City, UT 84112 USA.	emilie.franchow@psych.utah.edu		Suchy, Yana/0000-0001-6513-565X			Baudouin A, 2009, BRAIN COGNITION, V71, P240, DOI 10.1016/j.bandc.2009.08.007; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2009, SELF IDENTITY, V8, P115, DOI 10.1080/15298860802501474; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Benitez A, 2012, CLIN NEUROPSYCHOL, V26, P214, DOI 10.1080/13854046.2012.658439; Bielak AAM, 2010, NEUROPSYCHOLOGY, V24, P731, DOI 10.1037/a0019802; Brown GG, 1999, J GERIATR PSYCH NEUR, V12, P180, DOI 10.1177/089198879901200403; BRUCE ML, 1994, AM J PUBLIC HEALTH, V84, P1796, DOI 10.2105/AJPH.84.11.1796; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cummings J. L., 2007, HUMAN FRONTAL LOBES, P12; Dawson DR, 2000, BRAIN COGNITION, V44, P35; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demaree HA, 2004, COGNITION EMOTION, V18, P1079, DOI 10.1080/02699930441000085; Engelborghs S, 2005, INT J GERIATR PSYCH, V20, P1028, DOI 10.1002/gps.1395; Ewert S., 2014, CURRENT POPULATION P, P70; Franchow EI, 2015, EMOTION, V15, P78, DOI 10.1037/emo0000013; Gallo JJ, 1997, J AM GERIATR SOC, V45, P570, DOI 10.1111/j.1532-5415.1997.tb03089.x; Gamaldo AA, 2012, NEUROPSYCHOLOGY, V26, P534, DOI 10.1037/a0028686; Goldberg E., 1987, FRONTAL LOBES REVISI, P159; Gross J.J., 2007, EMOTION REGULATION C, V1st; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gunstad J, 2007, INT J NEUROSCI, V117, P477, DOI 10.1080/00207450600773483; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; HUBERT W, 1993, PSYCHONEUROENDOCRINO, V18, P265, DOI 10.1016/0306-4530(93)90023-E; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Insel K, 2006, J GERONTOL B-PSYCHOL, V61, pP102, DOI 10.1093/geronb/61.2.P102; Inzlicht M, 2007, PSYCHOL SCI, V18, P933, DOI 10.1111/j.1467-9280.2007.02004.x; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; Johns M, 2008, J EXP PSYCHOL GEN, V137, P691, DOI 10.1037/a0013834; Jongsma MLA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023363; Jurica PJ, 2001, DRS 2 DEMENTIA RATIN; Karp JF, 2006, PAIN MED, V7, P444, DOI 10.1111/j.1526-4637.2006.00212.x; KOVNER R, 1992, J SUBST ABUSE TREAT, V9, P133, DOI 10.1016/0740-5472(92)90080-8; Krampe RT, 2002, NEUROSCI BIOBEHAV R, V26, P769, DOI 10.1016/S0149-7634(02)00064-7; Kraybill ML, 2013, CLIN NEUROPSYCHOL, V27, P238, DOI 10.1080/13854046.2012.735702; Kraybill ML, 2011, CLIN NEUROPSYCHOL, V25, P210, DOI 10.1080/13854046.2010.542489; Lang FR, 1998, J GERONTOL B-PSYCHOL, V53, pP21, DOI 10.1093/geronb/53B.1.P21; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Levy JA, 2007, J GERIATR PSYCH NEUR, V20, P227, DOI 10.1177/0891988707308806; Lindau M, 2000, DEMENT GERIATR COGN, V11, P286, DOI 10.1159/000017251; Luria A. R., 1992, NEUROSCIENCES PATHS, VI, P335; Martin EA, 2011, COGNITION EMOTION, V25, P265, DOI 10.1080/02699931.2010.491652; Mayr U, 2001, PSYCHOL AGING, V16, P96, DOI 10.1037/0882-7974.16.1.96; McDaniel WF, 2000, CLIN NEUROPSYCHOL, V14, P72, DOI 10.1076/1385-4046(200002)14:1;1-8;FT072; Meiran N, 2001, EUR J COGN PSYCHOL, V13, P165, DOI 10.1080/09541440042000269; Mitchell M, 2008, J CLIN EXP NEUROPSYC, V30, P683, DOI 10.1080/13803390701679893; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P790, DOI 10.1002/1097-4679(199111)47:6<790::AID-JCLP2270470610>3.0.CO;2-C; Mitsis E. M., 2004, PROQUEST INFORM LEAR; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Nes LS, 2009, ANN BEHAV MED, V37, P173, DOI 10.1007/s12160-009-9096-5; Niermeyer MA, 2016, J INT NEUROPSYCH SOC, V22, P671, DOI 10.1017/S1355617716000473; Oaksford M, 1996, J EXP PSYCHOL LEARN, V22, P476, DOI 10.1037/0278-7393.22.2.476; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; PARASURAMAN R, 1991, PSYCHOL AGING, V6, P155, DOI 10.1037/0882-7974.6.2.155; Pietrzak RH, 2009, HUM PSYCHOPHARM CLIN, V24, P113, DOI 10.1002/hup.998; Razani J, 2007, APPL NEUROPSYCHOL, V14, P208, DOI 10.1080/09084280701509125; Reimers S, 2005, DEV PSYCHOL, V41, P661, DOI 10.1037/0012-1649.41.4.661; Riediger M, 2014, PSYCHOL AGING, V29, P103, DOI 10.1037/a0035766; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Royall DR, 2005, J AM GERIATR SOC, V53, P11, DOI 10.1111/j.1532-5415.2005.53004.x; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Schmeichel BJ, 2003, J PERS SOC PSYCHOL, V85, P33, DOI 10.1037/0022-3514.85.1.33; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Schoenberg MR, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P357, DOI 10.1007/978-0-387-76978-3_14; Stuss D.T., 2001, FRONTAL LOBES NEUROP, P101; Suchy Y., 2015, EXECUTIVE FUNCTIONIN; Suchy Y, 2011, J INT NEUROPSYCH SOC, V17, P101, DOI 10.1017/S135561771000130X; SULTZER DL, 1993, AM J PSYCHIAT, V150, P1806; Sutter C, 2012, NEUROPSYCHOLOGY, V26, P768, DOI 10.1037/a0030033; Szaflarski JP, 2002, NEUROLOGY, V59, P238, DOI 10.1212/WNL.59.2.238; Tranel, 2013, NEUROPSYCHOLOGICAL A; WEGNER DM, 1990, J PERS SOC PSYCHOL, V58, P409, DOI 10.1037/0022-3514.58.3.409; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; West R, 2001, EUR J COGN PSYCHOL, V13, P91, DOI 10.1080/09541440125750; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	81	14	14	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2017	23	4					341	351		10.1017/S1355617717000054			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	ES2YO	WOS:000399394000006	28287061				2022-02-06	
J	Gates, M; Mallory, G; Planchard, R; Nothdurft, G; Graffeo, C; Atkinson, J				Gates, Marcus; Mallory, Grant; Planchard, Ryan; Nothdurft, Georgia; Graffeo, Christopher; Atkinson, John			Triage Patterns of Traumatic Subarachnoid Hemorrhage: Is Referral to a Tertiary Care Center Necessary?	WORLD NEUROSURGERY			English	Article						Cost effective care; Isolated traumatic subarachnoid hemorrhage; Mild head injury	BRAIN-INJURY; CLINICAL-SIGNIFICANCE; DETERIORATION; MANAGEMENT; ADMISSION; SCORES; RISK	OBJECTIVE: Isolated traumatic subarachnoid hemorrhage (iTSAH) in mild head injuries has more evidence that triage to a tertiary care facility, intensive care unit admission, and repeat imaging is not warranted. Certain factors were identified that predict radiographic and clinical progression in hopes of preventing avoidable cost, which occur with transfer and subsequent management. METHODS: A retrospective analysis identified 67 patients transferred between January 2010 and December 2014 who met inclusion criteria. Primary outcomes assessing neurosurgical intervention, radiographic, and clinical progression were documented. Secondary outcomes included any operative intervention, length of stay, standardized hospital costs, disposition at discharge, and 30-day mortality. RESULTS: The mean age of the cohort was 67.7 +/- 16.4 years, with most patients (82.1%) having a Glasgow coma score of 15. Warfarin was used in 10 patients (14.9%), although 55.2% were on an antiplatelet or anticoagulation agent. No patient required neurosurgical intervention. One patient, on clopidogrel (Plavix) and warfarin, neurologically declined with radiographic progression. Older age seem to correlate with radiographic progression (P = 0.05). Dementia (P = 0.05) as well as warfarin use (P = 0.06) correlated with clinical progression. Cost in patients without other injuries was associated with warfarin use (P = 0.0002), injury severity scores (P = 0.01), and initial Glasgow coma score (P = 0.0003) on multivariate analysis. CONCLUSIONS: In this series of patients with mild traumatic brain injury, the rate of neurological deterioration due to expansion of iTSAH in patients is low, regardless of the use of antiplatelets/anticoagulants. Triage to a tertiary care facility generally is not warranted and can prove costly to patients with iTSAH without other injures.	[Gates, Marcus; Mallory, Grant; Planchard, Ryan; Nothdurft, Georgia; Graffeo, Christopher; Atkinson, John] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA		Gates, M (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.	Gates.marcus@mayo.edu	Graffeo, Christopher S/ABE-5578-2020	Graffeo, Christopher S/0000-0001-5314-1067; Planchard, Ryan/0000-0002-7550-9843			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Albertine P, 2016, EMERG RADIOL, V23, P207, DOI 10.1007/s10140-016-1377-2; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bardes JM, 2016, AM SURGEON, V82, P36; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; Deepika A, 2013, J HEAD TRAUMA REHAB, V28, P442, DOI 10.1097/HTR.0b013e31825e19e5; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; von der Brelie C, 2015, J TRAUMA ACUTE CARE, V79, P295, DOI 10.1097/TA.0000000000000722; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	19	14	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2017	100						417	423		10.1016/j.wneu.2017.01.046			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7BT	WOS:000401930000054	28130166				2022-02-06	
J	Maria, NSS; Reger, ML; Cai, Y; Baquing, MAT; Buen, F; Ponnaluri, A; Hovda, DA; Harris, NG; Giza, CC				Maria, Naomi S. Sta; Reger, Maxine L.; Cai, Yan; Baquing, Mary Anne T.; Buen, Floyd; Ponnaluri, Aditya; Hovda, David A.; Harris, Neil G.; Giza, Christopher C.			D-Cycloserine Restores Experience-Dependent Neuroplasticity after Traumatic Brain Injury in the Developing Rat Brain	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessments; learning and memory; neuroplasticity; receptors; TBI	IMPROVES FUNCTIONAL RECOVERY; RECEPTOR SUBUNIT COMPOSITION; LATERAL FLUID PERCUSSION; SYNAPTIC NMDA RECEPTORS; D-ASPARTATE RECEPTORS; CLOSED-HEAD INJURY; CLINICAL-TRIALS; POSTNATAL-DEVELOPMENT; OBJECT RECOGNITION; GLUR2 ENDOCYTOSIS	Traumatic brain injury (TBI) in children can cause persisting cognitive and behavioral dysfunction, and inevitably raises concerns about lost potential in these injured youth. Lateral fluid percussion injury (FPI) in weanling rats pathologically affects hippocampal N-methyl-D-aspartate receptor (NMDAR)- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-mediated glutamatergic neurotransmission subacutely within the first post-injury week. FPI to weanling rats has also been shown to impair enriched-environment (EE) induced enhancement of Morris water maze (MWM) learning and memory in adulthood. Recently, improved outcomes can be achieved using agents that enhance NMDAR function. We hypothesized that administering D-cycloserine (DCS), an NMDAR co-agonist, every 12 h (i.p.) would restore subacute glutamatergic neurotransmission and reinstate experience-dependent plasticity. Postnatal day 19 (P19) rats received either a sham or FPI. On post-injury day (PID) 1-3, animals were randomized to saline (Sal) or DCS. Firstly, immunoblotting of hippocampal NMDAR and AMPAR proteins were measured on PID4. Second, PID4 novel object recognition, an NMDAR-and hippocampal-mediated working memory task, was assessed. Third, P19 rats were placed in an EE (17 days), and MWM performance was measured, starting on PID30. On PID4, DCS restored reduced NR2A and increased GluR2 by 54%, and also restored diminished recognition memory in FPI pups. EE significantly improved MWM performance in shams, regardless of treatment. In contrast, FPI-EE-Sal animals only performed to the level of standard housed animals, whereas FPI-EE-DCS animals were comparable with sham-EE counterparts. This study shows that NMDAR agonist use during reduced glutamatergic transmission after developmental TBI can reinstate early molecular and behavioral responses that subsequently manifest in experience-dependent plasticity and rescued potential.	[Maria, Naomi S. Sta; Reger, Maxine L.; Cai, Yan; Baquing, Mary Anne T.; Buen, Floyd; Ponnaluri, Aditya; Hovda, David A.; Harris, Neil G.; Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Box 957039,58-125 CHS, Los Angeles, CA 90095 USA; [Maria, Naomi S. Sta] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Bioengn, Box 957039,58-125 CHS, Los Angeles, CA 90095 USA; [Reger, Maxine L.] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Psychol, Los Angeles, CA USA; [Buen, Floyd] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Head & Neck Surg, Los Angeles, CA USA; [Ponnaluri, Aditya] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Mech Engn, Los Angeles, CA USA; [Hovda, David A.] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Med & Mol Pharmacol, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Div Pediat Neurol, Los Angeles, CA USA; [Baquing, Mary Anne T.] Univ Calif Los Angeles, Brain Injury Res Ctr, Harbor UCLA Dept Obstet & Gynecol, Los Angeles, CA USA		Maria, NSS (corresponding author), Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Box 957039,58-125 CHS, Los Angeles, CA 90095 USA.; Maria, NSS (corresponding author), Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Bioengn, Box 957039,58-125 CHS, Los Angeles, CA 90095 USA.	naomi.santamaria@gmail.com		Sta Maria, Naomi/0000-0001-9710-2908; Harris, Neil/0000-0002-1965-6750	UCLA Brain Injury Research Center (BIRC) [NS27544, NS057420]; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS091222-01]; Winokur Family Foundation/Child Neurology Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K02NS057420, R01NS091222, R01NS027544] Funding Source: NIH RePORTER	We thank David Garfinkel for his excellent technical assistance. This work was supported by the UCLA Brain Injury Research Center (BIRC), NS27544, NS057420, NIH NINDS 1R01NS091222-01, and the Winokur Family Foundation/Child Neurology Foundation.	Adeleye A, 2010, EUR J PHARMACOL, V629, P25, DOI 10.1016/j.ejphar.2009.11.066; Albers GV, 2001, JAMA-J AM MED ASSOC, V286, P2673, DOI 10.1001/jama.286.21.2673; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Clark RE, 2000, J NEUROSCI, V20, P8853; CORDOBA F, 1984, PHARMACOL BIOCHEM BE, V21, P349, DOI 10.1016/S0091-3057(84)80093-3; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Dennis M, 2010, CORTEX, V46, P1043, DOI 10.1016/j.cortex.2009.10.008; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Flint AC, 1997, J NEUROSCI, V17, P2469; Gilchrist J., 2011, NONFATAL TRAUMATIC B, P1337; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Greenough W. T, 1976, NEURAL MECHANISMS LE, P255; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; HOOD WF, 1989, NEUROSCI LETT, V98, P91, DOI 10.1016/0304-3940(89)90379-0; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477, DOI 10.1152/jn.1938.1.6.477; KENNARD MA, 1942, MT SINAI J MED, V9, P594; KOLB B, 1988, BEHAV BRAIN RES, V28, P259, DOI 10.1016/0166-4328(88)90129-5; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; LANTHORN TH, 1994, AMINO ACIDS, V6, P247, DOI 10.1007/BF00813745; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Maei Hamid R, 2009, Front Integr Neurosci, V3, P4, DOI 10.3389/neuro.07.004.2009; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; R Development Core Team, 2010, R LANG ENV STAT COMP; Rao VLR, 2001, BRAIN RES, V911, P96; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; ROSENZWEIG MR, 1972, SCI AM, V226, P22, DOI 10.1038/scientificamerican0272-22; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Wenzel A, 1997, J NEUROCHEM, V68, P469; Wilcox KS, 1996, J NEUROPHYSIOL, V76, P3415, DOI 10.1152/jn.1996.76.5.3415; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com	63	14	14	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1692	1702		10.1089/neu.2016.4747			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500020	27931146	Green Published			2022-02-06	
J	Mashhadizadeh, S; Farbood, Y; Dianat, M; Khodadadi, A; Sarkaki, A				Mashhadizadeh, Shahram; Farbood, Yaghoub; Dianat, Mahin; Khodadadi, Ali; Sarkaki, Alireza			Therapeutic effects of ellagic acid on memory, hippocampus electrophysiology deficits, and elevated TNF-alpha level in brain due to experimental traumatic brain injury	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Blood-brain barrier; Ellagic acid; LTP; Memory; TNF-alpha; Traumatic brain injury	TUMOR-NECROSIS-FACTOR; LONG-TERM POTENTIATION; INTRACRANIAL-PRESSURE; SYNAPTIC-TRANSMISSION; ANTIOXIDANT ACTIVITY; OXIDATIVE STRESS; NEURON DEATH; RAT; INFLAMMATION; EXPRESSION	Objective(s): Cognitive defects such as learning and memory impairment are amongst the most repetitious sequelae after sever and moderate traumatic brain injury (TBI). It was suggested that ellagic acid (EA), an innate phenol product, display neuroprotective properties against oxidative and inflammatory damages after brain injury. The object of the current study was therapeutic properties of EA on blood-brain barrier (BBB) interruption and elevated content of TNF-alpha in brain tissue followed by neurologic aftereffects, cognitive and brain electrophysiology deficits as outcomes of diffuse TBI in rat. Materials and Methods: TBI was induced by a 200 g weight falling by a 2-m height through a free-falling tube onto the head of anesthetized rat. TBI rats treated immediately after trauma with EA (100 mg/kg, IP) once every 8 hr until 48 hr later. Neurologic outcomes, passive avoidance task (PAT), hippocampal long-term potentiation (LTP), BBB permeability and content of TNF-alpha in brain tissue were evaluated. Results: TBI induced significant impairments in neurological score, BBB function, PAT and hippocampal LTP in TBI+Veh group in compare with Sham+Veh (P<0.001). EA treatment decreased neurologic severity score (NSS), restored increased BBB permeability, cognitive and hippocampal LTP abnormalities, and elevated brain content of TNF-alpha due to TBI significantly (P<0.001). Conclusion: Our findings propose that EA can restore NSS, cognitive and LTP deficits and prevent brain inflammation may by restore BBB permeability as well as lowering brain content of TNF-alpha following TBI.	[Mashhadizadeh, Shahram; Farbood, Yaghoub; Dianat, Mahin; Sarkaki, Alireza] Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Golestan Blvd, Ahvaz, Iran; [Mashhadizadeh, Shahram; Farbood, Yaghoub; Dianat, Mahin; Sarkaki, Alireza] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Physiol, Golestan Blvd, Ahvaz, Iran; [Khodadadi, Ali] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Immunol, Golestan Blvd, Ahvaz, Iran		Sarkaki, A (corresponding author), Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Physiol, Golestan Blvd, Ahvaz, Iran.; Sarkaki, A (corresponding author), Ahvaz Jundishapur Univ Med Sci, Ahvaz Physiol Res Ctr, Golestan Blvd, Ahvaz, Iran.	sarkaki145@gmail.com	khodadadi, ali/N-2130-2017; Sarkaki, Alireza/Q-8363-2017; Mashhadizadeh, Shahram/AAN-2926-2021; Farbood, Yaghoob/M-3076-2017	khodadadi, ali/0000-0003-0442-273X; Sarkaki, Alireza/0000-0001-9272-6228; Mashhadizadeh, Shahram/0000-0003-2614-5657; Farbood, Yaghoob/0000-0002-6390-0079	Ahvaz Jundishapur University of Medical Sciences Ahvaz, Iran [PRC-147]	The results reported in this paper were part of Dr Shahram Mashhadizadeh's PhD thesis. This study was accomplished in Physiology Research Centers, Ahvaz, Iran. It was supported by the Vice-Chancellor for Research, Ahvaz Jundishapur University of Medical Sciences (Grant No: PRC-147), Ahvaz, Iran. Funding sources had no involvement in the conduct of the research and/or preparation of the article.	Abdul-Wahab RH, 2009, PAKISTAN J NUTR, V8, P1661; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Atta-Ur-Rahman, 2001, PLANTA MED, V67, P335, DOI 10.1055/s-2001-14306; Babu GN, 2008, NEUROCHEM RES, V33, P1145, DOI 10.1007/s11064-007-9564-x; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Baune Bernhard T, 2008, Am J Med Genet B Neuropsychiatr Genet, V147B, P1056, DOI 10.1002/ajmg.b.30712; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; BenNasr C, 1996, Z LEBENSM UNTERS FOR, V203, P374, DOI 10.1007/BF01231077; Beste C, 2010, J NEUROPHYSIOL, V104, P2523, DOI 10.1152/jn.00561.2010; BOKA G, 1994, NEUROSCI LETT, V172, P151, DOI 10.1016/0304-3940(94)90684-X; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; Chao PC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-33; Chen HS, 2011, J FOOD SCI, V76, pT192, DOI 10.1111/j.1750-3841.2011.02373.x; Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7&lt;1118::AID-JSFA570&gt;3.0.CO;2-9]; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Festa F, 2001, ANTICANCER RES, V21, P3903; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Golan H, 2004, CEREB CORTEX, V14, P97, DOI 10.1093/cercor/bhg108; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Huh JW, 2011, J NEUROTRAUM, V28, P245, DOI 10.1089/neu.2010.1639; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Khaksari M, 2013, IRAN J BASIC MED SCI, V16, P858; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Kostrzewa RM, 2003, NEUROTOX RES, V5, P375, DOI 10.1007/BF03033166; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lashgari R, 2006, BEHAV BRAIN RES, V171, P324, DOI 10.1016/j.bbr.2006.04.013; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Mansouri MT, 2013, EUR J PHARMACOL, V707, P46, DOI 10.1016/j.ejphar.2013.03.031; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Montgomery SL, 2012, J NEUROIMMUNE PHARM, V7, P42, DOI 10.1007/s11481-011-9287-2; Morton LW, 2000, CLIN EXP PHARMACOL P, V27, P152, DOI 10.1046/j.1440-1681.2000.03214.x; Narayanan BA, 1999, CANCER LETT, V136, P215, DOI 10.1016/S0304-3835(98)00323-1; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor JJ, 2005, BRAIN RES, V1062, P171; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Paxinos G, 2006, NEUROBIOL DIS; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Ribbers G. M., 2010, INT ENCY REHABILITAT; Rogerio AP, 2006, J PHARM PHARMACOL, V58, P1265, DOI 10.1211/jpp.58.9.0014; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Santello M, 2012, TRENDS NEUROSCI, V35, P638, DOI 10.1016/j.tins.2012.06.001; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Sarkaki A, 2014, Pak J Biol Sci, V17, P978, DOI 10.3923/pjbs.2014.991.998; Sarkaki A, 2008, BEHAV BRAIN RES, V186, P72, DOI 10.1016/j.bbr.2007.07.041; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Selig DK, 1996, LEARN MEMORY, V3, P42, DOI 10.1101/lm.3.1.42; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Umesalma S, 2010, BASIC CLIN PHARMACOL, V107, P650, DOI 10.1111/j.1742-7843.2010.00565.x; Uzar E, 2012, NEUROL SCI, V33, P567, DOI 10.1007/s10072-011-0775-1; Wada L, 2002, J AGR FOOD CHEM, V50, P3495, DOI 10.1021/jf011405l; WANG XK, 1994, MOL CHEM NEUROPATHOL, V23, P103, DOI 10.1007/BF02815404; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yang LB, 2002, J NEUROSCI, V22, P3025, DOI 10.1523/JNEUROSCI.22-08-03025.2002; Yu YM, 2005, J NUTR BIOCHEM, V16, P675, DOI 10.1016/j.jnutbio.2005.03.013	69	14	14	0	5	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	APR	2017	20	4					399	407		10.22038/IJBMS.2017.8581			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	EX5JG	WOS:000403276600008	28804609				2022-02-06	
J	McCredie, VA; Piva, S; Santos, M; Xiong, W; Manoel, ALD; Rigamonti, A; Hare, GMT; Chapman, MG; Baker, AJ				McCredie, Victoria A.; Piva, Simone; Santos, Marlene; Xiong, Wei; Manoel, Airton Leonardo de Oliveira; Rigamonti, Andrea; Hare, Gregory M. T.; Chapman, Martin G.; Baker, Andrew J.			The Impact of Red Blood Cell Transfusion on Cerebral Tissue Oxygen Saturation in Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Transfusion; Oximetry; Brain tissue oxygenation	NEAR-INFRARED SPECTROSCOPY; METABOLISM	There are a range of opinions on the benefits and thresholds for the transfusion of red blood cells in critically ill patients with traumatic brain injury (TBI) and an urgent need to understand the neurophysiologic effects. The aim of this study was to examine the influence of red blood cell transfusions on cerebral tissue oxygenation (SctO(2)) in critically ill TBI patients. This prospective observational study enrolled consecutive TBI patients with anemia requiring transfusion. Cerebral tissue oxygen saturation (SctO(2)) was measured noninvasively with bilateral frontal scalp probes using near-infrared spectroscopy (NIRS) technology. Data were collected at baseline and for 24 h after transfusion. The primary outcome was the applicability of a four-wavelength near-infrared spectrometer to monitor SctO(2) changes during a transfusion. Secondary outcomes included the correlation of SctO(2) with other relevant physiological variables, the dependence of SctO(2) on baseline hemoglobin and transfusion, and the effect of red blood cell transfusion on fractional tissue oxygen extraction. We enrolled 24 patients with severe TBI, of which five patients (21 %) were excluded due to poor SctO(2) signal quality from large subdural hematomas and bifrontal decompressive craniectomies. Twenty transfusions were monitored in 19 patients. The mean pre- and post-transfusion hemoglobin concentrations were significantly different [74 g/L (SD 8 g/L) and 84 g/L (SD 9 g/L), respectively; p value < 0.0001]. Post-transfusion SctO(2) was not significantly greater than pre-transfusion SctO(2) [left-side pre-transfusion 69 % (SD 7) vs. post-transfusion 70 % (SD 10); p = 0.68, and right-side pre-transfusion 69 % (SD 5) vs. post-transfusion 71 % (SD 7); p = 0.11]. In a multivariable mixed linear analysis, mean arterial pressure was the only variable significantly associated with a change in SctO(2). The bifrontal method of recording changes in NIRS signal was not able to detect a measurable impact on SctO(2) in this sample of patients receiving red blood cell transfusion therapy in a narrow but conventionally relevant, range of anemia.	[McCredie, Victoria A.; Chapman, Martin G.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave,Room D108, Toronto, ON M4N 3M5, Canada; [Piva, Simone] Univ Brescia Spedali Civili, Div Neuroanesthesia & Neurointens Care, Dept Anesthesia Intens Care & Perioperat Med, Brescia, Italy; [Santos, Marlene; Hare, Gregory M. T.; Baker, Andrew J.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Xiong, Wei] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Manoel, Airton Leonardo de Oliveira] St Michaels Hosp, Dept Med Imaging, Intervent Neuroradiol, Toronto, ON, Canada; [Rigamonti, Andrea; Hare, Gregory M. T.; Chapman, Martin G.; Baker, Andrew J.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Rigamonti, Andrea; Baker, Andrew J.] St Michaels Hosp, Dept Crit Care Med, Toronto, ON, Canada; [Hare, Gregory M. T.] Univ Toronto, Dept Physiol, Toronto, ON, Canada		McCredie, VA (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave,Room D108, Toronto, ON M4N 3M5, Canada.	Victoria.McCredie@sunnybrook.ca; pivadoc@gmail.com; SantosMar@smh.ca; wei.xiong@sunnybrook.com; airtonleo@bol.com.br; rigamontia@smh.ca; hareg@smh.ca; Martin.Chapman@sunnybrook.ca; BakerA@smh.ca	Hare, Greg/AAM-5599-2021; de Oliveira Manoel, Airton Leonardo/C-4724-2018; Piva, Simone/E-1902-2014	de Oliveira Manoel, Airton Leonardo/0000-0002-9593-1013; Piva, Simone/0000-0002-5483-8007; McCredie, Victoria/0000-0002-1590-2846	Physicians' Services Incorporated Foundation; St. Michael's Trauma-Neuro Research Group	This work was supported by grants from the Physicians' Services Incorporated Foundation and St. Michael's Trauma-Neuro Research Group. Caster Medical Systems supplied the foresight cerebral tissue oximetry monitors during the study period. We separately purchased all the probes for study use. Rainbow (R) pulse co-oximetry monitors were provided by Masimo Canada, and probes were purchased for each study patient. All funding and support sources were not involved in the collection, analysis, and interpretation of data.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Colquhoun DA, 2012, J CLIN MONIT COMPUT, V26, P91, DOI 10.1007/s10877-012-9338-0; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kiraly LN, 2009, J TRAUMA, V67, P29, DOI 10.1097/TA.0b013e3181af6a8c; Kurtz P, 2016, NEUROCRIT CARE, V24, P118, DOI 10.1007/s12028-015-0180-3; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Rosenthal G, 2009, CRIT CARE MED, V37, P379, DOI 10.1097/CCM.0b013e318193265f; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2015, NEUROCRIT CARE, V23, P210, DOI 10.1007/s12028-015-0141-x; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Topolovec-Vranic J, 2014, CAN RESPIR J, V21, P293, DOI 10.1155/2014/719270; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Wardle SP, 2000, J CEREBR BLOOD F MET, V20, P272, DOI 10.1097/00004647-200002000-00008; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Watzman HM, 2000, ANESTHESIOLOGY, V93, P947, DOI 10.1097/00000542-200010000-00012; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	26	14	14	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2017	26	2					247	255		10.1007/s12028-016-0310-6			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EN5EV	WOS:000396029300013	27757915				2022-02-06	
J	Patet, C; Quintard, H; Zerlauth, JB; Maibach, T; Carteron, L; Suys, T; Bouzat, P; Bervini, D; Levivier, M; Daniel, RT; Eckert, P; Meuli, R; Oddo, M				Patet, Camille; Quintard, Herve; Zerlauth, Jean-Baptiste; Maibach, Thomas; Carteron, Laurent; Suys, Tamarah; Bouzat, Pierre; Bervini, David; Levivier, Marc; Daniel, Roy T.; Eckert, Philippe; Meuli, Reto; Oddo, Mauro			Bedside cerebral microdialysis monitoring of delayed cerebral hypoperfusion in comatose patients with poor grade aneurysmal subarachnoid haemorrhage	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; PERFUSION COMPUTED-TOMOGRAPHY; CT PERFUSION; BLOOD-FLOW; ISCHEMIA; METABOLISM	Background Delayed cerebral ischaemia (DCI) is frequent after poor grade aneurysmal subarachnoid haemorrhage (SAH). Owing to the limited accuracy of clinical examination, DCI diagnosis is often based on multimodal monitoring. We examined the value of cerebral microdialysis (CMD) in this setting. Methods 20 comatose SAH participants underwent CMD monitoring-for hourly sampling of cerebral extracellular lactate/pyruvate ratio (LPR) and glucose-and brain perfusion CT (PCT). Patients were categorised as DCI when PCT (8 +/- 3 days after SAH) showed cerebral hypoperfusion, defined as cerebral blood flow <32.5 mL/100 g/min with a mean transit time >5.7 s. Clinicians were blinded to CMD data; for the purpose of the study, only patients who developed cerebral hypoperfusion in anterior and/or middle cerebral arteries were analysed. Results DCI (n=9/20 patients) was associated with higher CMD LPR (51 +/- 36 vs 31 +/- 10 in patients without DCI, p=0.0007) and lower CMD glucose (0.64 +/- 0.34 vs 1.22 +/- 1.05, p=0.0005). In patients with DCI, CMD changes over the 18 hours preceding PCT diagnosis revealed a pattern of CMD LPR increase (coefficient +2.96 (95% CI 0.13 to 5.79), p=0.04) with simultaneous CMD glucose decrease (coefficient -0.06 (95% CI -0.08 to -0.01), p=0.03, mixed-effects multilevel regression model). No significant CMD changes were noted in patients without DCI. Conclusions In comatose patients with SAH, delayed cerebral hypoperfusion correlates with a CMD pattern of lactate increase and simultaneous glucose decrease. CMD abnormalities became apparent in the hours preceding PCT, thereby suggesting that CMD monitoring may anticipate targeted therapeutic interventions.	[Patet, Camille; Quintard, Herve; Carteron, Laurent; Suys, Tamarah; Eckert, Philippe; Oddo, Mauro] Univ Lausanne Hosp, CHUV, Dept Intens Care Med, Neurosci Crit Care Res Grp, Lausanne, Switzerland; [Quintard, Herve] Univ Hosp, Dept Anesthesia & Crit Care, Nice, France; [Zerlauth, Jean-Baptiste; Meuli, Reto] Univ Lausanne Hosp, CHUV, Dept Radiol, Lausanne, Switzerland; [Maibach, Thomas] Univ Lausanne, Lausanne, Switzerland; [Bouzat, Pierre] Univ Hosp, Dept Anesthesia & Crit Care, Grenoble, France; [Bouzat, Pierre] Neurosci Inst, Grenoble, France; [Bervini, David; Levivier, Marc; Daniel, Roy T.] Univ Lausanne Hosp, CHUV, Div Neurosurg, Clin Neurosci, Lausanne, Switzerland		Oddo, M (corresponding author), Univ Lausanne Hosp, CHUV, Dept Intens Care Med, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	mauro.oddo@chuv.ch	Bouzat, Pierre/AAC-4105-2019; Bouzat, Pierre/L-6881-2014	Bouzat, Pierre/0000-0003-4667-6738; Bervini, David/0000-0003-4873-4452	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B_155957]; Novartis Foundation for Biomedical Research	Supported by research grants from the Swiss National Science Foundation (grant number 32003B_155957) and the Novartis Foundation for Biomedical Research (both to MO).	Binaghi S, 2007, AM J NEURORADIOL, V28, P750; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cremers CHP, 2014, J CEREBR BLOOD F MET, V34, P200, DOI 10.1038/jcbfm.2013.208; Dankbaar JW, 2010, STROKE, V41, P1927, DOI 10.1161/STROKEAHA.109.574392; Dankbaar JW, 2009, STROKE, V40, P3493, DOI 10.1161/STROKEAHA.109.559013; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Huang APH, 2014, J NEUROSURG, V120, P473, DOI 10.3171/2013.10.JNS13103; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00089; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Sanelli PC, 2011, AM J NEURORADIOL, V32, P2047, DOI 10.3174/ajnr.A2693; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Sarrafzadeh AS, 2010, J CEREBR BLOOD F MET, V30, P36, DOI 10.1038/jcbfm.2009.199; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Stocchetti N, 2011, NEUROCRIT CARE, V15, P324, DOI 10.1007/s12028-011-9597-5; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72	27	14	15	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	2017	88	4					332	338		10.1136/jnnp-2016-313766			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	EP8JO	WOS:000397621900011	27927702				2022-02-06	
J	Toman, E; Bishop, JRB; Davies, DJ; Su, ZJ; Criseno, S; Mason, A; Toogood, AA; Belli, A				Toman, Emma; Bishop, Jonathon R. B.; Davies, David J.; Su, Zhangjie; Criseno, Sherwin; Mason, Andrea; Toogood, Andrew A.; Belli, Antonio			Vitamin D Deficiency in Traumatic Brain Injury and Its Relationship with Severity of Injury and Quality of Life: A Prospective, Observational Study	JOURNAL OF NEUROTRAUMA			English	Article						endocrinology; neurotrauma; traumatic brain injury; vitamin D; vitamin D deficiency	NERVE GROWTH-FACTOR; D-RECEPTOR; 25-HYDROXYVITAMIN D; POTENTIAL ROLE; PREVALENCE; HEALTH; HYPOPITUITARISM; NEUROTOXICITY; ASSOCIATION; MODULATION	This single-center prospective observational study aims to describe the prevalence of vitamin D deficiency (VDD) in the traumatic brain injury (TBI) population and identify any relationship between vitamin D and severity of head injury or quality of life. One hundred twenty-four TBI patients had serum vitamin D (25-OHD) levels measured at the local post-TBI endocrine screening clinic over 20 months. Quality of Life after Brain Injury questionnaires were completed by the patient concurrently. A multivariate regressional analysis was performed, controlling for age, season, ethnicity, time since injury, TBI severity, and gender. A total of 34% (n = 42) of the cohort were vitamin D deficient (25-OHD <25nmol/L), with a further 23% (n = 29) having insufficient levels (25-OHD 25-50nmol/L). Vitamin D was significantly lower in patients with severe TBI than in patients with mild TBI (n = 95; p = 0.03; confidence interval [CI] 95% -23.60 to -1.21; mean effect size 12.40 nmol/L). There was a trend for self-reported quality of life to be better in patients with optimum vitamin D levels than in patients with deficient vitamin D levels, controlling for severity of injury (n = 81; p = 0.05; CI 95% -0.07 to 21.27). This is the first study to identify a significant relationship between vitamin D levels and severity of head injury. Clinicians should actively screen for and treat VDD in head-injured patients to reduce the risk of further morbidity, such as osteomalacia and cardiovascular disease. Future research should establish the natural history of vitamin D levels following TBI to identify at which stage VDD develops and whether vitamin D replacement could have a beneficial effect on recovery and quality of life.	[Toman, Emma] Queen Elizabeth Hosp, Surg Reconstruct & Microbiol Res Ctr, Natl Inst Hlth Res, Birmingham, W Midlands, England; [Davies, David J.] Queen Elizabeth Hosp, Surg Reconstruct & Microbiol Ctr, Birmingham, W Midlands, England; [Su, Zhangjie] Queen Elizabeth Hosp, Dept Neurosurg Trauma, Birmingham, W Midlands, England; [Criseno, Sherwin; Mason, Andrea; Toogood, Andrew A.] Queen Elizabeth Hosp, Dept Endocrinol, Birmingham, W Midlands, England; [Bishop, Jonathon R. B.] Univ Birmingham, Dept Med Stat, Birmingham, W Midlands, England; [Belli, Antonio] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England		Toman, E (corresponding author), Queen Elizabeth Hosp, Surg Reconstruct & Microbiol Res Ctr, Natl Inst Hlth Res, Edgbaston B15 2WB, England.	Emma.Toman@nhs.net	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933			Alizadeh N, 2015, J RES PHARM PRACT, V4, P193, DOI 10.4103/2279-042X.167051; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Balvers MGJ, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.10; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Boughey JC, 2004, AM SURGEON, V70, P500; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Briones TL, 2014, NEUROSCIENCE, V262, P143, DOI 10.1016/j.neuroscience.2013.12.064; Briones TL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-244; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Camu W, 2014, NEUROBIOL AGING, V35, P1198, DOI 10.1016/j.neurobiolaging.2013.11.005; Chen ZY, 2015, J CLIN ENDOCR METAB, V100, P516, DOI 10.1210/jc.2013-4330; DeLuca GC, 2013, NEUROPATH APPL NEURO, V39, P458, DOI 10.1111/nan.12020; Dini C, 2012, ANN I SUPER SANITA, V48, P319, DOI 10.4415/ANN_12_03_13; Edlich RF, 2009, J ENVIRON PATHOL TOX, V28, P133, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i2.50; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Ford L, 2006, ANN CLIN BIOCHEM, V43, P468, DOI 10.1258/000456306778904614; Hawes JE, 2015, BEHAV BRAIN RES, V286, P192, DOI 10.1016/j.bbr.2015.03.008; Holick MF, 2010, NUTR HEALTH SER, P1, DOI 10.1007/978-1-60327-303-9; Holick MF, 2011, J INVEST MED, V59, P872, DOI 10.2310/JIM.0b013e318214ea2d; Hollo A, 2012, EPILEPSY BEHAV, V24, P131, DOI 10.1016/j.yebeh.2012.03.011; Ibi M, 2001, NEUROPHARMACOLOGY, V40, P761, DOI 10.1016/S0028-3908(01)00009-0; Jamall OA, 2016, CLIN ENDOCRINOL, V85, P636, DOI 10.1111/cen.13045; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mehta S, 2009, J INFECT DIS, V200, P1022, DOI 10.1086/605699; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; National Health Service, VIT MIN VIT D; National Institute for Health and Clinical Excellence, VIT D INCR SUPPL US; NEVEU I, 1994, MOL BRAIN RES, V24, P70, DOI 10.1016/0169-328X(94)90119-8; Norman AW, 1998, AM J CLIN NUTR, V67, P1108, DOI 10.1093/ajcn/67.6.1108; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Office of National Statistics, 2011, ETHN NAT ID ENGL WAL; Orme RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062040; Pardridge WM, 2009, PHARM RES-DORDR, V26, P2227, DOI 10.1007/s11095-009-9939-6; Public Health England, NAT DIET NUTR SURV R; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Scientific Advisory Committee on Nutrition, VIT D HLTH IN PRESS; Shirazi HA, 2015, EXP MOL PATHOL, V98, P240, DOI 10.1016/j.yexmp.2015.02.004; Smith MP, 2006, NEUROCHEM RES, V31, P533, DOI 10.1007/s11064-006-9048-4; Socci F. I., 2014, CRIT CARE S1, V18, P471; Tang H., 2015, BRAIN INJURY; Villamor E, 2006, NUTR REV, V64, P226, DOI 10.1111/j.1753-4887.2006.tb00205.x; Wang JY, 2001, BRAIN RES, V904, P67, DOI 10.1016/S0006-8993(01)02450-7; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Wiklund I, 1990, Scand J Prim Health Care Suppl, V1, P15; WION D, 1991, J NEUROSCI RES, V28, P110, DOI 10.1002/jnr.490280111	50	14	14	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1448	1456		10.1089/neu.2016.4494			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600014	27825289	Green Accepted			2022-02-06	
J	Bragin, DE; Kameneva, MV; Bragina, OA; Thomson, S; Statom, GL; Lara, DA; Yang, YR; Nemoto, EM				Bragin, Denis E.; Kameneva, Marina V.; Bragina, Olga A.; Thomson, Susan; Statom, Gloria L.; Lara, Devon A.; Yang, Yirong; Nemoto, Edwin M.			Rheological effects of drag-reducing polymers improve cerebral blood flow and oxygenation after traumatic brain injury in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Brain metabolism; cerebral blood microcirculation; drag-reducing polymers; rheology; traumatic brain injury	FLUID SHEAR-STRESS; ADENOSINE RECEPTOR AGONISTS; HIGH INTRACRANIAL-PRESSURE; SEVERE HEAD-INJURY; MICROVASCULAR PERFUSION; ISCHEMIA; MECHANISMS; RESPONSES; MICROCIRCULATION; CIRCULATION	Cerebral ischemia has been clearly demonstrated after traumatic brain injury (TBI); however, neuroprotective therapies have not focused on improvement of the cerebral microcirculation. Blood soluble drag-reducing polymers (DRP), prepared from high molecular weight polyethylene oxide, target impaired microvascular perfusion by altering the rheological properties of blood and, until our recent reports, has not been applied to the brain. We hypothesized that DRP improve cerebral microcirculation and oxygenation after TBI. DRP were studied in healthy and traumatized rat brains and compared to saline controls. Using in-vivo two-photon laser scanning microscopy over the parietal cortex, we showed that after TBI, nanomolar concentrations of intravascular DRP significantly enhanced microvascular perfusion and tissue oxygenation in peri-contusional areas, preserved blood-brain barrier integrity and protected neurons. The mechanisms of DRP effects were attributable to reduction of the near-vessel wall cell-free layer which increased near-wall blood flow velocity, microcirculatory volume flow, and number of erythrocytes entering capillaries, thereby reducing capillary stasis and tissue hypoxia as reflected by a reduction in NADH. Our results indicate that early reduction in CBF after TBI is mainly due to ischemia; however, metabolic depression of contused tissue could be also involved.	[Bragin, Denis E.; Bragina, Olga A.; Thomson, Susan; Statom, Gloria L.; Lara, Devon A.; Nemoto, Edwin M.] Univ New Mexico, Sch Med, Dept Neurosurg, 1 Univ New Mexico,MSC10 5615, Albuquerque, NM 87131 USA; [Kameneva, Marina V.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Kameneva, Marina V.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Kameneva, Marina V.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Yang, Yirong] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA		Bragin, DE (corresponding author), Univ New Mexico, Sch Med, Dept Neurosurg, 1 Univ New Mexico,MSC10 5615, Albuquerque, NM 87131 USA.	dbragin@salud.unm.edu	Bragina, Olga A/H-6696-2016; Bragin, Denis/E-5494-2016	Bragina, Olga A/0000-0003-2810-9764; Bragin, Denis/0000-0003-4894-0061	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21NS091600-01A1, 8P30GM103400, P20GM109089-01A1]; American Heart AssociationAmerican Heart Association [14GRNT20380496]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS091600] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institutes of Health (1R21NS091600-01A1, 8P30GM103400 and P20GM109089-01A1) and American Heart Association (14GRNT20380496).	BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bragin DE, 2016, ACTA NEUROCHIR SUPPL, V122, P25, DOI 10.1007/978-3-319-22533-3_5; Bragin DE, 2013, STROKE, V44, P177, DOI 10.1161/STROKEAHA.112.668293; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brands J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077252; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Chance B, 1973, Adv Exp Med Biol, V37A, P277; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; Faul M, 2010, TRAUMATIC BRAIN INJU; Gannushkina I. V., 1984, Soviet Physics - Doklady, V29, P274; Gannushkina I. V., 1981, Soviet Physics - Doklady, V26; Golub' A. S., 1987, Soviet Physics - Doklady, V32, P620; Hu F, 2011, BIORHEOLOGY, V48, P149, DOI 10.3233/BIR-2011-0592; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Kameneva MV, 2012, INT J ENG SCI, V59, P168, DOI 10.1016/j.ijengsci.2012.03.014; Kameneva MV, 2004, BIORHEOLOGY, V41, P53; Kochanek PM, 2005, J CEREBR BLOOD F MET, V25, P1596, DOI 10.1038/sj.jcbfm.9600154; Kochanek PM, 2001, MAGNET RESON MED, V45, P924, DOI 10.1002/mrm.1123; Marascalco PJ, 2009, ASAIO J, V55, P503, DOI 10.1097/MAT.0b013e3181b1840f; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Martini RP, 2013, RESP CARE, V58, P162, DOI 10.4187/respcare.01942; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Pacella JJ, 2006, EUR HEART J, V27, P2362, DOI 10.1093/eurheartj/ehl165; Pacella JJ, 2012, MICROCIRCULATION, V19, P580, DOI 10.1111/j.1549-8719.2012.00190.x; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; RINK A, 1995, AM J PATHOL, V147, P1575; Sakai T, 2007, BRIT J ANAESTH, V98, P23, DOI 10.1093/bja/ael307; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Zhao R, 2010, BIORHEOLOGY, V47, P193, DOI 10.3233/BIR-2010-0570	55	14	16	1	17	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2017	37	3					762	775		10.1177/0271678X16684153			14	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	EL5KQ	WOS:000394660400002	28155574	Bronze, Green Published			2022-02-06	
J	Dardiotis, E; Siokas, V; Zafeiridis, T; Paterakis, K; Tsivgoulis, G; Dardioti, M; Grigoriadis, S; Simeonidou, C; Deretzi, G; Zintzaras, E; Jagiella, J; Hadjigeorgiou, GM				Dardiotis, Efthimios; Siokas, Vasileios; Zafeiridis, Tilemachos; Paterakis, Konstantinos; Tsivgoulis, Georgios; Dardioti, Maria; Grigoriadis, Savas; Simeonidou, Constantina; Deretzi, Georgia; Zintzaras, Elias; Jagiella, Jeremiasz; Hadjigeorgiou, Georgios M.			Integrins AV and B8 Gene Polymorphisms and Risk for Intracerebral Hemorrhage in Greek and Polish Populations	NEUROMOLECULAR MEDICINE			English	Article						Integrins; ITGAV; ITGB8; Intracerebral hemorrhage; Polymorphism; Tag SNPs	SINGLE NUCLEOTIDE POLYMORPHISMS; TRAUMATIC BRAIN-INJURY; ALPHA-V INTEGRINS; ASSOCIATION; STROKE; EXPRESSION	I limited number of genetic variants have been linked to the development of intracerebral hemorrhage (ICH). I (TM) ntegrin AV and/or B8-deficient mice were found to develop ICH. The present candidate gene association study was designed to investigate possible influence of integrin AV (ITGAV) and integrin B8 (ITGB8) gene region polymorphisms on the risk of ICH. 1015 participants (250 Greek and 193 Polish patients with primary ICH and 250 Greek and 322 Polish controls) were included in the study. Using logistic regression analyses, 11 tag single nucleotide polymorphisms (SNPs) for ITGAV and 11 for ITGB8 gene were tested for associations with ICH risk, lobar ICH risk and non-lobar ICH after adjustment for age, gender, history of hypertension and country of origin. Linear regression models were used to test the effect of tag SNPs on the ICH age of onset. Correction for multiple comparisons was carried out. The rs7565633 tag SNP of the ITGAV gene was independently associated with the risk of lobar ICH in the codominant model of inheritance [odds ratio (95 % confidence interval (CI)) 0.56 (0.36-0.86), p = 0.0013]. Furthermore, heterozygous individuals of the rs10251386 and the rs10239099 of the ITGB8 gene had significantly lower age of ICH onset compared to the wild-type genotypes [regression coefficient (b) -3.884 (95 % CI -6.519, -1.249), p = 0.0039 and b = -4.502 (95 % CI -7.159, -1.845), p = 0.0009, respectively]. The present study provides preliminary indication for an influence of ITGAV gene tag SNP in the development of lobar ICH and of ITGB8 gene variants in the age of ICH onset.	[Dardiotis, Efthimios; Siokas, Vasileios; Dardioti, Maria; Hadjigeorgiou, Georgios M.] Univ Thessaly, Univ Hosp Larissa, Dept Neurol, Lab Neurogenet,Fac Med,Biopolis, Mezourlo Hill, Larisa 41100, Greece; [Zafeiridis, Tilemachos] Gen Hosp Larissa, Intens Care Unit, Larisa, Greece; [Paterakis, Konstantinos] Univ Thessaly, Univ Hosp Larissa, Dept Neurosurg, Larisa, Greece; [Tsivgoulis, Georgios] Univ Athens, Attikon Univ Hosp, Sch Med, Dept Neurol 2, Athens, Greece; [Tsivgoulis, Georgios] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Grigoriadis, Savas] Aristotle Univ Thessaloniki, Hippokrat Univ Hosp, Dept Neurosurg 2, Thessaloniki, Greece; [Simeonidou, Constantina] Aristotle Univ Thessaloniki, Dept Physiol, Thessaloniki, Greece; [Deretzi, Georgia] Papageorgiou Gen Hosp, Dept Neurol, Thessaloniki, Greece; [Zintzaras, Elias] Univ Thessaly, Dept Biomath, Sch Med, Larisa, Greece; [Jagiella, Jeremiasz] Jagiellonian Univ, Coll Med, Dept Neurol, Krakow, Poland		Hadjigeorgiou, GM (corresponding author), Univ Thessaly, Univ Hosp Larissa, Dept Neurol, Lab Neurogenet,Fac Med,Biopolis, Mezourlo Hill, Larisa 41100, Greece.	gmhadji@med.uth.gr	Tsivgoulis, Georgios/AAD-7467-2019; Paterakis, Konstantinos/AAH-4554-2019; Tsivgoulis, Georgios/AAD-5360-2020	Tsivgoulis, Georgios/0000-0002-0640-3797; Zafeiridis, Tilemachos/0000-0001-5020-312X; Dardiotis, Efthimios/0000-0003-2957-641X	Research Committee of the University of Thessaly, Greece [2845]	The study was supported in part by a research grant of the Research Committee of the University of Thessaly, Greece (Code: 2845).	Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Dardiotis E, 2008, EUR NEUROL, V59, P307, DOI 10.1159/000121420; Dardiotis E, 2015, PHARMACOGENET GENOM, V25, P485, DOI 10.1097/FPC.0000000000000161; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Dardiotis E, 2011, PHARMACOGENET GENOM, V21, P136, DOI 10.1097/FPC.0b013e328343ab15; del Zoppo GJ, 2006, ARTERIOSCL THROM VAS, V26, P1966, DOI 10.1161/01.ATV.0000232525.65682.a2; Falcone GJ, 2014, LANCET NEUROL, V13, P405, DOI 10.1016/S1474-4422(14)70029-8; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Greenberg SM, 2002, CEREBROVASC DIS, V13, P42, DOI 10.1159/000049149; Han HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064839; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikram MA, 2012, CURR ATHEROSCLER REP, V14, P300, DOI 10.1007/s11883-012-0252-1; Jagiella J, 2014, NEUROL NEUROCHIR POL, V48, P105, DOI 10.1016/j.pjnns.2013.12.004; Lammie GA, 2002, BRAIN PATHOL, V12, P358; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; McCarty JH, 2005, DEVELOPMENT, V132, P165, DOI 10.1242/dev.01551; Mobley AK, 2009, J CELL SCI, V122, P1842, DOI 10.1242/jcs.043257; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rost NS, 2008, STROKE, V39, P2166, DOI 10.1161/STROKEAHA.107.501650; Sacco RL, 2000, NEW ENGL J MED, V342, P276, DOI 10.1056/NEJM200001273420410; Saharinen P, 2015, EMBO J, V34, P1293, DOI 10.15252/embj.201591504; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Su H, 2010, AM J PATHOL, V176, P1018, DOI 10.2353/ajpath.2010.090453; Wang QW, 2008, NEUROBIOL AGING, V29, P1485, DOI 10.1016/j.neurobiolaging.2007.03.018; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yamada Y, 2006, ARTERIOSCL THROM VAS, V26, P1920, DOI 10.1161/01.ATV.0000229694.97827.38; Zhu JW, 2002, DEVELOPMENT, V129, P2891; Ziegler A, 2011, BREAST CANCER RES TR, V128, P197, DOI 10.1007/s10549-010-1295-z	35	14	14	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	MAR	2017	19	1					69	80		10.1007/s12017-016-8429-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EN5EX	WOS:000396029500007	27476161				2022-02-06	
J	Lamanna, JJ; Urquia, LN; Hurtig, CV; Gutierrez, J; Anderson, C; Piferi, P; Federici, T; Oshinski, JN; Boulis, NM				Lamanna, Jason J.; Urquia, Lindsey N.; Hurtig, Carl V.; Gutierrez, Juanmarco; Anderson, Cody; Piferi, Pete; Federici, Thais; Oshinski, John N.; Boulis, Nicholas M.			Magnetic Resonance Imaging-Guided Transplantation of Neural Stem Cells into the Porcine Spinal Cord	STEREOTACTIC AND FUNCTIONAL NEUROSURGERY			English	Article						Image-guided neurosurgery; Interventional magnetic resonance imaging; Magnetic resonance imaging; Percutaneous transplantation; Spinal cord; Stereotactic techniques; Targeting; Cell therapy; Molecular imaging; Swine	AMYOTROPHIC-LATERAL-SCLEROSIS; PERCUTANEOUS SELECTIVE CORDOTOMY; PHASE-I; THERAPEUTICS DELIVERY; PROGENITOR CELLS; SAFETY OUTCOMES; RAT MODEL; TRIAL; INJURY; BRAIN	Background: Cell-based therapies are a promising treatment option for traumatic, tumorigenic and degenerative diseases of the spinal cord. Transplantation into the spinal cord is achieved with intravascular, intrathecal, or direct intraparenchymal injection. The current standard for direct injection is limited by surgical invasiveness, difficulty in reinjection, and the inability to directly target anatomical or pathological landmarks. The objective of this study was to present the proof of principle for minimally invasive, percutaneous transplantation of stem cells into the spinal cord parenchyma of live minipigs under MR guidance. Methods: An MR-compatible spine injection platform was developed to work with the ClearPoint SmartFrame system (MRI Interventions Inc.). The system was attached to the spine of 2 live minipigs, a percutaneous injection cannula was advanced into the spinal cord under MR guidance, and cells were delivered to the cord. Results: A graft of 2.5 x 10(6) human (n = 1) or porcine (n = 1) neural stem cells labeled with ferumoxytol nanoparticles was transplanted into the ventral horn of the spinal cord with MR guidance in 2 animals. Graft delivery was visualized with postprocedure MRI, and characteristic iron precipitates were identified in the spinal cord by Prussian blue histochemistry. Grafted stem cells were observed in the spinal cord of the pig injected with porcine neural stem cells. No postoperative morbidity was observed in either animal. Conclusion: This report supports the proof of principle for transplantation and visualization of pharmacological or biological agents into the spinal cord of a large animal under the guidance of MRI. (C) 2017 S. Karger AG, Basel	[Lamanna, Jason J.; Urquia, Lindsey N.; Hurtig, Carl V.; Gutierrez, Juanmarco; Federici, Thais; Boulis, Nicholas M.] Georgia Inst Technol, Sch Med, Dept Neurosurg, Atlanta, GA 30332 USA; [Oshinski, John N.] Georgia Inst Technol, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA 30332 USA; [Lamanna, Jason J.; Oshinski, John N.; Boulis, Nicholas M.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Lamanna, Jason J.; Oshinski, John N.; Boulis, Nicholas M.] Emory Univ, Atlanta, GA 30322 USA; [Anderson, Cody] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Piferi, Pete] MRI Intervent Inc, Irvine, CA USA		Boulis, NM (corresponding author), 101 Woodruff Circle,Room 6339, Atlanta, GA 30322 USA.	nboulis@emory.edu			National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454]; John and Mary Brock Discovery Fund; Atlanta Clinical and Translational Science Institute; Amyotrophic Lateral Sclerosis Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008169] Funding Source: NIH RePORTER	The Atlanta Clinical and Translational Science Institute, the John and Mary Brock Discovery Fund, and the Amyotrophic Lateral Sclerosis Association supported this work. It was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award No. UL1TR000454. We thank the Emory University Division of Animal Resources for veterinary care.	Barczewska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074658; Blanquer M, 2012, STEM CELLS, V30, P1277, DOI 10.1002/stem.1080; Castaneda RT, 2011, JOVE-J VIS EXP, DOI 10.3791/3482; Chhabra V, 2010, J NEUROSURG, V112, P497, DOI 10.3171/2009.7.JNS09572; Chung WH, 2013, J VET SCI, V14, P495, DOI 10.4142/jvs.2013.14.4.495; Duprez TP, 2008, AM J NEURORADIOL, V29, P1991, DOI 10.3174/ajnr.A1134; Ebert Allison D, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d02s6; Federici T, 2012, JOVE-J VIS EXP, DOI 10.3791/4371; Fritz J, 2012, AM J ROENTGENOL, V198, pW266, DOI 10.2214/AJR.11.6918; Fritz J, 2009, AM J ROENTGENOL, V192, pW161, DOI 10.2214/AJR.08.1569; Gowing G, 2014, NEUROREPORT, V25, P367, DOI 10.1097/WNR.0000000000000092; Guest J, 2011, BRAIN RES BULL, V84, P267, DOI 10.1016/j.brainresbull.2010.11.007; Jones LAT, 2010, SPINAL CORD, V48, P798, DOI 10.1038/sc.2010.29; Kanpolat Y, 2002, ACTA NEUROCHIR, V144, P595, DOI 10.1007/s00701-002-0945-2; KANPOLAT Y, 1993, ACTA NEUROCHIR, V123, P92, DOI 10.1007/BF01476292; Klein SM, 2005, HUM GENE THER, V16, P509, DOI 10.1089/hum.2005.16.509; Knoller N, 2005, J NEUROSURG-SPINE, V3, P173, DOI 10.3171/spi.2005.3.3.0173; Lamanna JJ, 2013, THER DELIV, V4, P1397, DOI [10.4155/TDE.13.111, 10.4155/tde.13.111]; Lammertse DP, 2012, SPINAL CORD, V50, P661, DOI 10.1038/sc.2012.39; Larson PS, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822f4a91; Lee JH, 2009, J NEUROSURG-SPINE, V11, P749, DOI 10.3171/2009.6.SPINE08710; Liu M, 2015, J MAGN RESON IMAGING, V42, P1740, DOI 10.1002/jmri.24924; Martin AJ, 2005, MAGN RESON MED, V54, P1107, DOI 10.1002/mrm.20675; Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653; Mazzini L, 2010, EXP NEUROL, V223, P229, DOI 10.1016/j.expneurol.2009.08.007; Mazzini L, 2012, CYTOTHERAPY, V14, P56, DOI 10.3109/14653249.2011.613929; McGirt MJ, 2002, STEREOT FUNCT NEUROS, V78, P53, DOI 10.1159/000068012; Netuka D, 2011, J NEUROSURG-SPINE, V14, P754, DOI 10.3171/2011.2.SPINE10715; Raore B, 2011, SPINE, V36, pE164, DOI 10.1097/BRS.0b013e3181d77a47; Richardson RM, 2011, STEREOT FUNCT NEUROS, V89, P141, DOI 10.1159/000323544; Riley J, 2008, STEREOT FUNCT NEUROS, V86, P67, DOI 10.1159/000112426; Riley J, 2014, NEUROSURGERY, V74, P77, DOI 10.1227/NEU.0000000000000156; Riley J, 2012, NEUROSURGERY, V71, P405, DOI 10.1227/NEU.0b013e31825ca05f; Riley J, 2009, NEUROSURGERY, V65, P754, DOI 10.1227/01.NEU.0000343524.45387.9E; Starr PA, 2010, J NEUROSURG, V112, P479, DOI 10.3171/2009.6.JNS081161; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Thu MS, 2012, NAT MED, V18, P463, DOI 10.1038/nm.2666	38	14	14	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1011-6125	1423-0372		STEREOT FUNCT NEUROS	Stereotact. Funct. Neurosurg.	MAR	2017	95	1					60	68		10.1159/000448765			9	Neurosciences; Neuroimaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EN2EK	WOS:000395822200010	28132063	Bronze, Green Accepted			2022-02-06	
J	Min, J; Moon, WJ; Jeon, JY; Choi, JW; Moon, YS; Han, SH				Min, Jeeyoung; Moon, Won-Jin; Jeon, Ji Young; Choi, Jin Woo; Moon, Yeon-Sil; Han, Seol-Heui			Diagnostic Efficacy of Structural MRI in Patients With Mild-toModerate Alzheimer Disease: Automated Volumetric Assessment Versus Visual Assessment	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						Alzheimer disease; medial temporal lobe; MRI; quantitative; Scheltens scale; volumetry	TRAUMATIC BRAIN-INJURY; MEDIAL TEMPORAL ATROPHY; HIPPOCAMPAL ATROPHY; RADIOLOGISTS INTERPRETATIONS; COGNITIVE IMPAIRMENT; LOBE; NEUROQUANT(R); ASSOCIATION; FREESURFER; DEMENTIA	OBJECTIVE. The purpose of this study was to compare the diagnostic efficacies of an automated volumetric assessment tool and visual assessment in the evaluation of medial temporal lobar atrophy in mild-to-moderate Alzheimer disease (AD). MATERIALS AND METHODS. This retrospective study included 30 patients with mild-to-moderate AD and 25 age-matched healthy control subjects undergoing MRI with a 3D fast spoiled gradient recalled-echo sequence at 3 T. The images were processed with fully automated volumetric analysis software. To assess medial temporal lobe (MTL) atrophy, two MTL indexes, which took into account the volumes of the hippocampus and the inferior lateral ventricle, were calculated with the automated volumetric assessment software. In addition, two neuroradiologists assessed MTL atrophy visually using the Scheltens scale. ROC curve analysis was used to compare the diagnostic performances of the two methods. The weighted kappa statistic was used to assess the intrarater and interrater reliability of visual inspection. RESULTS. The automated volumetric assessment tool had moderate sensitivity (63.3%) and high specificity (100%) in differentiating patients with mild-to-moderate AD from control subjects. Visual inspection showed sensitivity of 63.3% and specificity of 92.0%. The diagnostic performance was not significantly different between the two methods (p = 0.536-0.906). Intraobserver reliability for visual inspection was 0.858 and 0.902 for the two reviewers, and interobserver reliability was 0.692-0.780. CONCLUSION. Both the automated volumetric assessment tool and visual inspection can be used to evaluate MTL atrophy and differentiate patients with AD from healthy individuals with good diagnostic accuracy. Thus, the automated tool can be a useful and efficient adjunct in clinical practice for evaluating MTL atrophy in the diagnosis of AD.	[Min, Jeeyoung; Moon, Won-Jin; Jeon, Ji Young; Choi, Jin Woo] Konkuk Univ, Med Ctr, Dept Radiol, Sch Med, 120-1 Neungdong Ro, Seoul 05030, South Korea; [Jeon, Ji Young] Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea; [Moon, Yeon-Sil; Han, Seol-Heui] Konkuk Univ, Dept Neurol, Sch Med, Seoul, South Korea		Moon, WJ (corresponding author), Konkuk Univ, Med Ctr, Dept Radiol, Sch Med, 120-1 Neungdong Ro, Seoul 05030, South Korea.	mdmoonwj@kuh.ac.kr		Moon, Won-Jin/0000-0002-8925-7376; Choi, Jin Woo/0000-0002-0716-5137	Korean Health Technology RD; Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [HI12C0713]; Samsung Electronics, Suwon, Republic of Korea	Supported by a Korean Health Technology R& D Project Grant from the Ministry of Health & Welfare, Republic of Korea ( HI12C0713) and by Samsung Electronics, Suwon, Republic of Korea.	Azab M, 2015, AM J NEURORADIOL, V36, P1400, DOI 10.3174/ajnr.A4313; Bastos-Leite AJ, 2006, AM J NEURORADIOL, V27, P2141; Boutet C, 2012, NEURORADIOLOGY, V54, P1321, DOI 10.1007/s00234-012-1058-0; Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402; Cavallin L, 2012, ACTA RADIOL, V53, P318, DOI 10.1258/ar.2012.110552; Chee MWL, 2011, J COGNITIVE NEUROSCI, V23, P1065, DOI 10.1162/jocn.2010.21513; DeCarli C, 2007, ARCH NEUROL-CHICAGO, V64, P108, DOI 10.1001/archneur.64.1.108; Desikan RS, 2013, AM J NEURORADIOL, V34, P2075, DOI 10.3174/ajnr.A3644; Farid N, 2012, RADIOLOGY, V264, P542, DOI 10.1148/radiol.12112638; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frisoni GB, 2013, NEUROLOGY, V81, P487, DOI 10.1212/WNL.0b013e31829d86e8; Galluzzi S, 2008, DEMENT GERIATR COGN, V26, P314, DOI 10.1159/000161056; Giorgio A, 2013, J MAGN RESON IMAGING, V37, P1, DOI 10.1002/jmri.23671; Jack CR, 2012, RADIOLOGY, V263, P343, DOI 10.1148/radiol.12110433; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Lee JS, 2005, J KOREAN MED SCI, V20, P483, DOI 10.3346/jkms.2005.20.3.483; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moon WJ, 2012, KOREAN J RADIOL, V13, P674, DOI 10.3348/kjr.2012.13.6.674; Ochs AL, 2015, J NEUROIMAGING, V25, P721, DOI 10.1111/jon.12229; Ross DE, 2015, J NEUROPSYCH CLIN N, V27, P147, DOI 10.1176/appi.neuropsych.13040088; Ross DE, 2013, BRAIN INJURY, V27, P634, DOI 10.3109/02699052.2013.767939; Ross DE, 2013, J NEUROPSYCH CLIN N, V25, P32, DOI 10.1176/appi.neuropsych.11120377; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Urs R, 2009, J COMPUT ASSIST TOMO, V33, P73, DOI 10.1097/RCT.0b013e31816373d8; VERMERSCH P, 1994, J NEUROL NEUROSUR PS, V57, P1015, DOI 10.1136/jnnp.57.8.1015; Wahlund LO, 2000, J NEUROL NEUROSUR PS, V69, P630, DOI 10.1136/jnnp.69.5.630; Wattjes MP, 2009, RADIOLOGY, V253, P174, DOI 10.1148/radiol.2531082262	29	14	15	0	8	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	MAR	2017	208	3					617	623		10.2214/AJR.16.16894			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	EL4MT	WOS:000394596000033	28075620				2022-02-06	
J	Tang, QL; Wu, X; Weng, WJ; Li, HP; Feng, JF; Mao, QN; Gao, GY; Jiang, JY				Tang, Qilin; Wu, Xiang; Weng, Weiji; Li, Hongpeng; Feng, Junfeng; Mao, Qing; Gao, Guoyi; Jiang, Jiyao			The preventive effect of dexmedetomidine on paroxysmal sympathetic hyperactivity in severe traumatic brain injury patients who have undergone surgery: a retrospective study	PEERJ			English	Article						Paroxysmal sympathetic hyperactivity; Dexmedetomidine; Traumatic brain injury; Preventive effect; Prognosis	INTENSIVE-CARE-UNIT; AUTONOMIC INSTABILITY; DIENCEPHALIC SEIZURES; DIAGNOSTIC-CRITERIA; AFFERENT STIMULI; HEAD-INJURY; DYSAUTONOMIA; DYSTONIA; OVERRESPONSIVENESS; BROMOCRIPTINE	Background. Paroxysmal sympathetic hyperactivity (PSH) results and aggravates in secondary brain injury, which seriously affects the prognosis of severe traumatic brain injury patients. Although several studies have focused on the treatment of PSH, few have concentrated on its prevention. Methods. Ninety post-operation (post-op) severe traumatic brain injury (sTBI) patients admitted from October 2014 to April 2016 were chosen to participate in this study. Fifty of the post-op sTBI patients were sedated with dexmedetomidine and were referred as the "dexmedetomidine group" (admitted from May 2015 to April 2016). The other 40 patients (admitted from October 2014 to May 2015) received other sedations and were referred as the "control group." The two groups were then compared based on their PSH scores and the scores and ratios of those patients who met the criteria of "probable," "possible" and "unlikely" using the PSH assessment measure (PSH-AM) designed by Baguley et al. (2014). The durations of the neurosurgery intensive care unit (NICU) and hospital stays and the Glasgow outcome scale (GOS) values for the two groups were also compared to evaluate the therapeutic effects and the patients' prognosis. Results. The overall PSH score for the dexmedetomidine group was 5.26 +/- 4.66, compared with 8.58 +/- 8.09 for the control group. The difference between the two groups' PSH scores was significant (P = 0.017). The score of the patients who met the criterion of "probable" was 18.33 +/- 1.53 in the dexmedetomidine group and 22.63 +/- 2.97 in the control group, and the difference was statistically significant (P = 0.045). The ratio of patients who were classified as "unlikely" between the two groups was statistically significant (P = 0.028); that is, 42 (84%) in the dexmedetomidine group and 25 (62.5%) in the control group. The differences in NICU, hospital stays and GOS values between the two groups were not significant. Conclusion. Dexmedetomidine has a preventive effect on PSH in sTBI patients who have undergone surgery.	[Tang, Qilin; Wu, Xiang; Weng, Weiji; Feng, Junfeng; Mao, Qing; Gao, Guoyi; Jiang, Jiyao] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China; [Tang, Qilin; Wu, Xiang; Weng, Weiji; Feng, Junfeng; Mao, Qing; Gao, Guoyi; Jiang, Jiyao] Shanghai Inst Head Trauma, Shanghai, Peoples R China; [Li, Hongpeng] Rizhao City Hosp Traditional Chinese Med, Dept Neurosurg, Rizhao, Peoples R China		Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China.; Gao, GY (corresponding author), Shanghai Inst Head Trauma, Shanghai, Peoples R China.	gao3@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671198]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20152212]	This work was supported by the National Natural Science Foundation of China (No. 81671198) and grants from the Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (No. 20152212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, AM J PHYS MED REHAB, V88, P615, DOI 10.1097/PHM.0b013e3181aeab96; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; BHIGJEE AI, 1985, J NEUROL SCI, V71, P77, DOI 10.1016/0022-510X(85)90038-3; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Cai Y, 2014, MOL MED REP, V9, P1542, DOI 10.3892/mmr.2014.2034; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Cosar M, 2009, SURG NEUROL, V71, P54, DOI 10.1016/j.surneu.2007.08.020; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Dahmani S, 2005, ANESTHESIOLOGY, V103, P969, DOI 10.1097/00000542-200511000-00011; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Goddeau RP, 2007, NEUROCRIT CARE, V7, P217, DOI 10.1007/s12028-007-0066-0; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; JENNETT B, 1975, LANCET, V1, P480; Kern J, 2016, CHEST, V149, pE39, DOI 10.1016/j.chest.2015.08.003; Ko SB, 2010, NEUROLOGIST, V16, P384, DOI 10.1097/NRL.0b013e3181b1cdff; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Martin Eike, 2003, J Intensive Care Med, V18, P29, DOI 10.1177/0885066602239122; Mehta NM, 2008, JPEN-PARENTER ENTER, V32, P281, DOI 10.1177/0148607108316196; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Panzer Oliver, 2011, Anesthesiol Clin, V29, P587, DOI 10.1016/j.anclin.2011.09.002; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Russo RN, 2000, J PAEDIATR CHILD H, V36, P283, DOI 10.1046/j.1440-1754.2000.00485.x; SNEED RC, 1995, ARCH PHYS MED REHAB, V76, P101, DOI 10.1016/S0003-9993(95)80051-4; Thorley RR, 2001, ARCH PHYS MED REHAB, V82, P246, DOI 10.1053/apmr.2001.18698; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Venn RM, 2000, CRIT CARE, V4, P302, DOI 10.1186/cc712	48	14	15	0	7	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	FEB 15	2017	5								e2986	10.7717/peerj.2986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO7VZ	WOS:000396899500002	28229021	Green Submitted, Green Published, gold			2022-02-06	
J	Ouyang, W; Yan, QC; Zhang, Y; Fan, ZH				Ouyang, Wei; Yan, Qichao; Zhang, Yu; Fan, Zhiheng			Moderate injury in motor-sensory cortex causes behavioral deficits accompanied by electrophysiological changes in mice adulthood	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LATERAL FLUID PERCUSSION; SPATIAL MEMORY; RECOGNITION MEMORY; THETA-FREQUENCY; WORKING-MEMORY; HIPPOCAMPAL; STIMULATION; MODEL; ANTAGONISTS	Moderate traumatic brain injury (TBI) in children often happen when there's a sudden blow to the frontal bone, end with long unconscious which can last for hours and progressive cognitive deficits. However, with regard to the influences of moderate TBI during children adulthood, injury-induced alterations of locomotive ability, long-term memory performance, and hippocampal electrophysiological firing changes have not yet been fully identified. In this study, lateral fluid percussion (LFP) method was used to fabricate moderate TBI in motor and somatosensory cortex of the 6-weeks-old mice. The motor function, learning and memory function, extracellular CA1 neural spikes were assessed during acute and subacute phase. Moreover, histopathology was performed on day post injury (DPI) 16 to evaluate the effect of TBI on tissue and cell morphological changes in cortical and hippocampal CA1 subregions. After moderate LFP injury, the 6-weeks-old mice showed severe motor deficits at the early stage in acute phase but gradually recovered later during adulthood. At the time points in acute and subacute phase after TBI, novel object recognition (NOR) ability and spatial memory functions were consistently impaired in TBI mice; hippocampal firing frequency and burst probability were hampered. Analysis of the altered burst firing shows a clear hippocampal theta rhythm drop. These electrophysiological impacts were associated with substantially lowered NOR preference as compared to the sham group during adulthood. These results suggest that moderate TBI introduced at motorsenory cortex in 6-weeks- old mice causes obvious motor and cognitive deficits during their adulthood. While the locomotive ability progressively recovers, the cognitive deficits persisted while the mice mature as adult mice. The cognitive deficits may be attributed to the general suppressing of whole neural network, which could be labeled by marked reduction of excitability in hippocampal CA1 subregion.	[Ouyang, Wei; Yan, Qichao; Fan, Zhiheng] Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, Jinhua, Zhejiang, Peoples R China; [Zhang, Yu] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China		Ouyang, W (corresponding author), Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, Jinhua, Zhejiang, Peoples R China.	wouyang@zjnu.cn		Ouyang, Wei/0000-0003-2866-491X	Zhejiang Province Natural Science FoundationNatural Science Foundation of Zhejiang Province [LY15H090012]; General Administration of Sport of China [2014B101]	This work was supported by Zhejiang Province Natural Science Foundation (no. LY15H090012) and the General Administration of Sport of China (no. 2014B101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Amoros-Aguilar L, 2015, BEHAV NEUROSCI, V129, P149, DOI 10.1037/bne0000046; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Constantinou M, 2015, BIOSYSTEMS, V136, P73, DOI 10.1016/j.biosystems.2015.08.004; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Dewan MC, 2016, EPIDEMIOLOGY GLOBAL; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Floresco SB, 1997, J NEUROSCI, V17, P1880; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Guderian S, 2015, J NEUROSCI, V35, P14123, DOI 10.1523/JNEUROSCI.0801-15.2015; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Ho JW, 2015, J NEUROSCI, V35, P13323, DOI 10.1523/JNEUROSCI.2278-15.2015; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hoy K. E., 2015, CEREBRAL CORTEX; Huang TN, 2014, NAT NEUROSCI, V17, P240, DOI 10.1038/nn.3626; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kirkcaldie MTK, 2011, MOUSE NERVOUS SYSTEM; KUBIE JL, 1990, J NEUROSCI, V10, P1110; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Miller JP, 2015, BRAIN, V138, P1833, DOI 10.1093/brain/awv095; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Parker A, 1997, EUR J NEUROSCI, V9, P2423, DOI 10.1111/j.1460-9568.1997.tb01659.x; PARKIN AJ, 1994, NEUROPSYCHOLOGIA, V32, P39, DOI 10.1016/0028-3932(94)90067-1; Paxinos G., 2007, MOUSE BRAIN STEREOTA; Qin SZ, 2014, NAT NEUROSCI, V17, P1263, DOI 10.1038/nn.3788; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Robinson L, 2007, BRIT J PHARMACOL, V151, P688, DOI 10.1038/sj.bjp.0707273; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Sweet JA, 2014, HIPPOCAMPUS, V24, P1592, DOI 10.1002/hipo.22338; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Verleye M, 2003, NEUROSCI LETT, V353, P127, DOI 10.1016/j.neulet.2003.09.010; Warburton EC, 2015, BEHAV BRAIN RES, V285, P131, DOI 10.1016/j.bbr.2014.09.050; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Young JS, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0719-9	61	14	14	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171976	10.1371/journal.pone.0171976			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EL2BA	WOS:000394423900040	28196142	gold, Green Published, Green Submitted			2022-02-06	
J	Allison, RZ; Nakagawa, K; Hayashi, M; Donovan, DJ; Koenig, MA				Allison, Randall Z.; Nakagawa, Kazuma; Hayashi, Michael; Donovan, Daniel J.; Koenig, Matthew A.			Derivation of a Predictive Score for Hemorrhagic Progression of Cerebral Contusions in Moderate and Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Cerebral contusion; Traumatic brain injury; Triage; Critical care; Resource allocation	HEAD TRAUMA; LESIONS	After traumatic brain injury (TBI), hemorrhagic progression of contusions (HPCs) occurs frequently. However, there is no established predictive score to identify high-risk patients for HPC. Consecutive patients who were hospitalized (2008-2013) with non-penetrating moderate or severe TBI were studied. The primary outcome was HPC, defined by both a relative increase in contusion volume by >= 30 % and an absolute increase by >= 10 mL on serial imaging. Logistic regression models were created to identify independent risk factors for HPC. The HPC Score was then derived based on the final model. Among a total of 286 eligible patients, 61 (21 %) patients developed HPC. On univariate analyses, HPC was associated with older age, higher initial blood pressure, antiplatelet medications, anticoagulants, subarachnoid hemorrhage (SAH) subdural hematoma (SDH), skull fracture, frontal contusion, larger contusion volume, and shorter interval from injury to initial CT. In the final model, SAH (OR 6.33, 95 % CI, 1.80-22.23), SDH (OR 3.46, 95 % CI, 1.39-8.63), and skull fracture (OR 2.67, 95 % CI, 1.28-5.58) were associated with HPC. Based on these factors, the HPC Score was derived (SAH = 2 points, SDH = 1 point, and skull fracture = 1 point). This score had an area under the receiver operating curve of 0.77. Patients with a score of 0-2 had a 4.0 % incidence of HPC, while patients with a score of 3-4 had a 34.6 % incidence of HPC. A simple HPC Score was developed for early risk stratification of HPC in patients with moderate or severe TBI.	[Allison, Randall Z.] Univ Texas Med Branch, Dept Surg, Div Neurosurg, Galveston, TX 77555 USA; [Nakagawa, Kazuma; Donovan, Daniel J.; Koenig, Matthew A.] Queens Med Ctr, Inst Neurosci, Dept Surg, Honolulu, HI 96813 USA; [Nakagawa, Kazuma; Koenig, Matthew A.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA; [Hayashi, Michael; Donovan, Daniel J.] Univ Hawaii, John A Burns Sch Med, Dept Surg, Honolulu, HI 96822 USA; [Hayashi, Michael] Queens Med Ctr, Dept Surg, Honolulu, HI USA		Koenig, MA (corresponding author), Queens Med Ctr, Inst Neurosci, Dept Surg, 1301 Punchbowl St QET5, Honolulu, HI 96813 USA.	zainallison@gmail.com; knakagawa@queens.org; mhayashi@queens.org; donovand001@hawaii.rr.com; mkoenig@queens.org		Hayashi, Michael/0000-0001-9743-4945	National Institute on Minority Health and Health Disparities of the National Institutes of Health [P20MD000173]; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [P20MD000173] Funding Source: NIH RePORTER	Dr. Nakagawa was partially supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health (P20MD000173).	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Fabbri A, 2010, J NEUROL NEUROSUR PS, V81, P1275, DOI 10.1136/jnnp.2009.197467; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Reed SD, 2001, NEUROLOGY, V57, P305, DOI 10.1212/WNL.57.2.305; Sanus GZ, 2004, NEUROSURG QUART, V14, P97, DOI 10.1097/01.wnq.0000127718.06183.12; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	25	14	15	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2017	26	1					80	86		10.1007/s12028-016-0303-5			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EI2AI	WOS:000392287900012	27473209	Green Accepted			2022-02-06	
J	D'Hondt, F; Lassonde, M; Thebault-Dagher, F; Bernier, A; Gravel, J; Vannasing, P; Beauchamp, MH				D'Hondt, Fabien; Lassonde, Maryse; Thebault-Dagher, Fanny; Bernier, Annie; Gravel, Jocelyn; Vannasing, Phetsamone; Beauchamp, Miriam H.			Electrophysiological correlates of emotional face processing after mild traumatic brain injury in preschool children	COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE			English	Article						Mild traumatic brain injury; Emotional facial expression; Social skills; Childhood; Event-related potential	EVENT-RELATED POTENTIALS; FEARFUL FACIAL EXPRESSIONS; WEIGHTED IMAGING SWI; MINOR HEAD TRAUMA; YOUNG-CHILDREN; TIME-COURSE; EXPERIENCED MALTREATMENT; 3-YEAR-OLD CHILDREN; EARLY-CHILDHOOD; 1ST YEAR	Evidence suggests that social skills are affected by childhood mild traumatic brain injury (mTBI), but the neural and affective substrates of these difficulties are still underexplored. In particular, nothing is known about consequences on the perception of emotional facial expressions, despite its critical role in social interactions and the importance of the preschool period in the development of this ability. This study thus aimed to investigate the electrophysiological correlates of emotional facial expressions processing after early mTBI. To this end, 18 preschool children (mean age 53 +/- 8 months) who sustained mTBI and 15 matched healthy controls (mean age 55 +/- 11 months) were presented with pictures of faces expressing anger, happiness, or no emotion (neutral) while event-related potentials (ERP) were recorded. The main results revealed that P1 amplitude was higher for happy faces than for angry faces, and that N170 latency was shorter for emotional faces than for neutral faces in the control group only. These findings suggest that preschool children who sustain mTBI do not present the early emotional effects that are observed in healthy preschool children at visuospatial and visual expertise stages. This study provides new evidence regarding the consequences of childhood mTBI on socioemotional processing, by showing alterations of emotional facial expressions processing, an ability known to underlie social competence and appropriate social interactions.	[D'Hondt, Fabien; Lassonde, Maryse; Thebault-Dagher, Fanny; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [D'Hondt, Fabien; Lassonde, Maryse; Thebault-Dagher, Fanny] Univ Montreal, Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [D'Hondt, Fabien; Lassonde, Maryse; Thebault-Dagher, Fanny; Gravel, Jocelyn; Vannasing, Phetsamone; Beauchamp, Miriam H.] Univ Montreal, Ctr Rech, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [D'Hondt, Fabien] Univ Lille, CNRS, SCALab, UMR 9193,Sci Cognit & Sci Affect, F-59000 Lille, France; [D'Hondt, Fabien] CHU Lille, Clin Psychiat, CURE, F-59000 Lille, France		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.; Beauchamp, MH (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp Univ St Justine, Montreal, PQ, Canada.	miriam.beauchamp@umontreal.ca		Thebault-Dagher, Fanny/0000-0001-7601-2292; D'Hondt, Fabien/0000-0001-5683-0490; Gravel, Jocelyn/0000-0001-5901-4990	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); CHU Sainte-Justine Foundation	This study was funded by the Canadian Institutes of Health Research, but this fund did not exert any editorial direction or censorship on any part of this article. Fabien D'Hondt was funded by a postdoctoral fellowship from the CHU Sainte-Justine Foundation. The Cartool software (brainmapping.unige.ch/cartool) was programmed by Denis Brunet, from the Functional Brain Mapping Laboratory, Geneva, Switzerland, and is supported by the Center for Biomedical Imaging (CIBM) of Geneva and Lausanne.	Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bayley N., 2005, BAYLEY SCALES INFANT; Beauchamp M., 2010, PRINCIPLES PRACTICE, P315, DOI 10.1017/CBO9780511674815.024; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bellerose J, 2015, J INT NEUROPSYCHOL S, P1, DOI DOI 10.1902/JOP.2015.150455; BENTIN S, 1994, J EXP PSYCHOL LEARN, V20, P130, DOI 10.1037/0278-7393.20.1.130; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; BONADIO WA, 1989, AM J DIS CHILD, V143, P1061, DOI 10.1001/archpedi.1989.02150210095025; Bornstein MH, 2003, DEVELOPMENTAL SCI, V6, P585, DOI 10.1111/1467-7687.00314; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Calvo MG, 2014, J NONVERBAL BEHAV, V38, P549, DOI 10.1007/s10919-014-0191-3; Calvo MG, 2005, J EXP PSYCHOL HUMAN, V31, P502, DOI 10.1037/0096-1523.31.3.502; Carver LJ, 2003, DEV PSYCHOBIOL, V42, P148, DOI 10.1002/dev.10078; Cicchetti D, 2005, DEV PSYCHOPATHOL, V17, P641, DOI 10.1017/S09545794050315; Crowe Louise M, 2015, Handb Clin Neurol, V128, P661, DOI 10.1016/B978-0-444-63521-1.00041-8; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Curtis WJ, 2011, DEV PSYCHOPATHOL, V23, P373, DOI 10.1017/S0954579411000125; Dadds MR, 2008, CHILD PSYCHIAT HUM D, V39, P111, DOI 10.1007/s10578-007-0075-4; Dawson G, 2002, CHILD DEV, V73, P700, DOI 10.1111/1467-8624.00433; Dawson G, 2004, DEVELOPMENTAL SCI, V7, P340, DOI 10.1111/j.1467-7687.2004.00352.x; de Haan M, 2004, J CHILD PSYCHOL PSYC, V45, P1209, DOI 10.1111/j.1469-7610.2004.00320.x; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; Dekowska M, 2008, ACTA NEUROBIOL EXP, V68, P229; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dimberg U, 2011, J PSYCHOPHYSIOL, V25, P26, DOI 10.1027/0269-8803/a000029; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M., 2012, OXFORD HDB FACE PERC, P329, DOI [10.1093/oxfordhb/9780199559053.013.0017, DOI 10.1093/OXFORDHB/9780199559053.013.0017]; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; Greenes DS, 2003, ANN EMERG MED, V42, P515, DOI 10.1067/S0196-0644(03)00631-0; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Hayden MG, 2007, CHILD NERV SYST, V23, P431, DOI 10.1007/s00381-006-0277-2; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; Hinojosa JA, 2015, NEUROSCI BIOBEHAV R, V55, P498, DOI 10.1016/j.neubiorev.2015.06.002; Hoehl S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002389; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Izard C, 2001, PSYCHOL SCI, V12, P18, DOI 10.1111/1467-9280.00304; Izard CE, 2002, DEV PSYCHOPATHOL, V14, P761, DOI 10.1017/S0954579402004066; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Joyce C, 2005, CLIN NEUROPHYSIOL, V116, P2613, DOI 10.1016/j.clinph.2005.07.005; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Keenan HT, 2008, AM J PREV MED, V34, pS120, DOI 10.1016/j.amepre.2007.11.001; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kobiella A, 2008, COGNITION EMOTION, V22, P134, DOI 10.1080/02699930701394256; Kuefner D, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.067.2009; Kuppermann N, 2008, PEDIATR RADIOL, V38, pS670, DOI 10.1007/s00247-008-0996-5; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; Luu P., 2005, DETERMINATION HYDROC; MALATESTAMAGAI C, 1994, INT J BEHAV DEV, V17, P239, DOI 10.1177/016502549401700202; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Miller G, 2010, SCIENCE, V328, P297, DOI 10.1126/science.328.5976.297; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; NELSON CA, 1990, DEV PSYCHOL, V26, P171, DOI 10.1037/0012-1649.26.2.171; Olivares EI, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/514361; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Parker SW, 2005, CHILD DEV, V76, P54, DOI 10.1111/j.1467-8624.2005.00829.x; Peykarjou S, 2013, DEVELOPMENTAL SCI, V16, P905, DOI 10.1111/desc.12063; PHILIPPOT P, 1990, BRIT J SOC PSYCHOL, V29, P43, DOI 10.1111/j.2044-8309.1990.tb00885.x; Pinal D, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00075; Pollak SD, 2002, P NATL ACAD SCI USA, V99, P9072, DOI 10.1073/pnas.142165999; Pollak SD, 2008, CURR DIR PSYCHOL SCI, V17, P370, DOI 10.1111/j.1467-8721.2008.00608.x; Pourtois G, 2008, BRAIN TOPOGR, V20, P265, DOI 10.1007/s10548-008-0053-6; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Rellecke J, 2013, BRAIN TOPOGR, V26, P62, DOI 10.1007/s10548-012-0261-y; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rossion B, 2014, TRENDS COGN SCI, V18, P310, DOI 10.1016/j.tics.2014.02.013; Rotshtein P, 2010, HUM BRAIN MAPP, V31, P1089, DOI 10.1002/hbm.20921; Rousselet GA, 2008, J VISION, V8, DOI 10.1167/8.12.3; Rugg M.D., 1995, ELECTROPHYSIOLOGY MI; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schweinberger SR, 2002, NEUROPSYCHOLOGIA, V40, P2057, DOI 10.1016/S0028-3932(02)00050-7; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; SERRANO JM, 1992, DEV PSYCHOBIOL, V25, P411, DOI 10.1002/dev.420250603; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Somerville LH, 2011, DEV NEUROPSYCHOL, V36, P408, DOI 10.1080/87565641.2010.549865; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor MJ, 1999, CLIN NEUROPHYSIOL, V110, P910, DOI 10.1016/S1388-2457(99)00006-1; Taylor MJ, 2004, J COGNITIVE NEUROSCI, V16, P1426, DOI 10.1162/0898929042304732; Taylor-Colls S, 2015, CHILD DEV, V86, P877, DOI 10.1111/cdev.12348; Todd RM, 2008, NEUROPSYCHOLOGIA, V46, P595, DOI 10.1016/j.neuropsychologia.2007.10.011; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Vlamings PHJM, 2010, CHILD DEV, V81, P1304, DOI 10.1111/j.1467-8624.2010.01470.x; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Vuilleumier P, 2015, CURR OPIN NEUROL, V28, P29, DOI 10.1097/WCO.0000000000000159; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; WALDEN TA, 1990, BRIT J DEV PSYCHOL, V8, P65; Wechsler D., 2002, WECHSLER PRESCHOOL P; Widen SC, 2013, EMOT REV, V5, P72, DOI 10.1177/1754073912451492; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	119	14	14	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1530-7026	1531-135X		COGN AFFECT BEHAV NE	Cogn. Affect. Behav. Neurosci.	FEB	2017	17	1					124	142		10.3758/s13415-016-0467-7			19	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EK2QW	WOS:000393772800007	27699681	Bronze			2022-02-06	
J	McDonald, V; Hauner, KK; Chau, A; Krueger, F; Grafman, J				McDonald, Valerie; Hauner, Katherina K.; Chau, Aileen; Krueger, Frank; Grafman, Jordan			Networks underlying trait impulsivity: Evidence from voxel-based lesion-symptom mapping	HUMAN BRAIN MAPPING			English	Article						impulsivity; motor impulsivity; prefrontal cortex; traumatic brain injury; voxel-based lesion-symptom mapping	TRAUMATIC BRAIN-INJURY; RESPONSE-INHIBITION; PREFRONTAL CORTEX; SELF-AWARENESS; HEALTHY-ADULTS; PERSONALITY; BEHAVIOR; REGISTRATION; SOFTWARE; DOMAINS	Impulsivity is considered a multidimensional construct that encompasses a range of behaviors, including poor impulse control, premature decision-making, and the inability to delay gratification. In order to determine the extent to which impulsivity and its components share a common network, a voxel-based lesion-symptom mapping (VLSM) analysis was performed in a large sample of patients (N=131) with focal, penetrating traumatic brain injuries (pTBI). Impulsivity was assessed using the Barratt Impulsiveness Scale (BIS-11), a standard self-report measure that allows for unique estimates of global impulsivity and its factor analysis-derived components (e.g., motor impulsivity). Heightened global impulsivity was associated with damage to multiple areas in bilateral prefrontal cortex (PFC), left superior, middle and inferior temporal gyrus, and left hippocampus. Moreover, a cluster was identified within the left PFC associated specifically with motor impulsivity (defined as acting without thinking). The results were consistent with the existing literature on bilateral prefrontal cortical involvement in behavioral impulsivity, but also provided new evidence for a more complex neuroanatomical representation of this construct, characterized by left-lateralized temporal and hippocampal involvement, as well as a left-lateralized prefrontal network specifically associated with motor impulsivity. Hum Brain Mapp 38:656-665, 2017. (c) 2016 Wiley Periodicals, Inc.	[McDonald, Valerie; Hauner, Katherina K.; Chau, Aileen; Grafman, Jordan] Rehabil Inst Chicago, Cognit Neurosci Lab, 345 East Super St,Suite 1796, Chicago, IL 60611 USA; [Hauner, Katherina K.; Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Hauner, Katherina K.; Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA		Grafman, J (corresponding author), Rehabil Inst Chicago, Cognit Neurosci Lab, 345 East Super St,Suite 1796, Chicago, IL 60611 USA.	jgraf-man@northwestern.edu			Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12 HS023011]; National Institute of Neurological Disorders and Stroke intramural research programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Brain Injury Research Program; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS023011] Funding Source: NIH RePORTER	Contract grant sponsor: Agency for Healthcare Research and Quality to K. K. H.; Contract grant number: K12 HS023011; Contract grant sponsor: National Institute of Neurological Disorders and Stroke intramural research program; Contract grant sponsor: Brain Injury Research Program.	Aichert DS, 2012, J CLIN EXP NEUROPSYC, V34, P1016, DOI 10.1080/13803395.2012.706261; [Anonymous], 1960, DEP DEFENSE 1293; Asahi S, 2004, EUR ARCH PSY CLIN N, V254, P245, DOI 10.1007/s00406-004-0488-z; BARRATT ES, 1987, PERS INDIV DIFFER, V8, P43, DOI 10.1016/0191-8869(87)90009-2; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Brothers L., 2002, SO NEUROSCI SER, P367; Buss A.H., 1975, TEMPERAMENT THEORY P; Caswell AJ, 2015, PERS INDIV DIFFER, V76, P68, DOI 10.1016/j.paid.2014.11.059; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Daruna J. H., 1993, IMPULSIVE CLIENT THE, P23, DOI [10.1037/10500-002, DOI 10.1037/10500-002]; Delis DC., 2001, DELIS KAPLAN EXECUTI; Depue BE, 2016, CEREB CORTEX, V26, P1634, DOI 10.1093/cercor/bhu324; DICKMAN SJ, 1990, J PERS SOC PSYCHOL, V58, P95, DOI 10.1037/0022-3514.58.1.95; Diekhof EK, 2012, BRAIN RES, V1473, P63, DOI 10.1016/j.brainres.2012.07.010; Dom G, 2006, ADDICT BEHAV, V31, P298, DOI 10.1016/j.addbeh.2005.05.009; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P613, DOI 10.1016/0191-8869(85)90011-X; EYSENCK SBG, 1977, BRIT J SOC CLIN PSYC, V16, P57, DOI 10.1111/j.2044-8260.1977.tb01003.x; Farr OM, 2012, NEUROIMAGE, V63, P1070, DOI 10.1016/j.neuroimage.2012.07.049; GERBING DW, 1987, MULTIVAR BEHAV RES, V22, P357, DOI 10.1207/s15327906mbr2203_6; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Hogeveen J, 2016, EFFECTS HIGH DEFINIT; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Le K, 2014, AM J SPEECH-LANG PAT, V23, P271, DOI 10.1044/2014_AJSLP-13-0095; Logan Gordon D., 1994, P189; Lynam D., 2007, UPPSP MULTIDIM UNPUB; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Matsuo K, 2009, HUM BRAIN MAPP, V30, P1188, DOI 10.1002/hbm.20588; McNeil M., 1994, REVISED TOKEN TEST; Moeller FG, 2001, J SUBST ABUSE TREAT, V21, P193, DOI 10.1016/S0740-5472(01)00202-1; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; PARKER JDA, 1993, PERS INDIV DIFFER, V15, P267, DOI 10.1016/0191-8869(93)90216-P; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peluso MAM, 2007, J AFFECT DISORDERS, V100, P227, DOI 10.1016/j.jad.2006.09.037; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Revelle William, 1997, EXTRAVERSION IMPULSI, V189; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Schalling D, 1985, BIOL BASES PERSONALI; Schilling C, 2012, NEUROIMAGE, V59, P824, DOI 10.1016/j.neuroimage.2011.07.058; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Snowden RJ, 2011, PSYCHIAT RES, V187, P414, DOI 10.1016/j.psychres.2011.02.003; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stahl C, 2014, J EXP PSYCHOL GEN, V143, P850, DOI 10.1037/a0033981; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Swann AC, 2008, J AFFECT DISORDERS, V106, P241, DOI 10.1016/j.jad.2007.07.011; Szczepanski SM, 2014, NEURON, V83, P1002, DOI 10.1016/j.neuron.2014.08.011; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Williams GB, 2005, NEUROIMAGE, V24, P1042, DOI 10.1016/j.neuroimage.2004.10.023; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027	53	14	14	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	FEB	2017	38	2					656	665		10.1002/hbm.23406			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EK2WC	WOS:000393786500005	27667777	Green Published, Green Accepted			2022-02-06	
J	Peterson, AR; Kruse, AJ; Meester, SM; Olson, TS; Riedle, BN; Slayman, TG; Domeyer, TJ; Cavanaugh, JE; Smoot, MK				Peterson, Andrew R.; Kruse, Adam J.; Meester, Scott M.; Olson, Tyler S.; Riedle, Benjamin N.; Slayman, Tyler G.; Domeyer, Todd J.; Cavanaugh, Joseph E.; Smoot, M. Kyle			Youth Football Injuries A Prospective Cohort	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						youth football; flag football; concussion; youth sports	SCHOOL FOOTBALL; RISK-FACTORS; SPORTS; CONCUSSION; YOUNG; AGE	Background: There are approximately 2.8 million youth football players between the ages of 7 and 14 years in the United States. Rates of injury in this population are poorly described. Recent studies have reported injury rates between 2.3% and 30.4% per season and between 8.5 and 43 per 1000 exposures. Hypothesis: Youth flag football has a lower injury rate than youth tackle football. The concussion rates in flag football are lower than in tackle football. Study Design: Cohort study; Level of evidence, 3. Methods: Three large youth (grades 2-7) football leagues with a total of 3794 players were enrolled. Research personnel partnered with the leagues to provide electronic attendance and injury reporting systems. Researchers had access to deidentified player data and injury information. Injury rates for both the tackle and flag leagues were calculated and compared using Poisson regression with a log link. The probability an injury was severe and an injury resulted in a concussion were modeled using logistic regression. For these 2 responses, best subset model selection was performed, and the model with the minimum Akaike information criterion value was chosen as best. Kaplan-Meier curves were examined to compare time loss due to injury for various subgroups of the population. Finally, time loss was modeled using Cox proportional hazards regression models. Results: A total of 46,416 exposures and 128 injuries were reported. The mean age at injury was 10.64 years. The hazard ratio for tackle football (compared with flag football) was 0.45 (95% CI, 0.25-0.80; P = 0065). The rate of severe injuries per exposure for tackle football was 1.1 (95% CI, 0.33-3.4; P = 93) times that of the flag league. The rate for concussions in tackle football per exposure was 0.51 (95% CI, 0.16-1.7; P = 27) times that of the flag league. Conclusion: Injury is more likely to occur in youth flag football than in youth tackle football. Severe injuries and concussions were not significantly different between leagues. Concussion was more likely to occur during games than during practice. Players in the sixth or seventh grade were more likely to suffer a concussion than were younger players.	[Peterson, Andrew R.; Kruse, Adam J.; Meester, Scott M.; Olson, Tyler S.; Riedle, Benjamin N.; Slayman, Tyler G.; Domeyer, Todd J.; Cavanaugh, Joseph E.; Smoot, M. Kyle] Univ Iowa, 200 Hawkins Dr, Iowa City, IA 52246 USA		Peterson, AR (corresponding author), Univ Iowa, 200 Hawkins Dr, Iowa City, IA 52246 USA.	andrew-r-peterson@uiowa.edu		Peterson, Andrew/0000-0003-4555-7366; Kruse, Adam/0000-0002-8287-4048	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T35 HL007485] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T35HL007485] Funding Source: NIH RePORTER		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alic S., 2013, US FOOTBALL RELEASES; BIJUR PE, 1995, ARCH PEDIAT ADOL MED, V149, P1009, DOI 10.1001/archpedi.1995.02170220075010; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Dompier TP, 2007, J ATHL TRAINING, V42, P395; ELLISON LF, 1993, CHRONIC DIS CANADA, V14, P96; GOLDBERG B, 1988, PEDIATRICS, V81, P255; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; LINDER MM, 1995, CLIN J SPORT MED, V5, P167, DOI 10.1097/00042752-199507000-00006; Malina RM, 2007, CLIN J SPORT MED, V17, P362, DOI 10.1097/JSM.0b013e31815400f4; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; ROCHELLE RH, 1961, RES QUART, V32, P78, DOI 10.1080/10671188.1961.10762074; ROSER LA, 1970, CLIN ORTHOP RELAT R, P219; Silverstein Barry M, 1979, Phys Sportsmed, V7, P105, DOI 10.1080/00913847.1979.11948488; Stuart MJ, 2002, MAYO CLIN PROC, V77, P317, DOI 10.4065/77.4.317; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; ZARICZNYJ B, 1980, AM J SPORT MED, V8, P318, DOI 10.1177/036354658000800504	22	14	13	6	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	FEB	2017	5	2							2325967116686784	10.1177/2325967116686784			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	EL5QY	WOS:000394677100011	28255566	Green Published, gold			2022-02-06	
J	Dang, H; Stayman, JW; Sisniega, A; Zbijewski, W; Xu, J; Wang, XH; Foos, DH; Aygun, N; Koliatsos, VE; Siewerdsen, JH				Dang, Hao; Stayman, J. Webster; Sisniega, Alejandro; Zbijewski, Wojciech; Xu, Jennifer; Wang, Xiaohui; Foos, David H.; Aygun, Nafi; Koliatsos, Vassilis E.; Siewerdsen, Jeffrey H.			Multi-resolution statistical image reconstruction for mitigation of truncation effects: application to cone-beam CT of the head	PHYSICS IN MEDICINE AND BIOLOGY			English	Article						intracranial hemorrhage; cone-beam computed tomography; iterative reconstruction; projection truncation; truncation correction; scatter correction	TOMOGRAPHIC RECONSTRUCTION; TECHNICAL ASSESSMENT; COMPUTED-TOMOGRAPHY; ARTIFACT-CORRECTION; HILBERT TRANSFORM; OF-INTEREST; BREAST CT; QUALITY; MOBILE; SCANNER	A prototype cone-beam CT (CBCT) head scanner featuring model-based iterative reconstruction (MBIR) has been recently developed and demonstrated the potential for reliable detection of acute intracranial hemorrhage (ICH), which is vital to diagnosis of traumatic brain injury and hemorrhagic stroke. However, data truncation (e.g. due to the head holder) can result in artifacts that reduce image uniformity and challenge ICH detection. We propose a multi-resolution MBIR method with an extended reconstruction field of view (RFOV) to mitigate truncation effects in CBCT of the head. The image volume includes a fine voxel size in the (inner) nontruncated region and a coarse voxel size in the (outer) truncated region. This multi-resolution scheme allows extension of the RFOV to mitigate truncation effects while introducing minimal increase in computational complexity. The multi-resolution method was incorporated in a penalized weighted least-squares (PWLS) reconstruction framework previously developed for CBCT of the head. Experiments involving an anthropomorphic head phantom with truncation due to a carbonfiber holder were shown to result in severe artifacts in conventional single-resolution PWLS, whereas extending the RFOV within the multi-resolution framework strongly reduced truncation artifacts. For the same extended RFOV, the multi-resolution approach reduced computation time compared to the single-resolution approach (viz. time reduced by 40.7%, 83.0%, and over 95% for an image volume of 600(3), 800(3), 1000(3) voxels). Algorithm parameters (e.g. regularization strength, the ratio of the fine and coarse voxel size, and RFOV size) were investigated to guide reliable parameter selection. The findings provide a promising method for truncation artifact reduction in CBCT and may be useful for other MBIR methods and applications for which truncation is a challenge.	[Dang, Hao; Stayman, J. Webster; Sisniega, Alejandro; Zbijewski, Wojciech; Xu, Jennifer; Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Wang, Xiaohui; Foos, David H.] Carestream Hlth, Rochester, NY 14608 USA; [Aygun, Nafi; Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA		Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA.	jeff.siewerdsen@jhu.edu	Dang, Hao/U-4865-2018	Dang, Hao/0000-0001-5861-6535; Stayman, Joseph/0000-0003-4358-378X; Sisniega, Alejandro/0000-0003-2030-2711	Carestream Health (Rochester, NY); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-EB-018896]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB018896] Funding Source: NIH RePORTER	This work was supported by academic-industry partnership with Carestream Health (Rochester, NY) and by the National Institutes of Health Grant R01-EB-018896. The authors thank Mr Qian Cao for useful discussion of multi-resolution image reconstruction.	Boone JM, 2001, RADIOLOGY, V221, P657, DOI 10.1148/radiol.2213010334; Cao Q, 2015, INT M FULL 3 DIM IM, P452; Cao Q, 2016, PHYS MED BIOL, V61, DOI 10.1088/0031-9155/61/20/7263; Carrino JA, 2014, RADIOLOGY, V270, P816, DOI 10.1148/radiol.13130225; Dang H, 2016, Conf Proc Int Conf Image Form Xray Comput Tomogr, V2016, P557; Dang H, 2015, PHYS MED BIOL, V60, P6153, DOI 10.1088/0031-9155/60/16/6153; Dang H, 2012, MED PHYS, V39, P6484, DOI 10.1118/1.4754589; Defrise M, 2006, INVERSE PROBL, V22, P1037, DOI 10.1088/0266-5611/22/3/019; DELANEY AH, 1995, IEEE T IMAGE PROCESS, V4, P799, DOI 10.1109/83.388081; DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; Hamelin B, 2007, P ANN INT IEEE EMBS, P739, DOI 10.1109/IEMBS.2007.4352396; Hsieh J, 2004, MED PHYS, V31, P2385, DOI 10.1118/1.1776673; Huber P.J., 1981, ROBUST STAT; INDECK M, 1988, J TRAUMA, V28, P1020, DOI 10.1097/00005373-198807000-00018; JOSEPH PM, 1978, J COMPUT ASSIST TOMO, V2, P100, DOI 10.1097/00004728-197801000-00017; Kidwell CS, 2008, LANCET NEUROL, V7, P256, DOI 10.1016/S1474-4422(08)70041-3; Kolditz D, 2011, PHYS MED BIOL, V56, P39, DOI 10.1088/0031-9155/56/1/003; Koskinen SK, 2013, SKELETAL RADIOL, V42, P649, DOI 10.1007/s00256-012-1516-0; Kudo H, 2008, PHYS MED BIOL, V53, P2207, DOI 10.1088/0031-9155/53/9/001; Li TF, 2004, IEEE T NUCL SCI, V51, P2505, DOI 10.1109/TNS.2004.834824; Long Y, 2010, IEEE T MED IMAGING, V29, P1839, DOI 10.1109/TMI.2010.2050898; Masaryk Thomas, 2008, Radiol Manage, V30, P50; Navab N, 2010, IEEE T MED IMAGING, V29, P1412, DOI 10.1109/TMI.2009.2021947; Noo F, 2004, PHYS MED BIOL, V49, P3903, DOI 10.1088/0031-9155/49/17/006; Ohnesorge B, 2000, MED PHYS, V27, P39, DOI 10.1118/1.598855; Pan XC, 2005, MED PHYS, V32, P673, DOI 10.1118/1.1844171; Parizel PM, 2001, EUR RADIOL, V11, P1770, DOI 10.1007/s003300000800; Penninger RT, 2011, OTOL NEUROTOL, V32, P453, DOI 10.1097/MAO.0b013e31820d962c; SAUER K, 1993, IEEE T SIGNAL PROCES, V41, P534, DOI 10.1109/78.193196; Schafer S, 2011, MED PHYS, V38, P4563, DOI 10.1118/1.3597566; Siewerdsen J. H., 2009, SPIE MED IMAGING, V7261; Sisniega A, 2015, PHYS MED BIOL, V60, P1415, DOI 10.1088/0031-9155/60/4/1415; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Stayman JW, 2012, IEEE T MED IMAGING, V31, P1837, DOI 10.1109/TMI.2012.2199763; Wang AS, 2014, PHYS MED BIOL, V59, P1005, DOI 10.1088/0031-9155/59/4/1005; Xu J, 2016, PHYS MED BIOL, V61, P3180, DOI 10.1088/0031-9155/61/8/3180; Xu J, 2012, MED PHYS, V39, P4932, DOI 10.1118/1.4736805; Xu J, 2016, MED PHYS, V43, P5745, DOI 10.1118/1.4963220; Xu J, 2016, PHYS MED BIOL, V61, P5973, DOI 10.1088/0031-9155/61/16/5973; Yang WT, 2007, AM J ROENTGENOL, V189, P1312, DOI 10.2214/AJR.07.2403; Yu HY, 2006, MED PHYS, V33, P3640, DOI 10.1118/1.2348767; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; Zou Y, 2004, PHYS MED BIOL, V49, P941, DOI 10.1088/0031-9155/49/6/006	43	14	14	0	8	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-9155	1361-6560		PHYS MED BIOL	Phys. Med. Biol.	JAN 21	2017	62	2					539	559		10.1088/1361-6560/aa52b8			21	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging	EH4NV	WOS:000391748800001	28033118	Green Accepted			2022-02-06	
J	de Souza, JS; Carromeu, C; Torres, LB; Araujo, BHS; Cugola, FR; Maciel, RMB; Muotri, AR; Giannocco, G				de Souza, Janaina S.; Carromeu, Cassiano; Torres, Laila B.; Araujo, Bruno H. S.; Cugola, Fernanda R.; Maciel, Rui M. B.; Muotri, Alysson R.; Giannocco, Gisele			IGF1 neuronal response in the absence of MECP2 is dependent on TRalpha 3	HUMAN MOLECULAR GENETICS			English	Article							THYROID-HORMONE RECEPTOR; GROWTH-FACTOR-I; PLURIPOTENT STEM-CELLS; TRAUMATIC BRAIN-INJURY; RETT-SYNDROME; GENE-EXPRESSION; BINDING; PROLIFERATION; HIPPOCAMPUS; ASTROCYTES	Rett syndrome (RTT) is an X-linked neurodevelopmental disorder in which the MECP2 (methyl CpG-binding protein 2) gene is mutated. Recent studies showed that RTT-derived neurons have many cellular deficits when compared to control, such as: less synapses, lower dendritic arborization and reduced spine density. Interestingly, treatment of RTT-derived neurons with Insulin-like Growth Factor 1 (IGF1) could rescue some of these cellular phenotypes. Given the critical role of IGF1 during neurodevelopment, the present study used human induced pluripotent stem cells (iPSCs) from RTT and control individuals to investigate the gene expression profile of IGF1 and IGF1R on different developmental stages of differentiation. We found that the thyroid hormone receptor (TRalpha 3) has a differential expression profile. Thyroid hormone is critical for normal brain development. Our results showed that there is a possible link between IGF1/IGF1R and the TRalpha 3 and that over expression of IGF1R in RTT cells may be the cause of neurites improvement in neural RTT-derived neurons.	[de Souza, Janaina S.; Maciel, Rui M. B.; Giannocco, Gisele] Univ Fed Sao Paulo, UNIFESP EPM, Dept Med, Lab Endocrinol & Translat Med, Sao Paulo, SP, Brazil; [de Souza, Janaina S.; Carromeu, Cassiano; Torres, Laila B.; Cugola, Fernanda R.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Rady Childrens Hosp San Diego,Dept Pediat,Stem Ce, La Jolla, CA 92093 USA; [Araujo, Bruno H. S.] Univ Fed Sao Paulo, UNIFESP EPM, Neurosci Lab, Dept Neurol & Neurosurg, Sao Paulo, SP, Brazil; [Giannocco, Gisele] Univ Fed Sao Paulo, Dept Biol Sci, Diadema, SP, Brazil		Giannocco, G (corresponding author), Rua Pedro de Toledo 669,11 Andar, BR-04039032 Sao Paulo, SP, Brazil.	ggiannocco@unifesp.br	Giannocco, Gisele/I-2197-2015; Maciel, Rui M. B./A-9826-2013; Torres, Bruno/P-9975-2019; Cugola, Fernanda/I-9556-2016; Torres, Laila Brito/O-2599-2013; Sena de Souza, Janaina/H-1906-2016	Giannocco, Gisele/0000-0002-0126-7677; Maciel, Rui M. B./0000-0002-6123-6098; Torres, Bruno/0000-0003-0012-4217; Cugola, Fernanda/0000-0002-6677-2404; Sena de Souza, Janaina/0000-0003-3904-7458; Carromeu, Cassiano/0000-0002-7570-2213	California Institute for Regenerative Medicine (CIRM)California Institute for Regenerative Medicine [TR2-01814, TR4-06747]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH094753, R01MH103134, U19MH107367]; NARSAD Independent Investigator GrantNARSAD; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brasilia, Brazil)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [18952-12-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo, Brazil)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/08049-1]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH094753, U19MH107367, R01MH103134] Funding Source: NIH RePORTER	This work was supported by a grant from the California Institute for Regenerative Medicine (CIRM) TR2-01814, TR4-06747, the National Institutes of Health (NIH) R01MH094753, R01MH103134, U19MH107367, a NARSAD Independent Investigator Grant to A.R.M., and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brasilia, Brazil) 18952-12-7 to J.S.S., and from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo, Brazil) 2014/08049-1 to B.H.S.A.	Ahmed OM, 2008, INT J DEV NEUROSCI, V26, P147, DOI 10.1016/j.ijdevneu.2007.09.011; Ahmed RG, 2016, TOXICOL LETT, V258, P46, DOI 10.1016/j.toxlet.2016.05.020; Ahmed RG, 2016, FOOD CHEM TOXICOL, V95, P168, DOI 10.1016/j.fct.2016.06.017; Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Bauer M, 2008, J NEUROENDOCRINOL, V20, P1101, DOI 10.1111/j.1365-2826.2008.01774.x; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Bernal J, 2013, BBA-GEN SUBJECTS, V1830, P3893, DOI 10.1016/j.bbagen.2012.04.014; BINOUX M, 1991, ADV EXP MED BIOL, V293, P161; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; BRENT GA, 1991, ANNU REV PHYSIOL, V53, P17, DOI 10.1146/annurev.ph.53.030191.000313; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; Chatonnet F., 2013, PNAS, V110, P766; Desouza LA, 2005, MOL CELL NEUROSCI, V29, P414, DOI 10.1016/j.mcn.2005.03.010; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; Gilbert ME, 2016, ENDOCRINOLOGY, V157, P774, DOI 10.1210/en.2015-1643; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Harvey CB, 2002, THYROID, V12, P441, DOI 10.1089/105072502760143791; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; Holzenberger M, 2011, NESTLE NUTR WORKS SE, V68, P237, DOI 10.1159/000325914; Incerpi S, 2014, AM J PHYSIOL-CELL PH, V307, pC150, DOI 10.1152/ajpcell.00308.2013; Iskaros J, 2000, J CLIN ENDOCR METAB, V85, P2620, DOI 10.1210/jc.85.7.2620; Jimenez-Cervantes C, 1998, BBA-MOL CELL RES, V1403, P232, DOI 10.1016/S0167-4889(98)00063-9; Johnston M., 2015, F1000RES; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Manzano J, 2007, INT J DEV NEUROSCI, V25, P171, DOI 10.1016/j.ijdevneu.2007.01.003; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Martin S, 2015, HORM-INT J ENDOCRINO, V14, P651, DOI 10.14310/horm.2002.1577; Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128; Mendes-de-Aguiar CBN, 2008, J NEUROSCI RES, V86, P3117, DOI 10.1002/jnr.21755; Netchine I, 2009, J CLIN ENDOCR METAB, V94, P3913, DOI 10.1210/jc.2009-0452; Niblock MM, 2000, J NEUROSCI, V20, P4165; OCRANT I, 1990, ENDOCRINOLOGY, V127, P1260, DOI 10.1210/endo-127-3-1260; Pini G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00052; Pini Giorgio, 2012, Autism Res Treat, V2012, P679801, DOI 10.1155/2012/679801; Ribeiro RCJ, 1998, RECENT PROG HORM RES, V53, P351; Roskoden T, 1999, EXP BRAIN RES, V127, P307, DOI 10.1007/s002210050800; Ross P. D., 2016, HUM MOL GENET; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Rozario KS, 2000, ENDOTEXT; Sabatino L, 2007, BIOMED PHARMACOTHER, V61, P457, DOI 10.1016/j.biopha.2007.04.002; Schroeder AC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00040; SCHWARTZ HL, 1994, J BIOL CHEM, V269, P24777; Shigyo M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12055; Sinha RA, 2009, MOL CELL NEUROSCI, V40, P354, DOI 10.1016/j.mcn.2008.12.001; Stagi S, 2015, HORM RES PAEDIAT, V83, P118, DOI 10.1159/000370066; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Veeragavan S., 2016, HUM MOL GENT; Wang YF, 2011, COMP BIOCHEM PHYS A, V160, P474, DOI [10.1016/j.cbpa.2011.08.005, 10.1016/j.cbpa.2011.08.002]; White MF, 2014, DIABETES OBES METAB, V16, P4, DOI 10.1111/dom.12347; Yan H, 2011, J ENDOCRINOL, V211, P27, DOI 10.1530/JOE-11-0200; Zhang QP, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0264-0	60	14	14	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	JAN 15	2017	26	2					270	281		10.1093/hmg/ddw384			12	Biochemistry & Molecular Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Genetics & Heredity	EP0GX	WOS:000397066400003	28007906	Green Published, Bronze			2022-02-06	
J	Luo, H; Pace, E; Zhang, JS				Luo, Hao; Pace, Edward; Zhang, Jinsheng			BLAST-INDUCED TINNITUS AND HYPERACTIVITY IN THE AUDITORY CORTEX OF RATS	NEUROSCIENCE			English	Article						blast; tinnitus; traumatic brain injury (TBI); auditory cortex; spontaneous activity; bursting; rat	DORSAL COCHLEAR NUCLEUS; ENRICHED ACOUSTIC ENVIRONMENT; INDUCED HEARING-LOSS; INFERIOR COLLICULUS; NEURAL ACTIVITY; TRAUMA; MECHANISMS; SYNCHRONY; SOUND; CAT	Blast exposure can cause tinnitus and hearing impairment by damaging the auditory periphery and direct impact to the brain, which trigger neural plasticity in both auditory and non-auditory centers. However, the underlying neurophysiological mechanisms of blast-induced tinnitus are still unknown. In this study, we induced tinnitus in rats using blast exposure and investigated changes in spontaneous firing and bursting activity in the auditory cortex (AC) at one day, one month, and three months after blast exposure. Our results showed that spontaneous activity in the tinnitus-positive group began changing at one month after blast exposure, and manifested as robust hyperactivity at all frequency regions at three months after exposure. We also observed an increased bursting rate in the low frequency region at one month after blast exposure and in all frequency regions at three months after exposure. Taken together, spontaneous firing and bursting activity in the AC played an important role in blast-induced chronic tinnitus as opposed to acute tinnitus, thus favoring a bottom-up mechanism. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Luo, Hao; Pace, Edward; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI USA; [Zhang, Jinsheng] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI USA		Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Otolaryngol Head & Neck Surg, 5E-UHC,4201 St Antoine, Detroit, MI 48201 USA.	jinzhang@med.wayne.edu			Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]	This work was supported by the Department of Defense (grant award #W81XWH-11-2-0031). The authors thank Drs. Pamela VandeVord and Srini Kallakuri for their assistance during blast exposure using a shock tube in the Department of Biomedical Engineering, Wayne State University.	Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Bauer Carol A, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P413, DOI 10.1097/01.moo.0000134443.29853.09; Bilak M, 1997, EXP NEUROL, V147, P256, DOI 10.1006/exnr.1997.6636; Browne CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033272; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Chambers AR, 2016, NEURON, V89, P867, DOI 10.1016/j.neuron.2015.12.041; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, J NEUROPHYSIOL, V83, P2708, DOI 10.1152/jn.2000.83.5.2708; Eggermont JJ, 2007, HEARING RES, V229, P69, DOI 10.1016/j.heares.2007.01.008; Eggermont JJ, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00029; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Geckle L., 2004, FORC HLTH PROT C ALB; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Hughes LF, 2010, HEARING RES, V264, P79, DOI 10.1016/j.heares.2009.09.005; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kimura M, 1999, HEARING RES, V135, P146, DOI 10.1016/S0378-5955(99)00104-5; Krishnan A, 2009, AUDIOL NEURO-OTOL, V14, P88, DOI 10.1159/000158537; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Llano DA, 2012, J NEUROSCI, V32, P16141, DOI 10.1523/JNEUROSCI.2499-12.2012; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Mulders WHAM, 2013, HEARING RES, V298, P104, DOI 10.1016/j.heares.2012.12.008; Mulders WHAM, 2011, J COMP NEUROL, V519, P2637, DOI 10.1002/cne.22644; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Norena AJ, 2006, NEUROREPORT, V17, P559, DOI 10.1097/00001756-200604240-00001; Richardson BD, 2012, BRAIN RES; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Schaette R, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00034; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Shore SE, 2016, NAT REV NEUROL, V12, P150, DOI 10.1038/nrneurol.2016.12; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Wu C, 2016, J NEUROSCI, V36, P2068, DOI 10.1523/JNEUROSCI.3960-15.2016; Zhang J, 2015, HEAR RES; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0	40	14	14	1	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JAN 6	2017	340						515	520		10.1016/j.neuroscience.2016.11.014			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EH8RK	WOS:000392039800043	27865868	Bronze			2022-02-06	
J	Bailly, N; Afquir, S; Laporte, JD; Melot, A; Savary, D; Seigneuret, E; Delay, JB; Donnadieu, T; Masson, C; Arnoux, PJ				Bailly, Nicolas; Afquir, Sanae; Laporte, Jean-Dominique; Melot, Anthony; Savary, Dominique; Seigneuret, Eric; Delay, Jean-Baptiste; Donnadieu, Thierry; Masson, Catherine; Arnoux, Pierre-Jean			Analysis of Injury Mechanisms in Head Injuries in Skiers and Snowboarders	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						SKI; SNOWBOARD; HEAD INJURY; CONCUSSION; HELMET	ALPINE SKIERS; HELMET WEAR; SNOW-PARKS; RISK; SEVERITY; SEASONS; SLOPES; SCALE; AREAS	Purpose: Mechanisms of injury and description of head impacts leading to traumatic brain injury (TBI) in skiers and snowboarders have not been extensively documented. We investigate snow sport crashes leading to TBI 1) to identify typical mechanisms leading to TBI to better target prevention measures and 2) to identify the injury mechanisms and the head impact conditions. Methods: The subjects were skiers and snowboarders diagnosed of TBI and admitted between 2013 and 2015 to one of the 15 medical offices and three hospital centers involved in the study. The survey includes the description of the patients (age, sex, practice, skill level, and helmet use), the crash (type, location, estimated speed, causes, and fall description), and the injuries sustained (symptoms, head trauma scores, and other injuries). Sketches were used to describe the crash and impact locations. Clustering methods were used to distinguish profiles of injured participants. Results: A total of 295 skiers and 71 snowboarders were interviewed. The most frequent type of mechanism was falls (54%), followed by collision between users (18%) and jumps (15%). Collision with obstacle (13%) caused the most serious TBI. Three categories of patients were identified. First, men age 16-25 yr are more involved in crash at high speed or in connection with a jump. Second, women, children (G16 yr), and beginners are particularly injured in collisions between users. Third, those older than 50 yr, usually nonhelmeted, are frequently involved in falls. Ten crash scenarios were identified. Falling head first is the most frequent of skiers' falls (28%). Conclusion: Crash scenarios leading to TBI were identified and associated with profiles of injured participants. Those results should help to better target TBI prevention and protection campaigns.	[Bailly, Nicolas; Afquir, Sanae; Masson, Catherine; Arnoux, Pierre-Jean] Aix Marseille Univ, IFSTTAR, LBA UMR T24, F-13016 Marseille, France; [Bailly, Nicolas] Salomon SAS, Annecy, France; [Laporte, Jean-Dominique; Delay, Jean-Baptiste; Donnadieu, Thierry] Med Montagne Assoc, Chambery, France; [Melot, Anthony] Hop Nord Marseille, Dept Neurosurg, Marseille, France; [Savary, Dominique] Annecy Hosp, Dept Mobile Emergency, Annecy, France; [Savary, Dominique] Annecy Hosp, Intens Care Units, Annecy, France; [Seigneuret, Eric] Univ Hosp Grenoble, Dept Neurosurg, Grenoble, France		Bailly, N (corresponding author), Univ Mediterranee Bd P Dramard, Lab Biomecan Appl, IFSTTAR UMRT24, Fac Med Sect, F-13916 Marseille 20, France.	nicolas.bailly@ifsttar.fr	ARNOUX, Pierre Jean/AAK-6652-2021	ARNOUX, Pierre Jean/0000-0002-0311-560X			Association des Medecin de Montagne, 2013, REP EP SNOW SPORT FR; Bailly N, 2016, SCAND J MED SCI SPOR; Bergstrom KA, 2004, BRIT J SPORT MED, V38, P264, DOI 10.1136/bjsm.2002.000270; Brunner F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132002; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Goulet C, 2007, CAN J PUBLIC HEALTH, V98, P402, DOI 10.1007/BF03405428; Goulet C, 2010, J SCI MED SPORT, V13, P39, DOI 10.1016/j.jsams.2008.10.002; Greve MW, 2009, WILD ENVIRON MED, V20, P234, DOI 10.1580/08-WEME-OR-244R1.1; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; Hentschel S, 2001, CAN J NEUROL SCI, V28, P42; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; Kammerlander C, 2012, AGING CLIN EXP RES, V24, P448, DOI 10.3275/8273; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Koyama S, 2011, AM J SPORT MED, V39, P2656, DOI 10.1177/0363546511422331; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Levy AS, 2000, SEMIN NEUROL, V20, P233, DOI 10.1055/s-2000-9833; Lystad H, 1989, COLLISION INJURIES A; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; Nakaguchi H, 2002, J NEUROSURG, V97, P542, DOI 10.3171/jns.2002.97.3.0542; Richards Darrin, 2008, Journal of ASTM International, V5, DOI 10.1520/JAI101406; Ruedl G, 2010, BRIT J SPORT MED, V44, P204, DOI 10.1136/bjsm.2009.066779; Ruedl G, 2013, WILD ENVIRON MED, V24, P118, DOI 10.1016/j.wem.2012.11.021; Ruedl G, 2013, ACCIDENT ANAL PREV, V50, P1221, DOI 10.1016/j.aap.2012.09.019; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Scher I., 2006, Journal of ASTM International (JAI), V3, pJAI14203, DOI 10.1520/JAI14203; SHEALY JE, 2005, J ASTM INT, V2, P12092; Siu TLT, 2004, J CLIN NEUROSCI, V11, P236, DOI 10.1016/j.jocn.2003.08.003; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Xiang HY, 2003, INJURY, V34, P892, DOI 10.1016/S0020-1383(03)00055-X	36	14	14	2	99	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JAN	2017	49	1					1	10		10.1249/MSS.0000000000001078			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EF0PH	WOS:000390027700001	27580147				2022-02-06	
J	Clacy, A; Goode, N; Sharman, R; Lovell, GP; Salmon, PM				Clacy, Amanda; Goode, Natassia; Sharman, Rachael; Lovell, Geoff P.; Salmon, Paul M.			A knock to the system: A new sociotechnical systems approach to sport-related concussion	JOURNAL OF SPORTS SCIENCES			English	Article						Injury & prevention; decision making; dynamic systems; qualitative analysis; team sports	MANAGEMENT; PREVENTION; STRATEGIES; CAUSATION; INJURIES; MODELS	Broader contextual factors that influence concussion management have tended to be overlooked. To address this, the present study used a sociotechnical systems approach to identify perceived responsibilities and applied strategies for three domains of concussion management (i.e., prevention, identification and treatment). Participants were 118 members of the community rugby union system in Australia (69.2% male). Participants from throughout the rugby system (e.g., players, parents, coaches, club management) were asked open-ended questions about their perceived responsibilities and the strategies they use for concussion management. It was found that (a) proper training, technique correction and education were recurrent prevention themes; (b) the majority of key stakeholders felt that they could consistently identify concussion; however, medical aids (medics) were the only system actors who stated a responsibility to use standardised concussion assessment measures and (c) less than one third of the respondents indicated their involvement in treating concussion. This study identifies specific junctures in the system that prevents effective concussion management strategies. A sociotechnical systems approach improves the understanding of concussion prevention, and management beliefs and behaviours.	[Clacy, Amanda; Goode, Natassia; Salmon, Paul M.] Univ Sunshine Coast, Fac Arts Business & Law, Ctr Human Factors & Sociotech Syst, Maroochydore, Qld, Australia; [Sharman, Rachael; Lovell, Geoff P.] Univ Sunshine Coast, Fac Arts Business & Law, Sch Social Sci Fac, Maroochydore, Qld, Australia		Clacy, A (corresponding author), Univ Sunshine Coast, Fac Arts Business & Law, Ctr Human Factors & Sociotech Syst, Maroochydore, Qld, Australia.	aclacy@usc.edu.au		Salmon, Paul/0000-0001-7403-0286; Goode, Natassia/0000-0003-0736-7043			Ajzen I., 1985, INTENTIONS ACTIONS T; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Clacy A, 2015, PROCEDIA MANUF, V3, P1173, DOI 10.1016/j.promfg.2015.07.195; Clacy A, 2013, J BIOETHIC INQ, V10, P127, DOI 10.1007/s11673-012-9421-8; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Dallat C, 2015, PROCEDIA MANUF, V3, P1157, DOI 10.1016/j.promfg.2015.07.193; Dekker S, 2011, DRIFT INTO FAILURE: FROM HUNTING BROKEN COMPONENTS TO UNDERSTANDING COMPLEX SYSTEMS, P1; Donaldson A, 2016, AM J LIFESTYLE MED, V10, P120, DOI 10.1177/1559827614538751; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Goode N, 2015, PROCEDIA MANUF, V3, P1125, DOI 10.1016/j.promfg.2015.07.188; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Kerr HA, 2014, PEDIATR ANN, V43, pE309, DOI 10.3928/00904481-20141124-10; King D, 2014, J SCI MED SPORT, V17, P250, DOI 10.1016/j.jsams.2013.05.007; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McAllister-Deitrick J, 2014, ATHL TRAIN SPORTS HL, V6, P280, DOI DOI 10.3928/01484834-20141112-03; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Rasmussen J, 1997, SAFETY SCI, V27, P183, DOI 10.1016/S0925-7535(97)00052-0; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Salmon PM, 2017, APPL ERGON, V59, P637, DOI 10.1016/j.apergo.2015.07.017; Salmon PM, 2014, ACCIDENT ANAL PREV, V63, P111, DOI 10.1016/j.aap.2013.10.019	25	14	14	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2017	35	22					2232	2239		10.1080/02640414.2016.1265140			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FF1NY	WOS:000408667400011	27935422				2022-02-06	
J	Coats, B; Binenbaum, G; Smith, C; Peiffer, RL; Christian, CW; Duhaime, AC; Margulies, SS				Coats, Brittany; Binenbaum, Gil; Smith, Colin; Peiffer, Robert L.; Christian, Cindy W.; Duhaime, Ann-Christine; Margulies, Susan S.			Cyclic Head Rotations Produce Modest Brain Injury in Infant Piglets	JOURNAL OF NEUROTRAUMA			English	Article						abusive head trauma; biomechanics; pediatric traumatic brain injury; shaken baby syndrome	SHAKEN BABY SYNDROME; TRAUMATIC AXONAL INJURY; YOUNG-CHILDREN; NEONATAL PIG; RETINAL HEMORRHAGES; OVINE MODEL; AGE; FALLS; DIRECTION; RESPONSES	Repetitive back-and-forth head rotation from vigorous shaking is purported to be a central mechanism responsible for diffuse white matter injury, subdural hemorrhage, and retinal hemorrhage in some cases of abusive head trauma (AHT) in young children. Although animal studies have identified mechanisms of traumatic brain injury (TBI) associated with single rapid head acceleration-decelerations at levels experienced in a motor vehicle crash, few experimental studies have investigated TBI from repetitive head rotations. The objective of this study was to systematically investigate the post-injury pathological time-course after cyclic, low-velocity head rotations in the piglet and compare them with single head rotations. Injury metrics were the occurrence and extent of axonal injury (AI), extra-axial hemorrhage (EAH), red cell neuronal/axonal change (RCNAC), and ocular injury (OI). Hyperflexion/extension of the neck were purposefully avoided in the study, resulting in unscaled angular accelerations at the lower end of reported infant surrogate shaking kinematics. All findings were at the mild end of the injury spectrum, with no significant findings at 6 h post-injury. Cyclic head rotations, however, produced modest AI that significantly increased with time post-injury (p < 0.035) and had significantly greater amounts of RCNAC and EAH than noncyclic head rotations after 24 h post-injury (p < 0.05). No OI was observed. Future studies should investigate the contributions of additional physiological and mechanical features associated with AHT (e.g., hyperflexion/extension, increased intracranial pressure from crying or thoracic compression, and more than two cyclic episodes) to enhance our understanding of the causality between proposed mechanistic factors and AHT in infants.	[Coats, Brittany] Univ Utah, Dept Mech Engn, 1495 E 100 St,2157 MEK, Salt Lake City, UT 84112 USA; [Binenbaum, Gil] Childrens Hosp Philadelphia, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Binenbaum, Gil; Peiffer, Robert L.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Smith, Colin] Univ Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland; [Christian, Cindy W.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Duhaime, Ann-Christine] Harvard Univ, Boston, MA 02115 USA; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Coats, B (corresponding author), Univ Utah, Dept Mech Engn, 1495 E 100 St,2157 MEK, Salt Lake City, UT 84112 USA.	brittany.coats@utah.edu	Coats, Brittany/A-4523-2009	Smith, Colin/0000-0002-4507-5132	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS043126, K12 EY015398, R01 NS39679]; ARRA administrative supplemental award; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K12EY015398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545, T32NS043126] Funding Source: NIH RePORTER	Research funding was provided by NIH NINDS T32 NS043126, K12 EY015398, R01 NS39679 and its associated ARRA administrative supplemental award. The authors are grateful to Jill Ralston for assistance with animal handling, tissue processing, and scoring of axonal injury and red cell neuronal/axonal change; Sarah Sullivan for assistance with extra-axial hemorrhage scoring and statistical analysis; Justin Jones for assistance with data analysis; and Dr. Andrew Merryweather for using data motion capture to evaluate head motion during surrogate shaking.	Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Anderson RWG, 2014, J BIOMECH, V47, P2578, DOI 10.1016/j.jbiomech.2014.06.002; [Anonymous], 1956, NEWSWEEK, P90; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Bell E, 2011, CHILD ABUSE NEGLECT, V35, P74, DOI 10.1016/j.chiabu.2010.11.001; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Binenbaum G, 2009, J AAPOS, V13, P268, DOI 10.1016/j.jaapos.2009.03.005; Bonnier C, 2002, BRAIN PATHOL, V12, P320; BRAZY JE, 1988, J PEDIATR-US, V112, P457, DOI 10.1016/S0022-3476(88)80336-6; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; CDC, 2015, PERC DISTR TBI REL D; Choudhary AK, 2014, PEDIATR RADIOL, V44, P1130, DOI 10.1007/s00247-014-2959-3; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Coats B, 2010, INVEST OPHTH VIS SCI, V51, P4792, DOI 10.1167/iovs.10-5211; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; Dickerson J. W. T., 1966, Proceedings of the Royal Society, V166B, P384; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Eucker S., 2009, EFFECT HEAD ROTATION; Eucker S., 2008, REGIONAL CEREBRAL BL, P854; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Eucker SA, 2010, BRAIN RES, V1326, P128, DOI 10.1016/j.brainres.2010.02.059; Finnie JW, 2012, J CLIN NEUROSCI, V19, P1159, DOI 10.1016/j.jocn.2011.12.019; Finnie JW, 2010, J CLIN NEUROSCI, V17, P237, DOI 10.1016/j.jocn.2009.07.001; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Margulies S. S., 1999, COMPARISON DIFFUSE B; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Matschke J, 2009, PEDIATRICS, V124, P1587, DOI 10.1542/peds.2008-3734; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Ohman Anna Maria, 2008, Pediatr Phys Ther, V20, P53, DOI 10.1097/PEP.0b013e31815ebb27; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; PATTERSON DS, 1971, J NEUROCHEM, V18, P2027, DOI 10.1111/j.1471-4159.1971.tb05062.x; Prange M., 2001, ASME 2001 BIOENG C S, P833; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STOW PJ, 1988, BRIT J ANAESTH, V60, P167, DOI 10.1093/bja/60.2.167; Sullivan S, 2015, ACCIDENT ANAL PREV, V82, P143, DOI 10.1016/j.aap.2015.05.020; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Sullivan S, 2013, J NEUROTRAUM, V30, P1770, DOI 10.1089/neu.2013.2913; Sullivan S, 2013, J NEUROTRAUM, V30, P538, DOI 10.1089/neu.2012.2594; Tommasi DG, 2009, SPINE, V34, P1910, DOI 10.1097/BRS.0b013e3181afe826; Trenchs V, 2008, CHILD NERV SYST, V24, P815, DOI 10.1007/s00381-008-0583-y; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Yu B, 1999, J APPL BIOMECH, V15, P318, DOI 10.1123/jab.15.3.318	66	14	14	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					235	247		10.1089/neu.2015.4352			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100025	26953505	Green Published			2022-02-06	
J	Craig, A; Elbers, NA; Jagnoor, J; Gopinath, B; Kifley, A; Dinh, M; Pozzato, I; Ivers, RQ; Nicholas, M; Cameron, ID				Craig, A.; Elbers, N. A.; Jagnoor, J.; Gopinath, B.; Kifley, A.; Dinh, M.; Pozzato, I.; Ivers, R. Q.; Nicholas, M.; Cameron, I. D.			The psychological impact of traffic injuries sustained in a road crash by bicyclists: A prospective study	TRAFFIC INJURY PREVENTION			English	Article						Cycling injuries; road crash; depression; trauma; distress; pain catastrophizing	PAIN CATASTROPHIZING SCALE; MOTOR-VEHICLE CRASH; PSYCHOMETRIC PROPERTIES; EVENT SCALE; HEALTH; DEPRESSION; VALIDITY; DASS-21; ANXIETY; SAMPLE	Objective: The objective of this study was to investigate the psychological impact of traffic injuries in bicyclists (cyclists) in comparison to car occupants who also sustained traffic injuries. Factors predictive of elevated psychological distress were also investigated. Methods: An inception cohort prospective design was used. Participants included cyclists aged >= 17 years (mean age 41.7 years) who sustained a physical injury (n = 238) assessed within 28 days of the crash, following medical examination by a registered health care practitioner. Injury included musculoskeletal and soft tissue injuries andminor/moderate traumatic brain injury (TBI), excluding severe TBI, spinal cord injury, and severe multiple fractures. Assessment also occurred 6 months postinjury. Telephone-administered interviews assessed a suite ofmeasures including sociodemographic, preinjury health and injury factors. Psychological impact wasmeasured by pain catastrophization, trauma-related distress, and general psychological distress. The psychological health of the cyclists was compared to that of the car occupants (n = 234; mean age 43.1 years). A mixed model repeated measures analysis, adjusted for confounding factors, was used to determine differences between groups and regression analyses were used to determine contributors to psychological health in the cyclists 6 months postinjury. Results: Cyclists had significantly better psychological health (e. g., lower pain catastrophizing, lower rates of probable posttraumatic stress disorder [PTSD], and lower general distress levels) compared to car occupants at baseline and 6 months postinjury. Factors predictive of cyclists' psychological distress included younger age, greater perceived danger of death, poorer preinjury health, and greater amount of time in hospital after the injury. Conclusions: These data provide insight into how cyclists perceive and adjust to their traffic injuries compared to drivers and passengers who sustain traffic injuries, as well as direction for preventing the development of severe psychological injury. Future research should examine the utility of predictors of psychological health to improve recovery.	[Craig, A.; Elbers, N. A.; Jagnoor, J.; Gopinath, B.; Kifley, A.; Pozzato, I.; Cameron, I. D.] Univ Sydney, Kolling Inst Med Res, John Walsh Ctr Rehabil Res, Sydney Med Sch Northern, Corner Reserve Rd & First Ave, St Leonards, NSW 2065, Australia; [Jagnoor, J.; Ivers, R. Q.] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW, Australia; [Dinh, M.] Royal Prince Alfred Hosp, Dept Trauma Serv, Sydney, NSW, Australia; [Nicholas, M.] Univ Sydney, Kolling Inst Med Res, Pain Management Res Inst, Sydney Med Sch Northern, St Leonards, NSW, Australia		Craig, A (corresponding author), Univ Sydney, Kolling Inst Med Res, John Walsh Ctr Rehabil Res, Sydney Med Sch Northern, Corner Reserve Rd & First Ave, St Leonards, NSW 2065, Australia.	a.craig@sydney.edu.au	Gopinath, Bamini/K-4286-2019	Gopinath, Bamini/0000-0003-3573-359X; Elbers, N.A./0000-0002-8333-4211; Dinh, Michael/0000-0002-0086-455X; Ivers, Rebecca/0000-0003-3448-662X; jagnoor, Jagnoor/0000-0002-5276-9095	State Insurance Regulatory Authority [12/327]	This research was funded by a competitive grant from the State Insurance Regulatory Authority Grant No. 12/327 (formerly theMotor Accident Authority NSW).	Amoros Emmanuelle, 2011, BMC Public Health, V11, P653, DOI 10.1186/1471-2458-11-653; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Bauman A., 2008, 31 AUSTR TRANSP RES; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chong S, 2010, ACCIDENT ANAL PREV, V42, P290, DOI 10.1016/j.aap.2009.08.006; Chossegros L, 2011, ACCIDENT ANAL PREV, V43, P471, DOI 10.1016/j.aap.2010.10.004; Craig A, 1996, PSYCHOL HEALTH, V11, P331, DOI 10.1080/08870449608400262; Craig A, 2015, ARCH PHYS MED REHAB, V96, P1426, DOI 10.1016/j.apmr.2015.02.027; Crawford J, 2011, AUST PSYCHOL, V46, P3, DOI 10.1111/j.1742-9544.2010.00003.x; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Cripton PA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006654; de Rome L, 2014, TRAFFIC INJ PREV, V15, P81, DOI 10.1080/15389588.2013.781591; Dinh MM, 2015, EMERG MED AUSTRALAS, V27, P323, DOI 10.1111/1742-6723.12407; Elbers NA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1694-5; HANCOCK K, 1993, AUST NZ J PSYCHIAT, V27, P450, DOI 10.3109/00048679309075802; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Henley G, 2009, INJURY RES STAT SERI; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Nhac-Vu HT, 2014, TRAFFIC INJ PREV, V15, P138, DOI 10.1080/15389588.2013.804180; Jagnoor J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-199; Jeavons S, 2000, BEHAV RES THER, V38, P499, DOI 10.1016/S0005-7967(99)00073-X; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; Jorm AF, 2000, PSYCHOL MED, V30, P11, DOI 10.1017/S0033291799001452; Lawrence BM, 2015, TRAFFIC INJ PREV, V16, P513, DOI 10.1080/15389588.2014.973947; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Markovic N, 2016, TRAFFIC INJ PREV, V17, P610, DOI 10.1080/15389588.2015.1132314; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; Mead GE, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004366.pub6, 10.1002/14651858.CD004366.pub4]; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Rivera FP, 2015, INJURY PREV, V21, P47, DOI DOI 10.1136/injprev-00002-0038rep; Shinar D, 2012, ACCIDENT ANAL PREV, V44, P1, DOI 10.1016/j.aap.2010.12.031; Sterling M, 2003, PAIN, V106, P481, DOI 10.1016/j.pain.2003.09.013; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Weijermars W, 2016, TRAFFIC INJ PREV, V17, P863, DOI 10.1080/15389588.2016.1157591; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399	40	14	15	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.		2017	18	3					273	280		10.1080/15389588.2016.1248760			8	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	EL6GQ	WOS:000394718800008	27764546	Green Published			2022-02-06	
J	Diez, I; Drijkoningen, D; Stramaglia, S; Bonifazi, P; Marinazzo, D; Gooijers, J; Swinnen, SP; Cortes, JM				Diez, Ibai; Drijkoningen, David; Stramaglia, Sebastiano; Bonifazi, Paolo; Marinazzo, Daniele; Gooijers, Jolien; Swinnen, Stephan P.; Cortes, Jesus M.			Enhanced prefrontal functional-structural networks to support postural control deficits after traumatic brain injury in a pediatric population	NETWORK NEUROSCIENCE			English	Article						Traumatic brain injury; Prefrontal cortex; Network reorganization; Resting state; Functional networks; Structural networks; Brain hierarchical atlas	INFORMATION-FLOW; CEREBRAL-CORTEX; WHITE-MATTER; CONNECTIVITY; PERFORMANCE; REHABILITATION; ASSOCIATIONS; IMPAIRMENTS; ACTIVATION; INHIBITION	Traumatic brain injury (TBI) affects structural connectivity, triggering the reorganization of structural-functional circuits in a manner that remains poorly understood. We focus here on brain network reorganization in relation to postural control deficits after TBI. We enrolled young participants who had suffered moderate to severe TBI, comparing them to young, typically developing control participants. TBI patients (but not controls) recruited prefrontal regions to interact with two separated networks: (1) a subcortical network, including parts of the motor network, basal ganglia, cerebellum, hippocampus, amygdala, posterior cingulate gyrus, and precuneus; and (2) a task-positive network, involving regions of the dorsal attention system, together with dorsolateral and ventrolateral prefrontal regions. We also found that the increased prefrontal connectivity in TBI patients was correlated with some postural control indices, such as the amount of body sway, whereby patients with worse balance increased their connectivity in frontal regions more strongly. The increased prefrontal connectivity found in TBI patients may provide the structural scaffolding for stronger cognitive control of certain behavioral functions, consistent with the observations that various motor tasks are performed less automatically following TBI and that more cognitive control is associated with such actions.	[Diez, Ibai; Bonifazi, Paolo; Cortes, Jesus M.] Cruces Univ Hosp, Biocruces Hlth Res Inst, Baracaldo, Spain; [Drijkoningen, David; Gooijers, Jolien; Swinnen, Stephan P.] Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Grp Biomed Sci, Leuve, Belgium; [Stramaglia, Sebastiano] Univ Bari, Dipartimento Fis, Bari, Italy; [Stramaglia, Sebastiano] INFN, Bari, Italy; [Stramaglia, Sebastiano] BCAM, Bilbao, Spain; [Marinazzo, Daniele] Univ Ghent, Fac Psychol & Pedag Sci, Dept Data Anal, Ghent, Belgium; [Swinnen, Stephan P.] Katholieke Univ Leuven, Leuven Res Inst Neurosci & Dis LIND, Leuven, Belgium; [Bonifazi, Paolo; Cortes, Jesus M.] Ikerbasque Basque Fdn Sci, Bilbao, Spain; [Cortes, Jesus M.] Univ Basque Country, Dept Cell Biol & Histol, Leioa, Spain		Cortes, JM (corresponding author), Cruces Univ Hosp, Biocruces Hlth Res Inst, Baracaldo, Spain.; Cortes, JM (corresponding author), Ikerbasque Basque Fdn Sci, Bilbao, Spain.; Cortes, JM (corresponding author), Univ Basque Country, Dept Cell Biol & Histol, Leioa, Spain.	jesus.m.cortes@gmail.com	Gooijers, Jolien/AAH-9202-2020; Bonifazi, Paolo/N-9737-2018; Marinazzo, Daniele/H-4793-2019; Bonifazi, Paolo/AAA-8035-2020; Cortes, Jesus/D-9949-2012; stramaglia, sebastiano/H-7582-2015	Bonifazi, Paolo/0000-0001-6374-8997; Marinazzo, Daniele/0000-0002-9803-0122; Bonifazi, Paolo/0000-0001-6374-8997; Cortes, Jesus/0000-0002-9059-8194; stramaglia, sebastiano/0000-0002-5873-8564; Gooijers, Jolien/0000-0002-7569-7223; Diez, Ibai/0000-0001-5769-0178	Health Department of the Basque Government; Ministerio Economia, Industria y Competitividad (Spain) [DPI2016-79874-R]; FEDEREuropean Commission; Euskampus at UPV/EHU; Bizkaia Talent; European Commission through COFUND [AYD-000-285]; FWO Vlaanderen (Levenslijn)FWO [G.A114.11, G.0708.14]; Research Fund of KU Leuven [C16/15/070]; Inter-university Attraction Poles program of the Belgian federal government (Belspo) [P7/11]; research project Brain Aura Mathematical Simulation (BRAhMS) [AYD-000-285]	I.D. undertook a 2-month lab rotation to visit the laboratories of S.P.S. and D.M. that was funded by the Health Department of the Basque Government. J.M.C. acknowledges financial support from Ikerbasque: The Basque Foundation for Science; Grant DPI2016-79874-R from the Ministerio Economia, Industria y Competitividad (Spain); and FEDER and Euskampus at UPV/EHU. S.P.S. acknowledges financial support from Bizkaia Talent and the European Commission through COFUND with the research project Brain Aura Mathematical Simulation (BRAhMS; Grant AYD-000-285). S.P.S. was also supported by FWO Vlaanderen (Levenslijn G.A114.11 and G.0708.14), the Research Fund of KU Leuven (C16/15/070), and the Inter-university Attraction Poles program of the Belgian federal government (Belspo, P7/11).	ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Alonso-Montes C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01024; Amor TA, 2015, EPL-EUROPHYS LETT, V111, DOI 10.1209/0295-5075/111/68007; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; Bishop C. M., 2006, PATTERN RECOGN, P13451, DOI [10.1523/JNEUROSCI.1163-11.2011, DOI 10.1523/JNEUROSCI.1163-11.2011]; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Coxon JP, 2010, CEREB CORTEX, V20, P2368, DOI 10.1093/cercor/bhp306; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/NMETH.2482, 10.1038/nmeth.2482]; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diez I, 2015, BRAIN CONNECT, V5, P554, DOI 10.1089/brain.2014.0337; Diez I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10532; Drijkoningen D, 2015, HUM BRAIN MAPP, V36, P4897, DOI 10.1002/hbm.22958; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gooijers J, 2016, BRAIN, V139, P2469, DOI 10.1093/brain/aww177; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Maki-Marttunen V, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00024; Marinazzo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093616; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; NEWMAN MEJ, 2004, PHYS REV E 2, V69, DOI DOI 10.1103/PHYSREVE.69.026113; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Stramaglia S, 2015, IEEE ENG MED BIO, P4037, DOI 10.1109/EMBC.2015.7319280; Stramaglia S, 2016, IEEE T BIO-MED ENG, V63, P2518, DOI 10.1109/TBME.2016.2559578; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Impe A, 2012, NEUROBIOL AGING, V33, P1900, DOI 10.1016/j.neurobiolaging.2011.06.013; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	74	14	14	0	2	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	2472-1751			NETW NEUROSCI	Netw. Neurosci.		2017	1	2					116	142		10.1162/netn_a_00007			27	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	GZ6UC	WOS:000449588100003	29911675	Green Published, gold, Green Accepted			2022-02-06	
J	Gurer, B; Kertmen, H; Yilmaz, ER; Dolgun, H; Hasturk, AE; Sekerci, Z				Gurer, Bora; Kertmen, Hayri; Yilmaz, Erdal Resit; Dolgun, Habibullah; Hasturk, Askin Esen; Sekerci, Zeki			The Surgical Outcome of Traumatic Extraaxial Hematomas Causing Brain Herniation	TURKISH NEUROSURGERY			English	Article						Epidural hematoma; Herniation; Intracranial pressure; Outcome; Subdural hematoma	ACUTE SUBDURAL-HEMATOMA; SEVERE HEAD-INJURY; EXTRADURAL HEMATOMA; PROGNOSTIC-FACTORS; EPIDURAL HEMATOMA; ADULT PATIENTS; MORTALITY; CRANIOTOMY; VOLUME; PREDICTION	AIM: The aim of this study was to assess the surgical outcome and the prognostic importance of clinical and radiological data of patients operated emergently for an extraaxial hematoma causing brain herniation. MATERIAL and METHODS: This retrospective study comprised 108 adult patients who were operated due to herniated traumatic extraaxial hematomas from January 2000 to January 2013. RESULTS: Of 108 patients, 63 patients (58.3%) were diagnosed as subdural hematoma (SDH), and 45 patients (41.7%) as epidural hematoma (EDH). An unfavorable outcome was significantly increased for patients who were diagnosed as SDH (90.4%) compared with EDH patients (33.3%). Mortality rate for herniated SDH patients was 65.1%, and 26.6% for herniated EDH patients. High mortality and unfavorable outcome ratios were associated with Glasgow Coma Scale scores at admission, mean postoperative intracranial pressure (ICP) values, type of the brain herniation, interval from the time of trauma to the time of hematoma decompression, the duration of the brain herniation, intraoperative acute brain swelling, hematoma volume and thickness, degree of the midline shift and the obliteration of the basal cisterns. CONCLUSION: Our data showed that, postoperative ICP values were one most important predictor of the mortality. We recommended postoperative ICP monitoring for all patients presenting with the brain herniation due to traumatic extraaxial hematoma.	[Gurer, Bora] Fatih Sultan Mehmet Educ & Res Hosp, Neurosurg Clin, Istanbul, Turkey; [Kertmen, Hayri; Yilmaz, Erdal Resit; Dolgun, Habibullah; Sekerci, Zeki] Diskapi Yildirim Beyazit Educ & Res Hosp, Neurosurg Clin, Ankara, Turkey; [Hasturk, Askin Esen] Oncol Educ & Res Hosp, Neurosurg Clin, Ankara, Turkey		Gurer, B (corresponding author), Fatih Sultan Mehmet Educ & Res Hosp, Neurosurg Clin, Istanbul, Turkey.	boragurer@gmail.com	HASTURK, ASKIN ESEN/AAE-5065-2019; Dolgun, Habibullah/AAL-6610-2021; dolgun, habibullah/AAF-6745-2021; Gurer, Bora/K-1177-2012	Dolgun, Habibullah/0000-0002-1513-2044; Gurer, Bora/0000-0003-1500-6184			American Association for the Surgery of Trauma, 2003, J Trauma, V54, pS235; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; D'Amato L, 2007, J Neurosurg Sci, V51, P107; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JENNETT B, 1975, LANCET, V1, P480; Karasu A, 2010, ULUS TRAVMA ACIL CER, V16, P233; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Nelson JA, 2011, ACAD EMERG MED, V18, P78, DOI 10.1111/j.1553-2712.2010.00949.x; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; SHENKIN HA, 1982, J NEUROSURG, V57, P254, DOI 10.3171/jns.1982.57.2.0254; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; STENING WA, 1986, AUST NZ J SURG, V56, P549, DOI 10.1111/j.1445-2197.1986.tb07098.x; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Uzan M, 1998, J Neurosurg Sci, V42, P89; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wu JJ, 1999, J TRAUMA, V47, P39, DOI 10.1097/00005373-199907000-00009; Yanaka Kiyoyuki, 1993, Neurologia Medico-Chirurgica, V33, P552, DOI 10.2176/nmc.33.552	48	14	15	0	0	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	JAN	2017	27	1					37	52		10.5137/1019-5149.JTN.14809-15.0			16	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EH8SG	WOS:000392042000006	27593740	Bronze			2022-02-06	
J	Majdan, M; Brazinova, A; Rusnak, M; Leitgeb, J				Majdan, Marek; Brazinova, Alexandra; Rusnak, Martin; Leitgeb, Johannes			Outcome Prediction after Traumatic Brain Injury: Comparison of the Performance of Routinely Used Severity Scores and Multivariable Prognostic Models	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Abbreviated injury scale; Glasgow coma scale; outcome; prognosis; traumatic brain injury	GLASGOW COMA SCALE; EXTERNAL VALIDATION; MOTOR SCORE; IMPACT; MODERATE; CRASH; CLASSIFICATION; EPIDEMIOLOGY; MORTALITY; SURVIVAL	Objectives: Prognosis of outcome after traumatic brain injury (TBI) is important in the assessment of quality of care and can help improve treatment and outcome. The aim of this study was to compare the prognostic value of relatively simple injury severity scores between each other and against a gold standard model - the IMPACT-extended (IMP-E) multivariable prognostic model. Materials and Methods: For this study, 866 patients with moderate/severe TBI from Austria were analyzed. The prognostic performances of the Glasgow coma scale (GCS), GCS motor (GCSM) score, abbreviated injury scale for the head region, Marshall computed tomographic (CT) classification, and Rotterdam CT score were compared side-by-side and against the IMP-E score. The area under the receiver operating characteristics curve (AUC) and Nagelkerke's R-2 were used to assess the prognostic performance. Outcomes at the Intensive Care Unit, at hospital discharge, and at 6 months (mortality and unfavorable outcome) were used as end-points. Results: Comparing AUCs and R(2)s of the same model across four outcomes, only little variation was apparent. A similar pattern is observed when comparing the models between each other: Variation of AUCs <+/- 0.09 and R(2)s by up to +/- 0.17 points suggest that all scores perform similarly in predicting outcomes at various points (AUCs: 0.65-0.77; R(2)s: 0.09-0.27). All scores performed significantly worse than the IMP-E model (with AUC > 0.83 and R-2 > 0.42 for all outcomes): AUCs were worse by 0.10-0.22 (P < 0.05) and R(2)s were worse by 0.22-0.39 points. Conclusions: All tested simple scores can provide reasonably valid prognosis. However, it is confirmed that well-developed multivariable prognostic models outperform these scores significantly and should be used for prognosis in patients after TBI wherever possible.	[Majdan, Marek; Brazinova, Alexandra; Rusnak, Martin] Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Univ Namestie 1, Trnava 91701, Slovakia; [Majdan, Marek; Brazinova, Alexandra] Med Univ Vienna, Int Neurotrauma Res Org, A-1090 Vienna, Austria; [Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria		Majdan, M (corresponding author), Trnava Univ, Fac Hlth Sci & Social Work, Dept Publ Hlth, Univ Namestie 1, Trnava 91701, Slovakia.	mmajdan@truni.sk	Majdan, Marek/K-5017-2012; Brazinova, Alexandra/C-4265-2016	Majdan, Marek/0000-0001-8037-742X; Brazinova, Alexandra/0000-0003-0625-256X			Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; [Anonymous], 1971, JAMA, V215, P277; [Anonymous], 1976, ABBR INJ SCAL; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brazinova A, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0133-z; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Lesko MM, 2013, J NEUROTRAUM, V30, P17, DOI 10.1089/neu.2012.2438; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Mauritz W, 2009, EUR J EMERG MED, V16, P153, DOI 10.1097/MEJ.0b013e32832a0864; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; R Core Team, 2014, R LANG ENV STAT COMP; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6	42	14	18	0	10	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN-MAR	2017	8	1					20	29		10.4103/0976-3147.193543			10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	ED5GT	WOS:000388880300006	28149077	Green Published, gold			2022-02-06	
J	Mikkelsen, R; Rodevand, LN; Wiig, US; Zahl, SM; Berntsen, T; Skarbo, AB; Egge, A; Helseth, E; Andersson, S; Wester, K				Mikkelsen, Rebecka; Rodevand, Linn Nilsen; Wiig, Ulrikke Straume; Zahl, Sverre Morten; Berntsen, Torhild; Skarbo, Anne-Britt; Egge, Arild; Helseth, Eirik; Andersson, Stein; Wester, Knut			Neurocognitive and psychosocial function in children with benign external hydrocephalus (BEH)-a long-term follow-up study	CHILDS NERVOUS SYSTEM			English	Article						Benign external hydrocephalus (BEH); Cognition; Neuropsychology; Psychosocial function; Quality of life	TRAUMATIC BRAIN-INJURY; GENERIC CORE SCALES; QUALITY-OF-LIFE; EXECUTIVE FUNCTION; INFANTS; RELIABILITY; VALIDITY; VERSION	Long-term impact of benign external hydrocephalus (BEH) on cognition is largely unknown, and indication for neurosurgical CSF diversion procedure is debated. This study reports neuropsychological and psychosocial function in operated and non-operated BEH children. Eighty-six children (76 males) between 8 and 18 years (mean 13.9) diagnosed with BEH before 12 months were included, of whom 30.2 % were operated. Participants completed neuropsychological tests and questionnaires covering quality of life (PedsQL) and executive function (BRIEF). Both operated and non-operated BEH children performed significantly below normative means on several neuropsychological tests. The children scored themselves higher than the norm average on PedsQL; however, the parents reported life quality comparable to other children. Operated children performed poorer compared with non-operated children on tests of psychomotor speed, attention span, executive function, motor speed and coordination, and on the BRIEF subscale Monitoring. Operated children, but not their parents, reported more problems on PedsQL subscale School than non-operated children. Children with BEH display long-term subtle neurocognitive difficulties. Non-operated children performed significantly better on some neuropsychological measures and reported less psychosocial problems. This difference may be caused by a selection bias: neurosurgical intervention was more likely in children with clinically more pronounced symptoms.	[Mikkelsen, Rebecka; Rodevand, Linn Nilsen; Andersson, Stein] Univ Oslo, Dept Psychol, Oslo, Norway; [Wiig, Ulrikke Straume; Egge, Arild; Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Zahl, Sverre Morten] Aalesund Hosp, Dept Ear Nose & Throat, Alesund, Norway; [Zahl, Sverre Morten; Wester, Knut] Univ Bergen, Dept Clin Med K1, Bergen, Norway; [Berntsen, Torhild; Skarbo, Anne-Britt] Oslo Univ Hosp, Dept Clin Neurosci Children, Oslo, Norway; [Andersson, Stein] Oslo Univ Hosp, Dept Psychosomat Med, Oslo, Norway; [Wester, Knut] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway		Wester, K (corresponding author), Univ Bergen, Dept Clin Med K1, Bergen, Norway.; Wester, K (corresponding author), Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway.	kgwe@helse-bergen.no	Zahl, Sverre Morten/ABG-9908-2021; Helseth, Eirik/AAH-2466-2020	Zahl, Sverre Morten/0000-0003-3303-6977; Wester, Knut/0000-0001-8489-3931	Grieg Foundation, Bergen, Norway; Western Norway Regional Health Authority [911439]	This study was supported by a grant from the Grieg Foundation, Bergen, Norway. Sverre Morten Zahl was supported by a Ph.D. grant from the Western Norway Regional Health Authority, project no. 911439.	Anderson V., 2008, EXECUTIVE FUNCTIONS; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; ANDERSSON H, 1984, CHILD BRAIN, V11, P398; Boaz JC, 1999, NEUROIMAG CLIN N AM, V9, P73; Cohen J., 2013, STAT POWER ANAL BEHA; DANDY WE, 1946, ARCH SURG-CHICAGO, V52, P421, DOI 10.1001/archsurg.1946.01230050428003; Delis DC., 2001, DELIS KAPLAN EXECUTI; Fallmyr O, 2011, J NORWEGIAN PSYCHOL, V48, P339; Follmer DJ, 2014, SCH PSYCHOL, V68; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; LAUBSCHER B, 1990, EUR J PEDIATR, V149, P502, DOI 10.1007/BF01959405; Muenchberger H, 2006, CHILD NERV SYST, V22, P1242, DOI 10.1007/s00381-006-0080-0; ODITA JC, 1992, CHILD NERV SYST, V8, P36, DOI 10.1007/BF00316560; Reinfjell T, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-61; Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P9, DOI 10.1016/j.spen.2009.01.002; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Talley JL, 1992, CHILDRENS AUDITORY V; Trites R. L., 1977, NEUROPSYCHOLOGICAL T; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wechsler D., 2009, WECHSLER INTELLIGENC, VWechsler, D., 2009. Wechsler Intelligence Scale for Children, (third ed.) Pearson, San Antonio, TX.; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2011, WECHSLER ADULT INTEL; Yew AY, 2011, PEDIATR NEUROSURG, V47, P1, DOI 10.1159/000322357; Zahl SM, 2008, PEDIATRICS, V121, pE416, DOI 10.1542/peds.2007-1598; Zahl SM, 2011, NEUROSURG REV, V34, P417, DOI 10.1007/s10143-011-0327-4	27	14	15	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2017	33	1					91	99		10.1007/s00381-016-3267-z			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EL0YS	WOS:000394348300014	27848005				2022-02-06	
J	Mu, WY; Catenaccio, E; Lipton, ML				Mu, Weiya; Catenaccio, Eva; Lipton, Michael L.			Neuroimaging in Blast-Related Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blast; imaging; mild traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER ABNORMALITIES; IMAGING APPROACH; FUNCTIONAL CONNECTIVITY; MILITARY PERSONNEL; CORTICAL THICKNESS; MAJOR DEPRESSION; ENDURING FREEDOM; SERVICE MEMBERS; COMBAT VETERANS	Objective: To summarize imaging findings in blast-related mild traumatic brain injury. Design: Our structured review of the literature yielded 5 structural magnetic resonance imaging (sMRI), 18 diffusion tensor imaging, 9 functional magnetic resonance imaging (fMRI), 3 positron emission tomography, 4 magnetoencephalography, 2 electroencephalography, and 1 single-positron emission computerized tomography studies. Results: Four of the 5 sMRI studies reported decreased cortical thickness and decreased thalamus and amygdala volume. Diffusion tensor imaging studies showed abnormal diffusion within white matter tracts commonly associated with traumatic brain injury, including the corpus callosum (8 of the 18) and superior longitudinal fasciculus (8 of the 18). Resting-state fMRI studies reported a variety of functional network differences. Other functional imaging studies showed diffuse changes in activity, especially in the frontal, parietal, temporal, and cingulate regions. Conclusion: Vast variation in the sample, design, and measurement features across studies precludes salient conclusions regarding the effectiveness of neuroimaging to assess outcomes and elucidate pathomechanisms. The inherent spatial heterogeneity of mild traumatic brain injury pathology presents a major challenge to meaningful convergence across and generalizable inferences. Approaches to standardize methodology and facilitate access to data and integration across studies hold promise for enhancing our understanding of this complex brain disorder, but can only bear fruit if they are actually consistently implemented.	[Mu, Weiya; Catenaccio, Eva; Lipton, Michael L.] Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Lipton, Michael L.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA		Lipton, ML (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.lipton@einstein.yu.edu	Catenaccio, Eva/M-7250-2019	Catenaccio, Eva/0000-0003-0550-207X			ACRM, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI 10.1097/00001199-199309000-00010; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Buxton RB, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/9/096601; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Curry JF, 2014, J AFFECT DISORDERS, V152, P434, DOI 10.1016/j.jad.2013.10.012; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Jongh A, 2003, NEUROIMAGE, V20, P2291, DOI 10.1016/j.neuroimage.2003.07.030; Defense DoVAaDo, 2009, MAN CONC MILD TRAUM; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fox RJ, 2012, AM J NEURORADIOL, V33, P695, DOI 10.3174/ajnr.A2844; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Grady D, 2011, NY TIMES; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Horacek J, 2006, NEUROENDOCRINOL LETT, V27, P587; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; Luria A.R., 1966, HIGHER CORTICAL FUNC; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matthews S, 2012, PSYCHOSOM MED, V74, P471, DOI 10.1097/PSY.0b013e31824f888f; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McCrea M, 2014, MIL MED, V179, P990, DOI 10.7205/MILMED-D-13-00349; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meinzer M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-20; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Ossenkoppele R, 2014, NEUROLOGY, V82, P1768, DOI 10.1212/WNL.0000000000000432; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Radua J, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-6; Roy MJ, 2010, ANN NY ACAD SCI, V1208, P142, DOI 10.1111/j.1749-6632.2010.05689.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Tepmongkol S, 2013, EPILEPSY BEHAV, V29, P386, DOI 10.1016/j.yebeh.2013.08.017; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	74	14	15	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					55	69		10.1097/HTR.0000000000000213			15	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400006	27022955				2022-02-06	
J	Rose, SC; Schaffer, CE; Young, JA; McNally, KA; Fischer, AN; Heyer, GL				Rose, Sean C.; Schaffer, Caroline E.; Young, Julie A.; McNally, Kelly A.; Fischer, Anastasia N.; Heyer, Geoffrey L.			Utilization of conventional neuroimaging following youth concussion	BRAIN INJURY			English	Article						Mild traumatic brain injury; post-concussion syndrome; CT; MRI; paediatric	TRAUMATIC BRAIN-INJURY; MANAGEMENT; SPORT; STATEMENT; SYMPTOMS; MRI; DIAGNOSIS; CHILDREN	Background/objective: Conventional neuroimaging is not recommended for the routine diagnosis of concussion, but some patients with concussion undergo computed tomography (CT) or magnetic resonance imaging (MRI). The objective of this study was to explore the clinical factors that predict neuroimaging utilization in concussion.Methods: Concussion-related CT and MRI data were analysed from 1953 patients, aged 10-19 years, who presented to a sports concussion clinic within 30 days of injury.Results: The majority of CT scans (n = 193) were obtained during the acute concussion period (mean = 2.7 days post-concussion), whereas MRI scans (n = 134) were ordered later during recovery (mean = 39.4 days post-concussion). Predictors of CT utilization included loss of consciousness, amnesia and vomiting (all p < 0.001). Prior concussion (p = 0.002) and continued participation in activity after injury (p = 0.03) predicted greater MRI utilization. Neuroimaging with either CT (p = 0.024, hazard ratio = 1.2) or MRI (p < 0.001, hazard ratio = 2.75) was associated with prolonged symptoms. Only 3.1% of CTs and 1.5% of MRIs demonstrated signs of traumatic brain injury.Conclusion: Several clinical factors predict neuroimaging utilization in patients with concussion. CT is generally used acutely, while MRI is used in the sub-acute and chronic post-concussion periods. In a sports concussion clinic, delayed neuroimaging has limited clinical yield.	[Rose, Sean C.; Heyer, Geoffrey L.] Nationwide Childrens Hosp, Div Pediat Neurol, 700 Childrens Dr,ED 5, Columbus, OH 43205 USA; [Rose, Sean C.; Heyer, Geoffrey L.] Ohio State Univ, Dept Neurol, 700 Childrens Dr,ED 5, Columbus, OH 43210 USA; [Schaffer, Caroline E.] Clemson Univ, Dept Hlth Sci, Clemson, SC USA; [Young, Julie A.; Fischer, Anastasia N.] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH USA; [McNally, Kelly A.] Nationwide Childrens Hosp, Div Pediat Psychol & Neuropsychol, Columbus, OH USA; [McNally, Kelly A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA		Heyer, GL (corresponding author), Nationwide Childrens Hosp, Div Pediat Neurol, 700 Childrens Dr,ED 5, Columbus, OH 43205 USA.; Heyer, GL (corresponding author), Ohio State Univ, Dept Neurol, 700 Childrens Dr,ED 5, Columbus, OH 43210 USA.	geoffrey.heyer@nationwidechildrens.org		McNally, Kelly/0000-0001-9278-9413; Heyer, Geoffrey/0000-0001-9334-3739; Rose, Sean/0000-0001-5177-7715			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gur RE, 2013, AM J NEURORADIOL, V34, P2021, DOI 10.3174/ajnr.A3525; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Perez FA, 2012, NEUROIMAG CLIN N AM, V22, P467, DOI 10.1016/j.nic.2012.05.002; Rose SC, 2016, SPORTS HEALTH, V8, P37, DOI 10.1177/1941738115591948; Sullivan KA, 2014, J HEAD TRAUMA REHAB, V29, P54, DOI 10.1097/HTR.0b013e31828c708a; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	26	14	15	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	2					260	266		10.1080/02699052.2016.1235285			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EM2RO	WOS:000395163500014	28095029				2022-02-06	
J	Shibahashi, K; Sugiyama, K; Houda, H; Takasu, Y; Hamabe, Y; Morita, A				Shibahashi, Keita; Sugiyama, Kazuhiro; Houda, Hidenori; Takasu, Yuichi; Hamabe, Yuichi; Morita, Akio			The effect of tracheostomy performed within 72 h after traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Head trauma; neurosurgical intensive care; head injury; severer head injury; tracheostomy; traumatic brain injury	RECEIVING MECHANICAL VENTILATION; SEVERE HEAD-INJURY; TRIAL; METAANALYSIS; INTUBATION; SURVIVAL; COHORT; CARE	The optimal timing of tracheostomy in patients with traumatic brain injury (TBI) remains unclear. The purpose of this study was to examine the effects of tracheostomy performed within 72 h after admission. In this retrospective cohort study, the authors reviewed the data for a series of 120 consecutive patients who underwent tracheostomy after suffering TBI with an Abbreviated Injury Scale (AIS) score of >= 4. The exclusion criteria were as follows: age <18 years, severe chest injury with an AIS score of >= 4, and a requirement for intubation because of upper airway obstruction. Patients who underwent tracheostomy <= 72 h and >72 h after admission were classified into early group and control groups, respectively. The duration of mechanical ventilation, length of stay (LOS) in intensive care unit (ICU), incidence of pneumonia, adverse event rate, unnecessary tracheostomy and outcomes were compared between the two groups. Of the 120 patients, 29 were excluded from the study, 40 were classified into the early group, and 51 were classified into the control group. The duration of mechanical ventilation and LOS in ICU were significantly less in the early group than in the control group. The 30-day mortality rates were 3% and 8% for the early and control groups, respectively. There was no significant difference in the adverse event rate, incidence of pneumonia, unnecessary tracheostomy rate and the rate of favorable outcome between groups. The results of this study suggest that the performance of tracheostomy within 72 h of admission may decrease the duration of mechanical ventilation and LOS in ICU, with acceptable mortality and morbidity rates.	[Shibahashi, Keita; Sugiyama, Kazuhiro; Houda, Hidenori; Takasu, Yuichi; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan; [Shibahashi, Keita; Sugiyama, Kazuhiro; Houda, Hidenori; Takasu, Yuichi; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Intens Care Ctr, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan; [Morita, Akio] Nippon Med Sch, Dept Neurol Surg, Bunkyou Ku, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan.; Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Intens Care Ctr, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan.	kshibahashi@yahoo.co.jp		Morita, Akio/0000-0002-2497-5772; Sugiyama, Kazuhiro/0000-0003-4543-3064			Barquist ES, 2006, J TRAUMA, V60, P91, DOI 10.1097/01.ta.0000196743.37261.3f; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Carney N, 2016, NEUROSURGERY, V24, ps1, DOI DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dunham CM, 2014, INT J BURNS TRAUMA, V4, P14; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kocaeli H, 2008, ACTA NEUROCHIR, V150, P1263, DOI 10.1007/s00701-008-0153-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCredie V, 2017, NEUROCRIT CARE, V26, P14, DOI 10.1007/s12028-016-0297-z; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Scales DC, 2008, CRIT CARE MED, V36, P2547, DOI 10.1097/CCM.0b013e31818444a5; Stocchetti N, 2000, J NEUROSURG ANESTH, V12, P307, DOI 10.1097/00008506-200010000-00002; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	18	14	14	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2017	31	5					564	568		10.1080/02688697.2017.1302071			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FP8UT	WOS:000417922300008	28301956				2022-02-06	
J	Varner, CE; McLeod, S; Nahiddi, N; Lougheed, RE; Dear, TE; Borgundvaag, B				Varner, Catherine E.; McLeod, Shelley; Nahiddi, Negine; Lougheed, Rosamond E.; Dear, Taylor E.; Borgundvaag, Bjug			Cognitive Rest and Graduated Return to Usual Activities Versus Usual Care for Mild Traumatic Brain Injury: A Randomized Controlled Trial of Emergency Department Discharge Instructions	ACADEMIC EMERGENCY MEDICINE			English	Article							SYMPTOMS 3 MONTHS; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; CONCUSSION; MANAGEMENT; PREDICTION; VALIDATION; ADULTS; SCALE	ObjectivesIt is estimated that 15%-25% of patients with a mild traumatic brain injury (MTBI) diagnosed in the emergency department (ED) will develop postconcussive syndrome. The objective of this study was to determine if patients randomized to graduated return to usual activity discharge instructions had a decrease in their Post-Concussion Symptom Score (PCSS) 2 weeks after MTBI compared to patients who received usual care MTBI discharge instructions. MethodsThis was a pragmatic, randomized trial of adult (18-64 years) patients of an academic ED (annual census 60,000) diagnosed with MTBI occurring within 24 hours of ED visit. The intervention group received cognitive rest and graduated return to usual activity discharge instructions, and the control group received usual care discharge instructions that did not instruct cognitive rest or graduated return. Patients were contacted by text message or phone 2 and 4 weeks post-ED discharge and asked to complete the PCSS, a validated, 22-item questionnaire, to determine if there was a change in their symptoms. Secondary outcomes included change in PCSS at 4 weeks, number follow-up physician visits, and time off work/school. ResultsA total of 118 patients were enrolled in the study (58 in the control group and 60 in the intervention). The mean (SD) age was 35.2 (+/- 13.7) years and 43 (36.4%) were male. There was no difference with respect to change in PCSS at 2 weeks (10.5 vs. 12.8; 2.3, 95% confidence interval [CI]= 7.0 to 11.7) and 4 weeks post-ED discharge (21.1 vs 18.3; 2.8, 95% CI= 6.9 to 12.7) for the intervention and control groups, respectively. The number of follow-up physician visits and time off work/school were similar when the groups were compared. Thirty-eight (42.2%) and 23 (30.3%) of patients in this cohort had ongoing MTBI symptoms (PCSS>20) at 2 and 4 weeks, respectively. ConclusionsResults from this study suggest graduated return to usual activity discharge instructions do not impact rate of resolution of MTBI symptoms 2 weeks after ED discharge. Given that patients continue to experience symptoms 2 and 4 weeks after MTBI, more investigation is needed to determine how best to counsel and treat patients with postconcussive symptoms.	[Varner, Catherine E.; McLeod, Shelley; Nahiddi, Negine; Lougheed, Rosamond E.; Borgundvaag, Bjug] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Varner, Catherine E.; McLeod, Shelley; Borgundvaag, Bjug] Mt Sinai Hosp, Dept Emergency Med, Toronto, ON, Canada; [Varner, Catherine E.; McLeod, Shelley; Dear, Taylor E.; Borgundvaag, Bjug] Mt Sinai Hosp, Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada		Varner, CE (corresponding author), Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.; Varner, CE (corresponding author), Mt Sinai Hosp, Dept Emergency Med, Toronto, ON, Canada.; Varner, CE (corresponding author), Mt Sinai Hosp, Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada.	catherine.varner@sinaihealthsystem.ca	Borgundvaag, Bjug/AAH-4446-2020; Borgundvaag, Bjug/AAE-8228-2020; McLeod, Shelley/AAE-9636-2019	McLeod, Shelley/0000-0003-2686-6307; Varner, Catherine/0000-0002-9696-1329	College of Family Physicians of Canada Janus Research Grant Training Level 1	Funded by the College of Family Physicians of Canada Janus Research Grant Training Level 1.	[Anonymous], 2006, AC CONS EV AC CAR PL; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; *CDCP, 2007, HEADS FACTS PHYS MIL; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Eliyahu L, 2016, ACAD EMERG MED, V23, P531, DOI 10.1111/acem.12924; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Grafstein E, 2008, CAN J EMERG MED, V10, P151; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Valentine V, 2012, AM FAM PHYSICIAN, V85, P100	25	14	14	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JAN	2017	24	1					75	82		10.1111/acem.13073			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	EK4DD	WOS:000393876400008	27792852	Bronze			2022-02-06	
J	Workewych, AM; Muzzi, MC; Jing, R; Zhang, S; Topolovec-Vranic, J; Cusimano, MD				Workewych, Adriana M.; Muzzi, Madeline Ciuffetelli; Jing, Rowan; Zhang, Stanley; Topolovec-Vranic, Jane; Cusimano, Michael D.		Canadian Brain Injury Violence Res	Twitter and traumatic brain injury: A content and sentiment analysis of tweets pertaining to sport-related brain injury	SAGE OPEN MEDICINE			English	Article						Concussion; traumatic brain injury; sport-related traumatic brain injuries; Twitter; social media	CONCUSSION EDUCATION; SCHOOL; PLAYERS; HOCKEY; COACH	Objectives: Sport-related traumatic brain injuries are a significant public health burden, with hundreds of thousands sustained annually in North America. While sports offer numerous physical and social health benefits, traumatic brain injuries such as concussion can seriously impact a player's life, athletic career, and sport enjoyment The culture in many sports encourages winning at all costs, placing athletes at risk for traumatic brain injuries. As social media has become a central part of everyday life, the content of users' messages often reflects the prevailing culture related to a particular event or health issue. Methods: We hypothesized that Twitter data might be useful for understanding public perceptions and misperceptions of sport-related traumatic brain injuries. We performed a content and sentiment analysis of 7483 Twitter (R) tweets related to traumatic brain injuries in sports collected during June and July 2013. Results: We identified five major themes. Users tweeted about personal traumatic brain injuries experiences, reported traumatic brain injuries in professional athletes, shared research about sport-related concussions, and discussed policy and safety in injury prevention, such as helmet use. We identified mixed perceptions of and sentiment toward traumatic brain injuries in sports: both an understanding that brain injuries are serious and disregard for activities that might reduce the public burden of traumatic brain injuries were prevalent in our Twitter analysis. Conclusion: While the scientific and medical community considers a concussion a form of traumatic brain injuries, our study demonstrates a misunderstanding of this fact among the public. In our current digital age, social media can provide useful insight into the culture around a health issue, facilitating implementation of prevention and treatment strategies.	[Workewych, Adriana M.; Jing, Rowan; Zhang, Stanley; Cusimano, Michael D.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Neurosurg, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Workewych, Adriana M.; Jing, Rowan; Zhang, Stanley; Cusimano, Michael D.] St Michaels Hosp, Trauma & Neurosurg Program, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Muzzi, Madeline Ciuffetelli] Queens Univ, Queens Econ Dept, Kingston, ON, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dept Surg, Toronto, ON, Canada		Cusimano, MD (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Div Neurosurg, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Cusimano, MD (corresponding author), St Michaels Hosp, Trauma & Neurosurg Program, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Topolovec-Vranic, Jane/A-5293-2013; Cusimano, Michael/X-4059-2019	Topolovec-Vranic, Jane/0000-0001-7695-4212; 	Canadian Brain Injury and Violence Research Team; Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the Canadian Brain Injury and Violence Research Team, the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946, and the Ontario Neurotrauma Foundation. The funders had no involvement in study conception or design; data collection, interpretation, or analysis; manuscript preparation; or decision to submit to publication.	Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Berg GM, 2014, JAAPA-J AM ACAD PHYS, V27, DOI 10.1097/01.JAA.0000442712.05009.b1; Bosley JC, 2013, RESUSCITATION, V84, P206, DOI 10.1016/j.resuscitation.2012.10.017; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Collier Nigel, 2011, J Biomed Semantics, V2 Suppl 5, pS9, DOI 10.1186/2041-1480-2-S5-S9; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Cusimano MD, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.015, 10.1371/journal.pone.0156683]; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Duggan M., 2014, SOCIAL MEDIA UPDATE; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Graff DM, 2016, J CHILD NEUROL, V31, P1569, DOI 10.1177/0883073816666205; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris JK, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120215; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kelleher E, 2014, J PEDIATR SURG, V49, P341, DOI 10.1016/j.jpedsurg.2013.10.016; Kind T, 2015, INT REV PSYCHIATR, V27, P124, DOI 10.3109/09540261.2014.990421; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Leo P, 2016, EPIDEMIOLOGY; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Miyashita TL, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114554549; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Strauss A., 2015, BASICS QUALITATIVE R; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; Topolovec-Vranic J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141699; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z	45	14	14	5	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2050-3121			SAGE OPEN MED	SAGE Open Med.	JAN-DEC	2017	5								2050312117720057	10.1177/2050312117720057			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GS3AT	WOS:000443441700051	28890783	gold, Green Published			2022-02-06	
J	Carron, SF; Yan, EB; Alwis, DS; Rajan, R				Carron, Simone F.; Yan, Edwin B.; Alwis, Dasuni S.; Rajan, Ramesh			Differential Susceptibility of Cortical and Subcortical Inhibitory Neurons and Astrocytes in the Long Term Following Diffuse Traumatic Brain Injury	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						diffuse TBI; inhibition; E:I ratio; cortex; hippocampus; interneurons; astrocytes. parvalbumin (RRID:AB_10000343); calbindin (RRID:AB_10000347); calretinin (RRID:AB_10000320); neuropeptide Y (RRID:AB_1566510); somatostatin (RRID:AB_2255365); GFAP (RRID:AB_11212369)	CALRETININ-CONTAINING INTERNEURONS; CALCIUM-BINDING PROTEINS; EXCITATORY AMINO-ACIDS; DENTATE GRANULE CELLS; GABAERGIC INTERNEURONS; SYNAPTIC CONNECTIONS; PARVALBUMIN IMMUNOREACTIVITY; EPILEPTIFORM ACTIVITY; RECEPTOR SUBUNITS; PYRAMIDAL NEURONS	Long-term diffuse traumatic brain injury (dTBI) causes neuronal hyperexcitation in supragranular layers in sensory cortex, likely through reduced inhibition. Other forms of TBI affect inhibitory interneurons in subcortical areas but it is unknown if this occurs in cortex, or in any brain area in dTBI. We investigated dTBI effects on inhibitory neurons and astrocytes in somatosensory and motor cortex, and hippocampus, 8 weeks post-TBI. Brains were labeled with antibodies against calbindin (CB), parvalbumin (PV), calretinin (CR) and neuropeptide Y (NPY), and somatostatin (SOM) and glial fibrillary acidic protein (GFAP), a marker for astrogliosis during neurodegeneration. Despite persistent behavioral deficits in rotarod performance up to the time of brain extraction (TBI = 73.13 +/- 5.23% mean +/- SEM, Sham = 92.29 +/- 5.56%, P < 0.01), motor cortex showed only a significant increase, in NPY neurons in supragranular layers (mean cells/mm(2) +/- SEM, Sham = 16 +/- 0.971, TBI = 25 +/- 1.51, P = 0.001). In somatosensory cortex, only CR+ neurons showed changes, being decreased in supragranular (TBI = 19 +/- 1.18, Sham = 25 +/- 1.10, P < 0.01) and increased in infragranular (TBI = 28 +/- 1.35, Sham = 24 +/- 1.07, P < 0.05) layers. Heterogeneous changes were seen in hippocampal staining: CB+ decreased in dentate gyrus (TBI = 2 +/- 0.382, Sham = 4 +/- 0.383, P < 0.01), PV+ increased in CA1 (TBI = 39 +/- 1.26, Sham = 33 +/- 1.69, P < 0.05) and CA2/3 (TBI = 26 +/- 2.10, Sham = 20 +/- 1.49, P < 0.05), and CR+ decreased in CA1 (TBI = 10 +/- 1.02, Sham = 14 +/- 1.14, P < 0.05). Astrogliosis significantly increased in corpus callosum (TBI = 6.7 +/- 0.69, Sham = 2.5 +/- 0.38; P = 0.007). While dTBI effects on inhibitory neurons appear region- and type-specific, a common feature in all cases of decrease was that changes occurred in dendrite targeting interneurons involved in neuronal integration. (C) 2016 Wiley Periodicals, Inc.	[Carron, Simone F.; Yan, Edwin B.; Alwis, Dasuni S.; Rajan, Ramesh] Monash Univ, Dept Physiol, Melbourne, Vic 3800, Australia		Rajan, R (corresponding author), Monash Univ, Dept Physiol, Melbourne, Vic 3800, Australia.	Ramesh.Rajan@monash.edu	rajan, ramesh/L-4842-2019	Rajan, Ramesh/0000-0001-9862-0520	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP 1029311]	Grant sponsor: National Health and Medical Research Council of Australia; Grant number: APP 1029311.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Avoli M, 2011, PROG NEUROBIOL, V95, P104, DOI 10.1016/j.pneurobio.2011.07.003; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6; Barinka F, 2010, PHYSIOL RES, V59, P665, DOI 10.33549/physiolres.931930; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Beers DR, 2001, J NEUROCHEM, V79, P499, DOI 10.1046/j.1471-4159.2001.00582.x; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Cabungcal JH, 2013, P NATL ACAD SCI USA, V110, P9130, DOI 10.1073/pnas.1300454110; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carter DS, 2008, EPILEPSY RES, V79, P213, DOI 10.1016/j.eplepsyres.2008.02.006; CHARD PS, 1993, J PHYSIOL-LONDON, V472, P341, DOI 10.1113/jphysiol.1993.sp019950; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P263, DOI 10.1016/0166-2236(87)90170-6; Croce N, 2012, ACS CHEM NEUROSCI, V3, P312, DOI 10.1021/cn200127e; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; Deidda G, 2015, NAT NEUROSCI, V18, P87, DOI 10.1038/nn.3890; Dekkers J, 2004, NEUROSCIENCE, V123, P459, DOI 10.1016/j.neuroscience.2003.07.013; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; delRio MR, 1997, J NEUROSCI, V17, P5143; DEMEULEMEESTER H, 1989, NEUROSCI LETT, V99, P6, DOI 10.1016/0304-3940(89)90255-3; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Ellender TJ, 2014, J NEUROSCI, V34, P15208, DOI 10.1523/JNEUROSCI.1747-14.2014; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fan YF, 2007, J CEREBR BLOOD F MET, V27, P719, DOI 10.1038/sj.jcbfm.9600373; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galvin J, 2009, AM J OCCUP THER, V63, P701, DOI 10.5014/ajot.63.6.701; GARCIASEGURA LM, 1984, BRAIN RES, V296, P75, DOI 10.1016/0006-8993(84)90512-2; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gonchar Y, 1999, CEREB CORTEX, V9, P683, DOI 10.1093/cercor/9.7.683; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; GULYAS AI, 1992, NEUROSCIENCE, V48, P1, DOI 10.1016/0306-4522(92)90334-X; Gulyas AI, 1996, HIPPOCAMPUS, V6, P525, DOI 10.1002/(SICI)1098-1063(1996)6:5<525::AID-HIPO5>3.0.CO;2-H; GULYAS AI, 1991, J COMP NEUROL, V312, P371, DOI 10.1002/cne.903120305; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HALL S, 1991, J NEUROSURG, V75, P378, DOI 10.3171/jns.1991.75.3.0378; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; HENDRY SHC, 1984, P NATL ACAD SCI-BIOL, V81, P6526, DOI 10.1073/pnas.81.20.6526; Heo DH, 2012, J NEURO-ONCOL, V108, P45, DOI 10.1007/s11060-012-0801-z; Hestrin S, 1996, J NEUROSCI, V16, P5290; Hooks BM, 2013, J NEUROSCI, V33, P748, DOI 10.1523/JNEUROSCI.4338-12.2013; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Isaacs KR, 2000, EXP NEUROL, V163, P311, DOI 10.1006/exnr.2000.7347; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; JACOBOWITZ DM, 1991, J COMP NEUROL, V304, P198, DOI 10.1002/cne.903040205; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kang SS, 2012, J NEUROSCI, V32, P9277, DOI 10.1523/JNEUROSCI.1746-12.2012; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; KUBOTA Y, 1994, JPN J PHYSIOL, V44, pS145; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Kuruba R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024493; Lamy Michael, 2011, Ann Adv Automot Med, V55, P125; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li QJ, 2014, NEURAL REGEN RES, V9, P959, DOI 10.4103/1673-5374.133140; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Long LL, 2011, INT J NEUROSCI, V121, P69, DOI 10.3109/00207454.2010.530007; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MAGLOCZKY Z, 1993, NEUROSCIENCE, V56, P317, DOI 10.1016/0306-4522(93)90334-C; Magloczky Z, 1997, NEUROSCIENCE, V76, P377, DOI 10.1016/S0306-4522(96)00440-X; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marx M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00167; MCINTOSH TK, 1992, J CEREBR BLOOD F MET, V12, P697, DOI 10.1038/jcbfm.1992.95; Meaney DF, 2001, J NEUROSURG, V95, P1108; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Noe F, 2008, BRAIN, V131, P1506, DOI 10.1093/brain/awn079; Ouh In-Ohk, 2013, Lab Anim Res, V29, P156, DOI 10.5625/lar.2013.29.3.156; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Paxinos, 1999, CHEMOARCHITECTONIC A; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Perrenoud Q, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00036; Pirone A, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00099; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Raymond MJ, 1996, NEUROREHABILITATION, V6, P229, DOI 10.3233/NRE-1996-6309; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; RIBAK CE, 1990, J COMP NEUROL, V300, P449, DOI 10.1002/cne.903000402; RIBAK CE, 1985, BRAIN RES, V326, P251, DOI 10.1016/0006-8993(85)90034-4; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; ROGERS JH, 1992, BRAIN RES, V587, P147, DOI 10.1016/0006-8993(92)91439-L; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Savin C, 2009, J R SOC INTERFACE, V6, P655, DOI 10.1098/rsif.2008.0387; Schiffmann SN, 1999, P NATL ACAD SCI USA, V96, P5257, DOI 10.1073/pnas.96.9.5257; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Schwaller B, 1997, J BIOL CHEM, V272, P29663, DOI 10.1074/jbc.272.47.29663; Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395, DOI 10.1152/ajpcell.1999.276.2.C395; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; Semchenko V V, 2006, Neurosci Behav Physiol, V36, P613, DOI 10.1007/s11055-006-0065-1; Sherman A, 2006, EXPLORING THALAMUS I; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Tanaka YH, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00012; Toth K, 2010, BRAIN, V133, P2763, DOI 10.1093/brain/awq149; Toth Z, 1997, J NEUROSCI, V17, P8106; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; Urban Z, 2002, ACTA BIOL HUNG, V53, P205, DOI 10.1556/ABiol.53.2002.1-2.19; Van den Bosch L, 2002, EXP NEUROL, V174, P150, DOI 10.1006/exnr.2001.7858; VANBREDERODE JFM, 1991, NEUROSCIENCE, V44, P157, DOI 10.1016/0306-4522(91)90258-P; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Vezzani A, 2004, NEUROPEPTIDES, V38, P245, DOI 10.1016/j.npep.2004.05.004; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; WELKER C, 1974, J COMP NEUROL, V158, P437, DOI 10.1002/cne.901580405; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yenari MA, 2001, STROKE, V32, P1028, DOI 10.1161/01.STR.32.4.1028; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	146	14	14	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	DEC 1	2016	524	17					3530	3560		10.1002/cne.24014			31	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	DZ4BU	WOS:000385803400004	27072754				2022-02-06	
J	Chigurupati, H; Auddy, B; Biyani, M; Stohs, SJ				Chigurupati, Harsha; Auddy, Biswajit; Biyani, M.; Stohs, Sidney J.			Hepatoprotective Effects of a Proprietary Glycyrrhizin Product during Alcohol Consumption: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study	PHYTOTHERAPY RESEARCH			English	Article						alcohol; glycyrrhizin; D-mannitol; hepatoprotection; glutathione; AST; ALT; GGT	TRAUMATIC BRAIN-INJURY; INDUCED LIVER-INJURY; MODERATE DRINKERS; OXIDATIVE STRESS; CARBON-TETRACHLORIDE; PLASMA GLUTATHIONE; ACID; RAT; MANNITOL; DAMAGE	Traditionally, licorice has been used to treat liver problems. Glycyrrhizin, the primary active compound, has been shown to suppress elevations in liver enzymes that occur when the liver becomes diseased or damaged. This randomized, double-blind, placebo-controlled, crossover study evaluated the hepatoprotective effects of a proprietary glycyrrhizin product during alcohol consumption. Twelve healthy individuals (six male and six female subjects) in a clinic setting consumed vodka nightly for 12 days with the glycyrrhizin product or placebo (blank control), achieving a blood alcohol level of 0.12%. Liver function enzymes including alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), and alkaline phosphatase and serum reduced glutathione were measured at overnight visits 1, 6, and 12. In the alcohol only group, AST, ALT, and GGT significantly increased from baseline (overnight visit 1) to overnight visit 12. In the active group, no statistically significant increases were observed for AST, ALT, and GGT, while alkaline phosphatase significantly decreased and plasma glutathione decreased relative to the alcohol control group. These results suggest that consumption of the proprietary glycyrrhizin study product during alcohol consumption may support improved liver health compared with drinking alcohol alone. Copyright (C) 2016 John Wiley & Sons, Ltd.	[Chigurupati, Harsha; Auddy, Biswajit; Biyani, M.] Chigurupati Technol Private Ltd, Hyderabad, Andhra Pradesh, India; [Stohs, Sidney J.] Creighton Univ, 7068 Maumee Valley Court, Frisco, TX 75034 USA		Stohs, SJ (corresponding author), Creighton Univ, 7068 Maumee Valley Court, Frisco, TX 75034 USA.	sid.stohs9@gmail.com		biyani, manish/0000-0001-7622-5650	Chigurupati Technologies Private Limited	Funding for this study and the study product (NTX (R)) were provided by Chigurupati Technologies Private Limited. The authors thank Medicus Research for their assistance in conducting the study.	Ablise M, 2004, CHEM PHARM BULL, V52, P1436, DOI 10.1248/cpb.52.1436; ADAMS JD, 1983, J PHARMACOL EXP THER, V227, P749; Alatalo P, 2009, ALCOHOL ALCOHOLISM, V44, P199, DOI 10.1093/alcalc/agn099; Bansal S, 2012, J BIOL CHEM, V287, P15284, DOI 10.1074/jbc.M111.314062; Bruha R, 2012, WORLD J HEPATOL, V4, P81, DOI 10.4254/wjh.v4.i3.81; Cao Zong-xin, 2006, Chin J Integr Med, V12, P268, DOI 10.1007/s11655-006-0268-1; CEDERBAUM AI, 1983, BIOCHEM J, V210, P107, DOI 10.1042/bj2100107; Chang YY, 2013, J AGR FOOD CHEM, V61, P11016, DOI 10.1021/jf4038419; Cheel J, 2010, PHARMACOGN MAG, V6, P26, DOI 10.4103/0973-1296.59963; Cosentino M, 2013, WORLD J UROL, V31, P977, DOI 10.1007/s00345-012-1003-1; Danielsson J, 2014, WORLD J GASTROENTERO, V20, P11743, DOI 10.3748/wjg.v20.i33.11743; Deshpande N., 2014, WORLD J NUTR HLTH, V2, P24; Dhanda AD, 2015, WORLD J GASTROENTERO, V21, P11904, DOI 10.3748/wjg.v21.i42.11904; ENGLAND MD, 1986, CIRCULATION, V74, P134; FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205; Gandhi NM, 2004, J RADIAT RES, V45, P461, DOI 10.1269/jrr.45.461; Gharzouli K, 2001, EXP TOXICOL PATHOL, V53, P175, DOI 10.1078/0940-2993-00175; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; Gu XJ, 2014, CHIN J TRAUMATOL, V17, P1, DOI 10.3760/cma.j.issn.1008-1275.2014.01.001; Han KH, 2016, WORLD J GASTROENTERO, V22, P37, DOI 10.3748/wjg.v22.i1.37; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hietala J, 2005, ALCOHOL ALCOHOLISM, V40, P511, DOI 10.1093/alcalc/agh201; Hou SZ, 2014, INT J MOL SCI, V15, P15026, DOI 10.3390/ijms150915026; Hsiang CY, 2015, PHYTOMEDICINE, V22, P768, DOI 10.1016/j.phymed.2015.05.053; Hu CC, 2001, MUTAT RES-GEN TOX EN, V496, P117, DOI 10.1016/S1383-5718(01)00214-5; IKEDA Y, 1995, P NATL ACAD SCI USA, V92, P126, DOI 10.1073/pnas.92.1.126; Ishida T, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/650514; Izzo AA, 2016, PHYTOTHER RES, V30, P691, DOI 10.1002/ptr.5591; Jeong HG, 2002, FEBS LETT, V513, P208, DOI 10.1016/S0014-5793(02)02311-6; Jerca L, 1993, Rev Med Chir Soc Med Nat Iasi, V97, P253; Jung JC, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-0997-0; Kaur P, 2012, PHARMACOGN RES, V4, P189, DOI 10.4103/0974-8490.102260; Kim HJ, 2015, PAK J MED SCI, V31, P1043, DOI 10.12669/pjms.315.8025; Kim MS, 2016, WORLD J GASTROENTERO, V22, P8, DOI 10.3748/wjg.v22.i1.8; Laconi S, 2014, PHYTOTHER RES, V28, P1890, DOI 10.1002/ptr.5189; LAUTERBURG BH, 1984, J PHARMACOL EXP THER, V230, P7; LAUTERBURG BH, 1988, GUT, V29, P1153, DOI 10.1136/gut.29.9.1153; LECOMTE E, 1994, AM J CLIN NUTR, V60, P255, DOI 10.1093/ajcn/60.2.255; Lee CH, 2007, BIOL PHARM BULL, V30, P1898, DOI 10.1248/bpb.30.1898; Lee TD, 2004, ALCOHOL CLIN EXP RES, V28, P173, DOI 10.1097/01.ALC.0000108654.77178.03; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Li XL, 2012, MOLECULES, V17, P716, DOI 10.3390/molecules17010716; Liang B, 2015, WORLD J GASTROENTERO, V21, P5271, DOI 10.3748/wjg.v21.i17.5271; LIU J, 1994, FUND APPL TOXICOL, V22, P34, DOI 10.1006/faat.1994.1005; Llerena S, 2015, WORLD J HEPATOL, V7, P2703, DOI 10.4254/wjh.v7.i27.2703; Loguercio C, 1997, ITAL J GASTROENTEROL, V29, P168; Loguercio C, 1999, ALCOHOL CLIN EXP RES, V23, P1780, DOI 10.1097/00000374-199911000-00010; Mathurin P, 2012, J HEPATOL, V56, pS39, DOI 10.1016/S0168-8278(12)60005-1; MICHELET F, 1995, CLIN CHEM, V41, P1509; Nagamma T, 2012, ASIAN PAC J CANCER P, V13, P3513, DOI 10.7314/APJCP.2012.13.7.3513; NEMESANSZKY E, 1988, CLIN CHEM, V34, P525; Nwozo SO, 2014, J INTEGR MED-JIM, V12, P59, DOI 10.1016/S2095-4964(14)60006-6; Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074; O'Shea RS, 2010, AM J GASTROENTEROL, V105, P14, DOI 10.1038/ajg.2009.593; Omar HR, 2012, THER ADV ENDOCRINOL, V3, P125, DOI 10.1177/2042018812454322; Orazizadeh M, 2014, CHEM-BIOL INTERACT, V220, P214, DOI 10.1016/j.cbi.2014.07.001; Panda Vandana, 2012, Interdiscip Toxicol, V5, P207, DOI 10.2478/v10102-012-0034-1; Patel TK, 2016, TRENDS PLANT SCI, V21, P486, DOI 10.1016/j.tplants.2016.01.006; Pemberton PW, 2005, SCAND J GASTROENTERO, V40, P1102, DOI 10.1080/00365520510023495; PIERSON JL, 1986, BIOCHEM PHARMACOL, V35, P1533, DOI 10.1016/0006-2952(86)90121-8; Pisa PT, 2015, J HEALTH POPUL NUTR, V33, P146; Quan ZY, 2009, J SHANDONG U, V47, P80; Qureshi MS, 2015, PROF MED J, V22, P896; REINKE LA, 1987, P NATL ACAD SCI USA, V84, P9223, DOI 10.1073/pnas.84.24.9223; Shah D M, 1996, Cardiovasc Surg, V4, P97; Sil R, 2015, MOL CELL BIOCHEM, V409, P177, DOI 10.1007/s11010-015-2523-y; Sripradha Ramalingam, 2010, Indian J Med Sci, V64, P476; Thomes PG, 2013, AUTOPHAGY, V9, P63, DOI 10.4161/auto.22490; Tripathi M, 2009, FOOD CHEM TOXICOL, V47, P339, DOI 10.1016/j.fct.2008.11.028; VENDEMIALE G, 1989, J HEPATOL, V9, P359, DOI 10.1016/0168-8278(89)90146-3; Wang F, 2016, MOLECULES, V21, DOI 10.3390/molecules21010064; Wang J, 1999, Zhonghua Gan Zang Bing Za Zhi, V7, P42; Wang JM, 2015, CAN J PHYSIOL PHARM, V93, P261, DOI 10.1139/cjpp-2014-0536; Wang W, 2013, INT J NANOMED, V8, P1377, DOI 10.2147/IJN.S37788; Wang XY, 2015, INT J BIOL MACROMOL, V78, P354, DOI 10.1016/j.ijbiomac.2015.04.024; Whitfield JB, 2013, ALCOHOL CLIN EXP RES, V37, P575, DOI 10.1111/acer.12015; Wong M.-L., 2002, PHARMACOGENOMICS SEA, P417, DOI DOI 10.1002/3527600752; Wu CH, 2015, J AGR FOOD CHEM, V2015; Yildirim AO, 2013, EUR REV MED PHARMACO, V17, P2981; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017; Yu J, 2014, PHYTOTHER RES, V28, P933, DOI 10.1002/ptr.5072; Zelickson BR, 2011, BBA-BIOENERGETICS, V1807, P1573, DOI 10.1016/j.bbabio.2011.09.011; Zhang YJ, 2016, ENV RES PUBL HLTH, V13, P339, DOI [10.3390/iherph.13040399, DOI 10.3390/IHERPH.13040399]	84	14	15	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	DEC	2016	30	12					1943	1953		10.1002/ptr.5699			11	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	ED9PK	WOS:000389204700005	27539273				2022-02-06	
J	DellaValle, B; Brix, GS; Brock, B; Geji, M; Rungby, J; Larsen, A				DellaValle, Brian; Brix, Gitte S.; Brock, Birgitte; Geji, Michael; Rungby, Jorgen; Larsen, Agnete			Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain Trauma	FRONTIERS IN PHARMACOLOGY			English	Article						GLP-1; traumatic brain injury; TBI; sitagliptin; liraglutide; CREB; GIP; DPP-IV	GLUCAGON-LIKE PEPTIDE-1; MITOCHONDRIAL-FUNCTION; RECEPTOR AGONISTS; INHIBITOR; GLP-1; LIRAGLUTIDE; METABOLISM; ISCHEMIA; INJURY; TYPE-2	Introduction: Traumatic brain injury is a major cause of mortality and morbidity. We have previously shown that the injectable glucagon-like peptide-1 (GLP-1) analog, liraglutide, significantly improved the outcome in mice after severe traumatic brain injury (TBI). In this study we are interested in the effects of oral treatment of a different class of GLP-1 based therapy, dipeptidyl peptidase IV (DPP-IV) inhibition on mice after TBI. DPP-IV inhibitors reduce the degradation of endogenous GLP-1 and extend circulation of this protective peptide in the bloodstream. This class has yet to be investigated as a potential therapy for TBI. Methods: Mice were administrated once-daily 50 mg/kg of sitagliptin in a Nutellatm (R) ball or Nutella (R) alone throughout the study, beginning 2 days before severe trauma was induced with a stereotactic cryo-lesion. At 2 days post trauma, lesion size was determined. Brains were isolated for immunoblotting for assessment of selected biomarkers for pathology and protection. Results: Sitagliptin treatment reduced lesion size at day 2 post-injury by similar to 28% (p < 0.05). Calpain-driven necrotic tone was reduced similar to 2-fold in sitagliptin treated brains (p < 0.001) and activation of the protective cAMP-response element binding protein (CREB) system was significantly more pronounced (similar to 1.5-fold, p 9 0.05). The CREB-regulated, mitochondrial antioxidant protein manganese superoxide dismutase (MnSOD) was increased in sitagliptin-treated mice (p < 0.05). Conversely, apoptotic tone (alpha-spectrin fragmentation, Bcl-2 levels) and the neuroinflammatory markers IL-6, and lba-1 were not affected by treatment. Conclusions: This study shows, for the first time, that DPP-IV inhibition ameliorates both anatomical and biochemical consequences of TBI and activates CREB in the brain. Moreover, this work supports previous studies suggesting that the effect of GLP-1 analogs in models of brain damage relates to GLP-1 receptor stimulation in a dose-dependent manner.	[DellaValle, Brian; Brix, Gitte S.; Brock, Birgitte; Geji, Michael; Rungby, Jorgen; Larsen, Agnete] Aarhus Univ, Dept Biomed Pharmacol, Aarhus, Denmark; [DellaValle, Brian] Copenhagen Univ Hosp, Dept Clin Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Brock, Birgitte; Geji, Michael] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark; [Rungby, Jorgen] Bispebjerg Hosp, Dept Endocrinol, Copenhagen, Denmark		DellaValle, B (corresponding author), Aarhus Univ, Dept Biomed Pharmacol, Aarhus, Denmark.; DellaValle, B (corresponding author), Copenhagen Univ Hosp, Dept Clin Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.	briandellavalle@gmail.com	Rungby, Jorgen/AAQ-4332-2021	DellaValle, Brian/0000-0002-1427-8244; Larsen, Agnete/0000-0001-8765-8443	A. P. Moller foundation; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited; Novo NordiskNovo Nordisk	The authors thank A. P. Moller foundation for the financial support. The supplemental material is new, original work on tissue from a study conducted when BD was partly funded by Novo Nordisk Foundation, and Novo Nordisk.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Bao Y, 2015, CELL PHYSIOL BIOCHEM, V36, P2366, DOI 10.1159/000430199; Candeias EM, 2015, WORLD J DIABETES, V6, P807, DOI 10.4239/wjd.v6.i6.807; Chowen JA, 1999, NEUROPEPTIDES, V33, P212, DOI 10.1054/npep.1999.0757; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DellaValle B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1486-0; DellaValle B, 2014, ANN CLIN TRANSL NEUR, V1, P721, DOI 10.1002/acn3.99; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; El-Sahar AE, 2015, LIFE SCI, V126, P81, DOI 10.1016/j.lfs.2015.01.030; Galeotti T, 2005, BIOMED PHARMACOTHER, V59, P197, DOI 10.1016/j.biopha.2005.03.002; Gault VA, 2015, DIABETES OBES METAB, V17, P403, DOI 10.1111/dom.12432; Gejl M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00108; Gejl M, 2014, BASIC CLIN PHARMACOL, V115, P162, DOI 10.1111/bcpt.12240; Gejl M, 2012, J CEREBR BLOOD F MET, V32, P2146, DOI 10.1038/jcbfm.2012.118; Glushakov AV, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00034; Hakon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120074; Holst JJ, 2008, TRENDS MOL MED, V14, P161, DOI 10.1016/j.molmed.2008.01.003; Ihara M, 2015, AM J PHYSIOL-HEART C, V308, pH1287, DOI 10.1152/ajpheart.00835.2014; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Knudsen LB, 2016, J DIABETES INVEST, V7, P56, DOI 10.1111/jdi.12463; Lerche S, 2008, DIABETES, V57, P325, DOI 10.2337/db07-1162; Ma M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0218-z; Pintana H, 2013, J ENDOCRINOL, V218, P1, DOI 10.1530/JOE-12-0521; Pipatpiboon N, 2013, EUR J NEUROSCI, V37, P839, DOI 10.1111/ejn.12088; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Samikannu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082639; Sharma MK, 2014, J NEUROCHEM, V128, P459, DOI 10.1111/jnc.12469; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tsai TH, 2015, J HYPERTENS, V33, P1001, DOI 10.1097/HJH.0000000000000529; Yang D, 2013, BRAIN RES, V1517, P104, DOI 10.1016/j.brainres.2013.04.015; Ye YM, 2010, AM J PHYSIOL-HEART C, V298, pH1454, DOI 10.1152/ajpheart.00867.2009; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229	37	14	14	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	DEC 1	2016	7								450	10.3389/fphar.2016.00450			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	ED7UB	WOS:000389075800001	27990119	Green Published, gold			2022-02-06	
J	Zhang, C; Wu, JM; Liao, M; Wang, JL; Xu, CJ				Zhang, Chan; Wu, Jian-Min; Liao, Min; Wang, Jun-ling; Xu, Chao-Jin			The ROCK/GGTase Pathway Are Essential to the Proliferation and Differentiation of Neural Stem Cells Mediated by Simvastatin	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Simvastatin; Neural stem cells; ROCK; GGTase	PROTEIN PRENYLATION; KI-67 ANTIGEN; IN-VITRO; STATINS; CYCLE; CHOLESTEROL; NEUROGENESIS; CONSEQUENCES; SUPPRESSES; MECHANISMS	Simvastatin, a lipophilic and fermentation-derived natural statin, is reported to treat neurological disorders, such as traumatic brain injury, Parkinson's disease (PD), Alzheimer disease (AD), etc. Recently, research also indicated that simvastatin could promote regeneration in the dentate gyrus of adult mice by Wnt/beta-catenin signaling (Robin et al. in Stem Cell Reports 2:9-17, 2014). However, the effect and mechanisms by which simvastatin may affect the neural stem cells (NSCs; from the embryonic day 14.5 (E14.5) SD rat brain) are not fully understood. Here, we investigated the effects of different doses of simvastatin on the survival, proliferation, differentiation, migration, and cell cycle of NSCs as well as underlying intracellular signaling pathways. The results showed that simvastatin not only inhibits the proliferation of NSCs but also enhances the beta III-tubulin(+) neuron differentiation rate. Additionally, we find that simvastatin could also promote NSC migration and induce cell cycle arrest at M2 phrase. All these effects of simvastatin on NSCs were mimicked with an inhibitor of Rho kinase (ROCK) and a specific inhibitor of geranylgeranyl transferase (GGTase). In conclusion, these data indicate that simvastatin could promote neurogenesis of neural stem cells, and these effects were mediated through the ROCK/GGTase pathway.	[Zhang, Chan] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou 325035, Zhejiang, Peoples R China; [Wu, Jian-Min] Wenzhou Med Univ, Inst Genom Med, Wenzhou 325035, Zhejiang, Peoples R China; [Liao, Min; Xu, Chao-Jin] Wenzhou Med Univ, Dept Histol & Embryol, Inst Neurosci, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Jun-ling] Fudan Univ, Dept Clin Lab, Affiliated Huadong Hosp, Shanghai 200040, Peoples R China		Xu, CJ (corresponding author), Wenzhou Med Univ, Dept Histol & Embryol, Inst Neurosci, Wenzhou 325035, Zhejiang, Peoples R China.; Wang, JL (corresponding author), Fudan Univ, Dept Clin Lab, Affiliated Huadong Hosp, Shanghai 200040, Peoples R China.	Wangliujunling@163.com; xuzhaojin@gmail.com		Wu, Jianmin/0000-0002-8223-1667	Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [LY13H090007, LQ13C090004]; National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201589]	The project was supported by the Zhejiang Provincial Natural Science Foundation of China (LY13H090007) and Zhejiang Provincial Natural Science Foundation of China (LQ13C090004) and National Natural Sciences Foundation of China (Grant No. 81201589).	Abe K, 2003, DEV BRAIN RES, V143, P99, DOI 10.1016/S0165-3806(03)00096-8; Bender CM, 1998, CANCER RES, V58, P95; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; BRAUN N, 1988, VIRCHOWS ARCH B, V56, P25, DOI 10.1007/BF02889998; CASEY PJ, 1995, BIOCHEM SOC T, V23, P161, DOI 10.1042/bst0230161; CHAN PK, 1987, CANCER RES, V47, P3798; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; GERDES J, 1984, J IMMUNOL, V133, P1710; Huang F, 2010, ACTA BIOCH BIOPH SIN, V42, P325, DOI 10.1093/abbs/gmq025; Kill IR, 1996, J CELL SCI, V109, P1253; Kuipers HF, 2006, GLIA, V53, P115, DOI 10.1002/glia.20269; Lee MH, 2007, STEM CELLS, V25, P1654, DOI 10.1634/stemcells.2006-0753; Lin T, 2012, J ETHNOPHARMACOL, V142, P754, DOI 10.1016/j.jep.2012.05.057; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; MacCallum DE, 2000, J PATHOL, V190, P537; Matzno S, 2005, J PHARM PHARMACOL, V57, P1475, DOI 10.1211/jpp.57.11.0014; McKenney JM, 2003, CLIN CARDIOL, V26, P32, DOI 10.1002/clc.4960261507; Miron VE, 2007, GLIA, V55, P130, DOI 10.1002/glia.20441; Mullen PJ, 2010, BIOCHEM PHARMACOL, V79, P1200, DOI 10.1016/j.bcp.2009.12.007; Neuhaus O, 2004, LANCET NEUROL, V3, P369, DOI 10.1016/S1474-4422(04)00770-7; Robin NC, 2014, STEM CELL REP, V2, P9, DOI 10.1016/j.stemcr.2013.11.002; Roy A, 2011, NEUROSCIENTIST; SatoSuzuki I, 1996, NEUROSCI LETT, V220, P21, DOI 10.1016/S0304-3940(96)13221-3; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Smolders I, 2010, J NEUROSCI RES, V88, P3361, DOI 10.1002/jnr.22490; Storch Alexander, 2002, Journal of Neurology, V249; Sun ZH, 2003, ACT NEUR S, V87, P169; Vuletic S, 2006, DEMENT GERIATR COGN, V22, P392, DOI 10.1159/000095679; Walker AM, 2010, INT J ENV RES PUB HE, V7, P1996, DOI 10.3390/ijerph7051996; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; Xu CJ, 2011, NEUROPATH APPL NEURO, V37, P135, DOI 10.1111/j.1365-2990.2010.01117.x; Xu CJ, 2016, NEUROCHEM RES, V41, P1211, DOI 10.1007/s11064-016-1829-9; Xu CJ, 2011, MOL CELL BIOCHEM, V358, P173, DOI 10.1007/s11010-011-0932-0; Z-w P, 2013, MOL CELL BIOCHEM, V375, P105; Zhan Y, 2010, NEURAL REGEN RES; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhi WH, 2014, CNS NEUROSCI THER, V20, P218, DOI 10.1111/cns.12190	39	14	16	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	DEC	2016	60	4					474	485		10.1007/s12031-016-0811-y			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	ED1SS	WOS:000388625800007	27541019				2022-02-06	
J	Guise, C; Fernandes, MM; Nobrega, JM; Pathak, S; Schneider, W; Fangueiro, R				Guise, Catarina; Fernandes, Margarida M.; Nobrega, Joao M.; Pathak, Sudhir; Schneider, Walter; Fangueiro, Raul			Hollow Polypropylene Yarns as a Biomimetic Brain Phantom for the Validation of High-Definition Fiber Tractography Imaging	ACS APPLIED MATERIALS & INTERFACES			English	Article						hollow multifilament yarns; polypropylene; brain phantom; high-definition fiber tractography; water diffusion	MELT-SPINNING PROCESS; WHITE-MATTER; FRACTIONAL ANISOTROPY; DIFFUSION PHANTOMS; TRACKING; INJURY; MRI	Current brain imaging methods largely fail to provide detailed information about the location and severity of axonal injuries and do not anticipate recovery of the patients with traumatic brain injury. High-definition fiber tractography appears as a novel imaging modality based on water motion in the brain that allows for direct visualization and quantification of the degree of axons damage, thus predicting the functional deficits due to traumatic axonal injury and loss of cortical projections. This neuroimaging modality still faces major challenges because it lacks a "gold standard" for the technique validation and respective quality control. The present work aims to study the potential of hollow polypropylene yarns to mimic human white matter axons and construct a brain phantom for the calibration and validation of brain diffusion techniques based on magnetic resonance imaging, including high-definition fiber tractography imaging. Hollow multifilament polypropylene yarns were produced by melt-spinning process and characterized in terms of their physicochemical properties. Scanning electronic microscopy images of the filaments cross section has shown an inner diameter of approximately 12 pm, confirming their appropriateness to mimic the brain axons. The chemical purity of polypropylene yarns as well as the interaction between the water and the filament surface, important properties for predicting water behavior and diffusion inside the yarns, were also evaluated. Restricted and hindered water diffusion was confirmed by fluorescence microscopy. Finally, the yarns were magnetic resonance imaging scanned and analyzed using high-definition fiber tractography, revealing an excellent choice of these hollow polypropylene structures for simulation of the white matter brain axons and their suitability for constructing an accurate brain phantom.	[Guise, Catarina; Fernandes, Margarida M.; Fangueiro, Raul] Univ Minho, Ctr Text Sci & Technol 2C2T, Campus Azurem, P-4800058 Guimaraes, Portugal; [Pathak, Sudhir; Schneider, Walter] Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA; [Nobrega, Joao M.] Univ Minho, Inst Polymers & Composites I3N, Campus Azurem, P-4800058 Guimaraes, Portugal		Fernandes, MM; Fangueiro, R (corresponding author), Univ Minho, Ctr Text Sci & Technol 2C2T, Campus Azurem, P-4800058 Guimaraes, Portugal.	margaridafernandes@fibrenamics.com; rfangueiro@civil.uminho.pt	Fernandes, Margarida/AAL-7251-2021; Fernandes, Margarida M./T-8132-2018; FANGUEIRO, RAUL/ABB-6849-2021; Nobrega, Joao/ABE-1977-2021; Nobrega, Joao M/G-1825-2011	Fernandes, Margarida M./0000-0002-1529-3702; FANGUEIRO, RAUL/0000-0003-3303-6563; Nobrega, Joao/0000-0002-5303-6467; Nobrega, Joao M/0000-0002-5303-6467; Guise, Catarina/0000-0003-1144-1824	Portuguese Foundation for Science and Technology (FCT)Portuguese Foundation for Science and Technology [SFRH/BD/90324/2012]	This work is being supported by the Portuguese Foundation for Science and Technology (FCT) through the PhD grant SFRH/BD/90324/2012. Also, we thank Multicol, Portugal, for providing the material (polypropylene) used in this work.	Abhinav K, 2015, NEURO-ONCOLOGY, V17, P1199, DOI 10.1093/neuonc/nov113; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Assaf Y., 2014, DIFFUSION MRI QUANTI; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Bhattacharya S. S., 2015, INT J TEXT FASH TECH, V5, P15; Bihan Le, 2006, INT C SER, V1290, P1, DOI DOI 10.1016/J.ICS.2006.04.006; Chawla K., 2016, FIBROUS MAT; Chenevert T. L., 2010, DIFFUSION WEIGHTED M; Clarke, 2015, MAGNETIC RESONANCE I; Close TG, 2009, NEUROIMAGE, V47, P1288, DOI 10.1016/j.neuroimage.2009.03.077; Culjat MO, 2010, ULTRASOUND MED BIOL, V36, P861, DOI 10.1016/j.ultrasmedbio.2010.02.012; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Dowell N., 2010, DIFFUSION MRI THEORY, V4; Fernandes-Cabral DT, 2016, WORLD NEUROSURG, V92, DOI 10.1016/j.wneu.2016.04.128; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fernandez-Miranda JC, 2010, J NEUROSURG, V113, P990, DOI 10.3171/2009.10.JNS09933; Ferreira AM, 2014, MED DEVICES-EVID RES, V7, P115, DOI 10.2147/MDER.S44063; Fieremans E., 2009, THESIS; Fieremans E, 2008, PHYS MED BIOL, V53, P5405, DOI 10.1088/0031-9155/53/19/009; Freberg L., 2010, DISCOVERING BIOL PSY; Giannelli M., 2010, J APPL CLIN MED PHYS, V11, P1; Guise C, 2014, STUD HEALTH TECHNOL, V207, P163, DOI 10.3233/978-1-61499-474-9-163; Haider L, 2016, BRAIN, V139, P807, DOI 10.1093/brain/awv398; Hubbard PL, 2015, MAGN RESON MED, V73, P299, DOI 10.1002/mrm.25107; Hubbard PL, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P353, DOI 10.1016/B978-0-12-374709-9.00016-X; Jirak D., 2006, TEXTURE ANAL MAGNETI; Kim EY, 2008, KOREAN J RADIOL, V9, P391, DOI 10.3348/kjr.2008.9.5.391; Kochunov P, 2007, NEUROIMAGE, V35, P478, DOI 10.1016/j.neuroimage.2006.12.021; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Longo C, 2011, MATER RES-IBERO-AM J, V14, P442, DOI [10.1590/S1516-14392011000400003, 10.1590/S1516-14392011005000080]; MCROBBIE DW, 2006, MRI PICTURE PROTON; Meyabadi TF, 2010, J TEXT I, V101, P527, DOI 10.1080/00405000802561085; Nimsky C., 2016, ADV TECHNICAL STANDA, V43; OECD, 2019, MAGNETIC RESONANCE I, DOI [10.1787/1d89353f-en, DOI 10.1787/1D89353F-EN]; Oh TH, 1998, J APPL POLYM SCI, V68, P1209, DOI 10.1002/(SICI)1097-4628(19980523)68:8<1209::AID-APP2>3.3.CO;2-H; Pathak S. K., 2015, THESIS; Poupon C, 2008, MAGN RESON MED, V60, P1276, DOI 10.1002/mrm.21789; Presson N, 2015, MIL MED, V180, P109, DOI 10.7205/MILMED-D-14-00413; Pullens P, 2011, ANISOTROPIC PHANTOM; Richardson S, 2013, MAGN RESON MED, V69, P1603, DOI 10.1002/mrm.24410; Roy MD., 2014, INT J TEXT SCI, V3, P44; Rwei SP, 2001, J APPL POLYM SCI, V82, P2896, DOI 10.1002/app.2145.abs; SANTHOSKUMAR AU, 2010, J BIOREMED BIODEGRAD, V1, P1; Shin SS, 2014, PROG NEUROL SURG, V28, P86, DOI 10.1159/000358767; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Thomason ME, 2011, ANNU REV CLIN PSYCHO, V7, P63, DOI 10.1146/annurev-clinpsy-032210-104507; WEI QF, 2002, J IND TEXT, V32, P59; Zhou FL, 2012, ACS APPL MATER INTER, V4, P6311, DOI 10.1021/am301919s; Zuccolotto A., 2012, MRI HIGH DEFINITION; Zuccolotto A. P., 2016, Patent, Patent No. [WO/2016/007939, 007939]; Zulkifli Mohamad A., 2012, POLYPROPYLENE; [No title captured]	52	14	14	0	17	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244			ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	NOV 9	2016	8	44					29960	29967		10.1021/acsami.6b09809			8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science	EB9SK	WOS:000387737200015	27723307				2022-02-06	
J	Harada, K; Matsuo, K; Nakashima, M; Hobara, T; Higuchi, N; Higuchi, F; Nakano, M; Otsuki, K; Shibata, T; Watanuki, T; Matsubara, T; Fujita, Y; Shimoji, K; Yamagata, H; Watanabe, Y				Harada, Kenichiro; Matsuo, Koji; Nakashima, Mami; Hobara, Teruyuki; Higuchi, Naoko; Higuchi, Fumihiro; Nakano, Masayuki; Otsuki, Koji; Shibata, Tomohiko; Watanuki, Toshio; Matsubara, Toshio; Fujita, Yusuke; Shimoji, Keigo; Yamagata, Hirotaka; Watanabe, Yoshifumi			Disrupted orbitomedial prefrontal limbic network in individuals with later-life depression	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Medial frontal; MRI; Diffusion tensor; Uncinate fasciculus; Voxel-based morphometry	WHITE-MATTER ABNORMALITIES; TRAUMATIC BRAIN-INJURY; UNCINATE FASCICULUS; GREY-MATTER; CORTEX; HYPERINTENSITIES; TRACTOGRAPHY; METAANALYSIS; ASSOCIATION; INTEGRITY	Background: Depression in old age is an increasing contributor to poor health and accompanying health care costs. Although there is an abundance of literature on later-life depression (LLD), the neural correlates have not been clarified. The aim of this study was to determine whether patients with LLD show abnormal gray matter volume (GMV) and white matter integrity by using multiple image analysis methods. Methods: The study included 45 patients with LLD and 61 healthy participants who were matched for age, sex, years of education, and vascular risk factors. GMV was examined using voxel-based morphometry, while the white matter integrity was determined by tract-based spatial statistics and tract-specific analysis, which were obtained from high-resolution magnetic resonance images. Results: Patients with LLD showed significantly less GMV in the orbitofrontal cortex, anterior cingulate, insula, amygdala, and temporal regions, as well as higher fractional anisotropy in the uncinate fasciculus, compared with healthy participants. Patients with LLD who had reduced orbitofrontal and insular GMV had more severe clinical variables. The reduced orbitofrontal GMV was associated with higher fractional anisotropy in the uncinate fasciculus. Limitation: The effects of medication should also be considered when interpreting the results of this study. Conclusion: Our results suggest that regional GMV is linked to white matter integrity of the uncinate fasciculus in the orbitomedial prefrontal limbic network, and the disruption of this network may be involved in the pathophysiology of LLD. (C) 2016 Elsevier B.V. All rights reserved.	[Harada, Kenichiro; Matsuo, Koji; Nakashima, Mami; Hobara, Teruyuki; Higuchi, Naoko; Higuchi, Fumihiro; Nakano, Masayuki; Otsuki, Koji; Shibata, Tomohiko; Watanuki, Toshio; Matsubara, Toshio; Yamagata, Hirotaka; Watanabe, Yoshifumi] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, 1-1-1 Minamiko Gushi, Ube, Yamaguchi 7558505, Japan; [Nakashima, Mami] Nagato Ichinomiya Hosp, Shimonoseki, Yamaguchi, Japan; [Hobara, Teruyuki] Yamaguchi Grand Med Ctr, Dept Psychiat, Hofu, Yamaguchi, Japan; [Nakano, Masayuki] Katakura Hosp, Ube, Yamaguchi, Japan; [Otsuki, Koji] Konan Hosp, Matsue, Shimane, Japan; [Shibata, Tomohiko] Shinwaen Hosp, Onoda, Yamaguchi, Japan; [Matsubara, Toshio] Yamaguchi Univ, Org Univ Educ, Hlth Adm Ctr, Yamaguchi, Yamaguchi, Japan; [Fujita, Yusuke] Yamaguchi Univ, Grad Sch Med, Dept Biomol Engn Appl Mol Biosci, Ube, Yamaguchi, Japan; [Shimoji, Keigo] Tokyo Metropolitan Geriatr Hosp, Dept Radiol, Tokyo, Japan		Matsuo, K (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, 1-1-1 Minamiko Gushi, Ube, Yamaguchi 7558505, Japan.	kmatsuo@yamaguchi-u.ac.jp			Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Education, Science, Sports, and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24591716, 15K09832]	This work was supported by Grants-in-Aid for "Integrated research on neuropsychiatric disorders" from the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports, and Culture of Japan and JSPS KAKENHI Grant numbers 24591716 and 15K09832.	Aghajani M, 2014, PSYCHOL MED, V44, P2287, DOI 10.1017/S0033291713003000; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Alves GS, 2012, PSYCHIAT RES-NEUROIM, V203, P194, DOI 10.1016/j.pscychresns.2011.12.006; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andreescu C, 2008, NEUROPSYCHOPHARMACOL, V33, P2566, DOI 10.1038/sj.npp.1301655; Arnone D, 2013, MOL PSYCHIATR, V18, P1265, DOI 10.1038/mp.2012.150; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; BALDWIN RC, 1995, BRIT J PSYCHIAT, V167, P649, DOI 10.1192/bjp.167.5.649; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bezerra DM, 2012, J PSYCHIATR RES, V46, P1643, DOI 10.1016/j.jpsychires.2012.09.001; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Bracht T, 2015, J AFFECT DISORDERS, V170, P143, DOI 10.1016/j.jad.2014.08.031; Catani M, 2006, CURR OPIN NEUROL, V19, P599, DOI 10.1097/01.wco.0000247610.44106.3f; Charlton RA, 2015, AM J GERIAT PSYCHIAT, V23, P642, DOI 10.1016/j.jagp.2014.07.008; Choi KS, 2014, NEUROPSYCHOPHARMACOL, V39, P1332, DOI 10.1038/npp.2013.345; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; Dalby RB, 2010, PSYCHIAT RES-NEUROIM, V184, P38, DOI 10.1016/j.pscychresns.2010.06.008; Della Nave R, 2010, AM J NEURORADIOL, V31, P1675, DOI 10.3174/ajnr.A2128; Du MY, 2014, J PSYCHIATR NEUROSCI, V39, P397, DOI 10.1503/jpn.130275; Egger K, 2008, PSYCHIAT RES-NEUROIM, V164, P237, DOI 10.1016/j.pscychresns.2007.12.018; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Greenwald BS, 1996, AM J PSYCHIAT, V153, P1212; Guo WB, 2014, J AFFECT DISORDERS, V163, P70, DOI 10.1016/j.jad.2014.03.044; Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Klauser P, 2015, J AFFECT DISORDERS, V173, P45, DOI 10.1016/j.jad.2014.10.041; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Lai CH, 2013, PSYCHIAT RES-NEUROIM, V211, P37, DOI 10.1016/j.pscychresns.2012.06.006; Lavretsky H, 2007, AM J GERIAT PSYCHIAT, V15, P386, DOI 10.1097/JGP.0b013e3180325a16; Lesser IM, 1996, AM J PSYCHIAT, V153, P1280; Mai JK., 2008, ATLAS HUMAN BRAIN; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Martino J, 2014, CLIN ANAT, V27, P563, DOI 10.1002/ca.22321; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Rajkowska G, 2005, BIOL PSYCHIAT, V58, P297, DOI 10.1016/j.biopsych.2005.04.013; Sexton CE, 2012, ARCH GEN PSYCHIAT, V69, P680, DOI 10.1001/archgenpsychiatry.2011.1862; Shimony JS, 2009, BIOL PSYCHIAT, V66, P245, DOI 10.1016/j.biopsych.2009.02.032; Taylor Warren D, 2007, Neuropsychiatr Dis Treat, V3, P669; Taylor WD, 2003, BIOL PSYCHIAT, V53, P144, DOI 10.1016/S0006-3223(02)01490-7; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Vu NQ, 2013, CURR OPIN NEUROL, V26, P656, DOI 10.1097/WCO.0000000000000028; Weber K, 2010, J AFFECT DISORDERS, V124, P275, DOI 10.1016/j.jad.2009.11.016; Wen MC, 2014, INT J GERIATR PSYCH, V29, P1173, DOI 10.1002/gps.4129; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Yasmin H, 2009, NEURORADIOLOGY, V51, P831, DOI 10.1007/s00234-009-0580-1; Yuan YG, 2008, BIOL PSYCHIAT, V64, P541, DOI 10.1016/j.biopsych.2008.04.032; Yuen GS, 2014, J AFFECT DISORDERS, V166, P179, DOI 10.1016/j.jad.2014.05.008; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zhang AF, 2012, NEUROPSYCHOPHARMACOL, V37, P959, DOI 10.1038/npp.2011.279; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	56	14	14	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	NOV 1	2016	204						112	119		10.1016/j.jad.2016.06.031			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	DW7FT	WOS:000383817300016	27344619				2022-02-06	
J	Hugentobler, JA; Gupta, R; Slater, R; Paterno, MV; Riley, MA; Quatman-Yates, C				Hugentobler, Jason A.; Gupta, Resmi; Slater, Robert; Paterno, Mark V.; Riley, Michael A.; Quatman-Yates, Catherine			Influence of Age on Postconcussive Postural Control Measures and Future Implications for Assessment	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; postural sway; balance; adolescents	SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; CEREBRAL CONCUSSION; BRAIN-INJURY; BALANCE; CHILDREN; MANAGEMENT; STABILITY; ADOLESCENTS; VARIABILITY	Objective: To examine the influence of age, sex, attention-deficit hyperactivity disorder (ADHD) status, previous history of concussion, and days since injury on postconcussion postural control assessment in adolescents who have suffered a concussion. Design: Prospective cohort study. Setting: Hospital-based outpatient clinic. Participants: Seventy-one participants (42 males; 29 females) with mean age 14.14 +/- 2.44. Independent Variables: Age, sex, previous concussion history, ADHD status, total and severity of postconcussion symptoms, and days since injury. Main Outcome Measures: Total Balance Error Scoring System score, path length, center-of-pressure (COP) area, sample entropy, and Romberg quotient. Results: Pearson product-moment correlation coefficients were calculated to test for potential associations between the continuous participant characteristics and the postural control variables. Spearman correlation was used to test the association between symptom severity and the postural control variables. Standard multiple regression was used to model the extent to which participant characteristics accounted for the variance in the postural sway variables. Age was significantly associated with all of the postural sway variables except COP area for the eyes open condition and sample entropy in the anterior-posterior direction for the eyes closed condition. Sex, ADHD status, and previous concussion history did not significantly predict postural control scores. Conclusions: Age significantly influences scores on common postconcussion postural control assessments.	[Hugentobler, Jason A.; Paterno, Mark V.; Quatman-Yates, Catherine] Cincinnati Childrens Hosp Med Ctr, Dept Occupat Therapy & Phys Therapy, Cincinnati, OH 45229 USA; [Gupta, Resmi] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Slater, Robert] Univ Cincinnati, Cincinnati, OH USA; [Paterno, Mark V.; Quatman-Yates, Catherine] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Riley, Michael A.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Riley, Michael A.] Univ Cincinnati, Ctr Cognit Act & Percept, Cincinnati, OH USA		Hugentobler, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, 2800 Winslow Ave,Suite 3100,MLC 10001, Cincinnati, OH 45206 USA.	jason.hugentobler@cchmc.org	Quatman-Yates, Catherine/U-9580-2019; Quatman-Yates, Catherine/AAK-4507-2021		CCHMC Patient Services	C.Q.-Y. received internal grant funding from CCHMC Patient Services that provided equipment, human resources, and PI time to pursue this project. The other authors report no conflicts of interest.	[Anonymous], 2014, J ORTHOP SPORT PHYS, V44, pA159; [Anonymous], 2012, J ORTHOP SPORT PHYS, V42, pA41; [Anonymous], YOUTH SPORTS STAT; Barozzi S, 2014, EUR ARCH OTO-RHINO-L, V271, P2069, DOI 10.1007/s00405-014-2930-9; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Claeys K, 2011, EUR J APPL PHYSIOL, V111, P115, DOI 10.1007/s00421-010-1637-x; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Cumberworth VL, 2007, J LARYNGOL OTOL, V121, P449, DOI 10.1017/S0022215106004051; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Dusing SC, 2013, DEV PSYCHOBIOL, V55, P404, DOI 10.1002/dev.21045; Forte R, 2014, AGING CLIN EXP RES, V26, P645, DOI 10.1007/s40520-014-0216-0; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Jeter PE, 2014, J ALTERN COMPLEM MED, V20, P221, DOI 10.1089/acm.2013.0378; Kuznetsov N., 2014, COMPLEX SYSTEMS SPOR; Legrand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035301; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Ni M, 2014, ARCH PHYS MED REHAB, V95, P1620, DOI 10.1016/j.apmr.2014.04.022; Palmieri RM, 2002, J SPORT REHABIL, V11, P51, DOI 10.1123/jsr.11.1.51; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Quatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32, DOI 10.3810/psm.2014.09.2073; Quatman-Yates CC, 2013, INT J SPORTS PHYS TH, V8, P741; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; Runge Larsen L, 2014, BRIT J SPORT MED, V48, P622; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; Shorer Z, 2012, EUR J PEDIATR, V171, P1087, DOI 10.1007/s00431-012-1695-7; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Tsai CL, 2008, HUM MOVEMENT SCI, V27, P142, DOI 10.1016/j.humov.2007.08.002; Valovich TC, 2003, J ATHL TRAINING, V38, P51	45	14	14	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2016	26	6					510	517		10.1097/JSM.0000000000000286			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	EB6DO	WOS:000387471600012	27347855				2022-02-06	
J	Konczalla, J; Wanderer, S; Mrosek, J; Gueresir, E; Schuss, P; Platz, J; Seifert, V; Vatter, H				Konczalla, Juergen; Wanderer, Stefan; Mrosek, Jan; Gueresir, Erdem; Schuss, Patrick; Platz, Johannes; Seifert, Volker; Vatter, Hartmut			Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?	ACTA NEUROCHIRURGICA			English	Article						Levosimendan; dCVS; Delayed cerebral vasospasm; Takotsubo cardiomyopathy; Subarachnoid hemorrhage; SAH; ET-(A) receptor; ET-(B-1) receptor; ET-1; Endothelin; Prostaglandin F2alpha; PGF	ENDOTHELIN-B RECEPTORS; CEREBROSPINAL-FLUID; REPERFUSION INJURY; CARDIOGENIC-SHOCK; BASILAR ARTERY; BRAIN-INJURY; SPINAL-CORD; IN-VITRO; RAT; ISCHEMIA	Under physiological cerebral conditions, levosimendan, a calcium-channel sensitizer, has a dose-dependent antagonistic effect on prostaglandin F2alpha (PGF)-induced vasoconstriction. This circumstance could be used in antagonizing delayed cerebral vasospasm (dCVS), one of the main complications after subarachnoid hemorrhage (SAH), leading to delayed cerebral ischemia and ischemic neurological deficits. Data already exist that identified neuroprotective effects of levosimendan in a traumatic brain injury model and additionally, it has been proven that this compound prevents narrowing of the basilar artery (BA) luminal area after SAH in an in vitro rabbit model. Takotsubo cardiomyopathy, a severe ventricular dysfunction, is also a well-known complication after SAH, associated with pulmonary edema and prolonged intubation. The polypeptide endothelin-1 (ET-1) plays a key role in the development of dCVS after SAH. Therefore, the aim of the present investigation was to detect functional interactions between the calcium-sensitizing and the ET-1-dependent vasoconstriction after experimental-induced SAH; interactions between levosimendan and a substrate-specific vasorelaxation in the BA were also examined. It was reviewed whether levosimendan has a beneficial influence on endothelin(A) and/or endothelin(B-1) receptors (ET-(A) and ET-(B-1) receptors) in cerebral vessels after SAH. We also examined whether this drug could have antagonistic effects on a PGF-induced vasoconstriction. Under treatment with levosimendan after SAH, the endothelin system seems to be affected. The ET-1-induced contraction is decreased, not significantly. In addition, we detected changes in the nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway. Preincubation with levosimendan causes a modulatory effect on the ET-(B-1) receptor-dependent vasorelaxation. It induces an upregulation of the NO-cGMP pathway with a significantly increased relaxation. Even after PGF-induced precontraction a dose-dependent relaxation was registered, which was significantly higher (E-max) and earlier (pD(2)) compared to the concentration-effect curve without levosimendan. After experimental-induced dCVS, levosimendan seems to restore the well-known impaired function of the vasorelaxant ET-(B-1) receptor. Levosimendan also reversed the PGF-induced contraction dose-dependently. Both of these mechanisms could be used for antagonizing dCVS in patients suffering SAH. Levosimendan could even be used additionally in treating patients developing takotsubo cardiomyopathy.	[Konczalla, Juergen; Mrosek, Jan; Platz, Johannes; Seifert, Volker] Goethe Univ Frankfurt, Dept Neurosurg, Frankfurt, Germany; [Wanderer, Stefan] Inselspital Univ Hosp Bern, Dept Neurosurg, Freiburgstr 4, CH-3010 Bern, Switzerland; [Gueresir, Erdem; Schuss, Patrick; Vatter, Hartmut] Univ Bonn, Dept Neurosurg, Bonn, Germany		Wanderer, S (corresponding author), Inselspital Univ Hosp Bern, Dept Neurosurg, Freiburgstr 4, CH-3010 Bern, Switzerland.	stefan.wanderer@insel.ch	Guresir, Erdem/AAV-7224-2021; Konczalla, Juergen/AAJ-8528-2021; Guresir, Erdem/AAL-4484-2020; Schuss, Patrick/ABC-6469-2020	Guresir, Erdem/0000-0001-8319-0847; Schuss, Patrick/0000-0002-5806-2576; Konczalla, Juergen/0000-0001-9771-7806			Antonini M, 2010, ACTA ANAESTH SCAND, V54, P119, DOI 10.1111/j.1399-6576.2009.02105.x; Archan S, 2008, CURR OPIN ANESTHESIO, V21, P78, DOI 10.1097/ACO.0b013e3282f357a5; Asaeda M, 2005, NEUROSCI LETT, V373, P222, DOI 10.1016/j.neulet.2004.10.008; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Busani S, 2010, J TRAUMA, V68, pE108, DOI 10.1097/TA.0b013e31817c4284; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Dreier JP, 2013, ACTA NEUROCHIR SUPPL, V115, P125, DOI 10.1007/978-3-7091-1192-5_26; Figgitt DP, 2001, DRUGS, V61, P613, DOI 10.2165/00003495-200161050-00006; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Guresir E, 2013, J NEUROL SCI, V332, P128, DOI 10.1016/j.jns.2013.07.004; Hansen-Schwartz J, 2004, ACTA NEUROL SCAND, V109, P33, DOI 10.1034/j.1600-0404.2003.00170.x; Hein M, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-106; Jensen H, 2011, SCAND CARDIOVASC J, V45, P307, DOI 10.3109/14017431.2011.583356; Karakus E, 2013, BASIC CLIN PHARMACOL, V112, P156, DOI 10.1111/bcpt.12004; Karvouniaris M, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2011.02.030; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KASSELL NF, 1982, NEUROSURGERY, V11, P337, DOI 10.1227/00006123-198209000-00001; Katircioglu SF, 2008, J CARDIAC SURG, V23, P44, DOI 10.1111/j.1540-8191.2007.00486.x; KITAZONO T, 1995, J PHARMACOL EXP THER, V273, P1; Konczalla J, 2006, EXP BIOL MED, V231, P1064; Konczalla J, 2016, WORLD NEUROSURG, V88, P488, DOI 10.1016/j.wneu.2015.10.033; Konczalla J, 2013, CURR NEUROVASC RES, V10, P335, DOI 10.2174/15672026113109990030; Konczalla J, 2013, CURR NEUROVASC RES, V10, P126, DOI 10.2174/1567202611310020005; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; Lafci B, 2008, EUR SURG RES, V41, P1, DOI 10.1159/000121394; Mayer SA, 1999, STROKE, V30, P780, DOI 10.1161/01.STR.30.4.780; MAYER SA, 1995, J NEUROSURG, V83, P889, DOI 10.3171/jns.1995.83.5.0889; Nilsson T, 1997, NEUROSURGERY, V40, P346, DOI 10.1097/00006123-199702000-00023; Padayachee L, 2007, HEART LUNG CIRC S3, V16, P65; Papanikolaou J, 2014, INT J CARDIOL, V176, P1435, DOI 10.1016/j.ijcard.2014.08.039; Provencio JJ, 2013, ACTA NEUROCHIR SUPPL, V115, P233, DOI 10.1007/978-3-7091-1192-5_42; Roehl AB, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-81; Roehl AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-97; SALOM JB, 1995, CEREBROVAS BRAIN MET, V7, P131; Santoro F, 2013, CARDIOVASC THER, V31, pE133, DOI 10.1111/1755-5922.12047; SCHILLING L, 1995, J CEREBR BLOOD F MET, V15, P699, DOI 10.1038/jcbfm.1995.86; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; SEIFERT V, 1987, SURG NEUROL, V27, P243, DOI 10.1016/0090-3019(87)90037-1; Taccone FS, 2013, INTENS CARE MED, V39, P1497, DOI 10.1007/s00134-013-2945-5; Tung P, 2004, STROKE, V35, P548, DOI 10.1161/01.STR.0000114874.96688.54; Vatter H, 2006, NEUROSURGERY, V58, P1190, DOI 10.1227/01.NEU.0000199346.74649.66; Vatter H, 2002, NEUROSURGERY, V51, P445, DOI 10.1097/00006123-200208000-00027; Vatter H, 2007, J NEUROSURG, V107, P121, DOI 10.3171/JNS-07/07/0121; Vatter H, 2007, NEUROSURGERY, V60, P1100, DOI 10.1227/01.NEU.0000255471.75752.4B; Vatter H, 2011, ACTA NEUROCHIR SUPPL, V110, P177, DOI 10.1007/978-3-7091-0353-1_31	45	14	16	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2016	158	11					2075	2083		10.1007/s00701-016-2939-5			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EA1OR	WOS:000386362200008	27614436				2022-02-06	
J	Pfaller, AY; Nelson, LD; Apps, JN; Walter, KD; McCrea, MA				Pfaller, Adam Y.; Nelson, Lindsay D.; Apps, Jennifer N.; Walter, Kevin D.; McCrea, Michael A.			Frequency and Outcomes of a Symptom-Free Waiting Period After Sport-Related Concussion	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; sports; head injury; mild traumatic brain injury; symptom-free waiting period; clinical management	INTERNATIONAL-CONFERENCE; STANDARDIZED ASSESSMENT; CONSENSUS STATEMENT; HEAD-INJURY; HIGH-SCHOOL; FOOTBALL; MANAGEMENT; PLAYERS; ZURICH	Background: Guidelines and practices for the management of sport-related concussion (SRC) have evolved swiftly over the past 2 decades. Despite common recommendations for a symptom-free waiting period (SFWP) before returning to sport, past reports have suggested poor utilization rates for this intervention. Purpose: To obtain current estimates of the utilization and characterization of SFWPs with high school and collegiate athletes. Study Design: Descriptive epidemiology study. Methods: Data were extracted from a larger prospective study that followed athletes with SRC across 13 institutions in southeastern Wisconsin from 2012 to 2014. Participants included 143 contact and collision sport athletes who were followed serially through their recoveries after SRCs. Results: In the current study sample, 99.3% of athletes used an SFWP. The mean self-reported symptom duration was 6.35 days (median, 5 days), with 72.7% reporting symptom recovery within 1 week of injury, 93.7% within 2 weeks, and 99.3% within 30 days. Rate of same-season repeat concussion was low (3.8%) and was similar to or lower than the overall rate of concussion (4.3%). Five same-season repeat concussions occurred at a range of 8 to 42 days after initial injuries. Conclusion: In comparison with prior published data collected from 1999 to 2004, utilization and duration of SFWPs were higher in the current study samples (99.3% vs 60.3% of athletes reported an SFWP; mean duration, 6.1 vs 3.2 days), and athletes were withheld from sports for more days than previously reported (12.3 vs 7.4 days). Rate of same-season repeat concussion was equivalent to that of prior published data. The findings support improved adherence to clinical management guidelines through increased utilization of SFWPs after SRC.	[Pfaller, Adam Y.; Nelson, Lindsay D.; Apps, Jennifer N.; Walter, Kevin D.; McCrea, Michael A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Pfaller, Adam Y.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Apps, Jennifer N.] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA; [Walter, Kevin D.] Med Coll Wisconsin, Dept Orthopaed Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Walter, Kevin D.] Childrens Hosp Wisconsin, Dept Pediat & Adolescent Sports Med, Milwaukee, WI 53201 USA		Pfaller, AY (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	apfaller@mcw.edu			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; Clinical and Translational Science Institute [1ULI-RR031973 (-01)]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8ULITR000055]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031973] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: This work was supported by the US Army Medical Research and Materiel Command (award No. W81XWH-12-1-0004). The REDCap electronic database service used for the study was supported by the Clinical and Translational Science Institute (grant 1ULI-RR031973 (-01)) and by the National Center for Advancing Translational Sciences, National Institutes of Health (grant 8ULITR000055).	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Colorado Medical Society School and Sports Medicine Committee, 1990, COLO MED, V87, P4; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Helmick K, 2006, DEFENSE VETERANS BRA, P1; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Kelly JP, 1997, NEUROLOGY, V48, P581; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; National Collegiate Athletic Association, CONC GUID DIAGN MAN; National Federation of State High School Associations, REP JUL 2014 NFHS CO; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wisconsin Interscholastic Athletic Association, WIAA CONC POL	29	14	14	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	NOV	2016	44	11					2941	2946		10.1177/0363546516651821			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	EB4RE	WOS:000387359900007	27371548	Green Accepted			2022-02-06	
J	Ramli, R; Oxley, J				Ramli, Roszalina; Oxley, Jennie			Motorcycle helmet fixation status is more crucial than helmet type in providing protection to the head	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Helmet fixation; Helmet type; Motorcycle; Head injury	TRAUMATIC BRAIN-INJURY; FACIAL INJURIES; CRASH SEVERITY; COLLISIONS; ACCIDENTS; DESIGN; RIDERS; RISK; PAIN	Introduction: In Malaysia, motorcyclists continue to outnumber other road users in injuries and deaths. The objective of this study was to determine the association between helmet fixation and helmet type with head injury and severity of head injury among Malaysian motorcyclists. Methods: The study design was a prospective cross-sectional study. The participants involved injured motorcyclists who were admitted in five selected hospitals in Klang Valley, Malaysia. Participants who sustained head injury were selected as the cases while those with injury below the neck (IBN) were selected as the controls. Questionnaire comprising motorcyclist, vehicle, helmet and crash factors was examined. Diagnoses of injuries were obtained from the participants' medical records. Results: The total subjects with head injuries were 404 while those with IBN were 235. Majority of the cases (76.2%) and controls (80.4%) wore the half-head and open-face helmets, followed by the tropical helmets (5.4% and 6.0% of the cases and controls, respectively). Full-face helmets were used by 1.2% of the cases and 4.7% of the controls. 5.7% of the cases and 6.0% of the controls did not wear a helmet. 32.7% of the cases and 77.4% of the controls had their helmets fixed. Motorcyclists with ejected helmets were five times as likely to sustain head injury [adjusted odds ratio, AOR 5.73 (95% CI 3.38-9.73)] and four times as likely to sustain severe head injury [AOR of 4.83 (95% CI 2.76-8.45)]. The half head and open face helmets had AOR of 0.24 (95% CI 0.10-0.56) for severe head injury when compared to motorcyclists who did not wear a helmet. Conclusion: Helmet fixation is more effective than helmet type in providing protection to the motorcyclists. (C) 2016 Elsevier Ltd. All rights reserved.	[Ramli, Roszalina] Univ Kebangsaan Malaysia, Med Ctr, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Oxley, Jennie] Monash Univ, MIRI, Clayton, Vic, Australia		Ramli, R (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Dept Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia.	roszalina@ppukm.ukm.edu.my; jennie.oxley@monash.edu		Oxley, Jennie/0000-0002-7519-1994; Ramli, Roszalina/0000-0001-7445-0205			APROSYS, 2006, REP PERF RID PROT DE; Aziz A. A A., 1999, INT MED RES J, V3, P115; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; CANNELL H, 1982, BRIT J ORAL SURG, V20, P183, DOI 10.1016/S0007-117X(82)80036-X; Clay FJ, 2010, J PAIN, V11, P420, DOI 10.1016/j.jpain.2009.12.002; Conrad P, 1996, ACCIDENT ANAL PREV, V28, P193, DOI 10.1016/0001-4575(95)00056-9; Croft AC, 2005, MED SCI MONITOR, V11, pRA316; Department of Statistics (Malaysia), 2010, POP HOUS CENS MAL 20; Elliott MR, 2003, ACCIDENT ANAL PREV, V35, P833, DOI 10.1016/S0001-4575(02)00088-X; Fitzharris M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-11; Fleiss J, 2004, STAT METHODS RATES P; GILCHRIST A, 1988, ERGONOMICS, V31, P1395, DOI 10.1080/00140138808966784; Gustafsson H, SAE TECHNICAL PAPER; Hung DV, 2006, INJURY PREV, V12, P409, DOI 10.1136/ip.2006.012724; Hurt HH, 1998, P 16 ENH SAF VEH C, P2323; Kelsey JL., 1996, METHODS OBSERVATIONA; Kuala Lumpur City Hall, 2003, KUAL LUMP STRUCT PLA; Kulanthayan S., 2001, CRASH PREVENTION INJ, V2, P239; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Li LP, 2008, ACCIDENT ANAL PREV, V40, P1937, DOI 10.1016/j.aap.2008.06.019; Lin MR, 2004, NEUROEPIDEMIOLOGY, V23, P269, DOI 10.1159/000080091; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Luchter S, SAE TECHNICAL PAPER, P1; Nunn S, 2011, J FORENSIC SCI, V56, P429, DOI 10.1111/j.1556-4029.2010.01657.x; OpenEpi,, 2011, OP SOURC EP STAT PUB; ORSAY EM, 1994, ANN EMERG MED, V23, P802, DOI 10.1016/S0196-0644(94)70317-5; PATEL R, 1993, APPL ERGON, V24, P427, DOI 10.1016/0003-6870(93)90175-9; Pedder J, P IRCOBI C; Ramli R, 2013, THESIS; Ramli R, 2008, J CRANIOFAC SURG, V19, P316, DOI 10.1097/SCS.0b013e318163f94d; Ramli R, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-17; Rivara F P, 1999, Inj Prev, V5, P194; Rowland J, 1996, AM J PUBLIC HEALTH, V86, P41, DOI 10.2105/AJPH.86.1.41; Royal Malaysia Police, 2013, COMMUNICATION; Royal Malaysian Police, 2010, STAT REP ROAD ACC MA; RUTLEDGE R, 1993, ACCIDENT ANAL PREV, V25, P347, DOI 10.1016/0001-4575(93)90028-U; Sarani A, 2011, ADSA FACT SHEET, V1, P1; Sauter Carley, 2005, WMJ, V104, P39; SHIBATA A, 1994, ACCIDENT ANAL PREV, V26, P391, DOI 10.1016/0001-4575(94)90013-2; Thai KT, P 17 WORLD C ERG; Thom HH, 1981, MOTORCYCLE ACCIDENT, V1; Thompson D.C., 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001855, DOI 10.1002/14651858.CD001855]; TSAI YJ, 1995, AM J EPIDEMIOL, V142, P974, DOI 10.1093/oxfordjournals.aje.a117746; Van den Oord MHAH, 2012, APPL ERGON, V43, P958, DOI 10.1016/j.apergo.2012.01.004; VAUGHAN RG, 1977, MED J AUSTRALIA, V1, P125, DOI 10.5694/j.1326-5377.1977.tb130562.x; WHO, 2006, HELM ROAD SAF MAN DE; World Health Organization, 2009, GLOB STAT REP ROAD S; Xuequn Y, 2011, ACCIDENT ANAL PREV, V43, P214, DOI 10.1016/j.aap.2010.08.012; Yu WY, 2011, INT J EPIDEMIOL, V40, P794, DOI 10.1093/ije/dyr040	49	14	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	NOV	2016	47	11					2442	2449		10.1016/j.injury.2016.09.022			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EC5IE	WOS:000388167000007	27645615				2022-02-06	
J	Ransom, DM; Burns, AR; Youngstrom, EA; Vaughan, CG; Sady, MD; Gioia, GA				Ransom, Danielle M.; Burns, Alison R.; Youngstrom, Eric A.; Vaughan, Christopher G.; Sady, Maegan D.; Gioia, Gerard A.			Applying an Evidence-Based Assessment Model to Identify Students at Risk for Perceived Academic Problems following Concussion	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injury; Post-concussion symptoms; Pediatrics; Receiver operating characteristic; Academics; Evidence based practice	CHILDREN; PSYCHOLOGY; INVENTORY; INJURY; SPORT	Objectives: The aim of this study was to demonstrate the utility of an evidence-based assessment (EBA) model to establish a multimodal set of tools for identifying students at risk for perceived post-injury academic problems. Methods: Participants included 142 students diagnosed with concussion (age: M=14.95; SD=1.80; 59% male), evaluated within 4 weeks of injury (median=16 days). Demographics, pre-injury history, self- and parent-report measures assessing symptom severity and executive functions, and cognitive test performance were examined as predictors of self-reported post-injury academic problems. Results: Latent class analysis categorized participants into high (44%) and low (56%) levels of self-reported academic problems. Receiver operating characteristic analyses revealed significant discriminative validity for self- and parent-reported symptom severity and executive dysfunction and self-reported exertional response for identifying students reporting low versus high academic problems. Parent-reported symptom ratings [area under the receiver operating characteristic curve (AUC)=.79] and executive dysfunction (AUC=.74), and self-reported ratings of executive dysfunction (AUC=.84), symptoms (AUC=.80), and exertional response (AUC=.70) each classified students significantly better than chance (ps<.001). Hierarchical logistic regression indicated that, of the above, self-reported symptoms and executive dysfunction accounted for the most variance in the prediction of self-reported academic problems. Conclusions: Post-concussion symptom severity and executive dysfunction significantly predict perceived post-injury academic problems. EBA modeling identified the strongest set of predictors of academic challenges, offering an important perspective in the management of concussion by applying traditional strengths of neuropsychological assessment to clinical decision making.	[Ransom, Danielle M.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Burns, Alison R.; Vaughan, Christopher G.; Sady, Maegan D.; Gioia, Gerard A.] Childrens Natl Hlth Syst, Washington, DC USA; [Burns, Alison R.; Vaughan, Christopher G.; Sady, Maegan D.; Gioia, Gerard A.] George Washington Univ, Sch Med, Washington, DC USA; [Youngstrom, Eric A.] Univ N Carolina, Chapel Hill, NC USA		Gioia, GA (corresponding author), Childrens Natl Med Ctr, Div Neuropsychol, 15425 Shady Grove Rd,Suite 350, Rockville, MD 20850 USA.	ggioia@childrensnational.org	Youngstrom, Eric A./ABE-3258-2020	Youngstrom, Eric A./0000-0003-2251-6860	Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center (IDDRC) [P30HD040677]; Clinical and Translational Science Award [UL1TR000075]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD040677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000075] Funding Source: NIH RePORTER	This work was supported by the Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center (IDDRC; P30HD040677) and the Clinical and Translational Science Award (UL1TR000075).	Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Center for Disease Control and Prevention & National Center for Injury Prevention and Control, 2015, WHAT AR SIGNS SYMPT; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Findling RL, 2013, BIPOLAR DISORD, V15, P669, DOI 10.1111/bdi.12100; Gioia G. A., 2014, J CHILD NEUROL; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Hagenaars JA, 2002, APPL LATENT CLASS AN; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hunsley J, 2007, ANNU REV CLIN PSYCHO, V3, P29, DOI 10.1146/annurev.clinpsy.3.022806.091419; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kraemer HC, 1999, PSYCHOL METHODS, V4, P257, DOI 10.1037/1082-989X.4.3.257; Kraemer HC, 1992, EVALUATING MED TESTS; Lovell M, 2000, IMPACT IMMEDIATE POS; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCutcheon Allan L.., 1987, LATENT CLASS ANAL; McGill C., 2011, J INT NEUROPSYCH SOC, V17, P297; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Newman JB, 2013, CLIN NEUROPSYCHOL, V27, P779, DOI 10.1080/13854046.2013.789552; Pepe M.S., 2004, STAT EVALUATION MED; R Development Core Team, 2012, R LANG ENV STAT COMP; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sady MD, 2013, J INT NEUROPSYCH SOC, V19, P194, DOI DOI 10.1017/S1355617713000362; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Straus SE., 2011, EVIDENCE BASED MED P, V4th; Venkatraman ES, 1996, BIOMETRIKA, V83, P835, DOI 10.1093/biomet/83.4.835; Vermunt J.K., 2005, LATENT GOLD CHOICE 4; Youngstrom E, 2006, DEV PSYCHOPATHOL, V18, P989, DOI 10.1017/S0954579406060494; Youngstrom EA, 2014, J PEDIATR PSYCHOL, V39, P204, DOI 10.1093/jpepsy/jst062; Youngstrom EA, 2013, J CLIN CHILD ADOLESC, V42, P139, DOI 10.1080/15374416.2012.736358; Zhou XH., 2002, STAT METHODS DIAGNOS	37	14	14	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2016	22	10			SI		1038	1049		10.1017/S1355617716000916			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	EF4WM	WOS:000390332700009	27903334				2022-02-06	
J	Salisbury, DB; Parsons, TD; Monden, KR; Trost, Z; Driver, SJ				Salisbury, David B.; Parsons, Thomas D.; Monden, Kimberley R.; Trost, Zina; Driver, Simon J.			Brain-Computer Interface for Individuals After Spinal Cord Injury	REHABILITATION PSYCHOLOGY			English	Article						virtual reality; disability; inpatient rehabilitation; technology	REALITY EXPOSURE THERAPY; NEUROPATHIC PAIN; PATIENT; SYSTEM; ENVIRONMENT; TECHNOLOGY; VALIDATION; PRIORITIES; OUTCOMES	Purpose/Objective: To investigate the feasibility of brain-computer interface (BCI) with patients on an inpatient spinal cord injury (SCI) unit. Research Method/Design: This study included 25 participants aged 18-64 who sustained traumatic or nontraumatic SCI and did not have severe cognitive or psychiatric impairment. Participants completed a variety of screening measures related to cognition, psychological disposition, pain, and technology experience/interest. The Emotiv electroencephalography system was used in conjunction with a cube rotation and manipulation game presented on a laptop computer. Results: The majority of participants successfully completed the BCI game and reported enjoyment of the experience. Outside of a mild trend of lower performance among participants with a past or present head injury, there were no demographic variables, injury variables or screening measures significantly associated with BCI performance. Conclusions/Implications: The BCI paradigm demonstrated feasibility and safety across participant age range, educational and vocational background, and level of injury. Despite the rapid integration of technology into rehabilitation health care settings, there are few evidence-based studies regarding the feasibility of technology with specific inpatient populations. Clinical implications and challenges of using this technology in a rehabilitation setting are discussed.	[Salisbury, David B.] Baylor Inst Rehabil, Dept Neuropsychol, 411 North Washington Ave,Suite 5000, Dallas, TX 75246 USA; [Parsons, Thomas D.] Univ North Texas, Computat Neuropsychol & Simulat Lab, Denton, TX 76203 USA; [Monden, Kimberley R.] Baylor Univ, Med Ctr, Dept Surg, Waco, TX 76798 USA; [Trost, Zina] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Driver, Simon J.] Baylor Inst Rehabil, Dept Res, Dallas, TX USA		Salisbury, DB (corresponding author), Baylor Inst Rehabil, Dept Neuropsychol, 411 North Washington Ave,Suite 5000, Dallas, TX 75246 USA.	dsalisbury@bir-rehab.com	Monden, Kimberley/AAE-9831-2020	Monden, Kimberley/0000-0002-5207-0452; driver, simon/0000-0003-2356-432X			Alphonso AL, 2012, STUD HEALTH TECHNOL, V181, P305, DOI 10.3233/978-1-61499-121-2-305; Andujar M., 2011, P E LEARN WORLD C L, P539; Badcock NA, 2013, PEERJ, V1, DOI 10.7717/peerj.38; Burns A, 2014, NEUROSCIENTIST, V20, P639, DOI 10.1177/1073858414549015; Cinar E, 2013, NEURAL COMPUT APPL, V22, P29, DOI 10.1007/s00521-011-0744-x; Cincotti F, 2008, BRAIN RES BULL, V75, P796, DOI 10.1016/j.brainresbull.2008.01.007; Collinger JL, 2013, J REHABIL RES DEV, V50, P145, DOI 10.1682/JRRD.2011.11.0213; Danziger Z, 2014, BIOL CYBERN, V108, P183, DOI 10.1007/s00422-014-0589-3; Dobkin BH, 2007, J PHYSIOL-LONDON, V579, P637, DOI 10.1113/jphysiol.2006.123067; Dutta Arindam, 2013, Depress Res Treat, V2013, P640861, DOI 10.1155/2013/640861; Duvinage M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-56; Enzinger C, 2008, EXP BRAIN RES, V190, P215, DOI 10.1007/s00221-008-1465-y; Felix ER, 2014, PHYS MED REH CLIN N, V25, P545, DOI 10.1016/j.pmr.2014.04.007; Finnerup NB, 2013, PAIN, V154, pS71, DOI 10.1016/j.pain.2012.12.007; Hammell KRW, 2010, DISABIL REHABIL, V32, P1209, DOI 10.3109/09638280903420325; Hill NJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026018; Ikegami S, 2011, CLIN NEUROPHYSIOL, V122, P991, DOI 10.1016/j.clinph.2010.08.021; Inventado P. S., 2011, RES PRACT TECHNOL EN, V6, P107; Jatupaiboon N, 2013, SCI WORLD J, DOI 10.1155/2013/618649; Kaufmann T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00129; Kiper P, 2011, NEUROL NEUROCHIR POL, V45, P436; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Lin CT, 2010, GERONTOLOGY, V56, P112, DOI 10.1159/000230807; Mak Joseph N, 2009, IEEE Rev Biomed Eng, V2, P187, DOI 10.1109/RBME.2009.2035356; McMahan T., 2015, P 6 INT C APPL HUM F; McMahan T., 2015, P FDN DIG GAM C JUN; McNair D. M, 1971, MANUAL PROFILE MOOD; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Motraghi TE, 2014, J CLIN PSYCHOL, V70, P197, DOI 10.1002/jclp.22051; Murray C. D., 2009, J CYBER THERAPY REHA, V2, P105; Parsons TD, 2008, J BEHAV THER EXP PSY, V39, P250, DOI 10.1016/j.jbtep.2007.07.007; Rao JS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/753061; Ricker JH, 1996, NEUROPSY NEUROPSY BE, V9, P50; Rosas-Cholula G., 2010, SIGNAL P 300 DETECTI; Rupp Rudiger, 2014, Front Neuroeng, V7, P38, DOI 10.3389/fneng.2014.00038; Schreuder M, 2013, ARTIF INTELL MED, V59, P71, DOI 10.1016/j.artmed.2013.07.005; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Tate DG, 2002, ARCH PHYS MED REHAB, V83, pS18, DOI 10.1053/apmr.2002.36835; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Tidoni E, 2015, NEUROPSYCHOLOGIA, V79, P301, DOI 10.1016/j.neuropsychologia.2015.06.029; Pham TD, 2012, LECT NOTES COMPUT SC, V7667, P394, DOI 10.1007/978-3-642-34500-5_47; Vi C. T., 2012, DETECTING ERROR RELA; Wechsler D., 2001, MANUAL WECHSLER TEST; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007	47	14	14	0	18	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2016	61	4					435	441		10.1037/rep0000099			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	EC3BK	WOS:000387999200010	27684465				2022-02-06	
J	Sun, GZ; Yagmurlu, K; Belykh, E; Lei, T; Preul, MC				Sun, Guozhu; Yagmurlu, Kaan; Belykh, Evgenii; Lei, Ting; Preul, Mark C.			Management Strategy of a Transorbital Penetrating Pontine Injury by a Wooden Chopstick	WORLD NEUROSURGERY			English	Article						Foreign object; Penetrating orbitocranial injury; Pontine injury; Traumatic brain injury	BRAIN-STEM INJURY; ORBITOCRANIAL INJURY; SURGICAL-MANAGEMENT; INTRACRANIAL INJURY	BACKGROUND: Transorbital penetrating pontine injuries from small spear-like objects, which are extremely rare, provide neurosurgeons with life-threatening and challenging conditions to manage. CASE DESCRIPTION: We present an unusual case of transorbital penetrating pontine injury and discuss imaging, diagnosis, management strategy, and anatomy-injury correlation. A 23-year-old man sustained a penetrating cranial injury from a bamboo chopstick that extended from the right orbit to the pons and cerebellum. Using a frontotemporal approach, we successfully removed the chopstick. Follow-up studies confirmed a good outcome. CONCLUSIONS: Preoperative imaging, correct diagnosis, and surgical treatment are necessary to manage transorbital penetrating pontine injuries caused by spear-like objects, with specific attention paid to effective exposure and inventive means with total removal of the foreign object without causing further injury. A trajectory through the superior orbital fissure and paralateral to the cavernous sinus and into the pons seems to be the most prevalent and influences management of removal and injuries.	[Sun, Guozhu] Hebei Med Univ, Hosp 2, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China; [Sun, Guozhu; Yagmurlu, Kaan; Belykh, Evgenii; Lei, Ting; Preul, Mark C.] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Belykh, Evgenii] Irkutsk State Med Univ, Dept Neurosurg, Irkutsk, Russia		Preul, MC (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.	Neuropub@dignityhealth.org	Belykh, Evgenii/O-8279-2017	Belykh, Evgenii/0000-0003-2060-5739; YAGMURLU, KAAN/0000-0002-7635-2809			Arslan M, 2012, J NEUROSCI RURAL PRA, V3, P178, DOI 10.4103/0976-3147.98228; Cavalcanti DD, 2016, J NEUROSURG, V124, P1359, DOI 10.3171/2015.4.JNS141945; Cosan TE, 2006, EUR ARCH OTO-RHINO-L, V263, P327, DOI 10.1007/s00405-005-1009-z; de Andrade AF, 2006, J NEUROSURG, V104, P853, DOI 10.3171/jns.2006.104.5.853; Fezza J, 1999, OPHTHALMIC PLAST REC, V15, P366, DOI 10.1097/00002341-199909000-00012; GUNENC U, 1992, DOC OPHTHALMOL, V81, P369; Gupta SK, 2012, J NEUROSURG-PEDIATR, V9, P103, DOI 10.3171/2011.10.PEDS11230; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; HUNGERFORD J, 1982, J NEUROL NEUROSUR PS, V45, P1072, DOI 10.1136/jnnp.45.11.1072-a; ILDAN F, 1994, J TRAUMA, V36, P116, DOI 10.1097/00005373-199401000-00020; Kadota K, 1988, Neurol Med Chir (Tokyo), V28, P1128, DOI 10.2176/nmc.28.1128; Kahler RJ, 1998, NEUROSURGERY, V42, P1370, DOI 10.1097/00006123-199806000-00108; Kaneko-Ohtaki A, 2011, CLIN OPHTHALMOL, V5, P927, DOI 10.2147/OPTH.S22821; Kitakami A, 1999, NEUROL MED-CHIR, V39, P150, DOI 10.2176/nmc.39.150; Lasky JB, 1997, J TRAUMA, V42, P555, DOI 10.1097/00005373-199703000-00030; Lin Hung-Lin, 2007, J Chin Med Assoc, V70, P36; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; Matsuyama T, 2001, NEUROL MED-CHIR, V41, P345, DOI 10.2176/nmc.41.345; Mitilian D, 2009, ACTA NEUROCHIR, V151, P1295, DOI 10.1007/s00701-009-0418-y; Mzimbiri JM, 2016, NEUROSURGERY, V78, pE753, DOI 10.1227/NEU.0000000000001198; Paiva WS, 2012, BRIT J NEUROSURG, V26, P779, DOI 10.3109/02688697.2012.655809; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Quinn LM, 2006, ARCH OPHTHALMOL-CHIC, V124, P915, DOI 10.1001/archopht.124.6.915; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; Shin TH, 2012, J KOREAN NEUROSURG S, V52, P414, DOI 10.3340/jkns.2012.52.4.414; Teymoorian S, 2012, J NEUROIMAGING, V22, P201, DOI 10.1111/j.1552-6569.2010.00519.x; Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008; Xu FF, 2013, BRAIN INJURY, V27, P951, DOI 10.3109/02699052.2013.775502; Yagmurlu K., 2014, NEUROSURGERY, V10, P619; Yagmurlu K, 2014, OPER NEUROSURG, V10, P602, DOI 10.1227/NEU.0000000000000466	30	14	15	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2016	95								6220000000	10.1016/j.wneu.2016.07.104			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EF5EZ	WOS:000390354800115	27506405				2022-02-06	
J	Tayim, FM; Flashman, LA; Wright, MJ; Roth, RM; McAllister, TW				Tayim, Fadi M.; Flashman, Laura A.; Wright, Matthew J.; Roth, Robert M.; McAllister, Thomas W.			Recovery of episodic memory subprocesses in mild and complicated mild traumatic brain injury at 1 and 12 months post injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychology; traumatic brain injury; postconcussion syndrome; encoding; memory	WORKING-MEMORY; HEAD-INJURY; CONSOLIDATION DEFICITS; FUNCTIONAL MRI; DYSFUNCTION	Introduction: Episodic memory complaints are commonly reported after traumatic brain injury (TBI). The contributions of specific memory subprocesses (encoding, consolidation, and retrieval), however, are not well understood in mild TBI (mTBI). In the present study, we evaluated subprocesses of episodic memory in patients with mTBI using the item-specific deficit approach (ISDA), which analyzes responses on list learning tasks at an item level. We also conducted exploratory analyses to evaluate the effects of complicated mTBI (comp-mTBI) on memory. Method: We compared episodic verbal memory performance in mTBI (n = 92) at approximately 1 and 12 months post TBI, as well as in a healthy comparison (HC) group (n = 40) at equivalent time points. Episodic memory was assessed using the California Verbal Learning Test-2nd Edition (CVLT-II), and both standard CVLT-II scores and ISDA indices were evaluated. Results: Compared to the HC group, the mTBI group showed significantly poorer encoding and learning across time, as measured by ISDA and CVLT-II. Further analyses of these mTBI subgroups [(noncomplicated mTBI (NC-mTBI, n = 77) and comp-mTBI (n = 15)], indicated that it was the comp-mTBI group who continued to demonstrate poorer encoding ability than the HC group. When the patient groups were directly compared, the NC-mTBI group improved slightly on the ISDA Encoding Deficit Index. While the comp-mTBI group worsened slightly over time, their poorer encoding ability was not likely clinically meaningful. Conclusions: These findings indicate that, while the NC-mTBI and HC groups' performances were comparable by 12 months, a primary, long-term deficit in encoding of auditory verbal information remained problematic in the comp-mTBI group.	[Tayim, Fadi M.; Flashman, Laura A.; Roth, Robert M.; McAllister, Thomas W.] Geisel Sch Med Dartmouth, Sect Neuropsychiat, Dept Psychiat, Brain Imaging Lab, Lebanon, NH USA; [Wright, Matthew J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Wright, Matthew J.] Harbor UCLA Med Ctr, Div Psychol, Dept Psychiat, Torrance, CA 90509 USA; [Wright, Matthew J.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA		Tayim, FM (corresponding author), Wright State Univ, 30 East Apple St,Suite 6257, Dayton, OH 45409 USA.; Tayim, FM (corresponding author), Premier Hlth Clin Neurosci Inst, 30 East Apple St,Suite 6257, Dayton, OH 45409 USA.	fmtayim@premierhealth.com			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD048176]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048176] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [grant number R01 HD048176].	Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blakesley RE, 2009, NEUROPSYCHOLOGY, V23, P255, DOI 10.1037/a0012850; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Delis D.C., 2000, CALIFORNIA VERBAL LE; Ellis H. C., 1983, FUNDAMENTALS HUMAN M; Faul M, 2010, TRAUMATIC BRAIN INJU; First M.B., 1996, STRUCTURED CLIN INTE; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HITCH GJ, 1978, COGNITIVE PSYCHOL, V10, P302, DOI 10.1016/0010-0285(78)90002-6; HOLM S, 1979, SCAND J STAT, V6, P65; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silver JM, 2012, AM J PSYCHIAT, V169, P1230, DOI 10.1176/appi.ajp.2012.12091230; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vanderploeg RD, 2014, J CLIN EXP NEUROPSYC, V36, P58, DOI 10.1080/13803395.2013.864600; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wright MJ, 2011, J HEAD TRAUMA REHAB, V26, P182, DOI 10.1097/HTR.0b013e318218dcf9; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Wright MJ, 2009, J CLIN EXP NEUROPSYC, V31, P790, DOI 10.1080/13803390802508918	39	14	14	0	34	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV	2016	38	9					1005	1014		10.1080/13803395.2016.1182968			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DT6FA	WOS:000381577900007	27191799				2022-02-06	
J	Towns, SJ; Zeitzer, J; Kamper, J; Holcomb, E; Silva, MA; Schwartz, DJ; Nakase-Richardson, R				Towns, Stephanie J.; Zeitzer, Jamie; Kamper, Joel; Holcomb, Erin; Silva, Marc A.; Schwartz, Daniel J.; Nakase-Richardson, Risa			Implementation of Actigraphy in Acute Traumatic Brain Injury (TBI) Neurorehabilitation Admissions: A Veterans Administration TBI Model Systems Feasibility Study	PM&R			English	Article							SLEEP DISTURBANCES; PREVALENCE; CARE; REHABILITATION; PARAMETERS; DISORDERS; FATIGUE; BATTERY	Background: Sleep problems and disorders are prevalent in patients with traumatic brain injury (TBI) and are associated with negative outcomes. Incidence varies because of challenges including differences in assessment methods, particularly in the acute stages of recovery when patients are cognitively impaired and unable to complete traditional self-report methods. Actigraphy (ACG) recently has been validated in the acute TBI rehabilitation setting and may serve as a superior method of assessing sleep wake patterns at this stage of recovery. Although a few studies with small sample sizes have described the use of ACG, none have described feasibility and implementation protocols. Objective: To describe the feasibility and implementation protocol of ACG to evaluate sleep-wake patterns and white-light exposure data in patients with acute TBI during inpatient rehabilitation. Sleep-wake patterns and light exposure data are presented to characterize the sample using these methods to inform future research. Design: Retrospective study. Setting: Acute inpatient rehabilitation unit at a Veterans' Affairs Polytrauma Rehabilitation Center. Participants: Veterans (age >= 18 years) admitted to inpatient rehabilitation and enrolled in the Traumatic Brain Injury Model Systems study who were admitted and discharged in the calendar year 2013. Methods: Veterans underwent actigraph watch placement as soon as possible after admission. Records from the calendar year 2013 were reviewed to determine the number of admissions that met study criteria and what percentage of those patients had 3 days of continuous ACG data collected. The barriers to successful watch placement in this population were reviewed. Average sleep, light, and wake data from available records were collected for the study sample. Main Outcome Measurements: Percentage of patients who met study criteria and who had 72 hours of continuous ACG data collected. The barriers to successful watch placement in this population were reviewed. Average sleep, light, and wake data from available records were collected. Results: Of 22 eligible Traumatic Brain Injury Model Systems admissions, 3 consecutive nights of ACG data were successfully obtained for 86% (n = 19) of the sample. Barriers to data collection included patient access due to abbreviated lengths of stay, staff availability for ACG placement, and data collection protocols to prevent loss of data in Veterans' Affairs computing systems. Conclusions: ACG is feasible for collecting data about sleep, wake, and light exposure in patients who are in acute TBI inpatient rehabilitation settings.	[Towns, Stephanie J.; Kamper, Joel; Holcomb, Erin; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Zeitzer, Jamie] Stanford Univ, Stanford Ctr Sleep Sci & Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Zeitzer, Jamie] VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Palo Alto, CA USA; [Silva, Marc A.; Nakase-Richardson, Risa] DVBIC, Tampa, FL 33620 USA; [Schwartz, Daniel J.] James A Haley Vet Hosp, Dept Med, Tampa, FL 33612 USA; [Schwartz, Daniel J.; Nakase-Richardson, Risa] Univ S Florida, Dept Med, Tampa, FL 33620 USA; [Nakase-Richardson, Risa] HSR&D Ctr Innovat Disabil Rehabil & Res CINDRR, Tampa, FL 33620 USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.; Nakase-Richardson, R (corresponding author), DVBIC, Tampa, FL 33620 USA.; Nakase-Richardson, R (corresponding author), Univ S Florida, Dept Med, Tampa, FL 33620 USA.; Nakase-Richardson, R (corresponding author), HSR&D Ctr Innovat Disabil Rehabil & Res CINDRR, Tampa, FL 33620 USA.	risa.richardson@va.gov	Zeitzer, Jamie/AAO-2103-2020; Towns, Stephanie/AAS-5118-2021; Kamper, Joel/V-2450-2019; Silva, Marc A./J-1874-2019; Towns, Stephanie/AAF-2035-2020; Zeitzer, Jamie M/A-1168-2007	Zeitzer, Jamie/0000-0001-6174-5282; Kamper, Joel/0000-0001-5098-5176; Silva, Marc A./0000-0002-3879-6054; Zeitzer, Jamie M/0000-0001-6174-5282	General Dynamics Information Technology [W91YTZ-13-C-0015]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC) [W91YTZ-13-C-0015]; Veterans Affairs Health Services Research and Development Grant Center of Innovation on Disability Rehabilitation and Research [1 I50 HX001233-01]	grant, General Dynamics Information Technology (money to institution); grant, General Dynamics Information Technology W91YTZ-13-C-0015 (money to institution); The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions(W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), Veterans Affairs Health Services Research and Development Grant Center of Innovation on Disability Rehabilitation and Research (1 I50 HX001233-01).	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Attarian HP, 2004, ARCH NEUROL-CHICAGO, V61, P525, DOI 10.1001/archneur.61.4.525; Baker FC, 1999, J PSYCHOSOM RES, V47, P335, DOI 10.1016/S0022-3999(99)00017-3; Berger AM, 2008, J PAIN SYMPTOM MANAG, V36, P191, DOI 10.1016/j.jpainsymman.2007.10.008; Cellini N, 2013, CHRONOBIOL INT, V30, P691, DOI 10.3109/07420528.2013.782312; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Cruse D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-18; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hylkema T, 2009, J INTELL DISABIL RES, V53, P695, DOI 10.1111/j.1365-2788.2009.01177.x; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kamper J, 2015, P INT NEUR SOC ANN C; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Meadows R, 2010, CHRONOBIOL INT, V27, P842, DOI 10.3109/07420521003797732; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Okifuji A, 2011, CLIN J PAIN, V27, P289, DOI 10.1097/AJP.0b013e31820485db; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Richardson A, 2007, J CLIN NURS, V16, P1660, DOI 10.1111/j.1365-2702.2005.01546.x; Spivak E, 2007, SPINAL CORD, V45, P765, DOI 10.1038/sj.sc.3102040; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x; Zinkhan M, 2014, SLEEP MED, V15, P1107, DOI 10.1016/j.sleep.2014.04.015; Zoltman FS, 2010, BRAIN INJURY, V24, P748	34	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	NOV	2016	8	11					1046	1054		10.1016/j.pmrj.2016.04.005			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	ED0SX	WOS:000388553300003	27178377				2022-02-06	
J	Allitt, BJ; Iva, P; Yan, EB; Rajan, R				Allitt, Benjamin J.; Iva, Pippa; Yan, Edwin B.; Rajan, Ramesh			HYPO-EXCITATION ACROSS ALL CORTICAL LAMINAE DEFINES INTERMEDIATE STAGES OF CORTICAL NEURONAL DYSFUNCTION IN DIFFUSE TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						electrophysiology; sensory cortex; traumatic brain injury; cortical laminae	AXONAL INJURY; TIME-COURSE; RAT MODEL; INHIBITION; MECHANISMS; ADAPTATION; BARREL; PATHOPHYSIOLOGY; INTERNEURONS; ACTIVATION	Traumatic brain injury (TBI) is a major cause of morbidity and mortality world-wide and can result in persistent cognitive, sensory and behavioral dysfunction. Understanding the time course of TBI-induced pathology is essential to effective treatment outcomes. We induced TBI in rats using an impact acceleration method and tested for sensorimotor skill and sensory sensitivity behaviors for two weeks to find persistently poor outcomes post -injury. At two weeks post -injury we made high resolution extracellular recordings from barrel cortex neurons, to simple and complex whisker deflections. We found that the supragranular suppression of neural firing (compared to normal) previously seen in the immediate post-TBI aftermath had spread to include suppression of input and infragranular layers at two weeks post -injury; thus, there was suppression of whisker -driven firing rates in all cortical layers to both stimulus types. Further, there were abnormalities in temporal response patterns such that in layers 3-5 there was a temporal broadening of response patterns in response to both whisker deflection stimulus types and in L2 a narrowing of temporal patterns in response to the complex stimulus. Thus, at two weeks post-TBI, supragranular hypo -excitation has evolved to include deep cortical layers likely as a function of progressive atrophy and neurodegeneration. These results are consistent with the hypothesis that TBI alters the delicate excitatory/inhibitory balance in cortex and likely contributes to temporal broadening of responses and restricts the ability to code for complex sensory stimuli. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Allitt, Benjamin J.; Iva, Pippa; Yan, Edwin B.; Rajan, Ramesh] Monash Univ, Dept Physiol, Clayton, Vic, Australia		Rajan, R (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic, Australia.	ben.allitt@monash.edu; pliva1@student.monash.edu; Edwin.yan@monash.edu; ramesh.rajan@monash.edu	rajan, ramesh/L-4842-2019	Iva, Pippa/0000-0003-2398-1190; Rajan, Ramesh/0000-0001-9862-0520	Australian National HealthNational Health and Medical Research Council of Australia; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [APP 1029311]	This research was funded by the Australian National Health and Medical Research Council, grant # APP 1029311. The National Health and Medical Research Council did not contribute to study design, data collection, analysis, manuscript preparation or in the decision to submit this research for publication.	Abdi H., 2007, KENDALL RANK CORRELA; Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2001, J NEUROPHYSIOL, V86, P354, DOI 10.1152/jn.2001.86.1.354; Allitt BJ, 2016, J NEUROTRAUM, V33, P375, DOI 10.1089/neu.2015.3946; Alwis D. S., 2013, CLIN EXP PHARM PHYSL, V14, P13; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Camp AJ, 2009, INT J BIOCHEM CELL B, V41, P2118, DOI 10.1016/j.biocel.2009.05.007; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carron SF, 2016, J COMP NEUROL; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Cook NL, 2010, J MOL NEUROSCI, V42, P192, DOI 10.1007/s12031-010-9347-8; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gilmore E, 2010, NEUROLOGY, V74, pE28, DOI 10.1212/WNL.0b013e3181d55f8a; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Heiss JE, 2008, J NEUROSCI, V28, P13320, DOI 10.1523/JNEUROSCI.2646-08.2008; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Hoover E, 2014, J ACOUST SOC AM, V135, P2166, DOI DOI 10.1121/1.4877039; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Katayama Y, 1990, J NEUROSURG, V32, P15252; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Radnikow G, 2015, SENSORIMOTOR INTEGRA, P59, DOI [10.1007/978-1-4939-2975-7, DOI 10.1007/978-1-4939-2975-7]; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sawant-Pokam PM, 2016, CEREB CORTEX; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Theriot JJ, 2012, J NEUROSCI, V32, P15252, DOI 10.1523/JNEUROSCI.2092-12.2012; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147	78	14	14	2	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	OCT 15	2016	334						290	308		10.1016/j.neuroscience.2016.08.018			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DW1OK	WOS:000383412300026	27530700				2022-02-06	
J	Vallez Garcia, D; Otte, A; Dierckx, RAJO; Doorduin, J				Vallez Garcia, David; Otte, Andreas; Dierckx, Rudi A. J. O.; Doorduin, Janine			Three Month Follow-Up of Rat Mild Traumatic Brain Injury: A Combined [F-18]FDG and [C-11]PK11195 Positron Emission Study	JOURNAL OF NEUROTRAUMA			English	Article						brain glucose metabolism; mild traumatic brain injury; neuroinflammation; PET; rat model	DIFFUSE AXONAL INJURY; IN-VIVO; MICROGLIAL ACTIVATION; F-18-FDG PET; TERM-MEMORY; HEAD-INJURY; MODEL; NEUROINFLAMMATION; DYSFUNCTION; CONCUSSION	Mild traumatic brain injury (mTBI) is the most common cause of head trauma. The time course of functional pathology is not well defined, however. The purpose of this study was to evaluate the consequences of mTBI in rats over a period of 3 months by determining the presence of neuroinflammation ([C-11]PK11195) and changes in brain metabolism ([F-18]FDG) with positron emission tomography (PET) imaging. Male Sprague-Dawley rats were divided in mTBI (n=8) and sham (n=8) groups. In vivo PET imaging and behavioral tests (open field, object recognition, and Y-maze) were performed at different time points after induction of the trauma. Differences between groups in PET images were explored using volume-of-interest and voxel-based analysis. mTBI did not result in death, skull fracture, or suppression of reflexes. Weight gain was reduced (p=0.003) in the mTBI group compared with the sham-treated group. No statistical differences were found in the behavioral tests at any time point. Volume-of-interest analysis showed neuroinflammation limited to the subacute phase (day 12) involving amygdala, globus pallidus, hypothalamus, pons, septum, striatum, and thalamus (p<0.03, d>1.2). Alterations in glucose metabolism were detected over the 3 month period, with increased uptake in the medulla (p<0.04, d1.2), and decreased uptake in the globus pallidus, striatum, and thalamus (p<0.04, d 1.2). Similar findings were observed in the voxel-based analysis (p<0.05 at corrected cluster level). As a consequence of the mTBI, and in the absence of apparent behavioral alterations, relative brain glucose metabolism was found altered in several brain regions, which mostly correspond with those presenting neuroinflammation in the subacute stage.	[Vallez Garcia, David; Dierckx, Rudi A. J. O.; Doorduin, Janine] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, POB 30-001, NL-9700 RB Groningen, Netherlands; [Otte, Andreas] Offenburg Univ, Div Biomed Engn, Dept Elect Engn & Informat Technol, Offenburg, Germany		Vallez Garcia, D (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, POB 30-001, NL-9700 RB Groningen, Netherlands.	d.vallez-garcia@umcg.nl	Garcia, David Vallez/N-2348-2015	Garcia, David Vallez/0000-0003-3308-3167; Otte, Andreas/0000-0002-6290-6786; Doorduin, Janine/0000-0003-2925-9959			Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6; Doorduin J, 2008, CURR PHARM DESIGN, V14, P3297, DOI 10.2174/138161208786549443; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Faul M, 2010, TRAUMATIC BRAIN INJU; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Fueger BJ, 2006, J NUCL MED, V47, P999; Garcia DV, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0143900, 10.1371/journal.pone.0122363]; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Gilchrist J., 2011, NONFATAL TRAUMATIC B, P1337; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hilbe, 2012, GEN ESTIMATING EQUAT; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Li J, 2012, J NEUROTRAUM, V29, P2635, DOI 10.1089/neu.2012.2411; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marsteller DA, 2006, NUCL MED BIOL, V33, P71, DOI 10.1016/j.nucmedbio.2005.09.003; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Penny WD, 2006, STAT PARAMETRIC MAPP, P656; Prieto E, 2011, EUR J NUCL MED MOL I, V38, P2228, DOI 10.1007/s00259-011-1905-y; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Sanchez-Catasus C. A., 2014, PET SPECT NEUROLOGY, P923; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schiffer WK, 2007, J NUCL MED, V48, P277; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Turkheimer FE, 2007, J NUCL MED, V48, P158; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; West TA, 2014, J FAM PRACTICE, V63, P11; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196	64	14	14	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1855	1865		10.1089/neu.2015.4230			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300006	26756169	Green Submitted			2022-02-06	
J	Chen, C; Ma, TZ; Wang, LN; Wang, JJ; Tu, Y; Zhao, ML; Zhang, S; Sun, HT; Li, XH				Chen, Chong; Ma, Tie-Zhu; Wang, Li-Na; Wang, Jing-Jing; Tu, Yue; Zhao, Ming-Liang; Zhang, Sai; Sun, Hong-Tao; Li, Xiao-Hong			MILD HYPOTHERMIA FACILITATES THE LONG-TERM SURVIVAL OF NEWBORN CELLS IN THE DENTATE GYRUS AFTER TRAUMATIC BRAIN INJURY BY DIMINISHING A PRO-APOPTOTIC MICROENVIRONMENT	NEUROSCIENCE			English	Article						traumatic brain injury; mild hypothermia; survival; neurogenesis; apoptosis	ADULT HIPPOCAMPAL NEUROGENESIS; ENHANCED NEUROGENESIS; GRANULE CELLS; NEURONS; PROLIFERATION; MECHANISMS; FOREBRAIN; ISCHEMIA; NETWORK; STROKE	Although previous research has demonstrated that traumatic brain injury (TBI) accelerates the proliferation of neural stem cells in dentate gyrus of the hippocampus, most of these newborn cells undergo apoptosis in a traumatic microenvironment. Thus, promoting the long-term survival of newborn cells during neurogenesis is a compelling goal for the treatment of TBI. In this study, we investigated whether mild hypothermia (MHT) therapy, which mitigates the multiple secondary injury cascades of TBI, enhances the survival of newborn cells. SD rats were subjected to unilateral fluid percussion injury and received MHT therapy for 4 h (33.5 degrees C). Bromodeoxyuridine (BrdU) was administered to label the mitotic cells. Spatial learning and memory were evaluated with the Morris water maze test. Brain sections were immunostained with antibodies against BrdU, DCX (a neuroblast marker) or NeuN (a mature neuron marker). The apoptosis levels in the dentate gyrus were examined with antibodies against the apoptotic proteins FAS, FASL, Bcl-2 and cleaved caspase 3. The results indicated that MHT could significantly prevent TBI-induced cognitive impairments. At 1 week after injury, the density of BrdU-immunoreactive cells significantly increased in both TBI and TBI + MHT rats. At 4 weeks after injury, the density of BrdU-positive cells further increased in TBI + MHT rats, whereas the density declined in the TBI rats. The density of DCX-positive cells in SGZ of the hippocampus at 1 week after injury in the TBI + MHT rats was significantly greater than in the TBI rats. Moreover, the density of NeuN-positive cells in the subgranular zone at 4 weeks after injury and in the granule cell layer at 7 weeks after injury was significantly increased in the TBI + MHT rats. The TBI + MHT rats displayed a lower level of apoptosis in the dentate gyrus compared with the TBI rats. These data indicate that TBI could only facilitate a burst of proliferation and short-term survival of newborn cells, whereas TBI + MHT could facilitate long-term survival and maturation of newborn cells through diminishing pro-apoptotic microenvironment. These results suggest that MHT-mediated neurogenesis may have an important therapeutic potential for the endogenous repair of TBI. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Sun, Hong-Tao; Li, Xiao-Hong] Logist Univ Chinese Peoples Armed Police Forces, Inst Traumat Brain Injury & Neurol, Pingjin Hosp, Tianjin 300162, Peoples R China; Key Lab Neurotrauma Repair Tianjin, Tianjin 300162, Peoples R China		Sun, HT; Li, XH (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Inst Traumat Brain Injury & Neurol, Pingjin Hosp, Tianjin 300162, Peoples R China.	chenmo333@163.com; lixiaohong12@hotmail.com			National Nature Scientific Fund of China [81301050, 81401067, 81271392, 81471275, 81541034]; National Nature Scientific Fund of Tianjin [14JCQNJC10200, 15JCQNJC11100]	This work was supported by the National Nature Scientific Fund of China (81301050, 81401067, 81271392, 81471275, 81541034) and the National Nature Scientific Fund of Tianjin (14JCQNJC10200, 15JCQNJC11100).	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chen C, 2014, NEUROSCIENCE, V257, P1, DOI 10.1016/j.neuroscience.2013.10.056; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eisch AJ, 2002, PROG BRAIN RES, V138, P315, DOI 10.1016/S0079-6123(02)38085-3; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Harburg GC, 2007, NEUROSCIENCE, V144, P77, DOI 10.1016/j.neuroscience.2006.09.018; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Li XH, 2013, MOL NEUROBIOL, V48, P490, DOI 10.1007/s12035-013-8437-3; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Miyazawa T, 2003, NEUROL RES, V25, P457, DOI 10.1179/016164103101201850; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Okano HJ, 1996, DEV NEUROSCI-BASEL, V18, P199, DOI 10.1159/000111408; Olsen TS, 2003, LANCET NEUROL, V2, P410, DOI 10.1016/S1474-4422(03)00436-8; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Potts MB, 2009, J NEUROSCI RES, V87, P1848, DOI 10.1002/jnr.21996; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	40	14	19	6	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	OCT	2016	335						114	121		10.1016/j.neuroscience.2016.08.038			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DW9XR	WOS:000384016600011	27583772				2022-02-06	
J	Jacob, R; Cox, M; Koral, K; Greenwell, C; Xi, Y; Vinson, L; Reeder, K; Weprin, B; Huang, R; Booth, TN				Jacob, R.; Cox, M.; Koral, K.; Greenwell, C.; Xi, Y.; Vinson, L.; Reeder, K.; Weprin, B.; Huang, R.; Booth, T. N.			MR Imaging of the Cervical Spine in Nonaccidental Trauma: A Tertiary Institution Experience	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							ABUSIVE HEAD TRAUMA; SUBDURAL HEMORRHAGE; PEDIATRIC TRAUMA; INJURY; CHILDREN; CORD	BACKGROUND AND PURPOSE: Cervical MR imaging has demonstrated a utility for detecting soft tissue injury in nonaccidental trauma. The purpose of this study was to identify the incidence and types of cervical spine injury on MR imaging in nonaccidental trauma and to correlate cervical spine injury with parenchymal injury on brain MR imaging and findings on head CT. MATERIALS AND METHODS: A retrospective review of children diagnosed with nonaccidental trauma in a tertiary referral pediatric hospital over 8 years was performed. Inclusion criteria were children younger than 5 years of age, a confirmed diagnosis of nonaccidental trauma, and cervical spine MR imaging within 1 week of presentation. Brain and cervical spine MR imaging, head CT, cervical radiographs, and skeletal surveys were reviewed. RESULTS: There were 89 patients included in this study (48 males; mean age, 9.1 months [range, 1-59 months]). Cervical spine injury on MR imaging was found in 61 patients (69%). Ligamentous injury was seen in 60 patients (67%), with interspinous ligaments being most commonly involved. Abnormal capsular fluid (atlanto-occipital and atlantoaxial) was present in 28 patients (32%). Cervical spine injury on MR imaging was significantly associated with parenchymal restricted diffusion on brain MR imaging and parenchymal injury on head CT (P = .0004 and P = .0104, respectively). Children with restricted diffusion on brain MR imaging were 6.22 (point estimate) times more likely to have cervical spine injury on MR imaging. CONCLUSIONS: There is a high incidence of cervical spine injury in pediatric nonaccidental trauma. Positive findings may affect management and suggest a traumatic etiology.	[Jacob, R.; Koral, K.; Xi, Y.; Booth, T. N.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Childrens Med Ctr Dallas, Childrens Hlth, Dallas, TX USA; [Greenwell, C.; Vinson, L.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Dallas, Childrens Hlth, Dept Pediat Surg, Dallas, TX 75390 USA; [Weprin, B.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Dallas, Childrens Hlth, Dept Neurol Surg, Dallas, TX 75390 USA		Booth, TN (corresponding author), Childrens Med Ctr Dallas, Dept Radiol, 1935 Med Dist Dr, Dallas, TX 75235 USA.	tim.booth@childrens.com	xi, yin/M-2268-2016	xi, yin/0000-0001-9743-3010; Jacob, Roy/0000-0003-4599-2894; Greenwell, Cynthia/0000-0003-4822-2211; weprin, bradley/0000-0003-4466-4549			Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Benedetti PF, 2000, AM J ROENTGENOL, V175, P661, DOI 10.2214/ajr.175.3.1750661; Booth TN, 2012, AM J ROENTGENOL, V198, pW417, DOI 10.2214/AJR.11.8150; Choudhary AK, 2014, PEDIATR RADIOL, V44, P1130, DOI 10.1007/s00247-014-2959-3; Choudhary AK, 2012, RADIOLOGY, V262, P216, DOI 10.1148/radiol.11102390; Feldman KW, 2008, PEDIATR EMERG CARE, V24, P222, DOI 10.1097/PEC.0b013e31816b7aa4; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Hofbauer M, 2012, J TRAUMA ACUTE CARE, V73, P156, DOI 10.1097/TA.0b013e31824e32b5; Kadom N, 2014, PEDIATR RADIOL, V44, P839, DOI 10.1007/s00247-014-2874-7; Katz JS, 2010, J NEUROSURG-PEDIATR, V5, P470, DOI 10.3171/2009.11.PEDS09291; Kemp AM, 2010, ARCH DIS CHILD, V95, P355, DOI 10.1136/adc.2009.169110; Kemp A, 2014, PEDIATR RADIOL, V44, P604, DOI 10.1007/s00247-014-3066-1; Koch BL, 2007, AM J NEURORADIOL, V28, P1811, DOI 10.3174/ajnr.A0634; Koumellis P, 2009, ARCH DIS CHILD, V94, P216, DOI 10.1136/adc.2008.141671; Rooks VJ, 1998, PEDIATR RADIOL, V28, P193, DOI 10.1007/s002470050330; Rutty GN, 2005, NEUROPATH APPL NEURO, V31, P247, DOI 10.1111/j.1365-2990.2004.00633.x; Silva CT, 2010, AM J ROENTGENOL, V194, P500, DOI 10.2214/AJR.09.2837; Silvera VM, 2014, PEDIATR RADIOL, V44, P621, DOI 10.1007/s00247-014-3170-2	18	14	14	0	2	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	OCT	2016	37	10					1944	1950		10.3174/ajnr.A4817			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DW9MR	WOS:000383984600035	27231224	hybrid, Green Published			2022-02-06	
J	Roberts, SAG; Toman, E; Belli, A; Midwinter, MJ				Roberts, S. A. G.; Toman, E.; Belli, A.; Midwinter, M. J.			Decompressive craniectomy and cranioplasty: experience and outcomes in deployed UK military personnel	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Decompressive craniectomy; cranioplasty; military; complications; operative experience; outcomes	TRAUMATIC BRAIN-INJURY; COMPLICATIONS; AFGHANISTAN; WOUNDS	Object: In recent conflicts, many UK personnel sustained head injuries requiring damage-control surgery and aeromedical transfer to the UK. This study aims to examine indications, complications and outcomes of UK military casualties undergoing craniectomy and cranioplasty from conflicts in Afghanistan and Iraq. Methods: The UK military Joint Theatre Trauma Registry (JTTR) was searched for all UK survivors in Afghanistan and Iraq between 2004 and 2014 requiring craniectomy and cranioplasty resulting from trauma. Results: Fourteen decompressive craniectomies and cranioplasties were performed with blast and gunshot wounds equally responsible for head injury. Ten survivors (71%) had an Injury Severity Score (ISS) of 75, normally designated as 'unsurvivable'. Most were operated on the day of injury. Seventy-one percent received a reverse question mark incision and 7% received a bicoronal incision. Seventy-nine percent had bone flaps discarded. Overall infection rate was 43%. Acinetobacter spp was the causative organism in 50% of cases. Median Glasgow Outcome Scale (GOS) at final follow-up was 4. All casualties had a GOS score greater than 3. Conclusions: Timely neurosurgical intervention is imperative for military personnel given high survival rates in those sustaining what are designated 'un-survivable' injuries. Early decompression facilitates safe aeromedical evacuation of casualties. Excellent outcomes validate the UK military trauma system and the step-wise performance gains throughout recent conflicts however trauma registers most evolving to have specific relevance to military casualties. In high-energy trauma with contamination and soft-tissue destruction, surgery should be conducted with regard for future soft tissue reconstruction. Bone flaps should be discarded and cranioplasty performed according to local preference. Facilities receiving military casualties should have specialist microbiological input mindful of the difficulties treating unusual microbes.	[Roberts, S. A. G.] Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab C3NL, 3rd Floor,Burlington Danes Bldg, London W12 0NN, England; [Roberts, S. A. G.; Midwinter, M. J.] ICT Ctr, Joint Med Command, Med Directorate, ADMST,RCDM, Birmingham, W Midlands, England; [Toman, E.; Belli, A.] NIHR, SRMRC, Birmingham, W Midlands, England; [Midwinter, M. J.] Univ Queensland, Rurul Clin Sch, Brisbane, Qld 4072, Australia		Roberts, SAG (corresponding author), Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab C3NL, 3rd Floor,Burlington Danes Bldg, London W12 0NN, England.	stuartroberts@nhs.net	Midwinter, Mark J/P-6264-2015; Belli, Antonio/I-3799-2015; Midwinter, Mark/AAB-6527-2019	Midwinter, Mark J/0000-0003-1836-7137; Belli, Antonio/0000-0002-3211-9933; Midwinter, Mark/0000-0003-1836-7137			AARABI B, 1987, NEUROSURGERY, V20, P610, DOI 10.1227/00006123-198704000-00018; Aarabi B, 2009, CURR OPIN CRIT CARE, V15, P548, DOI 10.1097/MCC.0b013e32833190da; AMEEN AA, 1984, INJURY, V16, P88, DOI 10.1016/S0020-1383(84)80004-2; [Anonymous], 2001, J TRAUMA, V51, pS34; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Benziger T., 1950, PHYSL EFFECTS BLAST, V2, P1225; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Hampton T, 2011, JAMA-J AM MED ASSOC, V306, P477, DOI 10.1001/jama.2011.1092; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Hawley CA, 2015, J HEAD TRAUMA REHAB, V30, pE47, DOI 10.1097/HTR.0000000000000023; Hickey M, 1999, KOREAN WAR W CONFRON; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jackson PC, 2014, INJURY, V45, P44, DOI 10.1016/j.injury.2012.08.036; Jansen JO, 2014, TRANSFUSION MED, V24, P154, DOI 10.1111/tme.12093; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Kirkman E, 2011, PHILOS T R SOC B, V366, P286, DOI 10.1098/rstb.2010.0249; Kluger Yoram, 2007, Am J Disaster Med, V2, P21; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Lu FK, 2003, SHOCK WAVES, V12, P457, DOI 10.1007/s00193-003-0186-1; Midwinter M J, 2009, J R Army Med Corps, V155, P323; Midwinter MJ, 2011, PHILOS T R SOC B, V366, P192, DOI 10.1098/rstb.2010.0220; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Narotam PK, 2007, J NEUROSURG, V106, P45, DOI 10.3171/jns.2007.106.1.45; Penn-Barwell JG, 2015, BONE JOINT J ORTHO S, V97-B, P20; Penn-Barwell JG, 2015, J TRAUMA ACUTE CARE, V78, P1014, DOI 10.1097/TA.0000000000000580; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Ringdal KG, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-11; Roberts S A G, 2015, J R Nav Med Serv, V101, P20; Russell RBA, 2013, JSP 999 CLIN GUIDELI; Skovira JW, 2015, J NEUROTRAUM, V33, P1557; Smith Jason, 2007, J R Army Med Corps, V153, P239; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Turner S, 2008, J R Army Med Corps, V154, P282; Whitaker R, 1916, BRIT J SURG, V3, P708; Zanaty Mario, 2014, ScientificWorldJournal, V2014, P356042, DOI 10.1155/2014/356042	43	14	14	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	OCT	2016	30	5					529	535		10.1080/02688697.2016.1208807			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DW7IX	WOS:000383825500006	27437912	Green Submitted			2022-02-06	
J	Christensen, PC; Samadi-Bahrami, Z; Pavlov, V; Stys, PK; Moore, GRW				Christensen, Pia Crone; Samadi-Bahrami, Zahra; Pavlov, Vlady; Stys, Peter K.; Moore, G. R. Wayne			Ionotropic glutamate receptor expression in human white matter	NEUROSCIENCE LETTERS			English	Article						CNS; White matter; NMDA; AMPA; Ionotropic glutamate receptor; Spectral confocal microscopy	OPTIC-NERVE AXONS; NMDA RECEPTORS; MULTIPLE-SCLEROSIS; OLIGODENDROCYTE PROGENITORS; CEREBROSPINAL-FLUID; BRAIN-INJURY; EXCITOTOXICITY; MYELINATION; ASTROCYTES; MECHANISMS	Glutamate is the key excitatory neurotransmitter of the central nervous system (CNS). Its role in human grey matter transmission is well understood, but this is less clear in white matter (WM). Ionotropic glutamate receptors (iGluR) are found on both neuronal cell bodies and glia as well as on myelinated axons in rodents, and rodent WM tissue is capable of glutamate release. Thus, rodent WM expresses many of the components of the traditional grey matter neuron-to-neuron synapse, but to date this has not been shown for human WM. We demonstrate the presence of iGluRs in human WM by immunofluorescence employing high-resolution spectral confocal imaging. We found that the obligatory N-methyl-D-aspartic acid (NMDA) receptor subunit GluN1 and the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit GluA4 co-localized with myelin, oligodendroglial cell bodies and processes. Additionally, GluA4 colocalized with axons, often in distinct clusters. These findings may explain why human WM is vulnerable to excitotoxic events following acute insults such as stroke and traumatic brain injury and in more chronic inflammatory conditions such as multiple sclerosis (MS). Further exploration of human WM glutamate signalling could pave the way for developing future therapies modulating the glutamate-mediated damage in these and other CNS disorders. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Christensen, Pia Crone; Stys, Peter K.] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Samadi-Bahrami, Zahra; Pavlov, Vlady; Moore, G. R. Wayne] Univ British Columbia, Dept Pathol & Lab Med, ICORD, Vancouver, BC V5Z 1M9, Canada		Stys, PK (corresponding author), Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada.	pstys@ucalgary.ca			MS Society of Canada; CIHRCanadian Institutes of Health Research (CIHR); Canada Research ChairsCanada Research ChairsCGIAR; AI-HS Scientist Award	This work was supported in part by the MS Society of Canada, CIHR and Canada Research Chairs. PKS was supported by an AI-HS Scientist Award.	Alix JJP, 2008, J PHYSIOL-LONDON, V586, P4069, DOI 10.1113/jphysiol.2008.155077; Alix JJP, 2009, ANN NEUROL, V66, P682, DOI 10.1002/ana.21767; [Anonymous], 2003, NEUROSCI LETT, V345, P126; Arranz AM, 2008, GLIA, V56, P1353, DOI 10.1002/glia.20703; Baraban M., 2015, BRAIN RES; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Brand-Schieber E, 2003, GLIA, V42, P12, DOI 10.1002/glia.10136; Catts V.S., 2015, BIOL PSYCHOL; Christensen P. C., 2016, MUSCLE NERVE; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Court FA, 2008, J NEUROSCI, V28, P11024, DOI 10.1523/JNEUROSCI.2429-08.2008; Court FA, 2011, GLIA, V59, P1529, DOI 10.1002/glia.21196; De Biase LM, 2011, J NEUROSCI, V31, P12650, DOI 10.1523/JNEUROSCI.2455-11.2011; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields R Douglas, 2006, Novartis Found Symp, V276, P148; Gautier HOB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9518; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Guo FZ, 2012, J NEUROSCI, V32, P639, DOI 10.1523/JNEUROSCI.4073-11.2012; Hofstetter S, 2013, J NEUROSCI, V33, P12844, DOI 10.1523/JNEUROSCI.4520-12.2013; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kostic M, 2013, REV NEUROSCIENCE, V24, P71, DOI 10.1515/revneuro-2012-0062; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Lagopoulos J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059108; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Li C, 2013, GLIA, V61, P732, DOI 10.1002/glia.22469; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Lundgaard I, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001743; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Micu I, 2015, EXP NEUROL; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Ouardouz M, 2009, ANN NEUROL, V65, P151, DOI 10.1002/ana.21533; Ouardouz M, 2009, ANN NEUROL, V65, P160, DOI 10.1002/ana.21539; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Petersen SC, 2015, CURR BIOL, V25, pR562, DOI 10.1016/j.cub.2015.04.054; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; Pitt D, 2003, NEUROLOGY, V61, P1113, DOI 10.1212/01.WNL.0000090564.88719.37; Purger D., 2015, NEUROPHARMACOLOGY; Saab AS, 2013, CURR OPIN NEUROBIOL, V23, P1065, DOI 10.1016/j.conb.2013.09.008; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sarchielli P, 2003, ARCH NEUROL-CHICAGO, V60, P1082, DOI 10.1001/archneur.60.8.1082; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Steullet P., 2014, SCHIZOPHR RES; Stirling DP, 2010, TRENDS MOL MED, V16, P160, DOI 10.1016/j.molmed.2010.02.002; Stover JF, 1997, EUR J CLIN INVEST, V27, P1038, DOI 10.1046/j.1365-2362.1997.2250774.x; Stys PK, 2007, TRENDS PHARMACOL SCI, V28, P561, DOI 10.1016/j.tips.2007.10.003; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Sun Y., 2015, CEREB CORTEX; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Tisell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061817; Verkhratsky A, 2007, NEUROSCIENTIST, V13, P28, DOI 10.1177/1073858406294270; Wegner M, 2001, MICROSC RES TECHNIQ, V52, P746, DOI 10.1002/jemt.1059; Willard SS, 2013, INT J BIOL SCI, V9, P948, DOI 10.7150/ijbs.6426; Willard SS, 2013, INT J BIOL SCI, V9, P728, DOI 10.7150/ijbs.6475; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Zalc B, 2000, NEUROSCIENTIST, V6, P5, DOI 10.1177/107385840000600109; Zhang JD, 2013, J NEUROSCI RES, V91, P240, DOI 10.1002/jnr.23150; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	71	14	16	1	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 6	2016	630						1	8		10.1016/j.neulet.2016.07.030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DV5ZG	WOS:000383008600001	27443784				2022-02-06	
J	Dekker, SE; Duvekot, A; de Vries, HM; Geeraedts, LMG; Peerdeman, SM; de Waard, MC; Boer, C; Schober, P				Dekker, Simone E.; Duvekot, Anne; de Vries, Hielke-Martijn; Geeraedts, Leo M. G., Jr.; Peerdeman, Saskia M.; de Waard, Monique C.; Boer, Christa; Schober, Patrick			Relationship between tissue perfusion and coagulopathy in traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Traumatic brain injury; Coagulopathy; Perfusion; Oxygenation; Bleeding	NEAR-INFRARED SPECTROSCOPY; OXYGENATION CHANGES; CEREBRAL-ISCHEMIA; HYPOPERFUSION; BIOMARKERS; IMPACT	Background: Traumatic brain injury (TBI) erelated coagulopathy appears to be most prevalent in patients with tissue hypoperfusion, but evidence for this association is scarce. This study investigated the relationship between tissue perfusion and hemostatic derangements in TBI patients. Materials and methods: Coagulation parameters were measured on emergency department admission in patients with TBI (head abbreviated injury scale >= 3). The level of hypoperfusion was simultaneously assessed by near-infrared spectroscopy (NIRS) at the forehead and arm, and by base excess and lactate. Coagulopathy was defined as an international normalized ratio > 1.2 and/or activated partial thromboplastin time > 40 s and/or thrombocytopenia (< 120 x 10(9)/L). Results: TBI patients with coagulopathy (42%) had more signs of tissue hypoperfusion as indicated by increased lactate levels (2.1 [1.1-3.2] mmol/L versus 1.2 [1.0-1.7] mmol/L; P = 0.017) and a larger base deficit (-3.0 [-4.6 to -2.0] mmol/L versus -0.1 [-2.5 to 1.8] mmol/L; P < 0.001). There was no difference in the cerebral or somatic tissue oxygenation index. However, there was a distinct trend toward a moderate inverse association between the cerebral tissue oxygenation index and D-dimer levels (r = -0.40; P = 0.051) as marker of fibrinolysis. The presence of coagulopathy was associated with an increased inhospital mortality rate (45.5% versus 6.7%; P = 0.002). Conclusions: This is the first study to investigate the relationship between hemostatic derangements and tissue oxygenation using NIRS in TBI patients. This study showed that TBI-related coagulopathy is more profound in patients with metabolic acidosis and increased lactate levels. Although there was no direct relationship between tissue oxygenation and coagulopathy, we observed an inverse relationship between NIRS tissue oxygenation levels and fibrinolysis. (C) 2016 Elsevier Inc. All rights reserved.	[Dekker, Simone E.; Duvekot, Anne; de Vries, Hielke-Martijn; Boer, Christa; Schober, Patrick] Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Geeraedts, Leo M. G., Jr.] Vrije Univ Amsterdam, Med Ctr, Dept Surg, Amsterdam, Netherlands; [Peerdeman, Saskia M.] Vrije Univ Amsterdam, Med Ctr, Dept Neurosurg, Amsterdam, Netherlands; [de Waard, Monique C.] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands		Dekker, SE (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	s.dekker@vumc.nl	Schober, Patrick/G-7400-2012	Schober, Patrick/0000-0003-0814-081X; Boer, Christa/0000-0002-7781-6951	Department of Anesthesiology, VU University Medical Center, Amsterdam, the NetherlandsNetherlands Government	This study was supported by the Department of Anesthesiology, VU University Medical Center, Amsterdam, the Netherlands.	Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Dekker SE, 2014, ANESTHESIOLOGY, V121, P89, DOI 10.1097/ALN.0000000000000229; Duvekot A, 2015, ANESTHESIOLOGY, V123, P820, DOI 10.1097/ALN.0000000000000806; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Ganter MT, 2010, BEST PRACT RES-CLIN, V24, P15, DOI 10.1016/j.bpa.2009.09.010; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Lin BS, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0465-3; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Merzagora AC, 2011, J INNOV OPT HEAL SCI, V4, P251, DOI 10.1142/S1793545811001551; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Plomgaard AM, 2016, PEDIATR RES, V79, P528, DOI 10.1038/pr.2015.266; Ragaller Max, 2010, J Emerg Trauma Shock, V3, P1, DOI 10.4103/0974-2700.58649; Scheeren TWL, 2012, J CLIN MONIT COMPUT, V26, P279, DOI 10.1007/s10877-012-9348-y; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Schober P, 2013, HOSP HEALTHCARE EURO, P128; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taussky P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.12.FOCUS11280; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang CC, 2016, J SURG RES, V200, P669, DOI 10.1016/j.jss.2015.10.005; Wolf T, 1997, J CEREBR BLOOD F MET, V17, P950, DOI 10.1097/00004647-199709000-00004; Yousef KM, 2014, INTENS CRIT CARE NUR, V30, P346, DOI 10.1016/j.iccn.2014.05.001	37	14	16	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2016	205	1					147	154		10.1016/j.jss.2016.06.023			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DW0VE	WOS:000383360300021	27621012				2022-02-06	
J	Eagles, ME; Bradbury-Squires, DJ; Powell, MF; Murphy, JR; Campbell, GD; Maroun, FB				Eagles, Matthew E.; Bradbury-Squires, David J.; Powell, Maria F.; Murphy, Justin R.; Campbell, Graeme D.; Maroun, Falah B.			The Impact of a Concussion-U Educational Program on Knowledge of and Attitudes about Concussion	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Concussion; Sports injuries; Education; Head trauma; Brain injury; Traumatic	CHRONIC TRAUMATIC ENCEPHALOPATHY; HOCKEY PLAYERS; HEAD-INJURY; SPORT; VIDEO; STATEMENT; BEHAVIOR	Background: The diagnosis of a sports-related concussion is often dependent on the athlete self-reporting their symptoms. It has been suggested that improving youth athlete knowledge and attitudes toward concussion may increase self-reporting behaviour. The objective of this study was to determine if a novel Concussion-U educational program improves knowledge of and attitudes about concussion among a cohort of elite male Bantam and Midget AAA hockey players. Methods: Fifty-seven male Bantam and Midget AAA-level hockey players (mean age=14.521.13 years) were recruited from the local community. Each participant completed a modified version of the Rosenbaum Concussion Knowledge and Attitudes Survey-Student Version immediately before and after a Concussion-U educational presentation. Follow-up sessions were arranged 4 to 6 months after the presentation, and assessed retention of knowledge and attitude changes. Results: Forty-three players completed all three surveys. Concussion knowledge and attitude scores significantly (p<0.01) increased from pre- to post-presentation by 12.79 and 8.41%, respectively. At long-term follow-up, knowledge levels remained significantly (p<0.01) higher than baseline by 8.49%. Mean attitude scores were also increased at follow-up; however, this increase was not statistically significant. Conclusions: A Concussion-U educational program led to an immediate improvement in concussion knowledge and attitudes among elite male Bantam and Midget AAA hockey players. Increased knowledge was maintained at long-term follow-up, but improved attitude was not. Future studies should investigate whether similar educational programs influence symptom reporting and concussion incidence. In addition, they should focus on how to maintain improved concussion attitudes.	[Eagles, Matthew E.; Bradbury-Squires, David J.; Powell, Maria F.; Murphy, Justin R.; Campbell, Graeme D.; Maroun, Falah B.] Mem Univ Newfoundland, Fac Med, Dept Neurosurg, St John, NF, Canada		Eagles, ME (corresponding author), Mem Univ Newfoundland, Fac Med, 300 Prince Phillip Dr, St John, NF A1B 3V6, Canada.	meagles@mun.ca	Eagles, Matthew E/I-9547-2019	Eagles, Matthew E/0000-0003-2585-7230			Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Gerhardstein D, 2007, SCI NURS, V24; Ginns P, 2005, LEARN INSTR, V15, P313, DOI 10.1016/j.learninstruc.2005.07.001; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McNaughton-Filion L, 2015, INQUEST DEATH ROWAN; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	28	14	14	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	SEP	2016	43	5					659	664		10.1017/cjn.2016.263			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DZ2KQ	WOS:000385671100007	27464985	Bronze			2022-02-06	
J	Holla, FK; Postma, TJ; Blankenstein, MA; van Mierlo, TJM; Vos, MJ; Sizoo, EM; de Groot, M; Uitdehaag, BMJ; Buter, J; Klein, M; Reijneveld, JC; Heimans, JJ				Holla, F. K.; Postma, T. J.; Blankenstein, M. A.; van Mierlo, T. J. M.; Vos, M. J.; Sizoo, E. M.; de Groot, M.; Uitdehaag, B. M. J.; Buter, J.; Klein, M.; Reijneveld, J. C.; Heimans, J. J.			Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis	JOURNAL OF NEURO-ONCOLOGY			English	Article						Glioma; S100B; Survival; Chemotherapy; Prognosis	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; HIGH-GRADE GLIOMAS; SERUM S100B; RADIATION-THERAPY; S-100B PROTEIN; ADJUVANT TEMOZOLOMIDE; ANAPLASTIC GLIOMAS; S-100-BETA PROTEIN; PREDICTIVE-VALUE	The S100B protein is associated with brain damage and a breached blood-brain barrier. A previous pilot study showed that high serum levels of S100B are associated with shorter survival in glioma patients. The aim of our study was to assess the prognostic value in terms of survival and longitudinal dynamics of serum S100B for patients with newly diagnosed and recurrent glioma. We obtained blood samples from patients with newly diagnosed and recurrent glioma before the start (baseline) and at fixed time-points during temozolomide chemotherapy. S100B-data were dichotomized according to the upper limit of the reference value of 0.1 mu g/L. Overall survival (OS) was estimated with Kaplan-Meier curves and groups were compared with the log rank analysis. To correct for potential confounders a Cox regression analysis was used. We included 86 patients with newly-diagnosed and 27 patients with recurrent glioma. Most patients in both groups had baseline serum levels within normal limits. In the newly diagnosed patients we found no significant difference in OS between the group of patients with S100B levels > 0.1 mu g/L at baseline compared to those with < 0.1 mu g/L. In the patients with recurrent glioma we found a significantly shorter OS for patients with raised levels. In both groups, S100B values did not change significantly throughout the course of the disease. Serum S100B levels do not seem to have prognostic value in newly diagnosed glioma patients. In recurrent glioma patients S100B might be of value in terms of prognostication of survival.	[Holla, F. K.; Postma, T. J.; van Mierlo, T. J. M.; Sizoo, E. M.; de Groot, M.; Uitdehaag, B. M. J.; Reijneveld, J. C.; Heimans, J. J.] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, POB 7057, NL-1007 MB Amsterdam, Netherlands; [Blankenstein, M. A.] Vrije Univ Amsterdam, Med Ctr, Clin Chem, Amsterdam, Netherlands; [Vos, M. J.] Med Ctr Haaglanden, Dept Neurol, The Hague, Netherlands; [Uitdehaag, B. M. J.] Vrije Univ Amsterdam, Med Ctr, Epidemiol & Biostat, Amsterdam, Netherlands; [Buter, J.] Vrije Univ Amsterdam, Med Ctr, Med Oncol, Amsterdam, Netherlands; [Klein, M.] Vrije Univ Amsterdam, Med Ctr, Med Psychol, Amsterdam, Netherlands		Postma, TJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Neurol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	tj.postma@vumc.nl	Klein, Martin/C-4192-2012	Klein, Martin/0000-0003-4160-5746; Sizoo, Eefje/0000-0001-5994-0652; Klein, Martin/0000-0001-5553-7911			Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P546, DOI 10.1177/000456329703400510; Back MF, 2007, ANN ACAD MED SINGAP, V36, P338; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Brommeland T, 2007, ACTA NEUROL SCAND, V116, P380, DOI 10.1111/j.1600-0404.2007.00889.x; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; COCCHIA D, 1981, NATURE, V294, P85, DOI 10.1038/294085a0; Cohen AL, 2015, CANCER TREAT RES, V163, P15, DOI 10.1007/978-3-319-12048-5_2; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Dassan P, 2009, CEREBROVASC DIS, V27, P295, DOI 10.1159/000199468; Donato V, 2007, TUMORI, V93, P248; Foerch C, 2005, ARCH NEUROL-CHICAGO, V62, P1130, DOI 10.1001/archneur.62.7.1130; Gerlach R, 2006, NEUROSCIENCE, V141, P1697, DOI 10.1016/j.neuroscience.2006.05.008; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P1302, DOI 10.1016/j.clinbiochem.2012.07.094; Gradisek P, 2012, BRAIN INJURY, V26, P1472, DOI 10.3109/02699052.2012.694567; Hamberg AP, 2003, MELANOMA RES, V13, P45, DOI 10.1097/00008390-200302000-00008; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Ilhan-Mutlu A, 2013, NEUROSURG REV, V36, P45, DOI 10.1007/s10143-012-0401-6; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kluger HM, 2011, CLIN CANCER RES, V17, P2417, DOI 10.1158/1078-0432.CCR-10-2402; Kruijff S, 2012, ANN SURG ONCOL, V19, P620, DOI 10.1245/s10434-011-2027-2; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; LUDWIN SK, 1976, J COMP NEUROL, V165, P197, DOI 10.1002/cne.901650206; Lyubimova NV, 2011, B EXP BIOL MED+, V150, P732, DOI 10.1007/s10517-011-1236-9; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Martenson ED, 2001, J CLIN ONCOL, V19, P824, DOI 10.1200/JCO.2001.19.3.824; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; MICHETTI F, 1983, BRAIN RES, V262, P352, DOI 10.1016/0006-8993(83)91032-6; Moritz S, 2010, J NEUROSURG ANESTH, V22, P21, DOI 10.1097/ANA.0b013e3181bdf50d; Nuno M, 2013, NEUROSURGERY, V73, P458, DOI 10.1227/01.neu.0000431477.02408.5e; Portela LVC, 2002, CLIN CHEM, V48, P950; Rajendra A, 2004, J NEURO-ONCOL, V67, P345, DOI 10.1023/B:NEON.0000024216.15923.77; RICKMANN M, 1995, NEUROSCIENCE, V67, P977, DOI 10.1016/0306-4522(94)00615-C; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Sanchez-Pena P, 2008, CRIT CARE MED, V36, P2267, DOI 10.1097/CCM.0b013e3181809750; Sienkiewicz-Jarosz H, 2009, NEUROL NEUROCHIR POL, V43, P126; Speirs CK, 2015, INT J RADIAT ONCOL, V91, P268, DOI 10.1016/j.ijrobp.2014.10.027; STEFANSSON K, 1982, NATURE, V295, P63, DOI 10.1038/295063a0; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Syeda T, 2013, JCPSP-J COLL PHYSICI, V23, P112, DOI 02.2013/JCPSP.112115; Tubaro C, 2010, J CELL PHYSIOL, V223, P270, DOI 10.1002/jcp.22035; van Munster BC, 2010, INT J GERIATR PSYCH, V25, P234, DOI 10.1002/gps.2326; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; Vos MJ, 2004, ANTICANCER RES, V24, P2511; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Wiesmann M, 1998, CLIN CHEM, V44, P1056	47	14	14	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	SEP	2016	129	3					525	532		10.1007/s11060-016-2204-z			8	Oncology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Neurosciences & Neurology	DX7JU	WOS:000384563800016	27401156	hybrid, Green Published			2022-02-06	
J	Huang, SY; Lo, PH; Liu, WM; Cherng, YG; Yeh, CC; Chen, TL; Liao, CC				Huang, Shih-Yu; Lo, Po-Han; Liu, Wei-Min; Cherng, Yih-Giun; Yeh, Chun-Chieh; Chen, Ta-Liang; Liao, Chien-Chang			Outcomes After Nonobstetric Surgery in Pregnant Patients: A Nationwide Study	MAYO CLINIC PROCEEDINGS			English	Article							POSTOPERATIVE ADVERSE OUTCOMES; POPULATION-BASED-COHORT; TRAUMATIC BRAIN-INJURY; NONCARDIAC SURGERY; BREAST-CANCER; ACUTE APPENDICITIS; NONPREGNANT WOMEN; MANAGEMENT; RISK; CHOLECYSTECTOMY	Objective: To evaluate outcomes after nonobstetric surgical procedures in pregnant patients. Methods: We conducted a retrospective cohort study of 5591 pregnant women who underwent nonobstetric surgical procedures using Taiwan's National Health Insurance Research Database 2008-2012 claims data. Using a propensity score matching procedure, 22,364 nonpregnant women were selected for comparison. Logistic regression was used to calculate the odds ratios (ORs) and 95% CIs of postoperative complications and in-hospital mortality associated with pregnancy. Results: Pregnant women had higher risks of postoperative septicemia (OR = 1.75; 95% CI, 1.47-2.07), pneumonia (OR = 1.47; 95% CI, 1.01-2.13), urinary tract infection (OR = 1.29; 95% CI, 1.08-1.54), and in-hospital mortality (OR = 3.94; 95% CI, 2.62-5.92) compared with nonpregnant women. Pregnant women also had longer hospital stays and higher medical expenditures after nonobstetric surgical procedures than controls. Higher rates of postoperative adverse events in pregnant women receiving nonobstetric surgery were noted in all age groups. Conclusion: Surgical patients with pregnancy showed more adverse events, with a risk of in-hospital mortality approximately 4-fold higher after nonobstetric surgery compared with nonpregnant patients. These findings suggest the urgent need to revise the protocols for postoperative care for this population. (C) 2016 Mayo Foundation for Medical Education and Research	[Huang, Shih-Yu; Lo, Po-Han; Cherng, Yih-Giun] Shuang Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan; [Huang, Shih-Yu; Lo, Po-Han; Cherng, Yih-Giun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Liu, Wei-Min] Taipei Med Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Liu, Wei-Min] Taipei Med Univ, Coll Med, Sch Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, 252 Wuxing St, Taipei 110, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Sch Chinese Med, Taichung, Taiwan		Chen, TL; Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, 252 Wuxing St, Taipei 110, Taiwan.	ccliao@tmu.edu.tw; jacky48863027@yahoo.com.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564; Cherng, Yih-Giun/0000-0002-0201-4380	Shuang Ho Hospital, Taipei Medical University [104TMU-SHH-23]; Taiwan's Ministry of Science and Technology [MOST104-2314-B-038-027-MY2, NSC102-2314-B-038-021-MY3]; Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]	This study was supported in part by grants from Shuang Ho Hospital, Taipei Medical University (104TMU-SHH-23), Taiwan's Ministry of Science and Technology (MOST104-2314-B-038-027-MY2; NSC102-2314-B-038-021-MY3), and Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019).	Abbasi N, 2014, BJOG-INT J OBSTET GY, V121, P1509, DOI 10.1111/1471-0528.12736; Ali SA, 2012, BREAST J, V18, P139, DOI 10.1111/j.1524-4741.2011.01201.x; Andersson REB, 2001, INT J EPIDEMIOL, V30, P1281, DOI 10.1093/ije/30.6.1281; Aydin Y, 1999, J NEUROSURG, V91, P322, DOI 10.3171/jns.1999.91.2.0322; Azim HA, 2011, EUR J CANCER, V47, P74, DOI 10.1016/j.ejca.2010.09.007; Bagger JP, 2004, LANCET, V363, P706, DOI 10.1016/S0140-6736(04)15647-X; Berry C, 2011, AM J SURG, V201, P429, DOI 10.1016/j.amjsurg.2010.10.008; Cardonick E, 2010, CANCER J, V16, P76, DOI 10.1097/PPO.0b013e3181ce46f9; Chang CC, 2012, EPILEPSIA, V53, P987, DOI 10.1111/j.1528-1167.2012.03448.x; Chemg YG, 2013, PLOS ONE, V8; Cohen-Kerem R, 2005, AM J SURG, V190, P467, DOI 10.1016/j.amjsurg.2005.03.033; Erekson EA, 2012, J MATERN-FETAL NEO M, V25, P2639, DOI 10.3109/14767058.2012.704445; Fardiazar Zahra, 2014, Pak J Biol Sci, V17, P260; Hatch Q, 2014, J SURG RES, V190, P41, DOI 10.1016/j.jss.2014.03.028; Hernandez AF, 2004, J AM COLL CARDIOL, V44, P1446, DOI 10.1016/j.jacc.2004.06.059; Jeong JS, 2011, SURG LAPARO ENDO PER, V21, P24, DOI 10.1097/SLE.0b013e3182051e44; Jin F, 2001, BRIT J ANAESTH, V87, P608, DOI 10.1093/bja/87.4.608; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282; Kuy S, 2009, SURGERY, V146, P358, DOI 10.1016/j.surg.2009.03.033; Kuy S, 2009, ARCH SURG-CHICAGO, V144, P399, DOI 10.1001/archsurg.2009.48; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Lin CS, 2013, BRIT J SURG, V100, P1784, DOI 10.1002/bjs.9312; Maia Paula C, 2008, Rev Port Cardiol, V27, P321; McMaster J, 2014, GYNECOL ONCOL, V135, P539, DOI 10.1016/j.ygyno.2013.09.006; Moore HB, 2015, JAMA SURG, V150, P637, DOI 10.1001/jamasurg.2015.91; Neligan PJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10256; Nguyen GC, 2010, GASTROINTEST ENDOSC, V72, P954, DOI 10.1016/j.gie.2010.07.018; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Sadot E, 2010, SURG ENDOSC, V24, P383, DOI 10.1007/s00464-009-0571-7; Silvestri MT, 2011, OBSTET GYNECOL, V118, P1261, DOI 10.1097/AOG.0b013e318234d7bc; Tan EK, 2013, BEST PRACT RES CL OB, V27, P791, DOI 10.1016/j.bpobgyn.2013.08.001; van Mook WNKA, 2005, CURR OPIN CRIT CARE, V11, P430, DOI 10.1097/01.ccx.0000179807.15328.f0; Vartak S, 2008, MED CARE, V46, P25, DOI 10.1097/MLR.0b013e3181484927; Vogel TR, 2010, ANN SURG, V252, P1065, DOI 10.1097/SLA.0b013e3181dcf36e; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Yates Martin T, 2015, J Thorac Cardiovasc Surg, V149, P607, DOI 10.1016/j.jtcvs.2014.10.038; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770; Zingone F, 2015, ANN SURG, V261, P332, DOI 10.1097/SLA.0000000000000780	39	14	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0025-6196	1942-5546		MAYO CLIN PROC	Mayo Clin. Proc.	SEP	2016	91	9					1166	1172		10.1016/j.mayocp.2016.06.021			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6AK	WOS:000385943700008	27594184				2022-02-06	
J	Lopez-Picon, F; Snellman, A; Shatillo, O; Lehtiniemi, P; Gronroos, TJ; Marjamaki, P; Trigg, W; Jones, PA; Solin, O; Pitkanen, A; Haaparanta-Solin, M				Lopez-Picon, Francisco; Snellman, Anniina; Shatillo, Olena; Lehtiniemi, Paula; Gronroos, Tove J.; Marjamaki, Paivi; Trigg, William; Jones, Paul A.; Solin, Olof; Pitkanen, Asia; Haaparanta-Solin, Merja			Ex Vivo Tracing of NMDA and GABA-A Receptors in Rat Brain After Traumatic Brain Injury Using F-18-GE-179 and F-18-GE-194 Autoradiography	JOURNAL OF NUCLEAR MEDICINE			English	Article						N-methyl-aspartic acid receptor; gamma-aminobutyric acid receptor A; GE-179; GE-194; traumatic brain injury	POSTTRAUMATIC EPILEPSY; HIPPOCAMPUS; ANTAGONISTS; SUBUNITS; EXPRESSION; GLUTAMATE; THALAMUS; BINDING; EDEMA; MODEL	In vivo imaging of N-methyl-d-aspartate (NMDA) glutamate receptor and gamma-aminobutyric acid (GABA)-A receptor during progression of brain pathology is challenging because of the lack of imaging tracers with high affinity and specificity. Methods: We monitored changes in NMDA receptor and GABA-A receptor in a clinically relevant model of traumatic brain injury (TBI) induced by lateral fluid percussion in adult rats, using 2 new ligands for PET: (18)F-GE-179 for the open/active state of the NMDA receptor ion channel and F-18-GE-194 for GABA-A receptor. Ex vivo brain autoradiography of radioligands was performed at subacute (5-6 d) and chronic (40-42 d) time points after TBI. Results: At 5-6 d after TBI, F-18-GE-179 binding was higher in the cortical lesion area, in the lesion core, and in the hippocampus than in the corresponding contralateral regions; this increase was probably related to increased permeability of the blood-brain barrier. At 40-42 d after TBI, F-18-GE-179 binding was significantly higher in the medial cortex, in the corpus callosum, and in the thalamus than in the corresponding contralateral regions. Five to 6 days after TBI, F-18-GE-194 binding was significantly higher in the lesion core and significantly lower in the ipsilateral thalamus. By 40-42 d after TBI, the reduction in F-18-GE-194 binding extended to the cortical lesion, including the perilesional cortex around the lesion core. The reduction in thalamic binding was more extensive at 40-42 d than at 5-6 d after TBI, suggesting a progressive decrease in thalamic GABA-A receptor density. Immunohistochemistry against GABA-A alpha 1 subunit revealed a similar decrease to F-18-GE-194 binding, particularly during the chronic phase. Conclusion: Our data support the validity of novel F-18-GE-179 and F-18-GE-194 radioligands for the detection of changes in active NMDA receptor and GABA-A receptor in the injured brain. These tools are useful for follow-up evaluation of secondary postinjury pathologies.	[Lopez-Picon, Francisco; Snellman, Anniina; Gronroos, Tove J.; Marjamaki, Paivi; Haaparanta-Solin, Merja] Univ Turku, Turku PET Ctr, PET Preclin Lab, Turku, Finland; [Lopez-Picon, Francisco; Snellman, Anniina; Gronroos, Tove J.; Marjamaki, Paivi; Haaparanta-Solin, Merja] Univ Turku, Medicity Res Lab, Turku, Finland; [Shatillo, Olena; Pitkanen, Asia] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Lehtiniemi, Paula; Solin, Olof] Univ Turku, Turku PET Ctr, Radiopharmaceut Chem Lab, Turku, Finland; [Trigg, William; Jones, Paul A.] GE Healthcare Life Sci, Amersham, Bucks, England; [Solin, Olof] Abo Akad Univ, Accelerator Lab, Turku, Finland; [Solin, Olof] Univ Turku, Dept Chem, Turku, Finland		Haaparanta-Solin, M (corresponding author), Univ Turku, MediCity PET Preclin Lab, Tykistokatu 6A, FI-20520 Turku, Finland.	mehaaso@utu.fi	; Jones, Paul/M-1841-2013	Trigg, William/0000-0003-4046-0813; Snellman, Anniina/0000-0001-6191-0954; Haaparanta-Solin, Merja/0000-0002-3602-4587; Lopez Picon, Francisco R./0000-0002-3871-1735; Jones, Paul/0000-0002-8385-1702	Academy of FinlandAcademy of FinlandEuropean Commission [272249, 273909, 271683]; EUROCORES EuroEPINOMICS Program (EpiGENet); Strategic Funding of the University of Eastern Finland (UEF-Brain); GE Healthcare Ltd.;  [266891]	The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This study was supported by The Academy of Finland projects 272249, 273909, and 271683; project 266891; the EUROCORES EuroEPINOMICS Program (EpiGENet); Strategic Funding of the University of Eastern Finland (UEF-Brain); and GE Healthcare Ltd., which also provided the chemicals for <SUP>18</SUP>F-GE-179 and <SUP>18</SUP>F-GE-194 synthesis. No other potential conflict of interest relevant to this article was reported.	Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Bauer R, 1999, EXP TOXICOL PATHOL, V51, P143, DOI 10.1016/S0940-2993(99)80088-8; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Centers for Disease Control and Prevention, 2017, SEV TBI; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Kalviainen R, 1998, NEUROLOGY, V50, P1377, DOI 10.1212/WNL.50.5.1377; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; McGinnity CJ, 2015, J NEUROL NEUROSUR PS, V86, P1150, DOI 10.1136/jnnp-2014-309897; McGinnity CJ, 2014, J NUCL MED, V55, P423, DOI 10.2967/jnumed.113.130641; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Robins EG, 2010, BIOORG MED CHEM LETT, V20, P1749, DOI 10.1016/j.bmcl.2010.01.052; Rodnick ME, 2013, NUCL MED BIOL, V40, P901, DOI 10.1016/j.nucmedbio.2013.06.004; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111	26	14	14	0	9	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	SEP	2016	57	9					1442	1447		10.2967/jnumed.115.167403			6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DU7UK	WOS:000382419900034	27199360	Bronze			2022-02-06	
J	Mao, XX; Liu, J; Chen, C; Zhang, WD; Qian, R; Chen, XL; Lu, HJ; Ge, JB; Zhao, CJ; Zhang, DM; Wang, YH				Mao, Xingxing; Liu, Jin; Chen, Chen; Zhang, Weidong; Qian, Rong; Chen, Xinlei; Lu, Hongjian; Ge, Jianbing; Zhao, Chengjin; Zhang, Dongmei; Wang, Youhua			PCBP2 Modulates Neural Apoptosis and Astrocyte Proliferation After Spinal Cord Injury	NEUROCHEMICAL RESEARCH			English	Article						Spinal cord injury; PCBP2; Neuron; Apoptosis; Astrocyte; Proliferation	ASTROGLIAL CELL-PROLIFERATION; TRAUMATIC BRAIN-INJURY; SCAR FORMATION; GROWTH-FACTORS; CYCLIN D1; PROTEIN; ACTIVATION; EXPRESSION; DIFFERENTIATION; MECHANISMS	PCBP2, a member of the poly(C)-binding protein (PCBP) family, plays a pivotal role in posttranscriptional and translational regulation by interacting with single-stranded poly(C) motifs in target mRNAs. It is reported that several PCBP family members are involved in human malignancies. However, the distribution and function of PCBP2 in the central nervous system (CNS) remain unclear. In this study, we performed an acute spinal cord injury (SCI) model in adult rats and investigated the dynamic changes of PCBP2 expression in the spinal cord. Western blot and immunohistochemistry analysis revealed that PCBP2 presented in normal spinal cord. It gradually increased, reached a peak at 3 day, and then declined to basal levels at 14 days after SCI. We observed that the expression of PCBP2 was enhanced in the gray and white matter. Immunofluorescence indicated that PCBP2 was located in the neurons and astrocytes. Moreover, colocalization of PCBP2/active caspase-3 was detected in neurons, and colocalization of PCBP2/proliferating cell nuclear antigen was detected in astrocytes after SCI. These results indicated that PCBP2 might play an important role in neuronal apoptosis and astrocyte proliferation. In vitro, PCBP2-specific siRNA-transfected neuron showed significantly decrease of neuronal apoptosis and expression of cell cycle related proteins following glutamate stimulation. Meanwhile, PCBP2 knockdown also reduced primary astrocytes proliferation. All above indicated that PCBP2 might play a crucial role in cell proliferation and apoptosis. Collectively, our data suggested that PCBP2 might play important roles in CNS pathophysiology after SCI.	[Mao, Xingxing; Liu, Jin; Chen, Chen; Zhang, Weidong; Qian, Rong; Chen, Xinlei; Wang, Youhua] Nantong Univ, Dept Orthoped, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China; [Lu, Hongjian; Ge, Jianbing; Zhao, Chengjin] Second Peoples Hosp Nantong, Dept Rehabil, Nantong 226001, Jiangsu, Peoples R China; [Zhang, Dongmei] Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong, Peoples R China		Wang, YH (corresponding author), Nantong Univ, Dept Orthoped, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.	docwangyh@163.com					Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bramanti V, 2015, J NEUROSCI RES, V93, P521, DOI 10.1002/jnr.23506; Bramanti V, 2012, NEUROCHEM RES, V37, P2795, DOI 10.1007/s11064-012-0873-3; Bramanti V, 2010, NEUROCHEM RES, V35, P2070, DOI 10.1007/s11064-010-0256-6; Bramanti V, 2015, J NEUROSCI RES, V93, P1378, DOI 10.1002/jnr.23606; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Carnevale D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P388; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P25, DOI 10.2174/156720206775541741; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Du ZH, 2008, J BIOL CHEM, V283, P28757, DOI 10.1074/jbc.M803046200; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Eversole A, 2000, MOL CELL BIOL, V20, P5425, DOI 10.1128/MCB.20.15.5425-5432.2000; Fukushi S, 2001, VIRUS RES, V73, P67, DOI 10.1016/S0168-1702(00)00228-8; Grasso S, 2014, J NEUROSCI RES, V92, P86, DOI 10.1002/jnr.23289; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Harrop J S, 2000, Neurosurg Focus, V8, pe4; Hay DC, 2001, MOL CELL BIOL, V21, P3482, DOI 10.1128/MCB.21.10.3482-3490.2001; Hu CE, 2014, BIOCHEM BIOPH RES CO, V448, P437, DOI 10.1016/j.bbrc.2014.04.124; Iwanaga K, 2005, BIOCHEM BIOPH RES CO, V333, P888, DOI 10.1016/j.bbrc.2005.05.180; Johnson RL, 1997, AM J EPIDEMIOL, V146, P266; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Pan TT, 2006, BIOCHEM BIOPH RES CO, V347, P683, DOI 10.1016/j.bbrc.2006.06.144; Rieder E, 2003, J GEN VIROL, V84, P2203, DOI 10.1099/vir.0.19013-0; Roychoudhury P, 2007, MOL CARCINOGEN, V46, P198, DOI 10.1002/mc.20265; Sean P, 2008, VIROLOGY, V378, P243, DOI 10.1016/j.virol.2008.05.007; Sean P, 2009, VIROLOGY, V389, P45, DOI 10.1016/j.virol.2009.03.012; Tator C H, 1996, J Spinal Cord Med, V19, P206; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Tommerup N, 1996, GENOMICS, V32, P297, DOI 10.1006/geno.1996.0121; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wu JF, 2011, NEUROTHERAPEUTICS, V8, P221, DOI 10.1007/s13311-011-0028-2; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815	36	14	17	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	SEP	2016	41	9					2401	2414		10.1007/s11064-016-1953-6			14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DS3XV	WOS:000380716900022	27209304				2022-02-06	
J	Osler, T; Cook, A; Glance, LG; Lecky, F; Bouamra, O; Garrett, M; Buzas, JS; Hosmer, DW				Osler, Turner; Cook, Alan; Glance, Laurent G.; Lecky, Fiona; Bouamra, Omar; Garrett, Mark; Buzas, Jeffery S.; Hosmer, David W.			The differential mortality of Glasgow Coma Score in patients with and without head injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Glasgow Coma Score; Traumatic brain injury; Mortality; Logistic	TRAUMA; SCALE; PREDICTION; MODEL	Importance: The GCS was created forty years ago as a measure of impaired consciousness following head injury and thus the association of GCS with mortality in patients with traumatic brain injury (TBI) is expected. The association of GCS with mortality in patients without TBI (non-TBI) has been assumed to be similar. However, if this assumption is incorrect mortality prediction models incorporating GCS as a predictor will need to be revised. Objective: To determine if the association of GCS with mortality is influenced by the presence of TBI. Design/setting/participants: Using the National Trauma Data Bank (2012; N = 639,549) we categorized patients as isolated TBI (12.8%), isolated non-TBI (33%), both (4.8%), or neither (49.4%) based on the presence of AIS codes of severity 3 or greater. We compared the ability GCS to discriminate survivors from non-survivors in TBI and in non-TBI patients using logistic models. We also estimated the odds ratios of death for TBI and non-TBI patients at each value of GCS using linear combinations of coefficients. Main outcome measure: Death during hospital admission. Results: As the sole predictor in a logistic model GCS discriminated survivors from non-survivors at an acceptable level (c-statistic = 0.76), but discriminated better in the case of TBI patients (c-statistic = 0.81) than non-TBI patients (c-statistic = 0.70). In both unadjusted and covariate adjusted models TBI patients were about twice as likely to die as non-TBI patients with the same GCS for GCS values <8; for GCS values >8 TBI and non-TBI patients were at similar risk of dying. Conclusions: A depressed GCS predicts death better in TBI patients than non-TBI patients, likely because in non-TBI patients a depressed GCS may simply be the result of entirely reversible intoxication by alcohol or drugs; in TBI patients, by contrast, a depressed GCS is more ominous because it is likely due to a head injury with its attendant threat to survival. Accounting for this observation into trauma mortality datasets and models may improve the accuracy of outcome prediction. (C) 2016 Elsevier Ltd. All rights reserved.	[Osler, Turner] Univ Vermont, Dept Surg, 789 Orchard Shore Rd, Colchester, VT 05446 USA; [Cook, Alan] Chandler Reg Med Ctr, Trauma Res Program, Chandler, AZ USA; [Cook, Alan] Univ Arizona, Coll Med, Dept Surg, Phoenix, AZ USA; [Glance, Laurent G.] Univ Rochester, Dept Anesthesiol, Rochester, NY 14627 USA; [Lecky, Fiona] Univ Sheffield, Emergency Med, Sheffield S10 2TN, S Yorkshire, England; [Lecky, Fiona; Bouamra, Omar] Trauma Audit & Res Network, Salford, Lancs, England; [Garrett, Mark] Chandler Reg Med Ctr, Chandler, AZ USA; [Buzas, Jeffery S.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Hosmer, David W.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA		Osler, T (corresponding author), Univ Vermont, Dept Surg, 789 Orchard Shore Rd, Colchester, VT 05446 USA.	tosler@uvm.edu; alan.cook@dignityhealth.org; Laurent_glance@umc.rochester.edu; fiona.lecky@manchester.ac.uk; omar.bouamra@manchester.ac.uk; mark.garrett@bnaneuro.net; jbuzas@uvm.edu; hosmer@schoolph.umass.edu		bouamra, omar/0000-0002-3155-4634			Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Hosmer DW., 2013, APPL LOGISTIC REGRES, P177; Marina K, 2002, P 2002 JOINT STAT M; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Osler T, 2008, ANN SURG, V247, P1041, DOI 10.1097/SLA.0b013e31816ffb3f; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Royston P, 2008, MULTIVARIABLE MODEL MULTIVARIABLE MODEL; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; TEASDALE G, 1974, LANCET, V2, P81; [No title captured]	15	14	15	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2016	47	9					1879	1885		10.1016/j.injury.2016.04.016			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	DU5QG	WOS:000382265800003	27129906				2022-02-06	
J	Padaki, AS; Cole, BJ; Ahmad, CS				Padaki, Ajay S.; Cole, Brian J.; Ahmad, Christopher S.			Concussion Incidence and Return-to-Play Time in National Basketball Association Players: Results From 2006 to 2014	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussions; basketball; epidemiology	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; EPIDEMIOLOGY; PATHOPHYSIOLOGY	Background: Various research efforts have studied concussions in the National Football League, Major League Baseball, and the National Hockey League. However, no study has investigated the incidence and return-to-play trends in the National Basketball Association (NBA), which this study aims to do. Hypothesis: Increased media scrutiny and public awareness, in addition to the institution of a league-wide concussion protocol, may have resulted in more conservative return-to-play practices. Study Design: Descriptive epidemiology study. Methods: All concussions to NBA players that were publicly reported in the media from the beginning of the 2006 NBA season to the end of the 2014 season were included. The incidence and return-to-play statistics were generated by synthesizing information from publicly available records. Results: There were 134 publicly reported concussions to NBA players from the beginning of the 2006 season to the conclusion of the 2014 season, resulting in an average of 14.9 concussions per season. The incidence has not changed significantly during this time span. The average games missed after a concussion from 2006 to 2010 was 1.6, significantly less than the 5.0 games missed from 2011 to 2014, following the institution of the NBA concussion protocol (P = .023). Conclusion: Although the incidence of publicly reported concussions in the NBA has not changed appreciably over the past 9 seasons, the time missed after a concussion has. While players often returned in the same game in the 2006 season, the combination of implemented policy, national coverage, medical staff awareness, and player education may have contributed to players now missing an average of 4 to 6 games after a concussion. A multitude of factors has resulted in more conservative return-to-play practices for NBA players after concussions.	[Padaki, Ajay S.; Cole, Brian J.; Ahmad, Christopher S.] Columbia Univ, New York, NY USA; [Padaki, Ajay S.; Ahmad, Christopher S.] Columbia Univ, Med Ctr, 622 West 168th St,PH 1130, New York, NY 10032 USA; [Cole, Brian J.] Rush Univ, Med Ctr, Dept Orthopaed, Chicago, IL 60612 USA		Ahmad, CS (corresponding author), Columbia Univ, Med Ctr, 622 West 168th St,PH 1130, New York, NY 10032 USA.	csa4@columbia.edu	Cole, Brian/K-4268-2019; Padaki, Ajay/AAB-8358-2020	Ahmad, Christopher S./0000-0001-9235-5228; Padaki, Ajay/0000-0002-2124-0340			Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Cantu RC, 2007, NEUROSURGERY, V60, P963, DOI 10.1227/01.NEU.0000255430.62291.7B; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Dick R, 2007, J ATHL TRAINING, V42, P173; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Green GA, 2015, AM J SPORT MED, V43, P1118, DOI 10.1177/0363546514568089; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Makhni EC, 2014, PHYSICIAN SPORTSMED, V42, P154, DOI 10.3810/psm.2014.05.2067; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	24	14	14	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2016	44	9					2263	2268		10.1177/0363546516634679			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DV6CU	WOS:000383019300014	27022062				2022-02-06	
J	Paredes, I; Castano, AM; Cepeda, S; Alen, JAF; Salvador, E; Millan, JM; Lagares, A				Paredes, Igor; Maria Castano, Ana; Cepeda, Santiago; Fernandez Alen, Jose Antonio; Salvador, Elena; Maria Millan, Jose; Lagares, Alfonso			The Effect of Cranioplasty on Cerebral Hemodynamics as Measured by Perfusion Computed Tomography and Doppler Ultrasonography	JOURNAL OF NEUROTRAUMA			English	Article						cranioplasty; Lindegaard ratio; perfusion computed tomography; transcranial doppler sonography; trephined syndrome	SINKING SKIN-FLAP; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; NEUROLOGICAL IMPROVEMENT; SURGICAL COMPLICATIONS; PARADOXICAL HERNIATION; INTRACRANIAL-PRESSURE; ARTERY INFARCTION; CONTROLLED-TRIAL; BODY POSITION	Cranioplasties are performed to protect the brain and correct cosmetic defects, but there is growing evidence that this procedure may result in neurological improvement. We prospectively studied cranioplasties performed at our hospital over a 5-year period. The National Institute of Health Stroke Scale and Barthel index were recorded prior to and within 72 h after the cranioplasty. A perfusion computed tomography (PCT) and transcranial Doppler sonography (TCDS) were performed prior to and 72 h after the surgery. For the PCT, regions irrigated by the anterior cerebral artery, the middle cerebral artery (MCA), the posterior cerebral artery, and the basal ganglia were selected, as well as the mean values for the hemisphere. The sonography was performed in the sitting and the supine position for the MCA and internal carotid. The velocities, pulsatility index, resistance index, and Lindegaard ratio (LR) were obtained, as well as a variation value for the LR (Delta LR = LR sitting - LR supine). Fifty-four patients were included in the study. Of these, 23 (42.6%) patients presented with objective improvement. The mean cerebral blood flow of the defective side (m-CBF-d) increased from 101.86 to 117.17mL/100 g/min (p = 0.064), and the m-CBF of the healthy side (m-CBF-h) increased from 128.14 to 145.73mL/100 g/min (p = 0.028). With regard to the TCDS, the DLR was greater on the defective side prior the surgery in those patients who showed improvement (1.295 vs. -0.714; p = 0.002). Cranioplasty resulted in clinical improvement in 40% of the patients, with an increase in the post-surgical CBF. The larger variations in the LR when the patient is moved from the sitting to the supine position might predict the clinical improvement.	[Paredes, Igor; Maria Castano, Ana; Cepeda, Santiago; Fernandez Alen, Jose Antonio; Lagares, Alfonso] Univ Hosp 12 Octubre, Dept Neurosurg, Carretera Andalucia Km 5-400, Madrid 28041, Spain; [Salvador, Elena; Maria Millan, Jose] Univ Hosp 12 Octubre, Dept Neuroradiol, Madrid, Spain		Paredes, I (corresponding author), Univ Hosp 12 Octubre, Dept Neurosurg, Carretera Andalucia Km 5-400, Madrid 28041, Spain.	igor.paredes@salud.madrid.org	ALEN, JOSE A FERNANDEZ/G-4990-2018; Lagares, Alfonso/B-2969-2011; Cepeda, Santiago/AAE-3200-2021; Castano-Leon, Ana M/ABF-6322-2020; Sansinenea, Igor Paredes/S-6281-2019; Paredes, Igor/AAW-6313-2021	ALEN, JOSE A FERNANDEZ/0000-0002-3321-983X; Lagares, Alfonso/0000-0003-3996-0554; Cepeda, Santiago/0000-0003-1667-8548; Castano-Leon, Ana M/0000-0002-7918-5049; Paredes, Igor/0000-0002-3846-4164; Salvador, Elena/0000-0002-8324-6502			Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Bijlenga P, 2007, J NEUROL NEUROSUR PS, V78, P430, DOI 10.1136/jnnp.2006.099242; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Chalouhi N, 2012, NEUROLOGIST, V18, P423, DOI 10.1097/NRL.0b013e318272f7be; Coelho F, 2014, NEUROPSYCH DIS TREAT, V10, P695, DOI 10.2147/NDT.S52875; de Araujo AS, 2013, ARQ NEURO-PSIQUIAT, V71, P963, DOI 10.1590/0004-282X20130176; Decaminada N, 2008, NEURORADIOL J, V21, P459, DOI 10.1177/197140090802100402; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Erdogan E, 2003, NEUROL INDIA, V51, P479; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Fodstad H, 1979, Acta Neurochir Suppl (Wien), V28, P514; Gadde Judith, 2012, Del Med J, V84, P213; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Hofmeijer J, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-29; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Huang YH, 2013, INT J SURG, V11, P886, DOI 10.1016/j.ijsu.2013.07.013; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Janzen C, 2012, BRAIN INJURY, V26, P101, DOI 10.3109/02699052.2011.635357; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Kemmling A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-80; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Lin C. H., 2013, J FORMOS MED ASSOC, V114, P577; Maekawa M, 1999, NEUROL SURG TOKYO, V27, P717; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Narro-Donate JM, 2015, NEUROCIRUGIA, V26, P95, DOI 10.1016/j.neucir.2014.09.006; Mokri B, 2010, HEADACHE, V50, P1206, DOI 10.1111/j.1526-4610.2010.01715.x; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; NAKAMURA T, 1980, Neurologia Medico-Chirurgica, V20, P89, DOI 10.2176/nmc.20.89; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Ng D, 1997, J CLIN NEUROSCI, V4, P346, DOI 10.1016/S0967-5868(97)90103-X; Paredes I, 2015, NEUROCIRUGIA, V26, P115, DOI 10.1016/j.neucir.2014.10.001; Paredes Igor, 2011, Surg Neurol Int, V2, P88, DOI 10.4103/2152-7806.82370; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Romero FR, 2013, INT J SURG CASE REP, V4, P1007, DOI 10.1016/j.ijscr.2013.08.013; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Sarubbo S, 2014, NEURORADIOLOGY, V56, P237, DOI 10.1007/s00234-014-1318-2; Schwarz S, 2002, STROKE, V33, P497, DOI 10.1161/hs0202.102376; Sinha S, 2015, NEUROL INDIA, V63, P175, DOI 10.4103/0028-3886.156277; Song J, 2014, ACTA NEUROCHIR, V156, P193, DOI 10.1007/s00701-013-1908-5; Stelling H, 2011, BRIT J NEUROSURG, V25, P407, DOI 10.3109/02688697.2011.566385; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; STULA D, 1982, J MAXILLOFAC SURG, V10, P142, DOI 10.1016/S0301-0503(82)80030-1; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler PA., 2000, NEUROSURG FOCUS, V8, DOI [10.3171/foc.2000.8.1.1920, DOI 10.3171/FOC.2000.8.1.1920, DOI 10.3171/INS.2000.93.1.0053]; Won YD, 2008, ACTA NEUROCHIR SUPPL, V102, P15, DOI 10.1007/978-3-211-85578-2_3; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	55	14	15	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1586	1597		10.1089/neu.2015.4261			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300004	26541365	Green Published			2022-02-06	
J	Pomponi, M; Ricciardi, L; La Torre, G; Fusco, D; Morabito, B; Ricciardi, D; Di Gioia, A; Bernabei, R; Bentivoglio, AR				Pomponi, Massimiliano; Ricciardi, Lucia; La Torre, Giuseppe; Fusco, Domenico; Morabito, Bruno; Ricciardi, Diego; Di Gioia, Annamaria; Bernabei, Roberto; Bentivoglio, Anna Rita			Patient's Loss of Empathy Is Associated With Caregiver Burden	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Caregiver burden; patient's empathy; Parkinson's disease; alexithymia	EARLY PARKINSONS-DISEASE; TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; DEPRESSION RATING-SCALES; FRONTOTEMPORAL DEMENTIA; PREFRONTAL CORTEX; FAMILY CAREGIVERS; NEURAL CIRCUITRY; AUTISM; SYMPTOMS	Patients benefit from the presence of empathic caregivers (CGs). In this regard, empathy toward the patient is one of the clinical targets for improving patient outcomes. However, relatively little is known about the impact of patients' empathic responses on the CGs' burden. Among people living with Parkinson's disease (PwP), care partners play a major role. This study involved 28 spouse-patient couples. Empathy, stress burden, and mood disorders (such as anxiety and depression) were assessed over a 6-month period, before and after the reported intervention. Our observation points out that the improvement of patient empathy is necessary for a significant burden reduction among spouses caring for PwP.	[Pomponi, Massimiliano; Fusco, Domenico; Morabito, Bruno; Ricciardi, Diego; Bernabei, Roberto] Univ Cattolica Sacro Cuore, Sch Med, Teaching Hosp Agostino Gemelli, Dept ofGeriatr Neurosci & Orthoped, Rome, Italy; [Ricciardi, Lucia] UCL, Inst Neurol, Sobell Sobell Dept Motor Neurosci & Movement Diso, London, England; [La Torre, Giuseppe] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy; [Di Gioia, Annamaria] Univ Cattolica Sacro Cuore, Inst Psychiat, Rome, Italy; [Di Gioia, Annamaria] Univ Cattolica Sacro Cuore, Inst Psychol, Rome, Italy; [Bentivoglio, Anna Rita] Univ Cattolica Sacro Cuore, Inst Neurol, Dept Neurosci, Rome, Italy		Pomponi, M (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Teaching Hosp Agostino Gemelli, Dept ofGeriatr Neurosci & Orthoped, Rome, Italy.	massimilianopomponi@alice.it	Fusco, Domenico/AAL-3756-2020; La Torre, Giuseppe/AAI-6866-2020; Bernabei, Roberto/AAB-2704-2019; Bentivoglio, Anna Rita/K-3752-2018	Fusco, Domenico/0000-0002-8876-7497; La Torre, Giuseppe/0000-0002-1233-2040; Bernabei, Roberto/0000-0002-9197-004X; Bentivoglio, Anna Rita/0000-0002-9663-095X	AllerganAbbVieAllergan; IpsenIpsen; Merz; LundbeckLundbeck Corporation; AbbvieAbbVie; Chiesi PharmaceuticalsChiesi Pharmaceuticals Inc	The authors thank the participating patients and their families, as well as the staff of the participating general practitioners, specialists, and the staff of the Centro Studi Lorenzon. The authors also thank the ASL Treviso for the good and friendly cooperation. Anna Rita Bentivoglio received speaker's fee from Allergan, Ipsen, Merz, Lundbeck, Abbvie, and Chiesi Pharmaceuticals; consultancy fee from Merz; and research grants from Merz, Ipsen, and Chiesi Pharmaceuticals.	Aarsland D, 1999, INT J GERIATR PSYCH, V14, P866, DOI 10.1002/(SICI)1099-1166(199910)14:10<866::AID-GPS38>3.3.CO;2-Q; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Assogna F, 2016, PARKINSONISM RELAT D, V28, P1, DOI 10.1016/j.parkreldis.2016.03.021; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Batson C.D., 2011, ALTRUISM HUMANS; Bettio F.-A., 2010, LONG TERM CARE ELDER; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; BRAAK H, 1994, ACTA NEUROPATHOL, V88, P493, DOI 10.1007/BF00296485; Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; Chattat R, 2011, INT PSYCHOGERIATR, V23, P797, DOI 10.1017/S1041610210002218; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Decety J, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-22; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Diehl-Schmid J, 2013, J GERIATR PSYCH NEUR, V26, P221, DOI 10.1177/0891988713498467; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Fahn S., 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GEORGE LK, 1986, GERONTOLOGIST, V26, P253, DOI 10.1093/geront/26.3.253; GIVEN B, 1990, RES NURS HEALTH, V13, P77, DOI 10.1002/nur.4770130204; Greenfield K, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0045-9; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hanganu A, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00138; Huber M, 2009, FACTS FIGURES LONG T; Jones AP, 2010, J CHILD PSYCHOL PSYC, V51, P1188, DOI 10.1111/j.1469-7610.2010.02280.x; Kirkwood T, 2003, BRIT MED J, V326, P1297, DOI 10.1136/bmj.326.7402.1297; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lawson RA, 2014, J PARKINSON DIS, V4, P331, DOI 10.3233/JPD-140390; Leentjens AFG, 2000, INT J GERIATR PSYCH, V15, P644, DOI 10.1002/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L; Leentjens AFG, 2008, MOVEMENT DISORD, V23, P2015, DOI 10.1002/mds.22233; Leentjens AFG, 2011, MOVEMENT DISORD, V26, P407, DOI 10.1002/mds.23184; Legg L, 2013, J EPIDEMIOL COMMUN H, V67, P95, DOI 10.1136/jech-2012-201652; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P924, DOI 10.1002/mds.21355; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Mioshi E, 2009, DEMENT GERIATR COGN, V27, P76, DOI 10.1159/000193626; Naarding P, 2002, J NEUROPSYCH CLIN N, V14, P329, DOI 10.1176/appi.neuropsych.14.3.329; Narayan S, 2001, J GERONTOLOGICAL NUR, V17, P19; Nemiah J. C., 1976, MODERN TRENDS PSYCHO, V3, P430; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nielsen M, 2014, EPIDEMIOLOGY, V25, P225, DOI 10.1097/EDE.0000000000000042; NIH National Institute of Neurological Disorders and Stroke, 2015, PARK DIS CHALL PROGR; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Ory MG, 1999, GERONTOLOGIST, V39, P177, DOI 10.1093/geront/39.2.177; Ouchi Y, 1999, ANN NEUROL, V45, P601, DOI 10.1002/1531-8249(199905)45:5<601::AID-ANA8>3.0.CO;2-0; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pinquart M, 2003, J GERONTOL B-PSYCHOL, V58, pP112, DOI 10.1093/geronb/58.2.P112; Preller KH, 2014, ADDICT BIOL, V19, P452, DOI 10.1111/adb.12070; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reuter M, 2011, SOC COGN AFFECT NEUR, V6, P662, DOI 10.1093/scan/nsq083; Schrag A, 2006, PARKINSONISM RELAT D, V12, P35, DOI 10.1016/j.parkreldis.2005.06.011; Schreiner AS, 2006, AGING MENT HEALTH, V10, P107, DOI 10.1080/13607860500312142; SCHULZ R, 1987, J APPL SOC PSYCHOL, V17, P401, DOI 10.1111/j.1559-1816.1987.tb00321.x; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Torbey E, 2015, J AFFECT DISORDERS, V184, P216, DOI 10.1016/j.jad.2015.05.059; Weintraub D, 2006, AM J GERIAT PSYCHIAT, V14, P169, DOI 10.1097/01.JGP.0000192488.66049.4b; Weintraub D, 2015, MOVEMENT DISORD, V30, P121, DOI 10.1002/mds.26016; Winnicott DW, 1970, HOME IS WHERE WE STA, P112; World Health Organization (WHO), 2001, WORLD HLTH REPORT 20; Yarnall AJ, 2014, NEUROLOGY, V82, P308, DOI 10.1212/WNL.0000000000000066; Yates ME, 1999, J GERONTOL B-PSYCHOL, V54, pP12, DOI 10.1093/geronb/54B.1.P12; Zarit JM, 1990, REPRINT SERIES PEN 3, V189; Zarit S, 1987, INSTRUCTIONS BURDEN; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	74	14	14	1	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	SEP	2016	204	9					717	722		10.1097/NMD.0000000000000568			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	DX2XX	WOS:000384238100012	27570901				2022-02-06	
J	Mao, SS; Li, XH; Wang, J; Ding, X; Zhang, CY; Li, L				Mao, Susu; Li, Xiuhua; Wang, Jin; Ding, Xin; Zhang, Chenyu; Li, Liang			miR-17-92 facilitates neuronal differentiation of transplanted neural stem/precursor cells under neuroinflammatory conditions	JOURNAL OF NEUROINFLAMMATION			English	Article						miR-17-92; Neural stem/precursor cells; Transplantation; Neuroinflammation; JAK-STAT pathway; Differentiation	TRAUMATIC BRAIN-INJURY; STEM-CELLS; PRECURSOR CELLS; STEM/PROGENITOR CELLS; IN-VITRO; ASTROCYTE; LEUKEMIA; INFLAMMATION; ACTIVATION; CLUSTER	Background: Neural stem/precursor cells (NSCs) are of particular interest because of their potential application in cell therapy for brain damage. However, most brain injury cases are followed with neuroinflammatory stress, which affects the lineage selection of grafted NSCs by promoting astrocytogenesis, thus hampering the potential for neural replacement. The present study investigated the role of miR-17-92 in protecting against detrimental effects of neuroinflammation on NSC differentiation in cell therapy. Methods: NSCs were treated with conditioned medium from lesioned astrocytes with/without neutralizing antibodies of leukemia inhibitory factor (LIF) or/and ciliary neurotrophic factor (CNTF), respectively. Afterward, the levels of p-STAT3 and p-JAK2 were determined by western blotting while expression of glial fibrillary acidic protein (GFAP) and beta-tubulin III was assessed by immunostaining. The activation of JAK-STAT pathway and cell differentiation were also evaluated after we overexpressed miR-17-92 in NSCs under different neuroinflammatory conditions. After the transplantation of miR-17-92-overexpressing NSCs into injured mouse cortex, PH3, nestin, GFAP, and NeuN were analyzed by immunostaining. In addition, motor coordination of mice was evaluated by rotarod test. Results: Conditioned medium from lesioned astrocytes activated JAK-STAT pathway and facilitated astrocytic differentiation in NSCs while neutralizing antibodies of LIF and CNTF remarkably attenuated such effects. miR-17-92 cluster repressed the expression of multiple proteins including GP130, CNTFR, JAK2, and STAT3 in JAK-STAT pathway. Overexpression of miR-17-92 in NSCs systematically blocked the activation of JAK-STAT pathway mediated by LIF and CNTF, which facilitated neuronal differentiation in vitro. Furthermore, miR-17-92 increased neuronal generation of grafted NSCs and reduced astrogliosis, which resulted in the improvement of motor coordination of brain-injured mice. Conclusions: Our results suggest that miR-17-92 promotes neuronal differentiation of grafted NSCs under neuroinflammatory condition via inhibition of multiple proteins in JAK-STAT pathway.	[Mao, Susu; Li, Xiuhua; Wang, Jin; Ding, Xin; Zhang, Chenyu; Li, Liang] Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol,Sch Life Sci, NJU Adv Inst Life Sci,Collaborat Innovat Ctr Chem, 163 Xianlin Rd, Nanjing 210023, Jiangsu, Peoples R China; [Mao, Susu] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Coinnovat Ctr Neuroregenerat, Nantong 226001, Peoples R China		Li, L (corresponding author), Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol,Sch Life Sci, NJU Adv Inst Life Sci,Collaborat Innovat Ctr Chem, 163 Xianlin Rd, Nanjing 210023, Jiangsu, Peoples R China.	lijing@sibs.ac.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31471019]	This work was supported by grants from the National Natural Science Foundation of China (31471019).	Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brites D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00476; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Chau MJ, 2014, STEM CELLS, V32, P3075, DOI 10.1002/stem.1802; Coorey NJ, 2015, INVEST OPHTH VIS SCI, V56, P2151, DOI 10.1167/iovs.14-15695; Covacu R, 2017, NEUROSCIENTIST, V23, P27, DOI 10.1177/1073858415616559; DeVito WJ, 1999, J CELL BIOCHEM, V74, P278; Faijerson J, 2006, J NEUROSCI RES, V84, P1415, DOI 10.1002/jnr.21044; Fan XL, 2010, NEUROCHEM INT, V56, P291, DOI 10.1016/j.neuint.2009.11.001; Fan Z, 2016, MOL NEUROBIOL, V53, P7057, DOI 10.1007/s12035-015-9620-5; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Ideguchi M, 2008, J NEUROSCI RES, V86, P1936, DOI 10.1002/jnr.21652; Jhaveri K, 2016, CLIN BREAST CANCER, V16, P113, DOI 10.1016/j.clbc.2015.11.006; Kang SS, 2013, NEUROBIOL DIS, V49, P68, DOI 10.1016/j.nbd.2012.08.020; Kim DY, 2015, CELL DEATH DIFFER, V22, P2034, DOI 10.1038/cdd.2015.123; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Laterza C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3597; Laywell ED, 2005, J COMP NEUROL, V493, P321, DOI 10.1002/cne.20722; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Li HD, 2007, GLIA, V55, P24, DOI 10.1002/glia.20434; Li J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17212; Li YM, 2012, BLOOD, V119, P4486, DOI 10.1182/blood-2011-09-378687; Liu Q, 2016, NAT NEUROSCI, V19, P243, DOI 10.1038/nn.4211; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lukovic D, 2015, STEM CELLS, V33, P1036, DOI 10.1002/stem.1959; Ma SS, 2016, ONCOTARGET, V7, P13502, DOI 10.18632/oncotarget.6284; Makri G, 2010, STEM CELLS, V28, P127, DOI 10.1002/stem.258; Mao SS, 2015, PROTEIN CELL, V6, P529, DOI 10.1007/s13238-015-0168-y; Mao SS, 2014, FEBS J, V281, P1144, DOI 10.1111/febs.12680; MAYER M, 1994, DEVELOPMENT, V120, P143; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mosher KI, 2012, NAT NEUROSCI, V15, P1485, DOI 10.1038/nn.3233; Naka-Kaneda H, 2014, P NATL ACAD SCI USA, V111, P1604, DOI 10.1073/pnas.1315567111; Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Philippe L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00070; Seo H, 2016, BMB REP, V49, P128, DOI 10.5483/BMBRep.2016.49.2.202; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083067; Wang FW, 2011, STEM CELL RES, V7, P41, DOI 10.1016/j.scr.2011.03.004; Wu W, 2013, BRIT J CANCER, V108, P653, DOI 10.1038/bjc.2012.587; Zhang JF, 2016, J MOL NEUROSCI, V58, P507, DOI 10.1007/s12031-016-0712-0; Zhang MM, 2011, J IMMUNOL, V186, P4716, DOI 10.4049/jimmunol.1002989; Zhang X, 2013, NEUROBIOL AGING, V34, P663, DOI 10.1016/j.neurobiolaging.2012.06.012; Zhang YL, 2016, AM J CHINESE MED, V44, P103, DOI 10.1142/S0192415X16500075; Zhou YJ, 2016, J CELL MOL MED, V20, P939, DOI 10.1111/jcmm.12782	52	14	16	1	18	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	AUG 27	2016	13								208	10.1186/s12974-016-0685-5			14	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	DV4ER	WOS:000382878600001	27567678	gold, Green Published			2022-02-06	
J	Xu, J; Sisniega, A; Zbijewski, W; Dang, H; Stayman, JW; Wang, XH; Foos, DH; Aygun, N; Koliatsos, VE; Siewerdsen, JH				Xu, Jennifer; Sisniega, Alejandro; Zbijewski, Wojciech; Dang, Hao; Stayman, J. Webster; Wang, Xiaohui; Foos, David H.; Aygun, Nafi; Koliatsos, Vassillis E.; Siewerdsen, Jeffrey H.			Evaluation of detector readout gain mode and bowtie filters for cone-beam CT imaging of the head	PHYSICS IN MEDICINE AND BIOLOGY			English	Article						cone-beam CT; Bowtie filter; detector readout mode; image quality; dose; head imaging; flat-panel detector	FLAT-PANEL IMAGERS; X-RAY-DETECTOR; ACTIVE-MATRIX; BREAST CT; STATISTICAL RECONSTRUCTION; DIAGNOSTIC-RADIOLOGY; COMPUTED-TOMOGRAPHY; NOISE PERFORMANCE; OPTIMIZATION; QUALITY	The effects of detector readout gain mode and bowtie filters on cone-beam CT (CBCT) image quality and dose were characterized for a new CBCT system developed for point-of-care imaging of the head, with potential application to diagnosis of traumatic brain injury, intracranial hemorrhage (ICH), and stroke. A detector performance model was extended to include the effects of detector readout gain on electronic digitization noise. The noise performance for high-gain (HG), low-gain (LG), and dual-gain (DG) detector readout was evaluated, and the benefit associated with HG mode in regions free from detector saturation was quantified. Such benefit could be realized (without detector saturation) either via DG mode or by incorporation of a bowtie filter. Therefore, three bowtie filters were investigated that varied in thickness and curvature. A polyenergetic gain correction method was developed to equalize the detector response between the flood-field and projection data in the presence of a bowtie. The effect of bowtie filters on dose, scatter-to-primary ratio, contrast, and noise was quantified in phantom studies, and results were compared to a high-speed Monte Carlo (MC) simulation to characterize x-ray scatter and dose distributions in the head. Imaging in DG mode improved the contrast-to-noise ratio (CNR) by similar to 15% compared to LG mode at a dose (D-0, measured at the center of a 16 cm CTDI phantom) of 19 mGy. MC dose calculations agreed with CTDI measurements and showed that bowtie filters reduce peripheral dose by as much as 50% at the same central dose. Bowtie filters were found to increase the CNR per unit square-root dose near the center of the image by similar to 5-20% depending on bowtie thickness, but reduced CNR in the periphery by similar to 10-40%. Images acquired at equal CTDIw with and without a bowtie demonstrated a 24% increase in CNR at the center of an anthropomorphic head phantom. Combining a thick bowtie filter with a short arc (180 degrees + fan angle) scan centered on the posterior of the head reduced dose to the eye lens by up to 90%. Acquisition in DG mode (without a bowtie filter) was beneficial to the detection of small, low contrast lesions (e.g. subtle ICH) in CBCT. While bowtie filters were found to reduce dose, mitigate sensor saturation at the periphery in HG mode, and improve CNR at the center of the image, the image quality at the periphery was slightly reduced compared to DG mode, and the use of a bowtie required careful implementation of the polyenergetic flood-field correction to avoid artifacts.	[Xu, Jennifer; Sisniega, Alejandro; Zbijewski, Wojciech; Dang, Hao; Stayman, J. Webster; Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Wang, Xiaohui; Foos, David H.] Carestream Hlth, Rochester, NY 14608 USA; [Aygun, Nafi; Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA; [Koliatsos, Vassillis E.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA		Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA.	jeff.siewerdsen@jhu.edu	Dang, Hao/U-4865-2018	Dang, Hao/0000-0001-5861-6535; Sisniega, Alejandro/0000-0003-2030-2711; Stayman, Joseph/0000-0003-4358-378X			Antonuk LE, 2000, MED PHYS, V27, P289, DOI 10.1118/1.598831; Badal A, 2009, MED PHYS, V36, P4878, DOI 10.1118/1.3231824; Bartolac S, 2011, MED PHYS, V38, pS2, DOI 10.1118/1.3574885; Chen B, 2002, MED PHYS, V29, P755, DOI 10.1118/1.1461843; Daly MJ, 2006, MED PHYS, V33, P3767, DOI 10.1118/1.2349687; Dang H, 2015, PHYS MED BIOL, V60, P6153, DOI 10.1088/0031-9155/60/16/6153; Heiland M, 2004, DENTOMAXILLOFAC RAD, V33, P130, DOI 10.1259/dmfr/15309653; Hernandez AM, 2014, MED PHYS, V41, DOI 10.1118/1.4866216; Hsieh SS, 2013, MED PHYS, V40, DOI 10.1118/1.4789630; JOSEPH PM, 1978, J COMPUT ASSIST TOMO, V2, P100, DOI 10.1097/00004728-197801000-00017; Konstantinidis AC, 2012, NUCL INSTRUM METH A, V689, P12, DOI 10.1016/j.nima.2012.06.024; Koskinen SK, 2013, SKELETAL RADIOL, V42, P649, DOI 10.1007/s00256-012-1516-0; Lee D L, 2004, OPT SCI TECHN SPIE 4, P126; Lindfors KK, 2008, RADIOLOGY, V246, P725, DOI 10.1148/radiol.2463070410; Mail N, 2009, MED PHYS, V36, P22, DOI 10.1118/1.3017470; Maolinbay M, 2000, MED PHYS, V27, P1841, DOI 10.1118/1.1286721; Miracle AC, 2009, AM J NEURORADIOL, V30, P1088, DOI 10.3174/ajnr.A1653; Mozzo P, 1998, EUR RADIOL, V8, P1558, DOI 10.1007/s003300050586; Prakash P, 2011, MED PHYS, V38, P5612, DOI 10.1118/1.3633937; Roos P G, 2004, SPIE MED IMAGING 200, P139; Schafer S, 2011, MED PHYS, V38, P4563, DOI 10.1118/1.3597566; Scheuermann JR, 2016, PROC SPIE, V9783, DOI 10.1117/12.2217002; Shin MS, 2013, IEEE T ELECTRON DEV, V60, P1169, DOI 10.1109/TED.2013.2238674; Siewerdsen J.H., 2007, SPIE MED IMAGING 200; Siewerdsen JH, 1998, MED PHYS, V25, P614, DOI 10.1118/1.598243; Siewerdsen JH, 2004, MED PHYS, V31, P3057, DOI 10.1118/1.1758350; Siewerdsen JH, 1997, MED PHYS, V24, P71, DOI 10.1118/1.597919; Siewerdsen JH, 2000, MED PHYS, V27, P1903, DOI 10.1118/1.1286590; Sisniega A, 2013, MED PHYS, V40, DOI 10.1118/1.4801895; Stayman J W, 2016, SPIE MED IMAGING; Szczykutowicz TP, 2014, PHYS MED BIOL, V59, DOI 10.1088/0031-9155/59/5/1305; Tkaczyk J E, 2004, SPIE MED IMAGING 200, P403; Toth T L, 2005, SPIE MED IMAGING, P283; Wang AS, 2014, PHYS MED BIOL, V59, P1005, DOI 10.1088/0031-9155/59/4/1005; Xu J, 2016, PHYS MED BIOL, V61, P3180, DOI 10.1088/0031-9155/61/8/3180; Xu J, 2012, MED PHYS, V39, P4932, DOI 10.1118/1.4736805; Xu J, 2016, SPIE MED IMAGING; Yamamoto K, 2003, Orthod Craniofac Res, V6 Suppl 1, P160, DOI 10.1034/j.1600-0544.2003.249.x; Yang K, 2010, MED PHYS, V37, P3527, DOI 10.1118/1.3447720; Yang WT, 2007, AM J ROENTGENOL, V189, P1312, DOI 10.2214/AJR.07.2403; Yu Lifeng, 2009, Imaging Med, V1, P65, DOI 10.2217/iim.09.5; Zbijewski W, 2011, MED PHYS, V38, P4700, DOI 10.1118/1.3611039; Zbijewski W, 2009, SPIE MED IMAGING; Zhao W, 2015, PHYS MED BIOL, V60, P1339, DOI 10.1088/0031-9155/60/3/1339; Zhao Z, 2014, MED PHYS, V41, DOI 10.1118/1.4875688	45	14	14	0	7	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-9155	1361-6560		PHYS MED BIOL	Phys. Med. Biol.	AUG 21	2016	61	16					5973	5992		10.1088/0031-9155/61/16/5973			20	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging	DX2NZ	WOS:000384208600011	27435162				2022-02-06	
J	Kuhn, AW; Zuckerman, SL; Totten, D; Solomon, GS				Kuhn, Andrew W.; Zuckerman, Scott L.; Totten, Douglas; Solomon, Gary S.			Performance and Style of Play After Returning From Concussion in the National Hockey League	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						ice hockey; National Hockey League; concussion; athletic performance	4TH INTERNATIONAL-CONFERENCE; ELITE ICE HOCKEY; CONSENSUS STATEMENT; NOVEMBER 2012; KING-DEVICK; INJURIES; OUTCOMES; SPORT; FOOTBALL; ZURICH	Background: Few studies have empirically examined outcomes of concussion in the National Hockey League (NHL) and whether these athletes return to games after concussion at a performance level comparable to preconcussion play. Hypothesis: NHL players would not demonstrate changes in performance or style of play after returning from a concussion when compared with a group of control athletes. Study Design: Cohort study; Level of evidence, 3. Methods: NHL players with a reported hockey-related concussion during the 2008-2009 through 2014-2015 seasons were identified utilizing secondary media sources. Players who missed games for non-injury related causes were selected as the control group. Performance was operationally defined as the statistics for goals, assists, points, plus-minus, and shots, and style of play was operationally defined as the statistics for penalty minutes, blocked shots, hits, giveaways, and time on ice. Each gameplay statistic was recorded and totaled for the 5 games before and after each players injury or absence. After meeting strict inclusion criteria, the 2 groups were compared across each postconcussion/absence statistic by generalized linear models while incorporating the particular preconcussion/absence statistic, position played, games missed, and concussion history as covariates to control for intraplayer and between-group differences. Results: A total of 287 players sustained a concussion; 130 missed time for non-injury related reasons and were identified as controls. After the exclusion criteria were applied, 94 concussed players were compared with 58 controls. None of the models reached statistical significance, indicating that the concussion and control groups did not differ across performance or style of play after returning from a concussion or non-injury related absence. Conclusions: When compared with a control group, players who returned to consistent play after concussion did not demonstrate changes in performance or style of play.	[Kuhn, Andrew W.; Zuckerman, Scott L.; Totten, Douglas; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Kuhn, Andrew W.] Univ Michigan Hlth Syst, MedSport Sports Med & Phys Therapy, Ann Arbor, MI USA; [Zuckerman, Scott L.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Totten, Douglas] Carleton Coll, Minneapolis, MN USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu	Solomon, Gary/K-9011-2019; Kuhn, Andrew W/AAM-4820-2020	Kuhn, Andrew W/0000-0003-1836-7575; Totten, Douglas/0000-0002-0665-9653	Department of DefenseUnited States Department of Defense	One or more of the authors has declared the following potential conflict of interest or source of funding: A.W.K.'s father is the team physician for the National Hockey League's Nashville Predators Hockey Club. G.S.S. serves as the team neuropsychologist for the National Hockey League's Nashville Predators Hockey Club. However, no funding was received for this study, and neither the Nashville Predators nor the National Hockey League had any input into the design, execution, analysis, or decision to pursue or publish this study. G.S.S. is a consultant for University of Tennessee and Tennessee Tech Athletics, and Tennessee Titans; all monies paid to institution. He is a consultant for a Department of Defense grant, paid to institution.	Agel J, 2010, CAN J SURG, V53, P319; Amin NH, 2013, AM J SPORT MED, V41, P1864, DOI 10.1177/0363546513490659; [Anonymous], 2013, IBM SPSS STAT COMP P; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Brooks DA, 2007, NEUROREHABILITATION, V22, P169; Clark J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048925; Comper P, 2013, BRIT J SPORT MED, V47, pe1; Donaldson L, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041016; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Forward KE, 2014, PAED CHILD HEALT-CAN, V19, P418, DOI 10.1093/pch/19.8.418; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gray R, 2004, J EXP PSYCHOL-APPL, V10, P42, DOI 10.1037/1076-898X.10.1.42; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; HOLM S, 1979, SCAND J STAT, V6, P65; Izraelski Jason, 2014, J Can Chiropr Assoc, V58, P346; Jakoi A, 2013, AM J SPORT MED, V41, P107, DOI 10.1177/0363546512462679; Kuhn AW, 2015, CONCUSSION, P1; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Kutac P, 2015, J HUM KINET, V45, P187, DOI 10.1515/hukin-2015-0019; Kuzuhara K, 2009, J ATHL TRAINING, V44, P208, DOI 10.4085/1062-6050-44.2.208; LORENTZON R, 1988, AM J SPORT MED, V16, P389, DOI 10.1177/036354658801600414; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Milzman D., 2014, BR J SPORTS MED, V48, P639, DOI [10.1136/bjsports-2014-093494.213, DOI 10.1136/BJSPORTS-2014-093494.213]; Muraskin J., 2013, 7 ANN MIT SLOAN SPOR; Radlo SJ, 2001, RES Q EXERCISE SPORT, V72, P22, DOI 10.1080/02701367.2001.10608928; Schroeder GD, 2013, AM J SPORT MED, V41, P2604, DOI 10.1177/0363546513499229; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596	31	14	14	1	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2016	44	8					2152	2157		10.1177/0363546516638327			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	DU4UM	WOS:000382208100033	27159319				2022-02-06	
J	Liu, GM; Xu, K; Li, J; Luo, YG				Liu, Guo-min; Xu, Kun; Li, Juan; Luo, Yun-gang			Curcumin upregulates S100 expression and improves regeneration of the sciatic nerve following its complete amputation in mice	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; electrophysiology; complete nerve amputation; spinal cord; myelin sheath; myelinated fiber; epineurium anatomosis; neural regeneration	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; RAT MODEL; FUNCTIONAL RECOVERY; PROTEIN; HIPPOCAMPUS; DEPRESSION; PREDICTION; BIOMARKER; RESPONSES	The repair of peripheral nerve injury after complete amputation is difficult, and even with anastomosis, the rapid recovery of nerve function remains challenging. Curcumin, extracted from plants of the genus Curcuma, has been shown to have anti-oxidant and anti-inflammatory properties and to improve sciatic nerve crush injury in rats. Here, we determined whether curcumin had neuroprotective effects following complete peripheral nerve amputation injury. BALB/c mice underwent complete sciatic nerve amputation, followed by an immediate epineurium anastomosis. Mice were intragastrically administered curcumin at doses of 40 (high), 20 (moderate), and 10 mg/kg/d (low) for 1 week. We found that myelin in the mice of the high-and moderate-dose curcumin groups appeared with regular shape, uniform thickness, clear boundary, and little hyperplasia surrounding the myelin. High and moderate doses of curcumin markedly improved both action potential amplitude of the sciatic nerves and the conduction velocity of the corresponding motor neurons, and upregulated mRNA and protein expression of S100, a marker for Schwann cell proliferation, in L 4-6 spinal cord segments. These results suggest that curcumin is effective in promoting the repair of complete sciatic nerve amputation injury and that the underlying mechanism may be associated with upregulation of S100 expression.	[Liu, Guo-min] Jilin Univ, Dept Orthoped, Hosp 2, Changchun, Jilin Province, Peoples R China; [Xu, Kun; Li, Juan] Jilin Univ, Dept Hlth Lab, Sch Publ Hlth, Changchun, Jilin Province, Peoples R China; [Luo, Yun-gang] Jilin Univ, Dept Stomatol, Hosp 2, Changchun, Jilin Province, Peoples R China		Luo, YG (corresponding author), Jilin Univ, Dept Stomatol, Hosp 2, Changchun, Jilin Province, Peoples R China.	luoygjlu@sina.com			Jilin Provincial Science & Technology Development Project Fund of China [20150311038YY]	This research was supported by the Jilin Provincial Science & Technology Development Project Fund of China, No. 20150311038YY.	Agthong S, 2015, EXP NEUROBIOL, V24, P139, DOI 10.5607/en.2015.24.2.139; Ahmed T, 2011, SYNAPSE, V65, P572, DOI 10.1002/syn.20876; Angius D, 2012, BIOMATERIALS, V33, P8034, DOI 10.1016/j.biomaterials.2012.07.056; Arora V, 2011, PSYCHONEUROENDOCRINO, V36, P1570, DOI 10.1016/j.psyneuen.2011.04.012; Babu A, 2015, PHARM BIOL, V53, P838, DOI 10.3109/13880209.2014.943247; Cao J, 2012, BIOMED RES-INDIA, V23, P199; Cox KHM, 2015, J PSYCHOPHARMACOL, V29, P642, DOI 10.1177/0269881114552744; Morrone MDS, 2016, J NUTR BIOCHEM, V32, P181, DOI 10.1016/j.jnutbio.2016.03.010; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Du JS, 2013, MOL MED REP, V8, P1525, DOI 10.3892/mmr.2013.1682; Fang B, 2014, INT J MOL SCI, V15, P6378, DOI 10.3390/ijms15046378; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Goozee KG, 2016, BRIT J NUTR, V115, P449, DOI 10.1017/S0007114515004687; He YK, 2016, INT J IMMUNOPATH PH, V29, P217, DOI 10.1177/0394632016638099; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Hsu CH, 2007, ADV EXP MED BIOL, V595, P471; Huang HC, 2016, J ALZHEIMERS DIS, V52, P899, DOI 10.3233/JAD-150872; Jaisin Y, 2011, NEUROSCI LETT, V489, P192, DOI 10.1016/j.neulet.2010.12.014; Jangra A, 2016, INFLAMMATION, V39, P1025, DOI 10.1007/s10753-016-0332-4; Jeon Younghoon, 2013, Curr Ther Res Clin Exp, V74, P1, DOI 10.1016/j.curtheres.2012.10.001; Jia YX, 2014, EXP THER MED, V7, P1141, DOI 10.3892/etm.2014.1546; Jiang X, 2016, EVID-BASED COMPL ALT, V2016; Khuwaja G, 2011, BRAIN RES, V1368, P254, DOI 10.1016/j.brainres.2010.10.023; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Kuo YC, 2015, INT J NANOMED, V10, P2653, DOI 10.2147/IJN.S79528; 김지수, 2013, Management Science & Financial Engineering, V19, P19, DOI 10.7737/MSFE.2013.19.2.019; Lesko MM, 2014, BRAIN INJURY, V28, P987, DOI 10.3109/02699052.2014.890743; Liu HY, 2010, NEUROSCI LETT, V485, P83, DOI 10.1016/j.neulet.2010.08.035; Ma JX, 2016, NEUROSCI LETT, V610, P139, DOI 10.1016/j.neulet.2015.11.005; Ma JX, 2013, NEUROSCI LETT, V547, P26, DOI 10.1016/j.neulet.2013.04.054; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mazzone GL, 2014, J NEUROCHEM, V130, P598, DOI 10.1111/jnc.12748; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Ozdemir M, 2012, CURR STEM CELL RES T, V7, P364, DOI 10.2174/157488812802481481; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Shakeril M, 2013, ARCH TRAUMA RES, V2, P76, DOI 10.5812/atr.8549; Song SL, 2016, PATHOL RES PRACT, V212, P247, DOI 10.1016/j.prp.2015.11.012; Stankowska DL, 2017, NUTR NEUROSCI, V20, P273, DOI [10.1080/1028415X.2015.1119377, 10.1080/1028415x.2015.1119377]; Uher T, 2012, NEUROSCI LETT, V529, P139, DOI 10.1016/j.neulet.2012.09.003; Wang HM, 2010, J ALZHEIMERS DIS, V20, P1189, DOI 10.3233/JAD-2010-091336; Wang L, 2015, CELL MOL NEUROBIOL, V35, P827, DOI 10.1007/s10571-015-0177-7; Wang PW, 2014, J NEUROSCI RES, V92, P218, DOI 10.1002/jnr.23322; Wolf H, 2015, J NEUROTRAUM, V32, P23, DOI 10.1089/neu.2013.3202; Wu SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/372819; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; Yang JQ, 2014, PATHOL RES PRACT, V210, P357, DOI 10.1016/j.prp.2014.02.005; Yu LS, 2016, EXP THER MED, V11, P709, DOI 10.3892/etm.2016.3022; Zanjani TM, 2014, KOREAN J PAIN, V27, P246, DOI 10.3344/kjp.2014.27.3.246; Zhang C, 2010, J BIOL CHEM, V285, P28472, DOI 10.1074/jbc.M110.133520	49	14	15	7	20	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	AUG	2016	11	8					1304	1311		10.4103/1673-5374.189196			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DX1RZ	WOS:000384146000027	27651779	Green Published, gold			2022-02-06	
J	Chan, V; Pole, JD; Keightley, M; Mann, RE; Colantonio, A				Chan, Vincy; Pole, Jason D.; Keightley, Michelle; Mann, Robert E.; Colantonio, Angela			Children and youth with non-traumatic brain injury: a population based perspective	BMC NEUROLOGY			English	Article						Non-traumatic brain injury; International Classification of Diseases; Pediatrics	INPATIENT REHABILITATION; OLDER-ADULTS; ONTARIO; CANADA; ENCEPHALITIS; CHILDHOOD; DISCHARGE; VERSION	Background: Children and youth with non-traumatic brain injury (nTBI) are often overlooked in regard to the need for post-injury health services. This study provided population-based data on their burden on healthcare services, including data by subtypes of nTBI, to provide the foundation for future research to inform resource allocation and healthcare planning for this population. Methods: A retrospective cohort study design was used. Children and youth with nTBI in population-based healthcare data were identified using International Classification of Diseases Version 10 codes. The rate of nTBI episodes of care, demographic and clinical characteristics, and discharge destinations from acute care and by type of nTBI were identified. Results: The rate of pediatric nTBI episodes of care was 82.3 per 100,000 (N = 17,977); the average stay in acute care was 13.4 days (SD = 25.6 days) and 35 % were in intensive care units. Approximately 15 % were transferred to another inpatient setting and 6 % died in acute care. By subtypes of nTBI, the highest rates were among those with a diagnosis of toxic effect of substances (22.7 per 100,000), brain tumours (18.4 per 100,000), and meningitis (15.4 per 100,000). Clinical characteristics and discharge destinations from the acute care setting varied by subtype of nTBI; the proportion of patients that spent at least one day in intensive care units and the proportion discharged home ranged from 25.9 % to 58.2 % and from 50.6 % to 76.4 %, respectively. Conclusions: Children and youth with nTBI currently put an increased demand on the healthcare system. Active surveillance of and in-depth research on nTBI, including subtypes of nTBI, is needed to ensure that timely, appropriate, and targeted care is available for this pediatric population.	[Chan, Vincy; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada; [Chan, Vincy; Keightley, Michelle; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, 500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Chan, Vincy; Pole, Jason D.] Pediat Oncol Grp Ontario, 480 Univ Ave, Toronto, ON M5G 1V2, Canada; [Pole, Jason D.; Mann, Robert E.; Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, 150 Kilgour Rd, Toronto, ON M5G 1R8, Canada; [Mann, Robert E.] Ctr Addict & Mental Hlth, 33 Russell St, Toronto, ON M5S 3M1, Canada		Chan, V (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.; Chan, V (corresponding author), Univ Toronto, Rehabil Sci Inst, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.; Chan, V (corresponding author), Pediat Oncol Grp Ontario, 480 Univ Ave, Toronto, ON M5G 1V2, Canada.	vincy.chan@uhn.ca	Pole, Jason D./AAD-9148-2020; Chan, Vincy/AAA-7813-2020	Pole, Jason D./0000-0002-0413-5434; Chan, Vincy/0000-0002-6884-044X; Colantonio, Angela/0000-0003-2094-4765	Jane Gillett Pediatric ABI Studentship through the Ontario Neurotrauma Foundation; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Pediatric Oncology Group of Ontario; Brain Canada; CIBC; CIHR Research Chair in Gender, Work and Health [CGW-126580]	VC received support from the Jane Gillett Pediatric ABI Studentship through the Ontario Neurotrauma Foundation, the Doctoral Research Award from the Canadian Institutes of Health Research (CIHR) and Pediatric Oncology Group of Ontario, and a Brain Canada-CIBC Brain Cancer Training Award from Brain Canada and CIBC. AC received support through a CIHR Research Chair in Gender, Work and Health (#CGW-126580). The authors have no conflicts of interest.	Ahmad OB, 2001, AGE STANDARDIZATION; [Anonymous], 2015, BRAIN INJURY REHABIL; [Anonymous], 2009, J HOPKINS ACG SYSTEM; [Anonymous], 2015, BRAIN INJURY REHAB I; [Anonymous], 2011, EVIDENCE BASED REV R; Barbadoro P, 2012, EPIDEMIOL INFECT, V140, P753, DOI 10.1017/S0950268811001002; Britton PN, 2015, J PAEDIATR CHILD H, V51, P147, DOI 10.1111/jpc.12650; Canadian Institute for Health Information, 2007, BURD NEUR DIS DIS IN; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; CARF International, CARF CCAC STAND MAN; Centers for Medicare & Medicaid Serices, 2012, INP REH FAC PAT ASS; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Charlson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112479; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen A, 2013, HEALTHCARE POLICY, V7, P41; Chen A, 2014, J REHABIL MED, V46, P144, DOI 10.2340/16501977-1243; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Colantonio A, 2012, ONTARIO ACQUIRED BRA; Colantonio A, 2009, ABI DATASET PILOT PR; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Croxford R., 2006, CANADIAN I HLTH INFO; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; DeMatteo CA, 2008, ARCH PHYS MED REHAB, V89, P1803, DOI 10.1016/j.apmr.2008.02.025; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Faul M, 2010, TRAUAMTIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Forsyth R, 2012, CAN MED ASSOC J, V184, P1257, DOI 10.1503/cmaj.111045; Giustini Alessandro, 2013, Handb Clin Neurol, V110, P401, DOI 10.1016/B978-0-444-52901-5.00034-4; Greenberg ML., 2015, ATLAS CHILDHOOD CANC; Hviid A, 2007, EPIDEMIOLOGY, V18, P695, DOI 10.1097/EDE.0b013e3181567d31; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Koskiniemi M, 2001, J NEUROVIROL, V7, P400, DOI 10.1080/135502801753170255; Olsen SJ, 2015, EMERG INFECT DIS, V21, P280, DOI 10.3201/eid2102.140291; Parsons Daria, 2012, BMC Res Notes, V5, P584, DOI 10.1186/1756-0500-5-584; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Weingarten L, 2013, PEDIATR EMERG CARE, V29, P235, DOI 10.1097/PEC.0b013e318280d7f3; Wong CP, 2001, ARCH DIS CHILD, V84, P193, DOI 10.1136/adc.84.3.193	43	14	14	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	JUL 20	2016	16								110	10.1186/s12883-016-0631-2			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS0MG	WOS:000380289300001	27439699	gold, Green Published			2022-02-06	
J	Citron, BA; Ameenuddin, S; Uchida, K; Suo, WZ; SantaCruz, K; Festoff, BW				Citron, Bruce A.; Ameenuddin, Syed; Uchida, K.; Suo, William Z.; SantaCruz, Karen; Festoff, Barry W.			Membrane lipid peroxidation in neurodegeneration: Role of thrombin and proteinase-activated receptor-1	BRAIN RESEARCH			English	Article						Membrane lipid peroxidation; Reactive oxygen; Apoptosis; Neurodegenerative diseases; Spinal cord injury	PROTHROMBIN-MESSENGER-RNA; SPINAL-CORD-INJURY; OXIDATIVE STRESS; SERINE PROTEASES; CELL-DEATH; 4-HYDROXYNONENAL PROTEIN; ALZHEIMERS-DISEASE; MOUSE MODEL; PROINFLAMMATORY CYTOKINES; SIGNAL-TRANSDUCTION	Thrombin and membrane lipid peroxidation (MLP) have been implicated in various central nervous system (CNS) disorders from CNS trauma to stroke, Alzheimer's (AD) and Parkinson's (PD) diseases. Because thrombin also induces MLP in platelets and its involvement in neurodegenerative diseases we hypothesized that its deleterious effects might, in part, involve formation of MLP in neuronal cells. We previously showed that thrombin induced caspase-3 mediated apoptosis in motor neurons, via a proteinase-activated receptor (PAR1). We have now investigated thrombin's influence on the oxidative state of neurons leading to induction of MLP-protein adducts. Translational relevance of thrombin-induced MLP is supported by increased levels of 4-hydroxynonenal-protein adducts (HNEPA) in AD and PD brains. We now report for the first time that thrombin dose-dependently induces formation of HNEPA in NSC34 mouse motor neuron cells using anti-HNE and anti-acrolein monoclonal antibodies. The most prominent immunoreactive band, in SDS-PAGE, was at similar to 54 kDa. Membrane fractions displayed higher amounts of the protein-adduct than cytosolic fractions. Thrombin induced MLP was mediated, at least in part, through PAR1 since a PAR1 active peptide, PAR1AP, also elevated HNEPA levels. Of interest, glutamate and Fe2SO4 also increased the similar to 54 kDa HNEPA band in these cells but to a lesser extent. Taken together our results implicate the involvement of thrombin and MLP in neuronal cell loss observed in various CNS degenerative and traumatic pathologies. (c) 2016 Published by Elsevier B.V.	[Citron, Bruce A.; Ameenuddin, Syed; Suo, William Z.; SantaCruz, Karen; Festoff, Barry W.] Dept Vet Affairs Med Ctr, Neurobiol Res Lab, Kansas City, MO 64128 USA; [Citron, Bruce A.; Suo, William Z.; Festoff, Barry W.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66170 USA; [Festoff, Barry W.] Univ Kansas, Med Ctr, Dept Pharmacol, Kansas City, KS 66170 USA; [Festoff, Barry W.] Univ Kansas, Med Ctr, Dept Toxicol, Kansas City, KS 66170 USA; [Festoff, Barry W.] Univ Kansas, Med Ctr, Dept Therapeut, Kansas City, KS 66170 USA; [SantaCruz, Karen] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66170 USA; [SantaCruz, Karen] Univ Kansas, Med Ctr, Dept Lab Med, Kansas City, KS 66170 USA; [Festoff, Barry W.] Univ Kansas, Med Ctr, Dept Mol, Kansas City, KS 66170 USA; [Festoff, Barry W.] Univ Kansas, Med Ctr, Dept Integrat Physiol, Kansas City, KS 66170 USA; [Uchida, K.] Nagoya Univ, Lab Food & Biodynam, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Citron, Bruce A.] Bay Pines VA Healthcare Syst, Res & Dev 151, Bldg 22,Rm 123,POB 4125, Bay Pines, FL 33744 USA; [Citron, Bruce A.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Res & Dev 151, Bldg 22,Rm 123,POB 4125, Bay Pines, FL 33744 USA; [Ameenuddin, Syed] Mayo Clin & Mayo Fdn, Cellular Neurobiol Lab, 1501 Guggenheim Bldg,200 First St SW, Rochester, MN 55905 USA; [SantaCruz, Karen] Univ New Mexico, Dept Pathol, MSC8 4640, Albuquerque, NM 87131 USA		Festoff, BW (corresponding author), PHLOGISTIX Neurodiagnost, 4220 Shawnee Mission Pkwy Suite 350B, Fairway, KS 66205 USA.	bwfestoff@mac.com		Uchida, Koji/0000-0003-3894-5299	Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development)US Department of Veterans Affairs; Lied Fund of the University of Kansas Medical Center Research Institute, Inc.; Alzheimer's AssociationAlzheimer's Association; ALS Association; Veterans AffairsUS Department of Veterans Affairs [I01RX001520] Funding Source: NIH RePORTER	We thank Drs. N. Cashman, J.W. Fenton, II, Thomas Anderson and Michael D'Andrea for providing NSC34 cell lines, human alpha-thrombin, PAR1AP and PAR1C antibody, respectively. The authors are grateful to Michael Lucido and Sonia Malburg for expert technical assistance. This work was supported, in part, by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development), the Lied Fund of the University of Kansas Medical Center Research Institute, Inc., the Alzheimer's Association, and the ALS Association.	Abarikwu SO, 2012, BASIC CLIN PHARMACOL, V110, P441, DOI 10.1111/j.1742-7843.2011.00834.x; Ando Y, 1998, J NEUROL SCI, V156, P172, DOI 10.1016/S0022-510X(98)00042-2; Arai T, 2006, J NEUROPATH EXP NEUR, V65, P19, DOI 10.1097/01.jnen.0000196133.74087.cb; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bednar MM, 2000, EXPERT OPIN INV DRUG, V9, P355, DOI 10.1517/13543784.9.2.355; BEECHER KL, 1994, J NEUROSCI RES, V37, P108, DOI 10.1002/jnr.490370115; Ben Shimon M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00151; Blanc EM, 1997, J NEUROCHEM, V69, P570; Blanc EM, 1998, J NEUROCHEM, V70, P958; Blanc EM, 1998, GLIA, V22, P149, DOI 10.1002/(SICI)1098-1136(199802)22:2<149::AID-GLIA6>3.0.CO;2-2; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRAAK H, 1994, NEUROBIOL AGING, V15, P355, DOI 10.1016/0197-4580(94)90032-9; Bruce-Keller AJ, 1998, J NEUROPATH EXP NEUR, V57, P257, DOI 10.1097/00005072-199803000-00007; BUCZYNSKI A, 1993, ATHEROSCLEROSIS, V100, P223, DOI 10.1016/0021-9150(93)90208-C; Butterfield DA, 2006, NEUROSCI LETT, V397, P170, DOI 10.1016/j.neulet.2005.12.017; Camerer E, 2006, BLOOD, V107, P3912, DOI 10.1182/blood-2005-08-3130; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chapman J, 2013, SEMIN THROMB HEMOST, V39, P876, DOI 10.1055/s-0033-1357482; CHOI BH, 1995, NEUROBIOL AGING, V16, P675, DOI 10.1016/0197-4580(95)00065-M; Citron BA, 1997, NEUROSCI LETT, V230, P25, DOI 10.1016/S0304-3940(97)00468-0; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; Clark IA, 2015, BRIT J PHARMACOL, V172, P3714, DOI 10.1111/bph.13181; DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D; Donovan FM, 1997, J NEUROSCI, V17, P5316; Dugina TN, 2002, BIOCHEMISTRY-MOSCOW+, V67, P65, DOI 10.1023/A:1013952114485; Farooqui AA, 1998, CELL MOL NEUROBIOL, V18, P599, DOI 10.1023/A:1020261600498; Festoff BM, 2000, MOL MED, V6, P410, DOI 10.1007/BF03401784; Festoff BW, 2001, INT REV CYTOL, V211, P153, DOI 10.1016/S0074-7696(01)11018-1; Festoff BW, 1996, SEMIN THROMB HEMOST, V22, P267, DOI 10.1055/s-2007-999018; Figueroa BE, 1998, STROKE, V29, P1202, DOI 10.1161/01.STR.29.6.1202; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; Gabazza EC, 2004, INT J HEMATOL, V79, P117, DOI 10.1532/IJH97.03165; Gard AL, 2001, MICROSC RES TECHNIQ, V52, P709, DOI 10.1002/jemt.1055; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; GOROG P, 1995, ATHEROSCLEROSIS, V115, P121, DOI 10.1016/0021-9150(94)05506-E; Grammas P, 2006, J ALZHEIMERS DIS, V9, P51; Hanisch UK, 2004, J BIOL CHEM, V279, P51880, DOI 10.1074/jbc.M408318200; HO GJ, 1994, BIOMED PHARMACOTHER, V48, P296, DOI 10.1016/0753-3322(94)90175-9; HURST JS, 1987, CHEM-BIOL INTERACT, V61, P109, DOI 10.1016/0009-2797(87)90033-0; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ilic M, 2011, BIOORG MED CHEM LETT, V21, P4705, DOI 10.1016/j.bmcl.2011.06.089; Ji KA, 2004, GLIA, V48, P102, DOI 10.1002/glia.20059; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kabuta C., 2015, BIOCH BIOPHYSICAL RE; Kabuta C, 2015, BIOCHEM BIOPH RES CO, V463, P82, DOI 10.1016/j.bbrc.2015.05.027; Karabiyikoglu M, 2004, J CEREBR BLOOD F MET, V24, P159, DOI 10.1097/01.WCB.0000100062.36077.84; Kario K, 1999, STROKE, V30, P1033, DOI 10.1161/01.STR.30.5.1033; Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130; Kataoka S, 2000, J NEUROL SCI, V181, P82, DOI 10.1016/S0022-510X(00)00435-4; Krantic S, 2005, TRENDS NEUROSCI, V28, P670, DOI 10.1016/j.tins.2005.09.011; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; LeBlanc Andrea C., 2005, Current Alzheimer Research, V2, P389, DOI 10.2174/156720505774330573; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu Quan, 2003, Molecular Aspects of Medicine, V24, P305, DOI 10.1016/S0098-2997(03)00025-6; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Luo J, 2005, NEUROCHEM RES, V30, P291, DOI 10.1007/s11064-005-2602-7; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; MALLE E, 1995, ARTERIOSCL THROM VAS, V15, P377, DOI 10.1161/01.ATV.15.3.377; Mark RJ, 1997, J NEUROSCI, V17, P1046; Mark RJ, 1997, J NEUROCHEM, V68, P255; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; Mattson MP, 1998, INT J DEV NEUROSCI, V16, P737, DOI 10.1016/S0736-5748(98)00082-3; Mattson MP, 1997, NEUROREPORT, V8, P2275, DOI 10.1097/00001756-199707070-00036; Mattson MP, 1998, TRENDS NEUROSCI, V21, P53, DOI 10.1016/S0166-2236(97)01188-0; Montine KS, 1998, J NEUROPATH EXP NEUR, V57, P415, DOI 10.1097/00005072-199805000-00005; Murphy TC, 2003, J NEUROCHEM, V84, P1313, DOI 10.1046/j.1471-4159.2003.01628.x; Narayanan S, 1999, ANN CLIN LAB SCI, V29, P275; NICLOU S, 1994, CELL MOL BIOL, V40, P421; Niclou SP, 1998, EUR J NEUROSCI, V10, P1590, DOI 10.1046/j.1460-9568.1998.00183.x; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; NOSAL R, 1993, J LIPID MEDIATOR, V8, P121; Okonkwo DO, 2003, CLIN SPORT MED, V22, P467, DOI 10.1016/S0278-5919(02)00107-2; Pappolla MA, 1998, AM J PATHOL, V152, P871; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; Pedersen WA, 1999, EXP NEUROL, V155, P1, DOI 10.1006/exnr.1998.6890; Perluigi M, 2009, PROTEOM CLIN APPL, V3, P682, DOI 10.1002/prca.200800161; Przedborski S, 2005, PARKINSONISM RELAT D, V11, pS3, DOI 10.1016/j.parkreldis.2004.10.012; Riek-Burchardt M, 2002, NEUROSCI LETT, V329, P181, DOI 10.1016/S0304-3940(02)00645-6; Rofina JE, 2004, AMYLOID, V11, P90, DOI 10.1080/13506120412331285779; Rohatgi T, 2004, NEUROSCIENTIST, V10, P501, DOI 10.1177/1073858404269955; Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Siddiqui MA, 2012, HUM EXP TOXICOL, V31, P336, DOI 10.1177/0960327111432500; Smirnova IV, 1998, J NEUROBIOL, V36, P64, DOI 10.1002/(SICI)1097-4695(199807)36:1<64::AID-NEU6>3.3.CO;2-4; Smirnova IV, 1998, J MOL NEUROSCI, V10, P31, DOI 10.1007/BF02737083; Smirnova IV, 2001, J NEUROBIOL, V48, P87, DOI 10.1002/neu.1044; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMITHSWINTOSKY VL, 1995, J NEUROCHEM, V65, P1415; Springer JE, 1997, J NEUROCHEM, V68, P2469; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Suo Z., 2004, Current Drug Targets - Inflammation and Allergy, V3, P105, DOI 10.2174/1568010043483953; Suo ZM, 2003, J BIOL CHEM, V278, P37681, DOI 10.1074/jbc.M301406200; Suo ZM, 2003, J BIOL CHEM, V278, P31177, DOI 10.1074/jbc.M302137200; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; Thirumangalakudi L, 2009, NEUROSCI LETT, V452, P172, DOI 10.1016/j.neulet.2009.01.045; Turgeon VL, 1997, BRAIN RES REV, V25, P85, DOI 10.1016/S0165-0173(97)00015-5; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; Uchida K, 2015, FREE RADICAL RES, V49, P896, DOI 10.3109/10715762.2015.1036052; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Volkel W, 2006, NEUROCHEM INT, V48, P679, DOI 10.1016/j.neuint.2005.12.003; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Weinstein JR, 2005, J NEUROCHEM, V95, P1177, DOI 10.1111/j.1471-4159.2005.03499.x; WEINSTEIN JR, 1995, J NEUROSCI, V15, P2906; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674; Yang MS, 2004, BIOCHEM BIOPH RES CO, V317, P811, DOI 10.1016/j.bbrc.2004.03.118; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Zarkovic Kamelija, 2003, Molecular Aspects of Medicine, V24, P293, DOI 10.1016/S0098-2997(03)00024-4	110	14	15	0	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 15	2016	1643						10	17		10.1016/j.brainres.2016.04.071			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP4EE	WOS:000378448200002	27138068				2022-02-06	
J	Barton, DJ; Kumar, RG; McCullough, EH; Galang, G; Arenth, PM; Berga, SL; Wagner, AK				Barton, David J.; Kumar, Raj G.; McCullough, Emily H.; Galang, Gary; Arenth, Patricia M.; Berga, Sarah L.; Wagner, Amy K.			Persistent Hypogonadotropic Hypogonadism in Men After Severe Traumatic Brain Injury: Temporal Hormone Profiles and Outcome Prediction	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						biomarker screening assay; brain injury; hypopituitarism; outcome; posttraumatic hypogonadotrophic hypogonadism; Rehabilomics; sensitivity and specificity; TBI	ANEURYSMAL SUBARACHNOID HEMORRHAGE; FUNCTIONAL INDEPENDENCE MEASURE; ANTERIOR-PITUITARY FUNCTION; HEAD TRAUMA; TESTOSTERONE LEVELS; LONG-TERM; HYPOPITUITARISM; REHABILITATION; DYSFUNCTION; VALIDITY	Objective: To (1) examine relationships between persistent hypogonadotropic hypogonadism (PHH) and long-term outcomes after severe traumatic brain injury (TBI); and (2) determine whether subacute testosterone levels can predict PHH. Setting: Level 1 trauma center at a university hospital. Participants: Consecutive sample of men with severe TBI between 2004 and 2009. Design: Prospective cohort study. Main Measures: Post-TBI blood samples were collected during week 1, every 2 weeks until 26 weeks, and at 52 weeks. Serum hormone levels were measured, and individuals were designated as having PHH if 50% or more of samples met criteria for hypogonadotropic hypogonadism. At 6 and 12 months postinjury, we assessed global outcome, disability, functional cognition, depression, and quality of life. Results: We recruited 78 men; median (interquartile range) age was 28.5 (22-42) years. Thirty-four patients (44%) had PHH during the first year postinjury. Multivariable regression, controlling for age, demonstrated PHH status predicted worse global outcome scores, more disability, and reduced functional cognition at 6 and 12 months post-TBI. Two-step testosterone screening for PHH at 12 to 16 weeks postinjury yielded a sensitivity of 79% and specificity of 100%. Conclusion: PHH status in men predicts poor outcome after severe TBI, and PHH can accurately be predicted at 12 to 16 weeks.	[Barton, David J.; Kumar, Raj G.; McCullough, Emily H.; Galang, Gary; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA; [Berga, Sarah L.] Wake Forest Sch Med, Dept Obstet & Gynecol, Winston Salem, NC USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Barton, David J/C-9282-2011	Barton, David J/0000-0003-0976-0383	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR 323155-03]; NIDRR [H133A120087]; Rehabilitation Research Experience for Medical Students (RREMS) Program; UPMC Rehabilitation Institute; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE323155] Funding Source: NIH RePORTER	This work was supported by Centers for Disease Control and Prevention grant no. R49 CCR 323155-03, NIDRR grant no. H133A120087, the Rehabilitation Research Experience for Medical Students (RREMS) Program, and the UPMC Rehabilitation Institute.	Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Beninato M, 2006, ARCH PHYS MED REHAB, V87, P32, DOI 10.1016/j.apmr.2005.08.130; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Brain Trauma Foundation American Association of Neurological Surgeons, 2007, J NEUROTRAUMA S, V24, pS1, DOI DOI 10.1089/NEU.2007.9997; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, RAT TBI REL EM DEP V; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; CUMMING DC, 1983, J CLIN ENDOCR METAB, V57, P671, DOI 10.1210/jcem-57-3-671; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Donnelly P, 2000, CLIN ENDOCRINOL, V52, P197, DOI 10.1046/j.1365-2265.2000.00918.x; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fernandez-Rodriguez Eva, 2011, Front Endocrinol (Lausanne), V2, P25, DOI 10.3389/fendo.2011.00025; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hohl A., 2014, OPEN J ENDOCR METAB, V4, P13; Huang WJ, 2001, J CELL BIOCHEM, V80, P313, DOI 10.1002/1097-4644(20010301)80:3<313::AID-JCB30>3.0.CO;2-E; Huhtaniemi I, 2011, NAT REV UROL, V8, P335, DOI 10.1038/nrurol.2011.47; JENNETT B, 1975, LANCET, V1, P480; Kleindienst A, 2009, J NEUROTRAUM, V26, P1435, DOI 10.1089/neu.2008.0601; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Petak Steven M, 2002, Endocr Pract, V8, P440; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R, 1985, HALSTEAD REITAN NEUR; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; SMITH MS, 1987, BIOL REPROD, V36, P138, DOI 10.1095/biolreprod36.1.138; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; TEASDALE G, 1974, LANCET, V2, P81; The American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Wagner AK, 2014, AM J PHYS MED REHAB, V93, P913, DOI 10.1097/PHM.0000000000000114; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; WELSH TH, 1982, BIOL REPROD, V27, P1138, DOI 10.1095/biolreprod27.5.1138; Young TP, 2007, BRAIN INJURY, V21, P645, DOI 10.1080/02699050701210426; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	58	14	14	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					277	287		10.1097/HTR.0000000000000188			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000013	26360007	Green Accepted			2022-02-06	
J	Cai, LS; Qu, BX; Hurtle, BT; Dadiboyena, S; Diaz-Arrastia, R; Pike, VW				Cai, Lisheng; Qu, Baoxi; Hurtle, Bryan T.; Dadiboyena, Sureshbabu; Diaz-Arrastia, Ramon; Pike, Victor W.			Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain	ACS CHEMICAL NEUROSCIENCE			English	Article						Radioligand; in vitro assay; tangle; tau; Alzheimer's disease; PET	BETA-AMYLOID PATHOLOGY; SENILE DEMENTIA; FLORBETAPIR-PET; TAU-PATHOLOGY; PLAQUES; TRACER; TISSUE; DIAGNOSIS; SEVERITY; DEPOSITS	[F-18]THK-523 and [F-18]807 are promising radioligands for imaging neurofibrillary tangles (NFTs) with positron emission tomography (PET) in neurodegenerative diseases, such as Alzheimer's disease (AD) and traumatic brain injury. Although [F-18]THK-523 and [F-18]T807 are considered high-affinity selective radioligands for NFTs, uncertainty has existed as to whether PET radioligands for imaging NFTs bind to the same molecular site because in vitro assays for ligands binding to NFTs have been lacking. We labeled THK-523 and T807 with tritium to serve as reference radioligands for in vitro binding assays with AD brain homogenates for newly synthesized ligands. With these radioligands, we identified two distinct binding sites for small molecules, one site with high affinity for THK-523 and the other with high affinity for T807. Moreover, binding assays with [H-3]PIB confirmed that the two newly identified binding sites are also distinct from the thioflavin-T binding site where all current clinically useful PET radioligands for imaging beta-amyloid plaque bind with high affinity. The two newly identified binding sites are considered to reside on NFTs rather than on beta-amyloid plaques. Furthermore, we applied all three binding assays to a set of newly prepared compounds, based on chain modifications to THK-523. Some compounds with high affinity and selectivity for the THK-523 binding site emerged from this set, including one with amenability to labeling with. fluorine-18, namely, ligand 10b.	[Cai, Lisheng; Hurtle, Bryan T.; Dadiboyena, Sureshbabu; Pike, Victor W.] NIMH, Mol Imaging Branch, NIH, 10 Ctr Dr,Bldg 10,Room B3 C346, Bethesda, MD 20892 USA; [Qu, Baoxi; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD 20851 USA		Cai, LS (corresponding author), NIMH, Mol Imaging Branch, NIH, 10 Ctr Dr,Bldg 10,Room B3 C346, Bethesda, MD 20892 USA.	LishengCai@mail.nih.gov	Pike, Victor/AAJ-4139-2020	Diaz-Arrastia, Ramon/0000-0001-6051-3594	Intramural Research Program of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZIA-MH0023793]; Henry Jackson Foundation [306135-10.01-60855]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZIAMH002793] Funding Source: NIH RePORTER	This research was supported by the Intramural Research Program of the NIH, specifically the NIMH (ZIA-MH0023793), and by the Henry Jackson Foundation (Grant Award Number 306135-10.01-60855).	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cai LS, 2007, CURR MED CHEM, V14, P19, DOI 10.2174/092986707779313471; Carome M, 2011, JAMA-J AM MED ASSOC, V305, P1857, DOI 10.1001/jama.2011.579; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; DELAERE P, 1990, NEUROSCI LETT, V116, P87, DOI 10.1016/0304-3940(90)90391-L; DELAERE P, 1989, ACTA NEUROPATHOL, V77, P645, DOI 10.1007/BF00687893; Dickson DW, 1997, NEUROBIOL AGING, V18, pS21, DOI 10.1016/S0197-4580(97)00065-1; DUYCKAERTS C, 1987, ACTA NEUROPATHOL, V73, P167, DOI 10.1007/BF00693783; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Ganzer S, 2003, J NEURAL TRANSM, V110, P1149, DOI 10.1007/s00702-003-0017-7; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hampel H, 2009, J CLIN PSYCHIAT, V70, P922, DOI 10.4088/JCP.08m04606; Harada R, 2016, J NUCL MED, V57, P208, DOI 10.2967/jnumed.115.164848; Harada R, 2015, EUR J NUCL MED MOL I, V42, P1052, DOI 10.1007/s00259-015-3035-4; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lemoine L, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0220-4; Marquie M, 2015, ANN NEUROL, V78, P787, DOI 10.1002/ana.24517; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Miyata O, 2008, TETRAHEDRON, V64, P1270, DOI 10.1016/j.tet.2007.11.081; Ni RQ, 2013, BRAIN, V136, P2217, DOI 10.1093/brain/awt142; Okamura N, 2005, J NEUROSCI, V25, P10857, DOI 10.1523/JNEUROSCI.1738-05.2005; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Rowe CC, 2013, J NUCL MED, V54, P880, DOI 10.2967/jnumed.112.114785; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Stocklin G., 1993, RADIOPHARMACEUTICALS, VVol. 24; Szardenings AK, 2012, Patent, Patent No. [US/ 2012/ 0302755 A1, 0302755]; van Wieringen JP, 2014, J MED CHEM, V57, P391, DOI 10.1021/jm401384w; Wolk DA, 2011, ARCH NEUROL-CHICAGO, V68, P1398, DOI 10.1001/archneurol.2011.153; Zhang W, 2012, J ALZHEIMERS DIS, V31, P601, DOI 10.3233/JAD-2012-120712; Zhuang ZP, 2001, J MED CHEM, V44, P1905, DOI 10.1021/jm010045q	39	14	14	2	19	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUL	2016	7	7					897	911		10.1021/acschemneuro.6b00051			15	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	DS0OV	WOS:000380297500007	27171905	Green Accepted			2022-02-06	
J	Chiaravalloti, ND; Sandry, J; Moore, NB; DeLuca, J				Chiaravalloti, Nancy D.; Sandry, Joshua; Moore, Nancy B.; DeLuca, John			An RCT to Treat Learning Impairment in Traumatic Brain Injury: The TBI-MEM Trial	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; new learning; memory; cognitive rehabilitation	SYSTEMS BEHAVIOR SCALE; OF-THE-LITERATURE; COGNITIVE REHABILITATION; MULTIPLE-SCLEROSIS; EVERYDAY MEMORY; VISUAL-IMAGERY; HEAD-INJURY; PERFORMANCE; DEFICITS; RECOMMENDATIONS	Objective. To examine the efficacy of the modified Story Memory Technique (mSMT) to improve learning (ie, acquisition) and memory in participants with TBI. The mSMT is a behavioral intervention that teaches context and imagery to facilitate learning within 10 sessions over 5 weeks. Methods. A total of 69 participants with moderate-severe Traumatic Brain Injury (TBI), 35 in the treatment group and 34 in the placebo control group, completed this double-blind, placebo-controlled randomized clinical trial. A baseline neuropsychological assessment was administered, including questionnaires assessing everyday memory. Repeat assessments were conducted immediately posttreatment and 6 months following treatment. Participants in the treatment group were randomly assigned to a booster session or a non-booster session group after completion of treatment with the mSMT to examine the efficacy of monthly booster sessions in facilitating the treatment effect over time. Results. The treatment group demonstrated significant improvement on a prose memory task relative to the placebo group posttreatment ((2) = 0.064 medium effect). Similar results were noted on objective measures of everyday memory, specifically prospective memory (Cohen's w = 0.43, medium effect), and family report of disinhibition in daily life ((2) = 0.046, medium effect). Conclusion. The mSMT is effective for improving learning and memory in TBI. Classification of evidence. Based on widely accepted classification systems for treatment study design, this study provides class I evidence that the mSMT behavioral intervention improves both objective memory and everyday memory in persons with TBI over 5 weeks. Thus, this study extends the evidence for efficacy of the treatment protocol to a sample of persons with TBI.	[Chiaravalloti, Nancy D.; Sandry, Joshua; Moore, Nancy B.; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [Chiaravalloti, Nancy D.; Sandry, Joshua; DeLuca, John] Rutgers State Univ, Newark, NJ 07102 USA		Chiaravalloti, ND (corresponding author), Kessler Fdn, Traumat Brain Injury Res, 300 Execut Dr,Suite 70, W Orange, NJ 07052 USA.	nchiaravalloti@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	NIDRR [H133A070037]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The contents of this article were developed under the NIDRR Grant H133A070037. However, these contents do not necessarily represent the policy of the Department of Education, and endorsement by the Federal Government should not be assumed.	Allen DN, 1998, J REHABIL RES DEV, V35, P405; Allen DN, 1995, INT J REHABIL HLTH, V1, P189, DOI DOI 10.1007/BF02214731; American Association of Neurologic Surgeons, 2007, GUID MAN SEV HEAD IN; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Brewer GA, 2011, CONSCIOUS COGN, V20, P901, DOI 10.1016/j.concog.2011.02.015; Chiaravalloti ND, 2013, NEUROLOGY, V81, P2066, DOI 10.1212/01.wnl.0000437295.97946.a8; Chiaravalloti ND, 2012, J NEUROL, V259, P1337, DOI 10.1007/s00415-011-6353-x; Chiaravalloti N, 2009, CLIN NEUROPSYCHOL, V23, P231, DOI 10.1080/13854040802121158; Chiaravalloti ND, 2005, MULT SCLER, V11, P58, DOI 10.1191/1352458505ms1118oa; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; Delis D.C., 2000, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; Diamond BJ, 1997, BRAIN, V120, P1015, DOI 10.1093/brain/120.6.1015; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; Ernst A, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/820240; Flavia M, 2010, J NEUROL SCI, V288, P101, DOI 10.1016/j.jns.2009.09.024; Glosser G, 2002, NEUROPSYCHOLOGY, V16, P190, DOI 10.1037//0894-4105.16.2.190; Goldstein G, 1996, CLIN NEUROPSYCHOL, V10, P66, DOI 10.1080/13854049608406664; GOLDSTEIN G, 1988, CLIN NEUROPSYCHOL, V2, P251; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grilli MD, 2011, NEUROPSYCHOL REHABIL, V21, P847, DOI 10.1080/09602011.2011.627263; Hancock LM, 2015, J CLIN EXP NEUROPSYC, V37, P113, DOI 10.1080/13803395.2014.989818; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Karzmark P, 2012, APPL NEUROPSYCH-ADUL, V19, P81, DOI 10.1080/09084282.2011.643942; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kerner MJ, 1985, COGNITIVE REHABILITA, V1, P26; Krupp LB, 2011, NEUROLOGY, V76, P1500, DOI 10.1212/WNL.0b013e318218107a; Kurz A, 2009, INT J GERIATR PSYCH, V24, P163, DOI 10.1002/gps.2086; Lange G, 2000, ARCH PHYS MED REHAB, V81, P89, DOI 10.1016/S0003-9993(00)90227-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leavitt VM, 2014, BRAIN IMAGING BEHAV, V8, P394, DOI 10.1007/s11682-012-9183-2; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Ludbrook J, 2013, CLIN EXP PHARMACOL P, V40, P357, DOI 10.1111/1440-1681.12086; MCKINLAY W, 1999, REHABILITATION ADULT, P74; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; NINDS Common Data Elements, TRAUMATIC BRAIN INJU; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Rosenthal M, 2000, HDB REHABILITATION P; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; Sandry J., NEURODEGENE IN PRESS; Santos ME, 1998, BRAIN INJURY, V12, P759, DOI 10.1080/026990598122151; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; Tan X, 2012, FRONT HUM NEUROSCI, V6, DOI [10.3389/fnhum.2012.00314, 10.3389/fnhum.2012.00305]; Thoene A I, 1995, J Int Neuropsychol Soc, V1, P29; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; TWUM M, 1994, J CLIN EXP NEUROPSYC, V16, P630, DOI 10.1080/01688639408402674; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vanderploeg RD, 2014, J CLIN EXP NEUROPSYC, V36, P58, DOI 10.1080/13803395.2013.864600; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; WOOLF SH, 1992, ARCH INTERN MED, V152, P946, DOI 10.1001/archinte.152.5.946	68	14	14	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUL	2016	30	6					539	550		10.1177/1545968315604395			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DP3VE	WOS:000378423100004	26359341				2022-02-06	
J	Choi, BY; Kim, IY; Kim, JH; Lee, BE; Lee, SH; Kho, AR; Jung, HJ; Sohn, M; Song, HK; Suh, SW				Choi, Bo Young; Kim, In Yeol; Kim, Jin Hee; Lee, Bo Eun; Lee, Song Hee; Kho, A. Ra; Jung, Hee Jae; Sohn, Min; Song, Hong Ki; Suh, Sang Won			Decreased cysteine uptake by EAAC1 gene deletion exacerbates neuronal oxidative stress and neuronal death after traumatic brain injury	AMINO ACIDS			English	Article						EAAC1; Cysteine; Zinc; TBI; Reactive oxygen species; Microglia	TRANSIENT CEREBRAL-ISCHEMIA; ALTERS ZINC HOMEOSTASIS; GLUTAMATE TRANSPORTER; MICROGLIAL ACTIVATION; GLUTATHIONE; MICE; SUSCEPTIBILITY; SUPEROXIDE; INCREASES; RELEASE	Excitatory amino acid carrier type 1 (EAAC1), a high-affinity glutamate transporter, can expend energy to move glutamate into neurons. However, under normal physiological conditions, EAAC1 does not have a great effect on glutamate clearance but rather participates in the neuronal uptake of cysteine. This process is critical to maintaining neuronal antioxidant function by providing cysteine for glutathione synthesis. Previous study showed that mice lacking EAAC1 show increased neuronal oxidative stress following transient cerebral ischemia. In the present study, we sought to characterize the role of EAAC1 in neuronal resistance after traumatic brain injury (TBI). Young adult C57BL/6 wild-type or EAAC1 (-/-) mice were subjected to a controlled cortical impact model for TBI. Neuronal death after TBI showed more than double the number of degenerating neurons in the hippocampus in EAAC1 (-/-) mice compared with wild-type mice. Superoxide production, zinc translocation and microglia activation similarly showed a marked increase in the EAAC1 (-/-) mice. Pretreatment with N-acetyl cysteine (NAC) reduced TBI-induced neuronal death, superoxide production and zinc translocation. These findings indicate that cysteine uptake by EAAC1 is important for neuronal antioxidant function and survival following TBI. This study also suggests that administration of NAC has therapeutic potential in preventing TBI-induced neuronal death.	[Choi, Bo Young; Kim, In Yeol; Kim, Jin Hee; Lee, Bo Eun; Lee, Song Hee; Kho, A. Ra; Jung, Hee Jae; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, 1 Okcheon Dong,39 Hallymdaehak Gil, Chunchon 200702, South Korea; [Song, Hong Ki] Hallym Univ, Coll Med, Dept Neurol, Chunchon, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Incheon, South Korea		Suh, SW (corresponding author), Hallym Univ, Coll Med, Dept Physiol, 1 Okcheon Dong,39 Hallymdaehak Gil, Chunchon 200702, South Korea.	swsuh@hallym.ac.kr		Choi, Bo Young/0000-0002-9579-3503; SOHN, MIN/0000-0003-4021-2051	National Research Foundation of Korea (NRF) - Korea government (MEST)Ministry of Education, Science and Technology, Republic of KoreaNational Research Foundation of KoreaKorean Government [2012R1A2A2A01046132]; Hallym University [HRF-S-52]	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2012R1A2A2A01046132) and by Hallym University Specialization Fund (HRF-S-52).	Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P49; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Choi BY, 2014, INT J MOL SCI, V15, P19444, DOI 10.3390/ijms151119444; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; DEVRIES N, 1993, J CELL BIOCHEM, P270; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Himi T, 2003, J NEURAL TRANSM, V110, P1337, DOI 10.1007/s00702-003-0049-z; Jang BG, 2012, J TRACE ELEM MED BIO, V26, P85, DOI 10.1016/j.jtemb.2012.04.010; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lane MC, 2014, NEUROCHEM INT, V73, P152, DOI 10.1016/j.neuint.2013.11.013; Lee SA, 2009, ANESTH ANALG, V109, P1506, DOI 10.1213/ANE.0b013e3181b6709a; Li LL, 2011, J CEREBR BLOOD F MET, V31, P1283, DOI 10.1038/jcbfm.2010.222; Mazor D, 1996, EUR J HAEMATOL, V57, P241; Murakami K, 1998, J NEUROSCI, V18, P205; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Singh P, 2003, NEUROL INDIA, V51, P215; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Watabe M, 2008, J NEUROSCI, V28, P9404, DOI 10.1523/JNEUROSCI.3351-08.2008; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Won SJ, 2010, J NEUROSCI, V30, P15409, DOI 10.1523/JNEUROSCI.2084-10.2010; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393	45	14	15	0	7	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	JUL	2016	48	7					1619	1629		10.1007/s00726-016-2221-4			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN9OU	WOS:000377409900008	27040821				2022-02-06	
J	Ciulli, S; Citi, L; Salvadori, E; Valenti, R; Poggesi, A; Inzitari, D; Mascalchi, M; Toschi, N; Pantoni, L; Diciotti, S				Ciulli, Stefano; Citi, Luca; Salvadori, Emilia; Valenti, Raffaella; Poggesi, Anna; Inzitari, Domenico; Mascalchi, Mario; Toschi, Nicola; Pantoni, Leonardo; Diciotti, Stefano			Prediction of Impaired Performance in Trail Making Test in MCI Patients With Small Vessel Disease Using DTI Data	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Diffusion tensor imaging; executive functions; machine learning; mild cognitive impairment; neuroimaging	MILD COGNITIVE IMPAIRMENT; UNDERLIES EXECUTIVE DYSFUNCTION; ISCHEMIC VASCULAR-DISEASE; TRAUMATIC BRAIN-INJURY; DIFFUSION TENSOR MRI; WHITE-MATTER; LEUKOARAIOSIS; DAMAGE; DISCONNECTION; REGISTRATION	Mild cognitive impairment (MCI) is a common condition in patients with diffuse hyperintensities of cerebral white matter (WM) in T2-weightedmagnetic resonance images and cerebral small vessel disease (SVD). In MCI due to SVD, the most prominent feature of cognitive impairment lies in degradation of executive functions, i.e., of processes that supervise the organization and execution of complex behavior. The trail making test is a widely employed test sensitive to cognitive processing speed and executive functioning. MCI due to SVD has been hypothesized to be the effect of WM damage, and diffusion tensor imaging (DTI) is a well-established technique for in vivo characterization of WM. We propose a machine learning scheme tailored to 1) predicting the impairment in executive functions in patients with MCI and SVD, and 2) examining the brain substrates of this impairment. We employed data from 40 MCI patients with SVD and created feature vectors by averaging mean diffusivity (MD) and fractional anisotropy maps within 50 WM regions of interest. We trained support vector machines (SVMs) with polynomial as well as radial basis function kernels using different DTI-derived features while simultaneously optimizing parameters in leave-one-out nested cross validation. The best performance was obtained using MD features only and linear kernel SVMs, which were able to distinguish an impaired performance with high sensitivity (72.7%-89.5%), specificity (71.4%-83.3%), and accuracy (77.5%-80.0%). While brain substrates of executive functions are still debated, feature ranking confirm that MD in several WM regions, not limited to the frontal lobes, are truly predictive of executive functions.	[Ciulli, Stefano] Univ Florence, Dept Clin & Expt Biomed Sci, I-50134 Florence, Italy; [Ciulli, Stefano; Citi, Luca] Univ Essex, Sch Comp Sci & Elect Engn, Colchester CO4 3SQ, Essex, England; [Ciulli, Stefano; Toschi, Nicola] Univ Roma Tor Vergata, Med Phys Sect, Dept Biomed & Prevent, I-00173 Rome, Italy; [Salvadori, Emilia; Valenti, Raffaella; Poggesi, Anna; Inzitari, Domenico; Pantoni, Leonardo] Univ Florence, Neurosci Sect, NEUROFARBA Dept, I-50134 Florence, Italy; [Mascalchi, Mario] Univ Florence, Dept Clin & Expt Biomed Sci, I-50134 Florence, Italy; [Toschi, Nicola] Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA 02129 USA; [Diciotti, Stefano] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, I-47521 Cesena, Italy		Ciulli, S (corresponding author), Univ Florence, Dept Clin & Expt Biomed Sci, I-50134 Florence, Italy.; Ciulli, S (corresponding author), Univ Essex, Sch Comp Sci & Elect Engn, Colchester CO4 3SQ, Essex, England.; Ciulli, S (corresponding author), Univ Roma Tor Vergata, Med Phys Sect, Dept Biomed & Prevent, I-00173 Rome, Italy.	stefano.ciulli@gmail.com; lciti@essex.ac.uk; emilia.salvadori@unifi.it; raffyvalenti@gmail.com; anna.poggesi@unifi.it; domenico.inzitari@unifi.it; m.mascalchi@dfc.unifi.it; toschi@med.uniroma2.it; leonardo.pantoni@unifi.it; stefano.diciotti@unibo.it	Poggesi, Anna/AAK-5492-2021; Valenti, Raffaella/AAB-7974-2019; Diciotti, Stefano/C-4167-2008; Salvadori, Emilia/B-1115-2013; Inzitari, Domenico/AAH-8722-2020; Toschi, Nicola/J-2555-2012; Citi, Luca/G-2270-2011	Valenti, Raffaella/0000-0002-4975-3754; Diciotti, Stefano/0000-0001-8778-7819; Salvadori, Emilia/0000-0003-0404-0053; Toschi, Nicola/0000-0003-1929-5833; Citi, Luca/0000-0001-8702-5654; Ciulli, Stefano/0000-0002-9386-3088	Tuscany Region (Italy); Italian Health Ministry (Bando Ricerca Finalizzata) [RF-2010-2321706, NCT02033850]	This work was supported in part by Tuscany Region (Italy) and in part by the Italian Health Ministry (Bando Ricerca Finalizzata 2010, Grant number: RF-2010-2321706, ClinicalTrials.gov Identifier: NCT02033850, PI Leonardo Pantoni).	Alpaydin Ethem, 2010, INTRO MACHINE LEARNI; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bishop C. M., 1995, NEURAL NETWORKS PATT; Bishop CM., 2006, PATTERN RECOGN; Bondi MW, 2014, J INT NEUROPSYCH SOC, V20, P129, DOI 10.1017/S1355617714000010; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Cohen JR, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00075; Cook P.A., 2006, INT SOC MAGN RESON M, V2759, P2759; Della Nave R, 2007, AM J NEURORADIOL, V28, P1313, DOI 10.3174/ajnr.A0555; Diciotti S, 2013, AM J NEURORADIOL, V34, pE107, DOI 10.3174/ajnr.A3685; FILLEY CM, 2001, BEHAV NEUROLOGY WHIT; Ghosh SS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00004; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Goveas J, 2015, MAGN RESON IMAGING, V33, P853, DOI 10.1016/j.mri.2015.04.006; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hall M, 2009, SIGKDD EXPLOR, V11, P10, DOI 10.1145/1656274.1656278; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Haykin S., 1998, NEURAL NETWORKS COMP, V3rd ed.; Jokinen H, 2007, J NEUROL NEUROSUR PS, V78, P491, DOI 10.1136/jnnp.2006.096792; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lamar M, 2008, NEUROPSYCHOLOGIA, V46, P2597, DOI 10.1016/j.neuropsychologia.2008.04.007; Lamar M, 2009, BEHAV NEUROL, V22, P53, DOI 10.3233/BEN-2009-0237; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lin L, 2015, J MOL NEUROSCI, V56, P363, DOI 10.1007/s12031-015-0550-5; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Mascalchi M, 2014, HUM BRAIN MAPP, V35, P819, DOI 10.1002/hbm.22216; Meola A, 2015, HUM BRAIN MAPP, V36, P4964, DOI 10.1002/hbm.22990; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nowrangi MA, 2014, J NEUROPSYCH CLIN N, V26, P114, DOI 10.1176/appi.neuropsych.12070176; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan M, 2005, NEUROLOGY, V65, P1584, DOI 10.1212/01.wnl.0000184480.07394.fb; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Otsuka Y, 2012, AM J NEURORADIOL, V33, P726, DOI 10.3174/ajnr.A2853; Pantoni L, 2005, NEUROEPIDEMIOLOGY, V24, P51, DOI 10.1159/000081050; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Sachdev PS, 1999, MED J AUSTRALIA, V170, P81, DOI 10.5694/j.1326-5377.1999.tb126889.x; Salvadori E., ALZHEIMERS IN PRESS; Salvadori E, 2015, J ALZHEIMERS DIS, V43, P1313, DOI 10.3233/JAD-141449; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tuladhar AM, 2015, NEUROIMAGE-CLIN, V7, P518, DOI 10.1016/j.nicl.2015.02.003; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Witten IH, 2011, MOR KAUF D, P1; Xu Q, 2010, DEMENT GERIATR COGN, V30, P317, DOI 10.1159/000320491; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhou AH, 2009, J INT NEUROPSYCH SOC, V15, P898, DOI 10.1017/S1355617709990816	57	14	16	0	12	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194			IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	JUL	2016	20	4					1026	1033		10.1109/JBHI.2016.2537808			8	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mathematical & Computational Biology; Medical Informatics	DR8DJ	WOS:000380128300007	26960231	Green Accepted			2022-02-06	
J	Mathema, P; Evans, D; Moore, IS; Ranson, C; Martin, R				Mathema, Prabhat; Evans, Daniel; Moore, Isabel S.; Ranson, Craig; Martin, Rhodri			Concussed or Not? An Assessment of Concussion Experience and Knowledge Within Elite and Semiprofessional Rugby Union	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						brain concussion; head injury; signs and symptoms of concussion	SPORTS-RELATED CONCUSSION; PLAYERS; FOOTBALL; HISTORY; STATEMENT; INJURY; ZURICH; HEAD	Objective: The primary aim was to assess experience and knowledge of adult concussion among international, professional and semiprofessional players, coaches, medical staff, and referees within Rugby Union. The secondary aim was to identify preferred education dissemination routes. Design: Questionnaires devised specifically for players, coaches, medical staff, and referees. Setting and Participants: A total of 370 players, 44 coaches, 40 medical staff, and 33 referees from within Wales were surveyed. Main Outcome Measures: Knowledge of the signs and symptoms of concussion, return to play guidelines and consequences of concussion were investigated along with experiences of, and attitudes towards, concussion. Results: The respondents had extensive experience of sustaining or witnessing rugby-related concussion. Medical staff had the greatest level of concussion knowledge, with coaches having the least. Players and coaches exhibited a disconnection between being "knocked-out" and practically applying this when managing concussion. Almost half of the players and coaches did not indicate concussion could impair performance. Eighty percent of medical staff had felt pressured to clear a concussed player. Most players (82%), coaches (66%), and referees (64%) incorrectly believed protective equipment prevents concussion. Players and coaches prefer concussion education from medical staff, whereas medical staff and referees prefer such education from governing body Web sites or training courses. Conclusions: Several role-specific misconceptions and deficiencies in concussion knowledge were identified and should be targeted through education. Medical staff had the highest level of concussion knowledge and were the preferred sources of education for players and coaches. Therefore, they are encouraged to play a greater role in providing concussion education.	[Mathema, Prabhat; Ranson, Craig] Welsh Rugby Union, Med Serv, Cardiff, S Glam, Wales; [Evans, Daniel] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Evans, Daniel] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Moore, Isabel S.; Ranson, Craig] Cardiff Metropolitan Univ, Cardiff Sch Sport, Sports Injury Res Grp, Cyncoed Campus, Cardiff CF23 6XD, S Glam, Wales; [Martin, Rhodri] Cwm Taf Univ, Hlth Board, Sport & Exercise Med, Abercynon, Wales		Moore, IS (corresponding author), Cardiff Metropolitan Univ, Cardiff Sch Sport, Sports Injury Res Grp, Cyncoed Campus, Cardiff CF23 6XD, S Glam, Wales.	imoore@cardiffmet.ac.uk	Ranson, Craig/AAQ-5452-2020	Moore, Isabel/0000-0002-4746-3390; Ranson, Craig/0000-0002-3783-0505	Welsh Rugby Union	The study was funded by the Welsh Rugby Union.	Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Boffano P, 2011, J CRANIOFAC SURG, V22, P2053, DOI 10.1097/SCS.0b013e318231988d; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Hagglund M, 2013, BRIT J SPORT MED, V47, P738, DOI 10.1136/bjsports-2013-092215; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; IRB, IRB CONC MAN; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moore IS, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115596194; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; NICE, 2007, BEH CHANG PRINC EFF; RFU, CONC RET PLAY; RFU, 2014, ENGL PROF RUGB INJ S; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; WRU, CONC REC REM DOWNL G	34	14	14	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2016	26	4					320	325		10.1097/JSM.0000000000000256			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	DQ8DC	WOS:000379438300010	26513391	Green Accepted			2022-02-06	
J	Preiksaitis, A; Krakauskaite, S; Petkus, V; Rocka, S; Chomskis, R; Dagi, TF; Ragauskas, A				Preiksaitis, Aidanas; Krakauskaite, Solventa; Petkus, Vytautas; Rocka, Saulius; Chomskis, Romanas; Dagi, Teodoro Forcht; Ragauskas, Arminas			Association of Severe Traumatic Brain Injury Patient Outcomes With Duration of Cerebrovascular Autoregulation Impairment Events	NEUROSURGERY			English	Article						Cerebrovascular autoregulation monitoring; Duration of cerebrovascular autoregulation impairment; Traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; WAVE-FORM; REACTIVITY; CONSENSUS	BACKGROUND: Cerebrovascular autoregulation (CA) is an important hemodynamic mechanism that protects the brain against inappropriate fluctuations in cerebral blood flow in the face of changing cerebral perfusion pressure. Temporal CA failure is associated with worse outcomes in various acute neurological diseases. An integrative approach is presently used according to the existing paradigm for the association of series of temporal CA impairments with the outcomes of patients with traumatic brain injury (TBI). OBJECTIVE: To explore the influence of the duration of CA impairment events on severe TBI patient outcomes. Patient age was also included in the analysis of the prospectively collected clinical data. METHODS: CA monitoring included 33 prospective severe TBI patients. The pressure reactivity index [PRx(t)] was continuously monitored to collect information on the dynamics of CA status and to analyze associations between the duration of the longest CA impairment event and patient outcomes. RESULTS: The Glasgow outcome scale and the duration of the longest CA impairment were negatively correlated. The duration of autoregulation impairment significantly correlated with worse outcomes. Multidimensional representation of Glasgow outcome scale plots showed that better outcomes were obtained for younger patients (age, 47 years) and those whose longest CA impairment event was shorter than 40 minutes if PRx (t) was above 0.7 in the CA impairment event. CONCLUSION: Unfavorable outcomes for TBI patients are more significantly associated with the duration of the single longest CA impairment episode at a high PRx(t) value, rather than with averaged PRx(t) values or the average time of all CA impairment episodes.	[Preiksaitis, Aidanas; Rocka, Saulius] Vilnius Univ, Fac Med, Clin Neurol & Neurosurg, Vilnius, Lithuania; [Preiksaitis, Aidanas] Lithuanian Univ Hlth Sci, Med Acad, Dept Neurol, Kaunas, Lithuania; [Krakauskaite, Solventa; Petkus, Vytautas; Chomskis, Romanas; Ragauskas, Arminas] Kaunas Univ Technol, Hlth Telemat Sci Inst, Kaunas, Lithuania; [Dagi, Teodoro Forcht] Harvard Univ, Harvard Med Sch, Cambridge, MA 02138 USA		Ragauskas, A (corresponding author), K Barsausko St 59,Room A560, LT-51423 Kaunas, Lithuania.	telematics@ktu.lt			Research Council of LithuaniaResearch Council of Lithuania (LMTLT) [MIP-118/2012]; Swiss-Lithuanian ProjectResearch Council of Lithuania (LMTLT) [CH-3-SMM-01/06]	Funding was received from the Research Council of Lithuania Grant No. MIP-118/2012 and Swiss-Lithuanian Project No. CH-3-SMM-01/06. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; CZOSNYKA M, 1994, ACTA NEUROCHIR, P468; Czosnyka M, 2007, NEUROL RES, V29, P672, DOI 10.1179/016164107X240053; Hakim AM, 1998, NEUROLOGY, V51, pS44, DOI 10.1212/WNL.51.3_Suppl_3.S44; Kasprowicz M, 2010, PHYSIOL MEAS, V31, P1217, DOI 10.1088/0967-3334/31/9/011; Kirkness C J, 2001, Biol Res Nurs, V2, P175, DOI 10.1177/109980040100200303; Lavinio A, 2008, ACTA NEUROCHIR SUPPL, V102, P3, DOI 10.1007/978-3-211-85578-2_1; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Palomares SM, 2011, J NEUROL NEUROPHYSIO, V20, pS1, DOI DOI 10.4172/2155-9562.S1-004; Petkus V, 2014, ELEKTRON ELEKTROTECH, V20, P24, DOI 10.5755/j01.eee.20.8.5464; Petkus V, 2014, COMP MED SY, P427, DOI 10.1109/CBMS.2014.44; Ragauskas A, 2003, MED ENG PHYS, V25, P667, DOI 10.1016/S1350-4533(03)00082-1; Ragauskas A, 2015, CARNET2015 ABSTRACT, V1, P78; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Rickards CA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00120; Schmidt B, 2014, IJCNMH S1, V1, pS18; Schondorf R, 2001, J APPL PHYSIOL, V91, P2493, DOI 10.1152/jappl.2001.91.6.2493; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sviri G.E., 2010, J OPEN NEUROSURGERY, V3, P6; Thomas KN, 2009, J APPL PHYSIOL, V107, P506, DOI 10.1152/japplphysiol.91650.2008	29	14	14	1	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2016	79	1					75	82		10.1227/NEU.0000000000001192			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DU6OK	WOS:000382334300019	26695090				2022-02-06	
J	Yorke, AM; Littleton, S; Alsalaheen, BA				Yorke, Amy M.; Littleton, Sheila; Alsalaheen, Bara A.			Concussion Attitudes and Beliefs, Knowledge, and Clinical Practice: Survey of Physical Therapists	PHYSICAL THERAPY			English	Article							INTERNATIONAL-CONFERENCE; VESTIBULAR REHABILITATION; CONSENSUS STATEMENT; SPORT CONCUSSION; MANAGEMENT; EDUCATION; PLAYERS; ZURICH; HEADS	Background. A concussion is considered a mild traumatic brain injury that may cause physical, cognitive, affective, and sleep dysfunction. Physical therapists have been identified as health care providers involved in the multidisciplinary care of a patient with concussion. Objective. The purpose of this study was to describe the current attitudes and beliefs, knowledge, and practice of physical therapists in the treatment of patients with concussion. Methods. A 55-question electronic survey divided into 6 sections (1) demographics, (2) current practice in concussion, (3) youth concussion legislation, (4) attitudes and beliefs toward concussion management, (5) concussion knowledge, and (6) clinical decision making was developed and distributed online through selected American Physical Therapy Association sections. Results. A total of 1,272 physical therapists completed the survey. Seventy percent of the respondents (n=894) reported having concussion training. Although supportive of the role of the physical therapist in the treatment of a person with concussion, the respondents demonstrated less confidence when making return-to-play decisions. Respondents correctly answered, on average, 13 (out of 15) concussion knowledge questions, with gaps exhibited in understanding the clinical utilization of concussion severity scales, the conservative treatment of youth who sustain a concussion, and anticipated normal computed tomography and magnetic resonance imaging after a concussion. When provided with clinical scenarios, respondents were able to recognize when a referral to a physician was indicated; however, they demonstrated variability in identifying a need for vestibular or manual physical therapy. Limitations. Convenience sampling was utilized, limiting generalizability of the results of the study to the physical therapy profession as a whole. Conclusion. Physical therapists demonstrated a solid foundation of concussion knowledge, but gaps still existed. Future professional development opportunities should be developed to target identified gaps in knowledge and current practice patterns.	[Yorke, Amy M.; Alsalaheen, Bara A.] Univ Michigan, Phys Therapy Dept, Flint, MI 48502 USA; [Littleton, Sheila] Dept Intellectual & Dev Disabil, Nashville, TN USA		Yorke, AM (corresponding author), Univ Michigan, Phys Therapy Dept, Flint, MI 48502 USA.	amyorke@umflint.edu	Yorke, Amy/Q-4091-2019	Yorke, Amy/0000-0003-4998-0313			Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Adler RH, 2011, PHYS MED REH CLIN N, V22, P721, DOI 10.1016/j.pmr.2011.08.010; Ajzen I., 2005, ATTITUDES PERSONALIT, P117; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; American Physical Therapy Association, 2012, PHYS THER ROL MAN PE; American Youth Soccer Organization, CONC INF; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, CONC IN SPORTS; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; DESSY A, 2015, NEUROSURG QUART, V25, P423, DOI DOI 10.1097/WNQ.0000000000000085; Dillman D.A., 2009, INTERNET MAIL MIXED, V3rd ed.; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Jones CA, 2015, PHYS THER REHABIL J, V95, P663, DOI 10.2522/ptj.20130512; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; McGrann P., 2012, RCSI STUD MED J, V5, P33; Menon A, 2009, J REHABIL MED, V41, P1024, DOI 10.2340/16501977-0451; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; National Conference of State Legislatures, TRAUM BRAIN INJ YOUT; National Football League, 2014, 2014 PLAY HLTH SAF R; Pardini D., 2004, BR J SPORTS MED, V38, P661; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Wainwright SF, 2011, PHYS THER, V91, P87, DOI 10.2522/ptj.20100161; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	43	14	14	0	19	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUL	2016	96	7					1018	1028		10.2522/ptj.20140598			11	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	DQ1RK	WOS:000378977900011	26637654	Bronze			2022-02-06	
J	Bloch, A; Tamir, D; Vakil, E; Zeilig, G				Bloch, Ayala; Tamir, Dror; Vakil, Eli; Zeilig, Gabi			Specific Deficit in Implicit Motor Sequence Learning following Spinal Cord Injury	PLOS ONE			English	Article							CLOSED HEAD-INJURY; REACTION-TIME-TASK; BASAL GANGLIA; SUPPORTED EMPLOYMENT; DEPRESSION; BRAIN; ANXIETY; MULTISITE; VETERANS; AMNESIA	Background Physical and psychosocial rehabilitation following spinal cord injury (SCI) leans heavily on learning and practicing new skills. However, despite research relating motor sequence learning to spinal cord activity and clinical observations of impeded skill-learning after SCI, implicit procedural learning following spinal cord damage has not been examined. Objective To test the hypothesis that spinal cord injury (SCI) in the absence of concomitant brain injury is associated with a specific implicit motor sequence learning deficit that cannot be explained by depression or impairments in other cognitive measures. Methods Ten participants with SCI in T1-T11, unharmed upper limb motor and sensory functioning, and no concomitant brain injury were compared to ten matched control participants on measures derived from the serial reaction time (SRT) task, which was used to assess implicit motor sequence learning. Explicit generation of the SRT sequence, depression, and additional measures of learning, memory, and intelligence were included to explore the source and specificity of potential learning deficits. Results There was no between-group difference in baseline reaction time, indicating that potential differences between the learning curves of the two groups could not be attributed to an overall reduction in response speed in the SCI group. Unlike controls, the SCI group showed no decline in reaction time over the first six blocks of the SRT task and no advantage for the initially presented sequence over the novel interference sequence. Meanwhile, no group differences were found in explicit learning, depression, or any additional cognitive measures. Conclusions The dissociation between impaired implicit learning and intact declarative memory represents novel empirical evidence of a specific implicit procedural learning deficit following SCI, with broad implications for rehabilitation and adjustment.	[Bloch, Ayala] Natl Inst Rehabil Brain Injured, Tel Aviv, Israel; [Tamir, Dror] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Vakil, Eli] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Vakil, Eli] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Zeilig, Gabi] Chaim Sheba Med Ctr, Dept Neurol Rehabil, Tel Hashomer, Israel; [Zeilig, Gabi] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel		Bloch, A (corresponding author), Natl Inst Rehabil Brain Injured, Tel Aviv, Israel.	ayalabl@shikumil.org.il		Bloch, Ayala/0000-0002-1964-7053			ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CRAIG AR, 1994, BRIT J CLIN PSYCHOL, V33, P221, DOI 10.1111/j.2044-8260.1994.tb01116.x; Craig A, 2015, BRIT J HEALTH PSYCH, V20, P807, DOI 10.1111/bjhp.12143; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; Davidoff G, 1990, Arch Clin Neuropsychol, V5, P77, DOI 10.1016/0887-6177(90)90009-E; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; Jegede AB, 2010, CLIN AUTON RES, V20, P3, DOI 10.1007/s10286-009-0036-z; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; KNOPMAN D, 1991, NEUROPSYCHOLOGIA, V29, P245, DOI 10.1016/0028-3932(91)90085-M; Lum JAG, 2014, CORTEX, V51, P1, DOI 10.1016/j.cortex.2013.10.011; Lungu O, 2010, J NEUROPHYSIOL, V103, P2675, DOI 10.1152/jn.00006.2010; Macartney-Filgate M S, 1988, Arch Clin Neuropsychol, V3, P121, DOI 10.1016/0887-6177(88)90057-1; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Ottomanelli L, 2009, J REHABIL RES DEV, V46, P919, DOI 10.1682/JRRD.2008.10.0145; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rush AJ, 2005, NEUROPSYCHOPHARMACOL, V30, P405, DOI 10.1038/sj.npp.1300614; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Schueneman AL, 1982, SCI DIG, V4, P64; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; Siegert RJ, 2006, NEUROPSYCHOLOGY, V20, P490, DOI 10.1037/0894-4105.20.4.490; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Taylor L, 1991, COMPENDIUM NEUROPSYC; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Trieschmann R, 1988, SPINAL CORD INJURIES; Vahdat S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002186; Vakil E, 1998, CHILD NEUROPSYCHOL, V4, P161, DOI 10.1076/chin.4.3.161.3173; Vakil E, 2000, NEUROPSYCHOLOGIA, V38, P1, DOI 10.1016/S0028-3932(99)00058-5; Warren AM, 2008, NEUROPSYCHOLOGY INPA, P79; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wilkinson L, 2004, J EXP PSYCHOL LEARN, V30, P354, DOI 10.1037/0278-7393.30.2.354; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042993; [No title captured]	51	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2016	11	6							e0158396	10.1371/journal.pone.0158396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ0AM	WOS:000378859400058	27355834	Green Published, gold, Green Submitted			2022-02-06	
J	Brock, JH; Graham, L; Staufenberg, E; Collyer, E; Koffler, J; Tuszynski, MH				Brock, John H.; Graham, Lori; Staufenberg, Eileen; Collyer, Eileen; Koffler, Jacob; Tuszynski, Mark H.			Bone Marrow Stromal Cell Intraspinal Transplants Fail to Improve Motor Outcomes in a Severe Model of Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						bone marrow stromal cells; brain-derived neurotrophic factor; neuroprotection; severe spinal cord compression	MESENCHYMAL STEM-CELLS; PROMOTE FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; IMMUNE RECONSTITUTION; HINDLIMB FUNCTION; CEREBROSPINAL-FLUID; GROWTH-FACTOR; BRAIN; RAT; BDNF	Bone marrow stromal cells (BMSCs) have been reported to exert potential neuroprotective properties in models of neurotrauma, although precise mechanisms underlying their benefits are poorly understood. Despite this lack of knowledge, several clinical trials have been initiated using these cells. To determine whether local mechanisms mediate BMSC neuroprotective actions, we grafted allogeneic BMSCs to sites of severe, compressive spinal cord injury (SCI) in Sprague-Dawley rats. Cells were administered 48 h after the original injury. Additional animals received allogeneic MSCs that were genetically modified to secrete brain-derived neurotrophic factor (BDNF) to further determine whether a locally administered neurotrophic factor provides or extends neuroprotection. When assessed 2 months post-injury in a clinically relevant model of severe SCI, BMSC grafts with or without BDNF secretion failed to improve motor outcomes. Thus, allogeneic grafts of BMSCs do not appear to act through local mechanisms, and future clinical trials that acutely deliver BMSCs to actual sites of injury within days are unlikely to be beneficial. Additional studies should address whether systemic administration of BMSCs alter outcomes from neurotrauma.	[Brock, John H.; Graham, Lori; Staufenberg, Eileen; Collyer, Eileen; Koffler, Jacob; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, 0626 Univ Calif, La Jolla, CA 92093 USA; [Brock, John H.; Tuszynski, Mark H.] Vet Adm San Diego Healthcare Syst, La Jolla, CA USA		Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, 0626 Univ Calif, La Jolla, CA 92093 USA.	mtuszynski@ucsd.edu		koffler, jacob/0000-0002-8415-2938	Department of Defense Congressionally Directed Medical Research Program: Spinal Cord Injury Research Program (CDMRP-SCIRP); Veterans AdministrationUS Department of Veterans Affairs; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS42291]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Bernard and Anne Spitzer Charitable Trust	We thank Nicole Armstrong for technical assistance. This study was supported by the Department of Defense Congressionally Directed Medical Research Program: Spinal Cord Injury Research Program (CDMRP-SCIRP), the Veterans Administration, the NIH (NS42291), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the Bernard and Anne Spitzer Charitable Trust.	Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; Chang Y, 2010, J NEUROTRAUM, V27, P2033, DOI 10.1089/neu.2009.1265; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Conner JM, 1996, J NEUROSCI METH, V65, P93, DOI 10.1016/0165-0270(95)00151-4; Cui XY, 2013, BIOSCI TRENDS, V7, P202, DOI 10.5582/bst.2013.v7.5.202; Dasari Venkata Ramesh, 2014, World J Stem Cells, V6, P120, DOI 10.4252/wjsc.v6.i2.120; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Forostyak S, 2013, BIOCHIMIE, V95, P2257, DOI 10.1016/j.biochi.2013.08.004; Fouad K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00187; Gao MY, 2013, BIOMATERIALS, V34, P1529, DOI 10.1016/j.biomaterials.2012.10.070; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Gransee HM, 2015, J NEUROTRAUM, V32, P185, DOI 10.1089/neu.2014.3464; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Jin W, 2014, J TRAUMA ACUTE CARE, V76, P1228, DOI 10.1097/TA.0000000000000211; Kalwak K, 2002, BRIT J HAEMATOL, V118, P74, DOI 10.1046/j.1365-2141.2002.03560.x; Karamouzian S, 2012, CLIN NEUROL NEUROSUR, V114, P935, DOI 10.1016/j.clineuro.2012.02.003; Kim DH, 1996, NEUROREPORT, V7, P2221, DOI 10.1097/00001756-199609020-00033; Koskinen E, 2013, J NEUROTRAUM, V30, P1587, DOI 10.1089/neu.2013.2943; Kwon BK, 2013, EXP NEUROL, V248, P30, DOI 10.1016/j.expneurol.2013.05.012; Lee B.A., 2014, J SPINAL CORD MED; Li JM, 2004, BIOL BLOOD MARROW TR, V10, P540, DOI 10.1016/j.bbmt.2004.05.007; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Lu P, 2012, J NEUROSCI, V32, P8208, DOI 10.1523/JNEUROSCI.0308-12.2012; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Mitsui T, 2005, EXP NEUROL, V194, P410, DOI 10.1016/j.expneurol.2005.02.022; Mofidi A, 2011, MINI-REV MED CHEM, V11, P763, DOI 10.2174/138955711796355267; Nandoe RDS, 2006, CELL TRANSPLANT, V15, P563, DOI 10.3727/000000006783981602; Novitzky N, 2001, CYTOTHERAPY, V3, P211, DOI 10.1080/146532401753174043; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; Paul C, 2009, SPINE, V34, P328, DOI 10.1097/BRS.0b013e31819403ce; Ritfeld G.J., 2015, CELL TRANSPLANT; Saito F, 2012, RESTOR NEUROL NEUROS, V30, P127, DOI 10.3233/RNN-2011-0629; Sandner B., 2015, CELL TRANSPLANT; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Steffenhagen C, 2012, STEM CELLS DEV, V21, P1838, DOI 10.1089/scd.2011.0137; Stroncek DF, 2014, TISSUE ENG PART B-RE, V20, P200, DOI [10.1089/ten.TEB.2013.0529, 10.1089/ten.teb.2013.0529]; Swanger SA, 2005, CELL TRANSPLANT, V14, P775, DOI 10.3727/000000005783982594; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tewarie RDSN, 2009, J NEUROTRAUM, V26, P2313, DOI 10.1089/neu.2009.0987; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Vanelderen P, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.09.006; Vaquero J, 2009, HISTOL HISTOPATHOL, V24, P107, DOI 10.14670/HH-24.107; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Vawda R, 2013, CURR STEM CELL RES T, V8, P25, DOI 10.2174/1574888X11308010005; Williams KM, 2008, BEST PRACT RES CL HA, V21, P579, DOI 10.1016/j.beha.2008.06.003; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Zariffa J, 2011, SPINAL CORD, V49, P463, DOI 10.1038/sc.2010.140	61	14	14	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2016	33	12					1103	1114		10.1089/neu.2015.4009			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DN9WT	WOS:000377432100001	26414795	Green Published			2022-02-06	
J	Chio, CC; Wei, L; Chen, TG; Lin, CM; Shieh, JP; Yeh, PS; Chen, RM				Chio, Chung-Ching; Wei, Li; Chen, Tyng Guey; Lin, Chien-Min; Shieh, Ja-Ping; Yeh, Poh-Shiow; Chen, Ruei-Ming			Neuron-derived orphan receptor 1 transduces survival signals in neuronal cells in response to hypoxia-induced apoptotic insults	JOURNAL OF NEUROSURGERY			English	Article						NOR-1; neuronal cell; hypoxia; survival signals; CREB/cIAP2; traumatic brain injury	BLOOD-BRAIN-BARRIER; GENE-EXPRESSION; NUCLEAR RECEPTORS; PROTECTS; ACTIVATION; ELEMENT; INJURY; TISSUE; ALPHA	OBJECTIVE Hypoxia can induce cell death or trigger adaptive mechanisms to guarantee cell survival. Neuron-derived orphan receptor 1 (NOR-1) works as an early-response protein in response to a variety of environmental stresses. In this study, the authors evaluated the roles of NOR-1 in hypoxia-induced neuronal insults. METHODS Neuro-2a cells were exposed to oxygen/glucose deprivation (OGD). Cell viability, cell morphology, caspase-3 activity, DNA fragmentation, and cell apoptosis were assayed to determine the mechanisms of OGD-induced neuronal insults. RNA and protein analyses were carried out to evaluate the effects of OGD on expressions of NOR-1, cAMP response element-binding (CREB), and cellular inhibitor of apoptosis protein 2 (cIAP2) genes. Translations of these gene expressions were knocked down using RNA interference. Mice subjected to traumatic brain injury (TBI) and NOR-1 was immunodetected. RESULTS Exposure of neuro-2a cells to OGD decreased cell viability in a time-dependent manner. Additionally, OGD led to cell shrinkage, DNA fragmentation, and cell apoptosis. In parallel, treatment of neuro-2a cells with OGD time dependently increased cellular NOR-1 mRNA and protein expressions. Interestingly, administration of TBI also augmented NOR-1 levels in the impacted regions of mice. As to the mechanism, exposure to OGD increased nuclear levels of the transcription factor CREB protein. Downregulating CREB expression using RNA interference simultaneously inhibited OGD-induced NOR-1 mRNA expression. Also, levels of clAP2 mRNA and protein in neuro-2a cells were augmented by OGD. After reducing clAP2 translation, OGD-induced cell death was reduced. Sequentially, application of NOR-1 small interfering RNA to neuro-2a cells significantly inhibited OGD-induced cIAP2 mRNA expression and concurrently alleviated hypoxia-induced alterations in cell viability, caspase-3 activation, DNA damage, and cell apoptosis. CONCLUSIONS This study shows that NOR-1 can transduce survival signals in neuronal cells responsible for hypoxia-induced apoptotic insults through activation of a CREB/cIAP2-dependent mechanism.	[Chio, Chung-Ching] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Shieh, Ja-Ping] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Yeh, Poh-Shiow] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Chio, Chung-Ching; Chen, Ruei-Ming] Taipei Med Univ, Ctr Comprehens Canc, Taipei 110, Taiwan; [Lin, Chien-Min] Taipei Med Univ, Dept Neurosurg, Taipei 110, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan; [Wei, Li] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Chen, Tyng Guey] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei 110, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ, Wan Fang Hosp, Brain Dis Res Ctr, Taipei 110, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ Hosp, Anesthet & Toxicol Res Ctr, Taipei, Taiwan		Chen, RM (corresponding author), Taipei Med Univ, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan.	rmchen@tmu.edu.tw					Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Barco A, 2011, MOL NEUROBIOL, V44, P330, DOI 10.1007/s12035-011-8209-x; Chang HC, 2014, J AGR FOOD CHEM, V62, P3466, DOI 10.1021/jf403286w; Chang HC, 2011, J CEREBR BLOOD F MET, V31, P842, DOI 10.1038/jcbfm.2010.180; Chen RM, 2013, SURGERY, V154, P58, DOI 10.1016/j.surg.2013.02.003; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chio CC, 2013, ARCH TOXICOL, V87, P459, DOI 10.1007/s00204-012-0965-5; Chuang CY, 2011, ARCH TOXICOL, V85, P209, DOI 10.1007/s00204-010-0585-x; Chuang CY, 2011, IMMUNOBIOLOGY, V216, P707, DOI 10.1016/j.imbio.2010.10.009; Eftedal I, 2012, PHYSIOL GENOMICS, V44, P1201, DOI 10.1152/physiolgenomics.00073.2012; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Gerstner ER, 2009, NAT REV CLIN ONCOL, V6, P229, DOI 10.1038/nrclinonc.2009.14; Goyal L, 2001, CELL, V104, P805, DOI 10.1016/S0092-8674(01)00276-8; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Kagaya S, 2005, BIOL PHARM BULL, V28, P1603, DOI 10.1248/bpb.28.1603; Kim Y, 2006, MOL CELLS, V22, P8; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Liao MH, 2014, BRIT J NUTR, V111, P55, DOI 10.1017/S0007114513002043; Lin JW, 2012, NEURO-ONCOLOGY, V14, P302, DOI 10.1093/neuonc/nor217; Lin YL, 2010, J NUTR, V140, P2187, DOI 10.3945/jn.110.123505; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Mazzeo AT, 2007, J NEUROL SCI, V261, P1, DOI 10.1016/j.jns.2007.04.026; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; Okouchi M, 2007, ANTIOXID REDOX SIGN, V9, P1059, DOI 10.1089/ars.2007.1511; Ostergaard L, 2013, J CEREBR BLOOD F MET, V33, P1825, DOI 10.1038/jcbfm.2013.173; Park HA, 2015, ANTIOXID REDOX SIGN, V22, P93, DOI 10.1089/ars.2013.5570; Rius J, 2004, ARTERIOSCL THROM VAS, V24, P697, DOI 10.1161/01.ATV.0000121570.00515.dc; Shin HJ, 2003, TOXICOLOGY, V191, P121, DOI 10.1016/S0300-483X(03)00210-5; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wei JD, 2012, J ORTHOP RES, V30, P1058, DOI 10.1002/jor.22046; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Wu H, 2007, CELL, V131, P655, DOI 10.1016/j.cell.2007.10.042; Wu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072404; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	39	14	14	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2016	124	6					1654	1664		10.3171/2015.6.JNS1535			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DM6PZ	WOS:000376476200016	26613168	Bronze			2022-02-06	
J	Edlow, BL; Copen, WA; Izzy, S; van der Kouwe, A; Glenn, MB; Greenberg, SM; Greer, DM; Wu, O				Edlow, Brian L.; Copen, William A.; Izzy, Saef; van der Kouwe, Andre; Glenn, Mel B.; Greenberg, Steven M.; Greer, David M.; Wu, Ona			Longitudinal Diffusion Tensor Imaging Detects Recovery of Fractional Anisotropy Within Traumatic Axonal Injury Lesions	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Diffusion tensor imaging; Traumatic axonal injury; Fractional anisotropy; Apparent diffusion coefficient	WHITE-MATTER INJURY; BRAIN-INJURY; CORPUS-CALLOSUM; HEAD-INJURY; ACUTE MILD; DAMAGE; COMA; DISCONNECTION; DEGENERATION; DIAGNOSIS	Traumatic axonal injury (TAI) may be reversible, yet there are currently no clinical imaging tools to detect axonal recovery in patients with traumatic brain injury (TBI). We used diffusion tensor imaging (DTI) to characterize serial changes in fractional anisotropy (FA) within TAI lesions of the corpus callosum (CC). We hypothesized that recovery of FA within a TAI lesion correlates with better functional outcome. Patients who underwent both an acute DTI scan (a parts per thousand currency signday 7) and a subacute DTI scan (day 14 to inpatient rehabilitation discharge) at a single institution were retrospectively analyzed. TAI lesions were manually traced on the acute diffusion-weighted images. Fractional anisotropy (FA), apparent diffusion coefficient (ADC), axial diffusivity (AD), and radial diffusivity (RD) were measured within the TAI lesions at each time point. FA recovery was defined by a longitudinal increase in CC FA that exceeded the coefficient of variation for FA based on values from healthy controls. Acute FA, ADC, AD, and RD were compared in lesions with and without FA recovery, and correlations were tested between lesional FA recovery and functional recovery, as determined by disability rating scale score at discharge from inpatient rehabilitation. Eleven TAI lesions were identified in 7 patients. DTI detected FA recovery within 2 of 11 TAI lesions. Acute FA, ADC, AD, and RD did not differ between lesions with and without FA recovery. Lesional FA recovery did not correlate with disability rating scale scores. In this retrospective longitudinal study, we provide initial evidence that FA can recover within TAI lesions. However, FA recovery did not correlate with improved functional outcomes. Prospective histopathological and clinical studies are needed to further elucidate whether lesional FA recovery indicates axonal healing and has prognostic significance.	[Edlow, Brian L.; Izzy, Saef; Greenberg, Steven M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, 175 Cambridge St,Suite 300, Boston, MA 02114 USA; [Edlow, Brian L.; van der Kouwe, Andre; Wu, Ona] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Copen, William A.; van der Kouwe, Andre; Wu, Ona] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA USA; [Glenn, Mel B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Spaulding Rehabil Hosp,Dept Phys Med & Rehabil, Boston, MA USA; [Greer, David M.] Yale Univ, Sch Med, Yale New Haven Hosp, Dept Neurol, New Haven, CT USA		Edlow, BL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, 175 Cambridge St,Suite 300, Boston, MA 02114 USA.; Edlow, BL (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.	bedlow@mgh.harvard.edu	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Greer, David/0000-0002-2026-8333; Wu, Ona/0000-0002-5509-9461	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25NS065743, K23NS094538, R01NS059775, P41EB015896]; American Academy of Neurology/American Brain Foundation; National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, U.S. Department Health and Human Services to Spaulding Rehabilitation Hospital [H133A120085]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, R01NS059775, R25NS065743] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health (R25NS065743, K23NS094538, R01NS059775, and P41EB015896), the American Academy of Neurology/American Brain Foundation, and the National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, U.S. Department Health and Human Services to Spaulding Rehabilitation Hospital (H133A120085). However, the contents of this manuscript do not necessarily represent the policy of the Department of Health and Human Services and endorsement by the Federal Government should not be assumed.	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Armstrong R.C., 2015, EXP NEUROL; Armstrong R. C., 2015, NEUROPHARMACOLOGY; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jang SH, 2015, AM J PHYS MED REHAB, V94, P250, DOI 10.1097/PHM.0000000000000274; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kessler LG, 2015, STAT METHODS MED RES, V24, P9, DOI 10.1177/0962280214537333; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; STRICH SJ, 1961, LANCET, V2, P443; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; van de Looij Y, 2012, NMR BIOMED; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	56	14	14	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2016	24	3					342	352		10.1007/s12028-015-0216-8			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DN2ZP	WOS:000376932100004	26690938	Green Accepted			2022-02-06	
J	McLean, ACL; McLean, AL; Kalff, R; Walter, J				McLean, Anna C. Lawson; McLean, Aaron Lawson; Kalff, Rolf; Walter, Jan			Google Search Queries About Neurosurgical Topics: Are They a Suitable Guide for Neurosurgeons?	WORLD NEUROSURGERY			English	Article						Google trends; Internet; Neurosurgery; Patient guidance; Search queries	ONLINE INFORMATION; INTERNET; QUALITY; CANCER	OBJECTIVE: Google is the most popular search engine, with about 100 billion searches per month. Google Trends is an integrated tool that allows users to obtain Google's search popularity statistics from the last decade. Our aim was to evaluate whether Google Trends is a useful tool to assess the public's interest in specific neurosurgical topics. METHODS: We evaluated Google Trends statistics for the neurosurgical search topic areas "hydrocephalus," "spinal stenosis," "concussion," "vestibular schwannoma," and "cerebral arteriovenous malformation. "We compared these with bibliometric data from PubMed and epidemiologic data from the German Federal Monitoring Agency. In addition, we assessed Google users' search behavior for the search terms "glioblastoma" and "meningioma." RESULTS: Over the last 10 years, there has been an increasing interest in the topic "concussion" from Internet users in general and scientists. "Spinal stenosis," "concussion," and "vestibular schwannoma" are topics that are of special interest in high-income countries (eg, Germany), whereas "hydrocephalus" is a popular topic in low- and middle-income countries. The Google-defined top searches within these topic areas revealed more detail about people's interests (eg, "normal pressure hydrocephalus" or "football concussion"ranked among the most popular search queries within the corresponding topics). There was a similar volume of queries for "glioblastoma" and "meningioma." CONCLUSIONS: Google Trends is a useful source to elicit information about general trends in peoples' health interests and the role of different diseases across the world. The Internet presence of neurosurgical units and surgeons can be guided by online users' interests to achieve high-quality, professional-endorsed patient education.	[McLean, Anna C. Lawson; McLean, Aaron Lawson; Kalff, Rolf; Walter, Jan] Univ Jena, Jena Univ Hosp, Dept Neurosurg, Jena, Germany		Walter, J (corresponding author), Univ Jena, Jena Univ Hosp, Dept Neurosurg, Jena, Germany.	jan.walter@med.uni-jena.de	McLean, Aaron Lawson/D-6830-2013; Walter, Jan/AAE-4536-2021	McLean, Aaron Lawson/0000-0001-5528-6905; 			Alotaibi NM, 2016, WORLD NEUROSURG, V88, P619, DOI 10.1016/j.wneu.2015.11.011; Baldi I, 2014, NEUROCHIRURGIE; Berg GM, 2014, JAAPA-J AM ACAD PHYS, V27, DOI 10.1097/01.JAA.0000442712.05009.b1; Best J, 2015, EUR ARCH OTO-RHINO-L, V272, P3499, DOI 10.1007/s00405-014-3349-z; Brodbelt A, 2015, EUR J CANCER, V51, P533, DOI 10.1016/j.ejca.2014.12.014; Car J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007092.pub2; Carlsson T, 2015, INTERACT J MED RES, V4, P66, DOI 10.2196/ijmr.3819; Chou WYS, 2011, J CANCER SURVIV, V5, P263, DOI 10.1007/s11764-011-0179-5; Epstein D., 2011, SPORT ILLUS; Garcia GH, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01228; Ghobrial GM, 2014, CLIN NEUROL NEUROSUR, V118, P59, DOI 10.1016/j.clineuro.2013.12.013; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glynn RW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-442; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lee K, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4345; Madden T, 2015, AM J OBSTET GYNECOL; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Mohan R, 2015, J ARTHROPLASTY, V30, P803, DOI 10.1016/j.arth.2014.12.022; Murray G, 2016, BRIT J ORAL MAX SURG, V54, P163, DOI 10.1016/j.bjoms.2015.12.005; Ohaegbulam SC, 2001, NEUROSURGERY, V49, P226; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Prestin A, 2015, J HEALTH COMMUN, V20, P790, DOI 10.1080/10810730.2015.1018590; Rossignol L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076020; Sobota A, 2015, INT J GYNECOL CANCER, V25, P537, DOI 10.1097/IGC.0000000000000362; Sullivan TB, 2014, CLIN ORTHOP RELAT R, V472, P1597, DOI 10.1007/s11999-013-3425-5	25	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2016	90						179	185		10.1016/j.wneu.2016.02.045			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DS1MS	WOS:000380360500024	26898496				2022-02-06	
J	Murphy, MA; Horstemeyer, MF; Gwaltney, SR; Stone, T; LaPlaca, M; Liao, J; Williams, L; Prabhu, R				Murphy, M. A.; Horstemeyer, M. F.; Gwaltney, Steven R.; Stone, Tonya; LaPlaca, Michelle; Liao, Jun; Williams, Lakiesha; Prabhu, R.			Nanomechanics of phospholipid bilayer failure under strip biaxial stretching using molecular dynamics	MODELLING AND SIMULATION IN MATERIALS SCIENCE AND ENGINEERING			English	Article						traumatic brain injury (TBI); molecular dynamics (MD); nanoscale deformations; phospholipid bilayer; POPC; neuron; cell membrane	TRAUMATIC BRAIN-INJURY; LIPID-BILAYERS; PORE FORMATION; SIMULATIONS; DAMAGE; MEMBRANES; RUPTURE; TENSION; STRESS	The current study presents a nanoscale in silico investigation of strain rate dependency of membrane (phospholipid bilayer) failure when placed under strip biaxial tension with two planar areas. The nanoscale simulations were conducted in the context of a multiscale modelling framework in which the macroscale damage (pore volume fraction) progression is delineated into pore nucleation (number density of pores), pore growth (size of pores), and pore coalescence (inverse of nearest neighbor distance) mechanisms. As such, the number density, area fraction, and nearest neighbor distances were quantified in association with the stress-strain behavior. Deformations of a 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) bilayer were performed using molecular dynamics to simulate mechanoporation of a neuronal cell membrane due to injury, which in turn can result in long-term detrimental effects that could ultimately lead to cell death. Structures with 72 and 144 phospholipids were subjected to strip biaxial tensile deformations at multiple strain rates. Formation of a water bridge through the phospholipid bilayer was the metric to indicate structural failure. Both the larger and smaller bilayers had similar behavior regarding pore nucleation and the strain rate effect on pore growth post water penetration. The applied strain rates, planar area, and cross-sectional area had no effect on the von Mises strains at which pores greater than 0.1 nm(2) were detected (0.509 +/- 7.8%) or the von Mises strain at failure (epsilon(failure) = 0.68 +/- 4.8%). Additionally, changes in bilayer planar and cross-sectional areas did not affect the stress response. However, as the strain rate increased from 2.0 x 10(8) s(-1) to 1.0 x 10(9) s(-1), the yield stress increased from 26.5 MPa to 66.7 MPa and the yield strain increased from 0.056 to 0.226.	[Murphy, M. A.; Liao, Jun; Williams, Lakiesha; Prabhu, R.] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA; [Murphy, M. A.; Horstemeyer, M. F.; Stone, Tonya; Liao, Jun; Williams, Lakiesha; Prabhu, R.] Mississippi State Univ, CAVS, Mississippi State, MS 39759 USA; [Horstemeyer, M. F.; Stone, Tonya] Mississippi State Univ, Dept Mech Engn, Mississippi State, MS 39762 USA; [Gwaltney, Steven R.] Mississippi State Univ, Dept Chem, Mississippi State, MS 39762 USA; [Gwaltney, Steven R.] Mississippi State Univ, Ctr Computat Sci, Mississippi State, MS 39762 USA; [LaPlaca, Michelle] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA		Williams, L; Prabhu, R (corresponding author), 130 Creelman St, Mississippi State, MS 39762 USA.	lwilliams@abe.msstate.edu; rprabhu@abe.msstate.edu	Gwaltney, Steven/W-2783-2019; Liao, Jun/AAW-3591-2021; Stone, Tonya/L-9575-2019; Prabhu, Raj/M-7188-2017	Gwaltney, Steven/0000-0003-3833-5087; Liao, Jun/0000-0003-1049-5783; Stone, Tonya/0000-0002-8070-1928; Murphy, Michael/0000-0001-9158-1709; Prabhu, Raj/0000-0002-6073-4802; Horstemeyer, Mark/0000-0003-4230-0063	Center for Advanced Vehicular Systems (CAVS) through the Department of Agricultural and Biological Engineering at Mississippi State University; Tissue Engineering Research Center (TERC) through the Department of Agricultural and Biological Engineering at Mississippi State University; NSF EPSCoR research program [EPS_0903787]	This material is based upon work supported by the Center for Advanced Vehicular Systems (CAVS) and the Tissue Engineering Research Center (TERC) through the Department of Agricultural and Biological Engineering at Mississippi State University. We would also like to thank the NSF EPSCoR research program (EPS_0903787) for funding the multiscale aspect of the current research. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the NSF.	[Anonymous], 2014, BIOMED RES INT; [Anonymous], 2013, MATLAB 8 1 0 604 EDN; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; Evans E, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/095010; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Faul M, 2010, TRAUMATIC BRAIN INJU; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Horstemeyer MF, 2000, THEOR APPL FRACT MEC, V33, P31, DOI 10.1016/S0167-8442(99)00049-X; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koshiyama K, 2011, J BIOMECH, V44, P2053, DOI 10.1016/j.jbiomech.2011.05.014; Leach A.R., 2001, MOL MODELLING PRINCI; Leontiadou H, 2004, BIOPHYS J, V86, P2156, DOI 10.1016/S0006-3495(04)74275-7; NARTEN AH, 1971, J CHEM PHYS, V55, P2263, DOI 10.1063/1.1676403; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; NOCSAE, 2013, ND00213M13 NOCSAE DO; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Prabhu R, 2014, PNAS UNPUB; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shinoda W, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.134103; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; Tolpekina TV, 2004, J CHEM PHYS, V121, P8014, DOI 10.1063/1.1796254; Tomasini MD, 2010, EXP BIOL MED, V235, P181, DOI 10.1258/ebm.2009.009187; ZHANG YH, 1995, J CHEM PHYS, V103, P10252, DOI 10.1063/1.469927	29	14	14	0	14	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0965-0393	1361-651X		MODEL SIMUL MATER SC	Model. Simul. Mater. Sci. Eng.	JUN	2016	24	5							055008	10.1088/0965-0393/24/5/055008			19	Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Physics	DP1ZX	WOS:000378289000008					2022-02-06	
J	Plenger, P; Krishnan, K; Cloud, M; Bosworth, C; Qualls, D; de la Plata, CM				Plenger, Patrick; Krishnan, Kamini; Cloud, Matthew; Bosworth, Chris; Qualls, Devin; de la Plata, Carlos Marquez			fNIRS-based investigation of the Stroop task after TBI	BRAIN IMAGING AND BEHAVIOR			English	Article						fNIRS; TBI; Stroop; Frontal lobe; Interference effect; HbO	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; PREFRONTAL ACTIVATION; FUNCTIONAL MRI; FMRI; INTERFERENCE; PERFORMANCE; DEFICITS; CORTEX; FACILITATION	To evaluate neural changes during a Stroop task among individuals with TBI using functional near-infrared spectroscopy (fNIRS). Thirteen healthy controls and 14 patients with moderate to severe TBI were included in this study. Oxygenated hemoglobin (HbO) was recorded every tenth of a second using a 52-channel fNIRS unit. Data were acquired using a block design during a Stroop task (i.e., Condition A = Dot Color Naming, Condition B = Incongruent Condition). Visual stimuli were presented on a computer monitor. Behaviorally, response accuracy was similar between groups for condition A, but the TBI group made more errors than the control group during condition B. During condition A, the patient group demonstrated significant increases in HbO within bilateral frontal regions compared to controls (p<0.01). When examining the Stroop interference effect (B-A), controls showed increased HbO in bilateral frontal lobes and left inferior parietal region suggesting increased neural response to increased cognitive demand, whereas no differences were detected among the TBI group (p<0.05). No between group differences in latency of HbO response was observed during either condition. While the TBI group performed as accurately as controls on the simpler dot color naming condition of the Stroop task, neural activity was greater within the frontal lobes during this relatively simple task among the TBI group suggesting neural inefficiency. Furthermore, the spatial distribution of neural activity related to the interference effect was not different among patients, suggesting the neural demand for the simpler task was comparable to that of the more cognitive demanding task among the TBI sample. The results suggest that fNIRS can identify frontal lobe inefficiency in TBI commonly observed with fMRI.	[Plenger, Patrick; Krishnan, Kamini; Cloud, Matthew; Qualls, Devin; de la Plata, Carlos Marquez] Pate Rehabil, 2655 Villa Creek Dr,Suite 140, Dallas, TX 75234 USA; [Plenger, Patrick; Krishnan, Kamini; Bosworth, Chris; de la Plata, Carlos Marquez] Univ Texas Southwestern Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Bosworth, Chris; de la Plata, Carlos Marquez] Univ Texas Dallas, Ctr BrainHlth, 2200 W Mockingbird Ln, Dallas, TX 75235 USA		Plenger, P (corresponding author), Pate Rehabil, 2655 Villa Creek Dr,Suite 140, Dallas, TX 75234 USA.; Plenger, P (corresponding author), Univ Texas Southwestern Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	pplenger@paterehab.com					Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Coronado VG, 2014, J SAFETY RES, V48, P117, DOI 10.1016/j.jsr.2013.12.006; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Herrmann MJ, 2004, J NEUROPSYCH CLIN N, V16, P170, DOI 10.1176/appi.neuropsych.16.2.170; Hickok G, 1999, BRAIN LANG, V66, P233, DOI 10.1006/brln.1998.1995; Holtzer R, 2011, J GERONTOL A-BIOL, V66, P879, DOI 10.1093/gerona/glr068; Iidaka T, 2000, COGNITIVE BRAIN RES, V9, P73, DOI 10.1016/S0926-6410(99)00047-6; Indefrey P., 2000, NEW COGNITIVE NEUROS, P845; Lague-Beauvais M, 2013, NEUROIMAGE, V64, P485, DOI 10.1016/j.neuroimage.2012.09.042; MACLEOD CM, 1992, J EXP PSYCHOL GEN, V121, P12, DOI 10.1037/0096-3445.121.1.12; Malec J., 2005, MAYO PORTLAND ADAPTA; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; Mani TM, 2007, NEUROCASE, V13, P229, DOI 10.1080/13554790701594862; Morris T, 2010, HANDBOOK OF MEDICAL NEUROPSYCHOLOGY: APPLICATIONS OF COGNITIVE NEUROSCIENCE, P17, DOI 10.1007/978-1-4419-1364-7_2; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Schroeter ML, 2004, NEUROIMAGE, V23, P1317, DOI 10.1016/j.neuroimage.2004.08.001; Sliwinska MW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00161; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Steinbrink J, 2006, MAGN RESON IMAGING, V24, P495, DOI 10.1016/j.mri.2005.12.034; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taylor SF, 1997, NEUROIMAGE, V6, P81, DOI 10.1006/nimg.1997.0285; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Topper R, 1998, EXP BRAIN RES, V121, P371, DOI 10.1007/s002210050471; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; Yagishita S, 2008, NEUROIMAGE, V41, P1142, DOI 10.1016/j.neuroimage.2008.03.008	40	14	16	3	20	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2016	10	2					357	366		10.1007/s11682-015-9401-9			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU7JK	WOS:000382390000004	26058665				2022-02-06	
J	Su, TC; Lin, SH; Lee, PT; Yeh, SH; Hsieh, TH; Chou, SY; Su, TP; Hung, JJ; Chang, WC; Lee, YC; Chuang, JY				Su, Tzu-Chieh; Lin, Shu-Hui; Lee, Pin-Tse; Yeh, Shiu-Hwa; Hsieh, Tsun-Hsun; Chou, Szu-Yi; Su, Tsun-Ping; Hung, Jan-Jong; Chang, Wen-Chang; Lee, Yi-Chao; Chuang, Jian-Ying			The sigma-1 receptor-zinc finger protein 179 pathway protects against hydrogen peroxide-induced cell injury	NEUROPHARMACOLOGY			English	Article						Sig-1R; Znf179; DHEA/DHEAS; Reactive oxygen species; Hydrogen peroxide	TRAUMATIC BRAIN-INJURY; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; DEHYDROEPIANDROSTERONE DHEA; ALZHEIMERS-DISEASE; NEUROSTEROIDS; BINDING; ZNF179; DIFFERENTIATION; INVOLVEMENT	The accumulation of reactive oxygen species (ROS) have implicated the pathogenesis of several human diseases including neurodegenerative disorders, stroke, and traumatic brain injury, hence protecting neurons against ROS is very important. In this study, we focused on sigma-1 receptor (Sig-1R), a chaperone at endoplasmic reticulum, and investigated its protective functions. Using hydrogen peroxide (H2O2)-induced ROS accumulation model, we verified that apoptosis-signaling pathways were elicited by H2O2 treatment. However, the Sig-1R agonists, dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS), reduced the activation of apoptotic pathways significantly. By performing protein protein interaction assays and shRNA knockdown of Sig-1R, we identified the brain Zinc finger protein 179 (Znf179) as a downstream target of Sig-1R regulation. The neuroprotective effect of Znf179 over expression was similar to that of DHEAS treatment, and likely mediated by affecting the levels of antioxidant enzymes. We also quantified the levels of peroxiredoxin 3 (Prx3) and superoxide dismutase 2 (SOD2) in the hippocampi of wild-type and Znf179 knockout mice, and found both enzymes to be reduced in the knockout versus the wild-type mice. In summary, these results reveal that Znf179 plays a novel role in neuroprotection, and Sig-1R agonists may be therapeutic candidates to prevent ROS-induced damage in neurodegenerative and neurotraumatic diseases. (C) 2016 Elsevier Ltd. All rights reserved.	[Su, Tzu-Chieh; Lin, Shu-Hui; Chang, Wen-Chang] Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan; [Lin, Shu-Hui; Hsieh, Tsun-Hsun; Chou, Szu-Yi; Lee, Yi-Chao; Chuang, Jian-Ying] Taipei Med Univ, Grad Inst Neural Regenerat Med, 250 Wuxing St, Taipei 110, Taiwan; [Lee, Pin-Tse; Yeh, Shiu-Hwa] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan Township, Miaoli County, Taiwan; [Lee, Pin-Tse; Su, Tsun-Ping] NIDA, Cellular Pathobiol Sect, Intramural Res Program, Baltimore, MD USA; [Hung, Jan-Jong] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan; [Chang, Wen-Chang; Lee, Yi-Chao; Chuang, Jian-Ying] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 110, Taiwan		Lee, YC; Chuang, JY (corresponding author), Taipei Med Univ, Grad Inst Neural Regenerat Med, 250 Wuxing St, Taipei 110, Taiwan.	yclee@tmu.edu.tw; chuangcy@tmu.edu.tw		Lee, Yi-Chao/0000-0003-3451-183X; Chou, Szu-Yi/0000-0002-4387-749X	Ministry of Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [MOST 103-2320-B-038-046-MY3, MOST 103-2321-B-038-001, MOST 104-2923-B-038-002-MY3]; Taipei Medical University [TMU102-AE1-B25]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [ZIADA000549, ZIADA000206] Funding Source: NIH RePORTER	This work was supported by grants from the Ministry of Science and Technology (MOST 103-2320-B-038-046-MY3, MOST 103-2321-B-038-001, and MOST 104-2923-B-038-002-MY3) and Taipei Medical University (TMU102-AE1-B25).	Aly HF, 2011, ACTA BIOCHIM POL, V58, P513; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Charalampopoulos L, 2004, P NATL ACAD SCI USA, V101, P8209, DOI 10.1073/pnas.0306631101; Di Matteo V, 2003, CNS NEUROL DISORD-DR, V2, P95, DOI 10.2174/1568007033482959; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Camporez JPG, 2011, J PHYSIOL-LONDON, V589, P2585, DOI 10.1113/jphysiol.2011.206078; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Goyagi T, 2001, STROKE, V32, P1613, DOI 10.1161/01.STR.32.7.1613; Grimm A, 2014, BBA-MOL BASIS DIS, V1842, P2427, DOI 10.1016/j.bbadis.2014.09.013; Hanna DMF, 2015, PROG NEURO-PSYCHOPH, V60, P36, DOI 10.1016/j.pnpbp.2015.02.005; Hayashi T., 2005, Current Neuropharmacology, V3, P267, DOI 10.2174/157015905774322516; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hetz C, 2014, NAT REV NEUROSCI, V15, P233, DOI 10.1038/nrn3689; Hirata Y, 2011, J NEUROCHEM, V119, P839, DOI 10.1111/j.1471-4159.2011.07464.x; Ishikawa M, 2010, J RECEPT LIGAND CH R, V3, P25; Kimura T, 1997, AM J MED GENET, V69, P320; Kokona D, 2012, NEUROPHARMACOLOGY, V62, P2106, DOI 10.1016/j.neuropharm.2012.01.006; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; Lin DY, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-98; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Nguyen L, 2015, J PHARMACOL SCI, V127, P17, DOI 10.1016/j.jphs.2014.12.005; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Maurice T, 1996, J NEUROSCI RES, V46, P734; MONNET FP, 1995, P NATL ACAD SCI USA, V92, P3774, DOI 10.1073/pnas.92.9.3774; Pao PC, 2011, CELL DEATH DIFFER, V18, P1791, DOI 10.1038/cdd.2011.52; Peviani M, 2014, NEUROBIOL DIS, V62, P218, DOI 10.1016/j.nbd.2013.10.010; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Ruscher K, 2015, J PHARMACOL SCI, V127, P30, DOI 10.1016/j.jphs.2014.11.011; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Tsai SYA, 2015, P NATL ACAD SCI USA, V112, pE6562, DOI 10.1073/pnas.1518894112; Tuerxun T, 2010, NEUROSCI LETT, V469, P303, DOI 10.1016/j.neulet.2009.12.013; Urani A, 2001, J PHARMACOL EXP THER, V298, P1269; Wang SM, 2015, MOL NEUROBIOL, V51, P370, DOI 10.1007/s12035-014-8714-9; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	37	14	17	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	JUN	2016	105						1	9		10.1016/j.neuropharm.2016.01.015			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DN8EF	WOS:000377311300001	26792191	Green Accepted			2022-02-06	
J	Wilson, TJ; Chang, KWC; Yang, LJS				Wilson, Thomas J.; Chang, Kate W. C.; Yang, Lynda J. -S.			Depression and Anxiety in Traumatic Brachial Plexus Injury Patients Are Associated With Reduced Motor Outcome After Surgical Intervention for Restoration of Elbow Flexion	NEUROSURGERY			English	Article						Brachial plexus; Depression; Nerve transfer	CLINICAL-OUTCOMES; SURGERY; SYMPTOMS; HEALTH	BACKGROUND:Depression has been associated with poor outcomes in neurosurgical patients, including increased pain, poorer functional recovery, delayed return to work, and decreased patient satisfaction. No reports exist regarding an association of psychiatric diagnoses with outcomes after brachial plexus reconstruction. As outcomes and patient satisfaction become increasingly important to payers and physician reimbursement, assessing modifiable preoperative risk factors for their association with poor outcome and patient satisfaction is imperative.OBJECTIVE:To analyze patients undergoing brachial plexus reconstruction to assess the relationship of depression/anxiety with functional outcome.METHODS:Data were collected retrospectively on all patients who underwent brachial plexus reconstruction to restore elbow flexion between 2005 and 2013. Elbow flexion, graded via the Medical Research Council scale, was assessed at latest follow-up. Multiple variables, including the presence of Axis I psychiatric diagnoses, were assessed for their association with the dichotomous outcome of Medical Research Council scale score 3 (antigravity) vs <3 elbow flexion. Standard statistical methods were used.RESULTS:Thirty-seven patients met inclusion criteria. The median postsurgical follow-up time was 21 months. Operations included neurolysis (n = 3), nerve graft repair (n = 6), and nerve transfer (n = 28). Depression was present in 10 of 37 patients (27%). Of variables tested, only depression was associated with poor elbow flexion outcome (odds ratio: 6.038; P = .04).CONCLUSION:Preoperative depression is common after brachial plexus injury. The presence of depression is associated with reduced elbow flexion recovery after reconstruction. Our data suggest assessment and treatment of preoperative mental health is important in designing a comprehensive postoperative management plan to optimize outcomes and patient satisfaction.ABBREVIATIONS:MRC, Medical Research CouncilTBI, traumatic brain injury	[Wilson, Thomas J.; Chang, Kate W. C.; Yang, Lynda J. -S.] Univ Michigan, Dept Neurosurg, 1500 E Med Ctr Dr,Room 3552 TC, Ann Arbor, MI 48109 USA		Wilson, TJ (corresponding author), Univ Michigan, Dept Neurosurg, 1500 E Med Ctr Dr,Room 3552 TC, Ann Arbor, MI 48109 USA.	thowil@med.umich.edu					Ali ZS, 2015, J NEUROSURG, V122, P195, DOI 10.3171/2014.9.JNS132823; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; Bell D, 2011, CANCER BIOL THER, V11, P765, DOI 10.4161/cbt.11.8.15277; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carlsen BT, 2011, PLAST RECONSTR SURG, V127, P269, DOI 10.1097/PRS.0b013e3181f95be7; Dubuisson AS, 2002, NEUROSURGERY, V51, P673, DOI 10.1097/00006123-200209000-00011; Fann JR, 2015, JAMA PSYCHIAT, V72, P247, DOI 10.1001/jamapsychiatry.2014.2482; Franzblau L, 2015, DISABIL REHABIL, V37, P135, DOI 10.3109/09638288.2014.911971; Franzblau LE, 2015, J NEUROSURG, V122, P1413, DOI 10.3171/2015.2.JNS132686; Garg R, 2011, J BONE JOINT SURG AM, V93A, P819, DOI 10.2106/JBJS.I.01602; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Helmerhorst GTT, 2014, J BONE JOINT SURG AM, V96A, P495, DOI 10.2106/JBJS.L.01406; Kao LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116436; Kim DH, 2003, J NEUROSURG, V98, P1005, DOI 10.3171/jns.2003.98.5.1005; Lubelski D, 2015, J NEUROSURG-SPINE, V22, P267, DOI 10.3171/2014.10.SPINE14220; Matsuzaki S, 2015, J AFFECT DISORDERS, V176, P56, DOI 10.1016/j.jad.2015.01.020; McHugh GA, 2013, BONE JOINT RES, V2, P248, DOI 10.1302/2046-3758.211.2000206; Pakarinen M, 2014, SPINE J, V14, P2392, DOI 10.1016/j.spinee.2014.01.047; Parker SL, 2015, WORLD NEUROSURG, V83, P608, DOI 10.1016/j.wneu.2014.12.018; Raspopovic ED, 2014, PSYCHOGERIATRICS, V14, P118, DOI 10.1111/psyg.12049; Reynolds CF, 2012, ANNU REV PUBL HEALTH, V33, P123, DOI 10.1146/annurev-publhealth-031811-124544; Urban-Baeza A, 2015, J NEUROSURG-SPINE, V22, P75, DOI 10.3171/2014.10.SPINE131106	23	14	15	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2016	78	6					844	849		10.1227/NEU.0000000000001086			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DN2GO	WOS:000376882300033	26516821				2022-02-06	
J	Lee, NK; Yang, J; Chang, EH; Park, SE; Lee, J; Choi, SJ; Oh, W; Chang, JW; Na, DL				Lee, Na Kyung; Yang, Jehoon; Chang, Eun Hyuk; Park, Sang Eon; Lee, Jeongmin; Choi, Soo Jin; Oh, Wonil; Chang, Jong Wook; Na, Duk L.			Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer's Disease Mouse Model	PLOS ONE			English	Article							MARROW MONONUCLEAR-CELLS; TRANSGENIC MOUSE; BLOOD; BARRIER; RATS; INFUSION; TRANSPLANTATION; MANNITOL; ISCHEMIA; STROKE	Mesenchymal stem cells (MSCs) have a promising role as a therapeutic agent for neurodegenerative diseases such as Alzheimer's disease (AD). Prior studies suggested that intraarterially administered MSCs are engrafted into the brain in stroke or traumatic brain injury (TBI) animal models. However, a controversial standpoint exists in terms of the integrity of the blood brain barrier (BBB) in transgenic AD mice. The primary goal of this study was to explore the feasibility of delivering human umbilical cord-blood derived mesenchymal stem cells (hUCB-MSCs) into the brains of non-transgenic WT (C3H/C57) and transgenic AD (APP/PS1) mice through the intra-arterial (IA) route. Through two experiments, mice were infused with hUCB-MSCs via the right internal carotid artery and were sacrificed at two different time points: 6 hours (experiment 1) or 5 minutes (experiment 2) after infusion. In both experiments, no cells were detected in the brain parenchyma while MSCs were detected in the cerebrovasculature in experiment 2. The results from this study highlight that intra-arterial delivery of MSCs is not the most favorable route to be implemented as a potential therapeutic approach for AD.	[Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Chang, Jong Wook] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Na, Duk L.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Na, Duk L.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea; [Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Chang, Jong Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea; [Yang, Jehoon] Samsung Biomed Res Inst, Lab Anim Res Ctr, Seoul, South Korea; [Chang, Eun Hyuk] Samsung Elect Co Ltd, Samsung Adv Inst Technol SAIT, Samsung Biomed Res Inst, Seoul 135710, South Korea; [Choi, Soo Jin; Oh, Wonil] MEDIPOST Co Ltd, Biomed Res Inst, Gyeonggi Do 463400, South Korea		Chang, JW (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Na, DL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.; Na, DL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea.; Chang, JW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea.	kjistlife@hanmail.net; dukna@naver.com		Lee, Na Kyung/0000-0001-6116-2562	Korean Health Technology R&D Project, Ministry of Health and Welfare [HI12C1821]; Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [HI14C3484]	This study was supported by grants received from the Korean Health Technology R&D Project, Ministry of Health and Welfare (HI12C1821), and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, (HI14C3484), Republic of Korea. Three of the co-authors, EHC, SJC, and WIO, are currently employed by the following commercial companies: Samsung Electronics Co., Ltd and MEDIPOST Co., Ltd, respectively. The funders provided support in the form of salaries for authors [EHC, SJC, and WIO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Casey David A, 2010, P T, V35, P208; Chhabra Lovely, 2012, Indian Pacing Electrophysiol J, V12, P32; Choi JJ, 2008, ULTRASONIC IMAGING, V30, P189, DOI 10.1177/016173460803000304; COSOLO WC, 1989, AM J PHYSIOL, V256, pR443, DOI 10.1152/ajpregu.1989.256.2.R443; Cui LL, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt544; Do TM, 2014, NEUROPHARMACOLOGY, V81, P311, DOI 10.1016/j.neuropharm.2014.02.010; Guo L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt327; Kean TJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/732742; Khabbal J, 2015, CELL TRANSPLANT, V24, P819, DOI 10.3727/096368914X679336; Kim DH, 2015, STEM CELLS DEV, V24, P2378, DOI 10.1089/scd.2014.0487; Kim Hee Jin, 2015, Alzheimers Dement (N Y), V1, P95, DOI 10.1016/j.trci.2015.06.007; Kim JY, 2012, CELL DEATH DIFFER, V19, P680, DOI 10.1038/cdd.2011.140; Kim Ju-Yeon, 2012, World J Stem Cells, V4, P110, DOI 10.4252/wjsc.v4.i11.110; Kim JS, 2012, NANOMEDICINE-UK, V7, P219, DOI [10.2217/NNM.11.94, 10.2217/nnm.11.94]; Kristen D, 2008, MULTISCALE MODEL SIM, V7, P888; Lee HJ, 2010, NEUROSCI LETT, V481, P30, DOI 10.1016/j.neulet.2010.06.045; Lee PH, 2012, ANN NEUROL, V72, P32, DOI 10.1002/ana.23612; Lin H, 2011, CELL MOL IMMUNOL, V8, P19, DOI 10.1038/cmi.2010.57; Mitkari B, 2013, EXP NEUROL, V239, P158, DOI 10.1016/j.expneurol.2012.09.018; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Okuma Y, 2013, NEUROSCI LETT, V554, P156, DOI 10.1016/j.neulet.2013.08.058; Park HJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0180-4; Park KS, 2010, NANOMED-NANOTECHNOL, V6, P263, DOI 10.1016/j.nano.2009.07.005; Park SE, 2016, NEUROREPORT, V27, P235, DOI 10.1097/WNR.0000000000000526; Poduslo JF, 2001, NEUROBIOL DIS, V8, P555, DOI 10.1006/nbdi.2001.0402; Rosado-de-Castro PH, 2013, REGEN MED, V8, P145, DOI [10.2217/RME.13.2, 10.2217/rme.13.2]; Song SK, 2011, NEUROBIOL AGING, V32, P2183, DOI 10.1016/j.neurobiolaging.2009.12.017; Toyoshima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127302; Wagner B, 2013, ADV BIOCHEM ENG BIOT, V130, P19, DOI 10.1007/10_2012_155; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Yamamoto R, 1985, J JAPANESE SOC CLIN, V24, P150; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Yavagal DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093735	35	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155912	10.1371/journal.pone.0155912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM4BV	WOS:000376291500029	27203695	Green Published, Green Submitted, gold			2022-02-06	
J	Ravin, R; Blank, PS; Busse, B; Ravin, N; Vira, S; Bezrukov, L; Waters, H; Guerrero-Cazares, H; Quinones-Hinojosa, A; Lee, PR; Fields, RD; Bezrukov, SM; Zimmerberg, J				Ravin, Rea; Blank, Paul S.; Busse, Brad; Ravin, Nitay; Vira, Shaleen; Bezrukov, Ludmila; Waters, Hang; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo; Lee, Philip R.; Fields, R. Douglas; Bezrukov, Sergey M.; Zimmerberg, Joshua			Blast shockwaves propagate Ca2+ activity via purinergic astrocyte networks in human central nervous system cells	SCIENTIFIC REPORTS			English	Article							STRETCH-INDUCED INJURY; EXTRACELLULAR ATP; BRAIN-INJURY; MODEL; ANTAGONIST; ACTIVATION; EXPRESSION; RECEPTORS; MECHANISM; NEURONS	In a recent study of the pathophysiology of mild, blast-induced traumatic brain injury (bTBI) the exposure of dissociated, central nervous system (CNS) cells to simulated blast resulted in propagating waves of elevated intracellular Ca2+. Here we show, in dissociated human CNS cultures, that these calcium waves primarily propagate through astrocyte-dependent, purinergic signaling pathways that are blocked by P2 antagonists. Human, compared to rat, astrocytes had an increased calcium response and prolonged calcium wave propagation kinetics, suggesting that in our model system rat CNS cells are less responsive to simulated blast. Furthermore, in response to simulated blast, human CNS cells have increased expressions of a reactive astrocyte marker, glial fibrillary acidic protein (GFAP) and a protease, matrix metallopeptidase 9 (MMP-9). The conjoint increased expression of GFAP and MMP-9 and a purinergic ATP (P2) receptor antagonist reduction in calcium response identifies both potential mechanisms for sustained changes in brain function following primary bTBI and therapeutic strategies targeting abnormal astrocyte activity.	[Ravin, Rea; Blank, Paul S.; Busse, Brad; Ravin, Nitay; Vira, Shaleen; Bezrukov, Ludmila; Waters, Hang; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Integrat Biophys, NIH, Bethesda, MD 20892 USA; [Ravin, Rea; Ravin, Nitay] Celoptics Inc, Rockville, MD 20852 USA; [Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21287 USA; [Lee, Philip R.; Fields, R. Douglas] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Nervous Syst Dev & Plast, NIH, Bethesda, MD 20892 USA; [Bezrukov, Sergey M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Transport, NIH, Bethesda, MD 20892 USA		Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Integrat Biophys, NIH, Bethesda, MD 20892 USA.	zimmerbj@mail.nih.gov	Blank, Paul/Q-9673-2019	Guerrero-Cazares, Hugo/0000-0003-1307-719X	Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS070024]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD000713, ZIAHD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS070024] Funding Source: NIH RePORTER	We thank Dr. Sachiko Murase NINDS, NIH, for a generous gift of rat CNS cortex tissue. This work was supported by the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH) and under NIH award number R01NS070024 (A.Q.H.).	Alvarez-Maubecin V, 2000, J NEUROSCI, V20, P4091; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cleries R, 2012, COMPUT BIOL MED, V42, P438, DOI 10.1016/j.compbiomed.2011.12.012; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; De Neve J, 2013, STAT APPL GENET MOL, V12, P333, DOI 10.1515/sagmb-2012-0003; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Gordon GRJ, 2011, EXP PHYSIOL, V96, P393, DOI 10.1113/expphysiol.2010.053132; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Kennedy C, 2000, MOL PHARMACOL, V57, P926; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Malik N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096139; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Murase S, 2006, J NEUROSCI, V26, P9750, DOI 10.1523/JNEUROSCI.2745-06.2006; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Paemeleire K, 2000, J NEUROTRAUM, V17, P345, DOI 10.1089/neu.2000.17.345; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Ravin R., 2015, United States Patent, Patent No. [US 9,217,698, 9217698]; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Ricci G, 2009, J BIOL PHYS, V35, P317, DOI 10.1007/s10867-009-9157-9; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rouach N, 2000, J CELL BIOL, V149, P1513, DOI 10.1083/jcb.149.7.1513; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wanner IB, 2012, METHODS MOL BIOL, V814, P189, DOI 10.1007/978-1-61779-452-0_14; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x	55	14	14	3	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 10	2016	6								25713	10.1038/srep25713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL2UD	WOS:000375489800003	27162174	Green Published, gold			2022-02-06	
J	Gaastra, B; Longworth, A; Matta, B; Snelson, C; Whitehouse, T; Murphy, N; Veenith, T				Gaastra, Ben; Longworth, Aisling; Matta, Basil; Snelson, Catherine; Whitehouse, Tony; Murphy, Nick; Veenith, Tonny			The ageing population is neglected in research studies of traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Aged; mortality; outcome assessment (health care); traumatic brain injury	INTENSIVE-CARE-UNIT; CEREBRAL PERFUSION-PRESSURE; MIX PROGRAM DATABASE; BLUNT HEAD TRAUMA; ELDERLY-PATIENTS; ATRIAL-FIBRILLATION; SECONDARY ANALYSIS; MORTALITY; PREDICTION; METAANALYSIS	Introduction The UK population is ageing with increasing number of elderly patients suffering traumatic brain injury (TBI). The purpose of this study was to identify national TBI admission demographics, analyse the temporal evolution of TBI mortality in a single centre and conduct a systematic review of the literature to identify whether there is an age bias amongst researchers studying TBI. Methods National demographics for TBI were obtained from Health Episode Statistics. TBI patients admitted from 2000 to 2011 to Cambridge University Hospitals Neurocritical Care Unit (NCCU) were divided into age groups (<60, 60-74,75 years). Temporal evolution of mortality was analysed using a logistic regression method. A systematic literature review was conducted to identify primary TBI research studies. Patient's ages were extracted and an average mean age was calculated and compared over time. Results From 1998, national TBI admissions have increased with the greatest rise in>60-year age group (p<0.0001). In a tertiary referral critical care unit (n=1145), the 60-74 year age group (compared to<60) had a significantly lower improvement in mortality over time (OR: 1.15, 95% CI: 1.02-1.31). A literature review revealed a mean age of 32.73 years (SD +/- 12.85) for patients recruited to primary TBI studies. Conclusion Despite increased admissions of elderly patients following TBI and static mortality (single centre, 60-74 year age group) there is little or no evidence of a corresponding increase in the age of patients recruited for TBI studies. In addition to the difficulties this presents in forming evidence-based decisions for the patient with TBI, it may also represent a wider problem for ICU research in an ever-ageing critical care population. More research needs to be conducted to establish the treatment end points for an ageing population.	[Gaastra, Ben; Longworth, Aisling; Matta, Basil; Veenith, Tonny] Cambridge Univ Hosp NHS Trust, Neurocrit Care Unit, Cambridge, Cambs, England; [Snelson, Catherine; Whitehouse, Tony; Murphy, Nick; Veenith, Tonny] Univ Hosp Birmingham NHS Trust, Dept Crit Care Med, Birmingham, W Midlands, England		Veenith, T (corresponding author), Queen Elizabeth Med Ctr, Dept Crit Care Med, Birmingham B15 2TH, W Midlands, England.	tv227@cam.ac.uk	Veenith, Tonny/AAI-3067-2020; Whitehouse, Tony/AAC-1215-2020; Veenith, Tonny V/A-9948-2010	Veenith, Tonny/0000-0002-4125-8804; Whitehouse, Tony/0000-0002-4387-3421; Veenith, Tonny V/0000-0002-4125-8804; Gaastra, Ben/0000-0002-7517-6882	Association of Anaesthetists of Great Britain and Ireland; National Institute for Academic Anaesthesia	This work was supported by no funding. Dr Veenith is supported by Association of Anaesthetists of Great Britain and Ireland and National Institute for Academic Anaesthesia clinical research training fellowships. The authors report no declarations of interest.	Allen BB, 2014, PEDIATR CRIT CARE ME, V15, P62, DOI 10.1097/PCC.0b013e3182a556ea; Andersen FH, 2012, ACTA ANAESTH SCAND, V56, P1298, DOI 10.1111/j.1399-6576.2012.02782.x; Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; Appleby J., 2013, SPENDING HLTH SOCIAL; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7768; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Boumendil A, 2006, INTENS CARE MED, V32, P965, DOI 10.1007/s00134-006-0172-z; Bowling A, 1999, BRIT MED J, V319, P1353, DOI 10.1136/bmj.319.7221.1353; Conti M, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13671; Cornwell J., 2012, CARE FRAIL OLDER PEO; de Rooij SE, 2005, CRIT CARE, V9, pR307, DOI 10.1186/cc3536; Gnavi R, 2007, EUR J PUBLIC HEALTH, V17, P492, DOI 10.1093/eurpub/ckm005; Griesdale DEG, 2015, J CRIT CARE, V30, P111, DOI 10.1016/j.jcrc.2014.07.026; Hampshire PA, 2009, CRIT CARE, V13, DOI 10.1186/cc8016; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Harrison DA, 2007, CRIT CARE MED, V35, P1091, DOI 10.1097/01.CCM.0000259468.24532.44; Haynes RB, 2005, BMJ-BRIT MED J, V330, P1179, DOI 10.1136/bmj.38446.498542.8F; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; Karnad DR, 2004, CRIT CARE MED, V32, P1294, DOI 10.1097/01.CCM.0000128549.72276.00; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lip GYH, 2015, THROMB HAEMOSTASIS, V114, P826, DOI 10.1160/TH15-07-0565; Marcucci M, 2013, EUR J INTERN MED, V24, P800, DOI 10.1016/j.ejim.2013.08.697; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Ross A M, 1992, J Neurosci Nurs, V24, P88; Senaratne DNS, 2015, INDIAN J CRIT CARE M, V19, P155, DOI 10.4103/0972-5229.152758; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Torres OH, 2006, INTENS CARE MED, V32, P1052, DOI 10.1007/s00134-006-0170-1; Witham MD, 2007, DRUG AGING, V24, P187, DOI 10.2165/00002512-200724030-00002; Yap CH, 2006, EUR J CARDIO-THORAC, V29, P441, DOI 10.1016/j.ejcts.2005.12.046; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	39	14	14	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2016	30	2					221	226		10.3109/02688697.2015.1119240			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI3LK	WOS:000373399900011	26744221				2022-02-06	
J	Burkovskiy, I; Zhou, J; Lehmann, C				Burkovskiy, Ian; Zhou, Juan; Lehmann, Christian			Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome	MICROCIRCULATION			English	Article						stroke; immunodeficiency; cannabinoids; microcirculation	ISCHEMIC BRAIN-DAMAGE; SPINAL-CORD-INJURY; ENDOCANNABINOID SYSTEM; CB2 RECEPTORS; STROKE; INFLAMMATION; ACTIVATION; EXPRESSION; MIGRATION; BIOLOGY	ObjectiveSevere CNS injury, such as stroke, traumatic brain injury, or spinal cord injury, is known to increase susceptibility to infections. The increased susceptibility to infection is due to an impaired immune response and is referred to as CIDS. The CB2 receptor on immune cells presents a potential therapeutic target in CIDS as activation of this receptor has been shown to be involved in immunosuppression. The main purpose of this study was to determine the impact of CB2 receptor inhibition on leukocyte activation within the microcirculation following endotoxin challenge in an experimental stroke model. MethodsFive experimental groups (male C57BL/6 mice, age: 6-8 weeks) were subjected to the following treatments: control; endotoxemia (LPS 5 mg/kg, i.v.); transient cerebral hypoxia-ischemia (HI) + endotoxemia; HI + endotoxemia + CB2 receptor antagonist (AM630 2.5 mg/kg, i.v.). HI was induced by unilateral carotid artery occlusion, followed by 50 minute exposure to a low oxygen atmosphere (8% O-2). The CB2 receptor antagonist was given 15 min prior to LPS administration. Intravital microscopy (IVM) was carried out 2h after LPS administration. Brains were extracted and stained with tetrazolium chloride (TTC) to measure infarct volume. ResultsCompared to endotoxemic animals without CNS injury, mice subjected to HI displayed reduced leukocyte activation in intestinal submucosal venules indicative of CIDS. Administration of the CB2 receptor antagonist in animals with CIDS challenged with endotoxin restored peripheral leukocyte recruitment without a detrimental impact on infarct size. ConclusionWe conclude that the ECS is involved in the impaired immune response following CNS injury. Future studies should further explore the CB2 receptor pathway to develop novel therapies for CIDS.	[Burkovskiy, Ian; Lehmann, Christian] Dalhousie Univ, Dept Anaesthesia, Halifax, NS B3H 2Y, Canada; [Burkovskiy, Ian; Zhou, Juan; Lehmann, Christian] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 2Y, Canada; [Zhou, Juan; Lehmann, Christian] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 2Y, Canada		Lehmann, C (corresponding author), Dalhousie Univ, Dept Anaesthesia, Halifax, NS B3H 2Y, Canada.	chlehmann@dal.ca	Lehmann, Christian/G-4837-2013	Lehmann, Christian/0000-0001-6419-9168; Zhou, juan/0000-0002-3040-0238			Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Arevalo-Martin A, 2008, BRIT J PHARMACOL, V153, P216, DOI 10.1038/sj.bjp.0707466; Basu S, 2011, IMMUNOL RES, V51, P26, DOI 10.1007/s12026-011-8210-5; Binion DG, 1997, GASTROENTEROLOGY, V112, P1895, DOI 10.1053/gast.1997.v112.pm9178682; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Fernandez-Lopez D, 2007, PEDIATR RES, V62, P255, DOI 10.1203/PDR.0b013e318123fbb8; Fukumura D, 1996, DIGEST DIS SCI, V41, P2482, DOI 10.1007/BF02100147; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; Granger ND, 2010, INFLAMMATION MICROCI; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Hillard CJ, 2008, CURR PHARM DESIGN, V14, P2347, DOI 10.2174/138161208785740054; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Orgado JM, 2009, INT REV PSYCHIATR, V21, P172, DOI 10.1080/09540260902782828; Matsuda Naoyuki, 2007, Journal of Smooth Muscle Research, V43, P117, DOI 10.1540/jsmr.43.117; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; MILLER C H, 1991, Neurological Research, V13, P117; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Pandey R, 2009, PHARMACOL RES, V60, P85, DOI 10.1016/j.phrs.2009.03.019; Rahman SH, 2003, J GASTROINTEST SURG, V7, P26, DOI 10.1016/S1091-255X(02)00090-2; Rasband W.S, 1997, IMAGEJ US; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Salgado DR, 2010, CAN J ANESTH, V57, P940, DOI 10.1007/s12630-010-9365-6; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; Vogelgesang A, 2014, ACTA NEUROL SCAND, V129, P1, DOI 10.1111/ane.12165; Vogelgesang A, 2011, J NEUROIMMUNOL, V231, P105, DOI 10.1016/j.jneuroim.2010.09.023; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Yu SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132487; Zhao Y, 2010, J CARDIOVASC PHARM, V55, P292, DOI 10.1097/FJC.0b013e3181d2644d	41	14	14	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1073-9688	1549-8719		MICROCIRCULATION	Microcirculation	MAY	2016	23	4					283	292		10.1111/micc.12276			10	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	DM8KS	WOS:000376612100002	26999797				2022-02-06	
J	Chen, SY; Shi, QK; Zheng, SY; Luo, LS; Yuan, ST; Wang, X; Cheng, ZH; Zhang, WH				Chen, Shangyu; Shi, Qiankun; Zheng, Shuyun; Luo, Liangshen; Yuan, Shoutao; Wang, Xiang; Cheng, Zihao; Zhang, Wenhao			Role of alpha-II-spectrin breakdown products in the prediction of the severity and clinical outcome of acute traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						acute traumatic brain injury; alpha-II-spectrin breakdown products; prediction of the severity of injury; clinical outcome	SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; CELL-DEATH; CALPAIN; MECHANISMS; APOPTOSIS; RATS; ACCUMULATION; DEGRADATION; PROTEOLYSIS	alpha II-spectrin breakdown products are regarded as potential biomarkers for traumatic brain injury (TBI). The aim of the present study was to further evaluate these biomarkers by assessing their clinical utility in predicting the severity of injury and clinical outcome of patients with TBI. Eligible patients with acute TBI (n=17), defined by a Glasgow Coma Scale (GCS) score of <= 8, were enrolled. Ventricular cerebrospinal fluid (CSF) was sampled from each patient at 24, 72 and 120 h following TBI. An immunoblot assay was used to determine the concentrations of SBDPs in the CSF samples. The concentrations of SBDPs combined with the GCS score at 24 h after injury and the Glasgow Outcome Score (GOS) at 30 days after injury were compared and analyzed. The levels of SBDPs in CSF were markedly increased following acute TBI in comparison with those in the control group. In the early period after TBI, the levels of SBDPs were closely associated with GCS score. Comparisons of the SBDP levels with the severity of injury revealed significant differences between patients with the most severe brain injury and patients with severe brain injury in the first 24 h post-injury (P<0.05). The levels and dynamic changes of SBDPs in CSF exhibited a close association with GOS at 30 days after injury. The levels of SBDPs differed significantly between patients grouped according to prognosis (P<0.05). These results suggest that in the early period after TBI, the levels and dynamic changes of SBDPs in CSF can be useful in the prediction of the severity of injury and clinical outcome of patients.	[Chen, Shangyu; Shi, Qiankun; Zheng, Shuyun; Yuan, Shoutao; Wang, Xiang; Cheng, Zihao; Zhang, Wenhao] Nanjing Med Univ, Nanjing Hosp 1, Dept Crit Care Med, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China; [Luo, Liangshen] Nanjing Med Univ, Nanjing Hosp 1, Dept Neurosurg, Nanjing 210006, Jiangsu, Peoples R China		Zheng, SY (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Crit Care Med, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China.	syzheng915@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171786]	The present study was supported by the National Natural Science Foundation of China (grant no. 81171786).	Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cardali S, 2006, J Neurosurg Sci, V50, P25; Castillo MR, 1998, NEUROSCIENCE, V86, P1133, DOI 10.1016/S0306-4522(98)00070-0; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Kmietowicz Z, 2007, BRIT MED J, V335, P1182, DOI 10.1136/bmj.39415.528623.AD; MAJNO G, 1995, AM J PATHOL, V146, P3; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; Schober ME, 2014, BRAIN RES, V1574, P105, DOI 10.1016/j.brainres.2014.05.046; Schoch KM, 2013, J NEUROCHEM, V125, P909, DOI 10.1111/jnc.12144; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	27	14	15	0	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAY	2016	11	5					2049	2053		10.3892/etm.2016.3153			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DH3TR	WOS:000372710200082	27168849	Green Published, gold			2022-02-06	
J	Key-DeLyria, SE; Altmann, LJP				Key-DeLyria, Sarah E.; Altmann, Lori J. P.			Executive Function and Ambiguous Sentence Comprehension	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							WORKING-MEMORY CAPACITY; TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; BROCAS AREA; INDIVIDUAL-DIFFERENCES; FLUID INTELLIGENCE; PREFRONTAL CORTEX; FRONTAL LOBES	Purpose: Sentence comprehension is a critical skill in today's literate society. Recent evidence suggests that processing and comprehending language taps cognitive as well as linguistic abilities, a finding that has critical import for clinicians who have clients with language disorders. To promote awareness of the impact of cognition, especially executive function (EF) and working memory (WM), this opinion article presents current views of how sentences are processed and links the various steps of the process to specific EF and WM subcomponents. Method: The article focuses on ambiguous sentences, pointing out the similar types of processing needed when resolving an ambiguity and performing EF tasks. Results: We discuss the potential overlap between the neurobiology of sentence processing and EF and the evidence supporting a link between EF and sentence processes. Conclusion: Awareness of the potential role of EF and WM in sentence comprehension will help clinicians be more aware of potential cognitive-linguistic deficits in their clients. Future research will help to clarify the link between EF and sentence comprehension.	[Key-DeLyria, Sarah E.] Portland State Univ, Portland, OR 97207 USA; [Altmann, Lori J. P.] Univ Florida, Gainesville, FL USA		Key-DeLyria, SE (corresponding author), Portland State Univ, Portland, OR 97207 USA.	keydel@pdx.edu		Altmann, Lori/0000-0002-4935-3574; Key-DeLyria, Sarah/0000-0002-1202-7871			Altemeier LE, 2008, J CLIN EXP NEUROPSYC, V30, P588, DOI 10.1080/13803390701562818; Altmann GTM, 1998, TRENDS COGN SCI, V2, P146, DOI 10.1016/S1364-6613(98)01153-X; Altmann LJP, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/238956; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; American Speech-Language-Hearing Association, 2003, TECHNICAL REPORT; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A.D., 1986, WORKING MEMORY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Broadway JM, 2010, BEHAV RES METHODS, V42, P563, DOI 10.3758/BRM.42.2.563; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Burgess P., 1997, METHODOLOGY FRONTAL, P81; BUTLERHINZ S, 1990, J SPEECH HEAR RES, V33, P269, DOI 10.1044/jshr.3302.269; Cannizzaro MS, 2013, J PSYCHOLINGUIST RES, V42, P527, DOI 10.1007/s10936-012-9231-5; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Caplan D, 2013, PSYCHON B REV, V20, P243, DOI 10.3758/s13423-012-0369-9; Carpenter PA, 2000, CURR OPIN NEUROBIOL, V10, P195, DOI 10.1016/S0959-4388(00)00074-X; Carrow-Woolfolk E., 1999, CASL COMPREHENSIVE A; CHAPMAN RS, 1991, J SPEECH HEAR RES, V34, P1106, DOI 10.1044/jshr.3405.1106; Chapman RS, 1997, MENT RETARD DEV D R, V3, P307; Cho-Reyes S, 2012, APHASIOLOGY, V26, P1250, DOI 10.1080/02687038.2012.693584; Christianson K, 2001, COGNITIVE PSYCHOL, V42, P368, DOI 10.1006/cogp.2001.0752; Christianson K, 2010, J EXP PSYCHOL LEARN, V36, P538, DOI 10.1037/a0018027; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Cowan N, 2006, MEM COGNITION, V34, P1754, DOI 10.3758/BF03195936; Dronkers NF, 2004, COGNITION, V92, P145, DOI 10.1016/j.cognition.2003.11.002; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Engle R.W., 1999, MODELS WORKING MEMOR, P102, DOI DOI 10.1017/CBO9781139174909.007; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Farmer TA., 2012, CAMBRIDGE HDB PSYCHO, P354; Fedorenko E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00335; Fedorenko E, 2014, TRENDS COGN SCI, V18, P120, DOI 10.1016/j.tics.2013.12.006; Fedorenko E, 2012, BRAIN LANG, V120, P187, DOI 10.1016/j.bandl.2011.01.001; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Garnsey SM, 1997, J MEM LANG, V37, P58, DOI 10.1006/jmla.1997.2512; Golden CJ, 1978, STROOP COLOR WORD TE; Grossman M, 2002, BRAIN LANG, V80, P603, DOI 10.1006/brln.2001.2630; Hammill D. D., 1994, TEST ADOLESCENT ADUL; Harnishfeger Katherine Kipp, 1995, P175, DOI 10.1016/B978-012208930-5/50007-6; Hart DJ, 2003, INT J GERIATR PSYCH, V18, P1037, DOI 10.1002/gps.1013; Heitz RP, 2006, BEHAV BRAIN SCI, V29, P135, DOI 10.1017/S0140525X06319036; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Henry LA, 2012, J CHILD PSYCHOL PSYC, V53, P37, DOI 10.1111/j.1469-7610.2011.02430.x; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Hobson VL, 2010, INT J GERIATR PSYCH, V25, P525, DOI 10.1002/gps.2382; Hussey EK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00158; Im-Bolter N, 2006, CHILD DEV, V77, P1822, DOI 10.1111/j.1467-8624.2006.00976.x; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; January D, 2009, J COGNITIVE NEUROSCI, V21, P2434, DOI 10.1162/jocn.2008.21179; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; KAY J, 2009, PALPA PSYCHOLINGUIST; Kehagia AA, 2013, NEURODEGENER DIS, V11, P79, DOI 10.1159/000341998; Kemper S, 2001, PSYCHOL AGING, V16, P312, DOI 10.1037//0882-7974.16.2.312; Kempler D, 1998, BRAIN LANG, V64, P297, DOI 10.1006/brln.1998.1980; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Key-DeLyria S., J SPEECH LANGUAGE HE; KIMBALL J, 1973, COGNITION, V2, P15, DOI 10.1016/0010-0277(72)90028-5; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kray J, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00180; Lanfranchi S, 2010, J INTELL DISABIL RES, V54, P308, DOI 10.1111/j.1365-2788.2010.01262.x; Lehto JH, 1996, Q J EXP PSYCHOL-A, V49, P29, DOI 10.1080/027249896392793; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; LIEBERMAN P, 1992, BRAIN LANG, V43, P169, DOI 10.1016/0093-934X(92)90127-Z; Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; Martin RC, 2014, ACTA PSYCHOL, V152, P120, DOI 10.1016/j.actpsy.2014.08.006; Martin RC, 2006, COGN NEUROPSYCHOL, V23, P74, DOI 10.1080/02643290500179987; Mazuka R, 2009, LANG LINGUIST COMPAS, V3, P59, DOI 10.1111/j.1749-818x.2008.00102.x; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; McKinlay A, 2010, J INT NEUROPSYCH SOC, V16, P268, DOI 10.1017/S1355617709991299; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Montgomery JW, 2000, J SPEECH LANG HEAR R, V43, P293, DOI 10.1044/jslhr.4302.293; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Murray L. L., 2006, NEUROGENIC DISORDERS; Murray LL, 2012, AM J SPEECH-LANG PAT, V21, pS51, DOI 10.1044/1058-0360(2012/11-0067); Murray LL, 2006, J COMMUN DISORD, V39, P37, DOI 10.1016/j.jcomdis.2005.06.001; Myers P.S., 1999, RIGHT HEMISPHERE DAM; Nigg JT, 2002, J AM ACAD CHILD PSY, V41, P59, DOI 10.1097/00004583-200201000-00012; Novais-Santos S, 2007, NEUROIMAGE, V37, P361, DOI 10.1016/j.neuroimage.2007.03.077; Novick JM, 2014, LANG COGN NEUROSCI, V29, P186, DOI 10.1080/01690965.2012.758297; Novick JM, 2010, LANG LINGUIST COMPAS, V4, P906, DOI 10.1111/j.1749-818x.2010.00244.x; Novick JM, 2009, COGN NEUROPSYCHOL, V26, P527, DOI 10.1080/02643290903519367; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; NOVICK JM, 2004, 17 ANN CUNY C HUM SE; Nozari N, 2011, COGNITIVE PSYCHOL, V63, P1, DOI 10.1016/j.cogpsych.2011.05.001; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; RAYNER K, 1987, Q J EXP PSYCHOL-A, V39, P657, DOI 10.1080/14640748708401808; RAYNER K, 1983, J VERB LEARN VERB BE, V22, P358, DOI 10.1016/S0022-5371(83)90236-0; Reilly J, 2010, J COMMUN DISORD, V43, P438, DOI 10.1016/j.jcomdis.2010.04.011; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rogalski Y, 2010, J COMMUN DISORD, V43, P212, DOI 10.1016/j.jcomdis.2010.02.001; Rowe J, 2006, BRIT J CLIN PSYCHOL, V45, P5, DOI 10.1348/014466505X29594; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; Small JA, 2000, BRAIN LANG, V75, P232, DOI 10.1006/brln.2000.2355; Smith-Spark JH, 2003, EUR J COGN PSYCHOL, V15, P567, DOI 10.1080/09541440340000024; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stocco A, 2012, COGN AFFECT BEHAV NE, V12, P611, DOI 10.3758/s13415-012-0117-7; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Swets B, 2007, J EXP PSYCHOL GEN, V136, P64, DOI 10.1037/0096-3445.136.1.64; Thothathiri M, 2012, NEUROPSYCHOLOGIA, V50, P3284, DOI 10.1016/j.neuropsychologia.2012.09.021; Thothathiri M, 2012, BRAIN LANG, V120, P259, DOI 10.1016/j.bandl.2011.12.004; Trueswell JC, 1999, COGNITION, V73, P89, DOI 10.1016/S0010-0277(99)00032-3; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Vuong LC, 2014, LANG COGN NEUROSCI, V29, P312, DOI 10.1080/01690965.2013.836231; Vuong LC, 2011, BRAIN LANG, V116, P22, DOI 10.1016/j.bandl.2010.09.012; Waters GS, 1996, MEM COGNITION, V24, P342, DOI 10.3758/BF03213298; Wechsler D., 2008, WECHSLER ADULT INTEL; Weighall AR, 2008, J EXP CHILD PSYCHOL, V99, P75, DOI 10.1016/j.jecp.2007.10.004; Wiig E. H., 1989, TLC EXPANDED TEST LA; Wilson SP, 1998, DEV REV, V18, P86, DOI 10.1006/drev.1997.0445; Wiseheart R, 2009, ANN DYSLEXIA, V59, P151, DOI 10.1007/s11881-009-0028-7; Ye Z, 2008, BRAIN RES, V1203, P103, DOI 10.1016/j.brainres.2008.01.090; Ye Z, 2009, NEUROSCI BIOBEHAV R, V33, P1168, DOI 10.1016/j.neubiorev.2009.03.003; Yin XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050590; Zacks Rose T., 1994, P241; Zimmer B., 2010, NY TIMES	149	14	14	1	4	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2016	25	2								10.1044/2015_AJSLP-14-0111			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	DO6AE	WOS:000377863600013	27214025				2022-02-06	
J	Khan, F; Amatya, B; Judson, R; Chung, P; Truesdale, M; Elmalik, A; Galea, MP				Khan, Fary; Amatya, Bhasker; Judson, Rodney; Chung, Pearl; Truesdale, Melinda; Elmalik, Alaeldin; Galea, Mary P.			FACTORS ASSOCIATED WITH LONG-TERM FUNCTIONAL AND PSYCHOLOGICAL OUTCOMES IN PERSONS WITH MODERATE TO SEVERE TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; rehabilitation; disability; participation; outcome	QUALITY-OF-LIFE; CAREGIVER STRAIN; FOLLOW-UP; REHABILITATION; SCALE; POSTINJURY; VALIDATION; PEOPLE	Objective: To examine factors impacting long-term functional and psychological outcomes in persons with moderate-severe traumatic brain injury. Methods: A prospective cross-sectional study (n = 103) assessed the long-term (up to 5 years) impact of traumatic brain injury on participants' current activity and restriction in participation using validated questionnaires. Results: Participants' median age was 49.5 years (interquartile range (IQR) 20.4-23.8), the majority were male (77%), and 49% had some form of previous rehabilitation. The common causes of traumatic brain injury were falls (42%) and motor vehicle accidents (27%). Traumatic brain injury-related symptoms were: pain/headache (47%), dizziness (36%), bladder/bowel impairment (34%), and sensoryperceptual deficits (34%). Participants reported minimal change in their physical function and cognition (Functional Assessment Measure: motor (median 102, IQR 93-111) and cognition (median 89, IQR 78-95)). Participants were well adjusted to community-living; however, they reported high levels of depression. Factors significantly associated with poorer current level of functioning/well-being included: older age (>= 60 years), presence of traumatic brain injury-related symptoms, a lack of previous rehabilitation and those classified in "severe disability categories" at admission. Caregivers reported high levels of strain and burden (55%). Conclusion: Cognitive and psychosocial problems are more commonly reported than physical disability in the longer-term. A greater focus on participation and ageing with disability in these persons is needed.	[Khan, Fary; Amatya, Bhasker; Chung, Pearl; Elmalik, Alaeldin; Galea, Mary P.] Royal Melbourne Hosp, Dept Rehabil Med, 34-54 Poplar Rd, Melbourne, Vic 3052, Australia; [Khan, Fary; Galea, Mary P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Khan, Fary] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Amatya, Bhasker] Royal Melbourne Hosp, Trauma Serv, Parkville, Vic 3050, Australia; [Truesdale, Melinda] Royal Melbourne Hosp, Emergency Serv, Parkville, Vic 3050, Australia		Khan, F (corresponding author), Royal Melbourne Hosp, Dept Rehabil Med, 34-54 Poplar Rd, Melbourne, Vic 3052, Australia.	fary.khan@mh.org.au	Galea, Mary/F-4242-2010; Amatya, Bhasker/E-1062-2017	Galea, Mary/0000-0003-0045-7978; Amatya, Bhasker/0000-0003-4793-1104; Chung, Pearl/0000-0002-9572-2860			Access Economics, 2009, EC COSTS SPIN CORD I; Alderson AL, 2003, ARCH PHYS MED REHAB, V84, P668, DOI 10.1016/S0003-9993(03)04842-6; Australian Institute of Health and Welfare (AIHW), 2008, AUSTR I HLTH WELF HL, V35; BERKMAN LF, 1986, AM J EPIDEMIOL, V124, P372, DOI 10.1093/oxfordjournals.aje.a114408; Boycott N, 2013, J HEAD TRAUMA REHAB, V28, P106, DOI 10.1097/HTR.0b013e31823fe07e; Brain Injury Association of America (BIAA), 2011, FACTS TRAUM BRAIN IN; Brasure M, 2012, PUBLICATION AGENCY H; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; COCKERILL R, 1990, J REHABIL, V56, P41; De Silva M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006422.pub3; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Khan F, 2012, BRIT J SURG, V99, P88, DOI 10.1002/bjs.7776; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Khan F, 2007, DISABIL REHABIL, V29, P1241, DOI 10.1080/01443610600964141; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; Sloan S, 2008, ACQUIRED BRAIN INJUR; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; van Exel NJA, 2004, CLIN REHABIL, V18, P203, DOI 10.1191/0269215504cr723oa; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Winker PA, 2007, TRAUMATIC BRAIN INJU, P532; World Health Organization, 2007, INT CLASS FUNCT DIS	40	14	14	1	11	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2016	48	5					442	448		10.2340/16501977-2084			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DL6MM	WOS:000375753300005	27058885	gold, Green Submitted			2022-02-06	
J	Smith, E; Comiskey, C; Carroll, A				Smith, E.; Comiskey, C.; Carroll, A.			Prevalence of and risk factors for osteoporosis in adults with acquired brain injury	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Osteoporosis; Fracture risk; Dual energy X-ray absorptiometry; Stroke; Acquired brain injury; Traumatic brain injury	BONE-MINERAL DENSITY; VITAMIN-D STATUS; STROKE PATIENTS; REHABILITATION; IMMOBILIZATION; DIAGNOSIS; MASS; DENSITOMETRY; INDIVIDUALS; FRACTURES	Low bone mineral density (BMD) is common in older people with stroke, particularly in the paretic limb. Younger people with acquired brain injury (ABI), of all causes, are at increased risk of low BMD. To examine prevalence of low BMD, based on World Health Organisation diagnostic criteria, in patients with ABI. This is a cross-sectional study of 112 ABI patients. All completed a questionnaire, had laboratory investigations and DXA assessment of lumbar spine and one or both hips. Mean age +/- A SD of participants was 45.7 +/- A 13.7 years. Risk of vitamin D deficiency (25-OHD < 30 nmol/L) occurred in 27.7 %, 34.3 % had adequate levels (30-50 nmol/L) and 36.6 % had levels in excess of this. Based on T-scores, 41.1 % had osteopenia and 21.4 % had osteoporosis. A Z score of -1 or less but greater than -2 occurred in 25 %; a further 21.4 % had a Z score of -2 or less. Patients who could walk outdoors had significantly higher BMD at the neck of femur than those who walked indoors only and those who could not walk at all (p < 0.001). On multiple linear regression analysis, ambulatory ability and duration of disability were independent predictors of BMD at sound neck of femur and total proximal femur. Osteopenia and osteoporosis are common in young adults with ABI compared with the general population. Bone heath monitoring should form part of the long-term follow-up of this patient group.	[Smith, E.; Carroll, A.] Natl Rehabil Hosp, Dept Rehabil Med, Rochestown Ave, Dublin, Ireland; [Comiskey, C.] Trinity Coll Dublin, Sch Nursing & Midwifery, Hlth Care Stat, Gas Bldg,Dolier St, Dublin 2, Ireland		Smith, E (corresponding author), Natl Rehabil Hosp, Dept Rehabil Med, Rochestown Ave, Dublin, Ireland.	eimear.smith@nrh.ie	Comiskey, Catherine M/L-3794-2014; Carroll, Aine/ABG-2309-2020	Comiskey, Catherine M/0000-0003-3528-777X; Carroll, Aine/0000-0002-4383-8650	National Medical Rehabilitation Trust Ltd.	This study was funded by the National Medical Rehabilitation Trust Ltd. (There is no research grant number).	Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Baim S, 2005, J CLIN DENSITOM, V8, P371, DOI 10.1385/JCD:8:4:371; Banham-Hall N, 2013, PHYSIOTHERAPY, V99, P328, DOI 10.1016/j.physio.2012.12.009; Beaupre GS, 2006, AM J PHYS MED REHAB, V85, P464, DOI 10.1097/01.phm.0000214275.69286.7a; Cashman KD, 2013, BRIT J NUTR, V109, P1248, DOI 10.1017/S0007114512003212; delPuente A, 1996, OSTEOPOROSIS INT, V6, P50, DOI 10.1007/BF01626538; Demirbag D, 2005, ANN NUCL MED, V19, P695, DOI 10.1007/BF02985119; Dennison E, 2005, CURR OPIN RHEUMATOL, V17, P456, DOI 10.1097/01.bor.0000166384.80777.0d; Iwamoto J, 1999, AM J PHYS MED REHAB, V78, P202, DOI 10.1097/00002060-199905000-00002; Jorgensen L, 2002, STROKE, V33, P542, DOI 10.1161/hs0202.102375; Jorgensen L, 2004, AM J EPIDEMIOL, V160, P549, DOI 10.1093/aje/kwh252; Jorgensen L, 2001, CALCIFIED TISSUE INT, V68, P11, DOI 10.1007/BF02684997; Jorgensen L, 2001, BONE, V28, P655, DOI 10.1016/S8756-3282(01)00434-3; Jorgensen L, 2000, OSTEOPOROSIS INT, V11, P381, DOI 10.1007/s001980070103; Jorgensen L, 2000, BONE, V27, P701, DOI 10.1016/S8756-3282(00)00374-4; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Pack Alison M., 2003, Epilepsy Curr, V3, P91, DOI 10.1046/j.1535-7597.2003.03306.x; Pang MYC, 2005, OSTEOPOROSIS INT, V16, P1769, DOI 10.1007/s00198-005-1925-1; Pang MYC, 2005, BONE, V37, P103, DOI 10.1016/j.bone.2005.03.009; Poole KES, 2006, BMJ-BRIT MED J, V333, P1251, DOI 10.1136/bmj.39050.597350.47; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; Ramnemark A, 2000, STROKE, V31, P1572, DOI 10.1161/01.STR.31.7.1572; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sato Y, 2001, STROKE, V32, P1673, DOI 10.1161/01.STR.32.7.1673; Sato Y, 1999, AGE AGEING, V28, P265, DOI 10.1093/ageing/28.3.265; Schousboe JT, 2013, J CLIN DENSITOM, V16, P455, DOI 10.1016/j.jocd.2013.08.004; Schulz E, 2004, J CLIN ENDOCR METAB, V89, P4246, DOI 10.1210/jc.2003-030964; Suzuki T, 2005, EXP AGING RES, V31, P457, DOI 10.1080/03610730500206881; TAKAMOTO S, 1995, CALCIFIED TISSUE INT, V56, P259, DOI 10.1007/BF00318043; Watanabe Y, 2004, INT J REHABIL RES, V27, P163, DOI 10.1097/01.mrr.0000128062.38817.77; Worthen LC, 2005, J REHABIL RES DEV, V42, P761, DOI 10.1682/JRRD.2005.02.0036	32	14	16	0	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	MAY	2016	185	2					473	481		10.1007/s11845-016-1399-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK0AZ	WOS:000374576100026	26787314				2022-02-06	
J	Blackwood, BP; Bean, JF; Sadecki-Lund, C; Helenowski, IB; Kabre, R; Hunter, CJ				Blackwood, Brian P.; Bean, Jonathan F.; Sadecki-Lund, Corinne; Helenowski, Irene B.; Kabre, Rashmi; Hunter, Catherine J.			Observation for isolated traumatic skull fractures in the pediatric population: unnecessary and costly	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatric trauma; Skull fracture; Isolated; Management; Costs	BLUNT HEAD TRAUMA; BRAIN-INJURY; NEUROLOGIC EXAMINATION; RESOURCE UTILIZATION; CHILDRENS HOSPITALS; UNITED-STATES; MANAGEMENT; EMERGENCY; ADMISSION; OUTCOMES	Background: Blunt head trauma accounts for a majority of pediatric trauma admissions. There is a growing subset of these patients with isolated skull fractures, but little evidence guiding their management. We hypothesized that inpatient neurological observation for pediatric patients with isolated skull fractures and normal neurological examinations is unnecessary and costly. Methods: We performed a single center 10 year retrospective review of all head traumas with isolated traumatic skull fractures and normal neurological examination. Exclusion criteria included: penetrating head trauma, depressed fractures, intracranial hemorrhage, skull base fracture, pneumocephalus, and poly-trauma. In each patient, we analyzed: age, fracture location, loss of consciousness, injury mechanism, Emergency Department (ED) disposition, need for repeat imaging, hospital costs, intracranial hemorrhage, and surgical intervention. Results: Seventy-one patients presented to our ED with acute isolated skull fractures, 56% were male and 44% were female. Their ages ranged from 1 week to 12.4 years old. The minority (22.5%) of patients were discharged from the ED following evaluation, whereas 77.5% were admitted for neurological observation. None of the patients required neurosurgical intervention. Age was not associated with repeat imaging or inpatient observation (p= 0.7474, p= 0.9670). No patients underwent repeat head imaging during their index admission. Repeat imaging was obtained in three previously admitted patients who returned to the ED. Cost analysis revealed a significant difference in total hospital costs between the groups, with an average increase in charges of $4,291.50 for admitted patients (p < 0.0001). Conclusion: Pediatric isolated skull fractures are low risk conditions with a low likelihood of complications. Further studies are necessary to change clinical practice, but our research indicates that these patients can be discharged safely from the ED without inpatient observation. This change in practice, additionally, would allow for huge health care dollar savings. (c) 2016 Elsevier Inc. All rights reserved.	[Blackwood, Brian P.; Bean, Jonathan F.; Sadecki-Lund, Corinne; Kabre, Rashmi; Hunter, Catherine J.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Surg, Div Pediat Surg, 225 E Chicago Ave,Box 63, Chicago, IL 60611 USA; [Helenowski, Irene B.; Hunter, Catherine J.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, 310 E Super St,Searle 4-490, Chicago, IL 60611 USA; [Blackwood, Brian P.] Rush Univ, Med Ctr, Dept Gen Surg, 1750 W Harrison St,Suite 785, Chicago, IL 60612 USA		Blackwood, BP (corresponding author), 225 E Chicago Ave,Box 63, Chicago, IL 60611 USA.	brian_p_blackwood@rush.edu; jfbean@uic.edu; CSadeckiLund@luriechildrens.org; i-helenowski@northwestern.edu; rkabre@luriechildrens.org; chunter@luriechildrens.org					Adams J, 2001, J PEDIATR SURG, V36, P119, DOI 10.1053/jpsu.2001.20026; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Dias MS, 2004, J NEUROSURG, V101, P38, DOI 10.3171/ped.2004.101.2.0038; Faul M, 2010, TRAUMATIC BRAIN INJU; Fieldston ES, 2013, PEDIATRICS, V131, P1050, DOI 10.1542/peds.2012-2494; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Hassan SF, 2014, J TRAUMA ACUTE CARE, V77, P166, DOI 10.1097/TA.0000000000000256; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Macy ML, 2012, J HOSP MED, V7, P530, DOI 10.1002/jhm.1923; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Metzger RR, 2014, J PEDIATR SURG, V49, P1856, DOI 10.1016/j.jpedsurg.2014.09.038; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Plackett TP, 2015, J PEDIATR SURG, V50, P1758, DOI 10.1016/j.jpedsurg.2015.03.067; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Reid SR, 2012, CLIN PEDIATR, V51, P745, DOI 10.1177/0009922812446009; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Shortell SM, 2009, JAMA-J AM MED ASSOC, V302, P1223, DOI 10.1001/jama.2009.1373; Spencer MT, 2003, AM J EMERG MED, V21, P111, DOI 10.1053/ajem.2003.50031; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stimpson JP, 2014, ACAD MED, V89, P853, DOI 10.1097/ACM.0000000000000252; Varano P, 2015, J TRAUMA ACUTE CARE, V78, P1039, DOI 10.1097/TA.0000000000000604	29	14	15	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	APR	2016	51	4					654	658		10.1016/j.jpedsurg.2015.08.064			5	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	DJ8SE	WOS:000374482200029	26472656				2022-02-06	
J	Wee, HY; Ho, CH; Liang, FW; Hsieh, KY; Wang, CC; Wang, JJ; Chio, CC; Chang, CH; Kuo, JR				Wee, Hsiao-Yue; Ho, Chung-Han; Liang, Fu-Wen; Hsieh, Kuang-Yang; Wang, Che-Chuan; Wang, Jhi-Joung; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung			Increased Risk of New-Onset Depression in Patients With Traumatic Brain Injury and Hyperlipidemia: The Important Role of Statin Medications	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							UNITED-STATES; PREVALENCE; DISORDERS; COMORBIDITY; POPULATION; SYMPTOMS; OUTCOMES; HEALTH; CONSEQUENCES; CHOLESTEROL	Objective: Depression is a common complication after traumatic brain injury (TBI). This study aimed to evaluate the risk of hyperlipidemia for new-onset depression after TBI and the role of statin medications using a longitudinal population database. Method: A matched longitudinal cohort study of 3,792 subjects (1,264 TBI patients [ICD-9-CM code: 801-804 and 850-854] with preexisting hyperlipidemia [ICD-9-CM code: 272.0, 272.1, 272.2, 272.4] and 2,528 age-and sex-matched TBI patients without hyperlipidemia) was conducted using the Taiwan Longitudinal Health Insurance Database from January 2001 to December 2008. The incidence and hazard ratios (HRs) for the development of new-onset depression (ICD-9-CM code: 296.2X-296.3X, 300.4, and 311.X) after TBI were compared between the 2 groups. Results: The incidence rate of depression in TBI with preexisting hyperlipidemia was 136.61 per 10,000 person-years. TBI patients with preexisting hyperlipidemia had a 1.72-fold increased incidence rate ratio compared with those without hyperlipidemia (P=.0056). A Cox model showed hyperlipidemia to be an independent predictor of depression (HR = 1.61; 95% CI, 1.03-2.53). TBI patients with hyperlipidemia who were not treated with statins experienced a 1.95-fold incidence risk ratio (P=.0017) and higher risk of new-onset depression (HR = 1.61; 95% CI, 1.03-2.53) compared to TBI patients without hyperlipidemia. Conclusions: Preexisting hyperlipidemia could be an independent predictor of new-onset depression in TBI patients, and TBI patients with preexisting hyperlipidemia who were not treated with statins presented a higher risk of new-onset depression than TBI patients without hyperlipidemia. Our findings may provide some insight into the important role of statin medications in the development of new-onset depression in patients with traumatic brain injury. (C) Copyright 2016 Physicians Postgraduate Press, Inc.	[Wee, Hsiao-Yue; Wang, Che-Chuan; Chio, Chung-Ching; Chang, Chin-Hung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Hsieh, Kuang-Yang] Chi Mei Med Ctr, Dept Psychiat, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Hsieh, Kuang-Yang; Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Wang, Che-Chuan] Southern Taiwan Univ Sci & Technol, Dept Child Care, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Traumat Brain Ctr, Dept Neurosurg, 901 Jong Hwa Rd, Tainan 710, Taiwan.	kuojinnrung@gmail.com		Ho, Chung-Han/0000-0001-5925-8477; Liang, Fu-Wen/0000-0002-3396-037X	Chi-Mei Medical Center [CMFHR10337]	This work was supported by Chi-Mei Medical Center grant number CMFHR10337.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Aijanseppa S, 2002, INT J GERIATR PSYCH, V17, P629, DOI 10.1002/gps.666; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Can OD, 2012, BEHAV PHARMACOL, V23, P582, DOI 10.1097/FBP.0b013e328356c3f2; Chang HY, 2002, CHINESE J PHYSIOL, V45, P187; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chuang CS, 2014, GEN HOSP PSYCHIAT, V36, P497, DOI 10.1016/j.genhosppsych.2014.05.008; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Dortland AKBV, 2010, J CLIN PSYCHIAT, V71, P729, DOI 10.4088/JCP.08m04865blu; Fang CY, 2013, J BEHAV MED, V36, P143, DOI 10.1007/s10865-012-9409-1; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Harpole LH, 2005, GEN HOSP PSYCHIAT, V27, P4, DOI 10.1016/j.genhosppsych.2004.09.004; Higgins TL, 2003, CRIT CARE MED, V31, P45, DOI 10.1097/00003246-200301000-00007; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Kamezaki F, 2011, INTERNAL MED, V50, P2485, DOI 10.2169/internalmedicine.50.5667; Kaufert PA, 2008, MATURITAS, V61, P54, DOI 10.1016/j.maturitas.2008.09.009; Kawamoto R, 2012, ENDOCRINE, V42, P321, DOI 10.1007/s12020-012-9625-z; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Krentz AJ, 2003, DIABETES OBES METAB, V5, pS19, DOI 10.1046/j.1462-8902.2003.0310.x; Kuklina E. V., 2011, Morbidity and Mortality Weekly Report, V60, P109; Leone T, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-39; Llaneza P, 2012, MATURITAS, V71, P120, DOI 10.1016/j.maturitas.2011.11.017; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; McElroy SL, 2014, J CLIN PSYCHIAT, V75, P46, DOI [10.4088/JCP.13r08634, 10.4088/JCP.13010tx4c]; Miller RS, 2000, J TRAUMA, V48, P229, DOI 10.1097/00005373-200002000-00006; Morales K, 2006, J AM GERIATR SOC, V54, P70, DOI 10.1111/j.1532-5415.2005.00542.x; Nelson RH, 2013, PRIMARY CARE, V40, P195, DOI 10.1016/j.pop.2012.11.003; Oetting ER, 1999, SUBST USE MISUSE, V34, P947, DOI 10.3109/10826089909039389; Oquendo MA, 2013, J AFFECT DISORDERS, V150, P1179, DOI 10.1016/j.jad.2013.05.010; Pabayo R, 2014, J EPIDEMIOL COMMUN H, V68, P110, DOI 10.1136/jech-2013-203093; Pan A, 2011, ARCH GEN PSYCHIAT, V68, P42, DOI 10.1001/archgenpsychiatry.2010.176; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thomas J, 2003, DIABETES CARE, V26, P2311, DOI 10.2337/diacare.26.8.2311; Tsai TY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-976; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	45	14	15	0	4	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	APR	2016	77	4					505	511		10.4088/JCP.14m09749			7	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	DQ5LU	WOS:000379247700016	27035519				2022-02-06	
J	Vlagsma, TT; Koerts, J; Fasotti, L; Tucha, O; van Laar, T; Dijkstra, H; Spikman, JM				Vlagsma, T. T.; Koerts, J.; Fasotti, L.; Tucha, O.; van Laar, T.; Dijkstra, H.; Spikman, J. M.			Parkinson's patients' executive profile and goals they set for improvement: Why is cognitive rehabilitation not common practice?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Neuropsychological rehabilitation; Parkinson's disease; Acquired brain injury; Goal setting; Executive functions	TRAUMATIC BRAIN-INJURY; DISEASE PATIENTS; IMPAIRMENT; AWARENESS; DEFICITS; DYSFUNCTION; MEDICATION; LIFE	Impairments in executive functions (EF) are the core cognitive impairment in patients with Parkinson's disease (PD). Surprisingly, cognitive rehabilitation is not routinely offered to patients with PD. However, in patients with acquired brain injury (ABI), cognitive rehabilitation, in particular strategic executive training, is common practice and has been shown to be effective. In this study, we determined whether PD patients have different needs and aims with regard to strategic executive training than ABI patients, and whether possible differences might be a reason for not offering this kind of cognitive rehabilitation programme to patients with PD. Patients' needs and aims were operationalised by individually set goals, which were classified into domains of EF and daily life. In addition, patients with PD and ABI were compared on their cognitive, in particular EF, profile. Overall, PD patients' goals and cognitive profile were similar to those of patients with ABI. Therefore, based on the findings of this study, there is no reason to assume that strategic executive training cannot be part of standard therapy in PD. However, when strategic executive training is applied in clinical practice, disease-specific characteristics need to be taken into account.	[Vlagsma, T. T.; Koerts, J.; Tucha, O.; Spikman, J. M.] Univ Groningen, Dept Clin & Dev Neuropsychol, NL-9712 TS Groningen, Netherlands; [Fasotti, L.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Fasotti, L.] Rehabil Med Ctr Groot Klimmendaal, Arnhem, Netherlands; [van Laar, T.; Spikman, J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9712 TS Groningen, Netherlands; [Dijkstra, H.] Med Ctr Nij Smellinghe, Dept Med Psychol, Drachten, Netherlands		Vlagsma, TT (corresponding author), Univ Groningen, RuG,Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	t.t.vlagsma@rug.nl	van Laar, Teus/AAO-3906-2021; Tucha, Oliver/AAD-1403-2019	Spikman, Jacoba/0000-0002-6477-0763; van Laar, Teus/0000-0001-5088-480X	Dutch Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO); National Initiative Brain and Cognition (NIHC) [056-11-012]	This work was supported by the Dutch Organization for Scientific Research (NWO), the National Initiative Brain and Cognition (NIHC) under Grant [056-11-012]. This quick-result project is embedded in the pillar "The Healthy Brain, Program Cognitive Rehabilitation".	Barkley, 2011, DEFICITS EXECUTIVE F; Bloem BR, 2010, MULTIDISCIPLINAIRE R; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Broeders M, 2013, J INT NEUROPSYCH SOC, V19, P695, DOI 10.1017/S1355617713000295; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 2005, EFFECTIVENESS REHABI, P211, DOI DOI 10.1093/ACPROF:OSO/9780198526544.001.0001; Cahn DA, 1998, ARCH CLIN NEUROPSYCH, V13, P575, DOI 10.1016/S0887-6177(98)00024-9; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colman KSF, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/213983; Colman KSF, 2009, CORTEX, V45, P930, DOI 10.1016/j.cortex.2008.12.010; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Deelman B. G., 1980, NEUROPSYCHOLOGIE NED, P253; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Edwards JD, 2013, NEUROLOGY, V81, P1284, DOI 10.1212/WNL.0b013e3182a823ba; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Ertzgaard P, 2011, J REHABIL MED, V43, P8, DOI 10.2340/16501977-0664; Esselink RAJ, 2004, NEUROLOGY, V62, P201, DOI 10.1212/01.WNL.0000103235.12621.C3; Evans JJ, 2012, CURR OPIN NEUROL, V25, P651, DOI 10.1097/WCO.0b013e3283598f75; Fahn S, 1987, RECENT DEV PARKINSON, V2, P153; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Goldman JG, 2012, MOVEMENT DISORD, V27, P1129, DOI 10.1002/mds.25062; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Heerkens Y. F., 2002, NEDERLANDS VERTALING; Herrera E, 2011, J NEUROL SCI, V310, P237, DOI 10.1016/j.jns.2011.06.034; Hindle JV, 2013, MOVEMENT DISORD, V28, P1034, DOI 10.1002/mds.25377; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Klepac N, 2008, EUR J NEUROL, V15, P128, DOI 10.1111/j.1468-1331.2007.02011.x; Koerts J, 2012, PARKINSONISM RELAT D, V18, P194, DOI 10.1016/j.parkreldis.2011.10.002; Koerts J, 2011, J NEUROL SCI, V310, P172, DOI 10.1016/j.jns.2011.07.009; Kudlicka A, 2011, MOVEMENT DISORD, V26, P2305, DOI 10.1002/mds.23868; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LUTEIJN F, 1983, GRONINGER INTELLIGEN; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McKinlay A, 2010, J INT NEUROPSYCH SOC, V16, P268, DOI 10.1017/S1355617709991299; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mohlman Jan, 2010, Clin Case Stud, V9, P74; Mohlman J, 2011, J GERIATR PSYCH NEUR, V24, P91, DOI 10.1177/0891988711402350; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Naismith SL, 2013, MOVEMENT DISORD, V28, P1097, DOI 10.1002/mds.25457; Nombela Cristina, 2011, Front Neurol, V2, P82, DOI 10.3389/fneur.2011.00082; Perbal-Hatif Severine, 2012, Dialogues Clin Neurosci, V14, P425; Perna R, 2012, APPL NEUROPSYCH-ADUL, V19, P263, DOI 10.1080/09084282.2012.670147; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Paris AP, 2011, MOVEMENT DISORD, V26, P1251, DOI 10.1002/mds.23688; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reuter Iris, 2012, J Aging Res, V2012, P373294, DOI 10.1155/2012/373294; Sammer G, 2006, J NEUROL SCI, V248, P115, DOI 10.1016/j.jns.2006.05.028; Sinforiani E, 2004, ARCH GERONTOL GERIAT, P387; Solla P, 2014, J NEUROL, V261, P382, DOI 10.1007/s00415-013-7207-5; Spikman J. M., 2012, KLIN NEUROPSYCHOLOGI, P125; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vale S, 2008, EXP BIOL MED, V233, P941, DOI 10.3181/0707-MR-193; Wechsler D, 1987, MEMORY SCALE REVISED; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	64	14	14	2	40	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 3	2016	26	2					216	235		10.1080/09602011.2015.1013138			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DA5AT	WOS:000367815200003	25693688	Green Submitted			2022-02-06	
J	Cristofori, I; Zhong, WT; Mandoske, V; Chau, A; Krueger, F; Strenziok, M; Grafman, J				Cristofori, Irene; Zhong, Wanting; Mandoske, Valerie; Chau, Aileen; Krueger, Frank; Strenziok, Maren; Grafman, Jordan			Brain Regions Influencing Implicit Violent Attitudes: A Lesion-Mapping Study	JOURNAL OF NEUROSCIENCE			English	Article						aggression; implicit attitudes; traumatic brain injury	VENTROMEDIAL PREFRONTAL CORTEX; POSTTRAUMATIC-STRESS-DISORDER; INTIMATE PARTNER VIOLENCE; VOXEL-BASED LESION; ASSOCIATION TEST; HEAD-INJURY; AGGRESSIVE-BEHAVIOR; TEMPORAL CORTEX; GENDER; VETERANS	Increased aggression is common after traumatic brain injuries and may persist after cognitive recovery. Maladaptive aggression and violence are associated with dysfunction in the prefrontal and temporal cortex, but such dysfunctional behaviors are typically measured by explicit scales and history. However, it is well known that answers on explicit scales on sensitive topics-such as aggressive thoughts and behaviors-may not reveal true tendencies. Here, we investigated the neural basis of implicit attitudes toward aggression in humans using a modified version of the Implicit Association Task (IAT) with a unique sample of 112 Vietnam War veterans who suffered penetrating brain injury and 33 healthy controls who also served in combat in Vietnam but had no history of brain injury. We hypothesized that dorsolateral prefrontal cortex (dlPFC) lesions, due to the crucial role of the dlPFC in response inhibition, could influence performance on the IAT. In addition, we investigated the causal contribution of specific brain areas to implicit attitudes toward violence. We found a more positive implicit attitude toward aggression among individuals with lesions to the dlPFC and inferior posterior temporal cortex (ipTC). Furthermore, executive functions were critically involved in regulating implicit attitudes toward violence and aggression. Our findings complement existing evidence on the neural basis of explicit aggression centered on the ventromedial prefrontal cortex. These findings highlight that dlPFC and ipTC play a causal role in modulating implicit attitudes about violence and are crucially involved in the pathogenesis of aggressive behavior.	[Cristofori, Irene; Zhong, Wanting; Mandoske, Valerie; Chau, Aileen; Grafman, Jordan] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Cristofori, Irene; Zhong, Wanting; Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank; Strenziok, Maren] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA		Cristofori, I; Grafman, J (corresponding author), Rehabil Inst Chicago, Brain Injury Res Program, Cognit Neurosci Lab, 345 E Super St, Chicago, IL 60611 USA.	irene.cristofori@gmail.com; jgrafman@northwestern.edu	; Krueger, Frank/Q-1359-2015	Cristofori, Irene/0000-0003-2339-1457; Grafman, Jordan H./0000-0001-8645-4457; Krueger, Frank/0000-0003-3420-2463; Zhong, Wanting/0000-0002-6025-1739			Amodio DM, 2014, NAT REV NEUROSCI, V15, P670, DOI 10.1038/nrn3800; Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Banse R, 2014, AGGRESS BEH IN PRESS; Barbey AK, 2014, BRAIN, V137, P2823, DOI 10.1093/brain/awu207; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Bradley MM, 1999, C1 U FLOR CTR RES PS; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Buss AH, 2000, AGGRESSION QUESTIONN; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Delis DC., 2001, DELIS KAPLAN EXECUTI; Eckhardt CI, 2012, J INTERPERS VIOLENCE, V27, P471, DOI 10.1177/0886260511421677; Finley EP, 2010, J FAM VIOLENCE, V25, P737, DOI 10.1007/s10896-010-9331-7; Forbes CE, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00320; Forbes CE, 2012, CEREB CORTEX, V22, P2602, DOI 10.1093/cercor/bhr337; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Gozzi M, 2009, NEUROPSYCHOLOGIA, V47, P2125, DOI 10.1016/j.neuropsychologia.2009.04.002; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Gray NS, 2003, NATURE, V423, P497, DOI 10.1038/423497a; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; GROSS CG, 1992, PHILOS T ROY SOC B, V335, P3, DOI 10.1098/rstb.1992.0001; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hare TA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00050; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hayes, 2018, INTRO MEDIATION MODE; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Hoptman MJ, 2002, BIOL PSYCHIAT, V52, P9, DOI 10.1016/S0006-3223(02)01311-2; HYER L, 1991, J CLIN PSYCHOL, V47, P510, DOI 10.1002/1097-4679(199107)47:4<510::AID-JCLP2270470407>3.0.CO;2-F; Kaplan E, 1983, BOSTON NAMING TEST; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; Knutson KM, 2007, HUM BRAIN MAPP, V28, P915, DOI 10.1002/hbm.20320; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Lang P. J., 2008, TECH REP A 8; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lipsey, 2005, J EXPT CRIMINOLOGY, V1, P451, DOI [DOI 10.1007/S11292-005-3541-7, 10.1007/s11292-005-3541-7]; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; de Almeida RMM, 2015, PHYSIOL BEHAV, V143, P121, DOI 10.1016/j.physbeh.2015.02.053; McCollister KE, 2010, DRUG ALCOHOL DEPEN, V108, P98, DOI 10.1016/j.drugalcdep.2009.12.002; McNeil M., 1994, REVISED TOKEN TEST; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Nosek BA, 2005, J EXP PSYCHOL GEN, V134, P565, DOI 10.1037/0096-3445.134.4.565; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Quadflieg S, 2009, J COGNITIVE NEUROSCI, V21, P1560, DOI 10.1162/jocn.2009.21091; Rand, 2010, CRIMINAL VICTIMIZATI; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Robertson K, 2007, J INTERPERS VIOLENCE, V22, P639, DOI 10.1177/0886260506298835; Rudman LA, 2001, PERS SOC PSYCHOL B, V27, P1164, DOI 10.1177/0146167201279009; Seidenwurm D, 1997, AM J NEURORADIOL, V18, P625; Shapiro J. P., 2000, ATTITUDES GUNS VIOLE; Silver E, 2005, AM J PUBLIC HEALTH, V95, P2015, DOI 10.2105/AJPH.2003.021436; Silver Jonathan M., 1994, P313; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spielberger CD., 1988, MANUAL STATE TRAIT A; Sydeman, 1994, USE PSYCHOL TESTING, P292, DOI DOI 10.1002/9780470479216.CORPSY0943; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; Tsuchida A, 2012, CEREB CORTEX, V22, P2904, DOI 10.1093/cercor/bhr370; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; United States Department of Defense, 1960, ARM FORC QUAL TEST A; Warrington E. K., 1991, VISUAL OBJECT SPACE; Woermann FG, 2000, J NEUROL NEUROSUR PS, V68, P162, DOI 10.1136/jnnp.68.2.162; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104	74	14	14	0	40	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 2	2016	36	9					2757	2768		10.1523/JNEUROSCI.2975-15.2016			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DF2BV	WOS:000371145400018	26937013	Bronze, Green Published			2022-02-06	
J	Adil, MM; Bestow, LA; Qureshi, AI; Malik, AA; Jordan, LC				Adil, Malik M.; Bestow, Lauren A.; Qureshi, Adnan I.; Malik, Ahmed A.; Jordan, Lori C.			Hypertension Is Associated With Increased Mortality in Children Hospitalized With Arterial Ischemic Stroke	PEDIATRIC NEUROLOGY			English	Article						pediatric stroke; ischemic stroke; hypertension; mortality	TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE; RISK-FACTORS; CEREBROVASCULAR-DISEASE; CLINICAL-FEATURES; ADOLESCENTS; TRENDS; PREVALENCE; INFANTS; HEALTH	BACKGROUND: Recently a single-center study suggested that hypertension after stroke in children was a risk factor for mortality. Our goal was to assess the association between hypertension and outcome after arterial ischemic stroke in children from a large national sample. METHODS: Using the Healthcare Cost and Utilization Project Kids' Inpatient Database, children (1-18 years) with a primary diagnosis of ischemic stroke (International Classification of Diseases, Ninth Revision [ICD-9] codes 433-437.1) who also had a diagnosis of elevated blood pressure (ICD-9 code 796.2) or hypertension (ICD-9 codes 401 and 405) from 2003, 2006, and 2009 were identified. Clinical characteristics, discharge outcomes, and length of stay were assessed. Multivariable logistic regression was used to assess the relationship between hypertension and in-hospital mortality or discharge outcomes. RESULTS: Of 2590 children admitted with arterial ischemic stroke, 156 (6%) also had a diagnosis of hypertension. Ten percent of children with hypertension also had renal failure. Among patients with arterial ischemic stroke, hypertension was associated with increased mortality (7.4% vs 2.8%; P = 0.01) and increased length of stay (mean 11 +/- 17 vs 7 +/- 12 days; P = 0.004) compared with those without hypertension. After adjusting for age, sex, intubation, presence of a fluid and electrolyte disorder, and renal failure, children with hypertension had an increased odds of in-hospital death (odds ratio 1.2, 95% confidence interval [1.1-3.3, P = 0.04]). CONCLUSION: Hypertension was associated with an increased risk of in-hospital death for children presenting with arterial ischemic stroke. Further prospective study of blood pressure in children with stroke is needed.	[Adil, Malik M.] Ochsner Clin Fdn, Ochsner Neurosci Inst, Dept Neurol, New Orleans, LA 70121 USA; [Adil, Malik M.; Qureshi, Adnan I.; Malik, Ahmed A.] Zeenat Qureshi Stroke Inst, St Cloud, MN USA; [Bestow, Lauren A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Bestow, Lauren A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Jordan, Lori C.] Vanderbilt Univ, Sch Med, Dept Pediat, Div Pediat Neurol, Nashville, TN 37212 USA		Adil, MM (corresponding author), Ochsner Clin Fdn, 1514 Jefferson Hwy, New Orleans, LA 70121 USA.	malikmuhammad.adil@gmail.com	Adil, Malik M/I-8355-2019; Jordan, Lori/U-3167-2019	Adil, Malik M/0000-0002-4635-6462; Qureshi, Adnan/0000-0003-4962-540X			Beslow LA, 2011, STROKE, V42, P941, DOI 10.1161/STROKEAHA.110.604199; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BRODERICK J, 1993, J CHILD NEUROL, V8, P250, DOI 10.1177/088307389300800308; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Brush LN, 2013, NEUROLOGY, V80, P1225, DOI 10.1212/WNL.0b013e3182896ffb; Buckalew VM, 1996, AM J KIDNEY DIS, V28, P811, DOI 10.1016/S0272-6386(96)90380-7; deVeber G, 2003, ANN NEUROL, V53, P149, DOI 10.1002/ana.10461; Falkner B, 2004, HYPERTENSION, V43, P203, DOI 10.1161/01.HYP.0000109322.72948.24; Falkner B, 2006, J PEDIATR-US, V148, P195, DOI 10.1016/j.jpeds.2005.10.030; Flynn JT, 2002, PEDIATRICS, V110, P89, DOI 10.1542/peds.110.1.89; Fullerton HJ, 2003, NEUROLOGY, V61, P189, DOI 10.1212/01.WNL.0000078894.79866.95; Ganesan V, 2003, ANN NEUROL, V53, P167, DOI 10.1002/ana.10423; GIROUD M, 1995, J CLIN EPIDEMIOL, V48, P1343, DOI 10.1016/0895-4356(95)00039-9; KANTER RK, 1985, CLIN PEDIATR, V24, P320, DOI 10.1177/000992288502400603; Lee CY, 2012, PEDIATR NEPHROL, V27, P2301, DOI 10.1007/s00467-012-2254-1; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; Mallamaci F, 2014, NAT REV NEPHROL, V10, P623, DOI 10.1038/nrneph.2014.175; Mallick AA, 2014, LANCET NEUROL, V13, P35, DOI 10.1016/S1474-4422(13)70290-4; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Muntner P, 2004, JAMA-J AM MED ASSOC, V291, P2107, DOI 10.1001/jama.291.17.2107; Ostchega Y, 2009, AM J HYPERTENS, V22, P59, DOI 10.1038/ajh.2008.312; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; SCHOENBERG BS, 1978, NEUROLOGY, V28, P763, DOI 10.1212/WNL.28.8.763; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; Tran CL, 2012, HYPERTENSION, V60, P296, DOI 10.1161/HYPERTENSIONAHA.111.188813; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; You RX, 1997, STROKE, V28, P1913, DOI 10.1161/01.STR.28.10.1913	28	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	MAR	2016	56						25	29		10.1016/j.pediatrneurol.2015.11.002			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	DH3JN	WOS:000372683400007	26746784				2022-02-06	
J	Brown, EA; Kenardy, J; Chandler, B; Anderson, V; McKinlay, L; Le Brocque, R				Brown, Erin A.; Kenardy, Justin; Chandler, Bronwyn; Anderson, Vicki; McKinlay, Lynne; Le Brocque, Robyne			Parent-Reported Health-Related Quality of Life in Children With Traumatic Brain Injury: A Prospective Study	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						accidents and injuries; adolescents; assessment; children; quality of life	POSTTRAUMATIC-STRESS-DISORDER; EVENT SCALE; ADOLESCENTS; IMPACT; CHILDHOOD; SEVERITY; DISTRESS	Objective To identify which specific aspects of health-related quality of life (HRQL) are affected by traumatic brain injury (TBI) injury severity (Severity), time since injury (Time), and the interaction between Severity and Time, in a pediatric sample. It was hypothesized that Severity would decrease HRQL, Time would increase HRQL, and time to recover would be protracted for children with severe TBI. Methods This study followed a pediatric sample (n = 182, aged 6-14 years, recruited through three Australian hospitals) who sustained a mild or moderate-severe TBI across 3, 6, 12, and 18 months post-TBI. 12 specific HRQL outcomes were assessed via the Child Health Questionnaire-Parent Form 50 questionnaire. Results Dimensions of HRQL were differentially affected. Children with moderate-severe TBI generally experienced greater initial dysfunction than children with mild TBI; however, this difference disappeared by 18 months post-TBI. Conclusions Specific time points where HRQL outcomes may remediate are identified, and clinical recommendations regarding intervention strategies are discussed.	[Brown, Erin A.; Kenardy, Justin; Chandler, Bronwyn; Le Brocque, Robyne] Univ Queensland, Ctr Natl Res Disabil & Rehabil Med, Brisbane, Qld 4029, Australia; [Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [McKinlay, Lynne] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Parkville, Vic, Australia		Brown, EA (corresponding author), Univ Queensland, Royal Brisbane & Womens Hosp, Level UQ Oral Hlth Ctr 7, CONROD, Herston, Qld 4029, Australia.	e.brown5@uq.edu.au	Kenardy, Justin/F-2085-2010; Le Brocque, Robyne/F-4848-2010; Kenardy, Justin A/H-6603-2014	Le Brocque, Robyne/0000-0002-4574-1254; Kenardy, Justin A/0000-0001-9475-8450; McKinlay, Lynne/0000-0002-6677-0628; Brown, Erin A./0000-0001-9963-1192	National Health and Medical Research Council, AustraliaNational Health and Medical Research Council of Australia [301103]	This work was supported by the National Health and Medical Research Council, Australia (grant number 301103).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Brown EA, 2014, J PEDIATR PSYCHOL, V39, P512, DOI 10.1093/jpepsy/jsu014; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; De Young AC, 2014, J CHILD ADOL PSYCHOP, V24, P9, DOI 10.1089/cap.2013.0066; DeMatteo CA, 2014, BRAIN INJURY, V28, P114, DOI 10.3109/02699052.2013.848380; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jennett B., 1974, LANCET, V2, P8; Keane T., 1997, ASSESSING PSYCHOL TR; Kenardy J, 2012, J CLIN CHILD ADOLESC, V41, P5, DOI 10.1080/15374416.2012.632348; Landgraf JM, 1996, CHILD HLTH QUESTIONN; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Ravens-Sieberer U, 2002, RESTOR NEUROL NEUROS, V20, P151; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Waters E, 2000, J PEDIATR PSYCHOL, V25, P381, DOI 10.1093/jpepsy/25.6.381	29	14	14	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	MAR	2016	41	2					244	255		10.1093/jpepsy/jsv090			12	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	DJ4QY	WOS:000374193600008	26395759	Green Published, Bronze			2022-02-06	
J	Guevara, AB; Demonet, JF; Polejaeva, E; Knutson, KM; Wassermann, EM; Grafman, J; Krueger, F				Guevara, Andrea Brioschi; Demonet, Jean-Francois; Polejaeva, Elena; Knutson, Kristine M.; Wassermann, Eric M.; Grafman, Jordan; Krueger, Frank			Association Between Traumatic Brain Injury-Related Brain Lesions and Long-term Caregiver Burden	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						traumatic brain injury (TBI); dorsal anterior cingulate cortex (dACC); caregiver burden; dorsolateral prefrontal cortex (dlPFC); executive functions (EFs); dysexecutive syndrome	MENTAL-HEALTH; ANTERIOR CINGULATE; VERBAL FLUENCY; FAMILY NEEDS; HEAD-INJURY; TBI; METAANALYSIS; ACTIVATION; PREDICTORS; CORTEX	Objective: To investigate the association between traumatic brain injury (TBI)-related brain lesions and long-term caregiver burden in relation to dysexecutive syndrome. Setting: National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland. Participants: A total of 256 participants: 105 combat veterans with TBI, 23 healthy control combat veterans (HCv), and 128 caregivers. Outcome Measure: Caregiver burden assessed by the Zarit Burden Interview at 40 years postinjury. Design: Participants with penetrating TBI were compared with HCv on perceived caregiver burden and neuropsychological assessment measures. Data of computed tomographic scans (overlay lesion maps of participants with a penetrating TBI whose caregivers have a significantly high burden) and behavioral statistical analyses were combined to identify brain lesions associated with caregiver burden. Results: Burden was greater in caregivers of veterans with TBI than in caregivers of HCv. Caregivers of participants with lesions affecting cognitive and behavioral indicators of dysexecutive syndrome (ie, left dorsolateral prefrontal cortex and dorsal anterior cingulate cortex) showed greater long-term burden than caregivers of participants with lesions elsewhere in the brain. Conclusion and Implication: The TBI-related brain lesions have a lasting effect on long-term caregiver burden due to cognitive and behavioral factors associated with dysexecutive syndrome.	[Guevara, Andrea Brioschi; Polejaeva, Elena; Knutson, Kristine M.; Wassermann, Eric M.] NINDS, Behav Neurol Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Guevara, Andrea Brioschi] Univ Lausanne, Fac Biol & Med, Lausanne, VD, Switzerland; [Guevara, Andrea Brioschi; Demonet, Jean-Francois] Univ Lausanne, Leenaards Memory Ctr, CHUV, Lausanne, VD, Switzerland; [Grafman, Jordan] Northwestern Univ, Psychiat & Behav Sci & Cognit Neurol,Dept Phys Me, Rehabil Inst Chicago,Dept Psychol,Cognit Neurosci, Sch Med,Brain Injury Res,Azheimer Dis Ctr, Chicago, IL USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, 4400 Univ Dr,Mail Stop 2A1, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA		Krueger, F (corresponding author), George Mason Univ, Mol Neurosci Dept, 4400 Univ Dr,Mail Stop 2A1, Fairfax, VA 22030 USA.	FKrueger@gmu.edu	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Demonet, Jean-Francois/0000-0003-0100-6175	Intramural NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [Z99 NS999999] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977] Funding Source: NIH RePORTER		Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Audenaert K, 2000, EUR J NUCL MED, V27, P1800, DOI 10.1007/s002590000351; Badre D, 2012, P NATL ACAD SCI USA, V109, P19878, DOI 10.1073/pnas.1216902109; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Buchsbaum BR, 2005, HUM BRAIN MAPP, V25, P35, DOI 10.1002/hbm.20128; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cosseddu M, 2013, INT J GERIATR PSYCH, V28, P655, DOI 10.1002/gps.3892; de Vugt ME, 2006, DEMENT GERIATR COGN, V22, P35, DOI 10.1159/000093102; Delis DC., 2001, DELIS KAPLAN EXECUTI; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Doyle ST, 2013, BRAIN INJURY, V27, P1441, DOI 10.3109/02699052.2013.826505; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; FEINBERG L., 2011, VALUING INVALUABLE 2; Gauthier CT, 2009, CORTEX, V45, P164, DOI 10.1016/j.cortex.2007.09.006; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Guevara AB, 2015, J HEAD TRAUMA REHAB, V30, pE26, DOI 10.1097/HTR.0000000000000046; Hagen K, 2014, NEUROIMAGE, V85, P583, DOI 10.1016/j.neuroimage.2013.09.014; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Jacobson SC, 2011, BRAIN COGNITION, V77, P60, DOI 10.1016/j.bandc.2011.06.001; JETTE AM, 1986, J GEN INTERN MED, V1, P143, DOI 10.1007/BF02602324; Kaplan E., 2001, BOSTON NAMING TEST; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Knutson KM, 2008, DEMENT GERIATR COGN, V26, P467, DOI 10.1159/000167268; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kramer JH, 2007, J INT NEUROPSYCH SOC, V13, P386, DOI 10.1017/S1355617707070567; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Leggett AN, 2011, GERONTOLOGIST, V51, P76, DOI 10.1093/geront/gnq055; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Mars RB, 2011, NEURAL BASIS OF MOTIVATIONAL AND COGNITIVE CONTROL, P1; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Moules S, 1999, BRAIN INJURY, V13, P983; Nonterah CW, 2013, BRAIN INJURY, V27, P1287, DOI 10.3109/02699052.2013.812243; Pa J, 2010, J INT NEUROPSYCH SOC, V16, P640, DOI 10.1017/S1355617710000408; Papastavrou E, 2011, AGING MENT HEALTH, V15, P702, DOI 10.1080/13607863.2011.562178; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Scarmeas Nikolaos, 2004, Curr Neurol Neurosci Rep, V4, P374, DOI 10.1007/s11910-004-0084-7; Schintu S, 2014, CORTEX, V57, P244, DOI 10.1016/j.cortex.2014.04.009; Schreiner AS, 2006, AGING MENT HEALTH, V10, P107, DOI 10.1080/13607860500312142; Senhorini MCT, 2011, J CLIN EXP NEUROPSYC, V33, P864, DOI 10.1080/13803395.2011.561299; Shafritz KM, 2005, NEUROIMAGE, V25, P600, DOI 10.1016/j.neuroimage.2004.12.054; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Stern Y, 2013, FOLIA PHONIATR LOGO, V65, P49, DOI 10.1159/000353443; Su YL, 2012, NEUROSCI LETT, V525, P173, DOI 10.1016/j.neulet.2012.07.032; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; U. S. Department of Defense, 1984, TEST MAN ARM SERV VO; Warrington E. K., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WECHSLER MEMORY SCAL; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260	66	14	14	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		E48	E58		10.1097/HTR.0000000000000151			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NQ	WOS:000372981300005	26098258	Green Accepted			2022-02-06	
J	Hirshon, JM; Galvagno, SM; Comer, A; Millin, MG; Floccare, DJ; Alcorta, RL; Lawner, BJ; Margolis, AM; Nable, JV; Bass, RR				Hirshon, Jon Mark; Galvagno, Samuel M., Jr.; Comer, Angela; Millin, Michael G.; Floccare, Douglas J.; Alcorta, Richard L.; Lawner, Benjamin J.; Margolis, Asa M.; Nable, Jose V.; Bass, Robert R.			Maryland's Helicopter Emergency Medical Services Experience From 2001 to 2011: System Improvements and Patients' Outcomes	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; SCENE TRANSPORT; MORTALITY; SURVIVAL; TRIAGE; ADULTS; COST; CARE	Study objective: Helicopter emergency medical services (EMS) has become a well-established component of modern trauma systems. It is an expensive, limited resource with potential safety concerns. Helicopter EMS activation criteria intended to increase efficiency and reduce inappropriate use remain elusive and difficult to measure. This study evaluates the effect of statewide field trauma triage changes on helicopter EMS use and patient outcomes. Methods: Data were extracted from the helicopter EMS computer-aided dispatch database for in-state scene flights and from the state Trauma Registry for all trauma patients directly admitted from the scene or transferred to trauma centers from July 1, 2000, to June 30, 2011. Computer-aided dispatch flights were analyzed for periods corresponding to field triage protocol modifications intended to improve system efficiency. Outcomes were separately analyzed for trauma registry patients by mode of transport. Results: The helicopter EMS computer-aided dispatch data set included 44,073 transports. There was a statewide decrease in helicopter EMS usage for trauma patients of 55.9%, differentially affecting counties closer to trauma centers. The Trauma Registry data set included 182,809 patients (37,407 helicopter transports, 128,129 ambulance transports, and 17,273 transfers). There was an increase of 21% in overall annual EMS scene trauma patients transported; ground transports increased by 33%, whereas helicopter EMS transports decreased by 49%. Helicopter EMS patient acuity increased, with an attendant increase in patient mortality. However, when standardized with W statistics, both helicopter EMS- and ground-transported trauma patients showed sustained improvement in mortality. Conclusion: Modifications to state protocols were associated with decreased helicopter EMS use and overall improved trauma patient outcomes.	[Hirshon, Jon Mark; Floccare, Douglas J.; Lawner, Benjamin J.; Nable, Jose V.] Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA; [Hirshon, Jon Mark; Comer, Angela] Univ Maryland, Sch Med, Natl Study Ctr Trauma & EMS, Baltimore, MD 21201 USA; [Galvagno, Samuel M., Jr.] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Millin, Michael G.; Margolis, Asa M.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Floccare, Douglas J.; Alcorta, Richard L.; Bass, Robert R.] Maryland Inst Emergency Med Serv Syst, Baltimore, MD USA		Hirshon, JM (corresponding author), Univ Maryland, Sch Med, Dept Emergency Med, Baltimore, MD 21201 USA.; Hirshon, JM (corresponding author), Univ Maryland, Sch Med, Natl Study Ctr Trauma & EMS, Baltimore, MD 21201 USA.	jhirshon@umaryland.edu		Galvagno, Samuel/0000-0001-5563-4092			Air Medical Physician Association, 2002, Prehosp Emerg Care, V6, P464; *AM COLL SURG COMM, 2006, RES OPT CAR INJ PAT; Andruszkow H, 2013, CRIT CARE, V17, DOI 10.1186/cc12796; Baker SP, 2006, ANN EMERG MED, V47, P351, DOI 10.1016/j.annemergmed.2005.11.018; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Bledsoe BE, 2006, J TRAUMA, V60, P1257, DOI 10.1097/01.ta.0000196489.19928.c0; Brown JB, 2010, J TRAUMA, V69, P1030, DOI 10.1097/TA.0b013e3181f6f450; CAYTEN CG, 1991, J TRAUMA, V31, P471, DOI 10.1097/00005373-199104000-00005; Centers for Medicare & Medicaid Services, 2019, MED BEN POL MAN; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Davis DP, 2008, J TRAUMA, V64, P889, DOI 10.1097/TA.0b013e318148569a; Delgado MK, 2013, ANN EMERG MED, V62, P351, DOI 10.1016/j.annemergmed.2013.02.025; Desmettre T, 2012, CRIT CARE, V16, DOI 10.1186/cc11647; Floccare DJ, 2013, PREHOSP EMERG CARE, V17, P521, DOI 10.3109/10903127.2013.804139; Galvagno SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009228.pub2; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Hafner JW, 2012, PREHOSP EMERG CARE, V16, P434, DOI 10.3109/10903127.2012.689928; Hwang SY, 2012, AM J EMERG MED, V30, P749, DOI 10.1016/j.ajem.2011.05.022; Kennedy K, 1996, ANN EMERG MED, V28, P136, DOI 10.1016/S0196-0644(96)70053-7; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mackersie RC, 2006, PREHOSP EMERG CARE, V10, P287, DOI 10.1080/10903120600721636; Maryland Institute for Emergency Medical Services Systems, 2015, MAR MED PROT EM MED; Maryland State Emergency Services Board, STAT MAR EM MED SERV; Moore L, 2009, ANN SURG, V249, P1040, DOI 10.1097/SLA.0b013e3181a6cd97; National Association of EMS Physicians, 2011, Prehosp Emerg Care, V15, P541, DOI 10.3109/10903127.2011.598622; National EMS Advisory Council, RED ADV EV EMS CREAT; National Transportation Safety Board, 2009, SAF REC; Newgard CD, 2013, HEALTH AFFAIR, V32, P1591, DOI 10.1377/hlthaff.2012.1142; Norris R, 2002, J TRAUMA, V52, P229, DOI 10.1097/00005373-200202000-00005; Petrie David A, 2007, Air Med J, V26, P50, DOI 10.1016/j.amj.2006.10.005; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Schluter PJ, 2010, J TRAUMA, V68, P761, DOI 10.1097/TA.0b013e3181d3223b; Sullivent EE, 2011, PREHOSP EMERG CARE, V15, P295, DOI 10.3109/10903127.2011.569849; Taylor CB, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2009.09.030; Thomson David P, 2003, Prehosp Emerg Care, V7, P265, DOI 10.1080/10903120390936923	38	14	14	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	MAR	2016	67	3					332	340		10.1016/j.annemergmed.2015.07.503			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DG0IY	WOS:000371749700008	26433494				2022-02-06	
J	Keser, Z; Ucisik-Keser, FE; Hasan, KM				Keser, Zafer; Ucisik-Keser, Fehime Eymen; Hasan, Khader M.			Quantitative Mapping of Human Brain Vertical-Occipital Fasciculus	JOURNAL OF NEUROIMAGING			English	Article						Vertical-occipital fasciculus; quantitative mapping; deterministic; tractography	WERNICKE PERPENDICULAR FASCICULUS; THEORETICAL-ANALYSIS; IN-VIVO; TENSOR; TRACTOGRAPHY; VALIDATION; DISSECTION; PATHWAYS	PURPOSEThe vertical-occipital fasciculus (VOF), historically named as the fasciculus occipitalis verticalis of Wernicke, has been recently brought to the attention of the neuroscience community. In this study, we delineated and quantified this tract with deterministic diffusion tensor imaging protocol. METHODSFive (all males aged 24-37 years) and 10 (7 males and 3 females aged 20-51 years) right-handed healthy subjects were studied with 1 and 2 mm DT-MRI data sets, respectively. The DTI attributes of this pathway along with its cortical representation (Brodmann areas) were presented in standard Montreal Neurological Institute space. Nearby pathways such as inferior fronto-occipital (IFOF) and inferior longitudinal fasciculi (ILF) were used as reference pathways. RESULTSThe total volume of VOF has been found to be approximately .8-1% of whole brain in both data sets. The fractional anisotropy and axial diffusivity of this tract have been found to be relatively 10-15% lower than adjacent pathways such as IFOF and ILF in both data sets. Although IFOF and ILF showed somewhat leftward asymmetry in diffusivity, no right-left asymmetry has been observed in VOF. CONCLUSIONWe believe that our work will pave the way for future imaging studies investigating VOF in different conditions such as stroke, traumatic brain injury, and multiple sclerosis.	[Keser, Zafer] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Keser, Zafer] Univ Texas Hlth Sci Ctr Houston, TIRR Mem Hermann Neurorecovery Res Ctr, Houston, TX 77030 USA; [Ucisik-Keser, Fehime Eymen] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Imaging, Houston, TX 77030 USA; [Hasan, Khader M.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Radiol, Houston, TX 77030 USA		Hasan, KM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Diagnost & Intervent Imaging Dept, Sch Med, 6431 Fannin St, Houston, TX 77030 USA.	Khader.M.Hasan@uth.tmc.edu	Hasan, Khader M./ABB-5767-2020; Keser, Zafer/J-4586-2019	Keser, Zafer/0000-0001-6415-0874	Dunn Research Foundation	This work is funded by the Dunn Research Foundation. We thank Vipul Kumar Patel for helping in data acquisition.	Bartsch AJ, 2013, NEUROSURGERY, V73, pE381, DOI 10.1227/01.neu.0000430298.25585.1d; Blumenfeld H, 2011, NEUROANATOMY CLIN CA, P25; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Curran EJ, 1909, J COMP NEUROL PSYCHO, V19, P645, DOI 10.1002/cne.920190603; De Benedictis A, 2014, J ANAT, V225, P132, DOI 10.1111/joa.12204; Gerstmann J, 1940, ARCH NEURO PSYCHIATR, V44, P398, DOI 10.1001/archneurpsyc.1940.02280080158009; Hasan KM, 2007, MAGN RESON IMAGING, V25, P1196, DOI 10.1016/j.mri.2007.02.011; Hasan KM, 2011, J NEUROSCI, V31, P16826, DOI 10.1523/JNEUROSCI.4184-11.2011; Hasan KM, 2011, COMPUT BIOL MED, V41, P1062, DOI 10.1016/j.compbiomed.2010.10.008; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Hasan KM, 2009, MAGN RESON IMAGING, V27, P631, DOI 10.1016/j.mri.2008.10.007; Hasan KM, 2003, MAGNET RESON MED, V50, P589, DOI 10.1002/mrm.10552; Hoeve HJH, 1909, ANAT REC, V3, P247; Homola GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049451; Kamali A, 2014, NEUROSCIENCE, V277, P577, DOI 10.1016/j.neuroscience.2014.07.035; Kamali A, 2014, MAGN RESON IMAGING, V32, P796, DOI 10.1016/j.mri.2014.04.002; Keser Z, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00041; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Martino J, 2013, NEUROSURGERY, V73, pE382, DOI 10.1227/01.neu.0000430303.56079.0e; Martino J, 2013, NEUROSURGERY, V72, P87, DOI 10.1227/NEU.0b013e318274294b; Mendoza J, 2007, CLIN NEUROANATOMY NE, P281; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Takemura H, 2016, CEREB CORTEX, V26, P2205, DOI 10.1093/cercor/bhv064; Thiebaut de Schotten M, 2008, CORTEX, V44, P1097, DOI 10.1016/j.cortex.2008.02.003; Wahl M, 2010, NEUROIMAGE, V51, P531, DOI 10.1016/j.neuroimage.2010.02.072; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yeatman JD, 2014, P NATL ACAD SCI USA, V111, pE5214, DOI 10.1073/pnas.1418503111; Yeatman JD, 2013, BRAIN LANG, V125, P146, DOI 10.1016/j.bandl.2012.04.010	29	14	14	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	MAR-APR	2016	26	2					188	193		10.1111/jon.12268			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DG0DW	WOS:000371734400005	26073705				2022-02-06	
J	Mata-Mbemba, D; Mugikura, S; Nakagawa, A; Murata, T; Kato, Y; Tatewaki, Y; Takase, K; Kushimoto, S; Tominaga, T; Takahashi, S				Mata-Mbemba, Daddy; Mugikura, Shunji; Nakagawa, Atsuhiro; Murata, Takaki; Kato, Yumiko; Tatewaki, Yasuko; Takase, Kei; Kushimoto, Shigeki; Tominaga, Teiji; Takahashi, Shoki			Canadian CT head rule and New Orleans Criteria in mild traumatic brain injury: comparison at a tertiary referral hospital in Japan	SPRINGERPLUS			English	Article						Canadian computed tomography (CT) head rule; New Orleans Criteria; Computed tomography (CT); Traumatic brain injury; Mild traumatic brain injury	COMPUTED-TOMOGRAPHY; LOGISTIC-REGRESSION; VALIDATION	We compared Canadian computed tomography (CT) head rule (CCHR) and New Orleans Criteria (NOC) in predicting important CT findings in patients with mild traumatic brain injury (TBI). We included 142 consecutive patients with mild TBI [Glasgow coma scale (GCS) 13-15] who showed at least one of the risk factors stated in the CCHR or the NOC. We introduced two scores: a Canadian from the CCHR and a New Orleans from the NOC. A patient's score represented a sum of the number of positive items. We examined the relationship between scores or items and the presence of important CT findings. Only the Canadian was significantly associated with important CT findings in multivariate analyses and showed higher area under the receiver operating characteristic curve (AUC) either in all 142 patients (GCS 13-15: P = 0.0130; AUC = 0.69) or in the 67 with a GCS = 15 (P = 0.0128, AUC = 0.73). Of items, ">60 years" or ">= 65 years" included in either guideline was the strongest predictor of important CT finding, followed by "GCS < 15 after 2 h" included only in the CCHR. In a tertiary referral hospital in Japan, CCHR had higher performance than the NOC in predicting important CT findings.	[Mata-Mbemba, Daddy; Mugikura, Shunji; Murata, Takaki; Kato, Yumiko; Tatewaki, Yasuko; Takase, Kei; Takahashi, Shoki] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan; [Mata-Mbemba, Daddy; Nakagawa, Atsuhiro; Tominaga, Teiji] Tohoku Univ, Dept Neurosurg, Grad Sch Med, Sendai, Miyagi 9808574, Japan; [Kushimoto, Shigeki] Tohoku Univ, Div Emergency & Crit Care Med, Grad Sch Med, Sendai, Miyagi 9808574, Japan		Mugikura, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	mugi@rad.med.tohoku.ac.jp	Mata-Mbemba, Daddy/AAP-3184-2020				af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kavalci C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-31; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Nakajima Y, 2008, RADIAT MED, V26, P455, DOI 10.1007/s11604-008-0259-2; Novikov I, 2010, STAT MED, V29, P97, DOI 10.1002/sim.3728; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	18	14	16	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2193-1801			SPRINGERPLUS	SpringerPlus	FEB 25	2016	5								176	10.1186/s40064-016-1781-9			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5TK	WOS:000371415200006	27026873	Green Published, gold			2022-02-06	
J	White, TE; Surles-Zeigler, MC; Ford, GD; Gates, AS; Davids, B; Distel, T; LaPlaca, MC; Ford, BD				White, Todd E.; Surles-Zeigler, Monique C.; Ford, Gregory D.; Gates, Alicia S.; Davids, Benem; Distel, Timothy; LaPlaca, Michelle C.; Ford, Byron D.			Bilateral gene interaction hierarchy analysis of the cell death gene response emphasizes the significance of cell cycle genes following unilateral traumatic brain injury	BMC GENOMICS			English	Article						Traumatic brain injury; Cell death; Microarray; Bioinformatics; Gene interaction hierarchy	LONG-TERM DISABILITY; RAT CEREBRAL-CORTEX; SPINAL-CORD-INJURY; DEPENDENT KINASES; UNITED-STATES; IN-VITRO; PROVIDES NEUROPROTECTION; PROTEIN-KINASES; CORTICAL IMPACT; CDK INHIBITOR	Background: Delayed or secondary cell death that is caused by a cascade of cellular and molecular processes initiated by traumatic brain injury (TBI) may be reduced or prevented if an effective neuroprotective strategy is employed. Microarray and subsequent bioinformatic analyses were used to determine which genes, pathways and networks were significantly altered 24 h after unilateral TBI in the rat. Ipsilateral hemi-brain, the corresponding contralateral hemi-brain, and naive (control) brain tissue were used for microarray analysis. Results: Ingenuity Pathway Analysis showed cell death and survival (CD) to be a top molecular and cellular function associated with TBI on both sides of the brain. One major finding was that the overall gene expression pattern suggested an increase in CD genes in ipsilateral brain tissue and suppression of CD genes contralateral to the injury which may indicate an endogenous protective mechanism. We created networks of genes of interest (GOI) and ranked the genes by the number of direct connections each had in the GOI networks, creating gene interaction hierarchies (GIHs). Cell cycle was determined from the resultant GIHs to be a significant molecular and cellular function in post-TBI CD gene response. Conclusions: Cell cycle and apoptosis signalling genes that were highly ranked in the GIHs and exhibited either the inverse ipsilateral/contralateral expression pattern or contralateral suppression were identified and included STAT3, CCND1, CCND2, and BAX. Additional exploration into the remote suppression of CD genes may provide insight into neuroprotective mechanisms that could be used to develop therapies to prevent cell death following TBI.	[White, Todd E.; Surles-Zeigler, Monique C.; Gates, Alicia S.; Davids, Benem; Distel, Timothy; Ford, Byron D.] Morehouse Sch Med, Inst Neurosci, Dept Neurobiol, 720 Westview Dr SW, Atlanta, GA 30310 USA; [Ford, Gregory D.] Georgia Highlands Coll, Div Nat Sci & Phys Educ, 5441 Highway 20 NE, Cartersville, GA 30121 USA; [LaPlaca, Michelle C.] Georgia Inst Technol, Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA; [Distel, Timothy; Ford, Byron D.] Univ Calif Riverside, Sch Med, 900 Univ Ave, Riverside, CA 92521 USA		Ford, BD (corresponding author), Morehouse Sch Med, Inst Neurosci, Dept Neurobiol, 720 Westview Dr SW, Atlanta, GA 30310 USA.; Ford, BD (corresponding author), Univ Calif Riverside, Sch Med, 900 Univ Ave, Riverside, CA 92521 USA.	byron.ford@ucr.edu		Surles-Zeigler, Monique/0000-0002-2308-8813	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 NS 057993, U54 NS060659]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0055]; W.M. Keck FoundationW.M. Keck Foundation; BRIC NIH [5P20M006131-02]; Howard Hughes Medical InstituteHoward Hughes Medical Institute [52006306]; PHS Grant from Clinical and Translational Science Award program, NIH, National Center for Research Resources (NCRR) [UL1 RR025008, KL2 RR025009, TL1 RR025010]; Morehouse School of Medicine Grants from NCRR [U54 RR026137, G12RR003034, S21MD000101]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000455, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025009, G12RR003034, TL1RR025010, UL1RR025008, U54RR026137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS057993, U54NS060659] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [S21MD000101] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007056] Funding Source: NIH RePORTER	The authors would like to thank Brock Wester, Kaelin Brewster, and Samantha Simon for their technical assistance. This work was supported by National Institutes of Health (NIH) grants U01 NS 057993 (BDF), U54 NS060659 (BDF), Department of Defense Contract #W81XWH-10-2-0055 (BDF), the W.M. Keck Foundation (BDF); BRIC NIH grant #5P20M006131-02 (GDF), Howard Hughes Medical Institute grant #52006306 (GDF) and PHS Grant (UL1 RR025008, KL2 RR025009 or TL1 RR025010) from the Clinical and Translational Science Award program, NIH, National Center for Research Resources (NCRR) (MCL). The project described was supported by Morehouse School of Medicine Grants Number U54 RR026137, G12RR003034 and S21MD000101 from the NCRR, a component of NIH, and its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH.	Affymetrix, 2010, GENECHIP 3 IVT EXPR; Appert-Collin A, 2006, LIFE SCI, V79, P484, DOI 10.1016/j.lfs.2006.01.032; Arifin Muhammad Zafrullah, 2011, Asian J Neurosurg, V6, P72, DOI 10.4103/1793-5482.92160; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chang YW, 2009, J NEUROTRAUM, V26, P979, DOI [10.1089/neu.2008.0762, 10.1089/neu.2008-0762]; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Datta A, 2011, J PROTEOME RES, V10, P5199, DOI 10.1021/pr200673y; DeGracia DJ, 1996, J NEUROCHEM, V67, P2005; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Dressler Jan, 2009, Leg Med (Tokyo), V11 Suppl 1, pS54, DOI 10.1016/j.legalmed.2009.02.024; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Faul M, 2010, TRAUMATIC BRAIN INJU; Golsteyn RM, 2005, CANCER LETT, V217, P129, DOI 10.1016/j.canlet.2004.08.005; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; IPA&REG;, 2015, FAQS STAT CALC; IPA&REG;, 2013, IPA NETW GEN; IPA&REG;, 2013, IPA CAN PATHW OV; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Ji YH, 2008, MOL CELL BIOCHEM, V309, P49, DOI 10.1007/s11010-007-9642-z; Jones LL, 2000, J COMP NEUROL, V426, P468, DOI 10.1002/1096-9861(20001023)426:3<468::AID-CNE9>3.0.CO;2-I; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Li YG, 2012, TOXICOL APPL PHARM, V262, P194, DOI 10.1016/j.taap.2012.05.001; Li YG, 2011, TOXICOL APPL PHARM, V253, P261, DOI 10.1016/j.taap.2011.03.026; Liu Y, 2003, BRAIN RES, V972, P142, DOI 10.1016/S0006-8993(03)02519-8; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Meikrantz W, 1996, J BIOL CHEM, V271, P10205, DOI 10.1074/jbc.271.17.10205; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; O'Hare M, 2002, PHARMACOL THERAPEUT, V93, P135, DOI 10.1016/S0163-7258(02)00183-3; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Saha RN, 2009, J IMMUNOL, V183, P2068, DOI 10.4049/jimmunol.0801892; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; SHARP JW, 1990, EXP NEUROL, V109, P323, DOI 10.1016/S0014-4886(05)80023-8; Shi JQ, 2009, FEBS LETT, V583, P971, DOI 10.1016/j.febslet.2009.02.028; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Stenzel-Poore MP, 2004, STROKE, V35, P2683, DOI 10.1161/01.STR.0000143735.89281.bb; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Thomsen GM, 2014, STEM CELL RES, V13, P48, DOI 10.1016/j.scr.2014.04.013; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wainwright MS, 2003, DEV BRAIN RES, V146, P79, DOI 10.1016/j.devbrainres.2003.09.012; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; White TE, 2015, BRAIN NEUROTRAUMA MO, P378; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu XM, 2012, J MOL NEUROSCI, V47, P357, DOI 10.1007/s12031-012-9761-1; Xu ZF, 2005, NEUROBIOL DIS, V19, P461, DOI 10.1016/j.nbd.2005.01.027; Xu ZF, 2004, BIOCHEM BIOPH RES CO, V322, P440, DOI 10.1016/j.bbrc.2004.07.149; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	88	14	14	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	FEB 24	2016	17								130	10.1186/s12864-016-2412-0			29	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	DF8FS	WOS:000371593400001	26912237	Green Published, gold			2022-02-06	
J	Hong, S; Washington, PM; Kim, A; Yang, CP; Yu, TS; Kernie, SG				Hong, Sue; Washington, Patricia M.; Kim, Ahleum; Yang, Cui-Ping; Yu, Tzong-Shiue; Kernie, Steven G.			Apolipoprotein E Regulates Injury-Induced Activation of Hippocampal Neural Stem and Progenitor Cells	JOURNAL OF NEUROTRAUMA			English	Article						apolipoprotein E; hippocampus; neural stem; progenitor cells; neurogenesis; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; DENTATE GYRUS; EXPRESSING PROGENITORS; STEM/PROGENITOR CELLS; CEREBRAL-ISCHEMIA; ADULT HIPPOCAMPUS; TRANSGENIC MICE	Partial recovery from even severe traumatic brain injury (TBI) is ubiquitous and occurs largely through unknown mechanisms. Recent evidence suggests that hippocampal neural stem/progenitor cell (NSPC) activation and subsequent neurogenesis are responsible for at least some aspects of spontaneous recovery following TBI. Apolipoprotein E (ApoE) regulates postnatal neurogenesis in the hippocampus and is therefore a putative mediator of injury-induced neurogenesis. Further, ApoE isoforms in humans are associated with different cognitive outcomes following TBI. To investigate the role of ApoE in injury-induced neurogenesis, we exposed wild-type, ApoE-deficient, and human ApoE isoform-specific (ApoE3 and ApoE4) transgenic mice crossed with nestin-green fluorescent protein (GFP) reporter mice to controlled cortical impact (CCI) and assessed progenitor activation at 2 d post-injury using unbiased stereology. GFP+ progenitor cells were increased by approximately 120% in the ipsilateral hippocampus in injured wild-type mice, compared with sham mice (p<0.01). Co-localization of GFP+ cells with bromodeoxyrudine (BrdU) to label dividing cells indicated increased proliferation of progenitors in the injured hippocampus (p<0.001). This proliferative injury response was absent in ApoE-deficient mice, as no increase in GFP+ cells was observed in the injured hippocampus, compared with sham mice, despite an overall increase in proliferation indicated by increased BrdU+ cells (86%; p<0.05). CCI-induced proliferation of GFP+ cells in both ApoE3 and ApoE4 mice but the overall response was attenuated in ApoE4 mice due to fewer GFP+ cells at baseline. We demonstrate that ApoE is required for injury-induced proliferation of NSPCs after experimental TBI, and that this response is influenced by human APOE genotype.	[Hong, Sue; Washington, Patricia M.; Kim, Ahleum; Yu, Tzong-Shiue; Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Hong, Sue; Washington, Patricia M.; Kim, Ahleum; Yu, Tzong-Shiue; Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Yang, Cui-Ping] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China		Kernie, SG (corresponding author), Columbia Univ Coll Phys & Surg, 3959 Broadway,CHN 10-24, New York, NY 10032 USA.	sk3516@columbia.edu	Kernie, Steven/AAT-9912-2020	Yu, Tzong-Shiue/0000-0003-4277-6213; Kernie, Steven/0000-0003-1371-0549	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS095803, R21 NS083077, R56 NS089523] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095803, R21NS083077, R56NS089523] Funding Source: NIH RePORTER		Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gilley JA, 2011, HIPPOCAMPUS, V21, P33, DOI 10.1002/hipo.20719; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Halliday MR, 2013, JAMA NEUROL, V70, P1198, DOI 10.1001/jamaneurol.2013.3841; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; James ML, 2009, J STROKE CEREBROVASC, V18, P144, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.012; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kasai M, 2005, GENES CELLS, V10, P777, DOI 10.1111/j.1365-2443.2005.00876.x; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mauri M, 2006, FUNCT NEUROL, V21, P223; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Parent JM, 1997, J NEUROSCI, V17, P3727; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Qi JP, 2007, J ALZHEIMERS DIS, V12, P335; Quesseveur G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.30; Rajat S., 2008, EXP NEUROL, V213, P372; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; STERN Y, 1995, NEUROLOGY, V45, P55, DOI 10.1212/WNL.45.1.55; Sun D., 2014, J NEUROTRAU IN PRESS; Sun YL, 1998, J NEUROSCI, V18, P3261; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540; Yu TS, 2014, NEUROSCIENTIST; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	63	14	14	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2016	33	4					362	374		10.1089/neu.2014.3860			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DD2NH	WOS:000369758800006	25905575	Green Published			2022-02-06	
J	Ghodadra, A; Alhilali, L; Fakhran, S				Ghodadra, A.; Alhilali, L.; Fakhran, S.			Principal Component Analysis of Diffusion Tensor Images to Determine White Matter Injury Patterns Underlying Postconcussive Headache	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPATIAL STATISTICS; IMAGING FINDINGS; CORPUS-CALLOSUM; MIGRAINE; DYSFUNCTION; IMPAIRMENT; INTEGRITY; SYMPTOMS; ADULTS	BACKGROUND AND PURPOSE: Principal component analysis, a data-reduction algorithm, generates a set of principal components that are independent, linear combinations of the original dataset. Our study sought to use principal component analysis of fractional anisotropy maps to identify white matter injury patterns that correlate with posttraumatic headache after mild traumatic brain injury. MATERIALS AND METHODS: Diffusion tensor imaging and neurocognitive testing with the Immediate Post-Concussion Assessment and Cognitive Test were performed in 40 patients with mild traumatic brain injury and 24 without posttraumatic headache. Principal component analysis of coregistered fractional anisotropy maps was performed. Regression analysis of the major principal components was used to identify those correlated with posttraumatic headache. Finally, each principal component that correlated with posttraumatic headache was screened against other postconcussive symptoms and demographic factors. RESULTS: Principal component 4 (mean, 7.1 10.3) correlated with the presence of posttraumatic headache in mild traumatic brain injury (odds ratio per SD, 2.32; 95% CI, 1.29-4.67; P = .01). Decreasing principal component 4 corresponded with decreased fractional anisotropy in the midsplenium and increased fractional anisotropy in the genu of the corpus callosum. Principal component 4 identified patients with posttraumatic headache with an area under the receiver operating characteristic curve of 0.73 and uniquely correlated with posttraumatic headache and no other postconcussive symptom or demographic factors. CONCLUSIONS: Principal component analysis can be an effective data-mining method to identify white matter injury patterns on DTI that correlate with clinically relevant symptoms in mild traumatic brain injury. A pattern of reduced fractional anisotropy in the splenium and increased fractional anisotropy in the genu of the corpus callosum identified by principal component analysis can help identify patients at risk for posttraumatic headache after mild traumatic brain injury.	[Ghodadra, A.; Alhilali, L.; Fakhran, S.] Univ Pittsburgh, Dept Radiol, Med Ctr, 200 Lothrop St,Suite 201 East Wing, Pittsburgh, PA 15213 USA		Ghodadra, A (corresponding author), Univ Pittsburgh, Dept Radiol, Med Ctr, 200 Lothrop St,Suite 201 East Wing, Pittsburgh, PA 15213 USA.	ghodadraag@upmc.edu		Alhilali, Lea/0000-0002-9059-2454			Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jolliffe I., 2014, WILEY STATSREF STAT; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kim SN, 2012, PROG NEURO-PSYCHOPH, V37, P50, DOI 10.1016/j.pnpbp.2011.11.015; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Li XL, 2011, HEADACHE, V51, P237, DOI 10.1111/j.1526-4610.2010.01774.x; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Schulte T, 2013, NEUROIMAGE, V77, P195, DOI 10.1016/j.neuroimage.2013.03.056; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Xydis V, 2006, PEDIATR RADIOL, V36, P934, DOI 10.1007/s00247-006-0235-x; Yaeger K, 2014, AM J ROENTGENOL, V202, P614, DOI 10.2214/AJR.13.11091; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yu DH, 2013, CEPHALALGIA, V33, P34, DOI 10.1177/0333102412466964; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	31	14	14	1	2	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	FEB	2016	37	2					274	278		10.3174/ajnr.A4505			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DC3HU	WOS:000369111200019	26405087	Green Published, hybrid			2022-02-06	
J	Norris, CM; Sompol, P; Roberts, KN; Ansari, M; Scheff, SW				Norris, Christopher M.; Sompol, Pradoldej; Roberts, Kelly N.; Ansari, Mubeen; Scheff, Stephen W.			Pycnogenol protects CA3-CA1 synaptic function in a rat model of traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Hippocampus; Synaptic transmission; Oxidative stress; Pycnogenol (R)	LONG-TERM DEPRESSION; CONSTITUTIVELY ACTIVE CALCINEURIN; CONTROLLED CORTICAL IMPACT; DELAYED NEURONAL DEATH; AMYLOID-BETA PROTEIN; OXIDATIVE STRESS; GLUTAMATE-RECEPTOR; HIPPOCAMPAL SLICES; AREA CA1; POTENTIATION	Pycnogenol (PYC) is a patented mix of bioflavonoids with potent anti-oxidant and anti-inflammatory properties. Previously, we showed that PYC administration to rats within hours after a controlled cortical impact (CCI) injury significantly protects against the loss of several synaptic proteins in the hippocampus. Here, we investigated the effects of PYC on CA3-CA1 synaptic function following CCI. Adult Sprague-Dawley rats received an ipsilateral CCI injury followed 15 min later by intravenous injection of saline vehicle or PYC (10 mg/kg). Hippocampal slices from the injured (ipsilateral) and uninjured (contralateral) hemispheres were prepared at seven and fourteen days post-CCI for electrophysiological analyses of CA3-CA1 synaptic function and induction of long-term depression (LTD). Basal synaptic strength was impaired in slices from the ipsilateral, relative to the contralateral, hemisphere at seven days post-CCI and susceptibility to LTD was enhanced in the ipsilateral hemisphere at both post injury timepoints. No interhemispheric differences in basal synaptic strength or LTD induction were observed in rats treated with PYC. The results show that PYC preserves synaptic function after CCI and provides further rationale for investigating the use of PYC as a therapeutic in humans suffering from neurotrauma. (C) 2015 Elsevier Inc. All rights reserved.	[Norris, Christopher M.] Univ Kentucky, Coll Med, Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Norris, Christopher M.; Sompol, Pradoldej; Roberts, Kelly N.; Ansari, Mubeen; Scheff, Stephen W.] Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Scheff, Stephen W.] Univ Kentucky, Coll Med, Anat & Neurobiol, Lexington, KY 40536 USA		Norris, CM (corresponding author), Univ Kentucky, Coll Med, Pharmacol & Nutr Sci, Lexington, KY 40536 USA.; Norris, CM; Scheff, SW (corresponding author), Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.	cnorr2@uky.edu; pradoldej.sompol@uky.edu; knrobe2@uky.edu; mubeen.ansari@uky.edu; sscheff@email.uky.edu		Ansari, Mubeen Ahmad/0000-0002-1132-5965	Kentucky Spinal Cord and Head Injury Research Trust Fund [12-16A, 12-10A]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG027297] Funding Source: NIH RePORTER	This work was supported by grants from the Kentucky Spinal Cord and Head Injury Research Trust Fund (12-16A to SWS and 12-10A to CMN). Special thanks are due to Erin Abner, Richard J. Kryscio, and Frederick Schmitt of the Sanders-Brown Center on Aging for help on statistical analyses.	Abdul HM, 2011, AGING CELL, V10, P103, DOI 10.1111/j.1474-9726.2010.00645.x; Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Ansari MA, 2013, J NEUROTRAUM, V30, P1542, DOI 10.1089/neu.2013.2910; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P1510, DOI 10.1016/j.freeradbiomed.2008.08.025; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen X, 2013, NEUROSCIENCE, V253, P435, DOI 10.1016/j.neuroscience.2013.08.054; Coussens CM, 1997, J NEUROPHYSIOL, V78, P1; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; del Rey A, 2013, BRAIN BEHAV IMMUN, V33, P15, DOI 10.1016/j.bbi.2013.05.011; Dumas TC, 2012, HIPPOCAMPUS, V22, P188, DOI 10.1002/hipo.20881; Foster TC, 1997, HIPPOCAMPUS, V7, P602, DOI 10.1002/(SICI)1098-1063(1997)7:6<602::AID-HIPO3>3.0.CO;2-G; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; Foy MR, 2008, BEHAV NEUROSCI, V122, P301, DOI 10.1037/0735-7044.122.2.301; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Furling D, 2000, P NATL ACAD SCI USA, V97, P4351, DOI 10.1073/pnas.060574597; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kobayashi MS, 2000, FREE RADICAL RES, V32, P115, DOI 10.1080/10715760000300121; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Li AJ, 1997, BRAIN RES, V748, P30, DOI 10.1016/S0006-8993(96)01283-8; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu FJ, 2000, BIOL PHARM BULL, V23, P735, DOI 10.1248/bpb.23.735; Liu X, 2014, J NEUROSCI, V34, P8741, DOI 10.1523/JNEUROSCI.2752-13.2014; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maimoona A, 2011, J ETHNOPHARMACOL, V133, P261, DOI 10.1016/j.jep.2010.10.041; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; Mathis DM, 2011, JOVE-J VIS EXP, DOI 10.3791/2330; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; Mills F, 2014, P NATL ACAD SCI USA, V111, P8631, DOI 10.1073/pnas.1404670111; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nelson AB, 1998, DRUG DEV IND PHARM, V24, P139, DOI 10.3109/03639049809085598; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Norris CM, 2010, NEUROBIOL AGING, V31, P328, DOI 10.1016/j.neurobiolaging.2008.03.026; Norris CM, 1998, J NEUROSCI, V18, P3171; Norris CM, 1996, J NEUROSCI, V16, P5382; O'Dell T J, 1994, Learn Mem, V1, P129; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; Park Y, 2013, J CEREBR BLOOD F MET, V33, P1642, DOI 10.1038/jcbfm.2013.121; Peng QL, 2002, MOL BRAIN RES, V104, P55, DOI 10.1016/S0169-328X(02)00263-2; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Rezzani R, 2010, HYPERTENSION, V55, P1373, DOI 10.1161/HYPERTENSIONAHA.109.148254; Robillard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020676; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; RONG YQ, 1995, BIOTECHNOL THER, V5, P117; Ryan J, 2008, J PSYCHOPHARMACOL, V22, P553, DOI 10.1177/0269881108091584; Sama DM, 2013, AGEING RES REV, V12, P982, DOI 10.1016/j.arr.2013.05.008; Sama DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038170; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shioda N, 2007, J NEUROCHEM, V102, P1506, DOI 10.1111/j.1471-4159.2007.04600.x; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Spencer JPE, 2008, BRIT J NUTR, V99, pES60, DOI 10.1017/S0007114508965776; Spencer JPE, 2009, CHEM SOC REV, V38, P1152, DOI 10.1039/b800422f; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; Theadom A, 2013, EUR J NEUROL, V20, P1135, DOI 10.1111/ene.12099; Vouimba RM, 2000, BRAIN RES BULL, V53, P783, DOI 10.1016/S0361-9230(00)00377-4; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang JW, 2014, J SURG RES, V186, P328, DOI 10.1016/j.jss.2013.08.027; Watson JB, 2006, J NEUROSCI RES, V84, P1564, DOI 10.1002/jnr.21040; WEXLER EM, 1993, NEUROREPORT, V4, P591, DOI 10.1097/00001756-199305000-00034; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Williams RJ, 2012, FREE RADICAL BIO MED, V52, P35, DOI 10.1016/j.freeradbiomed.2011.09.010; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Yan HQ, 2014, BRAIN RES, V1548, P63, DOI 10.1016/j.brainres.2013.12.028	87	14	14	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2016	276						5	12		10.1016/j.expneurol.2015.11.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC8LF	WOS:000369470400002	26607913	Green Accepted			2022-02-06	
J	Killgore, WDS; Singh, P; Kipman, M; Pisner, D; Fridman, A; Weber, M				Killgore, William D. S.; Singh, Prabhjyot; Kipman, Maia; Pisner, Derek; Fridman, Andrew; Weber, Mareen			Gray matter volume and executive functioning correlate with time since injury following mild traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						mTBI; Mild traumatic brain injury; Concussion; VBM; Voxel-based morphometry; SPM8; Gray matter; Emotion regulation; Motor speed; Psychomotor vigilance	VOXEL-BASED MORPHOMETRY; POST-CONCUSSIVE SYNDROME; COGNITIVE FUNCTION; UNITED-STATES; CORTEX; RECOVERY; DENSITY; FMRI; DISTRACTION; PERFORMANCE	Most people who sustain a mild traumatic brain injury (mTBI) will recover to baseline functioning within a period of several days to weeks. A substantial minority of patients, however, will show persistent symptoms and mild cognitive complaints for much longer. To more clearly delineate how the duration of time since injury (TSI) is associated with neuroplastic cortical volume changes and cognitive recovery, we employed voxel-based morphometry (VBM) and select neuropsychological measures in a cross-sectional sample of 26 patients with mTBI assessed at either two-weeks, one-month, three-months, six-months, or one-year post injury, and a sample of 12 healthy controls. Longer duration of TSI was associated with larger gray matter volume (GMV) within the ventromedial prefrontal cortex (vmPFC) and right fusiform gyrus, and better neurocognitive performance on measures of visuospatial design fluency and emotional functioning. In particular, volume within the vmPFC was positively correlated with design fluency and negatively correlated with symptoms of anxiety, whereas GMV of the fusiform gyrus was associated with greater design fluency and Sustained visual psychomotor vigilance performance. Moreover, the larger GMV seen among the more chronic individuals was significantly greater than healthy controls, suggesting possible enlargement of these regions with time since injury. These findings are interpreted in light of burgeoning evidence suggesting that cortical regions often exhibit structural changes following experience or practice, and suggest that with greater time since an mTBI, the brain displays compensatory remodeling of cortical regions involved in emotional regulation, which may reduce distractibility during attention demanding visuo-motor tasks. (c) 2015 Elsevier Ireland Ltd. All rights reserved.	[Killgore, William D. S.; Singh, Prabhjyot; Pisner, Derek; Fridman, Andrew] Univ Arizona, Coll Med, Social Cognit & Affect Neurosci Lab, Tucson, AZ 85724 USA; [Killgore, William D. S.] Harvard Univ, Sch Med, McLean Hosp, Cambridge, MA 02138 USA; [Kipman, Maia] Tufts Univ, Sch Med, Medford, MA USA; [Weber, Mareen] Stanford Univ, Sch Med, Stanford Concuss & Brain Performance Ctr, Stanford, CA 94305 USA		Killgore, WDS (corresponding author), Univ Arizona, Coll Med, Dept Psychiat, Social Cognit & Affect Neurosci Lab, 1501N Campbell Ave, Tucson, AZ 85724 USA.	killgore@psychiatry.arizona.edu		Killgore, William/0000-0002-5328-0208	USAMRAA [W81XWH-12-1-0386]	This research was supported by a USAMRAA grant to WDSK (W81XWH-12-1-0386).	Aydin K, 2007, AM J NEURORADIOL, V28, P1859, DOI 10.3174/ajnr.A0696; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Comeau WL, 2010, BEHAV BRAIN RES, V214, P91, DOI 10.1016/j.bbr.2010.04.033; Crawford JR, 2008, J INT NEUROPSYCH SOC, V14, P1069, DOI 10.1017/S1355617708081228; Dambacher F, 2014, J COGNITIVE NEUROSCI, V26, P1775, DOI 10.1162/jocn_a_00595; Deng Z, 2014, NEUROSCIENCE, V275, P500, DOI 10.1016/j.neuroscience.2014.06.040; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dorfel D, 2014, NEUROIMAGE, V101, P298, DOI 10.1016/j.neuroimage.2014.06.051; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hinds O, 2013, J NEUROPHYSIOL, V109, P1250, DOI 10.1152/jn.00533.2011; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kerr AL, 2011, J COMMUN DISORD, V44, P538, DOI 10.1016/j.jcomdis.2011.04.011; Kolb B, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00015; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Leung MK, 2013, SOC COGN AFFECT NEUR, V8, P34, DOI 10.1093/scan/nss076; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Lou AR, 2013, ACTA OPHTHALMOL, V91, P58, DOI 10.1111/j.1755-3768.2011.02304.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Morey L.C., 2007, PERSONALITY ASSESSME; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Soh DW, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00108; Sosin DM, 1996, BRAIN INJURY, V10, P47; Strong CAH, 2011, J INT NEUROPSYCH SOC, V17, P230, DOI 10.1017/S1355617710001451; Sumiyoshi A, 2014, NEUROIMAGE, V98, P82, DOI 10.1016/j.neuroimage.2014.04.075; Wechsler D., 1999, WASI WECHSLER ABBREV; Welborn BL, 2009, SOC COGN AFFECT NEUR, V4, P328, DOI 10.1093/scan/nsp028; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Ziaei M, 2014, NEUROIMAGE, V87, P276, DOI 10.1016/j.neuroimage.2013.10.048; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	41	14	15	3	15	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 26	2016	612						238	244		10.1016/j.neulet.2015.12.033			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC8LU	WOS:000369471900041	26711488				2022-02-06	
J	Geddes, RI; Peterson, BL; Stein, DG; Sayeed, I				Geddes, Rastafa I.; Peterson, Bethany L.; Stein, Donald G.; Sayeed, Iqbal			Progesterone Treatment Shows Benefit in Female Rats in a Pediatric Model of Controlled Cortical Impact Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; WATER-MAZE; GENDER-DIFFERENCES; IMPROVED OUTCOMES; PREGNANT-WOMEN; CLINICAL-TRIAL; IMMATURE RATS; RECOVERY; NEUROPROTECTION	Purpose We recently showed that progesterone treatment can reduce lesion size and behavioral deficits after moderate-to-severe bilateral injury to the medial prefrontal cortex in immature male rats. Whether there are important sex differences in response to injury and progesterone treatment in very young subjects has not been given sufficient attention. Here we investigated progesterone's effects in the same model of brain injury but with pre-pubescent females. Methods Twenty-eight-day-old female Sprague-Dawley rats received sham (n = 14) or controlled cortical impact (CCI) (n = 21) injury, were given progesterone (8 mg/kg body weight) or vehicle injections on post-injury days (PID) 1-7, and underwent behavioral testing from PID 9-27. Brains were evaluated for lesion size at PID 28. Results Lesion size in vehicle-treated female rats with CCI injury was smaller than that previously reported for similarly treated age-matched male rats. Treatment with progesterone reduced the effect of CCI on extent of damage and behavioral deficits. Conclusion Pre-pubescent female rats with midline CCI injury to the frontal cortex have reduced morphological and functional deficits following progesterone treatment. While gender differences in susceptibility to this injury were observed, progesterone treatment produced beneficial effects in young rats of both sexes following CCI.	[Geddes, Rastafa I.; Peterson, Bethany L.; Stein, Donald G.; Sayeed, Iqbal] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA		Stein, DG (corresponding author), Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA.	dstei04@emory.edu	Stein, Donald/AAJ-5139-2020	Geddes, Rastafa/0000-0002-7313-761X	Emory Center for Injury Control, National Institutes of Health [R49CE001494-04]; Emory University Summer Undergraduate Research Experience (SURE) program; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R49CE001494-04]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001494] Funding Source: NIH RePORTER	This work was supported by the Emory Center for Injury Control, National Institutes of Health grant no. R49CE001494-04 to DGS, the Emory University Summer Undergraduate Research Experience (SURE) program, and by unrestricted gifts to the Brain Research Laboratory from BHR Pharma and Allen and Company. There were no employer/employee relationships with either of the companies although DGS had a consulting agreement with BHR to provide pre-clinical information on the use of progesterone for the treatment of TBI. None of the authors currently participate in any licensing agreement or receive any royalties from BHR Pharma. Allen and Company is an investment firm with no commercial interests in pharmacology or any other matter relating to the authors' research. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of this or any other manuscript.; This work was supported by unrestricted gifts in support of research from BHR Pharma, Allen and Company, the Emory Center for Injury Control, National Institutes of Health grant no. R49CE001494-04 to DGS, and the Emory University Summer Undergraduate Research Experience (SURE) program. The authors would like to acknowledge the contributions of our undergraduate research trainees (William Godwin, Maydda Qureshi, Leea Richardson, and Noah Rosen) towards the completion of this work.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 2000, J NEUROTRAUM, V17, P929; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berry C, 2012, AM J SURG, V204, P558, DOI 10.1016/j.amjsurg.2011.07.012; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coughlan T, 2009, INT J NEUROSCI, V119, P1718, DOI 10.1080/00207450903116430; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Dableh Liliane J, 2011, J Pain Res, V4, P91, DOI 10.2147/JPR.S17009; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Frye CA, 2011, J PSYCHOPHARMACOL, V25, P421, DOI 10.1177/0269881109349836; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Haider AH, 2007, ARCH SURG-CHICAGO, V142, P875, DOI 10.1001/archsurg.142.9.875; Halliwell C, 2009, DEV NEUROREHABIL, V12, P269, DOI 10.3109/17518420903087715; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; HOLMES GL, 1984, DEV BRAIN RES, V16, P45, DOI 10.1016/0165-3806(84)90061-0; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; HULL EM, 1981, PHYSIOL BEHAV, V26, P401, DOI 10.1016/0031-9384(81)90166-9; Kallai J, 2005, BEHAV BRAIN RES, V159, P187, DOI 10.1016/j.bbr.2004.10.015; Kaore SN, 2012, J PHARM PHARMACOL, V64, P1040, DOI 10.1111/j.2042-7158.2012.01464.x; Kolb B, 2000, NEUROPHARMACOLOGY, V39, P756, DOI 10.1016/S0028-3908(99)00260-9; Kolb B, 2013, PROG BRAIN RES, V207, P35, DOI 10.1016/B978-0-444-63327-9.00005-9; Kolb B, 2011, DEV MED CHILD NEUROL, V53, P4, DOI 10.1111/j.1469-8749.2011.04054.x; Lacroix L, 2002, BEHAV BRAIN RES, V133, P69, DOI 10.1016/S0166-4328(01)00442-9; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luoma JI, 2012, J STEROID BIOCHEM, V131, P30, DOI 10.1016/j.jsbmb.2011.11.002; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Mueller SC, 2009, J CHILD PSYCHOL PSYC, V50, P1227, DOI 10.1111/j.1469-7610.2009.02112.x; Newhouse P, 2007, BEHAV BRAIN RES, V183, P1, DOI 10.1016/j.bbr.2007.05.011; PARKER V, 1986, NEUROPHARMACOLOGY, V25, P663, DOI 10.1016/0028-3908(86)90224-8; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Peterson BL, 2015, BEHAV BRAIN RES, V286, P152, DOI 10.1016/j.bbr.2015.03.005; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Reddy DS, 2010, NEUROPHARMACOLOGY, V59, P573, DOI 10.1016/j.neuropharm.2010.08.017; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Robertson CL, 2014, J BIOENERG BIOMEMBR; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Schieb LJ, 2013, MMWR-MORBID MORTAL W, V62, P721; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Singh M, 2005, ANN NY ACAD SCI, V1052, P145, DOI 10.1196/annals.1347.010; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Tsuji M, 2012, EXP NEUROL, V233, P214, DOI 10.1016/j.expneurol.2011.10.004; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wong R, 2013, J CEREBR BLOOD F MET, V33, P1362, DOI 10.1038/jcbfm.2013.120; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2012, AM J SURG, V204, P803, DOI 10.1016/j.amjsurg.2011.05.002; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46	81	14	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146419	10.1371/journal.pone.0146419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6WB	WOS:000368655300020	26799561	gold, Green Published, Green Submitted			2022-02-06	
J	Stockslager, MA; Samuels, BC; Allingham, RR; Klesmith, ZA; Schwaner, SA; Forest, CR; Ethier, CR				Stockslager, Max A.; Samuels, Brian C.; Allingham, R. Rand; Klesmith, Zoe A.; Schwaner, Stephen A.; Forest, Craig R.; Ethier, C. Ross			System for Rapid, Precise Modulation of Intraocular Pressure, toward Minimally-Invasive In Vivo Measurement of Intracranial Pressure	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; OPTIC-NERVE HEAD; OUTFLOW FACILITY; OCULAR RIGIDITY; LUMBAR PUNCTURE; GOLDMANN APPLANATION; UVEOSCLERAL OUTFLOW; GLAUCOMA; PULSATION; EYE	Pathologic changes in intracranial pressure (ICP) are commonly observed in a variety of medical conditions, including traumatic brain injury, stroke, brain tumors, and glaucoma. However, current ICP measurement techniques are invasive, requiring a lumbar puncture or surgical insertion of a cannula into the cerebrospinal fluid (CSF)-filled ventricles of the brain. A potential alternative approach to ICP measurement leverages the unique anatomy of the central retinal vein, which is exposed to both intraocular pressure (IOP) and ICP as it travels inside the eye and through the optic nerve; manipulating IOP while observing changes in the natural pulsations of the central retinal vein could potentially provide an accurate, indirect measure of ICP. As a step toward implementing this technique, we describe the design, fabrication, and characterization of a system that is capable of manipulating IOP in vivo with <0.1 mmHg resolution and settling times less than 2 seconds. In vitro tests were carried out to characterize system performance. Then, as a proof of concept, we used the system to manipulate IOP in tree shrews (Tupaia belangeri) while video of the retinal vessels was recorded and the caliber of a selected vein was quantified. Modulating IOP using our system elicited a rapid change in the appearance of the retinal vein of interest: IOP was lowered from 10 to 3 mmHg, and retinal vein caliber sharply increased as IOP decreased from 7 to 5 mmHg. Another important feature of this technology is its capability to measure ocular compliance and outflow facility in vivo, as demonstrated in tree shrews. Collectively, these proof-of-concept demonstrations support the utility of this system to manipulate IOP for a variety of useful applications in ocular biomechanics, and provide a framework for further study of the mechanisms of retinal venous pulsation.	[Stockslager, Max A.; Klesmith, Zoe A.; Schwaner, Stephen A.; Forest, Craig R.; Ethier, C. Ross] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Samuels, Brian C.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Allingham, R. Rand] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA; [Ethier, C. Ross] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Ethier, C. Ross] Emory Univ, Atlanta, GA 30322 USA		Ethier, CR (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Ethier, CR (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	ross.ethier@bme.gatech.edu		Samuels, Brian/0000-0003-3860-6879	National Institute of Health BRAIN Initiative Grant (NEI) [1-U01-MH106027-01]; National Institute of Health BRAIN Initiative Grant (NIMH) [1-U01-MH106027-01]; National Institutes of Health Single Cell Grant [1 R01 EY023173]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T32EY007092, P30EY006360, R01EY023173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH106027] Funding Source: NIH RePORTER	CRE acknowledges the Georgia Research Alliance (gra.org). CRF acknowledges the National Institutes of Health BRAIN Initiative Grant (NEI and NIMH 1-U01-MH106027-01; nih.gov) and National Institutes of Health Single Cell Grant (1 R01 EY023173; nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SV, 2006, POSTGRAD MED J, V82, P713, DOI 10.1136/pgmj.2006.044792; Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; Boussommier-Calleja A, 2012, INVEST OPHTH VIS SCI, V53, P5838, DOI 10.1167/iovs.12-9923; Brubaker RF, 2003, SURV OPHTHALMOL, V48, pS17, DOI 10.1016/S0039-6257(03)00003-1; Brubaker RF, 2001, J GLAUCOMA, V10, pS45, DOI 10.1097/00061198-200110001-00017; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Chen W, P 2009 2 INT C BIOM, DOI [10.1109/BMEI.2009.5305808, DOI 10.1109/BMEI.2009.5305808]; Cheung CMG, 2004, BRIT J OPHTHALMOL, V88, P582, DOI 10.1136/bjo.2003.027219; Cioboata M, 2014, J Med Life, V7 Spec No. 2, P5; De Moraes CGV., 2008, J OPTOM, V1, P43, DOI DOI 10.3921/JOPTOM.2008.43; Eilaghi A, 2010, ANN BIOMED ENG, V38, P1586, DOI 10.1007/s10439-009-9879-7; EISENLOHR JE, 1962, INVEST OPHTH VISUAL, V1, P63; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Golzan SM, 2012, ANN BIOMED ENG, V40, P1940, DOI 10.1007/s10439-012-0563-y; GRANT WM, 1950, ARCH OPHTHALMOL-CHIC, V44, P204; GRANT WM, 1951, AMA ARCH OPHTHALMOL, V46, P113; Gurol ME, 2008, CURR ATHEROSCLER REP, V10, P324, DOI 10.1007/s11883-008-0050-y; Harder B, 2007, BR J OPHTHALMOL, V91, P399; HARRINGTON H, 1982, J NEUROSURG, V57, P703, DOI 10.3171/jns.1982.57.5.0703; Heimann H., 2010, ESSENTIALS OPHTHALMO, P67; Honjo M., 2011, ARCH OPHTHALMOL-CHIC, V119, P1171; Jacks AS, 2003, J NEUROL NEUROSUR PS, V74, P7, DOI 10.1136/jnnp.74.1.7; Kahook MY, 2013, CHANDLER AND GRANT'S GLAUCOMA, FIFTH EDITION, P1; KAST R, 1985, J NEUROL, V232, P260, DOI 10.1007/BF00313790; Kramer LA, 2012, RADIOLOGY, V263, P819, DOI 10.1148/radiol.12111986; Kymionis GD, 2008, J REFRACT SURG, V24, P173, DOI 10.3928/1081597X-20080201-08; Lee KJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0051-3; Lei YA, 2011, INVEST OPHTH VIS SCI, V52, P1865, DOI 10.1167/iovs.10-6019; Levine DN, 1998, MICROVASC RES, V56, P154, DOI 10.1006/mvre.1998.2098; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; Morgan WH, 1999, THESIS U W AUSTR; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; Ramulu PY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1335, DOI 10.1001/archophthalmol.2010.224; RUBEN JB, 1985, INVEST OPHTH VIS SCI, V26, P153; Sherwood JM, 2015, PLOS ONE UNPUB; Shetty AK, 1999, PEDIATRICS, V103, P1284, DOI 10.1542/peds.103.6.1284; Villamarin A, 2012, INVEST OPHTH VIS SCI, V53, P2831, DOI 10.1167/iovs.11-8752; Wall M, 2010, NEUROL CLIN, V28, P593, DOI 10.1016/j.ncl.2010.03.003; Wang AS, 2013, J GLAUCOMA, V22, P127, DOI 10.1097/IJG.0b013e3182254ba3; Wang J, 2013, INVEST OPHTH VIS SCI, V54, P1706, DOI 10.1167/iovs.12-9841	44	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147020	10.1371/journal.pone.0147020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB6ME	WOS:000368628300052	26771837	Green Published, gold, Green Submitted			2022-02-06	
J	Watts, LT; Long, JA; Boggs, RC; Manga, H; Huang, SL; Shen, Q; Duong, TQ				Watts, Lora Talley; Long, Justin Alexander; Boggs, Robert Cole; Manga, Hemanth; Huang, Shiliang; Shen, Qiang; Duong, Timothy Q.			Delayed Methylene Blue Improves Lesion Volume, Multi-Parametric Quantitative Magnetic Resonance Imaging Measurements, and Behavioral Outcome after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavioral outcomes; CCI; methylene blue; mitochondria; MRI; TBI	DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURIES; WHITE-MATTER INJURY; CYCLOSPORINE-A; OXIDATIVE STRESS; IN-VIVO; DAMAGE; NEUROPROTECTION; RAT; ISCHEMIA	Traumatic brain injury (TBI) remains a primary cause of death and disability in both civilian and military populations worldwide. There is a critical need for the development of neuroprotective agents that can circumvent damage and provide functional recovery. We previously showed that methylene blue (MB), a U.S. Food and Drug Administration-grandfathered drug with energy-enhancing and antioxidant properties, given 1 and 3h post-TBI, had neuroprotective effects in rats. This study aimed to further investigate the neuroprotection of delayed MB treatment (24h postinjury) post-TBI as measured by lesion volume and functional outcomes. Comparisons were made with vehicle and acute MB treatment. Multi-modal magnetic resonance imaging and behavioral studies were performed at 1 and 3h and 2, 7, and 14 days after an impact to the primary forelimb somatosensory cortex. We found that delaying MB treatment 24h postinjury still minimized lesion volume and functional deficits, compared to vehicle-treated animals. The data further support the potential for MB as a neuroprotective treatment, especially when medical teatment is not readily available. MB has an excellent safety profile and is clinically approved for other indications. MB clinical trials on TBI can thus be readily explored.	[Watts, Lora Talley; Long, Justin Alexander; Boggs, Robert Cole; Manga, Hemanth; Huang, Shiliang; Shen, Qiang; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, Div Res, San Antonio, TX USA		Watts, LT (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	wattsl@uthscsa.edu	Watts, Lora Talley/A-2724-2012; Duong, Tim/AAL-8357-2021	Watts, Lora Talley/0000-0002-2337-1504; Duong, Tim/0000-0001-6403-2827	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS45879]; Clinical Translational Science Awards (CTSA) [TL1, KL2, 8UL1TR000149, TL1TR001119, TR001118]; Mike Hogg Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001119, UL1TR000149, KL2TR001118, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045879] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01 NS45879; to T.Q.D.), a TL1 grant (to J.A.L.) and KL2 (to L.T.W.) through the Clinical Translational Science Awards (CTSA; parent grant 8UL1TR000149, TL1TR001119, and TR001118), and the Mike Hogg Fund (to L.T.W.).	Adelson PD, 1998, ACT NEUR S, V71, P104; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bardakci H, 2006, EUR SURG RES, V38, P482, DOI 10.1159/000096007; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Clifton Jack 2nd, 2003, Am J Ther, V10, P289; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Dore-Duffy P, 2011, NEUROL RES, V33, P176, DOI 10.1179/016164111X12881719352372; Evgenov OV, 2002, EUR RESPIR J, V20, P957, DOI 10.1183/09031936.02.00932001; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Huang SL, 2013, NEUROIMAGE, V72, P237, DOI 10.1016/j.neuroimage.2013.01.027; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ishiwata A, 2006, ACTA NEUROL SCAND, V114, P91, DOI 10.1111/j.1600-0404.2006.00661.x; Lin AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046585; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Miclescu A, 2010, CRIT CARE MED, V38, P2199, DOI 10.1097/CCM.0b013e3181f26b0c; MUTTAQIN Z, 1993, ACTA NEUROCHIR, V123, P76, DOI 10.1007/BF01476289; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rodriguez P, 2014, BRAIN RES, V1588, P144, DOI 10.1016/j.brainres.2014.09.007; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Rojas JC, 2009, NEUROTOX RES, V15, P260, DOI 10.1007/s12640-009-9027-z; SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheindlin S, 2008, MOL INTERV, V8, P268, DOI 10.1124/mi.8.6.1; Shen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079833; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Thomale UW, 2002, ACTA NEUROCHIR SUPPL, V81, P229; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Zhang XA, 2006, NEUROTOX RES, V9, P47, DOI 10.1007/BF03033307	55	14	14	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2016	33	2					194	202		10.1089/neu.2015.3904			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DA7PH	WOS:000367995800005	25961471	Green Published			2022-02-06	
J	Casaletto, KB; Moore, DJ; Woods, SP; Umlauf, A; Scott, JC; Heaton, RK				Casaletto, Kaitlin B.; Moore, David J.; Woods, Steven Paul; Umlauf, Anya; Scott, J. C.; Heaton, Robert K.			Abbreviated Goal Management Training Shows Preliminary Evidence as a Neurorehabilitation Tool for HIV-associated Neurocognitive Disorders among Substance Users	CLINICAL NEUROPSYCHOLOGIST			English	Article						Activities of daily living; Executive functions; Compensatory strategies.; Awareness	HUMAN-IMMUNODEFICIENCY-VIRUS; TRAUMATIC BRAIN-INJURY; METHAMPHETAMINE DEPENDENCE; NEUROPSYCHOLOGICAL IMPAIRMENT; SELF-AWARENESS; MEDICATION ADHERENCE; PROSPECTIVE MEMORY; DEFICITS; REHABILITATION; RISK	Objective: Substance use disorders are highly comorbid with and contribute to the increased prevalence of neurocognitive dysfunction observed in HIV infection. Despite their adverse impact on everyday functioning, there are currently no compensatory-based neurorehabilitation interventions validated for use among HIV+ substance users (HIV/SUD). This study examined the effectiveness of goal management training (GMT) alone or GMT as part of a metacognitive training among HIV/SUD individuals with executive dysfunction. Methods: Ninety HIV/SUD individuals were randomized to a single 15-min session: (1) GMT (n=30); (2) GMT plus metacognitive training (neurocognitive awareness; GMT+Meta; n=30); or (3) active control (n=30). Following a brief neurocognitive battery and study condition, participants performed a complex laboratory-based function task, Everyday Multitasking Test (Everyday MT), during which metacognition (awareness) was evaluated. Results: There was an increasing, but non-significant tendency for better Everyday MT performances across study conditions (Control <= GMT <= GMT+Meta; ps<.08). Post hoc analyses showed that GMT and GMT+Meta groups demonstrated small benefits (d=.20-.27) compared to the control arm but did not differ from one another (ds<.10). When GMT groups were combined, there were significant medium effect size benefits in Everyday MT performance and metacognitive task appraisals as compared to the control condition. Among participants who underwent GMT, benefits were most prominent in persons with poorer pre-training dual-tasking ability, depression, and methamphetamine use disorders (ds=.35-1.04). Conclusions: A brief compensatory strategy has benefits for everyday multitasking and metacognition among HIV+ substance users with executive dysfunction. Future work exploring more intensive trainings, potentially complimentary to other restorative approaches and/or pharmacological treatments, is warranted.	[Casaletto, Kaitlin B.] SDSU UCSD Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Moore, David J.; Umlauf, Anya; Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Woods, Steven Paul] Univ Houston, Dept Psychol, Houston, TX USA; [Scott, J. C.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Scott, J. C.] Philadelphia VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN4, Philadelphia, PA USA		Casaletto, KB (corresponding author), Univ Calif San Diego, Dept Psychiat, HIV Neurobehav Res Program, 220 Dickinson St,Suite B, San Diego, CA 92103 USA.	kablackstone@ucsd.edu		Scott, J. Cobb/0000-0001-6538-9043	NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [F31 DA035708, F31-DA035708, P50 DA026306] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30 MH062512] Funding Source: Medline; CSRD VA [IK2 CX000772] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P50DA026306, F31DA035708] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX000772] Funding Source: NIH RePORTER		Alfonso JP, 2011, DRUG ALCOHOL DEPEN, V117, P78, DOI 10.1016/j.drugalcdep.2010.12.025; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Bandura A, 1997, SELF EFFICACY THE EX; Becker JT, 2012, DISABIL REHABIL, V34, P1848, DOI 10.3109/09638288.2012.667188; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackstone K, 2013, AIDS BEHAV, V17, P74, DOI 10.1007/s10461-012-0308-9; Blackstone K, 2013, J ADDICT MED, V7, P255, DOI 10.1097/ADM.0b013e318293653d; Boivin MJ, 2010, NEUROPSYCHOLOGY, V24, P667, DOI 10.1037/a0019312; CALLAHAN CD, 2009, REH NEUR DIS PRACT, P75; Carey CL, 2006, AIDS BEHAV, V10, P185, DOI 10.1007/s10461-005-9056-4; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Casaletto KB, 2015, ADDICT BEHAV, V40, P45, DOI 10.1016/j.addbeh.2014.08.007; Casaletto KB, 2014, ARCH CLIN NEUROPSYCH, V29, P818, DOI 10.1093/arclin/acu061; Chana G, 2006, NEUROLOGY, V67, P1486, DOI 10.1212/01.wnl.0000240066.02404.e6; Chiao S, 2013, AIDS RES HUM RETROV, V29, P949, DOI [10.1089/aid.2012.0229, 10.1089/AID.2012.0229]; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Ellis RJ, 2003, J INFECT DIS, V188, P1820, DOI 10.1086/379894; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Gavrilin MA, 2002, J NEUROVIROL, V8, P240, DOI 10.1080/13550280290049660; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Hacker DJ, 1998, EDUC PSYCHO, P1; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Henry BL, 2010, ADDICT BEHAV, V35, P593, DOI 10.1016/j.addbeh.2010.01.013; Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004; Hinkin CH, 2007, AIDS BEHAV, V11, P185, DOI 10.1007/s10461-006-9152-0; Iudicello JE, 2014, J NEUROVIROL, V20, P85, DOI 10.1007/s13365-014-0233-y; Jackson JC, 2012, CRIT CARE MED, V40, P1088, DOI 10.1097/CCM.0b013e3182373115; Jernigan TL, 2005, AM J PSYCHIAT, V162, P1461, DOI 10.1176/appi.ajp.162.8.1461; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Langford D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-8; Le Berre AP, 2010, ALCOHOL CLIN EXP RES, V34, P1888, DOI 10.1111/j.1530-0277.2010.01277.x; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lysaker PH, 2008, J NERV MENT DIS, V196, P384, DOI 10.1097/NMD.0b013e3181710916; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Palepu A, 2004, ADDICTION, V99, P361, DOI 10.1111/j.1360-0443.2003.00670.x; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Purcell DW, 2001, J SUBST ABUSE, V13, P185, DOI 10.1016/S0899-3289(01)00072-4; Purohit V, 2011, MOL NEUROBIOL, V44, P102, DOI 10.1007/s12035-011-8195-z; Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021; Robertson I., 1996, GOAL MANAGEMENT TRAI; Robertson I., 1994, TEST EVERYDAY ATTENT; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Siegal S., 1988, NONPARAMETRIC STAT B; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Taylor MJ, 2007, J NEUROVIROL, V13, P150, DOI 10.1080/13550280701194230; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Vance DE, 2012, J ASSOC NURSE AIDS C, V23, P500, DOI 10.1016/j.jana.2012.01.005; Weber E, 2013, NEUROPSYCHOL REV, V23, P81, DOI 10.1007/s11065-013-9225-6; Weber E, 2013, J NEUROVIROL, V19, P65, DOI 10.1007/s13365-012-0141-y; *WHO, 1997, COMP INT DIAGN INT V	66	14	15	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2016	30	1					107	130		10.1080/13854046.2015.1129437			24	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DH4CM	WOS:000372733100008	26753986	Green Accepted			2022-02-06	
J	Forbes, CR; Glutting, JJ; Kaminski, TW				Forbes, Cameron R.; Glutting, Joseph J.; Kaminski, Thomas W.			Examining Neurocognitive Function in Previously Concussed Interscholastic Female Soccer Players	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						ANAM; head injury; neuropsychological; purposeful heading	TRAUMATIC BRAIN-INJURY; NORMATIVE DATA; FOOTBALL; SPORTS; SYMPTOMS; IMPACT; RISK; ENCEPHALOPATHY; EPIDEMIOLOGY; RELIABILITY	Awareness of sport-related concussions in soccer has gained recent attention in the medical community. Interestingly, purposeful headinga unique yet strategic and inherent part of soccerinvolves repeated subconcussive blows to the head. We divided 210 female interscholastic soccer players into control (CON [never concussed]) and experimental (EXP [previously concussed]) groups. We assessed neurocognitive performance using the Automated Neuropsychological Assessment Metrics computer program before and after the players' competitive season. Headers were recorded at all sanctioned matches. Data were analyzed using a series of one-way analyses of covariance and t tests. Both groups essentially played in the same number of games (EXP=16.1 vs. CON=16.1) and had an equal number of total headers (EXP=24.9 vs. CON=24.3). Additionally, headers per game were surprisingly low in both groups (1.4 in EXP vs. 1.3 in CON). Unexpectedly, there were no significant differences between the EXP and CON groups across all dependent variables measured (p > .05). This study suggests that although previously concussed players involve themselves in purposeful heading (i.e., subconcussive insults) throughout a competitive season, there appear to be no negative consequences on neuropsychological test performance or concussion-related symptoms. Additional research is needed to determine what may result during the course of a playing career.	[Forbes, Cameron R.] Univ Delaware, Dept Psychol, Newark, DE USA; [Glutting, Joseph J.] Univ Delaware, Sch Educ, Newark, DE USA; [Kaminski, Thomas W.] Univ Delaware, Human Performance Lab, Dept Kinesiol & Appl Physiol, Room 159,541 South Coll Ave, Newark, DE 19716 USA		Kaminski, TW (corresponding author), Univ Delaware, Human Performance Lab, Dept Kinesiol & Appl Physiol, Room 159,541 South Coll Ave, Newark, DE 19716 USA.	Kaminski@udel.edu					Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, SPORTS HEALTH, V1, P361, DOI 10.1177/1941738109343158; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graham J. W., 2003, HDB PSYCHOL, V2, P87, DOI DOI 10.1002/0471264385.WEI0204; Graham J. W., 1999, STAT STRATEGIES SMAL, V1, P1, DOI DOI 10.1177/0013164496056006006; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Jelicic H, 2009, DEV PSYCHOL, V45, P1195, DOI 10.1037/a0015665; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Little R. J., 2019, STAT ANAL MISSING DA, V793; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Randolph C, 2005, J ATHL TRAINING, V40, P139; REEVES D, 2001, AUTOMATED NEUROPSYCH; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rubin D.B., 1987, MULTIPLE IMPUTATION; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Schafer JL, 1997, CHAPMAN HALL SERIES, V72; Schafer JL, 2009, MULTIPLE IMPUTATION; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	51	14	14	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JAN 2	2016	5	1					14	24		10.1080/21622965.2014.933108			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DB7TH	WOS:000368718500003	25495584				2022-02-06	
J	Abe, K; Shimada, R; Okada, Y; Kibayashi, K				Abe, Keiichi; Shimada, Ryo; Okada, Yoshikazu; Kibayashi, Kazuhiko			Traumatic brain injury decreases serotonin transporter expression in the rat cerebrum	NEUROLOGICAL RESEARCH			English	Article						Traumatic brain injury; Depression; Serotonin transporter; SSRI	RANDOMIZED CONTROLLED-TRIAL; DEPRESSION; SERTRALINE; RECEPTOR; AXONS; MODEL	Objectives: An association has been postulated between traumatic brain injury (TBI) and depression. The serotonin transporter (SERT) regulates the concentration of serotonin in the synaptic cleft and represents a molecular target for antidepressants. We hypothesized that SERT expression in the brain changes following TBI. Methods: We performed immunohistochemistry, real-time polymerase chain reaction analysis for mRNA and western blot analysis for protein to examine the time-dependent changes in SERT expression in the cerebrum during the first 14 days after TBI, using a controlled cortical impact model in rats. Results: SERT immunoreactivity in neuronal fibres within the area adjacent to the cortical contusion decreased 1 to 14 days after injury. Significantly decreased SERT mRNA and protein expression were noted in the area adjacent to the cortical contusion 7 days after injury. There were no significant changes in SERT expression in the cingulum of the injured brain. Discussion: The findings of this study indicate that TBI decreases SERT expression in the cerebral cortex. The decreased levels of SERT expression after TBI may result in decreased serotonin neurotransmission in the brain and indicate a possible relationship with depression following TBI.	[Abe, Keiichi; Okada, Yoshikazu] Tokyo Womens Med Univ, Sch Med, Dept Neurosurg, Tokyo 1628666, Japan; [Shimada, Ryo; Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Tokyo 1628666, Japan		Shimada, R (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	shimada@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [26293164]	This work was supported by Grant-in-Aid for Scientific Research (B) to K.K. from the Japan Society for the Promotion of Science [No. 26293164].	Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Austin MC, 2002, NEUROSCIENCE, V114, P807, DOI 10.1016/S0306-4522(02)00289-0; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Banos JH, 2010, J HEAD TRAUMA REHAB, V25, P357, DOI 10.1097/HTR.0b013e3181d6c715; Croft HA, 2014, J CLIN PSYCHIAT, V75, pE1291, DOI 10.4088/JCP.14m08992; Dam H, 2007, NEUROL RES, V29, P717, DOI 10.1179/016164107X208059; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FUJITA M, 1993, NEUROSCI LETT, V162, P59, DOI 10.1016/0304-3940(93)90559-4; Horschitz S, 2001, BIOCHEM SOC T, V29, P728, DOI 10.1042/0300-5127:0290728; Inoue T, 2002, CNS NEUROL DISORD-DR, V1, P519, DOI 10.2174/1568007023338987; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Masuzawa Hideaki, 2003, No To Shinkei, V55, P933; Penna Aubin, 2007, J Vis Exp, P264, DOI 10.3791/264; Rapoport MJ, 2010, J CLIN PSYCHIAT, V71, P1125, DOI 10.4088/JCP.09m05086blu; Sakai N, 2000, SEIKAGAKU, V72, P1215; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Shimada R, 2012, J CLIN NEUROSCI, V19, P447, DOI 10.1016/j.jocn.2011.06.033; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sur C, 1996, NEUROSCIENCE, V73, P217, DOI 10.1016/0306-4522(96)00030-9; Zhou FC, 1998, BRAIN RES, V805, P241, DOI 10.1016/S0006-8993(98)00691-X	23	14	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	4					358	363		10.1080/01616412.2015.1110402			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DM4TK	WOS:000376339400012	27082144				2022-02-06	
J	Alshehri, MM; Sparto, PJ; Furman, JM; Fedor, S; Mucha, A; Henry, LC; Whitney, SL				Alshehri, Mohammed M.; Sparto, Patrick J.; Furman, Joseph M.; Fedor, Sheri; Mucha, Anne; Henry, Luke C.; Whitney, Susan L.			The usefulness of the video head impulse test in children and adults post-concussion	JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION			English	Article							TRAUMATIC BRAIN-INJURY; VESTIBULAR DAMAGE; NORMATIVE DATA; DIZZINESS; SYMPTOMS; RELIABILITY; VERTIGO; VHIT	OBJECTIVE: Dizziness after concussion have been reported in both youths and adults. It is not clear if the dizziness experienced post-concussion is from peripheral or central etiology. New technology has been developed to quickly and easily quantify the magnitude of peripheral vestibular disorders that is non-invasive and acceptable to youths and adults. The purpose of this study was to determine if youths and adults' post-concussion have evidence of decreased horizontal semicircular canal vestibulo-ocular reflex (VOR) gains as measured with the video head impulse test (vHIT), which would indicate a peripheral vestibular disorder. An additional purpose was to determine if VOR gain scores correlate with functional performance measures. Design: Descriptive cross sectional. SETTING: Large medical center out-patient concussion program. PARTICIPANTS: Fifty-six subjects with concussion. MAIN OUTCOMES/MEASURES: Subjects completed the vHIT testing, the Dizziness Handicap Inventory (DHI), the Vestibular Activities and Participation (VAP) scale, the Pediatric Vestibular Symptom Questionnaire, gait speed assessment, the Dynamic Gait Index (DGI) and a verbal analog scale of symptom provocation before and after the vHIT testing. RESULTS: There were no abnormal vHIT findings in any subject. Headaches, dizziness and nausea were significantly worse post vHIT testing (p < 0.05). Youths had better DGI and DHI scores than subjects older than 20 (p < 0.05). CONCLUSION: The vHIT did not detect horizontal semicircular canal weakness in any of the subjects tested. In addition, older adults reported more activity and participation limitations than the younger subjects with concussion.	[Alshehri, Mohammed M.] Univ Pittsburgh, Pittsburgh, PA USA; [Alshehri, Mohammed M.] Jazan Univ, Jizan, Saudi Arabia; [Sparto, Patrick J.; Whitney, Susan L.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15260 USA; [Sparto, Patrick J.; Furman, Joseph M.; Whitney, Susan L.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Furman, Joseph M.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Furman, Joseph M.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA USA; [Fedor, Sheri; Mucha, Anne] Univ Pittsburgh, Med Ctr, Ctr Rehab Serv, Pittsburgh, PA USA; [Henry, Luke C.] Univ Pittsburgh, Med Ctr, Dept Orthoped Surg, Pittsburgh, PA USA		Whitney, SL (corresponding author), Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15260 USA.; Whitney, SL (corresponding author), Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA.	whitney@pitt.edu		Sparto, Patrick/0000-0002-8351-3789			Alghwiri A, 2014, J VESTIBUL RES-EQUIL, V24, P325; Alghwiri AA, 2012, ARCH PHYS MED REHAB, V93, P1822, DOI 10.1016/j.apmr.2012.03.017; Alsalaheen BA, 2014, PEDIATR PHYS THER, V26, P191, DOI 10.1097/PEP.0000000000000037; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bartl K, 2009, ANN NY ACAD SCI, V1164, P331, DOI 10.1111/j.1749-6632.2009.03850.x; Bell SL, 2015, EUR ARCH OTO-RHINO-L, V272, P1287, DOI 10.1007/s00405-014-3397-4; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Friscia LA, 2014, OTOL NEUROTOL, V35, P884, DOI 10.1097/MAO.0000000000000421; GANNON RP, 1978, ARCH OTOLARYNGOL, V104, P404; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Grill E, 2012, J VESTIBUL RES-EQUIL, V22, P261, DOI 10.3233/VES-120459; Hamilton SS, 2015, INT J PEDIATR OTORHI, V79, P1283, DOI 10.1016/j.ijporl.2015.05.033; Hulse R, 2015, INT J PEDIATR OTORHI, V79, P1288, DOI 10.1016/j.ijporl.2015.05.034; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; MacDougall HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061488; Macdougall Hamish Gavin, 2012, Front Neurol, V3, P21, DOI 10.3389/fneur.2012.00021; Mahringer A, 2014, EUR ARCH OTO-RHINO-L, V271, P463, DOI 10.1007/s00405-013-2376-5; Manzari L, 2013, INT J AUDIOL, V52, P713, DOI 10.3109/14992027.2013.809485; Manzari L, 2011, EUR J NEUROL, V18, P45; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCaslin DL, 2014, EAR HEARING, V35, pE185, DOI 10.1097/AUD.0000000000000047; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Migliaccio AA, 2011, J VESTIBUL RES-EQUIL, V21, P227, DOI 10.3233/VES-2011-0421; Milonski J, 2014, INT J OCCUP MED ENV, V27, P583, DOI 10.2478/s13382-014-0278-4; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mueller M., 2014, J CLIN EPIDEMIOL; Murnane O, 2014, J AM ACAD AUDIOL, V25, P244, DOI 10.3766/jaaa.25.3.3; Mutlu B, 2013, J VESTIBUL RES-EQUIL, V23, P271, DOI 10.3233/VES-130488; Pan T, 2015, GAIT POSTURE, V42, P550, DOI 10.1016/j.gaitpost.2015.08.012; Pavlou M., J PEDAIT IN PRESS; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Tamber AL, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-101; TOGLIA JU, 1970, ARCHIV OTOLARYNGOL, V92, P485; WILLSON GN, 1981, J LARYNGOL OTOL, V95, P1213, DOI 10.1017/S0022215100092057; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	45	14	15	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0957-4271	1878-6464		J VESTIBUL RES-EQUIL	J. Vestib. Res.-Equilib. Orientat.		2016	26	5-6					439	446		10.3233/VES-160598			8	Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	EM2XG	WOS:000395178500005	28262647				2022-02-06	
J	Clark, AL; Sorg, SF; Schiehser, DM; Luc, N; Bondi, MW; Sanderson, M; Werhane, ML; Delano-Wood, L				Clark, Alexandra L.; Sorg, Scott F.; Schiehser, Dawn M.; Luc, Norman; Bondi, Mark W.; Sanderson, Mark; Werhane, Madeleine L.; Delano-Wood, Lisa			Deep white matter hyperintensities affect verbal memory independent of PTSD symptoms in veterans with mild traumatic brain injury	BRAIN INJURY			English	Article						White matter hyperintensities; white matter lesions; WMH; WML; DWMH; PVWMH; periventricular lesions; PVL; deep white matter lesions; DWML; TBI; PCS; cognition; neuropsychology; traumatic brain injury; postconcussive symptoms; head trauma	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; POSTTRAUMATIC-STRESS-DISORDER; APOLIPOPROTEIN-E GENOTYPE; MIDDLE-AGED PARTICIPANTS; DIFFUSE AXONAL INJURY; COGNITIVE IMPAIRMENT; POSTCONCUSSIVE SYMPTOMS; COMMUNITY SAMPLE; RISK-FACTORS; CARDIOVASCULAR HEALTH	Objective: Although white matter hyperintensity (WMH) pathology has been observed in the context of traumatic brain injury (TBI), the contribution of this type of macrostructural damage to cognitive and/or post-concussive symptomatology (PCS) remains unclear. Methods: Sixty-eight Veterans (mTBI = 46, Military Controls [MCs] = 22) with and without history of mild TBI (mTBI) underwent structural MRI and comprehensive cognitive and psychiatric assessment. WMH volume was identified as deep (DWMH) or periventricular (PVWMH) on fluidattenuated inversion recovery (FLAIR) images. Results: Group analyses revealed that mTBI history was not associated with increased WMH pathology (p's > 0.05). However, after controlling for post-traumatic stress disorder (PTSD) and intracranial volume, DWMH was associated with reduced short-and long-delayed memory performance within the mTBI group (p's < 0.05). Additionally, after adjusting for PTSD and time since injury, regression analyses revealed that WMH was not associated with self-reported ratings of PCS (p's > 0.05) in the mTBI group. Conclusions: The results demonstrate that, in relatively young Veterans with mTBI, DWMH differentially and negatively affects memory performance above and beyond the effects of PTSD symptoms. The findings may help to clarify prior mixed results as well as offer focused treatment implications for Veterans with history of neurotrauma and evidence of macrostructural white matter damage.	[Clark, Alexandra L.; Werhane, Madeleine L.] Univ Calif San Diego, San Diego State Univ, San Diego SDSU UCSD Joint Doctoral Program Clin P, San Diego, CA 92103 USA; [Clark, Alexandra L.; Sorg, Scott F.; Schiehser, Dawn M.; Luc, Norman; Bondi, Mark W.; Sanderson, Mark; Werhane, Madeleine L.; Delano-Wood, Lisa] VASDHS, San Diego, CA USA; [Sorg, Scott F.; Schiehser, Dawn M.; Bondi, Mark W.; Delano-Wood, Lisa] UCSD Sch Med, Dept Psychiat, San Diego, CA USA; [Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 151B, San Diego, CA 92161 USA.	ldelano@ucsd.edu			Veterans Affairs (Career Development Awards [CDA]); Department of Defense (Investigator-Initiated Research Grant [IIRG])	This work was supported by grants awarded by the Veterans Affairs (Career Development Awards [CDA]: L.D.-W., D.S.; Merit Award; L.D.-W.) as well as the Department of Defense (Investigator-Initiated Research Grant [IIRG]: L.D.-W.). This material is further supported with resources of the Veterans Affairs Center of Excellence for Stress and Mental Health (CESAMH: L.D.-W.; D.S.).	Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Clark AL, 2015, J HEAD TRAUMA REHABI; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; de Groot M, 2013, STROKE, V44, P1037, DOI 10.1161/STROKEAHA.112.680223; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DECARLI C, 1995, NEUROLOGY, V45, P2077, DOI 10.1212/WNL.45.11.2077; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Delano-Wood L, 2008, STROKE, V39, P794, DOI 10.1161/STROKEAHA.107.502534; Delano-Wood L, 2009, J INT NEUROPSYCH SOC, V15, P906, DOI 10.1017/S1355617709990257; Delis D., 2001, D KEFS EXAMINERS TEC; Delis D.C., 2001, CALIFORNIA VERBAL LE; Department of Defense, 2009, 2009 VA DOD CLIN PRA; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Gebeily S, 2014, INT J NEUROSCI, V124, P799, DOI 10.3109/00207454.2014.884087; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Soriano-Raya JJ, 2014, J CEREBR BLOOD F MET, V34, P861, DOI 10.1038/jcbfm.2014.26; Soriano-Raya JJ, 2012, J INT NEUROPSYCH SOC, V18, P874, DOI 10.1017/S1355617712000677; Kempton MJ, 2011, ARCH GEN PSYCHIAT, V68, P675, DOI 10.1001/archgenpsychiatry.2011.60; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Kim SH, 2011, J NEUROIMAGING, V21, P317, DOI 10.1111/j.1552-6569.2010.00527.x; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Libon DJ, 2008, STROKE, V39, P806, DOI 10.1161/STROKEAHA.107.489997; Libon DJ, 2008, STROKE, V39, P783, DOI 10.1161/STROKEAHA.108.515569; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maillard P, 2014, STROKE, V45, P1721, DOI 10.1161/STROKEAHA.113.004084; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Murray AD, 2005, RADIOLOGY, V237, P251, DOI 10.1148/radiol.2371041496; Nebes RD, 2001, AM J PSYCHIAT, V158, P878, DOI 10.1176/appi.ajp.158.987.878; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nyquist PA, 2015, NEUROBIOL AGING, V36, P1653, DOI 10.1016/j.neurobiolaging.2015.01.005; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Price CC, 2012, NEUROLOGY, V79, P734, DOI 10.1212/WNL.0b013e3182661ef6; Price CC, 2005, NEUROLOGY, V65, P376, DOI 10.1212/01.WNL.0000168877.06011.15; Raz N, 2007, NEUROPSYCHOLOGY, V21, P149, DOI 10.1037/0894-4105.21.2.149; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silbert LC, 2009, NEUROLOGY, V73, P120, DOI 10.1212/WNL.0b013e3181ad53fd; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith EE, 2008, ARCH NEUROL-CHICAGO, V65, P94, DOI 10.1001/archneurol.2007.23; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Sorg SF, 2015, J HEAD TRAUMA REHABI; Steffens DC, 2007, AM J GERIAT PSYCHIAT, V15, P839, DOI 10.1097/JGP.0b013e318048a1a0; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tombaugh T.N., 1996, TEST MEMORY MALINGER; United States Army Medical Research and Material Command, REP SURG GEN TRAUM B; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vannorsdall TD, 2009, ARCH CLIN NEUROPSYCH, V24, P209, DOI 10.1093/arclin/acp037; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; WANG R, 2014, LIVER TRANSPLANT, V21, P1076, DOI DOI 10.1111/ENE.12319; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Yoshita M, 2006, NEUROLOGY, V67, P2192, DOI 10.1212/01.wnl.0000249119.95747.1f	75	14	14	1	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	7					864	871		10.3109/02699052.2016.1144894			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DP2MI	WOS:000378322400005	27058006				2022-02-06	
J	Connery, AK; Peterson, RL; Baker, DA; Kirkwood, MW				Connery, Amy K.; Peterson, Robin L.; Baker, David A.; Kirkwood, Michael W.			The impact of pediatric neuropsychological consultation in mild traumatic brain injury: a model for providing feedback after invalid performance	CLINICAL NEUROPSYCHOLOGIST			English	Article						Validity testing; pediatric neuropsychological assessment; noncredible effort	POSTCONCUSSIVE SYMPTOMS; RECOGNITION TRIAL; CHILDREN; STATEMENT; ACADEMY; SCORES; PAIN; TOMM; TBI	Objective: In recent years, pediatric practitioners have increasingly recognized the importance of objectively measuring performance validity during clinical assessments. Yet, no studies have examined the impact of neuropsychological consultation when invalid performance has been identified in pediatric populations and little published guidance exists for clinical management. Here we provide a conceptual model for providing feedback after noncredible performance has been detected. In a pilot study, we examine caregiver satisfaction and postconcussive symptoms following provision of this feedback for patients seen through our concussion program. Methods: Participants (N=70) were 8-17-year-olds with a history of mild traumatic brain injury who underwent an abbreviated neuropsychological evaluation between 2 and 12months post-injury. We examined postconcussive symptom reduction and caregiver satisfaction after neuropsychological evaluation between groups of patients who were determined to have provided noncredible effort (n=9) and those for whom no validity concerns were present (n=61). Results: We found similarly high levels of caregiver satisfaction between groups and greater reduction in self-reported symptoms after feedback was provided using the model with children with noncredible presentations compared to those with credible presentations. Conclusion: The current study lends preliminary support to the idea that the identification and communication of invalid performance can be a beneficial clinical intervention that promotes high levels of caregiver satisfaction and a reduction in self-reported and caregiver-reported symptoms.	[Connery, Amy K.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; Childrens Hosp Colorado, Aurora, CO USA		Connery, AK (corresponding author), Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA.	amy.connery@childrenscolorado.org					Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Baker D. A., 2015, VALIDITY TESTING CHI, P125; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bodin D, 2007, CLIN NEUROPSYCHOL, V21, P884, DOI 10.1080/13854040600888784; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Breaux K. C., 2009, TECHNICAL MANAUL WEC; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P997, DOI 10.1016/j.acn.2005.06.003; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; BUSH SS, 2009, NEUROPSYCHOLOGY MALI, P530; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Connery A, 2015, VALIDITY TESTING CHI, P145; Delis DC., 1994, CALIFORNIA VERBAL LE; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Donders J., 2011, CASEBOOK CLIN NEUROP, P183; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Flaro L., 2009, NEUROPSYCHOLOGY MALI, P369; Green CM, 2014, J CLIN EXP NEUROPSYC, V36, P261, DOI 10.1080/13803395.2013.879096; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2004, MANUAL MED SYMPTOM V; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; Kirkwood M. W, 2015, VALIDITY TESTING CHI, P79; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; Larson JCG, 2015, ARCH CLIN NEUROPSYCH, V30, P192, DOI 10.1093/arclin/acv012; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; REITAN R, 1969, MANUAL ADM NEU UNPUB; Sherman E. M. S., 2015, VALIDITY TESTING CHI, P22; Slick D. J., 2012, PEDIAT FORENSIC NEUR, P113; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 2011, WASI 2 WECHSLER ABBR	48	14	14	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	4					579	598		10.1080/13854046.2016.1177596			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DO6YO	WOS:000377929600007	27142647				2022-02-06	
J	D'Alessandro, A; Nemkov, T; Moore, HB; Moore, EE; Wither, M; Nydam, T; Slaughter, A; Silliman, CC; Banerjee, A; Hansen, KC				D'Alessandro, Angelo; Nemkov, Travis; Moore, Hunter B.; Moore, Ernest E.; Wither, Matthew; Nydam, Trevor; Slaughter, Annie; Silliman, Christopher C.; Banerjee, Anirban; Hansen, Kirk C.			Metabolomics of trauma-associated death: shared and fluid-specific features of human plasma vs lymph	BLOOD TRANSFUSION			English	Article						small molecule; mass spectrometry; correlation; quantitative changes; trauma	MESENTERIC LYMPH; LUNG INJURY; HYDROGEN-SULFIDE; SUCCINATE; ACID; METABOLISM	Background. Water-soluble components in mesenteric lymph have been implicated in the pathophysiology of acute lung injury and distal organ failure following trauma and haemorrhagic shock. Proteomics analyses have recently shown similarities and specificities of post-trauma/haemorrhagic shock lymph and plasma. We hypothesise that the metabolic phenotype of post-trauma/haemorrhagic shock mesenteric lymph and plasma share common metabolites, but are also characterised by unique features that differentiate these two fluids. Materials and methods. Matched samples were collected from 5 brain-dead organ donors who had suffered extreme trauma/haemorrhagic shock. Metabolomics analyses were performed through ultra-high performance liquid chromatography mass spectrometry. Results. Overall, 269 metabolites were identified in either fluid. Despite significant overlapping, metabolic phenotypes of matched lymph or plasma from the same patients could be used to discriminate sample fluid or biological patient/traumatic-injury origin. Metabolites showing relatively high levels in both fluids included markers of haemolysis and cell lysis secondary to tissue injury. Discussion. High positive correlations were observed between the quantitative levels of markers of systemic metabolic derangement following traumatic/haemorrhagic hypoxaemia, such as succinate, oxoproline, urate and fatty acids. These metabolites might contribute to coagulopathies of trauma and neutrophil priming driving acute lung injury. Future studies will investigate whether the observed compositional specificities mirror functional or pathological adaptations after trauma and haemorrhage.	[D'Alessandro, Angelo; Nemkov, Travis; Wither, Matthew; Hansen, Kirk C.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Moore, Hunter B.; Moore, Ernest E.; Slaughter, Annie; Banerjee, Anirban] Univ Colorado Denver, Sch Med, Dept Surg, Aurora, CO USA; [Moore, Ernest E.; Nydam, Trevor] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Silliman, Christopher C.] Univ Colorado, Dept Paediat, 12801 East 17th Ave, Aurora, CO 80045 USA; [Silliman, Christopher C.] Bonfils Blood Ctr, Denver, CO USA		Hansen, KC (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, 12801 East 17th Ave, Aurora, CO 80045 USA.	kirk.hansen@UCDenver.edu	D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490	National Institutes of Health, National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32-GM008315, P50-GM049222]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR023015]; University of Colorado Comprehensive Cancer Center Core Support [P30 CA046934-17]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR023015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM049222, T32GM008315] Funding Source: NIH RePORTER	This work was supported in part by grants from the National Institutes of Health, National Institute of General Medical Sciences grants: T32-GM008315 and P50-GM049222, National Center for Research Resources (Grant Number S10RR023015), and University of Colorado Comprehensive Cancer Center Core Support (P30 CA046934-17).	Aller MA, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-27; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Chinopoulos C, 2013, J NEUROSCI RES, V91, P1030, DOI 10.1002/jnr.23196; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Clement CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009863; Cryer HG, 2014, J TRAUMA ACUTE CARE, V76, P592; CUTHBERTSON DP, 1982, SCOT MED J, V27, P158, DOI 10.1177/003693308202700210; D'Alessandro A, 2015, TRANSFUSION, V55, P1155, DOI 10.1111/trf.12975; D'Alessandro A, 2014, SHOCK, V42, P509, DOI 10.1097/SHK.0000000000000259; DAlessandro A, 2015, AM J PHYSL REGUL INT; de la Pena HC, 2000, ARCH MED RES, V31, P546, DOI 10.1016/S0188-4409(00)00238-1; Dzieciatkowska M, 2014, SHOCK, V42, P485, DOI 10.1097/SHK.0000000000000249; Hansen KC, 2015, INT IMMUNOL, V27, P219, DOI 10.1093/intimm/dxv012; Hasko G, 2006, CRIT CARE MED, V34, P1119, DOI 10.1097/01.CCM.0000206467.19509.C6; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Huang S, 2015, IJC HEART VASC, V7, P51, DOI 10.1016/j.ijcha.2015.01.010; Kinross J, 2009, CURR PHARM DESIGN, V15, P1537, DOI 10.2174/138161209788168119; Kinross JM, 2011, J PROTEOME RES, V10, P277, DOI 10.1021/pr1003278; Lee C, 2004, J TRAUMA, V57, P955, DOI 10.1097/01.ta.0000149495.44582.76; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Michel CC, 1997, EXP PHYSIOL, V82, P1; Mikhail J, 1999, AACN Clin Issues, V10, P85, DOI 10.1097/00044067-199902000-00008; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Morishita K, 2012, J TRAUMA ACUTE CARE, V72, P1541, DOI 10.1097/TA.0b013e318256df15; Nemkov T, 2015, AMINO ACIDS, V47, P2345, DOI 10.1007/s00726-015-2019-9; Peltz ED, 2015, J TRAUMA ACUTE CARE, V78, P742, DOI 10.1097/TA.0000000000000589; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Sauaia A, 2014, J TRAUMA ACUTE CARE, V76, P582, DOI 10.1097/TA.0000000000000147; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Spath B, 2012, PLATELETS, V23, P60, DOI 10.3109/09537104.2011.590255; Synenki L, 2007, CRIT CARE MED, V35, P842, DOI 10.1097/01.CCM.0000257254.87984.69; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Whiteman M, 2009, J CELL MOL MED, V13, P488, DOI 10.1111/j.1582-4934.2009.00645.x; Zallen G, 1999, J SURG RES, V83, P83, DOI 10.1006/jsre.1999.5569; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4	36	14	14	0	8	SIMTI SERVIZI SRL	MILAN	VIA DESIDERIO 21, MILAN, 20131, ITALY	1723-2007			BLOOD TRANSFUS-ITALY	Blood Transf.		2016	14	3					185	194		10.2450/2016.0208-15			10	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	DP6PO	WOS:000378619800001	27177401				2022-02-06	
J	Fuller, GW; Ransom, J; Mandrekar, J; Brown, AW				Fuller, Gordon W.; Ransom, Jeanine; Mandrekar, Jay; Brown, Allen W.			Long-Term Survival Following Traumatic Brain Injury: A Population-Based Parametric Survival Analysis	NEUROEPIDEMIOLOGY			English	Article						Craniocerebral trauma; Survival analysis; Mortality	ROCHESTER EPIDEMIOLOGY PROJECT; MEDICAL-RECORDS-LINKAGE; HEAD-INJURY; CLINICAL-TRIALS; RISK-FACTORS; MORTALITY; COHORT; SYSTEM	Background: Long-term mortality may be increased following traumatic brain injury (TBI); however, the degree to which survival could be reduced is unknown. We aimed at modelling life expectancy following post-acute TBI to provide predictions of longevity and quantify differences in survivorship with the general population. Methods: A population-based retrospective cohort study using data from the Rochester Epidemiology Project (REP) was performed. A random sample of patients from Olmsted County, Minnesota with a confirmed TBI between 1987 and 2000 was identified and vital status determined in 2013. Parametric survival modelling was then used to develop a model to predict life expectancy following TBI conditional on age at injury. Survivorship following TBI was also compared with the general population and age- and gender-matched non-head injured REP controls. Results: Seven hundred and sixty nine patients were included in complete case analyses. The median follow-up time was 16.1 years (interquartile range 9.0-20.4) with 120 deaths occurring in the cohort during the study period. Survival after acute TBI was well represented by a Gompertz distribution. Victims of TBI surviving for at least 6 months post-injury demonstrated a much higher ongoing mortality rate compared to the US general population and non-TBI controls (hazard ratio 1.47, 95% CI 1.15-1.87). US general population cohort life table data was used to update the Gompertz model's shape and scale parameters to account for cohort effects and allow prediction of life expectancy in contemporary TBI. Conclusions: Survivors of TBI have decreased life expectancy compared to the general population. This may be secondary to the head injury itself or result from patient characteristics associated with both the propensity for TBI and increased early mortality. Post-TBI life expectancy estimates may be useful to guide prognosis, in public health planning, for actuarial applications and in the extrapolation of outcomes for TBI economic models. (C) 2016 S. Karger AG, Basel	[Fuller, Gordon W.] Univ Sheffield, Sch Hlth & Related Res ScHARR, Hlth Serv Res Sect, Emergency Med Res Sheffield, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England; [Ransom, Jeanine; Mandrekar, Jay] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA		Fuller, GW (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Hlth Serv Res Sect, Emergency Med Res Sheffield, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.	g.fuller@sheffield.ac.uk		Brown, Allen W./0000-0001-7228-3351; Fuller, Gordon Ward/0000-0001-8532-3500	Mayo Clinic; National Institute for Health ResearchNational Institute for Health Research (NIHR) [DRF-2011-04-050, CL-2015-04-005] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD065987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034676] Funding Source: NIH RePORTER	The study was sponsored and funded by the Mayo Clinic. All authors had full access to the data in the study and had final responsibility for the decision to submit for publication.	Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Brown AW, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318280d3e6; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CUNNINGHAM VJ, 1985, MED INFORM, V10, P137, DOI 10.3109/14639238509010848; Drummond M., 2005, METHODS EC EVALUATIO; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Hamson-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Ishak KJ, 2013, PHARMACOECONOMICS, V31, P663, DOI 10.1007/s40273-013-0064-3; Latimer NR, 2013, MED DECIS MAKING, V33, P743, DOI 10.1177/0272989X12472398; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Soreide K, 2009, BRIT J SURG, V96, P697, DOI 10.1002/bjs.6643; St Sauver JL, 2012, INT J EPIDEMIOL, V41, P1614, DOI 10.1093/ije/dys195; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; Steyerberg, 2019, CLIN PREDICTION MODE; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	31	14	14	1	6	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2016	47	1					1	10		10.1159/000445997			10	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Neurosciences & Neurology	DW0FA	WOS:000383315100001	27165161	Green Accepted			2022-02-06	
J	Knox, L; Douglas, JM; Bigby, C				Knox, Lucy; Douglas, Jacinta M.; Bigby, Christine			Becoming a decision-making supporter for someone with acquired cognitive disability following traumatic brain injury	RESEARCH AND PRACTICE IN INTELLECTUAL AND DEVELOPMENTAL DISABILITIES			English	Article						Decision-making; supported decision-making; brain injury; qualitative	INDIVIDUALS; PARTNERS; AUTONOMY; TBI	Despite an increased awareness of society's obligation to ensure that people with cognitive disabilities have access to decision-making support, little is known about how this support should be provided. For people with traumatic brain injury, informal support mechanisms may provide the primary means of support but there is limited understanding of how this aids participation. As part of a larger project using constructivist grounded theory to explore processes used by adults with severe traumatic brain injury in making decisions after injury, the authors explored a single-case study, presented in this article. In particular, the study aimed to build an understanding of the evolution of decision-making support over time from multiple perspectives. Data consisted of seven in-depth, individual interviews with three participants: the central participant, Beau, and two participants whom he nominated as his decision-making supporters. Analysis of the data revealed several key themes relating to both the nature of the decision-making process and the factors that underpinned decision-making support. Relational factors included: (a) knowing who I am and what I value; (b) understanding the nature of the relationship; and (c) working with each other. Process factors included: (a) sharing a vision; (b) adjusting process to decisional circumstances; and (c) developing a supportive network. Findings emphasised that knowing the person well and sharing a focus on maximising autonomy contributed to positive decision-making support. However, the data also highlight potential challenges associated with the role of decision-making supporter and the importance of support for those who take on this role.	[Knox, Lucy; Douglas, Jacinta M.] La Trobe Univ, Dept Community & Allied Hlth, Melbourne, Vic, Australia; [Knox, Lucy; Douglas, Jacinta M.; Bigby, Christine] La Trobe Univ, Living Disabil Res Ctr, Melbourne, Vic, Australia; [Douglas, Jacinta M.] Summer Fdn, Box Hill, Vic, Australia		Knox, L (corresponding author), La Trobe Univ, Dept Community & Allied Hlth, Melbourne, Vic, Australia.; Knox, L (corresponding author), La Trobe Univ, Living Disabil Res Ctr, Melbourne, Vic, Australia.	L.Knox@latrobe.edu.au	bigby, Christine/I-8526-2015	bigby, Christine/0000-0001-7001-8976; Knox, Lucy/0000-0001-8331-6032	university postgraduate scholarship; Victorian Brain Injury Recovery Association; East Kew Branch of the Community Bendigo Bank Research Scholarship	Sincere thanks are extended to the participants in this research, who generously shared their experiences. This research was supported by a university postgraduate scholarship and Victorian Brain Injury Recovery Association and East Kew Branch of the Community Bendigo Bank Research Scholarship awarded to the first author.	Australian Institute of Health and Welfare, 2007, DIS AUSTR ACQ BRAIN; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Browning M, 2014, RES PRACT INTELLECT, V1, P34, DOI 10.1080/23297018.2014.902726; Carney T, 2014, RES PRACT INTELLECT, V1, P46, DOI 10.1080/23297018.2014.902727; Charmaz K., 2008, HDB CONSTRUCTIONIST, P397; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd edition; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corbin J, 2003, QUAL INQ, V9, P335, DOI 10.1177/1077800403009003001; Dey, 1999, GROUNDING GROUNDED T; DOUGLAS J, 2004, EVIDENCE BASED PRACT; Fellows LK, 2012, J INT NEUROPSYCH SOC, V18, P937, DOI 10.1017/S1355617712001294; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hunt MR, 2011, DISABIL REHABIL, V33, P961, DOI 10.3109/09638288.2010.515703; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kennedy TJT, 2006, MED EDUC, V40, P101, DOI 10.1111/j.1365-2929.2005.02378.x; Knox L, 2016, NEUROPSYCHOL REHABIL, V26, P236, DOI 10.1080/09602011.2015.1019519; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Knox L, 2013, DISABIL REHABIL, V35, P1926, DOI 10.3109/09638288.2013.766270; Kohn NA, 2014, DISABIL HEALTH J, V7, pS40, DOI 10.1016/j.dhjo.2013.03.005; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; National Institute of Neurological Disorders and Stroke, 2011, NINDS TRAUM BRAIN IN; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; QSR International Pty Ltd, 2010, NVIVO QUAL DAT AN SO; Schipper K, 2011, NURS ETHICS, V18, P526, DOI 10.1177/0969733011403554; Sloan S., 2007, BRAIN IMPAIR, V8, P251, DOI [10.1375/brim.8.3.251, DOI 10.1375/BRIM.8.3.251]; United Nations General Assembly, 2007, CONV RIGHTS PERS DIS	28	14	14	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2329-7018	2329-7026		RES PRACT INTELLECT	Res. Pract. Intellect. Dev. Disabil.		2016	3	1					12	21		10.1080/23297018.2015.1077341			10	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FF1TE	WOS:000408681000003					2022-02-06	
J	Lei, BL; Wang, HC; Jeong, ST; Hsieh, JT; Majeed, M; Dawson, H; Sheng, HX; Warner, DS; James, ML				Lei, Beilei; Wang, Haichen; Jeong, Seongtae; Hsieh, Justin T.; Majeed, Mohammed; Dawson, Hana; Sheng, Huaxin; Warner, David S.; James, Michael L.			Progesterone Improves Neurobehavioral Outcome in Models of Intracerebral Hemorrhage	NEUROENDOCRINOLOGY			English	Article						Progesterone; Sex differences; Intracerebral hemorrhage; Neurobehavior; Recovery; Murine model; Collagenase; Autologous blood; Aged mice	TRAUMATIC BRAIN-INJURY; RAT; STROKE; ESTROGEN; EDEMA; TRIAL; NEUROPROTECTION; EXPRESSION; HEMATOMAS; MICROGLIA	In models of acute brain injury, progesterone improves recovery through several mechanisms including modulation of neuroinflammation. Secondary injury from neuroinflammation is a potential therapeutic target after intracerebral hemorrhage (ICH). For potential translation of progesterone as a clinical acute ICH therapeutic, the present study sought to define efficacy of exogenous progesterone administration in ICH-relevant experimental paradigms. Young and aged C57BL/6 male, female, and ovariectomized (OVX) mice underwent left intrastriatal collagenase (0.05-0.075 U) or autologous whole blood (35 mu I) injection. Progesterone at varying doses (4-16 mg/kg) was administered at 2, 5, 24, 48, and 72 h after injury. Rotarod and Morris water maze latencies were measured on days 1-7 and days 28-31 after injury, respectively. Hematoma volume, brain water content (cerebral edema), complementary immunohistochemistry, multiplex cytokine arrays, and inflammatory proteins were as-sessed at prespecified time points after injury. Progesterone (4 mg/kg) administration improved rotarod and water maze latencies (p < 0.01), and decreased cerebral edema (p < 0.05), microglial proliferation, and neuronal loss (p < 0.01) in young and aged male, young OVX, and aged female mice. Brain concentration of proinflammatory cytokines and Toll-like receptor-associated proteins were also decreased after progesterone (4 mg/kg) treatment (p < 0.01). Progesterone treated young female mice showed no detectable effects. Exogenous progesterone improved short- and long-term neurobehavioral recovery and modulated neuroinflammation in male and OVX mice after ICH. Future studies should validate these findings, and address timing and length of administration before translation to clinical trial. (C) 2015 S. Karger AG, Basel	[Lei, Beilei; Wang, Haichen; Jeong, Seongtae; Hsieh, Justin T.; Majeed, Mohammed; Sheng, Huaxin; Warner, David S.; James, Michael L.] Duke Univ, Multidisciplinary Neuroprotect Labs, Durham, NC USA; [Lei, Beilei; Sheng, Huaxin; Warner, David S.; James, Michael L.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Wang, Haichen; Dawson, Hana; James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA; [Jeong, Seongtae; Warner, David S.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Hsieh, Justin T.] Chonnam Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Gwanju, South Korea; [Hsieh, Justin T.] Duke Natl Univ Singapore, Singapore, Singapore		James, ML (corresponding author), DUMC 3094, Durham, NC 27710 USA.	michael.james@duke.edu	James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210; Hsieh, Justin/0000-0002-9701-0998			Appelboom G, 2015, NEUROL RES, V37, P657, DOI 10.1179/1743132815Y.0000000047; Atif F, 2011, MOL MED, V17, P1084, DOI 10.2119/molmed.2010.00255; Baudry M, 2013, NEUROSCIENCE, V239, P280, DOI 10.1016/j.neuroscience.2012.10.051; Caligioni CS., 2009, CURRENT PROTOCOLS NE, DOI 10.1002/0471142301.nsa04is48; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Chen Z, 2011, ACTA NEUROCHIR SUPPL, V111, P289, DOI 10.1007/978-3-7091-0693-8_48; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Deinsberger W, 1998, NEUROL RES, V20, P349, DOI 10.1080/01616412.1998.11740530; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Ganti L, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/219097; Gokhale S, 2015, STROKE, V46, P886, DOI 10.1161/STROKEAHA.114.007682; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Habib P, 2013, J STEROID BIOCHEM, V138, P195, DOI 10.1016/j.jsbmb.2013.06.003; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harrison DE, 2012, LIFESPAN BIOMARKER; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Hwang-Levine J, 2011, NEUROCHEM RES, V36, P1870, DOI 10.1007/s11064-011-0508-0; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; James ML, 2008, NEUROCRIT CARE, V9, P139, DOI 10.1007/s12028-007-9030-2; Jiang C, 2011, INT IMMUNOPHARMACOL, V11, P1925, DOI 10.1016/j.intimp.2011.08.001; Lapchak PA, 2013, TRANSL STROKE RES, V4, P279, DOI 10.1007/s12975-012-0209-2; Lee HY, 2010, STROKE, V41, P739, DOI 10.1161/STROKEAHA.109.573543; Lei BL, 2014, JOVE-J VIS EXP, DOI 10.3791/51439; Lei BL, 2012, TRANSL STROKE RES, V3, pS94, DOI 10.1007/s12975-012-0176-7; Manwani B, 2015, J CEREBR BLOOD F MET, V35, P221, DOI 10.1038/jcbfm.2014.186; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mirza MA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0251-6; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Nakamura T, 2006, ACTA NEUROCHIR SUPPL, V96, P218; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Sheng SP, 2012, ANESTHESIOLOGY, V117, P1262, DOI 10.1097/ALN.0b013e3182746b81; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Soderpalm AHV, 2004, PSYCHONEUROENDOCRINO, V29, P339, DOI 10.1016/S0306-4530(03)00033-7; Su L, 2009, IMMUNOL LETT, V125, P151, DOI 10.1016/j.imlet.2009.07.003; Umeano O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081664; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Warner DS, 2014, JAMA NEUROL, V71, P1311, DOI 10.1001/jamaneurol.2014.1238; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yang J, 2015, STROKE, V46, P1009, DOI 10.1161/STROKEAHA.114.007154	50	14	14	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-3835	1423-0194		NEUROENDOCRINOLOGY	Neuroendocrinology		2016	103	6					665	677		10.1159/000442204			13	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	DX6TV	WOS:000384516900004	26562172				2022-02-06	
J	Mans, S; Folmer, ER; de Jongh, MAC; Lansink, KWW				Mans, Stefan; Folmer, Eline Reinders; de Jongh, Mariska A. C.; Lansink, Koen W. W.			Direct transport versus inter hospital transfer of severely injured trauma patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma centre; Triage; Mortality; Trauma; Severely injured patients; Pre-hospital transport; Pre-hospital care; Trauma systems; Multi trauma; Inter hospital transfer	CENTER CARE; OUTCOMES	Introduction: Several studies have suggested that severely injured patients should be transported directly to a trauma centre bypassing the nearest hospital. However, the evidence remains inconclusive. The purpose of this study was to examine the benefits in terms of mortality of direct transport to a trauma centre versus primary treatment in a level II or III centre followed by inter hospital transfer to a trauma centre for severely injured patients without Traumatic Brain Injury (TBI). Patients and methods: We used the regional trauma registry and included all patients with an Injury Severity Score (ISS) > 15 and an Abbreviated Injury Score <4 for head injury. We adjusted for survival bias by including "potential transfers'': patients who died at the nearest hospitals before transportation to a trauma centre. Results: A total of 439 patients was included. The majority of patients (349/439, 79%) was transported directly to the level I trauma centre (direct group). The transferred group was formed by the remaining 90 patients, of whom 81 were transferred to the level I trauma centre after initial stabilisation elsewhere and 9 patients died in the emergency room before transfer to a level 1 trauma centre could occur. There were no significant differences in baseline and injury characteristics between the groups. Overall, 60 patients died in-hospital including 41 of the 349 patients (12%) in the direct group and 19 of the 90 patients (21%) in the transferred group. Nine of the 19 deaths in the transferred group were ascribed to potential transfers. After adjusting for prehospital Revised Trauma Score (RTS) and ISS, the odds ratio of death was 2.40 (95% CI: 1.07-5.40) for patients in the transfer group. When potential transfer patients were excluded from the analysis, the adjusted odds ratio of death was 1.14 (95% CI: 0.43-3.01). Conclusions: After adjusting for survivor bias by including potential transfers, the results of this study suggest a lower risk of death for patients who are directly transported to a level I trauma centre than for patients who receive primary treatment in a level II or III centre and are transferred to a trauma centre. However, this finding was only significant when adjusting for survival bias and therefore we conclude that it is still uncertain if there is a lower risk of death for patients who are transported directly to a level I trauma centre. (C) 2015 Elsevier Ltd. All rights reserved.	[Mans, Stefan; de Jongh, Mariska A. C.; Lansink, Koen W. W.] Elisabeth Tweesteden Hosp, Trauma Ctr Brabant, Tilburg, Netherlands; [Folmer, Eline Reinders; Lansink, Koen W. W.] Elisabeth Tweesteden Hosp, Dept Surg, Tilburg, Netherlands		Mans, S (corresponding author), Elisabeth Tweesteden Hosp, Trauma Ctr Brabant, Tilburg, Netherlands.	s.mans@students.uu.nl					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cummings P, 2013, JAMA PEDIATR, V167, P656, DOI 10.1001/jamapediatrics.2013.1329; de Jongh MAC, 2008, INJURY, V39, P1007, DOI 10.1016/j.injury.2008.03.026; Fatovich DM, 2011, RESUSCITATION, V82, P886, DOI 10.1016/j.resuscitation.2011.02.040; Fatovich DM, 2011, RESUSCITATION, V82, P560, DOI 10.1016/j.resuscitation.2011.01.016; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Haas B, 2009, J AM COLL SURGEONS, V208, P28, DOI 10.1016/j.jamcollsurg.2008.09.004; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Williams T, 2013, PREHOSP EMERG CARE, V17, P442, DOI 10.3109/10903127.2013.804137	13	14	15	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2016	47	1					26	31		10.1016/j.injury.2015.09.020			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CZ8HD	WOS:000367339900006	26510409				2022-02-06	
J	Manzano, S; Holzinger, IB; Kellenberger, CJ; Lacroix, L; Klima-Lange, D; Hersberger, M; La Scala, G; Altermatt, S; Staubli, G				Manzano, Sergio; Holzinger, Iris Bachmann; Kellenberger, Christian J.; Lacroix, Laurence; Klima-Lange, Dagmar; Hersberger, Martin; La Scala, Giorgio; Altermatt, Stefan; Staubli, Georg			Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma	EMERGENCY MEDICINE JOURNAL			English	Article							COMPUTED-TOMOGRAPHY; UNITED-STATES; DECISION RULE; BRAIN-INJURY; CT; PREDICT; RISK; CHILDHOOD; SCANS	Objective To assess the accuracy of S001B serum level to detect intracranial injury in children with mild traumatic brain injury. Methods A multicenter prospective cohort study was carried out in the paediatric emergency departments of three tertiary hospitals in Switzerland between January 2009 and December 2011. Participants included children aged <16 years with a mild traumatic brain injury (GCS >= 13) for whom a head CT was requested by the attending physician. Venous blood was obtained within 6 h of the trauma in all children for S100B measurement before a head CT was performed. As the S100B value was not available during the acute care period, the patient's management was not altered. The main measures were protein S100B value and the CT result. Results 20/73 (27.4%) included children had an intracranial injury detected on CT. S100B receiver operating characteristics area under the curve was 0.73 (95% CI 0.60 to 0.86). With a 0.14 mu g/L cut-off point, S100B reached an excellent sensitivity of 95% (95% Cl 77% to 100%) and 100% (95% CI 81% to 100%) in all children and in children aged >2 years, respectively. The specificity, however, was 34% (95% CI 27% to 36%) and 37% (95% CI 30% to 37%), respectively. Conclusions S100B has an excellent sensitivity but poor specificity. It is therefore an accurate tool to help rule out an intracranial injury but cannot be used as the sole marker owing to its specificity. Used with clinical decision rules, S100B may help to reduce the number of unnecessary CT scans.	[Manzano, Sergio; Lacroix, Laurence] Univ Hosp Geneva, Pediat Emergency Dept, CH-1211 Geneva, Switzerland; [Holzinger, Iris Bachmann; Staubli, Georg] Univ Childrens Hosp, Pediat Emergency Dept, Zurich, Switzerland; [Holzinger, Iris Bachmann] Univ Childrens Hosp, Dept Diagnost Imaging, Zurich, Switzerland; [Klima-Lange, Dagmar] Ostschweizer Childrens Hosp, Dept Pediat Surg, St Gallen, Switzerland; [Hersberger, Martin] Univ Childrens Hosp, Div Clin Chem & Biochem, Zurich, Switzerland; [La Scala, Giorgio] Univ Hosp Geneva, Dept Pediat Surg, CH-1211 Geneva, Switzerland; [Altermatt, Stefan] Univ Childrens Hosp, Dept Pediat Surg, Geneva, Switzerland		Manzano, S (corresponding author), Univ Hosp Geneva, Pediat Emergency Dept, 6 Rue Willy Donze, CH-1211 Geneva, Switzerland.	sergio.manzano@hcuge.ch	La Scala, Giorgio/AAM-8031-2020; Lacroix, Laurence/ABF-5052-2021; Manzano, Sergio/ABG-6281-2020	La Scala, Giorgio/0000-0003-1572-598X; Lacroix, Laurence/0000-0002-6636-3344; Manzano, Sergio/0000-0001-9603-5520; Hersberger, Martin/0000-0002-4472-329X; Kellenberger, Christian/0000-0001-9122-2431			Astrand R, 2011, CLIN CHIM ACTA, V412, P2190, DOI 10.1016/j.cca.2011.08.009; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Filippidis AS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10185; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Hallen M, 2010, J TRAUMA, V69, P284, DOI 10.1097/TA.0b013e3181ca060b; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kotlyar S, 2011, J EMERG MED, V41, P285, DOI 10.1016/j.jemermed.2010.05.040; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Leidel BA, 2012, UNFALLCHIRURG, V115, P903, DOI 10.1007/s00113-010-1946-x; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Muller B, 2011, EMERG MED J, V28, P938, DOI 10.1136/emj.2010.095372; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	34	14	16	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2016	33	1					42	46		10.1136/emermed-2014-204513			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DA0BP	WOS:000367462000010	26283067	Bronze			2022-02-06	
J	Mufson, EJ; Perez, SE; Nadeem, M; Mahady, L; Kanaan, NM; Abrahamson, EE; Ikonomovic, MD; Crawford, F; Alvarez, V; Stein, T; McKee, AC				Mufson, Elliott J.; Perez, Sylvia E.; Nadeem, Muhammad; Mahady, Laura; Kanaan, Nicholas M.; Abrahamson, Eric E.; Ikonomovic, Milos D.; Crawford, Fiona; Alvarez, Victor; Stein, Thor; McKee, Ann C.			Progression of tau pathology within cholinergic nucleus basalis neurons in chronic traumatic encephalopathy: A chronic effects of neurotrauma consortium study	BRAIN INJURY			English	Article						Cognition; head injury; memory; mild brain injury; traumatic brain injury	MILD COGNITIVE IMPAIRMENT; NERVE GROWTH-FACTOR; BETA-AMYLOID DEPOSITION; ALZHEIMERS-DISEASE; BRAIN-INJURY; HEAD-INJURY; ACETYLTRANSFERASE ACTIVITY; FOREBRAIN NEURONS; CASPASE CLEAVAGE; UP-REGULATION	Objective: To test the hypothesis that the nucleus basalis of Meynert (nbM), a cholinergic basal forebrain (CBF) cortical projection system, develops neurofibrillary tangles (NFTs) during the progressive pathological stages of chronic traumatic encephalopathy (CTE) in the brain of athletes.Method: To characterize NFT pathology, tau-antibodies marking early, intermediate and late stages of NFT development in CBF tissue obtained at autopsy from eighteen former athletes and veterans with a history of repetitive mild traumatic brain injury (TBI) were used.Results: Analysis revealed that cholinergic nbM neurons develop intracellular tau-immunoreactive changes progressively across the pathological stages of CTE. In particular, there was an increase in pre-tangle (phosphorylated pS422) and oligomeric (TOC1 and TNT1) forms of tau in stage IV compared to stage II CTE cases. The nbM neurons also displayed pathologic TDP-43 inclusions and diffuse extracellular and vascular amyloid- (A) deposits in CTE. A higher percentage of pS422/p75(NTR), pS422 and TNT1 labelled neurons were significantly correlated with age at symptom onset, interval between symptom onset and death and age at death.Conclusion: The development of NFTs within the cholinergic nbM neurons could contribute to an axonal disconnection in CTE. Further studies are needed to determine the mechanism driving NFT formation in the nbM neurons and its relation to chronic cognitive dysfunction in CTE.	[Mufson, Elliott J.; Perez, Sylvia E.; Nadeem, Muhammad; Mahady, Laura] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Kanaan, Nicholas M.] Michigan State Univ, Dept Translat Sci & Mol Med, Coll Human Med, Grand Rapids, MI USA; [Abrahamson, Eric E.; Ikonomovic, Milos D.] Univ Pittsburgh, Dept Neurol & Psychiat, Pittsburgh, PA USA; [Abrahamson, Eric E.; Ikonomovic, Milos D.] VA Pittsburgh Hlthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Crawford, Fiona] Roskamp Inst, Sarasota, FL USA; [Alvarez, Victor; Stein, Thor; McKee, Ann C.] Boston Univ, Sch Med, VA Boston HlthCare Syst, Alzheimer Dis Ctr, Boston, MA USA; [Alvarez, Victor; Stein, Thor; McKee, Ann C.] Boston Univ, Sch Med, CTE Program, Boston, MA USA; [Alvarez, Victor; Stein, Thor; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA USA; [Alvarez, Victor; Stein, Thor; McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA USA		Mufson, EJ (corresponding author), Barrow Neurol Inst, Alzheimers Dis Res Lab, 350 W Thomas St, Phoenix, AZ 85013 USA.	elliott.mufson@dignityhealth.org	Kanaan, Nicholas M./J-3428-2016; Lang, Steven/AAE-8102-2021	Kanaan, Nicholas M./0000-0002-4362-2593; Lang, Steven/0000-0003-1669-9146	US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Department of Veterans AffairsUS Department of Veterans Affairs [W81XWH-13-2-0095]; Department of Veterans AffairsUS Department of Veterans Affairs [I01 RX001774]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U01NS086659-01]; National Institute of Aging, Boston University AD Center [P30AG13846, 0572063345-5]; Veterans Affairs Biorepository [CSP 501]; National Operating Committee on Standards for Athletic Equipment; Concussion Legacy Foundation; Andlinger Foundation; World Wrestling Entertainment; National Football League; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001774] Funding Source: NIH RePORTER	The authors report no conflicts of interest. This material is based upon work supported by the US Army Medical Research and Material Command and from the US Department of Veterans Affairs [2] under Award No. W81XWH-13-2-0095. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the US Government, or the US Department of Veterans Affairs, and no official endorsement should be inferred. This work was also supported by an award from the Department of Veterans Affairs No. I01 RX001774, National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering (U01NS086659-01) and National Institute of Aging, Boston University AD Center (P30AG13846; supplement 0572063345-5), the Veterans Affairs Biorepository (CSP 501), the National Operating Committee on Standards for Athletic Equipment, the Concussion Legacy Foundation, the Andlinger Foundation and the World Wrestling Entertainment and the National Football League.	[Anonymous], 2003, J NEUROPSYCH CLIN N, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bourgeois JA, 2002, J NEUROPSYCH CLIN N, V14, P463, DOI 10.1176/appi.neuropsych.14.4.463; Budson A.E., 2016, MEMORY LOSS ALZHEIME; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Collins M, 2012, ACTA NEUROPATHOL, V124, P717, DOI 10.1007/s00401-012-1045-x; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; David X Cifu D-AR, 2015, FED PRACTICE, V32, P44; DeKosky ST, 2002, ANN NEUROL, V51, P145, DOI 10.1002/ana.10069; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Donat CK, 2010, NEUROPATH APPL NEURO, V36, P225, DOI 10.1111/j.1365-2990.2009.01050.x; Doody RS, 2003, NEUROLOGIST, V9, P225, DOI 10.1097/01.nrl.0000087723.53475.48; Galvin JE, 2008, ALZ DIS ASSOC DIS, V22, P30, DOI 10.1097/WAD.0b013e3181630b81; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Garcia-Sierra F, 2003, J ALZHEIMERS DIS, V5, P65, DOI 10.3233/JAD-2003-5201; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Ghoshal N, 2001, J NEUROCHEM, V77, P1372, DOI 10.1046/j.1471-4159.2001.00346.x; Ginsberg SD, 2011, J CHEM NEUROANAT, V42, P102, DOI 10.1016/j.jchemneu.2011.05.012; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grossberg G, 2004, AM J GERIAT PSYCHIAT, V12, P420, DOI 10.1176/appi.ajgp.12.4.420; Guillozet-Bongaarts AL, 2006, J NEUROCHEM, V97, P1005, DOI 10.1111/j.1471-4159.2006.03784.x; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Guillozet-Bongaarts AL, 2007, ACTA NEUROPATHOL, V113, P513, DOI 10.1007/s00401-007-0209-6; HEFTI F, 1986, ANN NEUROL, V20, P275, DOI 10.1002/ana.410200302; HEFTI F, 1983, ANN NEUROL, V13, P109, DOI 10.1002/ana.410130127; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ikonomovic MD, 2006, METHOD ENZYMOL, V412, P123, DOI 10.1016/S0076-6879(06)12009-1; Johnson Gail V. W., 1998, Alzheimer's Disease Review, V3, P125; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kanaan NM, 2015, J NEUROPATHOLOGY EXP, V75, P19; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kaye NS, 2003, J NEUROPSYCHIATRY CL, V15, P383; King A, 2011, NEUROPATHOLOGY, V31, P239, DOI 10.1111/j.1440-1789.2010.01171.x; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; KORDOWER JH, 1988, J COMP NEUROL, V277, P465, DOI 10.1002/cne.902770402; Lopez-Pousa S, 2000, REV NEUROLOGIA, V31, P724, DOI 10.33588/rn.3108.2000316; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mesulam M, 2004, ANN NEUROL, V55, P815, DOI 10.1002/ana.20100; Mesulam M, 2012, BIOL PSYCHIAT, V71, P760, DOI 10.1016/j.biopsych.2012.02.025; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; MUFSON EJ, 1989, J COMP NEUROL, V285, P196, DOI 10.1002/cne.902850204; MUFSON EJ, 1989, EXP NEUROL, V105, P221, DOI 10.1016/0014-4886(89)90124-6; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Perez Sylvia E, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P115; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Sassin I, 2000, ACTA NEUROPATHOL, V100, P259, DOI 10.1007/s004019900178; SCHATTEMAN GC, 1988, J NEUROSCI, V8, P860; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Thomas A, 2001, CLIN NEUROPHARMACOL, V24, P31, DOI 10.1097/00002826-200101000-00007; Trovato M, 2006, BRAIN INJURY, V20, P339, DOI 10.1080/02699050500487811; Vana L, 2011, AM J PATHOL, V179, P2533, DOI 10.1016/j.ajpath.2011.07.044; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Ward SM, 2013, J ALZHEIMERS DIS, V37, P593, DOI 10.3233/JAD-131235; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341	83	14	15	1	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1399	1413		10.1080/02699052.2016.1219058			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100002	27834536	Green Accepted			2022-02-06	
J	Popkin, CA; Schulz, BM; Park, CN; Bottiglieri, TS; Lynch, TS				Popkin, Charles A.; Schulz, Brian M.; Park, Caroline N.; Bottiglieri, Thomas S.; Lynch, T. Sean			Evaluation, management and prevention of lower extremity youth ice hockey injuries	OPEN ACCESS JOURNAL OF SPORTS MEDICINE			English	Article						youth hockey; body checking; injury prevention; femoroacetabular impingement; apophyseal avulsions	MEDIAL COLLATERAL LIGAMENT; SPORTS-RELATED FRACTURES; BODY-CHECKING RULES; GROIN INJURIES; CONCUSSION KNOWLEDGE; SPINAL-INJURIES; HIP INJURIES; SURFACE SIZE; RISK-FACTORS; PLAYERS	Ice hockey is a fast-paced sport played by increasing numbers of children and adolescents in North America and around the world. Requiring a unique blend of skill, finesse, power and teamwork, ice hockey can become a lifelong recreational activity. Despite the rising popularity of the sport, there is ongoing concern about the high frequency of musculoskeletal injury associated with participation in ice hockey. Injury rates in ice hockey are among the highest in all competitive sports. Numerous research studies have been implemented to better understand the risks of injury. As a result, rule changes were adopted by the USA Hockey and Hockey Canada to raise the minimum age at which body checking is permitted to 13-14 years (Bantam level) from 11-12 years (Pee Wee). Continuing the education of coaches, parents and players on rules of safe play, and emphasizing the standards for proper equipment use are other strategies being implemented to make the game safer to play. The objective of this article was to review the evaluation, management and prevention of common lower extremity youth hockey injuries.	[Popkin, Charles A.; Park, Caroline N.; Bottiglieri, Thomas S.; Lynch, T. Sean] Columbia Univ, Dept Orthoped Surg, Ctr Shoulder Elbow & Sports Med, 622 West 168th St, New York, NY 10032 USA; [Schulz, Brian M.] Kerlan Jobe Orthoped Clin, Los Angeles, CA USA		Popkin, CA (corresponding author), Columbia Univ, Dept Orthoped Surg, Ctr Shoulder Elbow & Sports Med, 622 West 168th St, New York, NY 10032 USA.	cp2654@columbia.edu					Ackery AD, 2012, CLIN J SPORT MED, V22, P86, DOI 10.1097/JSM.0b013e3182342b69; Agel J, 2010, CAN J SURG, V53, P319; Anderson K, 2001, AM J SPORT MED, V29, P521, DOI 10.1177/03635465010290042501; Anderson SE, 2012, EUR J RADIOL, V81, P3740, DOI 10.1016/j.ejrad.2011.03.097; Ayeni OR, 2014, OPEN ACCESS J SPORTS, V5, P143, DOI 10.2147/OAJSM.S58985; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Chang R, 2009, SPORT BIOMECH, V8, P212, DOI 10.1080/14763140903229534; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fabricant PD, 2012, CLIN ORTHOP RELAT R, V470, P261, DOI 10.1007/s11999-011-2015-7; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Grant JA, 2013, SPORTS HEALTH, V5, P270, DOI 10.1177/1941738112473053; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; International Ice Hockey Federation (IIHF), 2016, IIHF MEM NAT ASS; Irshad K, 2001, SURGERY, V130, P759, DOI 10.1067/msy.2001.118093; Jakoi A, 2013, AM J SPORT MED, V41, P107, DOI 10.1177/0363546512462679; Kocher MS, 2006, CLIN SPORT MED, V25, P241, DOI 10.1016/j.csm.2006.01.001; Kukaswadia A, 2010, PEDIATRICS, V125, P735, DOI 10.1542/peds.2009-2083; Lacny S, 2014, BRIT J SPORT MED, V48, P1299, DOI 10.1136/bjsports-2014-093493; Laliberte DJ, 2009, SPORT J, V12, P1; LaPrade RF, 2009, BRIT J SPORT MED, V43, P1000, DOI 10.1136/bjsm.2009.067884; LaPrade RF, 2014, BRIT J SPORT MED, V48, P4, DOI 10.1136/bjsports-2013-093020; LeBlanc Kim Edward, 2003, Hernia, V7, P68, DOI 10.1007/s10029-002-0105-x; Lynch SA, 1999, SPORTS MED, V28, P137, DOI 10.2165/00007256-199928020-00006; MacCormick L, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518181; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Matic GT, 2015, PHYSICIAN SPORTSMED, V43, P119, DOI 10.1080/00913847.2015.1035210; McFaull S., 2001, CHIRPP NEWS, V19, P1; Mckay CD, 2014, CAN J PUBLIC HEALTH, V105, pE445, DOI 10.17269/cjph.105.4653; Meyers WC, 2008, ANN SURG, V248, P656, DOI 10.1097/SLA.0b013e318187a770; Molsa J, 2003, AM J SPORT MED, V31, P751; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; Morelli V, 2001, AM FAM PHYSICIAN, V64, P1405; Moslener MD, 2010, CURR SPORT MED REP, V9, P134, DOI 10.1249/JSR.0b013e3181dfccd9; Muschaweck U, 2010, SPORTS HEALTH, V2, P216, DOI 10.1177/1941738110367623; Nauth A, 2014, ORTHOP J SPORTS MED; PASHBY TJ, 1992, CAN J OPHTHALMOL, V27, P226; Philippon MJ, 2013, AM J SPORT MED, V41, P1357, DOI 10.1177/0363546513483448; Pinto M, 1999, CLIN J SPORT MED, V9, P70, DOI 10.1097/00042752-199904000-00005; Polites SF, 2014, PEDIATRICS, V133, pE1601, DOI 10.1542/peds.2013-3628; REYNEN PD, 1994, AM J SPORT MED, V22, P167, DOI 10.1177/036354659402200203; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Ross JR, 2015, ARTHROSCOPY, V31, P635, DOI 10.1016/j.arthro.2014.10.010; Shindle MK, 2010, CURR OPIN PEDIATR, V22, P54, DOI 10.1097/MOP.0b013e3283350f32; SIMONET WT, 1995, J TRAUMA, V38, P30, DOI 10.1097/00005373-199501000-00009; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; Smith AM., 2009, J ASTM INT, V6, P1; Smith AM, 2015, CURR SPORT MED REP, V14, P135, DOI 10.1249/JSR.0000000000000132; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; Smith DV, 2010, CURR SPORT MED REP, V9, P278, DOI 10.1249/JSR.0b013e3181f310e9; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Stull JD, 2011, AM J SPORT MED, V39, p29S, DOI 10.1177/0363546511414012; Swenson DM, 2012, AM J SPORT MED, V40, P2078, DOI 10.1177/0363546512453304; Swenson DM, 2010, CLIN J SPORT MED, V20, P293, DOI 10.1097/JSM.0b013e3181e8fae8; TATOR CH, 1991, CAN J SURG, V34, P63; Tator CH, 2016, CLIN J SPORT MED, V26, P232, DOI 10.1097/JSM.0000000000000232; Tlougan BE, 2011, SPORTS MED, V41, P967, DOI 10.2165/11592190-000000000-00000; Tyler TF, 2010, SPORTS HEALTH, V2, P231, DOI 10.1177/1941738110366820; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Vaughan G., 1996, PUCK STARTS HERE ORI; Vaz EW., 1982, PROFESSIONALIZATION; Veenema KR, 1999, PHYSICIAN SPORTSMED, V27, P62, DOI 10.3810/psm.1999.08.950; Waite BL, 2008, PHYS MED REHABIL CLI, V19, P305, DOI 10.1016/j.pmr.2007.12.005; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Watson RC, 1997, CLIN J SPORT MED, V7, P192, DOI 10.1097/00042752-199707000-00007; Wennberg R, 2005, CLIN J SPORT MED, V15, P67, DOI 10.1097/01.jsm.0000152712.27968.fe; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06; WOO SLY, 1987, J BONE JOINT SURG AM, V69A, P1200, DOI 10.2106/00004623-198769080-00014; Wright RW, 2004, AM J SPORT MED, V32, P1941, DOI 10.1177/0363546504264581; Zoga AC, 2008, RADIOLOGY, V247, P797, DOI 10.1148/radiol.2473070049	86	14	15	2	13	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1543			OPEN ACCESS J SPORTS	Open Access J. Sports Med.		2016	7						167	176		10.2147/OAJSM.S118595			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	ET0EJ	WOS:000399934400003	27920584	gold, Green Published			2022-02-06	
S	Semple, BD; Carlson, J; Noble-Haeusslein, LJ		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Semple, Bridgette D.; Carlson, Jaclyn; Noble-Haeusslein, Linda J.			Pediatric Rodent Models of Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury; Pediatric; Juvenile; Children; Behavior; Mice; Rodents	GLUTATHIONE-PEROXIDASE ACTIVITY; FLUID-PERCUSSION MODEL; IMMATURE RAT; DENTATE GYRUS; SEX-DIFFERENCES; YOUNG-RATS; ADULT RATS; BARRIER PERMEABILITY; COGNITIVE DEFICITS; CELL-PROLIFERATION	Due to a high incidence of traumatic brain injury (TBI) in children and adolescents, age-specific studies are necessary to fully understand the long-term consequences of injuries to the immature brain. Preclinical and translational research can help elucidate the vulnerabilities of the developing brain to insult, and provide model systems to formulate and evaluate potential treatments aimed at minimizing the adverse effects of TBI. Several experimental TBI models have therefore been scaled down from adult rodents for use in juvenile animals. The following chapter discusses these adapted models for pediatric TBI, and the importance of age equivalence across species during model development and interpretation. Many neurodevelopmental processes are ongoing throughout childhood and adolescence, such that neuropathological mechanisms secondary to a brain insult, including oxidative stress, metabolic dysfunction and inflammation, may be influenced by the age at the time of insult. The long-term evaluation of clinically relevant functional outcomes is imperative to better understand the persistence and evolution of behavioral deficits over time after injury to the developing brain. Strategies to modify or protect against the chronic consequences of pediatric TBI, by supporting the trajectory of normal brain development, have the potential to improve quality of life for brain-injured children.	[Semple, Bridgette D.; Carlson, Jaclyn] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Sch Med, Dept Neurol Surg, San Francisco, CA USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Sch Med, Dept Phys Therapy & Rehabil Sci, San Francisco, CA USA		Semple, BD (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS050159, R01 NS077767] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077767, R01NS050159] Funding Source: NIH RePORTER		Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson VA, 2014, DEV MED CHILD NEUROL, V56, P329, DOI 10.1111/dmcn.12387; Anthony D, 1998, CURR BIOL, V8, P923, DOI 10.1016/S0960-9822(07)00373-9; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Choe MC, 2016, J CHILD NEUROL, V31, P109, DOI 10.1177/0883073815572685; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; CRAIN B, 1973, BRAIN RES, V63, P195, DOI 10.1016/0006-8993(73)90088-7; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ellis TW, 2014, EXP NEUROL, V261, P434, DOI 10.1016/j.expneurol.2014.06.008; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Goodus MT, 2015, DEV NEUROSCI-BASEL, V37, P29, DOI 10.1159/000367784; Guevara R, 2011, EXP GERONTOL, V46, P923, DOI 10.1016/j.exger.2011.08.003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Herschkowitz N, 1997, NEUROPEDIATRICS, V28, P296, DOI 10.1055/s-2007-973720; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Huh JW, 2011, J NEUROTRAUM, V28, P245, DOI 10.1089/neu.2010.1639; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, V48, P2473, DOI DOI 10.3791/2473; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kercmar J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00337; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Lapchak PA, 2013, TRANSL STROKE RES, V4, P279, DOI 10.1007/s12975-012-0209-2; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; MCWILLIAMS JR, 1983, SCIENCE, V221, P572; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; NEHLIG A, 1991, NEUROSCIENCE, V40, P871, DOI 10.1016/0306-4522(91)90018-J; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; Osier N.D., 2015, BRAIN NEUROTRAUMA MO, P421; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Potts Mathew B, 2006, NeuroRx, V3, P143; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2016, J CHILD NEUROL, V31, P28, DOI 10.1177/0883073814549244; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Robertson Charlene M T, 2002, Pediatr Crit Care Med, V3, P345, DOI 10.1097/00130478-200210000-00003; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; SCHEFF SW, 1980, BRAIN RES, V199, P21, DOI 10.1016/0006-8993(80)90227-9; SCHENK F, 1985, BEHAV NEURAL BIOL, V43, P69, DOI 10.1016/S0163-1047(85)91510-9; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Terranova ML, 2005, CURR PROTOC TOXICOL, V13, P101; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Venna VR, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.128; Verger K, 2001, BRAIN INJURY, V15, P211; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003	112	14	14	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						325	343		10.1007/978-1-4939-3816-2_18	10.1007/978-1-4939-3816-2		19	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500020	27604726				2022-02-06	
J	Wu, E; Graham, DP				Wu, Emily; Graham, David P.			Association of Chronic Pain and Community Integration of Returning Veterans With and Without Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Brief Pain Inventory; community integration; traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; SPINAL-CORD-INJURY; IDENTIFICATION TEST AUDIT; FEMALE VETERANS; PTSD CHECKLIST; COMBAT VETERANS; MENTAL-HEALTH; PRIMARY-CARE; DEPRESSION	Objective: To evaluate the association between community integration and pain in veterans with and without mild blast-related traumatic brain injury (TBI). Design and Participants: A cross-sectional study of 198 Operation Enduring Freedom/Operation Iraqi Freedom veterans, 135 with mild TBI and 63 without TBI exposure. Main Measures: Community Integration Questionnaire (CIQ), Community Reintegration of Injured Service Members Instrument, Brief Pain Inventory. Results: Pain interference was significantly associated with CIQ social integration (P=.037), and pain severity was significantly associated with CIQ home integration (P=.038) and CIQ social integration (P=.044). Pain interference and pain severity had a significant interaction as related to the CIQ total score (P=.046), CIQ job score (P=.034), and CIQ productivity score (P=.034). Pain interference (P=.042) and pain severity (P=.015) were associated with community participation, but not perceived limitations (P>.05) or satisfaction (P>.05) as measures by the Community Reintegration of Injured Service Members Instrument. There was a significant interaction between TBI status and pain severity (P=.021) with community participation. Conclusions: Chronic pain has a negative association with the community integration of returning veterans. Although TBI status was associated with overall community integration ratings, depression had a stronger association with impairments. These findings suggest, above and beyond the treatment of depression, the importance of effectively managing TBI-related pain to foster improved social functioning and to promote the psychological and social well-being of returning veterans.	[Wu, Emily; Graham, David P.] Michael E DeBakey Vet Affairs VA Med Ctr, Neurorehabil Neurons Networks Traumat Brain Injur, Houston, TX USA; [Graham, David P.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Graham, David P.] South Cent Mental Illness Res Educ & Clin Ctr MIR, Dept Vet Affairs, Houston, TX USA		Graham, DP (corresponding author), Michael E DeBakey VA Med Ctr, Neurorehabil Neurons Networks Traumat Brain Injur, 2002 Holcombe Blvd,153 TBI,Bldg 100,STE 2B-126A, Houston, TX 77030 USA.	david.graham@va.gov			VA Medical Centers Research and Development Services, Rehabilitation Research and Development Service Career Development Award-2 [B7496W]; Neurorehabilitation: Neurons to Networks TBI Center of Excellence [B6812C]	The views expressed in this article are those of the author(s) and do not necessarily reflect the views, position, or policy of the Department of Veterans Affairs, the South Central MIRECC, the United States government, or Baylor College of Medicine. This material is based upon work supported (or supported in part) by the VA Medical Centers Research and Development Services, Rehabilitation Research and Development Service Career Development Award-2 (Grant # B7496W), and by the Neurorehabilitation: Neurons to Networks TBI Center of Excellence (Grant # B6812C).	Andersen J, 2010, PSYCHOSOM MED, V72, P498, DOI 10.1097/PSY.0b013e3181d969a1; Asnaani A, 2014, J ANXIETY DISORD, V28, P310, DOI 10.1016/j.janxdis.2014.01.005; Beckham JC, 1997, J PSYCHOSOM RES, V43, P379, DOI 10.1016/S0022-3999(97)00129-3; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Cerda M, 2013, DEPRESS ANXIETY, V30, P413, DOI 10.1002/da.22007; Chopra MP, 2014, AM J GERIAT PSYCHIAT, V22, P86, DOI 10.1016/j.jagp.2013.01.064; Cleeland C. S., 1989, MEASUREMENT PAIN SUB, P391; Cleeland CS., 2009, BRIEF PAIN INVENTORY; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Gill J, 2014, PSYCHIAT RES, V216, P116, DOI 10.1016/j.psychres.2014.01.046; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Gubata ME, 2012, TRISERVICE DISABILIT; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jensen MP, 2005, SPINAL CORD, V43, P704, DOI 10.1038/sj.sc.3101777; Karatzias T, 2013, J MENT HEALTH, V22, P501, DOI 10.3109/09638237.2013.819418; Kelsall HL, 2014, PAIN, V155, P685, DOI 10.1016/j.pain.2013.12.025; Kennedy P, 2006, SPINAL CORD, V44, P95, DOI 10.1038/sj.sc.3101787; Khalili Narjes, 2013, Iran J Nurs Midwifery Res, V18, P105; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kratz AL, 2013, REHABIL PSYCHOL, V58, P1, DOI 10.1037/a0031727; Kukihara H, 2014, PSYCHIAT CLIN NEUROS, V68, P524, DOI 10.1111/pcn.12159; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Leibach GG, 2014, NEUROREHABILITATION, V34, P167, DOI 10.3233/NRE-131013; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Putzke JD, 2002, PAIN, V100, P231, DOI 10.1016/S0304-3959(02)00069-6; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Roberts RE, 1983, AM J PSYCHIAT, V140, P1; Saberi HR, 2013, INT J OCCUP ENV MED, V4, P185; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Vardy J, 2014, J CLIN ONCOL, V32, P1677, DOI 10.1200/JCO.2013.52.8356; Walker EA, 2002, GEN HOSP PSYCHIAT, V24, P375, DOI 10.1016/S0163-8343(02)00203-7; Weathers F.W., 1993, 9 ANN C ISTSS; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009	49	14	14	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					E1	E12		10.1097/HTR.0000000000000152			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000001	26098259				2022-02-06	
J	Yengo-Kahn, AM; Zuckerman, SL; Stotts, J; Zalneraitis, BH; Gardner, RM; Kerr, ZY; Solomon, GS				Yengo-Kahn, Aaron M.; Zuckerman, Scott L.; Stotts, Jeff; Zalneraitis, Brian H.; Gardner, Ryan M.; Kerr, Zachary Y.; Solomon, Gary S.			Performance following a first professional concussion among National Basketball Association players	PHYSICIAN AND SPORTSMEDICINE			English	Article						Mild traumatic brain injury; concussion; National Basketball Association; performance; athletes; sport-related concussion; player impact estimate; post-concussive performance	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; EPIDEMIOLOGY; INJURIES; FOOTBALL; OUTCOMES; INFORMATION; RECOVERY; RETURN	Objectives: Basketball is a physical game played on a hardwood floor among high-jumping athletes at risk for injury. It is currently unknown how sport-related concussion (SRC) affects player performance after injury among professional basketball players. The objective of this study was to explore the impact of SRC on basketball performance among National Basketball Association (NBA) players.Methods: A retrospective, archival cohort study was performed that compared NBA player performance following concussion to pre-concussive performance. A comprehensive NBA injury database, compiled from publically available sources, was queried for NBA players who suffered concussion from 2005-06 to 2014-15 (10 seasons). Intra-and inter-player analyses were performed against a matched control group of players who missed playing time for personal reasons.Results: Following application of inclusion/exclusion criteria and a matching process, 51 concussed players and 51 control players were included in analysis. There were no statistically significant decrements in baseline to post-concussion performance metrics in intra-player or player vs. controls after 5 return games.Conclusions: Our findings suggest that at the NBA level, an athlete's performance in the initial 5 games following injury does not suffer from the after-effects of concussive injury. These results may be useful in counseling professional athletes following a concussion.	[Yengo-Kahn, Aaron M.; Zuckerman, Scott L.; Zalneraitis, Brian H.; Gardner, Ryan M.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Zuckerman, Scott L.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Sci, Med Ctr North T-4224, Nashville, TN 37212 USA; [Stotts, Jeff] St Vincent Hlth Syst, Dept Athlet Training, Little Rock, AR USA; [Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Sci, Med Ctr North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu	Solomon, Gary/K-9011-2019; Yengo-Kahn, Aaron/AAV-7647-2020	Yengo-Kahn, Aaron/0000-0002-5989-3064; Kerr, Zachary/0000-0003-1423-1259			Amin NH, 2013, AM J SPORT MED, V41, P1864, DOI 10.1177/0363546513490659; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bonfield CM, 2014, PROG NEUROL SURG, V28, P161, DOI 10.1159/000358777; Busfield BT, 2009, ARTHROSCOPY, V25, P825, DOI 10.1016/j.arthro.2009.02.021; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Classe J G, 1997, J Am Optom Assoc, V68, P43; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; de Oliveira RF, 2007, EXP PSYCHOL, V54, P180, DOI 10.1027/1618-3169.54.3.180; Dick R, 2007, J ATHL TRAINING, V42, P194; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Dubin J., 2015, ADV STATS GUIDE 2015; De Oliveira RF, 2006, J SPORT SCI, V24, P933, DOI 10.1080/02640410500357101; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harris JD, 2013, SPORTS HEALTH, V5, P562, DOI 10.1177/1941738113495788; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kioumourtzoglou E, 1998, PERCEPT MOTOR SKILL, V86, P771, DOI 10.2466/pms.1998.86.3.771; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Mangine GT, 2014, J STRENGTH COND RES, V28, P2406, DOI 10.1519/JSC.0000000000000550; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Media FSI, 2015, FOX SPORTS; Namdari S, 2009, AM J SPORT MED, V37, P943, DOI 10.1177/0363546508330150; Nba, 2015, NBA; Orchard J, 2002, BRIT J SPORT MED, V36, P16, DOI 10.1136/bjsm.36.1.16; Padaki AS, 2016, AM J SPORTS MED; Podlog L, 2015, J SCI MED SPORT, V18, P278, DOI 10.1016/j.jsams.2014.05.005; Samson K, 2012, WHY CONCUSSION RULES, p[1, 13]; SOUTHARD D, 1993, RES Q EXERCISE SPORT, V64, P284, DOI 10.1080/02701367.1993.10608812; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Yeh PC, 2012, AM J SPORT MED, V40, P589, DOI 10.1177/0363546511428601; Yengo-Kahn AM, 2016, AM J SPORT MED, V44, P801, DOI 10.1177/0363546515580313	34	14	14	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2016	44	3					297	303		10.1080/00913847.2016.1200956			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	DW3AW	WOS:000383515400016	27294806				2022-02-06	
J	Zhou, HX; Liu, ZG; Liu, XJ; Chen, QX				Zhou, Hai-xiao; Liu, Zhi-gang; Liu, Xiao-jiao; Chen, Qian-xue			Umbilical cord-derived mesenchymal stem cell transplantation combined with hyperbaric oxygen treatment for repair of traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; umbilical cord mesenchymal stem cells; transplantation; hyperbaric oxygen; rats; craniocerebral trauma; neurological function; neural regeneration	CEREBRAL PERFUSION-PRESSURE; DIFFERENTIATION	Transplantation of umbilical cord-derived mesenchymal stem cells (UC-MSCs) for repair of traumatic brain injury has been used in the clinic. Hyperbaric oxygen (HBO) treatment has long been widely used as an adjunctive therapy for treating traumatic brain injury. UC-MSC transplantation combined with HBO treatment is expected to yield better therapeutic effects on traumatic brain injury. In this study, we established rat models of severe traumatic brain injury by pressurized fluid (2.5-3.0 atm impact force). The injured rats were then administered UC-MSC transplantation via the tail vein in combination with HBO treatment. Compared with monotherapy, aquaporin 4 expression decreased in the injured rat brain, but growth-associated protein-43 expression, calaxon-like structures, and CM-Dil-positive cell number increased. Following combination therapy, however, rat cognitive and neurological function significantly improved. UC-MSC transplantation combined with HBO therapyfor repair of traumatic brain injury shows better therapeutic effects than monotherapy and significantly promotes recovery of neurological functions.	[Zhou, Hai-xiao] Wuhan Univ, Dept Plast Surg, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China; [Liu, Zhi-gang] Wuhan Univ, Dept Anesthesiol, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China; [Liu, Xiao-jiao; Chen, Qian-xue] Wuhan Univ, Dept Neurosurg, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China		Zhou, HX (corresponding author), Wuhan Univ, Dept Plast Surg, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China.	zhxiaoo@163.com		Chen, Qianxue/0000-0002-9413-1030			Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Chang DJ, 2011, BIOORG MED CHEM LETT, V21, P7050, DOI 10.1016/j.bmcl.2011.09.099; Chuang Sung-Kiang, 2011, J Evid Based Dent Pract, V11, P129, DOI 10.1016/j.jebdp.2011.06.008; Fuentes-Raspall R, 2012, CLIN ONCOL-UK, V24, pE126, DOI 10.1016/j.clon.2012.03.014; Guo BF, 2009, OTOLARYNG HEAD NECK, V140, P159, DOI 10.1016/j.otohns.2008.10.039; Guo JJ, 2013, STEM CELL RES, V11, P874, DOI 10.1016/j.scr.2013.05.004; Jasaitis A, 2012, CHEM PHYS, V396, P10, DOI 10.1016/j.chemphys.2011.04.003; Kunke D, 2009, BIOCHEM BIOPH RES CO, V386, P628, DOI 10.1016/j.bbrc.2009.06.084; Li L, 2011, BEHAV BRAIN RES, V217, P244, DOI 10.1016/j.bbr.2010.10.032; Lin SS, 2011, BONE, V48, pS143, DOI 10.1016/j.bone.2011.03.300; Qian J, 2013, INT J DEV NEUROSCI, V31, P280; Rocha FS, 2015, OR SURG OR MED OR PA, V120, P581, DOI 10.1016/j.oooo.2015.06.039; Tong L, 2010, BIOCHEM BIOPH RES CO, V401, P592, DOI 10.1016/j.bbrc.2010.09.107; Wang QH, 2000, CHUANGSHANG WAIKE ZA, V2, P42; Xiong Z, 2014, STEM CELL RES, V12, P387, DOI 10.1016/j.scr.2013.11.003; Yang YJ, 2008, UNDERSEA HYPERBAR M, V35, P113; Yu M, 2014, J NUTR BIOCHEM, V25, P227, DOI 10.1016/j.jnutbio.2013.10.011	19	14	17	0	7	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2016	11	1					107	113		10.4103/1673-5374.175054			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DD7ZF	WOS:000370142800031	26981097	Green Published, gold			2022-02-06	
J	Li, Y; Zhang, LY; Kallakuri, S; Cohen, A; Cavanaugh, JM				Li, Yan; Zhang, Liying; Kallakuri, Srinivasu; Cohen, Abigail; Cavanaugh, John M.			Correlation of mechanical impact responses and biomarker levels: A new model for biomarker evaluation in TBI	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Rodent; Head impact kinematics; Cerebrospinal fluid biomarker; Serum biomarker, head impact acceleration model	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID; AMYLOID-BETA; NF-H; SERUM BIOMARKER; HEAD-INJURY; PROTEIN; S100B	A modified Marmarou impact acceleration model was used to help screen biomarkers to assess brain injury severity. Anesthetized male Sprague-Dawley rats were subjected to a closed head injury from 1.25, 1.75 and 2.25 m drop heights. Linear and angular responses of the head were measured in vivo. 24 h after impact, cerebrospinal fluid (CSF) and serum were collected. CSF and serum levels of phosphorylated neurofilament heavy (pNF-H), glial fibrillary acidic protein (GFAP), interleukin 6 (IL-6), and amyloid beta (A beta) 1-42 were assessed by enzyme-linked immunosorbent assay (ELISA). Compared to controls, significantly higher CSF and serum pNFH levels were observed in all impact groups, except between 1.25 m and control in serum. Furthermore, CSF and serum pNF-H levels were significantly different between the impact groups. For GFAP, both CSF and serum levels were significantly higher at 225 m compared to 1.75 m, 125 m and controls. There was no significant difference in CSF and serum GFAP levels between 1.75 m and 125 m, although both groups were significantly higher than control. TBI rats also showed significantly higher levels of IL-6 versus control in both CSF and serum, but no significant difference was observed between each impact group. Levels of A beta were not significantly different between groups. Pearson's correlation analysis showed pNF-H and GFAP levels in CSF and serum had positive correlation with power (rate of impact energy), followed by average linear acceleration and surface righting (p < 0.01), which were good predictors for traumatic axonal injury according to histologic assessment in our previous study, suggesting that they are directly related to the injury mechanism. The model used in this study showed a unique ability in elucidating the relationship between biomarker levels and severity of the mechanical trauma to the brain. (C) 2015 The Authors. Published by Elsevier B.V.	[Li, Yan; Zhang, Liying; Kallakuri, Srinivasu; Cohen, Abigail; Cavanaugh, John M.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA		Zhang, LY (corresponding author), Wayne State Univ, Dept Biomed Engn, 818 W Hancock St, Detroit, MI 48201 USA.	lzhang@wayne.edu			 [NIHR01EB006508]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB006508] Funding Source: NIH RePORTER	This research was supported by NIHR01EB006508.	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Blennow K, 2011, ACTA NEUROL SCAND, V123, P245, DOI 10.1111/j.1600-0404.2010.01408.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Dilorenzo F.A., 1976, 760014 SAE; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Liu L., 2008, JOVE-J VIS EXP, V10, P21; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; Masters CL, 2006, J NEUROCHEM, V97, P1700, DOI 10.1111/j.1471-4159.2006.03989.x; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Newman J, 2000, P 44 STAPP CAR CRASH; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petrova TV, 2000, BRAIN RES, V853, P74, DOI 10.1016/S0006-8993(99)02251-9; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; PRICE DL, 1995, CURR OPIN NEUROL, V8, P268, DOI 10.1097/00019052-199508000-00004; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Shaw, 1998, NEUROFILAMENTS; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Stemberger LA, 1983, P NATL ACAD SCI USA, V80, P6126; Strong MJ, 2001, J NEUROCHEM, V76, P1315, DOI 10.1046/j.1471-4159.2001.00094.x; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang J, 2002, CURR TOP MICROBIOL, V265, P23; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Woertgen C, 2002, ACT NEUR S, V81, P205; Ye MM, 2012, J NANOMATER, V2012, DOI 10.1155/2012/583417; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang L., 2010, 8 WORLD C BRAIN INJ; Zhu Tao, 2004, Chin J Traumatol, V7, P32	63	14	14	1	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	DEC 15	2015	359	1-2					280	286		10.1016/j.jns.2015.08.035			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7JR	WOS:000367276200053	26671128				2022-02-06	
J	Gilboa, Y; Kerrouche, B; Longaud-Vales, A; Kieffer, V; Tiberghien, A; Aligon, D; Mariller, A; Mintegui, A; Canizares, C; Abada, G; Chevignard, MP				Gilboa, Yafit; Kerrouche, Bernadette; Longaud-Vales, Audrey; Kieffer, Virginie; Tiberghien, Anne; Aligon, Delphine; Mariller, Aude; Mintegui, Amaia; Canizares, Celine; Abada, Genevieve; Chevignard, Mathilde Paule			Describing the attention profile of children and adolescents with acquired brain injury using the Virtual Classroom	BRAIN INJURY			English	Article						Attention deficits; brain tumour; ecological assessment; traumatic brain injury; virtual reality	SUSTAINED ATTENTION; EXECUTIVE FUNCTIONS; EARLY-CHILDHOOD; DEFICITS; PERFORMANCE; REALITY; SURVIVORS; SKILLS; ADHD; MEDULLOBLASTOMA	Objectives: The objectives of the study were: (1) to describe the attention deficits profile of children with significant acquired brain injury (ABI) in comparison to matched controls, using the virtual classroom (VC); (2) to assess the utility of the VC in detecting attention deficits in children with ABI, as compared to classical neuropsychological tests and questionnaire-based assessment of attention; and (3) to determine how performance in the VC is affected by demographic and injury severity variables.Methods: Forty-one children with ABI and 35 age- and gender-matched controls, aged 8-16, were assessed with the VC. The results of the VC were compared to sub-tests of the Test of Everyday Attention for Children (TEA-Ch), the Conners' Parent Rating Scales-Revised: Short (CPRS-R:S) questionnaire and analysed according to demographic and injury severity variables.Results: Significant differences were found between the groups regarding the number of targets correctly identified in the VC. Significant inter-correlations were obtained between the VC variables. Significant correlations were found between the VC variables, the sub-tests of TEA-Ch and the CPRS-R:S and the demographic characteristics of the sample.Conclusion: The VC appears to be a sensitive and ecologically valid assessment tool for use in the diagnosis of attention deficits among children with ABI.	[Gilboa, Yafit] Hebrew Univ Jerusalem, Fac Med, Sch Occupat Therapy, IL-91240 Jerusalem, Israel; [Gilboa, Yafit; Chevignard, Mathilde Paule] Univ Paris 04, UPMC, CNRS, INSERM,Lab Imagerie Biomed, Paris, France; [Kerrouche, Bernadette; Tiberghien, Anne; Aligon, Delphine; Canizares, Celine] St Maurice Hosp, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France; [Longaud-Vales, Audrey; Kieffer, Virginie] Gustave Roussy, Dept Pediat Oncol, Villejuif, France; [Mariller, Aude; Mintegui, Amaia; Abada, Genevieve; Chevignard, Mathilde Paule] St Maurice Hosp, Rehabil Dept Children Acquired Neurol Injury, St Maurice, France		Gilboa, Y (corresponding author), Hebrew Univ Jerusalem, Fac Med, Sch Occupat Therapy, IL-91240 Jerusalem, Israel.	yafitgilboa@yahoo.com	Gilboa, Yafit/AAK-9021-2020; Gilboa, Yafit/AAO-5500-2021	Gilboa, Yafit/0000-0002-0734-3626; Gilboa, Yafit/0000-0002-0734-3626			Adams R, 2009, CHILD NEUROPSYCHOL, V15, P120, DOI 10.1080/09297040802169077; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Bart O, 2011, DISABIL REHABIL, V33, P1579, DOI 10.3109/09638288.2010.540291; Betts J, 2006, CHILD NEUROPSYCHOL, V12, P205, DOI 10.1080/09297040500488522; Bioulac S, 2012, EUR J PAEDIATR NEURO, V16, P514, DOI 10.1016/j.ejpn.2012.01.006; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Butler RW, 2006, MENT RETARD DEV D R, V12, P184, DOI 10.1002/mrdd.20110; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2014, BRAIN INJURY, V28, P252, DOI 10.3109/02699052.2013.860471; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Conklin HM, 2008, J CLIN ONCOL, V26, P3965, DOI 10.1200/JCO.2007.15.9970; Conners CK, 1997, CONNERS RATING SCALE; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Gilboa Y, 2011, INT C VIRT REH ICVR; Gilboa Y, 2011, RES DEV DISABIL, V32, P2608, DOI 10.1016/j.ridd.2011.06.014; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Kamphaus RW, 1998, BASC MONITOR ADHD MA; Kim Robyn, 2013, Percept Mot Skills, V117, P1361; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Manly T, 1999, TEA CH TEST EVERYDAY; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nolin P, 2009, STUD HEALTH TECHNOL, V144, P240, DOI 10.3233/978-1-60750-017-9-240; Nygren-de Boussard C, 2014, ARCH PHYS MED REHAB, V95, pS257; Palmer SL, 2007, J PEDIATR PSYCHOL, V32, P1040, DOI 10.1093/jpepsy/jsl056; Palmer SL, 2013, J CLIN ONCOL, V31, P3494, DOI 10.1200/JCO.2012.47.4775; Parsons TD, 2007, CHILD NEUROPSYCHOL, V13, P363, DOI 10.1080/13825580600943473; Parsons TD, 2008, STUD HEALTH TECHNOL, V132, P351; Pollak Y, 2009, J DEV BEHAV PEDIATR, V30, P2, DOI 10.1097/DBP.0b013e3181969b22; Reck SG, 2011, J EXP CHILD PSYCHOL, V108, P504, DOI 10.1016/j.jecp.2010.07.010; Reddick WE, 2014, PEDIATR BLOOD CANCER, V61, P1074, DOI 10.1002/pbc.24947; Rizzo AA, 2006, CNS SPECTRUMS, V11, P35, DOI 10.1017/S1092852900024196; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Sobeh J, 2012, CHILD NEUROPSYCHOL, V18, P144, DOI 10.1080/09297049.2011.594426; Stevens C, 2009, DEVELOPMENTAL SCI, V12, P634, DOI 10.1111/j.1467-7687.2009.00807.x; Teicher MH, 2008, J CHILD ADOL PSYCHOP, V18, P265, DOI 10.1089/cap.2007.0090; Thurman DJ, 2014, J CHILD NEUROL, P1; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Wechsler D., 2011, WECHSLER ABBREVIATED; Wolfe KR, 2013, CHILD NEUROPSYCHOL, V19, P370, DOI 10.1080/09297049.2012.669470; Woodcock R, 2001, TESTS OF COGNITIVE A	47	14	14	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1691	1700		10.3109/02699052.2015.1075148			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800022	26399584				2022-02-06	
J	Karuppagounder, SS; Kumar, A; Shao, DS; Zille, M; Bourassa, MW; Caulfield, JT; Alim, I; Ratan, RR				Karuppagounder, Saravanan S.; Kumar, Arnit; Shao, Diana S.; Zille, Marietta; Bourassa, Megan W.; Caulfield, Joseph T.; Alim, Ishraq; Ratan, Rajiv R.			Metabolism and epigenetics in the nervous system: Creating cellular fitness and resistance to neuronal death in neurological conditions via modulation of oxygen-, iron-, and 2-oxoglutarate-dependent dioxygenases	BRAIN RESEARCH			English	Article						Stroke; Brain; Epigenetics; Metabolism; 2-Oxoglutarate-dependent dioxygenases; Neuroprotection	HIF PROLYL-HYDROXYLASE; HISTONE DEACETYLASE INHIBITORS; INDUCIBLE FACTOR-I; SUBEROYLANILIDE HYDROXAMIC ACID; SPINAL MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; VALPROIC ACID; SODIUM-BUTYRATE; HUNTINGTONS-DISEASE; TET PROTEINS	Modern definitions of epigenetics incorporate models for transient but biologically important changes in gene expression that are unrelated to DNA code but responsive to environmental changes such as injury-induced stress. In this scheme, changes in oxygen levels (hypoxia) and/or metabolic co-factors (iron deficiency or diminished 2-oxoglutarate levels) are transduced into broad genetic programs that return the cell and the organism to a homeostatic set point. Over the past two decades, exciting studies have identified a superfamily of iron-, oxygen-, and 2-oxoglutarate-dependent dioxygenases that sit in the nucleus as modulators of transcription factor stability, co-activator function, histone demethylases, and DNA demethylases. These studies have provided a concrete molecular scheme for how changes in metabolism observed in a host of neurological conditions, including stroke, traumatic brain injury, and Alzheimer's disease, could be transduced into adaptive gene expression to protect the nervous system. We will discuss these enzymes in this short review, focusing primarily on the ten eleven translocation (TET) DNA demethylases, the jumonji (JmJc) histone demethylases, and the oxygen-sensing prolyl hydroxylase domain enzymes (HIP PHDs). This article is part of a Special Issue entitled SI: Neuroprotection. (C) 2015 Elsevier B.V. All rights reserved.	[Karuppagounder, Saravanan S.; Kumar, Arnit; Shao, Diana S.; Zille, Marietta; Bourassa, Megan W.; Caulfield, Joseph T.; Alim, Ishraq; Ratan, Rajiv R.] Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA; [Karuppagounder, Saravanan S.; Kumar, Arnit; Shao, Diana S.; Zille, Marietta; Bourassa, Megan W.; Caulfield, Joseph T.; Alim, Ishraq; Ratan, Rajiv R.] Cornell Univ, Dept Neurol, Weill Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10021 USA		Ratan, RR (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, Burke Med Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	rrr2001@med.cornell.edu	Zille, Marietta/P-1700-2018; Kumar, Amit/L-7132-2017	Zille, Marietta/0000-0002-0609-8956; Kumar, Amit/0000-0001-5017-9887	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01 NIA AG014930]; Dr. Miriam and Sheldon G. Adelson Program in Neurorehabilitation and Neural Repair; Sperling Center for Hemorrhagic Stroke Recovery at the Burke Medical Research Institute; New York State Department of Health Center for Research Excellence in Spinal Cord Injury [DOHC019772]; Clinical and Translational Science Center at Weill Cornell Medical College [TL1TR000459]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG014930] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health (P01 NIA AG014930, Project 1 to R.R.R.), the Dr. Miriam and Sheldon G. Adelson Program in Neurorehabilitation and Neural Repair, the Sperling Center for Hemorrhagic Stroke Recovery at the Burke Medical Research Institute and New York State Department of Health Center for Research Excellence in Spinal Cord Injury (Grant no. DOHC019772). This work was also supported by Grant TL1TR000459 of the Clinical and Translational Science Center at Weill Cornell Medical College.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Aleyasin H, 2015, ANTIOXID REDOX SIGN, V22, P121, DOI 10.1089/ars.2013.5595; Aminova LR, 2008, ANTIOXID REDOX SIGN, V10, P1989, DOI 10.1089/ars.2008.2039; Aminova LR, 2005, J BIOL CHEM, V280, P3996, DOI 10.1074/jbc.M409223200; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Berchner-Pfannschmidt U, 2008, J BIOL CHEM, V283, P31745, DOI 10.1074/jbc.M804390200; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.3.CO;2-#; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Castelo-Branco G, 2014, NEUROBIOL DIS, V71, P220, DOI 10.1016/j.nbd.2014.08.019; Castro AA, 2012, BEHAV BRAIN RES, V229, P208, DOI 10.1016/j.bbr.2012.01.016; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Chang X, 2015, EXP CELL RES, V334, P136, DOI 10.1016/j.yexcr.2015.04.004; Cherng CH, 2014, J FORMOS MED ASSOC, V113, P513, DOI 10.1016/j.jfma.2013.04.007; Chiu CT, 2011, NEUROPSYCHOPHARMACOL, V36, P2406, DOI 10.1038/npp.2011.128; Chou AH, 2011, NEUROBIOL DIS, V41, P481, DOI 10.1016/j.nbd.2010.10.019; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Del Signore SJ, 2009, AMYOTROPH LATERAL SC, V10, P85, DOI 10.1080/17482960802226148; Denk F, 2013, PAIN, V154, P1668, DOI 10.1016/j.pain.2013.05.021; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fleiss B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-70; Gardian G, 2004, NEUROMOL MED, V5, P235, DOI 10.1385/NMM:5:3:235; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Ge ZZ, 2013, EXP NEUROL, V241, P56, DOI 10.1016/j.expneurol.2012.12.006; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Hancock R.L., 2015, EPIGENOMICS, P1; Hao HH, 2013, NEUROSCI BULL, V29, P484, DOI 10.1007/s12264-013-1355-6; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; Hill PS, 2014, GENOMICS, V104, P324, DOI 10.1016/j.ygeno.2014.08.012; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Isles AR, 2015, GENES BRAIN BEHAV, V14, P64, DOI 10.1111/gbb.12184; Jia HQ, 2012, HUM MOL GENET, V21, P5280, DOI 10.1093/hmg/dds379; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karuppagounder SS, 2013, J NEUROSCI RES, V91, P1066, DOI 10.1002/jnr.23204; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Kidd SK, 2011, NEUROSCIENCE, V194, P189, DOI 10.1016/j.neuroscience.2011.08.010; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Klein C, 2015, NEUROBIOL AGING, V36, P832, DOI 10.1016/j.neurobiolaging.2014.10.003; Ko M, 2015, IMMUNOL REV, V263, P6, DOI 10.1111/imr.12239; Kuiper C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00359; Kukkar A, 2014, J FORMOS MED ASSOC, V113, P921, DOI 10.1016/j.jfma.2013.05.013; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Lee HY, 2014, MOL CELLS, V37, P43, DOI 10.14348/molcells.2014.2250; Lee JY, 2012, J NEUROCHEM, V121, P818, DOI 10.1111/j.1471-4159.2012.07731.x; Li T, 2015, MOL NEUROBIOL, V51, P142, DOI 10.1007/s12035-014-8734-5; Liu XS, 2012, NEUROSCIENCE, V220, P313, DOI 10.1016/j.neuroscience.2012.06.012; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Lu WH, 2013, J NEUROSCI RES, V91, P694, DOI 10.1002/jnr.23200; Lv L, 2012, EXP NEUROL, V233, P783, DOI 10.1016/j.expneurol.2011.11.042; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Matsushita Y, 2013, BRIT J PHARMACOL, V170, P991, DOI 10.1111/bph.12366; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; MONTI B, 2012, HOAJ BIOL, V1, pNIL29; Monti B, 2010, NEUROTOX RES, V17, P130, DOI 10.1007/s12640-009-9090-5; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Narver HL, 2008, ANN NEUROL, V64, P465, DOI 10.1002/ana.21449; Niatsetskaya Z, 2010, ANTIOXID REDOX SIGN, V12, P435, DOI 10.1089/ars.2009.2800; Noh H, 2014, NEUROSCIENCE, V266, P255, DOI 10.1016/j.neuroscience.2014.02.012; Olson DE, 2015, CHEM BIOL, V22, P439, DOI 10.1016/j.chembiol.2015.03.014; Ono K, 2009, PARKINSONISM RELAT D, V15, P649, DOI 10.1016/j.parkreldis.2009.03.002; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Shmakova A, 2014, BIOCHEM J, V462, P385, DOI 10.1042/BJ20140754; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Siddiq A, 2009, J NEUROSCI, V29, P8828, DOI 10.1523/JNEUROSCI.1779-09.2009; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Sleiman S., 2014, J NEUROSCI; Smith SMC, 2014, ASN NEURO, V6, DOI 10.1042/AN20130050; Speer RE, 2013, FREE RADICAL BIO MED, V62, P26, DOI 10.1016/j.freeradbiomed.2013.01.026; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugai F, 2004, EUR J NEUROSCI, V20, P3179, DOI 10.1111/j.1460-9568.2004.03765.x; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Thirstrup K, 2011, PHARMACOL RES, V64, P268, DOI 10.1016/j.phrs.2011.03.017; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Tsai LK, 2006, NEUROBIOL DIS, V24, P286, DOI 10.1016/j.nbd.2006.07.004; Vangeison G, 2008, J NEUROSCI, V28, P1988, DOI 10.1523/JNEUROSCI.5323-07.2008; Wang B, 2012, FREE RADICAL BIO MED, V52, P928, DOI 10.1016/j.freeradbiomed.2011.12.006; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wiley JC, 2011, AGING CELL, V10, P418, DOI 10.1111/j.1474-9726.2011.00680.x; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Xuan AG, 2012, LIFE SCI, V90, P463, DOI 10.1016/j.lfs.2012.01.001; Yildirim F, 2008, EXP NEUROL, V210, P531, DOI 10.1016/j.expneurol.2007.11.031; Ying MY, 2006, J BIOL CHEM, V281, P12580, DOI 10.1074/jbc.M511677200; Yoo YE, 2011, EXP NEUROL, V231, P147, DOI 10.1016/j.expneurol.2011.06.003; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Yu HM, 2015, NAT NEUROSCI, V18, P836, DOI 10.1038/nn.4008; Yu SH, 2012, J KOREAN NEUROSURG S, V51, P191, DOI 10.3340/jkns.2012.51.4.191; Zadori D, 2009, PHARMACOL BIOCHEM BE, V94, P148, DOI 10.1016/j.pbb.2009.08.001; Zaman K, 1999, J NEUROSCI, V19, P9821; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029	114	14	15	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 2	2015	1628				SI		273	287		10.1016/j.brainres.2015.07.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ9IW	WOS:000367412300005	26232572	Green Accepted			2022-02-06	
J	Almeida, OP; Hankey, GJ; Yeap, BB; Golledge, J; Flicker, L				Almeida, Osvaldo P.; Hankey, Graeme J.; Yeap, Bu B.; Golledge, Jonathan; Flicker, Leon			Prevalence, associated factors, mood and cognitive outcomes of traumatic brain injury in later life: the health in men study (HIMS)	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						traumatic brain injury; depression; cognitive impairment; dementia; epidemiology; prevalence	ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTOR; OLDER-ADULTS; DEPRESSION; EPIDEMIOLOGY; FALLS; PREVENTION; DISORDERS; HISTORY	BackgroundThe incidence of traumatic brain injury (TBI) is rising, as are its neuropsychiatric complications. This study aims to determine (1) the prevalence of TBI, (2) the association between history of past TBI and sociodemographic, lifestyle and clinical factors, and (3) the risk of depression and cognitive impairment in later life associated with exposure to TBI. MethodsCross-sectional study of a community-derived sample of 5486 Australian men aged 70-89 years. Information on TBI was retrieved from the Western Australian Data Linkage System (WADLS) and via self-report. We used the WADLS and self-report to ascertain history of past depression, and the Geriatric Depression Scale 15-items to assess current clinically significant symptoms of depression, defined by score 7. We defined cognitive impairment by a mini-mental state examination score <24 or a WADLS diagnosis of dementia. ResultsNine hundred fifty-three men had history of TBI (17.4%). Factors associated with TBI included coronary heart disease, stroke, poor self-perceived physical health and falls. TBI increased the odds ratio of past (odds ratio (OR)=1.55, 95% confidence interval (CI)=1.21, 1.99) and current depression (OR=1.77, 95% CI=1.36, 2.32), as well as of cognitive impairment (OR=1.23, 95% CI=1.00, 1.51). The population fractions of depression and cognitive impairment attributable to TBI were 6.9% (95% CI=3.3%, 10.3%) and 3.4% (95% CI=0.0%, 6.9%). ConclusionsHistory of TBI is common in older men, and is associated with increased risk of depression and cognitive impairment. If this association is truly causal, then the effective reduction of events leading to TBI (e.g., motor vehicle accidents and falls) may also decrease the prevalence of depression and cognitive impairment in later life. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [Almeida, Osvaldo P.; Flicker, Leon] WA Ctr Hlth & Ageing, Med Res Ctr, Perth, WA, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA 6001, Australia; [Hankey, Graeme J.; Yeap, Bu B.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Yeap, Bu B.] Fiona Stanley Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Golledge, Jonathan] James Cook Univ, Sch Med & Dent, Queensland Res Ctr Periral Vasc Dis, Townsville, Qld 4811, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA 6001, Australia		Almeida, OP (corresponding author), Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia.	osvaldo.almeida@uwa.edu.au	Hankey, Graeme J/H-4968-2014; golledge, jonathan/I-2371-2013; Almeida, Osvaldo P./A-4925-2008	Hankey, Graeme J/0000-0002-6044-7328; Almeida, Osvaldo P./0000-0002-8689-6199; golledge, jonathan/0000-0002-5779-8848; Flicker, Leon/0000-0002-3650-0475	National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia [279408, 379600, 403963, 513823, 540403, 540504, 540405, 634492, 1021416, 1045710, 1060557]	This work was funded through competitive project grants from the National Health and Medical Research Council of Australia (NHMRC), numbers 279408, 379600, 403963, 513823, 540403, 540504, 540405, 634492, 1021416, 1045710 and 1060557. The sponsors had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; or preparation, review, or approval of the manuscript.	Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Almeida OP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111882; Almeida OP, 2013, PREV MED, V57, P878, DOI 10.1016/j.ypmed.2013.09.021; Australian Bureau of Statistics (ABS), 2010, 3201 0 POP AG SEX AU; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; CORKIN S, 1989, J NEUROSCI, V9, P3876; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jablensky AV, 2005, AM J PSYCHIAT, V162, P79, DOI 10.1176/appi.ajp.162.1.79; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kerse N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002423; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Newson RB, 2013, STATA J, V13, P672, DOI 10.1177/1536867X1301300402; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strakowski SM, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0386-z; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; USDHHS, 2012, ADM AG AOA ADM COMM; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X	38	14	14	1	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	DEC	2015	30	12					1215	1223		10.1002/gps.4276			9	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	CW1XB	WOS:000364784100009	25703581	Green Submitted			2022-02-06	
J	MacLaughlin, BW; Plurad, DS; Sheppard, W; Bricker, S; Bongard, F; Neville, A; Smith, JA; Putnam, B; Kim, DY				MacLaughlin, Brian W.; Plurad, David S.; Sheppard, William; Bricker, Scott; Bongard, Fred; Neville, Angela; Smith, Jennifer A.; Putnam, Brant; Kim, Dennis Y.			The impact of intracranial pressure monitoring on mortality after severe traumatic brain injury	AMERICAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	67th Annual Meeting of the Southwestern-Surgical-Congress	APR 26-29, 2015	Monterey, CA	SW Surg Congress		Intracranial pressure monitor; Traumatic brain injury; Severe; Mortality; Outcomes	OUTCOMES	BACKGROUND: The effect of intracranial pressure (ICP) monitoring on mortality after severe traumatic brain injury (sTBI) remains unclear. We hypothesized that ICP monitoring would not be associated with improved survival in patients with sTBI. METHODS: A retrospective analysis was performed on sTBI patients, defined as admission Glasgow Coma Scale score of 8 or less with intracranial hemorrhage. Patients who underwent ICP monitoring were compared with patients who did not. The primary outcome measure was inhospital mortality. RESULTS: Of 123 sTBI patients meeting inclusion criteria, 40 (32.5%) underwent ICP monitoring. On bivariate and multivariate regression analyses, ICP monitoring was associated with decreased mortality (odds ratio = .32, 95% confidence interval = .10 to.99, P = .049). This finding persisted on propensity-adjusted analysis. CONCLUSIONS: ICP monitoring is associated with improved survival in adult patients with sTBI. In addition, significant variability exists in the use of ICP monitoring among patients with sTBI. (C) 2015 Elsevier Inc. All rights reserved.	[MacLaughlin, Brian W.; Plurad, David S.; Sheppard, William; Bricker, Scott; Bongard, Fred; Neville, Angela; Smith, Jennifer A.; Putnam, Brant; Kim, Dennis Y.] Harbor UCLA Med Ctr, Dept Surg, Div Trauma Acute Care Surg Surg Crit Care, Torrance, CA 90509 USA		Kim, DY (corresponding author), Harbor UCLA Med Ctr, Dept Surg, Div Trauma Acute Care Surg Surg Crit Care, 1000 West Carson St,Box 42, Torrance, CA 90509 USA.	dekim@dhs.lacounty.gov					Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; EDDY VA, 1995, AM SURGEON, V61, P24; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Guyot LL, 1998, ACT NEUR S, V71, P47; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60; Winn HR, 2011, YOUMANS NEUROSURGICA, V4, P3288	15	14	14	0	4	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	DEC	2015	210	6					1082	1086		10.1016/j.amjsurg.2015.08.007			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	CY1OZ	WOS:000366178300034	26482513				2022-02-06	
J	Pagan, E; Ownsworth, T; McDonald, S; Fleming, J; Honan, C; Togher, L				Pagan, Elizabeth; Ownsworth, Tamara; McDonald, Skye; Fleming, Jennifer; Honan, Cynthia; Togher, Leanne			A Survey of Multidisciplinary Clinicians Working in Rehabilitation for People with Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						multidisciplinary; rehabilitation; traumatic brain injury; clinicians	SPEECH-LANGUAGE PATHOLOGISTS; COGNITIVE REHABILITATION; SELF-EFFICACY; CONFIDENCE; NEUROPSYCHOLOGISTS; COLLABORATION; PERCEPTIONS; TEAM; COMMUNICATION; KNOWLEDGE	Little is known about clinicians' experiences in rehabilitation for people with traumatic brain injury (TBI). This survey study aimed to investigate clinicians' scope of practice, perceived barriers to practice, factors influencing confidence levels and professional development preferences. Participants included 305 clinicians (88% female, 97% aged 20-60 years) from psychology (28%), occupational therapy (27%), speech pathology (15%), physiotherapy (11%), social work (6%), rehabilitation medicine (3%) and nursing (3%) disciplines. Survey results indicated that goal setting, client or family education, and assessment for rehabilitation, were the most common activities across all disciplines (>90%). Client-related barriers, family-related barriers and client-therapist relationship barriers were more frequently selected than workplace context and professional skill barriers (p < .05). Clinicians working with clients with mild TBI reported significantly fewer barriers (p < .05); yet, they were less confident in overcoming barriers than clinicians working with clients with more severe TBI (p < .001). Clinicians with fewer years of experience (<2 years) reported significantly lower confidence in overcoming barriers than clinicians with 2-10 years and >10 years of experience (p < .01). The most commonly selected professional development areas included new interventions and therapies, translating rehabilitation research into everyday practice and client specific topics. These findings provide a unique multidisciplinary perspective on clinicians working in TBI rehabilitation in Australia. Understanding of the perceived barriers to practice and professional development needs may guide training and support initiatives for clinicians which, in turn, may enhance the quality of brain injury rehabilitation.	[Pagan, Elizabeth; Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia; [Pagan, Elizabeth; Ownsworth, Tamara] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld 4111, Australia; [Pagan, Elizabeth; Ownsworth, Tamara; McDonald, Skye; Fleming, Jennifer; Honan, Cynthia; Togher, Leanne] Univ New S Wales, Ctr Res Excellence Brain Recovery, Natl Hlth & Med Res Council, Sydney, NSW, Australia; [McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia; [Honan, Cynthia] Univ Tasmania, Sch Psychol, Launceston, Tas 7250, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, Sydney, NSW 2006, Australia		Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au	Togher, Leanne/AAC-7083-2019; Ownsworth, Tamara/ABB-6961-2021; Honan, Cynthia/O-6332-2017	Ownsworth, Tamara/0000-0003-1835-7094; Togher, Leanne/0000-0002-4518-6748; Honan, Cynthia/0000-0001-5735-4270	National Health and Medical Research Council Centre of Research Excellence in Brain Recovery [1083064]	This study was supported by the National Health and Medical Research Council Centre of Research Excellence in Brain Recovery (ID: 1083064).	Access Economics, 2009, EC COST SPINAL CORD; Ammentorp J, 2007, PATIENT EDUC COUNS, V66, P270, DOI 10.1016/j.pec.2006.12.012; [Anonymous], 2010, AR PRACT END REG STA; Australasian Faculty of Rehabilitation Medicine, 2011, STAND PROV INP AD RE; Australian Institute of Health and Welfare, 2007, AIHW B, V55; Barclay DA, 2013, J SOC WORK DISABIL R, V12, P159, DOI 10.1080/1536710X.2013.810093; Bishop M, 2006, AUST J REHABIL COUNS, V12, P73, DOI 10.1375/jrc.12.2.73; Boosman H, 2014, J INT NEUROPSYCH SOC, V20, P1034, DOI 10.1017/S1355617714000897; Booth Julie, 2002, J Interprof Care, V16, P31, DOI 10.1080/13561820220104140; Brooks V, 2014, CREAT NURS, V20, P90, DOI 10.1891/1078-4535.20.2.90; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook RS, 2013, J NEUROSCI NURS, V45, P108, DOI 10.1097/JNN.0b013e318282906e; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Evans JJ, 2012, CURR OPIN NEUROL, V25, P651, DOI 10.1097/WCO.0b013e3283598f75; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Government of South Australia, 2012, STAT REH CLIN NETW; Graham F, 2013, AUST OCCUP THER J, V60, P120, DOI 10.1111/1440-1630.12000; Hicks EJ, 2011, INT J SPEECH-LANG PA, V13, P145, DOI 10.3109/17549507.2011.485329; Holland K, 2012, SCAND J OCCUP THER, V19, P214, DOI 10.3109/11038128.2011.583939; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Jackson H, 2001, NEUROREHABILITATION, V16, P27; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Korner M, 2010, CLIN REHABIL, V24, P745, DOI 10.1177/0269215510367538; Mazmanian Paul E., 1993, Brain Injury, V7, P319, DOI 10.3109/02699059309034958; McDonald S, 2012, BRAIN IMPAIR, V13, P256, DOI 10.1017/BrImp.2012.21; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; Mitsch V., 2011, P 11 NAT RUR HLTH C; NSW Government, 2011, CAR SUPP PATHW PEOPL; Pedrazza M., 2013, J SOCIAL SCI, V2, P191, DOI DOI 10.3390/socsci2030191; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ryan C, 2013, BRIT J CLIN PHARMACO, V76, P980, DOI 10.1111/bcp.12154; Sander AM, 2009, CLIN NEUROPSYCHOL, V23, P1196, DOI 10.1080/13854040902845706; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Stringer AY, 2003, CLIN NEUROPSYCHOL, V17, P34, DOI 10.1076/clin.17.1.34.15625; Suddick KM, 2006, PHYSIOTHER RES INT, V11, P72, DOI 10.1002/pri.325; Tate R.L., 2008, HIGHER BRAIN FUNCTIO, V28, P129; Triola MM, 2012, MED TEACH, V34, pE15, DOI 10.3109/0142159X.2012.638010; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Turner BJ, 2008, AUST OCCUP THER J, V55, P96, DOI 10.1111/j.1440-1630.2007.00660.x; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; Wilding C, 2012, AUST OCCUP THER J, V59, P312, DOI 10.1111/j.1440-1630.2012.01031.x; Wittig PG, 2003, DISABIL REHABIL, V25, P97, DOI 10.1080/0963828021000024933; Wong D, 2014, AUST PSYCHOL, V49, P209, DOI 10.1111/ap.12061	47	14	14	0	27	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2015	16	3					173	195		10.1017/BrImp.2015.34			23	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DD4KV	WOS:000369892700003		Green Submitted			2022-02-06	
J	Zhong, ZQ; Tao, Y; Yang, H				Zhong, Zeqi; Tao, Yuan; Yang, Hui			Treatment with harmine ameliorates functional impairment and neuronal death following traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						traumatic brain injury; harmine; glutamate transporter 1; inflammatory; neuronal death; functional recovery	GLUTAMATE TRANSPORTER GLT-1; BETA-CARBOLINE ALKALOIDS; FOCAL CEREBRAL-ISCHEMIA; ANTISENSE KNOCKDOWN; RAT-BRAIN; MODEL; EXCITOTOXICITY; EPILEPSY; DAMAGE; MICE	Traumatic brain injury (TBI) is a leading cause of mortality in young individuals, and results in motor and cognitive deficiency. Excitotoxicity is an important process during neuronal cell death, which is caused by excessive release of glutamate following TBI. Astrocytic glutamate transporters have a predominant role in maintaining extracellular glutamate concentrations below excitotoxic levels, and glutamate transporter 1 (GLT-1) may account for >90% of glutamate uptake in the brain. The -carboline alkaloid harmine has been demonstrated to exert neuroprotective actions in vivo, and the beneficial effects were specifically due to elevation of GLT-1. However, whether harmine provides neuroprotection following TBI remains to be elucidated. The present study performed intraperitoneal harmine injections in rats (30 mg/kg per day for up to 5 days), in order to investigate whether harmine treatment attenuates brain edema and improves functional recovery in a rat model of TBI. The neuronal survival ratio and the protein expression of apoptosis-associated caspase 3 were also assessed in the hippocampus of the rat brain. Furthermore, the expression levels of GLT-1 and inflammatory cytokines were detected, in order to determine the underlying mechanisms. The results of the present study demonstrated that administration of harmine significantly attenuated cerebral edema, and improved learning and memory ability. In addition, harmine significantly increased the protein expression of GLT-1, and markedly attenuated the expression levels of interleukin-1 and tumor necrosis factor-, thereby attenuating apoptotic neuronal death in the hippocampus. These results provided in vivo evidence that harmine may exert neuroprotective effects by synergistically reducing excitotoxicity and inflammation following TBI.	[Zhong, Zeqi; Yang, Hui] Third Mil Med Univ, Xinqiao Hosp, Dept Neurosurg, Chongqing 400037, Peoples R China; [Tao, Yuan] Third Mil Med Univ, Res Inst Field Surg, Daping Hosp, Dept Neurol, Chongqing 400042, Peoples R China		Yang, H (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Neurosurg, 183 Xinqiao Rd, Chongqing 400037, Peoples R China.	huiyang24k@163.com					Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Astulla A, 2008, J NAT MED-TOKYO, V62, P470, DOI 10.1007/s11418-008-0259-7; Cao RH, 2007, CURR MED CHEM, V14, P479, DOI 10.2174/092986707779940998; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Fortunato JJ, 2010, BRAIN RES BULL, V81, P491, DOI 10.1016/j.brainresbull.2009.09.008; Han F, 2008, NEUROSCI LETT, V430, P275, DOI 10.1016/j.neulet.2007.11.021; Johnston MV, 2005, BRAIN PATHOL, V15, P234; Lai AY, 2006, J NEUROIMMUNOL, V175, P97, DOI 10.1016/j.jneuroim.2006.03.001; Lauderback CM, 2001, J NEUROCHEM, V78, P413, DOI 10.1046/j.1471-4159.2001.00451.x; Li Y, 2011, NEUROPHARMACOLOGY, V60, P1168, DOI 10.1016/j.neuropharm.2010.10.016; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Moura DJ, 2007, MUTAGENESIS, V22, P293, DOI 10.1093/mutage/gem016; Namura S, 2002, NEUROSCI LETT, V324, P117, DOI 10.1016/S0304-3940(02)00193-3; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; RAUEN T, 1994, NEUROSCI LETT, V169, P137, DOI 10.1016/0304-3940(94)90375-1; Reus GZ, 2010, OXID MED CELL LONGEV, V3, P325, DOI 10.4161/oxim.3.5.13109; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Samuelsson C, 2000, NEUROSCI LETT, V289, P185, DOI 10.1016/S0304-3940(00)01284-2; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TAUBER MG, 1985, J INFECT DIS, V151, P528, DOI 10.1093/infdis/151.3.528; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	27	14	15	0	8	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	DEC	2015	12	6					7985	7991		10.3892/mmr.2015.4437			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	CZ6CT	WOS:000367189500022	26496827	Green Submitted, Green Published, hybrid			2022-02-06	
J	Woods, DL; Wyma, JM; Yund, EW; Herron, TJ				Woods, David L.; Wyma, John M.; Yund, E. W.; Herron, Timothy J.			The Effects of Repeated Testing, Simulated Malingering, and Traumatic Brain Injury on Visual Choice Reaction Time	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						aging; concussion; head injury; reliability; response selection; feigning; effort; timing precision	TEST-RETEST RELIABILITY; MEASURING PROCESSING SPEED; COGNITIVE TEST-PERFORMANCE; VALIDITY TEST-PERFORMANCE; CLOSED-HEAD-INJURY; MULTIPLE-SCLEROSIS; VERBAL MEMORY; NIH TOOLBOX; CONCUSSION; ATTENTION	Choice reaction time (CRT), the time required to discriminate and respond appropriately to different stimuli, is a basic measure of attention and processing speed. Here, we describe the reliability and clinical sensitivity of a new CRT test that presents lateralized visual stimuli and adaptively adjusts stimulus onset asynchronies using a staircase procedure. Experiment 1 investigated the test-retest reliability in three test sessions performed at weekly intervals. Performance in the first test session was accurately predicted from age and computer-use regression functions obtained in a previously studied normative cohort. Central processing time (CentPT), the difference between the CRTs and simple reaction time latencies measured in a separate experiment, accounted for 55% of CRT latency and more than 85% of CRT latency variance. Performance improved significantly across the three test sessions. High intraclass correlation coefficients were seen for CRTs (0.90), CentPTs (0.87), and an omnibus performance measure (0.81) that combined CRT and minimal SOA z-scores. Experiment 2 investigated performance in the same participants when instructed to feign symptoms of traumatic brain injury (TBI): 87% produced abnormal omnibus z-scores. Simulated malingerers showed greater elevations in simple reaction times than CRTs, and hence reduced CentPTs. Latency-consistency z-scores, based on the difference between the CRTs obtained and those predicted based on CentPT latencies, discriminated malingering participants from controls with high sensitivity and specificity. Experiment 3 investigated CRT test performance in military veterans who had suffered combat-related TBI and symptoms of post-traumatic stress disorder, and revealed small but significant deficits in performance in the TBI population. The results indicate that the new CRT test shows high test-retest reliability, can assist in detecting participants performing with suboptimal effort, and is sensitive to the effects of TBI on the speed and accuracy of visual processing.	[Woods, David L.; Wyma, John M.; Yund, E. W.; Herron, Timothy J.] Vet Affairs Northern Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA; [Woods, David L.] UC Davis Dept Neurol, Sacramento, CA USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] UC Davis Ctr Mind & Brain, Davis, CA USA		Woods, DL (corresponding author), Vet Affairs Northern Calif Hlth Care Syst, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA.	dlwoods@ucdavis.edu		Woods, David/0000-0002-8804-3587; Herron, Timothy/0000-0002-4297-014X; Yund, E./0000-0002-6833-0052	VA Merit Grants [CX000583, CX001000]; Veterans AffairsUS Department of Veterans Affairs [I01CX000583, I01CX001000] Funding Source: NIH RePORTER	This research was supported by VA Merit Grants CX000583 and CX001000 to DW. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. We would also like to thank Ben Edwards, Oren Poliva, Masood Younus, Nabeel Rahman, Kerry Hubel, Nerene Lynskey, Kataraina George, and John McKeogh who helped to gather the data used in this report, and to Robert Hink who developed the MySQL database.	Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Egeland J, 2007, APPL NEUROPSYCHOL, V14, P113, DOI 10.1080/09084280701319953; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; Fong KNK, 2009, NEUROREHABILITATION, V24, P165, DOI 10.3233/NRE-2009-0465; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kertzman S, 2006, ISRAEL J PSYCHIAT, V43, P112; Klein RM, 2011, ACTA PSYCHOL, V136, P225, DOI 10.1016/j.actpsy.2010.08.003; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lapshin H, 2013, MULT SCLER J, V19, P1905, DOI 10.1177/1352458513488841; Lee KS, 2012, NEUROTOXICOLOGY, V33, P1362, DOI 10.1016/j.neuro.2012.08.013; Lemay S, 2004, CLIN NEUROPSYCHOL, V18, P284, DOI 10.1080/13854040490501718; McNally RJ, 2012, J TRAUMA STRESS, V25, P454, DOI 10.1002/jts.21713; Papapetropoulos S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/760196; Pellizzer G, 2007, EXP BRAIN RES, V180, P705, DOI 10.1007/s00221-007-0892-5; Plant RR, 2013, COGN AFFECT BEHAV NE, V13, P598, DOI 10.3758/s13415-013-0166-6; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Rogers PJ, 2013, PSYCHOPHARMACOLOGY, V226, P229, DOI 10.1007/s00213-012-2889-4; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Snyder PJ, 2001, NEUROPSYCHOLOGY, V15, P617, DOI 10.1037//0894-4105.15.4.617; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Versavel M, 1997, ARZNEIMITTEL-FORSCH, V47, P781; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wogar MA, 1998, BRIT J CLIN PSYCHOL, V37, P327, DOI 10.1111/j.2044-8260.1998.tb01389.x; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00540; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149	56	14	15	0	17	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 24	2015	9								595	10.3389/fnhum.2015.00595			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CY7DB	WOS:000366567300001	26635569	Green Published, gold			2022-02-06	
J	Semple, BD; Noble-Haeusslein, LJ; Gooyit, M; Tercovich, KG; Peng, ZH; Nguyen, TT; Schroeder, VA; Suckow, MA; Chang, M; Raber, J; Trivedi, A				Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Gooyit, Major; Tercovich, Kayleen G.; Peng, Zhihong; Nguyen, Trung T.; Schroeder, Valerie A.; Suckow, Mark A.; Chang, Mayland; Raber, Jacob; Trivedi, Alpa			Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HIGHLY SPECIFIC INHIBITOR; CENTRAL-NERVOUS-SYSTEM; GENE KNOCK-OUT; MATRIX METALLOPROTEINASES; CEREBROSPINAL-FLUID; HYPOXIA-ISCHEMIA; HEMORRHAGIC TRANSFORMATION; TISSUE INHIBITOR; MESSENGER-RNA	The gelatinases, matrix metalloproteinases (MMP)-2 and MMP-9, are thought to be key mediators of secondary damage in adult animal models of brain injury. Moreover, an acute increase in these proteases in plasma and brain extracellular fluid of adult patients with moderate-to-severe traumatic brain injuries (TBIs) is associated with poorer clinical outcomes and mortality. Nonetheless, their involvement after TBI in the pediatric brain remains understudied. Using a murine model of TBI at postnatal day 21 (p21), approximating a toddler-aged child, we saw upregulation of active and pro-MMP-9 and MMP-2 by gelatin zymography at 48 h post-injury. We therefore investigated the role of gelatinases on long-term structural and behavioral outcomes after injury after acute inhibition with a selective gelatinase inhibitor, p-OH SB-3CT. After systemic administration, p-OH SB-3CT crossed the blood-brain barrier at therapeutically-relevant concentrations. TBI at p21 induced hyperactivity, deficits in spatial learning and memory, and reduced sociability when mice were assessed at adulthood, alongside pronounced tissue loss in key neuroanatomical regions. Acute and short-term post-injury treatment with p-OH SB-3CT did not ameliorate these long-term behavioral, cognitive, or neuropathological deficits as compared to vehicle-treated controls, suggesting that these deficits were independent of MMP-9 and MMP-2 upregulation. These findings emphasize the vulnerability of the immature brain to the consequences of traumatic injuries. However, early upregulation of gelatinases do not appear to be key determinants of long-term recovery after an early-life injury.	[Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Tercovich, Kayleen G.; Trivedi, Alpa] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94117 USA; [Semple, Bridgette D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3052, Australia; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil, San Francisco, CA 94143 USA; [Gooyit, Major; Peng, Zhihong; Nguyen, Trung T.; Chang, Mayland] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Div Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Div Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Radiat Med, Div Neurosci, Portland, OR 97201 USA		Trivedi, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94117 USA.	alpa.mahuvakar@ucsf.edu	Peng, Zhihong/T-1359-2019; Tercovich, Kayleen/I-8941-2018	Tercovich, Kayleen/0000-0003-0450-8912; Peng, Zhihong/0000-0002-2764-4645; Suckow, Mark/0000-0001-7317-697X	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1NS077767, RO1NS050159]; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1052505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM075762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077767, R01NS050159] Funding Source: NIH RePORTER	LJN received two grants from the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) with grant numbers RO1NS077767 and RO1NS050159. BDS received a CJ Martin Early Career Fellowship from the Australian National Health and Medical Research Council with award number 1052505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2008, SEMIN CELL DEV BIOL, V19, P42, DOI 10.1016/j.semcdb.2007.06.003; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asahi M, 2001, NEUROREPORT, V12, P3003, DOI 10.1097/00001756-200109170-00050; Bednarek N, 2012, PEDIATR RES, V71, P63, DOI 10.1038/pr.2011.3; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Chou SHY, 2011, TRANSL STROKE RES, V2, P600, DOI 10.1007/s12975-011-0117-x; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; Cui J, 2012, MOL NEURODEGENER, V7, P1750; Davis MJ, 2012, BEHAV BRAIN RES, V229, P21, DOI 10.1016/j.bbr.2011.12.037; Demestre M, 2005, J NEUROIMMUNOL, V159, P146, DOI 10.1016/j.jneuroim.2004.09.015; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dragun P, 2008, J PHYSIOL PHARMACOL, V59, P441; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Fager N, 2000, MECH DEVELOP, V98, P105, DOI 10.1016/S0925-4773(00)00437-8; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Fernandez Eva, 2011, Pharmaceutics, V3, P53, DOI 10.3390/pharmaceutics3010053; Gooyit M, 2013, J MED CHEM, V56, P8139, DOI 10.1021/jm401217d; Gooyit M, 2012, ACS CHEM NEUROSCI, V3, P730, DOI 10.1021/cn300062w; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Jia F, 2014, J NEUROTRAUM, V24, P24; Jiang XF, 2001, NEUROSCI LETT, V305, P41, DOI 10.1016/S0304-3940(01)01800-6; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; Kawai N, 2003, J NEUROTRAUM, V20, P649, DOI 10.1089/089771503322144563; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Konrad K, 2003, COGNITIVE BRAIN RES, V16, P425, DOI 10.1016/S0926-6410(03)00057-0; Lazarov O, 2006, J NEUROSCI, V26, P429, DOI 10.1523/JNEUROSCI.3961-05.2006; Lee M, 2005, ORG LETT, V7, P4463, DOI 10.1021/ol0517269; Lee M, 2007, CHEM BIOL DRUG DES, V70, P371, DOI 10.1111/j.1747-0285.2007.00577.x; Liu CL, 2014, TURK NEUROSURG, V24, P363, DOI 10.5137/1019-5149.JTN.8551-13.0; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Lu A, 2013, NEUROSCIENCE, V253, P361, DOI 10.1016/j.neuroscience.2013.08.068; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Muradashvili N, 2014, METAB BRAIN DIS, V29, P29; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Oh LYS, 1999, J NEUROSCI, V19, P8464; Omouendze PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071263; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Pardridge William M, 2005, NeuroRx, V2, P1, DOI 10.1602/neurorx.2.1.1; Pastrana E, 2006, J NEUROSCI, V26, P5347, DOI 10.1523/JNEUROSCI.1111-06.2006; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Ranasinghe HS, 2012, DEV NEUROSCI-BASEL, V34, P417, DOI 10.1159/000343257; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Semple BD, 2015, NEUROBIOL DIS, P74; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Strolin Benedetti M, 2005, Expert Opin Drug Metab Toxicol, V1, P447; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Vaillant C, 1999, J NEUROSCI, V19, P4994; Verslegers M, 2015, BRAIN STRUCT FUNCT, V220, P1601, DOI 10.1007/s00429-014-0747-3; Verslegers M, 2013, PROG NEUROBIOL, V105, P60, DOI 10.1016/j.pneurobio.2013.03.004; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yang M, 2011, CURR PROT NEUROSCI, V8; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zheng KB, 2013, NEUROL INDIA, V61, P606, DOI 10.4103/0028-3886.125258	89	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143386	10.1371/journal.pone.0143386			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	WOS:000365251500056	26588471	Green Published, gold, Green Submitted			2022-02-06	
J	Chang, J; Phelan, M; Cummings, BJ				Chang, Janessa; Phelan, Michael; Cummings, Brian J.			A meta-analysis of efficacy in pre-clinical human stem cell therapies for traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Cell therapy; Cell transplantation; Stem cell therapy; Traumatic brain injury; Neurotrauma; Meta-analysis; Scientific rigor; Review	SPINAL-CORD-INJURY; UNITED-STATES; TRANSPLANTATION; ENGRAFTMENT; RECOVERY; STROKE; NEUROPROTECTION; FUTURE; SAFETY; MICE	Objectives: Evaluate the preclinical evidence for human cell therapies for the treatment of traumatic brain injury (TBI), determine behavioral effect sizes for modified and non-modified cells, and identify variables that correlate with greater effect sizes. Methods: A literature search identified 58 animal studies of TBI using human stem cells. Each study received a Quality Index (QI) score based on existing guidelines. Effect sizes for cell therapies were determined for the most common behavioral endpoints: Morris Water Maze (MWM) latency/correct quadrant, and modified Neurological Severity Score (mNSS). Results: 50 studies reported significant behavioral and/or histological improvement. The mean effect size for MWM latency was -1.08 for non-modified cells and -335 for modified cells. The mean effect size for MWM percent time in the correct quadrant was 1.66 for non-modified cells and 4.36 for modified cells. The mean effect size on the mNSS was -1.56 for non-modified cells and -4.46 for modified cells. No significant associations were found between methodological variables and effect sizes other than route of administration, where intra-lesional delivery resulted in larger effect sizes than i.v. or ventricular delivery. Studies with higher QI had smaller effect sizes; studies with larger effect sizes had greater standard errors. QI was not associated with journal impact factor. Conclusions: Although human cell therapy studies report improved behavioral outcomes in the majority of preclinical literature, the methods are too heterogeneous to facilitate direct comparisons and bias was detected. Replication and standardization are needed to identify procedural variables to yield the best results. We encourage the use of quality criteria and rigor for future studies of human cell therapy in animal models of TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Chang, Janessa; Cummings, Brian J.] Univ Calif Irvine, UC Inst Memory Impairments & Neurol Disorders, Dept Phys Med, Irvine, CA 92697 USA; [Chang, Janessa; Cummings, Brian J.] Univ Calif Irvine, UC Inst Memory Impairments & Neurol Disorders, Dept Rehabil, Irvine, CA 92697 USA; [Phelan, Michael] Univ Calif Irvine, Dept Stat, Ctr Stat Consulting, Irvine, CA 92697 USA; [Cummings, Brian J.] Univ Calif Irvine, UC Inst Memory Impairments & Neurol Disorders, Sue & Bill Gross Stem Cell Res Ctr, Neurol Surg, Irvine, CA 92697 USA		Cummings, BJ (corresponding author), Univ Calif Irvine, UC Inst Memory Impairments & Neurol Disorders, Dept Phys Med, Room 2026 Gross Hall,845 Hlth Sci Rd, Irvine, CA 92697 USA.	ChangJan@uphs.upenn.edu; phelanm@uci.edu; Cummings@uci.edu	Cummings, Brian J/C-9180-2012	Cummings, Brian J/0000-0003-3628-5290	California Institute for Regenerative MedicineCalifornia Institute for Regenerative Medicine [TR2-01767]	We wish to thank Dr. Steven Cramer for discussion of meta-analysis in stoke, Benita Lin for assistance with data entry, and Drs. Mitra Hooshmand and Aileen Anderson for critical review and comments. This work was supported, in part, by a grant from the California Institute for Regenerative Medicine (TR2-01767 to BJC).	Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; CDC, INJ PREV CONTR TRAUM; Cook D, 2014, J BIOMECH, V47, P1241, DOI 10.1016/j.jbiomech.2014.01.040; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Cummings BJ, 2006, NEUROL RES, V28, P474, DOI 10.1179/016164106X115116; FDA, 2013, GUID IND PRECL ASS I; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Laird N M, 1990, Int J Technol Assess Health Care, V6, P5; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; Lemmens R, 2013, CURR OPIN NEUROL, V26, P617, DOI 10.1097/WCO.0000000000000023; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; NINDS, STROKE; OLKIN I, 1995, J CLIN EPIDEMIOL, V48, P133, DOI 10.1016/0895-4356(94)00136-E; Piltti KM, 2013, STEM CELL TRANSL MED, V2, P961, DOI 10.5966/sctm.2013-0064; Piltti KM, 2013, STEM CELL TRANSL MED, V2, P204, DOI 10.5966/sctm.2012-0110; Roet KCD, 2011, EXP NEUROL, V229, P10, DOI 10.1016/j.expneurol.2011.03.001; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Shineman DW, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt90; Sontag CJ, 2014, STEM CELL REP, V2, P620, DOI 10.1016/j.stemcr.2014.03.005; Sontag CJ, 2013, STEM CELL TRANSL MED, V2, P731, DOI 10.5966/sctm.2012-0175; Tator CH, 2012, J NEUROSURG-SPINE, V17, P157, DOI 10.3171/2012.5.AOSPINE12116; Team R. C, 2014, LANG ENV STAT COMP; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vu Q, 2014, NEUROLOGY, V82, P1277, DOI 10.1212/WNL.0000000000000278; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863	40	14	14	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2015	273						225	233		10.1016/j.expneurol.2015.08.020			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW7BB	WOS:000365151800021	26342754				2022-02-06	
J	Lee, JEC; Garber, B; Zamorski, MA				Lee, Jennifer E. C.; Garber, Bryan; Zamorski, Mark A.			Prospective Analysis of Premilitary Mental Health, Somatic Symptoms, and Postdeployment Postconcussive Symptoms	PSYCHOSOMATIC MEDICINE			English	Article						military; traumatic brain injury; mental health; deployment; persistent postconcussive symptoms; prospective analysis	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; GULF-WAR; SERVICE MEMBERS; PTSD CHECKLIST; NATIONAL-GUARD; PRIMARY-CARE; IRAQ; DEPRESSION; ASSOCIATION	Objectives Many recent studies of service members returning from deployment have focused on the health impacts of mild traumatic brain injury (mTBI), including persistent postconcussive symptoms (PCS). However, cross-sectional study designs have made it difficult to understand the role of mental health in the etiology of persistent PCS. Methods Participants were 3319 military personnel (primarily men [90%] of 25-34 years [54%]) who had completed health surveys at basic training and after deployment, on average, 4.6 years later. Negative binomial regression was used to assess the association of PCS with demographic covariates, premilitary mental health and somatic symptoms, combat experiences and mTBI during deployment, in addition to postdeployment mental health and non-PCS somatic symptoms. Results Premilitary mental health and somatic symptoms predicted PCS even when adjusting for other variables, yielding an elevated incidence rate ratio (IRR) for posttraumatic stress disorder (PTSD; IRR = 1.23, 95% confidence interval [CI] = 1.06-1.41) and somatic symptoms (mild versus minimal somatic symptoms: IRR = 1.43, 95% CI = 1.31-1.55; moderate/severe versus minimal somatic symptoms: IRR = 1.69, 95% CI = 1.43-2.06), but not for depressive symptoms. When postdeployment mental health and somatic symptom measures were added to the model, the effect of premilitary somatic symptoms remained significant. Conclusions Findings point to potential etiological contributions of premilitary characteristics, particularly a tendency to experience somatic symptoms and PTSD, as well as mTBI and combat experiences, to the development of PCS. PCS were also strongly related to concurrent postdeployment mental health.	[Lee, Jennifer E. C.] Dept Natl Def, Mil Personnel Res & Anal, Ottawa, ON, Canada; [Garber, Bryan; Zamorski, Mark A.] Dept Natl Def, Directorate Mental Hlth, Ottawa, ON, Canada		Lee, JEC (corresponding author), Natl Def Hdq, Mil Personnel Res & Anal, 101 Colonel Dr, Ottawa, ON K1A 0K2, Canada.	jennifer.lee@forces.gc.ca			Canadian Department of National Defence	This project was funded by the Canadian Department of National Defence. No conflicts of interests are declared.	Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Eaton W., 2011, TXB PSYCHIAT EPIDEMI; Edge HJM, 2012, MIL PSYCHOL, V24, P71, DOI 10.1080/08995605.2012.642292; Garber BG, 2012, MILD TRAUMATIC BRAIN; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hotopf M, 2005, INT J EPIDEMIOL, V34, P791, DOI 10.1093/ije/dyi102; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; Iversen A, 2007, CLIN PSYCHOL REV, V27, P842, DOI 10.1016/j.cpr.2007.07.006; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2003, PRIM CARE COMPANI S, V5, P11; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lee JEC, 2013, 2013006 DGMPRA TM DE; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Olson CB, 2004, MIL PSYCHOL, V16, P53, DOI 10.1207/s15327876mp1601_4; Polusny MA, 2011, PSYCHOL MED, V41, P687, DOI 10.1017/S0033291710002047; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rona RJ, 2012, J PSYCHIATR RES, V46, P1191, DOI 10.1016/j.jpsychires.2012.05.009; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	35	14	14	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	NOV-DEC	2015	77	9					1006	1017		10.1097/PSY.0000000000000250			12	Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	CV7ZU	WOS:000364497100006	26458235				2022-02-06	
J	Lorivel, T; Gandin, C; Veyssiere, J; Lazdunski, M; Heurteaux, C				Lorivel, T.; Gandin, C.; Veyssiere, J.; Lazdunski, M.; Heurteaux, C.			Positive Effects of the Traditional Chinese Medicine MLC901 in Cognitive Tasks	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						anxiety disorders; cognitive flexibility; fear extinction; memory; MLC901; NeuroAiD; passive avoidance; posttraumatic stress disorder; stroke	POSTTRAUMATIC-STRESS-DISORDER; CONTEXTUAL FEAR EXTINCTION; TRAUMATIC BRAIN-INJURY; ELEVATED PLUS-MAZE; D2 KNOCKOUT MICE; HIPPOCAMPAL NEUROGENESIS; NEUROAID EFFICACY; ANIMAL-MODELS; DOUBLE-BLIND; OBJECT RECOGNITION	MLC901 (NurAiDII) is used as a treatment for stroke patients. It has been shown that MLC901 improves motor and cognitive recovery in ischemic and traumatic brain-injured rodents. The present study seeks to delineate cognitive effects induced by MLC901 in normal, non-injured mice. To this end, the behaviors of vehicle-and MLC901-treated C57BL/6 mice in hippocampus-dependent (passive avoidance, Morris water maze) and hippocampus-independent (novel object recognition) cognitive tasks are compared. The potential influence of the compound on the anxiety level and nycthemeral rhythm of mice is also assessed. In addition, the long-term effects of MLC901 on hippocampal neurogenesis are measured. The results clearly demonstrate that MLC901 promotes extinction in passive avoidance and reversal learning in the Morris water maze and improves the performance of mice in novel object recognition. In parallel, this study shows the long-term proneurogenesis effects of MLC901 that result in the increase in the number of mature neurons in the hippocampus. If these observations can be extended to humans, then MLC901 could represent a promising therapeutic strategy. (C) 2015 The Authors. Journal of Neuroscience Research Published by Wiley Periodicals, Inc.	[Lorivel, T.; Gandin, C.; Veyssiere, J.; Lazdunski, M.; Heurteaux, C.] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, UMR7275, F-06560 Valbonne, France		Heurteaux, C (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, UMR7275, 660 Route Lucioles Sophia Antipolis, F-06560 Valbonne, France.	heurteau@ipmc.cnrs.fr	HEURTEAUX, Catherine/M-4947-2016	HEURTEAUX, Catherine/0000-0002-9741-9777	Centre National de la Recherche ScientifiqueCentre National de la Recherche Scientifique (CNRS); Moleac	Contract grant sponsor: Centre National de la Recherche Scientifique; Contract grant sponsor: Moleac.	An B, 2012, J NEUROSCI, V32, P16845, DOI 10.1523/JNEUROSCI.3017-12.2012; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Boschen MJ, 2009, AUST NZ J PSYCHIAT, V43, P89, DOI 10.1080/00048670802607154; Brown MW, 2012, NEUROPSYCHOLOGIA, V50, P3122, DOI 10.1016/j.neuropsychologia.2012.07.034; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chen C, 2009, STROKE, V40, P859, DOI 10.1161/STROKEAHA.108.531616; Chen CLH, 2013, STROKE, V44, P3580, DOI 10.1161/STROKEAHA.113.003226; Chen CLH, 2013, STROKE, V44, P2093, DOI 10.1161/STROKEAHA.113.002055; Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040165; Cimadevilla JM, 2007, J NEUROSCI RES, V85, P1138, DOI 10.1002/jnr.21222; Daskalakis NP, 2013, PSYCHONEUROENDOCRINO, V38, P1895, DOI 10.1016/j.psyneuen.2013.06.006; Davis Michael, 2011, Dialogues Clin Neurosci, V13, P463; de Kleine RA, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21626; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Difede J, 2014, NEUROPSYCHOPHARMACOL, V39, P1052, DOI 10.1038/npp.2013.317; Dubrovina N I, 2012, Ross Fiziol Zh Im I M Sechenova, V98, P488; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Edmondson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066435; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Fitzgerald PJ, 2014, BRAIN RES BULL, V105, P46, DOI 10.1016/j.brainresbull.2013.12.007; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gan R, 2008, CEREBROVASC DIS, V25, P450, DOI 10.1159/000126919; Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gil-Mohapel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075125; Goldfinger JZ, 2014, J STROKE CEREBROVASC, V23, P1099, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.019; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Griebel G, 1997, PHARMACOL BIOCHEM BE, V57, P817, DOI 10.1016/S0091-3057(96)00402-9; Harandi AA, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/721613; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Heurteaux C, 2013, CEREBROVASC DIS, V35, P1, DOI 10.1159/000346228; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Huang ACW, 2013, BEHAV BRAIN RES, V237, P23, DOI 10.1016/j.bbr.2012.09.024; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709; Kalm M, 2013, EXP NEUROL, V247, P402, DOI 10.1016/j.expneurol.2013.01.006; Kao TK, 2013, EXP NEUROL, V247, P188, DOI 10.1016/j.expneurol.2013.04.010; Kaplan GB, 2011, PHARMACOL BIOCHEM BE, V99, P217, DOI 10.1016/j.pbb.2011.01.009; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Kleinman JT, 2013, BEHAV NEUROL, V26, P131, DOI [10.3233/BEN-2012-110235, 10.1155/2013/438965]; Koh PO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054217; Kong KH, 2009, CEREBROVASC DIS, V28, P514, DOI 10.1159/000247001; Liss B, 2001, MOL MEMBR BIOL, V18, P117; Litz BT, 2012, J PSYCHIATR RES, V46, P1184, DOI 10.1016/j.jpsychires.2012.05.006; Maati HMO, 2012, NEUROPHARMACOLOGY, V63, P692, DOI 10.1016/j.neuropharm.2012.05.035; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nam KN, 2013, CELL BIOCHEM FUNCT, V31, P707, DOI 10.1002/cbf.2959; Navarro JC, 2014, INT J STROKE, V9, P102, DOI 10.1111/ijs.12324; Navarro JC, 2013, INT J STROKE, V8, P491, DOI 10.1111/ijs.12044; O'Sullivan NC, 2007, J NEUROCHEM, V101, P1085, DOI 10.1111/j.1471-4159.2006.04418.x; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Pan YW, 2013, NEUROBIOL LEARN MEM, V105, P81, DOI 10.1016/j.nlm.2013.07.011; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; Peters J, 2010, SCIENCE, V328, P1288, DOI 10.1126/science.1186909; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Psotta L, 2013, NEUROBIOL LEARN MEM, V103, P34, DOI 10.1016/j.nlm.2013.03.003; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Quintard H, 2011, NEUROPHARMACOLOGY, V61, P622, DOI 10.1016/j.neuropharm.2011.05.003; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Schulz-Klaus B, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00205; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Shahripour RB, 2011, EUR J INTERN MED, V22, P509, DOI 10.1016/j.ejim.2011.01.002; Siddiqui FJ, 2013, CEREBROVASC DIS, V35, P8, DOI 10.1159/000346231; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Siow CHC, 2008, EUR NEUROL, V60, P264, DOI 10.1159/000155220; Suarez-Pereira I, 2015, HIPPOCAMPUS, V25, P51, DOI 10.1002/hipo.22349; Tang QQ, 2012, BRAIN RES, V1488, P81, DOI 10.1016/j.brainres.2012.09.034; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Venketasubramanian N, 2009, INT J STROKE, V4, P54, DOI 10.1111/j.1747-4949.2009.00237.x; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Young SHY, 2010, CEREBROVASC DIS, V30, P1, DOI 10.1159/000313398; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhuang PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035636	86	14	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV	2015	93	11					1648	1663		10.1002/jnr.23591			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CT5ET	WOS:000362831800004	25821139	hybrid, Green Published			2022-02-06	
J	Roumeliotis, N; Pettersen, G; Crevier, L; Emeriaud, G				Roumeliotis, Nadia; Pettersen, Geraldine; Crevier, Louis; Emeriaud, Guillaume			ICP monitoring in children: why are we not adhering to guidelines?	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Pediatric; Intracranial pressure monitoring; Practice guidelines; Glasgow coma score	BRAIN-INJURY; EPIDEMIOLOGY	Despite pediatric guidelines, variability exists in the management of severe traumatic brain injury (TBI), as somewhere between 7 and 60 % of children undergo intracranial pressure (ICP) monitoring. Reasons for this low adherence to TBI management guidelines remain unclear. The objective of this study was to evaluate the current practices at CHU Sainte-Justine with regards to ICP monitoring in severe TBI and explore the reasons why ICP monitoring is not undertaken. A retrospective review was conducted of all patients age 1 month to 18 years, with severe TBI (Glasgow Coma Scale (GCS) a parts per thousand currency sign8) from 2007 to 2014. Presence of ICP monitoring, head imaging reports, and reasons for lack of monitoring were recorded. Sixty-four patients with severe TBI were admitted. Twenty (31 %) patients had invasive ICP monitoring in the first 6 h and 5 in the following 24 h. Improvement of the GCS on arrival to tertiary care center (20 %, n = 13) and moribund status (20 %, n = 13) were the two main reasons ICP monitoring was not undertaken. Fourteen patients (21 %) with reassuring cerebral tomography (Rotterdam scores 1-3) and median GCS 7 (IQR 6-8) were initially followed with clinical surveillance, five of which ended up with an ICP monitor (> 6 h). Our study confirms that many children with severe TBI do not undergo ICP monitoring, mainly due to rapid improvement or moribund status. A subgroup of patients, with reassuring cerebral CT scan, was not monitored. Further research is necessary to assess if imaging should be considered in ICP indication, as in adult guidelines.	[Roumeliotis, Nadia; Pettersen, Geraldine; Emeriaud, Guillaume] Univ Montreal, Hop St Justine, Dept Crit Care, Montreal, PQ H3T 1C5, Canada; [Crevier, Louis] Univ Montreal, Hop St Justine, Dept Neurosurg, Montreal, PQ H3T 1C5, Canada		Roumeliotis, N (corresponding author), Univ Montreal, Hop St Justine, Dept Crit Care, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nadia.roumeliotis@gmail.com	Roumeliotis, Nadia/AAU-2218-2021	Roumeliotis, Nadia/0000-0001-7463-1233			Bratton S.L., 2007, J NEUROTRAUMA S1, V24; Centers for Disease Control and Prevention, 2012, 10 LEAD CAUS DEATH A; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049	7	14	14	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	NOV	2015	31	11					2011	2014		10.1007/s00381-015-2837-9			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CU4FT	WOS:000363483300007	26216060				2022-02-06	
J	Smart, CM; Krawitz, A				Smart, Colette M.; Krawitz, Adam			The Impact of Subjective Cognitive Decline on Iowa Gambling Task Performance	NEUROPSYCHOLOGY			English	Article						subjective cognitive decline; older adults; Iowa Gambling Task; decision making; prospect valence learning model; hierarchical Bayesian parameter estimation	TRAUMATIC BRAIN-INJURY; DECISION-MAKING; ALZHEIMERS-DISEASE; OLDER-ADULTS; AGE-DIFFERENCES; NEUROPSYCHOLOGICAL TESTS; FINANCIAL CAPACITY; LEARNING-MODELS; WORKING-MEMORY; IMPAIRMENT	Objective: To ascertain whether the Iowa Gambling Task (IGT) could be used to detect and identify measurable cognitive differences between older adults with subjective cognitive decline (SCD) as compared with healthy older controls (HC). Method: Older adults with self-identified SCD and age-matched controls completed a comprehensive neuropsychological assessment battery including the clinical version of the IGT, as well as self-report measures of mood and personality. Results: The groups did not differ on clinically normed scores on the IGT. However, the groups did differ in the specific decks chosen as they progressed through the task, with the SCD group choosing the advantageous, high loss-frequency deck (Deck C) more often toward the end of the task. Using hierarchical Bayesian parameter estimation, we show that the prospect valence learning (PVL) model outperforms the expectancy valence learning (EVL) model in parsimoniously accounting for task performance by both groups. The PVL model explains the difference in deck choices between groups as being because of an underlying difference in their learning rate, with the SCD group emphasizing the current outcome over past outcomes more than the HC group. Conclusions: Behavioral results indicate measureable differences in risky decision making in older adults with SCD as compared with healthy controls. Modeling results allow us to interpret this difference as potentially being because of rapid forgetting of trial-to-trial information. This work furthers our understanding of SCD, while demonstrating the use of computational modeling in the interpretation of neuropsychological data.	[Smart, Colette M.; Krawitz, Adam] Univ Victoria, Dept Psychol, Victoria, BC V8W 2Y2, Canada; [Smart, Colette M.] Univ Victoria, Ctr Aging, Victoria, BC V8W 2Y2, Canada		Smart, CM (corresponding author), Univ Victoria, Dept Psychol, POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada.	csmart@uvic.ca			Alzheimer Society of Canada [1216]	This study was supported by the Alzheimer Society of Canada (Young Investigator Award #1216 to Colette M. Smart). We are grateful to the following for their help with data collection for this study: Katrina Blommaert, Coral Candlish-Rutherford, Esther Direnfeld, Andrew Fortune, Drew Halliday, Julie Irwin, Sasha Jouk, Janet Love, Jenny MacSween, Bryce Mulligan, Lara Oberg, Mark Rajandran, Dawn-Lee Ricard, Chris Prechotko, Stacey Ross, Thomas Ross, Jennifer Tippett, and Vanessa Vaartnou. Colette M. Smart and Adam Krawitz are joint first authors.	Ahn Woo-Young, 2011, J Neurosci Psychol Econ, V4, P95; Ahn WY, 2008, COGNITIVE SCI, V32, P1376, DOI 10.1080/03640210802352992; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bangen KJ, 2010, J INT NEUROPSYCH SOC, V16, P630, DOI 10.1017/S1355617710000330; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Belleville S, 2007, NEUROPSYCHOLOGY, V21, P458, DOI 10.1037/0894-4105.21.4.458; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Brown SBRE, 2009, COGN AFFECT BEHAV NE, V9, P365, DOI 10.3758/CABN.9.4.365; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Busemeyer JR, 2002, PSYCHOL ASSESSMENT, V14, P253, DOI 10.1037//1040-3590.14.3.253; Cargin JW, 2008, J CLIN EXP NEUROPSYC, V30, P245, DOI 10.1080/13803390701377829; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Cassotti M, 2011, CHILD NEUROPSYCHOL, V17, P400, DOI 10.1080/09297049.2010.547463; Castle E, 2012, P NATL ACAD SCI USA, V109, P20848, DOI 10.1073/pnas.1218518109; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chiu YC, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-37; Cooper C, 2011, AGE AGEING, V40, P711, DOI 10.1093/ageing/afr121; Cramer K, 2004, AGING MENT HEALTH, V8, P161, DOI 10.1080/13607860410001649581; Crook T H 3rd, 1992, Int Psychogeriatr, V4, P165, DOI 10.1017/S1041610292000991; Crowe K. M., 2005, PSYCHIAT PSYCHOL LAW, V12, P56, DOI [10.1375/pplt.2005.12.1.56, DOI 10.1375/PPLT.2005.12.1.56, http://dx.doi.org/10.1375/pplt.2005.12.1.56]; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; DIXON RA, 1988, PSYCHOPHARMACOL BULL, V24, P671; Dritschel BH, 1998, BRAIN INJURY, V12, P875; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; Folstein MF., 2010, MINIMENTAL STATE EXA; Fridberg DJ, 2010, J MATH PSYCHOL, V54, P28, DOI 10.1016/j.jmp.2009.10.002; Golden CJ., 2002, STROOP COLOR WORD TE; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Griffith HR, 2003, NEUROLOGY, V60, P449, DOI 10.1212/WNL.60.3.449; Gutbrod K, 2006, NEUROPSYCHOLOGIA, V44, P1315, DOI 10.1016/j.neuropsychologia.2006.01.014; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Hot P, 2014, CLIN PSYCHOL SCI, V2, P328, DOI 10.1177/2167702613504094; Huntley JD, 2010, INT J GERIATR PSYCH, V25, P121, DOI 10.1002/gps.2314; Ivnik RJ, 1996, CLIN NEUROPSYCHOL, V10, P262, DOI 10.1080/13854049608406689; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; JORM AF, 1989, INT J GERIATR PSYCH, V4, P35, DOI 10.1002/gps.930040109; Kahneman D., 2012, THINKING FAST SLOW; Kentle R.L., 1991, BIG 5 INVENTORY VERS; Kliegel Matthias, 2005, Eur J Ageing, V2, P13, DOI 10.1007/s10433-005-0017-6; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lin CH, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-16; Lin CH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00220; Lucas JA, 1998, J CLIN EXP NEUROPSYC, V20, P194, DOI 10.1076/jcen.20.2.194.1173; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Mata R, 2011, ANN NY ACAD SCI, V1235, P18, DOI 10.1111/j.1749-6632.2011.06200.x; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mattis S., 2001, DEMENTIA RATING SCAL; Meyers J. E., 1996, REY COMPLEX FIGURE T; Peters E, 2007, PERSPECT PSYCHOL SCI, V2, P1, DOI 10.1111/j.1745-6916.2007.00025.x; Plummer M., 2013, RJAGS 3 11 COMPUTER; Plummer M., 2012, JAGS 3 3 0 JUST ANOT; R Development Core Team, 2012, R LANG ENV STAT COMP; Rabin LA, 2007, J CLIN EXP NEUROPSYC, V29, P752, DOI 10.1080/13825580601025908; Rabin LA, 2007, ALZHEIMERS DEMENT, V3, P109, DOI 10.1016/j.jalz.2007.02.002; Rabiner DJ, 2004, J ELDER ABUSE NEGL, V16, P65; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Reavis R, 2001, BEHAV NEUROSCI, V115, P196, DOI 10.1037//0735-7044.115.1.196; Reisberg B, 2008, INT PSYCHOGERIATR, V20, P1, DOI 10.1017/S1041610207006412; Reisberg B, 2008, ALZHEIMERS DEMENT, V4, pS98, DOI 10.1016/j.jalz.2007.11.017; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reynolds CR, 2003, ADULT MANIFEST ANXIE; Robertson I., 1994, TEST EVERYDAY ATTENT; ROSS BH, 1984, COGNITIVE PSYCHOL, V16, P371, DOI 10.1016/0010-0285(84)90014-8; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Seifert C. M., 1994, ANALOGY METAPHOR REM, P95; Shivapour SK, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00082; Sinz H, 2008, NEUROPSYCHOLOGIA, V46, P2043, DOI 10.1016/j.neuropsychologia.2008.02.002; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Smart CM, 2014, BIOL PSYCHOL, V103, P144, DOI 10.1016/j.biopsycho.2014.08.016; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steingroever H, 2013, J PROBL SOLVING, V5, P1, DOI 10.7771/1932-6246.1150; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tuokko H., 1995, THE CLOCK TEST ADMIN; Tuokko H., 2014, OXFORD HDB CLIN GERO, P1; Turnbull OH, 2006, NEUROPSYCHOLOGIA, V44, P300, DOI 10.1016/j.neuropsychologia.2005.04.019; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Weierich MR, 2011, SOC COGN AFFECT NEUR, V6, P195, DOI 10.1093/scan/nsq056; Welsh-Bohmer K. A., 2006, GERIATRIC NEUROPSYCH, P56, DOI DOI 10.1002/MDS.21507; Wetzels R, 2010, J MATH PSYCHOL, V54, P14, DOI 10.1016/j.jmp.2008.12.001; Wood S, 2005, PSYCHOL AGING, V20, P220, DOI 10.1037/0882-7974.20.2.220; Worthy DA, 2013, PSYCHON B REV, V20, P364, DOI 10.3758/s13423-012-0324-9; Yechiam E, 2005, PSYCHON B REV, V12, P387, DOI 10.3758/BF03193783; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zamarian L, 2011, J GERONTOL B-PSYCHOL, V66, P23, DOI 10.1093/geronb/gbq067; Zillmer E. A., 2001, TOWER OF LONDON DREX	97	14	16	1	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2015	29	6					971	987		10.1037/neu0000204			17	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CV9FF	WOS:000364592100017	26011116				2022-02-06	
J	Thaler, HW; Schmidsfeld, J; Pusch, M; Pienaar, S; Wunderer, J; Pittermann, P; Valenta, R; Gleiss, A; Fialka, C; Mousavi, M				Thaler, Heinrich Wolfgang; Schmidsfeld, Johen; Pusch, Michael; Pienaar, Simon; Wunderer, Joerg; Pittermann, Paul; Valenta, Rosmarie; Gleiss, Andreas; Fialka, Christian; Mousavi, Mehdi			Evaluation of S100B in the diagnosis of suspected intracranial hemorrhage after minor head injury in patients who are receiving platelet aggregation inhibitors and in patients 65 years of age and older	JOURNAL OF NEUROSURGERY			English	Article						minor head injury; intracranial hemorrhage; S100B; platelet aggregation inhibitors; older patients; traumatic brain injury	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; PROTEIN S-100B; SERUM-LEVELS; MILD; ADULTS; CT; MULTICENTER; RISK; METAANALYSIS	OBJECT Cranial CT (CCT) scans and hospital admission are increasingly performed to rule out intracranial hemorrhage in patients after minor head injury (MHI), particularly in older patients and in those receiving antiplatelet therapy. This leads to high radiation exposure and a growing financial burden. The aim of this study was to determine whether the astroglial-derived protein S100B that is released into blood can be used as a reliable negative predictive tool for intracranial bleeding in patients after MHI, when they are older than 65 years or being treated with antiplatelet drugs (low-dose aspirin, clopidogrel). METHODS The authors conducted a prospective observational study in 2 trauma hospitals. A total of 782 patients with MHI (Glasgow Coma Scale Score 13-15) who were on medication with platelet aggregation inhibitors (PAIs) or were age 65 years and older, independent of antiplatelet therapy, were included. Clinical examination, bloodwork, observation, and CCT were performed in the traumatology emergency departments. When necessary, patients were admitted and observation took place on the ward; in these patients, CCT was performed during their hospital stay. Patients with severe trauma, focal neurological deficits, posttraumatic seizures, anticoagulant therapy, alcohol intoxication, coagulation disorder, blood sampling more than 3 hours after trauma, and unknown time of the trauma were excluded from the study. The median age of the patients was 83 years, and 69% were female. Sensitivity, specificity, and positive and negative predictive values of S100B with reference to CCT findings were calculated. The cutoff of S100B was set at 0.105 mu g/L. RESULTS Of the 782 patients, 50 (6.4%) had intracranial bleeding. One patient with positive results on CCT scan showed an S100B level below 0.105 mu g/L. Of all patients, 33.1% were below the cutoff. S100B showed a sensitivity of 98.0% (CI 89.5%-99.7%), a negative predictive value of 99.6% (CI 97.9%-99.9%), a specificity of 35.3% (CI 31.9% -38.8%), and a positive predictive value of 9.4% (CI 7.2%-12.2%). CONCLUSIONS Levels of S100B below 0.105 mu g/L can accurately predict normal CCT findings after MHI in older patients and in those treated with PAIs. Combining conventional decision criteria with measurement of S100B can reduce the CCT scan and hospital admission rates by approximately 30%.	[Thaler, Heinrich Wolfgang; Pusch, Michael; Pienaar, Simon; Wunderer, Joerg; Pittermann, Paul; Fialka, Christian] Med Univ Vienna, Trauma Hosp Meidling, Vienna, Austria; [Schmidsfeld, Johen; Mousavi, Mehdi] Med Univ Vienna, Donauspital, Dept Traumatol, Vienna, Austria; [Valenta, Rosmarie] Med Univ Vienna, Kaiser Franz Josef Spital, Dept Radiol, Vienna, Austria; [Gleiss, Andreas] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria		Thaler, HW (corresponding author), Trauma Hosp Meidling, Kundratstr 37, A-1120 Vienna, Austria.	heinrich.thaler@auva.at		Valenta, Rudolf/0000-0001-5944-3365	Allgemeine Unfallversicherungsanstalt (AUVA-the Austrian Workers' Compensation Board); Medical Head Office, AUVA [FK 19/12]	This study was supported by a grant from the scientific fund of the Allgemeine Unfallversicherungsanstalt (AUVA-the Austrian Workers' Compensation Board); research account Nr FK 19/12, Medical Head Office, AUVA.	Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Davis PC, 2007, AM J NEURORADIOL, V28, P1619; Efron B., 1993, INTRO BOOTSTRAP; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; He H, 2012, BIOSTATISTICS, V13, P32, DOI 10.1093/biostatistics/kxr020; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Roudsari B, 2012, AM J ROENTGENOL, V198, P985, DOI 10.2214/AJR.11.6976; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI 10.1089/neu.2009-0928; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vaturi M, 2013, AM J CARDIOL, V112, P212, DOI 10.1016/j.amjcard.2013.03.022; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yuan MK, 2013, AM J ROENTGENOL, V201, P626, DOI 10.2214/AJR.12.9652; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	38	14	14	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2015	123	5					1202	1208		10.3171/2014.12.JNS142276			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CU3QL	WOS:000363439800014	26148794	Bronze			2022-02-06	
